<DOC>
<DOCNO>WT02-B10-1</DOCNO>
<DOCOLDNO>IA038-000728-B003-237</DOCOLDNO>
<DOCHDR>
http://www.deprenyl.com:80/Anipad.htm 208.129.179.70 19970111075536 text/html 6474
HTTP/1.0 200 OK
Server: Microsoft-IIS/2.0
Date: Sat, 11 Jan 1997 07:55:24 GMT
Content-Type: text/html
</DOCHDR>
<!DOCTYPE HTML PUBLIC "-//W3O/DTD HTML//EN">

<html>
<head>
<title>Anipryl Information</title>
<meta name="GENERATOR" content="Microsoft FrontPage 1.1">
<meta name="FORMATTER" content="Microsoft FrontPage 1.1">
</head>
<body background="images/Paper12l.jpg" bgcolor="#FFFFFF"
text="#000000" link="#FF0000" vlink="#400080" alink="#FFFF00">
<h1 align="center">Anipryl<sup><font size="4">&#174;</font></sup>
Information</h1>
<h1 align="center">for Canadian Veterinarians</h1>
<hr>
<h2>Bring old dogs back with Anipryl<sup><font size="2">&#174;</font></sup></h2>
<h2><font size="2"><em><strong>Approved by the Canadian Bureau of
Veterinary Medicine</strong></em></font></h2>
<ul>
    <li>First line therapy for canine Cushing's disease </li>
    <li>Proven safety and efficacy </li>
    <li>Convenient once-a-day-dosage </li>
    <li>Available exclusively through veterinarians </li>
</ul>
<h3>Indications</h3>
<ul>
    <li>Indicated for the treatment of uncomplicated pituitary
        dependent hyperadrenocorticism. </li>
</ul>
<h3><img src="images/anipactn.GIF" align="left" hspace="10"
width="155" height="199">Mode of action</h3>
<table >
    <tr>
        <td width="100%">
        <ul>
            <li>Research indicates that with aging, monoamine
                oxidase type B (MAOB), an enzyme which degrades
                dopamine, increases and thus, dopamine levels
                decrease. Anipryl<sup><font size="1">&#174;</font></sup>
                is an irreversible inhibitor of MAOB.<br>
                <br>
            </li>
            <li>Anipryl<sup><font size="1">&#174;</font></sup>
                therapy provides normalization of dopamine
                metabolism and HPA axis regulation. </li>
        </ul>
        </td>
    </tr>
</table>
<h3><br>
Current Availability of Anipryl<sup><font size="1">&#174;</font></sup>
in Canada</h3>
<ul>
    <li>Bottles of 30 tablets available in 2 mg, 5 mg and 15 mg
        strength </li>
    <li>Expecting 10 mg and 30 mg tablets before January, 1997<br>
    </li>
</ul>
<table border="1" bordercolor="#000000">
    <tr>
        <td align="center" width="98"><font color="#808080"><b>Dosage
        Strength</b></font> </td>
        <td align="center" width="98"><font color="#808080"><b>AVP</b></font> </td>
        <td align="center" width="98"><font color="#808080"><b>CDMV</b></font> </td>
        <td align="center" width="98"><font color="#808080"><b>MVDC</b></font> </td>
        <td align="center" width="98"><font color="#808080"><b>VP</b></font> </td>
        <td align="center" width="98"><font color="#808080"><b>WDDC</b></font> </td>
    </tr>
    <tr>
        <td align="center" width="98">2 mg</td>
        <td align="center" width="98">1070104 </td>
        <td align="center" width="98">6577</td>
        <td align="center" width="98">6717 </td>
        <td align="center" width="98">4580020</td>
        <td align="center" width="98">DHI0020 </td>
    </tr>
    <tr>
        <td align="center" width="98">5 mg</td>
        <td align="center" width="98">1070106 </td>
        <td align="center" width="98">6629</td>
        <td align="center" width="98">6718 </td>
        <td align="center" width="98">4580022</td>
        <td align="center" width="98">DHI0022 </td>
    </tr>
    <tr>
        <td align="center" width="98">15 mg</td>
        <td align="center" width="98">1070108 </td>
        <td align="center" width="98">6635</td>
        <td align="center" width="98">6719 </td>
        <td align="center" width="98">4580024</td>
        <td align="center" width="98">DHI0024 </td>
    </tr>
</table>
<h3>Dosing</h3>
<table border="1" bordercolor="#000000">
    <tr>
        <td align="center" width="197"><font color="#808080"><b>Body
        Weight (kg)</b></font> </td>
        <td align="center" width="197"><font color="#808080"><b>Tablet
        Dosage</b></font> </td>
        <td align="center" width="197"><font color="#808080"><b>Dosage
        Strength</b></font> </td>
    </tr>
    <tr>
        <td align="center" width="197">&lt;2.5</td>
        <td align="center" width="197">1 tablet </td>
        <td align="center" width="197">2 mg</td>
    </tr>
    <tr>
        <td align="center" width="197">2.6 - 7.5</td>
        <td align="center" width="197">1 tablet </td>
        <td align="center" width="197">5 mg</td>
    </tr>
    <tr>
        <td align="center" width="197">7.6 - 20</td>
        <td align="center" width="197">1 tablet </td>
        <td align="center" width="197">15 mg</td>
    </tr>
    <tr>
        <td align="center" width="197">21 - 35</td>
        <td align="center" width="197">2 tablets </td>
        <td align="center" width="197">15 mg</td>
    </tr>
</table>
<h2 align="center"><br>
<img src="images/pr.GIF" align="bottom" width="7" height="12">ANIPRYL<sup><font
size="4">&#174;</font></sup></h2>
<p align="center"><font size="1">l-Selegiline hydrochloride
(l-Deprenyl hydrochloride) </font></p>
<hr width="75%">
<p align="center"><b>When old dogs aren't all there, bring them
back with Anipryl.</b><sup><font size="1">&#174;<br>
</font></sup></p>
<hr width="75%">
<p><font size="2"><i>For </i><b><i>customer service</i></b><i>,
or to find out who your DAHI representative is, call 905-677-6566
or 1-800-345-8656; for technical information from our in-house
veterinarians call 1-800-520-2120.</i></font></p>
<hr>
<p align="center">[ <a href="index.htm" target="_top">DAHI Home
Page</a> | <a href="frmvettp.htm" target="_top">Veterinarians</a>
| <a href="frmowntp.htm" target="_top">Pet Owners</a> | <a
href="frminvtp.htm" target="_top">Investors</a> ]</p>
<p align="center">[ <a href="about.htm">About DAHI</a> | <a
href="contents.htm" target="_top">Contents</a> | <a
href="contacts.htm">Contacts</a> | <a href="Links.htm">Links</a>
| <a href="Press.htm">Press Releases</a> | <a href="request.htm">Request
for Information</a> ]</p>
<hr>
<p><font size="2"><em>Send comments to DAHI webmaster: </em></font><a
href="mailto:dahimaster@deprenyl.com"><font size="2"><em>dahimaster@deprenyl.com</em></font></a><font
size="2"><em><br>
Copyright &#169; 1996 </em>Deprenyl Animal Health, Inc.<em> All
rights reserved.<br>
Revised: October 16, 1996.</em></font></p>
</body>
</html>
</DOC>
<DOC>
<DOCNO>WT02-B10-2</DOCNO>
<DOCOLDNO>IA038-000728-B003-271</DOCOLDNO>
<DOCHDR>
http://www.deprenyl.com:80/Refs.htm 208.129.179.70 19970111075546 text/html 5709
HTTP/1.0 200 OK
Server: Microsoft-IIS/2.0
Date: Sat, 11 Jan 1997 07:55:31 GMT
Content-Type: text/html
</DOCHDR>
<!DOCTYPE HTML PUBLIC "-//W3O/DTD HTML//EN">

<html>
<head>
<title>Scientific Articles and Abstracts</title>
<meta name="GENERATOR" content="Microsoft FrontPage 1.1">
<meta name="FORMATTER" content="Microsoft FrontPage 1.1">
</head>
<body background="images/Paper12l.jpg" bgcolor="#FFFFFF"
text="#000000" link="#FF0000" vlink="#400080" alink="#FFFF00">
<h1 align="center"><b>Scientific Articles and Abstracts</b><sup><font
size="4"><b>*</b></font></sup> </h1>
<hr>
<p><strong>1992 </strong></p>
<p>Russell, M. J. <i>et al: </i>Familial Influence on Plaque
Formation in the Beagle Brain. <i>NeuroReport 3</i>:1093-1096;
1992. </p>
<p><strong>1993 </strong></p>
<p>Cummings, B. J. <i>et al: </i>B-Amyloid Accumulation in Aged
Canine Brain: A Model of Early Plaque Formation in Alzheimer's
Disease. <i>Neurobiology of Aging </i><em>14</em>:547-560; 1993. </p>
<p>Milgram, N.W. <i>et al: </i>The Effect of L-Deprenyl on
Behavior, Cognitive Function, and Biogenic Amines in the Dog. <i>Neurochemical
Research </i><em>18</em>(12): 1211-1219; 1993. </p>
<p>Head, E. <i>et al: </i>Cognitive Function and Alzheimer's-Like
Pathology in the Aged Canine: I. Spatial Learning and Memory.
(Abst.) <i>Society for Neuroscience Annual Meeting </i>Nov. 1993. </p>
<p>Bruyette, D.S. <i>et al: </i>L-Deprenyl Therapy of Canine
Pituitary Dependent Hyperadrenocorticism. (Abst.) <i>Journal of
Veterinary Internal Medicine </i><em>7</em>(2): 114; 1993. </p>
<p><strong>1994 </strong></p>
<p>Ruehl, W.W. <i>et al: </i>L-Deprenyl for Treatment of
Behavioral and Cognitive Problems in Dogs: Preliminary Report of
an Open Label Trial. (Abst.) <i>Applied Animal Behaviour Science </i><em>39</em>(2):
191; 1994. </p>
<p>Milgram, N.W. <i>et al: </i>Cognitive Functions and Aging in
the Dog: Acquisition of Nonspatial Visual Tasks. <i>Behavioral
Neuroscience 108</i>(1):57-68;<i> </i>1994. </p>
<p>Ruehl, W.W. <i>et al: </i>Treatment of Geriatric-Onset
Inappropriate Urine Elimination in Elderly Dogs. (Abst.) <i>Journal
of Veterinary Internal Medicine </i><em>8</em>(2): 178; 1994. </p>
<p>Ruehl, W.W. <i>et al: </i>Pretreatment Characterization of
Behavioral and Cognitive Problems in Elderly Dogs. (Abst.) <i>Journal
of Veterinary Internal Medicine </i><em>8</em>(2): 179; 1994. </p>
<p>Head, E. <i>et al: </i>L-Deprenyl Improves Short Term Spatial
Memory in Aged but not Young Dogs. (Abst.) <i>Proceedings of the
American Academy of Anti-Aging Medicine Annual Meeting </i>Dec.
1994. </p>
<p><strong>1995 </strong></p>
<p>Bruyette, D.S. <i>et al: </i>Canine Pituitary-Dependent
Hyperadrenocorticism: A Spontaneous Animal Model for
Neurodegenerative Disorders and their Treatment with L-Deprenyl. <i>Progress
in Brain Research </i>106:208-216; 1995. </p>
<p>Ruehl, W.W. <i>et al: </i>Canine Cognitive Dysfunction as a
Model for Human Age Related Cognitive Decline, Dementia and
Alzheimer's Disease: Clinical Presentation, Cognitive Testing,
Pathology and Response to L-Deprenyl Therapy. <i>Progress in
Brain Research </i>106:217-225; 1995. </p>
<p>Milgram, N.W., <i>et al. </i>Effects of Chronic Oral
Administration of L-Deprenyl in the Dog. <i>Pharmacology,
Biochemistry and Behavior </i>51 (2/3):421-428; 1995. </p>
<p>Head, E., <i>et al.: </i>Spatial Learning and Memory as a
Function of Age in the Dog. <i>Behavioral Neuroscience </i>109(5):851-858. </p>
<p>Cummings, B.J., and Cotman, C.W.: Image Analysis of B-Amyloid
Load in Alzheimer's Disease and Relation to Dementia Severity. <i>The
Lancet </i>346:1524-1528; 1995. </p>
<p><strong>1996 </strong></p>
<p>Bruyette, D.S. <i>et al: </i>L-Deprenyl for Canine Pituitary
Dependent Hyperadrenocorticism: Pivotal Efficacy Trial. <em>J.
Vet. Intern. Med. 10</em>(3):182; 1996.</p>
<p>Head, E., <i>et al: </i>The Effects of L-Deprenyl on Spatial
Short Term Memory in Young and Aged Dogs. <em>Prog.
Neuro-Psychopharmacol. &amp; Biol. Psychiat. 20</em>:515-530;
1996.</p>
<p>Cummings, B.J. <em>et al:</em> The Canine as an Animal Model
of Human Aging and Dementia. <em>Neurobiol. Aging 17</em> (2):
259-268. 1996.</p>
<p>Ruehl, W.W. <em>et al:</em> Effects of L-Deprenyl in Cats in a
One Month Dose Escalation Study (Abstr). <em>Vet. Pathol.</em>
1996.</p>
<p>Cummings, B.J. <em>et al:</em> &szlig;-Amyloid Accumulation
Correlates with Cognitive Dysfunction in the Aged Canine. <em>Neurobiol.
Learning Memory 66</em>:11-23; 1996.</p>
<p>Cummings, B.J. <em>et al:</em> Diffuse Plaques Contain
C-Terminal A&szlig;42 and Not A&szlig;40: Evidence from Cats and
Dogs. <em>Neurobiol. Aging 14</em>(4):653-659; 1996.</p>
<p><font size="2"><em>* Available upon request. Contact DAHI at
(913) 338-2120. </em></font></p>
<hr>
<p align="center">[ <a href="index.htm" target="_top">DAHI Home
Page</a> | <a href="frmvettp.htm" target="_top">Veterinarians</a>
| <a href="frmowntp.htm" target="_top">Pet Owners</a> | <a
href="frminvtp.htm" target="_top">Investors</a> ]</p>
<p align="center">[ <a href="about.htm">About DAHI</a> | <a
href="contents.htm" target="_top">Contents</a> | <a
href="contacts.htm">Contacts</a> | <a href="Links.htm">Links</a>
| <a href="Press.htm">Press Releases</a> | <a href="request.htm">Request
for Information</a> ]</p>
<hr>
<p><font size="2"><em>Send comments to DAHI webmaster: </em></font><a
href="mailto:dahimaster@deprenyl.com"><font size="2"><em>dahimaster@deprenyl.com</em></font></a><font
size="2"><em><br>
Copyright &#169; 1996 </em>Deprenyl Animal Health, Inc.<em> All
rights reserved.<br>
Revised: December 17, 1996.</em></font></p>
</body>
</html>
</DOC>
<DOC>
<DOCNO>WT02-B10-3</DOCNO>
<DOCOLDNO>IA038-000728-B003-295</DOCOLDNO>
<DOCHDR>
http://www.deprenyl.com:80/TrialAll.htm 208.129.179.70 19970111075602 text/html 12981
HTTP/1.0 200 OK
Server: Microsoft-IIS/2.0
Date: Sat, 11 Jan 1997 07:55:48 GMT
Content-Type: text/html
</DOCHDR>
<!DOCTYPE HTML PUBLIC "-//W3O/DTD HTML//EN">

<html>
<head>
<title>Clinical Trial Information</title>
<meta name="GENERATOR" content="Microsoft FrontPage 1.1">
<meta name="FORMATTER" content="Microsoft FrontPage 1.1">
</head>
<body background="images/Paper12l.jpg" bgcolor="#FFFFFF"
text="#000000" link="#FF0000" vlink="#400080" alink="#FFFF00">
<h1 align="center"><a name="Top">Clinical Trials</a></h1>
<hr>
<ul>
    <li>
        <h3 align="left"><a href="#Questions">Questions &amp;
        Answers Regarding Participation in l-Deprenyl Clinical
        Trials</a> </h3>
    </li>
    <li>
        <h3 align="left"><a href="#Study">Information for
        Potential Investigators</a> </h3>
    </li>
    <li>
        <h3 align="left"><a href="#Background">Background
        Information and Trial Purpose</a> </h3>
    </li>
</ul>
<div align="center"><center>
<table width="68%">
    <tr>
        <td width="75%"><font size="2"><em><strong>To discuss a
        potential case for the trial or obtain further
        information, call DAHI personnel at: 1- (800) 520-2120 or
        (913) 338-2120 or fax (913) 338-1051 </strong></em></font></td>
    </tr>
</table>
</center></div>
<hr>
<h2 align="center"><a name="Questions">Questions &amp; Answers</a>
Regarding Participation in<br>
l-Deprenyl Clinical Trials </h2>
<hr>
<p><b>Q: I might be interested in participating in a clinical
trial as an investigator - how do I proceed?</b> </p>
<p><b>A: </b>Read all the information concerning clinical trials.
Contact DAHI personnel at 1-(800) 520-2120 or (913) 338-2120. If
you wish to discuss a particular patient for potential
enrollment, please have the patient file available at the time of
the call. </p>
<p><b>Q: What is the authorization for this study?</b> </p>
<p><b>A: </b>DAHI has been granted an INAD (Investigational New
Animal Drug) exemption #8008 by the FDA's Center for Veterinary
Medicine (CVM) to conduct clinical trials with l-deprenyl in
dogs. These studies will be conducted in accord with all
applicable regulations and guidelines. Data will be submitted to
the FDA in support of an application for approval to market
l-deprenyl for use in dogs. The drug has been approved for market
in Canada by the Canadian Bureau of Veterinary Drugs, for a
distinct use, treatment of canine pituitary dependent
hyperadrenocorticism (PDH, Cushing's disease). </p>
<p><b>Q: What is known about the safety of l-deprenyl in general,
and specifically in dogs?</b> </p>
<p><b>A:</b> As is true of all drugs not yet FDA-approved for use
in the United States, by definition l-deprenyl's &quot;safety and
efficacy have not been established.&quot; This is precisely the
purpose of our clinical trials. As noted above, l-deprenyl has
been approved for use in dogs by Canadian authorities. The safety
of l-deprenyl in dogs has been addressed in laboratory dogs in
several safety studies conducted by independent contract
laboratories, and in each case the conclusion was that l-deprenyl
was safe. More than two hundred pet dogs with either senility
(cognitive dysfunction) or pituitary dependent
hyperadrenocorticism (PDH, Cushing's disease) received l-deprenyl
at doses equal to or greater than those to be used in this trial,
and were monitored for periods from a few days to more than 3
years. No serious adverse events thought to be l-deprenyl related
were reported. There are occasional reports of dogs exhibiting
vomiting, diarrhea, increased activity, or repetitive behaviors,
which generally were mild and resolved with dose adjustment or
discontinuation. </p>
<p><b>Q: How might my clients and their pets benefit by
participating in a clinical trial?</b> </p>
<p><b>A:</b> First, l-deprenyl may help their pet, although we
cannot and do not make guarantees to any pet owner. Second, the
pet may benefit as a result of the additional examinations and
laboratory evaluations which it receives. Third, society in
general may benefit from the knowledge we gain by conducting the
study. </p>
<p><b>Q: How might I benefit from participating as an
investigator in a clinical trial?</b> </p>
<p><b>A: </b>First, personal satisfaction. Second, intellectual
stimulation. Third, reimbursement for your services, according to
a pre-agreed arrangement. Numerous veterinarians who have
participated as clinical trial investigators have stated they
found it a rewarding experience which nevertheless was associated
with a considerable amount of time and effort, primarily with
respect to completing the paperwork and complying with the
various FDA stipulations. DAHI will work closely with you to
maximize efficiency and minimize effort. </p>
<p><b>Q: Who pays for what?</b> </p>
<p><b>A: </b>There are no costs during <b>pre-enrollment</b>.
Once you have discussed the potential candidate with DAHI
personnel and approval has been obtained for the enrollment
work-up, DAHI will pay for the <b>enrollment examination</b> and <b>re-examinations </b>,
the drug, and laboratory tests directly associated with
monitoring response to treatment. DAHI is NOT responsible for
diagnosis or treatment of concurrent conditions or problems not
related to l-deprenyl therapy; these responsibilities will be
assumed by the owner. </p>
<p><a href="#Top"><font size="2">Back to Top</font></a></p>
<hr>
<h2 align="center"><a name="Study">L-Deprenyl Study</a> on Canine
Cognitive Dysfunction in Aged Dogs</h2>
<h3 align="center">Information for Potential Investigators</h3>
<h3 align="center">Trial CD/HT </h3>
<hr>
<p><b><u>Patient Requirements*:</u></b> </p>
<ul>
    <li>Ten years of age or older </li>
    <li>Must show signs of cognitive dysfunction, examples
        include: gets lost in house/yard, wanders, goes to wrong
        door, acts confused and has loss of memory. They also
        must exhibit 2 or more of the following: activity/sleep
        changes, inappropriate elimination, decrease in social
        interaction, and decrease in quality of life.</li>
    <li>Current vaccination status for parainfluenza, infectious
        canine hepatitis, canine distemper, parvovirus and
        rabies. </li>
    <li>Absence of other concurrent systemic debilitating
        disease. </li>
    <li>Patient must have had a physical exam within the last six
        months. </li>
</ul>
<p>*NOTE: Specific inclusion/exclusion criteria will be discussed
with you by DAHI personnel.<br>
<br>
<b><u>General Trial Information:</u></b> </p>
<ol>
    <li>Once the dog has completed the screening process, the
        period of treatment is three months. As the Veterinary
        Investigator you should be available to perform all three
        required examinations (enrollment exam, month 1 and month
        3 re-exams). </li>
    <li>This is a placebo controlled double-blinded trial. The
        dogs will receive either placebo or l-deprenyl for the
        first month of the trial. All dogs that complete the
        first month, in compliance with the protocol, will
        receive l-deprenyl at the standard dose for the second
        and third months of the trial. </li>
    <li>DAHI will pay for all requested exams, procedures and
        laboratory tests associated with the trial. All work must
        be PRE-APPROVED by DAHI personnel. Case completion fees
        will be paid upon completion of the trial. <br>
    </li>
</ol>
<p><b><i><u>Owners should be able to:</u></i></b> </p>
<ul>
    <li>present dog at each of the three exams, </li>
    <li>complete an Owner Daily Observation Form (daily log)
        throughout the trial, </li>
    <li>administer tablets to the dog on a daily basis in the
        morning, </li>
    <li>
        <p align="left">refrain from making changes to the dog's
        environment during the trial </p>
    </li>
</ul>
<p align="right"><font size="1">DAHI CD/HT 10/31/95</font></p>
<p align="left"><a href="#Top"><font size="2">Back to Top</font></a></p>
<hr>
<h2 align="center"><a name="Background">Background Information</a>
and Trial Purpose</h2>
<h3 align="center">Trial - CD/HT</h3>
<hr>
<p>Canine Cognitive Dysfunction (CD) is a syndrome encountered in
pet dogs which is recognized by many veterinarians and pet owners
and has been reported in dogs in a number of veterinary and
research journals*. The syndrome or its clinical signs have been
alluded to under a variety of terms. Owners of affected dogs
often describe these signs as &quot;old age&quot; or
&quot;senility&quot;, but it is quite likely that in dogs, as in
people, these problems result form brain pathology*. Canine CD is
characterized by one or more clinical signs such as;
inappropriate urine elimination, confusion, disorientation,
decreased activity, changes in the wake/sleep cycle or signs
which suggest a decrease in the dog's interest in, or ability to
interact with, its environment.</p>
<p>The etiology of canine CD has not been identified. However, in
people with Cognitive Dysfunction there is usually an associated
neuronal degenerative process present such as Alzheimer's
disease, neuronal degeneration secondary to hypoxia
(multi-infarct dementia) or toxicity (ethanol, MPTP).
Inappropriate urine elimination (IUE) is one of the clinical
disorders in people suffering from dementia (e.g., severe
cognitive dysfunction) and is often referred to by physicians as
&quot;central incontinence&quot; to denote that the problem is
one of cognition and to distinguish it from pathology in lower
neural centers and/or the urinary tract. Several reports have
identified neurodegenerative lesions in the brains of aged dogs
similar to those present in human Alzheimer's patients. There
have been several articles in the medical literature, some of
them reports of placebo controlled blinded studies which document
that Alzheimer's patients improve when given l-deprenyl. In
laboratory experiments, elderly rats perform more poorly on
cognitive tests than young rats and l-deprenyl helps to normalize
the performance of these older rats. A small placebo controlled
study of elderly laboratory dogs showed that the dogs with the
poorest baseline performance in cognitive testing benefited the
most from l-deprenyl treatment. A second study also found
l-deprenyl helpful for laboratory dogs with poor baseline
cognitive performance.</p>
<p>Our current trial, CD/HT, is a 2 phase randomized placebo
controlled, double-blinded pivotal clinical trial. The purpose of
this trial is to evaluate the response of affected dogs to
l-deprenyl therapy using several parameters, and to assess the
efficacy and safety of l-deprenyl for treatment of acquired
cognitive dysfunction in dogs. </p>
<p>In the first treatment phase (weeks 1-4), each qualified dog
will be randomly assigned to an experimental group and treated
with either l-deprenyl or placebo for 4 weeks in a double-blinded
(masked) fashion and monitored for response. All eligible dogs
that complete the first phase will then be enrolled in the second
treatment phase (weeks 5-12). In the second phase all dogs will
be treated with a standard dose of l-deprenyl for 8 weeks in an
open label fashion and monitored for response.</p>
<p>During a previous CD pilot trial owners of enrolled dogs
reported improvement in all 15 parameters monitored, with
statistical significance attained in 13 of the 15. The
improvement was sustained in most dogs for at least 3 months, and
in some dogs for as long as they have been monitored (9 months). </p>
<p>The primary goal of this trial will be to evaluate the safety
and efficacy of l-deprenyl for the treatment of canine CD.</p>
<p align="left"><font size="2">* references available on request</font></p>
<p align="right"><font size="2">DAHI CD/HT 10/31/95</font></p>
<p align="left"><a href="#Top"><font size="2">Back to Top</font></a></p>
<hr>
<p align="center">[ <a href="index.htm" target="_top">DAHI Home
Page</a> | <a href="frmvettp.htm" target="_top">Veterinarians</a>
| <a href="frmowntp.htm" target="_top">Pet Owners</a> | <a
href="frminvtp.htm" target="_top">Investors</a> ]</p>
<p align="center">[ <a href="about.htm">About DAHI</a> | <a
href="contents.htm" target="_top">Contents</a> | <a
href="contacts.htm">Contacts</a> | <a href="Links.htm">Links</a>
| <a href="Press.htm">Press Releases</a> | <a href="request.htm">Request
for Information</a> ]</p>
<hr>
<p><font size="2"><em>Send comments to DAHI webmaster: </em></font><a
href="mailto:dahimaster@deprenyl.com"><font size="2"><em>dahimaster@deprenyl.com</em></font></a><font
size="2"><em><br>
Copyright &#169; 1996 </em>Deprenyl Animal Health, Inc.<em> All
rights reserved.<br>
Revised: October 24, 1996.</em></font></p>
<p>&#160;</p>
</body>
</html>
</DOC>
<DOC>
<DOCNO>WT02-B10-4</DOCNO>
<DOCOLDNO>IA038-000728-B003-318</DOCOLDNO>
<DOCHDR>
http://www.deprenyl.com:80/links.htm 208.129.179.70 19970111075610 text/html 2975
HTTP/1.0 200 OK
Server: Microsoft-IIS/2.0
Date: Sat, 11 Jan 1997 07:55:58 GMT
Content-Type: text/html
</DOCHDR>
<!DOCTYPE HTML PUBLIC "-//W3O/DTD HTML//EN">

<html>
<head>
<title>Links of Interest</title>
<meta name="GENERATOR" content="Microsoft FrontPage 1.1">
<meta name="FORMATTER" content="Microsoft FrontPage 1.1">
</head>
<body background="images/Paper12l.jpg" bgcolor="#FFFFFF"
text="#000000" link="#FF0000" vlink="#400080" alink="#FFFF00">
<h1>Other Web Links That May Be of Interest</h1>
<hr>
<ul>
    <li>
        <h3><a href="#Veterinarian">Veterinarians</a> </h3>
    </li>
    <li>
        <h3><a href="#Owner">Pet Owners</a> </h3>
    </li>
    <li>
        <h3><a href="#Investor">Investors</a> </h3>
    </li>
</ul>
<hr>
<h3><a name="Veterinarian">Veterinarian</a> Links</h3>
<p><a href="http://www.familyinternet.com/pet/aaha.htm"
target="_top">American Animal Hospital Association</a></p>
<p><a href="http://www.healthypet.com/" target="_top">Healthy
Pets</a></p>
<p><a href="http://www.vetinfonet.com/" target="_top">Veterinary
Information Network</a> (an America Online service)</p>
<hr>
<h3>Pet <a name="Owner">Owner</a> Links</h3>
<p><a href="http://www.acmepet.com/" target="_top">Acme Pet</a></p>
<p><a href="http://www.aspca.org/" target="_top">ASPCA</a></p>
<p><a href="http://www.avma.org/care4pets/" target="_top">AVMA
Care for Pets</a></p>
<p><a href="http://www.canismajor.com/dog/guide.html"
target="_top">Dog Owner's Guide</a></p>
<p><a href="http://www.healthypet.com/" target="_top">Healthy
Pets</a></p>
<p><a href="http://petstation.com" target="_top">PetStation</a></p>
<p><a href="http://www.thepetchannel.com/index.html"
target="_top">The Pet Channel</a></p>
<p>AOL members - Visit the <strong>Pet Care Forum</strong></p>
<hr>
<h3><a name="Investor">Investor</a> Links</h3>
<p><a href="http://www.stockpro.com" target="_top">StockPRO</a> -
from the High Growth Publishing Group</p>
<p><a
href="http://www.sec.gov/cgi-bin/srch-edgar?Deprenyl+Animal+Health"
target="_top">EDGAR</a>&#160;</p>
<p>&#160;</p>
<hr>
<p align="center">[ <a href="index.htm" target="_top">DAHI Home
Page</a> | <a href="frmvettp.htm" target="_top">Veterinarians</a>
| <a href="frmowntp.htm" target="_top">Pet Owners</a> | <a
href="frminvtp.htm" target="_top">Investors</a> ]</p>
<p align="center">[ <a href="about.htm">About DAHI</a> | <a
href="contents.htm" target="_top">Contents</a> | <a
href="contacts.htm">Contacts</a> | <a href="Links.htm">Links</a>
| <a href="Press.htm">Press Releases</a> | <a href="request.htm">Request
for Information</a> ]</p>
<hr>
<p><font size="2"><em>Send comments to DAHI webmaster: </em></font><a
href="mailto:dahimaster@deprenyl.com"><font size="2"><em>dahimaster@deprenyl.com</em></font></a><font
size="2"><em><br>
Copyright &#169; 1996 </em>Deprenyl Animal Health, Inc.<em> All
rights reserved.<br>
Revised: December 17, 1996.</em></font></p>
</body>
</html>
</DOC>
<DOC>
<DOCNO>WT02-B10-5</DOCNO>
<DOCOLDNO>IA038-000728-B004-55</DOCOLDNO>
<DOCHDR>
http://www.deprenyl.com:80/AnipQAal.htm 208.129.179.70 19970111075703 text/html 8211
HTTP/1.0 200 OK
Server: Microsoft-IIS/2.0
Date: Sat, 11 Jan 1997 07:56:46 GMT
Content-Type: text/html
</DOCHDR>
<!DOCTYPE HTML PUBLIC "-//W3O/DTD HTML//EN">

<html>
<head>
<title>Frequently Asked Questions</title>
<meta name="GENERATOR" content="Microsoft FrontPage 1.1">
<meta name="FORMATTER" content="Microsoft FrontPage 1.1">
</head>
<body background="images/Paper12l.jpg" bgcolor="#FFFFFF"
text="#000000" link="#FF0000" vlink="#400080" alink="#FFFF00">
<h1 align="center"><img src="images/aniplogo.JPG" align="bottom"
width="450" height="60"></h1>
<h2 align="center"><em>Frequently asked questions about Canine
Cushing's Disease &amp; Anipryl</em><sup><font size="2"><em>&#174;</em></font></sup><em> </em></h2>
<p align="left">Anipryl<sup><font size="1">&#174;</font></sup>
(l-selegiline) is available through veterinarians in Canada. DAHI
has applied to the U.S. FDA for pre-market approval in the U.S.
DAHI holds several U.S., Canadian, and other foreign patents
covering veterinary medical applications of l-deprenyl.</p>
<table border="1" cellspacing="4" width="100%">
    <tr>
        <td valign="top" rowspan="11" width="150">
        <h1>Enhancing the Quality of Life For Older Dogs </h1>
        <p>&#160; <img src="images/grldgsm.jpg" align="bottom"
        width="200" height="256"> </p>
        </td>
        <td valign="top" width="22%"><em><strong>Q</strong></em>-What
        is canine Cushing's disease?</td>
        <td valign="top" width="34%"><em><strong>A</strong></em>-Cushing's
        disease is a disorder of the pituitary gland and
        hypothalamic regulatory center of the brain. This disease
        is commonly encountered in middle aged and older pet
        dogs, and results in excessive blood cortisol. Excessive
        cortisol is associated with most of the clinical signs
        typical of the disease. </td>
    </tr>
    <tr>
        <td valign="top" width="22%"><em><strong>Q</strong></em>-What
        are the clinical signs? </td>
        <td valign="top" width="34%"><em><strong>A</strong></em>-The
        onset of Cushing's in most dogs is quite slow and the
        clinical signs are often thought by owners to be simple
        aging. Some of the more common clinical signs are
        increased water consumption and increased urination,
        changes in appetite, muscle weakness, lethargy, &quot;pot
        bellied&quot; appearance, hair loss, decreased activity,
        excessive panting and changes in the sleep patterns of
        your pet. </td>
    </tr>
    <tr>
        <td valign="top" width="22%"><em><strong>Q</strong></em>-How
        is Cushing's disease diagnosed? </td>
        <td width="34%"><em><strong>A</strong></em>-Cushing's
        disease is diagnosed by your veterinarian based on your
        dog's clinical signs, and results of laboratory tests,
        including special hormone tests.<br>
        </td>
    </tr>
    <tr>
        <td valign="top" width="22%"><em><strong>Q</strong></em>-When
        Cushing's disease is diagnosed, what are our options? </td>
        <td valign="top" width="34%"><em><strong>A</strong></em>-There
        is no cure for Cushing's disease, and until the recent
        approval of Anipryl<sup><font size="1">&#174;</font></sup>
        there were no approved drugs to help dogs with this
        disorder. Without treatment, the disease will be
        progressive and ultimately may be fatal. </td>
    </tr>
    <tr>
        <td valign="top" width="22%"><em><strong>Q</strong></em>-How
        does Anipryl<sup><font size="1">&#174;</font></sup> work? </td>
        <td valign="top" width="34%"><em><strong>A</strong></em>-Anipryl<sup><font
        size="1">&#174;</font></sup> helps restore the natural
        balance of important brain chemicals, especially
        dopamine, which in turn helps alleviate the clinical
        signs of Cushing's disease. Anipryl<sup><font size="1">&#174;</font></sup>
        also helps decrease toxic compounds (free radicals) in
        the brain. </td>
    </tr>
    <tr>
        <td valign="top" width="22%"><em><strong>Q</strong></em>-Is
        Anipryl<sup><font size="1">&#174;</font></sup> safe? </td>
        <td valign="top" width="34%"><em><strong>A</strong></em>-Anipryl<sup><font
        size="1">&#174;</font></sup> has been shown to be safe
        when used as directed. In clinical trials, no adverse
        interactions were found when Anipryl<sup><font size="1">&#174;</font></sup>
        was used with other common veterinary drugs.</td>
    </tr>
    <tr>
        <td valign="top" width="22%"><em><strong>Q</strong></em>-How
        effective is Anipryl<sup><font size="1">&#174;</font></sup>? </td>
        <td valign="top" width="34%"><em><strong>A</strong></em>-In
        several clinical trials conducted at veterinary colleges
        and private veterinary clinics throughout North America,
        more than 70% of treated pet dogs responded favorably,
        demonstrated by amelioration of clinical signs and
        improvement in cortisol regulation. </td>
    </tr>
    <tr>
        <td valign="top" width="22%"><em><strong>Q</strong></em>-How
        soon can I expect to see the results of Anipryl<sup><font
        size="1">&#174;</font></sup> treatment? </td>
        <td valign="top" width="34%"><em><strong>A</strong></em>-Many
        dogs treated with Anipryl<sup><font size="1">&#174;</font></sup>
        show positive response within 2 to 4 weeks. Some dogs
        require more time to respond. </td>
    </tr>
    <tr>
        <td valign="top" width="22%"><em><strong>Q</strong></em>-
        How long must my dog continue on Anipryl<sup><font
        size="1">&#174;</font></sup> therapy? </td>
        <td valign="top" width="34%"><em><strong>A</strong></em>-
        There is no cure for Cushing's disease. However, clinical
        trials demonstrated the positive results of long term
        Anipryl<sup><font size="1">&#174;</font></sup> therapy.
        Your pet will likely require treatment with Anipryl<sup><font
        size="1">&#174;</font></sup> daily, and your dog should
        be evaluated regularly by your veterinarian. </td>
    </tr>
    <tr>
        <td valign="top" width="22%"><em><strong>Q</strong></em>-How
        is Anipryl<sup><font size="1">&#174;</font></sup>
        provided and administered? </td>
        <td valign="top" width="34%"><em><strong>A</strong></em>-Anipryl<sup><font
        size="1">&#174;</font></sup> is available from your
        veterinarian as easy to administer tablets. Most dogs
        receive one tablet each day, usually in the morning. Your
        veterinarian will provide individualized instructions for
        your pet.</td>
    </tr>
</table>
<p><font size="2"><img src="images/pr.GIF" align="bottom"
width="7" height="12">Anipryl</font><sup><font size="1">&#174;</font><font
size="2"> </font></sup><font size="2">is a prescription
pharmaceutical available only through veterinarians in Canada.
Full disclosure is available on product labeling. Anipryl</font><sup><font
size="1">&#174;</font><font size="2"> </font></sup><font size="2">is
a registered trademark of Deprenyl Animal Health, Inc.</font>&#160;</p>
<hr>
<p align="center">[ <a href="index.htm" target="_top">DAHI Home
Page</a> | <a href="frmvettp.htm" target="_top">Veterinarians</a>
| <a href="frmowntp.htm" target="_top">Pet Owners</a> | <a
href="frminvtp.htm" target="_top">Investors</a> ]</p>
<p align="center">[ <a href="about.htm">About DAHI</a> | <a
href="contents.htm" target="_top">Contents</a> | <a
href="contacts.htm">Contacts</a> | <a href="Links.htm">Links</a>
| <a href="Press.htm">Press Releases</a> | <a href="request.htm">Request
for Information</a> ]</p>
<hr>
<p><font size="2"><em>Send comments to DAHI webmaster: </em></font><a
href="mailto:dahimaster@deprenyl.com"><font size="2"><em>dahimaster@deprenyl.com</em></font></a><font
size="2"><em><br>
Copyright &#169; 1996 </em>Deprenyl Animal Health, Inc.<em> All
rights reserved.<br>
Revised: October 24, 1996.</em></font></p>
</body>
</html>
</DOC>
<DOC>
<DOCNO>WT02-B10-6</DOCNO>
<DOCOLDNO>IA038-000728-B004-73</DOCOLDNO>
<DOCHDR>
http://www.deprenyl.com:80/cklist.htm 208.129.179.70 19970111075713 text/html 5027
HTTP/1.0 200 OK
Server: Microsoft-IIS/2.0
Date: Sat, 11 Jan 1997 07:57:00 GMT
Content-Type: text/html
</DOCHDR>
<!DOCTYPE HTML PUBLIC "-//W3O/DTD HTML//EN">

<html>
<head>
<title>Senior Dog Checklist</title>
<meta name="GENERATOR" content="Microsoft FrontPage 1.1">
<meta name="FORMATTER" content="Microsoft FrontPage 1.1">
</head>
<body background="images/Paper12l.jpg" bgcolor="#FFFFFF"
text="#000000" link="#FF0000" vlink="#400080" alink="#FFFF00">
<h1 align="center">Senior Dog Checklist</h1>
<hr>
<p align="center">If your dog is over 7 years, please review this
checklist and consult your veterinarian.&#160;</p>
<div align="center"><center>
<table border="2" cellpadding="2" cellspacing="3" width="64%">
    <tr>
        <td width="80%"></td>
        <td align="center" width="10%">YES</td>
        <td align="center" width="10%">NO</td>
    </tr>
    <tr>
        <td width="80%">Decreased general health</td>
        <td align="center" width="10%">__</td>
        <td align="center" width="10%">__</td>
    </tr>
    <tr>
        <td width="80%">Loss of house training</td>
        <td align="center" width="10%">__</td>
        <td align="center" width="10%">__</td>
    </tr>
    <tr>
        <td width="80%">Increased thirst</td>
        <td align="center" width="10%">__</td>
        <td align="center" width="10%">__</td>
    </tr>
    <tr>
        <td width="80%">Reduced activity</td>
        <td align="center" width="10%">__</td>
        <td align="center" width="10%">__</td>
    </tr>
    <tr>
        <td width="80%">Excessive panting</td>
        <td align="center" width="10%">__</td>
        <td align="center" width="10%">__</td>
    </tr>
    <tr>
        <td width="80%">Confusion or disorientation</td>
        <td align="center" width="10%">__</td>
        <td align="center" width="10%">__</td>
    </tr>
    <tr>
        <td width="80%">Less interaction with family</td>
        <td align="center" width="10%">__</td>
        <td align="center" width="10%">__</td>
    </tr>
    <tr>
        <td width="80%">Inability to recognize family</td>
        <td align="center" width="10%">__</td>
        <td align="center" width="10%">__</td>
    </tr>
    <tr>
        <td width="80%">Decreased hearing</td>
        <td align="center" width="10%">__</td>
        <td align="center" width="10%">__</td>
    </tr>
    <tr>
        <td width="80%">Sleeps more during day</td>
        <td align="center" width="10%">__</td>
        <td align="center" width="10%">__</td>
    </tr>
    <tr>
        <td width="80%">Altered appetite</td>
        <td align="center" width="10%">__</td>
        <td align="center" width="10%">__</td>
    </tr>
    <tr>
        <td width="80%">Weight change</td>
        <td align="center" width="10%">__</td>
        <td align="center" width="10%">__</td>
    </tr>
    <tr>
        <td width="80%">Difficulty climbing stairs</td>
        <td align="center" width="10%">__</td>
        <td align="center" width="10%">__</td>
    </tr>
    <tr>
        <td width="80%">Increased stiffness</td>
        <td align="center" width="10%">__</td>
        <td align="center" width="10%">__</td>
    </tr>
</table>
</center></div>
<p>If you checked YES to 1 or more of the signs listed, please
ask your veterinarian about further tests and examinations that
can help to determine if your older dog is suffering from a
treatable condition.</p>
<p>Your veterinarian can differentiate between minor signs of
aging and other, more damaging health problems. Early detection
of these problems can make an enormous difference in your senior
dog's quality, and maybe even, length of life.</p>
<p>New treatments are available from your veterinarian that may
reduce or eliminate many of the behavioural changes you have
noticed in your aging dog.</p>
<p>Together, you and your veterinarian may be able to bring your
senior dog back to its old self... or maybe even its young self.
Ask your veterinarian how. </p>
<p align="center"><img src="images/dahicana.gif" align="bottom"
width="251" height="63"></p>
<hr>
<p align="center">[ <a href="index.htm" target="_top">DAHI Home
Page</a> | <a href="frmvettp.htm" target="_top">Veterinarians</a>
| <a href="frmowntp.htm" target="_top">Pet Owners</a> | <a
href="frminvtp.htm" target="_top">Investors</a> ]</p>
<p align="center">[ <a href="about.htm">About DAHI</a> | <a
href="contents.htm" target="_top">Contents</a> | <a
href="contacts.htm">Contacts</a> | <a href="Links.htm">Links</a>
| <a href="Press.htm">Press Releases</a> | <a href="request.htm">Request
for Information</a> ]</p>
<hr>
<p><font size="2"><em>Send comments to DAHI webmaster: </em></font><a
href="mailto:dahimaster@deprenyl.com"><font size="2"><em>dahimaster@deprenyl.com</em></font></a><font
size="2"><em><br>
Copyright &#169; 1996 </em>Deprenyl Animal Health, Inc.<em> All
rights reserved.<br>
Revised: November 06, 1996.</em></font></p>
</body>
</html>
</DOC>
<DOC>
<DOCNO>WT02-B10-7</DOCNO>
<DOCOLDNO>IA038-000728-B004-94</DOCOLDNO>
<DOCHDR>
http://www.deprenyl.com:80/factsht.htm 208.129.179.70 19970111075721 text/html 7203
HTTP/1.0 200 OK
Server: Microsoft-IIS/2.0
Date: Sat, 11 Jan 1997 07:57:09 GMT
Content-Type: text/html
</DOCHDR>
<!DOCTYPE HTML PUBLIC "-//W3O/DTD HTML//EN">

<html>
<head>
<title>Investor Fact Sheet</title>
<meta name="GENERATOR" content="Microsoft FrontPage 1.1">
<meta name="FORMATTER" content="Microsoft FrontPage 1.1">
</head>
<body background="images/Paper12l.jpg" bgcolor="#FFFFFF"
text="#000000" link="#FF0000" vlink="#400080" alink="#FFFF00">
<h1 align="center">Investor Fact Sheet</h1>
<hr>
<p align="center"><img src="images/dahi_log.gif" align="bottom"
width="205" height="46"><br>
<br>
<b>A wholly-owned subsidiary of Draxis Health Inc.<br>
</b><font size="2"><b>(TSE: DAX; NASDAQ: DRAXF)</b></font></p>
<p>Deprenyl Animal Health, Inc. is a veterinary pharmaceutical
company established to commercialize the pharmaceutical Anipryl<sup><font
size="1">&#174;</font></sup> for use in veterinary medicine. </p>
<hr>
<h3>TABLE OF CONTENTS:</h3>
<ul>
    <li><a href="#Company">The Company</a> </li>
    <li><a href="#Status">Development Status</a> </li>
    <li><a href="#Market">The Market</a> </li>
    <li><a href="#Strategic">Strategic Alliances</a> </li>
    <li><a href="#Property">Intellectual Property</a> </li>
    <li><a href="#Manage">Management</a> </li>
    <li><a href="#Info">For Additional Information</a> </li>
</ul>
<hr>
<h3>The <a name="Company">Company</a></h3>
<p>Deprenyl Animal Health, Inc. (DAHI), a veterinary
pharmaceutical company, is engaged in obtaining worldwide
pre-marketing regulatory approval to commercialize Anipryl<sup><font
size="1">&#174;</font></sup> (l-selegiline hydrochloride), a
breakthrough therapy for treating canine senility or cognitive
dysfunction syndrome (also recognized as geriatric-onset
behavioral disorders) and Cushing's disease in pet dogs.
Geriatrics is a rapidly expanding and profitable sector of small
animal veterinary medicine. </p>
<p>DAHI received Canadian regulatory approval in September, 1995
for treating Cushing's disease with Anipryl<sup><font size="1">&#174;</font></sup>.
Canadian sales commenced in April, 1996, through DAHI's Canadian
distribution partner, Draxis Health Inc. </p>
<p>Since DAHI's March, 1991 IPO several other significant
milestones have been attained including the issuance of seven (7)
U.S. patents and the allowance of two (2) European patents, the
first regulatory approval for Anipryl<sup><font size="1">&#174;</font></sup>
(Canada), and the filing of its first completed application for
regulatory approval of Anipryl<sup><font size="1">&#174;</font></sup>
at the U.S. FDA. </p>
<hr>
<h3>Development <a name="Status">Status</a></h3>
<p>Currently, no other drugs are approved for treating canine
Cushing's disease or canine senility (cognitive dysfunction
syndrome). </p>
<p><i>Cushing's Disease Label Claim</i></p>
<ul>
    <li>Canadian regulatory approval, September, 1995 </li>
    <li>Filed first U.S. FDA New Animal Drug Application in
        October 1995 (Cushing's disease) </li>
</ul>
<p><i>Canine Senility or Cognitive Dysfunction Syndrome Label
Claim</i> </p>
<ul>
    <li>Pet owners often refer to cognitive dysfunction as
        senility, old dog syndrome (old dog behavior problems)</li>
    <li>Alzheimer's-like pathology in the brains of some
        afflicted pet dogs</li>
    <li>Pivotal (Phase III equivalent) clinical trial expected to
        conclude during early 1997 </li>
    <li>Substantial market opportunity for pharmaceutical
        intervention</li>
</ul>
<hr>
<h3>The <a name="Market">Market</a></h3>
<ul>
    <li>U.S. pet owners have an estimated 55.7 million dogs </li>
    <li>7.2 million (13%) of U.S. pet dogs are 10 years of age or
        older </li>
    <li>An estimated 35.9 million U.S. households own at least
        one pet dog </li>
    <li>Pet owners spend in excess of $20 billion per year on
        their pets including food, medical care and other
        supplies - demonstrated willingness of veterinarians and
        pet owners to invest in new products for maintaining pet
        health </li>
    <li>70% of U.S. pet owners view their pet &quot;as a family
        member&quot; </li>
    <li>Estimated that 1.5 million old U.S. dogs are afflicted
        with canine cognitive dysfunction syndrome </li>
    <li>An estimated 165,000 new North American cases of canine
        Cushing's disease occur each year</li>
</ul>
<p align="center">&#160; </p>
<hr>
<h3><a name="Strategic">Strategic</a> Alliances</h3>
<table cellpadding="2" cellspacing="5" width="100%">
    <tr>
        <td valign="top" width="75%">DAHI signed an agreement
        with Draxis Health Inc. in January, 1996 providing a
        10-year exclusive distribution right in Canada to its
        veterinary pharmaceutical Anipryl<sup><font size="1">&#174;</font></sup>.
        DAHI is a wholly-owned subsidiary of Draxis.
        <p>&#160; </p>
        </td>
        <td valign="bottom" width="164"><img
        src="images/dahiprod.gif" align="top" width="164"
        height="109"> <font size="2"><strong>Anipryl&#174;
        Production Suite<br>
        (Mikart, Inc.)</strong></font> </td>
    </tr>
</table>
<hr>
<h3>Intellectual <a name="Property">Property</a></h3>
<ul>
    <li>Seven U.S. patents issued </li>
    <li>Two European patents allowed </li>
    <li>Several patents covering DAHI's label claims have issued
        in other countries </li>
    <li>Additional patent applications are pending worldwide</li>
</ul>
<hr>
<h3><a name="Manage">Manage</a>ment</h3>
<p>Martin Barkin, MD, Chairman of the DAHI Board; President &amp;
CEO of Draxis Health Inc.<br>
David R. Stevens, DVM, PhD, President &amp; Chief Executive
Officer<br>
William W. Ruehl, VMD, PhD, Vice President, Scientific Affairs<br>
Laura D. Sayler, Director, Finance &amp; Administration <br>
Robert Dixon, Director, Sales<br>
Michael R. Grogan, Consultant, Marketing<br>
Daniel E. Walker, Consultant, Manufacturing &amp; Regulatory
Affairs</p>
<hr>
<h3>For Additional <a name="Info">Info</a>rmation, contact:</h3>
<p>Laura D. Sayler<br>
Deprenyl Animal Health, Inc.<br>
10955 Lowell, Suite 710<br>
Overland Park, KS 66210<br>
(913) 338-2120, fax (913) 338-3804 </p>
<hr>
<p align="center">[ <a href="index.htm" target="_top">DAHI Home
Page</a> | <a href="frmvettp.htm" target="_top">Veterinarians</a>
| <a href="frmowntp.htm" target="_top">Pet Owners</a> | <a
href="frminvtp.htm" target="_top">Investors</a> ]</p>
<p align="center">[ <a href="about.htm">About DAHI</a> | <a
href="contents.htm" target="_top">Contents</a> | <a
href="contacts.htm">Contacts</a> | <a href="Links.htm">Links</a>
| <a href="Press.htm">Press Releases</a> | <a href="request.htm">Request
for Information</a> ]</p>
<hr>
<p><font size="2"><em>Send comments to DAHI webmaster: </em></font><a
href="mailto:dahimaster@deprenyl.com"><font size="2"><em>dahimaster@deprenyl.com</em></font></a><font
size="2"><em><br>
Copyright &#169; 1996 </em>Deprenyl Animal Health, Inc.<em> All
rights reserved.<br>
Revised: December 19, 1996.</em></font></p>
</body>
</html>
</DOC>
<DOC>
<DOCNO>WT02-B10-8</DOCNO>
<DOCOLDNO>IA038-000728-B004-128</DOCOLDNO>
<DOCHDR>
http://www.deprenyl.com:80/Timeline.htm 208.129.179.70 19970111075737 text/html 9732
HTTP/1.0 200 OK
Server: Microsoft-IIS/2.0
Date: Sat, 11 Jan 1997 07:57:20 GMT
Content-Type: text/html
</DOCHDR>
<!DOCTYPE HTML PUBLIC "-//W3O/DTD HTML//EN">

<html>
<head>
<title>DAHI Timeline</title>
<meta name="GENERATOR" content="Microsoft FrontPage 1.1">
<meta name="FORMATTER" content="Microsoft FrontPage 1.1">
</head>
<body background="images/Paper12l.jpg" bgcolor="#FFFFFF"
text="#000000" link="#FF0000" vlink="#400080" alink="#FFFF00">
<h1 align="center">A Timeline of Innovation</h1>
<hr>
<p align="center"><em><strong>Milestones in the history of DAHI
&amp; the Anipryl</strong></em><sup><font size="1"><em><strong>&#174;</strong></em></font></sup><em><strong>
development program... we're advancing the practice of veterinary
medicine for the benefit of pets &amp; their owners.</strong></em></p>
<hr>
<table cellpadding="5" cellspacing="25" width="95%">
    <tr>
        <td>
        <h1><em>1996</em> </h1>
        </td>
        <td></td>
    </tr>
    <tr>
        <td align="right" valign="top"><em>November</em></td>
        <td>DAHI and Draxis shareholders approve Share Exchange
        Agreement. DAHI becomes a wholly-owned subsidiary of
        Draxis Health Inc.</td>
    </tr>
    <tr>
        <td align="right" valign="top"><em>July</em></td>
        <td>Draxis announces its intention to acquire the
        remaining shares of DAHI that it doesn't already own via
        share exchange -- shareholder votes are scheduled for
        November, 1996</td>
    </tr>
    <tr>
        <td align="right" valign="top"><em>June</em></td>
        <td>DAHI submits canine senility (cognitive dysfunction)
        data application to the Canadian Bureau of Veterinary
        Drugs</td>
    </tr>
    <tr>
        <td align="right" valign="top"><em>April</em></td>
        <td>DAHI completes first commercial shipment of Anipryl<sup><font
        size="1">&#174;</font></sup> to Canada</td>
    </tr>
    <tr>
        <td align="right" valign="top"><em>March</em></td>
        <td>DAHI obtains sixth U.S. patent covering Anipryl<sup><font
        size="1">&#174;</font></sup>: increased life expectancy
        in pet dogs</td>
    </tr>
    <tr>
        <td align="right" valign="top"><em>January</em></td>
        <td>DAHI/Draxis sign Canadian Distribution Agreement for
        Anipryl<sup><font size="1">&#174;</font></sup></td>
    </tr>
    <tr>
        <td width="20%">
        <h1><em>1995</em> </h1>
        </td>
        <td width="50%"></td>
    </tr>
    <tr>
        <td align="right" valign="top" width="20%"><em>December</em></td>
        <td width="50%">Letter of Intent with Draxis Health, Inc.
        for exclusive distribution of Anipryl<sup><font size="1">&#174;</font></sup>
        in Canada<sup><font size="1">*</font></sup> </td>
    </tr>
    <tr>
        <td align="right" valign="top" width="20%"><em>November</em></td>
        <td width="50%">European patent for Anipryl<sup><font
        size="1">&#174;</font></sup> therapy of canine cognitive
        dysfunction allowed </td>
    </tr>
    <tr>
        <td align="right" valign="top" width="20%"><em>October</em></td>
        <td width="50%">First regulatory approval for Anipryl<sup><font
        size="1">&#174;</font></sup>, from the Canadian Bureau of
        Veterinary Medicine, Health Protection Branch, for the
        treatment of canine Cushing's disease* </td>
    </tr>
    <tr>
        <td align="right" valign="top" width="20%"><em>September</em></td>
        <td width="50%">New Animal Drug Application filed with
        the Center for Veterinary Medicine, FDA: Anipryl<sup><font
        size="1">&#174;</font></sup> therapy for canine Cushing's
        disease* </td>
    </tr>
    <tr>
        <td align="right" valign="top" width="20%"><em>February</em></td>
        <td width="50%">European patent for Anipryl<sup><font
        size="1">&#174;</font></sup> therapy of canine Cushing's
        disease allowed* </td>
    </tr>
    <tr>
        <td width="20%">
        <h1><em>1994</em> </h1>
        </td>
        <td width="50%"></td>
    </tr>
    <tr>
        <td align="right" valign="top" width="20%"><em>October</em></td>
        <td width="50%">First New Drug Submission filed with
        Canadian Health Protection Branch: Anipryl<sup><font
        size="1">&#174;</font></sup> therapy for canine Cushing's
        disease* </td>
    </tr>
    <tr>
        <td align="right" valign="top"><em>June</em></td>
        <td>Pivotal clinical trial (Phase III equivalent) begins:
        canine Cushing's disease for FDA approval*</td>
    </tr>
    <tr>
        <td align="right" valign="top"><em>April</em></td>
        <td>Pivotal clinical trial (Phase III equivalent) begins:
        canine cognitive dysfunction*</td>
    </tr>
    <tr>
        <td align="right" valign="top" width="20%"><em>March</em></td>
        <td width="50%">$2.5 million private placement: Draxis
        Health, Inc.* </td>
    </tr>
    <tr>
        <td width="20%">
        <h1><em>1993</em> </h1>
        </td>
        <td width="50%"></td>
    </tr>
    <tr>
        <td align="right" valign="top" width="20%"><em>July</em></td>
        <td width="50%">Presentation of canine cognitive
        dysfunction clinical trial data before the American
        Veterinary Society of Animal Behavior*<sup><font size="1">&#134;</font></sup> </td>
    </tr>
    <tr>
        <td align="right" valign="top" width="20%"><em>June</em></td>
        <td width="50%">Final, statistically significant results
        from first major pilot clinical trial (Phase II
        equivalent) evaluating Anipryl<sup><font size="1">&#174;</font></sup>
        therapy in canine cognitive dysfunction syndrome
        announced </td>
    </tr>
    <tr>
        <td align="right" valign="top" width="20%"><em>May</em></td>
        <td width="50%">First presentation of Cushing's disease
        clinical data at the American College of Veterinary
        Internal Medicine annual<br>
        meeting<sup><font size="1">&#134;</font></sup> </td>
    </tr>
    <tr>
        <td align="right" valign="top" width="20%"><em>March</em></td>
        <td width="50%">Issuance of DAHI's second U.S. patent
        covering the use of Anipryl<sup><font size="1">&#174;</font></sup>
        in the management of canine Cushing's disease </td>
    </tr>
    <tr>
        <td width="20%">
        <h1><em>1992</em> </h1>
        </td>
        <td width="50%"></td>
    </tr>
    <tr>
        <td align="right" valign="top" width="20%"><em>October</em></td>
        <td width="50%">Major pilot studies begin: Cushing's
        disease and cognitive dysfunction syndrome* </td>
    </tr>
    <tr>
        <td align="right" valign="top" width="20%"><em>September</em></td>
        <td width="50%">First U.S. patent issued - cognitive
        dysfunction* </td>
    </tr>
    <tr>
        <td align="right" valign="top" width="20%"><em>August</em></td>
        <td width="50%">Immune system benefit of Anipryl<sup><font
        size="1">&#174;</font></sup> demonstrated in old dogs </td>
    </tr>
    <tr>
        <td align="right" valign="top" width="20%"><em>April</em></td>
        <td width="50%">Initial laboratory success in treating
        cognitive dysfunction syndrome with Anipryl<sup><font
        size="1">&#174;</font></sup> </td>
    </tr>
    <tr>
        <td align="right" valign="top"><em>March</em></td>
        <td>First success treating Cushing's disease with Anipryl<sup><font
        size="1">&#174;</font></sup> </td>
    </tr>
    <tr>
        <td>
        <h1><em>1991</em> </h1>
        </td>
        <td></td>
    </tr>
    <tr>
        <td align="right" valign="top"><em>December</em></td>
        <td>U.S. trademark Anipryl<sup><font size="1">&#174;</font></sup>
        issued </td>
    </tr>
    <tr>
        <td align="right" valign="top"><em>October</em></td>
        <td>First Cushing's disease trial in pet dogs -- Kansas
        State University</td>
    </tr>
    <tr>
        <td align="right" valign="top"><em>March</em></td>
        <td>Initial public offering (NASDAQ: DAHI) </td>
    </tr>
    <tr>
        <td>
        <h1><em>1990</em> </h1>
        </td>
        <td></td>
    </tr>
    <tr>
        <td align="right" valign="top"><em>December</em></td>
        <td>INADA filed at the U.S. FDA</td>
    </tr>
    <tr>
        <td align="right" valign="top"><em>July</em></td>
        <td>DAHI incorporated</td>
    </tr>
</table>
<p><font size="1">*<i>additional information available in the
DAHI press release packet</i></font><br>
<font size="1">&#134;<i>abstracts available from DAHI upon
request </i></font></p>
<hr>
<p align="center">[ <a href="index.htm" target="_top">DAHI Home
Page</a> | <a href="frmvettp.htm" target="_top">Veterinarians</a>
| <a href="frmowntp.htm" target="_top">Pet Owners</a> | <a
href="frminvtp.htm" target="_top">Investors</a> ]</p>
<p align="center">[ <a href="about.htm">About DAHI</a> | <a
href="contents.htm" target="_top">Contents</a> | <a
href="contacts.htm">Contacts</a> | <a href="Links.htm">Links</a>
| <a href="Press.htm">Press Releases</a> | <a href="request.htm">Request
for Information</a> ]</p>
<hr>
<p><font size="2"><em>Send comments to DAHI webmaster: </em></font><a
href="mailto:dahimaster@deprenyl.com"><font size="2"><em>dahimaster@deprenyl.com</em></font></a><font
size="2"><em><br>
Copyright &#169; 1996 </em>Deprenyl Animal Health, Inc.<em> All
rights reserved.<br>
Revised: December 17, 1996.</em></font></p>
</body>
</html>
</DOC>
<DOC>
<DOCNO>WT02-B10-9</DOCNO>
<DOCOLDNO>IA038-000728-B004-154</DOCOLDNO>
<DOCHDR>
http://www.deprenyl.com:80/Petstats.htm 208.129.179.70 19970111075746 text/html 3657
HTTP/1.0 200 OK
Server: Microsoft-IIS/2.0
Date: Sat, 11 Jan 1997 07:57:34 GMT
Content-Type: text/html
</DOCHDR>
<!DOCTYPE HTML PUBLIC "-//W3O/DTD HTML//EN">

<html>
<head>
<title>Market Facts - Pet Statistics</title>
<meta name="GENERATOR" content="Microsoft FrontPage 1.1">
<meta name="FORMATTER" content="Microsoft FrontPage 1.1">
</head>
<body background="images/Paper12l.jpg" bgcolor="#FFFFFF"
text="#000000" link="#FF0000" vlink="#400080" alink="#FFFF00">
<h1 align="center">MARKET FACTS </h1>
<hr>
<h2 align="center"><i>U.S. Pet Dog Statistics </i></h2>
<ul>
    <li>U.S. pet owners have approximately 55.7 million pet dogs
        of which 7.2 million, or 13%, are 10 years of age or
        older </li>
    <li>Approximately 35.9 million U.S. households own at least
        one dog </li>
    <li>In 1995, U.S. consumers spent $5.61 billion on pet dog
        health care </li>
    <li>91.5% of dog owners consider veterinarians the best
        source of pet health care knowledge and advice </li>
    <li>93% of dog owners have a &quot;regular veterinarian&quot; </li>
</ul>
<hr>
<table border="1" cellpadding="5" bordercolor="#000000">
    <tr>
        <td width="590"><b><i>U.S. Pet Owners Spend in Excess of
        $20 Billion Per Year on Their Pets Including Food,
        Medical Care and Other Supplies. </i></b><sup><font
        size="1"><b><i>&#134;</i></b></font></sup> </td>
    </tr>
</table>
<p></p>
<table border="1" cellpadding="5" bordercolor="#000000">
    <tr>
        <td width="590"><b><i>70% of U.S. Pet Owners View Their
        Pet &quot;As A Family Member.&quot;</i></b> </td>
    </tr>
</table>
<p></p>
<table border="1" cellpadding="5" bordercolor="#000000">
    <tr>
        <td width="590"><b><i>In North American Pet Dogs, There
        Are Estimated To Be 165,000 New Cases of Cushing's
        Disease and 1.5 - 2 Million New Cases of Canine Senility
        or Cognitive Dysfunction Each Year.</i></b> </td>
    </tr>
</table>
<hr>
<h2 align="center"><i>U.S. Pet Cat Statistics </i></h2>
<ul>
    <li>U.S. pet owners have approximately 63.4 million pet cats
        of which 6.9 million, or 11% are 10 years of age or older </li>
    <li>Approximately 30.2 million U.S. households own at least
        one cat </li>
    <li>In 1995, U.S. consumers spent $2.89 billion on pet cat
        health care </li>
    <li>92.8% of cat owners consider veterinarians the best
        source of pet health care knowledge and advice </li>
    <li>71% of cat owners have a &quot;regular veterinarian&quot; </li>
</ul>
<hr>
<p><sup><font size="1"><i>&#134;</i></font></sup><font size="2"><i>
Time Magazine, &quot;Reigning Cats and Dogs&quot;, August 16,
1993, page 50.</i></font></p>
<hr>
<p align="center">[ <a href="index.htm" target="_top">DAHI Home
Page</a> | <a href="frmvettp.htm" target="_top">Veterinarians</a>
| <a href="frmowntp.htm" target="_top">Pet Owners</a> | <a
href="frminvtp.htm" target="_top">Investors</a> ]</p>
<p align="center">[ <a href="about.htm">About DAHI</a> | <a
href="contents.htm" target="_top">Contents</a> | <a
href="contacts.htm">Contacts</a> | <a href="Links.htm">Links</a>
| <a href="Press.htm">Press Releases</a> | <a href="request.htm">Request
for Information</a> ]</p>
<hr>
<p><font size="2"><em>Send comments to DAHI webmaster: </em></font><a
href="mailto:dahimaster@deprenyl.com"><font size="2"><em>dahimaster@deprenyl.com</em></font></a><font
size="2"><em><br>
Copyright &#169; 1996 </em>Deprenyl Animal Health, Inc.<em> All
rights reserved.<br>
Revised: October 11, 1996.</em></font></p>
</body>
</html>
</DOC>
<DOC>
<DOCNO>WT02-B10-10</DOCNO>
<DOCOLDNO>IA038-000728-B004-189</DOCOLDNO>
<DOCHDR>
http://www.deprenyl.com:80/Mission.htm 208.129.179.70 19970111075805 text/html 2316
HTTP/1.0 200 OK
Server: Microsoft-IIS/2.0
Date: Sat, 11 Jan 1997 07:57:41 GMT
Content-Type: text/html
</DOCHDR>
<!DOCTYPE HTML PUBLIC "-//W3O/DTD HTML//EN">

<html>
<head>
<title>DAHI Mission Statement &amp; Objectives</title>
<meta name="GENERATOR" content="Microsoft FrontPage 1.1">
<meta name="FORMATTER" content="Microsoft FrontPage 1.1">
</head>
<body background="images/Paper12l.jpg" bgcolor="#FFFFFF"
text="#000000" link="#FF0000" vlink="#400080" alink="#FFFF00">
<h1 align="center">Mission Statement &amp; Objectives</h1>
<hr>
<h2 align="center">Our Mission</h2>
<blockquote>
    <p>To identify, develop, manufacture and profitably
    distribute worldwide superior, innovative medical products
    that improve pet animal health and advance the practice of
    veterinary medicine, for the benefit of both pets and their
    owners. </p>
</blockquote>
<hr>
<h2 align="center">Our Objectives</h2>
<ul>
    <li>Obtain U.S. regulatory approval for the use of Anipryl<sup><font
        size="1">&#174;</font></sup> in treating canine Cushing's
        disease </li>
    <li>Obtain U.S. and Canadian regulatory approval for the use
        of Anipryl<sup><font size="1">&#174;</font></sup> in
        treating canine cognitive dysfunction </li>
    <li>Establish DAHI as a recognized leader in providing
        revolutionary medical products for small animal
        veterinary medicine </li>
</ul>
<hr>
<p align="center">[ <a href="index.htm" target="_top">DAHI Home
Page</a> | <a href="frmvettp.htm" target="_top">Veterinarians</a>
| <a href="frmowntp.htm" target="_top">Pet Owners</a> | <a
href="frminvtp.htm" target="_top">Investors</a> ]</p>
<p align="center">[ <a href="about.htm">About DAHI</a> | <a
href="contents.htm" target="_top">Contents</a> | <a
href="contacts.htm">Contacts</a> | <a href="Links.htm">Links</a>
| <a href="Press.htm">Press Releases</a> | <a href="request.htm">Request
for Information</a> ]</p>
<hr>
<p><font size="2"><em>Send comments to DAHI webmaster: </em></font><a
href="mailto:dahimaster@deprenyl.com"><font size="2"><em>dahimaster@deprenyl.com</em></font></a><font
size="2"><em><br>
Copyright &#169; 1996 </em>Deprenyl Animal Health, Inc.<em> All
rights reserved.<br>
Revised: December 18, 1996.</em></font></p>
</body>
</html>
</DOC>
<DOC>
<DOCNO>WT02-B10-11</DOCNO>
<DOCOLDNO>IA038-000728-B004-225</DOCOLDNO>
<DOCHDR>
http://www.deprenyl.com:80/topicvet.htm 208.129.179.70 19970111075820 text/html 1987
HTTP/1.0 200 OK
Server: Microsoft-IIS/2.0
Date: Sat, 11 Jan 1997 07:58:06 GMT
Content-Type: text/html
</DOCHDR>
<!DOCTYPE HTML PUBLIC "-//W3O/DTD HTML//EN">

<html>
<head>
<title>Topics for Veterinarians</title>
<meta name="GENERATOR" content="Microsoft FrontPage 1.1">
<meta name="FORMATTER" content="Microsoft FrontPage 1.1">
</head>
<body background="images/Paper12l.jpg" bgcolor="#FFFFFF"
text="#000000" link="#FF0000" vlink="#400080" alink="#FFFF00">
<h1 align="center">Veterinarian Topics</h1>
<hr>
<ul>
    <li>
        <h3><a href="Brochure.htm">Questions about Anipryl<sup><font
        size="1">&#174;</font></sup></a> </h3>
    </li>
    <li>
        <h3><a href="Anipad.htm">Anipryl<sup><font size="1">&#174;</font></sup>
        Information</a> for Canadian Veterinarians </h3>
    </li>
    <li>
        <h3><a href="Refs.htm">Scientific Articles Reference</a> </h3>
    </li>
    <li>
        <h3><a href="request.htm">Request for Information</a> </h3>
    </li>
    <li>
        <h3><a href="links.htm#Veterinarian">Veterinarian Links</a> </h3>
    </li>
</ul>
<hr>
<p align="center">[ <a href="index.htm" target="_top">DAHI Home
Page</a> | <a href="frmvettp.htm" target="_top">Veterinarians</a>
| <a href="frmowntp.htm" target="_top">Pet Owners</a> | <a
href="frminvtp.htm" target="_top">Investors</a> ]</p>
<p align="center">[ <a href="about.htm">About DAHI</a> | <a
href="contents.htm" target="_top">Contents</a> | <a
href="contacts.htm">Contacts</a> | <a href="Links.htm">Links</a>
| <a href="Press.htm">Press Releases</a> | <a href="request.htm">Request
for Information</a> ]</p>
<hr>
<p><font size="2"><em>Send comments to DAHI webmaster: </em></font><a
href="mailto:dahimaster@deprenyl.com"><font size="2"><em>dahimaster@deprenyl.com</em></font></a><font
size="2"><em><br>
Copyright &#169; 1996 </em>Deprenyl Animal Health, Inc.<em> All
rights reserved.<br>
Revised: December 17, 1996.</em></font></p>
</body>
</html>
</DOC>
<DOC>
<DOCNO>WT02-B10-12</DOCNO>
<DOCOLDNO>IA038-000728-B004-248</DOCOLDNO>
<DOCHDR>
http://www.deprenyl.com:80/topicown.htm 208.129.179.70 19970111075828 text/html 3255
HTTP/1.0 200 OK
Server: Microsoft-IIS/2.0
Date: Sat, 11 Jan 1997 07:58:16 GMT
Content-Type: text/html
</DOCHDR>
<!DOCTYPE HTML PUBLIC "-//W3O/DTD HTML//EN">

<html>
<head>
<title>Topics for Pet Owners</title>
<meta name="GENERATOR" content="Microsoft FrontPage 1.1">
<meta name="FORMATTER" content="Microsoft FrontPage 1.1">
</head>
<body background="images/Paper12l.jpg" bgcolor="#FFFFFF"
text="#000000" link="#FF0000" vlink="#400080" alink="#FFFF00">
<h1 align="center">Pet Owner Topics</h1>
<hr>
<ul>
    <li>
        <h3><a href="AnipQAal.htm">Frequently Asked Questions
        about Canine Cushing's Disease and Anipryl<sup><font
        size="1">&#174;</font></sup></a> </h3>
    </li>
    <li>
        <h3><a href="cklist.htm">Health Checklist for Your Older
        Pet</a> </h3>
    </li>
    <li>
        <h3><a href="request.htm">Request for Information</a> </h3>
    </li>
    <li>
        <h3><a href="links.htm#Owner">Pet Owner Links</a> </h3>
    </li>
    <li>
        <h3>Articles of Interest (<a href="request.htm"><font
        size="2"><em>request reprints</em></font></a><font
        size="2"><em> from DAHI</em></font>) </h3>
        <blockquote>
            <dl>
                <dt><em><strong>Caring for Your Aging Pet</strong></em>
                    - Newsweek, November 2, 1992</dt>
                <dd><font size="2">Dogs and cats have an
                    increased likelihood of developing medical
                    problems as they get older</font></dd>
                <dt><em><strong>Animal Health Newsletter</strong></em>
                    - Cornell University College of Veterinary
                    Medicine, Jan. 1994</dt>
                <dd><font size="2">A promising new drug for
                    age-related neurologic diseases in dogs</font></dd>
                <dt><em><strong>Sick Pets: A Healthy
                    Pharmaceutical Market</strong></em> - The
                    Wall Street Journal. January 3, 1996</dt>
                <dt><em><strong>Well, Aren't You The Cat's Meow?</strong></em>
                    - Reprinted from Barron's, April 1, 1996</dt>
                <dd><font size="2"><em>Like never before,
                    Americans have taken to pampering their pets</em></font></dd>
            </dl>
        </blockquote>
    </li>
</ul>
<hr>
<p align="center">[ <a href="index.htm" target="_top">DAHI Home
Page</a> | <a href="frmvettp.htm" target="_top">Veterinarians</a>
| <a href="frmowntp.htm" target="_top">Pet Owners</a> | <a
href="frminvtp.htm" target="_top">Investors</a> ]</p>
<p align="center">[ <a href="about.htm">About DAHI</a> | <a
href="contents.htm" target="_top">Contents</a> | <a
href="contacts.htm">Contacts</a> | <a href="Links.htm">Links</a>
| <a href="Press.htm">Press Releases</a> | <a href="request.htm">Request
for Information</a> ]</p>
<hr>
<p><font size="2"><em>Send comments to DAHI webmaster: </em></font><a
href="mailto:dahimaster@deprenyl.com"><font size="2"><em>dahimaster@deprenyl.com</em></font></a><font
size="2"><em><br>
Copyright &#169; 1996 </em>Deprenyl Animal Health, Inc.<em> All
rights reserved.<br>
Revised: October 24, 1996.</em></font></p>
</body>
</html>
</DOC>
<DOC>
<DOCNO>WT02-B10-13</DOCNO>
<DOCOLDNO>IA038-000728-B004-277</DOCOLDNO>
<DOCHDR>
http://www.deprenyl.com:80/topicinv.htm 208.129.179.70 19970111075843 text/html 2881
HTTP/1.0 200 OK
Server: Microsoft-IIS/2.0
Date: Sat, 11 Jan 1997 07:58:23 GMT
Content-Type: text/html
</DOCHDR>
<!DOCTYPE HTML PUBLIC "-//W3O/DTD HTML//EN">

<html>
<head>
<title>Topics for Investors</title>
<meta name="GENERATOR" content="Microsoft FrontPage 1.1">
<meta name="FORMATTER" content="Microsoft FrontPage 1.1">
</head>
<body background="images/Paper12l.jpg" bgcolor="#FFFFFF"
text="#000000" link="#FF0000" vlink="#400080" alink="#FFFF00">
<h1 align="center">Investor Topics</h1>
<hr>
<ul>
    <li>
        <h3><a href="factsht.htm">Investor Fact Sheet</a> </h3>
    </li>
    <li>
        <h3><a href="Timeline.htm">DAHI Timeline</a> - milestones
        in the history of DAHI &amp; the Anipryl<sup><font
        size="2">&#174;</font></sup> development program </h3>
    </li>
    <li>
        <h3><a href="Petstats.htm">Market Facts - Pet Statistics</a> </h3>
    </li>
    <li>
        <h3><a href="request.htm">Request for Information</a> </h3>
    </li>
    <li>
        <h3>Link to <a
        href="http://www.sec.gov/cgi-bin/srch-edgar?Deprenyl+Animal+Health"
        target="_top">EDGAR</a> </h3>
    </li>
    <li>
        <h3><a href="links.htm#Investor">Investor Links</a> </h3>
    </li>
    <li>
        <h3>Articles of Interest (<a href="request.htm"><font
        size="2"><em>request reprints</em></font></a><font
        size="2"><em> from DAHI</em></font>) </h3>
        <blockquote>
            <dl>
                <dt><em><strong>Sick Pets: A Healthy
                    Pharmaceutical Market</strong></em> - The
                    Wall Street Journal. January 3, 1996</dt>
                <dt><em><strong>Well, Aren't You The Cat's Meow?</strong></em>
                    - Reprinted from Barron's, April 1, 1996</dt>
                <dd><font size="2"><em>Like never before,
                    Americans have taken to pampering their pets</em></font></dd>
            </dl>
        </blockquote>
    </li>
</ul>
<hr>
<p align="center">[ <a href="index.htm" target="_top">DAHI Home
Page</a> | <a href="frmvettp.htm" target="_top">Veterinarians</a>
| <a href="frmowntp.htm" target="_top">Pet Owners</a> | <a
href="frminvtp.htm" target="_top">Investors</a> ]</p>
<p align="center">[ <a href="about.htm">About DAHI</a> | <a
href="contents.htm" target="_top">Contents</a> | <a
href="contacts.htm">Contacts</a> | <a href="Links.htm">Links</a>
| <a href="Press.htm">Press Releases</a> | <a href="request.htm">Request
for Information</a> ]</p>
<hr>
<p><font size="2"><em>Send comments to DAHI webmaster: </em></font><a
href="mailto:dahimaster@deprenyl.com"><font size="2"><em>dahimaster@deprenyl.com</em></font></a><font
size="2"><em><br>
Copyright &#169; 1996 </em>Deprenyl Animal Health, Inc.<em> All
rights reserved.<br>
Revised: October 24, 1996.</em></font></p>
</body>
</html>
</DOC>
<DOC>
<DOCNO>WT02-B10-14</DOCNO>
<DOCOLDNO>IA038-000728-B004-311</DOCOLDNO>
<DOCHDR>
http://www.deprenyl.com:80/timeline.htm 208.129.179.70 19970111075927 text/html 9732
HTTP/1.0 200 OK
Server: Microsoft-IIS/2.0
Date: Sat, 11 Jan 1997 07:59:04 GMT
Content-Type: text/html
</DOCHDR>
<!DOCTYPE HTML PUBLIC "-//W3O/DTD HTML//EN">

<html>
<head>
<title>DAHI Timeline</title>
<meta name="GENERATOR" content="Microsoft FrontPage 1.1">
<meta name="FORMATTER" content="Microsoft FrontPage 1.1">
</head>
<body background="images/Paper12l.jpg" bgcolor="#FFFFFF"
text="#000000" link="#FF0000" vlink="#400080" alink="#FFFF00">
<h1 align="center">A Timeline of Innovation</h1>
<hr>
<p align="center"><em><strong>Milestones in the history of DAHI
&amp; the Anipryl</strong></em><sup><font size="1"><em><strong>&#174;</strong></em></font></sup><em><strong>
development program... we're advancing the practice of veterinary
medicine for the benefit of pets &amp; their owners.</strong></em></p>
<hr>
<table cellpadding="5" cellspacing="25" width="95%">
    <tr>
        <td>
        <h1><em>1996</em> </h1>
        </td>
        <td></td>
    </tr>
    <tr>
        <td align="right" valign="top"><em>November</em></td>
        <td>DAHI and Draxis shareholders approve Share Exchange
        Agreement. DAHI becomes a wholly-owned subsidiary of
        Draxis Health Inc.</td>
    </tr>
    <tr>
        <td align="right" valign="top"><em>July</em></td>
        <td>Draxis announces its intention to acquire the
        remaining shares of DAHI that it doesn't already own via
        share exchange -- shareholder votes are scheduled for
        November, 1996</td>
    </tr>
    <tr>
        <td align="right" valign="top"><em>June</em></td>
        <td>DAHI submits canine senility (cognitive dysfunction)
        data application to the Canadian Bureau of Veterinary
        Drugs</td>
    </tr>
    <tr>
        <td align="right" valign="top"><em>April</em></td>
        <td>DAHI completes first commercial shipment of Anipryl<sup><font
        size="1">&#174;</font></sup> to Canada</td>
    </tr>
    <tr>
        <td align="right" valign="top"><em>March</em></td>
        <td>DAHI obtains sixth U.S. patent covering Anipryl<sup><font
        size="1">&#174;</font></sup>: increased life expectancy
        in pet dogs</td>
    </tr>
    <tr>
        <td align="right" valign="top"><em>January</em></td>
        <td>DAHI/Draxis sign Canadian Distribution Agreement for
        Anipryl<sup><font size="1">&#174;</font></sup></td>
    </tr>
    <tr>
        <td width="20%">
        <h1><em>1995</em> </h1>
        </td>
        <td width="50%"></td>
    </tr>
    <tr>
        <td align="right" valign="top" width="20%"><em>December</em></td>
        <td width="50%">Letter of Intent with Draxis Health, Inc.
        for exclusive distribution of Anipryl<sup><font size="1">&#174;</font></sup>
        in Canada<sup><font size="1">*</font></sup> </td>
    </tr>
    <tr>
        <td align="right" valign="top" width="20%"><em>November</em></td>
        <td width="50%">European patent for Anipryl<sup><font
        size="1">&#174;</font></sup> therapy of canine cognitive
        dysfunction allowed </td>
    </tr>
    <tr>
        <td align="right" valign="top" width="20%"><em>October</em></td>
        <td width="50%">First regulatory approval for Anipryl<sup><font
        size="1">&#174;</font></sup>, from the Canadian Bureau of
        Veterinary Medicine, Health Protection Branch, for the
        treatment of canine Cushing's disease* </td>
    </tr>
    <tr>
        <td align="right" valign="top" width="20%"><em>September</em></td>
        <td width="50%">New Animal Drug Application filed with
        the Center for Veterinary Medicine, FDA: Anipryl<sup><font
        size="1">&#174;</font></sup> therapy for canine Cushing's
        disease* </td>
    </tr>
    <tr>
        <td align="right" valign="top" width="20%"><em>February</em></td>
        <td width="50%">European patent for Anipryl<sup><font
        size="1">&#174;</font></sup> therapy of canine Cushing's
        disease allowed* </td>
    </tr>
    <tr>
        <td width="20%">
        <h1><em>1994</em> </h1>
        </td>
        <td width="50%"></td>
    </tr>
    <tr>
        <td align="right" valign="top" width="20%"><em>October</em></td>
        <td width="50%">First New Drug Submission filed with
        Canadian Health Protection Branch: Anipryl<sup><font
        size="1">&#174;</font></sup> therapy for canine Cushing's
        disease* </td>
    </tr>
    <tr>
        <td align="right" valign="top"><em>June</em></td>
        <td>Pivotal clinical trial (Phase III equivalent) begins:
        canine Cushing's disease for FDA approval*</td>
    </tr>
    <tr>
        <td align="right" valign="top"><em>April</em></td>
        <td>Pivotal clinical trial (Phase III equivalent) begins:
        canine cognitive dysfunction*</td>
    </tr>
    <tr>
        <td align="right" valign="top" width="20%"><em>March</em></td>
        <td width="50%">$2.5 million private placement: Draxis
        Health, Inc.* </td>
    </tr>
    <tr>
        <td width="20%">
        <h1><em>1993</em> </h1>
        </td>
        <td width="50%"></td>
    </tr>
    <tr>
        <td align="right" valign="top" width="20%"><em>July</em></td>
        <td width="50%">Presentation of canine cognitive
        dysfunction clinical trial data before the American
        Veterinary Society of Animal Behavior*<sup><font size="1">&#134;</font></sup> </td>
    </tr>
    <tr>
        <td align="right" valign="top" width="20%"><em>June</em></td>
        <td width="50%">Final, statistically significant results
        from first major pilot clinical trial (Phase II
        equivalent) evaluating Anipryl<sup><font size="1">&#174;</font></sup>
        therapy in canine cognitive dysfunction syndrome
        announced </td>
    </tr>
    <tr>
        <td align="right" valign="top" width="20%"><em>May</em></td>
        <td width="50%">First presentation of Cushing's disease
        clinical data at the American College of Veterinary
        Internal Medicine annual<br>
        meeting<sup><font size="1">&#134;</font></sup> </td>
    </tr>
    <tr>
        <td align="right" valign="top" width="20%"><em>March</em></td>
        <td width="50%">Issuance of DAHI's second U.S. patent
        covering the use of Anipryl<sup><font size="1">&#174;</font></sup>
        in the management of canine Cushing's disease </td>
    </tr>
    <tr>
        <td width="20%">
        <h1><em>1992</em> </h1>
        </td>
        <td width="50%"></td>
    </tr>
    <tr>
        <td align="right" valign="top" width="20%"><em>October</em></td>
        <td width="50%">Major pilot studies begin: Cushing's
        disease and cognitive dysfunction syndrome* </td>
    </tr>
    <tr>
        <td align="right" valign="top" width="20%"><em>September</em></td>
        <td width="50%">First U.S. patent issued - cognitive
        dysfunction* </td>
    </tr>
    <tr>
        <td align="right" valign="top" width="20%"><em>August</em></td>
        <td width="50%">Immune system benefit of Anipryl<sup><font
        size="1">&#174;</font></sup> demonstrated in old dogs </td>
    </tr>
    <tr>
        <td align="right" valign="top" width="20%"><em>April</em></td>
        <td width="50%">Initial laboratory success in treating
        cognitive dysfunction syndrome with Anipryl<sup><font
        size="1">&#174;</font></sup> </td>
    </tr>
    <tr>
        <td align="right" valign="top"><em>March</em></td>
        <td>First success treating Cushing's disease with Anipryl<sup><font
        size="1">&#174;</font></sup> </td>
    </tr>
    <tr>
        <td>
        <h1><em>1991</em> </h1>
        </td>
        <td></td>
    </tr>
    <tr>
        <td align="right" valign="top"><em>December</em></td>
        <td>U.S. trademark Anipryl<sup><font size="1">&#174;</font></sup>
        issued </td>
    </tr>
    <tr>
        <td align="right" valign="top"><em>October</em></td>
        <td>First Cushing's disease trial in pet dogs -- Kansas
        State University</td>
    </tr>
    <tr>
        <td align="right" valign="top"><em>March</em></td>
        <td>Initial public offering (NASDAQ: DAHI) </td>
    </tr>
    <tr>
        <td>
        <h1><em>1990</em> </h1>
        </td>
        <td></td>
    </tr>
    <tr>
        <td align="right" valign="top"><em>December</em></td>
        <td>INADA filed at the U.S. FDA</td>
    </tr>
    <tr>
        <td align="right" valign="top"><em>July</em></td>
        <td>DAHI incorporated</td>
    </tr>
</table>
<p><font size="1">*<i>additional information available in the
DAHI press release packet</i></font><br>
<font size="1">&#134;<i>abstracts available from DAHI upon
request </i></font></p>
<hr>
<p align="center">[ <a href="index.htm" target="_top">DAHI Home
Page</a> | <a href="frmvettp.htm" target="_top">Veterinarians</a>
| <a href="frmowntp.htm" target="_top">Pet Owners</a> | <a
href="frminvtp.htm" target="_top">Investors</a> ]</p>
<p align="center">[ <a href="about.htm">About DAHI</a> | <a
href="contents.htm" target="_top">Contents</a> | <a
href="contacts.htm">Contacts</a> | <a href="Links.htm">Links</a>
| <a href="Press.htm">Press Releases</a> | <a href="request.htm">Request
for Information</a> ]</p>
<hr>
<p><font size="2"><em>Send comments to DAHI webmaster: </em></font><a
href="mailto:dahimaster@deprenyl.com"><font size="2"><em>dahimaster@deprenyl.com</em></font></a><font
size="2"><em><br>
Copyright &#169; 1996 </em>Deprenyl Animal Health, Inc.<em> All
rights reserved.<br>
Revised: December 17, 1996.</em></font></p>
</body>
</html>
</DOC>
<DOC>
<DOCNO>WT02-B10-15</DOCNO>
<DOCOLDNO>IA038-000728-B004-346</DOCOLDNO>
<DOCHDR>
http://www.deprenyl.com:80/PR112696.htm 208.129.179.70 19970111075956 text/html 8659
HTTP/1.0 200 OK
Server: Microsoft-IIS/2.0
Date: Sat, 11 Jan 1997 07:59:37 GMT
Content-Type: text/html
</DOCHDR>
<!DOCTYPE HTML PUBLIC "-//W3O/DTD HTML//EN">

<html>
<head>
<title>November 26, 1996 Press Release</title>
<meta name="GENERATOR" content="Microsoft FrontPage 1.1">
<meta name="FORMATTER" content="Microsoft FrontPage 1.1">
</head>
<body background="images/Paper12l.jpg" bgcolor="#FFFFFF"
text="#000000" link="#FF0000" vlink="#400080" alink="#FFFF00">
<p><font size="2"><b><u>FOR IMMEDIATE RELEASE </u></b><b><br>
November 26, 1996</b></font> </p>
<p align="center"><font size="4"><strong><i>DRAXIS HEALTH INC.
SUCCEEDS IN BID TO ACQUIRE BALANCE OF</i></strong></font><font
size="2"><strong> </strong></font><font size="4"><strong><i>DEPRENYL
ANIMAL HEALTH, INC.</i></strong></font></p>
<p><strong>TORONTO AND KANSAS CITY, November 26, 1996 --</strong>
DRAXIS Health Inc. (TSE: DAX; Nasdaq: DRAXF) and Deprenyl Animal
Health, Inc. (TSE: DAH; Nasdaq OTC Bulletin Board: DAHI) jointly
announced today that shareholders of both DRAXIS and Deprenyl
Animal Health, Inc. (&quot;DAHI&quot;) have approved the
acquisition by DRAXIS of all shares of DAHI not already owned by
DRAXIS through a mandatory share exchange. Under the terms of the
mandatory share exchange transaction, DAHI shareholders (other
than DRAXIS and its affiliates) will receive 1.35 DRAXIS common
shares for each DAHI share. The transaction will result in
5,725,188 DRAXIS common shares being issued, bringing the total
outstanding to 29,240,161 shares. </p>
<p>Dr. Martin Barkin, M.D., President and CEO of DRAXIS and
Chairman of DAHI, stated that uniting the two companies will
allow DRAXIS to accelerate DAHI's growth to profitability by
providing additional financial and marketing support. &quot;No
changes will take place in the winning team that brought DAHI to
this point,&quot; he said: &quot;I am confident that this
transaction will free DAHI's management team to focus on what it
has done so well - the development of <i>Anipryl&#174; </i>from
conception to marketplace.&quot; </p>
<p>Dr. David R. Stevens, D.V.M., President and CEO of DAHI, will
continue on as President of DAHI leading the company's further
development of <i>Anipryl&#174; </i>for cognitive dysfunction in
pet dogs, its outlicensing beyond North America, and its
marketing and sales in North America. </p>
<p>Dr. Stevens welcomed the formalization of the support that
DRAXIS had been giving DAHI over the past two years. &quot;DAHI
will now have the necessary resources to assure a successful
launch of <i>Anipryl&#174; </i>in the U.S. and in other countries
where <i>AnipryI&#174; </i>gains regulatory approval,&quot; he
said. DRAXIS, which has been funding the operating requirements
of DAHI over the past two years through periodic issuance of
convertible debt, will provide funds to complete expeditiously
the regulatory approvals of <i>Anipryl&#174;, </i>and to assure a
successful launch of <i>Anipryl&#174; </i>in the U.S. as soon as
regulatory approval is received. </p>
<p>Quotation of DAHI shares on the <i>Nasdaq OTC Bulletin Board </i>will
terminate at the close of trading on November 27, 1996, and DAHI
will be delisted from <em>The</em> <i>Toronto Stock Exchange </i>on
or about December 4, 1996. Shortly, DAHI shareholders will be
receiving instructions by mail on how to exchange their DAHI
share certificates for DRAXIS share certificates. </p>
<p>In connection with the share exchange, Mr. George Darnell, a
director of DAHI since June 13, 1995 has been appointed to the
board of DRAXIS. Mr. Laszlo Kadar, who has served as a DRAXIS
director since June 26, 1990, has resigned as a director of
DRAXIS to make way for the appointment of Mr. Darnell. Mr.
Darnell served as Executive Vice President of Baxter Diagnostics
Inc. from 1991 to his retirement in 1994. Mr. Darnell served as
President of the Baxter Dade Division from 1972 to 1991. Brian
King, Chairman of DRAXIS' board, welcomed Mr. Darnell to the
board of DRAXIS: &quot;George Darnell has had extensive
experience in the health care and pharmaceutical diagnostic
industry in the United States as well as international experience
and is expected to make a strong contribution to the DRAXIS
board.&quot; </p>
<p>DAHI was established in 1991 to develop <i>Anipryl&#174;, </i>a
specific formulation of 1-selegiline, for the treatment of
certain specified disorders of companion animals. DAHI has
developed <i>Anipryl&#174; </i>for the treatment of canine
Cushing's disease, a disorder that affects more than 160,000 pet
dogs in North America alone. DAHI received Canadian regulatory
approval in late 1995 to market <i>AnipryI&#174;</i> in Canada
for canine Cushing's disease. It awaits similar approval from the
U.S. Food &amp; Drug Administration. In May 1996 DAHI applied to
the Canadian health authorities for permission to market <i>Anipryl&#174; </i>for
canine cognitive dysfunction, a frequent behavioral deterioration
of geriatric dogs that affects up to 10 times as many dogs in
North America as does canine Cushing's disease and often results
in pet-owners having to euthanize their pet. </p>
<p>DRAXIS Health Inc. is an emerging Toronto-based pharmaceutical
company focused on neurological, dermatological and veterinary
markets in Canada and the United States. Products currently under
development include <i>Modafinil </i>for narcolepsy and
proprietary liposomed topical products for both the prescription
and over-the-counter markets. DRAXIS also operates a U.S.
division offering products for podiatric applications. DAHI, a
wholly owned subsidiary of DRAXIS, has filed for U.S. approval of
its proprietary compound <i>Anipryl&#174; </i>for canine
Cushing's disease. DRAXIS also has a 30% interest in ST&Euml;F
International Corp. (CDN: STEF; NASDAQ Bulletin Board: SEFFF), a
network marketing company specializing in science-based, consumer
health products. </p>
<p align="center">###</p>
<p><i>Except for historical information, this news release
contains certain forward looking statements that involve risk and
uncertainties which may cause actual results to differ materially
from the statements made. Such factors include, but are not
limited to, changing market conditions, clinical trial results,
the establishment of new corporate alliances, the impact of
competitive products and pricing, the timely development,
regulatory approval and market acceptance of the Company's
products, and other risks detailed from time-to-time in the
Company's filings with the U. S. Securities and Exchange
Commission and Canadian securities authorities.</i> </p>
<hr>
<p>To receive additional information on DRAXIS Health Inc. via
fax at no charge, dial 1-800-PRO-INFO and enter code DRAXF. </p>
<p><strong><i>For further information, please contact:</i></strong></p>
<p><strong><u>DRAXIS<br>
</u></strong>Dr. Martin Barkin<br>
President &amp; CEO <br>
TEL: (905) 677-5500 </p>
<table width="100%">
    <tr>
        <td width="50%"><strong><u>Canadian Investor Relations</u></strong><br>
        Robert Grahovar<br>
        Small Capital Equity Investor Relations, Ltd.<br>
        TEL: (416) 368-7459</td>
        <td width="50%"><strong><u>U.S. Investor Relations:</u></strong><strong> </strong><br>
        Paula Schwartz/Brian Gill <br>
        The Financial Relations Board, Inc <br>
        TEL: (212) 661-8030</td>
    </tr>
</table>
<p><strong><u>DAHI</u></strong><strong> <br>
</strong>Dr. David R. Stevens <br>
President &amp; CEO<br>
TEL: (913) 338-2120</p>
<p><strong><u>Investor Relations</u></strong><strong> <br>
</strong>Robert Kneeley <br>
RKC Communications <br>
TEL: (954) 351-1976</p>
<hr>
<p align="center">[ <a href="index.htm" target="_top">DAHI Home
Page</a> | <a href="frmvettp.htm" target="_top">Veterinarians</a>
| <a href="frmowntp.htm" target="_top">Pet Owners</a> | <a
href="frminvtp.htm" target="_top">Investors</a> ]</p>
<p align="center">[ <a href="about.htm">About DAHI</a> | <a
href="contents.htm" target="_top">Contents</a> | <a
href="contacts.htm">Contacts</a> | <a href="Links.htm">Links</a>
| <a href="Press.htm">Press Releases</a> | <a href="request.htm">Request
for Information</a> ]</p>
<hr>
<p><font size="2"><em>Send comments to DAHI webmaster: </em></font><a
href="mailto:dahimaster@deprenyl.com"><font size="2"><em>dahimaster@deprenyl.com</em></font></a><font
size="2"><em><br>
Copyright &#169; 1996 </em>Deprenyl Animal Health, Inc.<em> All
rights reserved.<br>
Revised: December 18, 1996.</em></font></p>
</body>
</html>
</DOC>
<DOC>
<DOCNO>WT02-B10-16</DOCNO>
<DOCOLDNO>IA038-000728-B005-25</DOCOLDNO>
<DOCHDR>
http://www.deprenyl.com:80/PR111596.htm 208.129.179.70 19970111080020 text/html 5788
HTTP/1.0 200 OK
Server: Microsoft-IIS/2.0
Date: Sat, 11 Jan 1997 08:00:06 GMT
Content-Type: text/html
</DOCHDR>
<!DOCTYPE HTML PUBLIC "-//W3O/DTD HTML//EN">

<html>
<head>
<title>November 15, 1996 Press Release</title>
<meta name="GENERATOR" content="Microsoft FrontPage 1.1">
<meta name="FORMATTER" content="Microsoft FrontPage 1.1">
</head>
<body background="images/Paper12l.jpg" bgcolor="#FFFFFF"
text="#000000" link="#FF0000" vlink="#400080" alink="#FFFF00">
<p><font size="2"><u>FOR IMMEDIATE RELEASE</u></font></p>
<p align="center"><font size="5"><b>DAHI Reports Reduced Losses
for Third Quarter</b> </font></p>
<p><strong>OVERLAND PARK, KANSAS, November 15, 1996 --</strong>
Deprenyl Animal Health, Inc. (NASD OTC Bulletin Board: DAHI;
Toronto Stock Exchange: DAH) today reported total revenue of
$47,000, including $33,073 from revenue-sharing from Canadian
sales of its veterinary pharmaceutical Anipryl&#174; for the
three months ended September 30, 1996. DAHI had total revenue of
$12,746, all from investment income, for the comparable three
months of 1995. </p>
<p>Deprenyl Animal Health, Inc., continues to fund research for
additional indications of Anipryl&#174; in geriatric dogs. It
reported a net loss of $582,196, or 8 cents per share based on a
weighted average of 7.5 million shares for the 1996 third
quarter, compared with a net loss of $643,000, or 10 cents per
share based on a weighted average of 6.5 million shares
outstanding for the 1995 third quarter. </p>
<p>The sale of Anipryl&#174; is currently limited to Canadian
veterinarians for the treatment of canine Cushing's disease in
geriatric dogs. The company is seeking approval to market
Anipryl&#174; for the same indication in the U.S., and is seeking
approval for the more common indication of cognitive dysfunction. </p>
<p>Nine months' revenues for 1996 were $937,270, which included
one-time revenues from the sale of distribution rights for
Anipryl&#174; in Canada to Draxis Health Inc. (NASDAQ: DRAXF;
TSE: DAX) and a milestone payment from Hoechst Veterinar GmbH.
The net loss for the nine months ended September 30, 1996 was
$1.0 million, or 14 cents per share based on a weighted average
of 7.5 million shares outstanding, versus $2.0 million, or 31
cents per share based on 6.5 million shares outstanding for the
nine months ended September 30, 1995. </p>
<p>Anipryl&#174; is being marketed to Canadian veterinarians for
treatment of canine Cushing's disease. Canadian regulators
recently approved two additional dosages of Anipryl&#174;, 10 and
30 milligram, as well as new 30-day blister packaging.
Anipryl&#174; is now approved in Canada in 2, 5, 10, 15 and 30
milligram dosages. </p>
<p>In September 1995, DAHI submitted a new animal drug
application with the U.S. Food &amp; Drug Administration for
treatment of canine Cushing's disease. Approximately 165,000
cases of canine Cushing's disease are diagnosed in geriatric dogs
each year in Canada and the U.S. </p>
<p>DAHI is also awaiting action from the Canadian Health
Protection Branch, Bureau of Veterinary Drugs, on its application
to market Anipryl&#174; for cognitive dysfunction. Approximately
150,000 cases of cognitive dysfunction occur in Canada each year.
The company continues its U.S. Phase III-equivalent clinical
trial for Anipryl&#174; as a treatment for cognitive dysfunction,
which occurs in approximately 1.5 million older dogs each year.</p>
<p>The shareholders of Deprenyl Animal Health, Inc., will meet
November 26, 1996, to vote on a friendly offer by Draxis Health
Inc. to acquire the outstanding shares of DAHI that it does not
currently own at an exchange rate of 1.35 Draxis shares for each
outstanding DAHI share. The exchange offer was recommended by an
independent committee of DAHI's board of directors in July 1996.
The proxy materials related to the exchange offer were mailed to
shareholders of both companies in late October. Draxis
shareholders will meet November 25 to vote on the exchange offer.</p>
<p>Draxis currently owns 44 percent of the outstanding common
shares of DAHI, as well as DAHI convertible debt that, if
converted, would result in an increase of Draxis' holdings in
DAHI to 52 percent. </p>
<p>Draxis, based in suburban Toronto, Ontario, is a leading
Canadian pharmaceutical company focused on neurology, dermatology
and veterinary markets in Canada and the United States. </p>
<p>Deprenyl Animal Health, Inc., was established in 1990 to
develop animal health applications for Anipryl&#174;. The Company
is also identifying other animal health product opportunities to
become a multi-product animal health pharmaceutical company.</p>
<hr>
<p><strong>For More Information: </strong></p>
<blockquote>
    <p><strong>Laura D. Sayler<br>
    Deprenyl Animal Health, Inc. <br>
    913-338-2120</strong></p>
</blockquote>
<hr>
<p align="center">[ <a href="index.htm" target="_top">DAHI Home
Page</a> | <a href="frmvettp.htm" target="_top">Veterinarians</a>
| <a href="frmowntp.htm" target="_top">Pet Owners</a> | <a
href="frminvtp.htm" target="_top">Investors</a> ]</p>
<p align="center">[ <a href="about.htm">About DAHI</a> | <a
href="contents.htm" target="_top">Contents</a> | <a
href="contacts.htm">Contacts</a> | <a href="Links.htm">Links</a>
| <a href="Press.htm">Press Releases</a> | <a href="request.htm">Request
for Information</a> ]</p>
<hr>
<p><font size="2"><em>Send comments to DAHI webmaster: </em></font><a
href="mailto:dahimaster@deprenyl.com"><font size="2"><em>dahimaster@deprenyl.com</em></font></a><font
size="2"><em><br>
Copyright &#169; 1996 </em>Deprenyl Animal Health, Inc.<em> All
rights reserved.<br>
Revised: December 18, 1996.</em></font></p>
</body>
</html>
</DOC>
<DOC>
<DOCNO>WT02-B10-17</DOCNO>
<DOCOLDNO>IA038-000728-B005-57</DOCOLDNO>
<DOCHDR>
http://www.deprenyl.com:80/PR103196.htm 208.129.179.70 19970111080038 text/html 5673
HTTP/1.0 200 OK
Server: Microsoft-IIS/2.0
Date: Sat, 11 Jan 1997 08:00:20 GMT
Content-Type: text/html
</DOCHDR>
<!DOCTYPE HTML PUBLIC "-//W3O/DTD HTML//EN">

<html>
<head>
<title>October 31, 1996 Press Release</title>
<meta name="GENERATOR" content="Microsoft FrontPage 1.1">
<meta name="FORMATTER" content="Microsoft FrontPage 1.1">
</head>
<body background="images/Paper12l.jpg" bgcolor="#FFFFFF"
text="#000000" link="#FF0000" vlink="#400080" alink="#FFFF00">
<h3 align="center"><font size="5"><b>Anipryl&#174; Available in
Additional Dosages in Canada</b> </font></h3>
<p align="center"><font size="4"><strong><i>Shareholders Set to
Vote on DRAXIS Exchange Offer for DAHI Shares</i></strong></font></p>
<p><strong>OVERLAND PARK, KANSAS, October 31, 1996 --</strong>
Deprenyl Animal Health, Inc. (NASD Bulletin Board: DAHI; TSE:
DAH) today announced that Canada's Health Protection Branch,
Bureau of Veterinary Drugs (&quot;HPB&quot;), has approved the 10
and 30 milligram dosages of the veterinary pharmaceutical
Anipryl&#174;, indicated for treating canine Cushing's disease.
The full complement of Anipryl&#174; dosages makes it easier and
less costly for Canadian dog owners to comply with once-daily
administration.</p>
<p>As a result, DAHI expects broader acceptance of the
pharmaceutical, which is marketed through Canadian veterinarians. </p>
<p>In addition, the HPB has approved new packaging for
Anipryl&#174;. It will now be available to pet owners in a
convenient 30-day blister package that improves the daily
administration and compliance of the pharmaceutical. The full
range of Anipryl&#174; dosages now approved in blister packaging
include 2, 5, 10, 15 and 30 milligrams.</p>
<p>Deprenyl Animal Health, Inc., developed Anipryl&#174; for
veterinary applications. DRAXIS Health Inc., headquartered in
Mississauga, Ontario, holds exclusive Canadian rights to
Anipryl&#174;.</p>
<p>In July, 1996, DRAXIS announced a friendly offer to acquire
the outstanding shares of Deprenyl Animal Health, Inc., that it
does not currently own at an exchange rate of 1.35 DRAXIS shares
for each outstanding DAHI share. The proxy materials related to
the exchange offer were mailed to shareholders of both companies
earlier this week. DRAXIS shareholders will vote on the offer
November 25, and DAHI shareholders will vote November 26. </p>
<p>Draxis currently owns 44 percent of the common stock of DAHI.
In addition, DRAXIS holds convertible debt which, if converted,
would increase DRAXIS' ownership to 52 percent.</p>
<p>DAHI has submitted trial data on Anipryl&#174; for two
indications, in two jurisdictions. In September 1995, DAHI
submitted a new animal drug application with the U.S. Food and
Drug Administration (FDA) to market Anipryl&#174; for canine
Cushing's disease in the United States.</p>
<p>Canine Cushing's disease is a degenerative condition that
affects older dogs and if left untreated is ultimately fatal.
Symptoms include loss of house training, excessive thirst,
reduced activity and a &quot;pot-bellied&quot; appearance. There
are approximately 150,000 new cases of canine Cushing's diagnosed
annually in the U.S. and 15,000 in Canada. </p>
<p>In addition, DAHI has filed with Canada's Health Protection
Branch, Bureau of Veterinary Drugs, for approval to market
Anipryl&#174; to treat cognitive dysfunction. DAHI is completing
U.S. clinical trials for cognitive dysfunction, and expects to
submit an application to the U.S. FDA during the second quarter
of 1997. </p>
<p>Cognitive dysfunction, also known as senility or old dog' s
syndrome, is an Alzheimer's-like disease afflicting geriatric
dogs. At least 1.5 million new cases of cognitive dysfunction
occur each year in North America. </p>
<p>Draxis is a marketing and research company that operates
Canadian neurological and dermatological pharmaceuticals
divisions, a U.S. consumer marketing company, and offers products
exclusively through U.S. podiatrists. </p>
<p>Deprenyl Animal Health, Inc., based in Overland Park, Kansas,
was founded in 1990 to develop animal health applications for
Anipryl&#174;. The company is also identifying other animal
health product opportunities to become a multi-product animal
health pharmaceutical company.</p>
<p align="center">###</p>
<p><i>Factors that could cause forward-looking statements in this
news release to differ materially from actual results are
discussed in the Company's periodic filings with the U.S.
Securities and Exchange Commission and Canada's securities
authorities.</i> </p>
<hr>
<p><strong>For Further Information: </strong></p>
<blockquote>
    <p><strong>Laura D. Sayler<br>
    Deprenyl Animal Health, Inc. <br>
    913-338-2120</strong></p>
</blockquote>
<hr>
<p align="center">[ <a href="index.htm" target="_top">DAHI Home
Page</a> | <a href="frmvettp.htm" target="_top">Veterinarians</a>
| <a href="frmowntp.htm" target="_top">Pet Owners</a> | <a
href="frminvtp.htm" target="_top">Investors</a> ]</p>
<p align="center">[ <a href="about.htm">About DAHI</a> | <a
href="contents.htm" target="_top">Contents</a> | <a
href="contacts.htm">Contacts</a> | <a href="Links.htm">Links</a>
| <a href="Press.htm">Press Releases</a> | <a href="request.htm">Request
for Information</a> ]</p>
<hr>
<p><font size="2"><em>Send comments to DAHI webmaster: </em></font><a
href="mailto:dahimaster@deprenyl.com"><font size="2"><em>dahimaster@deprenyl.com</em></font></a><font
size="2"><em><br>
Copyright &#169; 1996 </em>Deprenyl Animal Health, Inc.<em> All
rights reserved.<br>
Revised: December 18, 1996.</em></font></p>
</body>
</html>
</DOC>
<DOC>
<DOCNO>WT02-B10-18</DOCNO>
<DOCOLDNO>IA038-000728-B005-86</DOCOLDNO>
<DOCHDR>
http://www.deprenyl.com:80/96Q2RLS.htm 208.129.179.70 19970111080046 text/html 4983
HTTP/1.0 200 OK
Server: Microsoft-IIS/2.0
Date: Sat, 11 Jan 1997 08:00:34 GMT
Content-Type: text/html
</DOCHDR>
<!DOCTYPE HTML PUBLIC "-//W3O/DTD HTML//EN">

<html>
<head>
<title>August 15, 1996 Press Release</title>
<meta name="GENERATOR" content="Microsoft FrontPage 1.1">
<meta name="FORMATTER" content="Microsoft FrontPage 1.1">
</head>
<body background="images/Paper12l.jpg" bgcolor="#FFFFFF"
text="#000000" link="#FF0000" vlink="#400080" alink="#FFFF00">
<p><font size="1"><u>96Q2RLS</u></font></p>
<p><font size="1"><u>FOR IMMEDIATE RELEASE</u></font><u><br>
</u></p>
<h1 align="center"><font size="5"><b>Anipryl&#174; Sales in
Canada Cuts DAHI Second-Quarter Loss</b></font></h1>
<h1 align="center"><font size="4"><i>First Complete Quarter of
Veterinary Pharmaceutical Sales</i></font></h1>
<p><b>OVERLAND PARK, KANSAS, August 15, 1996</b> -- Deprenyl
Animal Health, Inc. (NASD OTC Bulletin Board: DAHI; Toronto Stock
Exchange: DAH) today reported total revenue of $75,114, including
$48,132 from the sale of its veterinary pharmaceutical
Anipryl&#174; for the three months ended June 30, 1996. DAHI had
total revenue of $22,077, all from investment income, for the
comparable three months of 1995. </p>
<p>Deprenyl Animal Health, Inc. continues to fund research for
additional indications of Anipryl&#174; in geriatric dogs. It
reported a net loss of $659,748, or 9 cents per share, for the
1996 second quarter, compared with a net loss of $758,639, or 12
cents per share, for the 1995 second quarter. </p>
<p>Six months' revenues for 1996 were $890,326, which included
one-time revenues from the sale of distribution rights for
Anipryl&#174; in Canada to Draxis Health Inc. (NASDAQ: DRAXF;
TSE: DAX) and a milestone payment from Hoechst Veterinar GmbH.
The net loss for the six months ended June 30, 1996 was $443,318,
or 6 cents per share, versus $1.4 million, or 21 cents per share,
for the six months ended June 30, 1995. </p>
<p>Anipryl&#174; is approved in Canada for treatment of canine
Cushing's disease. The company is awaiting action from the U.S.
Food &amp; Drug Administration on its canine Cushing's disease
application, which was submitted in September 1995. Approximately
165,000 cases of canine Cushing's disease are diagnosed each year
in Canada and the U.S. </p>
<p>DAHI is also awaiting action from the Canadian Health
Protection Branch, Bureau of Veterinary Drugs, on its application
to market Anipryl&#174; for cognitive dysfunction. Approximately
150,000 cases of cognitive dysfunction occur in Canada each year.
The company continues its U.S. Phase III-equivalent clinical
trial for Anipryl&#174; as a treatment for cognitive dysfunction,
which occurs in approximately 1.5 million older dogs each year. </p>
<p>During July 1996, the board of directors of Deprenyl Animal
Health, Inc. recommended the acceptance of an offer by Draxis to
acquire the shares of DAHI not already owned by Draxis through a
friendly tender offer. Draxis currently owns 44 percent of the
outstanding common shares of DAHI, as well as DAHI convertible
debt that, if converted, would result in an increase of Draxis'
holdings in DAHI to 52 percent. </p>
<p>Under the terms of the transaction, Draxis would exchange 1.35
shares of its common stock for each outstanding share of DAHI not
already owned by Draxis. Special meetings of the shareholders of
the two companies will be held in the fall to vote on the
transaction. </p>
<p>Draxis Health Inc., based in suburban Toronto, Ontario, is a
leading Canadian pharmaceutical company focused on neurology,
dermatology and veterinary markets in Canada and the United
States. </p>
<p>Deprenyl Animal Health was established in 1990 to develop
animal health applications for Anipryl&#174;. The Company is also
identifying other animal health product opportunities to become a
multi-product animal health pharmaceutical company. </p>
<hr>
<p><strong>For More Information: <br>
</strong><em><strong>Laura D. Sayler<br>
Deprenyl Animal Health, Inc. <br>
913-338-2120</strong></em></p>
<hr>
<p align="center">[ <a href="index.htm" target="_top">DAHI Home
Page</a> | <a href="frmvettp.htm" target="_top">Veterinarians</a>
| <a href="frmowntp.htm" target="_top">Pet Owners</a> | <a
href="frminvtp.htm" target="_top">Investors</a> ]</p>
<p align="center">[ <a href="about.htm">About DAHI</a> | <a
href="contents.htm" target="_top">Contents</a> | <a
href="contacts.htm">Contacts</a> | <a href="Links.htm">Links</a>
| <a href="Press.htm">Press Releases</a> | <a href="request.htm">Request
for Information</a> ]</p>
<hr>
<p><font size="2"><em>Send comments to DAHI webmaster: </em></font><a
href="mailto:dahimaster@deprenyl.com"><font size="2"><em>dahimaster@deprenyl.com</em></font></a><font
size="2"><em><br>
Copyright &#169; 1996 </em>Deprenyl Animal Health, Inc.<em> All
rights reserved.<br>
Revised: October 18, 1996.</em></font></p>
</body>
</html>
</DOC>
<DOC>
<DOCNO>WT02-B10-19</DOCNO>
<DOCOLDNO>IA038-000728-B005-113</DOCOLDNO>
<DOCHDR>
http://www.deprenyl.com:80/PR072596.htm 208.129.179.70 19970111080053 text/html 6711
HTTP/1.0 200 OK
Server: Microsoft-IIS/2.0
Date: Sat, 11 Jan 1997 08:00:42 GMT
Content-Type: text/html
</DOCHDR>
<!DOCTYPE HTML PUBLIC "-//W3O/DTD HTML//EN">

<html>
<head>
<title>July 25, 1996 Press Release</title>
<meta name="GENERATOR" content="Microsoft FrontPage 1.1">
<meta name="FORMATTER" content="Microsoft FrontPage 1.1">
</head>
<body background="images/Paper12l.jpg" bgcolor="#FFFFFF"
text="#000000" link="#FF0000" vlink="#400080" alink="#FFFF00">
<p><font size="2"><b><u>NEWS FOR IMMEDIATE RELEASE</u></b></font> </p>
<h2 align="center">DRAXIS Health Inc. to Acquire Balance of </h2>
<h2 align="center">Deprenyl Animal Health, Inc.</h2>
<p><b>TORONTO AND KANSAS CITY, July 25, 1996 - </b>Draxis Health
Inc. (TSE:DAX NASDAQ:DRAXF) and Deprenyl Animal Health, Inc.
(NASD OTC Bulletin Board: DAHI; Toronto Stock Exchange: DAH)
jointly announced today that DRAXIS will offer to acquire the
shares of Deprenyl Animal Health, Inc. (DAHI) not already owned
by DRAXIS through a friendly tender offer. DRAXIS presently holds
44% of the outstanding common shares of DAHI and DAHI convertible
debt that if converted would result in DRAXIS' holdings in DAHI
increasing to 52%.</p>
<p>The board of directors of Overland Park, Kansas-based DAHI
today reviewed the offer and voted to recommend its acceptance by
DAHI shareholders. The transaction was previously approved by the
Toronto-based DRAXIS board of directors.</p>
<p>Under the terms of the transaction, DRAXIS would exchange 1.35
shares of DRAXIS common stock for each outstanding share of DAHI
not already owned by DRAXIS. The board of directors of DRAXIS and
DAHI established independent committees to review the
transaction. The independent committee of DRAXIS retained
Montgomery Securities to advise the committee with respect to the
transaction. Hambrecht and Quist LLC was retained by, advised,
and provided a fairness opinion for the independent committee of
DAHI. In addition, an independent valuation on behalf of the
public shareholders of DAHI will be provided by KPMG Peat Marwick
Thorne. The final recommendation of the independent committee to
the board of directors of DRAXIS and DAHI was accepted by both
companies' boards and is being recommended by both companies to
their shareholders. Special meetings of the shareholders of the
two companies will be held in the fall to vote on the
transaction. </p>
<p>Dr. Martin Barkin, M.D., president and CEO of DRAXIS and
chairman of DAHI, stated that uniting the two companies will
allow DRAXIS to continue to support its former spin-off and
accelerate DAHI's growth to profitability by providing additional
financial and marketing support. &quot;No changes will take place
in the winning team that brought DAHI to this point,&quot; he
said. &quot;I am confident that this transaction will free DAHI's
leadership to focus on what is has done so well - develop
Anipryl&#174; and other compounds from conception to
marketplace.&quot;</p>
<p>After the completion of the transaction, Dr. David R. Stevens,
D.V.M., president and CEO of DAHI, will become President of
Deprenyl Animal Health, Inc., which will then have become a
wholly-owned subsidiary of DRAXIS. Dr. Stevens will continue to
lead DAHI's further development of Anipryl&#174; for cognitive
dysfunction in pet dogs, its outlicensing beyond North America,
and its marketing and sales in North America. Dr. Stevens
welcomed the formalization of support that DRAXIS had been giving
DAHI over the past two years. &quot;DAHI will now have the
necessary resources to assure a successful launch of
Anipryl&#174; in the U.S. and anywhere else Anipryl&#174; gains
regulatory approval,&quot; he said, adding: &quot;This merger of
talent and finance bodes well for DAHI and DRAXIS
shareholders.&quot;</p>
<p>Besides approval by the two companies' shareholders, the
transaction is also subject to approval of the appropriate
regulatory authorities. As a result of the proposed transaction,
DRAXIS, which has been funding the operating requirements of DAHI
over the past two years through periodic issuance of convertible
debt, will now directly assure sufficient funds to expeditiously
complete the regulatory approvals of Anipryl&#174;, and to assure
a successful launch of Anipryl&#174; in the U.S. as soon as a
regulatory approval is received.</p>
<p>DAHI was originally spun off by DRAXIS in 1991 to develop
Anipryl&#174;, a specific formulation of l-selegiline, for the
treatment of certain specified disorders of companion animals.
DAHI has developed Anipryl&#174; for the treatment of canine
Cushing's disease, a disorder that affects more than 160,000 pet
dogs in North America alone. DAHI received approval from the
Canadian government in late 1995 to market Anipryl&#174; in
Canada for canine Cushing's disease. It awaits similar approval
from the U.S. Food &amp; Drug Administration. DAHI applied in May
of 1996 to the Canadian health authorities for permission to
market Anipryl&#174; for canine cognitive dysfunction, an
Alzheimer's-like disease in geriatric dogs that affects up to 10
times as many dogs in North America as does canine Cushing's
disease.</p>
<p>DRAXIS Health Inc., based in Toronto, Canada, is a leading
Canadian pharmaceutical company focused on neurological,
dermatological and veterinary markets in Canada and the United
States.</p>
<p>DAHI, based in Overland Park, Kansas, was established in 1990
to develop animal health applications of Anipryl&#174;. The
company is engaged in identifying other animal health product
opportunities to become a multi-product animal health
pharmaceutical company.</p>
<p><strong>Contact:<br>
</strong><em><strong>Laura D. Sayler<br>
Deprenyl Animal Health, Inc. <br>
(913) 338-2120</strong></em></p>
<hr>
<p align="center">[ <a href="index.htm" target="_top">DAHI Home
Page</a> | <a href="frmvettp.htm" target="_top">Veterinarians</a>
| <a href="frmowntp.htm" target="_top">Pet Owners</a> | <a
href="frminvtp.htm" target="_top">Investors</a> ]</p>
<p align="center">[ <a href="about.htm">About DAHI</a> | <a
href="contents.htm" target="_top">Contents</a> | <a
href="contacts.htm">Contacts</a> | <a href="Links.htm">Links</a>
| <a href="Press.htm">Press Releases</a> | <a href="request.htm">Request
for Information</a> ]</p>
<hr>
<p><font size="2"><em>Send comments to DAHI webmaster: </em></font><a
href="mailto:dahimaster@deprenyl.com"><font size="2"><em>dahimaster@deprenyl.com</em></font></a><font
size="2"><em><br>
Copyright &#169; 1996 </em>Deprenyl Animal Health, Inc.<em> All
rights reserved.<br>
Revised: October 18, 1996.</em></font></p>
</body>
</html>
</DOC>
<DOC>
<DOCNO>WT02-B10-20</DOCNO>
<DOCOLDNO>IA038-000728-B005-133</DOCOLDNO>
<DOCHDR>
http://www.deprenyl.com:80/COGDYRLS.htm 208.129.179.70 19970111080101 text/html 4731
HTTP/1.0 200 OK
Server: Microsoft-IIS/2.0
Date: Sat, 11 Jan 1997 08:00:49 GMT
Content-Type: text/html
</DOCHDR>
<!DOCTYPE HTML PUBLIC "-//W3O/DTD HTML//EN">

<html>
<head>
<title>June 10, 1996 Press Release</title>
<meta name="GENERATOR" content="Microsoft FrontPage 1.1">
<meta name="FORMATTER" content="Microsoft FrontPage 1.1">
</head>
<body background="images/Paper12l.jpg" bgcolor="#FFFFFF"
text="#000000" link="#FF0000" vlink="#400080" alink="#FFFF00">
<p align="left"><font size="1">COGDYRLS</font></p>
<p align="center"><font size="5"><b>DAHI Submits Canine Cognitive
Dysfunction Claim</b></font><font size="4"> </font></p>
<p align="center"><font size="5"><b>For Anipryl&#174; to Canada's
Bureau of Veterinary Drugs</b></font></p>
<p>OVERLAND PARK, KANSAS, June 10, 1996 -- Deprenyl Animal
Health, Inc. (NASD OTC Bulletin Board: DAHI; Toronto Stock
Exchange: DAH) has filed a Supplemental New Drug Submission with
Canada's Health Protection Branch, Bureau of Veterinary Drugs,
for approval to market Anipryl&#174; (l-selegiline) for treating
cognitive dysfunction, an Alzheimer's-like disease in geriatric
dogs. Canine cognitive dysfunction shares certain
neuro-pathologic lesions with early-stage Alzheimer's disease in
people. </p>
<p>If approved, this will mark the second label indication for
Anipryl&#174;. </p>
<p>Approximately 150,000 cases of cognitive dysfunction occur in
Canada each year. It is a progressive, ultimately fatal disease
characterized by various behavior problems such as loss of house
training, inability to recognize familiar people and places,
tremors, and changes in sleep/wake patterns. Commonly referred to
as senility or old dog syndrome, pet owners are often reluctantly
forced to euthanize their companion animals afflicted with
cognitive dysfunction. </p>
<p>Following one month of Anipryl&#174; therapy, 75 percent of
dogs treated with Anipryl&#174; exhibited statistically
significant behavioral improvement, according to the final report
of the 93-patient clinical trial that was included as part of the
supplemental new drug submission. The improvement for the trial
population was maintained following two and three months </p>
<p>of Anipryl&#174; therapy. The proposed initial dosage of
Anipryl&#174; to treat cognitive dysfunction is 0.5mg per
kilogram of body weight, which could be increased to a maximum of
1mg per kilogram. </p>
<p>Anipryl&#174; is marketed in Canada by DRAXIS Health Inc.
(NASDAQ: DRAXF; TSE: DAX) to treat canine Cushing's disease.
There are approximately 15,000 cases of canine Cushing's disease
diagnosed in Canada each year. The approved initial dosage for
canine Cushing's is 1mg/kilogram, which could be increased to a
maximum 2mg/kilogram. </p>
<p>The company is awaiting action from the U.S. Food &amp; Drug
Administration on its canine Cushing's disease application, which
was submitted in September 1995. </p>
<p>The company expects to complete its U.S. Phase-III equivalent
clinical trial for cognitive dysfunction this year, and submit a
file seeking approval for that indication during the early part
of 1997. More than 1.5 million cases of canine cognitive
dysfunction occur in the U.S. annually. </p>
<p>DRAXIS Health currently owns 44 percent of the common stock of
DAHI, and its ownership could increase to as much as 52 percent
through the conversion of outstanding loans issued to DAHI. </p>
<p>Deprenyl Animal Health was established in 1990 to develop
animal health applications for Anipryl&#174;. The Company is also
identifying other animal health product opportunities to become a
multi-product animal health pharmaceutical company. </p>
<hr>
<p><strong>For More Information: <br>
</strong><em><strong>Laura D. Sayler<br>
Deprenyl Animal Health, Inc. <br>
913-338-2120</strong></em></p>
<hr>
<p align="center">[ <a href="index.htm" target="_top">DAHI Home
Page</a> | <a href="frmvettp.htm" target="_top">Veterinarians</a>
| <a href="frmowntp.htm" target="_top">Pet Owners</a> | <a
href="frminvtp.htm" target="_top">Investors</a> ]</p>
<p align="center">[ <a href="about.htm">About DAHI</a> | <a
href="contents.htm" target="_top">Contents</a> | <a
href="contacts.htm">Contacts</a> | <a href="Links.htm">Links</a>
| <a href="Press.htm">Press Releases</a> | <a href="request.htm">Request
for Information</a> ]</p>
<hr>
<p><font size="2"><em>Send comments to DAHI webmaster: </em></font><a
href="mailto:dahimaster@deprenyl.com"><font size="2"><em>dahimaster@deprenyl.com</em></font></a><font
size="2"><em><br>
Copyright &#169; 1996 </em>Deprenyl Animal Health, Inc.<em> All
rights reserved.<br>
Revised: October 18, 1996.</em></font></p>
</body>
</html>
</DOC>
<DOC>
<DOCNO>WT02-B10-21</DOCNO>
<DOCOLDNO>IA038-000728-B005-157</DOCOLDNO>
<DOCHDR>
http://www.deprenyl.com:80/96Q1RLS.htm 208.129.179.70 19970111080110 text/html 4170
HTTP/1.0 200 OK
Server: Microsoft-IIS/2.0
Date: Sat, 11 Jan 1997 08:00:57 GMT
Content-Type: text/html
</DOCHDR>
<!DOCTYPE HTML PUBLIC "-//W3O/DTD HTML//EN">

<html>
<head>
<title>May 16, 1996 Press Release</title>
<meta name="GENERATOR" content="Microsoft FrontPage 1.1">
<meta name="FORMATTER" content="Microsoft FrontPage 1.1">
</head>
<body background="images/Paper12l.jpg" bgcolor="#FFFFFF"
text="#000000" link="#FF0000" vlink="#400080" alink="#FFFF00">
<p><font size="2"><u>96Q1RLS</u></font></p>
<p><font size="2"><u>FOR IMMEDIATE RELEASE</u></font><u><br>
</u></p>
<p align="center"><font size="5"><b>DAHI Posts First Quarter Net
Income of Three Cents</b></font> </p>
<p align="center"><font size="4"><i>Sale of Distribution Rights
Boosts Revenue </i></font></p>
<p><b>OVERLAND PARK, KANSAS, May 16, 1996</b> -- Deprenyl Animal
Health, Inc. (NASD OTC Bulletin Board: DAHI; Toronto Stock
Exchange: DAH) today reported net income of $.03 per share for
the three months ended March 31, 1996, due largely to the
one-time revenues from the sale of distribution rights to its
veterinary pharmaceutical Anipryl&#174; in Canada to Draxis
Health Inc. (NASDAQ: DRAXF; TSE: DAX) and a milestone payment
from Hoechst Veterinar GmbH. DAHI lost $.10 per share for the
same period of 1995. </p>
<p>DAHI posted total revenues of $815,212 for the 1996 first
quarter, compared with revenues of $55,151 for the same period in
1995. Net income was $236,329 for the period ended March 31,
1996, compared with a net loss of $634,022 for the 1995 first
quarter. At March 31, 1996, DAHI had cash and cash equivalents of
$2 million. </p>
<p>DAHI's first quarter results included the company's first-ever
product sales revenue, resulting from the first shipment of
Anipryl&#174; to Canada during the 1996 first quarter. </p>
<p>&quot;We're pleased with the progress that we have made during
the first quarter,&quot; said David R. Stevens, President and
Chief Executive Officer of DAHI. &quot;We are very optimistic
about the prospect for sales of Anipryl&#174; in Canada, and
expect revenues to grow as Canadian veterinarians and pet owners
become familiar with the product.&quot; </p>
<p>Anipryl&#174; is approved in Canada for treatment of canine
Cushing's disease. The company is awaiting action from the U.S.
Food &amp; Drug Administration on its canine Cushing's disease
application, which was submitted in September 1995. DAHI is
currently evaluating its options for distribution of
Anipryl&#174; in the U.S. </p>
<p>Approximately 165,000 cases of canine Cushing's disease are
diagnosed each year in Canada and the U.S. </p>
<p>DAHI continues its Phase III-equivalent clinical trial for
Anipryl&#174; as a treatment for the indication cognitive
dysfunction, which occurs in approximately 1.5 million older dogs
in North America each year. </p>
<p>Deprenyl Animal Health was established in 1990 to develop
animal health applications for Anipryl&#174;. The Company is also
identifying other animal health product opportunities to become a
multi-product animal health pharmaceutical company. </p>
<hr>
<p><strong>For More Information: <br>
</strong><em><strong>Laura D. Sayler<br>
Deprenyl Animal Health, Inc. <br>
913-338-2120</strong></em></p>
<hr>
<p align="center">[ <a href="index.htm" target="_top">DAHI Home
Page</a> | <a href="frmvettp.htm" target="_top">Veterinarians</a>
| <a href="frmowntp.htm" target="_top">Pet Owners</a> | <a
href="frminvtp.htm" target="_top">Investors</a> ]</p>
<p align="center">[ <a href="about.htm">About DAHI</a> | <a
href="contents.htm" target="_top">Contents</a> | <a
href="contacts.htm">Contacts</a> | <a href="Links.htm">Links</a>
| <a href="Press.htm">Press Releases</a> | <a href="request.htm">Request
for Information</a> ]</p>
<hr>
<p><font size="2"><em>Send comments to DAHI webmaster: </em></font><a
href="mailto:dahimaster@deprenyl.com"><font size="2"><em>dahimaster@deprenyl.com</em></font></a><font
size="2"><em><br>
Copyright &#169; 1996 </em>Deprenyl Animal Health, Inc.<em> All
rights reserved.<br>
Revised: October 18, 1996.</em></font></p>
</body>
</html>
</DOC>
<DOC>
<DOCNO>WT02-B10-22</DOCNO>
<DOCOLDNO>IA038-000728-B005-193</DOCOLDNO>
<DOCHDR>
http://www.deprenyl.com:80/PATENT.htm 208.129.179.70 19970111080147 text/html 4113
HTTP/1.0 200 OK
Server: Microsoft-IIS/2.0
Date: Sat, 11 Jan 1997 08:01:32 GMT
Content-Type: text/html
</DOCHDR>
<!DOCTYPE HTML PUBLIC "-//W3O/DTD HTML//EN">

<html>
<head>
<title>March 27, 1996 Press Release</title>
<meta name="GENERATOR" content="Microsoft FrontPage 1.1">
<meta name="FORMATTER" content="Microsoft FrontPage 1.1">
</head>
<body background="images/Paper12l.jpg" bgcolor="#FFFFFF"
text="#000000" link="#FF0000" vlink="#400080" alink="#FFFF00">
<p><font size="2"><u>patent</u></font></p>
<p><font size="2"><u>FOR IMMEDIATE RELEASE<br>
</u></font></p>
<p align="center"><font size="5"><b>DAHI Earns Patent on Impact
of Anipryl&#174; </b></font></p>
<p align="center"><font size="5"><b>on Canine Life Expectancy</b></font><font
size="4"> </font></p>
<p align="center"><font size="4"><i>Sixth U.S. Patent Covers
l-Selegiline Treatment for Survival Curve Shifting</i></font></p>
<p>OVERLAND PARK, KANSAS, March 27, 1996 -- Deprenyl Animal
Health, Inc. (NASD OTC Bulletin Board: DAHI; Toronto Stock
Exchange: DAH) today reported that it received from the U.S.
Patent and Trademark Office a &quot;Notice of Allowance&quot; for
a patent covering the company's veterinary pharmaceutical
Anipryl&#174; (l-selegiline) to extend the life expectancy of
dogs. </p>
<p>In a two-year &quot;blinded&quot;, placebo-controlled trial
conducted under &quot;Good Laboratory Practices&quot; using 41
age-matched pairs of laboratory beagles, dogs between 10 and 15
years treated with l-selegiline daily had a statistically
significant increase (p = .024) in life expectancy compared to
placebo-treated controls. While the mechanism responsible for
increased life expectancy is unknown, DAHI believes that this
patent provides broad patent coverage for use of l-selegiline in
geriatric pet dogs. </p>
<p>This patent for &quot;survival curve shifting&quot; in dogs is
the sixth U.S. patent issued to DAHI covering new uses of
Anipryl&#174;. In addition, the company holds two European
patents for Anipryl&#174;. </p>
<p>Anipryl&#174; is approved for treatment of canine Cushing's
disease in Canada, and DAHI is expected to complete its first
shipment of the pharmaceutical this month. The Company has filed
its Phase III-equivalent clinical trial report with the U.S. Food
and Drug Administration covering the use of Anipryl&#174; therapy
in treating canine Cushing's disease. Approximately 165,000 cases
of canine Cushing's disease are diagnosed each year in Canada and
the U.S. </p>
<p>DAHI is currently evaluating its options for distribution of
Anipryl&#174; in the U.S., including negotiating with several
companies to establish a marketing alliance. Marketing rights in
selected European markets have been acquired by Hoechst
Veterinae, which is conducting clinical trials. </p>
<p>Deprenyl Animal Health was established in 1990 to develop
animal health applications for Anipryl&#174;. The Company is also
identifying other animal health product opportunities to become a
multi-product animal health pharmaceutical company. </p>
<hr>
<p><strong>FOR MORE INFORMATION: <br>
</strong><em><strong>Laura D. Sayler<br>
Deprenyl Animal Health, Inc. <br>
913-338-2120</strong></em></p>
<hr>
<p align="center">[ <a href="index.htm" target="_top">DAHI Home
Page</a> | <a href="frmvettp.htm" target="_top">Veterinarians</a>
| <a href="frmowntp.htm" target="_top">Pet Owners</a> | <a
href="frminvtp.htm" target="_top">Investors</a> ]</p>
<p align="center">[ <a href="about.htm">About DAHI</a> | <a
href="contents.htm" target="_top">Contents</a> | <a
href="contacts.htm">Contacts</a> | <a href="Links.htm">Links</a>
| <a href="Press.htm">Press Releases</a> | <a href="request.htm">Request
for Information</a> ]</p>
<hr>
<p><font size="2"><em>Send comments to DAHI webmaster: </em></font><a
href="mailto:dahimaster@deprenyl.com"><font size="2"><em>dahimaster@deprenyl.com</em></font></a><font
size="2"><em><br>
Copyright &#169; 1996 </em>Deprenyl Animal Health, Inc.<em> All
rights reserved.<br>
Revised: October 18, 1996.</em></font></p>
</body>
</html>
</DOC>
<DOC>
<DOCNO>WT02-B10-23</DOCNO>
<DOCOLDNO>IA038-000728-B005-214</DOCOLDNO>
<DOCHDR>
http://www.deprenyl.com:80/DISTFINL.htm 208.129.179.70 19970111080204 text/html 5868
HTTP/1.0 200 OK
Server: Microsoft-IIS/2.0
Date: Sat, 11 Jan 1997 08:01:45 GMT
Content-Type: text/html
</DOCHDR>
<!DOCTYPE HTML PUBLIC "-//W3O/DTD HTML//EN">

<html>
<head>
<title>January 11, 1996 Press Release</title>
<meta name="GENERATOR" content="Microsoft FrontPage 1.1">
<meta name="FORMATTER" content="Microsoft FrontPage 1.1">
</head>
<body background="images/Paper12l.jpg" bgcolor="#FFFFFF"
text="#000000" link="#FF0000" vlink="#400080" alink="#FFFF00">
<p><font size="1">DISTFINL</font></p>
<p><font size="1"><u>FOR IMMEDIATE RELEASE</u></font><u><br>
</u></p>
<p align="center"><font size="5"><b>DAHI/Draxis Complete
Anipryl&#174; Distribution Agreement</b></font><font size="4"> </font></p>
<p align="center"><font size="4"><i>Veterinary Pharmaceutical
Shipments to Canada to Start Mid-February</i></font></p>
<p>OVERLAND PARK, KANSAS, JANUARY 11, 1996 -- Deprenyl Animal
Health, Inc. (NASDAQ-BB: DAHI; TSE: DAH) has completed its
agreement with Draxis Health Inc. (NASDAQ: DRAXF; TSE: DAX) to
distribute DAHI's recently-approved veterinary drug
Anipryl&#174;(l-selegiline) in Canada. </p>
<p>As part of the 10-year exclusive distribution agreement,
originally announced last month, Draxis has paid an upfront fee
of approximately US$469,000 for specified Canadian rights to
Anipryl&#174;, as well as US$125,000 for reimbursement of
expenses incurred to date to prepare marketing materials for the
Canadian launch of Anipryl&#174;. The companies entered into a
revenue-sharing formula for Canadian sales of Anipryl&#174;. </p>
<p>DAHI has completed a training program for Draxis' sales
representatives and expects that the first shipments of
Anipryl&#174; will be delivered to Draxis' warehouses by
mid-February. </p>
<p>Draxis will operate a sales force that will market
Anipryl&#174; to Canada's veterinary market, and has retained a
marketing director whose sole responsibility will be for animal
products. DAHI will manufacture Anipryl&#174; and will operate a
technical support center, staffed by veterinarians, to assure
quality control and assist clinical veterinarians in Canada. </p>
<p>&quot;We are pleased to take this important step in moving
DAHI from a pure research company to a veterinary pharmaceutical
manufacturing and marketing company,&quot; said David R. Stevens,
President and Chief Executive Officer of DAHI. &quot;The Canadian
market acceptance of Anipryl&#174; may serve as an indicator of
the North American potential for this pharmaceutical.&quot; </p>
<p>DAHI is evaluating its options for distribution of
Anipryl&#174; in the U.S., including negotiating with several
companies to establish a marketing alliance. Marketing rights in
selected European markets have been acquired by Hoechst
Veterinae, which is conducting clinical trials. </p>
<p>Anipryl&#174; was approved for sale in Canada for canine
Cushing's disease, which affects approximately 15,000 older dogs
in the country each year. Anipryl improves the quality of life of
older dogs, often delaying the decision by pet owners to put
their companion animal to sleep. </p>
<p>DAHI recently submitted a New Animal Drug Application with the
U.S. Food and Drug Administration to market Anipryl&#174; in the
U.S., where there are approximately 150,000 new cases of canine
Cushing's disease annually. </p>
<p>DAHI is also conducting Phase III-equivalent trials to obtain
approval to market Anipryl&#174; for cognitive dysfunction.
Approximately 150,000 older dogs in Canada, and 1.5 million older
dogs in the U.S. are diagnosed with cognitive dysfunction each
year. </p>
<p>As part of the distribution agreement, Draxis will convert
approximately US$1.5 million of the US$3 million in loans
outstanding into DAHI shares at CDN$2.11 per share or US$1.55.
Draxis Health will also provide US$1 million of additional
operating capital in the form of a loan convertible to DAHI
common shares at the rate of CDN$2.11 per share or US$1.55.
Except for the conversion rates, the new loan is subject to the
same general terms and conditions as the existing loans. Based on
the terms of the distribution agreement, DAHI anticipates that it
will meet its operating capital needs for 1996. </p>
<p>As a result of the conversion, Draxis will own approximately
43 percent of the shares of DAHI, and its ownership could
increase to approximately 52 percent of DAHI, on a non-diluted
basis, through the conversion of all of the loans outstanding. </p>
<p>Draxis is a marketing and research company that operates
Canadian neurological and dermatological pharmaceutical
divisions, a U.S. consumer marketing company, and offers products
exclusively through U.S. podiatrists. </p>
<p>Deprenyl Animal Health was established in 1990 to develop
animal health applications for Anipryl&#174;. The Company is also
identifying other animal health product opportunities to become a
multi-product animal health pharmaceutical company. </p>
<hr>
<p align="center">[ <a href="index.htm" target="_top">DAHI Home
Page</a> | <a href="frmvettp.htm" target="_top">Veterinarians</a>
| <a href="frmowntp.htm" target="_top">Pet Owners</a> | <a
href="frminvtp.htm" target="_top">Investors</a> ]</p>
<p align="center">[ <a href="about.htm">About DAHI</a> | <a
href="contents.htm" target="_top">Contents</a> | <a
href="contacts.htm">Contacts</a> | <a href="Links.htm">Links</a>
| <a href="Press.htm">Press Releases</a> | <a href="request.htm">Request
for Information</a> ]</p>
<hr>
<p><font size="2"><em>Send comments to DAHI webmaster: </em></font><a
href="mailto:dahimaster@deprenyl.com"><font size="2"><em>dahimaster@deprenyl.com</em></font></a><font
size="2"><em><br>
Copyright &#169; 1996 </em>Deprenyl Animal Health, Inc.<em> All
rights reserved.<br>
Revised: October 18, 1996.</em></font></p>
</body>
</html>
</DOC>
<DOC>
<DOCNO>WT02-B10-24</DOCNO>
<DOCOLDNO>IA038-000728-B002-219</DOCOLDNO>
<DOCHDR>
http://www.deprenyl.com:80/ 208.129.179.70 19970111075254 text/html 8132
HTTP/1.0 200 OK
Server: Microsoft-IIS/2.0
Date: Sat, 11 Jan 1997 07:52:39 GMT
Content-Type: text/html
</DOCHDR>
<!DOCTYPE HTML PUBLIC "-//W3O/DTD HTML//EN">

<html>
<head>
<title>Deprenyl Animal Health, Inc.</title>
<meta name="GENERATOR" content="Microsoft FrontPage 1.1">
<meta name="FORMATTER" content="Microsoft FrontPage 1.1">
</head>
<body background="images/Paper12l.jpg" bgcolor="#FFFFFF"
text="#000000" link="#FF0000" vlink="#400080" alink="#FFFF00">
<p align="center"><img src="images/dah9998.gif" align="bottom"
width="120" height="120"><img src="images/dahlgp2.jpg"
align="bottom" width="370" height="120"></p>
<p><center><em><font size="2">A wholly-owned subsidiary of Draxis
Health Inc.</font></em><br>
<center><font size="2">(TSE: DAX; &#160; &#160;NASDAQ: DRAXF)</font></p>
<div align="center"><center>
<table cellpadding="0" cellspacing="8" width="80%" align="center">
    <tr>
        <td width="40%"><div align="center"><center> 
        <table cellpadding="4" cellspacing="0" width="100%">
            <tr>
                <td width="100%"><a href="frmvettp.htm"><img
                src="images/vethmpg.JPG" align="bottom"
                border="0" width="275" height="65"></a></td>
            </tr>
            <tr>
                <td width="100%"><a href="frmowntp.htm"><img
                src="images/pethmpg.JPG" align="bottom"
                border="0" width="275" height="67"></a></td>
            </tr>
            <tr>
                <td width="100%"><a href="frminvtp.htm"><img
                src="images/invhmpg.JPG" align="bottom"
                border="0" width="275" height="67"></a></td>
            </tr>
        </table>
        </center></div> </td>
        <td rowspan="3" width="6"><img src="images/reddot.GIF"
        align="bottom" width="3" height="250"></td>
        <td align="center" width="50%">
        <table width="100%">
            <tr>
                <td valign="top" width="10%"><font size="4"><strong><img
                src="images/tri_blu.GIF" align="bottom"
                width="17" height="18"></strong></font></td>
                <td width="50%"><a href="about.htm"><font
                size="4"><strong>About DAHI</strong></font></a> 
                <ul>
                    <li><font size="3">Mission Statement</font></li>
                    <li><font size="3">Company Timeline</font></li>
                </ul>
                </td>
            </tr>
            <tr>
                <td width="10%"><font size="4"><strong><img
                src="images/tri_blu.GIF" align="bottom"
                width="17" height="18"></strong></font></td>
                <td width="50%"><a href="contents.htm"><font
                size="4"><strong>Site Contents</strong></font></a></td>
            </tr>
            <tr>
                <td width="10%"><font size="4"><strong><img
                src="images/tri_blu.GIF" align="bottom"
                width="17" height="18"></strong></font></td>
                <td width="50%"><a href="contacts.htm"
                target="_top"><font size="4"><strong>Contacts</strong></font></a></td>
            </tr>
            <tr>
                <td width="10%"><font size="4"><strong><img
                src="images/tri_blu.GIF" align="bottom"
                width="17" height="18"></strong></font></td>
                <td width="50%"><a href="press.htm"><font
                size="4"><strong>Press releases</strong></font></a></td>
            </tr>
            <tr>
                <td valign="top" width="10%"><font size="4"><strong><img
                src="images/tri_blu.GIF" align="bottom"
                width="17" height="18"></strong></font></td>
                <td width="50%"><a href="request.htm"><font
                size="4"><strong>Request for Information</strong></font></a></td>
            </tr>
        </table>
        </td>
    </tr>
</table>
</center></div>
<h2 align="center"><em>Welcome to Deprenyl Animal Health, Inc. </em></h2>
<h2 align="center"><em>(DAHI)</em></h2>
<p align="left">DAHI, a veterinary pharmaceutical company, is
engaged in obtaining worldwide pre-marketing regulatory approval
to commercialize Anipryl<sup><font size="1">&#174;</font></sup>
(l-selegiline hydrochloride; l-deprenyl), a break-through therapy
for treating canine senility or cognitive dysfunction syndrome
(also recognized as geriatric-onset behavioral disorders) and
canine Cushing's disease.</p>
<p align="left">DAHI received Canadian regulatory approval in
September, 1995, for treating canine Cushing's disease with
Anipryl<sup><font size="1">&#174;</font></sup>. Canadian sales
commenced in April, 1996, through DAHI's Canadian distribution
partner, Draxis Health Inc. DAHI is a wholly-owned subsidiary of
Draxis. Draxis is an emerging Toronto-based pharmaceutical
company focused on neurological, dermatological and veterinary
markets in Canada and the United States.</p>
<hr>
<p align="left">This site is divided into three major sections: </p>
<table border="1" cellpadding="5" cellspacing="10" width="100%">
    <tr>
        <td align="center" width="20%">
        <h3>Veterinarians </h3>
        </td>
        <td width="50%">includes specific information about
        Anipryl<sup><font size="1">&#174;</font></sup>, clinical
        signs of canine Cushing's disease, laboratory tests for
        Cushing's disease, scientific articles reference list,
        and other links of interest</td>
    </tr>
    <tr>
        <td align="center" width="20%">
        <h3>Pet Owners </h3>
        </td>
        <td width="50%">includes Frequently Asked Questions about
        canine Cushing's disease and Anipryl<sup><font size="1">&#174;</font></sup>,
        related articles, and other links of interest</td>
    </tr>
    <tr>
        <td align="center" width="20%">
        <h3>Investors </h3>
        </td>
        <td width="50%">includes an investor fact sheet, market
        facts &amp; pet statistics, DAHI timeline, and other
        links of interest</td>
    </tr>
</table>
<hr>
<p align="center"><font face="Arial"><font size="2">This site
uses tables and frames for easier viewing and navigation.</font></p>
<p align="center"><font size="2">Download Microsoft</font><sup><font
size="1">&#174;</font></sup><font size="2"> </font><a
href="http://www.microsoft.com/ie" target="_top"><font size="2">Internet
Explorer</font></a><font size="2"> for the best online
experience.</font></font> </p>
<p align="center"><a href="http://www.microsoft.com/ie"
target="_top"><img src="images/ie3logo.gif"
alt="Download Microsoft Internet Explorer" align="bottom"
border="0" width="88" height="31"></a> </p>
<p align="center"><font face="Arial"><font size="2">Select </font><a
href="contents.htm" target="_top"><font size="2">Contents</font></a><font
size="2"> to navigate site without frames.</font></font></p>
<hr>
<p align="center">[ <a href="frmvettp.htm" target="_top">Veterinarians</a>
| <a href="frmowntp.htm" target="_top">Pet Owners</a> | <a
href="frminvtp.htm" target="_top">Investors</a> ]</p>
<p align="center">[ <a href="about.htm">About DAHI</a> | <a
href="contents.htm" target="_top">Contents</a> | <a
href="contacts.htm">Contacts</a> | <a href="Links.htm">Links</a>
| <a href="Press.htm">Press Releases</a> | <a href="request.htm">Request
for Information</a> ]</p>
<hr>
<p align="center"><b>This Web site developed, hosted, and managed
by </b><a href="http://www.pdainc.com" target="_top"><b>PDA, Inc.</b></a> </p>
<p align="center"><a href="http://www.pdainc.com" target="_top"><img
src="images/pdalgsm.gif" align="bottom" border="0" width="150"
height="61"></a> </p>
<hr>
<p><font size="2"><em>Send comments to DAHI webmaster: </em></font><a
href="mailto:dahimaster@deprenyl.com"><font size="2"><em>dahimaster@deprenyl.com</em></font></a><font
size="2"><em><br>
Copyright &#169; 1996 </em>Deprenyl Animal Health, Inc.<em> All
rights reserved.<br>
Revised: December 17, 1996.</em></font></p>
</body>
</html>
</DOC>
<DOC>
<DOCNO>WT02-B10-25</DOCNO>
<DOCOLDNO>IA018-000200-B013-450</DOCOLDNO>
<DOCHDR>
http://www.kfb.se:80/ 194.198.183.242 19970106204334 text/html 2583
HTTP/1.0 200 OK
Date: Mon, 06 Jan 1997 20:38:41 GMT
Server: Microsoft-Internet-Information-Server/1.0
Content-Type: text/html
Last-Modified: Sun, 15 Dec 1996 23:49:16 GMT
Content-Length: 2383
</DOCHDR>
<HTML><!-- Head Tag --><HEAD><TITLE>KommunikationsForskningsBeredningen</TITLE></HEAD><!-- Body Tag --><BODY TEXT="#4C4C4C" BACKGROUND="yel_bgr.gif"></BODY><!-- Link Tag --><A HREF="kfbnews.html"><!-- Graphic Tag --><IMG WIDTH=539 HEIGHT=28 BORDER=0 ALT="P&aring; g&aring;ng!" SRC="headflasha.gif"></A><TABLE WIDTH=542 BORDER=0 ><TR><TD WIDTH=80 BORDER=0 valign=top align=center ><H6><!-- Link Tag --><A HREF="ehvproge/index.html"><!-- Graphic Tag --><IMG WIDTH=20 HEIGHT=11 BORDER=0    SRC="storbritt.gif"></A>     <BR><!-- Link Tag --><A HREF="ehvproge/index.html">[In English]</H6></A></TD><TD WIDTH=15 BORDER=0 valign=top align=center> </TD><TD WIDTH=427 BORDER=0 align=left valign=top><!-- Link Tag --><A HREF="welcome.html"><!-- Graphic Tag --><IMG WIDTH=427 HEIGHT=45 BORDER=1 ALT="Vlkommen till KFB!" SRC="kfbpress.gif"></A><!-- Link Tag --><A HREF="forskbidrag.html"><!-- Graphic Tag --><IMG WIDTH=427 HEIGHT=21 BORDER=1 ALT="Sk forskningsbidrag1" SRC="forskbidrag.gif"></A><!-- Link Tag --><A HREF="drivm.html"><!-- Graphic Tag --><IMG WIDTH=427 HEIGHT=82 BORDER=1 ALT="Drivmedel" SRC="hdline1.gif"></A><!-- Link Tag --><A HREF="telemat.html"><!-- Graphic Tag --><IMG WIDTH=233 HEIGHT=83 BORDER=1 ALT="telematik" SRC="hdline2.gif"></A><!-- Link Tag --><A HREF="komforsk.html"><!-- Graphic Tag --><IMG WIDTH=189 HEIGHT=83 BORDER=1 ALT="Strategisk kommunikationsforskning" SRC="hdline3.gif"></A><BR><!-- Link Tag --><A HREF="Bibliotek.html"><!-- Graphic Tag --><IMG WIDTH=217 HEIGHT=46 BORDER=1 ALT="Biblioteket" SRC="hdline4.gif"></A><!-- Link Tag --><A HREF="fystran.html"><!-- Graphic Tag --><IMG WIDTH=205 HEIGHT=46 BORDER=1 ALT="Fysiska transporter" SRC="hdline5.gif"></A><BR><!-- Link Tag --><A HREF="projekt.html"><!-- Graphic Tag --><IMG WIDTH=205 HEIGHT=21 BORDER=1 ALT="Projektdatabasen" SRC="projektem.gif"></A><!-- Link Tag --><A HREF="gendir.html"><!-- Graphic Tag --><IMG WIDTH=218 HEIGHT=21 BORDER=1 ALT="e-mail och telnummer" SRC="telnr.gif"></A><!-- Link Tag --><A HREF="inters/index.html"><!-- Graphic Tag --><IMG WIDTH=427 HEIGHT=36 BORDER=1  SRC="inter.gif"></A><HR SIZE=2>http://www.kfb.se -- Revised: 1996-12-17<BR>Copyright &copy; 1996/97 <A HREF="welcome.html">KFB</A><BR><A HREF="MAILTO:tina.esh@kfb.se">tina.esh@kfb.se</A><HR SIZE=2>                           </TD></TR></TABLE></BODY></HTML>
</DOC>
<DOC>
<DOCNO>WT02-B10-26</DOCNO>
<DOCOLDNO>IA018-000200-B013-455</DOCOLDNO>
<DOCHDR>
http://www.kfb.se:80/kfbnews.html 194.198.183.242 19970106204341 text/html 3896
HTTP/1.0 200 OK
Date: Mon, 06 Jan 1997 20:38:52 GMT
Server: Microsoft-Internet-Information-Server/1.0
Content-Type: text/html
Last-Modified: Thu, 19 Dec 1996 20:20:54 GMT
Content-Length: 3696
</DOCHDR>
<HTML><HEAD><TITLE>P&Aring; G&Aring;NG JUST NU!</TITLE></HEAD><BODY BGCOLOR="#FFFFFF" ><H6><!-- Link Tag --><A HREF="index.html">[Home]</A></H6><!-- Graphic Tag --><IMG WIDTH=539 HEIGHT=28  SRC="head1.gif"><BR><TABLE WIDTH=535 BORDER=0 ><TR><TD WIDTH=220 BORDER=0 valign=top><!-- Graphic Tag --><IMG WIDTH=198 HEIGHT=49  SRC="jul.gif"><BR>Under 1997 kommer vi att f&aring; ordentlig fart p&aring; v&aring;r sajt. Bl a kommer b&aring;de projektregister och forskarrapporter att bli tillg&auml;ngliga fr&aring;n din dator. Det kommer att bli m&ouml;jligt att b&aring;de s&ouml;ka p&aring; rubriker, medverkande forskare och efter dinarienummer. <BR>Delar av detta kommer att visas upp p&aring; VTI:s och KFB:s forskardagar i Link&ouml;ping nu i Januari. V&auml;l m&ouml;tt d&auml;r och p&aring; kfb.se.<!-- Horizontal Line Tag --><HR WIDTH=100%><BR><!-- Graphic Tag --><IMG WIDTH=113 HEIGHT=165  SRC="nr6.gif"><H1><!-- Font Tag --><FONT COLOR="#BF361C">L&auml;s Kommunik&eacute;</FONT></H1><B>Nummer 6 ute nu!</B><BR>Du som &auml;r intresserad av att f&ouml;lja forskningen inom trafik, informationsteknik, milj&ouml;, samh&auml;llsplanering och transporter g&ouml;r det enklast genom att prenumerera p&aring; KFB Kommunik&eacute;. Tidningen kommer ut med 6 nummer per &aring;r och kostar bara 150:- inkl moms. Studerande betalar 100:- inklusive moms. Fyll i <A HREF="tidnkup.html">kupongen</A> och faxa in till oss p&aring; tel 08-662  66 09 eller posta den till KFB, Box 5706, 114 87 Stockholm.<P>L&auml;s en av artiklarna - <!-- Link Tag --><A HREF="nr6artikel.html"><B>Ett nyt&auml;nkande inom kollektiv- trafiken</B></A><BR><BR><BR><!-- Horizontal Line Tag --><HR WIDTH=100%><!-- Graphic Tag --><IMG WIDTH=113 HEIGHT=59  ALIGN= right SRC="transport.gif"><BR><B>V&auml;lkommen till TRANSPORTFORUM. </B>VTI:s och KFB:s forskardagar i Link&ouml;ping 8 och 9 januari 1997.<BR>F&ouml;r information ring Ing-Mari Eriksson eller Kenneth Asp, VTI, tel 013-13 69 39.<BR><!-- Horizontal Line Tag --><HR WIDTH=100% SIZE=1></TD><TD WIDTH=15 BORDER=0 align=center><!-- Graphic Tag --><IMG WIDTH=1 HEIGHT=482  SRC="vrule.gif"></TD><TD WIDTH=220 BORDER=0 VALIGN=TOP><!-- Graphic Tag --><IMG WIDTH=85 HEIGHT=63 VALIGN=TOP SRC="Press.gif"><!-- Horizontal Line Tag --><HR WIDTH=100%><BR><!-- Font Tag --><FONT COLOR="#BF361C"><H2>Nu &auml;r det dags</H2></FONT>att s&ouml;ka bidrag till transportforskningsprojekt inom EU:s fj&auml;rde ramprogram. <BR>Ans&ouml;kningsomg&aring;ngen b&ouml;rjar den 17 december och avslutas den 17 mars 1997.<BR>Svenska forskare har redan fr&aring;n start visat stort intresse och kommit med i konsortier som har bra projekt vilkett lett till att de valts ut och f&aring;tt finansiering.<BR>Den andra ans&ouml;kningsomg&aring;ngen har bekr&auml;ftat framg&aring;ngen. Av 225 inl&auml;mnade ans&ouml;kningar ingick svenskar i 56 av konsortierna. Den h&auml;r g&aring;ngen valdes 84 projekt ut och igen var svenskar med i vart tredje projekt.<BR>Nu startar tredje ans&ouml;kningsomg&aring;ngen..<BR><BR><!-- Graphic Tag --><IMG WIDTH=198 HEIGHT=228  SRC="utveck.gif"><!-- Horizontal Line Tag --><HR WIDTH=100%><BR><!-- Font Tag --><FONT COLOR="#BF361C"><H2>KONFERENSREGISTRET</H2></FONT>H&auml;r hittar du f&ouml;rteckning &ouml;ver aktuella konferenser inom transportomr&aring;det.</FONT><!-- Link Tag --><A HREF="vtitom9706.html">Konferenser t.o.m 1997-06</A><BR><!-- Link Tag --><A HREF="from9707.html">Konferenser fr.o.m. 1997-07</A><!-- Horizontal Line Tag --><HR WIDTH=100%><BR><A HREF="index.html"><IMG SRC="homeicon.gif" BORDER = 0 ALT="[Home]"></A></td></tr></TABLE></BODY></HTML>
</DOC>
<DOC>
<DOCNO>WT02-B10-27</DOCNO>
<DOCOLDNO>IA018-000200-B013-471</DOCOLDNO>
<DOCHDR>
http://www.kfb.se:80/ehvproge/index.html 194.198.183.242 19970106204349 text/html 2193
HTTP/1.0 200 OK
Date: Mon, 06 Jan 1997 20:38:59 GMT
Server: Microsoft-Internet-Information-Server/1.0
Content-Type: text/html
Last-Modified: Thu, 05 Dec 1996 09:15:24 GMT
Content-Length: 1993
</DOCHDR>
<HTML><!---------------------------------------------------------------><!-      AUTHOR:     	 mats holm                           ><!-      E-MAIL:      	     mats@softmachine.se                  ><!-      CREATED:   	 1996.11.22                 ><!-      MODIFIED:  	                     ><!-      FILE:               index.html                       ><!---------------------------------------------------------------><!-- Body Tag --><BODY TEXT="#FFFFFF" LINK="#BA8702" VLINK="#BA8702" ALINK="#FFFFFF" BACKGROUND="ehvpic/blue_bgr.gif"><H6><!-- Link Tag --><A HREF="introduction.html">[Intro]</A>     <!-- Link Tag --><A HREF="program.html">[R, D & D program]</A><!-- Link Tag --><A HREF="projects.html">[Projects]</A><!-- Link Tag --><A HREF="hood.html">[Under the hood]</A><!-- Link Tag --><A HREF="infra.html">[Infrastructure]</A><!-- Link Tag --><A HREF="energy.html">[Energy]</A><!-- Link Tag --><A HREF="perform.html">[Performance]</A><!-- Link Tag --><A HREF="market.html">[Market]</A><!-- Link Tag --><A HREF="../ehvprogs.html">[In Swedish]</A><BR><BR><!-- Link Tag --><MAP NAME="homed">    <AREA SHAPE="rect" COORDS="10,333,445,354" HREF="program.html">    <AREA SHAPE="rect" COORDS="9,298,526,315" HREF="market.html">    <AREA SHAPE="rect" COORDS="10,263,493,280" HREF="hood.html">    <AREA SHAPE="rect" COORDS="11,226,490,243" HREF="perform.html">    <AREA SHAPE="rect" COORDS="9,145,527,162" HREF="economic.html">    <AREA SHAPE="rect" COORDS="8,106,495,129" HREF="projects.html">    <AREA SHAPE="rect" COORDS="8,74,341,93" HREF="energy.html">				<AREA SHAPE="rect" COORDS="10,8,79,20" HREF="introduction.html">    <AREA SHAPE="rect" COORDS="116,7,187,22" HREF="../ehvprogs.html">    <AREA SHAPE="rect" COORDS="9,41,414,61" HREF="infra.html"></MAP><IMG SRC="ehvpic/homed.gif" WIDTH="539" HEIGHT="365" ALIGN="BOTTOM"  ISMAP USEMAP="#homed" BORDER=0>  <BR><!-- Link Tag --><A HREF="../index.html">[KFB Main]</A><BR></H6> </BODY></HTML>
</DOC>
<DOC>
<DOCNO>WT02-B10-28</DOCNO>
<DOCOLDNO>IA018-000200-B013-487</DOCOLDNO>
<DOCHDR>
http://www.kfb.se:80/welcome.html 194.198.183.242 19970106204400 text/html 2396
HTTP/1.0 200 OK
Date: Mon, 06 Jan 1997 20:39:07 GMT
Server: Microsoft-Internet-Information-Server/1.0
Content-Type: text/html
Last-Modified: Wed, 18 Dec 1996 15:49:58 GMT
Content-Length: 2196
</DOCHDR>
<HTML><!-- Head Tag --><HEAD><TITLE>Strategisk kommunikationsforskning</TITLE></HEAD><!-- Body Tag --><BODY TEXT="#4C4C4C" BACKGROUND="yel_bgr.gif"></BODY><!-- Link Tag --><A HREF="kfbnews.html"><!-- Graphic Tag --><IMG WIDTH=539 HEIGHT=28 BORDER=0 ALT="P&aring; g&aring;ng!" SRC="headflasha.gif"></A><TABLE WIDTH=542 BORDER=0 ><TR><TD WIDTH=60 BORDER=0 valign=top align=left><BR><H5>Presentation<BR>av KFB!<BR><BR><!-- Link Tag --><A HREF="forskbidrag.html">S&ouml;k forsknings-<BR>bidrag</A><BR><BR><!-- Link Tag --><A HREF="drivm.html">Drivmedel och fordon</A><BR><BR><!-- Link Tag --><A HREF="telemat.html">Telematik</A><BR><BR><!-- Link Tag --><A HREF="komforsk.html">Strategisk <BR>kommunikations-<BR>forskning</A><BR><BR><!-- Link Tag --><A HREF="fystran.html">Fysiska transporter</A><BR><BR><!-- Link Tag --><A HREF="inters/index.html">Internationella<BR>fr&aring;gor</A><BR><BR><!-- Link Tag --><A HREF="info.html">Informations-<BR>avdelningen</A><BR><BR><!-- Link Tag --><A HREF="projekt.html">Projektdatabasen</A><BR><BR><!-- Link Tag --><A HREF="bibliotek.html">Biblioteket</A><BR><BR><!-- Link Tag --><A HREF="gendir.html">Telefon och e-mail</A><BR><BR</TD></H5><TD WIDTH=50  BORDER=0 valign=top align=left></TD><TD WIDTH=300 BORDER=0 align=left valign=top><BR><IMG SRC="pumpl.gif" ALIGN=RIGHT><STRONG>KFB<BR></STRONG>KommunikationsForskningsBeredningen &auml;r en statlig myndighet som planerar, initierar, samordnar och st&ouml;djer &ouml;vergripande forskning, utveckling och demonstrationsverksamhet (FUD). <P>KFBs verksamhet omfattar transporter, trafik, post- och telekommunikationernas betydelse f&ouml;r milj&ouml;n, trafiks&auml;kerheten och den regionala utvecklingen. KFB svarar ocks&aring; f&ouml;r informationen och dokumentationen inom forskningsomr&aring;det.<BR><HR>Bes&ouml;ksadress:Linn&eacute;gatan 2  Stockholm<BR> Postadress: Box 5706, 114 87 Stockholm<BR>Tel: 08-459 17 00; +46 8 469 17 00<BR> Fax: 08-662 66 09; + 46 8 662 66 09<BR><HR SIZE=2><H6><!-- Link Tag --><A HREF="index.html">[Till KFB:s huvudsida]</A></H6>                           </TD></TR></TABLE></BODY></HTML>
</DOC>
<DOC>
<DOCNO>WT02-B10-29</DOCNO>
<DOCOLDNO>IA018-000200-B013-502</DOCOLDNO>
<DOCHDR>
http://www.kfb.se:80/forskbidrag.html 194.198.183.242 19970106204410 text/html 2334
HTTP/1.0 200 OK
Date: Mon, 06 Jan 1997 20:39:18 GMT
Server: Microsoft-Internet-Information-Server/1.0
Content-Type: text/html
Last-Modified: Fri, 20 Dec 1996 01:15:02 GMT
Content-Length: 2134
</DOCHDR>
<HTML><!-- Head Tag --><HEAD><TITLE>Forskningsbidrag</TITLE></HEAD><!-- Body Tag --><BODY TEXT="#4C4C4C" BACKGROUND="yel_bgr.gif"></BODY><!-- Link Tag --><A HREF="kfbnews.html"><!-- Graphic Tag --><IMG WIDTH=539 HEIGHT=28 BORDER=0 ALT="P&aring; g&aring;ng!" SRC="headflasha.gif"></A><TABLE WIDTH=542 BORDER=0 ><TR><TD WIDTH=60 BORDER=0 valign=top align=left><BR><H5><!-- Link Tag --><A HREF="welcome.html">Presentation<BR>av KFB!</A><BR><BR>S&ouml;k forsknings-bidrag<BR><BR><!-- Link Tag --><A HREF="drivm.html">Drivmedel och fordon</A><BR><BR><!-- Link Tag --><A HREF="telemat.html">Telematik</A><BR><BR><!-- Link Tag --><A HREF="komforsk.html">Strategisk <BR>kommunikations-<BR>forskning</A><BR><BR><!-- Link Tag --><A HREF="fystran.html">Fysiska transporter</A><BR><BR><!-- Link Tag --><A HREF="inters/index.html">Internationella<BR>fr&aring;gor</A><BR><BR><!-- Link Tag --><A HREF="info.html">Informations-<BR>avdelningen</A><BR><BR><!-- Link Tag --><A HREF="projekt.html">Projektdatabasen</A><BR><BR><!-- Link Tag --><A HREF="bibliotek.html">Biblioteket</A><BR><BR><!-- Link Tag --><A HREF="gendir.html">Telefon och e-mail</A><BR><BR</TD></H5><TD WIDTH=50  BORDER=0 valign=top align=left></TD><TD WIDTH=300 BORDER=0 align=left valign=top><BR><H3>Forskningsbidrag</H3>Ans&ouml;kningstillf&auml;llena f&ouml;r forskningsbidrag &auml;r  tv&aring; per &aring;r. 1/3 och 15/9.<BR>Under respektive forskningsomr&aring;de hittar du l&auml;nk till ansvariga handl&auml;ggare.<BR><BR>Ladda ner ans&ouml;kningshandlingarna,<BR><BR> <!-- Font Tag --><!-- Link Tag --><A HREF="ftp:///arkiv/ansokan.pdf">Som pdf-dokument.</A><BR><BR><!-- Link Tag --><A HREF="ftp:///arkiv/ANSOK.ZIP">Som PageMaker 5.0 (PC)</A><BR><BR><!-- Link Tag --><A HREF="ftp:///arkiv/Ansokningsblanketter.sea">Som Page Maker 6.0 (MacOS)</A><BR><BR>fyll i handlingarna och skicka i original till KFB. Box5706, 114 87 Stockholm. <BR><HR SIZE=2><H6><!-- Link Tag --><A HREF="index.html">[Till KFB:s huvudsida]</A></H6>                           </TD></TR></TABLE></BODY></HTML>
</DOC>
<DOC>
<DOCNO>WT02-B10-30</DOCNO>
<DOCOLDNO>IA018-000200-B014-8</DOCOLDNO>
<DOCHDR>
http://www.kfb.se:80/drivm.html 194.198.183.242 19970106204422 text/html 3457
HTTP/1.0 200 OK
Date: Mon, 06 Jan 1997 20:39:33 GMT
Server: Microsoft-Internet-Information-Server/1.0
Content-Type: text/html
Last-Modified: Wed, 18 Dec 1996 15:11:28 GMT
Content-Length: 3257
</DOCHDR>
<HTML><!-- Head Tag --><HEAD><TITLE>Drivmedel och fordon</TITLE></HEAD><!-- Body Tag --><BODY TEXT="#4C4C4C" BACKGROUND="yel_bgr.gif"></BODY><!-- Link Tag --><A HREF="kfbnews.html"><!-- Graphic Tag --><IMG WIDTH=539 HEIGHT=28 BORDER=0 ALT="P&aring; g&aring;ng!" SRC="headflasha.gif"></A><TABLE WIDTH=542 BORDER=0 ><TR><TD WIDTH=60 BORDER=0 valign=top align=left><BR><H5><!-- Link Tag --><A HREF="welcome.html">Presentation<BR>av KFB!</A><BR><BR><!-- Link Tag --><A HREF="forskbidrag.html">S&ouml;k forsknings-<BR>bidrag</A><BR><BR>Drivmedel och fordon<BR><BR><!-- Link Tag --><A HREF="telemat.html">Telematik</A><BR><BR><!-- Link Tag --><A HREF="komforsk.html">Strategisk <BR>kommunikations-<BR>forskning</A><BR><BR><!-- Link Tag --><A HREF="fystran.html">Fysiska transporter</A><BR><BR><!-- Link Tag --><A HREF="inters/index.html">Internationella<BR>fr&aring;gor</A><BR><BR><!-- Link Tag --><A HREF="info.html">Informations-<BR>avdelningen</A><BR><BR><!-- Link Tag --><A HREF="projekt.html">Projektdatabasen</A><BR><BR><!-- Link Tag --><A HREF="bibliotek.html">Biblioteket</A><BR><BR><!-- Link Tag --><A HREF="gendir.html">Telefon och e-mail</A><BR><BR</TD></H5><TD WIDTH=50  BORDER=0 valign=top align=left></TD><TD WIDTH=300 BORDER=0 align=left valign=top><BR><IMG SRC="drivm.gif" ALIGN=RIGHT><STRONG>DRIVMEDEL OCH FORDON<BR></STRONG><EM>M&aring;l:<BR></EM>Omr&aring;det inneh&aring;ller tv&aring; stycken delprogram&#59; Biobaserade drivmedel och El- och hybridfordon.<BR>Syftena med de b&aring;da delprogrammen &auml;r i m&aring;nga avseenden desamma. Programmet har till uppgift att ge svar p&aring; fr&aring;gan om m&ouml;jligheten att introducera alternativa drivmedel respektive el- och hybridfordon f&ouml;r att uppn&aring; milj&ouml;f&ouml;rdelar och dessutom valm&ouml;jligheter med inhemsk produktion av drivmedel samt att pr&ouml;va vilken realism alternativen har.<P><!-- Link Tag --><A HREF="bioprogs/index.html">BIOBASERADE DRIVMEDEL</A><BR>&#128; Drift och utveckling av fordon och motorer<DT>&#128; Anpassning och distribution av drivmedel<DT>&#128; Effektstudier p&aring; olika niv&aring;er<P><A HREF="ehvproge/index.html">EL- och HYBRIDFORDON</A><BR><!-- Link Tag --><A HREF="./ehvproge/index.html"></A>&#128; Basprojekt f&ouml;r demonstration i G&ouml;teborg och Malm&ouml;<BR>&#128; Specialprojekt, bl a i Stockholm, f&ouml;r s&auml;rskilda till&auml;mpningar<BR>&#128; St&ouml;d till utveckling av elhybridfordon<BR>&#128; Utv&auml;rdering p&aring; b&aring;de central och regional niv&aring;<BR>&#128; Forskning och studier kring villkoren f&ouml;r en storskalig introduktion av el- och hybridfordon<P>V&auml;lkommen att kontakta respektive <A HREF="gendir.html">handl&auml;ggare</A> om du skall s&ouml;ka forskningsbidrag. L&auml;s om </A><A HREF="projekt.html">p&aring;g&aring;ende projekt</A> som presenteras i <A HREF="bibliotek.html">forskarrapporter</A> n&auml;r de &auml;r avslutade.<p>Ansvarig f&ouml;r Drivmedel och Fordon &auml;r <A HREF="mailto:jan.parmeby@kfb.se">Jan Parmeby<P></A><HR SIZE=2><H6><!-- Link Tag --><A HREF="index.html">[Till KFB:s huvudsida]</A></H6>                           </TD></TR></TABLE></BODY></HTML>
</DOC>
<DOC>
<DOCNO>WT02-B10-31</DOCNO>
<DOCOLDNO>IA018-000200-B014-21</DOCOLDNO>
<DOCHDR>
http://www.kfb.se:80/telemat.html 194.198.183.242 19970106204433 text/html 2810
HTTP/1.0 200 OK
Date: Mon, 06 Jan 1997 20:39:41 GMT
Server: Microsoft-Internet-Information-Server/1.0
Content-Type: text/html
Last-Modified: Wed, 18 Dec 1996 15:49:54 GMT
Content-Length: 2610
</DOCHDR>
<HTML><!-- Head Tag --><HEAD><TITLE>Telematik</TITLE></HEAD><!-- Body Tag --><BODY TEXT="#4C4C4C" BACKGROUND="yel_bgr.gif"></BODY><!-- Link Tag --><A HREF="kfbnews.html"><!-- Graphic Tag --><IMG WIDTH=539 HEIGHT=28 BORDER=0 ALT="P&aring; g&aring;ng!" SRC="headflasha.gif"></A><TABLE WIDTH=542 BORDER=0 ><TR><TD WIDTH=60 BORDER=0 valign=top align=left><BR><H5><!-- Link Tag --><A HREF="welcome.html">Presentation<BR>av KFB!</A><BR><BR><!-- Link Tag --><A HREF="forskbidrag.html">S&ouml;k forsknings-<BR>bidrag</A><BR><BR><!-- Link Tag --><A HREF="drivm.html">Drivmedel och fordon</A><BR><BR>Telematik<BR><BR><!-- Link Tag --><A HREF="komforsk.html">Strategisk <BR>kommunikations-<BR>forskning</A><BR><BR><!-- Link Tag --><A HREF="fystran.html">Fysiska transporter</A><BR><BR><!-- Link Tag --><A HREF="inters/index.html">Internationella<BR>fr&aring;gor</A><BR><BR><!-- Link Tag --><A HREF="info.html">Informations-<BR>avdelningen</A><BR><BR><!-- Link Tag --><A HREF="projekt.html">Projektdatabasen</A><BR><BR><!-- Link Tag --><A HREF="bibliotek.html">Biblioteket</A><BR><BR><!-- Link Tag --><A HREF="gendir.html">Telefon och e-mail</A><BR><BR</TD></H5><TD WIDTH=50  BORDER=0 valign=top align=left></TD><TD WIDTH=300 BORDER=0 align=left valign=top><BR><IMG SRC="telematik.gif" ALIGN=RIGHT>TELEMATIK<STRONG><BR></STRONG>Ansvarig &auml;r <A HREF="mailto:klas.barklof@kfb.se">Klas Barkl&ouml;f</A><P><EM>M&aring;l:<BR></EM>Programmet Telematik har som m&aring;l att utr&ouml;na effekterna av telematikens &ouml;kade anv&auml;ndning, s&aring;v&auml;l f&ouml;r individen som samh&auml;llet samt vilka f&ouml;ljder den nya tekniken kan f&aring; ur bl a samh&auml;llsekonomisk, regional, social och juridisk synvinkel. De tekniska systemens s&auml;kerhet samt den personliga integreteten skall ocks&aring; behandlas.<P><EM>Definierade behovsomr&aring;den<BR></EM>&#128; N&auml;tverk i informationssamh&auml;llet<BR>&#128; Inf&ouml;rande av telematik<BR>&#128; Telematikens samh&auml;lleliga konsekvenser<BR>&#128; Post<BR>&#128; Handikappst&ouml;d<BR>&#128; &Ouml;vrig demonstrationsverksamhet<P>V&auml;lkommen att kontakta respektive <A HREF="gendir.html">handl&auml;ggare</A> om du skall s&ouml;ka forskningsbidrag. L&auml;s om </A><A HREF="projekt.html">p&aring;g&aring;ende projekt</A> som presenteras i <A HREF="bibliotek.html">forskarrapporter</A> n&auml;r de &auml;r avslutade.<BR><HR SIZE=2><H6><!-- Link Tag --><A HREF="index.html">[Till KFB:s huvudsida]</A></H6>                           </TD></TR></TABLE></BODY></HTML>
</DOC>
<DOC>
<DOCNO>WT02-B10-32</DOCNO>
<DOCOLDNO>IA018-000200-B014-29</DOCOLDNO>
<DOCHDR>
http://www.kfb.se:80/komforsk.html 194.198.183.242 19970106204440 text/html 3144
HTTP/1.0 200 OK
Date: Mon, 06 Jan 1997 20:39:51 GMT
Server: Microsoft-Internet-Information-Server/1.0
Content-Type: text/html
Last-Modified: Wed, 18 Dec 1996 15:33:02 GMT
Content-Length: 2944
</DOCHDR>
<HTML><!-- Head Tag --><HEAD><TITLE>Strategisk kommunikationsforskning</TITLE></HEAD><!-- Body Tag --><BODY TEXT="#4C4C4C" BACKGROUND="yel_bgr.gif"></BODY><!-- Link Tag --><A HREF="kfbnews.html"><!-- Graphic Tag --><IMG WIDTH=539 HEIGHT=28 BORDER=0 ALT="P&aring; g&aring;ng!" SRC="headflasha.gif"></A><TABLE WIDTH=542 BORDER=0 ><TR><TD WIDTH=60 BORDER=0 valign=top align=left><BR><H5><!-- Link Tag --><A HREF="welcome.html">Presentation<BR>av KFB!</A><BR><BR><!-- Link Tag --><A HREF="forskbidrag.html">S&ouml;k forsknings-<BR>bidrag</A><BR><BR><!-- Link Tag --><A HREF="drivm.html">Drivmedel och fordon</A><BR><BR><!-- Link Tag --><A HREF="telemat.html">Telematik</A><BR><BR>Strategisk <BR>kommunikations-<BR>forskning<BR><BR><!-- Link Tag --><A HREF="fystran.html">Fysiska transporter</A><BR><BR><!-- Link Tag --><A HREF="inters/index.html">Internationella<BR>fr&aring;gor</A><BR><BR><!-- Link Tag --><A HREF="info.html">Informations-<BR>avdelningen</A><BR><BR><!-- Link Tag --><A HREF="projekt.html">Projektdatabasen</A><BR><BR><!-- Link Tag --><A HREF="bibliotek.html">Biblioteket</A><BR><BR><!-- Link Tag --><A HREF="gendir.html">Telefon och e-mail</A><BR><BR</TD></H5><TD WIDTH=50  BORDER=0 valign=top align=left></TD><TD WIDTH=300 BORDER=0 align=left valign=top><BR><IMG SRC="komforsk.gif" ALIGN=RIGHT>STRATEGISK KOMMUNIKATIONSFORSKNING<P></STRONG>Ansvarig &auml;r <A HREF="mailto:klas.barklof@kfb.se">Klas Barkl&ouml;f</A><P><EM>M&aring;l:<BR></EM>Det l&aring;ngsiktiga m&aring;let f&ouml;r programmet strategisk kommunikationsforskning &auml;r att systematiskt f&ouml;rb&auml;ttra kunskapsunderlaget f&ouml;r kommunikationspolitiska st&auml;llningstaganden. Detta skall ske genom att underbygga en helhetssyn p&aring; kommunikationsv&auml;sendet och dess relationer till det &ouml;vriga samh&auml;llet samt dess effekter p&aring; naturmilj&ouml;n. F&ouml;r att n&aring; detta m&aring;l &auml;r det viktigt att programmet st&ouml;djer inf&ouml;rlivandet och utvecklingen av nya teorier och modeller inom kommunikationsforskningen.<BR> <BR><EM>Programmets inneh&aring;ll:<BR></EM>Programmet best&aring;r av sex kunskapsomr&aring;den eller aspekter som kommer att ha stor relevans f&ouml;r en strategisk kommunikationsforskning<BR>&#128; R&ouml;rlighet<DT>&#128; Uth&aring;llighet/b&auml;rkraft<BR>&#128; Internationalisering<DT>&#128; Teknikf&ouml;r&auml;ndringar<BR>&#128; Regelsystem<BR>&#128; Planeringsmodeller<P>V&auml;lkommen att kontakta respektive <A HREF="gendir.html">handl&auml;ggare</A> om du skall s&ouml;ka forskningsbidrag. L&auml;s om <A HREF="projekt.html">p&aring;g&aring;ende projekt</A> som presenteras i <A HREF="bibliotek.html">forskarrapporter</A> n&auml;r de &auml;r avslutade.<BR><HR SIZE=2><H6><!-- Link Tag --><A HREF="index.html">[Till KFB:s huvudsida]</A></H6>                           </TD></TR></TABLE></BODY></HTML>
</DOC>
<DOC>
<DOCNO>WT02-B10-33</DOCNO>
<DOCOLDNO>IA018-000200-B014-44</DOCOLDNO>
<DOCHDR>
http://www.kfb.se:80/Bibliotek.html 194.198.183.242 19970106204453 text/html 3182
HTTP/1.0 200 OK
Date: Mon, 06 Jan 1997 20:39:59 GMT
Server: Microsoft-Internet-Information-Server/1.0
Content-Type: text/html
Last-Modified: Wed, 18 Dec 1996 15:15:28 GMT
Content-Length: 2982
</DOCHDR>
<HTML><!-- Head Tag --><HEAD><TITLE>Biblioteket</TITLE></HEAD><!-- Body Tag --><BODY TEXT="#4C4C4C" BACKGROUND="yel_bgr.gif"></BODY><!-- Link Tag --><A HREF="kfbnews.html"><!-- Graphic Tag --><IMG WIDTH=539 HEIGHT=28 BORDER=0 ALT="P&aring; g&aring;ng!" SRC="headflasha.gif"></A><TABLE WIDTH=542 BORDER=0 ><TR><TD WIDTH=60 BORDER=0 valign=top align=left><BR><H5><!-- Link Tag --><A HREF="welcome.html">Presentation<BR>av KFB!</A><BR><BR><!-- Link Tag --><A HREF="forskbidrag.html">S&ouml;k forsknings-<BR>bidrag</A><BR><BR><!-- Link Tag --><A HREF="drivm.html">Drivmedel och fordon</A><BR><BR><!-- Link Tag --><A HREF="telemat.html">Telematik</A><BR><BR><!-- Link Tag --><A HREF="komforsk.html">Strategisk <BR>kommunikations-<BR>forskning</A><BR><BR><!-- Link Tag --><A HREF="fystran.html">Fysiska transporter</A><BR><BR><!-- Link Tag --><A HREF="inters/index.html">Internationella<BR>fr&aring;gor</A><BR><BR><!-- Link Tag --><A HREF="info.html">Informations-<BR>avdelningen</A><BR><BR><!-- Link Tag --><A HREF="projekt.html">Projektdatabasen</A><BR><BR>Biblioteket<BR><BR><!-- Link Tag --><A HREF="gendir.html">Telefon och e-mail</A><BR><BR</TD></H5><TD WIDTH=50  BORDER=0 valign=top align=left></TD><TD WIDTH=300 BORDER=0 align=left valign=top><BR><H2>Biblioteket</H2><P>I Kommunikationsforskningsberedningens (KFB) publikationsserier redovisar forskare sina projekt. Publiceringen  inneb&auml;r inte att KFB tar st&auml;llning till framf&ouml;rda &aring;sikter, slutsatser och resulat. </P><P>Om du saknar n&aring;gon rapport s&auml;nd oss g&auml;rna ett <!-- MailTo Tag --><A HREF="MAILTO:arne.kihlblom">e-mail</A>.</P><P><B>KFB-rapporter</B> f&ouml;rs&auml;ljs genom Fritzes Kundtj&auml;nst, <BR>106 47 Stockholm. Tel 08-690 90 90.<BR><B>&Ouml;vriga KFB-publikationer</B> best&auml;lls och erh&aring;lls direkt  fr&aring;n KFB. Man kan dessutom abonnera p&aring; tidningen KFB-Kommunik&eacute;.</P><P><B>KFB-reports</B> are sold through Fritzes&#146; Customer Service, <BR>S-106 47 Stockholm, Sweden. <BR><B>Other KFB publications </B>are ordered directly from The Swedish Transport and Communications Research Board, <BR>Box 1273,  S-111 92 Stockholm, Sweden </P><HR><H3>F&ouml;rteckning &ouml;ver rapporter </H3><!-- Link Tag --><A HREF="rapporter/rap_allm.html">&Ouml;vergripande</A><BR><BR><!-- Link Tag --><A HREF="rapporter/rap_elhybrid.html">El- och hybridfordon</A><BR><BR><!-- Link Tag --><A HREF="rapporter/rap_bio.html">Biobaserade drivmedel</A><BR><BR><!-- Link Tag --><A HREF="rapporter/rap_tele.html">Telematik</A><BR><BR><!-- Link Tag --><A HREF="rapporter/rap_fys.html">Fysiska transporter</A><BR><BR><!-- Link Tag --><A HREF="rapporter/rap_strat.html">Strategisk kommunikationsforskning</A><BR><BR><HR SIZE=2><H6><!-- Link Tag --><A HREF="index.html">[Till KFB:s huvudsida]</A></H6>                           </TD></TR></TABLE></BODY></HTML>
</DOC>
<DOC>
<DOCNO>WT02-B10-34</DOCNO>
<DOCOLDNO>IA018-000200-B014-58</DOCOLDNO>
<DOCHDR>
http://www.kfb.se:80/fystran.html 194.198.183.242 19970106204501 text/html 2974
HTTP/1.0 200 OK
Date: Mon, 06 Jan 1997 20:40:11 GMT
Server: Microsoft-Internet-Information-Server/1.0
Content-Type: text/html
Last-Modified: Wed, 18 Dec 1996 15:14:20 GMT
Content-Length: 2774
</DOCHDR>
<HTML><!-- Head Tag --><HEAD><TITLE>Fysiska transporter</TITLE></HEAD><!-- Body Tag --><BODY TEXT="#4C4C4C" BACKGROUND="yel_bgr.gif"></BODY><!-- Link Tag --><A HREF="kfbnews.html"><!-- Graphic Tag --><IMG WIDTH=539 HEIGHT=28 BORDER=0 ALT="P&aring; g&aring;ng!" SRC="headflasha.gif"></A><TABLE WIDTH=542 BORDER=0 ><TR><TD WIDTH=60 BORDER=0 valign=top align=left><BR><H5><!-- Link Tag --><A HREF="welcome.html">Presentation<BR>av KFB!</A><BR><BR><!-- Link Tag --><A HREF="forskbidrag.html">S&ouml;k forsknings-<BR>bidrag</A><BR><BR><!-- Link Tag --><A HREF="drivm.html">Drivmedel och fordon</A><BR><BR><!-- Link Tag --><A HREF="telemat.html">Telematik</A><BR><BR><!-- Link Tag --><A HREF="komforsk.html">Strategisk <BR>kommunikations-<BR>forskning</A><BR><BR>Fysiska transporter<BR><BR><!-- Link Tag --><A HREF="inters/index.html">Internationella<BR>fr&aring;gor</A><BR><BR><!-- Link Tag --><A HREF="info.html">Informations-<BR>avdelningen</A><BR><BR><!-- Link Tag --><A HREF="projekt.html">Projektdatabasen</A><BR><BR><!-- Link Tag --><A HREF="bibliotek.html">Biblioteket</A><BR><BR><!-- Link Tag --><A HREF="gendir.html">Telefon och e-mail</A><BR><BR</TD></H5><TD WIDTH=50  BORDER=0 valign=top align=left></TD><TD WIDTH=300 BORDER=0 align=left valign=top><BR><STRONG><IMG SRC="fystran.gif" ALIGN=RIGHT>FYSISKA TRANSPORTER<BR></A></STRONG>Ansvarig <A HREF="mailto:jan.parmeby@kfb.se">Jan Parmeby</A><P><EM>M&aring;l:<BR></EM>Programmet Fysiska transporter har som verksamhetsm&aring;l att st&ouml;dja Forskning, Utveckling och Demonstrationsverksamhet, FUD, som kan bidra till att h&ouml;ja de fysiska transporternas effektivitet och anpassa dem till samh&auml;llsf&ouml;r&auml;ndringarna och till den enskildes preferenser och beteenden under olika betingelser. Programmet syftar ocks&aring; till att ta fram ny kunskap f&ouml;r att h&ouml;ja trafiks&auml;kerheten, f&ouml;rb&auml;ttra milj&ouml;n och &ouml;ka framkomligheten. Detta skall ske genom att utveckla kunskaper om hela trafikprocessen och de trafiktekniska m&ouml;jligheterna att p&aring;verka denna.<P><EM>Programmets inneh&aring;ll:<BR></EM>&#128; Persontransporter<DT>&#128; Godstransporter<DT>&#128; Trafiks&auml;kerhet  och trafikteknik<DT>&#128; V&auml;g- och baninfrastruktur<P></DL>V&auml;lkommen att kontakta respektive <A HREF="gendir.html">handl&auml;ggare</A> om du skall s&ouml;ka forskningsbidrag. L&auml;s om </A><A HREF="projekt.html">p&aring;g&aring;ende projekt</A> som presenteras i <A HREF="bibliotek.html">forskarrapporter</A> n&auml;r de &auml;r avslutade.<BR><HR SIZE=2><H6><!-- Link Tag --><A HREF="index.html">[Till KFB:s huvudsida]</A></H6>                           </TD></TR></TABLE></BODY></HTML>
</DOC>
<DOC>
<DOCNO>WT02-B10-35</DOCNO>
<DOCOLDNO>IA018-000200-B014-69</DOCOLDNO>
<DOCHDR>
http://www.kfb.se:80/projekt.html 194.198.183.242 19970106204509 text/html 1941
HTTP/1.0 200 OK
Date: Mon, 06 Jan 1997 20:40:20 GMT
Server: Microsoft-Internet-Information-Server/1.0
Content-Type: text/html
Last-Modified: Wed, 18 Dec 1996 15:50:00 GMT
Content-Length: 1741
</DOCHDR>
<HTML><!-- Head Tag --><HEAD><TITLE>KFB-projekt</TITLE></HEAD><!-- Body Tag --><BODY TEXT="#4C4C4C" BACKGROUND="yel_bgr.gif"></BODY><!-- Link Tag --><A HREF="kfbnews.html"><!-- Graphic Tag --><IMG WIDTH=539 HEIGHT=28 BORDER=0 ALT="P&aring; g&aring;ng!" SRC="headflasha.gif"></A><TABLE WIDTH=542 BORDER=0 ><TR><TD WIDTH=60 BORDER=0 valign=top align=left><BR><H5><!-- Link Tag --><A HREF="welcome.html">Presentation<BR>av KFB!</A><BR><BR><!-- Link Tag --><A HREF="forskbidrag.html">S&ouml;k forsknings-<BR>bidrag</A><BR><BR><!-- Link Tag --><A HREF="drivm.html">Drivmedel och fordon</A><BR><BR><!-- Link Tag --><A HREF="telemat.html">Telematik</A><BR><BR><!-- Link Tag --><A HREF="komforsk.html">Strategisk <BR>kommunikations-<BR>forskning</A><BR><BR><!-- Link Tag --><A HREF="fystran.html">Fysiska transporter</A><BR><BR><!-- Link Tag --><A HREF="inters/index.html">Internationella<BR>fr&aring;gor</A><BR><BR><!-- Link Tag --><A HREF="info.html">Informations-<BR>avdelningen</A><BR><BR>Projektdatabasen<BR><BR><!-- Link Tag --><A HREF="bibliotek.html">Biblioteket</A><BR><BR><!-- Link Tag --><A HREF="gendir.html">Telefon och e-mail</A><BR><BR</TD></H5><TD WIDTH=50  BORDER=0 valign=top align=left></TD><TD WIDTH=300 BORDER=0 align=left valign=top><BR><H3>Projektdatabasen</H3>Projektregistret kommer att vara n&aring;bart fr&aring;n denna sida i b&ouml;rjan av 1997. Skicka g&auml;rna ett <!-- MailTo Tag --><A HREF="MAILTO:lars.mellin@kfb.se">e-mail</A> tillsvidare med f&ouml;rfr&aring;gningar om v&aring;ra projekt.   <HR SIZE=2><H6><!-- Link Tag --><A HREF="index.html">[Till KFB:s huvudsida]</A></H6>                           </TD></TR></TABLE></BODY></HTML>
</DOC>
<DOC>
<DOCNO>WT02-B10-36</DOCNO>
<DOCOLDNO>IA018-000200-B014-80</DOCOLDNO>
<DOCHDR>
http://www.kfb.se:80/gendir.html 194.198.183.242 19970106204518 text/html 6602
HTTP/1.0 200 OK
Date: Mon, 06 Jan 1997 20:40:28 GMT
Server: Microsoft-Internet-Information-Server/1.0
Content-Type: text/html
Last-Modified: Wed, 18 Dec 1996 15:19:58 GMT
Content-Length: 6402
</DOCHDR>
<HTML><!-- Head Tag --><HEAD><TITLE>Vi som jobbar p&aring; KFB</TITLE></HEAD><!-- Body Tag --><BODY TEXT="#4C4C4C" BACKGROUND="yel_bgr.gif"></BODY><!-- Link Tag --><A HREF="kfbnews.html"><!-- Graphic Tag --><IMG WIDTH=539 HEIGHT=28 BORDER=0 ALT="P&aring; g&aring;ng!" SRC="headflasha.gif"></A><TABLE WIDTH=542 BORDER=0 ><TR><TD WIDTH=60 BORDER=0 valign=top align=left><BR><H5><!-- Link Tag --><A HREF="welcome.html">Presentation<BR>av KFB!</A><BR><BR><!-- Link Tag --><A HREF="forskbidrag.html">S&ouml;k forsknings-<BR>bidrag</A><BR><BR><!-- Link Tag --><A HREF="drivm.html">Drivmedel och fordon</A><BR><BR><!-- Link Tag --><A HREF="telemat.html">Telematik</A><BR><BR><!-- Link Tag --><A HREF="komforsk.html">Strategisk <BR>kommunikations-<BR>forskning</A><BR><BR><!-- Link Tag --><A HREF="fystran.html">Fysiska transporter</A><BR><BR><!-- Link Tag --><A HREF="inters/index.html">Internationella<BR>fr&aring;gor</A><BR><BR><!-- Link Tag --><A HREF="info.html">Informations-<BR>avdelningen</A><BR><BR><!-- Link Tag --><A HREF="projekt.html">Projektdatabasen</A><BR><BR><!-- Link Tag --><A HREF="bibliotek.html">Biblioteket</A><BR><BR>Telefon och e-mail<BR><BR</TD></H5><TD WIDTH=50  BORDER=0 valign=top align=left></TD><TD WIDTH=300 BORDER=0 align=left valign=top><BR><IMG SRC="personal.gif" ALIGN=RIGHT>P&aring; kansliet i Stockholm jobbar generaldirekt&ouml;r Urban Karlstr&ouml;m och ytterligare ca 30 medarbetare.<HR><P><strong>Generaldirekt&ouml;r</strong><BR>Urban Karlstr&ouml;m, Generaldirekt&ouml;r, direkt 08-459 17 20,<BR>mobil 070-590 96 50, e-post <A HREF="mailto:urban.karlstrom@kfb.se">urban.karlstrom@kfb.se</A><P><strong>Organisation </strong><BR>Yngve Boye<BR>Stf GD, direkt, 08-459 17 30, e-post <A HREF="mailto:yngve.boye@kfb.se">yngve.boye@kfb.se</A><P>Kerstin Herodes<BR>GD-sekreterare, direkt 08-459 17 21, e-post <A HREF="mailto:kerstin.herodes@kfb.se">kerstin.herodes@kfb.se</A><P>Marita Lindgren<BR>Registrator, direkt 08-459 17 22, e-post <A HREF="mailto:marita.lindgren@kfb.se">marita.lindgren@kfb.se</A><P><strong>Planering</strong><BR>Yngve Boye<BR>&Ouml;vergripande planering, direkt 08-459 17 18, e-post<A HREF="mailto: yngve.boye@kfb.se"> yngve.boye@kfb.se</A><P><strong>Internationellt FoU-samarbete</strong><BR>Hans Mohlin<BR>Internationella fr&aring;gor, direkt 08-459 17 17, mobil 070-511 87 79, e-post <A HREF="mailto:hans.mohlin@kfb.se">hans.mohlin@kfb.se</A><P><strong>Enhet 1: Strategisk kommunikationsforskning, Telematik<BR></strong>Klas Barkl&ouml;f<BR>Enhetschef, direkt 08-459 17 03, e-post <A HREF="mailto:klas.barklof@kfb.se">klas.barklof@kfb.se</A><P>Joachim Benno<BR>Juridisk sakkunnig Telekommunikationer, direkt 08-459 17 33, e-post <A HREF="mailto:joachim.benno@kfb.se">joachim.benno@kfb.se</A><P>Marita Str&ouml;mqvist<BR>Enhetssekreterare, direkt 08-459 17 00, epost <A HREF="mailto:marita.stromqvist@kfb.se">marita.stromqvist@kfb.se</A><BR>                  <BR>Gunilla Lund&eacute;n<BR>Post- och telekommunikationer, direkt 08-459 17 34, e-post <A HREF="mailto:gunilla.lunden@kfb.se">gunilla.lunden@kfb.se</A><P>Per Norman<BR>Trafikpolitik o samh&auml;llsekonomi, direkt 08-459 17 35, e-post <A HREF="mailto:per.norman@kfb.se">per.norman@kfb.se</A><P>Christine Wallgren, Milj&ouml; och energi, direkt 08-459 17 05, e-post<A HREF="mailto: christine.wallgren@kfb.se"> christine.wallgren@kfb.se</A><P><strong>Enhet 2: Fysiska transporter, Drivmedel och fordon</strong><BR>Jan Parmeby<BR>Enhetschef, v&auml;g o infrastruktur, direkt  08-459 17 26, e-post <A HREF="mailto:jan.parmeby@kfb.se">jan.parmeby@kfb.se</A><P>Lena Dalsmyr<BR>enhetssekreterare, direkt 08-459 17 27,  e-post <A HREF="mailto:lena.dalsmyr@kfb.se">lena.dalsmyr@kfb.se</A><P>Nils Edstr&ouml;m<BR>Persontransporter, direkt 08-459 17 30,  e-post <A HREF="mailto:nils.edstrom@kfb.se">nils.edstrom@kfb.se</A><P>Tor Eriksson<BR>Godstransporter, direkt 08-459 17 28,  e-post <A HREF="mailto:tor.eriksson@kfb.se">tor.eriksson@kfb.se</A><P>Lars Wede<BR>Trafiks&auml;kerhet, direkt 08-459 17 00, e-post<A HREF="mailto:lars.wede@kfb.se"> lars.wede@kfb.se</A><P>Hans G Pettersson<BR>El- och hybridfordon, direkt 08-459 17 07, e-post <A HREF="mailto:hans.pettersson@kfb.se">hans.pettersson@kfb.se</A><P>David Bauner<BR>El- och hybridfordon, direkt 08-459 17 31,  ps&ouml;k 0740-122619, e-post <A HREF="mailto:david.bauner@kfb.se">david.bauner@kfb.se</A><P>S&ouml;ren Bucksch<BR>Biodrivmedel, direkt 08-459 17 29, e-post <A HREF="mailto:soren.bucksch@kfb.se">soren.bucksch@kfb.se</A><P>Tommy M&aring;nsson<BR>Biodrivmedel, direkt 08-459 17  02, e-post <A HREF="mailto:tommy.mansson@kfb.se">tommy.mansson@kfb.se</A><P><BR><strong>Information</strong><BR>Tina Esh<BR>Informationschef, direkt 08-459 17 24, mobil 070-511 87 79, e-post<A HREF="mailto: tina.esh@kfb.se"> tina.esh@kfb.se</A><P>Arne Kihlblom<BR>Informationssekreterare, direkt 08-459 17 25, e-post <A HREF="mailto:arne.kihlblom@kfb.se">arne.kihlblom@kfb.se</A><P>Anette Lakner<BR>Informationsassistent, direkt 08-459 17 23, e-post <A HREF="mailto:anette.lakner@kfb.se">anette.lakner@kfb.se</A><P><BR><strong>Administration</strong><BR>Kerstin Herodes<BR>Administrativt ansvarig, direkt 08-459  17 21, e-post <A HREF="mailto:kerstin.herodes@kfb.se">kerstin.herodes@kfb.se</A><P>Sofie Kling<BR>Vaktm&auml;stare, direkt 08-459 17 36,  e-post <A HREF="mailto:sofie.kling@kfb.se">sofie.kling@kfb.se</A><P>Ann-Christin Lindersson<BR>Receptionist, v&auml;xel 08-459 17 00<P>Lars Mellin<BR>Bibliotekarie, dokumentation, direkt 08-459 17 32, e-post <A HREF="mailto:lars.mellin@kfb.se">lars.mellin@kfb.se</A><P> Gun &Ouml;sterman<BR>Assistent, direkt 08-459 17 06, e-post <A HREF="mailto:gun.osterman@kfb.se">gun.osterman@kfb.se</A><P><strong>Ekonomi</strong><BR>Britt-Marie Eklund<BR>Ekonomiansvarig, direkt 08-459 17 09, e-post <A HREF="mailto:brittmarie.eklund@kfb.se">brittmarie.eklund@kfb.se</A><BR>                  <BR>Carina Lillthors<BR>Projektsekreterare, direkt 08-459 17 10, e-post <A HREF="mailto:carina.lillthors@kfb.se">carina.lillthors@kfb.se</A><BR><HR SIZE=2><H6><!-- Anchor Link Tag --><A HREF="#Upp!">[Upp!]</A>  <!-- Link Tag --><A HREF="index.html">[Till KFB:s huvudsida]</A></H6>                           </TD></TR></TABLE></BODY></HTML>
</DOC>
<DOC>
<DOCNO>WT02-B10-37</DOCNO>
<DOCOLDNO>IA018-000200-B014-90</DOCOLDNO>
<DOCHDR>
http://www.kfb.se:80/inters/index.html 194.198.183.242 19970106204527 text/html 4442
HTTP/1.0 200 OK
Date: Mon, 06 Jan 1997 20:40:37 GMT
Server: Microsoft-Internet-Information-Server/1.0
Content-Type: text/html
Last-Modified: Wed, 18 Dec 1996 21:50:54 GMT
Content-Length: 4242
</DOCHDR>
<HTML><!-- Head Tag --><HEAD><TITLE><!-- Anchor Point Tag --><A NAME="Upp!">Internationellt samarbete</A></TITLE></HEAD><!-- Body Tag --><BODY TEXT="#4C4C4C" LINK="#FFFFFF" BACKGROUND="interpic/yel_bgr.gif"></BODY><!-- Link Tag --><A HREF="../index.html"><!-- Graphic Tag --><IMG WIDTH=539 HEIGHT=28 BORDER=0 ALT="Till KFB huvudsida" SRC="interpic/kfbhead.gif"></A><TABLE WIDTH=542 BORDER=0 ><TR><TD WIDTH=90 BORDER=0 valign=top align=left ><BR><H5>SAMORDNING OCH  INTERNATIONELLA FR&Aring;GOR<BR><BR><!-- Link Tag --><A HREF="kontakt.html">Skapa kontakter</A><BR><BR><!-- Link Tag --><A HREF="utveckla.html">Utveckla</A><BR><BR><!-- Link Tag --><A HREF="samordna.html">Samordna</A><BR><BR><!-- Link Tag --><A HREF="stimulera.html">Stimulera</A><BR><BR><BR><!-- Graphic Tag --><IMG WIDTH=89 HEIGHT=82  SRC="interpic/cordis2smallet.gif"><!-- Link Tag --><A HREF="http://cordis.lu/transport/home.html">Information om research tasks<BR></A></TD><TD WIDTH=50 BORDER=0 align=center></TD><TD WIDTH=350 BORDER=0 align=left valign=top><BR></H5><!-- Font Tag --><B><FONT SIZE=4 COLOR="#BA8702">Nu &auml;r det dags att s&ouml;ka bidrag till transportforskningsprojekt inom EU:s fj&auml;rde ramprogram. </FONT></B><BR><BR><!-- Graphic Tag --><IMG WIDTH=199 HEIGHT=161 ALT="euflagga"  Align=right SRC="interpic/euflag.gif"><P>KFB, Kommunikations- forskningsberedningen, har hittills behandlat &ouml;ver 80 EU-framst&auml;llningar i tv&aring; ans&ouml;kningsomg&aring;ngar. De flesta har r&ouml;rt transportprogrammet. Den tredje och sista omg&aring;ngen genomf&ouml;rs <BR><B><!-- Font Tag --><FONT COLOR="#BA8702">17 december 1996 - 17 mars 1997</FONT></B>.</P><P>EU s&auml;tter upp m&aring;l f&ouml;r den internationella forskningen genom att v&auml;lja ut ett antal forskningsuppgifter (&#148;research tasks&#148;) d&auml;r det beh&ouml;vs forskningsinsatser. Information om dessa f&aring;r du under l&auml;nken Cordis. (Community R&D Information Service)</P><P>KFB, har som uppgift att bl a internationalisera svensk kommunikationsforskning och ge finansiellt st&ouml;d till forskare och andra som har projektid&eacute;er inom de av EU utsedda programomr&aring;dena. KFB ger tre typer av st&ouml;d: <!-- Link Tag --><A HREF="bidragsinfo.html"><!-- Font Tag --><FONT COLOR="#0000FF">utvecklingsbidrag, f&ouml;rhandlingsbidrag och kompletteringsfinansiering</FONT></A>.</P><P>Vi lever i ett dynamisk v&auml;rld d&auml;r storst&auml;derna v&auml;xer och arbetskraften blir r&ouml;rligare. M&auml;nniskor reser alltmer, transporterna &ouml;kar och informationsteknologin spr&auml;nger gr&auml;nser. Detta st&auml;ller stora krav p&aring; samh&auml;lls- och trafikplanering, milj&ouml;- och resursutnyttjande. </P><P>KFB har d&auml;rf&ouml;r f&aring;tt i uppdrag av riksdag och regering att genom s&aring;v&auml;l direkta som indirekta insatser st&ouml;dja kommunikationsforskningen i Sverige samt att medverka till ett internationellt samarbete. </P><P>Sveriges medverkan i internationell forskning kommer sannolikt att &ouml;ka i framtiden. Detta beroende p&aring; flera faktorer. Inte minst v&aring;rt medlemskap i EU. Sj&auml;lva m&aring;let f&ouml;r den europeiska gemenskapen - att &ouml;verbrygga avst&aring;nd - &ouml;kar intresset f&ouml;r kommunikationsfr&aring;gorna. </P><P>Det skapas en st&ouml;rre inre marknad f&ouml;r forskning d&auml;r en anpassning till den allt mer internationaliserade marknaden kan leda till b&auml;ttre effektivitet och st&ouml;rre m&aring;ngfald.De gemensamma forskningsresurserna &ouml;kar genom att svenska forskare har m&ouml;jlighet att f&aring; bidrag ur EU:s forskningsbudget. </P><HR SIZE=2>Ansvarig f&ouml;r  INTERNATIONELLA FR&Aring;GOR  &auml;r  <!-- MailTo Tag --><A HREF="MAILTO:hans.mohlin@kfb.se"><!-- Font Tag --><FONT COLOR="#0000FF">Hans Mohlin.</FONT></A><BR>Ansvarig f&ouml;r SAMORDNINGSSEKRETERIATET &auml;r <!-- MailTo Tag --><A HREF="MAILTO:yngve.boye@kfb.se"><!-- Font Tag --><FONT COLOR="#0000FF">Yngve Boye</FONT></A>.<BR><BR><!-- Anchor Link Tag --><A HREF="#Upp!"><!-- Font Tag --><FONT COLOR="#0000FF">Upp!</FONT></A>                           </TD></TR></TABLE></BODY></HTML>
</DOC>
<DOC>
<DOCNO>WT02-B10-38</DOCNO>
<DOCOLDNO>IA018-000200-B014-102</DOCOLDNO>
<DOCHDR>
http://www.kfb.se:80/index.html 194.198.183.242 19970106204539 text/html 2583
HTTP/1.0 200 OK
Date: Mon, 06 Jan 1997 20:40:46 GMT
Server: Microsoft-Internet-Information-Server/1.0
Content-Type: text/html
Last-Modified: Sun, 15 Dec 1996 23:49:16 GMT
Content-Length: 2383
</DOCHDR>
<HTML><!-- Head Tag --><HEAD><TITLE>KommunikationsForskningsBeredningen</TITLE></HEAD><!-- Body Tag --><BODY TEXT="#4C4C4C" BACKGROUND="yel_bgr.gif"></BODY><!-- Link Tag --><A HREF="kfbnews.html"><!-- Graphic Tag --><IMG WIDTH=539 HEIGHT=28 BORDER=0 ALT="P&aring; g&aring;ng!" SRC="headflasha.gif"></A><TABLE WIDTH=542 BORDER=0 ><TR><TD WIDTH=80 BORDER=0 valign=top align=center ><H6><!-- Link Tag --><A HREF="ehvproge/index.html"><!-- Graphic Tag --><IMG WIDTH=20 HEIGHT=11 BORDER=0    SRC="storbritt.gif"></A>     <BR><!-- Link Tag --><A HREF="ehvproge/index.html">[In English]</H6></A></TD><TD WIDTH=15 BORDER=0 valign=top align=center> </TD><TD WIDTH=427 BORDER=0 align=left valign=top><!-- Link Tag --><A HREF="welcome.html"><!-- Graphic Tag --><IMG WIDTH=427 HEIGHT=45 BORDER=1 ALT="Vlkommen till KFB!" SRC="kfbpress.gif"></A><!-- Link Tag --><A HREF="forskbidrag.html"><!-- Graphic Tag --><IMG WIDTH=427 HEIGHT=21 BORDER=1 ALT="Sk forskningsbidrag1" SRC="forskbidrag.gif"></A><!-- Link Tag --><A HREF="drivm.html"><!-- Graphic Tag --><IMG WIDTH=427 HEIGHT=82 BORDER=1 ALT="Drivmedel" SRC="hdline1.gif"></A><!-- Link Tag --><A HREF="telemat.html"><!-- Graphic Tag --><IMG WIDTH=233 HEIGHT=83 BORDER=1 ALT="telematik" SRC="hdline2.gif"></A><!-- Link Tag --><A HREF="komforsk.html"><!-- Graphic Tag --><IMG WIDTH=189 HEIGHT=83 BORDER=1 ALT="Strategisk kommunikationsforskning" SRC="hdline3.gif"></A><BR><!-- Link Tag --><A HREF="Bibliotek.html"><!-- Graphic Tag --><IMG WIDTH=217 HEIGHT=46 BORDER=1 ALT="Biblioteket" SRC="hdline4.gif"></A><!-- Link Tag --><A HREF="fystran.html"><!-- Graphic Tag --><IMG WIDTH=205 HEIGHT=46 BORDER=1 ALT="Fysiska transporter" SRC="hdline5.gif"></A><BR><!-- Link Tag --><A HREF="projekt.html"><!-- Graphic Tag --><IMG WIDTH=205 HEIGHT=21 BORDER=1 ALT="Projektdatabasen" SRC="projektem.gif"></A><!-- Link Tag --><A HREF="gendir.html"><!-- Graphic Tag --><IMG WIDTH=218 HEIGHT=21 BORDER=1 ALT="e-mail och telnummer" SRC="telnr.gif"></A><!-- Link Tag --><A HREF="inters/index.html"><!-- Graphic Tag --><IMG WIDTH=427 HEIGHT=36 BORDER=1  SRC="inter.gif"></A><HR SIZE=2>http://www.kfb.se -- Revised: 1996-12-17<BR>Copyright &copy; 1996/97 <A HREF="welcome.html">KFB</A><BR><A HREF="MAILTO:tina.esh@kfb.se">tina.esh@kfb.se</A><HR SIZE=2>                           </TD></TR></TABLE></BODY></HTML>
</DOC>
<DOC>
<DOCNO>WT02-B10-39</DOCNO>
<DOCOLDNO>IA018-000200-B014-111</DOCOLDNO>
<DOCHDR>
http://www.kfb.se:80/tidnkup.html 194.198.183.242 19970106204550 text/html 1964
HTTP/1.0 200 OK
Date: Mon, 06 Jan 1997 20:41:01 GMT
Server: Microsoft-Internet-Information-Server/1.0
Content-Type: text/html
Last-Modified: Mon, 04 Nov 1996 15:06:12 GMT
Content-Length: 1764
</DOCHDR>
<HTML><!---------------------------------------------------------------><!-      AUTHOR:   Mats Holm                         ><!-      E-MAIL:   mats@softmachine.se                  ><!-      CREATED:  1996-08-30                         ><!-      MODIFIED: 1996-10-27                   ><!-      FILE:     tidnkup.html                                    ><!-      PURPOSE:  faxa in pren                    ><!---------------------------------------------------------------><HEAD><TITLE>KFB Kommunik&eacute;, tack!</TITLE></HEAD><BODY TEXT="#3d3d3d" BGCOLOR="#ffffff" LINK="#e12b1e" ALINK="#e7e318" VLINK="#0e7112"><TABLE WIDTH=452 BORDER=0 ><TR><TD WIDTH=1 BORDER=0 align=left></TD><TD WIDTH=451 BORDER=0 align=left> <H6>[<A HREF="kfbnews.html">Back</A>] </H6><!-- Link Tag --><A HREF="kfbnews.html"><!-- Graphic Tag --><IMG WIDTH=458 HEIGHT=28 BORDER=0  SRC="head1smal.gif"></A><BR><H3>Jag/Vi vill g&auml;rna prenumerera p&aring; KFB Kommunik&eacute;:<P>Namn...............................................................<P>F&ouml;retag/organisation........................................<P>Adress...............................................................<P>Postnummer.....................................................<P>Ort.......................................................................<P>Telefon.................................................................<P>Fax.......................................................................<P>E-post..................................................................<P>Studerande   Ja         Nej      </H3></A><BR><HR><P>Faxa eller posta kupongen till KFB, Box 5706, 114 87 Stockholm.<BR>Fax 08-662 66 09<BR></td></tr></TABLE></BODY></HTML>
</DOC>
<DOC>
<DOCNO>WT02-B10-40</DOCNO>
<DOCOLDNO>IA018-000200-B014-118</DOCOLDNO>
<DOCHDR>
http://www.kfb.se:80/nr6artikel.html 194.198.183.242 19970106204558 text/html 4621
HTTP/1.0 200 OK
Date: Mon, 06 Jan 1997 20:41:08 GMT
Server: Microsoft-Internet-Information-Server/1.0
Content-Type: text/html
Last-Modified: Thu, 19 Dec 1996 17:29:32 GMT
Content-Length: 4421
</DOCHDR>
<HTML><HEAD><TITLEEtt nyt&auml;nkande inom kollektiv- <BR>trafiken</TITLE></HEAD><BODY TEXT="#3d3d3d" BGCOLOR="#ffffff" LINK="#e12b1e" ALINK="#e7e318" VLINK="#0e7112"><TABLE WIDTH=456 BORDER=0 ><TR><TD WIDTH=1 BORDER=0 align=left></TD><TD WIDTH=455 BORDER=0 align=left> <H6>[<A HREF="kfbnews.html">Back</A>] </H6><!-- Link Tag --><A HREF="kfbnews.html"><!-- Graphic Tag --><IMG WIDTH=458 HEIGHT=28 BORDER=0  SRC="head1smal.gif"></A><!-- Font Tag --><FONT COLOR="#FF6B20"><H2><P>Ett nyt&auml;nkande inom kollektiv- <BR>trafiken</P></H2></FONT><!-- Graphic Tag --><IMG WIDTH=144 HEIGHT=217 ALIGN=right SRC="hanhon.gif"><B><P>Hur skiljer sig kvinnors och m&auml;ns resvanor &aring;t? <BR>Finns det &ouml;verhuvudtaget n&aring;gra skillnader?<BR> Har kvinnor och m&auml;n olika attityder till resandet i sig? <BR>Det &auml;r n&aring;gra av de fr&aring;gest&auml;llningar f&ouml;rfattarna bakom KFB-rapporten &#148;Kvinnligt och manligt i kollektivtrafiken&#148; st&auml;ller sig.</P></B><P>Under senare tid har den kvinnliga kompetensen hamnat allt mer i fokus i utformningen av kollektivtrafiken. Tidigare studier har visat att det &auml;r en majoritet kvinnor som reser kollektivt. Samtidigt &auml;r det n&auml;stan uteslutande m&auml;n som sitter i beslutande st&auml;llning i landets l&auml;nstrafikf&ouml;retag. &Auml;r det m&ouml;jligen s&aring; att om man tar tillvara den kvinnliga kompetensen  som tydligen i h&ouml;g grad saknas i l&auml;nstrafikf&ouml;retagen idag  i utformningen av kollektivtrafiken s&aring; f&aring;r vi en trafik som &auml;r b&auml;ttre anpassad till alla dess brukare? Detta &auml;r en hypotes som n&auml;tverket och projektet Kvinnor  Kompetens  Kollektivtrafik (3K) arbetar utifr&aring;n. 3K-projektet startades under Svenska Lokaltrafikf&ouml;reningens Persontrafikdagar i Karlstad i fjol och ska p&aring;g&aring; till Persontrafikdagarna i september 1997 i Blekinge. F&ouml;r finansieringen st&aring;r Svenska Lokaltrafikf&ouml;reningen, Svenska Kommunf&ouml;rbundet och Landstingsf&ouml;rbundet. TFK  Institutet f&ouml;r transportforskning ansvarar f&ouml;r projektledningen.</P><BR><P>En viktig del i 3K:s arbete &auml;r att kartl&auml;gga och beskriva kvinnliga och manliga aspekter p&aring; resandet i kollektivtrafiken och initiera till forskning. I samverkan med 3K-projektet har TFK  Institutet f&ouml;r transportforskning p&aring; uppdrag &aring;t KFB gjort en kunskapssammanst&auml;llning &ouml;ver tidigare unders&ouml;kningar p&aring; omr&aring;det. Sammanst&auml;llningen behandlar skillnader mellan kvinnor och m&auml;n n&auml;r det g&auml;ller aktivitetsm&ouml;nster, resvanor attityder till resandet. Resultaten som st&auml;llts samman kommer bland annat fr&aring;n den p&aring;g&aring;ende Riksresvaneunders&ouml;kningen, resvaneunders&ouml;kningar i Stockholms l&auml;n och i G&ouml;teborgs lokaltrafikomr&aring;de. En del i arbetet har varit att unders&ouml;ka vad l&auml;nstrafikf&ouml;retagen i landet gjort ang&aring;ende kvinnliga och manliga resvanor och attityder. Detta visade sig dock inte vara alltf&ouml;r omfattande. Viktig forskning p&aring; omr&aring;det har bland annat Transport&oslash;konomisk institutt (t&oslash;i) i Oslo utf&ouml;rt, vars resultat ocks&aring; finns med i kartl&auml;ggningen. Sammanst&auml;llningen bekr&auml;ftar att det finns skillnader mellan kvinnor och m&auml;n:<P>M&auml;n g&ouml;r n&aring;got fler resor, m&aring;nga fler tj&auml;nsteresor, g&ouml;r l&auml;ngre resor och &auml;r oftare bilf&ouml;rare.</P></P><P>Kvinnor &aring;ker mer kollektivt och &auml;r oftare bilpassagerare. Kvinnors huvudresor best&aring;r av fler delresor. Kvinnor st&aring;r f&ouml;r st&ouml;rre delen av ink&ouml;psresorna. Kvinnor &auml;r mer positivt inst&auml;llda till kollektivtrafiken. Kvinnor prioriterar personlig trygghet och milj&ouml; h&ouml;gre.</P><P>Rapporten visar ocks&aring; att omr&aring;det kvinnor och kollektivtrafik &auml;r f&ouml;rh&aring;llandevis outforskat och att mer kunskap efterfr&aring;gas. Nu &aring;terst&aring;r f&ouml;r en KFB-finansierad arbetsgrupp best&aring;ende av experter inom olika omr&aring;den att prioritera angel&auml;gna forskningsbehov mot bakgrund av de kunskapsluckor som identifierats i rapporten.</P><H5>Peter Ros&eacute;n, TFK<BR> Institutet f&ouml;r transportforskning</H5><BR></td></tr></TABLE></BODY></HTML>
</DOC>
<DOC>
<DOCNO>WT02-B10-41</DOCNO>
<DOCOLDNO>IA018-000200-B014-135</DOCOLDNO>
<DOCHDR>
http://www.kfb.se:80/vtitom9706.html 194.198.183.242 19970106204618 text/html 32454
HTTP/1.0 200 OK
Date: Mon, 06 Jan 1997 20:41:17 GMT
Server: Microsoft-Internet-Information-Server/1.0
Content-Type: text/html
Last-Modified: Thu, 05 Dec 1996 09:14:20 GMT
Content-Length: 32253
</DOCHDR>
<HTML><HEAD><TITLE>Konferensregistret</TITLE></HEAD><BODY TEXT="#3d3d3d" BGCOLOR="#ffffff" LINK="#e12b1e" ALINK="#e7e318" VLINK="#0e7112"><TABLE WIDTH=456 BORDER=0 ><TR><TD WIDTH=1 BORDER=0 align=left></TD><TD WIDTH=455 BORDER=0 align=left> <H6>[<A HREF="kfbnews.html">Back</A>] </H6><!-- Link Tag --><A HREF="kfbnews.html"><!-- Graphic Tag --><IMG WIDTH=458 HEIGHT=28 BORDER=0  SRC="head1smal.gif"></A><!-- Font Tag --><FONT COLOR="#BF361C"><H2><P><!-- Anchor Point Tag --><A NAME="Up!">Nedan finner du aktuella konferenser inom transportomr&aring;det t.o.m. 1997-06</A></P></H2></FONT> Datum: 1996-12-03--1996-12-05<BR> Ort: Basel, Schweiz<BR> Titel: <!-- Font Tag --><FONT COLOR="#BF361C"><B> Eisenbahn Technologie 96, 4th international<BR>exhibition of products and services for<BR>inter-city, regional, suburban, urban and mountain<BR>railways<BR> </B></FONT> Arrang&ouml;r: Mack-Brooks Exhibitions Ltd<BR> Adress: Mack-Brooks Exhibitions Ltd, Doris Stidston, Forum<BR>Place, Hatfield, Herts.  AL20 ORN, Storbritannien.<BR>Tfn +44 1707 275 641, fax +44 1707 275 544<BR> K&auml;lla: Broschyr<BR><BR><!-- Horizontal Line Tag --><HR WIDTH=100% SIZE=1><BR><BR> Datum: 1996-12-03--1996-12-05<BR> Ort: Basel, Schweiz<BR> Titel: <!-- Font Tag --><FONT COLOR="#BF361C"><B> Innovation in the railway system<BR> </B></FONT> Arrang&ouml;r: Transport Board of the Institution of Civil<BR>Engineers<BR> Adress: Rachel Coninx, Thomas Telford Conferences,<BR>Institution of Civil Engineers, One Gresat George<BR>Street, London SW1P 3AA, Storbritannien.  Tfn +44<BR>171 222 7722, fax +44 171 233 1743<BR> K&auml;lla: Call for papers<BR><BR><!-- Horizontal Line Tag --><HR WIDTH=100% SIZE=1><BR><BR> Datum: 1996-12-03--<BR> Ort: Stockholm<BR> Titel: <!-- Font Tag --><FONT COLOR="#BF361C"><B> Nya v&auml;gtunnlar - s&aring; byggs de.  Konferens som<BR>behandlar teknik, s&auml;kerhet, milj&ouml; och gestaltning<BR> </B></FONT> Arrang&ouml;r: V&auml;gverket<BR> Adress: V&auml;gverket Region Stockholm, Projekt Ringen och<BR>Yttre Tv&auml;rleden, Box 4202, 171 04 Solna.  Fax 08-29 19 81<BR> K&auml;lla: Inbjudan<BR><BR><!-- Horizontal Line Tag --><HR WIDTH=100% SIZE=1><BR><BR> Datum: 1996-12-04--<BR> Ort: Crowthorne, Storbritannien<BR> Titel: <!-- Font Tag --><FONT COLOR="#BF361C"><B> Surface Treatment Seminar<BR> </B></FONT> Arrang&ouml;r: TRL<BR> Adress: Courses, Seminars &amp; Workshop Co-ordinator,<BR>FREEPOST TRA 203801, Transport Research<BR>Laboratory, Old Wokingham Road, Crowthorne,<BR>Berkshire RG45 6AU, Storbritannien.  Tfn 01344 770905, <BR>fax 01344 770356<BR> K&auml;lla: Broschyr<BR><BR><!-- Horizontal Line Tag --><HR WIDTH=100% SIZE=1><BR><BR> Datum: 1996-12-04--<BR> Ort: London, Storbritannien<BR> Titel: <!-- Font Tag --><FONT COLOR="#BF361C"><B> Re-evaluation of the Transport &amp; Works Act.  A one<BR>day conference which examines the success of the<BR>Transport &amp;Works Act in processing applications<BR>and what improvements may be considered in the<BR>light of the Central Railways Application<BR> </B></FONT> Arrang&ouml;r: Waterfront Conference Company<BR> Adress: Waterfront Conference Company, 9 Grosvenor<BR>Gardens, London SW1W 0BH, Storbritannien.  <BR>Fax +44 171 233 7611<BR> K&auml;lla: Broschyr<BR><BR><!-- Horizontal Line Tag --><HR WIDTH=100% SIZE=1><BR><BR> Datum: 1996-12-09--1996-12-11<BR> Ort: London, Storbritannien<BR> Titel: <!-- Font Tag --><FONT COLOR="#BF361C"><B> The smart card Europe<BR> </B></FONT> Arrang&ouml;r: IBC<BR> Adress: Lisa Minoprio, IBC Technical Services, Gilmoora<BR>House, 57-61 Mortimer Street, London W1N 8JX,<BR>Storbritannien.  Fax +44 171 636 1976<BR> K&auml;lla: Broschyr<BR><BR><!-- Horizontal Line Tag --><HR WIDTH=100% SIZE=1><BR><BR> Datum: 1996-12-09--1996-12-11<BR> Ort: Kuala Lumpur, Malaysia<BR> Titel: <!-- Font Tag --><FONT COLOR="#BF361C"><B> Rail tech 'Asia.  Rail technology and its<BR>fundamental role inte the growth of Asia's<BR>railways<BR> </B></FONT> Arrang&ouml;r: IIR<BR> Adress: IIR, tfn (65) 339 3521, fax (65) 336 4017<BR> K&auml;lla: IIR-registration fax<BR><BR><!-- Horizontal Line Tag --><HR WIDTH=100% SIZE=1><BR><BR> Datum: 1996-12-12--1996-12-15<BR> Ort: Turin, Italien<BR> Titel: <!-- Font Tag --><FONT COLOR="#BF361C"><B> Infomobility.  International conference and<BR>exhibition on transport telematics and intelligent<BR>transport systems<BR> </B></FONT> Arrang&ouml;r: ATA<BR> Adress: ATA, Mrs Claudia Rossi, Strada Torino 32 A, 10043<BR>Orbassona (TO) Italien.  Tfn +39 11 9032364, fax<BR>+39 11 9023637<BR> K&auml;lla: Preliminary program<BR><BR><!-- Horizontal Line Tag --><HR WIDTH=100% SIZE=1><BR><BR> Datum: 1997-01-08--1997-01-09<BR> Ort: Link&ouml;ping<BR> Titel: <!-- Font Tag --><FONT COLOR="#BF361C"><B> VTI &amp; KFB forskardagar, Transportforum<BR> </B></FONT> Arrang&ouml;r: VTI, KFB<BR> Adress: VTI Utveckling, Rose-Marie Leveau.  <BR>Tfn 013-20 42 27<BR> K&auml;lla: <BR><BR><!-- Horizontal Line Tag --><HR WIDTH=100% SIZE=1><BR><BR> Datum:     1997-01-12--1997-01-16<BR> Ort: Washington, D.C., USA<BR> Titel: <!-- Font Tag --><FONT COLOR="#BF361C"><B> Transportation Research Board, 76th annual meeting<BR> </B></FONT> Arrang&ouml;r: TRB<BR> Adress: Dr.  Richard F.  Pain, TRB, 2101 Constitution<BR>Ave., N.W., Washington, D.C. 20418, USA.  <BR>Tfn +1 202 334 2960, fax +1 202 334 2003<BR> K&auml;lla: Announcement<BR><BR><!-- Horizontal Line Tag --><HR WIDTH=100% SIZE=1><BR><BR> Datum: 1997-01-14--1997-01-15<BR> Ort: Lyon, Frankrike<BR> Titel: <!-- Font Tag --><FONT COLOR="#BF361C"><B> Vuln&eacute;rabilis 97.  Vulnerable road users, European<BR>congress<BR> </B></FONT> Arrang&ouml;r: CERTU &amp; Minist&egrave;re de l'Equipement, du Logement,<BR>des Transports et du Tourisme<BR> Adress: Comit&eacute; Scientifique, CERTU, Jacques Robin, 9, rue<BR>Juliette R&egrave;camier, F 69456 Lyon Cedex 06,<BR>Frankrike.  Tfn +33 72 74 59 31, <BR>fax +33 72 74 59 30<BR> K&auml;lla: Program<BR><BR><!-- Horizontal Line Tag --><HR WIDTH=100% SIZE=1><BR><BR> Datum: 1997-01-20--1997-01-24<BR> Ort: New Delhi, Indien<BR> Titel: <!-- Font Tag --><FONT COLOR="#BF361C"><B> Tunnelling Asia '97.  Asian regional conference<BR>and 2nd international symposium<BR> </B></FONT> Arrang&ouml;r: Adhering Committee of International Tunnelling<BR>Association (India) and Central Board of<BR>Irrigation and Power<BR> Adress: Secretary General, Adhering Committee of<BR>International Tunnelling Association (India), CBIP<BR>Building, Plot No. 4, Institutional Area, Malcha<BR>Marg.  Chanakyapuri, New Delhi-110021, Indien.<BR>Tfn (91)(11)301 5984, fax (91)(11)301 6347<BR> K&auml;lla: 2nd bulletin<BR><BR><!-- Horizontal Line Tag --><HR WIDTH=100% SIZE=1><BR><BR> Datum: 1997-01-27--1997-01-28<BR> Ort: London, Storbritannien<BR> Titel: <!-- Font Tag --><FONT COLOR="#BF361C"><B> Business application of global navigation<BR>satellite systems; the future of managing and<BR>monitoring transportation<BR> </B></FONT> Arrang&ouml;r: International Quality and Productivity Centre<BR> Adress: Kate Metcalf, tfn +44 171 421 3521, <BR>fax +44 171 831 9249<BR> K&auml;lla: Broschyr<BR><BR><!-- Horizontal Line Tag --><HR WIDTH=100% SIZE=1><BR><BR> Datum: 1997-01-30--1997-01-31<BR> Ort: M&uuml;nchen, Tyskland<BR> Titel: <!-- Font Tag --><FONT COLOR="#BF361C"><B> Mensch im Verkehr. 3.  VDI/BMW Gemeinschaftstagung<BR> </B></FONT> Arrang&ouml;r: Verein Deutscher Ingenieure, VDI och Bayerische<BR>Motoren Werke, BMW<BR> Adress: Verein Deutscher Ingenieure/VDI, VDI-Gesellschaft<BR>Fahrzeug- und Verkehrstechnik, Postfach 10 11 39,<BR>D-40002 D&uuml;sseldorf, Tyskland.  Tfn +49 (02 11)62 14-264, <BR>fax +49 (02 11)62 14-163<BR> K&auml;lla: Broschyr<BR><BR><!-- Horizontal Line Tag --><HR WIDTH=100% SIZE=1><BR><BR> Datum: 1997-02-03--<BR> Ort: K&ouml;penhamn, Danmark<BR> Titel: <!-- Font Tag --><FONT COLOR="#BF361C"><B> Banetransport<BR> </B></FONT> Arrang&ouml;r: Transport&ouml;konomisk Forening, T&Ouml;F<BR> Adress: T&Ouml;F, R&aring;dhusstraede 4 A, 1466 K&ouml;penhamn K, Danmark.<BR>Tfn 33 91 22 50, fax 33 91 22 17<BR> K&auml;lla: T&Ouml;F-Kontakt 4/1996<BR><BR><!-- Horizontal Line Tag --><HR WIDTH=100% SIZE=1><BR><BR> Datum: 1997-02-10--1997-02-11<BR> Ort: Sandvika, Norge<BR> Titel: <!-- Font Tag --><FONT COLOR="#BF361C"><B> Informasjon som virkemiddel i<BR>trafiks&auml;kerhetsarbeidet<BR> </B></FONT> Arrang&ouml;r: Trygg Trafikk<BR> Adress: Trygg Trafikk, Postboks 2610, St.  Hanshaugen,<BR>0131 Oslo, Norge.  Tfn 22 20 92 15, fax 22 11 01 95<BR> K&auml;lla: Invitasjon<BR><BR><!-- Horizontal Line Tag --><HR WIDTH=100% SIZE=1><BR><BR> Datum: 1997-02-19--1997-02-22<BR> Ort: Padova, Italien<BR> Titel: <!-- Font Tag --><FONT COLOR="#BF361C"><B> Urbania.  Cities on the move<BR> </B></FONT> Arrang&ouml;r: PadovaFiere<BR> Adress: PadovaFiere, Via Tommaseo 59, Padova, Italien.<BR>Tfn +39/49/840 111, fax +39/49/840 570<BR> K&auml;lla: Broschyr<BR><BR><!-- Horizontal Line Tag --><HR WIDTH=100% SIZE=1><BR><BR> Datum: 1997-02-25--1997-02-26<BR> Ort: K&ouml;penhamn, Danmark<BR> Titel: <!-- Font Tag --><FONT COLOR="#BF361C"><B> Godstransportkonferencen '97<BR> </B></FONT> Arrang&ouml;r: Transport&ouml;konomisk Forening<BR> Adress: Transport&ouml;konomisk Forening, R&aring;dhusstraede 4 A,<BR>1466 K&ouml;penhamn K, Danmark.  Tfn +45 33 91 22 50,<BR>fax +45 33 91 22 17<BR> K&auml;lla: T&Ouml;F-kontakt<BR><BR><!-- Horizontal Line Tag --><HR WIDTH=100% SIZE=1><BR><BR> Datum: 1997-02-25--1997-02-27<BR> Ort: Singapore<BR> Titel: <!-- Font Tag --><FONT COLOR="#BF361C"><B> World of concrete 97<BR> </B></FONT> Arrang&ouml;r: CI-PREMIER Conference Organisation<BR> Adress: CI-Premier Pte Ltd, 150 Orchard Road #07-14,<BR>Orchard Plaza, Singapore 238841, Republic of<BR>Singapore.  Tfn 065-733-2922, fax 065-235-3530<BR> K&auml;lla: CI conference announcement<BR><BR><!-- Horizontal Line Tag --><HR WIDTH=100% SIZE=1><BR><BR> Datum: 1997-02-26--1997-02-28<BR> Ort: Florens, Italien<BR> Titel: <!-- Font Tag --><FONT COLOR="#BF361C"><B> Virtual automobile and the role of<BR>experimentation, Florence ATA 1997. 5th<BR>international conference<BR> </B></FONT> Arrang&ouml;r: Associazione Tecnica dell'Automobile, SAE, etc.<BR> Adress: ATA, Strada Torino 32A, 10043 Orbassano (TO),<BR>Italien.  Tfn +39 11 9023638, fax +39 11 9023637<BR> K&auml;lla: Call for papers (abstr senast 96-04-30)<BR><BR><!-- Horizontal Line Tag --><HR WIDTH=100% SIZE=1><BR><BR> Datum: 1997-03-03--1997-03-07<BR> Ort: Wiesbaden, Tyskland<BR> Titel: <!-- Font Tag --><FONT COLOR="#BF361C"><B> Optics and optoelectronics for public safety, 2nd<BR>European symposium.  Cargo &amp; substande<BR>identification, Security &amp; law enforcement.<BR>Traffic safety systems &amp; applications<BR> </B></FONT> Arrang&ouml;r: European Optical Society, etc.<BR> Adress: EUROPTO c/o Direct Communications GmbH, Xantener<BR>Strasse 22, D-10707 Berlin, Tyskland.  <BR>Tfn +49 30 881 50 47, fax +49 30 88 68 29 46<BR> K&auml;lla: Call for papers<BR><BR><!-- Horizontal Line Tag --><HR WIDTH=100% SIZE=1><BR><BR> Datum: 1997-03-10--1997-03-12<BR> Ort: Amsterdam, Nederl&auml;nderna<BR> Titel: <!-- Font Tag --><FONT COLOR="#BF361C"><B> Tunnel control and communication<BR> </B></FONT> Arrang&ouml;r: Independent Technical Conferences Ltd<BR> Adress: Judy Whitham, Tunnel Control and Communication,<BR>Independent Technical Conferences Ltd, PO Box 452,<BR>Kempston, Bedford MK43 9PL, Storbritannien.  <BR>Tfn +44 1234 854756, fax +44 1234 841375<BR> K&auml;lla: Call for papers<BR><BR><!-- Horizontal Line Tag --><HR WIDTH=100% SIZE=1><BR><BR> Datum: 1997-03-10--1997-03-13<BR> Ort: Long Beach, Kalifornien, USA<BR> Titel: <!-- Font Tag --><FONT COLOR="#BF361C"><B> Geosynthetics 97.  Leading-edge innovations and<BR>trends in design, manufacturing and construction<BR> </B></FONT> Arrang&ouml;r: International Geosynthetics Society, IGS<BR> Adress: Industial Fabrics Association International, 345<BR>Cedar Street, Suite 800, St.  Paul, MN 55101-1088,<BR>USA.  Tfn +1 612/222-2508, fax +1 612/222-8215<BR> K&auml;lla: Broschyr<BR><BR><!-- Horizontal Line Tag --><HR WIDTH=100% SIZE=1><BR><BR> Datum: 1997-03-11--1997-03-12<BR> Ort: Stockholm<BR> Titel: <!-- Font Tag --><FONT COLOR="#BF361C"><B> Bergdagarna 1997<BR> </B></FONT> Arrang&ouml;r: BK Bergspr&auml;ngningskommitt&eacute;n och Stiftelsen Svensk<BR>Bergteknisk Forskning, SveBeFo<BR> Adress: Kerstin Ren&aring;s eller Annica Nordmark,<BR>Berspr&auml;ngningskommitt&eacute;n, tfn 08-679 17 21<BR> K&auml;lla: Brev<BR><BR><!-- Horizontal Line Tag --><HR WIDTH=100% SIZE=1><BR><BR> Datum: 1997-03-12--1997-03-14<BR> Ort: Madrid, Spanien<BR> Titel: <!-- Font Tag --><FONT COLOR="#BF361C"><B> Porous asphalt<BR> </B></FONT> Arrang&ouml;r: Ministerio de Obras Publicas, Transportes y Medio<BR>Ambiente<BR> Adress: Centro de Estudios de Carreteras, Autovia de<BR>Colmenar, km 18.2, 28790 El Goloso, Madrid,<BR>Spanien<BR> K&auml;lla: Brev<BR><BR><!-- Horizontal Line Tag --><HR WIDTH=100% SIZE=1><BR><BR> Datum: 1997-03-19--<BR> Ort: Paris-Villepinte, Frankrike<BR> Titel: <!-- Font Tag --><FONT COLOR="#BF361C"><B> EuroModal 97.  International transport - turning<BR>ideology into a cost-effective economic instrument<BR> </B></FONT> Arrang&ouml;r: International Union of Railways<BR> Adress: International Union of Railways, tfn 33 1 44 49 20 51, <BR>fax 33 1 44 49 20 59<BR> K&auml;lla: Press release<BR><BR><!-- Horizontal Line Tag --><HR WIDTH=100% SIZE=1><BR><BR> Datum: 1997-03-20--1997-03-21<BR> Ort: Cachan, Frankrike<BR> Titel: <!-- Font Tag --><FONT COLOR="#BF361C"><B> Enseignement des mat&eacute;riaux de construction.  Le<BR>point sur la question<BR> </B></FONT> Arrang&ouml;r: AFREM, AUGC, ACI etc<BR> Adress: J.L.  Cl&eacute;met, &Eacute;cole Normale Sup&eacute;rieure de Cachan,<BR>94235 Cachan cedex, Frankrike<BR> K&auml;lla: Appel &agrave; communications<BR><BR><!-- Horizontal Line Tag --><HR WIDTH=100% SIZE=1><BR><BR> Datum: 1997-04-07--1997-04-11<BR> Ort: Cape Town, Sydafrika<BR> Titel: <!-- Font Tag --><FONT COLOR="#BF361C"><B> Strategies beyond 2000, 6th international heavy<BR>haul railway conference<BR> </B></FONT> Arrang&ouml;r: International Heavy Haul Association<BR> Adress: IHHA &quot;6&quot; 1997, P.O.  Box 2737, Joubert Park, 2044,<BR>Republic of South Africa.  Tfn +27 11 773 8486,<BR>fax +27 11 773 2393<BR> K&auml;lla: First announcement<BR><BR><!-- Horizontal Line Tag --><HR WIDTH=100% SIZE=1><BR><BR> Datum: 1997-04-09--1997-04-13<BR> Ort: Las Vegas, USA<BR> Titel: <!-- Font Tag --><FONT COLOR="#BF361C"><B> Automated people movers, 6th international conference<BR> </B></FONT> Arrang&ouml;r: ASCE<BR> Adress: K&auml;lla:    Public Transport International<BR><BR><!-- Horizontal Line Tag --><HR WIDTH=100% SIZE=1><BR><BR> Datum: 1997-04-09--1997-04-11<BR> Ort: Braga, Portugal<BR> Titel: <!-- Font Tag --><FONT COLOR="#BF361C"><B> Human factors in road traffic, Seminar II<BR> </B></FONT> Arrang&ouml;r: Univ do Minho<BR> Adress: Jorge A.  Santos, Univ do Minho, Braga, Portugal.<BR> K&auml;lla: Lista fr&aring;n Bj&ouml;rn Peters<BR><BR><!-- Horizontal Line Tag --><HR WIDTH=100% SIZE=1><BR><BR> Datum: 1997-04-12--1997-04-17<BR> Ort: Wien, &Ouml;sterrike<BR> Titel: <!-- Font Tag --><FONT COLOR="#BF361C"><B> World tunnel congress '97, 23rd General assembly<BR>of the International Tunneling Association<BR> </B></FONT> Arrang&ouml;r: Austrian Society of Engineers and Architects,<BR>Austrian Society for Geomechanics<BR> Adress: World Tunnel Congress '97, c/o ICOS Congress<BR>Organisation, Service Ges.m.b.H., Johannesgasse 14, <BR>A-1010 Wien, &Ouml;sterrike<BR> K&auml;lla: Broschyr<BR><BR><!-- Horizontal Line Tag --><HR WIDTH=100% SIZE=1><BR><BR> Datum: 1997-04-14--1997-04-17<BR> Ort: Pretoria, Sydafrika<BR> Titel: <!-- Font Tag --><FONT COLOR="#BF361C"><B> African road safety congress, 3rd<BR> </B></FONT> Arrang&ouml;r: Economic Commission for Africa och OECD<BR> Adress: 3rd African Road Safety Congress, Conference<BR>Planners, Attn.  Cilla Taylor, P O Box 82, Irene,<BR>1675 Sydafrika.  Tfn +27 12 63-1681, fax +27 12 63-1680<BR> K&auml;lla: Call for papers<BR><BR><!-- Horizontal Line Tag --><HR WIDTH=100% SIZE=1><BR><BR> Datum: 1997-04-15--1997-04-17<BR> Ort: Lule&aring;<BR> Titel: <!-- Font Tag --><FONT COLOR="#BF361C"><B> Ground freezing and frost action in soils,<BR>international symposium<BR> </B></FONT> Arrang&ouml;r: Tekniska h&ouml;gskolan i Lule&aring;<BR> Adress: Lena Allheim Karbin, CENTEK, Tekniska h&ouml;gskolan i<BR>Lule&aring;, 971 87 Lule&aring;.  Tfn 0920-917 75,<BR>fax 0920-990 20<BR> K&auml;lla: Call for papers (abstr senast 1996-05-24)<BR><BR><!-- Horizontal Line Tag --><HR WIDTH=100% SIZE=1><BR><BR> Datum: 1997-04-22--1997-04-27<BR> Ort: Paris, Frankrike<BR> Titel: <!-- Font Tag --><FONT COLOR="#BF361C"><B> INTERMAT 97.  International equipment and<BR>techniques for civil engineering and construction<BR>exhibition<BR> </B></FONT> Arrang&ouml;r: INTERMAT<BR> Adress: Laurent Chrion, CEP Exposium-INTERMAT, 1 Rue Du<BR>Parc, F-92593 Levallois-Perret Cedex, Frankrike.<BR>Tfn +33 (1) 49 68 52 48, fax +33 (1) 47 37 74 56<BR> K&auml;lla: Broschyr<BR><BR><!-- Horizontal Line Tag --><HR WIDTH=100% SIZE=1><BR><BR> Datum: 1997-04-22--1997-04-24<BR> Ort: Madrid, Spanien<BR> Titel: <!-- Font Tag --><FONT COLOR="#BF361C"><B> Measurement and modelling in environmental<BR>pollution, MMEP 97<BR> </B></FONT> Arrang&ouml;r: Wessex Institute of Technology &amp; Technical<BR>University of Madrid<BR> K&auml;lla:     SGI:s konferenslista<BR><BR><!-- Horizontal Line Tag --><HR WIDTH=100% SIZE=1><BR><BR> Datum: 1997-04-28--1997-05-02<BR> Ort: Whistler, British Columbia, Kanada<BR> Titel: <!-- Font Tag --><FONT COLOR="#BF361C"><B> Environmental software systems, 2nd international<BR>symposium<BR> </B></FONT> Arrang&ouml;r: German Computer Society, University of Guelph &amp;<BR>Austrian Research Centre Seibersdorf<BR> Adress: David A Swayne, Department of Computing and<BR>Information Science, University of Guelph, Guelph,<BR>Ontario, Kanada N1G 2W1<BR> K&auml;lla: <BR><BR><!-- Horizontal Line Tag --><HR WIDTH=100% SIZE=1><BR><BR> Datum:     1997-05-04--1997-05-10<BR> Ort: Anchorage, Alaska, USA<BR> Titel: <!-- Font Tag --><FONT COLOR="#BF361C"><B> Cold region development, 5th international<BR>symposium.  ISCORD '97<BR> </B></FONT> Arrang&ouml;r: American Society of Civil Engineers, ASCE<BR> Adress: Chairman of the Organizing Committee, The Northern<BR>Forum, 4101 University Drive, APU Carr-Gottstein<BR>Center, Suite 221, Anchorage, AK 99508 Alaska, USA.  <BR>Fax (907) 561-6645<BR> K&auml;lla: Broschyr<BR><BR><!-- Horizontal Line Tag --><HR WIDTH=100% SIZE=1><BR><BR> Datum: 1997-05-04--1997-05-07<BR> Ort: Toronto, Kanada<BR> Titel: <!-- Font Tag --><FONT COLOR="#BF361C"><B> Transportation; Emerging realities.  Canadian<BR>Transportation Research Forum (CTRF), 32nd annual<BR>conference<BR> </B></FONT> Arrang&ouml;r: Canadian Transportation Research Forum<BR> Adress: David M.  Cape, Department of Economics, Ryerson<BR>Polytechnic University, 350 Victoria Street,<BR>Toronto, Ontario, Kanada M5B 2K3.  <BR>Fax (416)763-0809<BR> K&auml;lla: Call for papers (abstr senast 96-11-30)<BR><BR><!-- Horizontal Line Tag --><HR WIDTH=100% SIZE=1><BR><BR> Datum: 1997-05-06--1997-05-08<BR> Ort: Macau<BR> Titel: <!-- Font Tag --><FONT COLOR="#BF361C"><B> Ground improvement techniques<BR> </B></FONT> Arrang&ouml;r: University of Macau &amp; International Society for<BR>Soil Mechanics &amp; Foundation Engineering<BR> Adress: CI-Premier Pte Ltd, 150 Orchard Road #07-14,<BR>Orchard Plaza, Singapore 238841, Singapore.  <BR>Tfn (65) 733-2922, fax (65)235-3530<BR> K&auml;lla: Preliminary announcement<BR><BR><!-- Horizontal Line Tag --><HR WIDTH=100% SIZE=1><BR><BR> Datum: 1997-05-12--1997-05-14<BR> Ort: Wien, &Ouml;sterrike<BR> Titel: <!-- Font Tag --><FONT COLOR="#BF361C"><B> Mobility &amp; safety, international conference.<BR>International and interdisciplinary solutions<BR> </B></FONT> Arrang&ouml;r: Kuratorium f&uuml;r Verkehrssicherheit<BR> Adress: Mobility &amp; Safety, c/o ICOS Congress, Organisation<BR>Service GmbH, Johannesgasse 14, A-1010 Wien,<BR>&Ouml;sterrike.<BR> K&auml;lla: Call for papers (Abstr senast 1996-06-30)<BR><BR><!-- Horizontal Line Tag --><HR WIDTH=100% SIZE=1><BR><BR> Datum: 1997-05-14--1997-05-16<BR> Ort: Vaulx-en-Velin, Frankrike<BR> Titel: <!-- Font Tag --><FONT COLOR="#BF361C"><B> Mechanical tests for bituminous materials.  Recent<BR>improvements and future prospects. 4th<BR>international Rilem symposium, MTBM<BR> </B></FONT> Arrang&ouml;r: MTBM<BR> Adress: H Di Benedetto, L Arnaud, ENTPE - LGM Rue Maurice<BR>Audin, 69518 Vaulx-en-Velin, Frankrike.  <BR>Tfn (33) 72 04 71 44, fax (33) 72 04 71 56<BR> K&auml;lla: Call for papers (abstr senast 96-01-01)<BR><BR><!-- Horizontal Line Tag --><HR WIDTH=100% SIZE=1><BR><BR> Datum: 1997-05-14--1997-05-16<BR> Ort: Kuala Lumpur, Malaysia<BR> Titel: <!-- Font Tag --><FONT COLOR="#BF361C"><B> Vehicle and track performance.  Exporail (Asia)<BR> </B></FONT> Arrang&ouml;r: Institution of Civil Engineers<BR> Adress: Sue Frye, Thomas Telford Conferences, Institution<BR>of Civil Engineers, One Great George Street,<BR>London SW1P 3AA, Storbritannien.  <BR>Tfn +44 171 222 7722, fax +44 171 233 1743<BR> K&auml;lla: Call for papers<BR><BR><!-- Horizontal Line Tag --><HR WIDTH=100% SIZE=1><BR><BR> Datum: 1997-05-15--1997-05-16<BR> Ort: Singapore<BR> Titel: <!-- Font Tag --><FONT COLOR="#BF361C"><B> Inspection appraisal repairs and maintenance of<BR>buildings and structures<BR> </B></FONT> Arrang&ouml;r: International Society of Technology, Law and<BR>Insurance, etc.<BR> Adress: Conference Director John S Y Tan, 150 Orchard Road<BR>#07-14, Orchard Plaza, Singapore 238841. <BR> Tfn (65)733-2922, fax (65)235-3530<BR> K&auml;lla: Preliminary announcement<BR><BR><!-- Horizontal Line Tag --><HR WIDTH=100% SIZE=1><BR><BR> Datum: 1997-05-26--1997-05-28<BR> Ort: Luzern, Schweiz<BR> Titel: <!-- Font Tag --><FONT COLOR="#BF361C"><B> Sustainable top achievements of the railways -<BR>solutions for the long-term future<BR> </B></FONT> Arrang&ouml;r: Schweizerisches Institut f&uuml;r Betriebs&ouml;konomie, SIB<BR> Adress: Schweizerisches Institut f&uuml;r Betriebs&ouml;konomie, Mr<BR>Hugo G&ouml;tz, Auenstrasse 4, CH-8600 D&uuml;bendorf,<BR>Schweiz.  Tfn +41 1 822 06 66, fax +41 1 822 07 77<BR> K&auml;lla: Call for papers<BR><BR><!-- Horizontal Line Tag --><HR WIDTH=100% SIZE=1><BR><BR> Datum: 1997-05-29--1997-05-31<BR> Ort: Stockholm<BR> Titel: <!-- Font Tag --><FONT COLOR="#BF361C"><B> Engineering structures and extreme events.  Risk<BR>analysis and simulation<BR> </B></FONT> Arrang&ouml;r: Kungl. tekniska h&ouml;gskolan<BR> Adress: Kungl. tekniska h&ouml;gskolan, Structural Engineering,<BR>100 44 Stockholm.  Tfn 08-790 68 88, fax 08-21 69 49<BR> K&auml;lla: First announcement<BR><BR><!-- Horizontal Line Tag --><HR WIDTH=100% SIZE=1><BR><BR> Datum: 1997-06-01--1997-06-04<BR> Ort: Los Angeles, Kalifornien, USA<BR> Titel: <!-- Font Tag --><FONT COLOR="#BF361C"><B> Partnerships for a peaceful community. 3rd<BR>national violence prevention conference<BR> </B></FONT> Arrang&ouml;r: Violence Prevention Coalition of Greater Los<BR>Angeles<BR> Adress: Violence Prevention Coalition of Greater Los<BR>Angeles, 313 N.  Figueroa St.  Rm 127, Los<BR>Angeles, Kalifornien 90012, USA.  <BR>Tfn 213 240-7785, fax 213 250-2594<BR> K&auml;lla: Call for abstracts (abstr senast97-01-15)<BR><BR><!-- Horizontal Line Tag --><HR WIDTH=100% SIZE=1><BR><BR> Datum: 1997-06-02--1997-06-06<BR> Ort: Stuttgart, Tyskland<BR> Titel: <!-- Font Tag --><FONT COLOR="#BF361C"><B> City Transport '97.  Public transport exhibition<BR> </B></FONT> Arrang&ouml;r: UITP<BR> Adress: UITP, International Union of Public Transport,<BR>Avenue de l'Uruguay 19, B-1050 Bryssel, Belgien.<BR>Tfn +32 2 673 61 05, fax +32 2 660 10 72<BR> K&auml;lla: Broschyr<BR><BR><!-- Horizontal Line Tag --><HR WIDTH=100% SIZE=1><BR><BR> Datum: 1997-06-03--1997-06-05<BR> Ort: London, Storbritannien<BR> Titel: <!-- Font Tag --><FONT COLOR="#BF361C"><B> Ground improvement geosystems.  Densification and<BR>reinforcement<BR> </B></FONT> Arrang&ouml;r: British Geotechnical Society, Comite francais de<BR>la mecanique des sols et des travaux de<BR>foundations &amp; TC-17 ISSMFE<BR> Adress: K&auml;lla:    SGI:s konferenslista<BR><BR><!-- Horizontal Line Tag --><HR WIDTH=100% SIZE=1><BR><BR> Datum: 1997-06-08--1997-06-11<BR> Ort: Ottawa, Kanada<BR> Titel: <!-- Font Tag --><FONT COLOR="#BF361C"><B> Engineering materials, 1997 international<BR>conference<BR> </B></FONT> Arrang&ouml;r: Canadian Society for Civil Engineering och Japan<BR>Society of Civil Engineers<BR> Adress: Akthem Al-Manaseer, Department of Civil<BR>Engineering and Construction, Bradley University,<BR>Peoria, Illinois, USA 61625.  Fax 309-677-2867<BR> K&auml;lla: Call for papers<BR><BR><!-- Horizontal Line Tag --><HR WIDTH=100% SIZE=1><BR><BR> Datum: 1997-06-08--1997-06-11<BR> Ort: Quebec, Kanada<BR> Titel: <!-- Font Tag --><FONT COLOR="#BF361C"><B> Transportation: New horizons of opportunity<BR> </B></FONT> Arrang&ouml;r: Northeast Association of State Transportation<BR>Officials, NASTO<BR> Adress: NASTO 1997, Minist&egrave;re des Transports du Qu&eacute;bec,<BR>700, boulevard Ren&eacute;-Levesque Est, 27e &eacute;tage,<BR>Qu&eacute;bec, Kanada, G1R 5H1.  Tfn (418)646-1997, <BR>fax (418)643-6181<BR> K&auml;lla: Broschyr<BR><BR><!-- Horizontal Line Tag --><HR WIDTH=100% SIZE=1><BR><BR> Datum: 1997-06-09--1997-06-14<BR> Ort: Spindleruv Mlyn, Tjeckien<BR> Titel: <!-- Font Tag --><FONT COLOR="#BF361C"><B> Sustainable energy opportunities for a greater<BR>Europe.  The energy efficiency challenge<BR> </B></FONT> Arrang&ouml;r: European Council for an Energy Efficient Economy,<BR>ECEEE<BR> Adress: Hanne Paulli eller Iben Spliid, Danish Energy<BR>Agency, tfn +45 3392 6700, fax +45 3311 4743<BR> K&auml;lla: Call for papers<BR><BR><!-- Horizontal Line Tag --><HR WIDTH=100% SIZE=1><BR><BR> Datum: 1997-06-09--1997-06-13<BR> Ort: Avignon, Frankrike<BR> Titel: <!-- Font Tag --><FONT COLOR="#BF361C"><B> Transport and air pollution, 4th international<BR>scientific symposium<BR> </B></FONT> Arrang&ouml;r: INRETS<BR> Adress: Robert Joumard eller Jean Delsey, INRETS case 24,<BR>69675 Bron cedex, Frankrike.  Tfn (33)72 36 23 00,<BR>fax (33)72 37 68 37<BR> K&auml;lla: Call for papers<BR><BR><!-- Horizontal Line Tag --><HR WIDTH=100% SIZE=1><BR><BR> Datum: 1997-06-09--1997-06-11<BR> Ort: Toronto, Kanada<BR> Titel: <!-- Font Tag --><FONT COLOR="#BF361C"><B> Multidisciplinary road safety conference, 10th<BR>Canadian<BR> </B></FONT> Arrang&ouml;r: Ryerson Vehicle Safety Research Centre, Ryerson<BR>Polytechnic University<BR> Adress: Vehicle Safety Research Office, Ryerson<BR>Polytechnic University, 350 Victoria St., Toronto,<BR>Ontario, M5B 2K3.  Tfn (416)979-5192, <BR>fax (416)979-5174<BR> K&auml;lla: Call for papers<BR><BR><!-- Horizontal Line Tag --><HR WIDTH=100% SIZE=1><BR><BR> Datum: 1997-06-10--1997-06-14<BR> Ort: M&uuml;nchen, Tyskland<BR> Titel: <!-- Font Tag --><FONT COLOR="#BF361C"><B> Transport 97<BR> </B></FONT> Arrang&ouml;r: Messe M&uuml;nchen<BR> Adress: K&auml;lla:    Public Transport International<BR><BR><!-- Horizontal Line Tag --><HR WIDTH=100% SIZE=1><BR><BR> Datum: 1997-06-11--1997-06-12<BR> Ort: Leicestershire, Storbritannien<BR> Titel: <!-- Font Tag --><FONT COLOR="#BF361C"><B> Real world crash injury research<BR> </B></FONT> Arrang&ouml;r: Loughborough University, Vehicle Safety Research<BR>Centre<BR> Adress: Judy Brewin, ICE Ergonomics, Swingbridge Road,<BR>Loughborough, Leicestershire, LE11 0JB,<BR>Storbritannien.  Tfn +44 1509 23 61 61, fax +44 1509 61 07 25<BR> K&auml;lla: First announcement<BR><BR><!-- Horizontal Line Tag --><HR WIDTH=100% SIZE=1><BR><BR> Datum: 1997-06-11--1997-06-12<BR> Ort: Baden-Baden, Tyskland<BR> Titel: <!-- Font Tag --><FONT COLOR="#BF361C"><B> Driving safely in Europe, 3rd ADAC/BASt symposium<BR> </B></FONT> Arrang&ouml;r: Allgemeiner Deutscher Automobil-Club E.V. &amp;<BR>Bundesanstalt f&uuml;r Strassenwesen<BR> Adress: ADAC, Am Westpark 8, D-81373 M&uuml;nchen, Tyskland.<BR>Tfn +49 89 7676 2123, fax +49 89 7676 2598<BR> K&auml;lla: Program<BR><BR><!-- Horizontal Line Tag --><HR WIDTH=100% SIZE=1><BR><BR> Datum: 1997-06-12--1997-06-14<BR> Ort: G&ouml;teborg<BR> Titel: <!-- Font Tag --><FONT COLOR="#BF361C"><B> Advanced design of concrete structures<BR> </B></FONT> Arrang&ouml;r: Chalmers tekniska h&ouml;gskola<BR> Adress: Per &Aring;hman, Byggm&auml;staref&ouml;reningen V&auml;st, Ekmansgatan<BR>1, 411 32 G&ouml;teborg.  Tfn 031 20 04 60, fax 031-16 00 85<BR> K&auml;lla: Call for papers<BR><BR><!-- Horizontal Line Tag --><HR WIDTH=100% SIZE=1><BR><BR> Datum: 1997-06-16--1997-06-20<BR> Ort: Toronto, Kanada<BR> Titel: <!-- Font Tag --><FONT COLOR="#BF361C"><B> IRF world meeting, 13th.  &quot;Roads sustaining the<BR>economy and the environment&quot; and TAC's 1997 annual<BR>conference<BR> </B></FONT> Arrang&ouml;r: International Road Federation<BR> Adress: Ministry of Transportation, 1201 Wilson Avenue,<BR>Downsview, Ontario, Kanada M3M 1J8.  Tfn<BR>(416)235-5107, fax (416)235-5151<BR> K&auml;lla: Preliminary announcement<BR><BR><!-- Horizontal Line Tag --><HR WIDTH=100% SIZE=1><BR><BR> Datum: 1997-06-16--1997-06-18<BR> Ort: Chania, Grekland<BR> Titel: <!-- Font Tag --><FONT COLOR="#BF361C"><B> Transportation systems -97. 8th IFAC symposium<BR> </B></FONT> Arrang&ouml;r: Department of Production and Management<BR>Engineering<BR> Adress: 8th IFAC Symposium on Transportation Systems,<BR>Department of Production and Management<BR>Engineering, Technical University of Crete,<BR>University Campus, 73100 Chania, Grekland.  <BR>Tfn +30 821 69549, fax +30 821 69410<BR> K&auml;lla: Call for papers (abstr senast 96-07-31)<BR><BR><!-- Horizontal Line Tag --><HR WIDTH=100% SIZE=1><BR><BR> Datum: 1997-06-16--1997-06-19<BR> Ort: Florens, Italien<BR> Titel: <!-- Font Tag --><FONT COLOR="#BF361C"><B> ISATA 30th<BR> </B></FONT> Arrang&ouml;r: ISATA International Association<BR> Adress: ISATA, 32A Queen Street, Croydon, London CR0 1SY,<BR>Storbritannien.  Tfn +44 181 681 3069, fax +44 181 686 1490<BR> K&auml;lla: Call for papers<BR><BR><!-- Horizontal Line Tag --><HR WIDTH=100% SIZE=1><BR><BR> Datum: 1997-06-23--1996-06-25<BR> Ort: Ottawa, Kanada<BR> Titel: <!-- Font Tag --><FONT COLOR="#BF361C"><B> DIVINE concluding conference - Dynamic Interaction<BR>Vehicle-Infrastructure Experiment<BR> </B></FONT> Arrang&ouml;r: OECD<BR> Adress: Conference Secretariat, Pierre Lamoureux, DIVINE<BR>Concluding Conference, National Research Council<BR>Canada, Ottawa, Ontario, Kanada K1A 0R6.  <BR>Tfn (613) 993-9431, fax (613) 993-7250<BR> K&auml;lla: Premier avis<BR><BR><!-- Horizontal Line Tag --><HR WIDTH=100% SIZE=1><BR><BR> Datum: 1997-06-23--1997-06-27<BR> Ort: Aten, Grekland<BR> Titel: <!-- Font Tag --><FONT COLOR="#BF361C"><B> Engineering geology and the environment<BR> </B></FONT> Arrang&ouml;r: International Association of Engineering Geology<BR> Adress: K&auml;lla:    SGI:s konferenslista<BR><BR><!-- Horizontal Line Tag --><HR WIDTH=100% SIZE=1><BR><BR><BR>[<!-- Anchor Link Tag --><A HREF="#Up!">Up!</A>] [<!-- Link Tag --><A HREF="vtifrom9707.html">Konferenser fr o m 1997-07</A>]</td></tr></TABLE></BODY></HTML>
</DOC>
<DOC>
<DOCNO>WT02-B10-42</DOCNO>
<DOCOLDNO>IA018-000200-B014-150</DOCOLDNO>
<DOCHDR>
http://www.kfb.se:80/from9707.html 194.198.183.242 19970106204628 text/html 17067
HTTP/1.0 200 OK
Date: Mon, 06 Jan 1997 20:41:37 GMT
Server: Microsoft-Internet-Information-Server/1.0
Content-Type: text/html
Last-Modified: Thu, 05 Dec 1996 09:14:00 GMT
Content-Length: 16866
</DOCHDR>
<HTML><HEAD><TITLE>Konferensregistret</TITLE></HEAD><BODY TEXT="#3d3d3d" BGCOLOR="#ffffff" LINK="#e12b1e" ALINK="#e7e318" VLINK="#0e7112"><TABLE WIDTH=456 BORDER=0 ><TR><TD WIDTH=1 BORDER=0 align=left></TD><TD WIDTH=455 BORDER=0 align=left> <H6>[<A HREF="kfbnews.html">Back</A>] </H6><!-- Link Tag --><A HREF="kfbnews.html"><!-- Graphic Tag --><IMG WIDTH=458 HEIGHT=28 BORDER=0  SRC="head1smal.gif"></A><!-- Font Tag --><FONT COLOR="#BF361C"><H2><P><!-- Anchor Point Tag --><A NAME="Up!">Nedan finner du aktuella konferenser inom transportomr&aring;det fr.o.m. 1997-07</A></P></H2></FONT><BR> Datum: 1997-07--<BR> Ort: Chicago, Illinois, USA<BR> Titel: <FONT COLOR="#BF361C"><B> Traffic Congestion and Traffic Safety in the 21st<BR>Century<BR> </B></FONT> Arrang&ouml;r: Urban Transportation Divison m fl<BR> Adress: Conference &amp; Convention Department, ASCE, 345 East<BR>47th Street, New York, NY 10017, USA.  Tfn705-7285, fax 212-705-7975<BR> K&auml;lla: Call for papers (abstr senast1996-04-26)<BR><BR><!-- Horizontal Line Tag --><HR WIDTH=100% SIZE=1><BR><BR> Datum: 1997-07-08--1997-07-11<BR> Ort: Saratoga Springs, New York, USA<BR> Titel: <!-- Font Tag --><FONT COLOR="#BF361C"><B> How industry will procure energy efficiency<BR>services in the 21st century. 1997 summer study on<BR>energy efficiency in industry<BR> </B></FONT> Arrang&ouml;r: American Council for an Energy-Efficient Economy<BR> Adress: Debbie Giallombardo, ACEEE Conference Office, 1001<BR>Conn.  Ave., N.W., Suite 801, Washington, D.C.<BR>20036, USA.  Tfn (202)429-8873, fax (202)429-2248<BR> K&auml;lla: Call for papers<BR><BR><!-- Horizontal Line Tag --><HR WIDTH=100% SIZE=1><BR><BR> Datum: 1997-07-08--1997-07-11<BR> Ort: Sacramento, Kalifornien, USA<BR> Titel: <!-- Font Tag --><FONT COLOR="#BF361C"><B> Meeting the challenge, research and practice, 2nd<BR>national seismic conference of bridges and<BR>highways<BR> </B></FONT> Arrang&ouml;r: Federal Highway Administration and the California<BR>Department of Transportation<BR> Adress: Barbara Murdock, Henderson Associates, 1000<BR>Vermont Avenue NW, 6th floor, Washington, D.C.<BR>20005, USA.  Tfn 202-682-3739, fax 202-682-2535<BR> K&auml;lla: Call for abstracts (abstr senast 96-11-01)<BR><BR><!-- Horizontal Line Tag --><HR WIDTH=100% SIZE=1><BR><BR> Datum: 1997-07-20--1997-07-26<BR> Ort: Boston, Massachusetts, USA<BR> Titel: <!-- Font Tag --><FONT COLOR="#BF361C"><B> Coastal zone 97.  Charting the future of coastal<BR>zone management<BR> </B></FONT> Arrang&ouml;r: Urban Harbours Institute<BR> Adress: Gary Magnuson, NOAA, National Ocean Service, 1305<BR>East-West Highway N/EA, Silver Spring, MD 20910,<BR>USA.  Fax (301)713-4263<BR> K&auml;lla: Call for papers<BR><BR><!-- Horizontal Line Tag --><HR WIDTH=100% SIZE=1><BR><BR> Datum: 1997-07-21--1997-07-23<BR> Ort: Portland, Oregon, USA<BR> Titel: <!-- Font Tag --><FONT COLOR="#BF361C"><B> Intersections without traffic signal, 3rd<BR>international symposium<BR> </B></FONT> Arrang&ouml;r: NCATT<BR> Adress: National Center for Advanced Transportation<BR>Technology (NCATT), University of Idaho, Moscow,<BR>Idaho 83844-1026, USA.  Tfn 208-885-6002, fax 885-6608<BR> K&auml;lla: Call for papers (abstr senast 1996-05-01)<BR><BR><!-- Horizontal Line Tag --><HR WIDTH=100% SIZE=1><BR><BR> Datum: 1997-08-10--1997-08-14<BR> Ort: Seattle, USA<BR> Titel: <!-- Font Tag --><FONT COLOR="#BF361C"><B> Asphalt pavements, 8th international conference<BR> </B></FONT> Arrang&ouml;r: International Society for Asphalt Pavements<BR> Adress: 8th International Conference on Asphalt Pavements,<BR>UW Engineering Professional Programs, 3201 Fremont<BR>Avenue North, Seattle, WA 98103, USA<BR> K&auml;lla: Call for papers (abstr senast 95-10-31)<BR><BR><!-- Horizontal Line Tag --><HR WIDTH=100% SIZE=1><BR><BR> Datum: 1997-08-17--1997-08-22<BR> Ort: Sydney, Australien<BR> Titel: <!-- Font Tag --><FONT COLOR="#BF361C"><B> Durability of concrete. 4th CANMET/ACI<BR>international conference<BR> </B></FONT> Arrang&ouml;r: CANMET, American Concrete Institute, etc.<BR> Adress: K&auml;lla:    Vejdirektoratets lista okt -95<BR><BR><!-- Horizontal Line Tag --><HR WIDTH=100% SIZE=1><BR><BR> Datum: 1997-08-25--1997-08-27<BR> Ort: Singapore<BR> Titel: <!-- Font Tag --><FONT COLOR="#BF361C"><B> Our world in concrete &amp; structures<BR> </B></FONT> Arrang&ouml;r: CI-PREMIER Conference Organisation<BR> Adress: CI-Premier Pte Ltd, 150 Orchard Road #07-14,<BR>Orchard Plaza, Singapore 238841, Republic of<BR>Singapore.  Tfn 065-733-2922, fax 065-235-3530<BR> K&auml;lla: CI Conference Announcement<BR><BR><!-- Horizontal Line Tag --><HR WIDTH=100% SIZE=1><BR><BR> Datum: 1997-08-28--1997-08-29<BR> Ort: Singapore<BR> Titel: <!-- Font Tag --><FONT COLOR="#BF361C"><B> Fibre reinforced concrete<BR> </B></FONT> Arrang&ouml;r: CI-PREMIER Conference Organisation<BR> Adress: CI-Premier Pte Ltd, 150 Orchard Road #07-14,<BR>Orchard Plaza, Singapore 238841, Republic of<BR>Singapore.  Tfn 065-733-2922, fax 065-235-3530<BR> K&auml;lla: CI Conference Announcement<BR><BR><!-- Horizontal Line Tag --><HR WIDTH=100% SIZE=1><BR><BR> Datum: 1997-09-03--1997-09-04<BR> Ort: Ronneby<BR> Titel: <!-- Font Tag --><FONT COLOR="#BF361C"><B> Persontrafikdagar<BR> </B></FONT> Arrang&ouml;r: Svenska Lokaltrafikf&ouml;reningen<BR> Adress: Svenska Lokaltrafikf&ouml;reningen, tfn 08-788 08 60,<BR>fax 08- 788 08 78<BR> K&auml;lla: Telefonsamtal<BR><BR><!-- Horizontal Line Tag --><HR WIDTH=100% SIZE=1><BR><BR> Datum: 1997-09-06--1997-09-12<BR> Ort: Hamburg<BR> Titel: <!-- Font Tag --><FONT COLOR="#BF361C"><B> Soil mechanics and foundation engineering, 14th<BR>international conference<BR> </B></FONT> Arrang&ouml;r: ISSMFE<BR> Adress: K&auml;lla:    SGI:s konferenslista<BR><BR><!-- Horizontal Line Tag --><HR WIDTH=100% SIZE=1><BR><BR> Datum: 1997-09-15--1997-09-19<BR> Ort: Barcelona, Spanien<BR> Titel: <!-- Font Tag --><FONT COLOR="#BF361C"><B> Bicycle planning conference, 10th international<BR> </B></FONT> Arrang&ouml;r: Ajuntament de Barcelona, European Cyclists'<BR>Federation, etc.<BR> Adress: Congreso VeloCity '97, Ajuntament de Barcelona,<BR>&Agrave;mbit de la Via P&uacute;blica, Pl.  Pi i Sunyer, 8-10,<BR>4t, E-08002, Barcelona, Spanien.  Tfn +34 3 402 34<BR>81, fax +34 3 402 34 18<BR> K&auml;lla: Preliminary information<BR><BR><!-- Horizontal Line Tag --><HR WIDTH=100% SIZE=1><BR><BR> Datum: 1997-09-16--1997-09-18<BR> Ort: Innsbruck, &Ouml;sterrike<BR> Titel: <!-- Font Tag --><FONT COLOR="#BF361C"><B> Composite construction - Conventional and<BR>innovative<BR> </B></FONT> Arrang&ouml;r: IABSE<BR> Adress: Composite Construction, c/o IABSE, ETH<BR>H&ouml;nggerberg, CH-8093 Z&uuml;rich, Schweiz<BR> K&auml;lla: Call for papers (abstr senast 96-05-15)<BR><BR><!-- Horizontal Line Tag --><HR WIDTH=100% SIZE=1><BR><BR> Datum: 1997-09-21--1997-09-25<BR> Ort: Annecy, Frankrike<BR> Titel: <!-- Font Tag --><FONT COLOR="#BF361C"><B> Alcohol, drugs and traffic safety, T'97<BR> </B></FONT> Arrang&ouml;r: CERMT<BR> Adress: CERMT, BP 132, 74004 Annecy Cedex, Frankrike.  Fax<BR>+33 50 45 36 92<BR> K&auml;lla: Lista fr&aring;n Bj&ouml;rn Peters<BR><BR><!-- Horizontal Line Tag --><HR WIDTH=100% SIZE=1><BR><BR> Datum: 1997-09-23--1997-09-26<BR> Ort: Bordeaux, Frankrike<BR> Titel: <!-- Font Tag --><FONT COLOR="#BF361C"><B> Industrial applications of emulsion<BR> </B></FONT> Arrang&ouml;r: COLAS S.A. m fl<BR> Adress: CME, 50 place Marcel-Pagnol, 92100<BR>Boulogne-Billancourt, Frankrike.  Tfn (33-1)47 61<BR>76 89, fax (33-1)47 61 74 65<BR> K&auml;lla: Broschyr<BR><BR><!-- Horizontal Line Tag --><HR WIDTH=100% SIZE=1><BR><BR> Datum: 1997-10-06--1997-10-10<BR> Ort: Marrakech, Marocko<BR> Titel: <!-- Font Tag --><FONT COLOR="#BF361C"><B> Rail mode: from economic necessity to financial<BR>return, World congress<BR> </B></FONT> Arrang&ouml;r: International Union of Railways<BR> Adress: International Union of Railways, tfn 33 1 44 49 20 51, <BR>fax 33 1 44 49 20 59<BR> K&auml;lla: Press release<BR><BR><!-- Horizontal Line Tag --><HR WIDTH=100% SIZE=1><BR><BR> Datum: 1997-10-08--1997-10-10<BR> Ort: Venedig, Italien<BR> Titel: <!-- Font Tag --><FONT COLOR="#BF361C"><B> Superplasticizers and other chemical admixtures in<BR>concrete, 5th CANMET/ACI international conference<BR> </B></FONT> Arrang&ouml;r: CANMET<BR> Adress: V.M.  Malhotra, CANMET, 405 Rochester Street,<BR>Ottawa, ON, Kanada K1A 0G1.  Fax (613)992-9389<BR> K&auml;lla: Call for papers reminder<BR><BR><!-- Horizontal Line Tag --><HR WIDTH=100% SIZE=1><BR><BR> Datum: 1997-10-08--1997-10-10<BR> Ort: Arles en Provence, Frankrike<BR> Titel: <!-- Font Tag --><FONT COLOR="#BF361C"><B> Urban areas and an ageing population.  Urban<BR>planning and the elderly<BR> </B></FONT> Arrang&ouml;r: INRETS<BR> Adress: Ms Mich&egrave;le Bidal, INRETS - Centre Marseille -<BR>Salon de Provence, MA - D&eacute;partement M&eacute;canismes<BR>d'Accidents, Chemin de la Croix Blanche, F 13300<BR>Salon de Provence, Frankrike.  Fax (33) 90 56 25 51, fr&aring;n 961018 <BR>fax (33)04 90 56 25 51<BR> K&auml;lla: Call for papers<BR><BR><!-- Horizontal Line Tag --><HR WIDTH=100% SIZE=1><BR><BR> Datum: 1997-10-13--1997-10-16<BR> Ort: Queensland, Australien<BR> Titel: <!-- Font Tag --><FONT COLOR="#BF361C"><B> Accident investigation, reconstruction,<BR>interpretation and the law, 2nd international<BR>conference, AIRIL '97<BR> </B></FONT> Arrang&ouml;r: Texas A&amp;M University, University of British<BR>Columbia, etc.<BR> Adress: AIRIL 97 Secretariat, School of Civil Engineering,<BR>QUT, GPO Box 2434, Brisbane, Qld.  Australien<BR>Tfn +61 7 38 64 25 44, fax +61 7 38 64 15 15<BR> K&auml;lla: Announcement<BR><BR><!-- Horizontal Line Tag --><HR WIDTH=100% SIZE=1><BR><BR> Datum: 1997-10-21--1997-10-24<BR> Ort: Berlin, Tyskland<BR> Titel: <!-- Font Tag --><FONT COLOR="#BF361C"><B> ERTICO/ITS America/VERTIS 4th world congress on<BR>intelligent transport systems<BR> </B></FONT> Arrang&ouml;r: Adress:<BR> K&auml;lla: Lista fr&aring;n Bj&ouml;rn Peters<BR><BR><!-- Horizontal Line Tag --><HR WIDTH=100% SIZE=1><BR><BR> Datum: 1997-11-09--1997-11-12<BR> Ort: Boston, MA, USA<BR> Titel: <!-- Font Tag --><FONT COLOR="#BF361C"><B> Intelligent transportation systems, ITSC '97<BR> </B></FONT> Arrang&ouml;r: Institute of Electrical and Electronics Engineers,<BR>IEEE<BR> Adress: IEEE Boston Section, 255 Bear Hill Road, Waltham,<BR>MA 02154, USA.  Tfn 617-890-5290, fax 617-890-5294<BR> K&auml;lla: Call for papers<BR><BR><!-- Horizontal Line Tag --><HR WIDTH=100% SIZE=1><BR><BR> Datum: 1997-11-10--1997-11-14<BR> Ort: Singapore<BR> Titel: <!-- Font Tag --><FONT COLOR="#BF361C"><B> Shell and spatial structures: design,<BR>construction, performance and economics.<BR>International symposium -97<BR> </B></FONT> Arrang&ouml;r: International Association for Shell and Spatial<BR>Structures<BR> Adress: John S.Y.  Tan, IASS 97, Conference Logistics and<BR>Services, 150 Orchard Road #07-14, Orchard Plaza,<BR>Singapore 238841.  Tfn (065)733-2922, <BR>fax (065)235-3530<BR> K&auml;lla: Call for papers<BR><BR><!-- Horizontal Line Tag --><HR WIDTH=100% SIZE=1><BR><BR> Datum: 1997-11-11--1997-11-13<BR> Ort: London, Storbritannien<BR> Titel: <!-- Font Tag --><FONT COLOR="#BF361C"><B> Railtex 97<BR> </B></FONT> Arrang&ouml;r: Mack Brooks Exhibitions Ltd<BR> Adress: Judy Aspden, Mack Brooks Exhibitions Ltd, Forum<BR>Place, Hatfield, Hertfordshire, AL10 0RN,<BR>Storbritannien.  Tfn +44 1707 275 641, fax +44<BR>1707 275 544<BR> K&auml;lla: Infoblad<BR><BR><!-- Horizontal Line Tag --><HR WIDTH=100% SIZE=1><BR><BR> Datum: 1997-11-16--1997-11-19<BR> Ort: Florens, Italien<BR> Titel: <!-- Font Tag --><FONT COLOR="#BF361C"><B> Role of rail research in reducing costs and<BR>enhancing competitiveness, World rail research<BR>congress WCRR97<BR> </B></FONT> Arrang&ouml;r: International Union of Railways<BR> Adress: International Union of Railways, <BR>tfn 33 1 44 49 20 51, fax 33 1 44 49 20 59<BR> K&auml;lla: Press release<BR><BR><!-- Horizontal Line Tag --><HR WIDTH=100% SIZE=1><BR><BR> Datum: 1998-02-25--1998-03-01<BR> Ort: Melbourne, Australien<BR> Titel: <!-- Font Tag --><FONT COLOR="#BF361C"><B> Safety in action<BR> </B></FONT> Arrang&ouml;r: Safety Institute of Australia, etc.<BR> Adress: Safety in Action, Suite 17, 51 55 City Road,<BR>Southband, Victoria 3006, Australien<BR> K&auml;lla: First announcement<BR><BR><!-- Horizontal Line Tag --><HR WIDTH=100% SIZE=1><BR><BR> Datum: 1998-03-16--1986-03-20<BR> Ort: Lule&aring;<BR> Titel: <!-- Font Tag --><FONT COLOR="#BF361C"><B> PIARC 98, Winter road congress, 10th international<BR> </B></FONT> Arrang&ouml;r: PIARC<BR> Adress: Xth PIARC International Winter Road Congress, PO<BR>Box 809, 971 25 Lule&aring;.  Tfn 0920 433 00, <BR>fax 0920 433 05<BR> K&auml;lla: Broschyr<BR><BR><!-- Horizontal Line Tag --><HR WIDTH=100% SIZE=1><BR><BR> Datum: 1998-05-17--1998-05-21<BR> Ort: Durban, Sydafrika<BR> Titel: <!-- Font Tag --><FONT COLOR="#BF361C"><B> Managing pavements, 4th international conference<BR> </B></FONT> Arrang&ouml;r: Transportation Research Board, etc.<BR> Adress: Fourth International Conference on Managing<BR>Pavements, Conference Secretariat, P O Box 82,<BR>IRENE, 1675 Sydafrika.  Tfn +27-12-63 1681, <BR>fax +27-12-63 1680<BR> K&auml;lla: Call for papers (abstr senast 1996-09-30)<BR><BR><!-- Horizontal Line Tag --><HR WIDTH=100% SIZE=1><BR><BR> Datum: 1998-05-17--1998-05-20<BR> Ort: Amsterdam, Nederl&auml;nderna<BR> Titel: <!-- Font Tag --><FONT COLOR="#BF361C"><B> Injury prevention and control, 4th World<BR>conference<BR> </B></FONT> Arrang&ouml;r: World Health Organization and its Collaborating<BR>Centres for Safety Promotion and Injury Control<BR> Adress: Conference Secretariat 'Injury prevention and<BR>control', P.O.  Box 1558, 6501 BN Nijmegen,<BR>Nederl&auml;nderna.  Tfn +31 24 323 44 71, <BR>fax +31 24 360 11 59<BR> K&auml;lla: Broschyr<BR><BR><!-- Horizontal Line Tag --><HR WIDTH=100% SIZE=1><BR><BR> Datum: 1998-05-31--1998-06-05<BR> Ort: Bangkok, Thailand<BR> Titel: <!-- Font Tag --><FONT COLOR="#BF361C"><B> Fly ash, silica fume, slag and natural pozzolans<BR>in concrete, 6th CANMET/ACI international<BR>conference<BR> </B></FONT> Arrang&ouml;r: CANMET/ACI<BR> Adress: V.M.  Malhotra, CANMET, 405 Rochester Street,<BR>Ottawa, ON, Kanada K1A 0G1.  Fax 613-992-9389<BR> K&auml;lla: Call for papers<BR><BR><!-- Horizontal Line Tag --><HR WIDTH=100% SIZE=1><BR><BR> Datum: 1998-06-07--1998-06-11<BR> Ort: Tokushima, Japan<BR> Titel: <!-- Font Tag --><FONT COLOR="#BF361C"><B> Recent advances in concrete technology,<BR>CANMET/ACI/JCI 4th international conference<BR> </B></FONT> Arrang&ouml;r: CANMET/ACI/JCI<BR> Adress: V.M.  Malhotra, CANMET, 405 Rochester Street,<BR>Ottowa, ON, Kanada K1A 0G1.  Fax 613-992-9389<BR> K&auml;lla: Call for papers<BR><BR><!-- Horizontal Line Tag --><HR WIDTH=100% SIZE=1><BR><BR> Datum: 1998-07-18--1998-07-23<BR> Ort: San Francisco, CA, USA<BR> Titel: <!-- Font Tag --><FONT COLOR="#BF361C"><B> <!-- Font Tag --><FONT COLOR="#BF361C"><B>Structural engineers world congress, SEWC<BR></B></FONT> </B></FONT> Arrang&ouml;r: American Society of Civil Engineers<BR> Adress: SEWC, Conference Manager, American Society of<BR>Civil Engineers, 345 East 47th Street, New York,<BR>NY 10017, USA<BR> K&auml;lla: Call for papers<BR><BR><!-- Horizontal Line Tag --><HR WIDTH=100% SIZE=1><BR><BR> Datum: 1998-09-12--1998-09-17<BR> Ort: Lissabon, Portugal<BR> Titel: <!-- Font Tag --><FONT COLOR="#BF361C"><B> <!-- Font Tag --><FONT COLOR="#BF361C"><B> Concrete roads, 8th international symposium </B></FONT><BR> Arrang&ouml;r: CEMBUREAU<BR> Adress: K&auml;lla:    Vejdirektorates lista nov -95<BR><!-- Horizontal Line Tag --><HR WIDTH=100% SIZE=1><BR><!-- Horizontal Line Tag --><HR WIDTH=100% SIZE=1><BR> Datum: 1998-09-21--1998-09-25<BR> Ort: Qingdao, Kina<BR> Titel: <!-- Font Tag --><FONT COLOR="#BF361C"><B> <!-- Font Tag --><FONT COLOR="#BF361C"><B> Safety and high efficiency, running into 21st<BR>century. 12th wheelset congress<BR> </B></FONT> Arrang&ouml;r: China Railway Society<BR> Adress: Ms Chen Yun-eh, China Railway Society, 10, Fuxing<BR>road, Beijing, Kina 100844.  Tfn 086 10 63242621,<BR>fax 086 10 63967184<BR> K&auml;lla: Call for papers<BR><BR><!-- Horizontal Line Tag --><HR WIDTH=100% SIZE=1><BR><!-- Anchor Link Tag --><A HREF="#Up!">Up!</A></td></tr></TABLE></BODY></HTML>
</DOC>
<DOC>
<DOCNO>WT02-B10-43</DOCNO>
<DOCOLDNO>IA018-000200-B014-160</DOCOLDNO>
<DOCHDR>
http://www.kfb.se:80/ehvproge/introduction.html 194.198.183.242 19970106204638 text/html 3656
HTTP/1.0 200 OK
Date: Mon, 06 Jan 1997 20:41:49 GMT
Server: Microsoft-Internet-Information-Server/1.0
Content-Type: text/html
Last-Modified: Thu, 10 Oct 1996 08:42:02 GMT
Content-Length: 3456
</DOCHDR>
<!---------------------------------------------------------------><!-      AUTHOR:        mats holm                           ><!-      E-MAIL:            mats@softmachine.se                  ><!-      CREATED:   	  1996.10.01                       ><!-      MODIFIED:  	                     ><!								FILE:																introducrton.html   <!---------------------------------------------------------------><!-- Head Tag --><HEAD><TITLE>KFB-Swedish Research and Communications Board</TITLE></HEAD><!-- Body Tag --><BODY TEXT="#4C4C4C" BACKGROUND="ehvpic/yel_bgr.gif"></BODY><!-- Link Tag --><A HREF="index.html"><!-- Graphic Tag --><IMG WIDTH=534 HEIGHT=28 BORDER=0  SRC="ehvpic/kfbhead.gif"></A><TABLE WIDTH=535 BORDER=0 ><TR><TD WIDTH=130 BORDER=0 valign=top><!-- Link Tag --><A HREF="program.html"><!-- Graphic Tag --><IMG WIDTH=108 HEIGHT=36 BORDER=0  SRC="ehvpic/kna_pro.gif"></A><!-- Link Tag --><A HREF="projects.html"><!-- Graphic Tag --><IMG WIDTH=108 HEIGHT=35 BORDER=0  SRC="ehvpic/kna_proj.gif"></A><!-- Link Tag --><A HREF="hood.html"><!-- Graphic Tag --><IMG WIDTH=108 HEIGHT=36 BORDER=0  SRC="ehvpic/kna_hood.gif"></A><!-- Link Tag --><A HREF="infra.html"><!-- Graphic Tag --><IMG WIDTH=108 HEIGHT=17 BORDER=0  SRC="ehvpic/kna_infra.gif"></A><!-- Link Tag --><A HREF="energy.html"><!-- Graphic Tag --><IMG WIDTH=108 HEIGHT=18 BORDER=0  SRC="ehvpic/kna_energ.gif"></A><!-- Link Tag --><A HREF="economic.html"><!-- Graphic Tag --><IMG WIDTH=108 HEIGHT=17 BORDER=0  SRC="ehvpic/kna_eco.gif"></A><!-- Link Tag --><A HREF="perform.html"><!-- Graphic Tag --><IMG WIDTH=108 HEIGHT=17 BORDER=0  SRC="ehvpic/kna_perfa.gif"></A><!-- Link Tag --><A HREF="market.html"><!-- Graphic Tag --><IMG WIDTH=108 HEIGHT=18 BORDER=0  SRC="ehvpic/kna_mark.gif"></A></TD><TD WIDTH=15 BORDER=0 align=center></TD><TD WIDTH=300 BORDER=0 align=left valign=top><BR><H4>Welcome to browse the various sections of the KFB EV & Hybrid program web pages! </H4><P>The pages are set up as follows: <B><!-- Font Tag --><FONT COLOR="#BF361C">R, D & D program</FONT></B> contains a description of the assignment to KFB and a description of strategies, methods and principles employed. By clicking on one of the five <B><!-- Font Tag --><FONT COLOR="#BF361C">topics</FONT></B> (infrastructure, energy and emissions etc.) you reach scores of assessment areas associated to large scale EV and Hybrid introduction. <B><!-- Font Tag --><FONT COLOR="#BF361C">what is under the hood</FONT></B> contains a technical account of EVs and Hybrids of today and tomorrow. <B><!-- Font Tag --><FONT COLOR="#BF361C">projects</FONT></B> takes you to an overview of major associated demonstration and research projects. Demo program pages have links to vehicle data. </P><P>The web pages which you have accessed reside on the KFB server in Stockholm regarding program issues and project information. All vehicle related material is located on the Data Base server at Lund University of Technology, Department of Industrial Engineering and Automation. Our ambition is to offer a consistent graphics interface as to leave you undisturbed by which server you are currently visiting.</P><P>Please don&#180;t hesitate to forward your comments on the web pages and related questions to <!-- MailTo Tag --><A HREF="MAILTO:EV@kfb.se">EV@kfb.se</A>.<BR></P><!-- Horizontal Line Tag --><HR WIDTH=100%>   </TD></TR></TABLE></BODY></HTML>
</DOC>
<DOC>
<DOCNO>WT02-B10-44</DOCNO>
<DOCOLDNO>IA018-000200-B014-175</DOCOLDNO>
<DOCHDR>
http://www.kfb.se:80/ehvproge/program.html 194.198.183.242 19970106204648 text/html 4444
HTTP/1.0 200 OK
Date: Mon, 06 Jan 1997 20:41:56 GMT
Server: Microsoft-Internet-Information-Server/1.0
Content-Type: text/html
Last-Modified: Thu, 10 Oct 1996 08:42:12 GMT
Content-Length: 4244
</DOCHDR>
<HTML><!---------------------------------------------------------------><!   AUTHOR:       mats holm                           ><!      E-MAIL:mats@softmachine.se                  ><!      CREATED:     1996.09.26                       ><!     MODIFIED:                       ><! Anchor Point Tag --><A NAME="Up!"><!-      FILE: program.html></A>             <!---------------------------------------------------------------><!-- Head Tag --><HEAD><TITLE>KFB-Swedish Research and Communications Board</TITLE></HEAD><!-- Body Tag --><BODY BACKGROUND="ehvpic/yel_bgr.gif"></BODY><!-- Head Tag --><HEAD><TITLE>KFB-Swedish Research and Communications Board</TITLE></HEAD><!-- Body Tag --><BODY TEXT="#4C4C4C" BACKGROUND="ehvpic/yel_bgr.gif"></BODY><!-- Link Tag --><A HREF="index.html"><!-- Graphic Tag --><IMG WIDTH=534 HEIGHT=28 BORDER=0  SRC="ehvpic/kfbhead.gif"></A><TABLE WIDTH=535 BORDER=0 ><TR><TD WIDTH=130 BORDER=0 valign=top><!-- Link Tag --><A HREF="program.html"><!-- Graphic Tag --><IMG WIDTH=108 HEIGHT=36 BORDER=0  SRC="ehvpic/kna_proa.gif"></A><!-- Link Tag --><A HREF="projects.html"><!-- Graphic Tag --><IMG WIDTH=108 HEIGHT=35 BORDER=0  SRC="ehvpic/kna_proj.gif"></A><!-- Link Tag --><A HREF="hood.html"><!-- Graphic Tag --><IMG WIDTH=108 HEIGHT=36 BORDER=0  SRC="ehvpic/kna_hood.gif"></A><!-- Link Tag --><A HREF="infra.html"><!-- Graphic Tag --><IMG WIDTH=108 HEIGHT=17 BORDER=0  SRC="ehvpic/kna_infra.gif"></A><!-- Link Tag --><A HREF="energy.html"><!-- Graphic Tag --><IMG WIDTH=108 HEIGHT=18 BORDER=0  SRC="ehvpic/kna_energ.gif"></A><!-- Link Tag --><A HREF="economic.html"><!-- Graphic Tag --><IMG WIDTH=108 HEIGHT=17 BORDER=0  SRC="ehvpic/kna_eco.gif"></A><!-- Link Tag --><A HREF="perform.html"><!-- Graphic Tag --><IMG WIDTH=108 HEIGHT=17 BORDER=0  SRC="ehvpic/kna_perfa.gif"></A><!-- Link Tag --><A HREF="market.html"><!-- Graphic Tag --><IMG WIDTH=108 HEIGHT=18 BORDER=0  SRC="ehvpic/kna_mark.gif"></A></TD><TD WIDTH=15 BORDER=0 align=center></TD><TD WIDTH=300 BORDER=0 align=left valign=top><BR><!-- Graphic Tag --><IMG WIDTH=232 HEIGHT=30  SRC="ehvpic/program.gif">   <P><B>Welcome to the web pages of the KFB Electric and Hybrid vehicle program</B>. Through these pages, we present a general overview of our assignment, our current activities and monthly updated (minimum) report on the status of the different project fleets. </P><!-- Link Tag --><A HREF="../index.html">KFB</A> is responsible for a national program (SEK 120 Million, USD 17 Million total ) for <B>research, development and demonstration</B> of electric and hybrid vehicles. The program will continue until the end of 1999. The main goals are to assess the possibility and environmental potential for a large scale introduction of electric and hybrid vehicles, and to take the first steps towards emission-free motoring. Focusing on demonstration, between 200 and 400 vehicles, including passenger cars, buses and light and heavy trucks run or will run in city project fleets within the program. Others are included for evaluation through linked projects. All demonstration activities will be evaluated regarding vehicle proficiency, user acceptance, and economy, including a systems analysis and a concluding systems study to assess decisive areas.<BR><P>Program manager is Mr. <!-- MailTo Tag --><A HREF="MAILTO:hans.pettersson@kfb.se">Hans G Pettersson</A>, M.Sc. Eng.<bild p&aring; Hans><BR><BR><!-- MailTo Tag --><A HREF="MAILTO:david.bauner@kfb.se">David Bauner</A> is responsible for evaluation. </P><BR><BR><P><B>KFB, the Swedish Transport and Communications Research Board,</B> is a government authority with planning, initiating,coordinating and supporting functions in Swedish transport and communications research. KFB`s activities encompass transportation, traffic, postal services and telecommunications,as well as the impact of tranports and communications on the environment, traffic safety and regional development. KFB is also responsible for information and documentation wthin its areas of responsibility.</P><!-- Horizontal Line Tag --><HR WIDTH=100%><!-- Anchor Link Tag --><A HREF="#Up!"><H6>Up!</H6></A><BR></TD></TR></TABLE></BODY></HTML>
</DOC>
<DOC>
<DOCNO>WT02-B10-45</DOCNO>
<DOCOLDNO>IA018-000200-B014-189</DOCOLDNO>
<DOCHDR>
http://www.kfb.se:80/ehvproge/projects.html 194.198.183.242 19970106204700 text/html 3632
HTTP/1.0 200 OK
Date: Mon, 06 Jan 1997 20:42:10 GMT
Server: Microsoft-Internet-Information-Server/1.0
Content-Type: text/html
Last-Modified: Mon, 04 Nov 1996 15:04:34 GMT
Content-Length: 3432
</DOCHDR>
<HTML><!---------------------------------------------------------------><!-      AUTHOR:       mats holm                           ><!-      E-MAIL:            mats@softmachine.se                  ><!-      CREATED:     1996.09.26                       ><!-      MODIFIED:                       ><!-- Anchor Point Tag --><A NAME="Up!"><!-      FILE: projects.html></A>             <!---------------------------------------------------------------><!-- Head Tag --><HEAD><TITLE>EHV-Projects</TITLE></HEAD><!-- Body Tag --><BODY TEXT="#4C4C4C" BACKGROUND="ehvpic/yel_bgr.gif"></BODY><!-- Link Tag --><A HREF="index.html"><!-- Graphic Tag --><IMG WIDTH=534 HEIGHT=28 BORDER=0  SRC="ehvpic/kfbhead.gif"></A><TABLE WIDTH=535 BORDER=0 ><TR><TD WIDTH=130 BORDER=0 valign=top><!-- Link Tag --><A HREF="program.html"><!-- Graphic Tag --><IMG WIDTH=108 HEIGHT=36 BORDER=0  SRC="ehvpic/kna_pro.gif"></A><!-- Link Tag --><A HREF="projects.html"><!-- Graphic Tag --><IMG WIDTH=108 HEIGHT=35 BORDER=0  SRC="ehvpic/kna_proja.gif"></A><!-- Link Tag --><A HREF="hood.html"><!-- Graphic Tag --><IMG WIDTH=108 HEIGHT=36 BORDER=0  SRC="ehvpic/kna_hood.gif"></A><!-- Link Tag --><A HREF="infra.html"><!-- Graphic Tag --><IMG WIDTH=108 HEIGHT=17 BORDER=0  SRC="ehvpic/kna_infra.gif"></A><!-- Link Tag --><A HREF="energy.html"><!-- Graphic Tag --><IMG WIDTH=108 HEIGHT=18 BORDER=0  SRC="ehvpic/kna_energ.gif"></A><!-- Link Tag --><A HREF="economic.html"><!-- Graphic Tag --><IMG WIDTH=108 HEIGHT=17 BORDER=0  SRC="ehvpic/kna_eco.gif"></A><!-- Link Tag --><A HREF="perform.html"><!-- Graphic Tag --><IMG WIDTH=108 HEIGHT=17 BORDER=0  SRC="ehvpic/kna_perfa.gif"></A><!-- Link Tag --><A HREF="market.html"><!-- Graphic Tag --><IMG WIDTH=108 HEIGHT=18 BORDER=0  SRC="ehvpic/kna_mark.gif"></A></TD><TD WIDTH=15 BORDER=0 align=center></TD><TD WIDTH=300 BORDER=0 align=left valign=top><BR><!-- Graphic Tag --><IMG WIDTH=129 HEIGHT=39  SRC="ehvpic/projects.gif"><BR><P>KFB co-finance a number of projects dealing with Electric and Hybrid vehicles. A few is presented below. Further project presentations will be added to this inventory.</P><!-- Link Tag --><A HREF="gborg.html"><!-- Graphic Tag --><IMG WIDTH=85 HEIGHT=39 BORDER=0  SRC="ehvpic/elbil.gif "></A><!-- Link Tag --><A HREF="gborg.html"><B>G&ouml;teborg.</B></A><BR> One of two base projects in the KFB program<BR><BR><!-- Link Tag --><A HREF="malmoe.html"><!-- Graphic Tag --><IMG WIDTH=83 HEIGHT=84 BORDER=0  SRC="ehvpic/malmoe.gif "></A><!-- Link Tag --><A HREF="malmoe.html"><B>Malm&ouml. </B></A><BR>One of two base projects in the KFB program<BR><BR><!-- Link Tag --><A HREF="batteri.html"><!-- Graphic Tag --><!-- Graphic Tag --><IMG WIDTH=100 HEIGHT=49 BORDER=0  SRC="ehvpic/batt.gif"><!-- Link Tag --><A HREF="batteri.html"><B>Stockholm.</B> </A><BR>Batteri exchange courier minivans in the national&#146;s capitol<BR><BR><!-- Link Tag --><A HREF="elhybridbus.html"><B>Electric and hybrid buses .  </B></A><BR>Research to tailor the optimal hybrid drivetrain<BR><BR><B>The <!-- Link Tag --><A HREF="http://www.iea.lth.se/~niklas/work/evdatabase/index.html">EV Database.</B>  </A><BR>Monthly updated vehicle database, including figures on the national EC fleet<BR><BR><!-- Horizontal Line Tag --><HR WIDTH=100%><!-- Anchor Link Tag --><A HREF="#Up!"><H6>Up!</H6></A><BR>   </TD></TR></TABLE></BODY></HTML>
</DOC>
<DOC>
<DOCNO>WT02-B10-46</DOCNO>
<DOCOLDNO>IA018-000200-B014-202</DOCOLDNO>
<DOCHDR>
http://www.kfb.se:80/ehvproge/hood.html 194.198.183.242 19970106204708 text/html 6991
HTTP/1.0 200 OK
Date: Mon, 06 Jan 1997 20:42:18 GMT
Server: Microsoft-Internet-Information-Server/1.0
Content-Type: text/html
Last-Modified: Thu, 10 Oct 1996 08:41:48 GMT
Content-Length: 6791
</DOCHDR>
<HTML><!---------------------------------------------------------------><!-      AUTHOR:     	  mats holm                           ><!-      E-MAIL:      	     mats@softmachine.se                  ><!-      CREATED:   	  1996.09.26                       ><!-      MODIFIED:  	                     ><!-- Anchor Point Tag --><A NAME="Up!"><!-      FILE: hood.html></A>         <!---------------------------------------------------------------><!-- Head Tag --><HEAD><TITLE>KFB-Swedish Research and Communications Board</TITLE></HEAD><!-- Body Tag --><BODY TEXT="#4C4C4C" BACKGROUND="ehvpic/yel_bgr.gif"></BODY><!-- Link Tag --><A HREF="index.html"><!-- Graphic Tag --><IMG WIDTH=534 HEIGHT=28 BORDER=0  SRC="ehvpic/kfbhead.gif"></A><TABLE WIDTH=535 BORDER=0 ><TR><TD WIDTH=130 BORDER=0 valign=top><!-- Link Tag --><A HREF="program.html"><!-- Graphic Tag --><IMG WIDTH=108 HEIGHT=36 BORDER=0  SRC="ehvpic/kna_pro.gif"></A><!-- Link Tag --><A HREF="projects.html"><!-- Graphic Tag --><IMG WIDTH=108 HEIGHT=35 BORDER=0  SRC="ehvpic/kna_proj.gif"></A><!-- Link Tag --><A HREF="hood.html"><!-- Graphic Tag --><IMG WIDTH=108 HEIGHT=36 BORDER=0  SRC="ehvpic/kna_hooda.gif"></A><!-- Link Tag --><A HREF="infra.html"><!-- Graphic Tag --><IMG WIDTH=108 HEIGHT=17 BORDER=0  SRC="ehvpic/kna_infra.gif"></A><!-- Link Tag --><A HREF="energy.html"><!-- Graphic Tag --><IMG WIDTH=108 HEIGHT=18 BORDER=0  SRC="ehvpic/kna_energ.gif"></A><!-- Link Tag --><A HREF="economic.html"><!-- Graphic Tag --><IMG WIDTH=108 HEIGHT=17 BORDER=0  SRC="ehvpic/kna_eco.gif"></A><!-- Link Tag --><A HREF="perform.html"><!-- Graphic Tag --><IMG WIDTH=108 HEIGHT=17 BORDER=0  SRC="ehvpic/kna_perfa.gif"></A><!-- Link Tag --><A HREF="market.html"><!-- Graphic Tag --><IMG WIDTH=108 HEIGHT=18 BORDER=0  SRC="ehvpic/kna_mark.gif"></A></TD><TD WIDTH=15 BORDER=0 align=center></TD><TD WIDTH=300 BORDER=0 align=left valign=top><BR><!-- Graphic Tag --><IMG WIDTH=299 HEIGHT=22  SRC="ehvpic/hood.gif"><BR><BR><!-- Graphic Tag --><IMG WIDTH=198 HEIGHT=124 ALIGN=right  SRC="ehvpic/mrum.gif"><I>Until recently, road vehicle drivetrains (engine, transmission and wheels) have been essentially the same regardless of vehicle size, operation profile and location. For various reasons, customers and manufacturers look to alternatives to conventional gasoline and diesel cars, trucks and buses. </I><BR><BR><BR><BR><H4>Principles of vehicle propulsion</H4><P>Electric and hybrid vehicles differ from conventional vehicles by the means of propulsion. In a conventional vehicle, a gasoline or diesel engine turn the wheels through a transmission including a clutch and a gearbox. <BR><BR><!-- Graphic Tag --><IMG WIDTH=362 HEIGHT=256  SRC="ehvpic/princip.gif"><BR>An advanced EV or hybrid needs none of this. Some cars, especially heavier vehicles, use electric motors with only one moving part: the wheel itself. The dominating solution, though, is to have a front-mounted electric motor turning the wheels through a reduction gearbox and a simple driveshaft. This means a drastic reduction in the number of moving parts compared to a gasoline powered vehicle.</P><P> Electric vehicles ("EVs") are radically different from today's gasoline powered vehicle in several ways. Instead of storing gasoline, the EV stores electric energy in a large, rechargeable battery. A vehicle system controller sends this power to the electric drive motor whenever the driver pushes down on the accelerator pedal.</P><BR><BR><B>EV engine configuration</B> <BR><BR><!-- Graphic Tag --><IMG WIDTH=236 HEIGHT=114  SRC="ehvpic/bakv.gif" align=right>Most modern EVs also have a feature called "regenerative" brakes. Apart from generating friction heat when braking (like the disc or drum brakes of gasoline vehicles), an EV can also use the EV motor to help brake the vehicle, thereby generating electricity which charges the battery. Regenerating brakes also reduces the wear on the mechanic brakes.</P><BR><BR><BR><BR><H2>EV unique features:</H2><P><B>Clean</B> EVs have no tailpipe emissions. Such emissions, if any, are generated and controlled at theelectric powerplant. In Sweden, electricity is produced from about equal shares of hydropower and nuclear energy. A few percent is produced by burning fossil fuels, predominantly wintertime.</P><P><B>Quiet</B> The more advanced EV motors emit almost no sound. Unlike gasoline vehicles, there isno "combustion" requiring a muffler. In fact, the EV is so quiet that the EVdevelopment teams have to work harder to "silence" other noisy components (like airconditioning and power steering) which become audible without the gasoline enginenoise.</P><P><B>Smooth</B> Electric motor vehicles require no clutch or gearshift. Most advanced EVs use single-speed AC motors with no transmission. Acceleration is smooth and seamless, smoother than the best transmission on today's luxury cars.</P><!-- Graphic Tag --><IMG WIDTH=142  HEIGHT=190  SRC="ehvpic/tanka.gif" align=left ><B>Home Recharging</B> The EV can be recharged at home. Most of the vehicle users mainly recharge their vehicle at night. This is especially convenient for those who don't like to refuel at gasoline stations. The downside is it can take up to seven hours to recharge an "empty" battery.<BR><BR><P><B>Limited Range</B> Today's EV either uses the less expensive lead acid batteries or more advanced batteries like nickel metal hydride or nickel cadmium. Vehicle range depends largely on the type of battery used, but also, vehicle weight, driving style and other components such as charger and traction motor affects the range. Equipped with lead-acid batteries, the typical Lead acid powered EVs only have about 50 miles range between charges but are the least expensive. Advanced batteries have about 100 miles range between charges but are very expensive. </P><BR><BR><H2><!-- Font Tag -->Hybrid vehicles</H2><I>Hybrid passenger vehicles are usually configured as an EV with an additional primary power source such as a small gasoline, or, preferably, a biofuels engine. The engine propels a generator, which charges the batteries and provides energy to the tractionary engine. In general, hybrid vehicle development is in an earlier stage than that of the EV. </I><H4>Hybrid vehicle drivetrains</H4>The hybrid concept signify a number of options:<BR><BLOCKQUOTE><!-- Font Tag --><FONT COLOR="#BF361C"> Unlimited mileage<BR> Exhaust free operation<BR> Engine optimization<BR> AC Power production <BR> Detachable APU</FONT></BLOCKQUOTE> <!-- Horizontal Line Tag --><HR WIDTH=100%><!-- Anchor Link Tag --><A HREF="#Up!"><H6>Up!</H6></A><BR>   </TD></TR></TABLE></BODY></HTML>
</DOC>
<DOC>
<DOCNO>WT02-B10-47</DOCNO>
<DOCOLDNO>IA018-000200-B014-211</DOCOLDNO>
<DOCHDR>
http://www.kfb.se:80/ehvproge/infra.html 194.198.183.242 19970106204717 text/html 4230
HTTP/1.0 200 OK
Date: Mon, 06 Jan 1997 20:42:27 GMT
Server: Microsoft-Internet-Information-Server/1.0
Content-Type: text/html
Last-Modified: Thu, 10 Oct 1996 08:41:54 GMT
Content-Length: 4030
</DOCHDR>
<HTML><!---------------------------------------------------------------><!-      AUTHOR:       mats holm                           ><!-      E-MAIL:            mats@softmachine.se                  ><!-      CREATED:   	  1996.09.26                       ><!-      MODIFIED:  	                     ><!-- Anchor Point Tag --><A NAME="Up!"><!-      FILE:                infra.html>  </A>           <!---------------------------------------------------------------><!-- Head Tag --><HEAD><TITLE>KFB-Swedish Research and Communications Board</TITLE></HEAD><!-- Body Tag --><BODY TEXT="#4C4C4C" BACKGROUND="ehvpic/yel_bgr.gif"></BODY><!-- Link Tag --><A HREF="index.html"><!-- Graphic Tag --><IMG WIDTH=534 HEIGHT=28 BORDER=0  SRC="ehvpic/kfbhead.gif"></A><TABLE WIDTH=535 BORDER=0 ><TR><TD WIDTH=130 BORDER=0 valign=top><!-- Link Tag --><A HREF="program.html"><!-- Graphic Tag --><IMG WIDTH=108 HEIGHT=36 BORDER=0  SRC="ehvpic/kna_pro.gif"></A><!-- Link Tag --><A HREF="projects.html"><!-- Graphic Tag --><IMG WIDTH=108 HEIGHT=35 BORDER=0  SRC="ehvpic/kna_proj.gif"></A><!-- Link Tag --><A HREF="hood.html"><!-- Graphic Tag --><IMG WIDTH=108 HEIGHT=36 BORDER=0  SRC="ehvpic/kna_hood.gif"></A><!-- Link Tag --><A HREF="infra.html"><!-- Graphic Tag --><IMG WIDTH=108 HEIGHT=17 BORDER=0  SRC="ehvpic/kna_infr.gif"></A><!-- Link Tag --><A HREF="energy.html"><!-- Graphic Tag --><IMG WIDTH=108 HEIGHT=18 BORDER=0  SRC="ehvpic/kna_energ.gif"></A><!-- Link Tag --><A HREF="economic.html"><!-- Graphic Tag --><IMG WIDTH=108 HEIGHT=17 BORDER=0  SRC="ehvpic/kna_eco.gif"></A><!-- Link Tag --><A HREF="perform.html"><!-- Graphic Tag --><IMG WIDTH=108 HEIGHT=17 BORDER=0  SRC="ehvpic/kna_perfa.gif"></A><!-- Link Tag --><A HREF="market.html"><!-- Graphic Tag --><IMG WIDTH=108 HEIGHT=18 BORDER=0  SRC="ehvpic/kna_mark.gif"></A></TD><TD WIDTH=15 BORDER=0 align=center></TD><TD WIDTH=300 BORDER=0 align=left valign=top><BR><BR><!-- Graphic Tag --><IMG WIDTH=170 HEIGHT=24  SRC="ehvpic/infra.gif"></H4><!-- Graphic Tag --><IMG WIDTH=248 HEIGHT=144  SRC="ehvpic/laddstat.gif" alig=bottom><BR><BR><H4>Home and roadside charging </H4>Trams have since long served as public transport EVs, providing (locally) emission-free city transportation.  However, they require large infrastructure investments and cannot cater for the needs of sprawling cities. For battery-powered vehicles, chargers can be included in the vehicle and only require an ordinary outlet in the garage or at work. A discussion whether roadside charging should be the concern of city administrations or be left to commercial actors will be an important topic of the initial years.<BR><BR><BR><H4>Battery exchange systems</H4>To avoid the problem of limited range, systems allowing the empty battery to be replaced by a charged battery can be a solution.<BR> <B>Primary batteries</B>, e.g. the Zn-Air battery, can not be recharged and must be replaced with a new battery once it is emptied. This creates the need for replacement systems and exchange logistics for primary batteries. <B><BR>Secondary </B>(rechargeable)<B> batteries</B> must also be completed wth a local battery exchange system. An example of this is the stockholm battery echange project. <BR><BR><BR><!-- Graphic Tag --><IMG WIDTH=283 HEIGHT=135  SRC="ehvpic/servkst.gif"><H4>Service networks </H4>The need to provide a national wide supply of spareparts and knowledgeable EV mechanics is a major challenge to the introduction of new EV makes and models. <BR><BR><BR><H4>Electricity grid loads</H4>Loads from electric vehicle charging are manageable within the foreseeable future. As an example a population of 10 000 EVs in G&ouml;teborg would need less than 1 % of the electric energy used in the city. A greater problem may be fast charging during the day, when loads in general are higher.<BR><BR><!-- Horizontal Line Tag --><HR WIDTH=100%><!-- Anchor Link Tag --><A HREF="#Up!"><H6>Up!</H6></A><BR>   </TD></TR></TABLE></BODY></HTML>
</DOC>
<DOC>
<DOCNO>WT02-B10-48</DOCNO>
<DOCOLDNO>IA018-000200-B014-225</DOCOLDNO>
<DOCHDR>
http://www.kfb.se:80/ehvproge/energy.html 194.198.183.242 19970106204727 text/html 4798
HTTP/1.0 200 OK
Date: Mon, 06 Jan 1997 20:42:37 GMT
Server: Microsoft-Internet-Information-Server/1.0
Content-Type: text/html
Last-Modified: Fri, 11 Oct 1996 08:58:32 GMT
Content-Length: 4598
</DOCHDR>
<HTML>

<!--------------------------------------------------------------->
<!-      AUTHOR:        mats holm                           >
<!-      E-MAIL:            mats@softmachine.se                  >
<!-      CREATED:     1996.09.26                       >
<!-      MODIFIED:  	                     >
<!-- Anchor Point Tag --><A NAME="Up!"><!-      FILE: energy.html></A>         
<!--------------------------------------------------------------->

<!-- Head Tag --><HEAD><TITLE>KFB-Swedish Research and Communications Board</TITLE>
</HEAD>

<!-- Body Tag --><BODY TEXT="#4C4C4C" BACKGROUND="ehvpic/yel_bgr.gif">
</BODY>

<!-- Link Tag --><A HREF="index.html"><!-- Graphic Tag --><IMG WIDTH=534 HEIGHT=28 BORDER=0  SRC="ehvpic/kfbhead.gif"></A>
<TABLE WIDTH=535 BORDER=0 >
<TR>
<TD WIDTH=130 BORDER=0 valign=top>
<!-- Link Tag --><A HREF="program.html"><!-- Graphic Tag --><IMG WIDTH=108 HEIGHT=36 BORDER=0  SRC="ehvpic/kna_pro.gif"></A>
<!-- Link Tag --><A HREF="projects.html"><!-- Graphic Tag --><IMG WIDTH=108 HEIGHT=35 BORDER=0  SRC="ehvpic/kna_proj.gif"></A>
<!-- Link Tag --><A HREF="hood.html"><!-- Graphic Tag --><IMG WIDTH=108 HEIGHT=36 BORDER=0  SRC="ehvpic/kna_hood.gif"></A>
<!-- Link Tag --><A HREF="infra.html"><!-- Graphic Tag --><IMG WIDTH=108 HEIGHT=17 BORDER=0  SRC="ehvpic/kna_infra.gif"></A>
<!-- Link Tag --><A HREF="energy.html"><!-- Graphic Tag --><IMG WIDTH=108 HEIGHT=18 BORDER=0  SRC="ehvpic/kna_energia.gif"></A>
<!-- Link Tag --><A HREF="economic.html"><!-- Graphic Tag --><IMG WIDTH=108 HEIGHT=17 BORDER=0  SRC="ehvpic/kna_eco.gif"></A>
<!-- Link Tag --><A HREF="perform.html"><!-- Graphic Tag --><IMG WIDTH=108 HEIGHT=17 BORDER=0  SRC="ehvpic/kna_perfa.gif"></A>
<!-- Link Tag --><A HREF="market.html"><!-- Graphic Tag --><IMG WIDTH=108 HEIGHT=18 BORDER=0  SRC="ehvpic/kna_mark.gif"></A>
</TD>
<TD WIDTH=15 BORDER=0 align=center></TD>
<TD WIDTH=300 BORDER=0 align=left valign=top>

<BR>


<!-- Graphic Tag --><IMG WIDTH=299 HEIGHT=22  SRC="ehvpic/rub_ener.gif"><BR><BR>

<!-- Graphic Tag --><IMG WIDTH=276 HEIGHT=169  SRC="ehvpic/blacar.gif"  >

<BR>
<BR>
<BR>


Dealing with the environmental consequences for the entire life cycle of electric and hybrid vehicles, energy production and distribution, drivetrain energy loss, incorporated material types including 
battery  and vehicle recycling must be considered. In Sweden, transportation accounts for 22% of the total energy consumed. The sector&#146;s use of energy is principally by fossil-based fuels.<BR>
<BR>
<BR>


<H4>Electric vehicles and energy production</H4>Battery-powered vehicles produce no local emissions. Its consumption of primary energy is also less than a conventional ICE (<I>internal combustion engine</I>, for example using petrol or diesel fuel). A smaller EV consumes about 10 kWh/100 km of electric energy from the grid. Larger passenger vehicles double or triple this amount. An ICE vehicle consuming 7 liters of gasoline per 100 km equals, for comparison, a consumption of 62 kW, production and transportation of the fuel excluded. However, the environment is affected in different ways depending on how the electricity is produced. Each country has a very distinct profile on what primary sources are used. 
<BR>
<BR>
<BR>


<H4>Electricity production in Sweden</H4>In Sweden, nuclear and water power each account for about half of the electric energy produced. A few percent is produced by fossil fuels at demand peaks, predominantly during wintertime.
<BR>
<BR>
<BR>


<!-- Graphic Tag --><IMG WIDTH=283 HEIGHT=210  SRC="ehvpic/tree.gif">
<H4>Life cycle environmental impact</H4>


<P>Replacing conventional drive trains with hybrids can be a tool to diminish several of the problems connected with road traffic. One of the principal shortcomings of the ICE (internal combustion engine) is the technical challenge to optimize the system for the whole range of power output required in daily traffic. By using a hybrid system, the ICE can be optimized  to provide only the mean required power. For a regular passenger vehicle, this means only 15-20 kW. </P>

Both primary and secondary (rechargeable) batteries must be recycled. For the SAFT NiCd battery, a complete recycling facility is in operation outside Oskarshamn in Southern Sweden. 



<P>For longer term, hydrogen produced without net CO2 may be used for fuel cell hybrids</P>






<!-- Horizontal Line Tag --><HR WIDTH=100%>

<!-- Anchor Link Tag --><A HREF="#Up!"><H6>Up!</H6></A><BR>


   

</TD></TR></TABLE>
</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT02-B10-49</DOCNO>
<DOCOLDNO>IA018-000200-B014-239</DOCOLDNO>
<DOCHDR>
http://www.kfb.se:80/ehvproge/perform.html 194.198.183.242 19970106204736 text/html 6482
HTTP/1.0 200 OK
Date: Mon, 06 Jan 1997 20:42:46 GMT
Server: Microsoft-Internet-Information-Server/1.0
Content-Type: text/html
Last-Modified: Thu, 10 Oct 1996 08:42:10 GMT
Content-Length: 6282
</DOCHDR>
<HTML><!---------------------------------------------------------------><!-      AUTHOR:       mats holm                           ><!-      E-MAIL:            mats@softmachine.se                  ><!-      CREATED:   	  1996.09.26                       ><!-      MODIFIED:  	                     ><!-- Anchor Point Tag --><A NAME="Up!"><!-      FILE: perform.html></A>                <!---------------------------------------------------------------><!-- Head Tag --><HEAD><TITLE>KFB-Swedish Research and Communications Board</TITLE></HEAD><!-- Head Tag --><HEAD><TITLE>KFB-Swedish Research and Communications Board</TITLE></HEAD><!-- Body Tag --><BODY TEXT="#4C4C4C" BACKGROUND="ehvpic/yel_bgr.gif"></BODY><!-- Link Tag --><A HREF="index.html"><!-- Graphic Tag --><IMG WIDTH=534 HEIGHT=28 BORDER=0  SRC="ehvpic/kfbhead.gif"></A><TABLE WIDTH=535 BORDER=0 ><TR><TD WIDTH=130 BORDER=0 valign=top><!-- Link Tag --><A HREF="program.html"><!-- Graphic Tag --><IMG WIDTH=108 HEIGHT=36 BORDER=0  SRC="ehvpic/kna_pro.gif"></A><!-- Link Tag --><A HREF="projects.html"><!-- Graphic Tag --><IMG WIDTH=108 HEIGHT=35 BORDER=0  SRC="ehvpic/kna_proj.gif"></A><!-- Link Tag --><A HREF="hood.html"><!-- Graphic Tag --><IMG WIDTH=108 HEIGHT=36 BORDER=0  SRC="ehvpic/kna_hood.gif"></A><!-- Link Tag --><A HREF="infra.html"><!-- Graphic Tag --><IMG WIDTH=108 HEIGHT=17 BORDER=0  SRC="ehvpic/kna_infra.gif"></A><!-- Link Tag --><A HREF="energy.html"><!-- Graphic Tag --><IMG WIDTH=108 HEIGHT=18 BORDER=0  SRC="ehvpic/kna_energ.gif"></A><!-- Link Tag --><A HREF="economic.html"><!-- Graphic Tag --><IMG WIDTH=108 HEIGHT=17 BORDER=0  SRC="ehvpic/kna_eco.gif"></A><!-- Link Tag --><A HREF="perform.html"><!-- Graphic Tag --><IMG WIDTH=108 HEIGHT=17 BORDER=0  SRC="ehvpic/kna_perfaa.gif"></A><!-- Link Tag --><A HREF="market.html"><!-- Graphic Tag --><IMG WIDTH=108 HEIGHT=18 BORDER=0  SRC="ehvpic/kna_mark.gif"></A></TD><TD WIDTH=15 BORDER=0 align=center></TD><TD WIDTH=300 BORDER=0 align=left valign=top><BR><!-- Graphic Tag --><IMG WIDTH=314 HEIGHT=23  SRC="ehvpic/perform.gif"><BR><BR><!-- Graphic Tag --><IMG WIDTH=199 HEIGHT=158  SRC="ehvpic/winner.gif"><BR><BR><H4>Vehicle performance</H4>There are many myths connected to electric vehicles. One is that electric cars are inherently low performing in actual traffic. This view is however related to the earlier commercially available technologies, that to a large degree came from the area of vehicles and devices of material handlingwithin industry. As a contrast, the dedicated electric car technologies developed in the 1990s are very different from the earlier developments with respect of overall performance, battery life, power-to-weight ratios, and peak range capability.<P>Good electric cars (i.e. semi-conversions or purpose-built) have the potential to fulfil the needs of many fleet operators even with the commercially available battery technologies of today (lead-acid and Nickel-Cadmium), and with the technologies on the verge of commercialisation (e.g. Nickel-Metal Hydride and Lithium-ion), these cars will be attractive even for private car ownership. With batterytechnologies presently in the "laboratories'" (e.g. Lithium-Solid-Polymer), range will no longer be a problem. Cost issues still have to be resolved, though, but as in many cases of technological change, we can never in advance know how far costs can be cut by actors on a real market. </P><P>A hybrid vehicle can be tailored to imitate or exceed the range, torque etc. of a conventional car. An EV should rather be viewed in its own light. </P><BR><BR><H5>The battery is the most decisive factor for EV performance.</H5><BR><!-- Graphic Tag --><IMG WIDTH=312 HEIGHT=292  SRC="ehvpic/SCHLUTER.gif"><BR><BR><BR><H4>Operational functionality</H4>In the Swedish city projects, EVs have operated since 1993, reaching as much as 37 000 km in two and a half years of circulation for some vehicles.<P>For heavy vehicles and cargo transport, hybrid systems offer the highest potential due to the energy needed for a full working day. Regarding bus operation, passenger opinions and factors like the &#148;environmental appeal&#148; of new vehicle technology are important to fleet operators apart from hard facts on emissions and life cycle improvements.</P>In the present project running at KFB regarding electric and hybrid buses, several bus types are evaluated from different angels. As bus buyers are fewer, buy vehicles by the dozen rather than single and see vehicle cost as a smaller portion of total expenses, there is an openness towards environmentally sound propulsion technology, manifested for example in the ethanol and natural gas buses becoming increasingly popular by public transport authorities.<BR><BR><BR><H4>Traffic performance and safety</H4><P>EVs and hybrids must be granted performance to comply with city traffic tempo. This is achieved for the various demonstration vehicles, receiving positive remarks on acceleration and handling from vehicle drivers. Dealing with the negative aspects of EV soundlessness, no accidents or even close encounters have been reported. Part of the explanation may be that everywhere EVs operate, virtually soundless bicycles may also appear, forcing pedestrians to turn their heads regardless of traffic noise.</P><P>When this is written, only regular steel-bodied EVs with proven crash safety features run in KFB supported projects. However, there is a clear indication that EVs and hybrids may profit from lighter bodies, mostly due to the potential in extending range through weight reduction. Light vehicle structures is traditionally viewed as less safe by customers and national vehicle certification agencies, and the challenge to produce and market  safe, light vehicles remains. In all cases all vehicles running on swedish roads must conform to applicable safety certifications.</P>The <!-- Link Tag --><A HREF="http://www.iea.lth.se/~niklas/work/evdatabase/index.html">EV Database </A>  has updated information on vehicles running in the program.<!-- Horizontal Line Tag --><HR WIDTH=100%><!-- Anchor Link Tag --><A HREF="#Up!"><H6>Up!</H6></A><BR>   </TD></TR></TABLE></BODY></HTML>
</DOC>
<DOC>
<DOCNO>WT02-B10-50</DOCNO>
<DOCOLDNO>IA018-000200-B014-250</DOCOLDNO>
<DOCHDR>
http://www.kfb.se:80/ehvproge/market.html 194.198.183.242 19970106204746 text/html 7183
HTTP/1.0 200 OK
Date: Mon, 06 Jan 1997 20:42:56 GMT
Server: Microsoft-Internet-Information-Server/1.0
Content-Type: text/html
Last-Modified: Thu, 10 Oct 1996 08:42:08 GMT
Content-Length: 6983
</DOCHDR>
<HTML><!---------------------------------------------------------------><!-      AUTHOR:       mats holm                           ><!-      E-MAIL:            mats@softmachine.se                  ><!-      CREATED:   	  1996.09.26                       ><!-      MODIFIED:  	                     ><!-- Anchor Point Tag --><A NAME="Up!"><!-      FILE: market.html></A>                <!---------------------------------------------------------------><!-- Head Tag --><HEAD><TITLE>KFB-Swedish Research and Communications Board</TITLE></HEAD><!-- Head Tag --><HEAD><TITLE>KFB-Swedish Research and Communications Board</TITLE></HEAD><!-- Body Tag --><BODY TEXT="#4C4C4C" BACKGROUND="ehvpic/yel_bgr.gif"></BODY><!-- Link Tag --><A HREF="index.html"><!-- Graphic Tag --><IMG WIDTH=534 HEIGHT=28 BORDER=0  SRC="ehvpic/kfbhead.gif"></A><TABLE WIDTH=535 BORDER=0 ><TR><TD WIDTH=130 BORDER=0 valign=top><!-- Link Tag --><A HREF="program.html"><!-- Graphic Tag --><IMG WIDTH=108 HEIGHT=36 BORDER=0  SRC="ehvpic/kna_pro.gif"></A><!-- Link Tag --><A HREF="projects.html"><!-- Graphic Tag --><IMG WIDTH=108 HEIGHT=35 BORDER=0  SRC="ehvpic/kna_proj.gif"></A><!-- Link Tag --><A HREF="hood.html"><!-- Graphic Tag --><IMG WIDTH=108 HEIGHT=36 BORDER=0  SRC="ehvpic/kna_hood.gif"></A><!-- Link Tag --><A HREF="infra.html"><!-- Graphic Tag --><IMG WIDTH=108 HEIGHT=17 BORDER=0  SRC="ehvpic/kna_infra.gif"></A><!-- Link Tag --><A HREF="energy.html"><!-- Graphic Tag --><IMG WIDTH=108 HEIGHT=18 BORDER=0  SRC="ehvpic/kna_energ.gif"></A><!-- Link Tag --><A HREF="economic.html"><!-- Graphic Tag --><IMG WIDTH=108 HEIGHT=17 BORDER=0  SRC="ehvpic/kna_eco.gif"></A><!-- Link Tag --><A HREF="perform.html"><!-- Graphic Tag --><IMG WIDTH=108 HEIGHT=17 BORDER=0  SRC="ehvpic/kna_perfa.gif"></A><!-- Link Tag --><A HREF="market.html"><!-- Graphic Tag --><IMG WIDTH=108 HEIGHT=18 BORDER=0  SRC="ehvpic/kna_marka.gif"></A></TD><TD WIDTH=15 BORDER=0 align=center></TD><TD WIDTH=300 BORDER=0 align=left valign=top><BR><!-- Graphic Tag --><IMG WIDTH=243 HEIGHT=40  SRC="ehvpic/market.gif"><!-- Graphic Tag --><IMG WIDTH=254 HEIGHT=176  SRC="ehvpic/green.gif"><BR><BR><P>The development of societally benign and desirable fuels and vehicle technologies involves changes within industry, infrastructure, consumers, and market, but can usually not be propelled by market forces alone. In relation to gasoline cars, as being the 'main-stream' car propulsion technology, the alternatives are inherently hampered by not having the same long history of technical development, established market, and support by vested interests. Therefor, managing an early market of electric and hybrid electric cars involve both private and public interests in order to decrease some of the uncertainty that follows any new technology.</P><P>One must however also be aware of the strength of the technological 'paradigm' to strike back when threatened. Rapid developments of sail-boats and of gas-lightning occurred when faced with competition from steam-boats and electric-lightning, respectively. By the same token, gasoline cartechnology will probably be much further developed in areas of emissions and energy consumption when confronted by a competing alternative that perform well in those areas, as the electric car do.</P><!-- Graphic Tag --><IMG WIDTH=197 HEIGHT=130 ALIGN=left SRC="ehvpic/vespa.gif"><P>As a secondary effect, the development of alternative fuels and vehicles is often perceived as to increase the market push for cleaner conventional vehicles. In a short term perspective, this is the most obvious result of the evolving presence of alternative fuels on the automotive industry agenda. </P><P>The question, whether or not gasoline cars will stay on top for another century, or if electric propulsion will rapidly or slowly take over, still resides within the future. What we do know, however, is that electric cars today gather more support by industry and government than ever before andthat electric cars have been developed that gives sports car performance and more than 400 km range from one charge.</P><P>This means that the technological development of electric cars in recent years have taken a big step forward, with a consequent shift in focus from vehicle related issues to issues of early market and infrastructure - a shift that in itself is an indication of the promise of electric propulsion.</P><P>According to researchers studying technical changes in society, bigger changes in market demand must follow the &#148;closing in&#148; of technology, that is when vehicle manufacturers and customers agree on general product specifications. For newer types of propulsion technologies and fuels like electric vehicles, this closing of technology is not carried through. To do this, an iteration of evaluation reports and vehicle upgrading must occur in established partnerships.</P><B><!-- Font Tag --><FONT COLOR="#BF361C">Specifications are needed </FONT></B><BLOCKQUOTE>  to set a long term goal<BR> to relate car to legislation<BR> to create a coherent market<BR> to ensure a good and safe design<BR> to simplify certification</BLOCKQUOTE><BR><B><!-- Font Tag --><FONT COLOR="#BF361C">Specifications characteristics</FONT></B><BLOCKQUOTE> must not stall development<BR> must allow for market differencies<BR> must be &#148;global&#148;<BR> must be strict but flexible <BR> must be long term valid</BLOCKQUOTE><P>The Swedish car market represents a very small portion of world sales. It is decentralised and is constituted of relatively wealthy but demanding customers. The climate is varied fom north to south and changes with the season. This makes Sweden a tough market, suitable as a test site for new vehicle technology</P><P>So far, most of the passenger vehicles in the projects supported by KFB were made by the French manufacturer Renault. It is probable that backing from at least one large auto manufacturer is indispensable to sustain vehicle deliveries and service levels while running a growing number of new-tech as well as high-tech vehicles under commercial cinditions. On the other hand, studying market response to developimg competiton is vital. Hence, it is the intention of the program to broaden competition.</P><P>To fulfil individual transportation needs there are other ways than just owning a car , paying mortgages, insurance and repairs. Simply renting a car, subscribing to different kinds of public service car-sharing or sharing a fleet of cars with a few friends or neighbours, may all be ways to cope with rising operating costs. In France, for example, several research projects aim to develop ways to offer attractive vehicles with high availability to the city public.</P>  <!-- Horizontal Line Tag --><HR WIDTH=100%><!-- Anchor Link Tag --><A HREF="#Up!"><H6>Up!</H6></A><BR>   </TD></TR></TABLE></BODY></HTML>
</DOC>
<DOC>
<DOCNO>WT02-B10-51</DOCNO>
<DOCOLDNO>IA018-000200-B014-261</DOCOLDNO>
<DOCHDR>
http://www.kfb.se:80/ehvprogs.html 194.198.183.242 19970106204800 text/html 2934
HTTP/1.0 200 OK
Date: Mon, 06 Jan 1997 20:43:07 GMT
Server: Microsoft-Internet-Information-Server/1.0
Content-Type: text/html
Last-Modified: Mon, 04 Nov 1996 15:05:06 GMT
Content-Length: 2734
</DOCHDR>
<HTML><!---------------------------------------------------------------><!-      AUTHOR:     	 mats holm                           ><!-      E-MAIL:      	mats@softmachine.se                  ><!-      CREATED:   	 1996.08.31                         ><!-      MODIFIED:  	 1996.11.01                   ><!-      FILE:        ehvprogs.html                       ><!---------------------------------------------------------------><BODY TEXT="#3d3d3d" BGCOLOR="#ffffff" LINK="#e12b1e" ALINK="#e7e318" VLINK="#0e7112"><TABLE WIDTH=453 BORDER=0 ><TR><TD WIDTH=1 BORDER=0 align=left></TD><TD WIDTH=452 BORDER=0 align=left><H6>Denna sida inneh&aring;ller endast en kort sammanfattning p&aring; svenska. F&ouml;r &ouml;vrig information h&ouml;nvisar vi till de <!-- Link Tag --><A HREF="ehvproge/index.html">engelska sidorna.</A></H6><BR><A HREF="kfbnews.html"><IMG VSPACE=0 SRC="flash.gif"IMG BORDER=0></A><IMG VSPACE=0 SRC="infoallm.gif" ALT="[allm&auml;n]"><P><STRONG>El- och hybridfordon</STRONG><IMG SRC="volvotest.gif" ALIGN=RIGHT><P>KFB driver p&aring; uppdrag fr&aring;n riksdag och regering ett program f&ouml;r forskning, utveckling och demonstration av el-och hybridfordon.<P>Programmets syfte &auml;r:<BR>&#128; att utr&ouml;na m&ouml;jligheterna att introducera och anv&auml;nda el- och hybridfordon i ett kortare och ett l&auml;ngre perspektiv<BR>&#128; att utr&ouml;na effekterna i olika h&auml;nseenden av en introduktion av el- och hybridfordon<BR>&#128; att fr&auml;mja introduktionen av el- och hybridfordon i samband med programmets genomf&ouml;rande.<P>Programmet fokuserar p&aring; praktiska demonstrationer av l&auml;tta och tunga el- och hybridfordon. I Sverige sker f&ouml;rs&ouml;k, med st&ouml;d fr&aring;n KFB, p&aring; flera platser. Bilarna anv&auml;nds dels f&ouml;r persontransporter, dels f&ouml;r l&auml;ttare godsdistribution. KFB har ocks&aring; st&ouml;tt utvecklingen av konceptfordonen Volvo ECB och ECT.<P>Fordon som kan k&ouml;rs b&aring;de p&aring; bensin eller biobaserade br&auml;nslen och el, sk elhybrider kommer troligtvis vara det mest realistiska alternativet till dagens fordon. Detta p.g.a sv&aring;righeterna at ta fram sm&aring; l&auml;tta och milj&ouml;v&auml;nliga batterier. <P>Vill du veta mera om hur elbilarna anv&auml;nds kan du bes&ouml;ka v&aring;r <A HREF="http://www.iea.lth.se/~niklas/work/evdatabase/index.html">Elbilsdatabas i Lund.<BR></A></P>Vill du veta mer? Kontakta g&auml;rna ansvarig handl&auml;ggare<A HREF="mailto:hans.petterson@kfb.se"> Hans G Pettersson</A>, programansvarig eller <A HREF="MAILTO:david.bauner@kfb.se">David Bauner</A> som arbetar med utv&auml;rdering.<P><HR></TD></TR></TABLE></BODY></HTML>
</DOC>
<DOC>
<DOCNO>WT02-B10-52</DOCNO>
<DOCOLDNO>IA018-000200-B014-274</DOCOLDNO>
<DOCHDR>
http://www.kfb.se:80/ehvproge/economic.html 194.198.183.242 19970106204809 text/html 4117
HTTP/1.0 200 OK
Date: Mon, 06 Jan 1997 20:43:19 GMT
Server: Microsoft-Internet-Information-Server/1.0
Content-Type: text/html
Last-Modified: Thu, 10 Oct 1996 08:41:40 GMT
Content-Length: 3917
</DOCHDR>
<HTML><!---------------------------------------------------------------><!-      AUTHOR:       mats holm                           ><!-      E-MAIL:            mats@softmachine.se                  ><!-      CREATED:   	  1996.09.26                       ><!-      MODIFIED:  	                     ><!-- Anchor Point Tag --><A NAME="Up!"><!-      FILE:                infra.html>        </A>     <!---------------------------------------------------------------><!-- Head Tag --><HEAD><TITLE>KFB-Swedish Research and Communications Board</TITLE></HEAD><!-- Body Tag --><BODY TEXT="#4C4C4C" BACKGROUND="ehvpic/yel_bgr.gif"></BODY><!-- Link Tag --><A HREF="index.html"><!-- Graphic Tag --><IMG WIDTH=534 HEIGHT=28 BORDER=0  SRC="ehvpic/kfbhead.gif"></A><TABLE WIDTH=535 BORDER=0 ><TR><TD WIDTH=130 BORDER=0 valign=top><!-- Link Tag --><A HREF="program.html"><!-- Graphic Tag --><IMG WIDTH=108 HEIGHT=36 BORDER=0  SRC="ehvpic/kna_pro.gif"></A><!-- Link Tag --><A HREF="projects.html"><!-- Graphic Tag --><IMG WIDTH=108 HEIGHT=35 BORDER=0  SRC="ehvpic/kna_proj.gif"></A><!-- Link Tag --><A HREF="hood.html"><!-- Graphic Tag --><IMG WIDTH=108 HEIGHT=36 BORDER=0  SRC="ehvpic/kna_hood.gif"></A><!-- Link Tag --><A HREF="infra.html"><!-- Graphic Tag --><IMG WIDTH=108 HEIGHT=17 BORDER=0  SRC="ehvpic/kna_infra.gif"></A><!-- Link Tag --><A HREF="energy.html"><!-- Graphic Tag --><IMG WIDTH=108 HEIGHT=18 BORDER=0  SRC="ehvpic/kna_energ.gif"></A><!-- Link Tag --><A HREF="economic.html"><!-- Graphic Tag --><IMG WIDTH=108 HEIGHT=17 BORDER=0  SRC="ehvpic/kna_ecoa.gif"></A><!-- Link Tag --><A HREF="perform.html"><!-- Graphic Tag --><IMG WIDTH=108 HEIGHT=17 BORDER=0  SRC="ehvpic/kna_perfa.gif"></A><!-- Link Tag --><A HREF="market.html"><!-- Graphic Tag --><IMG WIDTH=108 HEIGHT=18 BORDER=0  SRC="ehvpic/kna_mark.gif"></A></TD><TD WIDTH=15 BORDER=0 align=center></TD><TD WIDTH=300 BORDER=0 align=left valign=top><BR><!-- Graphic Tag --><IMG WIDTH=210 HEIGHT=22  SRC="ehvpic/econom.gif"><P>Today, the cost of an electric vehicle to the user is primarily the capital cost of the vehicle and the batteries. An electric vehicle has very few moving parts in comparison to an ICE-powered vehicle, implying low maintenance costs when technology is settled. </P><!-- Graphic Tag --><IMG WIDTH=255 HEIGHT=186  SRC="ehvpic/huv.gif"><P>Life cycle cost includes the cost for exploitation of virgin resources, production costs, fuel, service and spare costs and the cost for recycling discarded vehicle components.<BR> Only some of these costs, however, are transparent to the user. Microeconomic issues or &#148;User life cycle costs&#148; includes sticker price plus interest or leasing fee, energy cost, service fees and costs deriving from downtime or spares. What is the value of an vehicle limited to 100 km range to dynamic company activities? On the other hand, what is the value of a implemented, environmentally oriented transport policy to a market desperately looking for unique selling points? Finding answers to these questions will help to indicate the role of EVs and hybrids in a corporate environment.</P><P> To private owners, other questions may dominate. Buying an electric vehicle, for example, the owner will have to change the battery pack over periods ranging from one to seven years depending on battery type. What kind of leasing or insurance systems will emerge? Will this field evolve to a separate market with fierce competition and excellent customer value, or pose the greatest threat to large scale market shift? Will the foreseeable battery development make the battery management systems of last year&#146;s model obsolete, or will development stall for the sake of large scale production?</P></P><!-- Horizontal Line Tag --><HR WIDTH=100%><!-- Anchor Link Tag --><A HREF="#Up!"><H6>Up!</H6></A><BR>   </TD></TR></TABLE></BODY></HTML>
</DOC>
<DOC>
<DOCNO>WT02-B10-53</DOCNO>
<DOCOLDNO>IA018-000200-B014-289</DOCOLDNO>
<DOCHDR>
http://www.kfb.se:80/info.html 194.198.183.242 19970106204822 text/html 2735
HTTP/1.0 200 OK
Date: Mon, 06 Jan 1997 20:43:30 GMT
Server: Microsoft-Internet-Information-Server/1.0
Content-Type: text/html
Last-Modified: Wed, 18 Dec 1996 15:27:48 GMT
Content-Length: 2535
</DOCHDR>
<HTML><!-- Head Tag --><HEAD><TITLE>Informationsavdelningen</TITLE></HEAD><!-- Body Tag --><BODY TEXT="#4C4C4C" BACKGROUND="yel_bgr.gif"></BODY><!-- Link Tag --><A HREF="kfbnews.html"><!-- Graphic Tag --><IMG WIDTH=539 HEIGHT=28 BORDER=0 ALT="P&aring; g&aring;ng!" SRC="headflasha.gif"></A><BR><TABLE WIDTH=542 BORDER=0 ><TR><TD WIDTH=60 BORDER=0 valign=top align=left><BR><H5>Presentation av KFB!<BR><BR><!-- Link Tag --><A HREF="forskbidrag.html">S&ouml;k forsknings-<BR>bidrag</A><BR><BR><!-- Link Tag --><A HREF="drivm.html">Drivmedel och fordon</A><BR><BR><!-- Link Tag --><A HREF="telemat.html">Telematik</A><BR><BR><!-- Link Tag --><A HREF="komforsk.html">Strategisk <BR>kommunikations-<BR>forskning</A><BR><BR><!-- Link Tag --><A HREF="fystran.html">Fysiska transporter</A><BR><BR><!-- Link Tag --><A HREF="inters/index.html">Internationella<BR>fr&aring;gor</A><BR><BR><!-- Link Tag --><A HREF="info.html">Informations-<BR>avdelningen</A><BR><BR><!-- Link Tag --><A HREF="projekt.html">Projektdatabasen</A><BR><BR><!-- Link Tag --><A HREF="bibliotek.html">Biblioteket</A><BR><BR><!-- Link Tag --><A HREF="gendir.html">Telefon och e-mail</A><BR><BR</TD></H5><TD WIDTH=50  BORDER=0 valign=top align=left></TD><TD WIDTH=300 BORDER=0 align=left valign=top><BR><BR><IMG SRC="komunike.gif" ALIGN=RIGHT>KFB har ett &ouml;vergripande ansvar f&ouml;r information och dokumentation. F&ouml;r att sprida forskningsresultat och annan relevant information anordnas presskonferenser, seminarier, konferenser som till exempel KFBs och VTIs forskardagar, TransportForum, samt KFBs Telematikdag. Vidare anordnas speciella temadagar.<P>En stor m&auml;ngd publikationer produceras vilka best&aring;r av forskarrapporter, b&ouml;cker, tidskrifter, kunskaps&ouml;versikter, nyhetsbrev, informationsbroschyrer och sammanfattningar av forskningsprojekt. Dessa kan du hitta i v&aring;rt <A HREF="bibliotek.html">Bibliotek.</A><P>En viktig informationsk&auml;lla &auml;r ocks&aring; tidningen <!-- Link Tag --><A HREF="kfbnews.html">KFB Kommunik&eacute;<A HREF="kfbnews.html"></A><BR></A>Inom vissa omr&aring;den finns &auml;ven multimedia- och videopresentationer. <P>KFB deltar ocks&aring; i m&auml;ssor och utst&auml;llningar, debatter och remissarbete.<P>Informationschef &auml;r <A HREF="mailto:tina.esh@kfb.se">Tina Esh.</A><HR SIZE=2><H6><!-- Link Tag --><A HREF="index.html">[Till KFB:s huvudsida]</A></H6>                           </TD></TR></TABLE></BODY></HTML>
</DOC>
<DOC>
<DOCNO>WT02-B10-54</DOCNO>
<DOCOLDNO>IA018-000200-B014-300</DOCOLDNO>
<DOCHDR>
http://www.kfb.se:80/bibliotek.html 194.198.183.242 19970106204829 text/html 3182
HTTP/1.0 200 OK
Date: Mon, 06 Jan 1997 20:43:40 GMT
Server: Microsoft-Internet-Information-Server/1.0
Content-Type: text/html
Last-Modified: Wed, 18 Dec 1996 15:15:28 GMT
Content-Length: 2982
</DOCHDR>
<HTML><!-- Head Tag --><HEAD><TITLE>Biblioteket</TITLE></HEAD><!-- Body Tag --><BODY TEXT="#4C4C4C" BACKGROUND="yel_bgr.gif"></BODY><!-- Link Tag --><A HREF="kfbnews.html"><!-- Graphic Tag --><IMG WIDTH=539 HEIGHT=28 BORDER=0 ALT="P&aring; g&aring;ng!" SRC="headflasha.gif"></A><TABLE WIDTH=542 BORDER=0 ><TR><TD WIDTH=60 BORDER=0 valign=top align=left><BR><H5><!-- Link Tag --><A HREF="welcome.html">Presentation<BR>av KFB!</A><BR><BR><!-- Link Tag --><A HREF="forskbidrag.html">S&ouml;k forsknings-<BR>bidrag</A><BR><BR><!-- Link Tag --><A HREF="drivm.html">Drivmedel och fordon</A><BR><BR><!-- Link Tag --><A HREF="telemat.html">Telematik</A><BR><BR><!-- Link Tag --><A HREF="komforsk.html">Strategisk <BR>kommunikations-<BR>forskning</A><BR><BR><!-- Link Tag --><A HREF="fystran.html">Fysiska transporter</A><BR><BR><!-- Link Tag --><A HREF="inters/index.html">Internationella<BR>fr&aring;gor</A><BR><BR><!-- Link Tag --><A HREF="info.html">Informations-<BR>avdelningen</A><BR><BR><!-- Link Tag --><A HREF="projekt.html">Projektdatabasen</A><BR><BR>Biblioteket<BR><BR><!-- Link Tag --><A HREF="gendir.html">Telefon och e-mail</A><BR><BR</TD></H5><TD WIDTH=50  BORDER=0 valign=top align=left></TD><TD WIDTH=300 BORDER=0 align=left valign=top><BR><H2>Biblioteket</H2><P>I Kommunikationsforskningsberedningens (KFB) publikationsserier redovisar forskare sina projekt. Publiceringen  inneb&auml;r inte att KFB tar st&auml;llning till framf&ouml;rda &aring;sikter, slutsatser och resulat. </P><P>Om du saknar n&aring;gon rapport s&auml;nd oss g&auml;rna ett <!-- MailTo Tag --><A HREF="MAILTO:arne.kihlblom">e-mail</A>.</P><P><B>KFB-rapporter</B> f&ouml;rs&auml;ljs genom Fritzes Kundtj&auml;nst, <BR>106 47 Stockholm. Tel 08-690 90 90.<BR><B>&Ouml;vriga KFB-publikationer</B> best&auml;lls och erh&aring;lls direkt  fr&aring;n KFB. Man kan dessutom abonnera p&aring; tidningen KFB-Kommunik&eacute;.</P><P><B>KFB-reports</B> are sold through Fritzes&#146; Customer Service, <BR>S-106 47 Stockholm, Sweden. <BR><B>Other KFB publications </B>are ordered directly from The Swedish Transport and Communications Research Board, <BR>Box 1273,  S-111 92 Stockholm, Sweden </P><HR><H3>F&ouml;rteckning &ouml;ver rapporter </H3><!-- Link Tag --><A HREF="rapporter/rap_allm.html">&Ouml;vergripande</A><BR><BR><!-- Link Tag --><A HREF="rapporter/rap_elhybrid.html">El- och hybridfordon</A><BR><BR><!-- Link Tag --><A HREF="rapporter/rap_bio.html">Biobaserade drivmedel</A><BR><BR><!-- Link Tag --><A HREF="rapporter/rap_tele.html">Telematik</A><BR><BR><!-- Link Tag --><A HREF="rapporter/rap_fys.html">Fysiska transporter</A><BR><BR><!-- Link Tag --><A HREF="rapporter/rap_strat.html">Strategisk kommunikationsforskning</A><BR><BR><HR SIZE=2><H6><!-- Link Tag --><A HREF="index.html">[Till KFB:s huvudsida]</A></H6>                           </TD></TR></TABLE></BODY></HTML>
</DOC>
<DOC>
<DOCNO>WT02-B10-55</DOCNO>
<DOCOLDNO>IA018-000200-B014-311</DOCOLDNO>
<DOCHDR>
http://www.kfb.se:80/bioprogs/index.html 194.198.183.242 19970106204843 text/html 1986
HTTP/1.0 200 OK
Date: Mon, 06 Jan 1997 20:43:50 GMT
Server: Microsoft-Internet-Information-Server/1.0
Content-Type: text/html
Last-Modified: Thu, 05 Dec 1996 09:14:44 GMT
Content-Length: 1786
</DOCHDR>
<HTML><!---------------------------------------------------------------><!-      AUTHOR:     	 mats holm                           ><!-      E-MAIL:      	     mats@softmachine.se                  ><!-      CREATED:   	 1996.11.15                   ><!-      MODIFIED:  	                     ><!-      FILE:               index.html                       ><!---------------------------------------------------------------><!-- Body Tag --><BODY BGCOLOR="#FFFFFF" TEXT="#FFFFFF"><H6><!-- Link Tag --><A HREF="uppdrag.html">[KFB:s uppdrag]</A><!-- Link Tag --><A HREF="projects.html">[Projekt]</A><!-- Link Tag --><A HREF="litteratur.html">[Litteratur]</A><!-- Link Tag --><A HREF="renalkohol.html">[Renalkohol]</A><!-- Link Tag --><A HREF="blandbransle.html">[Blandbr&auml;nsle]</A><!-- Link Tag --><A HREF="biogas.html">[Biogas]</A><!-- Link Tag --><A HREF="resultat.html">[Utv&auml;rderingar]</A><!-- Link Tag --><A HREF="miljo.html">[Milj&ouml; & H&auml;lsa]</A><BR></A><BR><!-- Link Tag --><MAP NAME="bio">	 <AREA SHAPE="rect" COORDS="10,333,445,354" HREF="miljo.html">    <AREA SHAPE="rect" COORDS="9,298,526,315" HREF="resultat.html">    <AREA SHAPE="rect" COORDS="10,263,493,280" HREF="biogas.html">    <AREA SHAPE="rect" COORDS="11,226,490,243" HREF="blandbransle.html">    <AREA SHAPE="rect" COORDS="9,145,527,162" HREF="renalkohol.html">    <AREA SHAPE="rect" COORDS="8,106,495,129" HREF="litteratur.html">    <AREA SHAPE="rect" COORDS="8,74,341,93" HREF="projects.html">   <AREA SHAPE="rect" COORDS="9,41,414,61" HREF="uppdrag.html">   </MAP><IMG SRC="biopic/bio.gif" WIDTH="539" HEIGHT="365" ALIGN="BOTTOM"  ISMAP USEMAP="#bio" BORDER=0> <BR> <!-- Link Tag --><A HREF="../index.html">[KFB huvudsida]</A><BR></H6> </BODY></HTML>
</DOC>
<DOC>
<DOCNO>WT02-B10-56</DOCNO>
<DOCOLDNO>IA018-000200-B014-320</DOCOLDNO>
<DOCHDR>
http://www.kfb.se:80/rapporter/rap_allm.html 194.198.183.242 19970106204852 text/html 10478
HTTP/1.0 200 OK
Date: Mon, 06 Jan 1997 20:44:02 GMT
Server: Microsoft-Internet-Information-Server/1.0
Content-Type: text/html
Last-Modified: Mon, 04 Nov 1996 15:08:24 GMT
Content-Length: 10277
</DOCHDR>
<HTML><HEAD><TITLE>Rapporter</TITLE></HEAD><BODY TEXT="#3d3d3d" BGCOLOR="#ffffff" LINK="#e12b1e" ALINK="#e7e318" VLINK="#0e7112"><TABLE WIDTH=454 BORDER=0 ><TR><TD WIDTH=1 BORDER=0 align=left></TD><TD WIDTH=453 BORDER=0 align=left> <H6>[<A HREF="../index.html">Home</A>][<A HREF="../bibliotek.html">Up</A>] </H6><A HREF="../kfbnews.html"><IMG VSPACE=0 SRC="../flash.gif"IMG BORDER=0></A><IMG VSPACE=0 SRC="../infoallm.gif" ><P><BR><B>F&Ouml;RFATTARE/AUTHOR </B><BR>Ingemar Leksell, Lars L&ouml;fgren, inst f&ouml;r till&auml;mpad milj&ouml;vetenskap, G&ouml;teborgs universitet<BR><BR><B>SERIE/SERIES</B><BR>KFB-rapport 1995:5<BR>ISBN 91-88370-88-7<BR>ISSN  0282-8014<BR><BR><B>TITEL/TITLE </B><BR>V&auml;rdering av lokala luftf&ouml;roreningseffekter. Hur v&auml;rdera bilavgasernas h&auml;lsoeffekter i t&auml;torter?Valuation of the local effects of air pollution. How to place monetary values on health effects of exhast emissions in urban areas.<BR><BR><B>PUBLICERINGSDATUM/DATE OF PUBLISHING </B><BR>April 1995<BR><BR><BR><!-- Horizontal Line Tag --><HR><BR><BR><B>UTGIVARE/PUBLISHER</B><BR>KFBs DNR 93-224-23<BR>KFB - Kommunikationsforskningsberedningen, Stockholm<BR><BR><B>REFERAT (Syfte, Metod, Resultat)</B><BR><B>Syfte: </B>Projektets syfte &auml;r att utveckla en metod f&ouml;r ekonomisk v&auml;rdering av lokala skadeeffekter, s&auml;rskilt h&auml;lsoeffekter, av bilavgaser i t&auml;tortsmilj&ouml;er. V&auml;rdet uttrycks i kronor per kg avgaskomponent och beror av utsl&auml;ppets l&auml;ge, tidpunkt, av v&auml;dersituationen etc.<BR><P><B>Metod:</B> Hela kedjan fr&aring;n emission till skadev&auml;rdering ing&aring;r: Emission-spridning-exponering-dos-ekomisk v&auml;rdering. Vid dosber&auml;kning har den lokala spridningsmodellen f&ouml;r G&ouml;teborgsregionen till&auml;mpats. Ber&auml;knade halter har kopplats till befolkningsdata f&ouml;r att skatta stadsdosen. H&auml;nsyn har &auml;ven tagits till lokala haltf&ouml;rh&ouml;jningar i gatumilj&ouml;n (ger gaturumsdosen). De ekonomiska v&auml;rderingarna av s&auml;nkta luftf&ouml;roreningshalter utg&aring;r fr&aring;n betalningsviljor som framkommit i andra sammanhang. </P><P><B>Resultat: </B>Ett ekonomiskt v&auml;rde har &aring;satts varje inandat mg av de olika bilavgaskomponenterna : kv&auml;veoxider, kolv&auml;ten (VOC) och partiklar. Denna dosv&auml;rdering skall kunna anv&auml;ndas i alla svenska t&auml;torter. I en storstad visar sig ett genomsnittligt utsl&auml;pp leda till en inandad dos som till 2/3 &auml;r &#148;stadsdos&#148; och till 1/3 &auml;r &#148;gaturumsdos&#148;. I mindre st&auml;der st&aring;r gaturumsdosen f&ouml;r en l&auml;gre andel. Ett utsl&auml;pp i centrala G&ouml;teborg leder till en tiopotens h&ouml;gre dos &auml;n genomsnittsutsl&auml;ppet i staden. F&ouml;rslag ges dessutom till en separat ekonomisk v&auml;rdering av utsl&auml;ppen med h&auml;nsyn till naturskadorna (40-45 kr/kg kv&auml;veoxider och ca 20 kr/kg VOC oberoende av exakt l&auml;ge av utsl&auml;ppet).</P><BR><B>ABSTRACT (Aim, Method, Results)</B><BR><B>The aim</B> of the project is to develop a method for monetary valuation of local health effects of exhaust emissions in urban areas. The value will be expressed in SEK per kg of emission component. It is dependent on the location and time of the emission, the weather conditions etc.<BR><P><B>Method:</B> The following chain has been studied: emission-dispersion-exposure-dose-economic valuation. For the dose calculations was used the local dispersion model that has been developed for Gothenburg. The calculated concentrations were coupled to population density data to get the &#148;urban dose&#148;. Local excess concentrations in the streets have also been considered and will give the &#148;street dose&#148;. The valuations of health effects have used already available WTP data (&#148;willingness to pay&#148;). </P><P><B>Results:</B> A monetary value has been given to each inhaled mg of different exhaust emission components: nitrogen oxides, hydrocarbons (VOC) and particulate matter. The derived dose valuation can be used in all Swedish towns and cities. It is shown that an average car emission in a Swedish big city will lead to a total inhaled dose that is composed of urban dose (2/3) and street dose (1/3). In a smaller town the street dose amounts to a smaller share of the total dose. An emission in central Gothenburg will lead to an approx ten times higher dose than the average car emission in Gothenburg. Moreover, the report suggests a separate monetary value of the emissions with respect to effects on nature (on forests, lakes etc): 40-45 SEK per kg of nitrogen oxides and approx. 20 SEK per kg of VOC.</P><P><B>Key words:</B> air pollution; automobile exhaust emissions; dispersion model; environmental economics; health effects; dose calculation; monetary valuation; population dose; urban areas</P><BR><!-- Horizontal Line Tag --><HR><BR><BR><B>F&Ouml;RFATTARE/AUTHOR </B><BR>Bengt Johansson, LTH, Inst f&ouml;r milj&ouml;- och energisystem<BR><BR><B>SERIE/SERIES</B><BR>KFB-rapport 1995:11<BR>ISBN 91-88370-94-1<BR>ISSN 0282-8014<BR><BR><B>TITEL/TITLE </B><BR>Biomassebaserade energib&auml;rare f&ouml;r transportsektornBiomass-based energy carriers in the transportation sector<BR><BR><B>PUBLICERINGSDATUM/DATE OF PUBLISHING </B><BR>Mars 1995<BR><BR><B>UTGIVARE/PUBLISHER</B><BR>KFBs DNR 93-146-23<BR>KFB - Kommunikationsforskningsberedningen, Stockholm<BR><BR><B>REFERAT (Syfte, Metod, Resultat)</B><BR>Syftet med rapporten &auml;r att studera de tekniska och ekonomiska f&ouml;ruts&auml;ttningarna f&ouml;r att genom anv&auml;ndning av olika biomassebaserade energib&auml;rare inom transportsektorn erh&aring;lla minskade utsl&auml;pp av koldioxid (CO2) och att &ouml;versiktligt studera inverkan p&aring; andra milj&ouml;faktorer av en &ouml;kad anv&auml;ndning av biomassebaserade energib&auml;rare.<BR><P>Reduktionen av CO2 -emissioner per hektar jord- och skogsmark utnyttjad f&ouml;r biomasseproduktion (kg CO2 /ha, &aring;r) samt kostnad f&ouml;r CO2 -reduktion (SEK/kg CO2) ber&auml;knas f&ouml;r ers&auml;ttning av bensin och diesel med rapsmetylester, biogas fr&aring;n lusern, etanol fr&aring;n vete samt etanol, metanol, v&auml;tgas och elektricitet producerad fr&aring;n Salix och avverkningsrester. </P><P>Av studerade drivmedel ger de som baseras p&aring; Salix st&ouml;rst CO2-reduktion per hektar. Anv&auml;ndning av metanol fr&aring;n Salix och avverkningsrester tycks p&aring; medell&aring;ng sikt ge l&auml;gst kostnader f&ouml;r CO2-reduktion. Anv&auml;ndning av br&auml;nslecellsfordon, i vilka metanol eller v&auml;tgas utnyttjas som energib&auml;rare, kan p&aring; l&auml;ngre sikt komma att m&ouml;jligg&ouml;ra ett mer energieffektivt utnyttjande av biomassa &auml;n dagens fordon med f&ouml;rbr&auml;nningsmotorer.</P><BR><B>ABSTRACT (Aim, Method, Results)</B><BR>The purpose of the report is to study the technical and economic prerequisites to attain reduced carbon dioxide (CO2) emissions through the use of biomass-based energy carriers in the transportation sector, and to study other environmental impacts resulting from an increased use of biomass-based energy carriers.<BR><P>CO2 emission reduction per unit arable and forest land used for biomass production (kg CO2/ha, year), and costs for CO2 emission reduction (SEK/kg CO2) are estimated for the substitution of petrol and diesel with rape methyl ester, biogas from lucern , ethanol from wheat and ethanol, methanol, hydrogen and electricity from Salix and logging residues.</P><P>Of the studied energy carriers, those based on Salix provide the largest CO2 emission reduction. In a mediumlongperspective, the costs for CO2 emission reduction seem to be lowest for methanol from Salix and logging residues. The use of fuel-cell vehicles, using methanol or hydrogen as energy carriers, can in a longer perspective provide more energy efficient utilization of biomass for transportation than the use of internal combustion engine vehicles.</P><BR><!-- Horizontal Line Tag --><HR><BR><BR><B>F&Ouml;RFATTARE/AUTHOR </B><BR>Emin Tengstr&ouml;m, Elisabet Gajewska and Marie Thynell. G&ouml;teborg University<BR><BR><B>SERIE/SERIES</B><BR>KFB Report 1995:17 (2nd ed.)<BR>ISBN 91-88868-00-1<BR>ISSN 0282-8014<BR><BR><B>TITEL/TITLE </B><BR>Sustainable Mobility in Europe and the Role of the Automobile. A Critical Inquiry<BR><BR><B>PUBLICERINGSDATUM/DATE OF PUBLISHING </B><BR>August 1995<BR><BR><B>UTGIVARE/PUBLISHER</B><BR><B>KFBs DNR</B> 93-84-63<BR>KFB  Kommunikationsforsknings-beredningen, Stockholm<BR><BR><B>ABSTRACT (Aim, Method, Results)</B><BR><B>The aim</B> of the inquiry is to study the current responses in Europe to the problems of road transport, particularly the problems of increasing car use. The basic point of departure is the new Common Transport Policy (CTP) of the EU as of December 1992. The catchword of this document, &#148;sustainable mobility&#148;, has also inspired the title of the report.<BR><P><B>Methods:</B> Relevant actors, that is, organizations of various types and at all levels wich play a role in influencing the transport policy in Europe, are identified. Written documents containing strategies for the transformation of existing transport systems are interpreted and subjected to critical analysis focusing on the future role of the automobile in the transport systems.</P><P><B>The findings</B> may be summarized in the folloving way: The present situation of road transport in Europe is a result of interaction failure rather than of market failure or government failure. The reason for this is lack of agreement in the perceptions of problems, goals, measures and their implementation. A way out of this dilemma is indicated; intensified controversies about the preceptions could create opportunities for new forms of interaction.</P><HR><BR><A HREF="../index.html"><IMG SRC="../homeicon.gif" BORDER = 0></A><A HREF="../bibliotek.html"><IMG SRC="../upicon.gif" BORDER = 0 ></A></td></tr></TABLE></BODY></HTML>
</DOC>
<DOC>
<DOCNO>WT02-B10-57</DOCNO>
<DOCOLDNO>IA018-000200-B014-331</DOCOLDNO>
<DOCHDR>
http://www.kfb.se:80/rapporter/rap_elhybrid.html 194.198.183.242 19970106204903 text/html 3340
HTTP/1.0 200 OK
Date: Mon, 06 Jan 1997 20:44:10 GMT
Server: Microsoft-Internet-Information-Server/1.0
Content-Type: text/html
Last-Modified: Fri, 18 Oct 1996 10:02:54 GMT
Content-Length: 3140
</DOCHDR>
<HTML><HEAD><TITLE>Rapporter</TITLE></HEAD><BODY TEXT="#3d3d3d" BGCOLOR="#ffffff" LINK="#e12b1e" ALINK="#e7e318" VLINK="#0e7112"><TABLE WIDTH=454 BORDER=0 ><TR><TD WIDTH=1 BORDER=0 align=left></TD><TD WIDTH=453 BORDER=0 align=left> <H6>[<A HREF="../index.html">Home</A>][<A HREF="../bibliotek.html">Up</A>] </H6><A HREF="../kfbnews.html"><IMG VSPACE=0 SRC="../flash.gif"IMG BORDER=0></A><IMG VSPACE=0 SRC="../infoallm.gif" ><P><BR><I>The Automobile at the Cross-Roads (ACROSS)Slutrapport<BR><BR></I><B>Farv&auml;l till bensinbilen</B><P>Kanehira Maruo, Avdelningen f&ouml;r humanteknologi, Institutionen f&ouml;r tv&auml;rvetenskapliga studier av m&auml;nniskans villkor, G&ouml;teborgs Universitet</P> <B>Referat (syfte, metod, resultat)</B><BR>Syftet med den h&auml;r rapporten &auml;r att beskriva och j&auml;mf&ouml;ra de tv&aring; milj&ouml;drivna teknikf&ouml;r&auml;ndringar som har haft och som kan komma att ha stor betydelse f&ouml;r bilteknologins utveckling, n&auml;mligen katalysatorteknikens inf&ouml;rande och elbilsteknologins genombrott.<BR><P>Metod: Intervjuer och litteraturstudie.</P><P>Resultat: Elbilen har idag blivit det hetaste alternativet till bensinbilen. Reformulerad bensin, etanol, metanol, naturgas och biogas verkar endast partiellt eller kortsiktigt kunna l&ouml;sa den globala energif&ouml;rs&ouml;rjningen och de globala milj&ouml;-problemen. Den s k "technology forcing"-strategin fungerade v&auml;l n&auml;r man  inf&ouml;rde  katalysatortekniken p&aring; 70-talet, och samma strategi har hittills fungerat v&auml;l n&auml;r man f&ouml;rs&ouml;ker utveckla elbilsteknologin. Det viktigaste &auml;r att "technology forcing"-strategin och andra strategier, t ex ekonomiska styrmedel, till&auml;mpas samtidigt. </P><B>Abstract (aim, method, results)</B><BR>The aim of this report is to describe and compare those two environmentally motivated technical changes that have been and may continue to be of great importance for development of the automotive technology, namely the introduction of catalytic converter technology, and the breakthrough of electric-vehicle technology.<BR><P>Methods: Interviews and textual studies.</P><P>Results: The electric vehicle has become the most exiting alternative to the gasoline car. Reformulated gasoline, ethanol, methanol, natural gas, and biogas seem to be able to offer only partial or short-sighted solutions to global energy-supply problem and environmental problems. The so called "technology forcing" strategy functioned well when catalytic converter technology was introduced, and the same strategy has hitherto functioned well during the state of California's attempt to force the development of electric vehicle technology. The most important thing is, however, to apply the technology forcing strategy and other strategies such as the use of economic instruments simultaneously. </P><HR><BR><A HREF="../index.html"><IMG SRC="../homeicon.gif" BORDER = 0></A><A HREF="../bibliotek.html"><IMG SRC="../upicon.gif" BORDER = 0 ></A></td></tr></TABLE></BODY></HTML>
</DOC>
<DOC>
<DOCNO>WT02-B10-58</DOCNO>
<DOCOLDNO>IA018-000200-B014-345</DOCOLDNO>
<DOCHDR>
http://www.kfb.se:80/rapporter/rap_bio.html 194.198.183.242 19970106204912 text/html 18539
HTTP/1.0 200 OK
Date: Mon, 06 Jan 1997 20:44:21 GMT
Server: Microsoft-Internet-Information-Server/1.0
Content-Type: text/html
Last-Modified: Mon, 04 Nov 1996 15:08:30 GMT
Content-Length: 18338
</DOCHDR>
<HTML><HEAD><TITLE>Rapporter</TITLE></HEAD><BODY TEXT="#3d3d3d" BGCOLOR="#ffffff" LINK="#e12b1e" ALINK="#e7e318" VLINK="#0e7112"><TABLE WIDTH=454 BORDER=0 ><TR><TD WIDTH=1 BORDER=0 align=left></TD><TD WIDTH=453 BORDER=0 align=left> <H6>[<A HREF="../index.html">Home</A>][<A HREF="../bibliotek.html">Up</A>] </H6><A HREF="../kfbnews.html"><IMG VSPACE=0 SRC="../flash.gif"IMG BORDER=0></A><IMG VSPACE=0 SRC="../infoallm.gif" ><P><BR><B>F&Ouml;RFATTARE</B><P>Roger Westerholm, Margareta T&ouml;rnqvist, Ulf Rannug and Lars EhrenbergStockholm University, S-106 91 Stockholm</P><BR><B>TITEL</B><BR>CHEMICAL AND BIOLOGICAL CHARACTERIZATION OF EXHAUST EMISSIONS FROM TWO BIOETHANOL FUELS CONTAINING DIFFERENT DIESEL IGNITION IMPROVERS<BR><BR><B>KFBs DNR</B> 92-72-472<BR><BR><B>SAMMANFATTNING</B><BR>I denna rapport presenteras resultat och slutsatser fr&aring;n ett projekt med syftet att unders&ouml;ka potentiella milj&ouml;- och h&auml;lsoeffekter fr&aring;n tv&aring; olika t&auml;ndf&ouml;rb&auml;ttrare, Avocet&reg; och Beraid&reg;. I etanolbr&auml;nsle A tillsattes Beraid&reg; och i etanolbr&auml;nsle B tillsattes Avocet&reg;. Emissionerna fr&aring;n etanolbr&auml;nsle A och B har j&auml;mf&ouml;rts med analys av reglerade och icke-reglerade avgaskomponenter. Receptoraffinitets- och mutagenicitetstest har till&auml;mpats p&aring; partikelbundna och semivolatila f&ouml;reningar i emissionerna. Vidare har en riskuppskattning av carcinogena avgaskomponenter utf&ouml;rts. Resultat: Emissionen av kolmonoxid, partiklar, eten och partikelbundna polycykliska aromatiska kolv&auml;ten (PAH) var l&auml;gre fr&aring;n br&auml;nsle B j&auml;mf&ouml;rt med br&auml;nsle A, d&auml;remot var emissionen av butadien h&ouml;gre fr&aring;n br&auml;nsle B. Emissionen av de &ouml;vriga avgaskomponenterna var ungef&auml;r likv&auml;rdig fr&aring;n de b&aring;da br&auml;nslena. I stort sett var ocks&aring; den uppm&auml;tta biologiska effekten likv&auml;rdig mellan de b&aring;da br&auml;nslena, m&ouml;jligen gav br&auml;nsle B n&aring;got l&auml;gre indirekt mutagenicitet. Ur cancerrisksynpunkt var de b&aring;da br&auml;nslena approximativt likv&auml;rdiga, den n&aring;got h&ouml;gre (ej signifikant) emissionen av butadien fr&aring;n br&auml;nsle B uppv&auml;gs av en l&auml;gre partikel- och etenemission.<BR></P><B>ABSTRACT</B><BR>This report describes the results of an investigaton on the potential environmental and health impacts of exhaust emissions from ethanol fuel containing two different diesel ignition improvers (DI), Avocet&reg; and Beraid&reg;. Avocet&reg; was used in fuel B and Beraid&reg; in fuel A. Emissions from these two ethanol fuels were compared with respect to there contents of regulated and unregulated exhaust components, affinity of binding to the dioxin receptor and mutagenicity of compounds associated with particles and the semivolatile phase. Risk estimates of exhaust components judged to be carcinogenic. Emissions from fuel B, contain smaller amounts of CO, particles, ethene and total particle-associated polycyclic aromatic hydrocarbons (PAH), but higher amounts of butadiene than did emissions from fuel A with respect to the other components measured, these two fuels were approximately the same. In general the two fuelemissions give similar responses in the biological tests, perhaps with a tendency to lower values of S9 - dependent mutagenicity in the case of fuel B. From the point of view of cancer risk, these two ignition improvers are, within the limits of uncertainty, approximately equivalent. In this case the somewhat (not significantly) higher emission of butadiene from fuel B may balance for the lower amounts of particles and ethene emitted from this fuel.<BR><BR><!-- Horizontal Line Tag --><HR WIDTH=100%><BR><B>F&Ouml;RFATTARE</B><BR>Cla&euml;s Pilo, SDAB Transport och Milj&ouml; <BR><BR><B>SERIE</B><BR>KFB-meddelande 1996:20<BR><BR><B>ISSN</B> 1401-1271<BR><BR><B>TITEL</B><BR>Analys av erfarenheter fr&aring;n introduktion av biodrivmedel<BR><BR><B>PUBLICERINGSDATUM</B><BR>September 1996<BR><BR><B>UTGIVARE</B><BR>KFB - Kommunikationsforskningsberedningen<BR><BR><B>KFBs DNR</B>95-387-742<BR><BR><B>BAKGRUND</B><BR>En betydande satsning p&aring; FUD r&ouml;rande biodrivmedel sker f&ouml;r n&auml;rvarande i Sverige med tyngdpunkt p&aring; bioalkolholer och biogas som f&ouml;rberedelse f&ouml;r framtida introduktion. KFB sammanh&aring;ller ett program f&ouml;r utveckling och demonstration av alkohol och biogas som drivmedel om 120 Mkr under en fyra&aring;rsperiod. <P>I KFBs program ing&aring;r att genomf&ouml;ra en systemstudie i syfte att ge en helhetsbild av biodrivmedlens potential i fr&aring;ga om milj&ouml;, ekonomi, struktureffekter mm vid storskalig introduktion.</P><P>Det &auml;r angel&auml;get att den svenska satsningen inte sker isolerat. Vi m&aring;ste f&ouml;lja motsvarande utveckling i andra l&auml;nder, l&auml;ra av deras erfarenheter och s&ouml;ka undvika deras misstag. </P><P>F&ouml;religgande delstudie "Analys av erfarenheter fr&aring;n introduktion av biodrivmedel" har genomf&ouml;rts inom ramen f&ouml;r  KFBs systemstudie.</P><B>KUNSKAPSL&Auml;GE</B><P>Sverige hade under 70- och 80-talet en stark internationell st&auml;llning i fr&aring;ga om distribution och anv&auml;ndning av motoralkoholer och f&ouml;ljde noga den internationella forskningen. Sverige tog genom SMAB/SDAB initiativet till den f&ouml;rsta ISAF-konferensen (ISAF = International Symposia on Alcohol Fuels) i Stockholm &aring;r 1976 och har sedan dess aktivt medverkat i ISAF, som idag &auml;r den vetenskapligt fr&auml;msta sammanslutningen inom omr&aring;det alkoholdrivmedel. Sverige har initierat den f&ouml;rsta Workshopen inom ISAF, som genomf&ouml;rdes i augusti 1995 i Saltsj&ouml;baden under namnet "Biofuels for Transportation. From R&D to Market". Vi har idag goda kontakter med de fr&auml;msta akt&ouml;rerna inom omr&aring;det, men har ej haft n&aring;gon samlad bild av de erfarenheter som gjorts i olika l&auml;nder n&auml;r det g&auml;ller introduktion av biodrivmedel. </P><BR><B>METODIK</B><BR><P>Analysen har i f&ouml;rsta hand avsett erfarenheter av inf&ouml;rande av f&ouml;ljande biodrivmedel: </P><BLOCKQUOTE>- Bioetanol<BR>- Biometanol<BR>- Blandbr&auml;nslen bensin - bioalkoholer<BR>- Blandbr&auml;nslen bensin - bioetrar (som ETBE, ETAE, MTBE, TAME med bioursprung)<BR>- Biogas.</BLOCKQUOTE><B>D&auml;remot har biodrivmedel som VME, RME och REE inte ing&aring;tt i studien</B>					<P>Vissa erfarenheter av inf&ouml;rande av fossila drivmedel som naturgas (CNG) och propan (LPG) har ocks&aring; behandlats.</P><P>Insamling av underlag har skett genom det tidigare rapporterade projektet &#148;Kunskaps&ouml;versikt &ouml;ver biodrivmedel&#148; (Dnr 95-388-742).</P><P>Underlaget har i huvudsak begr&auml;nsats till material som publicerats under tiden 1990-95 och s&aring;dana rapporter som v&auml;ntas komma under 1996.</P><!-- Horizontal Line Tag --><HR WIDTH=100%><BR><B>F&Ouml;RFATTARE</B><P>Cla&euml;s Pilo, SDAB Transport och Milj&ouml;SERIE </P>KFB-meddelande 1996:21<BR><BR>ISSN 1401-1271<BR><BR><B>TITEL</B><BR>Biodrivmedel. Internationell litteratur&ouml;versikt<BR><BR><B>PUBLICERINGSDATUM</B><BR>September 1996<BR><BR><BR><B>UTGIVARE</B><BR>KFB -Kommunikationsforskningsberedningen<BR><BR>KFBs DNR 95-388-742<BR><BR><B>Bakgrund </B><BR>En betydande satsning p&aring; FUD r&ouml;rande biodrivmedel sker f&ouml;r n&auml;rvarande i Sverige med tyngdpunkt p&aring; bioalkolholer och biogas som f&ouml;rberedelse f&ouml;r framtida introduktion. KFB sammanh&aring;ller ett program f&ouml;r utveckling och demonstration av alkohol och biogas som drivmedel om 120 Mkr under en fyra&aring;rsperiod. <BR><P>I KFBs program ing&aring;r att genomf&ouml;ra en systemstudie i syfte att ge en helhetsbild av biodrivmedlens potential i fr&aring;ga om milj&ouml;, ekonomi, struktureffekter mm vid storskalig introduktion.</P><p><B>Det &auml;r angel&auml;get att den svenska satsningen inte sker isolerat. Vi m&aring;ste f&ouml;lja motsvarande utveckling i andra l&auml;nder, l&auml;ra av deras erfarenheter och s&ouml;ka undvika deras misstag. </B></p><P>F&ouml;religgande  delstudie "Kunskaps&ouml;versikt &ouml;ver biodrivmedel" har genomf&ouml;rts inom ramen f&ouml;r  KFBs systemstudie. Den har resulterat i en sammanst&auml;llning av internationella, vetenskapligt h&ouml;gklassiga rapporter r&ouml;rande biodrivmedel fr&aring;n perioden 1990-96.</P><BR><BR><B>Kunskapsl&auml;ge</B><BR>Sverige hade under 70- och 80-talet en stark internationell st&auml;llning i fr&aring;ga om distribution och anv&auml;ndning av motoralkoholer och f&ouml;ljde noga den internationella forskningen. Sverige tog genom SMAB/SDAB initiativet till den f&ouml;rsta ISAF-konferensen (ISAF = International Symposia on Alcohol Fuels) i Stockholm &aring;r 1976 och har sedan dess aktivt medverkat i ISAF, som idag &auml;r den vetenskapligt fr&auml;msta sammanslutningen inom omr&aring;det alkoholdrivmedel. Sverige har initierat den f&ouml;rsta Workshopen inom ISAF, som genomf&ouml;rdes i augusti 1995 i Saltsj&ouml;baden under namnet "Biofuels for Transportation. From R&D to Market". Vi har idag goda kontakter med de fr&auml;msta akt&ouml;rerna inom omr&aring;det, men har ej haft n&aring;gon samlad bild av den senaste litteraturen. <BR><BR><B>Begr&auml;nsningar</B><BR>Drivmedel:<BR>- Bioetanol<BR>- Biometanol<BR>- Bioalkohol-blandbr&auml;nslen<BR>- Biogas<BR>- Bioetrar (ETBE, ETAE, MTBE, TAME, DME)<BR>- D&auml;remot ej: VME, RME och REE<BR><BR>Tidsramar:<BR>- Rapporter publicerade under tiden 1990-95<BR>- Rapporter som v&auml;ntas publiceras under 1996<BR><BR>Geografiska begr&auml;nsningar:<BR>- Brasilien<BR>- Europa (speciellt Frankrike och Tyskland)<BR>- Nordamerika (Canada, USA)<BR>- Internationella organisationer    (ECE, ECMT, IEA, OECD, WHO, UN)<BR>- Internationella konferenser (ISAF)<BR>- D&auml;remot ej Sverige <BR>- &Ouml;vriga l&auml;nder endast osystematiskt t&auml;ckta<BR><BR>Litteratursammanst&auml;llningen omfattar ca 350 rapporter, varav ca 120 med abstracts.<BR><BR><!-- Horizontal Line Tag --><HR WIDTH=100%><BR><B>F&Ouml;RFATTARE</B><BR>Bengt Johansson, Lunds universitet<BR><BR><B>SERIE</B><BR>KFB-meddelande 1996:22<BR><BR><B>ISSN </B>1401-1271<BR><BR><B>TITEL</B><BR>M&ouml;jligheter att ers&auml;tta bensin och diesel med drivmedel fr&aring;n svenska biobr&auml;nslen<BR><BR><B>PUBLICERINGSDATUM</B><BR>Oktober 1996<BR><BR><B>UTGIVARE</B><BR>KFB - Kommunikationsforskningsberedningen<BR>KFBs DNR 95-377-742<BR><BR><B>Sammanfattning</B><BR>I f&ouml;religgande rapport diskuteras vilka f&ouml;ruts&auml;ttningar det finns f&ouml;r att utnyttja biobr&auml;nsle som ers&auml;ttning f&ouml;r bensin och diesel med h&auml;nsyn tagen till tillg&auml;ngliga biobr&auml;nsleresurser, olika restriktioner f&ouml;r utnyttjande av biobr&auml;nslen f&ouml;r energi&auml;ndam&aring;l (t ex ekologiska, industri-, och jordbrukspolitiska restriktioner) och det biobr&auml;nslebehov som kan komma att finnas f&ouml;r el- och v&auml;rmeproduktion. Den &aring;rliga svenska biobr&auml;nsleanv&auml;ndningen skulle kunna &ouml;ka med ca 125 TWh j&auml;mf&ouml;rt med 1994. Denna m&auml;ngd skulle vara tillr&auml;cklig f&ouml;r att t&auml;cka dagens behov av drivmedel liksom uppskattat drivmedelsbehov kring &aring;r 2015. &Auml;ven om biobr&auml;nslena i f&ouml;rsta hand anv&auml;nds f&ouml;r v&auml;rme- och elproduktion, vilket tycks vara ett mer effektivt s&auml;tt att erh&aring;lla koldioxidreduktion &auml;n att anv&auml;nda biobr&auml;nslena f&ouml;r drivmedelsproduktion, kommer det att kunna finnas en betydande m&auml;ngd biobr&auml;nslen kvar f&ouml;r produktion av drivmedel om andra icke-fossila energik&auml;llor anv&auml;nds f&ouml;r elproduktion och/eller betydande energieffektiviseringar genomf&ouml;rs. 	Att exportera biobr&auml;nslen f&ouml;r att ers&auml;tta fossila br&auml;nslen f&ouml;r el- och v&auml;rmeproduktion i andra l&auml;nder kan visa sig vara ett mer eller lika kostnadseffektivt s&auml;tt att minska koldioxidutsl&auml;ppen som att utnyttja de svenska biobr&auml;nsleresurserna f&ouml;r inhemsk drivmedelsproduktion. Uppskattningarna &auml;r emellertid beh&auml;ftade med stora os&auml;kerheter och till stor del beroende av lokaliseringen av biobr&auml;nsleresurserna och de potentiella anv&auml;ndarna. <BR><BR><!-- Horizontal Line Tag --><HR><BR><BR><B>F&Ouml;RFATTARE/AUTHOR</B> Lars Brolin, Mats Hagelberg och Annika Norstr&ouml;m, Vattenfall Energisystem AB<BR><BR><B>SERIE/SERIES</B><BR>KFB-rapport 1995:3<BR>ISBN 91-88370-86-0<BR>ISSN 0282-8014<BR><BR><B>TITEL/TITLE </B><BR>Biogas som drivmedel f&ouml;r fordonBiogas as an automotive fuel<BR><BR><B>PUBLICERINGSDATUM/DATE OF PUBLISHING </B><BR>Februari 1995<BR><B>UTGIVARE/PUBLISHER</B><P>KFBs DNR 94-27-742<BR>KFB - Kommunikationsforskningsberedningen, Stockholm</P><B>REFERAT (Syfte, Metod, Resultat)</B><BR>Syftet med den f&ouml;religgande studien har varit att klarl&auml;gga f&ouml;ruts&auml;ttningarna f&ouml;r att i st&ouml;rre omfattning anv&auml;nda biogas som drivmedel f&ouml;r fordon i Sverige. Rapporten ger ett underlag f&ouml;r bed&ouml;mning av hur vidare satsningar inom omr&aring;det b&ouml;r ske och redovisar n&aring;gra av de m&ouml;jligheter och komplikationer som kan f&ouml;rknippas med en s&aring;dan satsning.<P>I rapporten konstateras att biogas kan bli ett intressant drivmedelsalternativ, eftersom teknik med goda milj&ouml;prestanda finns utvecklad och de ekonomiska f&ouml;ruts&auml;ttningarna i m&aring;nga fall &auml;r rimliga i f&ouml;rh&aring;llande till andra alternativ.</P><P>Vid utnyttjande av biogas fr&aring;n slam och avfall begr&auml;nsas potentialen till biogasdrift av lokala bussflottor och renh&aring;llningsfordon i st&auml;der med mer &auml;n 20 000 inv&aring;nare. Genom utnyttjande av jordbruksgr&ouml;dor och g&ouml;dsel som r&aring;vara f&ouml;r gasproduktionen kan potentialen &ouml;kas kraftigt men till st&ouml;rre kostnader.</P><P>F&ouml;r att introducera biogas f&ouml;r fordonsdrift i Sverige &auml;r det viktigt att uppf&ouml;ra anl&auml;ggningar d&auml;r hela systemet fr&aring;n gasproduktion till gasutnyttjande demonstreras. Det &auml;r ocks&aring; viktigt att skapa en f&ouml;r br&auml;nsletypen gynnsam och stabil skattesituation.ABSTRACT (Aim, Method, Results)The aim of this study is to describe the possibilities for extended use of biogas as an automotive fuel in Sweden. The report gives information that could be used in the development process and points out the major advantages and problems that could be forecasted.</P><P>One conclusion from this study is that biogas could be an interesting alternative automotive fuel as a technology with good technical and environmental prestanda are available on the market and that the system economics seems to be acceptable.</P><P>With the usage of sewage sludge and municipal organic waste for biogas production it will be possible to supply city buses and a vehicle fleet for refuse collection in cities with over 20 000 inhabitants. The potential could be larger if, for example, manure and crops grown for this purpose are used as feed stock for gas production but this is less cost effective.</P><P>One important step for the introduction of biogas as an automotive fuel i Sweden would be the construction of a demonstration plant where know-how could be extracted from the operation of a complete system. Another important factor is that the tax situation for biogas fuel is favourable and stable in the future.</P><BR><!-- Horizontal Line Tag --><HR WIDTH=100%><BR><BR><B>F&Ouml;RFATTARE/AUTHOR </B><BR>Mats EkelundTomas Kullbjer<BR><BR><B>SERIE/SERIES</B><BR>KFB-rapport 1995:14<BR>ISBN 91-88370-97-6<BR>ISSN 0282-8014<BR><BR><B>TITEL/TITLE </B><BR>Biogasdrivna bussar i Link&ouml;ping<BR>Biogas propelled buses in the city of Link&ouml;ping, Sweden<BR><BR><B>PUBLICERINGSDATUM/DATE OF PUBLISHING </B><BR>April 1995<BR><BR><B>UTGIVARE/PUBLISHER</B><BR><BR>KFBs DNR 90-43-732 <BR>KFB - Kommunikationsforskningsberedningen, Stockholm<BR><BR><B>REFERAT (Syfte, Metod, Resultat)</B><BR>Syftet med projektet var att identifiera skillnaden i driftf&ouml;ruts&auml;ttningar, ekonomi och emissionsniv&aring;er samt f&ouml;ruts&auml;ttningarna f&ouml;r biogasproduktion j&auml;mf&ouml;rt med ordinarie drift.<P>Fem bussar utrustades med gasmotorer som konverterats fr&aring;n dieselmotorer. Bussarna har k&ouml;rts i ordinarie trafik i Link&ouml;ping. Gasen kommer fr&aring;n kommunens avloppsreningsverk och renas fr&aring;n koldioxid innan bussarna tankas.</P><P>Projektet har visat att det &auml;r tekniskt m&ouml;jligt att anv&auml;nda gasen f&ouml;r fordonsdrift, att f&ouml;ruts&auml;ttningarna att uppn&aring; l&aring;ga emissionsniv&aring;er &auml;r goda och att st&ouml;rre fordonsflottor kan drivas till rimliga kostnader.</P><B>ABSTRACT</B> (Aim, Method, Results)<BR>The aim of the project was to identify the difference in operation, costs, level of emissions and production of biogas for biogas propelled buses compared to ordinary dieselbus operation.<P>Five buses have been equipped with gas engines which have been converted from diesel engines. The buses have been operated in ordinary traffic in the city of Link&ouml;ping. The gas was delivered from the waste water treatment plant and was separated from carbondioxid before the buses were fuelled.</P><B>The project has shown that it is technically possible to use biogas as fuel for buses, that the possibilities to reach low level of emissions are good and that bigger fleets of biogas propelled buses can be operated at reasonable costs.</B><BR><HR><BR><A HREF="../index.html"><IMG SRC="../homeicon.gif" BORDER = 0></A><A HREF="../bibliotek.html"><IMG SRC="../upicon.gif" BORDER = 0 ></A></td></tr></TABLE></BODY></HTML>
</DOC>
<DOC>
<DOCNO>WT02-B10-59</DOCNO>
<DOCOLDNO>IA018-000200-B014-351</DOCOLDNO>
<DOCHDR>
http://www.kfb.se:80/rapporter/rap_tele.html 194.198.183.242 19970106204919 text/html 5798
HTTP/1.0 200 OK
Date: Mon, 06 Jan 1997 20:44:30 GMT
Server: Microsoft-Internet-Information-Server/1.0
Content-Type: text/html
Last-Modified: Fri, 18 Oct 1996 10:03:04 GMT
Content-Length: 5598
</DOCHDR>
<HTML><HEAD><TITLE>Rapporter</TITLE></HEAD><BODY TEXT="#3d3d3d" BGCOLOR="#ffffff" LINK="#e12b1e" ALINK="#e7e318" VLINK="#0e7112"><TABLE WIDTH=454 BORDER=0 ><TR><TD WIDTH=1 BORDER=0 align=left></TD><TD WIDTH=453 BORDER=0 align=left> <H6>[<A HREF="../index.html">Home</A>][<A HREF="../bibliotek.html">Up</A>] </H6><A HREF="../kfbnews.html"><IMG VSPACE=0 SRC="../flash.gif"IMG BORDER=0></A><IMG VSPACE=0 SRC="../infoallm.gif" ><P><BR><B>REDAKT&Ouml;R/EDITOR</B><BR>J&ouml;rgen Nissen<BR><BR><B>SERIE/SERIES</B><BR>KFB-rapport 1996:1<BR><BR><B>ISBN</B> 91-88868-01-X<BR><B>ISSN </B>1104-2621<BR><BR><B>TITEL/TITLE</B><BR> Posten och informationssamh&auml;llet. En f&ouml;rstudie<BR>Postal Services and the Information Society - A preliminary study<BR><BR><B>PUBLICERINGSDATUM/DATE PUBLISHED </B><BR>Februari 1996/February 1996<BR><BR><B>UTGIVARE/PUBLISHER</B><BR><BR><B>KFBs DNR</B> 93-163-813<BR>KFB, Kommunikations-forsknings-beredningen<BR><BR><B>REFERAT (Syfte, Metod, Resultat)</B><BR>Postverksamhetens f&ouml;ruts&auml;ttningar i det moderna samh&auml;llet &auml;r studiens bakomliggande fr&aring;gest&auml;llning. Syftet var att pr&ouml;va en rad, f&ouml;r postomr&aring;det delvis nya  teoretiska och metodiska perspektiv f&ouml;r att se vilka insikter de olika infallsvinklarna kan ge upphov till och f&ouml;r att ge underlag f&ouml;r fortsatt forskning. Studiens vetenskapliga fokus &auml;r posthanteringens villkor i det moderna samh&auml;llet. Med posthantering avser vi fr&auml;mst f&ouml;rmedlingen av brev, paket och ekonomiska transaktioner. F&ouml;rstudien organiserades som sju olika delstudier i syfte att t&auml;cka n&aring;gra centrala fr&aring;gest&auml;llningar: &#147Posten och stora tekniska system&#147, &#147Posten och den oj&auml;mna produktivitetsutvecklingen (det &#180;post-industriella&#180;dilemmat)&#147, &#147Utbud och efterfr&aring;gan p&aring; posttj&auml;nster: Ett transport- och kommunikationsekonomiskt problemomr&aring;de&#147, &#147Posten och tekniken i historisk belysning&#147,  &#147F&ouml;ruts&auml;ttningarna f&ouml;r postverksamhet i ett modernst samh&auml;lle - Postens egen syn&#147, &#147Postens gr&auml;nsyta&#147 och &#147Informationsvanor - och ny teknik&#147. Samtliga delstudier pekar p&aring; fortsatta forskningsbehov. <BR><BR>       <B>ABSTRACT (Aim, Method, Results)</B><BR>The underlying objective was to study the conditions for postal services in a modern society and thereby test a series of theoretical and methodical perspectives (some not previously applied to the postal services) in order to see what insight the various approaches could give, and lay the foundations for continued research. The scientific focus lies on the conditions governing postal services in modern society. By postal services we mean the conveyance of letters, parcels and bank transactions. The preliminary study was organised into seven separate but related sub studies which were to cover some key issues: &#147The postal service and large technical systems&#147, &#147The postal service and unbalanced productivity development (the &#180;post-industrial&#180; dilemma)&#147, &#147The supply and demand of postal services: A problem area relating to the economics governing transport and communications&#147, &#147The postal service and technology from an historic perspective&#147, "The conditions for postal services in a modern society - The Post Office&#180;s own view&#147, &#147The postal service&#180;s interface&#147 and &#147Information habits and new technology&#147. All studies conducted as part of the report indicate a need for continued research.<BR><BR><!-- Horizontal Line Tag --><HR><BR><BR><B>F&Ouml;RFATTARE/AUTHOR </B><BR>Birger Rapp och Jo Sk&aring;medal, Link&ouml;pings universitet<BR><BR><B>SERIE/SERIES</B><BR>KFB-rapport 1996:2<BR>ISBN 91-88868-05-2<BR>ISSN 1104-2621<BR><BR><B>TITEL/TITLE</B><BR>Telekommunikationernas implikationer p&aring; resandet. En litteraturgenomg&aring;ng av arbete p&aring; distans och resande  nationellt och internationellt<BR><BR><B>PUBLICERINGSDATUM/DATE OF PUBLISHING </B><BR>Mars 1996<BR><BR><B>UTGIVARE/PUBLISHER</B><BR><B>KFBs DNR</B> 95-223-833<BR>KFB, Kommunikationsforskningsberedningen<BR><BR><B>REFERAT (Syfte, Metod, Resultat)</B><BR>Denna rapport &auml;r utf&ouml;rd p&aring; uppdrag av Kommunikationsforskningsberedningen (KFB). Uppdraget g&auml;llde att ta fram en &ouml;versikt &ouml;ver &#148;Arbete p&aring; distans och re-sande - nationellt och internationellt, baserad fr&auml;mst p&aring; litteratur-studier&#148;. Arbetet har huvudsakligen genomf&ouml;rts med hj&auml;lp av datas&ouml;kningar, litte-ratur-studier och samman-st&auml;llningar av relevant sekund&auml;rmaterial.<BR><P>Syftet med den genomf&ouml;rda litteraturstudien &auml;r att belysa olika hypoteser om telekommunikation och hur telekommunikationen kan p&aring;verka resan-det. De empiriska studier, som gjorts inom omr&aring;det lyfts fram. Avsikten med rapporten &auml;r bland annat att &ouml;ka f&ouml;rst&aring;elsen f&ouml;r hur telekommunikation och transporter samverkar samt de komplexa samband som r&aring;der. Olika forskares syn p&aring; telekommunikationens inver-kan p&aring; resandet belyses. Rapporten avslutas med en redovisning av vilka databaser och personer som har kontaktats. </P><HR><BR><A HREF="../index.html"><IMG SRC="../homeicon.gif" BORDER = 0></A><A HREF="../bibliotek.html"><IMG SRC="../upicon.gif" BORDER = 0 ></A></td></tr></TABLE></BODY></HTML>
</DOC>
<DOC>
<DOCNO>WT02-B10-60</DOCNO>
<DOCOLDNO>IA018-000200-B014-364</DOCOLDNO>
<DOCHDR>
http://www.kfb.se:80/rapporter/rap_fys.html 194.198.183.242 19970106204933 text/html 21529
HTTP/1.0 200 OK
Date: Mon, 06 Jan 1997 20:44:41 GMT
Server: Microsoft-Internet-Information-Server/1.0
Content-Type: text/html
Last-Modified: Mon, 04 Nov 1996 15:08:34 GMT
Content-Length: 21328
</DOCHDR>
<HTML><HEAD><TITLE>Rapporter</TITLE></HEAD><BODY TEXT="#3d3d3d" BGCOLOR="#ffffff" LINK="#e12b1e" ALINK="#e7e318" VLINK="#0e7112"><TABLE WIDTH=454 BORDER=0 ><TR><TD WIDTH=1 BORDER=0 align=left></TD><TD WIDTH=453 BORDER=0 align=left> <H6>[<A HREF="../index.html">Home</A>][<A HREF="../bibliotek.html">Up</A>] </H6><A HREF="../kfbnews.html"><IMG VSPACE=0 SRC="../flash.gif"IMG BORDER=0></A><IMG VSPACE=0 SRC="../infoallm.gif" ><P><BR> <B>F&Ouml;RFATTARE/AUTHOR </B><BR>Hans L&ouml;fsten, Handelsh&ouml;gskolan vid G&ouml;teborgs universitet<BR><BR><B>SERIE/SERIES</B><BR>KFB-rapport 1995:4<BR>ISBN 91-88370-87-9<BR>ISSN 0282-8014<BR><BR><B>TITEL/TITLE </B><BR>Transportation Costing for Decision Making.<BR>Transportation Industry Market Structure in Sweden and its Implications for Pricing and Costing<BR><BR><B>PUBLICERINGSDATUM/DATE OF PUBLISHING</B> <BR>January 1995<BR><BR><B>UTGIVARE/PUBLISHER</B><BR>KFBs DNR 92-126-43<BR>KFB - Kommunikationsforskningsberedningen, Stockholm<BR><BR><B>REFERAT</B> (Syfte, Metod, Resultat)<BR>Syftena med f&ouml;religgande studie &auml;r dels att (1) analysera strukturen p&aring; den svenska transport- marknaden och dess konsekvenser f&ouml;r priss&auml;ttning och kalkylering, dels att (2) analysera olika problem vid kalkylering av transporter och utveckla l&auml;mpliga principer f&ouml;r kalkylering. Modellerna som utvecklas i part IV visar olika f&ouml;rflyttningar av transporter och bygger p&aring; sambanden mellan (i) olika kostnader f&ouml;r transport av godset (ii) kostnader f&ouml;r att hantera godset p&aring; terminal och (iii) allokering av gemensamma kostnader. Det grundl&auml;ggande angreppss&auml;ttet  bygger p&aring; analys av vilka olika produktionsresurser  som &auml;r n&ouml;dv&auml;ndiga f&ouml;r olika steg. Det kan konstateras att aktivitetsbaserad kalkylering inte &auml;r l&auml;mplig f&ouml;r beslutssituationer som pr&auml;glas av kapacitets&ouml;verv&auml;ganden och alternativkostnads- resonemang. ABC &auml;r d&auml;remot l&auml;mplig som kalkylmetod  vid terminaler d&auml;r kapacitets&ouml;verv&auml;ganden &auml;r av mindre betydelse och d&auml;r aktiviteterna &auml;r samma &ouml;ver tiden.<P>Mikroekonomisk analys anv&auml;nds f&ouml;r att studera marknadsstrukturen. I Sverige &auml;r koncentrationen av utbudssidan mycket kraftig och vi har n&auml;stan en marknad som utm&auml;rks av duopol. Det existerar en sorts priskartell, d&auml;r det f&ouml;rsta steget mot en kartellbindning &auml;r h&ouml;ga priser och kraftiga priss&auml;nkningar, s k kvasipermanenta priser.     </P><B>ABSTRACT (Aim, Method, Results)</B><BR>The aims of this study were (1) to analyse the Swedish transportation industry market structure and explain its consequences to transport carrier costing and pricing and (2) to analyse the transportation costing problem area and develop appropriate costing principles. The models developed in part IV represent the operation of  transportation movements by a carrier, (ii) terminal handling costs of the goods and (iii) allocation of the overhead costs. The basic approach is the analysis of a task in terms of the production resources necessary for each stage. Fullcosting methods as activity-based costing is not appropriate for capacity considerations and considerations about opportunity costs is missing. ABC is on the contrary appropriate for cost allocation at the terminals because there is usually no capacity problems and the activities are the same over the time.<BR></B><P>Microeconomic analysis is used for explicitly consider market structure effects. In Sweden there is a very strong concentration  of supply and we nearly have a dupoly-case. In this country exists a sort of price-fixing (a pricing-cartel) agreement. The first step toward the establishment of a cartel and to inefficiency are higher prices and large price reductions, i e quasipermanent prices. </P><!-- Horizontal Line Tag --><HR WIDTH=100%><BR><B>F&Ouml;RFATTARE/AUTHOR</B><BR> Peter W Cardebring, Christiane Warnecke, TFK Transportforschung GmbH<BR><BR><B>SERIE/SERIES</B><BR>KFB Report 1995:16<BR>ISBN 91-88370-99-2<BR>ISSN 1104-2621<BR><BR><B>TITEL/TITLE </B><BR>Combi-Terminal and Intermodal Freight Centre development - an assessment<BR><BR><B>PUBLICERINGSDATUM/DATE OF PUBLISHING </B><BR>August 1995<BR><BR><B>UTGIVARE/PUBLISHER</B><BR>KFBs DNR 93-122-43<BR>KFB - Swedish Transport and Communications Research Board, Stockholm<BR><BR><B>REFERAT (Syfte, Metod, Resultat)</B><BR>Syftet med denna studie har varit att unders&ouml;ka och analysera utvecklingen av kombi-terminaler och integrerade godstransportcenter p&aring; kontinenten och dess m&ouml;jliga p&aring;verkan p&aring; utvecklingen i Sverige. P&aring; kontinenten har l&auml;nderna Holland, Italien, Tyskland och Polen analyserats d&aring; de utg&ouml;r viktiga handelspartner f&ouml;r Sverige samt driver delvis olika terminal-strategier. Den existerande situationen och aktuella utvecklingsplaner har unders&ouml;kts med en koncentration p&aring; viktiga marknadsakt&ouml;rer, terminal-&auml;gar-struktur och de f&ouml;r&auml;ndringar som kan f&ouml;rv&auml;ntas inom den n&auml;rmaste framtiden. Studien visar att utvecklingen av intermodala terminaler &auml;r en nationell fr&aring;ga vilken ofta drivs av de nationella j&auml;rn-v&auml;garna. N&auml;tverket av intermodala terminaler &auml;r generellt sett bra utvecklat i de unders&ouml;kta l&auml;nderna (utom f&ouml;r Polen d&auml;r en utbyggnad planeras), men kapacitets- och effektivitetsproblem finns. Vad g&auml;ller utvecklingen av integrerade godstransportcenter s&aring; p&aring;g&aring;r en dynamisk utveckling i b&aring;de Tyskland och i Italien vilken ofta drivs av lokala/regionala intressegrupper och j&auml;rnv&auml;garna. I Sverige och i Holland &aring;terfinns terminalstrukturer/omr&aring;den (liknande IFC) av samma typ vilka inte har utvecklats enligt en medveten terminalstrategi. Ansvariga f&ouml;r planering &auml;r lokala och regionala myndigheter. I Polen b&ouml;rjar olika akt&ouml;rer att intressera sig f&ouml;r en m&ouml;jlig utveckling av godstransportcenter.<BR><BR><B>ABSTRACT (Aim, Method, Results)</B><BR>The purpose of the study is to analyze the Combi-terminal and Intermodal Freight Centre development (IFC) on the continent and it&#146;s possible influence on the development in Sweden. On the continent four countries, Italy, the Netherlands, Germany and Poland, have been investigated because they all are important trade partners to Sweden and pursue some-what different terminal strategies. For these countries the present situation and existing deve-lopment plans have been analysed with a focus on the important market actors, the structure of the terminal ownership and the changes which can be expected during the  next years. The study shows that the development of intermodal terminals is a national question which is usually driven by the national railways. The network of intermodal terminals is in general well developed in the five contries (except for Poland were an extension is planned), but capacity and efficiency problems exist. For the development of Intermodal Freight Centres (IFC) a pronounced development takes place in Italy and Germany which is driven by local/regional interest groups and by the  railways. In Sweden and the Netherlands similar structures/areas (like IFC) can be found, but have not been developed specifically. Responsible for the planning are local and regional authorities. In Poland first thoughts are put to the development of Intermodal Freight Centres (IFC).<BR><BR><HR><BR><BR><B>F&Ouml;RFATTARE/AUTHOR </B><BR>Mats B&ouml;rjesson<BR><BR><B>SERIE/SERIES</B><BR>KFB-rapport 1995:7<BR>ISBN 91-88370-90-9<BR>ISSN 0282-8014<BR><BR><B>TITEL/TITLE </B><BR>Modeller f&ouml;r samordning av samh&auml;lls-betalda resorModels for coordination of special transport services and other transports paid by authorities<BR><BR><B>PUBLICERINGSDATUM/DATE OF PUBLISHING </B><BR>Maj 1995<BR><BR><B>UTGIVARE/PUBLISHER</B><BR>KFBs DNR 94-40-732<BR>KFB - Kommunikationsforskningsberedningen, Stockholm<BR><BR><B>REFERAT (Syfte, Metod, Resultat)</B><BR>Studien j&auml;mf&ouml;r samarbetet mellan landstinget i S&ouml;rmland och kommunerna i &ouml;stra l&auml;nsdelen med olika samarbetsformer i Hallands, V&auml;rmlands, &Ouml;rebro och G&auml;vleborgs l&auml;n. F&ouml;r vissa typer av rationaliseringar och samarbete har j&auml;mf&ouml;relser gjorts f&ouml;r hela landet.<BR><BR>Erfarenheten &auml;r att den effektivaste l&ouml;sningen f&ouml;r samh&auml;llsbetalda transporter &auml;r samverkan mellan kommuner och landsting av b&aring;de upphandling och resor genom en best&auml;llnings-central. Samordningen skall ske genom att resen&auml;rerna f&ouml;rbest&auml;ller resan (20 - 60 min) och att best&auml;llningscentralen har r&auml;tt att justera avresetiden (10-30 min). Transport&ouml;rer skall ers&auml;ttas enligt en taxa som medger att best&auml;llningscentralen kan ber&auml;kna ers&auml;ttningen i f&ouml;rv&auml;g.<BR><BR><B>ABSTRACT (Aim, Method, Results)</B><BR>The aim of the project is to compile experiences of different ways to organize coordination measurements for personal transports paid by local authorities and county councils.<BR><P>The most efficient organization is a cooperation between local authorities and county councils concerning purchasing and coordination of trips in a booking office. The coordination will be more effective if the trips are booked 20-60 min in advance and if the booking office is allowed to change the time of departure 10-30 min.</P><P>The control of charges and the administration of invoices can be reduced if the compensation to transport operators are calculated in advance instead of calculated by taximeter.</P><BR><!-- Horizontal Line Tag --><HR><BR><BR><B>F&Ouml;RFATTARE/AUTHOR </B><BR>Christer Agerback, Mats Ekelund<BR><BR><B>SERIE/SERIES</B><BR>KFB-rapport 1995:13<BR>ISBN 91-88370-96-8<BR>ISSN 0282-8014<BR><BR><B>TITEL/TITLE</B><BR>Motorgasdrivna bussar i SundsvallLPG propelled buses in the city of Sundsvall, Sweden<BR><B>PUBLICERINGSDATUM/DATE OF PUBLISHING </B><BR>Maj 1995<BR><BR><B>UTGIVARE/PUBLISHER</B><BR>KFBs DNR 90-46-732<BR>KFB - Kommunikationsforskningsberedningen, Stockholm<BR><BR><B>REFERAT (Syfte, Metod, Resultat)</B><BR>Prov med motorgasdrivna stadsbussar har gjorts f&ouml;rut. Provet med tv&aring; &auml;ldre Volvobussar i trafik i Sundsvall, gjordes med syftet att prova om avgasutsl&auml;ppen gick att s&auml;nka dramatiskt och om tillg&auml;ngligheten kunde h&aring;llas uppe med nyutvecklad teknik. Motorgas &auml;r l&auml;tt till-g&auml;nglig i Sundsvall och proven skulle utf&ouml;ras med motorerna optimerade f&ouml;r mager resp idealisk br&auml;nsle-luftblandning. V&auml;rmeutvecklingen gjorde dock att b&aring;da motorerna an-passades enligt magerbr&auml;nsleprincipen.<H6></H6><P>Resultatet blev att NOX-, HC- och CO-utsl&auml;ppen reducerades mer &auml;n v&auml;ntat. Koldioxidutsl&auml;ppen (CO2) s&auml;nktes med 8 % j&auml;mf&ouml;rt med motsvarande dieseldrift. V&auml;rmeutvecklingen orsakade skador i motorerna och motorhaverier &auml;ven i magerbr&auml;nsleutf&ouml;randet. Allt eftersom erfarenheterna har kommit, har dock denna sv&aring;righet kunnat minskas. Bussen med den nyare motorn k&ouml;rdes utan st&ouml;rningar under de sista 12 av de 18 m&aring;nadernas provdrift. Vid projektets genomf&ouml;rande var denna buss sannolikt den renaste bussen i drift i v&auml;rlden enligt ECE R49 m&auml;tmetod.</P><B>ABSTRACT (Aim, Method, Results)</B><BR>Trying LPG in heavy duty buses has been done before. This test, with two Volvo buses in operation in the city of Sundsvall, Sweden, had the objective to show how low the exhaust emissions and how high accessibility could be with engines optimised for LPG-operation. LPG is also readily available in the Sundsvall area. Lean Burn and stoichiometric optimi-sation was tested, but the stoichiometric technique had to be eliminated due to a heat release that was too high. Both buses thereby became Lean Burn operated.<BR><P>The results shoved that the NOX, HC and CO exhausts volumes were more reduced than anticipated. Carbon Dioxide (CO2) exhaust was also reduced by over all 8 % compared with diesel operation under identical conditions. Heat release has been a concern and a source of trouble, both engines have suffered break downs. As time went by and experiences accumulated, the issue became of less significance. The newer of the two buses operated without interruption for the last 12 months of the project. At the time for the project, this newer bus was maybe the cleanest operating bus in the world, according to the ECE R49 test method.</P><!-- Horizontal Line Tag --><HR><BR><B>F&Ouml;RFATTARE/AUTHOR </B><BR>Per Gunnar Andersson, Trivector<BR><BR><B>SERIE/SERIES</B><BR>KFB-rapport 1995:15<BR><BR>ISBN 91-88370-98-4<BR>ISSN 0282-8014<BR><BR><B>TITEL/TITLE</B> <BR>Modern sp&aring;rv&auml;gstrafik. En inventering av l&auml;get i Sverige, Europa och USAModern Light Rail systems in Sweden, Europe and the United States<BR><BR><B>PUBLICERINGSDATUM/DATE OF PUBLISHING </B><BR>Augusti 1995<BR><BR><B>UTGIVARE/PUBLISHER</B><BR>KFBs dnr 91-97-732 <BR>KFB -  Kommunikationsforskningsberedningen, Stockholm<BR><BR><B>REFERAT (Syfte, Metod, Resultat)</B><BR>Syftet med projektet har varit att klarl&auml;gga l&auml;get vad g&auml;ller utvecklingen av modern sp&aring;rv&auml;gstrafik. Flera utredningar har gjorts om sp&aring;rv&auml;gstrafik i  Sverige. I Europa f&ouml;rnyas sp&aring;rv&auml;gstekniken vilket &auml;r av intresse f&ouml;r Sverige.<BR><P>Projektet har genomf&ouml;rts som en litteraturstudie samt intervjuer och diskussioner med nyckelpersoner inom utredningar som har p&aring;g&aring;tt och p&aring;g&aring;r i Sverige.</P><P>Rapporten redovisar en genomg&aring;ng av sp&aring;rv&auml;gen och dess utveckling de senaste 15 &aring;ren. I rapporten beskrivs befintliga och planerade system i  Sverige och j&auml;mf&ouml;relser har gjorts med &ouml;vriga Europa och USA. Det &auml;r endast system som kan vara av intresse f&ouml;r svenska  f&ouml;rh&aring;llanden som har behandlats. Sp&aring;rv&auml;gen har &auml;ven j&auml;mf&ouml;rts med andra trafikslag som bussar, automatbanor och tunnelbanor. En genomg&aring;ng redovisar finansieringssystem i Sverige, Tyskland, Frankrike och USA.</P><BR><B>ABSTRACT (Aim, Method, Results)</B><BR>The aim of this project is to describe the situation concerning the development of Light Rail systems. A number of studies has been done on Light Rail systems in Sweden. In Europe there are a lot of new ideas in Light Rail transit which can be of great interest for planners in Sweden.<BR><P>The project is realized as a literature study and interviews with key persons in the Swedish Light Rail studies.</P><P>This report is an examination of Light Rail systems and its development during the last 15 years. In the report, existing and planned Swedish systems are described. Comparisons have been made between cities in Europe and USA. Only systems of interest for Swedish conditions are  discussed. Light Rail is also compared with other modes of transport such as buses, people movers and underground systems. Different forms of financing Light Rail in Sweden, Germany, France and the United States are described.</P><BR><BR><!-- Horizontal Line Tag --><HR><BR><BR><B>F&Ouml;RFATTARE/AUTHOR</B><BR> Agneta St&aring;hl, Karin Brundell-Freij, Oscar Gr&ouml;nvall, Majvi Magdeburg<BR><BR><B>SERIE/SERIES </B><BR>KFB-Rapport 1996:7<BR>ISBN 91-88868-08-7<BR>ISSN 1104-2621<BR><BR><B>TITEL/TITLE</B><BR> Tillg&auml;nglig kollektivtrafik f&ouml;r &auml;ldre och handikappade. Betydelsen av reskedjans olika delar.Accessible public transport for elderly and physically disabled. Significance of the various links in the transportation chain<BR><BR><B>PUBLICERINGSDATUM/DATE PUBLISHED</B><BR>Maj 1996<BR><BR><B>UTGIVARE/PUBLISHER </B><BR>KFB - Kommunikationsforskningsberedningen<BR>KFBs DNR  88-251-731<BR><BR><B>REFERAT (Syfte, Metod, Resultat)</B><BR><B>Syftet</B> med projektet var att utv&auml;rdera effekterna (r&ouml;rlighet, s&auml;kerhet, livskvalitet) bland de &auml;ldre i tv&aring; olika bostadsomr&aring;den i Bor&aring;s. Likv&auml;rdiga &aring;tg&auml;rder genomf&ouml;rdes i den fysiska milj&ouml;n. I ett av omr&aring;dena inf&ouml;rdes Servicelinjetrafik, i det andra genomf&ouml;rdes sm&auml;rre &aring;tg&auml;rder p&aring; befintliga 12-meters bussar. &Auml;ldres attityder till och v&auml;rderingar av olika &aring;tg&auml;rder studerades.      Ett flertal <B>studier</B> genomf&ouml;rdes; postenk&auml;t (f&ouml;re-efterstudie) till samtliga personer &ouml;ver 65 &aring;r i de b&aring;da omr&aring;dena, intervjuer med fotg&auml;ngare och bussresen&auml;rer, r&auml;kningar av fotg&auml;ngare och busspassagerare, f&auml;rdtj&auml;nstm&auml;tningar, intervjuer med personer med synneds&auml;ttningar samt en s&auml;rskild stated-preference studie. <BR><BR>    <B> De sammanfattande resultaten</B> av projektet &auml;r att antalet resen&auml;rer i kollektivtrafiken &ouml;kar i b&aring;da omr&aring;dena men &ouml;kningen &auml;r betydligt st&ouml;rre i det omr&aring;de d&auml;r Servicelinjetrafik introducerats. Antalet fotg&auml;ngare i bostadsomr&aring;dena &ouml;kar. Attityderna &auml;r positivare till f&ouml;r&auml;ndringarna i kollektivtrafiken &auml;n till f&ouml;r&auml;ndringar i den fysiska milj&ouml;n. De boende i omr&aring;det d&auml;r Servicelinjetrafik introducerats &auml;r emellertid mer positiva till &aring;tg&auml;rderna i den fysiska milj&ouml;n &auml;n de boende i omr&aring;det d&auml;r &aring;tg&auml;rder inom den traditionella kollektivtrafiken genomf&ouml;rts. Effekterna och attityderna &auml;r mest positiva bland de &auml;ldsta (75+) och bland de mer funktionsnedsatta.<BR><BR>     <B> Slutsatserna</B> av projektet &auml;r att det &auml;r m&ouml;jligt att attrahera nya &auml;ldre resen&auml;rer till kollektivtrafiken och att &ouml;ka resandet bland tidigare resen&auml;rer genom att &ouml;ka kvaliteten i kollektivresan. Detta har i sin tur positiva effekter p&aring; f&auml;rdtj&auml;nstresandet. &Aring;tg&auml;rderna i den fysiska milj&ouml;n har &auml;ven positiv effekt p&aring; resandet, s&auml;rskilt i de omr&aring;den som erbjuder h&ouml;gst kvalitet i kollektivresan, d v s d&auml;r Servicelinjetrafik inf&ouml;rts.<BR><BR><B>ABSTRACT (Aim, Method, Results)</B><BR><B>The aim</B> of the project was to evaluate the overall benefit (mobility, safety, quality of life etc) for the elderly population in two different residential areas in Bor&aring;s. In both areas similar measures were undertaken in the physical environment. In the public transport system, a service route was introduced in one of the areas, and measures on the buses were undertaken in the other area. The elderly&#146;s attitudes towards and values of different measures were studied.<BR><BR>     Many <B>studies</B> were undertaken; a questionnaire (before-after-study) to all people over the age of 65 in both the residential areas, interviews with pedestrians and bus-passengers, counting of passengers on the buses and pedestrians in the areas, counting of passengers in the special transport system (STS), interviews with a group of vision impaired people and a special stated preference study.<BR><BR>    <B>The summarized resut</B> of the project is that the number of passengers in the public transport system increases in both area but the increase is bigger where the service route traffic were introduced; more pedestrians is out in both neighborhoods; measures in both the public transport system and the physical environment are appreciated by the elderly; there is a more positive attitude to the changes in the public transport system than in the physical environment; the residents in the area where the service route was introduced value however the measures in the physical environment higher than do the residents where changes on the buses in the mainstream service were made. Furthermore the effect and the attitudes are more positive among the oldest (75+) and the group of people reporting more severe impairments. <BR><BR>     <B>The conclusion</B> of the project is that it is possible to attract new passengers and to increase the use of the public transport system by offering a better quality and a higher adaptation level in the system. This, in turn, has a positive effect on the use of STS. The effect of measures in the physical environment is also positive, but such measures are likely to be more appreciated when the public transport system also offers a higher adaptation level (i.e. service routes).<BR><!-- Horizontal Line Tag --><HR><BR><A HREF="../index.html"><IMG SRC="../homeicon.gif" BORDER = 0></A><A HREF="../bibliotek.html"><IMG SRC="../upicon.gif" BORDER = 0 ></A></td></tr></TABLE></BODY></HTML>
</DOC>
<DOC>
<DOCNO>WT02-B10-61</DOCNO>
<DOCOLDNO>IA018-000200-B014-373</DOCOLDNO>
<DOCHDR>
http://www.kfb.se:80/rapporter/rap_strat.html 194.198.183.242 19970106204940 text/html 909
HTTP/1.0 200 OK
Date: Mon, 06 Jan 1997 20:44:52 GMT
Server: Microsoft-Internet-Information-Server/1.0
Content-Type: text/html
Last-Modified: Fri, 18 Oct 1996 10:03:02 GMT
Content-Length: 710
</DOCHDR>
<HTML><HEAD><TITLE>Rapporter</TITLE></HEAD><BODY TEXT="#3d3d3d" BGCOLOR="#ffffff" LINK="#e12b1e" ALINK="#e7e318" VLINK="#0e7112"><TABLE WIDTH=454 BORDER=0 ><TR><TD WIDTH=1 BORDER=0 align=left></TD><TD WIDTH=453 BORDER=0 align=left> <H6>[<A HREF="../index.html">Home</A>][<A HREF="../bibliotek.html">Up</A>] </H6><A HREF="../kfbnews.html"><IMG VSPACE=0 SRC="../flash.gif"IMG BORDER=0></A><IMG VSPACE=0 SRC="../infoallm.gif" ><P>Rapporter &auml;r under sammanst&auml;llning. V&auml;lkommen &aring;ter.<HR><BR><A HREF="../index.html"><IMG SRC="../homeicon.gif" BORDER = 0></A><A HREF="../bibliotek.html"><IMG SRC="../upicon.gif" BORDER = 0 ></A></td></tr></TABLE></BODY></HTML>
</DOC>
<DOC>
<DOCNO>WT02-B10-62</DOCNO>
<DOCOLDNO>IA018-000200-B014-387</DOCOLDNO>
<DOCHDR>
http://www.kfb.se:80/inters/kontakt.html 194.198.183.242 19970106205003 text/html 5097
HTTP/1.0 200 OK
Date: Mon, 06 Jan 1997 20:45:10 GMT
Server: Microsoft-Internet-Information-Server/1.0
Content-Type: text/html
Last-Modified: Wed, 18 Dec 1996 22:01:52 GMT
Content-Length: 4897
</DOCHDR>
<HTML><!-- Head Tag --><HEAD><TITLE>KFB skapar n&auml;tverk</TITLE></HEAD><!-- Body Tag --><BODY TEXT="#4C4C4C" LINK="#FFFFFF" BACKGROUND="interpic/yel_bgr.gif"></BODY><!-- Link Tag --><A HREF="../index.html"><!-- Graphic Tag --><IMG WIDTH=539 HEIGHT=28 BORDER=0 ALT="Till KFB huvudsida" SRC="interpic/kfbhead.gif"></A><TABLE WIDTH=542 BORDER=0 ><TR><TD WIDTH=90 BORDER=0 valign=top align=left ><BR><H5>SAMORDNING OCH  INTERNATIONELLA FR&Aring;GOR<BR><BR></H5>Skapa kontakter<BR><BR><!-- Link Tag --><A HREF="utveckla.html">Utveckla</A><BR><BR><!-- Link Tag --><A HREF="samordna.html">Samordna</A><BR><BR><!-- Link Tag --><A HREF="stimulera.html">Stimulera</A><BR><BR><BR></TD><TD WIDTH=50 BORDER=0 align=center></TD><TD WIDTH=350 BORDER=0 align=left valign=top><BR><H2><!-- Font Tag --><FONT COLOR="#BA8702">SKAPA KONTAKTER</FONT></H2><P>Vilka l&auml;nder och forskningsomr&aring;den &auml;r intressanta f&ouml;r Sverige? Vilka n&auml;tverk finns och vad kan man g&ouml;ra f&ouml;r att skapa nya n&auml;tverk? Detta &auml;r n&aring;gra av de mest centrala fr&aring;gorna i KFB:s arbete. KFB betonar s&aring;v&auml;l i sin verksamhetsid&eacute; som i sin inriktningsplan vikten av att bygga upp internationella n&auml;tverk. N&auml;tverken underl&auml;ttar f&ouml;r forskningsverksamma att h&aring;lla sig &agrave; jour med vad som h&auml;nder inom olika omr&aring;den samt att samarbeta i viktiga fr&aring;gor.</P> <P>De flesta forskare tillh&ouml;r redan n&auml;tverk, ofta &auml;mnesorienterade s&aring;dana. Men det finns &auml;ven uppgiftsorienterade n&auml;tverk (t ex. inom trafiks&auml;kerhetsforskning) samt konsortier som samarbetar inom EU-projekt.</P> <P>Forskarna &auml;r ofta n&ouml;jda med den samarbetsniv&aring; som de uppn&aring;tt men f&ouml;r KFB, och resultatanv&auml;ndarna, &auml;r detta ibland otillr&auml;ckligt. KFB arbetar f&ouml;r att f&ouml;ra ihop olika kompetenser, att koppla samman forskare och anv&auml;ndare och att skapa n&auml;tverk inom omr&aring;den d&auml;r detta saknas.  </P><B>INSATSER<BR><BR>-kartl&auml;ggning av  internationella forskningsmilj&ouml;er och  redan existerande n&auml;tverk <BR><BR>-genomf&ouml;rande av internationella konferenser<BR><BR>-stimulerar forskare att jobba med kollegor i andra l&auml;nder (utbytestj&auml;nstg&ouml;ring) - &ouml;kar antalet stipendiater  <BR><BR>-inr&auml;ttande av g&auml;stprofessurer </B><P>N&auml;tverkens existens och kvalitet varierar mellan olika forskningsomr&aring;den och olika l&auml;nder. Ur kartl&auml;ggningarna v&auml;ljs angel&auml;gna &auml;mnesomr&aring;den som saknar fungerande n&auml;tverk. Konferenser eller seminarier kring dessa &auml;mnen blir fr&ouml;n ur vilket det v&auml;xer nya n&auml;tverk. </P><P>Svenska och utl&auml;ndska forskare kan f&aring; stipendier respektive projektmedel f&ouml;r att &ouml;ka sin kompetens utomlands, t ex genom studier eller deltagande i projekt. Inom EU:s fj&auml;rde ramprogram finns en s&auml;rskild aktivitet (Stimulation of the Training and Mobility of Researchers) som finansiellt st&ouml;der n&auml;tverksbildning och forskarutbyte. Den sammanlagda budgeten &auml;r 7 miljarder kronor. KFB verkar f&ouml;r att detta program utnyttjas inom kommunikationsforskningen. Ansvarig myndighet i Sverige f&ouml;r n&auml;mnda program &auml;r Naturvetenskapliga forskningsr&aring;det (NFR).</P><P>F&ouml;r en effektiv internationalisering &auml;r det n&ouml;dv&auml;ndigt f&ouml;r KFB att veta vilka som har ansvar f&ouml;r forskning om transporter och telematik i viktigare l&auml;nder samt hur administrationen &auml;r uppbyggd och fungerar. KFB sj&auml;lv deltar d&auml;rf&ouml;r i s&aring;v&auml;l nationella som internationella n&auml;tverk. <P>I samarbete med sina motsvarigheter i grannl&auml;nderna har KFB inr&auml;ttat Nordisk Transportforskning (NTF). NTF:s verksamhet finansieras med gemensamma medel. Den huvudsakliga aktiviteten best&aring;r i att anordna konferenser kring &auml;mnen som har gemensamt intresse samt att st&ouml;dja varandra i EU:s forskninigsarbete. Det &auml;r likas&aring; viktigt att ha en god inblick i organisation och funktion av EU-kommissionens forskningsarbete. Att delta i styr- och arbetsgrupper &auml;r ett effektivt s&auml;tt att uppn&aring; detta m&aring;l. </P></P><HR SIZE=2>Ansvarig f&ouml;r  INTERNATIONELLA FR&Aring;GOR  &auml;r  <!-- MailTo Tag --><A HREF="MAILTO:hans.mohlin@kfb.se"><!-- Font Tag --><FONT COLOR="#0000FF">Hans Mohlin.</FONT></A><BR>Ansvarig f&ouml;r SAMORDNINGSSEKRETERIATET &auml;r <!-- MailTo Tag --><A HREF="MAILTO:yngve.boye@kfb.se"><!-- Font Tag --><FONT COLOR="#0000FF">Yngve Boye</FONT></A>.<BR><BR><!-- Anchor Link Tag --><A HREF="#Upp!"><!-- Font Tag --><FONT COLOR="#0000FF">Upp!</FONT></A>                           </TD></TR></TABLE></BODY></HTML>
</DOC>
<DOC>
<DOCNO>WT02-B10-63</DOCNO>
<DOCOLDNO>IA018-000200-B014-399</DOCOLDNO>
<DOCHDR>
http://www.kfb.se:80/inters/utveckla.html 194.198.183.242 19970106205020 text/html 4420
HTTP/1.0 200 OK
Date: Mon, 06 Jan 1997 20:45:26 GMT
Server: Microsoft-Internet-Information-Server/1.0
Content-Type: text/html
Last-Modified: Wed, 18 Dec 1996 21:42:48 GMT
Content-Length: 4220
</DOCHDR>
<HTML><!-- Head Tag --><HEAD><TITLE>KFB utvecklar nationell forskning</TITLE></HEAD><!-- Body Tag --><BODY TEXT="#4C4C4C" LINK="#FFFFFF" BACKGROUND="interpic/yel_bgr.gif"></BODY><!-- Link Tag --><A HREF="../index.html"><!-- Graphic Tag --><IMG WIDTH=539 HEIGHT=28 BORDER=0 ALT="Till KFB huvudsida" SRC="interpic/kfbhead.gif"></A><TABLE WIDTH=542 BORDER=0 ><TR><TD WIDTH=90 BORDER=0 valign=top align=left ><BR><H5>SAMORDNING OCH  INTERNATIONELLA FR&Aring;GOR<BR><BR></H5><!-- Link Tag --><A HREF="kontakt.html">Skapa kontakter</A><BR><BR>Utveckla<BR><BR><!-- Link Tag --><A HREF="samordna.html">Samordna</A><BR><BR><!-- Link Tag --><A HREF="stimulera.html">Stimulera</A><BR><BR><BR></A></TD><TD WIDTH=50 BORDER=0 align=center></TD><TD WIDTH=350 BORDER=0 align=left valign=top><BR></H5><H2><!-- Font Tag --><FONT COLOR="#BA8702">UTVECKLA</FONT></H2><P>En utg&aring;ngspunkt f&ouml;r den svenska forskningspolitiken &auml;r att integrera EU-programmen i den nationella planeringen. Det &auml;r viktigt att Sverige tar tillvara de m&ouml;jligheter till &ouml;kat forskningssamarbete som medlemskapet i EU ger. </P><P>KFB har som m&aring;ls&auml;ttning att snabbt och effektivt &ouml;ka den nationella kunskapen och kompetensen inom aktuella omr&aring;den. Detta genom samarbete med internationellt framst&aring;ende forskare och ledande forskningsmilj&ouml;er. KFB har utformat en strategi f&ouml;r hur forskningen p&aring; kommunikationsomr&aring;det ska internationaliseras: <BR>Man bevakar den internationella forskningen och bed&ouml;mer inom vilka forskningsomr&aring;den Sverige har nytta av att h&auml;mta in utl&auml;ndska forskningsresultat. Man s&ouml;ker ocks&aring; omr&aring;den d&auml;r svensk kompetens kan tillf&ouml;ra den internationella forskningen n&aring;got unikt. KFB arbetar f&ouml;r att svenska forskare ska delta aktivt och ha en ledande roll i internationella projekt.<BR><BR><B>INSATSER<BR><BR>-kartl&auml;ggning av internationellt viktiga fr&aring;gor och deras utveckling<BR><BR-st&ouml;der svenskt deltagande i EU:s forskningsprogram<BR><BR>-st&ouml;der svenskt deltagande inom &ouml;vrig FUD (forskning, utveckling, demonstration)<BR></B> <P>Det &auml;r EU som avg&ouml;r vilka forskningsuppgifter (research tasks) som b&ouml;r prioriteras och f&ouml;r vilka forskningsbidrag b&ouml;r utg&aring;. KFB ger tre typer av finansiella bidrag: <BR><BR><B><!-- Link Tag --><A HREF="bidragsinfo.html#UTVECKLINGSBIDRAG"><!-- Font Tag --><FONT COLOR="#0000FF">utvecklingsbidrag</FONT></A></B> <BR>- f&ouml;r projekt som befinner sig i uppbyggnadsskedet<BR><BR><B><!-- Link Tag --><A HREF="bidragsinfo.html#F&Ouml;RHANDLINGSBIDRAG"><!-- Font Tag --><FONT COLOR="#0000FF">f&ouml;rhandlingsbidrag</FONT></A></B><BR> - f&ouml;r projekt som godk&auml;nts och som kommer att f&aring; EU-medel <BR><BR> <B><!-- Link Tag --><A HREF="bidragsinfo.html#KOMPLETTERINGSFINANSIERING"><!-- Font Tag --><FONT COLOR="#0000FF">kompletteringsfinansiering</FONT></A></B><BR> - f&ouml;r slutf&ouml;rande av projekt.<BR></P><P>KFB har redan fr&aring;n starten av EU:s fj&auml;rde ramprogram satsat h&aring;rt p&aring; att svenska representanter ska kunna vara med i forskningsverksamheten. N&aring;gra av uppgifterna har varit att p&aring;verka utformning och inneh&aring;ll av s&auml;rprogrammen Transport och Telematik i en f&ouml;r Sverige positiv riktning, att sprida information och kunskap om programmen, att ha inflytande vid utv&auml;rderingen av inl&auml;mnade projektf&ouml;rslag samt att sprida kunskap om svensk forskning. </P> <HR SIZE=2>Ansvarig f&ouml;r  INTERNATIONELLA FR&Aring;GOR  &auml;r  <!-- MailTo Tag --><A HREF="MAILTO:hans.mohlin@kfb.se"><!-- Font Tag --><FONT COLOR="#0000FF">Hans Mohlin.</FONT></A><BR>Ansvarig f&ouml;r SAMORDNINGSSEKRETERIATET &auml;r <!-- MailTo Tag --><A HREF="MAILTO:yngve.boye@kfb.se"><!-- Font Tag --><FONT COLOR="#0000FF">Yngve Boye</FONT></A>.<BR><BR><!-- Anchor Link Tag --><A HREF="#Upp!"><!-- Font Tag --><FONT COLOR="#0000FF">Upp!</FONT></A>                           </TD></TR></TABLE></BODY></HTML>
</DOC>
<DOC>
<DOCNO>WT02-B10-64</DOCNO>
<DOCOLDNO>IA018-000200-B014-408</DOCOLDNO>
<DOCHDR>
http://www.kfb.se:80/inters/samordna.html 194.198.183.242 19970106205031 text/html 4869
HTTP/1.0 200 OK
Date: Mon, 06 Jan 1997 20:45:41 GMT
Server: Microsoft-Internet-Information-Server/1.0
Content-Type: text/html
Last-Modified: Wed, 18 Dec 1996 20:51:42 GMT
Content-Length: 4669
</DOCHDR>
<HTML><!-- Head Tag --><HEAD><TITLE>KFB samordnar internationell och nationell forskning</TITLE></HEAD><!-- Body Tag --><BODY TEXT="#4C4C4C" LINK="#FFFFFF" BACKGROUND="interpic/yel_bgr.gif"></BODY><!-- Link Tag --><A HREF="../index.html"><!-- Graphic Tag --><IMG WIDTH=539 HEIGHT=28 BORDER=0 ALT="Till KFB huvudsida" SRC="interpic/kfbhead.gif"></A><TABLE WIDTH=542 BORDER=0 ><TR><TD WIDTH=90 BORDER=0 valign=top align=left ><BR><H5>SAMORDNING och INTERNATIONELLA FR&Aring;GOR<BR><BR></H5><!-- Link Tag --><A HREF="kontakt.html">Skapa kontakter</A><BR><BR><!-- Link Tag --><A HREF="utveckla.html">Utveckla</A><BR><BR>Samordna<BR><BR><!-- Link Tag --><A HREF="stimulera.html">Stimulera</A><BR><BR><BR></TD><TD WIDTH=50 BORDER=0 align=center></TD><TD WIDTH=350 BORDER=0 align=left valign=top><BR> <H2><!-- Font Tag --><FONT COLOR="#BA8702">SAMORDNA</FONT></H2><P>Behovet av samordning mellan internationell och nationell forskning p&aring; kommunikationsforskningsomr&aring;det har blivit extra tydligt i och med EES-avtalet och framf&ouml;r allt efter Sveriges intr&auml;de i EU. N&auml;r och hur ska Sverige vara med och p&aring;verka? Och hur mycket medel ska avs&auml;ttas f&ouml;r internationella forskningsprojekt?</P> <P>De strategiska fr&aring;gorna &auml;r viktiga. I dag &auml;r det bara en dryg tiondel av de offentliga forsknings- och utvecklingsresurserna i Europa som disponeras p&aring; ett samordnat s&auml;tt. M&aring;let &auml;r att &ouml;ka samarbetet och f&ouml;rb&auml;ttra samordningen f&ouml;r att uppn&aring; &ouml;kad effektivitet. </P><P>Inom ramprogrammets samtliga s&auml;rprogram - varav ett &auml;r Transportprogrammet - arbetar man f&ouml;r att samordna nationell forskning och forskning som bedrivs inom EU. Samordningen kan ske p&aring; olika s&auml;tt:Genom n&auml;tverk, informella ministerm&ouml;ten och en gemensam informationsbas redan p&aring; den politiska niv&aring;n (d&auml;r m&aring;len s&auml;tts f&ouml;r FoU-verksamheten) hoppas man kunna l&auml;gga en bra grund.   Samordning kan ocks&aring; ske vid genomf&ouml;randet av forskningsprogram och &ouml;ver huvud taget n&auml;r det g&auml;ller internationellt FoU-samarbete. Exempelvis genom att utbyta information om p&aring;g&aring;ende nationella program och genom systematiskt samr&aring;d inf&ouml;r m&ouml;ten med internationella organ. </P><B>INSATSER</B><BR><BR> <B>-g&aring;r igenom aktuella forskningsplaner och tydligg&ouml;r kopplingen mellan nationell och internationell FUD</B><BR><BR><B>-verkar f&ouml;r att &ouml;ka antalet svenska handl&auml;ggare och experter i EU-kommisssionens forskningsavdelningar</B><P>KFB har unders&ouml;kt vilka fr&aring;gor man i olika l&auml;nder bed&ouml;mer som mest intressanta under perioden fram till sekelskiftet. Man har ocks&aring; fr&aring;gat kommunikationsdepartementets myndigheter och statliga f&ouml;retag vilka forskningsomr&aring;den de &ouml;nskar ska ing&aring; i kommande ramprogram inom EU. Underlaget ska ligga till grund f&ouml;r det svenska st&auml;llningstagandet n&auml;r det femte ramprogrammets inneh&aring;ll utformas. </P><P> EU-kommissionen anlitar nationella experter n&auml;r olika fr&aring;gor ska beredas. En viktig uppgift &auml;r utv&auml;rderingen av inl&auml;mnade projektf&ouml;rslag. H&auml;r arbetar KFB f&ouml;r att &ouml;ka antalet svenska representanter.</P><P>En annan viktig del av KFB:s arbete best&aring;r i att hj&auml;lpa projektdeltagarna att f&aring; en snabb spridning av de resultat som uppn&aring;tts. Hittills har exploateringen av FUD-resultat varit d&aring;lig. </P><P>KFB:s vetenskapliga r&aring;d bist&aring;r ledningen med r&aring;d och synpunkter. R&aring;det har bland annat till uppgift att &#148;att ta in impulser utifr&aring;n och st&auml;mma av de svenska FoU-satsningarna p&aring; kommunikationsomr&aring;det med vad som h&auml;nder vid den internationella forskningsfronten&#148; och ger ocks&aring; st&ouml;d vid uppl&auml;ggningen av hur kunskap ska spridas om svensk forsknings starka sidor. </P><HR SIZE=2>Ansvarig f&ouml;r  INTERNATIONELLA FR&Aring;GOR  &auml;r  <!-- MailTo Tag --><A HREF="MAILTO:hans.mohlin@kfb.se"><!-- Font Tag --><FONT COLOR="#0000FF">Hans Mohlin.</FONT></A><BR>Ansvarig f&ouml;r SAMORDNINGSSEKRETERIATET &auml;r <!-- MailTo Tag --><A HREF="MAILTO:yngve.boye@kfb.se"><!-- Font Tag --><FONT COLOR="#0000FF">Yngve Boye</FONT></A>.<BR><BR><!-- Anchor Link Tag --><A HREF="#Upp!"><!-- Font Tag --><FONT COLOR="#0000FF">Upp!</FONT></A>                           </TD></TR></TABLE></BODY></HTML>
</DOC>
<DOC>
<DOCNO>WT02-B10-65</DOCNO>
<DOCOLDNO>IA018-000200-B014-427</DOCOLDNO>
<DOCHDR>
http://www.kfb.se:80/inters/stimulera.html 194.198.183.242 19970106205043 text/html 2454
HTTP/1.0 200 OK
Date: Mon, 06 Jan 1997 20:45:50 GMT
Server: Microsoft-Internet-Information-Server/1.0
Content-Type: text/html
Last-Modified: Wed, 18 Dec 1996 22:00:46 GMT
Content-Length: 2254
</DOCHDR>
<HTML><!-- Head Tag --><HEAD><TITLE>KFB g&ouml;r svensk forskning k&ouml;d utomlands</TITLE></HEAD><!-- Body Tag --><BODY TEXT="#4C4C4C" LINK="#FFFFFF" BACKGROUND="interpic/yel_bgr.gif"></BODY><!-- Link Tag --><A HREF="../index.html"><!-- Graphic Tag --><IMG WIDTH=539 HEIGHT=28 BORDER=0 ALT="Till KFB huvudsida" SRC="interpic/kfbhead.gif"></A><TABLE WIDTH=542 BORDER=0 ><TR><TD WIDTH=90 BORDER=0 valign=top align=left ><BR><H5>SAMORDNING OCH  INTERNATIONELLA FR&Aring;GOR<BR><BR></H5><!-- Link Tag --><A HREF="kontakt.html">Skapa kontakter</A><BR><BR><!-- Link Tag --><A HREF="utveckla.html">Utveckla</A><BR><BR><!-- Link Tag --><A HREF="samordna.html">Samordna</A><BR><BR>Stimulera<BR><BR></TD><TD WIDTH=50 BORDER=0 align=center></TD><TD WIDTH=350 BORDER=0 align=left valign=top><BR> <H2><!-- Font Tag --><FONT COLOR="#BA8702">STIMULERA</FONT></H2><P>I KFB:s arbete ing&aring;r att g&ouml;ra svensk forskning k&auml;nd f&ouml;r omv&auml;rlden. Att stimulera och underl&auml;tta f&ouml;r forskarna att p&aring; olika s&auml;tt sprida kunskap och k&auml;nnedom om svensk FUD-verksamhet. </P><BR><B>INSATSER<BR><BR>-hittar former f&ouml;r att &ouml;ka publicering i internationella facktidskrifter<BR><BR>- st&ouml;der aktivt deltagande i internationella konferenser<BR></B><P>KFB samlar in information om internationella tidskrifter och viktiga konferenser. Dessutom st&auml;ller man krav p&aring; att forskarna aktivt deltar i internationella konferenser som f&ouml;redragsh&aring;llare eller seminarieledare.</P><P>I varje projektans&ouml;kan b&ouml;r det finnas en plan f&ouml;r hur arbetet och resultaten ska presenteras. </P><HR SIZE=2>Ansvarig f&ouml;r  INTERNATIONELLA FR&Aring;GOR  &auml;r  <!-- MailTo Tag --><A HREF="MAILTO:hans.mohlin@kfb.se"><!-- Font Tag --><FONT COLOR="#0000FF">Hans Mohlin.</FONT></A><BR>Ansvarig f&ouml;r SAMORDNINGSSEKRETERIATET &auml;r <!-- MailTo Tag --><A HREF="MAILTO:yngve.boye@kfb.se"><!-- Font Tag --><FONT COLOR="#0000FF">Yngve Boye</FONT></A>.<BR><BR><!-- Anchor Link Tag --><A HREF="#Upp!"><!-- Font Tag --><FONT COLOR="#0000FF">Upp!</FONT></A>                           </TD></TR></TABLE></BODY></HTML>
</DOC>
<DOC>
<DOCNO>WT02-B10-66</DOCNO>
<DOCOLDNO>IA018-000200-B015-1</DOCOLDNO>
<DOCHDR>
http://www.kfb.se:80/inters/bidragsinfo.html 194.198.183.242 19970106205054 text/html 7648
HTTP/1.0 200 OK
Date: Mon, 06 Jan 1997 20:46:03 GMT
Server: Microsoft-Internet-Information-Server/1.0
Content-Type: text/html
Last-Modified: Wed, 18 Dec 1996 21:24:06 GMT
Content-Length: 7448
</DOCHDR>
<HTML><!-- Head Tag --><HEAD><TITLE>EU-projekt</TITLE></HEAD><!-- Body Tag --><BODY TEXT="#4C4C4C" LINK="#FFFFFF" BACKGROUND="interpic/yel_bgr.gif"></BODY><!-- Link Tag --><A HREF="../index.html"><!-- Graphic Tag --><IMG WIDTH=539 HEIGHT=28 BORDER=0 ALT="Till KFB huvudsida" SRC="interpic/kfbhead.gif"></A><TABLE WIDTH=542 BORDER=0 ><TR><TD WIDTH=90 BORDER=0 valign=top align=left ><BR><H5>SAMORDNING OCH  INTERNATIONELLA FR&Aring;GOR<BR><BR></H5><!-- Link Tag --><A HREF="kontakt.html">Skapa kontakter</A><BR><BR><!-- Link Tag --><A HREF="utveckla.html">Utveckla</A><BR><BR><!-- Link Tag --><A HREF="samordna.html">Samordna</A><BR><BR><!-- Link Tag --><A HREF="stimulera.html">Stimulera</A><BR><BR><BR><!-- Graphic Tag --><IMG WIDTH=89 HEIGHT=82  SRC="interpic/cordis2smallet.gif"><!-- Link Tag --><A HREF="http://cordis.lu/transport/home.html">Information om research tasks<BR></A></TD><TD WIDTH=50 BORDER=0 align=center></TD><TD WIDTH=350 BORDER=0 align=left valign=top><BR><H2><!-- Font Tag --><FONT COLOR="#BA8702">KFB hanterar EU-projekt vid tre tillf&auml;llen:</FONT></H2> <B>Utvecklingsskedet</B> - projekten f&ouml;rbereds och bemannas (konsortie bildas).<BR><BR><B>F&ouml;rhandlingsskedet</B> - projekten utformas definitivt, Tekniska Annex tas fram och genom f&ouml;rhandling med kommissionen beslutar man om kontrakt.<BR><BR><B>Kompletteringsfinansieringsskedet</B> - nationell kompletteringsfinansiering klaras ut.<BR><BR><!-- Graphic Tag --><IMG WIDTH=340 HEIGHT=225 ALT="De tre bidragsformerna" SRC="interpic/kedja.gif"><H4><!-- Font Tag --><FONT COLOR="#BA8702"><!-- Anchor Point Tag --><A NAME="UTVECKLINGSBIDRAG">UTVECKLINGSBIDRAG</A></FONT></H4><B>Syfte</B><BR>Att stimulera svenska forskare att delta i bra EU-projekt inom transportprogrammet. <BR><BR><B>Finansiering</B><BR>Bidraget &auml;r h&ouml;gst 25 000 kronor. Den som &auml;r samordnare inom konsortiet kan eventuellt f&aring; h&ouml;gre bidrag. </P><B>Ans&ouml;kan</B><BR>Ans&ouml;kan (1-2 A4-sidor) ska redovisa projektid&eacute;n och till vilken fr&aring;gest&auml;llning (research task) den &auml;r knuten. H&auml;r ska ocks&aring; framg&aring; vilken vana du som s&ouml;kande har av forskningsomr&aring;det i fr&aring;ga och av internationell forskning &ouml;ver huvud taget. Du ska ocks&aring; ange till vad bidraget ska anv&auml;ndas (resor, arbetskostnader etcetera) samt kostnader f&ouml;r detta.<BR>Posta ans&ouml;kan till KFB, Box 5706, 114 87 Stockholm.</P><B>Beslut</B><BR>Besluts-PM skrivs och beslut tas av KFB:s enhetschef.</P><B>Kontrakt</B><BR>Beslutsbrev utformas.</P><B>Utbetalning </B><BR>Bidraget utbetalas efter rekvisition d&aring; ans&ouml;kningsomg&aring;ngen &auml;r slut. I rekvisitionen ska de kostnader man haft redovisas. Kopia p&aring; ans&ouml;kan bifogas. Om ans&ouml;kan inte har l&auml;mnats till EU ska detta motiveras.  </P><BR><BR><H4><!-- Font Tag --><FONT COLOR="#BA8702"><!-- Anchor Point Tag --><A NAME="F&Ouml;RHANDLINGSBIDRAG">F&Ouml;RHANDLINGSBIDRAG</A></FONT></H4><B>Syfte</B><BR>Att &ouml;ka sannolikheten f&ouml;r att svenska forskare f&aring;r l&auml;mpliga arbetsuppgifter till sk&auml;lig ers&auml;ttning.Det &auml;r i det h&auml;r skedet som KFB ocks&aring; tar st&auml;llning till om KFB kommer att kunna st&auml;lla upp som kompletteringsfinansi&auml;r.</P><B>Finansiering</B><BR>Projektet har nu godk&auml;nts f&ouml;r att f&aring; delfinansiering fr&aring;n EU-budgeten. Konsortiet ska, genom interna f&ouml;rhandlingar, komma fram till hur projektet ska genomf&ouml;ras, vem som g&ouml;r vad och till vilken ers&auml;ttning. Bidraget uppg&aring;r till h&ouml;gst 25 000 kronor f&ouml;r den som ing&aring;r som partner i konsortiet. Koordinator kan f&aring; h&ouml;gst 100 000 kronor.  </P><B>Ans&ouml;kan</B><BR><NOBR></NOBR>Ans&ouml;kan (1-2 A4-sidor) ska klarg&ouml;ra vad medlen ska anv&auml;ndas till. N&auml;r det g&auml;ller beg&auml;ran om kompletteringsfinansiering beh&ouml;vs en detaljerad beskrivning av projektet s&aring; att KFB kan bed&ouml;ma om det ska prioriteras i den fortsatta hanteringen. H&auml;r kan den ans&ouml;kan som l&auml;mnats in till kommissionen anv&auml;ndas. Det beh&ouml;vs ocks&aring; en uppskattning av hur stort belopp som kan kr&auml;vas f&ouml;r kompletteringen. <BR>Posta ans&ouml;kan till KFB, Box 5706, 114 87 Stockholm.</P><B>Beslut</B><BR>Besluts-PM skrivs och beslut tas av generaldirekt&ouml;ren. Beslutet anger hur stort bidrag som har beviljats och klarg&ouml;r ocks&aring; om KFB &auml;r beredd att st&ouml;dja projektet fram&ouml;ver.</P><B>Kontrakt</B><BR>Beslutsbrev utformas.</P><B>Utbetalning</B><BR>Bidraget utbetalas efter rekvisition d&aring; kontraktsf&ouml;rhandlingen &auml;r avslutad. I rekvisitionen redovisas de kostnader som man haft.       </P><BR><BR><!-- Font Tag --><FONT COLOR="#BA8702"><H4><!-- Anchor Point Tag --><A NAME="KOMPLETTERINGSFINANSIERING">KOMPLETTERINGSFINANSIERING</A></H4></FONT><B>Syfte</B><BR>Att g&ouml;ra det m&ouml;jligt f&ouml;r den svenska forskaren att genomf&ouml;ra projektet.</P><B>Finansiering</B><BR>I de flesta fall har KFB redan klargjort om man kommer att l&auml;mna kompletteringsbidrag eller inte. H&auml;lften av det totala finansieringsbidraget betalas av EU. Den andra halvan st&aring;r KFB f&ouml;r genom kompletteringsbidraget. I detta skede s&ouml;ker KFB aktivt efter samfinansi&auml;rer som t ex V&auml;gverket och Nutek. </P><B>   Ans&ouml;kan</B><BR>Ans&ouml;kan g&ouml;rs p&aring; KFB:s ordinarie <!-- Link Tag --><A HREF="../forskbidrag.html">ans&ouml;kningsblankett</A>. Detta oberoende av om man gjort en framst&auml;llning i samband med ans&ouml;kan om f&ouml;rhandlingsbidrag. </P><B>Beslut</B><BR>Besluts-PM skrivs och beslut tas av generaldirekt&ouml;ren. I beslutet framg&aring;r vilka motprestationer KFB f&ouml;rv&auml;ntar sig t ex vad g&auml;ller informationsspridning.Kontrakt utarbetas.</P><B>Kontrakt</B><BR>I kontraktet l&auml;ggs stor vikt vid betalningsplanen. Den b&ouml;r vara samordnad med kommissionens betalningsplan. Detta f&ouml;r att undvika ekonomiska problem f&ouml;r de svenska deltagarna och f&ouml;r att underl&auml;tta KFB:s uppf&ouml;ljning av projektet. H&auml;r fastst&auml;lls ocks&aring; de krav som KFB har p&aring; inl&auml;mnande av rapporter (progress-, midterm- och final assessment report) samt hanteringen av resultat, rapporter och informationsspridning.</P><B>Utbetalning</B><BR>Utbetalningarna f&ouml;ljer den plan som gjorts upp i kontraktet. Generellt g&auml;ller att KFB betalar ut efter rekvisition. Det g&ouml;rs ingen f&ouml;rskottsbetalning. KFB:s betalning &auml;r prelimin&auml;r tills kommissionen har godk&auml;nt inl&auml;mnade rapporter och kostnadsredovisningar. Om projekten inte godk&auml;nns kan pengarna &aring;terkr&auml;vas.</P><HR SIZE=2>Ansvarig f&ouml;r  INTERNATIONELLA FR&Aring;GOR  &auml;r  <!-- MailTo Tag --><A HREF="MAILTO:hans.mohlin@kfb.se"><!-- Font Tag --><FONT COLOR="#0000FF">Hans Mohlin.</FONT></A><BR>Ansvarig f&ouml;r SAMORDNINGSSEKRETERIATET &auml;r <!-- MailTo Tag --><A HREF="MAILTO:yngve.boye@kfb.se"><!-- Font Tag --><FONT COLOR="#0000FF">Yngve Boye</FONT></A>.<BR><BR><!-- Anchor Link Tag --><A HREF="#Upp!"><!-- Font Tag --><FONT COLOR="#0000FF">Upp!</FONT></A>                           </TD></TR></TABLE></BODY></HTML>
</DOC>
<DOC>
<DOCNO>WT02-B10-67</DOCNO>
<DOCOLDNO>IA018-000200-B015-13</DOCOLDNO>
<DOCHDR>
http://www.kfb.se:80/vtifrom9707.html 194.198.183.242 19970106205109 text/html 17067
HTTP/1.0 200 OK
Date: Mon, 06 Jan 1997 20:46:14 GMT
Server: Microsoft-Internet-Information-Server/1.0
Content-Type: text/html
Last-Modified: Thu, 05 Dec 1996 09:14:00 GMT
Content-Length: 16866
</DOCHDR>
<HTML><HEAD><TITLE>Konferensregistret</TITLE></HEAD><BODY TEXT="#3d3d3d" BGCOLOR="#ffffff" LINK="#e12b1e" ALINK="#e7e318" VLINK="#0e7112"><TABLE WIDTH=456 BORDER=0 ><TR><TD WIDTH=1 BORDER=0 align=left></TD><TD WIDTH=455 BORDER=0 align=left> <H6>[<A HREF="kfbnews.html">Back</A>] </H6><!-- Link Tag --><A HREF="kfbnews.html"><!-- Graphic Tag --><IMG WIDTH=458 HEIGHT=28 BORDER=0  SRC="head1smal.gif"></A><!-- Font Tag --><FONT COLOR="#BF361C"><H2><P><!-- Anchor Point Tag --><A NAME="Up!">Nedan finner du aktuella konferenser inom transportomr&aring;det fr.o.m. 1997-07</A></P></H2></FONT><BR> Datum: 1997-07--<BR> Ort: Chicago, Illinois, USA<BR> Titel: <FONT COLOR="#BF361C"><B> Traffic Congestion and Traffic Safety in the 21st<BR>Century<BR> </B></FONT> Arrang&ouml;r: Urban Transportation Divison m fl<BR> Adress: Conference &amp; Convention Department, ASCE, 345 East<BR>47th Street, New York, NY 10017, USA.  Tfn705-7285, fax 212-705-7975<BR> K&auml;lla: Call for papers (abstr senast1996-04-26)<BR><BR><!-- Horizontal Line Tag --><HR WIDTH=100% SIZE=1><BR><BR> Datum: 1997-07-08--1997-07-11<BR> Ort: Saratoga Springs, New York, USA<BR> Titel: <!-- Font Tag --><FONT COLOR="#BF361C"><B> How industry will procure energy efficiency<BR>services in the 21st century. 1997 summer study on<BR>energy efficiency in industry<BR> </B></FONT> Arrang&ouml;r: American Council for an Energy-Efficient Economy<BR> Adress: Debbie Giallombardo, ACEEE Conference Office, 1001<BR>Conn.  Ave., N.W., Suite 801, Washington, D.C.<BR>20036, USA.  Tfn (202)429-8873, fax (202)429-2248<BR> K&auml;lla: Call for papers<BR><BR><!-- Horizontal Line Tag --><HR WIDTH=100% SIZE=1><BR><BR> Datum: 1997-07-08--1997-07-11<BR> Ort: Sacramento, Kalifornien, USA<BR> Titel: <!-- Font Tag --><FONT COLOR="#BF361C"><B> Meeting the challenge, research and practice, 2nd<BR>national seismic conference of bridges and<BR>highways<BR> </B></FONT> Arrang&ouml;r: Federal Highway Administration and the California<BR>Department of Transportation<BR> Adress: Barbara Murdock, Henderson Associates, 1000<BR>Vermont Avenue NW, 6th floor, Washington, D.C.<BR>20005, USA.  Tfn 202-682-3739, fax 202-682-2535<BR> K&auml;lla: Call for abstracts (abstr senast 96-11-01)<BR><BR><!-- Horizontal Line Tag --><HR WIDTH=100% SIZE=1><BR><BR> Datum: 1997-07-20--1997-07-26<BR> Ort: Boston, Massachusetts, USA<BR> Titel: <!-- Font Tag --><FONT COLOR="#BF361C"><B> Coastal zone 97.  Charting the future of coastal<BR>zone management<BR> </B></FONT> Arrang&ouml;r: Urban Harbours Institute<BR> Adress: Gary Magnuson, NOAA, National Ocean Service, 1305<BR>East-West Highway N/EA, Silver Spring, MD 20910,<BR>USA.  Fax (301)713-4263<BR> K&auml;lla: Call for papers<BR><BR><!-- Horizontal Line Tag --><HR WIDTH=100% SIZE=1><BR><BR> Datum: 1997-07-21--1997-07-23<BR> Ort: Portland, Oregon, USA<BR> Titel: <!-- Font Tag --><FONT COLOR="#BF361C"><B> Intersections without traffic signal, 3rd<BR>international symposium<BR> </B></FONT> Arrang&ouml;r: NCATT<BR> Adress: National Center for Advanced Transportation<BR>Technology (NCATT), University of Idaho, Moscow,<BR>Idaho 83844-1026, USA.  Tfn 208-885-6002, fax 885-6608<BR> K&auml;lla: Call for papers (abstr senast 1996-05-01)<BR><BR><!-- Horizontal Line Tag --><HR WIDTH=100% SIZE=1><BR><BR> Datum: 1997-08-10--1997-08-14<BR> Ort: Seattle, USA<BR> Titel: <!-- Font Tag --><FONT COLOR="#BF361C"><B> Asphalt pavements, 8th international conference<BR> </B></FONT> Arrang&ouml;r: International Society for Asphalt Pavements<BR> Adress: 8th International Conference on Asphalt Pavements,<BR>UW Engineering Professional Programs, 3201 Fremont<BR>Avenue North, Seattle, WA 98103, USA<BR> K&auml;lla: Call for papers (abstr senast 95-10-31)<BR><BR><!-- Horizontal Line Tag --><HR WIDTH=100% SIZE=1><BR><BR> Datum: 1997-08-17--1997-08-22<BR> Ort: Sydney, Australien<BR> Titel: <!-- Font Tag --><FONT COLOR="#BF361C"><B> Durability of concrete. 4th CANMET/ACI<BR>international conference<BR> </B></FONT> Arrang&ouml;r: CANMET, American Concrete Institute, etc.<BR> Adress: K&auml;lla:    Vejdirektoratets lista okt -95<BR><BR><!-- Horizontal Line Tag --><HR WIDTH=100% SIZE=1><BR><BR> Datum: 1997-08-25--1997-08-27<BR> Ort: Singapore<BR> Titel: <!-- Font Tag --><FONT COLOR="#BF361C"><B> Our world in concrete &amp; structures<BR> </B></FONT> Arrang&ouml;r: CI-PREMIER Conference Organisation<BR> Adress: CI-Premier Pte Ltd, 150 Orchard Road #07-14,<BR>Orchard Plaza, Singapore 238841, Republic of<BR>Singapore.  Tfn 065-733-2922, fax 065-235-3530<BR> K&auml;lla: CI Conference Announcement<BR><BR><!-- Horizontal Line Tag --><HR WIDTH=100% SIZE=1><BR><BR> Datum: 1997-08-28--1997-08-29<BR> Ort: Singapore<BR> Titel: <!-- Font Tag --><FONT COLOR="#BF361C"><B> Fibre reinforced concrete<BR> </B></FONT> Arrang&ouml;r: CI-PREMIER Conference Organisation<BR> Adress: CI-Premier Pte Ltd, 150 Orchard Road #07-14,<BR>Orchard Plaza, Singapore 238841, Republic of<BR>Singapore.  Tfn 065-733-2922, fax 065-235-3530<BR> K&auml;lla: CI Conference Announcement<BR><BR><!-- Horizontal Line Tag --><HR WIDTH=100% SIZE=1><BR><BR> Datum: 1997-09-03--1997-09-04<BR> Ort: Ronneby<BR> Titel: <!-- Font Tag --><FONT COLOR="#BF361C"><B> Persontrafikdagar<BR> </B></FONT> Arrang&ouml;r: Svenska Lokaltrafikf&ouml;reningen<BR> Adress: Svenska Lokaltrafikf&ouml;reningen, tfn 08-788 08 60,<BR>fax 08- 788 08 78<BR> K&auml;lla: Telefonsamtal<BR><BR><!-- Horizontal Line Tag --><HR WIDTH=100% SIZE=1><BR><BR> Datum: 1997-09-06--1997-09-12<BR> Ort: Hamburg<BR> Titel: <!-- Font Tag --><FONT COLOR="#BF361C"><B> Soil mechanics and foundation engineering, 14th<BR>international conference<BR> </B></FONT> Arrang&ouml;r: ISSMFE<BR> Adress: K&auml;lla:    SGI:s konferenslista<BR><BR><!-- Horizontal Line Tag --><HR WIDTH=100% SIZE=1><BR><BR> Datum: 1997-09-15--1997-09-19<BR> Ort: Barcelona, Spanien<BR> Titel: <!-- Font Tag --><FONT COLOR="#BF361C"><B> Bicycle planning conference, 10th international<BR> </B></FONT> Arrang&ouml;r: Ajuntament de Barcelona, European Cyclists'<BR>Federation, etc.<BR> Adress: Congreso VeloCity '97, Ajuntament de Barcelona,<BR>&Agrave;mbit de la Via P&uacute;blica, Pl.  Pi i Sunyer, 8-10,<BR>4t, E-08002, Barcelona, Spanien.  Tfn +34 3 402 34<BR>81, fax +34 3 402 34 18<BR> K&auml;lla: Preliminary information<BR><BR><!-- Horizontal Line Tag --><HR WIDTH=100% SIZE=1><BR><BR> Datum: 1997-09-16--1997-09-18<BR> Ort: Innsbruck, &Ouml;sterrike<BR> Titel: <!-- Font Tag --><FONT COLOR="#BF361C"><B> Composite construction - Conventional and<BR>innovative<BR> </B></FONT> Arrang&ouml;r: IABSE<BR> Adress: Composite Construction, c/o IABSE, ETH<BR>H&ouml;nggerberg, CH-8093 Z&uuml;rich, Schweiz<BR> K&auml;lla: Call for papers (abstr senast 96-05-15)<BR><BR><!-- Horizontal Line Tag --><HR WIDTH=100% SIZE=1><BR><BR> Datum: 1997-09-21--1997-09-25<BR> Ort: Annecy, Frankrike<BR> Titel: <!-- Font Tag --><FONT COLOR="#BF361C"><B> Alcohol, drugs and traffic safety, T'97<BR> </B></FONT> Arrang&ouml;r: CERMT<BR> Adress: CERMT, BP 132, 74004 Annecy Cedex, Frankrike.  Fax<BR>+33 50 45 36 92<BR> K&auml;lla: Lista fr&aring;n Bj&ouml;rn Peters<BR><BR><!-- Horizontal Line Tag --><HR WIDTH=100% SIZE=1><BR><BR> Datum: 1997-09-23--1997-09-26<BR> Ort: Bordeaux, Frankrike<BR> Titel: <!-- Font Tag --><FONT COLOR="#BF361C"><B> Industrial applications of emulsion<BR> </B></FONT> Arrang&ouml;r: COLAS S.A. m fl<BR> Adress: CME, 50 place Marcel-Pagnol, 92100<BR>Boulogne-Billancourt, Frankrike.  Tfn (33-1)47 61<BR>76 89, fax (33-1)47 61 74 65<BR> K&auml;lla: Broschyr<BR><BR><!-- Horizontal Line Tag --><HR WIDTH=100% SIZE=1><BR><BR> Datum: 1997-10-06--1997-10-10<BR> Ort: Marrakech, Marocko<BR> Titel: <!-- Font Tag --><FONT COLOR="#BF361C"><B> Rail mode: from economic necessity to financial<BR>return, World congress<BR> </B></FONT> Arrang&ouml;r: International Union of Railways<BR> Adress: International Union of Railways, tfn 33 1 44 49 20 51, <BR>fax 33 1 44 49 20 59<BR> K&auml;lla: Press release<BR><BR><!-- Horizontal Line Tag --><HR WIDTH=100% SIZE=1><BR><BR> Datum: 1997-10-08--1997-10-10<BR> Ort: Venedig, Italien<BR> Titel: <!-- Font Tag --><FONT COLOR="#BF361C"><B> Superplasticizers and other chemical admixtures in<BR>concrete, 5th CANMET/ACI international conference<BR> </B></FONT> Arrang&ouml;r: CANMET<BR> Adress: V.M.  Malhotra, CANMET, 405 Rochester Street,<BR>Ottawa, ON, Kanada K1A 0G1.  Fax (613)992-9389<BR> K&auml;lla: Call for papers reminder<BR><BR><!-- Horizontal Line Tag --><HR WIDTH=100% SIZE=1><BR><BR> Datum: 1997-10-08--1997-10-10<BR> Ort: Arles en Provence, Frankrike<BR> Titel: <!-- Font Tag --><FONT COLOR="#BF361C"><B> Urban areas and an ageing population.  Urban<BR>planning and the elderly<BR> </B></FONT> Arrang&ouml;r: INRETS<BR> Adress: Ms Mich&egrave;le Bidal, INRETS - Centre Marseille -<BR>Salon de Provence, MA - D&eacute;partement M&eacute;canismes<BR>d'Accidents, Chemin de la Croix Blanche, F 13300<BR>Salon de Provence, Frankrike.  Fax (33) 90 56 25 51, fr&aring;n 961018 <BR>fax (33)04 90 56 25 51<BR> K&auml;lla: Call for papers<BR><BR><!-- Horizontal Line Tag --><HR WIDTH=100% SIZE=1><BR><BR> Datum: 1997-10-13--1997-10-16<BR> Ort: Queensland, Australien<BR> Titel: <!-- Font Tag --><FONT COLOR="#BF361C"><B> Accident investigation, reconstruction,<BR>interpretation and the law, 2nd international<BR>conference, AIRIL '97<BR> </B></FONT> Arrang&ouml;r: Texas A&amp;M University, University of British<BR>Columbia, etc.<BR> Adress: AIRIL 97 Secretariat, School of Civil Engineering,<BR>QUT, GPO Box 2434, Brisbane, Qld.  Australien<BR>Tfn +61 7 38 64 25 44, fax +61 7 38 64 15 15<BR> K&auml;lla: Announcement<BR><BR><!-- Horizontal Line Tag --><HR WIDTH=100% SIZE=1><BR><BR> Datum: 1997-10-21--1997-10-24<BR> Ort: Berlin, Tyskland<BR> Titel: <!-- Font Tag --><FONT COLOR="#BF361C"><B> ERTICO/ITS America/VERTIS 4th world congress on<BR>intelligent transport systems<BR> </B></FONT> Arrang&ouml;r: Adress:<BR> K&auml;lla: Lista fr&aring;n Bj&ouml;rn Peters<BR><BR><!-- Horizontal Line Tag --><HR WIDTH=100% SIZE=1><BR><BR> Datum: 1997-11-09--1997-11-12<BR> Ort: Boston, MA, USA<BR> Titel: <!-- Font Tag --><FONT COLOR="#BF361C"><B> Intelligent transportation systems, ITSC '97<BR> </B></FONT> Arrang&ouml;r: Institute of Electrical and Electronics Engineers,<BR>IEEE<BR> Adress: IEEE Boston Section, 255 Bear Hill Road, Waltham,<BR>MA 02154, USA.  Tfn 617-890-5290, fax 617-890-5294<BR> K&auml;lla: Call for papers<BR><BR><!-- Horizontal Line Tag --><HR WIDTH=100% SIZE=1><BR><BR> Datum: 1997-11-10--1997-11-14<BR> Ort: Singapore<BR> Titel: <!-- Font Tag --><FONT COLOR="#BF361C"><B> Shell and spatial structures: design,<BR>construction, performance and economics.<BR>International symposium -97<BR> </B></FONT> Arrang&ouml;r: International Association for Shell and Spatial<BR>Structures<BR> Adress: John S.Y.  Tan, IASS 97, Conference Logistics and<BR>Services, 150 Orchard Road #07-14, Orchard Plaza,<BR>Singapore 238841.  Tfn (065)733-2922, <BR>fax (065)235-3530<BR> K&auml;lla: Call for papers<BR><BR><!-- Horizontal Line Tag --><HR WIDTH=100% SIZE=1><BR><BR> Datum: 1997-11-11--1997-11-13<BR> Ort: London, Storbritannien<BR> Titel: <!-- Font Tag --><FONT COLOR="#BF361C"><B> Railtex 97<BR> </B></FONT> Arrang&ouml;r: Mack Brooks Exhibitions Ltd<BR> Adress: Judy Aspden, Mack Brooks Exhibitions Ltd, Forum<BR>Place, Hatfield, Hertfordshire, AL10 0RN,<BR>Storbritannien.  Tfn +44 1707 275 641, fax +44<BR>1707 275 544<BR> K&auml;lla: Infoblad<BR><BR><!-- Horizontal Line Tag --><HR WIDTH=100% SIZE=1><BR><BR> Datum: 1997-11-16--1997-11-19<BR> Ort: Florens, Italien<BR> Titel: <!-- Font Tag --><FONT COLOR="#BF361C"><B> Role of rail research in reducing costs and<BR>enhancing competitiveness, World rail research<BR>congress WCRR97<BR> </B></FONT> Arrang&ouml;r: International Union of Railways<BR> Adress: International Union of Railways, <BR>tfn 33 1 44 49 20 51, fax 33 1 44 49 20 59<BR> K&auml;lla: Press release<BR><BR><!-- Horizontal Line Tag --><HR WIDTH=100% SIZE=1><BR><BR> Datum: 1998-02-25--1998-03-01<BR> Ort: Melbourne, Australien<BR> Titel: <!-- Font Tag --><FONT COLOR="#BF361C"><B> Safety in action<BR> </B></FONT> Arrang&ouml;r: Safety Institute of Australia, etc.<BR> Adress: Safety in Action, Suite 17, 51 55 City Road,<BR>Southband, Victoria 3006, Australien<BR> K&auml;lla: First announcement<BR><BR><!-- Horizontal Line Tag --><HR WIDTH=100% SIZE=1><BR><BR> Datum: 1998-03-16--1986-03-20<BR> Ort: Lule&aring;<BR> Titel: <!-- Font Tag --><FONT COLOR="#BF361C"><B> PIARC 98, Winter road congress, 10th international<BR> </B></FONT> Arrang&ouml;r: PIARC<BR> Adress: Xth PIARC International Winter Road Congress, PO<BR>Box 809, 971 25 Lule&aring;.  Tfn 0920 433 00, <BR>fax 0920 433 05<BR> K&auml;lla: Broschyr<BR><BR><!-- Horizontal Line Tag --><HR WIDTH=100% SIZE=1><BR><BR> Datum: 1998-05-17--1998-05-21<BR> Ort: Durban, Sydafrika<BR> Titel: <!-- Font Tag --><FONT COLOR="#BF361C"><B> Managing pavements, 4th international conference<BR> </B></FONT> Arrang&ouml;r: Transportation Research Board, etc.<BR> Adress: Fourth International Conference on Managing<BR>Pavements, Conference Secretariat, P O Box 82,<BR>IRENE, 1675 Sydafrika.  Tfn +27-12-63 1681, <BR>fax +27-12-63 1680<BR> K&auml;lla: Call for papers (abstr senast 1996-09-30)<BR><BR><!-- Horizontal Line Tag --><HR WIDTH=100% SIZE=1><BR><BR> Datum: 1998-05-17--1998-05-20<BR> Ort: Amsterdam, Nederl&auml;nderna<BR> Titel: <!-- Font Tag --><FONT COLOR="#BF361C"><B> Injury prevention and control, 4th World<BR>conference<BR> </B></FONT> Arrang&ouml;r: World Health Organization and its Collaborating<BR>Centres for Safety Promotion and Injury Control<BR> Adress: Conference Secretariat 'Injury prevention and<BR>control', P.O.  Box 1558, 6501 BN Nijmegen,<BR>Nederl&auml;nderna.  Tfn +31 24 323 44 71, <BR>fax +31 24 360 11 59<BR> K&auml;lla: Broschyr<BR><BR><!-- Horizontal Line Tag --><HR WIDTH=100% SIZE=1><BR><BR> Datum: 1998-05-31--1998-06-05<BR> Ort: Bangkok, Thailand<BR> Titel: <!-- Font Tag --><FONT COLOR="#BF361C"><B> Fly ash, silica fume, slag and natural pozzolans<BR>in concrete, 6th CANMET/ACI international<BR>conference<BR> </B></FONT> Arrang&ouml;r: CANMET/ACI<BR> Adress: V.M.  Malhotra, CANMET, 405 Rochester Street,<BR>Ottawa, ON, Kanada K1A 0G1.  Fax 613-992-9389<BR> K&auml;lla: Call for papers<BR><BR><!-- Horizontal Line Tag --><HR WIDTH=100% SIZE=1><BR><BR> Datum: 1998-06-07--1998-06-11<BR> Ort: Tokushima, Japan<BR> Titel: <!-- Font Tag --><FONT COLOR="#BF361C"><B> Recent advances in concrete technology,<BR>CANMET/ACI/JCI 4th international conference<BR> </B></FONT> Arrang&ouml;r: CANMET/ACI/JCI<BR> Adress: V.M.  Malhotra, CANMET, 405 Rochester Street,<BR>Ottowa, ON, Kanada K1A 0G1.  Fax 613-992-9389<BR> K&auml;lla: Call for papers<BR><BR><!-- Horizontal Line Tag --><HR WIDTH=100% SIZE=1><BR><BR> Datum: 1998-07-18--1998-07-23<BR> Ort: San Francisco, CA, USA<BR> Titel: <!-- Font Tag --><FONT COLOR="#BF361C"><B> <!-- Font Tag --><FONT COLOR="#BF361C"><B>Structural engineers world congress, SEWC<BR></B></FONT> </B></FONT> Arrang&ouml;r: American Society of Civil Engineers<BR> Adress: SEWC, Conference Manager, American Society of<BR>Civil Engineers, 345 East 47th Street, New York,<BR>NY 10017, USA<BR> K&auml;lla: Call for papers<BR><BR><!-- Horizontal Line Tag --><HR WIDTH=100% SIZE=1><BR><BR> Datum: 1998-09-12--1998-09-17<BR> Ort: Lissabon, Portugal<BR> Titel: <!-- Font Tag --><FONT COLOR="#BF361C"><B> <!-- Font Tag --><FONT COLOR="#BF361C"><B> Concrete roads, 8th international symposium </B></FONT><BR> Arrang&ouml;r: CEMBUREAU<BR> Adress: K&auml;lla:    Vejdirektorates lista nov -95<BR><!-- Horizontal Line Tag --><HR WIDTH=100% SIZE=1><BR><!-- Horizontal Line Tag --><HR WIDTH=100% SIZE=1><BR> Datum: 1998-09-21--1998-09-25<BR> Ort: Qingdao, Kina<BR> Titel: <!-- Font Tag --><FONT COLOR="#BF361C"><B> <!-- Font Tag --><FONT COLOR="#BF361C"><B> Safety and high efficiency, running into 21st<BR>century. 12th wheelset congress<BR> </B></FONT> Arrang&ouml;r: China Railway Society<BR> Adress: Ms Chen Yun-eh, China Railway Society, 10, Fuxing<BR>road, Beijing, Kina 100844.  Tfn 086 10 63242621,<BR>fax 086 10 63967184<BR> K&auml;lla: Call for papers<BR><BR><!-- Horizontal Line Tag --><HR WIDTH=100% SIZE=1><BR><!-- Anchor Link Tag --><A HREF="#Up!">Up!</A></td></tr></TABLE></BODY></HTML>
</DOC>
<DOC>
<DOCNO>WT02-B10-68</DOCNO>
<DOCOLDNO>IA018-000200-B015-24</DOCOLDNO>
<DOCHDR>
http://www.kfb.se:80/ehvproge/gborg.html 194.198.183.242 19970106205118 text/html 3551
HTTP/1.0 200 OK
Date: Mon, 06 Jan 1997 20:46:29 GMT
Server: Microsoft-Internet-Information-Server/1.0
Content-Type: text/html
Last-Modified: Thu, 10 Oct 1996 08:41:46 GMT
Content-Length: 3351
</DOCHDR>
<HTML><!---------------------------------------------------------------><!-      AUTHOR:       mats holm                           ><!-      E-MAIL:            mats@softmachine.se                  ><!-      CREATED:     1996.09.26                       ><!-      MODIFIED:                       ><!-- Anchor Point Tag --><A NAME="Up!"><!-      FILE: projects.html></A>             <!---------------------------------------------------------------><!-- Head Tag --><HEAD><TITLE>KFB-Swedish Research and Communications Board</TITLE></HEAD><!-- Head Tag --><HEAD><TITLE>KFB-Swedish Research and Communications Board</TITLE></HEAD><!-- Body Tag --><BODY TEXT="#4C4C4C" BACKGROUND="ehvpic/yel_bgr.gif"></BODY><!-- Link Tag --><A HREF="index.html"><!-- Graphic Tag --><IMG WIDTH=534 HEIGHT=28 BORDER=0  SRC="ehvpic/kfbhead.gif"></A><TABLE WIDTH=535 BORDER=0 ><TR><TD WIDTH=130 BORDER=0 valign=top><!-- Link Tag --><A HREF="program.html"><!-- Graphic Tag --><IMG WIDTH=108 HEIGHT=36 BORDER=0  SRC="ehvpic/kna_pro.gif"></A><!-- Link Tag --><A HREF="projects.html"><!-- Graphic Tag --><IMG WIDTH=108 HEIGHT=35 BORDER=0  SRC="ehvpic/kna_proj.gif"></A><!-- Link Tag --><A HREF="hood.html"><!-- Graphic Tag --><IMG WIDTH=108 HEIGHT=36 BORDER=0  SRC="ehvpic/kna_hood.gif"></A><!-- Link Tag --><A HREF="infra.html"><!-- Graphic Tag --><IMG WIDTH=108 HEIGHT=17 BORDER=0  SRC="ehvpic/kna_infra.gif"></A><!-- Link Tag --><A HREF="energy.html"><!-- Graphic Tag --><IMG WIDTH=108 HEIGHT=18 BORDER=0  SRC="ehvpic/kna_energ.gif"></A><!-- Link Tag --><A HREF="economic.html"><!-- Graphic Tag --><IMG WIDTH=108 HEIGHT=17 BORDER=0  SRC="ehvpic/kna_eco.gif"></A><!-- Link Tag --><A HREF="perform.html"><!-- Graphic Tag --><IMG WIDTH=108 HEIGHT=17 BORDER=0  SRC="ehvpic/kna_perfa.gif"></A><!-- Link Tag --><A HREF="market.html"><!-- Graphic Tag --><IMG WIDTH=108 HEIGHT=18 BORDER=0  SRC="ehvpic/kna_mark.gif"></A></TD><TD WIDTH=15 BORDER=0 align=center></TD><TD WIDTH=300 BORDER=0 align=left valign=top><BR><!-- Graphic Tag --><IMG WIDTH=283 HEIGHT=189  SRC="ehvpic/gborgbil.gif"><BR><H3>G&ouml;teborg</H3><P>G&ouml;teborg has since long included EVs in the city agenda. Already in September 1991, an introduction programme for EVs in G&ouml;teborg, initiated by local politicians and elaborated by community officials, was approved by the G&ouml;teborg Municipal Council. The first target of this programme was 1000 electric cars in the G&ouml;teborg area by the mid 1990s, provided that acceptable external financing were obtained. Due to a number of factors, the time schedule has been revised, leaving goals unaltered except with respect to delay.</P><P>&#148Electric Vehicles in G&ouml;teborg&#148; is managed in co-operation between The City of G&ouml;teborg, G&ouml;teborg Energi, Vattenfall, Volvo and KFB. Demonstrations will encompass over 50 passenger and light distribution vehicles in 1997. </P><P>&#148Electric Vehicles in G&ouml;teborg&#148 is one of the two principal projects of the KFB program.</P>See<!-- Link Tag --><A HREF="http://www.iea.lth.se/~niklas/work/evdatabase/carsproj.html#Express-G1"> listing</A> of the G&ouml;teborg vehicles.<BR><!-- Horizontal Line Tag --><HR WIDTH=100%><!-- Anchor Link Tag --><A HREF="#Up!"><H6>Up!</H6></A><BR>   </TD></TR></TABLE></BODY></HTML>
</DOC>
<DOC>
<DOCNO>WT02-B10-69</DOCNO>
<DOCOLDNO>IA018-000200-B015-34</DOCOLDNO>
<DOCHDR>
http://www.kfb.se:80/ehvproge/malmoe.html 194.198.183.242 19970106205129 text/html 3032
HTTP/1.0 200 OK
Date: Mon, 06 Jan 1997 20:46:39 GMT
Server: Microsoft-Internet-Information-Server/1.0
Content-Type: text/html
Last-Modified: Thu, 10 Oct 1996 08:42:04 GMT
Content-Length: 2832
</DOCHDR>
<HTML><!---------------------------------------------------------------><!-      AUTHOR:       mats holm                           ><!-      E-MAIL:            mats@softmachine.se                  ><!-      CREATED:     1996.09.26                       ><!-      MODIFIED:                       ><!-- Anchor Point Tag --><A NAME="Up!"><!-      FILE: projects.html></A>             <!---------------------------------------------------------------><!-- Head Tag --><HEAD><TITLE>KFB-Swedish Research and Communications Board</TITLE></HEAD><!-- Head Tag --><HEAD><TITLE>KFB-Swedish Research and Communications Board</TITLE></HEAD><!-- Body Tag --><BODY TEXT="#4C4C4C" BACKGROUND="ehvpic/yel_bgr.gif"></BODY><!-- Link Tag --><A HREF="index.html"><!-- Graphic Tag --><IMG WIDTH=534 HEIGHT=28 BORDER=0  SRC="ehvpic/kfbhead.gif"></A><TABLE WIDTH=535 BORDER=0 ><TR><TD WIDTH=130 BORDER=0 valign=top><!-- Link Tag --><A HREF="program.html"><!-- Graphic Tag --><IMG WIDTH=108 HEIGHT=36 BORDER=0  SRC="ehvpic/kna_pro.gif"></A><!-- Link Tag --><A HREF="projects.html"><!-- Graphic Tag --><IMG WIDTH=108 HEIGHT=35 BORDER=0  SRC="ehvpic/kna_proj.gif"></A><!-- Link Tag --><A HREF="hood.html"><!-- Graphic Tag --><IMG WIDTH=108 HEIGHT=36 BORDER=0  SRC="ehvpic/kna_hood.gif"></A><!-- Link Tag --><A HREF="infra.html"><!-- Graphic Tag --><IMG WIDTH=108 HEIGHT=17 BORDER=0  SRC="ehvpic/kna_infra.gif"></A><!-- Link Tag --><A HREF="energy.html"><!-- Graphic Tag --><IMG WIDTH=108 HEIGHT=18 BORDER=0  SRC="ehvpic/kna_energ.gif"></A><!-- Link Tag --><A HREF="economic.html"><!-- Graphic Tag --><IMG WIDTH=108 HEIGHT=17 BORDER=0  SRC="ehvpic/kna_eco.gif"></A><!-- Link Tag --><A HREF="perform.html"><!-- Graphic Tag --><IMG WIDTH=108 HEIGHT=17 BORDER=0  SRC="ehvpic/kna_perfa.gif"></A><!-- Link Tag --><A HREF="market.html"><!-- Graphic Tag --><IMG WIDTH=108 HEIGHT=18 BORDER=0  SRC="ehvpic/kna_mark.gif"></A></TD><TD WIDTH=15 BORDER=0 align=center></TD><TD WIDTH=300 BORDER=0 align=left valign=top><BR><H3>Malm&ouml;</H3><P>&#148;Electric Vehicles in Malm&ouml;&#148; is a co-operation project between the City of Malm&ouml;, the national energy producer and distributor Sydkraft AB and KFB. The project started in 1995, including the development of a strategy for city charging infrastructure. Vehicle demonstrations will encompass over 50 passenger and light distribution vehicles in 1997. </P><P>&#148;Electric Vehicles in Malm&ouml;&#148; is one of the two principal projects of the KFB program.</P>See<!-- Link Tag --><A HREF="http://www.iea.lth.se/~niklas/work/evdatabase/carsproj.html#Clio-M4"> listing</A> of the Malm&ouml; vehicles.<BR><!-- Horizontal Line Tag --><HR WIDTH=100%><!-- Anchor Link Tag --><A HREF="#Up!"><H6>Up!</H6></A><BR>   </TD></TR></TABLE></BODY></HTML>
</DOC>
<DOC>
<DOCNO>WT02-B10-70</DOCNO>
<DOCOLDNO>IA018-000200-B015-48</DOCOLDNO>
<DOCHDR>
http://www.kfb.se:80/ehvproge/batteri.html 194.198.183.242 19970106205141 text/html 2867
HTTP/1.0 200 OK
Date: Mon, 06 Jan 1997 20:46:48 GMT
Server: Microsoft-Internet-Information-Server/1.0
Content-Type: text/html
Last-Modified: Thu, 10 Oct 1996 08:41:38 GMT
Content-Length: 2667
</DOCHDR>
<HTML><!---------------------------------------------------------------><!-      AUTHOR:       mats holm                           ><!-      E-MAIL:            mats@softmachine.se                  ><!-      CREATED:     1996.09.26                       ><!-      MODIFIED:                       ><!-- Anchor Point Tag --><A NAME="Up!"><!-      FILE: batteri.html></A>             <!---------------------------------------------------------------><!-- Head Tag --><HEAD><TITLE>KFB-Swedish Research and Communications Board</TITLE></HEAD><!-- Head Tag --><HEAD><TITLE>KFB-Swedish Research and Communications Board</TITLE></HEAD><!-- Body Tag --><BODY TEXT="#4C4C4C" BACKGROUND="ehvpic/yel_bgr.gif"></BODY><!-- Link Tag --><A HREF="index.html"><!-- Graphic Tag --><IMG WIDTH=534 HEIGHT=28 BORDER=0  SRC="ehvpic/kfbhead.gif"></A><TABLE WIDTH=535 BORDER=0 ><TR><TD WIDTH=130 BORDER=0 valign=top><!-- Link Tag --><A HREF="program.html"><!-- Graphic Tag --><IMG WIDTH=108 HEIGHT=36 BORDER=0  SRC="ehvpic/kna_pro.gif"></A><!-- Link Tag --><A HREF="projects.html"><!-- Graphic Tag --><IMG WIDTH=108 HEIGHT=35 BORDER=0  SRC="ehvpic/kna_proj.gif"></A><!-- Link Tag --><A HREF="hood.html"><!-- Graphic Tag --><IMG WIDTH=108 HEIGHT=36 BORDER=0  SRC="ehvpic/kna_hood.gif"></A><!-- Link Tag --><A HREF="infra.html"><!-- Graphic Tag --><IMG WIDTH=108 HEIGHT=17 BORDER=0  SRC="ehvpic/kna_infra.gif"></A><!-- Link Tag --><A HREF="energy.html"><!-- Graphic Tag --><IMG WIDTH=108 HEIGHT=18 BORDER=0  SRC="ehvpic/kna_energ.gif"></A><!-- Link Tag --><A HREF="economic.html"><!-- Graphic Tag --><IMG WIDTH=108 HEIGHT=17 BORDER=0  SRC="ehvpic/kna_eco.gif"></A><!-- Link Tag --><A HREF="perform.html"><!-- Graphic Tag --><IMG WIDTH=108 HEIGHT=17 BORDER=0  SRC="ehvpic/kna_perfa.gif"></A><!-- Link Tag --><A HREF="market.html"><!-- Graphic Tag --><IMG WIDTH=108 HEIGHT=18 BORDER=0  SRC="ehvpic/kna_mark.gif"></A></TD><TD WIDTH=15 BORDER=0 align=center></TD><TD WIDTH=300 BORDER=0 align=left valign=top><BR><H3>Courier EV Battery Exchange </H3><P>Stockholm Energi, local energy manufacturer and distributor, manages a project in co-operation with City of Stockholm vehicle operators MFO and courier companies Svenska Milj&ouml;bud AB and Elbudet AB. Ten Elcat light distribution EVs operate from a central garage offering battery exchange. </P>See<!-- Link Tag --><A HREF="http://www.iea.lth.se/~niklas/work/evdatabase/carsproj.html#Elcat-B1"> listing</A> of the battery exchange vehicles.<BR><!-- Horizontal Line Tag --><HR WIDTH=100%><!-- Anchor Link Tag --><A HREF="#Up!"><H6>Up!</H6></A><BR>   </TD></TR></TABLE></BODY></HTML>
</DOC>
<DOC>
<DOCNO>WT02-B10-71</DOCNO>
<DOCOLDNO>IA018-000200-B015-60</DOCOLDNO>
<DOCHDR>
http://www.kfb.se:80/ehvproge/elhybridbus.html 194.198.183.242 19970106205156 text/html 2765
HTTP/1.0 200 OK
Date: Mon, 06 Jan 1997 20:46:59 GMT
Server: Microsoft-Internet-Information-Server/1.0
Content-Type: text/html
Last-Modified: Thu, 10 Oct 1996 08:41:42 GMT
Content-Length: 2565
</DOCHDR>
<HTML><!---------------------------------------------------------------><!-      AUTHOR:       mats holm                           ><!-      E-MAIL:            mats@softmachine.se                  ><!-      CREATED:     1996.09.26                       ><!-      MODIFIED:                       ><!-- Anchor Point Tag --><A NAME="Up!"><!-      FILE: projects.html></A>             <!---------------------------------------------------------------><!-- Head Tag --><HEAD><TITLE>KFB-Swedish Research and Communications Board</TITLE></HEAD><!-- Head Tag --><HEAD><TITLE>KFB-Swedish Research and Communications Board</TITLE></HEAD><!-- Body Tag --><BODY TEXT="#4C4C4C" BACKGROUND="ehvpic/yel_bgr.gif"></BODY><!-- Link Tag --><A HREF="index.html"><!-- Graphic Tag --><IMG WIDTH=534 HEIGHT=28 BORDER=0  SRC="ehvpic/kfbhead.gif"></A><TABLE WIDTH=535 BORDER=0 ><TR><TD WIDTH=130 BORDER=0 valign=top><!-- Link Tag --><A HREF="program.html"><!-- Graphic Tag --><IMG WIDTH=108 HEIGHT=36 BORDER=0  SRC="ehvpic/kna_pro.gif"></A><!-- Link Tag --><A HREF="projects.html"><!-- Graphic Tag --><IMG WIDTH=108 HEIGHT=35 BORDER=0  SRC="ehvpic/kna_proj.gif"></A><!-- Link Tag --><A HREF="hood.html"><!-- Graphic Tag --><IMG WIDTH=108 HEIGHT=36 BORDER=0  SRC="ehvpic/kna_hood.gif"></A><!-- Link Tag --><A HREF="infra.html"><!-- Graphic Tag --><IMG WIDTH=108 HEIGHT=17 BORDER=0  SRC="ehvpic/kna_infra.gif"></A><!-- Link Tag --><A HREF="energy.html"><!-- Graphic Tag --><IMG WIDTH=108 HEIGHT=18 BORDER=0  SRC="ehvpic/kna_energ.gif"></A><!-- Link Tag --><A HREF="economic.html"><!-- Graphic Tag --><IMG WIDTH=108 HEIGHT=17 BORDER=0  SRC="ehvpic/kna_eco.gif"></A><!-- Link Tag --><A HREF="perform.html"><!-- Graphic Tag --><IMG WIDTH=108 HEIGHT=17 BORDER=0  SRC="ehvpic/kna_perfa.gif"></A><!-- Link Tag --><A HREF="market.html"><!-- Graphic Tag --><IMG WIDTH=108 HEIGHT=18 BORDER=0  SRC="ehvpic/kna_mark.gif"></A></TD><TD WIDTH=15 BORDER=0 align=center></TD><TD WIDTH=300 BORDER=0 align=left valign=top><BR><H3>Electric and hybrid buses  </H3><!-- Graphic Tag --><IMG WIDTH=227 HEIGHT=107  SRC="ehvpic/blabus.gif"><BR>Swedish cities and traffic authorities look to the potential of electric and hybrid buses for commuting and city traffic. A cooperative effort is initiated by KFB to evaluate vehicle drive systems and components as a function of three various transporting assignments.<BR><!-- Horizontal Line Tag --><HR WIDTH=100%><!-- Anchor Link Tag --><A HREF="#Up!"><H6>Up!</H6></A><BR>   </TD></TR></TABLE></BODY></HTML>
</DOC>
<DOC>
<DOCNO>WT02-B10-72</DOCNO>
<DOCOLDNO>IA018-000200-B015-72</DOCOLDNO>
<DOCHDR>
http://www.kfb.se:80/bioprogs/uppdrag.html 194.198.183.242 19970106205204 text/html 4706
HTTP/1.0 200 OK
Date: Mon, 06 Jan 1997 20:47:14 GMT
Server: Microsoft-Internet-Information-Server/1.0
Content-Type: text/html
Last-Modified: Thu, 05 Dec 1996 09:15:08 GMT
Content-Length: 4506
</DOCHDR>
<HTML><!---------------------------------------------------------------><! AUTHOR:       mats holm                           ><! E-MAIL:mats@softmachine.se                  ><! CREATED:     1996.11.15                     ><! MODIFIED:                       ><! Anchor Point Tag --><A NAME="Up!"><!-      FILE: uppdrag.html></A>             <!---------------------------------------------------------------><!-- Head Tag --><HEAD><TITLE>KFB-Biobaserade drivmedel/uppdraget</TITLE></HEAD><!-- Body Tag --><BODY TEXT="#4C4C4C" BACKGROUND="biopic/yel_bgr.gif"></BODY><!-- Link Tag --><A HREF="index.html"><!-- Graphic Tag --><IMG WIDTH=534 HEIGHT=28 BORDER=0  SRC="biopic/kfbhead.gif"></A><TABLE WIDTH=535 BORDER=0 ><TR><TD WIDTH=130 BORDER=0 valign=top><!-- Link Tag --><A HREF="uppdrag.html"><!-- Graphic Tag --><IMG WIDTH=108 HEIGHT=18 BORDER=0  SRC="biopic/kna_proa.gif"></A><!-- Link Tag --><A HREF="projects.html"><!-- Graphic Tag --><IMG WIDTH=108 HEIGHT=18 BORDER=0  SRC="biopic/kna_proj.gif"></A><!-- Link Tag --><A HREF="litteratur.html"><!-- Graphic Tag --><IMG WIDTH=108 HEIGHT=18 BORDER=0  SRC="biopic/kna_hood.gif"></A><!-- Link Tag --><A HREF="renalkohol.html"><!-- Graphic Tag --><IMG WIDTH=108 HEIGHT=17 BORDER=0  SRC="biopic/kna_infra.gif"></A><!-- Link Tag --><A HREF="blandbransle.html"><!-- Graphic Tag --><IMG WIDTH=108 HEIGHT=18 BORDER=0  SRC="biopic/kna_energ.gif"></A><!-- Link Tag --><A HREF="biogas.html"><!-- Graphic Tag --><IMG WIDTH=108 HEIGHT=17 BORDER=0  SRC="biopic/kna_eco.gif"></A><!-- Link Tag --><A HREF="resultat.html"><!-- Graphic Tag --><IMG WIDTH=108 HEIGHT=17 BORDER=0  SRC="biopic/kna_perfa.gif"></A><!-- Link Tag --><A HREF="miljo.html"><!-- Graphic Tag --><IMG WIDTH=108 HEIGHT=18 BORDER=0  SRC="biopic/kna_mark.gif"></A></TD><TD WIDTH=15 BORDER=0 align=center></TD><TD WIDTH=300 BORDER=0 align=left valign=top><BR><!-- Graphic Tag --><IMG WIDTH=154 HEIGHT=21  SRC="biopic/uppdrag.gif"><BR><P>1 december 1992 antog KFBs styrelse (d&aring;varande TFB) ett program f&ouml;r verksamheten. I programmet preciserades syftet: att utveckla, prova och utv&auml;rdera teknik och system f&ouml;r anv&auml;ndning av motoralkoholer, </P><BLOCKQUOTE><B>att</B> stimulera st&ouml;rre producenter och anv&auml;ndare till ett aktivt deltagande i utvecklings- och demonstrationsprojekt,<BR><BR><B>att</B> &ouml;ka kunskapen om motoralkoholernas l&aring;ngsiktiga anv&auml;ndbarhet, milj&ouml;potential och kostnadsbild,<BR><BR><B>att</B> klarl&auml;gga om och under vilka f&ouml;ruts&auml;ttningar motoralkoholer &auml;r mogna f&ouml;r en introduktion i st&ouml;rre skala.</BLOCKQUOTE>Programmet fokuserar p&aring; tre olika inriktningar. <B>Renalkoholer</B>, vilka har den st&ouml;rsta potentialen f&ouml;r h&auml;lso och milj&ouml;f&ouml;rb&auml;ttring, men kr&auml;ver helt nya motorer.<BR><B>Blandbr&auml;nslen</B> som kan man anv&auml;nda i dagens motorer. H&auml;r g&auml;ller det att ta fram blandbr&auml;nslen som knav&auml;ndas av s&aring; m&aring;nga som m&auml;jligt av dagens och morgondagens fordon.<BR>Samt <B>biogas</B>, dvs metangas fr&aring;n biobaserade r&aring;varor.<BR><BR><!-- Graphic Tag --><IMG WIDTH=170 HEIGHT=112 ALIGN=RIGHT SRC="biopic/sop.gif"><P>KFBs program har sin tyngdpunkt i tunga fordon eftersom milj&ouml;potentialen bed&ouml;ms vara st&ouml;rst inom detta fordonssegment. Det &auml;r ocks&aring; en central uppgift f&ouml;r KFB att p&aring; olika s&auml;tt st&ouml;dja utvecklingen av en v&auml;l fungerande och milj&ouml;anpassad kollektivtrafik. Utveckling av olika busskoncept &auml;r d&auml;rf&ouml;r viktigt i programmet.Samarbete och samfinansiering med andra myndigheter, forskare, producenter och anv&auml;ndare av fordon och drivmedel &auml;r en f&ouml;ruts&auml;ttning f&ouml;r programmets genomf&ouml;rande. En del projekt startades med anslag fr&aring;n annat h&aring;ll f&ouml;re det egentliga biodrivmedelsprogrammet, men ger resultat som kan anv&auml;ndas i utv&auml;rderingen av biodrivmedelsprogrammet.</P>Handl&auml;ggare f&ouml;r omr&aring;det <B>Biobaserade drivmedel</B> &auml;r <!-- MailTo Tag --><A HREF="MAILTO:soren.bucksch@kfb.se">S&ouml;ren Bucksch</A>. <BR><BR><!-- MailTo Tag --><A HREF="MAILTO:tommy.mansson@kfb.se">Tommy M&aring;nsson</A> arbetar med systemstudien och utv&auml;rdering av programmet.<!-- Horizontal Line Tag --><HR WIDTH=100%><H6><!-- Anchor Link Tag --><A HREF="#Up!">[Up!]</H6></A><BR></TD></TR></TABLE></BODY></HTML>
</DOC>
<DOC>
<DOCNO>WT02-B10-73</DOCNO>
<DOCOLDNO>IA018-000200-B015-83</DOCOLDNO>
<DOCHDR>
http://www.kfb.se:80/bioprogs/projects.html 194.198.183.242 19970106205212 text/html 4183
HTTP/1.0 200 OK
Date: Mon, 06 Jan 1997 20:47:22 GMT
Server: Microsoft-Internet-Information-Server/1.0
Content-Type: text/html
Last-Modified: Thu, 05 Dec 1996 09:14:56 GMT
Content-Length: 3983
</DOCHDR>
<HTML><!---------------------------------------------------------------><!-      AUTHOR:      mats holm                           ><!-      E-MAIL:      mats@softmachine.se                  ><!-      CREATED:     1996.11.15                      ><!-      MODIFIED:                       ><!-- Anchor Point Tag --><A NAME="Up!"><!-      FILE: projects.html></A>             <!---------------------------------------------------------------><!-- Head Tag --><HEAD><TITLE>KFB-Biobaserade drivmedel/projekt</TITLE></HEAD><!-- Body Tag --><BODY TEXT="#4C4C4C" BACKGROUND="biopic/yel_bgr.gif"></BODY><!-- Link Tag --><A HREF="index.html"><!-- Graphic Tag --><IMG WIDTH=534 HEIGHT=28 BORDER=0  SRC="biopic/kfbhead.gif"></A><TABLE WIDTH=535 BORDER=0 ><TR><TD WIDTH=130 BORDER=0 valign=top><!-- Link Tag --><A HREF="uppdrag.html"><!-- Graphic Tag --><IMG WIDTH=108 HEIGHT=18 BORDER=0  SRC="biopic/kna_pro.gif"></A><!-- Link Tag --><A HREF="projects.html"><!-- Graphic Tag --><IMG WIDTH=108 HEIGHT=18 BORDER=0  SRC="biopic/kna_proja.gif"></A><!-- Link Tag --><A HREF="litteratur.html"><!-- Graphic Tag --><IMG WIDTH=108 HEIGHT=18 BORDER=0  SRC="biopic/kna_hood.gif"></A><!-- Link Tag --><A HREF="renalkohol.html"><!-- Graphic Tag --><IMG WIDTH=108 HEIGHT=17 BORDER=0  SRC="biopic/kna_infra.gif"></A><!-- Link Tag --><A HREF="blandbransle.html"><!-- Graphic Tag --><IMG WIDTH=108 HEIGHT=18 BORDER=0  SRC="biopic/kna_energ.gif"></A><!-- Link Tag --><A HREF="biogas.html"><!-- Graphic Tag --><IMG WIDTH=108 HEIGHT=17 BORDER=0  SRC="biopic/kna_eco.gif"></A><!-- Link Tag --><A HREF="resultat.html"><!-- Graphic Tag --><IMG WIDTH=108 HEIGHT=17 BORDER=0  SRC="biopic/kna_perfa.gif"></A><!-- Link Tag --><A HREF="miljo.html"><!-- Graphic Tag --><IMG WIDTH=108 HEIGHT=18 BORDER=0  SRC="biopic/kna_mark.gif"></A></TD><TD WIDTH=15 BORDER=0 align=center></TD><TD WIDTH=300 BORDER=0 align=left valign=top><BR><!-- Graphic Tag --><IMG WIDTH=78 HEIGHT=18  SRC="biopic/projekt.gif"><BR><P>Tyngdpunkten ligger p&aring; f&auml;ltprov med fordon. Hittills har det fr&auml;mst g&auml;llt tunga fordon - bussar och lastbilar - men &auml;ven utveckling och test av personbilar ing&aring;r i programmet. S&aring;v&auml;l fordon f&ouml;r alkoholdrift - ren etanol och blandbr&auml;nslen - som f&ouml;r biogas ing&aring;r.</P><P>Det har visat sig att drivmedlens sammans&auml;ttning har stor betydelse f&ouml;r att f&ouml;rb&auml;ttra emissionerna, b&aring;de f&ouml;r diesel- och bensinmotorer. Visst utvecklingsarbete genomf&ouml;rs och m&ouml;jligheterna till ytterligare f&ouml;rb&auml;ttringar kommer att bed&ouml;mas. KFBs anslag &auml;r dock inte avsett att anv&auml;ndas f&ouml;r att utveckla sj&auml;lva produktionen av drivmedel.</P><P>V&auml;l fungerande system f&ouml;r distribution, lagring och hantering &auml;r en f&ouml;ruts&auml;ttning f&ouml;r en storskalig introduktion av biobaserade br&auml;nslen. Den teknik som kommer att anv&auml;ndas vid demonstrationsprojekten blir delvis provisorier. KFB kommer dock att unders&ouml;ka vilka l&aring;ngsiktiga och storskaliga problem som finns och bed&ouml;ma behoven av ytterligare utveckling. </P><P>Prov med biodrivmedel p&aring;g&aring;r p&aring; m&aring;nga st&auml;llen i landet. Kartan nedan visar p&aring; prov p&aring; motoralkoholer och biogas.</P><!-- Graphic Tag --><IMG WIDTH=225 HEIGHT=340  SRC="biopic/karta.gif"><P>Projekt som ing&aring;r i programmet Biobaserade drivmedel dokumenteras oftast i form av KFB-skrifter men ibland ocks&aring; av projektdeltagarna. <!-- Link Tag --><A HREF="../bibliotek.html">Projektrapporter och annat tryckt material</A> finns f&ouml;rtecknat i en publikationslista som fortl&ouml;pande uppdateras.</P><!-- Horizontal Line Tag --><HR WIDTH=100%><!-- MailTo Tag --><A HREF="MAILTO:arne.kihlblom@kfb.se"><H6>[Kontakta oss g&auml;rna]</A><!-- Anchor Link Tag --><A HREF="#Up!">[Up!]</H6></A><BR>   </TD></TR></TABLE></BODY></HTML>
</DOC>
<DOC>
<DOCNO>WT02-B10-74</DOCNO>
<DOCOLDNO>IA018-000200-B015-92</DOCOLDNO>
<DOCHDR>
http://www.kfb.se:80/bioprogs/litteratur.html 194.198.183.242 19970106205219 text/html 3933
HTTP/1.0 200 OK
Date: Mon, 06 Jan 1997 20:47:30 GMT
Server: Microsoft-Internet-Information-Server/1.0
Content-Type: text/html
Last-Modified: Thu, 05 Dec 1996 09:14:48 GMT
Content-Length: 3733
</DOCHDR>
<HTML><!-      E-MAIL:      	     mats@softmachine.se                  ><!-      CREATED:   	  1996.11.15                       ><!-      MODIFIED:  	                     ><!-- Anchor Point Tag --><A NAME="Up!"><!-      File. litteratur.html></A>         <!---------------------------------------------------------------><!-- Head Tag --><HEAD><TITLE>KFB-Biobaserade drivmedel/litteratur</TITLE></HEAD><!-- Body Tag --><BODY TEXT="#4C4C4C" BACKGROUND="biopic/yel_bgr.gif"></BODY><!-- Link Tag --><A HREF="index.html"><!-- Graphic Tag --><IMG WIDTH=534 HEIGHT=28 BORDER=0  SRC="biopic/kfbhead.gif"></A><TABLE WIDTH=535 BORDER=0 ><TR><TD WIDTH=130 BORDER=0 valign=top><!-- Link Tag --><A HREF="uppdrag.html"><!-- Graphic Tag --><IMG WIDTH=108 HEIGHT=18 BORDER=0  SRC="biopic/kna_pro.gif"></A><!-- Link Tag --><A HREF="projects.html"><!-- Graphic Tag --><IMG WIDTH=108 HEIGHT=18 BORDER=0  SRC="biopic/kna_proj.gif"></A><!-- Link Tag --><A HREF="litteratur.html"><!-- Graphic Tag --><IMG WIDTH=108 HEIGHT=18 BORDER=0  SRC="biopic/kna_hooda.gif"></A><!-- Link Tag --><A HREF="renalkohol.html"><!-- Graphic Tag --><IMG WIDTH=108 HEIGHT=17 BORDER=0  SRC="biopic/kna_infra.gif"></A><!-- Link Tag --><A HREF="blandbransle.html"><!-- Graphic Tag --><IMG WIDTH=108 HEIGHT=18 BORDER=0  SRC="biopic/kna_energ.gif"></A><!-- Link Tag --><A HREF="biogas.html"><!-- Graphic Tag --><IMG WIDTH=108 HEIGHT=17 BORDER=0  SRC="biopic/kna_eco.gif"></A><!-- Link Tag --><A HREF="resultat.html"><!-- Graphic Tag --><IMG WIDTH=108 HEIGHT=17 BORDER=0  SRC="biopic/kna_perfa.gif"></A><!-- Link Tag --><A HREF="miljo.html"><!-- Graphic Tag --><IMG WIDTH=108 HEIGHT=18 BORDER=0  SRC="biopic/kna_mark.gif"></A></TD><TD WIDTH=15 BORDER=0 align=center></TD><TD WIDTH=300 BORDER=0 align=left valign=top><BR><!-- Graphic Tag --><IMG WIDTH=102 HEIGHT=15  SRC="biopic/rub_litt.gif"><BR><BR><!-- Graphic Tag --><IMG  SRC="biopic/litteratur.jpg"><H6>S&auml;nd ett<!-- MailTo Tag --><A HREF="MAILTO:arne.kihlbom@kfb.se"> e-mail </A>med namn och adress och skriv vad du &ouml;nskar information om, s&aring; skickar vi dig tryckt informationsmaterial.</H6><P>Informationsfr&aring;gorna har f&aring;tt stort utrymme inom programmet. De projekt som ing&aring;r dokumenteras oftast i form av KFB-skrifter men ibland ocks&aring; av projektdeltagarna.</P><P> <!-- Link Tag --><A HREF="../bibliotek.html">Projektrapporter</A> och annat tryckt material finns f&ouml;rtecknat i en publikationslista som fortl&ouml;pande uppdateras.</P><!-- Graphic Tag --><IMG WIDTH=113 HEIGHT=55 ALIGN=RIGHT SRC="biopic/rentrafik.gif"><P>Nyheter fr&aring;n programmet - och &auml;ven annat &#148;externt&#148; material - presenteras i nyhetsbrevet <B>REN TRAFIK</B>, som utges regelbundet.</P><H6>Den som &ouml;nskar kan abbonera gratis p&aring; Ren Trafik. Best&auml;ll g&auml;rna per<!-- MailTo Tag --><A HREF="MAILTO:arne.kihlbom@kfb.se"> e-mail.</A></H6>Ett anv&auml;ndarn&auml;tverk inom omr&aring;det etanol (som biodrivmedel) har bildats p&aring; initiativ av KFB. Syftet med n&auml;tverket &auml;r att f&ouml;ra ut information till en tydlig m&aring;lgrupp, d&auml;r information fr&aring;n KFB och andra organisatier genererar ett erfarenhetsutbyte. <BR><P>Programomr&aring;det &auml;r mycket internationellt, vilket ocks&aring; avspeglar sig i informationsmaterialet; m&aring;nga centrala skrifter utges p&aring; engelska, n&aring;gon &auml;ven p&aring; tyska och franska. </P><BR><!-- Horizontal Line Tag --><HR WIDTH=100%><!-- MailTo Tag --><A HREF="MAILTO:arne.kihlblom@kfb.se"><H6>[Kontakta oss g&auml;rna]</A><!-- Anchor Link Tag --><A HREF="#Up!">[Up!]</H6></A><BR>   </TD></TR></TABLE></BODY></HTML>
</DOC>
<DOC>
<DOCNO>WT02-B10-75</DOCNO>
<DOCOLDNO>IA018-000200-B015-104</DOCOLDNO>
<DOCHDR>
http://www.kfb.se:80/bioprogs/renalkohol.html 194.198.183.242 19970106205233 text/html 4489
HTTP/1.0 200 OK
Date: Mon, 06 Jan 1997 20:47:37 GMT
Server: Microsoft-Internet-Information-Server/1.0
Content-Type: text/html
Last-Modified: Thu, 05 Dec 1996 09:15:00 GMT
Content-Length: 4289
</DOCHDR>
<HTML><!---------------------------------------------------------------><!-      AUTHOR:       mats holm                           ><!-      E-MAIL:       mats@softmachine.se                  ><!-      CREATED:   	  1996.09.26                       ><!-      MODIFIED:  	                     ><!-- Anchor Point Tag --><A NAME="Up!"><!-      FILE:                renalkohol.html>  </A>           <!---------------------------------------------------------------><!-- Head Tag --><HEAD><TITLE>KFB-Biobaserade drivmedel/renalkohol</TITLE></HEAD><!-- Body Tag --><BODY TEXT="#4C4C4C" BACKGROUND="biopic/yel_bgr.gif"></BODY><!-- Link Tag --><A HREF="index.html"><!-- Graphic Tag --><IMG WIDTH=534 HEIGHT=28 BORDER=0  SRC="biopic/kfbhead.gif"></A><TABLE WIDTH=535 BORDER=0 ><TR><TD WIDTH=130 BORDER=0 valign=top><!-- Link Tag --><A HREF="uppdrag.html"><!-- Graphic Tag --><IMG WIDTH=108 HEIGHT=18 BORDER=0  SRC="biopic/kna_pro.gif"></A><!-- Link Tag --><A HREF="projects.html"><!-- Graphic Tag --><IMG WIDTH=108 HEIGHT=18 BORDER=0  SRC="biopic/kna_proj.gif"></A><!-- Link Tag --><A HREF="litteratur.html"><!-- Graphic Tag --><IMG WIDTH=108 HEIGHT=18 BORDER=0  SRC="biopic/kna_hood.gif"></A><!-- Link Tag --><A HREF="renalkohol.html"><!-- Graphic Tag --><IMG WIDTH=108 HEIGHT=17 BORDER=0  SRC="biopic/kna_infr.gif"></A><!-- Link Tag --><A HREF="blandbransle.html"><!-- Graphic Tag --><IMG WIDTH=108 HEIGHT=18 BORDER=0  SRC="biopic/kna_energ.gif"></A><!-- Link Tag --><A HREF="biogas.html"><!-- Graphic Tag --><IMG WIDTH=108 HEIGHT=17 BORDER=0  SRC="biopic/kna_eco.gif"></A><!-- Link Tag --><A HREF="resultat.html"><!-- Graphic Tag --><IMG WIDTH=108 HEIGHT=17 BORDER=0  SRC="biopic/kna_perfa.gif"></A><!-- Link Tag --><A HREF="miljo.html"><!-- Graphic Tag --><IMG WIDTH=108 HEIGHT=18 BORDER=0  SRC="biopic/kna_mark.gif"></A></TD><TD WIDTH=15 BORDER=0 align=center></TD><TD WIDTH=300 BORDER=0 align=left valign=top><BR><BR><!-- Graphic Tag --><IMG WIDTH=116 HEIGHT=15  SRC="biopic/renalkohol.gif"><BR><!-- Graphic Tag --><IMG WIDTH=340 HEIGHT=135  SRC="biopic/etanolbil.gif"><BR><BR><H6>FFV (Flexible Fuel Vehicles) fungerar lika bra p&aring; ren etanol som p&aring; bensin och blandningar av dem. Ett 50-tal bilar ing&aring;r i det projekt som KFB st&ouml;djer.</H6><BR><P>Om motoralkoholer skulle ers&auml;tta bensin och diesel skulle trafikens skadliga inverkan p&aring; milj&ouml;n drastiskt sjunka. Detta skulle vara ett faktum &auml;ven om alkoholen kom fr&aring;n naturgas.  I l&aring;nga loppet &auml;r det dock n&ouml;dv&auml;ndigt att producera alkoholen fr&aring;n f&ouml;rnybara k&auml;llor. I Sverige kan vi t.ex. anv&auml;nda &ouml;verskott fr&aring;n jordbruk och tr&auml;industri.  </P><P>I Brasilien, som &auml;r det enda landet i v&auml;rlden med ett fungerande tankningssystem f&ouml;r motoralkoholer, anv&auml;nder man sockerr&ouml;r till att producera alkoholen.<BR>4,5 miljon fordon k&ouml;r idag p&aring; etanol i Brasilien. Alla &ouml;vriga fordon med konventionella Otto-motorer k&ouml;rs p&aring; bensin med 22% inblandning av etanol.</P><!-- Graphic Tag --><IMG WIDTH=142 HEIGHT=128 ALIGN=RIGHT SRC="biopic/etanolbuss.gif"><P>I Kalifornien  fanns det 1993 8.000 fordon som k&ouml;rde p&aring; alkohol. De tre st&ouml;rsta biltillverkarna i USA har ocks&aring; certifierat motorer f&ouml;r flexibel br&auml;nsledrift. Motorerna kan k&ouml;ras p&aring; alkohol eller bensin eller en blandning av dom tv&aring;.</P><P>Det mest omfattande projektet i v&auml;steuropa har genomf&ouml;rts av Storstockholms Lokaltrafik (SL), med 32 st bussar f&ouml;rsedda med Scania motorer f&ouml;r etanoldrift. Experimentet utf&ouml;ll s&aring; lyckat att SL beslutat att k&ouml;pa in ytterligare etanolbussar.<BR>En rapport om projektet <!-- Font Tag --><B>"Flottf&ouml;rs&ouml;k med 32 etanolbussar vid AB Storstockholms Lokaltrafik"</B> (KFB-rapport 1994:2) finns att <!-- Link Tag --><A HREF="../bibliotek.html">best&auml;lla</A>. En sammanfattande bearbetning finns ocks&aring;.</P><!-- Horizontal Line Tag --><HR WIDTH=100%><!-- MailTo Tag --><A HREF="MAILTO:arne.kihlblom@kfb.se"><H6>[Kontakta oss g&auml;rna]</A><!-- Anchor Link Tag --><A HREF="#Up!">[Up!]</H6></A><BR>   </TD></TR></TABLE></BODY></HTML>
</DOC>
<DOC>
<DOCNO>WT02-B10-76</DOCNO>
<DOCOLDNO>IA018-000200-B015-120</DOCOLDNO>
<DOCHDR>
http://www.kfb.se:80/bioprogs/blandbransle.html 194.198.183.242 19970106205247 text/html 4407
HTTP/1.0 200 OK
Date: Mon, 06 Jan 1997 20:47:54 GMT
Server: Microsoft-Internet-Information-Server/1.0
Content-Type: text/html
Last-Modified: Thu, 05 Dec 1996 09:14:42 GMT
Content-Length: 4207
</DOCHDR>
<HTML><!---------------------------------------------------------------><!-  AUTHOR:        mats holm                           ><!-  E-MAIL:            mats@softmachine.se      ><!- CREATED:      1996.11.15                       ><!-  MODIFIED:  	                     ><!-- Anchor Point Tag --><A NAME="Up!"><!-      FILE: blandbransle.html></A>         <!---------------------------------------------------------------><!-- Head Tag --><HEAD><TITLE>KFB-Biobaserade drivmedel/blandbr&auml;nsle</TITLE></HEAD><!-- Body Tag --><BODY TEXT="#4C4C4C" BACKGROUND="biopic/yel_bgr.gif"></BODY><!-- Link Tag --><A HREF="index.html"><!-- Graphic Tag --><IMG WIDTH=534 HEIGHT=28 BORDER=0  SRC="biopic/kfbhead.gif"></A><TABLE WIDTH=535 BORDER=0 ><TR><TD WIDTH=130 BORDER=0 valign=top><!-- Link Tag --><A HREF="uppdrag.html"><!-- Graphic Tag --><IMG WIDTH=108 HEIGHT=18 BORDER=0  SRC="biopic/kna_pro.gif"></A><!-- Link Tag --><A HREF="projects.html"><!-- Graphic Tag --><IMG WIDTH=108 HEIGHT=18 BORDER=0  SRC="biopic/kna_proj.gif"></A><!-- Link Tag --><A HREF="litteratur.html"><!-- Graphic Tag --><IMG WIDTH=108 HEIGHT=18 BORDER=0  SRC="biopic/kna_hood.gif"></A><!-- Link Tag --><A HREF="renalkohol.html"><!-- Graphic Tag --><IMG WIDTH=108 HEIGHT=17 BORDER=0  SRC="biopic/kna_infra.gif"></A><!-- Link Tag --><A HREF="blandbransle.html"><!-- Graphic Tag --><IMG WIDTH=108 HEIGHT=18 BORDER=0  SRC="biopic/kna_energia.gif"></A><!-- Link Tag --><A HREF="biogas.html"><!-- Graphic Tag --><IMG WIDTH=108 HEIGHT=17 BORDER=0  SRC="biopic/kna_eco.gif"></A><!-- Link Tag --><A HREF="resultat.html"><!-- Graphic Tag --><IMG WIDTH=108 HEIGHT=17 BORDER=0  SRC="biopic/kna_perfa.gif"></A><!-- Link Tag --><A HREF="miljo.html"><!-- Graphic Tag --><IMG WIDTH=108 HEIGHT=18 BORDER=0  SRC="biopic/kna_mark.gif"></A></TD><TD WIDTH=15 BORDER=0 align=center></TD><TD WIDTH=300 BORDER=0 align=left valign=top><BR><!-- Graphic Tag --><IMG WIDTH=275 HEIGHT=15  SRC="biopic/blandbransle.gif"><BR><BR><!-- Graphic Tag --><IMG WIDTH=283 HEIGHT=188  SRC="biopic/timmerbil.gif"><BR><BR><H6>Timmerbil som drivs med en blandning av biobaserad etanol, <BR>diesel och emulgator.</H6><P>Blandbr&auml;nslen, dvs alkohol i n&aring;gon form inblandad i bensin eller dieselolja, som kan anv&auml;ndas i dagens motorer, &auml;r intressanta under en &ouml;verg&aring;ngstid tills motorer och fordon f&ouml;r renalkoholdrift har introducerats i tillr&auml;cklig omfattning p&aring; marknaden. </P><P>Det finns dessutom m&ouml;jligheter att uppn&aring; milj&ouml;f&ouml;rb&auml;ttringar, t.ex. i form av minskade utsl&auml;pp av partiklar och koldioxid. De hittils vunna erfarenheterna pekar mot en inblandning med upp till 15% etanol i diesel kan g&ouml;ras utan omst&auml;llning p&aring; befintliga motorer. K&ouml;rbarheten p&aring;verkas som regel inte. </P><P>S.k. gasohol (10%-ig inblandning av etanol i bensin) har anv&auml;nts i USA sedan mitten av 80-talet. 3 miljoner kubikmeter etanol har avsatts p&aring; detta s&auml;tt varje &aring;r. Nya regler som fr&auml;mjer inblandningen av etanol eller eter i bensinen g&ouml;r att konsumtionen av etanol antagligen kommer att &ouml;ka till 5 miljoner kubikmeter per &aring;r.</P><P>Inblandning av eter i bensinen &ouml;kar kraftigt i v&auml;steuropa till f&ouml;ljd av att blyet i bensinen har tagits bort. Eter tros bli allt mer vanlig &auml;ven i nordamerika och Japan.</P> <P>Dieselolja kan tillf&ouml;ras etanol tillsammans med ett emulgeringsmedel och fungera som drivmedel. Vid ett f&ouml;rs&ouml;k i Stockholm har man som blandning anv&auml;nt 15 % etanol och ca 0,5 % emulgeringsmedel i Milj&ouml; Klass 1 diesel. Inblandning av etanol i diesel g&ouml;r det &auml;ven m&ouml;jligt att anv&auml;nda katalysatorrening. Liknande f&ouml;rs&ouml;k har &auml;ven gjorts i Australien, Argentina och Tyskland. Med lyckade resultat. Planer finns p&aring; att ut&ouml;ka projektet i Stockholm.</P><!-- Horizontal Line Tag --><HR WIDTH=100%><!-- MailTo Tag --><A HREF="MAILTO:arne.kihlblom@kfb.se"><H6>[Kontakta oss g&auml;rna]</A><!-- Anchor Link Tag --><A HREF="#Up!">[Up!]</H6></A><BR>   </TD></TR></TABLE></BODY></HTML>
</DOC>
<DOC>
<DOCNO>WT02-B10-77</DOCNO>
<DOCOLDNO>IA018-000200-B015-133</DOCOLDNO>
<DOCHDR>
http://www.kfb.se:80/bioprogs/biogas.html 194.198.183.242 19970106205257 text/html 5762
HTTP/1.0 200 OK
Date: Mon, 06 Jan 1997 20:48:08 GMT
Server: Microsoft-Internet-Information-Server/1.0
Content-Type: text/html
Last-Modified: Thu, 05 Dec 1996 09:14:38 GMT
Content-Length: 5562
</DOCHDR>
<HTML><!---------------------------------------------------------------><!-      AUTHOR:       mats holm                           ><!-      E-MAIL:            mats@softmachine.se                  ><!-      CREATED:   	  1996.09.26                       ><!-      MODIFIED:  	                     ><!-- Anchor Point Tag --><A NAME="Up!"><!-      FILE:                renalkohol.html>        </A>     <!---------------------------------------------------------------><!-- Head Tag --><HEAD><TITLE>KFB-Biobaserade drivmedel/biogas</TITLE></HEAD><!-- Body Tag --><BODY TEXT="#4C4C4C" BACKGROUND="biopic/yel_bgr.gif"></BODY><!-- Link Tag --><A HREF="index.html"><!-- Graphic Tag --><IMG WIDTH=534 HEIGHT=28 BORDER=0  SRC="biopic/kfbhead.gif"></A><TABLE WIDTH=535 BORDER=0 ><TR><TD WIDTH=130 BORDER=0 valign=top><!-- Link Tag --><A HREF="uppdrag.html"><!-- Graphic Tag --><IMG WIDTH=108 HEIGHT=18 BORDER=0  SRC="biopic/kna_pro.gif"></A><!-- Link Tag --><A HREF="projects.html"><!-- Graphic Tag --><IMG WIDTH=108 HEIGHT=18 BORDER=0  SRC="biopic/kna_proj.gif"></A><!-- Link Tag --><A HREF="litteratur.html"><!-- Graphic Tag --><IMG WIDTH=108 HEIGHT=18 BORDER=0  SRC="biopic/kna_hood.gif"></A><!-- Link Tag --><A HREF="renalkohol.html"><!-- Graphic Tag --><IMG WIDTH=108 HEIGHT=17 BORDER=0  SRC="biopic/kna_infra.gif"></A><!-- Link Tag --><A HREF="blandbransle.html"><!-- Graphic Tag --><IMG WIDTH=108 HEIGHT=18 BORDER=0  SRC="biopic/kna_energ.gif"></A><!-- Link Tag --><A HREF="biogas.html"><!-- Graphic Tag --><IMG WIDTH=108 HEIGHT=17 BORDER=0  SRC="biopic/kna_ecoa.gif"></A><!-- Link Tag --><A HREF="resultat.html"><!-- Graphic Tag --><IMG WIDTH=108 HEIGHT=17 BORDER=0  SRC="biopic/kna_perfa.gif"></A><!-- Link Tag --><A HREF="miljo.html"><!-- Graphic Tag --><IMG WIDTH=108 HEIGHT=18 BORDER=0  SRC="biopic/kna_mark.gif"></A></TD><TD WIDTH=15 BORDER=0 align=center></TD><TD WIDTH=300 BORDER=0 align=left valign=top><BR><!-- Graphic Tag --><IMG WIDTH=162 HEIGHT=18 SRC="biopic/biogas.gif"><BR><BR><P>Biogas &auml;r ben&auml;mningen p&aring; den gasblandning som bildas n&auml;r bakterier bryter ner organiskt material som inneh&aring;ller kol i syrefri milj&ouml;. Gasen inneh&aring;ller den br&auml;nnbara gasen metan (CH<KBD>4</KBD>), koldioxid (CO<KBD>2</KBD>) och vatten (H<KBD>2</KBD>O) samt mindre m&auml;ngder av andra komponenter.</P><P>Biogas bildas spontant i naturen och processen fortg&aring;r i syrefattiga milj&ouml;er d&auml;r organiskt material finns tillg&auml;ngligt, exempelvis i mossar och sj&ouml;bottnar samt i vommen hos idisslare.</P><P>Biogas har hittills fr&auml;mst utvunnits ur slam fr&aring;n reningsverk, r&ouml;tgas. Biogas fr&aring;n avfallsupplag (soptippar) brukar kallas deponigas. N&auml;r koldioxiden &auml;r avskild och metanhalten uppg&aring;r till minst 95% talar man om biometan. Det &auml;r biometan som &auml;r aktuellt som drivmedel i fordon.</P><P>L&aring;ga emissioner av milj&ouml;f&ouml;rst&ouml;rande &auml;mnen &auml;r en av gasdriftens stora f&ouml;rdelar.</P><BR><!-- Graphic Tag --><IMG WIDTH=344 HEIGHT=248  SRC="biopic/biogasskiss.gif"><BR><H6><!-- Font Tag --><FONT COLOR="#000000">Biogasens v&auml;g fr&aring;n produktion till konsumtion.</FONT></H6><BR><BR><!-- Font Tag --><B><FONT SIZE=4 >Produktion av biogas</FONT></B><BR>Det finns flera tekniska l&ouml;sningar f&ouml;r utvinning av biogas fr&aring;n organiska restprodukter, avloppsvatten och odlad biomassa. gemensamt f&ouml;r teknikerna &auml;r att man anv&auml;nder en luftt&auml;t tank f&ouml;r att skapa en milj&ouml; liknande den som finns n&auml;r biogas bildas spontant i naturen. Tanken brukar kallas biogasreaktor, fermentor eller r&ouml;tkammare. N&auml;r det g&auml;ller deponeringar skapas den n&ouml;dv&auml;ndiga luftt&auml;ta milj&ouml;n i sj&auml;lva avfallsupplaget.<BR><BR><!-- Font Tag --><B><FONT SIZE=4 >Tankning av biogas</FONT></B><BR>Tankning av gas g&ouml;rs i helt slutet system och kan ske enligt 2 principer.<BLOCKQUOTE>-Snabbtankning och L&aring;ngsamtankning<BR></BLOCKQUOTE><P><B>Snabbtankning</B> fungerar ungef&auml;r p&aring; samma s&auml;tt som bensin- eller dieseltankning. En buss tankas p&aring; mellan 10 och 15 minuter, ett l&auml;tt fordon p&aring; 3 till 4 minuter.</P><P><B>L&aring;ngsamtankning</B> tar ett par timmar och &auml;r l&auml;mplig f&ouml;r f&ouml;retag med stora fordonsflottor.</P><P>Utrustningen f&ouml;r en tankstation finns att k&ouml;pa i fabriksf&ouml;rdiga moduler.</P><!-- Font Tag --><B><FONT SIZE=4 >Gasmotorn</FONT></B><BR>Biogas kan anv&auml;ndas i en vanlig s.k. Otto-motor anpassad f&ouml;r gasdrift. Metangas har dessutom ett relativt h&ouml;gt oktantal vilket medger h&ouml;gt kompressionsf&ouml;rh&aring;llande och h&ouml;g verkningsgrad. Kompressionen &auml;r dock l&auml;gre &auml;n f&ouml;r dieselmotorer.<BR><BR><!-- Graphic Tag --><IMG WIDTH=170 HEIGHT=83  SRC="biopic/zbuss.gif"><H6>En gasbuss.</H6><BR><P>En j&auml;mf&ouml;relse mellan gasdrivna ottomotorer och dieselmotorer visar att gasmotorn har:</P><BLOCKQUOTE>-l&auml;gre verkningsgrad<BR>-l&auml;gre moment vid h&ouml;ga varv<BR>-h&ouml;gre moment vid l&aring;ga varv<BR>-l&auml;gre toppeffekt<BR>-l&auml;gre bullerniv&aring;<BR>-l&auml;gre avgasemissioner</BLOCKQUOTE><BR><!-- Horizontal Line Tag --><HR WIDTH=100%><!-- MailTo Tag --><A HREF="MAILTO:arne.kihlblom@kfb.se"><H6>[Kontakta oss g&auml;rna]</A><!-- Anchor Link Tag --><A HREF="#Up!">[Up!]</H6></A><BR>   </TD></TR></TABLE></BODY></HTML>
</DOC>
<DOC>
<DOCNO>WT02-B10-78</DOCNO>
<DOCOLDNO>IA018-000200-B015-150</DOCOLDNO>
<DOCHDR>
http://www.kfb.se:80/bioprogs/resultat.html 194.198.183.242 19970106205309 text/html 5916
HTTP/1.0 200 OK
Date: Mon, 06 Jan 1997 20:48:16 GMT
Server: Microsoft-Internet-Information-Server/1.0
Content-Type: text/html
Last-Modified: Thu, 05 Dec 1996 09:15:04 GMT
Content-Length: 5716
</DOCHDR>
<HTML><!---------------------------------------------------------------><!-      AUTHOR:       mats holm                           ><!-      E-MAIL:            mats@softmachine.se                  ><!-      CREATED:   	  1996.09.26                       ><!-      MODIFIED:  	                     ><!-- Anchor Point Tag --><A NAME="Up!"><!-      FILE: resultat.html></A>                <!---------------------------------------------------------------><!-- Head Tag --><HEAD><TITLE>KFB-Biobaserade drivmedel/utv&auml;rderingar och resultat</TITLE></HEAD><!-- Body Tag --><BODY TEXT="#4C4C4C" BACKGROUND="biopic/yel_bgr.gif"></BODY><!-- Link Tag --><A HREF="index.html"><!-- Graphic Tag --><IMG WIDTH=534 HEIGHT=28 BORDER=0  SRC="biopic/kfbhead.gif"></A><TABLE WIDTH=535 BORDER=0 ><TR><TD WIDTH=130 BORDER=0 valign=top><!-- Link Tag --><A HREF="uppdrag.html"><!-- Graphic Tag --><IMG WIDTH=108 HEIGHT=18 BORDER=0  SRC="biopic/kna_pro.gif"></A><!-- Link Tag --><A HREF="projects.html"><!-- Graphic Tag --><IMG WIDTH=108 HEIGHT=18 BORDER=0  SRC="biopic/kna_proj.gif"></A><!-- Link Tag --><A HREF="litteratur.html"><!-- Graphic Tag --><IMG WIDTH=108 HEIGHT=18 BORDER=0  SRC="biopic/kna_hood.gif"></A><!-- Link Tag --><A HREF="renalkohol.html"><!-- Graphic Tag --><IMG WIDTH=108 HEIGHT=17 BORDER=0  SRC="biopic/kna_infra.gif"></A><!-- Link Tag --><A HREF="blandbransle.html"><!-- Graphic Tag --><IMG WIDTH=108 HEIGHT=18 BORDER=0  SRC="biopic/kna_energ.gif"></A><!-- Link Tag --><A HREF="biogas.html"><!-- Graphic Tag --><IMG WIDTH=108 HEIGHT=17 BORDER=0  SRC="biopic/kna_eco.gif"></A><!-- Link Tag --><A HREF="resultat.html"><!-- Graphic Tag --><IMG WIDTH=108 HEIGHT=17 BORDER=0  SRC="biopic/kna_perfaa.gif"></A><!-- Link Tag --><A HREF="miljo.html"><!-- Graphic Tag --><IMG WIDTH=108 HEIGHT=18 BORDER=0  SRC="biopic/kna_mark.gif"></A></TD><TD WIDTH=15 BORDER=0 align=center></TD><TD WIDTH=300 BORDER=0 align=left valign=top><BR><!-- Graphic Tag --><IMG WIDTH=273 HEIGHT=18  SRC="biopic/resultat.gif"><BR><!-- Graphic Tag --><IMG WIDTH=284 HEIGHT=182  SRC="biopic/bilsped.gif"><P>Avsev&auml;rda resurser avs&auml;tts till utv&auml;rderingar som framf&ouml;r allt avser <B>h&auml;lsa, milj&ouml;, teknik</B> och <B>ekonomi</B>. Man m&auml;ter och analyserar emissionerna och deras lokala, regionala och globala milj&ouml;- och h&auml;lsoeffekter. Alkohol- och biogasteknikens tillf&ouml;rlitlighet och utvecklingspotential bed&ouml;ms. Ekonomiska utv&auml;rderingar g&ouml;rs b&aring;de inom de olika projekten och p&aring; &ouml;vergripande programniv&aring;. P&aring; programniv&aring;n bed&ouml;mer man ocks&aring; potentialen f&ouml;r produktion och anv&auml;ndning av de olika drivmedlen; f&ouml;r olika k&auml;llor, typer av fordon och trafiktill&auml;mpning. &Auml;ven effekterna av en storskalig introduktion kommer att bed&ouml;mas.</P><P>Utv&auml;rdering av de olika projekten sker kontinuerligt enligt en s&auml;rskild utv&auml;rderingsplan. Autoemission K-B E Consultant ansvarar f&ouml;r de delar som avser emissionsm&auml;tningar samt bed&ouml;mningar avseende h&auml;lsa och milj&ouml;. &Auml;ven fr&aring;gor om teknik och ekonomi ing&aring;r i planen.</P><P>Som ett resultat av utv&auml;rderingen har KFB p&aring;b&ouml;rjat en systemstudie f&ouml;r att ta fram ekonomiska utv&auml;rderingar samt bed&ouml;mningar av potentialen f&ouml;r produktion och anv&auml;ndning av olika drivmedel. Systemstudien beskrivs n&auml;rmare i n&auml;sta avsnitt.P&aring; uppdrag av Riksrevisionsverket granskade IM-gruppen vintern 95/96 biodrivmedelsprogrammet. IM-gruppen sammanfattar sina synpunkter i bl a f&ouml;ljande: </P><!-- Font Tag --><B><FONT SIZE=3><BLOCKQUOTE>&#148;Det &auml;r uppenbart att beslutet 1991 om de 120 miljonerna satte ig&aring;ng m&aring;nga aktiviteter i n&auml;tverket. Det &auml;r ocks&aring; uppenbart att vi idag, j&auml;mf&ouml;rt med 1991, har ett betydande antal f&ouml;retag/institutioner i samarbete i vad vi skulle kunna kalla ett motoralkoholn&auml;tverk.</BLOCKQUOTE></FONT></B>----<!-- Font Tag --><B><BLOCKQUOTE>Kunskapsl&auml;get &auml;r nu (februari 1996) att man med ganska stor s&auml;kerhet kan s&auml;ga att renetanoldrift i vart fall vad g&auml;ller tunga fordon fungerar tekniskt v&auml;l under svenska f&ouml;rh&aring;llanden och att milj&ouml;f&ouml;rdelarna blir betydande. FFV-motorer i l&auml;tta fordon &auml;r etablerad teknik. Vad g&auml;ller blandbr&auml;nsle etanol-diesel i vanliga tunga fordon kvarst&aring;r &auml;nnu fr&aring;gan om br&auml;nslet &auml;r ofarligt f&ouml;r motorerna p&aring; m&aring;nga &aring;rs sikt. Mycket stora v&auml;rden st&aring;r h&auml;r p&aring; spel. Allm&auml;nt g&auml;ller emellertid att teknikfr&aring;gorna, s&aring;v&auml;l vad g&auml;ller tunga som l&auml;tta fordon, inte &auml;r mer komplicerade &auml;n att motorindustrin l&ouml;ser dem p&aring; n&aring;gra &aring;rs sikt.</BLOCKQUOTE>----<BLOCKQUOTE>En av de viktigaste konsekvenserna av programmet &auml;r att kunnandet kring etanol och motorer nu &auml;r vitt spritt i m&aring;nga kommuner &ouml;ver landet. detta inneb&ouml;r sannolikt att en betydande startstr&ouml;cka undviks, om/n&auml;r beslut fattas att skattesubventionera alkoholbr&auml;nsle. samtidigt &auml;r det t&auml;nkbart att det spridda kunnandet och intresset som programmet stimulerat i sig inneb&auml;r en politisk faktor som verkar f&ouml;r ett s&aring;dant beslut"</BLOCKQUOTE></B><BR><!-- Horizontal Line Tag --><HR WIDTH=100%><!-- MailTo Tag --><A HREF="MAILTO:arne.kihlblom@kfb.se"><H6>[Kontakta oss g&auml;rna]</A><!-- Anchor Link Tag --><A HREF="#Up!">[Up!]</H6></A><BR></TD></TR></TABLE></BODY></HTML>
</DOC>
<DOC>
<DOCNO>WT02-B10-79</DOCNO>
<DOCOLDNO>IA018-000200-B015-161</DOCOLDNO>
<DOCHDR>
http://www.kfb.se:80/bioprogs/miljo.html 194.198.183.242 19970106205318 text/html 6689
HTTP/1.0 200 OK
Date: Mon, 06 Jan 1997 20:48:28 GMT
Server: Microsoft-Internet-Information-Server/1.0
Content-Type: text/html
Last-Modified: Thu, 05 Dec 1996 09:14:52 GMT
Content-Length: 6489
</DOCHDR>
<HTML><!---------------------------------------------------------------><!- AUTHOR:   mats holm ><!- E-MAIL:    mats@softmachine.se  ><!- CREATED:  1996.11.15                   ><!- MODIFIED:  	                     ><!-- Anchor Point Tag --><A NAME="Up!"><!-      FILE: milj&ouml;.html></A>                <!---------------------------------------------------------------><!-- Head Tag --><HEAD><TITLE>KFB-Biobaserde drivmedel/milj&ouml; och h&auml;lsa</TITLE></HEAD><!-- Body Tag --><BODY TEXT="#4C4C4C" BACKGROUND="biopic/yel_bgr.gif"></BODY><!-- Link Tag --><A HREF="index.html"><!-- Graphic Tag --><IMG WIDTH=534 HEIGHT=28 BORDER=0  SRC="biopic/kfbhead.gif"></A><TABLE WIDTH=535 BORDER=0 ><TR><TD WIDTH=130 BORDER=0 valign=top><!-- Link Tag --><A HREF="uppdrag.html"><!-- Graphic Tag --><IMG WIDTH=108 HEIGHT=18 BORDER=0  SRC="biopic/kna_pro.gif"></A><!-- Link Tag --><A HREF="projects.html"><!-- Graphic Tag --><IMG WIDTH=108 HEIGHT=18 BORDER=0  SRC="biopic/kna_proj.gif"></A><!-- Link Tag --><A HREF="litteratur.html"><!-- Graphic Tag --><IMG WIDTH=108 HEIGHT=18 BORDER=0  SRC="biopic/kna_hood.gif"></A><!-- Link Tag --><A HREF="renalkohol.html"><!-- Graphic Tag --><IMG WIDTH=108 HEIGHT=17 BORDER=0  SRC="biopic/kna_infra.gif"></A><!-- Link Tag --><A HREF="blandbransle.html"><!-- Graphic Tag --><IMG WIDTH=108 HEIGHT=18 BORDER=0  SRC="biopic/kna_energ.gif"></A><!-- Link Tag --><A HREF="biogas.html"><!-- Graphic Tag --><IMG WIDTH=108 HEIGHT=17 BORDER=0  SRC="biopic/kna_eco.gif"></A><!-- Link Tag --><A HREF="resultat.html"><!-- Graphic Tag --><IMG WIDTH=108 HEIGHT=17 BORDER=0  SRC="biopic/kna_perfa.gif"></A><!-- Link Tag --><A HREF="miljo.html"><!-- Graphic Tag --><IMG WIDTH=108 HEIGHT=18 BORDER=0  SRC="biopic/kna_marka.gif"></A></TD><TD WIDTH=15 BORDER=0 align=center></TD><TD WIDTH=300 BORDER=0 align=left valign=top><BR><!-- Graphic Tag --><IMG WIDTH=166 HEIGHT=18  SRC="biopic/miljo.gif"><BR><BR><P>Vid all f&ouml;rbr&auml;nning bildas avfallsprodukter, som i m&aring;nga fall &auml;r skadliga f&ouml;r milj&ouml; och h&auml;lsa. Koloxid, koldioxid, kolv&auml;ten och kv&auml;veoxider &auml;r n&aring;gra exempel p&aring; o&ouml;nskade &auml;mnen som i stora m&auml;ngder bildas vid f&ouml;rbr&auml;nning i bil-, buss- och lastbilsmotorer.</P><P>S&aring; l&auml;nge vi anv&auml;nder fossila drivmedel i v&aring;ra fordon f&aring;r vi hela tiden ett tillskott av koldioxid vilket starkt bidrar till v&auml;xthuseffekten. L&ouml;sningen p&aring; detta kan vara biobaserade drivmedel som framst&auml;lls ur f&ouml;rnybara r&aring;varor, t ex skog och spannm&aring;l. H&auml;r stannar koldioxiden i ett slutet kretslopp. Lika mycket koldioxid som frig&ouml;rs vid f&ouml;rbr&auml;nningen, lika mycket tar v&auml;xterna upp f&ouml;r sin tillv&auml;xt.</P><BR><!-- Font Tag --><B><FONT SIZE=3>J&auml;mf&ouml;relse av olika br&auml;nslens utsl&auml;pp</FONT></B><BR><BR><!-- Table Tag --><TABLE BORDER=1><!-- Font Tag --><TR><TD>Br&auml;nsle/fordon</TD><TD>NOx(g/kWh)</TD><TD>CO(g/kWh)</TD><TD>Kolv&auml;ten(g/kWh)</TD><TD>Partiklar(g/kWh)</TD></TR><TR><TD>Milj&ouml;dieselbuss</TD><TD>8,0</TD><TD>0,8</TD><TD>0,5</TD><TD>0,4</TD></TR><TR><TD>Milj&ouml;diesel medkatalysator</TD><TD>6,3</TD><TD>0,1</TD><TD>0,1</TD><TD>0,1</TD></TR><TR><TD>NaturgasbussVolvo</TD><TD>2,0</TD><TD>0,3</TD><TD>2,0</TD><TD>0,05</TD></TR><TR><TD>Naturgasmotorprototyp</TD><TD>0,1</TD><TD>0,4</TD><TD>0,1</TD><TD><0,02</TD></TR><TR><TD>Etanolbuss</TD><TD>4,5</TD><TD>0,1</TD><TD>0,2</TD><TD>0,05</TD></TR><TR><TD>LPG-buss</TD><TD>2,1</TD><TD>0,3</TD><TD>0,2</TD><TD>- </TD></TR></TABLE><H6>Emissionsdata f&ouml;r reglerade &auml;mnen fr&aring;n olika br&auml;nslen. Data f&ouml;r kolv&ouml;ten avser summan av b&aring;de metankolv&auml;te och &ouml;vriga kolv&auml;ten. Testmetod ECE  R49.</H6><P>Gasdrivna fordon har stora m&ouml;jligheter till goda emissionsprestanda. Biometan har en mycket enhetlig kolv&auml;tesammans&auml;ttning, normalt saknas tyngre kolv&auml;ten helt, vilket &auml;r en f&ouml;rdel gentemot naturgas, som i och f&ouml;r sig har mycket goda emissionsdata.</P><P>Utsl&auml;ppen av framf&ouml;r allt NO<KBD>x</KBD> och partiklar vid naturgasdrift &auml;r l&aring;ga. Utsl&auml;ppen av kolv&auml;ten fr&aring;n naturgasfordon best&aring;r framf&auml;r allt av metan, som &auml;r en v&auml;xthusgas. Metan har dock ingen inverkan p&aring; den lokala milj&ouml;n. Emissioner fr&aring;n dieseldrivna fordon inneh&aring;ller mer av oreglerade skadliga &auml;mnen som bensen och polyaromatiska kolv&auml;ten (PAC).</P>Drift av fordon med biometan i st&auml;llet f&ouml;r exempelvis dieselolja ger bl a f&ouml;ljande milj&ouml;f&ouml;rdelar:<BR><BR>Betydligt l&auml;gre utsl&auml;pp av:<BR><BLOCKQUOTE>-kv&auml;veoxider<BR>-partiklar<BR>-kolv&auml;ten (exkl metan)<BR>-vissa icke-reglerade &auml;mnen, t.ex. bensen, PAC</BLOCKQUOTE><BR><H6>Figurerna nedan illustrerar v&auml;gtrafikens utsl&auml;pp. Inf&ouml;rande av nya alternativ (t ex biobaserade br&auml;nslen och el-/hybridfordon)  kan kanske v&auml;nda kurvan f&ouml;r koldioxiden.<BR>(k&auml;lla V&auml;gverkets Milj&ouml;rapport 1993).</H6> <BR><!-- Font Tag --><B>Kv&auml;veoxider och Kolv&auml;ten. </B><BR><!-- Graphic Tag --><IMG WIDTH=188 HEIGHT=164  SRC="biopic/kvaveoxid.gif"><BR><BR><!-- Font Tag --><B>Svaveloxid. </B>Ton/&aring;r<BR><!-- Graphic Tag --><IMG WIDTH=171 HEIGHT=166 SRC="biopic/svaveldioxid.gif"><BR><BR><!-- Font Tag --><B>Koldioxid.</B> Ton/&aring;r<BR><!-- Graphic Tag --><IMG  SRC="biopic/koldioxid.gif"><BR><BR><P>&Ouml;verg&aring;ng fr&aring;n diesel till biodrivmedel har f&ouml;ruts&auml;ttningar att ge renare fordon. Genom &ouml;verg&aring;ng till alkoholer f&ouml;rb&auml;ttras motorns energiverkningsgrad. Detta inneb&auml;r minskade emissioner av olika slag. Enligt en livscykelanalys som utf&ouml;rts av Ecotraffic s&aring; kan man minska utsl&auml;ppen av klimatgaser med i storleksordningen 65-80% j&auml;mf&ouml;rt med diesel och bensin. Om denna milj&ouml;potential verkligen kommer att utnyttjas fullt ut sammanh&auml;nger dock med en rad faktorer, d&auml;r bl a teknikval kan komma att f&aring; en avg&ouml;rande betydelse.</P><BR><!-- Horizontal Line Tag --><HR WIDTH=100%><!-- MailTo Tag --><A HREF="MAILTO:arne.kihlblom@kfb.se"><H6>[Kontakta oss g&auml;rna]</A><!-- Anchor Link Tag --><A HREF="#Up!">[Up!]</H6></A><BR>   </TD></TR></TABLE></BODY></HTML>
</DOC>
<DOC>
<DOCNO>WT02-B10-80</DOCNO>
<DOCOLDNO>IA073-000479-B022-271</DOCOLDNO>
<DOCHDR>
http://www.dawnbreaker.com:80/home.html 204.249.112.36 19970208232657 text/html 3959
HTTP/1.0 200 OK
Date: Sat, 08 Feb 1997 23:28:11 GMT
Server: Apache/1.0.5
Content-type: text/html
Content-length: 3788
Last-modified: Thu, 26 Dec 1996 22:38:13 GMT
</DOCHDR>
<HTML> 
<HEAD>
<TITLE>W</TITLE>
<TITLE>We</TITLE>
<TITLE>Wel</TITLE>
<TITLE>Welc</TITLE>
<TITLE>Welco</TITLE>
<TITLE>Welcom</TITLE>
<TITLE>Welcome</TITLE>
<TITLE>Welcome </TITLE>
<TITLE>Welcome t</TITLE>
<TITLE>Welcome to</TITLE>
<TITLE>Welcome to </TITLE>
<TITLE>Welcome to D</TITLE>
<TITLE>Welcome to Da</TITLE>
<TITLE>Welcome to Daw</TITLE>
<TITLE>Welcome to Dawn</TITLE>
<TITLE>Welcome to Dawnb</TITLE>
<TITLE>Welcome to Dawnbr</TITLE>
<TITLE>Welcome to Dawnbre</TITLE>
<TITLE>Welcome to Dawnbrea</TITLE>
<TITLE>Welcome to Dawnbreak</TITLE>
<TITLE>Welcome to Dawnbreake</TITLE>
<TITLE>Welcome to Dawnbreaker</TITLE></HEAD> 
<BODY link=006633 bgcolor="#ffffff"> 

<CENTER>
<!-- Graphic Tag -->
<IMG WIDTH=216 HEIGHT=160  SRC="graphics/DawnB2.gif"><BR><P>


<!-- Graphic Tag -->
<IMG WIDTH=499 HEIGHT=19  SRC="graphics/rule.gif"></CENTER><P>


<H3>ABOUT DAWNBREAKER</H3>
<P>

Dawnbreaker is a professional services firm providing commercialization assistance to advanced technology firms and their investors. Dawnbreaker specializes in business planning, market research, and negotiations using a unique blend of individualized mentoring, training seminars, and consulting. Two distinguishing features characterize Dawnbreaker's work. First, is the emphasis on measurable results. Second, is the use of a process to grow our clients' business. Dawnbreaker's success is measured by the success of our clients. Fifty percent of our clients receive private sector financing within eighteen months after developing business plans with our assistance.<P>

Dawnbreaker has been in business since 1989 and has worked with over 400 small, advanced technology firms through the <!-- Link Tag --><A HREF="http://www.sbaonline.sba.gov/SBIR/sbir.html">Small Business Innovation Research Program</A> (DOE and DoD), as well as the <!-- Link Tag --><A HREF="http://www.atp.nist.gov/">Advanced Technology Program</A> (ATP).<P>

<CENTER>
<IMG WIDTH=505 HEIGHT=53  SRC="graphics/SUN.gif"><P>
<IMG WIDTH=62 HEIGHT=29  SRC="graphics/dhmbut.gif">
<A HREF="staff.html"><IMG WIDTH=59 HEIGHT=29  SRC="graphics/lstffbut.gif" border=0></A>
<A HREF="service.html"><IMG WIDTH=90 HEIGHT=29  SRC="graphics/lservbut.gif" border=0></A>
<A HREF="clients.html"><IMG WIDTH=79 HEIGHT=29  SRC="graphics/lclnbut.gif" border=0></A><BR>
<A HREF="success.html"><IMG WIDTH=83 HEIGHT=29  SRC="graphics/lsuccbut.gif" border=0></A>
<A HREF="events.html"><IMG WIDTH=73 HEIGHT=29  SRC="graphics/levntbut.gif" border=0></A>
<A HREF="foryou.html"><IMG WIDTH=87 HEIGHT=29  SRC="graphics/lforUbut.gif" border=0></A>
<A HREF="books.html"><IMG WIDTH=70 HEIGHT=29  SRC="graphics/lbookbut.gif" border=0></A>
<P>
<A HREF="home.html">Home</A>&nbsp;&nbsp;
<A HREF="staff.html">Staff</A>&nbsp;&nbsp;
<A HREF="service.html">Services</A>&nbsp;&nbsp;
<A HREF="clients.html">Clients</A>&nbsp;&nbsp;
<A HREF="success.html">Success</A>&nbsp;&nbsp;
<A HREF="events.html">Events</A>&nbsp;&nbsp;
<A HREF="foryou.html">For You</A>&nbsp;&nbsp;
<A HREF="books.html">Books</A>
<P>

</CENTER><P>

<!-- Horizontal Line Tag -->
<HR WIDTH=50% SIZE=3 ALIGN=Center>
<P>

<CENTER>
<B>Dawnbreaker<BR></B>
2117 Buffalo Road<BR>
Suite 193<BR>
Rochester, NY 14624<BR>
(716) 264-0539<BR>
(716) 264-0782 FAX<BR>

<A HREF="MAILTO:jcservo@dawnbreaker.com">
jcservo@dawnbreaker.com</A><P>

Dawnbreaker is a registered trademark.

<P>
<!-- Horizontal Line Tag -->
<HR WIDTH=50% SIZE=3 ALIGN=Center>
<P>
<B>http://www.dawnbreaker.com</B><BR>
<!-- Link Tag --><A HREF="http://www2.apple.com/whymac/"><IMG WIDTH=40 HEIGHT=40  SRC="graphics/applogo.gif" border=0></A><BR>
 Site designed and maintained by<BR>
 <!-- MailTo Tag -->
Blair Hornbuckle at <A HREF="MAILTO:MetaviewCo@aol.com">Metaview Communications.</A><BR>
Last updated December 4, 1996</CENTER><P>
</BODY> 
</HTML> 
</DOC>
<DOC>
<DOCNO>WT02-B10-81</DOCNO>
<DOCOLDNO>IA073-000479-B022-168</DOCOLDNO>
<DOCHDR>
http://www.dawnbreaker.com:80/success.html 204.249.112.36 19970208232614 text/html 8512
HTTP/1.0 200 OK
Date: Sat, 08 Feb 1997 23:27:23 GMT
Server: Apache/1.0.5
Content-type: text/html
Content-length: 8341
Last-modified: Sat, 04 Jan 1997 17:12:41 GMT
</DOCHDR>
<HTML> 
<HEAD><TITLE>Success</TITLE></HEAD> 
<BODY bgcolor="#ffffff"> 
<!-- Graphic Tag -->
<CENTER><IMG WIDTH=157 HEIGHT=116  SRC="graphics/DawnB.gif"><P><BR></CENTER>

<!-- Graphic Tag -->
<IMG WIDTH=499 HEIGHT=19  SRC="graphics/rule.gif"></CENTER><P>
<H3>SUCCESS</H3>

We put ourselves on the line! Dawnbreaker measures its success by the success of our clients in obtaining private sector funding directly related to the tools and skills developed in our programs.<P>
The result:  Fifty percent of the companies we have assisted during the last four programs received private sector investments within 18 months. The cumulative value of these contracts is in excess of $52 million. Increased sales during the 18-month period following program completion exceeded $30 million. While other sources collect long-term follow up data, we measure only near-term financial impact (18 months) that can be directly traced back to the effective use of the business plans developed via this program and the principals' increased business acumen resulting from Dawnbreaker's mentoring process.  This near-term focus increases the likelihood that participating companies will successfully cross the "valley of death," and attain their commercialization objectives.<P>

A sample of client success stories are highlighted under each program heading. General descriptions of the three programs also follow.<P>

<H4><A HREF="#CAP">Commercialization Assistance Program</A> (CAP)</H4><P>

If you are interested in seeing the types of opportunities which have been showcased in previous CAP programs, please preview the following. For further information on any of these companies, please contact the company directly using the contact information listed at the end of each success story. To obtain information on the new opportunities to be showcased in our October Commercialization Opportunity Forum, please register on the event page.<P>

<!-- Table Tag --><TABLE>
<TR><TD></TD><TD><A HREF="Aerodyne.html">Aerodyne</A></TD><TD>(instrumentation)</TD></TR>
<TR><TD></TD><TD><A HREF="ACI.html">AndCare</A></TD><TD>(medical)</TD></TR>
<TR><TD></TD><TD><A HREF="Aqua.html">Aquatech Services</A></TD><TD>(environmental remediation)</TD></TR>
<TR><TD></TD><TD><A HREF="ADA.html">ADA</A></TD><TD>(instrumentation, pollution control)</TD></TR>
<TR><TD></TD><TD><A HREF="Atlantia.html">Atlantia</A></TD><TD>(deep-sea drilling)</TD></TR>
<TR><TD></TD><TD><A HREF="Boron.html">Boron Biologicals</A></TD><TD>(medical)</TD></TR>
<TR><TD></TD><TD><A HREF="INET.html">INET</A></TD><TD>(utilities)</TD></TR>
<TR><TD></TD><TD><A HREF="LSRtech.html">LSR Technologies</A></TD><TD>(pollution control)</TD></TR>
<TR><TD></TD><TD><A HREF="IST.html">International Sensor Technology</A> </TD><TD>(instrumentation)</TD></TR>
<TR><TD></TD><TD><A HREF="Ocean.html">Ocean Optics</A></TD><TD>(instrumentation)</TD></TR>
<TR><TD></TD><TD><A HREF="Spectral.html">Spectral Sciences</A></TD><TD>(instrumentation)</TD></TR>
<TR><TD></TD><TD><A HREF="TRI.html">TRI</A></TD><TD>(optics, instrumentation)</TD></TR>
<TR><TD></TD><TD><A HREF="Vortec.html">Vortec</A></TD><TD>(environmental remediation)</TD></TR>
</TABLE>

<H4><A HREF="#Strategic Plan">Strategic Planning Program</A></H4><P>

<TABLE>
 
<TR><TD><IMG WIDTH=35 HEIGHT=18  SRC="graphics/new.gif"></TD><TD><A HREF="DispTech.html">Displaytech</A></TD><TD>(miniature liquid crystal displays)</TD></TR>
<TR><TD></TD><TD><A HREF="PhysOpt.html">Physical Optics</A></TD><TD>(optical display technology)</TD></TR>
</TABLE>

<H4><A HREF="#Indicators">Indicators of Commercial Potential</A></H4><P>

<TABLE>
<TR><TD><IMG WIDTH=35 HEIGHT=18  SRC="graphics/new.gif"></TD><TD><A HREF="AdTech.html">AdTech</A></TD><TD>(engineering, analysis, testing)</TD></TR>
<TR><TD><IMG WIDTH=35 HEIGHT=18  SRC="graphics/new.gif"></TD><TD><A HREF="AnalyticalServ.html">Analytical Services & Materials</A></TD><TD>(specializes in a variety of aerospace related disciplines)</TD></TR>
<TR><TD><IMG WIDTH=35 HEIGHT=18  SRC="graphics/new.gif"></TD><TD><A HREF="ArcovaSuccess.html">American Research Corporation of Virginia </A></TD><TD>(instrumentation)</TD></TR>
<TR><TD></TD><TD><A HREF="Full.html">Full Circle</A></TD><TD>(radiation shielded packaging)</TD></TR>
<TR><TD><IMG WIDTH=35 HEIGHT=18  SRC="graphics/new.gif"></TD><TD><A HREF="FMRISuccess.html">Fairfax Materials Research, Inc.</A></TD><TD>(hybrid metals)</TD></TR>
<TR><TD><IMG WIDTH=35 HEIGHT=18  SRC="graphics/new.gif"></TD><TD><A HREF="MCCI.html">MCCI</A></TD><TD>(graphical programming technology)</TD></TR>
<TR><TD><IMG WIDTH=35 HEIGHT=18  SRC="graphics/new.gif"></TD><TD><A HREF="StrainMon.html">Strain Monitor Systems</A></TD><TD>(strain monitoring with "smart" materials)</TD></TR>
<TR><TD><IMG WIDTH=35 HEIGHT=18  SRC="graphics/new.gif"></TD><TD><A HREF="TMSTechnologies.html">TMS Technologies, Inc.</A></TD><TD>(microelectromechanical systems (MEMS))</TD></TR>
</TABLE>
<P>
<HR SIZE=6 ALIGN=Center>
<P>

<H4><A NAME="CAP">Commercialization Assistance Program</A></H4><P>

This program is designed for groups of up to 100 companies and is typically sponsored by an organization, such as a federal agency, with a vested interest in the success of the companies. The purpose of the CAP is to speed up the rate of successful commercialization of R&D. This is accomplished via a process which contains the following components: (1) comprehensive business research and strategic planning, (2) development of a business plan, a stand-alone executive summary, and presentation materials, (3) targeted outreach to potential strategic allies and investors, and (4) a Commercialization Opportunity Forum which brings together well-prepared technology entrepreneurs with prequalified investors and teaming partners.<P>

The success of this program is measured by the success of our clients. Specifically, we look at <P>
<UL TYPE=disc>
<LI>how many finalists receive private sector financing within 18 months of the Forum,
<LI>the dollar value of those signed agreements, 
<LI>the dollar value of increased sales, 
<LI>and the increase in the number of jobs.
</UL>
The program is designed for use with geographically dispersed or remote clients and consists of guided mentoring, the use of local resources, and three events spaced over a 6-9 month period.<P>

<H4><A NAME="Strategic Plan">Strategic Planning Program</A></H4><P>

The Strategic Planning Program was conducted in 1995 as a pilot for companies which had received awards from the Advanced Technology Program (ATP). Success for this program is measured by:<P>

<UL TYPE=disc>
<LI>Private sector investment
<LI>Increased sales
</UL>
<H4><A NAME="Indicators">Indicators of Commercial Potential</A></H4><P>

This program is an outgrowth of a pilot program that Dawnbreaker conducted for the Department of Defense in 1994 and 1995. The program is designed for use with Phase I SBIR and STTR recipients. The objective is to increase the likelihood that companies will receive Phase II financing by appropriately addressing preliminary commercialization issues in their Phase II proposals.<P>

Success is measured by:<P>

<UL TYPE=disc>
<LI>Receipt of Phase II award
<LI>Headway with private sector commercialization
</UL>
<CENTER>
<IMG WIDTH=505 HEIGHT=53  SRC="graphics/SUN.gif"><P>
<A HREF="home.html"><IMG WIDTH=63 HEIGHT=29  SRC="graphics/lhmbut.gif" border=0></A>
<A HREF="staff.html"><IMG WIDTH=59 HEIGHT=29  SRC="graphics/lstffbut.gif" border=0></A>
<A HREF="service.html"><IMG WIDTH=90 HEIGHT=29  SRC="graphics/lservbut.gif" border=0></A>
<A HREF="clients.html"><IMG WIDTH=79 HEIGHT=29  SRC="graphics/lclnbut.gif" border=0></A><BR>
<IMG WIDTH=85 HEIGHT=29  SRC="graphics/dsuccbut.gif">
<A HREF="events.html"><IMG WIDTH=73 HEIGHT=29  SRC="graphics/levntbut.gif" border=0></A>
<A HREF="foryou.html"><IMG WIDTH=87 HEIGHT=29  SRC="graphics/lforUbut.gif" border=0></A>
<A HREF="books.html"><IMG WIDTH=70 HEIGHT=29  SRC="graphics/lbookbut.gif" border=0></A>
<P>
<A HREF="home.html">Home</A>&nbsp;&nbsp;
<A HREF="staff.html">Staff</A>&nbsp;&nbsp;
<A HREF="service.html">Services</A>&nbsp;&nbsp;
<A HREF="clients.html">Clients</A>&nbsp;&nbsp;
<A HREF="success.html">Success</A>&nbsp;&nbsp;
<A HREF="events.html">Events</A>&nbsp;&nbsp;
<A HREF="foryou.html">For You</A>&nbsp;&nbsp;
<A HREF="books.html">Books</A>
<P></CENTER>

</BODY> 
</HTML> 
</DOC>
<DOC>
<DOCNO>WT02-B10-82</DOCNO>
<DOCOLDNO>IA073-000479-B022-200</DOCOLDNO>
<DOCHDR>
http://www.dawnbreaker.com:80/events.html 204.249.112.36 19970208232627 text/html 1794
HTTP/1.0 200 OK
Date: Sat, 08 Feb 1997 23:27:43 GMT
Server: Apache/1.0.5
Content-type: text/html
Content-length: 1623
Last-modified: Thu, 05 Dec 1996 09:03:28 GMT
</DOCHDR>
<HTML> 
<HEAD><TITLE>Events</TITLE></HEAD> 
<BODY bgcolor="#ffffff"> 

<!-- Graphic Tag -->
<CENTER><!-- Graphic Tag -->
<CENTER><!-- Graphic Tag -->
<IMG WIDTH=157 HEIGHT=116  SRC="graphics/DawnB.gif"><P><BR></CENTER>

<!-- Graphic Tag -->
<IMG WIDTH=499 HEIGHT=19  SRC="graphics/rule.gif"></CENTER><P>
<H3>UPCOMING EVENTS</H3>
<H4>FOR INVESTORS</H4>
<B>Dawnbreaker Commercialization Opportunity Forum for the U.S. Department of Energy</B><P>
September, 1997 -- stay tuned for details.<P>

<CENTER>
<IMG WIDTH=505 HEIGHT=53  SRC="graphics/SUN.gif"><P>
<A HREF="home.html"><IMG WIDTH=63 HEIGHT=29  SRC="graphics/lhmbut.gif" border=0></A>
<A HREF="staff.html"><IMG WIDTH=59 HEIGHT=29  SRC="graphics/lstffbut.gif" border=0></A>
<A HREF="service.html"><IMG WIDTH=90 HEIGHT=29  SRC="graphics/lservbut.gif" border=0></A>
<A HREF="clients.html"><IMG WIDTH=79 HEIGHT=29  SRC="graphics/lclnbut.gif" border=0></A><BR>
<A HREF="success.html"><IMG WIDTH=85 HEIGHT=29  SRC="graphics/lsuccbut.gif" border=0></A>
<IMG WIDTH=73 HEIGHT=29  SRC="graphics/devntbut.gif" border=0>
<A HREF="foryou.html"><IMG WIDTH=87 HEIGHT=29  SRC="graphics/lforUbut.gif" border=0></A>
<A HREF="books.html"><IMG WIDTH=70 HEIGHT=29  SRC="graphics/lbookbut.gif" border=0></A>
<p>
<A HREF="home.html">Home</A>&nbsp;&nbsp;
<A HREF="staff.html">Staff</A>&nbsp;&nbsp;
<A HREF="service.html">Services</A>&nbsp;&nbsp;
<A HREF="clients.html">Clients</A>&nbsp;&nbsp;
<A HREF="success.html">Success</A>&nbsp;&nbsp;
<A HREF="events.html">Events</A>&nbsp;&nbsp;
<A HREF="foryou.html">For You</A>&nbsp;&nbsp;
<A HREF="books.html">Books</A>
<P>
</CENTER>
</BODY> 
</HTML> 
</DOC>
<DOC>
<DOCNO>WT02-B10-83</DOCNO>
<DOCOLDNO>IA073-000479-B022-222</DOCOLDNO>
<DOCHDR>
http://www.dawnbreaker.com:80/foryou.html 204.249.112.36 19970208232638 text/html 3142
HTTP/1.0 200 OK
Date: Sat, 08 Feb 1997 23:27:54 GMT
Server: Apache/1.0.5
Content-type: text/html
Content-length: 2971
Last-modified: Thu, 05 Dec 1996 08:53:00 GMT
</DOCHDR>
<HTML> 
<HEAD><TITLE>Biz Plan How To</TITLE></HEAD> 
<BODY bgcolor="#ffffff"> 

<!-- These tags are for top and bottom navigation, but currently don't work.
<A HREF="foryou.html#PageBottom"><IMG WIDTH=18 HEIGHT=18  SRC="graphics/upbut.gif" border=0></A> <A HREF="foryou.html#PageTop"><IMG WIDTH=18 HEIGHT=18  SRC="graphics/dwnbut.gif" border=0></A>>

<!-- Graphic Tag -->
<CENTER><IMG WIDTH=157 HEIGHT=116  SRC="graphics/DawnB.gif"><P><BR></CENTER>


<!-- Graphic Tag -->
<IMG WIDTH=499 HEIGHT=19  SRC="graphics/rule.gif"></CENTER><P>
<P>
This section is intended to provide you with useful information, and introduce you further to our work. We've included links to aid you in market research, an article we've written on business planning, and (coming soon) activities to help you sharpen your skills in sizing emerging markets and selecting strategies for commercialization.<P>

<B>Market Research Tools</B><P>
<BLOCKQUOTE><A HREF="http://www.ld.com/cbd/today/index.html-ssi">Commerce Business Daily Today's Index</A><BR>
DOE Environmental Management<BR>
<A HREF="http://www.doc.gov/inquery/BudgetFY96/BudgetFY96.html">Federal budget 96</A><BR>
<A HREF="http://www.doc.gov/BudgetFY97/index.html">Federal budget 97</A><BR>
<A HREF="http://www.nttc.edu/">National Tech Transfer Center</A><BR>
<A HREF="http://www.sbaonline.sba.gov/Research_And_Development/">SBIR Office of Technology R&D</A><BR>
<A HREF="http://www.sec.gov/">Security and Exchange Commission</A><BR>
<A HREF="http://weber.u.washington.edu/~dev/sic.html">SIC Codes</A><BR>
<A HREF="http://198.76.84.1/welcome/ctis/bus_op.html">US Agency for Int'l Development</A><BR>
<A HREF="http://www.uspto.gov/">US Patent and Trademark Office</A><P>
</BLOCKQUOTE>

<B>How To Articles</B><P>
<BLOCKQUOTE><A HREF="article1.html">Developing effective business plans</A><P>
</BLOCKQUOTE>

<CENTER>
<IMG WIDTH=505 HEIGHT=53  SRC="graphics/SUN.gif"><P>
<A HREF="home.html"><IMG WIDTH=63 HEIGHT=29  SRC="graphics/lhmbut.gif" border=0></A>
<A HREF="staff.html"><IMG WIDTH=59 HEIGHT=29  SRC="graphics/lstffbut.gif" border=0></A>
<A HREF="service.html"><IMG WIDTH=90 HEIGHT=29  SRC="graphics/lservbut.gif" border=0></A>
<A HREF="clients.html"><IMG WIDTH=79 HEIGHT=29  SRC="graphics/lclnbut.gif" border=0></A><BR>
<A HREF="success.html"><IMG WIDTH=85 HEIGHT=29  SRC="graphics/lsuccbut.gif" border=0></A>
<A HREF="events.html"><IMG WIDTH=73 HEIGHT=29  SRC="graphics/levntbut.gif" border=0></A>
<IMG WIDTH=87 HEIGHT=29  SRC="graphics/dforUbut.gif" border=0>
<A HREF="books.html"><IMG WIDTH=70 HEIGHT=29  SRC="graphics/lbookbut.gif" border=0></A>
<P>
<A HREF="home.html">Home</A>&nbsp;&nbsp;
<A HREF="staff.html">Staff</A>&nbsp;&nbsp;
<A HREF="service.html">Services</A>&nbsp;&nbsp;
<A HREF="clients.html">Clients</A>&nbsp;&nbsp;
<A HREF="success.html">Success</A>&nbsp;&nbsp;
<A HREF="events.html">Events</A>&nbsp;&nbsp;
<A HREF="foryou.html">For You</A>&nbsp;&nbsp;
<A HREF="books.html">Books</A>
<P></CENTER>

</BODY> 
</HTML> 
</DOC>
<DOC>
<DOCNO>WT02-B10-84</DOCNO>
<DOCOLDNO>IA073-000479-B022-245</DOCOLDNO>
<DOCHDR>
http://www.dawnbreaker.com:80/books.html 204.249.112.36 19970208232647 text/html 2574
HTTP/1.0 200 OK
Date: Sat, 08 Feb 1997 23:28:02 GMT
Server: Apache/1.0.5
Content-type: text/html
Content-length: 2403
Last-modified: Thu, 05 Dec 1996 08:52:42 GMT
</DOCHDR>
<HTML> 
<HEAD><TITLE>Dawnbreaker Books</TITLE></HEAD> 
<BODY bgcolor="#ffffff"> 

<!-- Graphic Tag -->
<CENTER><IMG WIDTH=157 HEIGHT=116  SRC="graphics/DawnB.gif"><P><BR></CENTER>


<!-- Graphic Tag -->
<IMG WIDTH=499 HEIGHT=19  SRC="graphics/rule.gif"></CENTER><P>
<P>
<H3>PUBLICATIONS</H3>
Dawnbreaker Press publishes books written by Dr. Jenny Servo and Paul Hauler to accompany our programs. These include:<P>

<BLOCKQUOTE>Servo, Jenny & Hauler, Paul<BR>
<B>Business Planning for Scientists and Engineers</B>&nbsp; (second edition)<BR>
Rochester, NY, 1995. <B>$29.95</B><P>

Servo, Jenny & Hauler, Paul<BR>
<B>Knock their Socks Off: Making Winning Presentations to Investors</B>&nbsp<BR>
Rochester, NY, 1995.<B> $19.95</B><P>

Servo, Jenny<BR>
<B>Indicators of Commercial Potential</B>&nbsp<BR>
Rochester, NY,  1996. <B>$29.95</B><P>
</BLOCKQUOTE>
Orders can be placed by mail or fax. Add 8% Sales Tax (NY only) plus $3.50 Shipping & Handling.<P>Please <B>fax Purchase Order</B> or <B>mail a check</B>. Make checks or purchase orders to:<P>
<B>Dawnbreaker Press<BR></B>
Suite 193, 2117 Buffalo Road<BR>
Rochester, NY 14624<BR>
Fax: (716) 264-0782<P>
Call (716) 264-0539 or 
<A HREF="MAILTO:jcservo@dawnbreaker.com">e-mail</A> with questions.<P>

<CENTER>
<IMG WIDTH=505 HEIGHT=53  SRC="graphics/SUN.gif"><P>
<A HREF="home.html"><IMG WIDTH=63 HEIGHT=29  SRC="graphics/lhmbut.gif" border=0></A>
<A HREF="staff.html"><IMG WIDTH=59 HEIGHT=29  SRC="graphics/lstffbut.gif" border=0></A>
<A HREF="service.html"><IMG WIDTH=90 HEIGHT=29  SRC="graphics/lservbut.gif" border=0></A>
<A HREF="clients.html"><IMG WIDTH=79 HEIGHT=29  SRC="graphics/lclnbut.gif" border=o></A><BR>
<A HREF="success.html"><IMG WIDTH=85 HEIGHT=29  SRC="graphics/lsuccbut.gif" border=0></A>
<A HREF="events.html"><IMG WIDTH=73 HEIGHT=29  SRC="graphics/levntbut.gif" border=0></A>
<A HREF="foryou.html"><IMG WIDTH=87 HEIGHT=29  SRC="graphics/lforUbut.gif" border=0></A>
<IMG WIDTH=70 HEIGHT=29  SRC="graphics/dbookbut.gif" border=0>
<P>
<A HREF="home.html">Home</A>&nbsp;&nbsp;
<A HREF="staff.html">Staff</A>&nbsp;&nbsp;
<A HREF="service.html">Services</A>&nbsp;&nbsp;
<A HREF="clients.html">Clients</A>&nbsp;&nbsp;
<A HREF="success.html">Success</A>&nbsp;&nbsp;
<A HREF="events.html">Events</A>&nbsp;&nbsp;
<A HREF="foryou.html">For You</A>&nbsp;&nbsp;
<A HREF="books.html">Books</A>
<P>
</CENTER>

</BODY> 
</HTML> 

</BODY> 
</HTML> 
</DOC>
<DOC>
<DOCNO>WT02-B10-85</DOCNO>
<DOCOLDNO>IA073-000479-B023-198</DOCOLDNO>
<DOCHDR>
http://www.dawnbreaker.com:80/Aerodyne.html 204.249.112.36 19970208232850 text/html 4927
HTTP/1.0 200 OK
Date: Sat, 08 Feb 1997 23:30:02 GMT
Server: Apache/1.0.5
Content-type: text/html
Content-length: 4756
Last-modified: Tue, 10 Dec 1996 17:45:37 GMT
</DOCHDR>
<HTML> 
<HEAD><TITLE>Aerodyne's Success</TITLE></HEAD>

<BODY bgcolor="#ffffff"> 
<CENTER><!-- Graphic Tag --><IMG WIDTH=404 HEIGHT=288  SRC="graphics/ARIfinal.jpg">

<BODY> 
<H2 ALIGN=CENTER>Aerodyne Research, Inc.</H2>
<H3 ALIGN=CENTER>Billerica, MA 
</H3>
<!-- Graphic Tag --><IMG WIDTH=216 HEIGHT=146  SRC="graphics/ARI.logo.gif"></CENTER>
<CENTER>
<P>

<IMG WIDTH=499 HEIGHT=19  SRC="graphics/rule.gif">
</CENTER><P>
1993 CAP participant<BR>
SBIR:DE-AC01-85-ER80308<P>

<B>Success criteria:</B><P>

<!-- List Tag --><UL TYPE=disc>
<LI>increased sales
<LI>licensing
</UL>

Aerodyne Research, Inc. has provided research and development services to clients working to solve national and international problems since 1970. We contribute understanding of and solutions to critical issues such as global and regional environmental quality and the development of clean, efficient energy and propulsion sources. We design improved remote sensing, surveillance, image processing, tracking and assessment systems for the national defense. We also develop advanced materials and devises for electronic, electro-optical, environmental and energy applications.<P>

The Atmospheric Chemistry and Environmental Change group at Aerodyne performs laboratory and field experiments, designs and uses mathematical models, and develops and utilizes advanced field measurement techniques to understand the sources, environmental transformations and environmental fate of pollutants and biospheric emissions.<P>

Our DOE SBIR grant for the development of an Ozone Flux Meter has contributed to the development of technologies with applications in: measurement of sources of radiatively important trace species (RITS), acid gas depositions, air pollution characterization; remote monitoring of gas phase pollutants over highways, landfills, and hazardous waste disposal sites; as well as wide area surveys from airborne and/or van mounted platforms.<P>

Aerodyne Research follows two-pronged approach to developing its technology-based product business. We produce and market the highly complex, low volume products ourselves and arrange with other well-positioned firms to produce and market our less complex, high volume products. Our DOE SBIR lead, in part, to the development of our atmospheric trace gas detector systems and our astigmatic multi-pass absorption cell.<P>

The full diode laser trace gas detector system can instantaneously detect part-per-billion concentrations of many trace gases in the atmosphere. We have sold several of these systems to western European research institutions. We have also provided a trace gas detector for our own use in NASA-sponsored studies of the environmental impact of aircraft exhaust.<P>

An innovative optical component developed under the SBIR program is our astigmatic multi-pass absorption cell ("AMAC"). We have been issues an United States Patent (number 5,291,265) covering the AMAC technology. We fully developed two versions of the AMAC into standard products. After producing and selling several AMAC units ourselves, we established a licensing arrangement with NEW FOCUS, Inc., a major optical supply house, under which they produce, market, and distribute the AMAC units. NEW FOCUS, Inc. placed the AMAC in its winter 1995 catalog and has been experiencing increasing sales.<P>

Our DOE Ozone Flux Meter SBIR has led to the development of a series of trace gas detectors, and has led to the following accomplishments:<P>

Patent Award: "Off Axis Cavity Absorption Cell", #5,291,265, P.L. Kebabian (March 1, 1994)<P>
Trace Gas Detector System Sales: International revenues in excess of $1 million.<P>
Astigmatic Multi-pass Absorption Cell Sales and Licensing Agreement: NEW FOCUS, Inc.<P>

<B>Sources:</B><P>

Zahniser, M.S. et al., "Measurement of trace gas fluxes using tunable diode laser spectroscopy." Phil. Trans. R. Soc. Lond. A (1995) 351, 371-382.<P>

Fowler, D. et al., "Measurements of CH4 and N2O fluxes at the landscape scale using micrometerological methods." Phil. Trans. R. Soc. Lond. A (1995) 351, 339-356.<P>

<B>For more information about this product or associated R&D service,  contact:</B><P>

Dr. Mark Zahniser, Principal Scientist<BR>
(508) 663-9500, Ext 224<BR>
(508) 663-4918 fax<BR>
E-mail: <!-- MailTo Tag --><A HREF="MAILTO:mz@aerodyne.com">mz@aerodyne.com</A><P>

Ms. Laurie Dean, Commercialization Manager<BR>
(508) 663-9500, Ext 270<BR>
(508) 663-4818 (fax)<BR>
E-mail: <!-- MailTo Tag --><A HREF="MAILTO:lsdean@aerodyne.com">lsdean@aerodyne.com</A><P>

<CENTER>
<IMG WIDTH=505 HEIGHT=53  SRC="graphics/SUN.gif"><P>
<A HREF="success.html"><IMG WIDTH=171 HEIGHT=29  SRC="graphics/bak2succ.gif" border=0></A>
<p><A HREF="success.html">Back to Success</A></CENTER>
</BODY> 
</HTML> 
</DOC>
<DOC>
<DOCNO>WT02-B10-86</DOCNO>
<DOCOLDNO>IA073-000479-B023-231</DOCOLDNO>
<DOCHDR>
http://www.dawnbreaker.com:80/ACI.html 204.249.112.36 19970208232901 text/html 4329
HTTP/1.0 200 OK
Date: Sat, 08 Feb 1997 23:30:15 GMT
Server: Apache/1.0.5
Content-type: text/html
Content-length: 4158
Last-modified: Thu, 05 Dec 1996 08:52:24 GMT
</DOCHDR>
<HTML> 
<HEAD><TITLE>AndCare's Success</TITLE></HEAD>
<!--WIDTH=288 HEIGHT=239-->

<BODY bgcolor="#ffffff"> 
<CENTER><!-- Graphic Tag --><IMG SRC="graphics/ACImon.jpg"></CENTER>

<BODY> 
<H2 ALIGN=CENTER>AndCare, Inc.</H2>
<H3 ALIGN=CENTER>Research Triangle Park, NC<P>
</H3>
<CENTER>
<IMG WIDTH=499 HEIGHT=19  SRC="graphics/rule.gif">
</CENTER><P>
1991 CAP participant<P>

<B>Success criteria:</B><P>

<!-- List Tag --><UL TYPE=disc>
<LI>private sector developmental funding
<LI>private placement
<LI>marketing partnership
</UL>

AndCare is a diagnostic-device company based in the Research Triangle area of North Carolina. The company focuses on the research, development, and commercialization of medical and environmental diagnostic devices.<P>

AndCare's core sensor technology includes a sensor containing immobilized enzymes, antibodies or other reagents on a disposable plastic strip and a portable electronic monitor, about the size of a paperback novel, to display the readout of the reaction signal.<P>

The company's sensor technology works as follows: a small sample is combined with a premeasured amount of chemical reagent. The disposable sensor is inserted into the portable monitor, and the sample is placed on the sensor. After electrochemical stripping analysis, the concentration of the substance being tested for is displayed on the monitor in minutes.<P>

AndCare's technology offers several advantages over other testing methods:<P>

<!-- List Tag --><UL TYPE=disc>
<LI>The sample is confined to the disposable sensor and never touches the monitor, increasing safety and decreasing the risk of sample contamination.
<LI>The system is cost-effective, with increased convenience and rapid test results.
<LI>The patented, easy-to-use sensor and monitor system requires minimal training for healthcare or environmental workers.
</UL>
AndCare's patented sensor technology has been demonstrated in the company's LeadCareTM System, a point-of-care diagnostic device for measuring the level of lead in a patient's blood. LeadCare employs an electrochemical stripping sensor containing electrodes coated with colloidal-sized gold particles on a disposable plastic strip. The LeadCare System also includes a portable electronic monitor about the size of a paperback novel, to display the readout of the reaction signal and store data from testing for further analysis.<P>

With LeadCare, a small amount of whole blood or other sample from the patient is combined with a pre-measured amount of chemical reagent. The system's disposable sensor strip is inserted into the portable monitor and the treated sample is placed on the sensor. In less than five minutes, a measurement of the lead concentration in the sample is displayed on the monitor.<P>

"The use of colloidal gold in the sensor is one of the many unique features of the AndCare lead-testing technology recognized in this patent," said Robert Henkens, Ph.D., and AndCare's chairman and chief scientific officer. "AndCare's lead-detection system meets the analytical challenge of producing a practical device that can accurately and precisely screen young children for blood lead, a need recognized by the Centers for Disease Control."<P>

Lead, a toxic metal, is prevalent in today's industrialized society. Exposure to even minute amounts of lead, which was used until the late 1970's in residential paints and until the 1980's in gasoline, has been shown to cause several medical problems including developmental and learning disabilities in children.<P>

Clinical trials for the LeadCare System are currently underway at Boston Children's Hospital and elsewhere. Initial feedback has been very positive.<P>

The launch of the LeadCare System is currently scheduled for fourth quarter, 1996<P>

<B>For more information on AndCare Inc., please contact:
</B><P>

Dr. Steven Wegner<BR>
President & CEO<BR>
(919) 544-8220  -  phone<BR>
(919) 544-9808 - fax<P>

<CENTER>
<IMG WIDTH=505 HEIGHT=53  SRC="graphics/SUN.gif"><P>
<A HREF="success.html"><IMG WIDTH=171 HEIGHT=29  SRC="graphics/bak2succ.gif" border=0></A>
<p><A HREF="success.html">Back to Success</A></CENTER>
</BODY> 
</HTML> 
</DOC>
<DOC>
<DOCNO>WT02-B10-87</DOCNO>
<DOCOLDNO>IA073-000479-B023-258</DOCOLDNO>
<DOCHDR>
http://www.dawnbreaker.com:80/Aqua.html 204.249.112.36 19970208232916 text/html 4706
HTTP/1.0 200 OK
Date: Sat, 08 Feb 1997 23:30:28 GMT
Server: Apache/1.0.5
Content-type: text/html
Content-length: 4535
Last-modified: Thu, 05 Dec 1996 08:52:37 GMT
</DOCHDR>
<HTML> 
<HEAD><TITLE>Aquatech's Success</TITLE></HEAD>

<BODY bgcolor="#ffffff"> 
<CENTER>
<IMG WIDTH=360 HEIGHT=275  SRC="graphics/Aqua1.jpg"><P>
<IMG WIDTH=360 HEIGHT=296  SRC="graphics/Aqua2.gif"><p>
</CENTER><P>
<HR SIZE=6 ALIGN=Center><P>
<H2 ALIGN=CENTER>Aquatech Services, Inc.</H2>
<H3 ALIGN=CENTER>Fair Oaks, CA<P>
</H3>
<CENTER>
<IMG WIDTH=499 HEIGHT=19  SRC="graphics/rule.gif">
</CENTER><P>
1995 CAP participant<BR>
SBIR:DE-FG03-91ER810105<P>

<B>Success criteria:</B><P>

<!-- List Tag --><UL TYPE=disc>
<LI>strategic alliance
<LI>investors
</UL>

Aquatech, a U.S.-based environmental technology development firm, has developed and successfully demonstrated a proprietary process for treating saline waste water from the oil, gas, and coal mining operations. The process enables mine operators to achieve compliance with environmental regulations and to recover clean water for use in agricultural or industrial processes.<P>

Waste water from energy resource production operations is highly saline and contaminated with other environmentally regulated compounds. Its discharge into streams, rivers, and other natural bodies of water results in severe water quality degradation and ecosystem destruction, including death of vegetation and fish. Energy and mineral producers are under increasing pressure to treat and dispose of these effluents to comply with national and international environmental mandates and to reduce their pollution liability exposure. This is especially true in areas of Central Europe where environmental degradation has reached unsustainable levels.<P>

To date, private investors and the U.S. Department of Energy have invested more than $3 million in the development and commercial demonstration of the Aquatech process. Aquatech is under contract to deliver equipment and technical services for a long-term demonstration of the process at Morcinek Mines, Silesia, Poland. This is part of a research and demonstration program funded jointly by Aquatech, the U.S. Department of Energy, Environmental Protection Agency, the Polish Ecofund and the Polish National Fund for the Environment.<P>

The demonstration project, as well as the further application of the process to mines throughout Poland and other parts of Central Europe, uses coalbed methane that is currently vented into the atmosphere, to fuel the process. This use of coalbed methane is not only cost-effective, but also reduces greenhouse gas emission, thereby helping to fulfill the goals of the Framework Convention on Climate Change, ratified by the U.S. and more than 100 other countries.<P>

Aquatech's proprietary process offers the following direct benefits to the user:<P>

<!-- List Tag --><UL TYPE=disc>
<LI>Elimination of pollution liabilities resulting from new and additional contamination of water resources by saline discharges from mining operations.
<LI>Reclamation of a substantial portion of the effluent stream as fresh water for agricultural or industrial uses.
<LI>Environmental, water resource and fishery benefits resulting from the prevention of damage from saline discharge that destroys water resources and ecosystems.
<LI>Compliance with national environmental regulations designed to eliminate waste water discharges and pollution fines.
<LI>Support of international treaty obligations regarding water pollution and global climate change.
</UL>
Aquatech  has focused its initial commercial efforts on the multi-billion dollar emerging market in Poland and neighboring countries in Central Europe. Poland  has recently committed to a $9 billion program to improve its environmental infrastructure. Water discharges from mining activities constitute the single largest source of water pollution in Poland. The extension of the Polish mine project beyond the demonstration phase has the support of the Polish government, the Polish Ecofund and the Polish National Fund for the Environment and the World Business Counsel for Sustainable Development.<P>

<B>Sources:</B><P>

(1) Aquatech Press Release, May 1996<P>

<B>For more information on Aquatech, please contact:</B><P>

John Tait<BR>
Principal<BR>
Aquatech Services, Inc.<BR>
(916) 723-5107<BR>
(916) 723-6709 FAX<BR>
E-mail: <!-- MailTo Tag --><A HREF="MAILTO:103220.1655@compuserve.com">103220.1655@compuserve.com</A><P>

<CENTER>
<IMG WIDTH=505 HEIGHT=53  SRC="graphics/SUN.gif"><P>
<A HREF="success.html"><IMG WIDTH=171 HEIGHT=29  SRC="graphics/bak2succ.gif" border=0></A>
<p><A HREF="success.html">Back to Success</A></CENTER>
</BODY> 
</HTML> 
</DOC>
<DOC>
<DOCNO>WT02-B10-88</DOCNO>
<DOCOLDNO>IA073-000479-B023-283</DOCOLDNO>
<DOCHDR>
http://www.dawnbreaker.com:80/ADA.html 204.249.112.36 19970208232928 text/html 2719
HTTP/1.0 200 OK
Date: Sat, 08 Feb 1997 23:30:42 GMT
Server: Apache/1.0.5
Content-type: text/html
Content-length: 2548
Last-modified: Thu, 05 Dec 1996 08:52:26 GMT
</DOCHDR>
<HTML> 
<HEAD><TITLE>ADA's Success</TITLE></HEAD>

<BODY bgcolor="#ffffff"> 

<CENTER><IMG  SRC="graphics/ADAbox.jpeg"></CENTER>

<BODY> 
<H2 ALIGN=CENTER>ADA Technologies, Inc.</H2>
<H3 ALIGN=CENTER>Englewood, CO<P>
</H3>
<CENTER>
<IMG WIDTH=499 HEIGHT=19  SRC="graphics/rule.gif">
</CENTER><P>
1990, 1991 CAP participant<BR>
SBIR Department of Energy<P>

<B>Success criteria:</B><P>

<!-- List Tag --><UL TYPE=disc>
<LI>licensing<BR>
<LI>increased sales<P>
</UL>

ADA Technologies developed its multigas analyzer with money provided by the US Department of Energy&#146;s Small Business Innovation Research Program. (1) The analyzer measures ammonia and other gas constituents in the parts-per-million range.<P>

On December 3, 1991 Patent No 5,070,246 was issued, protecting the technology employed in the ADA Multigas Analyzer. Rights to manufacture the Analyzer have been licensed to LAND Combustion . The Analyzer is configured to measure ammonia, nitric acid, and sulfur dioxide simultaneously on a continuous basis, thereby meeting EPA requirements for continuous monitoring. It provides rapid, accurate, and simultaneous measurement of gas composition which is then available for feedback to system operations controls. (2,3,4)<P>

ADA is a recognized authority in the field of control technology, with extensive experience bearing on problems associated with low-sulfur coals. ADA can economically develop recommendations and evaluate hardware changes using field testing equipment and instrumentation custom developed for these tasks. ADA has developed a reputation for excellence in working side-by-side with plant personnel to solve emission problems.<P>
 
<B>Sources:</B><P>

(1) Coal & Synfuels Technology, December 4, 1989<BR>
(2) ADA Technologies, Inc. Abstracts, Summer 1991, Vol 1, No 1.<BR>
(3) ADA Technologies, Inc. Abstracts, Summer 1992, Vol 2, No 2.<BR>
(4) LAND Combustion - product literature, 1994<P>

<B>For more information on ADA Technologies, Inc., please contact:</B><P>

John Wurster<BR>
Vice President, Sales & Marketing<BR>
ADA Technologies, Inc.<BR>
(303) 792-5615<BR>
(800) 232-0296<BR>
Fax: (303) 792-5633<BR>
Email: <A HREF="MAILTO:ADAABS@ADATECH.COM">ADAABS@ADATECH.COM</A><P>

Visit our WEB Site:   <!-- Link Tag --><A HREF="http://www.adatech.com/">http://www.adatech.com</A><P>

<CENTER>
<IMG WIDTH=505 HEIGHT=53  SRC="graphics/SUN.gif"><P>
<A HREF="success.html"><IMG WIDTH=171 HEIGHT=29  SRC="graphics/bak2succ.gif" border=0></A>
<p><A HREF="success.html">Back to Success</A></CENTER>
</BODY> 
</HTML> 
</DOC>
<DOC>
<DOCNO>WT02-B10-89</DOCNO>
<DOCOLDNO>IA073-000479-B023-311</DOCOLDNO>
<DOCHDR>
http://www.dawnbreaker.com:80/Atlantia.html 204.249.112.36 19970208232938 text/html 3128
HTTP/1.0 200 OK
Date: Sat, 08 Feb 1997 23:30:54 GMT
Server: Apache/1.0.5
Content-type: text/html
Content-length: 2957
Last-modified: Thu, 05 Dec 1996 08:52:40 GMT
</DOCHDR>
<HTML> 
<HEAD><TITLE>Atlantia's Success</TITLE></HEAD>

<BODY bgcolor="#ffffff"> 

<BODY> 
<H2 ALIGN=CENTER>ATLANTIA Corporation</H2>
<H3 ALIGN=CENTER>Houston, TX<P>
</H3>
<CENTER>
<IMG WIDTH=499 HEIGHT=19  SRC="graphics/rule.gif">
</CENTER><P>

1993 CAP participant<BR>
SBIR:DE-FG012-90ER80888<P>

<B>Success criteria:</B><P>

<!-- List Tag --><UL TYPE=disc>
<LI>increased sales<BR>
<LI>strategic alliance<P>
</UL>

Atlantia Corporation based in Houston, Texas, is an engineering firm with an established track record in the offshore platform business. They participated in the SBIR program so that they could develop a tension leg platform concept for use in developing oil and gas reserves in deep water.<P>

A cooperative effort between Atlantia Corporation and the British-Borneo Petroleum Syndicate, P.L.C. subsidiary, British-Petroleum Inc. has resulted in the commercial development of the SeaStar, a low cost production system for deepwater marginal fields. The companies have now signed an agreement to formalize the basis for their future activities in relation to utilization of SeaStar in the Gulf of Mexico.<P>

Atlantia's SeaStar production system is a single column tension leg platform developed for offshore oil and gas of up to 50,000 boe (barrels of oil equivalent) per day, in water depths ranging from 600 to over 6,000 feet. Intended for use on deepwater fields with recoverable reserves from 10 to 100 million boe in size, the SeaStar family includes 40 proprietary hull shapes which can be constructed and installed in less than two years. (1)<P>

During 1995, British-Borneo and Atlantia worked together developing a site-specific SeaStar design. The joint design was created for use on British-Borneo's recently acquired &#147Morpeth&#148; field in the Gulf of Mexico. Water depth at the field is approximately 1,630-ft. Reserves at "Morpeth" are estimated at 50 million barrels of oil and 50 Bef of natural gas.<P>

Regarding the strategic alliance with Atlantia, Alan Gaylor, CEO of British-Borneo said that &#147Atlantia is one of the most innovative designers of low cost production facilities in the world. The SeaStar will be a state-of-the-art production facility that substantially reduces cost structures for smaller oil and gas field developments in deep water, leading to a commercial advantage for both companies. (2,1)<P>

<B>Sources:</B><P>

(1) Atlantia Press Release, December 1995<BR>
(2) Gulf of Mexico Newsletter, December 8, 1995<P>


<B>For more information on Atlantia, please contact:</B><P>

Patricia B. Blandford<BR>
Vice President, Marketing<BR>
ATLANTIA Corporation<BR>
(713) 850-8885<P>

E-mail: <!-- MailTo Tag --><A HREF="MAILTO:PatB@Atlantia.com">PatB@Atlantia.com</A><P>

<CENTER>
<IMG WIDTH=505 HEIGHT=53  SRC="graphics/SUN.gif"><P>
<A HREF="success.html"><IMG WIDTH=171 HEIGHT=29  SRC="graphics/bak2succ.gif" border=0></A>
<p><A HREF="success.html">Back to Success</A></CENTER>
</BODY> 
</HTML> 
</DOC>
<DOC>
<DOCNO>WT02-B10-90</DOCNO>
<DOCOLDNO>IA073-000479-B024-1</DOCOLDNO>
<DOCHDR>
http://www.dawnbreaker.com:80/Boron.html 204.249.112.36 19970208232954 text/html 2722
HTTP/1.0 200 OK
Date: Sat, 08 Feb 1997 23:31:08 GMT
Server: Apache/1.0.5
Content-type: text/html
Content-length: 2551
Last-modified: Thu, 05 Dec 1996 08:52:45 GMT
</DOCHDR>
<HTML> 
<HEAD><TITLE>Boron's Success</TITLE></HEAD>

<BODY bgcolor="#ffffff"> 
<CENTER><IMG WIDTH=360 HEIGHT=235  SRC="graphics/Boron.jpg">
</CENTER>
<H2 ALIGN=CENTER>Boron Biologicals, Inc.</H2>
<H3 ALIGN=CENTER>Raleigh, NC<P>
</H3>
<CENTER>
<IMG WIDTH=499 HEIGHT=19  SRC="graphics/rule.gif">
</CENTER><P>
1993 CAP participant<BR>
SBIR:DE-FG02-90ER80893<P>

<B>Success criteria:</B><P>

<!-- List Tag --><UL TYPE=disc>
<LI>strategic alliance
<LI>increased sales
</UL>

Based in Raleigh, NC, Boron Biologicals, Inc. (BBI) was founded by Dr. Bernard Spielvogel in 1986 to develop new molecular structures fabricated on the element boron. The company has positioned itself to be the top supplier of boronated compounds for Boron Neutron Capture Therapy (BNCT) cancer research. The company is currently selling products for evaluation in a variety of applications, including cancer clinical trials, and is positioned to introduce products for the rapidly growing DNA diagnostics markets over the next 6-12 months. In addition, this revolutionary and proprietary chemistry permits BBI to continue to add to a substantial pipeline of reagents, diagnostics, drugs, and industrial products.<P>

The company is currently producing both B-10 enriched p-boronophenyalanine (BPA) and sodium borocaptate (BSH) under Drug Master Files submitted to the FDA. In addition to supplying BPA to Brookhaven National Laboratory and others in the U.S., BBI is supplying BSH for the upcoming clinical trials by the European Consortium. BBI has also been supplying both BPA and BSH to European and Japanese workers in BNCT, as well as to BNCT researchers throughout the world.<P>

BBI's business development strategy capitalizes on the company's near-term product opportunities in DNA-based products together with the sales of existing compounds. BBI is negotiating combined license/supply agreements with leading multi-national life science companies for DNA sequencing and diagnostic applications and is preparing to sell sequencing kits under its own label through standard distributors. (1)<P>

<B>Sources:
</B><P>

(1) Executive Summary, BBI<P>

<B>For more information on Boron Biologicals, Inc., please contact:</B><P>

Dr. Bernard F. Spielvogel<BR>
President & CEO<BR>
Boron Biologicals, Inc.<BR>
Phone: (919) 832-2044<P>



















<CENTER>
<IMG WIDTH=505 HEIGHT=53  SRC="graphics/SUN.gif"><P>
<A HREF="success.html"><IMG WIDTH=171 HEIGHT=29  SRC="graphics/bak2succ.gif" border=0></A>
<p><A HREF="success.html">Back to Success</A></CENTER>
</BODY> 
</HTML> 
</DOC>
<DOC>
<DOCNO>WT02-B10-91</DOCNO>
<DOCOLDNO>IA073-000479-B024-26</DOCOLDNO>
<DOCHDR>
http://www.dawnbreaker.com:80/INET.html 204.249.112.36 19970208233009 text/html 1522
HTTP/1.0 200 OK
Date: Sat, 08 Feb 1997 23:31:22 GMT
Server: Apache/1.0.5
Content-type: text/html
Content-length: 1351
Last-modified: Thu, 05 Dec 1996 08:53:16 GMT
</DOCHDR>
<HTML> 
<HEAD><TITLE>INET's Success</TITLE></HEAD>
<BODY bgcolor="#ffffff"> 

<BODY> 
<H2 ALIGN=CENTER>INET Corporation</H2>
<H3 ALIGN=CENTER>Newark, CA<P>
</H3>
<CENTER>
<IMG WIDTH=499 HEIGHT=19  SRC="graphics/rule.gif">
</CENTER><P>

1991, 1993 CAP participant<BR>
DE-AC03-83ER80093<P>

<B>Success criteria:</B><P>

<!-- List Tag --><UL TYPE=disc>
<LI>increased sales<P>
</UL>

INET Corporation is a privately-held, California Corporation founded in 1978. The company was an early participant in the SBIR program and utilized this R&D in combination with a license from a major company.<P>

In 1993 INET introduced the IMS 2000, an autonomous data acquisition, process control, and portable test and measurement system  that can be used in the electric utility industry to provide equipment condition monitoring, display, alarm, and control. (1, 2)<P>

INET is a preferred supplier to TVA.<P>

<B>Sources:</B><P>

(1) INET Press Release, October 21, 1993<BR>
(2) ADTech News<P>

<B>For more information on INET CORPORATION, please contact:</B><P>

Herman Miller<BR>
Chairman/CEO<BR>
INET CORPORATION<BR>
(510) 797-9600<P>

<CENTER>
<IMG WIDTH=505 HEIGHT=53  SRC="graphics/SUN.gif"><P>
<A HREF="success.html"><IMG WIDTH=171 HEIGHT=29  SRC="graphics/bak2succ.gif" border=0></A>
<p><A HREF="success.html">Back to Success</A></CENTER>
</BODY> 
</HTML> 
</DOC>
<DOC>
<DOCNO>WT02-B10-92</DOCNO>
<DOCOLDNO>IA073-000479-B024-58</DOCOLDNO>
<DOCHDR>
http://www.dawnbreaker.com:80/LSRtech.html 204.249.112.36 19970208233021 text/html 2359
HTTP/1.0 200 OK
Date: Sat, 08 Feb 1997 23:31:35 GMT
Server: Apache/1.0.5
Content-type: text/html
Content-length: 2188
Last-modified: Thu, 05 Dec 1996 08:53:28 GMT
</DOCHDR>
<HTML> 
<HEAD><TITLE>LSR Technologies' Success</TITLE></HEAD>

<BODY bgcolor="#ffffff"> 

<BODY> 
<H2 ALIGN=CENTER>LSR Technologies, Inc.</H2>
<H3 ALIGN=CENTER>Acton, MA<P>
</H3>
<CENTER>
<IMG WIDTH=499 HEIGHT=19  SRC="graphics/rule.gif">
</CENTER><P>
1993 CAP participant<P>

<B>Success criteria:</B><P>

<!-- List Tag --><UL TYPE=disc>
<LI>joint venture
<LI>increased sales
<LI>equity investment
</UL>

LSR Technologies, Inc. of Acton, Massachusetts is a developer of new technology for physical and chemical separations. Through the SBIR program, LSR developed the Core Separator, and advanced dust collector and the most efficient of its kind. The device can be used to control particulate air emissions from industrial sources especially those which employ coal or other low-grade fuels. It can also be used for the recovery of valuable product material.<P>

The Core Separator is the most efficient centrifugal collector on the market today. Dust emissions from this device are typically 3-6 times lower than from conventional mechanical collectors. Its performance, in fact, approaches that of fabric filters and electrostatic precipitators (ESP), but at much lower cost and maintenance. The Core Separator is a highly differentiated product. It is protected by existing and pending patents. Because of its low cost and unique features, many units have been sold in just its first year of introduction.<P>

In its first year of commercial offering, eighteen (18) Core Separator installations were completed in a broad range of industrial applications. Several were used for emission control purposes and have met all regulatory requirements. Others were installed to recover feed stock material and in some cases produced paybacks of less than six months.<P>

<B>For more information on LSR Technologies, Inc., please contact:</B><P>

S. Ronald Wysk<BR>
Managing Director<BR>
LSR Technologies, Inc.<BR>
(508) 635-0123 - phone<BR>
(508) 635-0058 - fax<P>

<CENTER>
<IMG WIDTH=505 HEIGHT=53  SRC="graphics/SUN.gif"><P>
<A HREF="success.html"><IMG WIDTH=171 HEIGHT=29  SRC="graphics/bak2succ.gif" border=0></A>
<p><A HREF="success.html">Back to Success</A></CENTER>
</BODY> 
</HTML> 
</DOC>
<DOC>
<DOCNO>WT02-B10-93</DOCNO>
<DOCOLDNO>IA073-000479-B024-85</DOCOLDNO>
<DOCHDR>
http://www.dawnbreaker.com:80/IST.html 204.249.112.36 19970208233029 text/html 2372
HTTP/1.0 200 OK
Date: Sat, 08 Feb 1997 23:31:45 GMT
Server: Apache/1.0.5
Content-type: text/html
Content-length: 2201
Last-modified: Thu, 05 Dec 1996 08:53:21 GMT
</DOCHDR>
<HTML> 
<HEAD><TITLE>IST's Success</TITLE></HEAD>

<BODY bgcolor="#ffffff"> 
<CENTER><!-- Graphic Tag -->
<!-- Graphic Tag -->
<IMG WIDTH=360 HEIGHT=184  SRC="graphics/laser.gif">
<IMG BORDER=0  SRC="graphics/laserdev.jpeg">
</CENTER> 
<BODY> 
<H2 ALIGN=CENTER>International Sensor Technology, Inc.</H2>
<H3 ALIGN=CENTER>Pullman. WA<P>
</H3>
<CENTER>
<IMG WIDTH=499 HEIGHT=19  SRC="graphics/rule.gif">
</CENTER><P>
1993 CAP participant<BR>
SBIR: DE-AC03-84ER80165<P>

<B>Success criteria:</B><BR>
<!-- List Tag --><UL TYPE=disc>
<LI>acquisition of assets<BR>
<LI>licensing<P>
</UL>
International Sensor Technology (IST) was founded by Peter and Elke Braunlich while Peter was a professor of Physics at Washington State University (WSU). IST has pioneered the development of laser heating technology in TLD systems for personal radiation protection. The technology has potential uses in radiation therapy, nuclear waste management, radiation processing, environmental, and radiation-hard electronics applications in government, medicine, and the nuclear industry. The patented laser-heating technique provides increased speed and accuracy over current methods. <P>

Success comes in many forms. In a December 13, 1995 press release Keithley Instruments announced that it had purchased the principal assets of International Sensor Technology, Inc. Keithley's Radiation Measurements Division will fulfill current and expected future contracts with the U.S. Navy for IST's thermoluminescent dosimetry (TLD) technology (1) and will commercialize the technology over the next few years. Laser TLD offers significant speed and resolution advantages in many applications measuring radiation exposure. (2)<P>

<B>Sources:</B><P>

(1) Keithley Radiation Measurements Press Release, 12/13/95<BR>
(2) 1995 Annual Report - Keithley Instruments<P>

<B>For more information on Keithley Instruments:</B><P>
<!-- Link Tag --><A HREF="http://www.keithley.com/">http://www.keithley.com</A><P>

<CENTER>
<IMG WIDTH=505 HEIGHT=53  SRC="graphics/SUN.gif"><P>
<A HREF="success.html"><IMG WIDTH=171 HEIGHT=29  SRC="graphics/bak2succ.gif" border=0></A>
<p><A HREF="success.html">Back to Success</A></CENTER>
</BODY> 
</HTML> 
</DOC>
<DOC>
<DOCNO>WT02-B10-94</DOCNO>
<DOCOLDNO>IA073-000479-B024-113</DOCOLDNO>
<DOCHDR>
http://www.dawnbreaker.com:80/Ocean.html 204.249.112.36 19970208233041 text/html 2559
HTTP/1.0 200 OK
Date: Sat, 08 Feb 1997 23:31:56 GMT
Server: Apache/1.0.5
Content-type: text/html
Content-length: 2388
Last-modified: Thu, 05 Dec 1996 08:53:33 GMT
</DOCHDR>
<HTML> 
<HEAD><TITLE>Ocean Optics Success</TITLE></HEAD>

<BODY bgcolor="#ffffff"> 

<BODY> 
<H2 ALIGN=CENTER>Ocean Optics, Inc.</H2>
<H3 ALIGN=CENTER>Dunedin, FL<P>
</H3>
<CENTER>
<IMG WIDTH=499 HEIGHT=19  SRC="graphics/rule.gif">
</CENTER><P>

1991, 1993 CAP participant<BR>
SBIR: DE-FG05-90ER80858<P>

<B>Success criteria:</B><P>

<!-- List Tag --><UL TYPE=disc>
<LI>increased sales<BR>
<LI>equity investors<BR>
<LI>debt financing<P>
</UL>

Ocean Optics Inc., was founded in 1989 to develop environmental sensors. OOI won two Small Business Innovation Research grants from the U.S. Department of Energy to develop an instrument to determine the oceans role in global warming. In the process of designing the instrument, OOI researchers developed a breakthrough technology - a miniature fiber - optic spectrometer that is 1000 times smaller and 10 times less expensive than conventional systems. (1)<P>

In April 1992, OOI introduced the S1000, "The Worlds First Miniature Fiber-Optic Spectrometer." Since then, Ocean Optics has sold thousands of spectrometers to customers world-wide and won four major industry awards, including the "Best New Product of the Year" (1992) by Fiber Optic Product News and Photonic Spectras Circle of Excellence Award.<P>

Today Oceans optics is a leading manufacturer of low-cost, miniature fiberoptic spectrometers, probes, light sources and accessories for industrial process control, environmental monitoring, medical, and research applications. The companys revolutionary line of UV, VIS and NIR spectrometers includes PC plug-in, benchtop and notebook platforms, available in 12 different diffraction gratings and five standard input fibers for configurement to a wide range of application needs. All Ocean Optic spectrometers can be optimized to measure spectral characteristics such as absorbency, transmission, reflection, irradiance and fluorescence. (2)<P>

<B>Sources:</B><P>

(1) Laser Focus World, December 1994<BR>
(2) Ocean Optics Press Release, 1995<P>

<B>For more information on Ocean Optics, please contact:</B><P>

Leeward Bean<BR>
Vice President, Marketing<BR>
Ocean Optics Inc.<BR>
(813) 733-2447<P>

<CENTER>
<IMG WIDTH=505 HEIGHT=53  SRC="graphics/SUN.gif"><P>
<A HREF="success.html"><IMG WIDTH=171 HEIGHT=29  SRC="graphics/bak2succ.gif" border=0></A>
<p><A HREF="success.html">Back to Success</A></CENTER>
</BODY> 
</HTML> 
</DOC>
<DOC>
<DOCNO>WT02-B10-95</DOCNO>
<DOCOLDNO>IA073-000479-B024-141</DOCOLDNO>
<DOCHDR>
http://www.dawnbreaker.com:80/Spectral.html 204.249.112.36 19970208233052 text/html 2564
HTTP/1.0 200 OK
Date: Sat, 08 Feb 1997 23:32:06 GMT
Server: Apache/1.0.5
Content-type: text/html
Content-length: 2393
Last-modified: Thu, 05 Dec 1996 08:53:41 GMT
</DOCHDR>
<HTML> 
<HEAD><TITLE>LSR Technologies' Success</TITLE></HEAD>

<BODY bgcolor="#ffffff"> 
<CENTER><!-- Graphic Tag --><IMG WIDTH=288 HEIGHT=239  SRC="graphics/Scope.jpg"></CENTER>
<BODY> 
<H2 ALIGN=CENTER>Spectral Sciences, Inc. (SSI)</H2>
<H3 ALIGN=CENTER>Burlington, MA<P>
</H3>
<CENTER>
<IMG WIDTH=499 HEIGHT=19  SRC="graphics/rule.gif">
</CENTER><P>
1993 CAP participant<BR>
SBIR:DE-AC02-988ER80605<P>

<B>Success criteria:</B><P>

<!-- List Tag --><UL TYPE=disc>
<LI>increased sales
<LI>licensing
<LI>strategic alliance
</UL>

Spectral Sciences, Inc. (SSI) is a small R&D company located in Burlington, Massachusetts which performs research, technology development, and modeling in optics and related fields. SSI's specialties include Gas Analysis Instrumentation, Laser Applications, Advanced Sensors, Atmospheric Studies, and Aerospace Experiment Planning and Data Analysis.<P>

With support from the SBIR program, SSI has developed new, patented diode, laser-based technology for sensing gaseous species. SSI has licensed this DiRTiGAS technology to Monitor Labs for pollution monitoring applications, and the two companies are jointly developing a variety of sensors for process streams and the open air.<P>

One new Monitor Labs/SSI product is an in situ monitor designed for installation in smokestacks or ducts, and is presently undergoing beta testing. For this application, the combination of diode laser spectroscopy and in-stack placement offer a unique combination of fast response, high sensitivity, and absence of interferences, and long-term, unattended operation.<P>

Several additional sensing technologies including gas-correlation, Raman, and conductive-polymer, have been developed by SSI for process control, health and safety, and meteorological applications.<P>

<B>For more information on Spectral Sciences, Inc., please contact:</B><P>

Steven Adler-Golden<BR>
Principal Scientist<BR>
Spectral Sciences, Inc.<BR>
Phone : (617) 273-4770<BR>
E-mail: <!-- MailTo Tag --><A HREF="MAILTO:sag@spectral.com">sag@spectral.com</A><BR>
or visit SSI's web site at <!-- Link Tag --><A HREF="http://www.spectral.com/">http://www.spectral.com</A><P>


<CENTER>
<IMG WIDTH=505 HEIGHT=53  SRC="graphics/SUN.gif"><P>
<A HREF="success.html"><IMG WIDTH=171 HEIGHT=29  SRC="graphics/bak2succ.gif" border=0></A>
<p><A HREF="success.html">Back to Success</A></CENTER>
</BODY> 
</HTML> 
</DOC>
<DOC>
<DOCNO>WT02-B10-96</DOCNO>
<DOCOLDNO>IA073-000479-B024-168</DOCOLDNO>
<DOCHDR>
http://www.dawnbreaker.com:80/TRI.html 204.249.112.36 19970208233059 text/html 3330
HTTP/1.0 200 OK
Date: Sat, 08 Feb 1997 23:32:15 GMT
Server: Apache/1.0.5
Content-type: text/html
Content-length: 3159
Last-modified: Thu, 05 Dec 1996 08:54:03 GMT
</DOCHDR>
<HTML> 
<HEAD><TITLE>TRI/Omniview's Success</TITLE></HEAD>

<BODY bgcolor="#ffffff"> 

<BODY> 
<H2 ALIGN=CENTER>TRI/Omniview</H2>
<H3 ALIGN=CENTER>Knoxville, TN<P>
</H3>
<CENTER>
<IMG WIDTH=499 HEIGHT=19  SRC="graphics/rule.gif">
</CENTER><P>
1990, 1991 CAP participant<BR>
SBIR: DE-FG05-90ER80858<P>


<B>Success criteria:</B><P>

<!-- List Tag --><UL TYPE=disc>
<LI>increased sales<BR>
<LI>strategic alliances<BR>
<LI>equity investment<BR>
<LI>licensing<P>
</UL>

Omniview was developed by TRI largely as a result of SBIR funding from NASA and DOE. Omniview (R) is so revolutionary that it is closer to a human eye than to existing video systems. It pans, tilts, magnifies, and rotates a video image with no pointing mechanism. Omniview was developed to eliminate the camera pointing mechanism in remote viewing applications where size, weight, reliability, response or covertness are considerations. (1)<P>

In order to leverage development of Omniview, TRI has entered into several strategic partnerships with other high tech companies. In fact, TRI received a big boost earlier this year when Motorola took a minority equity stake in the company.<P>

"Motorola invests in companies with leveragable technology that may hold out a promise of spawning new applications and new businesses," says Robert Burton, vice president and general manager of New Enterprises at Motorola. "Omniview is a perfect fit with what Motorola is doing and where it is heading."<P>

While TRI intends to handle R&D, prototype development and after-market servicing for Omniview, the company has teamed up with Siemens Industrial Automation, Inc. for actual product manufacturing. TRI will be the first U.S. company not owned by Siemens to have products made at the company's high tech manufacturing facility in Johnson City, Tenn. TRI is a perfect fit with Siemens says Michael E. Washington, manager of business development for Siemens Industrial Automation.<P>

Omniview has a chance to revolutionize the image, communications, and broadcasting business, says Masamura Yamaji, CEO of Omniview Systems, Inc., a Japanese licensee. "With existing systems the picture taking side of the camera controls the image. But with Omniview, the viewer can control the image."<P>

In 1993, Benthos, Inc. teamed up with TRI, Inc. to develop underwater uses for TRI's Omniview imaging system. "It gives us an add-on capability to our standard video inspection system," says Roger Whyte imaging product line manager at Benthos Inc. In exchange for funding R&D efforts, Benthos received exclusive rights for the manufacturing and use of Omniview for underwater applications. (2)<P>

<B>Sources:</B><P>

(1) TRI product literature<BR>
(2) Imaging Edition, 2/95<P>

<B>For more information on Omniview, please contact:</B><P>

TRI, Inc. <BR>
7325 Oak Ridge Highway<BR>
Knoxville, TN 37913<BR>
E mail: <A HREF="MAILTO:martinl@Omniview.com/">
 martinl@Omniview.com</A>

<CENTER>
<IMG WIDTH=505 HEIGHT=53  SRC="graphics/SUN.gif"><P>
<A HREF="success.html"><IMG WIDTH=171 HEIGHT=29  SRC="graphics/bak2succ.gif" border=0></A>
<p><A HREF="success.html">Back to Success</A></CENTER>
</BODY> 
</HTML> 
</DOC>
<DOC>
<DOCNO>WT02-B10-97</DOCNO>
<DOCOLDNO>IA073-000479-B024-198</DOCOLDNO>
<DOCHDR>
http://www.dawnbreaker.com:80/Vortec.html 204.249.112.36 19970208233110 text/html 4016
HTTP/1.0 200 OK
Date: Sat, 08 Feb 1997 23:32:24 GMT
Server: Apache/1.0.5
Content-type: text/html
Content-length: 3845
Last-modified: Thu, 05 Dec 1996 08:54:06 GMT
</DOCHDR>
<HTML> 
<HEAD><TITLE>Vortec's Success</TITLE></HEAD>

<BODY bgcolor="#ffffff"> 

<BODY> 
<H2 ALIGN=CENTER>Vortec Corporation</H2>
<H3 ALIGN=CENTER>Collegeville, PA<P>
</H3>
<CENTER>
<IMG WIDTH=499 HEIGHT=19  SRC="graphics/rule.gif">
</CENTER><P>
1993 CAP participant<BR>
SBIR:DE-FG01-90ER8-856<P>

<B>Success criteria:</B><P>

<!-- List Tag --><UL TYPE=disc>
<LI>increased sales<BR>
<LI>licensing<BR>
<LI>strategic alliance<P>
</UL>
Since its founding in 1984, the primary effort of Vortec Corporation has focused on the research and development (R&D) necessary  to be at the leading edge in high temperature, waste processing and recycling technologies. R&D to date has emphasized waste vitrification, waste recycling, glass melting and refining, high temperature heat recovery, furnace development, and advanced power cycle assessment.Vortec is now at a stage where its patented technologies are ready to meet market demands and opportunities. (1)<P>

Vortec Corporation of Collegeville, PA has been awarded an <B>$11.6 million prime contract</B> by the U.S. Department of Energy Morgantown Energy Technology Center to construct a transportable vitrification process to demonstrate the remediation of hazardous and radioactive soils. The contract is sponsored by the DOE Office of Technology Development (EM-50) and is headed by the Deputy Assistant Secretary, Dr. Clyde Frank.<P>

The U.S. Department of Energy has selected the gaseous diffusion plant located in Paducah, Kentucky as the commercial demonstration site for the Vortec Corporation advanced vitrification process. (2) The waste remediation plant will incorporate the use of the Vortec patented glass melting system known as the CMS (TM)for the vitrification process unit. Vitrification is being used for the processing of radioactive solid waste at the site because it produces a glass product which is chemically stable for thousands of years. The Vortec CMS (TM) is unique in that it allows for the simultaneous processing of organic, heavy metal, and radionuclide containing waste materials. (1)<P>

Ormet Primary Aluminum Corporation of Wheeling, WV has entered into a <B>licensing agreement</B> with Vortec Corporation to purchase Vortec's patented Cyclone Melting System (CMSTM) for the recycling of spent aluminum pot liners (SPL). Disposal of SPL, a cyanide and fluoride containing waste (KO88), is a problem that has been plaguing the aluminum industry for years. The predicament is being brought to a head due to the EPA land ban scheduled to be enacted in 1996. The Vortec CMS (TM) vitrification process purchased by Ormet not only meets EPA requirements, but also recycles the waste into value-added glass and ceramic products - thus eliminating the long term liability of landfilling wastes. (1)<P>

WELKO Industriale s.p.a. (ITALY) a major supplier of ceramic tile manufacturing equipment and Vortec Corporation (USA) are introducing a new ceramic tile which incorporates recycled industrial waste into the tile product. This new product is called EKOTILE because it is ecologically and environmentally sound approach for solving industrial waste disposal problems. The <B>strategic alliance</B> between Vortec and Welko combines the necessary engineering and technical capability for building turn-key ceramic tile manufacturing lines using the new technology. (3)<P>

<B>Sources:</B><P>

(1) Vortec Review. Vol 1; No 1; Spring 1995<BR>
(2) METC3: January 1996<BR>
(3) EKOTILE:VCAG95v2SP95<P>

<B>For more information on Vortec, please contact:</B><P>

Dr. James Hnat<BR>
President<BR>
Vortec Corporation<BR>
Phone: (215) 489-2255<BR>

<CENTER>
<IMG WIDTH=505 HEIGHT=53  SRC="graphics/SUN.gif"><P>
<A HREF="success.html"><IMG WIDTH=171 HEIGHT=29  SRC="graphics/bak2succ.gif" border=0></A>
<p><A HREF="success.html">Back to Success</A></CENTER>
</BODY> 
</HTML> 
</DOC>
<DOC>
<DOCNO>WT02-B10-98</DOCNO>
<DOCOLDNO>IA073-000479-B024-223</DOCOLDNO>
<DOCHDR>
http://www.dawnbreaker.com:80/DispTech.html 204.249.112.36 19970208233120 text/html 4197
HTTP/1.0 200 OK
Date: Sat, 08 Feb 1997 23:32:35 GMT
Server: Apache/1.0.5
Content-type: text/html
Content-length: 4026
Last-modified: Thu, 05 Dec 1996 08:52:53 GMT
</DOCHDR>
<HTML> 
<HEAD><TITLE>Displaytech's Success</TITLE></HEAD>

<BODY bgcolor="#ffffff"> 
<CENTER>
<IMG WIDTH=360 HEIGHT=263  SRC="graphics/DispTech.gif">
<BODY> 
<H2 ALIGN=CENTER>DISPLAYTECH, Inc.</H2>
<H3 ALIGN=CENTER>Boulder, CO 
</H3>
<P>

<IMG WIDTH=499 HEIGHT=19  SRC="graphics/rule.gif">
</CENTER><P>
1995 Strategic Planning participant<BR>
Advanced Technology Program<P>

<B>Success criteria:</B><P>

<!-- List Tag --><UL TYPE=disc>
<LI>private placement
</UL>

Displaytech is a privately held company in Boulder, Colorado developing miniature liquid crystal displays. The company also develops and manufactures electro-optic component products used in industrial inspection and measurement, medical imaging, and research. All of the company's products are based on its proprietary surface-stabilized ferroelectric liquid crystal technology. (1)<P>

In May Displaytech announced initiation of the  ChronoColor Miniature Display Developers Program. Through this program selected manufacturers of end user display products will be able to receive the company's electronic miniature displays for new product development.<P>

Small, light weight high resolution miniature displays that have low power requirements and can be magnified into high screen quality images bring together the thus far opposing trends of large viewing screens and portability.<P>

"Miniature displays have the capability to change the way people view and retrieve information," said president Mark Handschy. "An entire range of new products are possible with this technology: products such as telefax pagers, videoconferencing cellular phones, information appliances, workstation quality computer displays mounted in eyeglass frames... the list is limited only by one's imagination."<P>

Miniature displays, which generally measure less than an inch diagonally, produce images on a very small surface that can be magnified or projected for viewing. Displaytech's  ChronoColor Miniature Display is built on a silicon chip that measures about 1/2 inch diagonally. The 1280 x 1024  ChronoColor Miniature Display is expected to measure 8 millimeters by 6 millimeters.<P>

The  ChronoColor Display is based on the company's proprietary liquid crystal technology (fast switching ferroelectric liquid crystals) and the standard technologies of CMOS (complementary metal oxide semiconductor) memory and LED's (light emitting diodes). The  ChronoColor Miniature Display will be equipped with interfaces that make it compatible with VGA systems.<P>

The Developers' Program is targeted to experienced manufacturers of display products who are committed to developing miniature display technology. Under the Developers' Program, manufacturers will be able to evaluate the  ChronoColor Display for their particular products. As end user display product manufacturers develop products, Displaytech will ramp up its scalable manufacturing process.<P>

"We have been investing in product manufacturing for the last years and a half. At the end of 1996, we will have facilities in place to produce commercial quantities of the  ChronoColor Miniature Display," said Haviland Wright, CEO.<P>

Dislaytech is currently developing miniature displays with 256 x 256 resolution, and 640 x 480 through 1280 x 1024 resolutions. The company will distribute 640 x 480 displays through the Developers' Program. Developers will receive their first displays in early 1997. (2)<P>

ChronoColor is a registered trademark.<P>

<B>Sources:</B><P>

(1)  News release, Displaytech, May 15, 1996<BR>
(2)  News release, Displaytech, May 13, 1996<P>

<B>For more information on DISPLAYTECH, Inc., please contact:</B><P>

Haviland Wright, CEO<BR>
DISPLAYTECH, Inc.<BR>
2200 Central Avenue<BR>
Boulder, CO 80301<BR>
Phone: (303) 449-8933<BR>
Fax: (303) 449-8934<P>

<CENTER>
<IMG WIDTH=505 HEIGHT=53  SRC="graphics/SUN.gif"><P>
<A HREF="success.html"><IMG WIDTH=171 HEIGHT=29  SRC="graphics/bak2succ.gif" border=0></A>
<p><A HREF="success.html">Back to Success</A></CENTER>
</BODY> 
</HTML> 
</DOC>
<DOC>
<DOCNO>WT02-B10-99</DOCNO>
<DOCOLDNO>IA073-000479-B024-275</DOCOLDNO>
<DOCHDR>
http://www.dawnbreaker.com:80/PhysOpt.html 204.249.112.36 19970208233138 text/html 3022
HTTP/1.0 200 OK
Date: Sat, 08 Feb 1997 23:32:54 GMT
Server: Apache/1.0.5
Content-type: text/html
Content-length: 2851
Last-modified: Thu, 05 Dec 1996 08:53:36 GMT
</DOCHDR>
<HTML> 
<HEAD><TITLE>Physical Optics' Success</TITLE></HEAD>

<BODY bgcolor="#ffffff"> 

<H2 ALIGN=CENTER>Physical Optics Corporation</H2>
<H3 ALIGN=CENTER>Torrance, CA<P>
</H3>
<CENTER>
<IMG WIDTH=499 HEIGHT=19  SRC="graphics/rule.gif">
</CENTER><P>
1995 Strategic Planning participant<BR>
Advanced Technology Program<P>

<B>Success criteria:</B><P>

<!-- List Tag --><UL TYPE=disc>
<LI>increased sales
</UL>

Physical Optics Coporation (POC) has developed a unique holographic Light 
Shaping Diffuser (LSD) screen technology. The Light Shaping Diffuser 
controls the light energy distribution within a desired elliptical or 
circular solid angle, providing at least one order of magnitude better 
display brightness as compared to currently used Lambertian diffusers. <P>

POC's potential diffuser applications include: (1) consumer TV projection 
screens, high contrast screens for use in LCDs, and projection screens 
for overhead and slide projectors; (ii) beam homogenizers for OEM systems 
such as spectrometers, blood analyzers, and endoscopes; and (iii) beam 
shapers for lighting products such as flashlights, automotive interior 
lighting, bar code scanners, lighted signs, 3-D displays, and cockpit 
displays. <P>

For the next five years, display devices are projected to 
experience "meteoric growth" (Electronic News, 1994). POC is confident 
that its Light Shaping Diffusers will become an integral part of these 
display devices. POC has a strong patent position in diffuser products 
and is pursuing joint ventures and licensing agreements to address those 
opportunities that are beyond the companies corporate capabilities.<P>

POC participated in the Advanced Technology Program (ATP) which helped 
POC to optimize the Light Shaping Diffuser fabrication process, develop 
the diffuser pattern replication methodology and optimize perfomance of 
the LCD. As a result, POC was able to increase its market share both in 
the U.S. and abroad. Since the completion of the ATP, we have further 
enhanced the performance, yield and manufacturing proceess to address 
specific customer requirements for LCD display, projection displays,  
directional displays, HDTV screen and cockpit displays. The technical 
advances achieved during the course of the ATP have improved diffuser 
performance in many systems, such as "remote source lighting". This has 
enabled POC to spin-off a subsidiary, "FarLight".<P>

<B>For more information, please contact:</B><P>

Dr. Gajendra Savant<BR>
Vice President Operations, Applied Technology<BR>
Physical Optics Corporation<BR>
Phone (310) 320-3088<BR>
Fax: (310) 320-8067<P>

<CENTER>
<IMG WIDTH=505 HEIGHT=53  SRC="graphics/SUN.gif"><P>
<A HREF="success.html"><IMG WIDTH=171 HEIGHT=29  SRC="graphics/bak2succ.gif" border=0></A>
<p><A HREF="success.html">Back to Success</A></CENTER>
</BODY> 
</HTML> 
</DOC>
<DOC>
<DOCNO>WT02-B10-100</DOCNO>
<DOCOLDNO>IA073-000479-B025-10</DOCOLDNO>
<DOCHDR>
http://www.dawnbreaker.com:80/AdTech.html 204.249.112.36 19970208233158 text/html 2933
HTTP/1.0 200 OK
Date: Sat, 08 Feb 1997 23:33:08 GMT
Server: Apache/1.0.5
Content-type: text/html
Content-length: 2762
Last-modified: Thu, 05 Dec 1996 09:01:44 GMT
</DOCHDR>
<HTML> 
<HEAD><TITLE>AdTech's Success</TITLE></HEAD>

<BODY bgcolor="#ffffff"> 
<CENTER>

<BODY> 
<H2 ALIGN=CENTER>AdTech Systems Research, Inc.</H2>
<H3 ALIGN=CENTER>Beavercreek, OH </H3>
<P>

<IMG WIDTH=499 HEIGHT=19  SRC="graphics/rule.gif">
</CENTER><P>
1995 DoD Indicators participant<P>

<B>Success criteria:</B><P>

<!-- List Tag --><UL TYPE=disc>
<LI>Phase II award from Air Force
</UL>

AdTech Systems Research, Inc.provides research & development, engineering, and technical services to various government agencies and prime contractors. AdTech's expertise is in two interrelated areas: (1) analytical/computer modeling for analysis of materials and structures; and (2) experimental mechanical testing of metals, non-metals, and their composites.<P>

In 1996 AdTech received a Phase II award from the Air Force to continue its work with advanced composite joints. The Air Force and the aerospace industry have identified advanced composites as candidate material systems for a variety of aero propulsion, aero structure, space structure, and airframe components. A number of these applications involve joints, between similar and dissimilar material systems. Some of these are mechanical joints such as bolted and riveted connections. Others are fabricated by welding, brazing, hot isostatic pressing (HIPing), cold isostatic pressing and by a variety of other methods. Often, structural integrity and service life of components containing such joints is limited by the integrity of the joints. Therefore, for design improvement as well as for component life prediction goals, methods are needed which can predict load carrying capacity and life of components containing joints. Under this Phase II SBIR, AdTech is developing a product in the form of a user friendly, interactive, intelligent, computer software package which can be readily used by aerospace engineers to improve the design and evaluation of advanced material joints.<P>

The direct benefit of the Phase II will be a comprehensive design tool for evaluating conceptual designs and optimizing existing designs to maximize the advantages of using composite materials. Industries which could benefit from this advance include aircraft/aerospace; automotive; and power generation.<P>

<B>Sources:</B><P>

(1) Correspondence from AdTech,  8/19/96<P>

<B>For more information on AdTech Systems Research, Inc., please contact:</B><P>

Tony Hand<BR>
Business Development Manager<BR>
AdTech Systems Research, Inc<BR>
Phone:  (513) 426-3329<BR>
Fax: (513) 426-8087<P>

<CENTER>
<IMG WIDTH=505 HEIGHT=53  SRC="graphics/SUN.gif"><P>
<A HREF="success.html"><IMG WIDTH=171 HEIGHT=29  SRC="graphics/bak2succ.gif" border=0></A>
<p><A HREF="success.html">Back to Success</A></CENTER>
</BODY> 
</HTML> 
</DOC>
<DOC>
<DOCNO>WT02-B10-101</DOCNO>
<DOCOLDNO>IA073-000479-B025-53</DOCOLDNO>
<DOCHDR>
http://www.dawnbreaker.com:80/AnalyticalServ.html 204.249.112.36 19970208233226 text/html 2966
HTTP/1.0 200 OK
Date: Sat, 08 Feb 1997 23:33:38 GMT
Server: Apache/1.0.5
Content-type: text/html
Content-length: 2795
Last-modified: Sat, 04 Jan 1997 15:38:44 GMT
</DOCHDR>
<HTML>

<HEAD>

<TITLE>Analytical Services & Materials</TITLE>

</HEAD>

<BODY bgcolor="#ffffff"> 


<BODY> 

<H2 ALIGN=CENTER>Analytical Services & Materials</H2>
<H3 ALIGN=CENTER>Hampton, Virginia</H3>


<CENTER><P><IMG WIDTH=499 HEIGHT=19  SRC="graphics/rule.gif">
</CENTER><P>
DoD Indicators of Commercial Potential program, 1995<BR>
Phase 1 - Platinum substitutes and two-phase glass analyzers as low-cost alternatives to platinum aluminide coatings<P>

<B>Success criteria:</B><P>

<!-- List Tag -->

<UL TYPE=disc>
<LI>Navy Phase II - NADEP Cherry Point
</UL>


AS&M is a research and development company that has spent fifteen years specializing in a variety of aerospace related disciplines. One such discipline, coatings of materials, has emerged as one of AS&M's leading research areas. This can be attributed to industrys demand for corrosion protection coupled with AS&M's strong background in materials science.<P>

Primary focus has been on sol-gel coatings which can be used for forming oxide coatings on a variety of substrates. One coating which has developed at AS&M while working on the National Aerospace Plane (NASP) program is a two-phase glass (TPG) coating. This coating was designed in cooperation with NASA-Langely Research Center, to protect titanium alloys from oxidation and hot corrosion at high temperatures (750-1200C). Success in this program has lead to further development for other applications, particularly in the aerospace and power generation industry. Currently, further development is being funded through a Phase II contract with the Navy at Cherry Point, NC. The objective is to help increase the service life of a jet engine by protecting its turbine blades from oxidation and hot corrosion. Ultimately, this will save a considerable amount of maintenance costs that are incurred from costly repairs.<P>

In addition to the turbine blade industry, this coating has also shown great promise in applications with similar environmental conditions. Thermocouples, automobile engine valves, and high-speed missile surfaces are areas that can use the protective nature of this coating. AS&M plan s to market this coating to the commercial turbine engine, automobile, and defense industry.<P>

<B>For further information on Analytical Services & Materials, please contact:</B><P>

Dan Burcher<BR>
Manager, Product Development<BR>
Analytical Services & Materials<BR>
107 Research Drive<BR>
Hampton, VA 23666<BR>
Phone: (757) 865-7093<BR>
Fax: (757) 865-7309<BR>

<A HREF="MAILTO:burcher@asm-usa.com">burcher@asm-usa.com</A><BR>


<CENTER><IMG WIDTH=505 HEIGHT=53  SRC="graphics/SUN.gif"><P>

<A HREF="success.html"><IMG WIDTH=171 HEIGHT=29  SRC="graphics/bak2succ.gif" border=0></A><p>

<A HREF="success.html">Back to Success</A></CENTER></BODY> </HTML> 

</DOC>
<DOC>
<DOCNO>WT02-B10-102</DOCNO>
<DOCOLDNO>IA073-000479-B025-87</DOCOLDNO>
<DOCHDR>
http://www.dawnbreaker.com:80/ArcovaSuccess.html 204.249.112.36 19970208233243 text/html 3585
HTTP/1.0 200 OK
Date: Sat, 08 Feb 1997 23:33:54 GMT
Server: Apache/1.0.5
Content-type: text/html
Content-length: 3414
Last-modified: Sat, 04 Jan 1997 17:12:18 GMT
</DOCHDR>
<HTML> 

<HEAD>

<TITLE>American Research Corporation of Virginia (ARCOVA)'s Success
</TITLE>

</HEAD>

<BODY bgcolor="#ffffff"> 


<BODY> 

<H2 ALIGN=CENTER>American Research Corporation of Virginia (ARCOVA)
</H2>
<H3 ALIGN=CENTER>Radford, Virginia</H3>


<CENTER><P><IMG WIDTH=499 HEIGHT=19  SRC="graphics/rule.gif">
</CENTER><P>
Indicators of Commercial Potential Program, 1995<BR>
SBIR Air Force, Topic 95.1-177<P>
<B>Success criteria:</B><P>

<!-- List Tag -->

<UL TYPE=disc>
<LI>Phase II - U.S. Air Force
<LI>Strategic ally
</UL>


American Research Corporation of Virginia will spin-off a separate company called Monolithic Magnetics, Inc. to design, manufacture, and market patented, low-cost monolithic modules for use by the power supply and instrumentation segments of the computer and electronics markets. The technology which serves as the basis for the new business is under development by ARCOVA and involves the spray deposition of low loss ferrites that serve as cores for magnetic components. The increased performance efficiency, higher power density, and improved transient characteristics afforded by integrated planar magnetic circuitry are important in the development of very high speed integrated circuits.<P>

The technology will provide benefits to U.S. Agencies that employ high efficiency power converters in aeronautical, aerospace, and electronic warfare applications. Commercial uses include aircraft, computers, automotive electrical systems, hybrid/electric vehicles, medical diagnostics, communication systems and consumer electronics.<P>

The military market is highly specialized and is less sensitive to price than to size, weight, and performance. The availability of monolithic magnetic devices will provide the Department of Defense and its contractors with the ability to produce power converters and power supplies operational at megahertz frequencies, that can be miniaturized for use in electronic packages for spaceborne, airborne, and critical defense missions.<P>

Civilian markets are more easily delineated. Price is a more sensitive factor, but high performance planar power converter units offer many advantages that favor their introduction in a wide range of applications. Commercial applications include communication and aeronautical equipment, medical devices, consumer electronics, power electronic systems, personal computer power supplies, automotive power electronics, electric and hybrid electric vehicles, power generation and electric motor drive systems.<P>

<B>Next commercialization step:</B><P>
Monolithic Magnetics, Inc. is looking to establish cooperative relationships with Original Equipment Manufacturers of electronic power converters for sales to manufacturers of computers, electronic office equipment and consumer electronics.<P>

<B>Source:</B><P>
Correspondence from Dr. Varshney, 12/96<P>

<B>For further information, please contact:</B><P>

Dr. Usha Varshney<BR>
Director of Research<BR>
American Research Corporation of Virginia<BR>
1509 Fourth Street<BR>
PO Box 3406<BR>
Redford, VA 24143<BR>
Phone: (540) 731-0655<BR>
Fax: (540) 731-0836<BR>

<A HREF="MAILTO:varshney@nrv.net">varshney@nrv.net</A><BR>

<CENTER><IMG WIDTH=505 HEIGHT=53  SRC="graphics/SUN.gif"><P>

<A HREF="success.html"><IMG WIDTH=171 HEIGHT=29  SRC="graphics/bak2succ.gif" border=0></A><p>

<A HREF="success.html">Back to Success</A></CENTER></BODY> </HTML> 

</DOC>
<DOC>
<DOCNO>WT02-B10-103</DOCNO>
<DOCOLDNO>IA073-000479-B025-116</DOCOLDNO>
<DOCHDR>
http://www.dawnbreaker.com:80/Full.html 204.249.112.36 19970208233257 text/html 2429
HTTP/1.0 200 OK
Date: Sat, 08 Feb 1997 23:34:12 GMT
Server: Apache/1.0.5
Content-type: text/html
Content-length: 2258
Last-modified: Thu, 05 Dec 1996 08:53:03 GMT
</DOCHDR>
<HTML> 
<HEAD><TITLE>Full Circle's Success</TITLE></HEAD>

<BODY bgcolor="#ffffff"> 
<H2 ALIGN=CENTER>Full Circle Research, Inc.</H2>
<H3 ALIGN=CENTER>San Marcos, CA<P>
</H3>
<CENTER>
<IMG WIDTH=499 HEIGHT=19  SRC="graphics/rule.gif">
</CENTER><P>
1994 DoD Indicators participant<P>

<B>Success criteria:</B><BR>
<UL TYPE=disc>
<LI>Phase II award
<LI>Strategic alliance
</UL>

Space Electronics, Inc. (SEI) of San Diego, CA and Full Circle Research, Inc. (FCR) of San Marcos, CA announced the formation of a strategic alliance to cooperate in the research, development, manufacturing, and sale of microelectronic devices for military and commercial space projects.<P>

Full Circle Research will focus on research and engineering development of technologies related to radiation tolerant or hardened microelectronics. Space Electronics will focus on applied development, prototype fabrication, production, and sales of microelectronic components utilizing these technologies.<P>

At this time Full Circle Research, Inc. is engaged in a Small Business Innovative Research (SBIR) program to develop technologies to permit use of radiation shielded packages for microcircuits. This program is sponsored by:<P>

<BLOCKQUOTE>United States Air Force<BR>
Air Force Material Command<BR>
Phillips Laboratory (PL)<BR>
Kirtland AFB, New Mexico 87117-6008<P>
</BLOCKQUOTE>
Space Electronics, Inc. is the world leader in space IC radiation hardening by shielding with their Rad-Pak &reg; technology.<P>

The agreement includes joint R&D, licensing of FCR developed technologies, and an exchange of Board of Directors seats. (1)<P>

<B>Source:</B><P>
(1) Press release, Space Electronics, November 1, 1995<P>

<B>For more information call:</B><P>

James P. Spratt<BR>
Full Circle Research<BR>
(619) 431-5622<BR>
E-mail: <A HREF="MAILTO:73513,1327@compuserve.com">73513,1327@compuserve.com</A><P>

Robert Czajkowski<BR>
Space Electronics<BR>
(619) 452-4167<BR>
E-mail: <A HREF="MAILTO:102005,1635@compuserve.com">102005,1635@compuserve.com</A><P>

<CENTER>
<IMG WIDTH=505 HEIGHT=53  SRC="graphics/SUN.gif"><P>
<A HREF="success.html"><IMG WIDTH=171 HEIGHT=29  SRC="graphics/bak2succ.gif" border=0></A>
<p><A HREF="success.html">Back to Success</A></CENTER>
</BODY> 
</HTML> 
</DOC>
<DOC>
<DOCNO>WT02-B10-104</DOCNO>
<DOCOLDNO>IA073-000479-B025-144</DOCOLDNO>
<DOCHDR>
http://www.dawnbreaker.com:80/FMRISuccess.html 204.249.112.36 19970208233310 text/html 2247
HTTP/1.0 200 OK
Date: Sat, 08 Feb 1997 23:34:24 GMT
Server: Apache/1.0.5
Content-type: text/html
Content-length: 2076
Last-modified: Sat, 04 Jan 1997 17:12:30 GMT
</DOCHDR>
<HTML> 

<HEAD>

<TITLE>Fairfax Materials Research, Inc. (FMRI)</TITLE>

</HEAD>

<BODY bgcolor="#ffffff"> 


<BODY> 

<H2 ALIGN=CENTER>Fairfax Materials Research, Inc. (FMRI)</H2>
<H3 ALIGN=CENTER>Springfield, Virginia</H3>


<CENTER><P><IMG WIDTH=499 HEIGHT=19  SRC="graphics/rule.gif">
</CENTER><P>
Indicators of Commercial Potential Program, 1995<BR>
Navy<P>
<B>Success criteria:</B><P>

<!-- List Tag -->

<UL TYPE=disc>
<LI>Phase II - Navy
<LI>Strategic ally
<LI>Follow-on funding commitment
</UL>

FMRI specializes in designing and developing hybrid metals for use at high temperatures and in aggressive environments. The IHPTET objectives for the next generation of gas turbines require a 100% increase in thrust-to-weight ratio and 50% decrease in fuel burn by 2010. Current service materials will not support the 20% increase in operating temperature necessary to achieve these goals.<P> Molybdenum disilicide, a hybrid metal-ceramic with an operating temperature to 2000F, can do the job if it can be produced in ductile form. FMRI plans to accomplish the ductilization by microalloying with a set of candidate elements selected using computer codes which determine metallurgical properties from the electronic structure. The technology has dual-use applications for military and commercial aircraft; high-temperature coatings for re-entry vehicles; furnace linings; and bearing seals.<P>

<B>Next commercialization step: </B><P>
Metallurgical testing and development<P>

<B>Source:</B><P>
 Correspondence from Dr. Mike Duesbery, 12/6/96<P>

<B>For further information, please contact:</B><P>

Dr. Mike Duesbery<BR>
Fairfax Materials Research, Inc.<BR>
7305 Beechwood Drive<BR>
Springfield, VA 22153-2336<BR>
Phone: (703) 912-4201<BR>
Fax: (703) 912-4202<BR>

<A HREF="MAILTO:duesbery@aol.com">duesbery@aol.com</A><BR>

<CENTER><IMG WIDTH=505 HEIGHT=53  SRC="graphics/SUN.gif"><P>

<A HREF="success.html"><IMG WIDTH=171 HEIGHT=29  SRC="graphics/bak2succ.gif" border=0></A><p>

<A HREF="success.html">Back to Success</A></CENTER></BODY> </CENTER>
</BODY> 
</HTML> 

</DOC>
<DOC>
<DOCNO>WT02-B10-105</DOCNO>
<DOCOLDNO>IA073-000479-B025-172</DOCOLDNO>
<DOCHDR>
http://www.dawnbreaker.com:80/MCCI.html 204.249.112.36 19970208233322 text/html 2712
HTTP/1.0 200 OK
Date: Sat, 08 Feb 1997 23:34:35 GMT
Server: Apache/1.0.5
Content-type: text/html
Content-length: 2541
Last-modified: Thu, 05 Dec 1996 08:53:31 GMT
</DOCHDR>
<HTML> 
<HEAD><TITLE>MCCI's Success</TITLE></HEAD>

<BODY bgcolor="#ffffff"> 
<CENTER>

<BODY> 
<H2 ALIGN=CENTER>Management Communications and Control, Inc. (MCCI)</H2>
<H3 ALIGN=CENTER>Arlington, VA</H3>
<P>

<IMG WIDTH=499 HEIGHT=19  SRC="graphics/rule.gif">
</CENTER><P>
1995 DoD Indicators participant<P>

<B>Success criteria:</B><P>

<!-- List Tag --><UL TYPE=disc>
<LI>DoD Fast Track
<LI>Phase II SBIR award from Navy
</UL>

Management Communications and Control, Inc. (MCCI) is a small software tool development company focused on graphical programming technology for large parallel Digital Signal Processing (DSP) systems. MCCI has a ten year corporate history which includes successful development of a graphical programming software tool for the Navy's standard signal processor and support of several large defense contractors in the application of graphical programming methods in SONAR system designs. MCCI is developing a commercial graphical DSP programming toolset under an ARPA funded program and a Navy SBIR Phase II contract.<P>

MCCI's autocoding toolset supports DSP graphical programming in a format similar to block diagrams or management pert charts. Our design tools support development of top level program designs from the user's graphical specifications. Detailed design and coding tools automatically generate DSP code for the complete application. Included run time utility programs perform the functions of application management, process execution control, and data communications making user  development of run time support unnecessary. Our toolset generates high performance, production quality code with execution efficiency that meets or exceeds that of hand optimized production code. We will offer an unique capability to support graphical programming and produce production quality code. Using our toolset, users will realize a tenfold decrease in DSP software development costs to produce high performance production code.<P>

<B>Sources:</B><P>

(1)  Correspondence from MCCI,  7/2/96<P>

<B>For more information on Management Communications and Control, Inc., please contact:</B><P>

Christopher Robbins, President<BR>
Management Communications and Control, Inc.<BR>
2000 N. 14th St, Suite 220<BR>
Arlington, VA 22201<BR>
Phone: (703) 522-7177<BR>
Fax: (703) 358-9242<P>

<CENTER>
<IMG WIDTH=505 HEIGHT=53  SRC="graphics/SUN.gif"><P>
<A HREF="success.html"><IMG WIDTH=171 HEIGHT=29  SRC="graphics/bak2succ.gif" border=0></A>
<p><A HREF="success.html">Back to Success</A></CENTER>
</BODY> 
</HTML> 
</DOC>
<DOC>
<DOCNO>WT02-B10-106</DOCNO>
<DOCOLDNO>IA073-000479-B025-202</DOCOLDNO>
<DOCHDR>
http://www.dawnbreaker.com:80/StrainMon.html 204.249.112.36 19970208233334 text/html 3304
HTTP/1.0 200 OK
Date: Sat, 08 Feb 1997 23:34:47 GMT
Server: Apache/1.0.5
Content-type: text/html
Content-length: 3133
Last-modified: Sat, 07 Dec 1996 17:08:05 GMT
</DOCHDR>
<HTML> 

<HEAD>

<TITLE>Strain Monitor's Success</TITLE>

</HEAD>

<BODY bgcolor="#ffffff"> 


<BODY> 

<H2 ALIGN=CENTER>Strain Monitor Systems, Inc.</H2>
<H3 ALIGN=CENTER>Atlanta, GA</H3>


<CENTER><P><IMG WIDTH=499 HEIGHT=19  SRC="graphics/rule.gif">
</CENTER><P>
1994 DoD Indicators participant<P>

<B>Success criteria:</B><P>

<!-- List Tag -->

<UL TYPE=disc>
<LI>awarded a Phase II from NSF
</UL>


The company goal is to develop and exploit a wide offering of products and engineering services related to structural strain measurement. SMS products will allow inexpensive, reliable, and timely prediction of structural failures to an extent not possible under competing technologies.<P>

The patented SMS <I>Intelli</I> Sense (TM) technology involves so-called "smart" materials, in particular Peak Strain Indicating (PSI) steel alloys capable of "remembering" peak strains placed upon them. These alloys are engineered into sensor systems that allow, for example, a bridge toe to be structurally interrogated remotely by phone. The systems allow bridges and airplanes to proactively announce their pending structural failure in time for remedies. For the first time the user can know accurately and immediately how close to failure a structural element has come. Furthermore, that information can be captured with no external support systems. It does not matter whether the damage arose from instantaneous strain, corrosion, or fatigue. The strain instrument "remembers" the maximum strain/deformation it has experienced  so that the information may be monitored in real time or at some later time. <P>

The SMS IntelliSense technology is equally useful in military and civilian planes, equipment, bridges, and buildings. The significant maintenance savings and safety enhancements offered by the SMS technology are valuable in both environments.<P>

Potential customers include all government agencies responsible for bridge maintenance and safety; as well as manufacturers and operators of stressed structures, including airplanes, pipelines, and pressure vessels. The technology is of particular value in earthquake prone areas and can be used to monitor bridges, pipelines, tunnels, viaducts, runways, and buildings. Other applications include fasteners and other mechanical applications.<P>

Next commercialization step: SMS is looking for strategic allies in the areas of civil engineering, aerospace applications, and fasteners.<P>

<B>Source:</B><P>
Correspondence from Raemon Polk, 12/4/96<P>

<B>For further information on Strain Monitor Systems, Inc , please contact:</B><P>

Raemon Polk<BR>
Vice President<BR>
Strain Monitor Systems, Inc.<BR>
430 10th Street, N.W., Suite N-102<BR>
Phone: (404) 609-9507<BR>
Fax: (404) 609-9807<BR>
<A HREF="MAILTO:rpolk@intellisense.com">rpolk@intellisense.com</A><BR>
<!-- Link Tag -->
<A HREF="http://www.intellisense.com">www.intellisense.com</A><P>

<CENTER><IMG WIDTH=505 HEIGHT=53  SRC="graphics/SUN.gif"><P>

<A HREF="success.html"><IMG WIDTH=171 HEIGHT=29  SRC="graphics/bak2succ.gif" border=0></A><p>

<A HREF="success.html">Back to Success</A></CENTER></BODY> </HTML> 
</DOC>
<DOC>
<DOCNO>WT02-B10-107</DOCNO>
<DOCOLDNO>IA073-000479-B025-231</DOCOLDNO>
<DOCHDR>
http://www.dawnbreaker.com:80/TMSTechnologies.html 204.249.112.36 19970208233344 text/html 2730
HTTP/1.0 200 OK
Date: Sat, 08 Feb 1997 23:34:59 GMT
Server: Apache/1.0.5
Content-type: text/html
Content-length: 2559
Last-modified: Sat, 04 Jan 1997 17:12:56 GMT
</DOCHDR>
<HTML> 

<HEAD>

<TITLE>TMS Technologies, Inc.</TITLE>

</HEAD>

<BODY bgcolor="#ffffff"> 


<BODY> 

<H2 ALIGN=CENTER>TMS Technologies, Inc.</H2>
<H3 ALIGN=CENTER>Ithaca, NY</H3>


<CENTER><P><IMG WIDTH=499 HEIGHT=19  SRC="graphics/rule.gif">
</CENTER><P>

Indicators of Commercial Potential Program, 1995 
Army<p>

<B>Success criteria:</B><P>

<!-- List Tag -->

<UL TYPE=disc>
<LI>Phase II - U.S. Army, Communications Electronics Command, Fort Monmouth, NJ, September, 1996
</UL>



TMS Technologies was formed to commercialize a new technology for microelectromechanical systems (MEMS). MEMS represents the marriage of mechanics and microelectronics. In this technology, conventional integrated circuit processing techniques are used to fabricate mechanical devices (moving structures) at the dimensions of microelectronic devices, and in some cases to integrate the two on a single silicon chip.<P>

TMS utilizes a proprietary plasma micromachining technology to product MEMS devices with high performance and excellent manufacturability for a wide variety of applications. The Phase II SBIR project is concerned with developing a high efficiency DC to DC power converter based on a micromechanical switch technology. This is in contrast to current switching power supplies in which the switching function is accomplished with transistors.<P>

High efficiency switching power supplies have applications in virtually all portable, battery operated electronic instruments, including laptop computers and cellular phones. The military has specific interest in this technology for communications terminals. A very small, high efficiency power converter could also find application in distributed power supply systems, including board level power converters.<P>

<B>Commercialization Strategy:</B><P>
Toward the end of the Phase II project, TMS will likely seek to partner with an established power supply manufacturer to move this technology into full commercial production<P>

<B>Source:</B><P>
Correspondence from Gregory J. Galvin, Ph.D., 12/5/96<P>

<B>For further information, please contact:</B><P>

Gregory J. Galvin, Ph.D.<BR>
President<BR>
TMS Technologies, Inc.<BR>
22 Thornwood Drive<BR>
Ithaca, NY 14850<BR>
Phone: (607) 257-1525<BR>
Fax: (607) 257-1612<BR>
<A HREF="MAILTO:tms2inc@aol.com">tms2inc@aol.com</A><BR>

<CENTER>
<IMG WIDTH=505 HEIGHT=53  SRC="graphics/SUN.gif"><P>

<A HREF="success.html"><IMG WIDTH=171 HEIGHT=29  SRC="graphics/bak2succ.gif" border=0></A><p>

<A HREF="success.html">Back to Success</A>
</CENTER>
</BODY> 
</HTML> 

</DOC>
<DOC>
<DOCNO>WT02-B10-108</DOCNO>
<DOCOLDNO>IA073-000479-B025-263</DOCOLDNO>
<DOCHDR>
http://www.dawnbreaker.com:80/article1.html 204.249.112.36 19970208233400 text/html 20652
HTTP/1.0 200 OK
Date: Sat, 08 Feb 1997 23:35:08 GMT
Server: Apache/1.0.5
Content-type: text/html
Content-length: 20480
Last-modified: Wed, 26 Jun 1996 15:31:11 GMT
</DOCHDR>
<HTML> 
<HEAD><TITLE>Biz Plan How To Article</TITLE></HEAD> 
<BODY bgcolor="#ffffff"> 

<!-- These tags are for top and bottom navigation, but currently don't work.
<A HREF="foryou.html#PageBottom"><IMG WIDTH=18 HEIGHT=18  SRC="graphics/upbut.gif" border=0></A> <A HREF="foryou.html#PageTop"><IMG WIDTH=18 HEIGHT=18  SRC="graphics/dwnbut.gif" border=0></A>>

<!-- Graphic Tag -->
<CENTER><IMG WIDTH=157 HEIGHT=116  SRC="graphics/DawnB.gif"><P><BR></CENTER>


<!-- Graphic Tag -->
<IMG WIDTH=499 HEIGHT=19  SRC="graphics/rule.gif"></CENTER><P>
<P>

The article is copyrighted by Dawnbreaker. However, you are free to reprint this as long as you credit Dawnbreaker as the source, and do not reprint it for sale. This section will be updated quarterly.<P>
<H1>Developing effective business plans<BR>
 for advanced technology firms</H1>

<P>

<I><FONT SIZE=4>by Dr. Jenny Servo</FONT>&nbsp;</I><P>


This article was written for the National Science Foundation. It describes the steps which advanced technology firms should follow to develop winning business plans.<P>
<P>

<H3>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Index</H3>
<!-- List Tag -->
<OL TYPE=A>
<LI><!-- Anchor Link Tag -->
<A HREF="#intro">Introduction</A>
<LI><!-- Anchor Link Tag -->
<A HREF="#audience">Know your Audience</A>
<LI><!-- Anchor Link Tag -->
<A HREF="#obstacles">Obstacles to Business Planning</A>
<LI><!-- Anchor Link Tag -->
<A HREF="#theory">Business Planning as Theory Construction</A>
<LI><!-- Anchor Link Tag -->
<A HREF="#Process">Business Planning - the Process</A>
<LI><!-- Anchor Link Tag -->
<A HREF="#outline">Generic Business Plan Outline</A>
<LI><!-- Anchor Link Tag -->
<A HREF="#formatting">Formatting your Business Plan</A>
<LI><!-- Anchor Link Tag -->
<A HREF="#using">Using your Business Plan</A>
<LI><!-- Anchor Link Tag -->
<A HREF="#simple">Profound Simplicity</A>
</OL>

<Center>
<IMG WIDTH=499 HEIGHT=19  SRC="graphics/rule.gif"></CENTER><P>
<H4><A NAME="intro">A.	Introduction </A></H4>

Most companies avoid writing a business plan until they are in dire need of money. Propelled forward by the need to finance business growth, the technology entrepreneur begins this unique form of communication with the intent of convincing potential investors that they can make a good return on their investment (ROI) if they finance their firm. When developed for this purpose, the business plan has an external focus and must thoroughly address issues of importance to private investors. More experienced entrepreneurs also recognize that a business plan has great internal value, serving as a guide to help the company chart a course towards successful Phase III commercialization. 'Commercialization' as used here refers to (a) the sale of product or technology to private sector or military customers, and/or (b) the investment of developmental funds by the private sector in the company or a specific technology.<P>

Irrespective of the reasons for writing a business plan, the time invested can be far more fruitful if the entrepreneur views business planning as a transformational process for his or her management team. In making this statement, it is recognized that often the management team may consist of one person - the founder/technology entrepreneur. The end product of well-conceived planning is not only an excellent selling document, but increased business acumen which enables the technology entrepreneur to effectively use this tool to raise capital.<P>

The purpose of this chapter is to (1) describe the requirements of the audience for a company's business plan (i.e. potential investors), (2) provide a generic business plan outline, (3) examine methods for conducting the research required for business plan development, and (4) provide suggestions for appropriate use of business plans in seeking external funds. If you do not require external financing, your company in essence is the investor in itself. You should proceed to develop a business plan in the identical fashion suggested and then step back to examine the business opportunity from an investor's perspective. This vantage point will assist you in determining if you have charted the appropriate course of action.<P>

<H4><!-- Anchor Point Tag -->
<A NAME="audience">B.	Know your Audience</A></H4>

Your business plan is a communication tool. Therefore, in order to develop an effective selling document, the technology entrepreneur must first begin with a solid understanding of the audience. The audience for a business plan is not the same as the audience for a grant proposal. When you develop a Phase I or Phase II SBIR proposal, your task is to communicate effectively with other technologists. You, therefore, emphasize the significance of the problem, your methods for solving the problem, your qualifications, and the innovativeness/originality of the proposed work. However, as you enter Phase III and seek private sector investment, the technology entrepreneur communicates with a different group - with investors whose mission is to create value.<P>

Understanding the investor's perspective is often difficult for scientists. Scientists and investors move in different circles - circles that rarely intersect except when the agenda is money. It's money that brings scientists and investors together. Investors wish to create wealth and need a vehicle for doing so. Scientists seek financial resources to continue nurturing their dream. In essence, the investor sees money as the end and the scientists sees money as the means. What unlikely bedfellows!<P>

Investors carry the weight of fiduciary responsibility and manage other people's money. Creativity in the realm of finance can result in a prison sentence and heavy fines. Thus, individuals trained in finance are taught many procedures to appropriately track the movement of money and to predict investments which will result in the creation of additional wealth for their clients. The phrase that most befits investors is "I'm from Missouri, Prove it to me!" Give me data. Give me procedures. Minimize my risk.<P>

In the relationship between investors and scientists, scientists are the suitors. This is an unfamiliar position for new technology entrepreneurs. It is important to keep in mind that when seeking private sector financing, the technology entrepreneur is asking the investor to part with that which is at the core of their professional life - financial resources. The technology entrepreneur must therefore act as a visitor in the investor's world and learn to speak the language of business. The entrepreneur must de-emphasize discussions of technology and instead emphasize information regarding customers, markets, distribution channels, intellectual property, sales plans, engineering and manufacturing plans, human resource and financial requirements. These are the parameters that determine if your business opportunity will create value for potential investors. These are the variables of greatest interest to your audience - the investor.<P>

<H4><!-- Anchor Point Tag -->
<A NAME="obstacles">C.	Obstacles to Business Planning</A></H4>

Without a doubt, good business planning takes time! Unfortunately, many technology entrepreneurs begin the business planning process too late - waiting until they are in urgent need of financial resources before they begin. Due to lack of time and lack of familiarity with the process, they approach business planning at a superficial level - quickly finding answers to generic questions that must be addressed in business planning. However, good planning cannot be approached superficially. A rushed attempt at business planning will often fail in obtaining the desired funds. As a result, the new technology entrepreneur might falsely conclude that business concepts are unimportant, simple, and little more than conjecture - thus, distancing himself further from the benefits of good business planning.<P>

Another obstacle that prevents technology entrepreneurs from developing a business plan is the belief that they already have one. It's the plan in the entrepreneur's head. The entrepreneur believes that he has all the pertinent information. He simply hasn't had time to write it down yet. However, what the entrepreneur believes to be a business plan is nothing more than a "Mind Map", or a set of untested hypotheses and assumptions about the business environment in which the entrepreneur operates. This is the Pre-condition in Figure 1. The Mind Map is expressed simply, it also lacks depth of understanding. Just as it is insufficient for a scientist to base predictions strictly on hypotheses and assumptions, it is equally inappropriate for entrepreneurs to base their decisions on untested hypotheses. In business, as in science, conjecture must gradually be replaced by certitude!<P>

FIGURE 1
(Insert Figure 1 about here)<P>

<H4><!-- Anchor Point Tag -->
<A NAME="theory">D.	Business Planning as Theory Construction</A></H4>

In the practice of science, a scientist strives to observe, explain, predict, and control the phenomenon of interest. A technology entrepreneur must aspire to no less in the business planning process. The scientist, as business planner, must observe the world in which the business opportunity exists. The most important variables to which he or she must attend are the customers, competitors, market size, financial resources, risks, human resources, and technology/product. (Technology is listed last intentionally, as the potential investor usually assumes the viability of the technology at the outset and validates this later.)<P>

The entrepreneur must gather sufficient information to explain the behavior of these variables so that adequate predictions can be made regarding their probable interaction. Strategies then need to be developed to maximize the likelihood that the course of development can be controlled in the desired fashion - which is, in the creation of a commercially viable business. Business planning then is like "theory construction" or "model building." <P>

At the outset, a scientist's view of his business contains numerous assumptions and hypotheses. However, through the application of a systematic approach these assumptions may be tested and even discarded if necessary. A business plan is nothing more than the business counterpart of scientific theory and embodies the scientist's understanding of the business world in which the technology exists and can be commercialized.<P>

<H4><!-- Anchor Point Tag -->
<A NAME="Process">E.	Business Planning - the Process</A></H4>

The most important aspect of business planning is the process itself. This process contains a number of discrete steps:<P>

clarification of the company vision and mission,
information gathering (customers, market, competitors, distribution channels, costs associated with R&D, engineering, manufacturing and financing options),	
review of information - synthesis, inferences and deductions,
decision making
re-evaluation of mind map,
number crunching
strategizing, and
writing<P>

The business planning process is iterative and not linear in nature. As the entrepreneur gathers more information, the vantage point and positions taken will shift. During this process, the technology entrepreneur must be willing to part with perspectives that upon examination fail to coincide with the evidence at hand. In most cases, the outcome of good strategic business planning is change... a modification in the technology, the product, the team, the direction, or the assessment of the opportunity itself. This is where the transformational value of business planning becomes evident.<P>

Business planning is always added to a very busy schedule and, therefore, requires a firm commitment at the outset. It is recommended that the technology entrepreneur anticipate that approximately 300 person-hours will be required for the business planning process over a three month period. Once the entrepreneur has made a commitment to proceed, a project manager should be selected and a schedule established for completion of the process.<P>

The project manager should either be the company President or someone else within the management team. It is important that the technology entrepreneur include other people from the management team in this process. This will assure that their perspectives also shift in light of new data gleaned as the work progresses. Tasks such as secondary data gathering, number crunching, and editing can be undertaken by others on behalf of the team. Thus, by outsourcing some tasks, the management team can reduce demands on its time.<P>

Don't overlook the services of the NASA Regional Technology Transfer Centers, graduate students, and accountants with regard to these activities. However, all other tasks should be undertaken by the management team. The technology entrepreneur's team will miss the opportunity for growth if data synthesis, decision-making, and strategizing are allocated to others. This will compromise the ability of the team to interface effectively with potential investors. This business plan must be yours! Ownership must be felt by the team!<P>

<H4><!-- Anchor Point Tag -->
<A NAME="outline">F.	Generic Business Plan Outline</A></H4>

When you actually begin to write the business plan, you should expect that the process will be similar to writing a technical paper. First a draft is produced (referred to in Figure 1 as the Business/Operational Plan) and then a briefer, more polished final draft will follow (Business Plan). The latter is what you will share with potential investors. As this is a different style of writing, expect that the actual preparation of the business plan will take more time than that required to write a technical paper.<P>

<H5>Business Plan Outline</H5><P>

<!-- List Tag -->
<OL TYPE=I>
<LI>Executive Summary
<LI>Company & Technology Description
<LI>Customers
<LI>Market
<LI>Industry Analysis
<LI>Competitors
<LI>Marketing/Sales Plan
<LI>R&D Plan
<LI>Manufacturing/Engineering Plan
<LI>Human Resource Plan
<LI>Contingencies
<LI>Financials (Cash Flow, Profit & Loss Statement, Balance Sheet)
<LI>Appendices
<LI>References
</OL><P>

The overall objective of a business plan is to present a compelling argument for investment. The document begins with a presentation of background information regarding the company, the technology, the industry, the market, the competitors and then concludes with the presentation of a detailed plan for capturing a piece of that market and creating value for both the investor and the firm. The information presented in the plan is clustered into various sections, all of which are fairly generic (See Table 1). Don't get hung up on the actual Chapter headings used in the table of contents. These may vary somewhat from one outline to another. The variation is irrelevant. What is important is the level of detail and specificity.<P>

Specificity is what differentiates excellent from poor business plans. Again, remember that your audience consists of risk averse investors who wish to create value. They are not enamored with technology, but with the possibility that your technology presents for developing wealth. The more facts that you can provide, the better. <P>

Fill your business plan with certitude! Reduce conjecture! When developing models for emerging markets, base the model on a number of well established data points and benchmarks. Cite your sources, just as you do when preparing a technical paper. Define your market segments with specificity, rather than presenting data at the industry level. For example, if you have produced a high-efficiency heater that could be used in the high-end market - size that niche, rather than representing your market as the total HVAC market.<P>

<H4><!-- Anchor Point Tag -->
<A NAME="formatting">G.	Formatting your Business Plan</A></H4>

Potential investors are presented with thousands of business plans each year. They quickly scan the Executive Summary, look at the financials and then decide if they will read any further. Your Executive Summary is, therefore, very important. It must sizzle! Don't write it when you are tired - it needs to be exciting for an investor. Don't make it sound academic - brag a bit! Talk about your accomplishments - specifically those that have relevance for value creation. Don't make it sound as if your focus is merely to obtain funds for R&D. Talk about and represent a genuine desire for a partnership with the investor. Make it apparent that there will be an opportunity for significant return on investment. However, do not spell out the terms of a potential agreement as this needs to be negotiated. Be brief - but not so short that the excitement is lost. <P>

The visual appearance of a business plan is quite different than that of a grant proposal. Your objective when formatting the business plan is to make it distinctive. You want to make it stand out from the rest. It should be accessible and easy to read. This is done via the use of graphics, color, spacing, and type font. I am not suggesting that form is more important than content. Good content must be there - but then, go that extra mile. In the business world, a book is judged by its cover. Appearance is taken as a reflection of the professionalism of your firm.<P>

There are common errors made in formatting business plans which are deadly. Before you present a copy of your business plan to an investor, check it thoroughly. Make sure that:<P>

<!-- List Tag -->
<UL TYPE=disc>
<LI>It has a Table of Contents;
<LI>it has page numbers;
<LI>it is double spaced;
<LI>it uses a type face that is easy to read - such as 12 point Times Roman;
<LI>it is bound.
</UL><P>

<H4><!-- Anchor Point Tag -->
<A NAME="using">H.	Using your Business Plan</A></H4><P>

An excellent business plan contains detailed, proprietary information about your firm's strategy for developing a place in the market. This is not the kind of information that you will want anyone, but a serious investor to have. Therefore, be cautious in the distribution of your business plan and pre qualify potential investors before providing them with a copy to review.<P>

How do you meet investors? The most common way to meet investors is through third party introductions. A lawyer, an accountant, another technologist, a consultant, or a friend may make the introduction for you. After the introduction, call to set up an appointment to meet with the potential investor.<P>

At a meeting, present salient information regarding your business opportunity to the potential investor. Always bear in mind the motivation of the investor and address business issues rather than focusing on the technology. This first meeting should be on a non-confidential basis. Spend time during this meeting getting to know each other. Ask questions to determine if the potential investor is a good match for you. Typical questions include: What kind of experience have they had with helping companies at this stage of development? What is the typical return on investment that they look for? What is their experience in this industry or marketplace? Do they have established relationships with company X, Y, Z - potential good strategic partners for you? Are they currently investing in a competitor? In this meeting it is important to get a feeling for the person with whom you are dealing. Develop an understanding of how they work and what else the investor brings to the table besides money. Ultimately, any potential business relationship depends on trust. This is what each of you must assess during your first meeting. In closing, leave a copy of your Executive Summary with the potential investor and establish a time and a reason for the next interaction. Always keep in mind that you are the suitor in this relationship and be sure to initiate the scheduled follow-up activities.<P>

If you decide to proceed, the next typical step is to ask the potential investor to sign a Confidentiality Agreement. Some investors will sign a Confidentiality Agreement, others will not. Therefore, at this point the technology entrepreneur must make a decision as to whether he wishes to share the business plan with a potential investor on a non-confidential basis. When confronted with this situation, some entrepreneurs decide to remove sections of the plan that they consider particularly sensitive and share an edited version on a non-confidential basis. However, it is preferable for 
</DOC>
<DOC>
<DOCNO>WT02-B10-109</DOCNO>
<DOCOLDNO>IA073-000479-B023-131</DOCOLDNO>
<DOCHDR>
http://www.dawnbreaker.com:80/cap.html 204.249.112.36 19970208232826 text/html 2205
HTTP/1.0 200 OK
Date: Sat, 08 Feb 1997 23:29:38 GMT
Server: Apache/1.0.5
Content-type: text/html
Content-length: 2034
Last-modified: Fri, 26 Apr 1996 18:36:25 GMT
</DOCHDR>
<HTML> <HEAD><TITLE>Commercialization Assistance Program</TITLE></HEAD> <BODY bgcolor="#ffffff"> <!-- Graphic Tag --><CENTER><IMG WIDTH=157 HEIGHT=116  SRC="graphics/DawnB.gif"><P><BR></CENTER><!-- Graphic Tag --><IMG WIDTH=499 HEIGHT=19  SRC="graphics/rule.gif"></CENTER><P><BODY> <H3>COMMERCIALIZATION ASSISTANCE PROGRAM (CAP)</H3>This program is designed for groups of up the 100 companies and is typically sponsored by an organization with a vested interest in the success of the companies. Dawnbreaker has conducted this program on 5 ocassions for the U.S. Department of Energy. Participating companies are those which  have received Phase II  R&D funding through the Small Business Innovation Research program (SBIR).<P>The purpose of the CAP is to speed up the rate of successful commercialization of R&D. This is accomplished via a process which contains the following components:<P><!-- List Tag --><UL TYPE=disc><LI>comprehensive business research and strategic planning,<LI>developing a business plan, a stand-alone Executive Summary, and presentation materials,<LI>targeted outreach to potential strategic allies and investors, and<LI>a Commercialization Opportunity Forum which brings together well-prepared technology entrepreneurs with prequalified investors and teaming partners.</UL>The success of this program is measured by the success of our clients. Specifically, we look at:<P><!-- List Tag --><UL TYPE=disc><LI>how many finalists receive private sector financing within 18 months of the Forum,<LI>the dollar value of those signed agreements<LI>the dollar value of increased sales, and<LI>the increase in the number of jobs.</UL>The program is designed for use with geographically dispersed or remote clients. The program consists of guided mentoring and 3 events spaced over a 6-9 month period.<P><CENTER><IMG WIDTH=505 HEIGHT=53  SRC="graphics/sun.gif"><P><A HREF="service.html"><IMG WIDTH=172 HEIGHT=29  SRC="graphics/lbk2svbt.gif" border=0></A></CENTER></BODY> </HTML>
</DOC>
<DOC>
<DOCNO>WT02-B10-110</DOCNO>
<DOCOLDNO>IA073-000479-B023-9</DOCOLDNO>
<DOCHDR>
http://www.dawnbreaker.com:80/toms.html 204.249.112.36 19970208232728 text/html 2006
HTTP/1.0 200 OK
Date: Sat, 08 Feb 1997 23:28:43 GMT
Server: Apache/1.0.5
Content-type: text/html
Content-length: 1835
Last-modified: Thu, 05 Dec 1996 08:54:00 GMT
</DOCHDR>
<HTML> 
<HEAD><TITLE>Ron Toms</TITLE></HEAD> 
<BODY bgcolor="#ffffff"> 

<CENTER>
<!-- Graphic Tag -->
<IMG WIDTH=105 HEIGHT=175  SRC="graphics/toms.gif"><P>
<B>Ronald S.H. Toms<P>
Associate</B><P></CENTER>

<!-- Graphic Tag -->
<IMG WIDTH=499 HEIGHT=19  SRC="graphics/rule.gif"></CENTER><P>

Ron Toms has had a varied career as an aeronautical engineer, a rocket scientist, a planner of missions to the planets, a director of geothermal research, and a program officer for Small Business Innovation Research (SBIR). He has a multi-disciplinary background in the engineering and physical sciences.<P>

Born in England and educated at the Royal Naval Engineering College in Aeronautical Engineering (M.S.), and at London University in Mathematical Physics (a second M.S.), he became director of aerodynamics research at Bristol Aeroplane Company in 1949, developing the aerodynamic design of supersonic ramjets and the Concorde. He came to the U.S. in 1957 to build the first hypersonic wind tunnel for the U.S. Navy. In small businesses he developed and tested the first nuclear-powered ion rocket in the early '60s, and later joined the Jet Propulsion Laboratory where he planned Mariner, Viking and Voyager missions to all the planets except Pluto.<P>

In 1975 Ron came to ERDA, which later became the Department of Energy (DOE), to direct research and technology development in geothermal energy, and joined the SBIR program at DOE in 1987. Ron retired from DOE in 1992 and became an associate of Dawnbreaker in 1993.<P>

<!-- MailTo Tag -->
<A HREF="MAILTO:rtoms@dawnbreaker.com">rtoms@dawnbreaker.com</A><P>

<CENTER>
<IMG WIDTH=505 HEIGHT=53  SRC="graphics/sun.gif"><P>

<A HREF="staff.html"><IMG WIDTH=141 HEIGHT=29  SRC="graphics/bak2staf.gif" border=0></A><p>
<A HREF="staff.html">Back to Staff</A></CENTER>
</BODY> 
</HTML> 
</DOC>
<DOC>
<DOCNO>WT02-B10-111</DOCNO>
<DOCOLDNO>IA073-000479-B022-329</DOCOLDNO>
<DOCHDR>
http://www.dawnbreaker.com:80/dugan.html 204.249.112.36 19970208232718 text/html 1795
HTTP/1.0 200 OK
Date: Sat, 08 Feb 1997 23:28:34 GMT
Server: Apache/1.0.5
Content-type: text/html
Content-length: 1624
Last-modified: Thu, 05 Dec 1996 08:52:55 GMT
</DOCHDR>
<HTML> 
<HEAD><TITLE>John Dugan</TITLE></HEAD> 
<BODY bgcolor="#ffffff"> 

<CENTER>
<!-- Graphic Tag -->
<IMG WIDTH=105 HEIGHT=175  SRC="graphics/dugan.gif"><P>
<B>John Dugan<P>
Senior Associate</B><P>

<!-- Graphic Tag -->
<IMG WIDTH=499 HEIGHT=19  SRC="graphics/rule.gif"></CENTER><P>

John Dugan brings to Dawnbreaker a varied background acquired during a 40 year career. He has held positions at three major firms: Sperry Gyroscope Corporation, Jones and Laughlin Steel Corporation, and Eastman Kodak Company.<P>

At Sperry, John worked as an aeronautical electronics field engineer, working primarily with the Air Force and Navy. At Jones and Laughlin, he held positions in capital budgeting and planning, mathematical-economic model development, commercial research and marketing planning. At Eastman Kodak he held positions in management systems development, product-market management, and planning systems development, market intelligence and with the Company's Office of Innovation as a business analysis resource.<P>

Within Dawnbreaker, Mr. Dugan specializes in assisting our clients with business plan development and marketing. John has a Bachelor of Electrical Engineering degree from Manhattan College and a Master of Science degree in Industrial Administration from Carnegie-Mellon University.<P>
<!-- MailTo Tag -->
<A HREF="MAILTO:jdugan@dawnbreaker.com">jdugan@dawnbreaker.com</A><P>
<CENTER>
<IMG WIDTH=505 HEIGHT=53  SRC="graphics/sun.gif"><P>

<A HREF="staff.html"><IMG WIDTH=141 HEIGHT=29  SRC="graphics/bak2staf.gif" border=0></A><p>
<A HREF="staff.html">Back to Staff</A></CENTER>
</BODY> 
</HTML> 
</DOC>
<DOC>
<DOCNO>WT02-B10-112</DOCNO>
<DOCOLDNO>IA073-000479-B022-306</DOCOLDNO>
<DOCHDR>
http://www.dawnbreaker.com:80/Hauler.html 204.249.112.36 19970208232710 text/html 2366
HTTP/1.0 200 OK
Date: Sat, 08 Feb 1997 23:28:23 GMT
Server: Apache/1.0.5
Content-type: text/html
Content-length: 2195
Last-modified: Thu, 05 Dec 1996 08:53:07 GMT
</DOCHDR>
<HTML> 
<HEAD><TITLE>Hauler</TITLE></HEAD> 
<BODY bgcolor="#ffffff"> 

<!-- Graphic Tag -->
<CENTER><!-- Graphic Tag -->
<IMG WIDTH=105 HEIGHT=175  SRC="graphics/hauler.gif"><P>
<B>Paul D. Hauler<P>
Executive Vice President</B><P></CENTER>

<!-- Graphic Tag -->
<IMG WIDTH=499 HEIGHT=19  SRC="graphics/rule.gif"></CENTER><P>

Mr. Hauler has a rich and varied background in general management, marketing, business, and strategic planning. He has personally and successfully run $3, $10, and $20 million dollar companies in both the start-up and mature mode. Positions which Mr. Hauler has held include:<P>

<!-- List Tag -->
<UL TYPE=disc>
<LI>President of Videk (a corporate venture)
<LI>General Manager of Keuffel & Esser Co.
<LI>President of Taylor Instrument Company PTY, Ltd.
<LI>Vice President of Marketing for Boeing Electronics
</UL>
Many of these roles have required restructuring and turn-around efforts to increase productivity and reduce costs. Mr. Hauler is no stranger to the venture capital community and has frequently interfaced with venture capitalists when considering divestiture and acquisition activities.<P>

Mr. Hauler worked with NASA for 4 years where he served as the Director for Industry Affairs. Here his efforts were focused upon marketing the numerous technologies which NASA produced to various publics. NASA's "Spin-Off" magazine and TechBrief brochures are both consequences of those efforts.<P>

Mr. Hauler is Director-Strategic Relations for The Center for Integrated Manufacturing Studies at Rochester Institute of Technology and works part-time with Dawnbreaker. Within Dawnbreaker, he specializes in assisting more mature management teams with their business plans, strategic planning and negotiations. Mr. Hauler is also the co-author of Business Planning for Scientists and Engineers, the primary text used with Dawnbreaker's clients.<P>

<!-- MailTo Tag -->
<A HREF="MAILTO:phauler@dawnbreaker.com">phauler@dawnbreaker.com</A><P>


<CENTER>
<IMG WIDTH=505 HEIGHT=53  SRC="graphics/sun.gif"><P>

<A HREF="staff.html"><IMG WIDTH=141 HEIGHT=29  SRC="graphics/bak2staf.gif" border=0></A><p>
<A HREF="staff.html">Back to Staff</A></CENTER>
</BODY> 
</HTML> 
</DOC>
<DOC>
<DOCNO>WT02-B10-113</DOCNO>
<DOCOLDNO>IA073-000479-B023-69</DOCOLDNO>
<DOCHDR>
http://www.dawnbreaker.com:80/jservo.html 204.249.112.36 19970208232802 text/html 1902
HTTP/1.0 200 OK
Date: Sat, 08 Feb 1997 23:29:15 GMT
Server: Apache/1.0.5
Content-type: text/html
Content-length: 1731
Last-modified: Thu, 05 Dec 1996 08:53:25 GMT
</DOCHDR>
<HTML> 
<HEAD><TITLE>John Servo</TITLE></HEAD> 
<BODY bgcolor="#ffffff"> 

<CENTER>
<!-- Graphic Tag -->
<IMG WIDTH=105 HEIGHT=175  SRC="graphics/jservo.gif"><P>
<B>John Servo<P>
Vice President</B><P></CENTER>

<!-- Graphic Tag -->
<IMG WIDTH=499 HEIGHT=19  SRC="graphics/rule.gif"></CENTER><P>

John Servo joined Dawnbreaker in 1991 and has primary responsibility for the company's interface with the investment community. He is responsible for telephone outreach to Fortune 500 companies and venture capital firms, assessing their technology and investment interests, as well as assuring good participation at the Forums that we conduct for the U.S. Department of Energy and the National Institute of Standards.<P>

John is also an active member of our commercialization team and works with small and large firms participating in the DOE, DoD, and ATP programs. Mr. Servo has a strong background in sales, acquired over a 20 year career as a master salesman, sales trainer, sales manager, and general manager. He is skilled in analyzing what needs to be done from a management, pricing, and product mix perspective in order to make companies more profitable.<P>

Mr. Servo also works with our market research team, being responsible for primary research initiatives to assess potential customer interests. He also serves as a reviewer of draft agreements and as a mentor to companies involved with negotiations.<P>

<!-- MailTo Tag -->
<A HREF="MAILTO:jservo@dawnbreaker.com">jservo@dawnbreaker.com</A><P>


<CENTER>
<IMG WIDTH=505 HEIGHT=53  SRC="graphics/sun.gif"><P>

<A HREF="staff.html"><IMG WIDTH=141 HEIGHT=29  SRC="graphics/bak2staf.gif" border=0></A><p>
<A HREF="staff.html">Back to Staff</A></CENTER>
</BODY> 
</HTML> 
</DOC>
<DOC>
<DOCNO>WT02-B10-114</DOCNO>
<DOCOLDNO>IA073-000479-B023-163</DOCOLDNO>
<DOCHDR>
http://www.dawnbreaker.com:80/bizplan.html 204.249.112.36 19970208232838 text/html 2907
HTTP/1.0 200 OK
Date: Sat, 08 Feb 1997 23:29:54 GMT
Server: Apache/1.0.5
Content-type: text/html
Content-length: 2736
Last-modified: Fri, 26 Apr 1996 19:17:44 GMT
</DOCHDR>
<HTML> 
<HEAD><TITLE>Business Planning</TITLE></HEAD> 
<BODY bgcolor="#ffffff"> 
<!-- Graphic Tag -->
<CENTER><IMG WIDTH=157 HEIGHT=116  SRC="graphics/DawnB.gif"><P><BR></CENTER>

<!-- Graphic Tag -->
<IMG WIDTH=499 HEIGHT=19  SRC="graphics/rule.gif"></CENTER><P>
<BODY> 



<H3>BUSINESS PLAN DEVELOPMENT</H3>

<B>Plans are nothing. Planning is everything!</B> -- Dwight D. Eisenhower<P>

So we many companies approach business plan development as something they must do when in dire need of money. They approach business planning as a writing exercise; as something that can be accomplished by shutting yourself away for a week-end and writing down everything you know.  Nothing could be further from the truth!<P>

Business planning is a transformational process and a comprehensive activity which involves strategic planning, market research, competitor analysis, development of operational plans, financial forecasts and analysis of value. Once one has completed the process of conducting this business research and planning phase, the information is then packaged as a business plan. Most often the purpose of such a plan is to serve as a compelling and logical case for investment by internal or external investors and/or teaming partners.<P>

As there are so many different formats for business plans, we have included the outline of the one we have developed over time. Our purpose in including this is to show you what a comprehensive business plan should contain. However, remember that a business plan is only as good as the planning and research which has preceeds it. You wouldn't write a technical paper without conducting your experimental research first; neither should you draft a business plan until you have conducted appropriate business planning and research. Our book entitled <!-- Link Tag -->
<A HREF="books.html">"Business Planning for Scientist and Engineers"</A> provides a good conceptual framework for accomplishing the research.<P>

Dawnbreaker can assist individual companies with business plan development and/or critique business plans. See a <A HREF="foryou.html">related article</A>.<P>

<B>Business Plan Outline</B><P>

<!-- List Tag -->
<OL TYPE=I>
<LI>Executive Summary
<LI>Company & Technology Description
<LI>Customers
<LI>Market
<LI>Industry Analysis	
<LI>Competitors
<LI>Marketing/Sales Plan
<LI>R&D Plan
<LI>Manufacturing/Engineering Plan
<LI>Human Resource Plan
<LI>Contingencies
<LI>Financials
<OL TYPE=a>
<LI>Cash Flow
<LI>Profit & Loss Statement
<LI>Balance Sheet
</OL>
<LI>Appendices
<LI>References
</OL>

<CENTER>
<IMG WIDTH=505 HEIGHT=53  SRC="graphics/sun.gif"><P>

<A HREF="service.html"><IMG WIDTH=172 HEIGHT=29  SRC="graphics/lbk2svbt.gif" border=0></A></CENTER>

</BODY> 
</HTML> 
</DOC>
<DOC>
<DOCNO>WT02-B10-115</DOCNO>
<DOCOLDNO>IA073-000479-B023-36</DOCOLDNO>
<DOCHDR>
http://www.dawnbreaker.com:80/hanrott.html 204.249.112.36 19970208232748 text/html 1516
HTTP/1.0 200 OK
Date: Sat, 08 Feb 1997 23:29:02 GMT
Server: Apache/1.0.5
Content-type: text/html
Content-length: 1345
Last-modified: Thu, 05 Dec 1996 08:53:04 GMT
</DOCHDR>
<HTML> 
<HEAD><TITLE>Bob Hanrott</TITLE></HEAD> 
<BODY bgcolor="#ffffff"> 

<CENTER>

<!-- Graphic Tag -->
<IMG WIDTH=105 HEIGHT=175  SRC="graphics/Hanrott.gif"><P>

<B>Bob Hanrott<P>
Associate</B><P>
<!-- Graphic Tag -->
<IMG WIDTH=499 HEIGHT=19  SRC="graphics/rule.gif"></CENTER><P>
Bob is a new addition to the Dawnbreaker team, having worked with us on two DoD projects. Mr. Hanrott has an MBA from Sloan School of Management, London Business School and a BA & MA from Oxford. He has successfully developed and sold his own business (West Design Products Ltd.), and worked for numerous large firms. He was the Sales Director for CMA, a telecommunications marketing firm; Chairman and Marketing Manager for West Design Products Ltd.; Product Manager for Glaxo Pharmaceuticals Plc, and Deputy Head, Confederation of British Industry, North American Trade Department.<P>

Within Dawnbreaker, Mr. Hanrott specializes in working with smaller firms, providing assistance with issues of marketing, strategic planning, and sales.<P>
<!-- MailTo Tag -->
<A HREF="MAILTO:bhanrott@dawnbreaker.com">bhanrott@dawnbreaker.com</A><P>

<CENTER>
<IMG WIDTH=505 HEIGHT=53  SRC="graphics/sun.gif"><P>

<A HREF="staff.html"><IMG WIDTH=141 HEIGHT=29  SRC="graphics/bak2staf.gif" border=0></A><p>
<A HREF="staff.html">Back to Staff</A></CENTER>
</BODY> 
</HTML> 
</DOC>
<DOC>
<DOCNO>WT02-B10-116</DOCNO>
<DOCOLDNO>IA073-000479-B023-100</DOCOLDNO>
<DOCHDR>
http://www.dawnbreaker.com:80/jcservo.html 204.249.112.36 19970208232814 text/html 2247
HTTP/1.0 200 OK
Date: Sat, 08 Feb 1997 23:29:27 GMT
Server: Apache/1.0.5
Content-type: text/html
Content-length: 2076
Last-modified: Thu, 05 Dec 1996 08:53:23 GMT
</DOCHDR>
<HTML> 
<HEAD><TITLE>Jenny Servo</TITLE></HEAD> 
<BODY bgcolor="#ffffff"> 

<CENTER>
<!-- Graphic Tag -->
<IMG WIDTH=105 HEIGHT=175  SRC="graphics/jcservo.gif"><P>
<B>Dr. Jenny C. Servo<P>
President</B><P></CENTER>

<!-- Graphic Tag -->
<IMG WIDTH=499 HEIGHT=19  SRC="graphics/rule.gif"></CENTER><P>

Dr. Servo is the founder and president of Dawnbreaker. She has written extensively on the topic of innovation with articles appearing in The Futurist, Intrapreneurial Excellence, and Innovation in the Work Place. Dr. Servo is also the senior author on the books that are used with our clients including Business Planning for Scientists and Engineers; Knock Their Socks Off: Making Winning Presentations to Investors; and Indicators of Commercial Potential. <P>

Within Dawnbreaker, Dr. Servo specializes in the design of programs for Federal and State Agencies and in assisting small, advanced technology firms with business planning, market research, strategic planning, and organizational development. She is a frequent speaker at many national and state-related SBIR Conferences.<P>

From 1985-1988, Jenny worked as a consultant to Kodak's Office of Innovation where she was responsible for developing training programs for innovation facilitators and monitoring customer satisfaction with the Office of Innovation. Dr. Servo was also responsible for monitoring various aspects of Kodak's internal venturing process and providing recommendations on the training needs of new venture management teams. Dr. Servo is bilingual in Spanish and in the mid-80's consulted with the Organization of American States on issues regarding technology transfer. <P>

Jenny received her MS from the University of Kansas and her Ph.D. from the University of Rochester. <P>

<!-- MailTo Tag -->
<A HREF="MAILTO:jcservo@dawnbreaker.com">jcservo@dawnbreaker.com</A><P>


<CENTER>
<IMG WIDTH=505 HEIGHT=53  SRC="graphics/sun.gif"><P>

<A HREF="staff.html"><IMG WIDTH=141 HEIGHT=29  SRC="graphics/bak2staf.gif" border=0></A><p>
<A HREF="staff.html">Back to Staff</A></CENTER>
</BODY> 
</HTML> 
</DOC>
<DOC>
<DOCNO>WT02-B10-117</DOCNO>
<DOCOLDNO>IA017-000185-B023-165</DOCOLDNO>
<DOCHDR>
http://complimed.com:80/ 207.66.215.5 19970106091758 text/html 1807
HTTP/1.0 200 OK
Date: Mon, 06 Jan 1997 09:32:32 GMT
Server: Apache/1.1.1
Content-type: text/html
Content-length: 1636
Last-modified: Fri, 22 Nov 1996 19:58:51 GMT
</DOCHDR>
<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 3.2//EN">
<HTML>
<HEAD>
   <TITLE>Welcome to CSS Communications</TITLE>
</HEAD>
<BODY TEXT="#000000" BGCOLOR="#FFFFFF" LINK="#0000FF" VLINK="#FF0000" ALINK="#FF0000">
<CENTER><A HREF="http://www.cssnw.com/webserv.htm">
<IMG SRC="/icons/lightning.gif" ALT="Welcome to CSS Communications"></A>
</CENTER>

<CENTER>

<P><IMG SRC="/icons/rule01.gif" HEIGHT=22 WIDTH=468></P>

<P> Providing Business Internet <A 
HREF="http://www.cssnw.com/webserv.htm">Services</A> to 
Whatcom and Skagit Counties.</P>

<P> <IMG SRC="/icons/rule01.gif" HEIGHT=22 WIDTH=468></P>

</CENTER>

<P> </P>

<H3 ALIGN=CENTER>Hot Links</H3>

<DL>
<DD>
<IMG SRC="/icons/bullet1.gif" HEIGHT=7 WIDTH=5> 
<A HREF="http://www.cssnw.com">Computer Systems &amp; Services<BR></A>
<IMG SRC="/icons/bullet1.gif" HEIGHT=7 WIDTH=5> 
<A HREF="complimed/index.html">CompliMed</A><BR>
<IMG SRC="/icons/bullet1.gif" HEIGHT=7 WIDTH=5>
<A HREF="simonlaw/index.html">Simonarson, Visser, Zender &amp; Thurston<BR></A> 
<IMG SRC="/icons/bullet1.gif" HEIGHT=7 WIDTH=5>
<A HREF="mtbakerskiarea/index.html">Mt. Baker Ski Area<BR></A>
<CENTER><A HREF="http://www.unitedmedia.com/comics/dilbert">
<IMG SRC="/icons/get_dilb.gif" ALT="The Dilbert Zone"></A></CENTER> </DD> </DL>

<CENTER><P><IMG SRC="/icons/rule01.gif" HEIGHT=22 WIDTH=468></P></CENTER>

<P> If you have comments or suggestions, email <I><A HREF="mailto:dwitte@cssnw.com">dwitte@cssnw.com</A></I>
</P>
<CENTER><P><IMG SRC="/icons/apache_pb.gif"></P>
<IMG SRC="/cgi-bin/Count.cgi?ft=2&dd=D&frgb=0;0;0|df=csscomm.dat" 
ALT="CSS Communications Counter">
</CENTER>
<!fortune>
</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT02-B10-118</DOCNO>
<DOCOLDNO>IA017-000185-B023-183</DOCOLDNO>
<DOCHDR>
http://complimed.com:80/complimed/index.html 207.66.215.5 19970106091809 text/html 2322
HTTP/1.0 200 OK
Date: Mon, 06 Jan 1997 09:32:52 GMT
Server: Apache/1.1.1
Content-type: text/html
Content-length: 2151
Last-modified: Mon, 02 Dec 1996 20:14:23 GMT
</DOCHDR>
<HTML>
<HEAD>
<TITLE>CompliMed</TITLE>
<META NAME="description" CONTENT="Complimed: Complimentary Medical
Research Group: Our mission is to be the one source solution for health
care providers by providing quality homeopathic and alternative
products, informative, educational programs and excellent customer
service.">
<META NAME="keywords" CONTENT="Complimed, Complimentary Medical Research
Group, alternative medicine, therapy, therapies, homeopathic products,
resources, health, healthcare, homeopathy, allergies,  Complimed,
Complimentary Medical Research Group, alternative medicine, therapy,
therapies, homeopathic products, resources, health, healthcare,
homeopathy, allergies,  Complimed, Complimentary Medical Research Group,
alternative therapy, medicine, therapies, homeopathic products,
resources, health, healthcare, homeopathy, allergies,  Complimed,
Complimentary Medical Research Group, alternative therapies, medicine,
therapy,  homeopathic products, resources, health, healthcare,
homeopathy, allergies,  Complimed, Complimentary Medical Research Group,
alternative medicine, therapy, therapies, homeopathic products,
resources, health, healthcare, homeopathy, allergies, alternative
medicine">
</HEAD>

<BODY BGCOLOR="#FFFFFF">
<A HREF="header.map"><IMG SRC="header.gif" ALT="Complimed: Complementary Medical Research Group" BORDER=0 ISMAP></A><BR><IMG SRC="line.gif" BORDER=0 HSPACE=0 VSPACE=0><P>

<CENTER>
<H5>
[<A HREF="resource.html">Resources</A>] 
[<A HREF="new.html">What's New</A>] 
[<A HREF="article.html">Recent Article</A>] <BR>
[<A HREF="alt.html">Integration of Alternative Therapies</A>] 
[<A HREF="products.html">Product Listing</A>] <BR>
[<A HREF="profile.html">Profile</A>] 
[<A HREF="contact.html">Ordering & Contact</A>] 
</H5>
<IMG SRC="/cgi-bin/Count.cgi?ft=2&dd=D&frgb=0;0;0|df=complimed.dat" 
ALT="CompliMed Counter"><BR> <H6>Copyright Complimed 1996<BR>
This Internet site prepared by <A HREF="http://www.prosser.com/">Media Access.</A><BR>
If you have any comments about your visit to this site, please write 
<A HREF="mailto:webninja@prosser.com">webninja@prosser.com</A></H6>

</CENTER>
</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT02-B10-119</DOCNO>
<DOCOLDNO>IA017-000185-B023-200</DOCOLDNO>
<DOCHDR>
http://complimed.com:80/simonlaw/index.html 207.66.215.5 19970106091819 text/html 3626
HTTP/1.0 200 OK
Date: Mon, 06 Jan 1997 09:33:03 GMT
Server: Apache/1.1.1
Content-type: text/html
Content-length: 3455
Last-modified: Mon, 11 Nov 1996 19:04:45 GMT
</DOCHDR>
<HTML>
<HEAD>

<TITLE>Simonarson, Visser, Zender
& Thurston</TITLE>

<!-- Date: July 10, 1996  5:07 PM -->
<META name = "description" content = "Continuing the traditions established since 1914, the Simonarson Law Firm provides expertise and
the highest quality legal services through the work of dedicated attorneys and staff. ">
<META name = "key words" content = "Practice areas, Business & Commercial Law, Litigation, Employment & Labor Law, Municipal Law, Land Use & Real Estate Law, Probate & Estate Planning, Attorneys, Peter J. Visser, Daniel D. Zender, Hal Thurston, Hugh Lewis



, Laughlan H. Clark, Deborra Garrett, Steven J. Chance, Robert A. Carmichael, Bryan D. Lane, water quality, shoreline management, growth management, forest
practices, endangered species act, habitat conservation plan, HCP,
zoning, permitting, water district, discrimination, insurance
defense, landlord, tenant, unlawful detainer, timber trespass,
condominium law, community association, tribes, national historic
preservation act, clean water act, watershed analysis, bankruptcy,
limited liability partnership, subchapter s, Bellingham, Lynden, Whatcom County,
Washington, Western Washington University">

</HEAD>

<BODY BACKGROUND = "image/SVZTbg.GIF" BGCOLOR="#FEF9CA" LINK="#074D0C" VLINK="#550000">

<p align = "center">
<IMG  SRC="image/logo6med.jpeg"  ALIGN = "Center">
<p align = "center">
<center>
<ul>
<TABLE WIDTH=400 BORDER=0 CELLPADDING=5 CELLSPACING=5>
<tr><td>
<BR><B><font size = "3">
1700 D Street
<BR>P.O. Box 5226 
<BR>Bellingham, WA 98227
<BR>Phone (360) 647-1500
<BR>Fax (360) 647-1501

<td valign = "right"><BR><B><font size = "3">
 1610 Grover Street 
<BR>P.O. Box 631
<BR>Lynden, WA 98264
<BR>Phone (360) 354-4494
<br>Fax (360) 354-0621
</td></tr></table></ul>
<p align = "center">
<b><A HREF="mailto:simonlaw@simonlaw.com">email simonlaw@simonlaw.com</A></B>
<P>
</center>
<BR>
<table>
<tr><td>
<H3>
<B>
<DIR>
<IMG  SRC="image/SVZT.GIF"  ALIGN=BOTTOM> <A HREF="firm.html"> <font size = "6">O</font size>ur Firm</A>
<BR><BR>
<IMG  SRC="image/SVZT.GIF"  ALIGN=BOTTOM> <A HREF="practice.html"> <font size = "6">O</font size>ur Practice</A>
<BR><BR>
<IMG  SRC="image/SVZT.GIF"  ALIGN=BOTTOM> <A HREF="clients.html"> <font size = "6">R</font size>epresentative Firm Clients</A>
<BR><BR>
<IMG  SRC="image/SVZT.GIF"  ALIGN=BOTTOM>  <A HREF="links.html"><font size = "6">L</font size>ocal Links of Interest</A>
</H3></B>

</DIR>
</td>
</tr>
</TABLE>


<center>

<BR><font size = "3">
<A HREF="index.html">Home Page</A>&#160;|
<A HREF="firm.html">Our Firm</A>&#160;|
<A HREF="practice.html">Our Practice</A>&#160;|
<A HREF="clients.html">Clients</A>
<P>
<A HREF="RC.html">Robert A. Carmichael</A>&#160;|
<A HREF="SC.html">Steven J. Chance</A>&#160;|
<A HREF="LC.html">Laughlan H. Clark</A>&#160;|
<A HREF="DG.html">Deborra Garrett</A>
<BR>
<A HREF="BL.html">Bryan D. Lane</A>&#160;|
<A HREF="HL.html">Hugh Lewis</A>&#160;|
<A HREF="HT.html">Hal Thurston</A>&#160;|
<A HREF="PV.html">Peter J. Visser</A>&#160;|
<A HREF="DZ.html">Daniel D. Zender</A>
</center>
<BR><BR>
<CENTER>
<IMG SRC="/cgi-bin/Count.cgi?ft=2&dd=D&frgb=0;0;0|df=simonlaw.dat" 
ALT="Simonarson Counter"> </CENTER><BR><BR><BR><BR>
<FONT SIZE=2>
&copy;SVZT
<P>
<A HREF="http://www.viewit.com/ah/HDC.html">Hurley Design Communications</A><BR>
<A
HREF="mailto:ahurley@viewit.com">Contact ahurley@viewit.com
</A>with questions or comments regarding this site.

</FONT>


</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT02-B10-120</DOCNO>
<DOCOLDNO>IA017-000185-B023-213</DOCOLDNO>
<DOCHDR>
http://complimed.com:80/mtbakerskiarea/index.html 207.66.215.5 19970106091827 text/html 2351
HTTP/1.0 200 OK
Date: Mon, 06 Jan 1997 09:33:13 GMT
Server: Apache/1.1.1
Content-type: text/html
Content-length: 2180
Last-modified: Mon, 16 Dec 1996 18:41:30 GMT
</DOCHDR>
<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 3.2//EN">
<HTML>
<HEAD>
   <TITLE>MOUNT BAKER
</TITLE>
   <META NAME="GENERATOR" CONTENT="Mozilla/3.0Gold (Win95; I) [Netscape]">
</HEAD>
<BODY TEXT="#FFFFFF" BGCOLOR="#000000" LINK="#FF9000" VLINK="#FF9000">

<CENTER><P><IMG SRC="logo.gif" HEIGHT=145 WIDTH=340>
</P> 
<IMG SRC="snowflake2.gif" HEIGHT=18 WIDTH=16>
<A HREF="current.html">CURRENT MOUNTAIN
CONDITIONS</A> <BR>

<P><IMG SRC="hp.jpg" HEIGHT=225 WIDTH=386>
</P></CENTER>

<CENTER><TABLE BORDER=1 >
<TR>
<TD><IMG SRC="naturalfacts.gif" HEIGHT=192 WIDTH=150></TD>
</TR>
</TABLE></CENTER>

<IMG SRC="snowflake2.gif" HEIGHT=18 WIDTH=16>
<A HREF="map.html">MAP TO MT BAKER</A> <BR>
<IMG SRC="snowflake2.gif" HEIGHT=18 WIDTH=16>
<A HREF="expansion.html">NEW WHITE SALMON
DAY LODGE &amp; $5 MILLION EXPANSION PROJECT</A> <BR>
<IMG SRC="snowflake2.gif" HEIGHT=18 WIDTH=16>
<A HREF="prices.html">DAILY LIFT TICKETS
&amp; OTHER PRICES</A> <BR>
<IMG SRC="snowflake2.gif" HEIGHT=18 WIDTH=16>
<A HREF="lowdown.html">THE LOW DOWN</A> <BR>
<IMG SRC="snowflake2.gif" HEIGHT=18 WIDTH=16>
<A HREF="rental.html">RENTAL INFORMATION</A>
<BR>
<IMG SRC="snowflake2.gif" HEIGHT=18 WIDTH=16>
<A HREF="lessons.html">SKI SCHOOL</A> <BR>
<IMG SRC="snowflake2.gif" HEIGHT=18 WIDTH=16>
<A HREF="trail.html">TRAIL MAP</A> <BR>
<IMG SRC="snowflake2.gif" HEIGHT=18 WIDTH=16>
<A HREF="places.html">PLACES TO STAY</A> <BR>
</P>

<P>Mt. Baker Ski Area, Inc.<BR>
1017 Iowa Street<BR>
Bellingham, WA 98226<BR>
</P>

<P>(360) 734-6771 or fax (360) 734-5332 </P>

<P>You are visitor number <IMG SRC="/cgi-bin/Count.cgi?ft=2&dd=C&frgb=0;0;0|df=mtbaker.dat" ALT="Mt. Baker Counter" HEIGHT=24 WIDTH=94>.<BR>
</P>

<P>Problems? E-mail Dan Witte at <A HREF="mailto:dwitte@cssnw.com">dwitte@cssnw.com</A>

<HR></P>

<P><A HREF="http://www.sportsite.com/cgi-bin/htimage/opt/httpd/image-map/mainbar.conf"><IMG ISMAP SRC="mainbar.gif" HEIGHT=30 WIDTH=221></A>
</P>

<P><A HREF="http://www.sportsite.com/cedro/main/html/sportsite_hp.html">SportSite</A>
| <A HREF="http://www.sportsite.com/cedro/sia/html/sia_hp.html">SnowLink</A>
| <A HREF="http://www.sportsite.com/cedro/main/html/search.html">Search</A>
</P>

</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT02-B10-121</DOCNO>
<DOCOLDNO>IA017-000185-B023-227</DOCOLDNO>
<DOCHDR>
http://complimed.com:80/complimed/header.map 207.66.215.5 19970106091834 text/html 908
HTTP/1.0 200 OK
Date: Mon, 06 Jan 1997 09:33:20 GMT
Server: Apache/1.1.1
Content-type: text/html
</DOCHDR>
<html>
<head><title>Menu for /complimed/header.map</title></head>

<body>
<h1>Menu for /complimed/header.map</h1>
<hr>








<pre>          <a href="http://dogbert.cssnw.com/complimed/resource.html">resource.html</a></pre>
<pre>          <a href="http://dogbert.cssnw.com/complimed/new.html">new.html</a></pre>
<pre>          <a href="http://dogbert.cssnw.com/complimed/article.html">article.html</a></pre>
<pre>          <a href="http://dogbert.cssnw.com/complimed/alt.html">alt.html</a></pre>
<pre>          <a href="http://dogbert.cssnw.com/complimed/products.html">products.html</a></pre>
<pre>          <a href="http://dogbert.cssnw.com/complimed/profile.html">profile.html</a></pre>
<pre>          <a href="http://dogbert.cssnw.com/complimed/contact.html">contact.html</a></pre>


</body>
</html>
</DOC>
<DOC>
<DOCNO>WT02-B10-122</DOCNO>
<DOCOLDNO>IA017-000185-B023-237</DOCOLDNO>
<DOCHDR>
http://complimed.com:80/complimed/resource.html 207.66.215.5 19970106091841 text/html 1951
HTTP/1.0 200 OK
Date: Mon, 06 Jan 1997 09:33:27 GMT
Server: Apache/1.1.1
Content-type: text/html
Content-length: 1780
Last-modified: Mon, 16 Sep 1996 23:14:41 GMT
</DOCHDR>
<HTML>
<HEAD>
<TITLE>CompliMed: Resources</TITLE>
</HEAD>

<BODY BGCOLOR="#FFFFFF">
<A HREF="subheader.map"><IMG SRC="subheader.gif" ALT="Complimed: Complementary Medical Research Group" BORDER=0 ISMAP></A>
<H2>Resources</H2>
<A HREF="http://www.pitt.edu/~cbw/altm.html">Alternative Medical 
Resources by University of Pittsburgh</A><BR>
<A HREF="http://www.columbia.net">Columbia/HCA Healthcare System</A><BR>
<A HREF="http://www.nim.nih.gov/h">History of Medicine Division, National Library of Medicine</A><BR>
<A HREF="http://coombs.ana.edu.au/SpecialProj/ASAP/WWWVL-HSTM.html">History of Science, Technology and Medicine</A><BR>
<A HREF="http://www.cc.emory.edu.WHSCL/medweb.atlmed.html">Medweb: Alternative Medicine</A><BR>
<A HREF="http://www.nim.nih.gov">NIH Medical Images</A><BR>
<A HREF="http://www.yahoo.com/Health/Alternative_Medicine/Yale Medical Center">Yahoo-Health:Alternative Medicine</A><BR>
<A HREF="http://info.med.yale.edu/medical">Yale University School of Medicine</A><BR>
<H2>Newsgroups</H2>
<A HREF="news:alt.health">alt.health</A><BR>
<A HREF="news:misc.health.alternative">misc.health.alternative</A><P>

<CENTER>
<HR WIDTH=75%>
<H5>
[<A HREF="resource.html">Resources</A>] 
[<A HREF="new.html">What's New</A>] 
[<A HREF="article.html">Recent Article</A>] <BR>
[<A HREF="alt.html">Integration of Alternative Therapies</A>] 
[<A HREF="products.html">Product Listing</A>] <BR>
[<A HREF="profile.html">Profile</A>] 
[<A HREF="contact.html">Ordering & Contact</A>] 
</H5>
<H6>Copyright Complimed 1996<BR>
This Internet site prepared by <A HREF="http://www.prosser.com/">Media Access.</A><BR>
If you have any comments about your visit to this site, please write 
<A HREF="mailto:webninja@prosser.com">webninja@prosser.com</A></H6>

</CENTER>
</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT02-B10-123</DOCNO>
<DOCOLDNO>IA017-000185-B023-250</DOCOLDNO>
<DOCHDR>
http://complimed.com:80/complimed/new.html 207.66.215.5 19970106091848 text/html 2248
HTTP/1.0 200 OK
Date: Mon, 06 Jan 1997 09:33:34 GMT
Server: Apache/1.1.1
Content-type: text/html
Content-length: 2077
Last-modified: Sun, 15 Sep 1996 21:17:49 GMT
</DOCHDR>
<HTML>
<HEAD>
<TITLE>CompliMed: What's New</TITLE>
</HEAD>

<BODY BGCOLOR="#FFFFFF">
<A HREF="subheader.map"><IMG SRC="subheader.gif" ALT="Complimed: Complementary Medical Research Group" BORDER=0 ISMAP></A>
<H2>What's New at CompliMed&#153;</H2>
TRAUMA medicated cream offers temporary relief from minor aches and pains associated with:<P>
<IMG SRC="trauma.gif" ALIGN=LEFT BORDER=2 ALT="Trauma Medicated Cream" VSPACE=6 WIDTH=216 HEIGHT=77>
<UL>
<LI>Sports Injuries
<LI>Arthritis
<LI>Back Aches
<LI>Muscle aches and
<LI>Over exertion
</UL>
<BR CLEAR=LEFT>
TRAUMA medicated cream is the effective choice.  Your patients will benefit from the immediate relief and not be burdened with side-effects, as Trauma is a non-steroidal, anti-inflammatory analgesic.  <B><I>It can be used with ultrasound equipment.</I></B><P>
TRAUMA medicated cream is available in the patented-laminated tube.  The cream is protected by an inner lining which eliminates any direct contact with the metal tube.<P>
TRAUMA medicated cream may be purchased by licensed providers and pharmacists only.  The anti-inflammatory results of TRAUMA medicated cream can be enhanced with TRAUMA sublingual tablets and liquid drops.  Provide patient care with confidence as TRAUMA is safe for children and adults!<P>
TRAUMA and all CompliMed products are manufactured in the U.S. under an FDA drug manufacturing license and Washington State Pharmaceutical License.<P>
<CENTER>
<HR WIDTH=75%>
<H5>
[<A HREF="resource.html">Resources</A>] 
[<A HREF="new.html">What's New</A>] 
[<A HREF="article.html">Recent Article</A>] <BR>
[<A HREF="alt.html">Integration of Alternative Therapies</A>] 
[<A HREF="products.html">Product Listing</A>] <BR>
[<A HREF="profile.html">Profile</A>] 
[<A HREF="contact.html">Ordering & Contact</A>] 
</H5>
<H6>Copyright Complimed 1996<BR>
This Internet site prepared by <A HREF="http://www.prosser.com/">Media Access.</A><BR>
If you have any comments about your visit to this site, please write 
<A HREF="mailto:webninja@prosser.com">webninja@prosser.com</A></H6>

</CENTER>
</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT02-B10-124</DOCNO>
<DOCOLDNO>IA017-000185-B023-268</DOCOLDNO>
<DOCHDR>
http://complimed.com:80/complimed/article.html 207.66.215.5 19970106091857 text/html 9844
HTTP/1.0 200 OK
Date: Mon, 06 Jan 1997 09:33:42 GMT
Server: Apache/1.1.1
Content-type: text/html
Content-length: 9673
Last-modified: Sun, 15 Sep 1996 21:17:47 GMT
</DOCHDR>
<HTML>
<HEAD>
<TITLE>CompliMed: Recent Article</TITLE>
</HEAD>

<BODY BGCOLOR="#FFFFFF">
<A HREF="subheader.map"><IMG SRC="subheader.gif" ALT="Complimed: Complementary Medical Research Group" BORDER=0 ISMAP></A><P>
<B><I>Recent Article</I></B><BR><H2>Poten-C-cords&#153;</H2>
<B>Advantages and Uses</B><BR>
Poten-C-cords implement the principle of what has been termed harmonizing potencies, potency chords, multi-attenuations or multiple potencies. This technique utilizes several potencies of the same homeopathic substance in a single tablet, pillule or liquid preparation.  Although the principle behind Poten-C-cords was first described during the early decades of the twentieth century, it was not until the 1970's that the application of preparations based on this principle became well known.  Clinical utilization of this practice then became widespread with the use of multiple potencies for both single substances and combinations of several substances.  Poten-C-cords are administered with the objective of obtaining more intensive results by utilizing a spectrum of potencies to augment the overall therapeutic effect.  The purpose of mixed potencies is to avail patients of the advantages of providing both  "high" and  "low" attenuations at the same time.<P>
<P>
<B>History</B><BR>
Dr. Manfred Vosgerau documents in Bases and Results of Therapy with Balanced Potencies, that when potencies are combined as harmonizing potencies, the individual degrees of potency maintain their independent action, so that there is no immediate averaging effect on the different potencies.  In 1911, Cahis of Barcelona was the first to prepare medicinal agents based on the principle of potency chords. He likened such preparations to musical melodies or chords and theorized the sum total therapeutic effect to be quite different from the individual potencies themselves.  Cahis found that his multiple potency chords did, in fact, enhance therapeutic effects. He discovered that multiple attenuations initiated primary healing responses which were less uncomfortable for the patient than with one attenuation level, i.e. they reduced or eliminated the healing crisis or symptom aggravation.  Dr. Kroner investigated the action of potency chords by first prescribing and serially administering the different individual attenuations on separate occasions, and in later tests, mixed the different attenuations for administration in one single multi-attenuation dosage.  Kroner's results paralleled those of Cahis, finding that the action of potency chords was, in fact, different from and superior to the result achieved when the patient took the same, separate, unmixed attenuations in consecutive sequence.  Dr. Herman Junker published a study in 1982 entitled "On the Effects of Extremely Potentized Substances on Paramecia".  He potentized substances 1X to 27X, and his data quite clearly shows that some potencies inhibit while other potencies stimulate.  This effect is sinusoidal with stimulatory maxima and minima occuring at different potencies.<P>
<P>
<B>Potency Relationships</B><BR>
It is important to recognize the various relationships between Individual potencies, the body, and disease states.  Lower potency levels have direct relationships with normal physiological concentrations in the body.  This is a meaningful first step in the selection of a potency for a patient and his symptoms.<P>
<P>
Many enzymes in the body have cellular concentrations of 1X10-4M to 1X10-6M.  These levels correspond to potencies in the ranges of 3X to 6X (2C - 3C).  Regulatory enzymes and transfer or communicative molecules, such as Acetyl CoA have been measured at cellular levels of 1X10-9M - 1X10-10M corresponding to potencies of 9X - 12X (6C).  Hormone levels are measured or estimated to be present at physiological concentrations of 1X10-9M - 1X10-22M representing potencies of 9X to 22X (6C - 12C).  These concentration levels within the cells, tissues, blood and fluids illustrate the potential relationships between homeopathic potencies and physiological activities.<P>
<P>
There also exists a meaningful relationship between potency and the progress of an illness.  The resonant potency for an individual changes during the course of the disease.  Initially, at the onset of the illness, higher potencies are resonant with the disease state.  As symptoms worsen, the resonant potency decreases to lower potency levels, and as healing and recovery occurs, the resonant potency increases again.<P>
<P>
Van Benochoten has also demonstrated that potencies have harmonic relationships with each other.  His work demonstrates a harmonic relationship between the 3X potencies and 6X, 12X, 30X, and 200X potencies.  Another harmonic relationship exists between 6X and 1M, and another between 12X and 10M, 50M and CM potencies.  The unique harmonic relationships of the low and medium potencies provides the basis for the use of resonant, harmonizing, or multiple potencies.<P>
<P>
<TABLE BORDER=3>
<TR><TD>

<TABLE BORDER=0 CELLPADDING=10>
<TR><TD>
<B>Potency Influences:</B></TD>
<TD><B>Potency Ranges:</B></TD></TR>
<TR><TD>
organs and tissues</TD><TD>low<BR>1x, 3x, 6x, 9x<BR>(3c)</TD></TR>
<TR><TD>
hormonal regulation of organs,<BR>tissues and cellular function</TD><TD><IMG SRC="down.gif"></TD></TR>
<TR><TD>
intermediary regulation of<BR>intercellular metabolic systems<BR>and enzymes</TD><TD>medium<BR>12x, 30x<BR>(6C, 12C)</TD></TR>
<TR><TD>
functional regulation at the level<BR>of gene expression</TD><TD><IMG SRC="up.gif"></TD></TR>
<TR><TD>
miasms and constitional<BR>expression</TD><TD>medium high<BR>60x, 100x, 200x<BR>(30C, 60C)</TD></TR>
<TR><TD>
energetic influences</TD><TD>high<BR>1000x, 1M<BR>CM, LM</TD></TR>
</TABLE>

</TD></TR>
</TABLE><P>


<B>Potency Selection</B><BR>
This scientific data leads to the conclusion that administration of a single potency may not have the desired effect.   Favorable, clinical results are based on the characteristic inhibitory or stimulatory action of the substance and the need for the administered potency to be in harmony with the body's current demands.  This sinusoidal activity seems to be more critical at lower potencies of 3C to 30C, than at higher potencies which have other than gross physiological activity.  To optimize the body's response it is beneficial to use a Poten-C-cord to ensure maximum initial physiological action, and to provide additional potencies for use as the patient's disease progresses and is in need of a higher potency.  <P>
<P>
Using a Poten-C-cord takes the guess work out of selecting a potency as all acute level potencies are provided - 6C, 12C, 30C, and 60C.  The Poten-C-cord may also be used as a single dose in constitutional prescribing replacing or preceding the application of a higher potency.  Clinical evidence indicates that patients exhibit fewer aggravations as the body utilizes the potency that it resonates with.  The same Poten-C-cord can be used on day two, three, etc., as the body's need for different potencies is satisfied.  <P>
<P>
Poten-C-cords are both physiologically balanced and practical because they:<P>
<UL>
<LI>Effect the biology at multiple maxima and minima, thus ensuring a resonant response.
<LI>Make changing potencies as the disease progresses unnecessary
<LI>Produce fewer patient aggravations as the patient's resonance is always matched
<LI>Improve patient compliance and reduce practitioner interventions
<LI>Decrease the necessity of keeping an extensive inventory of "single potency" remedies
</UL>
<P>
CompliMed&#153; offers a wide selection of Poten-C-cords for health care professionals.  There are times when the use of more than one potency at a time of a given remedy is beneficial.  For example, when both an acute symptomatic episode and a constitutional predisposition need to be addressed.  CompliMed&#153; has utilized these valuable research findings to construct formulations which are both contemporary and unique.  The Poten-C-cords include the most frequently used remedies and polycrests providing an efficacious group of homeopathic formulations designed specifically for today's patient and physician needs.<P>
<B>General References</B><BR>
<H6>
Coulter.  Homeopathic Science and Modern Medicine:  The Physics of Healing with Microdoses.  1980<BR>
Dhawale.Principles and Practices of Homeopathy.  Bombay:  Karnatak Publishing,1967<BR>
Junker. "On the Effects of Extremely Potentized Substances in Paramecia", 1982.<BR>
Kroner. Dr. Bericht uber die 80, Versammlung des homoopathicschen Zentravereins, Deutschland, pp. 353<BR>
Resch and Gutmanm.  Scientific Foundations of Homeopathy.  Germany:  Barthel & Barthel Publishing, 1987.<BR>
Van Benschoten.  "Anatomical Resonance of Homeopathic Potencies",  Biological Therapy,  Vol. X No. 1,  1992, pp. 197-208.<BR>
Vithoulkas.  The Science of Homeopathy.  Grove Press, 1981.<BR>
cf. M. Vosgerau. "Basis and Results of Therapy with Balanced Potencies," Homotoxin Journal, Vol. 9, No. 6, 1970-pp. 135-143.<BR>
</H6><CENTER>

<HR WIDTH=75%>
<H5>
[<A HREF="resource.html">Resources</A>] 
[<A HREF="new.html">What's New</A>] 
[<A HREF="article.html">Recent Article</A>] <BR>
[<A HREF="alt.html">Integration of Alternative Therapies</A>] 
[<A HREF="products.html">Product Listing</A>] <BR>
[<A HREF="profile.html">Profile</A>] 
[<A HREF="contact.html">Ordering & Contact</A>] 
</H5>
<H6>Copyright Complimed 1996<BR>
This Internet site prepared by <A HREF="http://www.prosser.com/">Media Access.</A><BR>
If you have any comments about your visit to this site, please write 
<A HREF="mailto:webninja@prosser.com">webninja@prosser.com</A></H6>

</CENTER>
</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT02-B10-125</DOCNO>
<DOCOLDNO>IA017-000185-B023-281</DOCOLDNO>
<DOCHDR>
http://complimed.com:80/complimed/alt.html 207.66.215.5 19970106091905 text/html 5276
HTTP/1.0 200 OK
Date: Mon, 06 Jan 1997 09:33:51 GMT
Server: Apache/1.1.1
Content-type: text/html
Content-length: 5105
Last-modified: Sun, 15 Sep 1996 21:17:46 GMT
</DOCHDR>
<HTML>
<HEAD>
<TITLE>CompliMed: Integration of Alternative Therapies</TITLE>
</HEAD>

<BODY BGCOLOR="#FFFFFF">
<A HREF="subheader.map"><IMG SRC="subheader.gif" ALT="Complimed: Complementary Medical Research Group" BORDER=0 ISMAP></A><P>
<B><I>Integration of Alternative Therapies</I></B><BR><H2>Homeopathy Goes Mainstream</H2>
The past 20 years have seen tremendous growth in the number of patients seeking homeopathic care and, consequently, a dramatic increase in the number of practitioners seeking knowledge of and educational opportunities in homeopathy towards application in their practices. The practice of Homeopathy was considered a fringe or alternative and obscure philosophy and practice of medicine.  It has, however, found its way onto center stage, if not completely into the mainstream of progressive and integrated medical practice.<P>
<IMG SRC="pic3.gif" BORDER=2 HSPACE=6 VSPACE=6 ALIGN=LEFT ALT="Patients visit providers of alternative therapies." WIDTH=180 HEIGHT=177>In 1990, it was estimated that 1 in 3 Americans used alternative therapies and most did not tell their conventional physician.  In 1993, Dr. Eisenberg & colleagues published a survey in Journal of Family Practice estimating that patients made 425 million visits to providers of alternative therapies (compared with 388 million visits to primary care physicians) and spent $13.7 billion dollars, $10.3 billion of which was out of pocket.<P>
This growth in homeopathy has been paralleled by an equally impressive increase in homeopathic research.  Homeopathic research now appears in prominent, pier-reviewed scientific and medical journals.  Most prominent among these have been the articles by Dr. Jennifer Jacobs appearing in Pediatrics on the homeopathic treatment of diarrhea in children, and Dr. David Taylor Reilly's report on reproducible outcomes in homeopathy appearing in the Lancet.  Both of these double blind placebo controlled studies meet the most stringent criteria for medical methodology and support positive homeopathic treatment outcomes.<P>
Additionally, in response to the demand for more research into alternative therapies, last October the Office of Alternative Medicine (OAM) funded eight Complementary and Alternative Medicine Research Centers to evaluate various complementary or alternative medicine (CAM) therapies through high quality research.  These centers are expected to focus the scope of their activities on the areas of rehabilitation, women's health, pain, pain management, aging, cancer prevention and treatment, allergy treatment, and the safety, efficacy, and cost-effectiveness of CAM therapies for common, chronic medical conditions.<P>
The acceptance of alternative therapies in conventional medical practices is growing. Many major medical schools and universities are responding to the requests for more research and education, and have added to their curriculum Complimentary Medical courses that include classes on Homeopathy.  These universities include the College of Physicians and Surgeons at Columbia University, Harvard Medical School, The University of Illinois College of Medicine, Georgetown University Medical School and the University of Arizona, just to name a few.  In the state of Washington, Blue Cross offered a 1-year pilot program in which the response was so "overwhelming" that is has added a plan, called AlternaPath, that will provide coverage for those services traditionally disallowed by most health insurance plans.  Approved medications under this plan include herbal and homeopathic remedies, and vitamins.<P>
<B>General References</B><BR>
<H6>Blumberg, D L, MD, et al. "The Physician and Unconventional Medicine", <I>Alterntive Therapies</I>. 1995; 1(3); pp. 31. <BR>
Borkan J, Neher J, Anson O, Smoker B. "Referrals for alternative therapies",  <I>J Fam Pract</I>.  1994; 39(6); pp. 545-550. <BR>
"Cross offers Insurance Coverage for Naturopathy, Homeopathy, and Acupuncture", <I>Alternative Therapies</I>. 1996; 2(2); pp. 28.<BR>
Jacobs J, et al. "Treatment of Acute Childhood Diarhea with Homeopathic Medicine: A Randomized Clinical Trial in Nicaragua", <I>Pediatrics</I>. 1994, 93(5); pp. 719-725.<BR>
Reilly D, Taylor MA, Beattie NGM, et al. "Is evidence for homeopathy reproducible?", <I>Lancet</I>.  1994; 344; pp. 1601-1606.<BR>
Villaire M.  "OAM Sets Goals for Eight New Centers; Centers Provide Initial Details", <I>Alternative Therapies</I>. 1996; 2(2)l pp. 20-22, 90.</H6><P>

<CENTER>
<HR WIDTH=75%>
<H5>
[<A HREF="resource.html">Resources</A>] 
[<A HREF="new.html">What's New</A>] 
[<A HREF="article.html">Recent Article</A>] <BR>
[<A HREF="alt.html">Integration of Alternative Therapies</A>] 
[<A HREF="products.html">Product Listing</A>] <BR>
[<A HREF="profile.html">Profile</A>] 
[<A HREF="contact.html">Ordering & Contact</A>] 
</H5>
<H6>Copyright Complimed 1996<BR>
This Internet site prepared by <A HREF="http://www.prosser.com/">Media Access.</A><BR>
If you have any comments about your visit to this site, please write 
<A HREF="mailto:webninja@prosser.com">webninja@prosser.com</A></H6>

</CENTER>
</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT02-B10-126</DOCNO>
<DOCOLDNO>IA017-000185-B023-297</DOCOLDNO>
<DOCHDR>
http://complimed.com:80/complimed/products.html 207.66.215.5 19970106091913 text/html 4080
HTTP/1.0 200 OK
Date: Mon, 06 Jan 1997 09:33:58 GMT
Server: Apache/1.1.1
Content-type: text/html
Content-length: 3909
Last-modified: Sun, 15 Sep 1996 21:17:51 GMT
</DOCHDR>
<HTML>
<HEAD>
<TITLE>CompliMed: Product Listing</TITLE>
</HEAD>

<BODY BGCOLOR="#FFFFFF">
<A HREF="subheader.map"><IMG SRC="subheadera.gif" ALT="Complimed: Complementary Medical Research Group" BORDER=0 ISMAP></A>

<CENTER>
<TABLE>
<TR>
<TD VALIGN=TOP>

<TABLE CELLPADDING=8 BORDER=1>
<TR><TD WIDTH=200>
<B>Acute</B>
<UL>
<LI>Aconitum napellus
<LI>Apis mellifica
<LI>Arnica montana
<LI>Engergize
<LI>Infecticin
<LI>Inflammaion
<LI>Influenza CM
<LI>Trauma
<LI>Viral CM
<LI>Viral Cold CM
</UL>
</TD></TR></TABLE><P>

<TABLE CELLPADDING=8 BORDER=1>
<TR><TD WIDTH=200>
<B>Allergies</B>
<UL>
<LI>Arsenicum Album
<LI>Allergy CM
<LI>Animal Hair/Dander
<LI>Dairy
<LI>Grain
<LI>Grass Pollen
<LI>Mold/Yeast/Dust
<LI>Pollen/Hayfever
<LI>Tree Pollen
</UL>
</TD></TR></TABLE><P>

<TABLE CELLPADDING=8 BORDER=1>
<TR><TD WIDTH=200>
<B>Circulatory</B>
<UL>
<LI>Aurinic (RX)
<LI>Myocorcin (RX)
<LI>Rautonia (RX)
<LI>Scleromed (RX)
<LI>Vericocin
</UL>
</TD></TR></TABLE><P>

<TABLE CELLPADDING=8 BORDER=1>
<TR><TD WIDTH=200>
<B>Constitutional</B>
<UL>
<LI>Metabolin
<LI>MetaboSlim
<LI>Prevention
<LI>Psoriasin (RX)
</UL>
</TD></TR></TABLE><P>

<TABLE CELLPADDING=8 BORDER=1>
<TR><TD WIDTH=200>
<B>Detoxification</B>
<UL>
<LI>Bacticin
<LI>Enviro-Chem
<LI>Enviro-Met
<LI>Enviro-Pest
<LI>Hemopuritox
<LI>Lymphaticin
<LI>Stimutox
<LI>Vermicin
<LI>Viracin
</UL>
</TD></TR></TABLE><P>

<TABLE CELLPADDING=8 BORDER=1>
<TR><TD WIDTH=200>
<B>Gastrointestinal</B>
<UL>
<LI>Medacolic
<LI>Diarramed
<LI>Gastrica
<LI>Lycopodium clavatum
<LI>Nux vomica
</UL>
</TD></TR></TABLE><P>

<TABLE CELLPADDING=8 BORDER=1>
<TR><TD WIDTH=200>
<B>Glandular Support</B>
<UL>
<LI>Adrenal/Spleen
<LI>Liver/Gallbladder
<LI>Pancreas
<LI>Thymus
<LI>Thyroid
</UL>
</TD></TR></TABLE><P>

</TD>
<TD VALIGN=TOP>

<TABLE CELLPADDING=8 BORDER=1>
<TR><TD WIDTH=200>
<B>Men</B>
<UL>
<LI>Clinigland-M
<LI>Empromen (RX)
<LI>Prostamed
</UL>
</TD></TR></TABLE><P>

<TABLE CELLPADDING=8 BORDER=1>
<TR><TD WIDTH=200>
<B>Muscular/Skeletal</B>
<UL>
<LI>Arthricin
<LI>Calcarea Carbonica
<LI>Diarthrosis
<LI>Osteo-Cal
<LI>Rhus toxicondendron
<LI>Spinaflex
<LI>Trauma
</UL>
</TD></TR></TABLE><P>

<TABLE CELLPADDING=8 BORDER=1>
<TR><TD WIDTH=200>
<B>Pain & Nerves</B>
<UL>
<LI>Attenticin
<LI>Belladonna
<LI>Chamomilla
<LI>Gelsemium sempervirens
<LI>Insomnia Plus
<LI>Ignatia amara
<LI>Magnesia Phosphorica
<LI>Migramed
<LI>Quietiva
<LI>Sciatica/Back Pain
</UL>
</TD></TR></TABLE><P>


<TABLE CELLPADDING=8 BORDER=1>
<TR><TD WIDTH=200>
<B>Renal-Hepatic</B>
<UL>
<LI>Mededema
<LI>Cystimed
<LI>Heptachol
<LI>Nephramed
<LI>Renocalin
</UL>
</TD></TR></TABLE><P>

<TABLE CELLPADDING=8 BORDER=1>
<TR><TD WIDTH=200>
<B>Respiratory</B>
<UL>
<LI>Asthmica
<LI>Bryonia alba
<LI>Dulpulmon
<LI>Natrum Muriaticum
<LI>NicoRx
<LI>Phosphorus
<LI>Sinutarrh
<LI>Sore Throat
</UL>
</TD></TR></TABLE><P>

<TABLE CELLPADDING=8 BORDER=1>
<TR><TD WIDTH=200>
<B>Skin</B>
<UL>
<LI>Acnezema
<LI>Medaderm
<LI>Clinaskin-H
<LI>Silicea
<LI>Sulphur
</UL>
</TD></TR></TABLE><P>

<TABLE CELLPADDING=8 BORDER=1>
<TR><TD WIDTH=200>
<B>Women</B>
<UL>
<LI>Clinigland-F
<LI>Estrofemin
<LI>Femerin PMS
<LI>Gynacin
<LI>Pulsatilla nigricans
<LI>Menofemin
<LI>Sepia
</UL>
</TD></TR></TABLE><P>

</TD>
</TR>
</TABLE><P>

<IMG SRC="pic1.gif" ALT="CompliMed" BORDER=2 VPSPACE=10><P>


<HR WIDTH=75%>
<H5>
[<A HREF="resource.html">Resources</A>] 
[<A HREF="new.html">What's New</A>] 
[<A HREF="article.html">Recent Article</A>] <BR>
[<A HREF="alt.html">Integration of Alternative Therapies</A>] 
[<A HREF="products.html">Product Listing</A>] <BR>
[<A HREF="profile.html">Profile</A>] 
[<A HREF="contact.html">Ordering & Contact</A>] 
</H5>
<H6>Copyright Complimed 1996<BR>
This Internet site prepared by <A HREF="http://www.prosser.com/">Media Access.</A><BR>
If you have any comments about your visit to this site, please write 
<A HREF="mailto:webninja@prosser.com">webninja@prosser.com</A></H6>

</CENTER>
</BODY>
</HTML>

</DOC>
<DOC>
<DOCNO>WT02-B10-127</DOCNO>
<DOCOLDNO>IA017-000185-B023-312</DOCOLDNO>
<DOCHDR>
http://complimed.com:80/complimed/profile.html 207.66.215.5 19970106091922 text/html 4185
HTTP/1.0 200 OK
Date: Mon, 06 Jan 1997 09:34:06 GMT
Server: Apache/1.1.1
Content-type: text/html
Content-length: 4014
Last-modified: Sun, 15 Sep 1996 21:17:51 GMT
</DOCHDR>
<HTML>
<HEAD>
<TITLE>CompliMed: Profile</TITLE>
</HEAD>

<BODY BGCOLOR="#FFFFFF">
<A HREF="subheader.map"><IMG SRC="subheader.gif" ALT="Complimed: Complementary Medical Research Group" BORDER=0 ISMAP></A>
<IMG SRC="pic2.gif" BORDER=2 HSPACE=10 VSPACE=4 ALIGN=LEFT ALT="CompliMed incorporates a complete line of homeopathic products." WIDTH=180 HEIGHT=184><P>
<B><I>Company Profile</I></B><BR><H2>About CompliMed&#153;</H2>
Today's patients are better educated than ever before.  They also expect relief from their ailments, and are persistent in their pursuit of relief, especially when conventional medicines are not working for them.  Consequently, Pharmacists and Doctors are looking for health care products which are non-habit forming, have no adverse side affects and, most importantly, are effective in relieving the uncomfortable and often painful symptoms of their acute and chronically diseased patients.<P>
CompliMed incorporates a complete line of homeopathic products, nutritional products, herbal products, and conventional medicine to licensed health care practitioners. The Complimed Medical Research Group&#153; (CMRG), a division of CompliMed, offers services to assist conventional health care practitioners in learning about the products, therapies, legalities, insurance reimbursement possibilities, and more. Our consulting physicians make themselves available to practitioners & pharmacists to answer product and related therapy questions for specific cases.<P>
As part of our involvement with the medical community, CompliMed has been selected to participate in extensive clinical studies conducted by some of the nations leading universities and HMO providers who are researching the integration of alternative therapies into traditional medical practice.<P>
<B>BLI HISTORY</B><BR>
<IMG SRC="pic4.gif" BORDER=2 HSPACE=6 VSPACE=6 ALIGN=RIGHT ALT="CompliMed incorporates a complete line of homeopathic products.">CompliMed is the professional division of Botanical Laboratories, Inc. (BLI), one of the leading U.S. manufacturers of homeopathic tablets, creams, and liquid preparations.  BLI produces and packages a wide range of homeopathic products for companies worldwide and our procedures conform strictly to the guidelines prescribed by the Homeopathic Pharmacopeia of the United States.  BLI operates under an FDA drug manufacturing license, and produces a wide range of high-quality prescription and over-the-counter products.  The laboratory and automated production facility adheres to strict Good Manufacturing Practices, and is currently maintained and inspected in strict compliance with FDA regulations.<P>
As a result of good management and organization, a commitment to research and development, and a strong staff of committed, long-term employees,  BLI ranks among the top homeopathic manufacturers in the United States.<P>
<B>RESEARCH AND DEVELOPMENT</B><BR>
CompliMed formulations are based on extensive research and development conducted by a highly trained staff of professional Chemists, Biologists, Microbiologists, and Biochemists in key Quality Control, Production, Pharmacy and Laboratory positions.  Staff members have four-year Bachelor of Science or Master degrees in their respective fields of expertise, along with certifications and advanced training in GMP's and homeopathic processing and manufacturing.<P>


<CENTER>
<HR WIDTH=75%>
<H5>
[<A HREF="resource.html">Resources</A>] 
[<A HREF="new.html">What's New</A>] 
[<A HREF="article.html">Recent Article</A>] <BR>
[<A HREF="alt.html">Integration of Alternative Therapies</A>] 
[<A HREF="products.html">Product Listing</A>] <BR>
[<A HREF="profile.html">Profile</A>] 
[<A HREF="contact.html">Ordering & Contact</A>] 
</H5>
<H6>Copyright Complimed 1996<BR>
This Internet site prepared by <A HREF="http://www.prosser.com/">Media Access.</A><BR>
If you have any comments about your visit to this site, please write 
<A HREF="mailto:webninja@prosser.com">webninja@prosser.com</A></H6>

</CENTER>
</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT02-B10-128</DOCNO>
<DOCOLDNO>IA017-000185-B023-326</DOCOLDNO>
<DOCHDR>
http://complimed.com:80/complimed/contact.html 207.66.215.5 19970106091930 text/html 3759
HTTP/1.0 200 OK
Date: Mon, 06 Jan 1997 09:34:15 GMT
Server: Apache/1.1.1
Content-type: text/html
Content-length: 3588
Last-modified: Tue, 05 Nov 1996 19:35:51 GMT
</DOCHDR>
<HTML>
<HEAD>
<TITLE>Complimed: Orders & Contact</TITLE>
</HEAD>

<BODY BGCOLOR="#FFFFFF">
<A HREF="subheader.map"><IMG SRC="subheader.gif" ALT="Complimed: Complementary Medical Research Group" BORDER=0 ISMAP></A>
<H2>Ordering Information & Contacting Us</H2>

<I><B>How to Order</B></I><BR>
Our office hours are Monday - Friday, 8 a.m. to 5 p.m., Pacific time. Call, fax or mail in your orders. If you need information or have any questions, feel free to use the form below.<P>
<CENTER>
<B>1-800-232-4005</B> or <B>1-360-384-5656</B> (after-hours voicemail)<BR>
Fax: 1-360-384-1140, 24 hrs. a day<BR>
1441 West Smith Road, Ferndale, WA 98248<P>


<FORM METHOD="POST" ACTION="/cgi-bin/complimed/complimed.cgi">
<!-- Hidden Variables for client.cgi script -->
  <input type=hidden name="required" value="business,phone">
  <input type=hidden name="recipient" value="dwitte@cssnw.com">
  <input type=hidden name="subject" 
value="Faxback from the CompliMed Website">
  <input type=hidden name="sort" value="order:business,DEA,contact,address,city,phone,fax,credapp,message">
  <input type=hidden name="title" value="Thank You For Your Response">
  <input type=hidden name="return_link_url" 
				 value="http://www.complimed.com/">
  <input type=hidden name="return_link_title" value="Back to the First Page">
  <input type=hidden name="bgcolor" value="#FFFFFF">

<TABLE BORDER=2 CELLSPACING=2 CELLPADDING=5 ALIGN=CENTER WIDTH=85%>
  
<TR>
    <TD COLSPAN=2 ALIGN=CENTER>
      <B>Business Name</B><BR>
      <INPUT TYPE="text" NAME="business" SIZE="60"><BR></TD>
  </TR>
  <TR>
    <TD COLSPAN=2 ALIGN=CENTER>
      <B>DEA or State License Number</B><BR>
      <INPUT TYPE="text" NAME="DEA" SIZE="60"><BR></TD>
  </TR>
  <TR>
    <TD COLSPAN=2 ALIGN=CENTER>
      <B>Contact, Title/Discipline</B><BR>
      <INPUT TYPE="text" NAME="contact" SIZE="60"><BR></TD>
  </TR>
  <TR>
    <TD ALIGN=CENTER>
      <B>Address</B><BR>
      <INPUT TYPE="text" NAME="address" SIZE="30"><BR></TD>
    <TD ALIGN=CENTER>
      <B>City, State, Zip</B><BR>
      <INPUT TYPE="text" NAME="city" SIZE="30"><BR></TD>
  </TR>
  <TR>
    <TD ALIGN=CENTER>
      <B>Phone, with area code</B><BR>
      <INPUT TYPE="text" NAME="phone" SIZE="30"><BR></TD>
    <TD ALIGN=CENTER>
      <B>Fax, if applicable</B><BR>
      <INPUT TYPE="text" NAME="fax" SIZE="30"><BR></TD>
  </TR>
  <TR>
  	<TD COLSPAN=2 ALIGN=CENTER>
  		<INPUT TYPE="CHECKBOX" NAME="credapp" VALUE="Need a credit application">Check here if you need a credit application for future orders<BR>
  </TR>
  <TR>
    <TD ALIGN=CENTER COLSPAN=2>
      <B>Message Box</B>-
      Please enter any questions or comments below.<BR>
      <TEXTAREA NAME="message" ROWS="10" COLS="60" WRAP></TEXTAREA></TD>
  </TR>
  <TR>
    <TD ALIGN=CENTER>
      <INPUT TYPE="reset" VALUE="Clear Entries"></TD>
    <TD ALIGN=CENTER>
      <INPUT TYPE="submit" VALUE="Send Information"></TD>
  </TR>
</TABLE>
</FORM>

</CENTER>

<CENTER>
<HR WIDTH=75%>
<H5>
[<A HREF="resource.html">Resources</A>] 
[<A HREF="new.html">What's New</A>] 
[<A HREF="article.html">Recent Article</A>] <BR>
[<A HREF="alt.html">Integration of Alternative Therapies</A>] 
[<A HREF="products.html">Product Listing</A>] <BR>
[<A HREF="profile.html">Profile</A>] 
[<A HREF="contact.html">Ordering & Contact</A>] 
</H5>
<H6>Copyright Complimed 1996<BR>
This Internet site prepared by <A HREF="http://www.prosser.com/">Media Access.</A><BR>
If you have any comments about your visit to this site, please write 
<A HREF="mailto:webninja@prosser.com">webninja@prosser.com</A></H6>

</CENTER>
</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT02-B10-129</DOCNO>
<DOCOLDNO>IA017-000185-B024-12</DOCOLDNO>
<DOCHDR>
http://complimed.com:80/simonlaw/firm.html 207.66.215.5 19970106091937 text/html 3244
HTTP/1.0 200 OK
Date: Mon, 06 Jan 1997 09:34:23 GMT
Server: Apache/1.1.1
Content-type: text/html
Content-length: 3073
Last-modified: Fri, 01 Nov 1996 20:12:42 GMT
</DOCHDR>
<HTML>
<HEAD>

<TITLE>Simonarson, Visser, Zender
& Thurston - Representative Clients</TITLE>

<!-- Date: July 10, 1996  5:07 PM -->


<META name = "description" content = "Continuing the traditions established since 1914, the Simonarson Law Firm provides expertise and
the highest quality legal services through the work of dedicated attorneys and staff. ">
<META name = "key words" content = "Practice areas, Business & Commercial Law, Litigation, Employment & Labor Law, Municipal Law, Land Use & Real Estate Law, Probate & Estate Planning, Attorneys, Peter J. Visser, Daniel D. Zender, Hal Thurston, Hugh Lewis, Laughlan H. Clark, Deborra Garrett, Steven J. Chance, Robert A. Carmichael, Bryan D. Lane, water quality, shoreline management, growth management, forest
practices, endangered species act, habitat conservation plan, HCP,
zoning, permitting, water district, discrimination, insurance
defense, landlord, tenant, unlawful detainer, timber trespass,
condominium law, community association, tribes, national historic
preservation act, clean water act, watershed analysis, bankruptcy,
limited liability partnership, subchapter s, Bellingham, Lynden, Whatcom County,
Washington, Western Washington University">
</HEAD>


<BODY BACKGROUND = "image/SVZTbg.GIF" BGCOLOR="#FEF9CA" LINK="#074D0C" VLINK="#550000">




<IMG  SRC="image/SVZT2.GIF"  ALIGN=BOTTOM><font color="#550000"> <font size = "7">O</font size><font size = "5"><b>ur Firm</A></font color></font size></b>
<P><BR><BR>

Continuing the traditions established since 1914, the Simonarson Law Firm provides expertise and
the highest quality legal services through the work of dedicated attorneys and staff.  A brief
description of the firm's attorneys follows:<P>
<ul>
<TABLE WIDTH=400 BORDER=0 CELLPADDING=5 CELLSPACING=5>

  <TR>

    <TD><B><UL>
<LI><A HREF="RC.html">Robert A. Carmichael</A>

<LI><A HREF="SC.html">Steven J. Chance</A>

<LI><A HREF="LC.html">Laughlan H. Clark</A>

<LI><A HREF="DG.html">Deborra Garrett</A>

<LI><A HREF="BL.html">Bryan D. Lane</A></UL></B><P><P></H2>

</TD>   

 <TD><B><UL>
<LI><A HREF="HL.html">Hugh Lewis</A>
<LI><A HREF="HT.html">Hal Thurston</A>
<LI><A HREF="PV.html">Peter J. Visser</A>
<LI><A HREF="DZ.html">Daniel D. Zender</A></UL></B>
</TD>

  </TR>

</TABLE></ul></center>

<BR><BR><BR><BR>
<center>

<BR><font size = "3">
<A HREF="index.html">Home Page</A>&#160;|
<A HREF="firm.html">Our Firm</A>&#160;|
<A HREF="practice.html">Our Practice</A>&#160;|
<A HREF="clients.html">Clients</A>
<P>

<A HREF="RC.html">Robert A. Carmichael</A>&#160;|
<A HREF="SC.html">Steven J. Chance</A>&#160;|
<A HREF="LC.html">Laughlan H. Clark</A>&#160;|
<A HREF="DG.html">Deborra Garrett</A>&#160;|
<A HREF="BL.html">Bryan D. Lane</A>&#160;|
<A HREF="HL.html">Hugh Lewis</A>&#160;|
<A HREF="HT.html">Hal Thurston</A>&#160;|
<A HREF="PV.html">Peter J. Visser</A>&#160;|
<A HREF="DZ.html">Daniel D. Zender</A>&#160
</center>
<BR><BR><BR><BR>
<FONT SIZE=2>
&copy;SVZT
</FONT>
</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT02-B10-130</DOCNO>
<DOCOLDNO>IA017-000185-B024-25</DOCOLDNO>
<DOCHDR>
http://complimed.com:80/simonlaw/practice.html 207.66.215.5 19970106091945 text/html 8181
HTTP/1.0 200 OK
Date: Mon, 06 Jan 1997 09:34:30 GMT
Server: Apache/1.1.1
Content-type: text/html
Content-length: 8010
Last-modified: Mon, 09 Dec 1996 18:02:39 GMT
</DOCHDR>
<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 3.2//EN">
<HTML>
<HEAD>
   <TITLE>Simonarson, Visser, Zender
&amp; Thurston - Practice Areas</TITLE>
   <META NAME="description" CONTENT="Continuing the traditions established since 1914, the Simonarson Law Firm provides expertise andthe highest quality legal services through the work of dedicated attorneys and staff.">
   <META NAME="key words" CONTENT="Practice areas, Business & Commercial Law, Litigation, Employment & Labor Law, Municipal Law, Land Use & Real Estate Law, Probate & Estate Planning, Attorneys, Peter J. Visser, Daniel D. Zender, Hal Thurston, Hugh Lewis, Laughlan H. Clark, Deborra Garrett, Steven J. Chance, Robert A. Carmichael, Bryan D. Lane, water quality, shoreline management, growth management, forestpractices, endangered species act, habitat conservation plan, HCP,zoning, permitting, water district, discrimination, insurancedefense, landlord, tenant, unlawful detainer, timber trespass,condominium law, community association, tribes, national historicpreservation act, clean water act, watershed analysis, bankruptcy,limited liability partnership, subchapter s, Bellingham, Lynden, Whatcom County,Washington, Western Washington University">
   <META NAME="GENERATOR" CONTENT="Mozilla/3.0Gold (Win95; I) [Netscape]">
</HEAD>
<BODY BGCOLOR="#FEF9CA" LINK="#074D0C" VLINK="#550000" BACKGROUND="image/SVZTbg.GIF">

<P><!-- Date: July 10, 1996  5:07 PM --><IMG SRC="image/SVZT2.GIF" HEIGHT=82 WIDTH=84 ALIGN=BOTTOM><FONT COLOR="#550000">
<FONT SIZE=+4>O</FONT><B><FONT SIZE=+2>ur Practice</FONT></B></FONT> </P>

<P><BR>
<B>Corporate and Business Law.</B> We handle simple and complex business
transactions including: construction contract formation and negotiation,
preparation of agreements for sales of goods and services, sales financing
and secured transactions, and a variety of other related issues.</P>

<P> We also assist our clients in forming business entities including:
partnerships, limited partnerships, limited liability companies and partnerships,
and corporations (including those with Subchapter S elections).</P>

<P> <B>Debtor-Creditor and Bankruptcy Law.</B> We represent creditors in
the collection of both secured and unsecured debt, including pre-judgment
and post-judgment procedures such as garnishment and attachment, and real
estate mortgage foreclosures and forfeitures. </P>

<P>We represent the interests of lenders and other creditors in bankruptcy
proceedings and in negotiating debt workout alternatives to bankruptcy.
</P>

<P><B>Employment Law.</B> We provide ongoing advice and counsel to employers
who are addressing a wide variety of personnel matters including: personnel
manuals and other written materials, disability and reasonable accommodation
issue, discrimination issues, wage, hour and benefit issues, and many other
legal issues which bear on the human side of running a business. </P>

<P><B>Land Use and Natural Resource Law.</B> In this area of our legal
practice, we work on issues pertaining to the Federal Endangered Species
Act and are directly involved in the development of the first all-species
habitat conservation plan in the nation. We have been integral in the development
of statewide watershed analysis processes which will eliminate the rigid
uniform rules previously utilized. Our practice involves work on water
quality and quantity issues such as problems with the Federal Clean Water
Act's Section 303(d) listing process. We also work with the cultural concerns
of Native Tribes under the National Historic Preservation Act and other
state laws.</P>

<P>The firm also maintains a busy local and regional land use practice.
We have extensive experience and a successful record in handling land development
issues involving the State Growth Management Act, the State Environmental
Policy Act (SEPA), state shoreline regulations, local zoning and development
ordinances, wetland and sensitive land (critical area) laws, and water
rights.</P>

<P><B>Real Estate and Community Association Law.</B> We prepare documentation
to facilitate real estate purchases and sales, commercial and residential
property leases, easements, covenants, mortgage documentation, and other
forms of agreement relating to real estate practice and development. </P>

<P><B>Condominium Law.</B> We have extensive experience in organizing residential
and commercial condominiums and planned unit developments. We also provide
advice to homeowner and condominium associations on a wide variety of matters.
</P>

<P><B>Commercial Litigation.</B> When problems arise, we represent clients
in all facets of commercial litigation including: trials, administrative
hearings, arbitrations, appeals, and alternative dispute resolution. Our
areas of expertise include: contract litigation, commercial and residential
landlord tenant and unlawful detainer actions, construction litigation
including lien claims and public works disputes, timber trespass claims,
quiet title actions and boundary disputes, business dissolutions and commercial
disputes, including trade secrets litigation and consumer protection act
claims. </P>

<P><B>Litigation.</B> The litigation attorneys have successfully represented
plaintiffs and defendants in cases involving a broad range of substantive
legal issues including: insurance defense, plaintiff injuries and wrongful
death claims; insurance coverage disputes, bad faith, and unfair trade
practices; employment-related issues such as litigation and preventive
counseling for employers and select plaintiff cases involving statutory
discrimination; complex civil and commercial litigation including real
property and land use issues. We have also successfully represented clients
in business disputes, professional negligence matters, agricultural issues,
and products liability. </P>

<P>We are committed to the appropriate use of alternative dispute resolution
methods including arbitration, traditional and innovative mediation, and
court-assisted settlement conferences. In addition to our work on behalf
of clients in these forums, our attorneys regularly serve as arbitrators
and mediators. </P>

<P><B>Probate and Estate Planning.</B> Probate and estate planning issues
are becoming more critical every day. Family relationships that change
more frequently and medical advances that prolong life can present many
challenges for the family or individual planning their estate. </P>

<P>We are committed to preparing an estate plan which best suits the circumstances
of each client, even though it may cost less than more exotic possible
plans. We also provide probate and guardianship services when necessary,
and utilize less costly alternatives to probate when they are available
and appropriate. </P>

<P><B>Municipal.</B> Our firm represents water, sewer and public utility
districts, municipal corporations, cities, and other local government entities.
Our areas of practice include commercial transactions, land use, zoning
policies and related issues, risk management, personnel and labor relations
issues, and municipal/private partnerships. We also represent municipalities
and public entities in litigation including: defense of tort/liability
matters, environmental litigation, and plaintiff liability. </P>

<CENTER><P><BR>
<BR>
<BR>
<BR>
<BR>
<FONT SIZE=+0><A HREF="index.html">Home Page</A>&nbsp;| <A HREF="firm.html">Our
Firm</A>&nbsp;| <A HREF="practice.html">Our Practice</A>&nbsp;| <A HREF="clients.html">Clients</A>
</FONT></P></CENTER>

<CENTER><P><FONT SIZE=+0><A HREF="RC.html">Robert A. Carmichael</A>&nbsp;|
<A HREF="SC.html">Steven J. Chance</A>&nbsp;| <A HREF="LC.html">Laughlan
H. Clark</A>&nbsp;| <A HREF="DG.html">Deborra Garrett</A> <BR>
<A HREF="BL.html">Bryan D. Lane</A>&nbsp;| <A HREF="HL.html">Hugh Lewis</A>&nbsp;|
<A HREF="HT.html">Hal Thurston</A>&nbsp;| <A HREF="PV.html">Peter J. Visser</A>&nbsp;|
<A HREF="DZ.html">Daniel D. Zender</A> <BR>
<BR>
<BR>
<BR>
</FONT><FONT SIZE=-1>&copy;SVZT </FONT></P></CENTER>

</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT02-B10-131</DOCNO>
<DOCOLDNO>IA017-000185-B024-37</DOCOLDNO>
<DOCHDR>
http://complimed.com:80/simonlaw/clients.html 207.66.215.5 19970106091959 text/html 3356
HTTP/1.0 200 OK
Date: Mon, 06 Jan 1997 09:34:38 GMT
Server: Apache/1.1.1
Content-type: text/html
Content-length: 3185
Last-modified: Fri, 01 Nov 1996 20:12:41 GMT
</DOCHDR>
<HTML>
<HEAD>

<TITLE>Simonarson, Visser, Zender
& Thurston - Representative Clients</TITLE>

<!-- Date: July 10, 1996  5:07 PM -->

<META name = "description" content = "Continuing the traditions established since 1914, the Simonarson Law Firm provides expertise and
the highest quality legal services through the work of dedicated attorneys and staff. ">
<META name = "key words" content = "Practice areas, Business & Commercial Law, Litigation, Employment & Labor Law, Municipal Law, Land Use & Real Estate Law, Probate & Estate Planning, Attorneys, Peter J. Visser, Daniel D. Zender, Hal Thurston, Hugh Lewis, Laughlan H. Clark, Deborra Garrett, Steven J. Chance, Robert A. Carmichael, Bryan D. Lane, water quality, shoreline management, growth management, forest
practices, endangered species act, habitat conservation plan, HCP,
zoning, permitting, water district, discrimination, insurance
defense, landlord, tenant, unlawful detainer, timber trespass,
condominium law, community association, tribes, national historic
preservation act, clean water act, watershed analysis, bankruptcy,
limited liability partnership, subchapter s, Bellingham, Lynden, Whatcom County,
Washington, Western Washington University">


</HEAD>

<BODY BACKGROUND = "image/SVZTbg.GIF" BGCOLOR="#FEF9CA" LINK="#074D0C" VLINK="#550000">



<IMG  SRC="image/SVZT2.GIF"  ALIGN=BOTTOM><font color="#550000"> <font size = "7">R</font size><font size = "5"><b>epresentative Clients</A></font color></font size></b>
<P><BR>

We are proud to represent clients such as:
<UL>
<TABLE WIDTH=500 BORDER=0 CELLPADDING=5 CELLSPACING=5 >
<TR>
<TD valign = "top">
<UL>
<LI>Georgia Pacific Corporation
<LI>Washington Forest Protection Association
<LI>Murray Pacific Corporation
<LI>Trillium Corporation
<LI>Crown Pacific, Ltd.
<LI>Rayonier Inc.
<LI>Scott Paper Company
<LI>Intalco Aluminum Corporation
<LI>Womencare Shelter
<LI>Birch Bay Water and Sewer District
<LI>Whatcom County Water and Sewer District No. 13
</UL>
</TD>

<TD valign = "top">
<UL>
<LI>Seafirst Bank
<LI>General Growth Companies
<LI>Pemco Insurance Company
<LI>Northwest Air Pollution Authority
<LI>City of Lynden
<LI>Chicago Title Insurance Company
<LI>Hoksbergen Hay Company
<LI>Glacier Water District
<LI>Northwest Youth Services
<LI>Mutual of Enumclaw Insurance Company
<LI>Local and regional businesses and professional practices
</UL>
</TD></TR></TABLE>
</UL>
<P>
<BR><BR><BR><BR>
<center>

<BR><font size = "3">
<A HREF="index.html">Home Page</A>&#160;|
<A HREF="firm.html">Our Firm</A>&#160;|
<A HREF="practice.html">Our Practice</A>&#160;|
<A HREF="clients.html">Clients</A>
<P>

<A HREF="RC.html">Robert A. Carmichael</A>&#160;|
<A HREF="SC.html">Steven J. Chance</A>&#160;|
<A HREF="LC.html">Laughlan H. Clark</A>&#160;|
<A HREF="DG.html">Deborra Garrett</A>
<BR>
<A HREF="BL.html">Bryan D. Lane</A>&#160;|
<A HREF="HL.html">Hugh Lewis</A>&#160;|
<A HREF="HT.html">Hal Thurston</A>&#160;|
<A HREF="PV.html">Peter J. Visser</A>&#160;|
<A HREF="DZ.html">Daniel D. Zender</A>
</center>
<BR><BR><BR><BR>
<FONT SIZE=2>
&copy;SVZT
</FONT>
</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT02-B10-132</DOCNO>
<DOCOLDNO>IA017-000185-B024-51</DOCOLDNO>
<DOCHDR>
http://complimed.com:80/simonlaw/links.html 207.66.215.5 19970106092009 text/html 2823
HTTP/1.0 200 OK
Date: Mon, 06 Jan 1997 09:34:54 GMT
Server: Apache/1.1.1
Content-type: text/html
Content-length: 2652
Last-modified: Fri, 01 Nov 1996 20:12:43 GMT
</DOCHDR>
<HTML>
<HEAD>

<TITLE>Simonarson, Visser, Zender
& Thurston - Practice Areas</TITLE>

<!-- Date: July 10, 1996  5:07 PM -->

<META name = "key words" content = "Practice areas, Business & Commercial Law, Litigation, Employment & Labor Law, Municipal Law, Land Use & Real Estate Law, Probate & Estate Planning, Attorneys, Peter J. Visser, Daniel D. Zender, Hal Thurston, Hugh Lewis, Laughlan H. Clark, Deborra Garrett, Steven J. Chance, Robert A. Carmichael, Bryan D. Lane">


</HEAD>


<BODY BACKGROUND = "image/SVZTbg.GIF" BGCOLOR="#FEF9CA" LINK="#074D0C" VLINK="#550000">


<IMG  SRC="image/SVZT2.GIF"  ALIGN=BOTTOM><font color="#550000"> <font size = "7">O</font size><font size = "5"><b>ur Links</A></font color></font size></b>
<P>
<BR>
<p align = "center">
<center>
<TABLE WIDTH=500 BORDER=1 CELLPADDING=0 CELLSPACING=0>

<TR><TD valign = "center">
</TD></TR>
<TR><TD valign = "top"><h4>
<IMG  SRC="image/bell.GIF"  ALIGN=Bottom> <P>
<A HREF="http://www.city-govt.ci.bellingham.wa.us">City of Bellingham</A><P>
</h4></TD>
<TD valign = "top"><h4>
<IMG  SRC="image/airplane.GIF"  ALIGN=Bottom><BR><BR><BR><P> 
<A HREF="http://www.bellingham.org">City of Bellingham Visitors Bureau</A>
</h4></TD></TR>
<TR><TD valign = "top"><h4>
<IMG  SRC="image/capital.GIF"  ALIGN=Bottom> <BR><BR><P>
<A HREF="http://www.wa.gov">Washington State Government</A>
</h4></TD><TD valign = "top"><h4>
<IMG  SRC="image/grads.gif"  ALIGN=Bottom> <P>
<A HREF="http://www.wwu.edu/">Western Washington University</A>
</h4></TD></TR>
<TR><TD valign = "top"><h4>
<IMG  SRC="image/scale.gif"  ALIGN=Bottom> <P>
<A HREF="http://www.pacificrim.net/~chase/b/wb1.html">Whatcom County Bar <BR>
Association</A>
</h4></TD><TD valign = "top"><h4>
<IMG  SRC="image/county.GIF"  ALIGN=Bottom> <P>
<A HREF="http://www.pacificrim.net/~chamber/">Whatcom County Chamber of Commerce</A>
</h4></TD>
</TR>
</TABLE>


<P><P>
<BR><BR><BR><BR>
<center>

<BR><font size = "3">
<A HREF="index.html">Home Page</A>&#160;|
<A HREF="firm.html">Our Firm</A>&#160;|
<A HREF="practice.html">Our Practice</A>&#160;|
<A HREF="clients.html">Clients</A>
<P>

<A HREF="RC.html">Robert A. Carmichael</A>&#160;|
<A HREF="SC.html">Steven J. Chance</A>&#160;|
<A HREF="LC.html">Laughlan H. Clark</A>&#160;|
<A HREF="DG.html">Deborra Garrett</A>
<BR>
<A HREF="BL.html">Bryan D. Lane</A>&#160;|
<A HREF="HL.html">Hugh Lewis</A>&#160;|
<A HREF="HT.html">Hal Thurston</A>&#160;|
<A HREF="PV.html">Peter J. Visser</A>&#160;|
<A HREF="DZ.html">Daniel D. Zender</A>
</center>
<BR><BR><BR><BR>
<FONT SIZE=2>
&copy;SVZT
</FONT>
</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT02-B10-133</DOCNO>
<DOCOLDNO>IA017-000185-B024-65</DOCOLDNO>
<DOCHDR>
http://complimed.com:80/simonlaw/RC.html 207.66.215.5 19970106092016 text/html 2332
HTTP/1.0 200 OK
Date: Mon, 06 Jan 1997 09:35:02 GMT
Server: Apache/1.1.1
Content-type: text/html
Content-length: 2161
Last-modified: Fri, 01 Nov 1996 20:12:44 GMT
</DOCHDR>
<HTML> <HEAD>

<TITLE>Simonarson, Visser, Zender & Thurston - Robert A. Carmichael</TITLE>

<!-- Date: July 10, 1996  5:07 PM -->


</HEAD>

<BODY BACKGROUND = "image/SVZTbg.GIF" BGCOLOR="#FEF9CA" LINK="#074D0C"
VLINK="#550000">


<IMG  SRC="image/CARMICHA.JPEG"  ALIGN=Right>




<H1>ROBERT A. CARMICHAEL</H1><P>ROBERT A. CARMICHAEL practices in the areas of
land use, natural resources, real estate, and municipal law.  He particularly
focuses on local and regional land use development and routinely represents
clients on complex issues involving local, state and federal agencies.

Mr. Carmichael generally attempts to keep his clients out of court. 
Nevertheless, he has successfully litigated numerous cases, which include several
reported decisions from the Washington Court of Appeals, Washington Supreme Court
and Ninth Circuit Court of Appeals.

Prior to joining the firm in 1992, Mr. Carmichael served for 8 years as a Whatcom
County Senior Deputy Prosecutor in both the criminal and civil divisions.  During
his tenure with Whatcom County, Mr. Carmichael co-authored the County's first
critical areas ordinance under the State Growth Management Act.  He is a 1980
graduate of the University of California at Berkeley (member - Phi Beta Kappa)
and a 1983 graduate of the University of Washington School of Law.


<BR><BR> <P> <BR><A HREF="mailto:carmichael@simonlaw.com">email carmichael@simonlaw.com</A><P>
<BR><center>

<BR><font size = "3">
<A HREF="index.html">Home Page</A>&#160;|
<A HREF="firm.html">Our Firm</A>&#160;|
<A HREF="practice.html">Our Practice</A>&#160;|
<A HREF="clients.html">Clients</A>
<P>
<A HREF="RC.html">Robert A. Carmichael</A>&#160;|
<A HREF="SC.html">Steven J. Chance</A>&#160;|
<A HREF="LC.html">Laughlan H. Clark</A>&#160;|
<A HREF="DG.html">Deborra Garrett</A>
<BR>
<A HREF="BL.html">Bryan D. Lane</A>&#160;|
<A HREF="HL.html">Hugh Lewis</A>&#160;|
<A HREF="HT.html">Hal Thurston</A>&#160;|
<A HREF="PV.html">Peter J. Visser</A>&#160;|
<A HREF="DZ.html">Daniel D. Zender</A>
</center>


<BR><BR><BR><BR>
<FONT SIZE=2>
&copy;SVZT
</FONT>

</BODY> </HTML>
</DOC>
<DOC>
<DOCNO>WT02-B10-134</DOCNO>
<DOCOLDNO>IA017-000185-B024-78</DOCOLDNO>
<DOCHDR>
http://complimed.com:80/simonlaw/SC.html 207.66.215.5 19970106092026 text/html 1745
HTTP/1.0 200 OK
Date: Mon, 06 Jan 1997 09:35:10 GMT
Server: Apache/1.1.1
Content-type: text/html
Content-length: 1574
Last-modified: Fri, 01 Nov 1996 20:12:44 GMT
</DOCHDR>
<HTML> <HEAD>

<TITLE>Simonarson, Visser, Zender & Thurston - Steven J. Chance</TITLE>

<!-- Date: July 10, 1996  5:07 PM -->



</HEAD>

<BODY BACKGROUND = "image/SVZTbg.GIF" BGCOLOR="#FEF9CA" LINK="#074D0C" VLINK="#550000">


<IMG  SRC="image/CHANCE.JPEG"  ALIGN=RIGHT>

<H1>STEVEN J. CHANCE</H1><P>STEVEN J. CHANCE practices in litigation, negotiation, and mediation of
personal injury and insurance  cases.  He is a member of the Washington State
Trial Lawyers Association, and the American Bar Association.  Steve graduated
from Western Washington University and the University of San Diego Paralegal
Program.  Through a unique clerkship program, Steve "read the law" with us, and
was admitted to the Washington State Bar in 1990.

<BR><BR> <P> <BR><A HREF="mailto:chance@simonlaw.com">email chance@simonlaw.com</A><P>
<BR><BR><BR><BR><BR><BR>
<center>

<BR><font size = "3">
<A HREF="index.html">Home Page</A>&#160;|
<A HREF="firm.html">Our Firm</A>&#160;|
<A HREF="practice.html">Our Practice</A>&#160;|
<A HREF="clients.html">Clients</A>
<P>
<A HREF="RC.html">Robert A. Carmichael</A>&#160;|
<A HREF="SC.html">Steven J. Chance</A>&#160;|
<A HREF="LC.html">Laughlan H. Clark</A>&#160;|
<A HREF="DG.html">Deborra Garrett</A>
<BR>
<A HREF="BL.html">Bryan D. Lane</A>&#160;|
<A HREF="HL.html">Hugh Lewis</A>&#160;|
<A HREF="HT.html">Hal Thurston</A>&#160;|
<A HREF="PV.html">Peter J. Visser</A>&#160;|
<A HREF="DZ.html">Daniel D. Zender</A>
</center>
<BR><BR><BR><BR>

<FONT SIZE=2>
&copy;SVZT
</FONT>


</BODY> </HTML>
</DOC>
<DOC>
<DOCNO>WT02-B10-135</DOCNO>
<DOCOLDNO>IA017-000185-B024-95</DOCOLDNO>
<DOCHDR>
http://complimed.com:80/simonlaw/LC.html 207.66.215.5 19970106092041 text/html 1978
HTTP/1.0 200 OK
Date: Mon, 06 Jan 1997 09:35:26 GMT
Server: Apache/1.1.1
Content-type: text/html
Content-length: 1807
Last-modified: Fri, 01 Nov 1996 20:12:43 GMT
</DOCHDR>
<HTML> <HEAD>

<TITLE>Simonarson, Visser, Zender & Thurston - Laughlan H. Clark</TITLE>

<!-- Date: July 10, 1996  5:07 PM -->


</HEAD>

<BODY BACKGROUND = "image/SVZTbg.GIF" BGCOLOR="#FEF9CA" LINK="#074D0C"
VLINK="#550000">


<IMG  SRC="image/CLARK.JPEG"  ALIGN=RIGHT>

<H1>LAUGHLAN (LOCH) CLARK</H1><P>LAUGHLAN (LOCH) CLARK'S practice includes
representation of: lenders, suppliers, and contractors in collection matters,
(including lien, bond, and retainage actions, foreclosures, workouts, and
bankruptcy claims); commercial landlords in unlawful detainer and collection, and
businesses in real estate transactions, and contract litigation. Loch has served
on the Executive Committee of, and is a member of the Creditor-Debtor Section,
and the Real Property Probate and Trust Section of the Washington State Bar
Association. A graduate of Western Washington University (1976) and University of
Puget Sound Law School (1980), Loch has practiced law in Bellingham since 1981.
<BR><BR> <P> <BR><A HREF="mailto:lclark@simonlaw.com">email lclark@simonlaw.com</A> 
<P>
<BR><BR><BR><BR>
<center>

<BR><font size = "3">
<A HREF="index.html">Home Page</A>&#160;|
<A HREF="firm.html">Our Firm</A>&#160;|
<A HREF="practice.html">Our Practice</A>&#160;|
<A HREF="clients.html">Clients</A>
<P>
<A HREF="RC.html">Robert A. Carmichael</A>&#160;|
<A HREF="SC.html">Steven J. Chance</A>&#160;|
<A HREF="LC.html">Laughlan H. Clark</A>&#160;|
<A HREF="DG.html">Deborra Garrett</A>
<BR>
<A HREF="BL.html">Bryan D. Lane</A>&#160;|
<A HREF="HL.html">Hugh Lewis</A>&#160;|
<A HREF="HT.html">Hal Thurston</A>&#160;|
<A HREF="PV.html">Peter J. Visser</A>&#160;|
<A HREF="DZ.html">Daniel D. Zender</A>
</center>
<BR><BR><BR><BR>
<FONT SIZE=2>
&copy;SVZT
</FONT>
</BODY> </HTML>
</DOC>
<DOC>
<DOCNO>WT02-B10-136</DOCNO>
<DOCOLDNO>IA017-000185-B024-109</DOCOLDNO>
<DOCHDR>
http://complimed.com:80/simonlaw/DG.html 207.66.215.5 19970106092049 text/html 1814
HTTP/1.0 200 OK
Date: Mon, 06 Jan 1997 09:35:35 GMT
Server: Apache/1.1.1
Content-type: text/html
Content-length: 1643
Last-modified: Fri, 01 Nov 1996 20:12:41 GMT
</DOCHDR>
<HTML> <HEAD>

<TITLE>Simonarson, Visser, Zender & Thurston - Deborra Garrett</TITLE>

<!-- Date: July 10, 1996  5:07 PM -->



</HEAD>


<BODY BACKGROUND = "image/SVZTbg.GIF" BGCOLOR="#FEF9CA" LINK="#074D0C" VLINK="#550000">



<IMG  SRC="image/GARRETT.JPEG"  ALIGN=RIGHT>


<H1>DEBORRA GARRETT</H1><P>DEBORRA GARRETT works in employment law and personal
injury/civil litigation.  Deborra counsels employers and represents employees and
employers in court.  She has won several significant cases in the local,
appellate and federal court systems. <P> Deborra graduated from Pennsylvania
State University (1972) and the George Washington University National Law Center
(1976).  She is active in the Washington State Trial Lawyers Association,
American Trial Lawyers Association and Washington Women Lawyers. <BR><BR> <P>
<BR><A HREF="mailto:dgarrett@simonlaw.com">email dgarrett@simonlaw.com</A> 
<P>
<BR><BR><BR><BR>
<center>

<BR><font size = "3">
<A HREF="index.html">Home Page</A>&#160;|
<A HREF="firm.html">Our Firm</A>&#160;|
<A HREF="practice.html">Our Practice</A>&#160;|
<A HREF="clients.html">Clients</A>
<P>
<A HREF="RC.html">Robert A. Carmichael</A>&#160;|
<A HREF="SC.html">Steven J. Chance</A>&#160;|
<A HREF="LC.html">Laughlan H. Clark</A>&#160;|
<A HREF="DG.html">Deborra Garrett</A>
<BR>
<A HREF="BL.html">Bryan D. Lane</A>&#160;|
<A HREF="HL.html">Hugh Lewis</A>&#160;|
<A HREF="HT.html">Hal Thurston</A>&#160;|
<A HREF="PV.html">Peter J. Visser</A>&#160;|
<A HREF="DZ.html">Daniel D. Zender</A>
</center>
<BR><BR><BR><BR>
<FONT SIZE=2>
&copy;SVZT
</FONT>

</BODY> </HTML>
</DOC>
<DOC>
<DOCNO>WT02-B10-137</DOCNO>
<DOCOLDNO>IA017-000185-B024-130</DOCOLDNO>
<DOCHDR>
http://complimed.com:80/simonlaw/BL.html 207.66.215.5 19970106092104 text/html 2036
HTTP/1.0 200 OK
Date: Mon, 06 Jan 1997 09:35:50 GMT
Server: Apache/1.1.1
Content-type: text/html
Content-length: 1865
Last-modified: Fri, 01 Nov 1996 20:12:41 GMT
</DOCHDR>
<HTML> <HEAD>

<TITLE>Simonarson, Visser, Zender & Thurston - Bryan D. Lane</TITLE>

<!-- Date: July 10, 1996  5:07 PM -->




</HEAD>

<BODY BACKGROUND = "image/SVZTbg.GIF" BGCOLOR="#FEF9CA" LINK="#074D0C" VLINK="#550000">

<IMG  SRC="image/LANE.JPEG"  ALIGN=RIGHT>

<H1>BRYAN D. LANE</H1><P>BRYAN D. LANE focuses his practice on resolution of
commercial, real estate and construction disputes.  He graduated from Western
Washington University (BA/Ed. 1984), and received his law degree from Willamette
University College of Law (cum laude, 1988).  At Willamette, Bryan served as an
editor of the Willamette Law Review and on the Moot Court Board.  Bryan worked in
private practice in Seattle for six years before joining the firm in 1994.   He
is currently serving as the Northwest Washington Trustee of the Young Lawyers
Division of the Washington State Bar Association and participates in the Whatcom
County Volunteer Lawyer Program.  He also volunteers his time with other
community groups, both in Bellingham and in his hometown of Aberdeen. <BR><BR>
<P> <BR><A HREF="mailto:blane@simonlaw.com">email blane@simonlaw.com</A> <P>
<BR><BR> <center>

<BR><font size = "3">
<A HREF="index.html">Home Page</A>&#160;|
<A HREF="firm.html">Our Firm</A>&#160;|
<A HREF="practice.html">Our Practice</A>&#160;|
<A HREF="clients.html">Clients</A>
<P>
<A HREF="RC.html">Robert A. Carmichael</A>&#160;|
<A HREF="SC.html">Steven J. Chance</A>&#160;|
<A HREF="LC.html">Laughlan H. Clark</A>&#160;|
<A HREF="DG.html">Deborra Garrett</A>
<BR>
<A HREF="BL.html">Bryan D. Lane</A>&#160;|
<A HREF="HL.html">Hugh Lewis</A>&#160;|
<A HREF="HT.html">Hal Thurston</A>&#160;|
<A HREF="PV.html">Peter J. Visser</A>&#160;|
<A HREF="DZ.html">Daniel D. Zender</A>
 </center>
<BR><BR><BR><BR>
<FONT SIZE=2>
&copy;SVZT
</FONT>
</BODY> </HTML>
</DOC>
<DOC>
<DOCNO>WT02-B10-138</DOCNO>
<DOCOLDNO>IA017-000185-B024-140</DOCOLDNO>
<DOCHDR>
http://complimed.com:80/simonlaw/HL.html 207.66.215.5 19970106092112 text/html 1863
HTTP/1.0 200 OK
Date: Mon, 06 Jan 1997 09:35:58 GMT
Server: Apache/1.1.1
Content-type: text/html
Content-length: 1692
Last-modified: Fri, 01 Nov 1996 20:12:42 GMT
</DOCHDR>
<HTML> <HEAD>

<TITLE>Simonarson, Visser, Zender & Thurston - Hugh Lewis</TITLE>

<!-- Date: July 10, 1996  5:07 PM -->



</HEAD>


<BODY BACKGROUND = "image/SVZTbg.GIF" BGCOLOR="#FEF9CA" LINK="#074D0C" VLINK="#550000">



<IMG  SRC="image/LEWIS.JPEG"  ALIGN=RIGHT>

<H1>HUGH LEWIS</H1><P>HUGH LEWIS practices in the areas of real estate and commercial matters.  He
enjoys working in the areas of condominium law, commercial leasing, business
entity formation, along with a variety of other commercial and real estate
matters.  His clients and co-workers enjoy Hugh's quick sense of humor, high
energy level, and devotion to several community groups.  A member of the
Washington State, Virginia, and District of Columbia Bars, Hugh graduated from
the University of California at Berkeley (1970), and the George Washington
University National Law Center (1973). 
<BR><BR> <P> <BR><A HREF="mailto:hugh@simonlaw.com">email hugh@simonlaw.com</A> <P>
<BR><BR><BR><BR>
<center>


<BR><font size = "3">
<A HREF="index.html">Home Page</A>&#160;|
<A HREF="firm.html">Our Firm</A>&#160;|
<A HREF="practice.html">Our Practice</A>&#160;|
<A HREF="clients.html">Clients</A>
<P>
<A HREF="RC.html">Robert A. Carmichael</A>&#160;|
<A HREF="SC.html">Steven J. Chance</A>&#160;|
<A HREF="LC.html">Laughlan H. Clark</A>&#160;|
<A HREF="DG.html">Deborra Garrett</A>
<BR>
<A HREF="BL.html">Bryan D. Lane</A>&#160;|
<A HREF="HL.html">Hugh Lewis</A>&#160;|
<A HREF="HT.html">Hal Thurston</A>&#160;|
<A HREF="PV.html">Peter J. Visser</A>&#160;|
<A HREF="DZ.html">Daniel D. Zender</A>
</center>

<BR><BR><BR><BR>
<FONT SIZE=2>
&copy;SVZT
</FONT>

</BODY> </HTML>
</DOC>
<DOC>
<DOCNO>WT02-B10-139</DOCNO>
<DOCOLDNO>IA017-000185-B024-153</DOCOLDNO>
<DOCHDR>
http://complimed.com:80/simonlaw/HT.html 207.66.215.5 19970106092121 text/html 3769
HTTP/1.0 200 OK
Date: Mon, 06 Jan 1997 09:36:05 GMT
Server: Apache/1.1.1
Content-type: text/html
Content-length: 3598
Last-modified: Fri, 01 Nov 1996 20:12:42 GMT
</DOCHDR>
<HTML> <HEAD>

<TITLE>Simonarson, Visser, Zender & Thurston - Hal Thurston</TITLE>

<!-- Date: July 10, 1996  5:07 PM -->



</HEAD>


<BODY BACKGROUND = "image/SVZTbg.GIF" BGCOLOR="#FEF9CA" LINK="#074D0C" VLINK="#550000">



<IMG  SRC="image/THURSTON.JPEG"  ALIGN=RIGHT>


<H1>Hal Thurston</H1><P>HAL THURSTON is a trial attorney who handles a general civil trial practice.  Primary areas of
focus include both insurance defense and plaintiff's personal injury, as well as professional
negligence.  Hal is an aggressive litigator with a calm and professional style.  A graduate of Ohio
State University (1970) and Georgetown University Law School (1974), Hal is a member of the
Washington State Trial Lawyers Association, the American Trial Lawyers Association, and the
Washington Defense Trial Lawyers.  He has taught litigation skills to other lawyers at the
National Institute of Trial Advocacy.
<P>
Hal has been successful in scores of jury trials and arbitrations throughout Northwestern
Washington.  He has tried cases in Whatcom, Skagit, Snohomish, King, Island and San Juan
Counties, plus the Federal District Court.  In a prior incarnation he tried medical malpractice
cases in Washington, D.C.  The subject matter of Hal's cases is equally varied.  
<P>
<UL>

<LI> He was the lead attorney representing a group of dairy farmers in a 6.5 week trial that resulted
in a $2.9 million verdict.<P>  

<LI> Recently he successfully defended a consortium of municipalities who were sued for their
sewage disposal practices.  Their dismissal was affirmed in the appellate court.   Zander v.
Whatcom County, 128 Wn.2d 1015, 911 P.2d 1343 (1996).<P>

<LI> Representing the defense in a one car automobile accident case in which his client (the driver)
had been killed, Hal persuaded a jury that the plaintiff/passenger who was either asleep or passed
out at the time of the accident was 70% at fault for his own injuries, and therefore was entitled to
recover nothing.  The Court of Appeals reversed, but the Supreme Court reinstated the defense
verdict.  Geschwind v. Flanagan, 121 Wn.2d 833, 854 P.2d 1061 (1993).<P>
     
<LI> Hal has frequently litigated insurance coverage issues.  Stoughton v. Mutual of Enumclaw, 61
Wn. App. 365, 810 P.2d 80 (1991), established that the "business pursuits" exclusion found in a
homeowner's policy excludes coverage for casual daylabor, reversing an earlier summary 
judgment against the insurer.<P>

<LI> Several significant medical malpractice suits have been tried or settled for claimants,
sometimes before suit has been filed.  Boundary law suits have been tried in several different
counties.  Both claimants and manufacturers have employed Hal in products liability suits. 
<P>
</UL>

<BR><BR> <P> <BR><A HREF="mailto:hthurston@simonlaw.com">email hthurston@simonlaw.com</A><P>
<BR><BR><BR><BR>
<center>

<BR><font size = "3">
<A HREF="index.html">Home Page</A>&#160;|
<A HREF="firm.html">Our Firm</A>&#160;|
<A HREF="practice.html">Our Practice</A>&#160;|
<A HREF="clients.html">Clients</A>
<P>
<A HREF="RC.html">Robert A. Carmichael</A>&#160;|
<A HREF="SC.html">Steven J. Chance</A>&#160;|
<A HREF="LC.html">Laughlan H. Clark</A>&#160;|
<A HREF="DG.html">Deborra Garrett</A>
<BR>
<A HREF="BL.html">Bryan D. Lane</A>&#160;|
<A HREF="HL.html">Hugh Lewis</A>&#160;|
<A HREF="HT.html">Hal Thurston</A>&#160;|
<A HREF="PV.html">Peter J. Visser</A>&#160;|
<A HREF="DZ.html">Daniel D. Zender</A>
</center>
<BR><BR><BR><BR>
<FONT SIZE=2>
&copy;SVZT
</FONT>

</BODY> </HTML>
</DOC>
<DOC>
<DOCNO>WT02-B10-140</DOCNO>
<DOCOLDNO>IA017-000185-B024-172</DOCOLDNO>
<DOCHDR>
http://complimed.com:80/simonlaw/PV.html 207.66.215.5 19970106092131 text/html 2513
HTTP/1.0 200 OK
Date: Mon, 06 Jan 1997 09:36:16 GMT
Server: Apache/1.1.1
Content-type: text/html
Content-length: 2342
Last-modified: Fri, 01 Nov 1996 20:12:43 GMT
</DOCHDR>
<HTML> <HEAD>

<TITLE>Simonarson, Visser, Zender & Thurston - Peter J. Visser</TITLE>

<!-- Date: July 10, 1996  5:07 PM -->



</HEAD>

<BODY BACKGROUND = "image/SVZTbg.GIF" BGCOLOR="#FEF9CA" LINK="#074D0C" VLINK="#550000">



<IMG  SRC="image/VISSER.JPEG"  ALIGN=RIGHT>


<P><P>


<H1>PETER J. VISSER</H1><P>PETER J. VISSER was born December 14, 1941 (seven days after the attack on Pearl Harbor), in
Bellingham, Washington.  He went to Lynden schools, graduating from Lynden Christian High
School in 1959.  He currently lives in Lynden, and works primarily out of our Lynden office.
<P>
Pete graduated from the University of Washington in 1963 and the University of Washington Law
School in 1966.  He joined Einar Simonarson in the practice in 1974, after working for the
Washington Attorney General for three years, and practicing law on his own in Lynden for four
years.  He is now the senior member of the law firm.
<P>
Pete's practice emphasizes municipal law, business law and estate planning and probate.  He is legal
counsel to the City of Lynden, and Glacier Water District as well as several water associations.  He
recently turned the day to day representation of Birch Bay Water and Sewer District over to Bob
Carmichael, after twenty-one years representing that District.
<P>
 Pete is a member of the Washington State, Whatcom County, and American Bar Associations and
the Washington State Association of Municipal Attorneys and the Northwest Washington Estate
Planning Council.


<BR><BR> <P> <BR><A HREF="mailto:pjvisser@simonarson.com">email pjvisser@simonarson.com</A><P>
<BR><BR>
<center>


<BR><font size = "3">
<A HREF="index.html">Home Page</A>&#160;|
<A HREF="firm.html">Our Firm</A>&#160;|
<A HREF="practice.html">Our Practice</A>&#160;|
<A HREF="clients.html">Clients</A>
<P>
<A HREF="RC.html">Robert A. Carmichael</A>&#160;|
<A HREF="SC.html">Steven J. Chance</A>&#160;|
<A HREF="LC.html">Laughlan H. Clark</A>&#160;|
<A HREF="DG.html">Deborra Garrett</A>
<BR>
<A HREF="BL.html">Bryan D. Lane</A>&#160;|
<A HREF="HL.html">Hugh Lewis</A>&#160;|
<A HREF="HT.html">Hal Thurston</A>&#160;|
<A HREF="PV.html">Peter J. Visser</A>&#160;|
<A HREF="DZ.html">Daniel D. Zender</A>
</center>
<BR><BR><BR><BR>

<FONT SIZE=2>
&copy;SVZT
</FONT>

</BODY> </HTML>
</DOC>
<DOC>
<DOCNO>WT02-B10-141</DOCNO>
<DOCOLDNO>IA017-000185-B024-184</DOCOLDNO>
<DOCHDR>
http://complimed.com:80/simonlaw/DZ.html 207.66.215.5 19970106092139 text/html 1839
HTTP/1.0 200 OK
Date: Mon, 06 Jan 1997 09:36:25 GMT
Server: Apache/1.1.1
Content-type: text/html
Content-length: 1668
Last-modified: Fri, 01 Nov 1996 20:12:41 GMT
</DOCHDR>
<HTML> <HEAD>

<TITLE>Simonarson, Visser, Zender & Thurston - Daniel D. Zender</TITLE>

<!-- Date: July 10, 1996  5:07 PM -->



</HEAD>


<BODY BACKGROUND = "image/SVZTbg.GIF" BGCOLOR="#FEF9CA" LINK="#074D0C" VLINK="#550000">



<IMG  SRC="image/ZENDER.JPEG"  ALIGN=RIGHT>

<H1>DANIEL ZENDER</H1><P>DANIEL ZENDER practices in the areas of land use, natural resources, real estate and business
law.  He is a licensed land surveyor, with a degree in forest engineering.  He represents developers,
property owners and businesses.  He is especially active in forest practices, represents many major
forest land owners, and is active at the federal, state and regional levels in forestry issues.  He is a
lifetime Whatcom County resident, graduated from the University of Washington (1967) and from
Gonzaga School of Law (1973, magna cum laude).<P>




<BR><BR> <P> <BR><A HREF="mailto:dzender@simonlaw.com">email dzender@simonlaw.com</A><P>
<BR>
<center>

<BR><font size = "3">
<A HREF="index.html">Home Page</A>&#160;|
<A HREF="firm.html">Our Firm</A>&#160;|
<A HREF="practice.html">Our Practice</A>&#160;|
<A HREF="clients.html">Clients</A>
<P>
<A HREF="RC.html">Robert A. Carmichael</A>&#160;|
<A HREF="SC.html">Steven J. Chance</A>&#160;|
<A HREF="LC.html">Laughlan H. Clark</A>&#160;|
<A HREF="DG.html">Deborra Garrett</A>
<BR>
<A HREF="BL.html">Bryan D. Lane</A>&#160;|
<A HREF="HL.html">Hugh Lewis</A>&#160;|
<A HREF="HT.html">Hal Thurston</A>&#160;|
<A HREF="PV.html">Peter J. Visser</A>&#160;|
<A HREF="DZ.html">Daniel D. Zender</A>
</center>
<BR><BR><BR><BR>
<FONT SIZE=2>
&copy;SVZT
</FONT>
 </BODY> </HTML>
</DOC>
<DOC>
<DOCNO>WT02-B10-142</DOCNO>
<DOCOLDNO>IA017-000185-B024-199</DOCOLDNO>
<DOCHDR>
http://complimed.com:80/mtbakerskiarea/current.html 207.66.215.5 19970106092147 text/html 2393
HTTP/1.0 200 OK
Date: Mon, 06 Jan 1997 09:36:32 GMT
Server: Apache/1.1.1
Content-type: text/html
Content-length: 2222
Last-modified: Fri, 03 Jan 1997 20:11:53 GMT
</DOCHDR>
<HTML><HEAD><TITLE>Current Conditions</TITLE></HEAD>
<BODY TEXT="#FFFFFF" BGCOLOR="#000000" LINK="#FF9000" VLINK="#FF9000"><CENTER><P><A HREF="index.html"><IMG SRC="logo_sm.gif" BORDER=0 HEIGHT=49 WIDTH=160></A><BR></P><TABLE BORDER=1 ><TR><TD><IMG SRC="conditions.gif" ALT="Current Conditions" HEIGHT=22 WIDTH=204></TD></TR></TABLE><P>Send snow report comments to <A 
HREF="mailto:snowman@cssnw.com">snowman@cssnw.com</A></P>
<META begin>
<hr>Date: Jan 3rd, 1997<br>
Time: 5:00am<br>
New Snow: 6 inches.<br>
Base: 140 inches.<br>
Temp: 26 degrees.<br>
<p>Wow, it snowed again last night with 6" of fresh dry powder on top
of an already incredible base of 140", there is plenty of room for
riding on this beautiful stuff.  When you get to the top there
is 163".  The current condition is SUNNY!!!!  More dry powder is
expected this weekend.  It sounds like we will get light snow showers this 
weekend with sun breaks possible.  It shouldn't dump like it has been lately 
and there will be visibility to be able to see where your skiing.  Come up
 and enjoy a fabulous weekend.<p><br><hr>
<TABLE BORDER=1 ><TR><TD>
<IMG SRC="reports.gif" ALT="Snow Reports" HEIGHT=19 WIDTH=150>
</TD></TR></TABLE>
<BLOCKQUOTE><P>Reports on daily ski area conditions updated at 5:30am and 2:00pm every
day of operation </P>

<TABLE BORDER=1 >
<TR>
<TD>Bellingham</TD>

<TD>(360) 671-0211</TD>
</TR>

<TR>
<TD>Vancouver BC</TD>

<TD>(604) 688-1595</TD>
</TR>

<TR>
<TD>Seattle</TD>

<TD>(206) 634-0200</TD>
</TR>
</TABLE>

<P><B>SKI AREA OPERATING HOURS:</B></P>

<LI>Weekends &amp; Holidays - 8:30-3:30</LI>

<LI>Midweek / Non-Holiday - 9:00-3:30</LI>
</BLOCKQUOTE><TR>
<TD><IMG SRC="good4u.gif" HEIGHT=17 WIDTH=294></TD>
</TR><TABLE BORDER=1 >
<TR>
<TD><IMG SRC="snowboard.gif" HEIGHT=190 WIDTH=280></TD>
</TR>
</TABLE><P><IMG SRC="snowflake1.gif" HEIGHT=18 WIDTH=16>
<A HREF="index.html">Back to Mt Baker Home Page.</A></P>
<P><IMG SRC="snowflake1.gif" HEIGHT=18 WIDTH=16>
<A HREF="history.html">Check out snow report history.</A> <BR>
<HR></P>
<P>You are visitor number <IMG SRC="/cgi-bin/Count.cgi?ft=2&dd=C&frgb=0;0;0|df=skireport.dat" ALT="Mt. Baker Ski Report Counter" HEIGHT=24 WIDTH=94>.<BR>
</P><br></CENTER></BODY></HTML>
</DOC>
<DOC>
<DOCNO>WT02-B10-143</DOCNO>
<DOCOLDNO>IA017-000185-B024-212</DOCOLDNO>
<DOCHDR>
http://complimed.com:80/mtbakerskiarea/map.html 207.66.215.5 19970106092154 text/html 659
HTTP/1.0 200 OK
Date: Mon, 06 Jan 1997 09:36:41 GMT
Server: Apache/1.1.1
Content-type: text/html
Content-length: 489
Last-modified: Fri, 06 Dec 1996 04:31:10 GMT
</DOCHDR>
<!--Free map from Vicinity-->
<TABLE BORDER=5><TR><TH>
<A
HREF="http://www.vicinity.com/yt.hm?CMD=MAP&FAM=mapblast&SEC=blast&GC=X:-121.71098|Y:48.8361|LT:48.83293|LN:-121.71822|LS:1000000|c:Bellingham|s:WA&IC=::5:Mt+Baker&LV=7">
<CENTER><IMG BORDER=0 WIDTH=425 HEIGHT=250
SRC="http://www.vicinity.com/gif?&CT=48.83293:-121.71822:1000000&IC=48.8361:-121.71098:5:Mt+Baker&FAM=mapblast"></CENTER></A>
</TH></TR></TABLE>
<center>Click on the map to browse</center>
<!--End of Vicinity Map-->

</DOC>
<DOC>
<DOCNO>WT02-B10-144</DOCNO>
<DOCOLDNO>IA017-000185-B024-222</DOCOLDNO>
<DOCHDR>
http://complimed.com:80/mtbakerskiarea/expansion.html 207.66.215.5 19970106092207 text/html 2634
HTTP/1.0 200 OK
Date: Mon, 06 Jan 1997 09:36:47 GMT
Server: Apache/1.1.1
Content-type: text/html
Content-length: 2463
Last-modified: Tue, 05 Nov 1996 21:10:10 GMT
</DOCHDR>
<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 3.2//EN">
<HTML>
<HEAD>
   <TITLE>$5 MILLION EXPANSION PROJECT COMPLETE!
</TITLE>
   <META NAME="GENERATOR" CONTENT="Mozilla/3.0Gold (Win95; I) [Netscape]">
</HEAD>
<BODY BACKGROUND="mtbaker_bg.gif">

<CENTER><P><A HREF="index.html"><IMG SRC="logo_sm.gif" BORDER=0 HEIGHT=49 WIDTH=160></A>
<BR>
</P></CENTER>

<CENTER><TABLE BORDER=1 >
<TR>
<TD><IMG SRC="expansion.gif" ALT="$5 MILLION EXPANSION PROJECT COMPLETE!" HEIGHT=33 WIDTH=272></TD>
</TR>
</TABLE></CENTER>

<P>The opening of Mt. Baker Ski Area's new White Salmon Day Lodge marks
the completion of a four-year, $5 million expansion project. In 1990 the
project began with the creation of the White Salmon Base Area. </P>

<P>The project continued as we doubled the size of our intermediate terrain
with the addition of two new quad chairlifts, Chair #7 and the Hemispheres
Chair #8. </P>

<P>With the completion of the White Salmon Day Lodge and the surrounding
base area, you now have direct slope access to the area's increased terrain,
as well as the convenience of easy lodge access when you're ready to grab
some lunch! </P>

<P>Mt. Baker Ski Area's White Salmon Day Lodge was specially recognized
with a Certificate of Achievement from the Federal Environmental Executive,
and is being featured in national publications due to its naturalistic
and innovative design. </P>

<CENTER><TABLE BORDER=1 >
<TR>
<TD><IMG SRC="natural.gif" HEIGHT=26 WIDTH=300></TD>
</TR>
</TABLE></CENTER>

<CENTER><TABLE BORDER=1 >
<TR>
<TD><IMG SRC="lodgemt.jpg" HEIGHT=200 WIDTH=310></TD>

<TD><IMG SRC="deck.jpg" HEIGHT=200 WIDTH=191></TD>
</TR>
</TABLE></CENTER>

<P>
<HR><IMG SRC="snowflake1.gif" HEIGHT=18 WIDTH=16> <A HREF="index.html">HOME
PAGE</A> <BR>
<IMG SRC="snowflake1.gif" HEIGHT=18 WIDTH=16> NEW WHITE SALMON DAY LODGE
&amp; $5 MILLION EXPANSION PROJECT <BR>
<IMG SRC="snowflake1.gif" HEIGHT=18 WIDTH=16> <A HREF="prices.html">DAILY
LIFT TICKETS &amp; OTHER PRICES</A> <BR>
<IMG SRC="snowflake1.gif" HEIGHT=18 WIDTH=16> <A HREF="conditions.html">CURRENT
MOUNTAIN CONDITIONS</A> <BR>
<IMG SRC="snowflake1.gif" HEIGHT=18 WIDTH=16> <A HREF="lowdown.html">THE
LOW DOWN</A> <BR>
<IMG SRC="snowflake1.gif" HEIGHT=18 WIDTH=16> <A HREF="rental.html">RENTAL
INFORMATION</A> <BR>
<IMG SRC="snowflake1.gif" HEIGHT=18 WIDTH=16> <A HREF="lessons.html">SKI
SCHOOL</A> <BR>
<IMG SRC="snowflake1.gif" HEIGHT=18 WIDTH=16> <A HREF="trail.html">TRAIL
MAP</A> <BR>
</P>

</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT02-B10-145</DOCNO>
<DOCOLDNO>IA017-000185-B024-235</DOCOLDNO>
<DOCHDR>
http://complimed.com:80/mtbakerskiarea/prices.html 207.66.215.5 19970106092215 text/html 3802
HTTP/1.0 200 OK
Date: Mon, 06 Jan 1997 09:37:01 GMT
Server: Apache/1.1.1
Content-type: text/html
Content-length: 3631
Last-modified: Fri, 08 Nov 1996 02:07:36 GMT
</DOCHDR>
<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 3.2//EN">
<HTML>
<HEAD>
   <TITLE>DAILY LIFT TICKET RATES, 95-96
</TITLE>
   <META NAME="GENERATOR" CONTENT="Mozilla/3.0Gold (Win95; I) [Netscape]">
</HEAD>
<BODY TEXT="#FFFFFFF" BGCOLOR="#000000" LINK="#FF9000" VLINK="#FF9000">

<CENTER><P><A HREF="index.html"><IMG SRC="logo_sm.gif" BORDER=0 HEIGHT=49 WIDTH=160></A>
<BR>
</P></CENTER>

<CENTER><TABLE BORDER=1 >
<TR>
<TD><IMG SRC="rates.gif" ALT="DAILY LIFT TICKET RATES, 96-97" HEIGHT=22 WIDTH=228></TD>
</TR>
</TABLE></CENTER>

<CENTER><TABLE BORDER=1 >
<TR>
<TD>
<PRE><B>WEEKEND &amp; HOLIDAY
</B>                              U.S      CDN
Adult               16 &amp; over $29      $37
Youth               7-15      $21.50   $27.50
Senior              60-69     $21.50   $27.50
Super Senior        70+       Free
Child               6 &amp; under Free

<B>AFTERNOON 12:30-3:30 Wknd &amp; Hldy Only
</B>Adult               16 &amp; over $22.00   $28.00
Youth               7-15      $16.00   $20.50
Senior              60-69     $16.00   $20.50
Super Senior        70+       $5       $5
Child               6 &amp; under Free

<B>MIDWEEK / NON-HOLIDAY (Mon-Fri)

</B>Adult               16 &amp; over $17.50   $23
Youth               7-15      $13.50   $16.50
Senior              60-69     $13.50   $16.50
Super Senior        70+       $5       $5
Child               6 &amp; under Free

<B>BEGINNER CHAIR #2 ONLY
</B>Weekends &amp; Holidays Only; Non-exchangeable
                              $18.50    $24

<B>BEGINNER ROPE TOW
</B>Weekends &amp; Holidays Only      Free

<B>GROUP RATES
</B>Available for groups of 20 or more Adults on
weekends &amp; holidays only.  Reservations must
be made one week in advanace to be eligible 
for discount. Complete pricing info and 
reservations available at (360) 734-6771.

<B>*NOTE</B>:   Canadian prices are as of 
9-1-96 and are dependent on current exchange 
rates.  Various exchange rates apply and are 
subject to change, up or down, without notice.
All prices include WSST and are subject to 
change without notice.
</PRE>
</TD>
</TR>
</TABLE></CENTER>

<CENTER><TABLE BORDER=1 >
<TR>
<TD><IMG SRC="reports.gif" ALT="SNOW REPORTS" HEIGHT=19 WIDTH=150></TD>
</TR>
</TABLE></CENTER>

<P>Reports on daily ski area conditions updated at 5:30am and 2:00pm every
day of operation </P>

<TABLE BORDER=1 >
<TR>
<TD>Bellingham</TD>

<TD>(360) 671-0211</TD>
</TR>

<TR>
<TD>Vancouver BC</TD>

<TD>(604) 688-1595</TD>
</TR>

<TR>
<TD>Seattle</TD>

<TD>(206) 634-0200</TD>
</TR>
</TABLE>

<P>or see <A HREF="current.html">Current Conditions</A> here on Internet
</P>

<CENTER><TABLE BORDER=1 >
<TR>
<TD><IMG SRC="hours.gif" ALT="OPERATION HOURS" HEIGHT=18 WIDTH=173></TD>
</TR>
</TABLE></CENTER>

<TABLE BORDER=1 >
<TR>
<TD>Weekends &amp; Holidays</TD>

<TD>8:30 - 3:30</TD>
</TR>

<TR>
<TD>Midweek/Non-holiday</TD>

<TD>9:00 - 3:30</TD>
</TR>
</TABLE>

<P>
<HR><IMG SRC="snowflake2.gif" HEIGHT=18 WIDTH=16> <A HREF="index.html">HOME
PAGE</A> <BR>
<IMG SRC="snowflake2.gif" HEIGHT=18 WIDTH=16> <A HREF="expansion.html">NEW
WHITE SALMON DAY LODGE &amp; $5 MILLION EXPANSION PROJECT</A> <BR>
<IMG SRC="snowflake2.gif" HEIGHT=18 WIDTH=16> <A HREF="conditions.html">CURRENT
MOUNTAIN CONDITIONS</A> <BR>
<IMG SRC="snowflake2.gif" HEIGHT=18 WIDTH=16> <A HREF="lowdown.html">THE
LOW DOWN</A> <BR>
<IMG SRC="snowflake2.gif" HEIGHT=18 WIDTH=16> <A HREF="rental.html">RENTAL
INFORMATION</A> <BR>
<IMG SRC="snowflake2.gif" HEIGHT=18 WIDTH=16> <A HREF="lessons.html">SKI
SCHOOL</A> <BR>
<IMG SRC="snowflake2.gif" HEIGHT=18 WIDTH=16> <A HREF="trail.html">TRAIL
MAP</A> <BR>
</P>

<P>
<HR></P>

</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT02-B10-146</DOCNO>
<DOCOLDNO>IA017-000185-B024-248</DOCOLDNO>
<DOCHDR>
http://complimed.com:80/mtbakerskiarea/lowdown.html 207.66.215.5 19970106092227 text/html 3061
HTTP/1.0 200 OK
Date: Mon, 06 Jan 1997 09:37:09 GMT
Server: Apache/1.1.1
Content-type: text/html
Content-length: 2890
Last-modified: Tue, 05 Nov 1996 21:10:08 GMT
</DOCHDR>
<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 3.2//EN">
<HTML>
<HEAD>
   <TITLE>THE LOW DOWN
</TITLE>
   <META NAME="GENERATOR" CONTENT="Mozilla/3.0Gold (Win95; I) [Netscape]">
</HEAD>
<BODY BACKGROUND="mtbaker_bg.gif">

<CENTER><P><A HREF="index.html"><IMG SRC="logo_sm.gif" BORDER=0 HEIGHT=49 WIDTH=160></A>
<BR>
</P></CENTER>

<CENTER><TABLE BORDER=1 >
<TR>
<TD><IMG SRC="lowdown.gif" ALT="THE LOW DOWN" HEIGHT=45 WIDTH=379></TD>
</TR>
</TABLE></CENTER>

<CENTER><TABLE BORDER=1 >
<TR>
<TD>
<H2>SEASON PASSES</H2>

<P>Mt. Baker season passes for the 95-96 season are on sale September 15.
Preseason rates are in effect through October 31. Prices increase $55 on
November 1st. You may purchase passes at our business office in Bellingham,
over the phone or fax with a Visa/Master Card or via mail. Contact our
business office at 360-734-6771 for more information. </P>

<H2>WINTER EMPLOYMENT OPPORTUNITIES</H2>

<P>Mt. Baker is accepting applications for winter employement through September
30 or the first 100 applications submitted. Full-time and part-time positions
are available. Departments hiring are: Lift operations, lift ticket sales,
rental shop, retail shop, ski and snowboard instruction. </P>

<H2>GIFT CERTIFICATES</H2>

<P>Gift certificates are available through our business office for lift
tickets, rentals, instruction, intro packages for skiers or snowboarders
and for goods in our retail shop. Contact 360-734-6771 for more info. </P>

<H2>FALL CALENDAR</H2>

<P>Sept 15 - Preseason Season Passes on sale. </P>

<P>Sept 26 - First day of Outdoor Emergency Care course for those interested
in obtaining National Ski Patrol credentials. </P>

<P>Sept 30 - Last day winter employment applications are accepted unless
the 100 maximum has already been met. </P>

<P>Oct. 19-21 - Komo Kulshan Ski Club Ski Swap. </P>

<P>Oct. 31 - Last day of Preseason Season Pass rates. </P>

<P>November 1st! First day of ski area operation marked on the calendar
DEPENDENT ON CONDITIONS OF COURSE (as in amount of snowfall). </P>
</TD>
</TR>
</TABLE></CENTER>

<P>
<HR><IMG SRC="snowflake1.gif" HEIGHT=18 WIDTH=16> <A HREF="index.html">HOME
PAGE</A> <BR>
<IMG SRC="snowflake1.gif" HEIGHT=18 WIDTH=16> <A HREF="expansion.html">NEW
WHITE SALMON DAY LODGE &amp; $5 MILLION EXPANSION PROJECT</A> <BR>
<IMG SRC="snowflake1.gif" HEIGHT=18 WIDTH=16> <A HREF="prices.html">DAILY
LIFT TICKETS &amp; OTHER PRICES</A> <BR>
<IMG SRC="snowflake1.gif" HEIGHT=18 WIDTH=16> <A HREF="conditions.html">CURRENT
MOUNTAIN CONDITIONS</A> <BR>
<IMG SRC="snowflake1.gif" HEIGHT=18 WIDTH=16> THE LOW DOWN <BR>
<IMG SRC="snowflake1.gif" HEIGHT=18 WIDTH=16> <A HREF="rental.html">RENTAL
INFORMATION</A> <BR>
<IMG SRC="snowflake1.gif" HEIGHT=18 WIDTH=16> <A HREF="lessons.html">SKI
SCHOOL</A> <BR>
<IMG SRC="snowflake1.gif" HEIGHT=18 WIDTH=16> <A HREF="trail.html">TRAIL
MAP</A> <BR>
</P>

<P>
<HR></P>

</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT02-B10-147</DOCNO>
<DOCOLDNO>IA017-000185-B024-260</DOCOLDNO>
<DOCHDR>
http://complimed.com:80/mtbakerskiarea/rental.html 207.66.215.5 19970106092236 text/html 3055
HTTP/1.0 200 OK
Date: Mon, 06 Jan 1997 09:37:21 GMT
Server: Apache/1.1.1
Content-type: text/html
Content-length: 2884
Last-modified: Tue, 05 Nov 1996 23:11:59 GMT
</DOCHDR>
<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 3.2//EN">
<HTML>
<HEAD>
   <TITLE>RENTAL INFORMATION
</TITLE>
   <META NAME="GENERATOR" CONTENT="Mozilla/3.0Gold (Win95; I) [Netscape]">
</HEAD>
<BODY BACKGROUND="mtbaker_bg.gif">

<CENTER><P><A HREF="index.html"><IMG SRC="logo_sm.gif" BORDER=0 HEIGHT=49 WIDTH=160></A>
<BR>
</P></CENTER>

<CENTER><TABLE BORDER=1 >
<TR>
<TD><IMG SRC="rental.gif" ALT="SKI & SNOWBOARD RENTAL" HEIGHT=22 WIDTH=247></TD>
</TR>
</TABLE></CENTER>

<H2 ALIGN=CENTER>Rental facility is located at <BR>
HEATHER MEADOWS MOUNTAIN SHOP</H2>

<TABLE BORDER=1 >
<TR>
<TD>
<TABLE BORDER=1 >
<TR>
<TD><IMG SRC="intro.gif" ALT="INTRO PACKAGES" HEIGHT=19 WIDTH=340></TD>
</TR>
</TABLE>

<P>Includes: <BR>
Full Day Rentals + 1.5 hr Lesson + Beginner Lift Ticket </P>

<PRE>               INTRO SKI PKG    SNOWBOARD PKG  
Adult 16 &amp; up      $35              $42
Youth  8-15        $32              $40
</PRE>
</TD>
</TR>
</TABLE>

<PRE>INSTRUCTION INFO &amp; PRICES
                         SKIS, BOOTS    SKIS     BOOTS 
                         &amp; POLES        ONLY     ONLY
<B>SKI RENTAL
</B>    Adult (18+)          $19           $13       $28
    Youth (13-17)        $17           $13       $28
    Child (12 &amp; under)   $14           $9        $23
    Demo Equipment       $30           $25

                         SNOWBOARD
                         &amp; BOOTS       BOARD     BOOTS
<B>SNOWBOARDS
</B>    All Ages             $29           $22      $10     
</PRE>

<H2>YOU'LL NEED TO KNOW...</H2>

<UL>
<LI>All rentals require ID for deposit. Snowboard &amp; Demo rentals require
a credit card imprintNO EXCEPTIONS. </LI>

<LI>INTRO PKGS SIGN UP AT INSTRUCTION DESK </LI>

<LI>Rental shop opens 1/2 hour before ski area. </LI>

<LI>Group rates available-call (360) 734-6771 </LI>

<LI>Nordic &amp; Snowshoe rentals available </LI>

<LI>All prices US; CDN subject to current exchange </LI>
</UL>

<CENTER><TABLE BORDER=1 >
<TR>
<TD><IMG SRC="slalom.gif" ALT="BANKED SLALOM" HEIGHT=156 WIDTH=300></TD>
</TR>
</TABLE></CENTER>

<P>
<HR><IMG SRC="snowflake1.gif" HEIGHT=18 WIDTH=16> <A HREF="index.html">HOME
PAGE</A> <BR>
<IMG SRC="snowflake1.gif" HEIGHT=18 WIDTH=16> <A HREF="expansion.html">NEW
WHITE SALMON DAY LODGE &amp; $5 MILLION EXPANSION PROJECT</A> <BR>
<IMG SRC="snowflake1.gif" HEIGHT=18 WIDTH=16> <A HREF="prices.html">DAILY
LIFT TICKETS &amp; OTHER PRICES</A> <BR>
<IMG SRC="snowflake1.gif" HEIGHT=18 WIDTH=16> <A HREF="conditions.html">CURRENT
MOUNTAIN CONDITIONS</A> <BR>
<IMG SRC="snowflake1.gif" HEIGHT=18 WIDTH=16> <A HREF="lowdown.html">THE
LOW DOWN</A> <BR>
<IMG SRC="snowflake1.gif" HEIGHT=18 WIDTH=16> RENTAL INFORMATION <BR>
<IMG SRC="snowflake1.gif" HEIGHT=18 WIDTH=16> <A HREF="lessons.html">SKI
SCHOOL</A> <BR>
<IMG SRC="snowflake1.gif" HEIGHT=18 WIDTH=16> <A HREF="trail.html">TRAIL
MAP</A> <BR>
</P>

<P>
<HR></P>

</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT02-B10-148</DOCNO>
<DOCOLDNO>IA017-000185-B025-8</DOCOLDNO>
<DOCHDR>
http://complimed.com:80/mtbakerskiarea/lessons.html 207.66.215.5 19970106092247 text/html 3281
HTTP/1.0 200 OK
Date: Mon, 06 Jan 1997 09:37:30 GMT
Server: Apache/1.1.1
Content-type: text/html
Content-length: 3110
Last-modified: Tue, 05 Nov 1996 21:10:09 GMT
</DOCHDR>
<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 3.2//EN">
<HTML>
<HEAD>
   <TITLE>INSTRUCTION PROGRAMS
</TITLE>
   <META NAME="GENERATOR" CONTENT="Mozilla/3.0Gold (Win95; I) [Netscape]">
</HEAD>
<BODY BACKGROUND="mtbaker_bg.gif">

<CENTER><P><A HREF="index.html"><IMG SRC="logo_sm.gif" BORDER=0 HEIGHT=49 WIDTH=160></A>
<BR>
</P></CENTER>

<CENTER><TABLE BORDER=1 >
<TR>
<TD><IMG SRC="instruction.gif" ALT="INSTRUCTION PROGRAMS" HEIGHT=22 WIDTH=236></TD>
</TR>
</TABLE></CENTER>

<P><B>MEETING PLACE:</B> Heather Meadows Instruction Desk </P>

<P><B>START TIMES:</B> 10:30 &amp; 1:00 daily. See separate brochure for
times of privates and kids programs. </P>

<P><B>ALL THE INFO:</B> See separate Instruction Brochure for complete
pricing info and program details on Adaptive, Youth District Schools, Kids
Race Team, Women's Seminars, Seniors Specials and Daycare Packages for
Kids. </P>

<TABLE BORDER=1 >
<TR>
<TD>
<TABLE BORDER=1 >
<TR>
<TD><IMG SRC="intro.gif" ALT="INTRO PACKAGES" HEIGHT=19 WIDTH=340></TD>
</TR>
</TABLE>

<P>Includes: <BR>
Full Day Rentals + 1.5 hr Lesson + Beginner Lift Ticket </P>

<PRE>               INTRO SKI PKG    SNOWBOARD PKG  
Adult 16 &amp; up      $35              $42
Youth  8-15        $32              $40
 </PRE>
</TD>
</TR>
</TABLE>

<H2>PRIVATES: ALL ABILITIES !</H2>

<P>Available daily between 9am &amp; 2pm based on bookings. All ages ski
or snowboard $50 </P>

<H2>DAILY SKILL DEVELOPMENT: Group Sessions</H2>

<P>For skiing and snowboarding from beginning skills through confident
turns on blue runs. Adult $18 for 1 1/5 hrs. </P>

<H2>ADVANCED ABILITIES OR &quot;THREE AMIGOS&quot;</H2>

<P>Advanced techniques available in private sessions or get together a
minimum of three &quot;Amigos&quot; and you all get group rates. </P>

<H2>Kids age 4-7: BEAR CUB INTRO SKI SESSIONS</H2>

<P>&quot;Wee Wildlife&quot; Ski Skill Development Sessions from beginner
skills through confident turns on easy blue runs. More advanced skill development
available in private sessions. </P>

<CENTER><TABLE BORDER=1 >
<TR>
<TD><IMG SRC="wonders.gif" ALT="NATURAL WONDERS" HEIGHT=17 WIDTH=209></TD>
</TR>
</TABLE></CENTER>

<CENTER><TABLE BORDER=1 >
<TR>
<TD><IMG SRC="skiing.jpg" ALT="SKIING AT MT BAKER" HEIGHT=202 WIDTH=300></TD>
</TR>
</TABLE></CENTER>

<P>
<HR><IMG SRC="snowflake1.gif" HEIGHT=18 WIDTH=16> <A HREF="index.html">HOME
PAGE</A> <BR>
<IMG SRC="snowflake1.gif" HEIGHT=18 WIDTH=16> <A HREF="expansion.html">NEW
WHITE SALMON DAY LODGE &amp; $5 MILLION EXPANSION PROJECT</A> <BR>
<IMG SRC="snowflake1.gif" HEIGHT=18 WIDTH=16> <A HREF="prices.html">DAILY
LIFT TICKETS &amp; OTHER PRICES</A> <BR>
<IMG SRC="snowflake1.gif" HEIGHT=18 WIDTH=16> <A HREF="conditions.html">CURRENT
MOUNTAIN CONDITIONS</A> <BR>
<IMG SRC="snowflake1.gif" HEIGHT=18 WIDTH=16> <A HREF="lowdown.html">THE
LOW DOWN</A> <BR>
<IMG SRC="snowflake1.gif" HEIGHT=18 WIDTH=16> <A HREF="rental.html">RENTAL
INFORMATION</A> <BR>
<IMG SRC="snowflake1.gif" HEIGHT=18 WIDTH=16> SKI SCHOOL <BR>
<IMG SRC="snowflake1.gif" HEIGHT=18 WIDTH=16> <A HREF="trail.html">TRAIL
MAP</A> <BR>
</P>

<P>
<HR></P>

</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT02-B10-149</DOCNO>
<DOCOLDNO>IA017-000185-B025-20</DOCOLDNO>
<DOCHDR>
http://complimed.com:80/mtbakerskiarea/trail.html 207.66.215.5 19970106092256 text/html 2194
HTTP/1.0 200 OK
Date: Mon, 06 Jan 1997 09:37:41 GMT
Server: Apache/1.1.1
Content-type: text/html
Content-length: 2023
Last-modified: Tue, 05 Nov 1996 21:10:04 GMT
</DOCHDR>
<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 3.2//EN">
<HTML>
<HEAD>
   <TITLE>Mount Baker Trail Map
</TITLE>
   <META NAME="GENERATOR" CONTENT="Mozilla/3.0Gold (Win95; I) [Netscape]">
</HEAD>
<BODY BACKGROUND="mtbaker_bg.gif">

<CENTER><P><A HREF="index.html"><IMG SRC="logo_sm.gif" BORDER=0 HEIGHT=49 WIDTH=160></A>
<BR>
</P></CENTER>

<CENTER><TABLE BORDER=1 >
<TR>
<TD><IMG SRC="trailmap.gif" HEIGHT=22 WIDTH=117></TD>
</TR>
</TABLE></CENTER>

<CENTER><P><BR>
</P></CENTER>

<CENTER><TABLE BORDER=1 >
<CAPTION>
<CENTER><P><BR>
</P></CENTER>
</CAPTION>

<TR>
<TD COLSPAN=3><IMG SRC="mtbakertrail.gif" HEIGHT=226 WIDTH=468></TD>
</TR>

<TR>
<TD><A HREF="mtbakertrail1.gif"><IMG SRC="closeup.gif" BORDER=0 HEIGHT=22 WIDTH=141></A></TD>

<TD><A HREF="mtbakertrail2.gif"><IMG SRC="closeup.gif" BORDER=0 HEIGHT=22 WIDTH=141></A></TD>

<TD><A HREF="mtbakertrail3.gif"><IMG SRC="closeup.gif" BORDER=0 HEIGHT=22 WIDTH=141></A></TD>
</TR>
</TABLE></CENTER>

<CENTER><TABLE BORDER=1 >
<TR>
<TD><IMG SRC="legend.gif" HEIGHT=232 WIDTH=480></TD>
</TR>
</TABLE></CENTER>

<CENTER><TABLE BORDER=1 >
<TR>
<TD><IMG SRC="responsibility.gif" HEIGHT=216 WIDTH=195></TD>
</TR>
</TABLE></CENTER>

<CENTER><P><BR>
</P></CENTER>

<P>
<HR><IMG SRC="snowflake1.gif" HEIGHT=18 WIDTH=16> <A HREF="index.html">HOME
PAGE</A> <BR>
<IMG SRC="snowflake1.gif" HEIGHT=18 WIDTH=16> <A HREF="expansion.html">NEW
WHITE SALMON DAY LODGE &amp; $5 MILLION EXPANSION PROJECT</A> <BR>
<IMG SRC="snowflake1.gif" HEIGHT=18 WIDTH=16> <A HREF="prices.html">DAILY
LIFT TICKETS &amp; OTHER PRICES</A> <BR>
<IMG SRC="snowflake1.gif" HEIGHT=18 WIDTH=16> <A HREF="conditions.html">CURRENT
MOUNTAIN CONDITIONS</A> <BR>
<IMG SRC="snowflake1.gif" HEIGHT=18 WIDTH=16> <A HREF="lowdown.html">THE
LOW DOWN</A> <BR>
<IMG SRC="snowflake1.gif" HEIGHT=18 WIDTH=16> <A HREF="rental.html">RENTAL
INFORMATION</A> <BR>
<IMG SRC="snowflake1.gif" HEIGHT=18 WIDTH=16> <A HREF="lessons.html">SKI
SCHOOL</A> <BR>
<IMG SRC="snowflake1.gif" HEIGHT=18 WIDTH=16> TRAIL MAP <BR>
</P>

</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT02-B10-150</DOCNO>
<DOCOLDNO>IA017-000185-B025-34</DOCOLDNO>
<DOCHDR>
http://complimed.com:80/mtbakerskiarea/places.html 207.66.215.5 19970106092304 text/html 2742
HTTP/1.0 200 OK
Date: Mon, 06 Jan 1997 09:37:50 GMT
Server: Apache/1.1.1
Content-type: text/html
Content-length: 2571
Last-modified: Mon, 16 Dec 1996 18:42:35 GMT
</DOCHDR>
<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 3.2//EN">
<HTML>
<HEAD>
   <TITLE>Places to Stay</TITLE>
   <META NAME="Author" CONTENT="Dan Witte">
   <META NAME="GENERATOR" CONTENT="Mozilla/3.0Gold (Win95; I) [Netscape]">
   <META NAME="Description" CONTENT="Places to stay near Mt. Baker">
</HEAD>
<BODY TEXT="#FFFFFF" BGCOLOR="#000000" LINK="#FF9000" VLINK="#FF9000">

<CENTER><P><IMG SRC="places.gif" ALT="Places to stay near Mt. Baker" HEIGHT=40 WIDTH=172 ALIGN=CENTER></P></CENTER>

<CENTER><P>Nearest accommodations are 17 miles from Mt. Baker Ski Area.
Listed are just a few of the places to stay.</P></CENTER>

<CENTER><P><B><FONT COLOR="#0000FF">IN GLACIER</FONT></B></P></CENTER>

<CENTER><TABLE BORDER=1 >
<TR>
<TD><FONT COLOR="#FFFFFF">Glacier Creek Motel &amp; Cabins</FONT></TD>

<TD>360-599-2991</TD>
</TR>

<TR>
<TD>Mt. Baker Chalets &amp; Condos</TD>

<TD>360-599-2405</TD>
</TR>

<TR>
<TD>Mt. Baker Lodging</TD>

<TD>800-709-7669</TD>
</TR>

<TR>
<TD>Snowline Inn</TD>

<TD>800-228-0119</TD>
</TR>

<TR>
<TD>Vacation Rentals Cabin/Suite</TD>

<TD>360-599-2142</TD>
</TR>

<TR>
<TD>Cabin Country B&amp;B</TD>

<TD>360-599-2903</TD>
</TR>
</TABLE></CENTER>

<CENTER><P><B><FONT COLOR="#0000FF">IN MAPLE FALLS</FONT></B></P></CENTER>

<CENTER><TABLE BORDER=1 >
<TR>
<TD>Country Hill B&amp;B</TD>

<TD>360-599-1049</TD>
</TR>

<TR>
<TD>Thurston House B&amp;B</TD>

<TD>360-599-2261</TD>
</TR>

<TR>
<TD>Yodeler Inn B&amp;B</TD>

<TD>360-599-2156</TD>
</TR>

<TR>
<TD>Glacier Guest Suite</TD>

<TD>360-599-2927</TD>
</TR>
</TABLE></CENTER>

<CENTER><P><B><FONT COLOR="#0000FF">OVERNIGHT RV PARKING AT THE SKI AREA</FONT></B></P></CENTER>

<CENTER><P>Overnight parking for self-contained RVs is permitted in designated
areas only.</P></CENTER>

<P><IMG SRC="snowflake2.gif" HEIGHT=18 WIDTH=16> <A HREF="index.html">HOME
PAGE</A> <BR>
<IMG SRC="snowflake2.gif" HEIGHT=18 WIDTH=16> <A HREF="map.html">MAP TO
MT BAKER</A> <BR>
<IMG SRC="snowflake2.gif" HEIGHT=18 WIDTH=16> <A HREF="expansion.html">NEW
WHITE SALMON DAY LODGE &amp; $5 MILLION EXPANSION PROJECT</A> <BR>
<IMG SRC="snowflake2.gif" HEIGHT=18 WIDTH=16> <A HREF="prices.html">DAILY
LIFT TICKETS &amp; OTHER PRICES</A> <BR>
<IMG SRC="snowflake2.gif" HEIGHT=18 WIDTH=16> <A HREF="lowdown.html">THE
LOW DOWN</A> <BR>
<IMG SRC="snowflake2.gif" HEIGHT=18 WIDTH=16> <A HREF="rental.html">RENTAL
INFORMATION</A> <BR>
<IMG SRC="snowflake2.gif" HEIGHT=18 WIDTH=16> <A HREF="lessons.html">SKI
SCHOOL</A> <BR>
<IMG SRC="snowflake2.gif" HEIGHT=18 WIDTH=16> <A HREF="trail.html">TRAIL
MAP</A> <BR>
</P>

</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT02-B10-151</DOCNO>
<DOCOLDNO>IA017-000185-B025-48</DOCOLDNO>
<DOCHDR>
http://complimed.com:80/complimed/subheader.map 207.66.215.5 19970106092313 text/html 1006
HTTP/1.0 200 OK
Date: Mon, 06 Jan 1997 09:37:59 GMT
Server: Apache/1.1.1
Content-type: text/html
</DOCHDR>
<html>
<head><title>Menu for /complimed/subheader.map</title></head>

<body>
<h1>Menu for /complimed/subheader.map</h1>
<hr>








<pre>          <a href="http://dogbert.cssnw.com/complimed/index.html">index.html</a></pre>
<pre>          <a href="http://dogbert.cssnw.com/complimed/resource.html">resource.html</a></pre>
<pre>          <a href="http://dogbert.cssnw.com/complimed/new.html">new.html</a></pre>
<pre>          <a href="http://dogbert.cssnw.com/complimed/article.html">article.html</a></pre>
<pre>          <a href="http://dogbert.cssnw.com/complimed/alt.html">alt.html</a></pre>
<pre>          <a href="http://dogbert.cssnw.com/complimed/products.html">products.html</a></pre>
<pre>          <a href="http://dogbert.cssnw.com/complimed/profile.html">profile.html</a></pre>
<pre>          <a href="http://dogbert.cssnw.com/complimed/contact.html">contact.html</a></pre>


</body>
</html>
</DOC>
<DOC>
<DOCNO>WT02-B10-152</DOCNO>
<DOCOLDNO>IA017-000185-B025-61</DOCOLDNO>
<DOCHDR>
http://complimed.com:80/mtbakerskiarea/history.html 207.66.215.5 19970106092320 text/html 14416
HTTP/1.0 200 OK
Date: Mon, 06 Jan 1997 09:38:06 GMT
Server: Apache/1.1.1
Content-type: text/html
Content-length: 14244
Last-modified: Fri, 03 Jan 1997 20:11:53 GMT
</DOCHDR>
<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 3.2//EN">
<HTML>
<HEAD>
   <TITLE>Mount Baker Snow Report</TITLE>
</HEAD>

<BODY TEXT="#FFFFFF" BGCOLOR="#000000" LINK="#FF9000" VLINK="#FF9000">

<H1 ALIGN=CENTER>Past Mount Baker Snow Reports</H1>

<P>Here are the past snow reports for Mount Baker Ski Area. </P>

<P>
<HR></P>
<META begin>
Date: Jan 3rd, 1997<br>
Time: 5:00am<br>
New Snow: 6 inches.<br>
Base: 140 inches.<br>
Temp: 26 degrees.<br>
<p>Wow, it snowed again last night with 6" of fresh dry powder on top
of an already incredible base of 140", there is plenty of room for
riding on this beautiful stuff.  When you get to the top there
is 163".  The current condition is SUNNY!!!!  More dry powder is
expected this weekend.  It sounds like we will get light snow showers this 
weekend with sun breaks possible.  It shouldn't dump like it has been lately 
and there will be visibility to be able to see where your skiing.  Come up
 and enjoy a fabulous weekend.<p><br>
<br>
Date: 1/2/97<br>
Time: 2:00pm<br>
New Snow: 5 inches.<br>
Base: 145 inches.<br>
Temp: 30 degrees.<br>
<p>Well, it's back to snowing again.  5" of fresh today with 8" in the last
 24 hours.  We have a 145" base with 160" on top, conditions
are soft packed.  We are looking forward to the freezing levels
dropping to 1500' over the next few days.  Come up and join us
for a fantastic holiday weekend.  <p><br>
<br>
Date: 12/30/96<br>
Time: 2:00pm<br>
New Snow: 2 inches.<br>
Base: 145 inches.<br>
Temp: 35 degrees.<br>
<p>Ok, everyone, it's time to play in all that stuff we've been looking at for the past few days.
We will be reopening tomorrow, Tuesday the 31st, at 8:30am in full holiday operation. The Mt. Baker Hwy.
will be open at 5:00am. It's currently raining lightly on the mountain but the 
freezing levels are expected to drop back below 3000'. 
See you on the mountain!!


<p><br>
<br>
Date: 12/26/96<br>
Time: 2:00pm<br>
New Snow: 0 inches.<br>
Base: 137 inches.<br>
Temp: 25 degrees.<br>
<p>Ok, this is an excellent season, clear with high broken clouds
today so it was fantastic, cold, dry powder.  Currently
there is no new snow in the last 24 hours but we are looking
forward to more snow in the next 24 hours, with the low SW of
us moving over and skimming our area.  The forecast is for 2-6"
of new (hopefully more) for the weekend with very cold dry 
conditions.  The Mt Baker Highway is in excellent condition
for travel so come up here and have some FUN!!!!  LATER...your
 furry snow friend...<p><br>
<br>
Date: 12/26/96<br>
Time: 5:30am<br>
New Snow: 0 inches.<br>
Base: 137 inches.<br>
Temp: 16 degrees.<br>
<p>Hello everybody. Hope you're read to ski off that Christmas dinner. It's currently clear and 16 degs. There's been no new snow in the past 24 hours. Slope conditions are powder and packed powder. See you on the
                                            mountain!<p><br>
<br>
Date: 12-25-96<br>
Time: 2:00pm<br>
New Snow: 0 inches.<br>
Base: 137 inches.<br>
Temp: 14 degrees.<br>
<p>Merry Christmas everybody. We are closed today but will reoprn
tomorrow at 8:30am. There's been no new snow in the past 24
hours but we have 137' at the base and 152' on top of the 
mountain. 
Again have a Merry Christmas and see you on the mountain!<p><br>
<br>
Date: 12/23/96<br>
Time: 2:00pm<br>
New Snow: 10 inches.<br>
Base: 135 inches.<br>
Temp: 22 degrees.<br>
<p>Well more snow has dumped here in Bellingham over night this means great powder in the mountains. We have received an
   incredible amount of snow so far this season with a 135" base and 150" on top! It has been snowing today and 22
  degrees with 10" today and 15" in the last 24 hours. The lines are short, the snow is awesome so come up and enjoy. CAN'T
  figure out what to get that boardhead or skier for Christmas! Stop by the office on Iowa St. Have a great holiday week and
    don't forget we'll all be home for Christmas so the area won't be open.. See you soon! next to the freeway or call us at
360/734-6771 and order a few gift passes, they make GREAT stocking stuffers (my stocking is the 3rd one from the right!) So
                          put in your Santa orders and have a great holiday week!!!<p><br>
<br>
Date: 12/23/96<br>
Time: 5:30am<br>
New Snow: 6 inches.<br>
Base: 135 inches.<br>
Temp: 23 degrees.<br>
<p>Well more snow has dumped here in Bellingham over night this 
means great powder in the mountains. We have received an incredible amount of snow so far this season with a 135" base and 150" on
 top! It has been snowing this morning and 23 degrees with 6" today and 9" in the last 24 hours. The lines are short, the snow is awesome
  so come up and enjoy. CAN'T figure out what to get that boardhead or skier for Christmas! Stop by the office on Iowa St.  Have a great
holiday week and don't forget we'll all be home for Christmas so the area won't be open..  See you soon!
 next to the freeway or call us at 360/734-6771 and order a few gift passes, they make GREAT stocking stuffers (my stocking
              is the 3rd one from the right!) So put in your Santa orders and have a great holiday week!!!<p><br>
<br>
Date: 12/21/96<br>
Time: 5:50am<br>
New Snow: 4 inches.<br>
Base: 130 inches.<br>
Temp: 25 degrees.<br>
<p>Well the prediction is for more wonderful fluffy snow.  
Freezing levels are below 2000' and dropping to 500' overnight so
that means fantastic snow for us.  We have received and 
incredible amount of snow so far this season with a 130" base
and 145" on top!  It has been snowing this morning and 25 degrees 
with a forecast for more snow.  The lines are small, the snow is
awesome so come up and enjoy.  CAN'T figure out what to get
that boardhead or skier for Christmas!  Stop by the office on
Iowa St next to the freeway or call us at 360/734-6771 and
order a few gift passes, they make GREAT stocking stuffers 
(my stocking is the 3rd one from the right!)  So put in
your Santa orders and have a great holiday week!!!<p><br>
<br>
Date: 12-20-96<br>
Time: 2:00pm<br>
New Snow: 3 inches.<br>
Base: 130 inches.<br>
Temp: 28 degrees.<br>
<p>
 We are in full holiday operation today from 8:30-3:30. We have 3" of new snow with 11" in the past 24 hours. It's snowing lightly with powder and
                      packed powder. We will be in full holiday operation until January 5th. See you on the mountain.<p><br>
<br>
Date: 12/16/96<br>
Time: 5:30<br>
New Snow: 3 inches.<br>
Base: 132 inches.<br>
Temp: 18 degrees.<br>
<p>We are in full holiday operation today from 8:30-3:30.  We have 3" of new snow with 9" in the past 24 hours. It's clear and sunny today with powder and packed powder.  We will be in full holiday operation until January 5th.  See you on the mountain.<p><br>
<br>
Date: 12/14/96<br>
Time: 5:30<br>
New Snow: 7 inches.<br>
Base: 133 inches.<br>
Temp: 19 degrees.<br>
<p>Well it looks like another great day today.  We've had 15 inches of new snow in the past 24 hours.  Base of 133" with 148" on top.  Conditions are powder and packed powder and it's clear and sunny.  We are in full operation today from 8:30 - 3:30.  We'll see you on the mountain.<p><br>
<br>
Date: 12/13/96<br>
Time: 2:00p<br>
New Snow: 8 inches.<br>
Base: 130 inches.<br>
Temp: 26 degrees.<br>
<p>Wow, what a day.  Just got back from skiing!  The powder is 
deep the vis is questionable but if you fall, what the hell
it just doesn't matter.  Looks like this 26 degrees, 130" 
base, 145" at the top with 8" of fresh today (I can attest
to having to dig the car out) and 26" of new in the past
24 Hours, no kidding thats greater than 1"/hour the whole time.
Have a great weekend, get up here and enjoy the fluff it is
definitely a blast, and for all you people that have never
experienced it NOW is the time for all good skiers/boarders
to come to the aid of the snowman....  Have a great weekend,
see you monday!!!<p><br>
<br>
Date: 12/12/96<br>
Time: 5:30a<br>
New Snow: 5 inches.<br>
Base: 122 inches.<br>
Temp: 26 degrees.<br>
<p>Current conditions are powder (no duh it's been dumping) it 
looks really cool up here so definitely come up and check
out the awesome beauty of it all.  Trees packed with snow, 
15' snow banks along the road..  Definitely a lot of snow.
There is 122" at the base with 137" on top, 5" of new snow with
9" in the last 24 hours and about 8' in the last week and a
half.  It's a great time to ride the snow.  For all you
holiday shoppers you can buy gift certificates for your
snow hound either visit the office on Iowa next to the freeway 
or call 360/734-6771 8-5 m-f with your order.  Get them
a present they will appreciate (no a knitted sweater is not cool)

Later,..... ;-)<p><br>
<br>
Date: 12/11/96<br>
Time: 5:30am<br>
New Snow: 12 inches.<br>
Base: 120 inches.<br>
Temp: 25 degrees.<br>
<p>Well I am currently dealing with a coronary thanks to all
this new snow I have to shovel...  There has been 12" of new
this morning with 19" in the last 24 hours..  We have 120" of
snow on the base (yes 120") with 135" on top.  Now as I look
out the window it's getting SUNNY!! (12:00p) So if your not
here--- YOU SHOULD BE...  Drop everything, get up here, 
spray some powder and enjoy yourself...

Have A GREAT DAY! <p><br>
<br>
Date: 12/10/96<br>
Time: 5:30am<br>
New Snow: 6 inches.<br>
Base: 115 inches.<br>
Temp: 31 degrees.<br>
<p>Guess what...  It's snowing AGAIN..  We have had 85" of new
snow in the last week and it's only December.  The base
is at 115" with the summit at 130" we have had 6" of new.  
 If you haven't been skiing yet WHAT ARE YOU
 WAITING FOR??? CHRISTMAS??? Get up here and enjoy these incredible early season conditions. Have a great
   week and dream about being here if your working... I hear a sick day calling me.... Later, snow worshippers...  
Oh by the way Mt Baker is your best ski value at only $17.50
for a lift pass at the Mon-Wed non-holiday rate.  <p><br>
<br>
Date: 12/9/96<br>
Time: 5:00am<br>
New Snow: 2 inches.<br>
Base: 113 inches.<br>
Temp: 22 degrees.<br>
<p>Wow, after a tremendous week of snow, snow, snow the
weather has opened up to SUN!!!  It is extremely nice
on the mountain today.  The powder is light and fluffy
thanks to the 22 degree temperature.  The base is 113" 
with 128" on top, thats 10'8" of AWESOME SNOW!  There
has been 2" of fresh with 11" in the last 24 hours so 
you know that you can get fresh tracks just about anywhere
on the mountain.  If you haven't been skiing yet WHAT ARE
YOU WAITING FOR??? CHRISTMAS???  Get up here and enjoy
these incredible early season conditions.  Have a great 
week and dream about being here if your working...
I hear a sick day calling me....  Later, snow worshippers...<p><br>
<br>
Date: 11/19/96<br>
Time: 1:50pm<br>
New Snow: 5 inches.<br>
Base: 42 inches.<br>
Temp: 24 degrees.<br>
<p>Well the snow is here in full force.  It is 28 degrees with 6" of new in the last 24 hours oh wait a minute thats just in BELLINGHAM!!!!  At the mountain it's looking fantastic!  We are open in full Midweek operation from 9:00-3:30 with a 42" base, 52" on top and 24 degrees!! Talk about SWEEEET powder!!  Get up here and check it out..  There have been temporary road closures on the Sumas/Kendall highway so if you are coming from Canada it would be best to take south I-5 to Iowa St, get off and get back on to go to north I-5 because the Sunset exit is closed for construction but it's only about a 5 minute detour. 

GET up here and play in the POWDER!!!<p><br>
<br>
Date: 11/18/96<br>
Time: 9:00am<br>
New Snow: 6 inches.<br>
Base: 37 inches.<br>
Temp: 23 degrees.<br>
<p>CAN YOU SAY POWDER!!!!  We will be opening Tuesday November 19th with a 37" Base and 47" on top.  There is plenty of crystal clear, clean powder to go around so get up here and find your share.  Chairs 1,2,3,5,6,8 and the heather meadows base area will be open from 9-3:30.  The forecast is for more snow through Thursday, so break out your boards and hit it!!!  See you all on the mountain!<p><br>
<br>
Date: 11/16/96<br>
Time: 1:30pm<br>
New Snow: 6 inches.<br>
Base: 18 inches.<br>
Temp: 29 degrees.<br>
<p>The snow is falling again!  We have an 18" base with 26" on top and 6" of new snow in the last 24 hours.  We are temporarily closed until the base builds up but with this new snowstorm coming through it could be anytime soon.  Continued snow is in the forcast so STAY TUNED to this station for a reopening announcement.<p><br>
<br>
Date: 11/15/96<br>
Time: 11:00a<br>
New Snow: .5 inches.<br>
Base: 14 inches.<br>
Temp: 30 degrees.<br>
<p>Currently 30 degrees and snowing lightly on the mountain.  There is 14" of snow at the base with 25" on top of the mountain.  We had 3 days of great skiing and snowboarding last weekend but we are temporarily closed until we receive additional snow. The forecast is for low freezing levels with lots of precipitation in the form of SNOW!!!  Look here for daily updates.<p><br>
<br>
Date: 11/12/96<br>
Time: 9:00a<br>
New Snow: 0 inches.<br>
Base: 18 inches.<br>
Temp: 45 degrees.<br>
<p>We had 3 great days of skiing but are temporarily closed and waiting for additional snow.  There is 30" on top.  The forecast is for cooling temperatures towards the end of the week with an increasing chance of more snow.  Look here or call the ski report for additional information.<p><br>
<br>
Date: 11/8/96<br>
Time: 9:00am<br>
New Snow: 5 inches.<br>
Base: 35 inches.<br>
Temp: 35 degrees.<br>
<p>Overcast with 52" of snow on top.  Opening day is tomorrow November 9!!!  We will be open from 8:30-3:30 with both base areas and all 8 chairlifts running.  The trails are groomed and ready for skiing.  Forcast is for clear and sunny skies this weekend.  See you on the mountain.<p><br>
<br>
<P>Date: 11/7/96<BR>
Time: 9:00am<BR>
New Snow: 0 inches.<BR>
Base: 30 inches.<BR>
Temp: 28 degrees.<BR>
</P>

<P>It's currently overcast. If we don't get rain thursday or friday, we
may be able to open saturday. Keep your eyes here or call the phone lines
for current information and an official opening date. If the phone line
doesn't answer, try back right away.</P>

<P><BR>
<BR>

<HR>Send me <A HREF="index.html">Back to the Mt. Baker
Ski Area home page.</A> </P>

</BODY>
</HTML>


</DOC>
<DOC>
<DOCNO>WT02-B10-153</DOCNO>
<DOCOLDNO>IA017-000185-B025-80</DOCOLDNO>
<DOCHDR>
http://complimed.com:80/mtbakerskiarea/conditions.html 207.66.215.5 19970106092339 text/html 2344
HTTP/1.0 200 OK
Date: Mon, 06 Jan 1997 09:38:20 GMT
Server: Apache/1.1.1
Content-type: text/html
Content-length: 2173
Last-modified: Wed, 20 Nov 1996 21:09:38 GMT
</DOCHDR>
<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 3.2//EN">
<HTML>
<HEAD>
   <TITLE>CURRENT CONDITIONS
</TITLE>
   <META NAME="GENERATOR" CONTENT="Mozilla/3.0Gold (Win95; I) [Netscape]">
</HEAD>
<BODY BACKGROUND="mtbaker_bg.gif">

<CENTER><P><A HREF="index.html"><IMG SRC="logo_sm.gif" BORDER=0 HEIGHT=49 WIDTH=160></A>
<BR>
</P></CENTER>

<CENTER><TABLE BORDER=1 >
<TR>
<TD><IMG SRC="conditions.gif" ALT="CURRENT CONDITIONS" HEIGHT=22 WIDTH=204></TD>
</TR>
</TABLE></CENTER>

<CENTER><TABLE BORDER=1 >
<TR>
<TD><IMG SRC="http://www.mtbakerskiarea.com/reports.gif" ALT="SNOW REPORTS" HEIGHT=19 WIDTH=150></TD>
</TR>
</TABLE></CENTER>

<BLOCKQUOTE>
<P>Reports on daily ski area conditions updated at 5:30am and 2:00pm every
day of operation </P>

<TABLE BORDER=1 >
<TR>
<TD>Bellingham</TD>

<TD>(360) 671-0211</TD>
</TR>

<TR>
<TD>Vancouver BC</TD>

<TD>(604) 688-1595</TD>
</TR>

<TR>
<TD>Seattle</TD>

<TD>(206) 634-0200</TD>
</TR>
</TABLE>

<P>SKI AREA OPERATING HOURS: </P>

<LI>Weekends &amp; Holidays - 8:30-3:30; </LI>

<LI>Midweek / Non-Holiday - 9:00-3:30 </LI>
</BLOCKQUOTE>

<CENTER><TABLE BORDER=1 >
<TR>
<TD><IMG SRC="good4u.gif" HEIGHT=17 WIDTH=294></TD>
</TR>
</TABLE></CENTER>

<CENTER><TABLE BORDER=1 >
<TR>
<TD><IMG SRC="snowboard.gif" HEIGHT=190 WIDTH=280></TD>
</TR>
</TABLE></CENTER>

<P><IMG SRC="snowflake1.gif" HEIGHT=18 WIDTH=16>
<A HREF="index.html">HOME PAGE</A> <BR>
<IMG SRC="snowflake1.gif" HEIGHT=18 WIDTH=16>
<A HREF="expansion.html">NEW WHITE SALMON
DAY LODGE &amp; $5 MILLION EXPANSION PROJECT</A> <BR>
<IMG SRC="snowflake1.gif" HEIGHT=18 WIDTH=16>
<A HREF="prices.html">DAILY LIFT TICKETS
&amp; OTHER PRICES</A> <BR>
<IMG SRC="snowflake1.gif" HEIGHT=18 WIDTH=16>
<A HREF="lowdown.html">THE LOW DOWN</A> <BR>
<IMG SRC="snowflake1.gif" HEIGHT=18 WIDTH=16>
<A HREF="rental.html">RENTAL INFORMATION</A>
<BR>
<IMG SRC="snowflake1.gif" HEIGHT=18 WIDTH=16>
<A HREF="lessons.html">SKI SCHOOL</A> <BR>
<IMG SRC="snowflake1.gif" HEIGHT=18 WIDTH=16>
<A HREF="trail.html">TRAIL MAP</A> <BR>
</P>

<P>
<HR></P>
You are visitor number <IMG SRC="/cgi-bin/Count.cgi?ft=2&dd=C&frgb=0;0;0|df=skireport.dat" ALT="Mt. Baker Ski Report Counter">.<BR>

</BODY>
</HTML>


</DOC>
<DOC>
<DOCNO>WT02-B10-154</DOCNO>
<DOCOLDNO>IA093-000995-B028-272</DOCOLDNO>
<DOCHDR>
http://www.nyspi.cpmc.columbia.edu:80/ 156.111.80.30 19970121072025 text/html 8915
HTTP/1.0 200 OK
MIME-Version: 1.0
Server: GLACI/2.01
Date: Tue Jan 21 02:24:32 1997
Content-Type: text/html
Content-Length: 8785
</DOCHDR>
<HTML>
<TITLE>New York State Psychiatric Institute</TITLE>
<BODY BACKGROUND="MARBLE.JPG">
<CENTER>
<IMG SRC = "PIHEADR.JPG">
</CENTER>
<HR>
<P>
New York State Psychiatric Institute (N.Y.S.P.I.), the oldest psychiatric
research institute in the United States and one of the largest devoted to
mental health research in the world, has a three-fold mandate: <A HREF="#PI_Research">research</A>,
<A HREF="#PI_Education">education and training</A>, and <A HREF="#PI_Clinical">clinical services</A>.
<P>
Its history is one of significant accomplishments.  Among the most
illustrious are the establishment of the relationship between paresis and
the spirochete responsible for syphilis, the creation of the key
experimental animal model for the study of epilepsy, the first psychiatric
research program in genetics in the country, the introduction to the U.S.
of lithium carbonate, which has been the most successful treatment of
manic-depression, and the completion of DSM-III, the official diagnostic
manual of the American Psychiatric Association.
<P>
Renowned for its past achievements, it continues to make contributions to
the understanding of mental disorders, to the care of people with mental
disabilities, and to the prevention of mental disease.
<HR>
<CENTER>
<H2>New York State Psychiatric Institute</H2>
</CENTER>
<CENTER>
<TABLE BORDER=4 CELLPADDING=4 CELLSPACING=2>
<TR>
	<TD><LI><A HREF = "/USERS/ETHAYER/BROCHURE.HTM"><CENTER>Who We Are</CENTER></A></TD>
	<TD><LI><A HREF = "/NYSPI/PI_CAREV.HTM"><CENTER>Clinical and Administrative Reports</CENTER></A></TD>
	<TD><LI><A HREF = "/NYSPI/PI_ADMIN.HTM"><CENTER>Administration</CENTER></A></TD>
</TR>
<TR>
	<TD><LI><A HREF = "/NYSPI/PI_RCDP.HTM"><CENTER>Research and Clinical Departments</CENTER></A></TD>
	<TD><LI><A HREF = "/NYSPI/PI_EDDP.HTM"><CENTER>Education and Training in Psychiatry</CENTER></A></TD>
	<TD><LI><A HREF = "/NYSPI/PI_RCSDP.HTM"><CENTER>Research Support and Clinical Support Services</CENTER></A></TD>
</TR>
<TR>
	<TD><LI><A HREF = "/NYSPI/PI_RFMH.HTM"><CENTER>Research Foundation for Mental Hygiene, Inc.</CENTER></A></TD>
	<TD><LI><A HREF = "/NYSPI/PI_RSCH.HTM"><CENTER>Special Activities and Awards</CENTER></A></TD>
        <TD><LI><A HREF = "/NYSPI/RFMHGRNT/RF_SPON1.HTM"><CENTER>Sponsored Research</CENTER></A></TD>
</TR>
<TR>
        <TD><LI><A HREF = "/NYSPI/RESPAPRS/RSP_INDX.HTM"><CENTER>Research Materials</CENTER></A></TD>
	<TD><LI><A HREF = "SEARCH.HTM"><CENTER>Search All of NYSPI</CENTER></A></TD>
        <TD><LI><A HREF = "/NYSPI/PI_IRSCS.HTM"><CENTER>Internet Resources</CENTER></A></TD>
</TR>
<TR>
	<TD><LI><A HREF = "/NYSPI/EVENTS/Evntindx.HTM"><CENTER>Calendar of Events</CENTER></A></TD>
	<TD></TD>
        <TD><LI><A HREF = "/NYSPI/JOBS/JOBINDEX.HTM"><CENTER>Job Opportunities</CENTER></A></TD>
</TR>
<TR>
	<TD><LI><A HREF = "http://156.111.80.209/Newsletter1"><CENTER>NYSPI Newsletter</CENTER></A></TD>
        <TD><LI><A HREF = "/NYSPI/PHONE/nypidirk.HTM"><CENTER>NYSPI-Phone/Mail Directory</CENTER></A></TD>
	<!--<TD><LI><A HREF = "/NYSPI/MAILWARN.HTM"><CENTER>NYSPI-Phone/Mail Directory</CENTER></A></TD>-->
	<TD><LI><A HREF = "http://156.111.80.209/Testweb"><CENTER>NYSPI Internal Web Page</CENTER></A></TD>
</TR>
</TABLE>
</CENTER>
<CENTER>
<TABLE BORDER=4 CELLPADDING=4 CELLSPACING=2>
<TR>
	<TD COLSPAN=2 ALIGN=CENTER><A HREF ="http://cpmcnet.columbia.edu/">CPMCNet</A></TD>
</TR>
<TR>
	<TD><LI><A HREF = "http://cpmcnet.columbia.edu/dept/pi/psych.html"><CENTER>Columbia Univ. Department of Psychiatry</CENTER></A></TD>
	<TD><LI><A HREF = "http://cpmcnet.columbia.edu/research/fac-prof.html"><CENTER>Faculty Profiles</CENTER></A></TD>
</TR>
<TR>
	<TD><LI><A HREF = "http://cpmcnet.columbia.edu/www/search2.cgi?query=Psychiatry&index=alla&href=/"><CENTER>Psychiatry News</CENTER></A></TD>
	<!--<TD><LI><A HREF = 
"http://cpmcnet.columbia.edu/health.sci/research/local/campus/camp088.html"><CENTER>N.Y.S.P.I.</CENTER></A></TD>-->
</TR>
</TABLE>
</CENTER>
<HR>
If you have any questions or comments please E-mail us at: <Address><A HREF= "mailto: webgroup@rf1.cpmc.columbia.edu"> webgroup@rf1.cpmc.columbia.edu</A></Address>
<HR>
<U><A NAME = "PI_Research"><A HREF = "/NYSPI/PI_RCDP.HTM"><B>RESEARCH</B></A></A></U>
<P>
More than three hundred biological, behavioral, and social reseach
studies are being conducted at Psychiatric Institute.
<P>
A view of the Institute at any given time will reveal laboratory
technicians in the neuroscience laboratories examining the serotonin
protein, which facilitates communication between neurons in the brain.  A
few floors below, clinical histories are being recorded in the Depression
Evaluation Service to determine whether a patient suffers from chronic
endogenous depression, atypical depression where some capacity for
pleasure remains, or from another variant of depressive disorder.
Clinical psychopharmacologists, just down the hall, discuss with cautious
optimism the efficacy of a drug which seems to curb the craving for
cigarette smoking, while their neighbors weigh the advantages of using
antidepressant medication in the treatment of bulimia.
<P>
Not far away, in the Anxiety Disorders CLinic, patients who have for
years been virtually housebound because of the fear of public places
(agoraphobia) are discovering that within a few months of combined
treatment with monoamine oxidase inhibitors and psychotherapy they can
resume normal activities.
<P>
In the developmental psychobiology laboratories of the Lawrence C. Kolb
Research Laboratory Building, the 14 story annex of Psychiatric
Institute, scientists are observing the behavior of infant rats separated
from their mothers.  They have concluded that premature maternal
deprivation produces a collection of adverse physiological and behavioral
responses whose long-term effects may include vulnerability to disease.
<P>
In the Howard Hughes Institute in Molecular Neurobiology and Behavior,
established at P.I. because of the widely recognized scientific strengths
of its researchers in neuroscience, the simple nervous cell structure of
the marine snail, Aplysia, serves as the basis for extensive and
innovative investigations of the mechanisms of learning and memory.
<P>
Some researchers in Child Psychiatry are investigating the use of drugs in treating hyperactive children; others are trying to make sense out of the rash of teen-age suicides that have plagued many communities recently.
<P>
And, with the city as a laboratory, epidemiologists are examining data on the characteristics of the homeless population using New York City shelters; others are doing longitudinal studies of the course of mental illness in children.
<P>
Sponsored research projects at P.I. totaling over twelve million dollars annually, are administered through the Research Foundation for Mental Hygiene.  Results from some of these projects will eventually produce breakthroughs as remarkable as those for which the Institute is already famous.
<HR>
<U><A NAME = "PI_Education"><A HREF = "/NYSPI/PI_EDDP.HTM"><B>EDUCATION and TRAINING</B></A></A></U>
<P>
The Institute provides psychiatric training for medical students from the Columbia College of Physicians and Surgeons, and residency training for psychiatrists, including programs at the Creedmoor and Middletown Psychiatric Centers.
<P>
A post-residency fellowship in public psychiatry trains psychiatrists who plan to pursue careers as leaders in public sector mental health.
<P>
A fellowship program in Child Psychiatry and research fellowships in specialized areas are also offered here and at other state facitlities.
<P>
Other training includes programs in psychology, social work, and nursing.
<HR>
<U><A NAME = "PI_Clinical"><A HREF = "/NYSPI/PI_RCDP.HTM"><B>CLINICAL SERVICES</B></A></A></U>
<P>
Committed to the community in which it is located, P.I.'s Washington Heights Community Service treats a total of 700 people a year at its outpatient and full-care inpatient units.  Inpatient clinical services are also available to people participating in research programs.
<P>
Special purpose outpatient clinics, combining research and treatment, serve close to 4,000 people annually from the entire metropolitan area.  These range from a depression and attempted suicide clinic for children and adolescents to a sexual agression clinic engaged in reversing the aberrant habits of sexual offenders.
<P>
The multi-disciplinary nature of Psychiatric Institute provides its scientists with the ideal environment for both independent and collaborative research and its students with ample opportunity to acquire the most sophisticated knowledge in the field.
</BODY>
</HTML>




</DOC>
<DOC>
<DOCNO>WT02-B10-155</DOCNO>
<DOCOLDNO>IA093-000995-B028-459</DOCOLDNO>
<DOCHDR>
http://www.nyspi.cpmc.columbia.edu:80/SEARCH.HTM 156.111.80.30 19970121072229 text/html 836
HTTP/1.0 200 OK
MIME-Version: 1.0
Server: GLACI/2.01
Date: Tue Jan 21 02:26:34 1997
Content-Type: text/html
Content-Length: 707
</DOCHDR>
<html>
 <head>
  <title>NYSPI - SEARCH ENGINE</title>
 </head>
 <body background="./images/marble.jpg">
  <center>
   <h1>NYSPI - Search Engine</h1>
  </center>
<hr size=2 width=75%><p>
<form method=POST action="http://www.nyspi.cpmc.columbia.edu/cgi-bin/search.pl">
<center><table border>
<tr>
<th>Text to Search For: </th><th><input type=text name="terms" size=40><br></th>
</tr><tr>
<th>Boolean: <select name="boolean">
<option>AND
<option>OR
</select> </th> <th>Case <select name="case">
<option>Insensitive
<option>Sensitive
</select><br></th>
</tr><tr>
<th colspan=2><input type=submit value="Search!"> <input type=reset><br></th>
</tr></table></form></center>
</body></html>
</DOC>
<DOC>
<DOCNO>WT02-B10-156</DOCNO>
<DOCOLDNO>IA093-000995-B028-258</DOCOLDNO>
<DOCHDR>
http://www.nyspi.cpmc.columbia.edu:80/sitelist.txt 156.111.80.30 19970121072015 text/html 218
HTTP/1.0 200 OK
MIME-Version: 1.0
Server: GLACI/2.01
Date: Tue Jan 21 02:24:21 1997
Content-Type: text/html
</DOCHDR>
<BODY><H1>Error 404</H1>
Unable to open the specified file<hr><ADDRESS>httpd-info@glaci.com</ADDRESS></BODY>
</DOC>
<DOC>
<DOCNO>WT02-B10-157</DOCNO>
<DOCOLDNO>IA093-000995-B028-411</DOCOLDNO>
<DOCHDR>
http://www.nyspi.cpmc.columbia.edu:80/NYSPI/PI_RSCH.HTM 156.111.80.30 19970121072201 text/html 11648
HTTP/1.0 200 OK
MIME-Version: 1.0
Server: GLACI/2.01
Date: Tue Jan 21 02:26:07 1997
Content-Type: text/html
Content-Length: 11517
</DOCHDR>
<HTML> <HEAD><TITLE>Special Activities and Awards</TITLE></HEAD>
<BODY BACKGROUND="..\IMAGES\MARBLE.JPG">

<H1 ALIGN="CENTER">
Special Activities and Awards
</H1>
<HR>
<H2 ALIGN="CENTER">
New York State Office of Mental Health<BR>
Seventh Annual Research Conference</H2>
<P ALIGN="JUSTIFY">
The lights may have gone out for several hours at the Desmond Hotel, where the Seventh Annual New York State Office of Mental Health Research Conference was taking place, but there was no blackout of information transfer! With only flashlights and candles to help them refer to their notes, presenters went right on with their talks and audiences stayed right in their seats. This was a group, stalwart and true to the service of research, who didn't disappoint Dr. John Oldham, Chief Medical Officer of the OMH, Director of Psychiatric Institute, and primary organizer of the Conference.
<P ALIGN="JUSTIFY">
The subject of violence took a large share of the spotlight at this conference, reflecting the concerns of American society today. In the first plenary session, Dr. Paul Fink, former President of the American Psychiatric Association, who heads the Albert Einstein Center for the Study of Violence, provided a sociological overview of violent behavior. He hardly needed to cite the grim statistics of the ever increasing numbers of assaultive crimes or of the huge amount of violence in what is considered entertainment. With little guidance from home, how are young people to resist the power and the glamour, false though they may be, of violent behavior as depicted by the media? He offered several strategies, ranging from gun control, environmental modifications, and demand for ethical standards in television, to a plea for every person in the audience to become an "enlightened witness," i.e., to take responsibility for just one child who may be suffering from abuse and, by so doing, validate that child's very existence.
<P ALIGN="JUSTIFY">
In a special presentation on the last day of the conference, Dr. John Mann, Psychiatric Institute's new Director of Neuroscience, citing many of the same statistics as Dr. Fink had, approached the issue of violence from a neurobiological point of view. Neurochemists from his and other laboratories have demonstrated that reduced levels of serotonergic activity are associated with aggressive and suicidal behavior. They are now exploring ways in which this information may help them in recognizing and treating high risk patients. Anatomists in his group see that lesions in the orbital prefrontal cortex seem to be involved in disinhibition and may lower the threshold for suicidal or aggressive behavior. The researchers are even looking at how cholesterol may play a role in regulating the serotonergic system.
<P ALIGN="JUSTIFY">
Even in the individual paper sessions, researchers concerned themselves with aspects of the problem of violence in society. For example, Dr. Gail Wasserman reported on the first year of her study of the younger brothers of teen-aged adjudicated delinquents, a study designed to determine what the predictors are for similar antisocial behavior in these children. Dr. Rene Hen, speaking from a basic science vantage point, described his work with gene-altered mice in which he studies the function of 5-HT1B in regulating aggressive behavior.
<P ALIGN="JUSTIFY">
The conference offers an enormous amount of information meant to enhance the knowledge and skills of mental health professionals from all over New York State. In addition to dozens of paper sessions and poster sessions, this year given by a considerable number of people from psychiatric centers in other parts of the United States as well as by researchers from throughout New York State, there were other venues for the exchange of information. There were open forums both for clinicians and researchers and for patients, families, patient advocates, and researchers. In fact, the Office of Mental Health has made a concerted effort to involve consumers of mental health services in the workings of the conference by inviting several of them to participate in the paper sessions, both as discussants and presenters.
<P ALIGN="JUSTIFY">
Still another feature of the conference which has helped to gain it national attention and importance is the broadcast via satellite television of a two-hour symposium wherein researchers describe aspects of their work and Dr. Oldham, as moderator, takes questions from listeners from as far away as Texas or as close as persons in the first row of the audience. This year, the speakers were Dr. Herbert Pardes, Dean of Columbia's medical school, Dr. Arnold Friedhof from the New York University medical school, Dr. Myrna Weissman, Psychiatric Institute's Director of Clinical Epidemiology, and Dr. Donald Klein, Director of Therapeutics at PI, who replaced Cornell's Dr. Jack Barchas, unable to come because of illness.
<P ALIGN="JUSTIFY">
All this does not convey the camaraderie and conviviality of the conference. Dr. Robert Cancro, Director of the Nathan Kline Psychiatric Institute, gave public credit to Dr. Oldham for this feeling at the Research Awards dinner the second evening. This year's honorees were Dr. Marvin Herz from the University of Rochester, Dr. Alexander Glassman from Psychiatric Institute,  and Dr. Abel Lajtha from Nathan Kline's Center for Neurochemistry.
<P ALIGN="CENTER">
<HR>
<H2 ALIGN="CENTER"><B>New York State Office of Mental Health
1994 Research Awards</B></H2>
<P ALIGN="CENTER">
<B>The Heinz E. Lehmann Research Award</B>
<P ALIGN="CENTER">
For a lifetime of outstanding research accomplishments<BR>
Marvin Herz, M.D.<BR>
University of Rochester
<P ALIGN="CENTER">
<B>The 1994 Annual Awards for Excellence in Research</B>
<P ALIGN="CENTER">
For outstanding contributions to psychiatric research<BR>
Alexander Glassman, M.D.<BR>
Psychiatric Institute
<P ALIGN="CENTER">
Abel Lajtha, M.D.<BR>
Nathan S. Kline Institute
<P ALIGN="CENTER"><B>
</B><HR>
<H2 ALIGN="CENTER">
Psychiatric Institute
Annual Scientific Conference
</H2>
<P ALIGN="JUSTIFY">
In the last decade of the 20th century, it is not in the arts that we find the most innovative or imaginative work taking place, observed Dr. Eric Kandel at Psychiatric Institute's Annual Scientific Conference at Arden House in November, but in the sciences, particularly in neurobiology. Dr. Kandel, Director of the Howard Hughes Medical Institute, was the after-dinner speaker at the conference and he once again dazzled the audience with his approach to what he called "the central unsolved issue in biology: the problem of the mind." Describing two forms of learning, the explicit and the implicit, he explained some of the brain mechanisms which transform short-term memory into long-term memory. Elegant reasoning and an imaginative leap into the future brought him to predict a "little red pill" which will enhance memory. The real revolution in the field of psychiatry, he stressed, is the merger between cognitive psychology and neuroscience which is invigorating scientists to explore cognition and emotion from the point of view of molecular biology, as exemplified by his laboratories.
<P ALIGN="JUSTIFY">
In fact, a talk given the following morning by a member of Psychiatric Institute's Center for Neurobiology and Behavior, Dr. Rene Hen, provided a glimpse of the "gene knock-out" strategy researchers are using in mice to chart specific changes in behavior that mimic human behavior. Dr. Hen's presentation followed an overview of studies from the neuroscience laboratories of Dr. John Mann. Dr. Mann and his colleagues are looking at aggression and suicide from a biological vantage point: on the one hand, they use imaging technology to localize impaired circuitry in the brain, and, on the other, they utilize chemical probes to explore such areas as the relationship of serotonin to high cholesterol.
<P ALIGN="JUSTIFY">
The Arden House Conference traditionally gives Institute researchers an opportunity to hear about the wide variety of studies being conducted by their colleagues. It opened this year with presentations covering some long-term studies. Dr. Rachel Klein, talking about anxiety and learning disorders in children, confirmed that childhood separation anxiety can result in panic disorder in adults, but learning disorders, often considered a risk factor for future psychopathology, do not necessarily result in psychiatric disorders in adults. Dr. Salvatore Mannuzza pointed out that children with Attention Deficit Disorder were more likely than controls to exhibit antisocial behavior, abuse alcohol and drugs, attain a lower level of academic success, and suffer affective disorders in adulthood. Dr. Susan Wolk, describing a longitudinal study of childhood depression, concluded that it is "recurrent and disabling over time."
<P ALIGN="JUSTIFY">
Reporting on new research, Dr. Jonathan Javitch spoke of the molecular level investigations of the binding sites of different antipsychotic drugs. Other reports of new research included a study by Dr. Sharon Schwartz which found no evidence of higher rates of disorder among the children of Holocaust survivors, and a Washington Heights study by Dr. Ann Stueve which found that stressful life events do not necessarily make depression worse unless they take place within three months before the onset of the disorder. Dr. Mitchell Nobler reported that ECT acutely decreases regional cerebral blood flow and cerebral metabolic rate, while Dr. Xavier Amador made the connection between schizophrenic patients' low insight into their illness and treatment non-compliance.
<P ALIGN="JUSTIFY">
As has been customary, the conference included a choice of six workshops during the afternoon session. And for the second year, posters provided additional information about other research projects currently underway at the Institute. The presentations with which the two-day meetings ended concerned the difficult-to-treat patient. As Dr. Zafar Sharif pointed out in the first talk on schizophrenia, the clinician must take the following steps in dealing with the refractory patient: carefully reconsider the diagnosis, ascertain whether medication dosage is adequate, assess compliance, and consider side effects. <BR>
Dr. Steven Roose, talking about depression, added a consideration of the duration of treatment and the possible augmentation of standard treatment with other strategies.
<P ALIGN="JUSTIFY">
Once again, the success of the conference was in large part due to the work of the program committee, Drs. Stanley Bone, Francine Cournos, David Kahn, Judith Rabkin, and Stephen Rayport, and to the administrative coordinator, Ms. Myra Stewart. 
<HR>
<H2 ALIGN="CENTER">
Departmental Awards
</H2>
<P ALIGN="CENTER">
<B>The Tenth <BR>
Edward J. Sachar Award</B>
<P ALIGN="CENTER">
March 18, 1994
<P ALIGN="CENTER">
Jack Barchas, M.D.
<P ALIGN="CENTER">
Professor and Chairman
<P ALIGN="CENTER">
Department of Psychiatry
<P ALIGN="CENTER">
Cornell University Medical College
<P ALIGN="CENTER">
New York, New York
<P ALIGN="CENTER">
<B>The Fourth <BR>
Emily Mumford Award</B>
<P ALIGN="CENTER">
September 23, 1994
<P ALIGN="CENTER">
Richard Surles, Ph.D.
<P ALIGN="CENTER">
Commissioner
<P ALIGN="CENTER">
New York State Office of Mental Health
<P ALIGN="CENTER">
Albany, New York

<!-- This document was created using BeyondPress(TM) 1.0-439896. -->
</BODY></HTML>
</DOC>
<DOC>
<DOCNO>WT02-B10-158</DOCNO>
<DOCOLDNO>IA093-000995-B030-17</DOCOLDNO>
<DOCHDR>
http://www.nyspi.cpmc.columbia.edu:80/NYSPI/PIDPT_E.HTM 156.111.80.30 19970121072845 text/html 11820
HTTP/1.0 200 OK
MIME-Version: 1.0
Server: GLACI/2.01
Date: Tue Jan 21 02:32:51 1997
Content-Type: text/html
Content-Length: 11689
</DOCHDR>
<HTML>
<HEAD><TITLE>Epidem of Brain</TITLE></HEAD>
<BODY BACKGROUND="..\IMAGES\MARBLE.JPG">

<H1 ALIGN="CENTER">
Epidemiology of Brain Disorders
</H1>
<P ALIGN="CENTER">
<B>Zena A. Stein, M.A., M.B., B.Ch., Chief of Psychiatric Research<BR>
Jennie Kline, Ph.D., Research Scientist VI<BR>
Maureen Durkin, Ph.D., Research Scientist V<BR>
Bruce Levin, Ph.D., Research Scientist V<BR>
Richard Neugebauer, Ph.D., Research Scientist V<BR>
Ruth Ottman, Ph.D., Research Scientist V</B>
<P ALIGN="JUSTIFY">
Research by Jennie Kline, Ph.D. on the causes of abnormal prenatal development through the study of spontaneous abortions of known karyotype and morphology has proceeded. The research has yielded a number of insights on determinants for spontaneous abortions of different karyotypes. During the past year, results for oral contraceptives were published, those for smoking are in press, and those for IUD use are in preparation.
<P ALIGN="JUSTIFY">
With funding from the National Institute on Aging (NIA), Drs. Kline, Levin, Stein, Susser, Warburton, and Ms. Kinney are examining whether age at menopause varies with prior reproductive history. The study tests hypotheses regarding the role of accelerated reproductive aging in the occurrence of spontaneous abortions of different karyotypes and the timing of menopause. The fieldwork, now ongoing, draws on 625 women who enrolled in the previous case-control of karyotyped spontaneous abortions in 1974-1986. Concurrent with this study, Dr. Kline, together with Drs. Reuss, Levin, and Timor, carried out a pilot study to assess whether the numbers of growing ovarian follicles, as visualized by ultrasound, provide an indicator of reproductive age. This study, now complete, shows the numbers of antral follicles decline with age. Drawing on this result, Dr. Kline is planning a new study to test whether ovarian age, estimated from antral follicle counts, is related to selected reproductive outcomes.
<P ALIGN="JUSTIFY">
Dr. Kline, with Dr. Ng, has also been examining data from their study "Cocaine Abuse: Effect on Pregnancy and Newborn." Drawing on a data from nearly 400 pregnant women who provided hair samples for analysis for cocaine, they have recently shown that hair testing is far more sensitive in detecting cocaine exposure in the preceding six months than either report or urine testing. Analysis of associations with intrauterine growth retardation will begin shortly. The fieldwork for a subsequent study, "Neurodevelopment of Children Exposed to Cocaine In Utero," is drawing to a close. The study sought to follow-up 568 children, born in 1985-6 to cocaine exposed and unexposed mothers. Location of the infants has proven formidable; analyses will draw on about 190 children who were located and tested for neuropsychologic function.
<P ALIGN="JUSTIFY">
Dr. Ottman is continuing her investigation of genetic contributions to seizure disorders by studying families containing &gt;3 persons with epilepsy, selected from her original database of 1,957 families of probands with epilepsy. Her research team is extending the 40 families into larger pedigrees by collecting additional information about seizure disorders in branches of the families that were not originally included in the study. The results of these investigations indicate that in a small proportion of families, the distribution of epilepsy appears consistent with an autosomal dominant genetic susceptibility. Dr. Ottman is pursuing this finding by undertaking genetic linkage analysis in these families, in order to identify and chromosomally localize genes that have a major effect on susceptibility.
<P ALIGN="JUSTIFY">
Dr. Ottman's research team is also continuing with analyses of the full dataset of 1,957 families, in order to unravel other features of the genetic epidemiology of seizure disorders. Recent studies with Dr. Nicole Schupf indicate reduced rates of reproduction in persons with epilepsy. Much of this reduction appears to be explained by reduced marriage rates, but even within marriage, live birth rates appear to be decreased after onset of epilepsy in affected women.
<P ALIGN="JUSTIFY">
Another set of studies is aimed at identifying clinically defined subgroups of epilepsy with high genetic risk. The results indicate significant heterogeneity in familial risks of epilepsy, and suggest that the influences on risk in offspring may differ from those in parents and siblings. Thus, risks were higher in relatives of probands whose epilepsy was idiopathic/cryptogenic or associated with neurodeficit than in relatives of probands with other etiologies. Among relatives of probands with symptomatic epilepsy (excluding neurodeficit), risks were not significantly higher than in general population. Parents and siblings, but not offspring, of probands with generalized onset seizures had higher risks than those of probands with partial seizures. Offspring, but not parents or siblings, of probands with onset prior to age 10 had higher risks than those of probands with later onset.
<P ALIGN="JUSTIFY">
Dr. Ottman has also recently undertaken research on the comorbidity of epilepsy and migraine headache. Her findings indicate that migraine and epilepsy are strongly associated: risk of migraine was 25% in persons with epilepsy, compared with only 12% in their relatives without epilepsy. This finding suggests that clinicians treating patients with either epilepsy or migraine should be sensitive to symptoms, and familiar with diagnostic and treatment principles of both disorders. The reasons for the association between the two disorders are unclear. The comorbidity does not appear to be explained by shared environmental risk factors, or a direct causal effect of one disorder on the other. Dr. Ottman is currently investigating the possible role of a shared genetic susceptibility to migraine and epilepsy.
<P ALIGN="JUSTIFY">
Dr. Neugebauer continued with analyses of data collected in the Miscarriage and Depression Study, with particular attention to the role of stressful events as a risk factor for chromosomally normal spontaneous abortion. He also completed analyses in a study examining the possible association between maternal and perinatal complications and suicide risk in offspring through linkage of New York City birth and death certificate data.
<P ALIGN="JUSTIFY">
Research by Dr. Neugebauer in two new areas was also commenced. He collaborated with researchers in the Department of Therapeutics' Biological Studies Unit in a series of investigations of the effect of prenatal exposure to famine and risk of psychiatric disorders in adulthood. Second, Dr. Neugebauer, together with Drs. Wasserman and Bird in the Department of Child Psychiatry, is developing a study plan to integrate an epidemiologic investigation of the psychiatric consequences of urban children's exposure to violence and a treatment program to be offered in the school setting for symptomatic children. In this regard, Dr. Neugebauer has developed a measure of children's exposure to violence, as witnesses or victims, and a measure of post traumatic stress disorder suitable for children as young as eight. The latter measure uses cartoon figures and an accompanying caption to assess relevant areas of psychopathology. These two measures are being piloted in a study based at Harlem Hospital which focuses on eight- and nine-year-olds with prenatal exposure to cocaine.
<P ALIGN="JUSTIFY">
Dr. Bruce Levin has a long-standing interest in the intersection of statistical inference for discrete data and computational methods in statistics. This interest has resulted in the development of analytic methods for a variety of problems from a unified viewpoint (that of finite and infinite dimensional linear exponential families). A product of this work is the computing program for conditional maximum likelihood analysis of polychotomous outcome data.
<P ALIGN="JUSTIFY">
Dr. Levin also devotes time to the problem of applying general empirical Bayes methods to test homogeneity hypotheses in large sparse data sets. He works with Dr. Kline on a project to elucidate maternal age associations with trisomy, to define procedures for determining onset of peri-menopausal symptoms, and to study the natural changes in o&ouml;cyte pools. Dr. Levin is co-principal investigator in the Statistics, Epidemiology, and Data Management Core of the HIV Center and, in this capacity, chairs a weekly consultation for the Center. Dr. Levin is Deputy Head of the Division of Biostatistics at the Columbia University School of Public Health. He is also Consulting Editor in Statistics for the American Journal of Public Health.
<P ALIGN="JUSTIFY">
Dr. Maureen Durkin's research included epidemiologic studies of neurodevelopmental disorders in children, epidemiology and prevention of pediatric injuries in northern Manhattan, and classification and frequency of disabilities resulting from severe injuries to children in central Harlem.
<P ALIGN="JUSTIFY">
Zena Stein, M.D. continued her research interests in studies of HIV infection, especially those relating to women and children, and in the epidemiology of mental retardation. In mental retardation, she participated in studies of the exposures to lead of women and children in Yugoslavia, led by Dr. Graziano. She also advised on a projected study of HIV infection in China, and consulted with the AIDS program at the Department of Health in Barcelona, Spain. Dr. Stein attended a meeting in Chicago as a consultant to the Robert Wood Johnson Foundation Oversight Committee on Project Begin.
<P ALIGN="JUSTIFY">
In addition to these activities, Dr. Stein continues as Co-Director of the HIV Center. Here her principal research efforts have been to study the epidemiology of perinatal HIV infection, including risks for maternal-infant transmission, factors involved in survival, and neuro- developmental effects on infected infants. With colleagues in the New York City Department of Health, she has clarified the protective role of uncomplicated Cesarean section in the transmission of HIV infection from mother to infants. In Durban, South Africa, she initiated a controlled trial of Vitamin A supplementation to HIV-infected infants; the result was fewer severe episodes of gastroenteritis in affected infants. One of her main activities is to explore preventive approaches to HIV infection in women, in particular the acceptability and effectiveness of the newly available woman's condom, and of the longer-established chemical barriers, mainly spermicides. A CDC-funded activity in Philadelphia, based on the sexually-transmitted disease clinics, will test the acceptability and the effects on recurrent infections of making a range of these options available to women.
<P ALIGN="JUSTIFY">
In 1994, Dr. Stein received the Physicians and Surgeons Distinguished Service Award from Columbia University College of Physicians and Surgeons. She was invited to give a plenary session lecture on Methods Women Can Use at the Tenth International AIDS Conference in Yokohama, Japan.
<P ALIGN="JUSTIFY">
International activities have continued to play a major role among Dr. Stein's concerns. Dr. Stein continues to be the principal investigator in the Fogarty International Center-funded International Training Grant on Epidemiology Related to AIDS. Since 1993, several fellows have joined the Columbia programs for varying durations of time, both for the purpose of formal studies, and for designing epidemiological studies of HIV/AIDS in their home countries. 
<!-- This document was created using BeyondPress(TM) 1.0-439896. -->
</BODY></HTML>
</DOC>
<DOC>
<DOCNO>WT02-B10-159</DOCNO>
<DOCOLDNO>IA093-000995-B030-258</DOCOLDNO>
<DOCHDR>
http://www.nyspi.cpmc.columbia.edu:80/NYSPI/PIDPT_T.HTM 156.111.80.30 19970121073218 text/html 19814
HTTP/1.0 200 OK
MIME-Version: 1.0
Server: GLACI/2.01
Date: Tue Jan 21 02:36:24 1997
Content-Type: text/html
Content-Length: 19683
</DOCHDR>
<HTML>
<HEAD><TITLE>Therapeutics</TITLE></HEAD>
<BODY BACKGROUND="..\IMAGES\MARBLE.JPG">

<H1 ALIGN="CENTER">
Therapeutics
</H1>
<P ALIGN="CENTER">
<B>Donald F. Klein, M.D., Director<BR>
Michael R. Liebowitz, M.D., Director, Anxiety Disorders Clinic<BR>
Abby J. Fyer, M.D., Co-Director, Anxiety Disorders Clinic<BR>
Laszlo Papp,  M.D., Director, Biological Studies Unit<BR>
Frederic M. Quitkin, M.D., Director, Depression Evaluation Service</B>
<P ALIGN="JUSTIFY">
The Department of Therapeutics is composed of four interactive divisions that have continued in their endeavors to evaluate, define and treat mood, anxiety and related disorders. As director of the department, Dr. Donald Klein provides scientific and administrative guidance on methodology, critical evaluation, and future directions of research.
<P ALIGN="JUSTIFY">
A mutual exchange of ideas and techniques among the researchers has provided for growth within each division as well as for collaborations within the department and with other departments in the Institute. Below, each clinic describes its research projects of the past year.
<H3 ALIGN="JUSTIFY">
<B>Anxiety Disorders Clinic</B>
</H3>
<P ALIGN="JUSTIFY">
The Anxiety Disorders Clinic has continued its work to advance an understanding of the diagnosis, etiology, and treatment of DSM-IV anxiety disorders. Efforts have been particularly concentrated on panic disorder and agoraphobia, social phobia, obsessive-<BR>
compulsive disorder (OCD), generalized anxiety, hypochondriasis, post-traumatic stress disorder, and new areas of research activity involving the neuropsychiatric sequelae of Lyme disease, mixed anxiety and depression, and cross-cultural studies.
<P ALIGN="JUSTIFY">
The Hispanic Anxiety Disorders Clinic, which provides services to monolingual Spanish-speaking patients, was first opened for services in August 1990 as part of the Anxiety Disorders Clinic. In September 1991, we received NIMH funding in the form of an administrative supplement to a Program Project Grant (PPG). The Hispanic Clinic has now become one of the components of the PPG, and has received funding to study the phenomena of ataques de nervios in our Hispanic population. Pilot studies of ataque de nervios completed in our clinic in this area have revealed unique findings.
<P ALIGN="JUSTIFY">
Our satellite clinic established for research and clinical activities in Staten Island continues to complement Freedom From Fear's presence in Staten Island. In July 1993, Dr. Brian Fallon added to our family of satellites by opening a clinic, in collaboration with the Family Medicine Center of the St. Joseph Medical Center, located in Stamford, Connecticut.
<P ALIGN="JUSTIFY">
A number of specific areas of study within the Anxiety Disorders CIinic have been quite active.
<P ALIGN="JUSTIFY">
<B>Panic Disorder</B>  An open trial of the 5HT3 antagonist ondansetron was completed in the earlier part of the year, under the direction of Dr. Michael Liebowitz. Results from this pilot were so favorable that a multi-center, industry supported, double-blind efficacy trial was initiated, which confirmed our findings. A full Phase-III development program is now under way in which we are participating. Ondansetron may work faster and be better tolerated than existing anti-panic medication treatments. A multi-center trial of sertraline in panic disorder has also begun in our clinic.
<P ALIGN="JUSTIFY">
Dr. Franklin Schneier is directing an NIMH-funded study of the efficacy of another serotonergic medication, fluoxetine, in the treatment of panic disorder. This study, which compares fluoxetine to placebo and a standard medication, imipramine, is now in progress. Fluoxetine has become a commonly used medication for panic disorder even though controlled data are lacking. Related studies are examining the effects of long-term treatment and discontinuation of treatment.
<P ALIGN="JUSTIFY">
We have also completed a study of acetazolamide, a carbonic anhydrase inhibitor in panic disorder. The study was designed to test the CO2 hypersensitivity model of panic disorder by chemically raising brain CO2 to see if patients accommodate over time with decreased panic attacks. Preliminary results with acetazolamide appear to be modest.
<P ALIGN="JUSTIFY">
<B>Social Phobia</B>  Dr. Franklin Schneier completed an NIMH-funded double-blind study of moclobemide in social phobia. Moclobemide is an investigational MAO-A selective reversible MAO inhibitor which can be taken without dietary restrictions and has fewer adverse effects than standard MAOIs. However, in contrast to earlier findings, moclobemide in our study did not show potent effects in social phobia. A multi-center industry supported placebo-controlled trial also found results similar to ours.
<P ALIGN="JUSTIFY">
We and other investigators have already shown that the nonselective MAOI phenelzine is effective in social phobia. We are now testing the efficacy of the selective MAO-B inhibitor L-deprenyl in social phobia. Efficacy in the MAO-B selective range would support dopaminergic involvement in social phobia.
<P ALIGN="JUSTIFY">
To follow-up on their collaboration which demonstrated the efficacy of both phenelzine and cognitive-behavioral group therapy (CBGT) in social phobia, Dr. Liebowitz and Dr. Richard Heimberg of SUNY at Albany were recently funded to study the acute efficacy of combined phenelzine and CBGT in comparison to single component treatments and placebo. In the earlier study, phenelzine had a faster rate of onset and somewhat greater acute efficacy than CBGT, while CBGT effect appeared more durable following treatment discontinuation. It is hoped that the combined treatment would maximize the benefits of both individual therapies.
<P ALIGN="JUSTIFY">
Dr. Schneier is continuing to study the effect of anxiety disorders on functioning and the impact of treatment, important clinical issues with implications for third party reimbursement. We also have pioneered the study of social phobia in subjects whose symptoms are secondary to medical disabilities such as familial intention tremor, stuttering, etc. A diagnostic classification and assessment study of secondary social phobia is now being developed. A recent study of social phobia symptoms among stutterers suggests that social phobia is a problem for a sizeable subgroup and that much of the functional impairment experienced by stutterers may be attributable to the severity of social phobia symptoms.
<P ALIGN="JUSTIFY">
<B>Post-Traumatic Stress Disorder</B>  Dr. Randall D. Marshall is currently conducting an open trial of paroxetine for post-traumatic stress disorder. He is developing a psychotherapy research program for PTSD, and is also collaborating on a feasibility study of long-term psychodynamic psychotherapy and psychoanalysis at Columbia. He is also investigating the incidence and relevance of childhood trauma in persons with anxiety disorder, a study which was made possible through a grant from the Sara Chait Foundation.
<P ALIGN="JUSTIFY">
Additionally, Dr. Marshall has received funding, in the form of a Basic Science Research Grant (BRSG) to assess the therapeutic alliance and personality in panic disorder and obsessive-compulsive disorder in patients receiving medication and psychotherapy treatments.
<P ALIGN="JUSTIFY">
<B>Obsessive-Compulsive Disorder (OCD)</B>  In collaboration with Dr. Edna Foa of the Medical College of Pennsylvania, we are nearing completion of an NIMH-supported double-blind, placebo-controlled study of clomipramine and behavioral therapy, a very important study for the field as a whole.
<P ALIGN="JUSTIFY">
Dr. Fallon and Dr. Liebowitz completed their double-blind, placebo-controlled study of intravenous clomipramine (CMI) for patients with refractory OCD. The data indicate that the administration of CMI intravenously is safe and significantly more effective than IV placebo in these oral CMI refractory OCD patients. The improvement increased during the four-week non-blind evaluation period after the last infusion. These data suggest that IV CMI is an effective treatment for oral CMI refractory patients.
<P ALIGN="JUSTIFY">
Dr. Liebowitz and colleagues in adult and child psychiatry have received funding from the Eli Lilly Company to complete an NIMH-funded comparison of fluoxetine and placebo in child and adolescent OCD.
<P ALIGN="JUSTIFY">
<B>Somatoform Disorders  </B>Dr. Fallon, Director of the Somatic Disorders Program, continues to conduct a placebo-controlled study of fluoxetine for patients with hypochondriasis. Redefined as having "Heightened Illness Concern," hypochondriacs are being recruited in New York, Staten Island, and at the St. Joseph Hospital Family Medicine Center. Dr. Fallon also received a grant to expand his somatoform studies to include a study of subthreshold somatization disorder, using hypnotic suggestion and imipramine vs. placebo. These somatoform studies are supported by grants to Dr. Fallon from the NIMH and a Psychiatric Institute Research Scientist Grant (PIRSG).
<P ALIGN="JUSTIFY">
<B>Lyme Disease  </B>Studies of the neuropsychiatric aspects of Lyme disease have continued under the direction of Dr. Fallon. In collaboration with the Department of Child Psychiatry, studies are being conducted assessing psychopathology among children with neurologic late Lyme disease. Studies of psychopathology among adults with Lyme are also in progress. In collaboration with Dr. Prohovnik and Dr. Mann of the Department of Neuroscience, studies of adults with Lyme encephalopathy are being conducted with neuropsychological assessments and brain imaging both before and after repeated antibiotic treatment. The results from these studies will have a significant impact upon the treatment of this illness. These studies are supported by grants to Dr. Fallon from the Lyme Research Foundation, the Marvel Platoff Foundation, the American Suicide Foundation, and a PIRSG.
<P ALIGN="JUSTIFY">
<B>Ataque de Nervios</B>  We have completed several studies of ataque de nervios, a label applied by Hispanics to a variety of emotional states involving loss of emotional control. We have found that in a clinical sample with anxiety and depression, ataque de nervios is often applied to what we would diagnose as panic attacks. CO2 challenge studies are planned to verify this. In addition, ataque symptoms seem to differ in patients with different psychiatric comorbidity, suggesting that ataque self-labeling may reflect features of coexisting psychiatric illness.
<P ALIGN="JUSTIFY">
<B>Staten Island Research Clinic</B>  The Staten Island Research Clinic located at Freedom From Fear in Staten Island continues to conduct research in the areas of depression, anxiety, and child psychiatric disorder. Sharon Davies, R.N. is our on-site clinic coordinator.
<P ALIGN="JUSTIFY">
<B>St. Joseph Medical Center</B>  In July 1993, Dr. Fallon established a collaboration with the Family Medicine Center of the St. Joseph Medical Center in Stamford, Connecticut. Dr. Robert Feinstein, director of the Behavioral Medicine Program there, and Dr. Joseph Connelly, director of the Family Medicine Center, consider this collaboration an opportunity to conduct state-of-the-art research on hypochondriasis and somatization in the primary care setting. Donna Vermes, R.N. is our on-site clinic coordinator.
<H3 ALIGN="JUSTIFY">
<B>Depression Evaluation Service</B>
</H3>
<P ALIGN="JUSTIFY">
The Depression Evaluation Service (DES) is a research clinic whose major goal is the identification of different subtypes of depressive disorders and of specific psychopharmacological treatment for these subtypes. We continue to study "atypical" depression, further refining the criteria. We are continuing the study comparing fluoxetine, imipramine, and placebo in atypical depressives. We anticipate that SSRIs will be as effective in this disorder as MAOIs. We have studied 120 patients and are at the halfway mark of this study.
<P ALIGN="JUSTIFY">
During 1994, the DES completed a study of alcoholics with primary depression who were randomized to either imipramine or placebo treatment. The results are being prepared for publication and show that depression in alcoholics is treatable and when it responds, it is associated with decreases in drinking behavior. We then began a follow-up study with a similar design using fluoxetine (Prozac). Twenty patients have completed the study so far and Prozac is showing evidence of good safety and tolerability. The number of patients studied is too small to draw any conclusions about benefits as yet. This study is funded by the National Institute on Alcohol Abuse and Alcoholism (NIAAA).
<P ALIGN="JUSTIFY">
A pilot study was conducted randomly assigning non-depressed alcoholics to naltrexone (Trexan) or placebo. Nineteen patients have completed this study which shows excellent benefits for the active drug. This confirms two control studies in the literature in other populations of alcoholic patients.
<P ALIGN="JUSTIFY">
A pilot study of measurement of receptors on platelet membranes in depressed patients was also begun. Preliminary data have been collected on a sample of normal control subjects as well as a sample of patients entering depression studies. The hope of this study is to confirm previous observations that platelet markers are abnormal in depressed patients and to explore whether this abnormality predicts treatment outcome. If this proves to be predictive, this would be the basis for submitting a grant application.
<P ALIGN="JUSTIFY">
In the past year, we have received NIH funding to assess the efficacy and safety of testosterone replacement therapy in HIV+ men with late stage illness. The clinical syndrome included loss of sexual desire with or without sexual dysfunction, often accompanied by low mood, low energy, low appetite, weight loss, and sometimes wasting. The study consists of 12 weeks of open treatment followed by a six-week double blind placebo controlled discontinuation trial. To date, of the first 81 men whose data have been analyzed, 85% <BR>
of study completers were clear-cut responders in terms of androgenic effect. Of the 44 study completers who had mood problems at baseline, 64% were rated as much improved. Another study, conducted in collaboration with Dr. Lange's Virology Lab at Roosevelt/<BR>
St. Luke's Hospital, is assessing the in vitro effects of testosterone cypionate on viral activity. This study is ongoing, and some pilot work is planned regarding possible extension to women with AIDS and clinical symptomatology.
<P ALIGN="JUSTIFY">
We are in the third year of a five-year study of the efficacy and safety of fluoxetine in treatment of Axis I depressive disorders in HIV+ men and women. To date, we are getting an excellent response to both active and placebo medication.
<P ALIGN="JUSTIFY">
We completed studies of the diagnosis and treatment of depressive disorders in methadone maintenance patients in collaboration with two community methadone clinics, Bridge Plaza Treatment Center (Ronald Brady, Clinic Director and Co-Investigator, and Long Island Jewish/Hillside Hospital).
<P ALIGN="JUSTIFY">
Activities of 1994 include the following accomplishments:
<P ALIGN="JUSTIFY">
* Detailed data analysis on the imipramine versus placebo trial in depressed methadone patients, completed in the previous year, shows a robust antidepressant effect on mood outcome, and more modest effects on drug use.
<P ALIGN="JUSTIFY">
* A study of the power of the locally developed SCID-Substance Abuse Comorbidity version to predict remission of depression during methadone induction was completed and data analysis is underway.
<P ALIGN="JUSTIFY">
* The NIDA awarded funding on an RO1 for four years for a placebo-controlled trial of sertraline in depressed methadone patients (Dr. Nunes, Principal Investigator).
<P ALIGN="JUSTIFY">
* The NIDA awarded funding on a Center grant for medications development (Dr. Herbert Kleber, Principal Investigator) on which Dr. Nunes is Principal Investigator of Project 3, which involves a series of pharmacotherapy clinical trials for cocaine abuse.
<H3 ALIGN="JUSTIFY">
<B>Biological Studies Unit</B>
</H3>
<P ALIGN="JUSTIFY">
The Biological Studies Unit (BSU) serves as a centralized research laboratory at Psychiatric Institute. The BSU provides well-maintained, state-of-the-art equipment and highly skilled technicians to investigators throughout the Institute and the Columbia-Presbyterian Medical Center. Since 1984, the BSU has also been part of the Mental Health Clinical Research Center (MHCRC). In addition to providing facilities, equipment, and staff to investigators funded by federal and private agencies, the BSU, as one of the arms of the MHCRC, runs its own research program with the main focus on the psychobiology of anxiety disorders.
<P ALIGN="JUSTIFY">
The BSU maintains a sophisticated pulmonary laboratory capable of recording and analyzing on-line respiratory rate, tidal volume, end-tidal carbon dioxide concentration, oxygen consumption CO2 production on a breath-by-breath basis. Monitoring of respiration in ambulatory patients is also available. Aided by several ongoing RO1 grants, a series of respiratory challenges such as CO2 inhalation, hyperventilation, and breathing against increased airway resistance have been developed and perfected over the past several years. Respiratory challenges have also been conducted under "tryptophan depletion" condition and during varying "cognitive" environment. These methodologies led to an increasingly accurate description of the prominent respiratory abnormalities seen in panic disorder patients. As one of the four sites for the largest NIMH-sponsored treatment study of panic disorder, the BSU has made it possible to monitor the respiratory status of hundreds of panic disorder patients before and after medication and psychotherapy. Preliminary results indicate significant medication but not psychotherapy effects. The respiratory laboratory has also been utilized to assess the pulmonary physiology of patients with obsessive compulsive disorder, social phobia, premenstrual dysphoric disorder, and depression. The established safety of these respiratory procedures prompted investigators to test children and adolescents with anxiety disorders as well. The inclusion of the elderly with anxiety disorders is the subject of a recently submitted RO1 grant from the BSU. <BR>
The longitudinal approach of examining the physiology of anxiety disorders through the lifespan is a major strength of this program.
<P ALIGN="JUSTIFY">
In addition to conducting studies in anxiety disorders, the BSU continues to accommodate research in depression, seasonal affective disorder, schizophrenia, HIV neuropsychiatry, drug abuse, and eating disorders. Newly proposed projects are reviewed for scientific merit and approved protocols are done. One of the greatest strengths of the BSU is that it allows investigators to conduct projects without having to invest in expensive technologies or in training new technical staff.
<P ALIGN="JUSTIFY">
In 1994, after 10 years of directing the BSU, Dr. Jack Gorman became Deputy Director of Psychiatric Institute. Dr. Laszlo Papp, formerly Assistant Director of the BSU, was promoted to Associate Professor of Clinical Psychiatry and Director. Dr. Jeremy Coplan was named Assistant Director. Drs. Papp and Coplan are both supported by Scientist Development Awards from NIMH. 
<!-- This document was created using BeyondPress(TM) 1.0-439896. -->
</BODY></HTML>
</DOC>
<DOC>
<DOCNO>WT02-B10-160</DOCNO>
<DOCOLDNO>IA093-000995-B028-360</DOCOLDNO>
<DOCHDR>
http://www.nyspi.cpmc.columbia.edu:80/NYSPI/PI_EDDP.HTM 156.111.80.30 19970121072109 text/html 11608
HTTP/1.0 200 OK
MIME-Version: 1.0
Server: GLACI/2.01
Date: Tue Jan 21 02:25:14 1997
Content-Type: text/html
Content-Length: 11477
</DOCHDR>
<HTML>
<HEAD><TITLE>Education</TITLE></HEAD>
<BODY BACKGROUND="..\IMAGES\MARBLE.JPG">

<H1 ALIGN="CENTER">
Education in Psychiatry
</H1>
<P ALIGN="CENTER"><B>
Postgraduate Education
</B>
<P ALIGN="CENTER">
<B>Ronald O. Rieder, M.D., Director, Residency Training<BR>
Lisa A. Mellman, M.D., Associate Director,  Residency Training<BR>
Jules Ranz, M.D., Director, Public Psychiatry Fellowship<BR>
James Ryan, M.D. and Stephen Hyler, M.D., Educational Research Laboratory<BR>
Mark Sorenson, M.D., Director, Columbia University Program<BR>
for Creedmoor Residency Training</B>
<HR>
<CENTER>
<H4><A HREF="http://cpmcnet.columbia.edu/dept/pi/educ-prg.html">Educational Programs at Columbia University</A></H4>
</CENTER>
<HR>
<P ALIGN="JUSTIFY">
The Department of Postgraduate Psychiatric Education directs residency training in the core program at Psychiatric Institute (PI) and Presbyterian Hospital (PH), training for affiliated residency programs at Creedmoor and Middletown, research training in clinical research, and the Fellowship in Public Psychiatry. It also directs the weekly Grand Rounds at Psychiatric Institute, and oversees the use of the audio-visual resources of the Educational Research Laboratory. Reports from the component sections of the department follow.
<H5><A HREF="PIDPEGEU.HTM"<EM>Medical Student Education</EM></A></H5>
<H3 ALIGN="JUSTIFY">
<B>Residency Training-the Core Program</B>
</H3>
<P ALIGN="JUSTIFY">
There are now 49 psychiatric residents in the adult psychiatry program. Eleven PGY I's, 14 PGY II's, 13 PGY III's, and 11 PGY IV's. Two adult psychiatry residents entered the Child Psychiatry Fellowship upon completing their PGY III year, one resident as part of the five- year Child and Adult Psychiatry Program, and the other as a Child Psychiatry Fellow. In June 1993, 14 psychiatric residents graduated from the Adult Psychiatry Program. Ten graduates remain affiliated with the department in some capacity. Their careers continue to reflect the diversity of departmental activities and of the educational program: two entered research fellowships at PI, two entered Public Psychiatry Fellowships at PI, two continued in the joint Child and Adult Psychiatry Program at PI, one entered the Consultation-Liaison Fellowship at PH, and three took clinical positions-one at PI and two at PH. Two of the above graduates also became candidates at the Center for Psychoanalytic Training and Research. Four residents left the Institute: one for a clinical/research position at Mt. Sinai Medical Center, one for a research position at the University of Medicine and Dentistry of New Jersey, one for a clinical position at the University of Louisville in Kentucky, and one for a child psychiatry fellowship at Brown University.
<P ALIGN="JUSTIFY">
Although recruitment into psychiatry has fallen, the residency continues to attract the highest quality medical students. With more than ten times the number of applicants than available positions, the department has been able to be very selective in its recruitment process. The residents who began their PGY I year in July 1994 continue to represent a cross-section of interests and achievement from research to clinical perspectives and reflect an increase in the recruitment of Asian residents. The credit for this success in attracting excellent applicants goes to the faculty, the educational program, and the exceptional reputation of the department.
<P ALIGN="JUSTIFY">
The residents who began the five-year Child and Adult Psychiatry Program in 1991 entered the child psychiatry portion as PGY IV's in July 1994. Two PGY III's, one PGY II, and two PGY I's are in this track. The participants in this combined track continue to be enthusiastic. Beginning in July 1994, a new research track was offered to four residents. This track includes a PGY I rotation at the Creedmoor Schizophrenia Research Unit, a PGY II rotation on the PI 7 clinical research unit, and devoted time for research in the PGY III and IV years. This track was highly successful in recruiting excellent residents interested in research beginning in 1994. Even more applicants applied for this track in 1994 to begin training in 1995.
<H3 ALIGN="JUSTIFY">
<B>Program in Clinical Research Training</B>
</H3>
<P ALIGN="JUSTIFY">
Four fellows completed training in clinical research in June 1994. Two have remained at Columbia, the other two at Cornell. In July, 13 fellows began or continued in programs supported by this department. The eight in the NIMH Fellowship in Affective, Anxiety, and Related Disorders were distributed as follows: one in anxiety disorders and seven in affective disorders. Five are pursuing schizophrenia research training. Even with the many positions available for research training, other excellent applicants are turned away. The department received an excellent score on its application for continued NIMH support of both the Fellowship in Affective, Anxiety, and Related Disorders and the Fellowship in Schizophrenia Research.
<H3 ALIGN="JUSTIFY">
<B>Fellowship Program in Public Psychiatry</B>
</H3>
<P ALIGN="JUSTIFY">
The Public Psychiatry Fellowship Training Program continues to attract an increasing quality of Fellows. The program is now acknowledged to be the premier fellowship of its type in the country, receiving applicants in the past few years from Massachusetts, Philadelphia, Washington, DC, Texas, Mississippi, North Carolina, and New Mexico. The 1994-95 class consists of nine fellows, including one Mead-Johnson Fellow, four chief residents, and two residents each from Psychiatric Institute and Payne Whitney. This year three Fellows are working in non-traditional community service agencies-Housing Works, the Association to Benefit Children, and Hamilton-Madison House. Two Fellows are involved in supportive residential services at St. Luke's/Roosevelt and Middletown Psychiatric Center. One Fellow is at the Washington Heights Community Service, and one is at St. Vincent's Hospital. Of special interest is a collaboration with the Bisexual, Lesbian, and Gay Fellowship at Bellevue Hospital, involving two Fellows, one as coordinator of that program.
<P ALIGN="JUSTIFY">
The most recent survey of alumni (June 1994) confirms continued success in placing and retaining graduates in key roles in the public sector. Ninety-two percent are working actively in publicly-funded services, and over 55% have management positions. As evidence of the high academic standing of our graduates, 83% hold academic appointments.
<P ALIGN="JUSTIFY">
The Public Psychiatry Fellowship is completing the final year of a three-year SAMHSA training grant paying partial support for one Fellow each year.
<P ALIGN="JUSTIFY">
Dr. Ranz, Director of the Public Psychiatry Fellowship Program, is President (1995-96) of the New York Regional Chapter of the American Association of Psychiatric Administrators.
<P ALIGN="JUSTIFY">
The most important event for the Fellowship this year was the recruitment of Dr. Sara Kellermann as a member of the Fellowship faculty. Dr. Kellermann's special perspective, gained from her experience as New York City Department of Mental Health Commissioner from 1980-90, has added greatly to the quality of seminar discussions. Other additions to the voluntary faculty include Drs. Lew Opler, Paula Panzer, and Ruth Graver. The latter two are the first graduates of the program to become members of the Fellowship faculty.
<H3 ALIGN="JUSTIFY">
<B>Creedmoor and Middletown Residency Programs</B>
</H3>
<P ALIGN="JUSTIFY">
The Columbia-Creedmoor Residency Training Program continued to expand it's programs. Currently there are 17 psychiatric residents in the program: three PGY-I's, four PGY-II's, five PGY-III's, four PGY-IV's, and one PGY-V chief resident. The Columbia portion of the curriculum provides comprehensive training in psychotherapy and psychopharmacology. There are also extensive clinical rotations at CPMC. The continued development of the Schizophrenia Research Unit Staff at Creedmoor has also benefitted the residency program. These changes have had clear effects on residents' performance and recruitment. For four years, Creedmoor has been a site for third-year Columbia medical student rotations in psychiatry. The development of the rotation is further evidence of Columbia's confidence in the level of training and clinical experience available at Creedmoor. In addition, Presbyterian Hospital has over recent years hired several Creedmoor residency graduates. Currently 20 Creedmoor staff hold Columbia faculty positions.
<P ALIGN="JUSTIFY">
The Columbia-Middletown Residency Training Program provides approximately 200 classroom hours for an average of seven Middletown Hospital residents and ancillary personnel. The curriculum is varied and utilizes the efforts of 40 different faculty members. The staff provides broad exposure to the biological and clinical sciences. The students have been dedicated, reliable, and highly complimentary about the program.
<H3 ALIGN="JUSTIFY">
<B>Educational Research Laboratory</B>
</H3>
<P ALIGN="JUSTIFY">
The Education Research Audio-Visual Lab provides ongoing recording, playback, and editing services to all educational departments in Psychiatric Institute. The Friday Departmental Grand Rounds are being videotaped and are available for viewing, or borrowing, from the PI Library.
<P ALIGN="CENTER">
<!--<B>Drs. Ze'ev Levin, Scott Masters, and Justine Kent, Chief Residents, with <BR>
Drs. Ronald Rieder, center, and Lisa Mellman, far right.</B>-->
<P ALIGN="CENTER">
Psychiatric Residents 1994-1995
<P ALIGN="JUSTIFY">
<B>&#009;PGY II&#009;PGY III&#009;PGY IV</B>
<P ALIGN="JUSTIFY">
&#009;Karen Anderson&#009;Melissa Dubroff&#009;Christopher Allegra
<P ALIGN="JUSTIFY">
&#009;Ann Dolinsky&#009;Risa Fishman&#009;Pamela Collins
<P ALIGN="JUSTIFY">
&#009;Molly Finnerty&#009;David Lowenthal&#009;Lawrence Kegeles
<P ALIGN="JUSTIFY">
 &#009;Jay Gingrich&#009;Caroline Miner&#009;Justine Kent, Chief Resident
<P ALIGN="JUSTIFY">
 &#009;Elizabeth Haase&#009;Adriana Notarfrancesco&#009;Ze'ev Levin, Chief Resident
<P ALIGN="JUSTIFY">
&#009;Stephanie LeMelle&#009;Cathy Raduns&#009;Scott Masters, Chief Resident
<P ALIGN="JUSTIFY">
 &#009;Laurel Mayer&#009;Mary Ross&#009;Katherine Michels
<P ALIGN="JUSTIFY">
&#009;Margarita Munoz&#009;Daniel Schechter&#009;Satish Reddy
<P ALIGN="JUSTIFY">
&#009;Wilfred Raby&#009;Stuart Seidman&#009;Carlos Ruiz
<P ALIGN="JUSTIFY">
&#009;Anne Skomorowsky&#009;Naomi Simon&#009;Helen Smith
<P ALIGN="JUSTIFY">
&#009;Pamela Smith&#009;Blair H. Simpson&#009;Craig Tomlinson
<P ALIGN="JUSTIFY">
&#009;Gregory Sullivan&#009;Andrew Singer&#009;Adele Tutter
<P ALIGN="JUSTIFY">
&#009;Elizabeth Tillinghast&#009;Maria Sullivan&#009;Peter Walsh
<P ALIGN="JUSTIFY">
&#009;Augusta Tilney
<P ALIGN="CENTER">
<!--<B>Drs. Herbert Pardes, Ronald Rieder, Lisa Mellman, and Ms. Dee Matthews with the <BR>
1994 graduating psychiatry residents. From left to right: Dr. Printz, Dr. Yovell, <BR>
Dr. Constantino, Dr. Schwartz - Chief Resident, Dr. Dago, Dr. Dickstein - Chief Resident, <BR>
Dr. Pine, Dr. Wasserstein, Dr. Collins, Dr. Brzustowicz, Dr. Pardes, Dr. Kieserman, <BR>
Dr. Abraham, Dr. Taylor, Ms. Matthews, Dr. Mellman, Dr. Bongiovi - Chief Resident, <BR>
and Dr. Rieder.</B>-->

<!-- This document was created using BeyondPress(TM) 1.0-439896. -->
</BODY></HTML>
</DOC>
<DOC>
<DOCNO>WT02-B10-161</DOCNO>
<DOCOLDNO>IA093-000995-B030-286</DOCOLDNO>
<DOCHDR>
http://www.nyspi.cpmc.columbia.edu:80/NYSPI/PIDPEGEU.HTM 156.111.80.30 19970121073255 text/html 6719
HTTP/1.0 200 OK
MIME-Version: 1.0
Server: GLACI/2.01
Date: Tue Jan 21 02:36:57 1997
Content-Type: text/html
Content-Length: 6589
</DOCHDR>
<HTML>
<HEAD><TITLE> Med Student Education</TITLE></HEAD>
<BODY BACKGROUND="..\IMAGES\MARBLE.JPG">

<H1 ALIGN="CENTER">
Medical Student Education
</H1>
<P ALIGN="CENTER"><B>
</B>
<P ALIGN="CENTER">
<B>Eric R. Marcus, M.D., Director, Undergraduate Psychiatric Education<BR>
Janis Cutler, M.D., Associate Director</B>
<P ALIGN="JUSTIFY">
The Department of Medical Student Education in Psychiatry at the New York State Psychiatric Institute is responsible for approximately 500 medical students in six  affiliated hospitals including New York State Psychiatric Institute and Creedmoor Psychiatric Center, Columbia-Presbyterian Medical Center, Harlem Hospital Center, and St. Luke's-Roosevelt Hospital Center. We supervise a teaching curriculum at the Columbia University College of Physicians &amp; Surgeons that extends throughout the four years of medical school on a year round basis. The department is also responsible for helping to develop the whole medical school curriculum. We also are generating research in medical education-organization, curriculum, and the developmental processes of medical students in their training. The division is administered by Dr. Eric R. Marcus, Director, Dr. Janis Cutler, Associate Director, and Ms. Edith White, Administrator. Program development and the organization of teaching and research are done by the central staff. The teaching is done by the full-time and voluntary faculty of the Department of Psychiatry. Because we are one of the largest teaching departments of psychiatry in the world, we are able to offer teaching programs of a wide range and considerable depth.
<H3 ALIGN="JUSTIFY">
<B>Undergraduate Psychiatry Curriculum</B>
</H3>
<P ALIGN="JUSTIFY">
The first-year course in psychiatry at the medical school begins with psychopathology. Although this is heuristically illogical, the research in our division has shown that medical students' identification with physicians starts very early in their training and is the major motivating factor for their learning. Therefore, clinical psychiatrists teach this course, the students see patients immediately, and the focus is on illness. The course thereby provides students with one of their first introductions to patient care and to the general principles of interviewing. This course was rated outstanding for the fourth year in a row and in the past few years has been one of the highest rated courses in the first year of medical school.
<P ALIGN="JUSTIFY">
The second-year course continues the teaching of psychopathology, adds a developmental context and, in addition, provides an introduction to different types of therapy. Students continue to see patients. Small group discussion follows every lecture. This year, the end of the course coincided with Department of Medicine courses on medical interviewing and physical examination. The students therefore received a combined psychiatric-medicine experience integrating information in techniques in the two fields. The student ratings for this course continue to be higher than ever before.
<P ALIGN="JUSTIFY">
Our third-year psychiatry clerkship, five weeks in length, remains our most intensively supervised course and is the most demanding of faculty time. Student ratings consistently place it among the highest of the clinical clerkships at the medical school. Because of changes in hospital services, this course has required continued administrative attention to keep the quality of the experience high. This year, Dr. Joel Solomon revamped third-year teaching at St. Luke's-Roosevelt and Henry McCurtis made changes at Harlem Hospital. These changes were enthusiastically received by the students and faculty. Affiliated hospital teaching sites have struggled to do their best amidst the health care funding crisis. A major part of our job this year has been to rally enthusiastic support among full-time and voluntary faculty so that teaching remains a high priority.
<P ALIGN="JUSTIFY">
Our fourth-year electives continue to provide the broadest range of experience in clinical and research psychiatry. The electives attract top Columbia students as well as students from other medical schools around the country and the world.
<P ALIGN="JUSTIFY">
The College of Physicians and Surgeons at Columbia University, having successfully won a large Robert Wood Johnson Medical Education grant, has entirely reshaped the first two years of the medical school curriculum providing a model for American medical education in the 21st century. The new curriculum involves broadening the base of medical education from the basic medical sciences to include epidemiological sciences and the human behavioral sciences. The new curriculum attempts to integrate all three sciences with clinical work beginning in the first year. The Department of Medical Student Education in Psychiatry has played a major role in providing relevant pedagogical theory, in organizing subsections of teaching, and in implementing the teaching program of this demonstration project. This new curriculum is now in its second year and has been greeted with great excitement by the faculty and students. As part of that new effort, we participated in the development of a new clerkship in family practice which started this year most successfully. In addition, a mentoring program was started to provide on-going support to students during their medical school years. 
<H3 ALIGN="JUSTIFY">
<B>Research Projects</B>
</H3>
<P ALIGN="JUSTIFY">
Research focusing on the emotional process of becoming a doctor continued with application to the curriculum of knowledge about student identification processes. We are using this research information to plan course content, sequence, and pedagogical style. Research was also begun in exploring the reasons for and against career choice in psychiatry by medical students. Research was also begun on substance abuse epidemiology among medical, dental, and nursing students.
<H3 ALIGN="JUSTIFY">
<B>Awards</B>
</H3>
<P ALIGN="JUSTIFY">
Dr. Cutler won an award as outstanding woman doctor of the year from the American Medical Women's Association branch at the College of Physicians and Surgeons. She also won the American Psychiatric Association's Roeske Certificate of Excellence in medical student education.
<P ALIGN="JUSTIFY">
Outcome measures of the education program remain high with students performing above average on national board exams, with student reviews of courses in psychiatry in the excellent to outstanding range. 
<P ALIGN="CENTER">
</BODY></HTML>


</DOC>
<DOC>
<DOCNO>WT02-B10-162</DOCNO>
<DOCOLDNO>IA093-000995-B028-341</DOCOLDNO>
<DOCHDR>
http://www.nyspi.cpmc.columbia.edu:80/NYSPI/PI_RCDP.HTM 156.111.80.30 19970121072059 text/html 2098
HTTP/1.0 200 OK
MIME-Version: 1.0
Server: GLACI/2.01
Date: Tue Jan 21 02:25:06 1997
Content-Type: text/html
Content-Length: 1968
</DOCHDR>
<HTML>
<HEAD>
<TITLE>N.Y.S.P.I. Research and Clinical Departments</TITLE>

<META NAME="GENERATOR" CONTENT="Internet Assistant for Microsoft Word 2.0z">
</HEAD>
<BODY BACKGROUND="..\IMAGES\MARBLE.JPG">

<H2>N.Y.S.P.I. Research and Clinical Departments</H2>
<HR>
<UL>
<LI><A HREF="PIDPT_AP.HTM">Analytical Psychopharmacology</A>
<LI><A HREF="PIDPT_BI.HTM">Biological Psychiatry</A>
<LI><A HREF="PIDPT_BM.HTM">Biometrics Research</A>
<LI><A HREF="PIDPT_PY.HTM">Biopsychology</A>
<LI><A HREF="PIDPT_BS.HTM">Biostatistics</A>
<LI><A HREF="PIDPT_CH.HTM">Child Psychiatry</A>
<LI><A HREF="PIDPT_SP.HTM">Clinical and Genetic Epidemiology</A>
<LI><A HREF="PIDPT_CB.HTM">Clinical Psychobiology</A>
<LI><A HREF="PIDPT_CP.HTM">Clinical Psychology</A>
<LI><A HREF="PIDPT_CL.HTM">Clinical Psychopharmacology</A>
<LI><A HREF="PIDPT_CO.HTM">Communication Sciences</A>
<LI><A HREF="PIDPT_DP.HTM">Developmental Psychobiology</A>
<LI><A HREF="PIDPT_E.HTM">Epidemiology of Brain Disorders</A>
<LI><A HREF="PIDPT_EP.HTM">Epidemiology of Mental Disorders</A>
<LI><A HREF="PIDPT_EA.HTM">Epidemiology of Substance Abuse</A>
<LI><A HREF="PIDPT_GC.HTM">General C1inical Research Service</A>
<LI><A HREF="PIDPT_GE.HTM">Geriatrics and Gerontology</A>
<LI><A HREF="PIDPT_HV.HTM">HIV Center for Clinical and Behavioral Studies</A>
<LI><A HREF="PIDPT_LI.HTM">Lithium Studies and Manic Depression</A>
<LI><A HREF="PIDPT_ME.HTM">Medical Genetics</A>
<LI><A HREF="PIDPT_NE.HTM">Neurobiology and Behavior</A>
<LI><A HREF="PIDPT_NR.HTM">Neuroscience</A>
<LI><A HREF="PIDPT_CE.HTM">Psychoanalytic Center</A>
<LI><A HREF="PIDPT_RA.HTM">Research Assessment and Training</A>
<LI><A HREF="PIDPT_SO.HTM">Social Psychiatry</A>
<LI><A HREF="PIDPT_ST.HTM">Statistical Genetics</A>
<LI><A HREF="PIDPT_DA.HTM">Substance Abuse</A>
<LI><A HREF="PIDPT_T.HTM">Therapeutics</A>
<LI><A HREF="PIDPT_WH.HTM">Washington Heights Community Service</A><B>
</B>
</UL>
</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT02-B10-163</DOCNO>
<DOCOLDNO>IA093-000995-B029-216</DOCOLDNO>
<DOCHDR>
http://www.nyspi.cpmc.columbia.edu:80/NYSPI/PIDPT_AP.HTM 156.111.80.30 19970121072643 text/html 9731
HTTP/1.0 200 OK
MIME-Version: 1.0
Server: GLACI/2.01
Date: Tue Jan 21 02:30:38 1997
Content-Type: text/html
Content-Length: 9601
</DOCHDR>
<HTML>
<HEAD><TITLE>Analytical Psych</TITLE></HEAD>
<BODY BACKGROUND="..\IMAGES\MARBLE.JPG">

<H1 ALIGN="CENTER">
Analytical Psychopharmacology
</H1>
<P ALIGN="CENTER">
<B>Thomas B. Cooper, M.A., Chief of Psychiatric Research<BR>
Amiram I. Barkai, Ph.D., Research Scientist VI<BR>
Basalingappa L. Hungund, Ph.D., Research Scientist IV<BR>
Ee-sing Lo, Ph.D., Research Scientist IV<BR>
Raymond F. Suckow, Ph.D., Research Scientist IV</B>
<P ALIGN="JUSTIFY">
The Department continues its involvement in all clinical psychopharmacological research protocols involving drug, drug metabolites, and endogenous compounds of current interest in biological psychiatric research. The laboratory is currently the core laboratory for two NIMH center grants (Drs. Klein and Mann) and one NIDA center grant <BR>
(Dr. Kleber).
<P ALIGN="JUSTIFY">
Analytical development work during the past year has involved assay of neurotransmitters and metabolites in urine, plasma, and spinal fluid in studies of aggression and stress in adolescents and adults. Neuroendocrine response studies to challenge medication e.g. fenfluramine, mCPP, methylphenidate, pindolol, etc. have been evaluated as probes into serotonergic and other neurotransmitter responsivity. Studies involve assays of drugs and metabolites, melatonin, growth hormone, cortisol, prolactin, dexamethasone, catecholamine, indolamines, platelet binding analysis of drugs have been completed. This aspect of the workload is the responsibility of Ms. Novacenko, Ms. Fein, Ms. Huttinot, and Mr. Green.
<P ALIGN="JUSTIFY">
Dr. Raymond Suckow has received a second grant-in-aid from Ciba-Geigy Corp. to begin another phase of a pharmacokinetic study of reserpine comparing two formulations at a reduced dose. The application of a highly sensitive HPLC method previously developed in this laboratory and further modified to enhance the sensitivity (femtomole) permitted the monitoring of the elimination of reserpine in human subjects for several days following <BR>
a single dose.
<P ALIGN="JUSTIFY">
Studies involving the isolation, identification, and quantitation of the major metabolite of bupropion were performed using a highly specialized semi-preparative chiral column. Both isomers were isolated and the optical rotation of each was determined. A purity <BR>
&gt;97% was achieved which will permit future in vitro and in vivo biological testing. This work was supported in part by a Psychiatric Institute Research Support Grant.
<P ALIGN="JUSTIFY">
New analytical procedures and modifications of existing methods were applied to the quantitation of risperidone and the 9-hydroxy metabolite, and paroxetine in anticipation of future clinical studies and grant applications. Other drug assays performed on a routine schedule included, but were not limited to, fluoxetine, sertraline, fluvoxamine, as well as the  tricyclic antidepressants and their respective active metabolites.
<P ALIGN="JUSTIFY">
Dr. Hungund continues his NIMH-supported research in attempting to understand the biochemical mechanisms of alcohol tolerance and dependence. We have extended these studies to examine the possibility of the existence of multiple forms of phospholipase PLA2 specific for selected phospholipids in the plasma membrane. Based on these ongoing studies, we believe this key enzyme may play an important role in adaptation mechanism to various amounts of alcohol consumption. Similarly acyltransferases responsible for the incorporation of acyl groups into lysopholipids generated by activation of PLA2s appear to be involved in repair mechanism. Our results so far indicate that both substrate specific PLA2s and acyltransferases exist in CNS membrane and that both enzymes are affected differentially in response to various doses of alcohol exposure in adult mice.
<P ALIGN="JUSTIFY">
The results of studies on the mechanism of fetal alcohol affects (FAE) are very encouraging. We have shown an aberrant ganglioside profile in the fetal brain that was exposed to alcohol in utero on GD7 and 8. We have also shown that similar alcohol exposure led to accumulation of FAEEs, nonoxidative metabolites of ethanol, in various fetal organs. FAEEs are implicated in organ injury in chronic alcoholics. It is also interesting to note that treatment of pregnant rats prior to alcohol exposure prevented/reduced both aberrant ganglioside composition and FAEE accumulation. Thus GM1 may have a therapeutic value in prevention of fetal alcohol effects.
<P ALIGN="JUSTIFY">
In a collaborative study with Dr. Patrick McGrath, a marker for chronic alcohol abuse has been developed. Preliminary studies suggest that polyunsaturated FAEEs accumulate in significant amounts in the blood of alcohol abusers. Similar accumulation of FAEEs but of saturated origin are reported to be found in the blood of acutely intoxicated human subjects. Thus, these markers may serve as an useful tool in diagnosing chronic vs. social drinkers and also in monitoring patients undergoing detoxification since no FAEEs are formed in the absence of alcohol in the system.
<P ALIGN="JUSTIFY">
Dr. Barkai has continued his studies on the effects of haloperidol on calcium binding in localized areas of the rat brain. The results indicate that pretreatment of rats with this psychoactive drug enhanced calcium binding in several limbic structures, particularly in the hippocampus. These effects appear to be due to an increase in binding affinity involving cooperativity to calcium binding.
<P ALIGN="JUSTIFY">
Dr. Barkai is currently engaged in a study of the effects of several antidepressants on the dynamics of local cerebral blood flow (rCBF) in the rat following electrically-induced cerebral activation. These studies are designed to test the hypothesis that continuous treatment with antidepressants would cause differential alterations in rCBF responses to activating stimuli. Preliminary results indicate that the magnitude of rCBF responses to a single electroshock treatment and their return to 'baseline' values, varied in different brain regions. In some regions, the rate of decay of rCBF increments was significantly slower in rats treated with antidepressants. Such a slower decay in rCBF responses represents a compensatory increase in rCBF that is present for a longer period of time in treated animals. These preliminary results provided a basis for a grant application entitled "Local Cerebral Blood Flow and Antidepressants."
<P ALIGN="JUSTIFY">
In addition, Dr. Barkai has continued the collaboration with Dr. Hungund in studies on the acylation and deacylation of neuronal membrane phospholipids. These studies are aimed at understanding mechanisms of ethanol effects on the nervous system.
<P ALIGN="JUSTIFY">
Dr. Lo has focussed upon the development of highly sensitive HPLC techniques for the assay of epinephrine, norepinephrine, and dopamine in human plasma, spinal fluid, and urine. These procedures are currently being applied to an NIMH-funded study of stress in heart transplant patients (Drs. Shapiro, Sloane, Liaison Psychiatry). Dr. Lo has also published studies on the pharmacokinetics of betamethasone using transdermal patches. This work was made possible because Dr. Lo had developed a highly sensitive polyclonal antibody to dexamethasone which cross-reacted with betamethasone. After optimizing the assay for betamethasone we were able to obtain full kinetic profiles of this compound formulation for the first time.
<P ALIGN="JUSTIFY">
Dr. Lo, in collaboration with Dr. K.S. Hui (NKI), has pursued his long standing interest in enkephalins. A NIDA-funded study has resulted in the purification of brain Arg0-Met5- enkephalin to homogeneity with further identification by RIA, ELISA, HPLC, micro- sequencing, inhibition of amino-enkephalinase and suppression of contraction of vas deferens. Results indicate that this peptide is an immediate precursor and endogenous inhibitor of met-enkephalins.
<P ALIGN="JUSTIFY">
Mr. Trivedi has developed an assay for the stereoisomers of methylphenidate in plasma. The assay has picogram/ml sensitivity and is suitable for application in studies in children (collaboration with Dr. Greenhill).
<P ALIGN="JUSTIFY">
The unit continues to collaborate with investigators within the medical school and at many academic research centers in the USA, Canada, and Israel. The development of mass spectrometric procedures for cocaine and its five major metabolites in plasma, tissue, and other body fluids has made possible a NIDA-funded collaboration with Dr. Morishima (Department of Anesthesiology) investigating the hemodynamics and behavioral response to cocaine and cocaethyl in the pregnant sheep and rat. This study includes investigation of the pharmacokinetics of maternal-fetal and fetal-maternal transport of these toxic compounds.
<P ALIGN="JUSTIFY">
Collaborative work on clozapine blood levels and therapeutic response has been most productive. Two separate studies (Dr. Potkin of the University of California at Irvine and Dr. Lieberman of Hillside  Hospital, Long Island Jewish Hospital) have demonstrated threshold blood levels above which clinical response is optimal. This has major importance in the management of clozapine treatment in this difficult treatment-refractory population. 
<P ALIGN="CENTER"><B>
<!--<B>Drs. David Strauss, left, and Edward Nu&ntilde;ez, center, with Mr. Thomas Cooper at the <BR>
Psychiatric Institute Annual Scientific Conference.</B>-->
</B>
<!-- This document was created using BeyondPress(TM) 1.0-439896. -->
</BODY></HTML>
</DOC>
<DOC>
<DOCNO>WT02-B10-164</DOCNO>
<DOCOLDNO>IA093-000995-B029-236</DOCOLDNO>
<DOCHDR>
http://www.nyspi.cpmc.columbia.edu:80/NYSPI/PIDPT_BI.HTM 156.111.80.30 19970121072654 text/html 9505
HTTP/1.0 200 OK
MIME-Version: 1.0
Server: GLACI/2.01
Date: Tue Jan 21 02:31:02 1997
Content-Type: text/html
Content-Length: 9375
</DOCHDR>
<HTML>
<HEAD><TITLE>Biological Psych</TITLE></HEAD>
<BODY BACKGROUND="..\IMAGES\MARBLE.JPG">

<H1 ALIGN="CENTER">
Biological Psychiatry
</H1>
<P ALIGN="CENTER">
<B>Harold A. Sackeim, Ph.D., Chief of Psychiatric Research<BR>
D.P. Devanand, M.D., Psychiatrist (Research) II<BR>
Mitchell S. Nobler, M.D., Psychiatrist (Research) II<BR>
Joan Prudic, M.D., Psychiatrist II<BR>
James R. Moeller, Ph.D., Research Scientist IV<BR>
Bobba J. Moody, M.S.W., Research Scientist III<BR>
Yakov Stern, Ph.D., Research Scientist IV</B>
<P ALIGN="JUSTIFY">
During 1994, the department conducted clinical and basic research in a variety of areas. This work involved clinical populations with major depressive disorder, schizophrenia, acute mania, Alzheimer's disease, Huntington's chorea, stroke, and other psychiatric and neurological populations. The department provided primary clinical services through its Memory Disorders Center, Huntington's Chorea Center, Late Life Depression Center, Electroconvulsive Therapy Service, and inpatient depression subunit. The department also provides the clinical electroencephalogram (EEG) service at the New York State Psychiatric Institute.
<P ALIGN="JUSTIFY">
Federal funding was continued from the National Institute of Mental Health (NIMH) for research on the affective and cognitive consequences of electroconvulsive therapy (Principal Investigator: Dr. Sackeim; Co-Principal Investigators: Drs. Devanand and Prudic), continuation pharmacological treatment following response to ECT (Principal Investigator: Dr. Sackeim; Co-Principal Investigator: Dr. Prudic), and the treatment of psychosis and behavioral disturbance in Alzheimer's disease (Principal Investigator: Dr. Devanand). The MERIT Award to Dr. Sackeim on the affective and cognitive consequences of ECT was renewed for another five years. The conclusion of this next funding period will represent 20 years of continuous research aimed at improving this form of treatment.
<P ALIGN="JUSTIFY">
New R01 support was received from the National Institute of Mental Health for a study of the predictors of questionable dementia (Principal Investigator: Dr. Devanand). Many older individuals report deficits in their cognitive functioning, but it is often difficult to predict the ultimate outcome in such cases. This study uses functional and structural brain imaging and neuropsychological measures to identify early signs of incipient Alzheimer's disease. This project received a supplement to add MRI measures of hippocampal atrophy as another predictor. Another new R01 from the National Institute of Mental Health concerns the pharmacological treatment of dysthymia in the elderly (Principal Investigator: Dr. Devanand). This work involves a random assignment, placebo-controlled trial, assessing the efficacy and safety of fluoxetine as treatment for chronic mild depression in late life. The study is conducted in the Late Life Depression Research Center.
<P ALIGN="JUSTIFY">
The National Institute of Aging (NIA) continued support for a large program project grant on the epidemiology of Alzheimer's disease in Northern Manhattan (Principal Investigator: Dr. Mayeux), for a study of the predictors of the course of Alzheimer's disease (Principal Investigator: Dr. Stern), and for the Alzheimer's Disease Clinical Research Center (Principal Investigator: Dr. Shelanski). NIA funding continued for a project on the neuropathology of schizophrenia, involving collaborations among the Divisions of Brain Imaging and Neuropathology and Neurotoxicology, and the Department of Biological Psychiatry (Principal Investigator: Dr. Prohovnik).
<P ALIGN="JUSTIFY">
The department is also participating in the center grant from the Memory Loss and Aging Consortium of the Charles A. Dana Foundation (Center Directors: Drs. E. Kandel and R. P. Rowland), with Drs. Mayeux and Sackeim each as principal investigators on projects within the center. New findings to emerge in this research included the first demonstration that pre-existing cognitive impairment in the context of major depression predisposes to more severe and persistent amnesia following ECT.
<P ALIGN="JUSTIFY">
Dr. Sackeim was named an Honorary Fellow of the American Psychiatric Association, the Jules Roth Scholar in Residence at the State University of New York in Purchase, and he received the Joel Elkes International Award from the American College of Neuropsychopharmacology.
<P ALIGN="JUSTIFY">
The following sections highlight the new research conducted in the Huntington's Chorea Center and the Memory Disorders Center.
<H3 ALIGN="JUSTIFY">
<B>Huntington's Disease Center</B>
</H3>
<P ALIGN="JUSTIFY">
The Huntington's Disease Center at the New York State Psychiatric Institute was opened in October 1991 to offer diagnostic, treatment, and counseling services to Huntington's disease patients and families. Services include neurological, neuropsychological, and psychiatric assessments as well as social work services.
<P ALIGN="JUSTIFY">
Since its inception, the Center has served over 100 people and their families and is actively following approximately 70 patients, making this Center one of the largest in the country. The Center is staffed by two neurologists, a psychiatric attending and resident, a nurse practitioner, and a social worker. Over the past three years training has been provided for two fellows in movement disorders, four psychiatric residents each spending six months in the Center, three genetic counseling students, and four social work graduate students.
<P ALIGN="JUSTIFY">
In 1993, Columbia University became part of the Huntington's Study Group, a group of 20 Centers throughout the United States and Canada who have created a collective database and systematic examination forms, with the goal of conducting large multi-center therapeutic interventions for Huntington's disease. Our Center has been an active participant in these efforts.
<P ALIGN="JUSTIFY">
As part of the Huntington's Study Group, we are currently participating in a phase II trial of OPC-14117, a powerful antioxidant, in a double-blind placebo-controlled, parallel design. This study is being conducted at the Irving Center for Clinical Research at Presbyterian Hospital.
<H3 ALIGN="JUSTIFY">
<B>Memory Disorders Center</B>
</H3>
<P ALIGN="JUSTIFY">
The Memory Disorders Center continues to serve its role as a diagnostic and treatment center for dementia disorders. The center evaluates approximately 200 new patients yearly and has over 200 patients on its active follow-up roster at any time. Through its role as the primary diagnostic site for the Center for Alzheimer's Disease clinical core, the center serves as a referral resource for ongoing dementia research.
<P ALIGN="JUSTIFY">
To determine whether limited educational or occupational attainment are risk factors for incident dementia, 593 non-demented individuals age 60 or older in a registry of elders at-risk for dementia in North Manhattan were identified and followed for one to four years. The risk of dementia was increased in subjects with either low education (RR=2.02; <BR>
1.33-3.06) or low lifetime occupational attainment (RR=2.25; 1.32-3.84). Risk was greatest for subjects with both low education and low lifetime occupational attainment (RR=2.87; 1.32-3.84). The findings suggested that increased educational and occupational attainment may reduce the risk of incident AD, either by decreasing the ease of clinical detection of AD, or by imparting a reserve that delays the onset of clinical manifestations.
<P ALIGN="JUSTIFY">
We have also examined age at symptom onset of AD as a predictor of rate and pattern of cognitive decline. Forty-four early (onset before age 65) and 83 late onset patients were compared. Although early and late onset subjects were comparable at baseline for overall dementia severity on the modified Mini-Mental State exam, there was significantly more rapid decline in early onset subjects after two years of follow-up. The results provided longitudinal evidence of more rapid cognitive decline in subjects with early onset Alzheimer's disease, and suggest that early onset AD may be characterized by predominant impairment of attentional skills.
<P ALIGN="JUSTIFY">
To examine whether extrapyramidal signs (EPS) or psychotic features are associated with more rapid progression of Alzheimer's disease, 236 patients with mild Alzheimer's disease were recruited in three cities and followed semiannually. Using Cox proportional hazards models which adjusted for age, sex, disease severity, and estimated duration of illness at study entry, the presence of EPS at entry was associated with higher relative risk of reaching the endpoints of moderate cognitive impairment (RR=2.35, 95% CI=1.12-4.92) or severe functional impairment (2.31, 1.37-3.90), nursing home entry (2.51, 1.32-4.76), or death (3.04, 1.31-7.05). Psychosis predicted only the functional endpoint (1.85,1.18-2.90). This study confirmed that EPS and psychosis are robust predictors of disease endpoints and rapid progression in Alzheimer's disease. 
<P ALIGN="CENTER"><B>
<!--<B>Drs. Herbert Pardes, left, and Davangere Devanand at the <BR>
Psychiatric Institute Annual Scientific Conference.</B>-->
</B>
<!-- This document was created using BeyondPress(TM) 1.0-439896. -->
</BODY></HTML>
</DOC>
<DOC>
<DOCNO>WT02-B10-165</DOCNO>
<DOCOLDNO>IA093-000995-B029-249</DOCOLDNO>
<DOCHDR>
http://www.nyspi.cpmc.columbia.edu:80/NYSPI/PIDPT_BM.HTM 156.111.80.30 19970121072703 text/html 4196
HTTP/1.0 200 OK
MIME-Version: 1.0
Server: GLACI/2.01
Date: Tue Jan 21 02:31:10 1997
Content-Type: text/html
Content-Length: 4066
</DOCHDR>
<HTML>
<HEAD><TITLE>Biometric Research</TITLE></HEAD>
<BODY BACKGROUND="..\IMAGES\MARBLE.JPG">

<H1 ALIGN="CENTER">
Biometrics Research
</H1>
<P ALIGN="CENTER">
<B>Robert L. Spitzer, M.D., Chief of Psychiatric Research<BR>
Michael B. First, M.D., Psychiatrist (Research) I<BR>
Janet B.W. Williams, D.S.W., Research Scientist V<BR>
Miriam Gibbon, M.S.W., Research Scientist IV</B>
<P ALIGN="JUSTIFY">
Drs. Spitzer and Williams continue their work with a group of primary care physicians in the refinement of PRIME-MD (Primary Care Evaluation of Mental Disorders), a new procedure for diagnosing mental disorders in the primary care setting. During the past year, over four thousand primary care physicians have been trained in administering PRIME-MD.
<P ALIGN="JUSTIFY">
Utilizing the database from the PRIME-MD 1000 Study, Drs. Spitzer and Williams and their colleagues have investigated patterns of impairment in the domains of health-related quality of life (social, role and occupational functioning, mental health, bodily pain, and general health) to determine if different mental disorders have different patterns of impairment and how these patterns compare with those associated with general medical disorders. The results indicate that the most common types of disorders (mood, anxiety, alcohol, eating, and somatoform disorders) have distinctive patterns. Furthermore, the impairment associated with these mental disorders is far greater, in general, than that associated with common types of medical disorders.
<P ALIGN="JUSTIFY">
DSM-IV, the most recent edition of the American Psychiatric Association's Diagnostic and Statistical Manual of Mental Disorders, was published in May 1994. Several members of the department played major roles in its preparation. Dr. First served as Editor of Text and Criteria for DSM-IV, Dr. Spitzer was special advisor to the DSM-IV Task Force, and Dr. Williams was Chair of the Multiaxial Work Group. Dr. First has given numerous extensive workshops on using the new DSM-IV at a number of Office of Mental Health (OMH) facilities. In addition, a five-hour videotaped presentation by Dr. First has been distributed to all OMH facilities for the purpose of staff training. Dr. First is also serving as Editor of the <BR>
DSM-IV-PC, a version of the DSM-IV for primary care clinicians.
<P ALIGN="JUSTIFY">
One of the most important products of the Biometrics Research department is the Structured Clinical Interview for DSM (SCID). The SCID is a diagnostic instrument that is widely used by researchers and clinicians in order to guide the diagnostic evaluation process. The introduction of the DSM-IV has necessitated a major revision of the SCID in order to update it for the new classification. This new version of the SCID also provides several new features to increase the instrument's usefulness. Drafts of the revised SCID were field tested at a number of research sites in order to elicit feedback. A final version of the SCID was made available at the end of the year.
<P ALIGN="JUSTIFY">
Dr. Williams has continued to collaborate in the analysis of data from the Psychosocial/Qualitative Assessment Core of the HIV Center. She and her colleagues have examined psychopathology in male and female intravenous drug users with and without HIV infection. They are currently exploring the relationship of personality pathology to the development of Axis I symptoms and disorders. Dr. Williams has also participated in the development of DSM-IV-PC as a member of the DSM-IV Primary Care Work Group. A major role of hers this year has been as Founding President of the Society for Social Work and Research, already 275 members-strong. She founded the organization to help build an infrastructure of supports and linkages for social workers who are interested in research. Dr. Williams is in charge of planning the first national social work research conference, which will be held in Washington, DC in April 1995.
<!-- This document was created using BeyondPress(TM) 1.0-439896. -->
</BODY></HTML>
</DOC>
<DOC>
<DOCNO>WT02-B10-166</DOCNO>
<DOCOLDNO>IA093-000995-B029-264</DOCOLDNO>
<DOCHDR>
http://www.nyspi.cpmc.columbia.edu:80/NYSPI/PIDPT_PY.HTM 156.111.80.30 19970121072712 text/html 10065
HTTP/1.0 200 OK
MIME-Version: 1.0
Server: GLACI/2.01
Date: Tue Jan 21 02:31:18 1997
Content-Type: text/html
Content-Length: 9935
</DOCHDR>
<HTML>
<HEAD><TITLE>Biopsychology</TITLE></HEAD>
<BODY BACKGROUND="..\IMAGES\MARBLE.JPG">

<H1 ALIGN="CENTER">
Biopsychology
</H1>
<P ALIGN="CENTER">
<B>John Gibbon, Ph.D., Chief of Psychiatric Research<BR>
W. Crawford Clark, Ph.D., Research Scientist VI<BR>
Gerard Bruder, Ph.D., Research Scientist V<BR>
Michael Terman, Ph.D., Research Scientist V<BR>
Steven Fairhurst, M.S., Research Scientist III<BR>
James Towey, Ph.D., Research Scientist II</B>
<P ALIGN="JUSTIFY">
Using behavioral, cognitive, and physiological measures, the Biopsychology department continues its central mission to investigate brain-behavior relationships in terms of underlying neural and psychological mechanisms. The department comprises four research units: Psychophysiology, Light Therapy, Timing, and Pain.
<H3 ALIGN="JUSTIFY">
<B>Psychophysiology Unit</B>
</H3>
<P ALIGN="JUSTIFY">
Drs. Bruder and Towey, who direct the Psychophysiology Unit, investigate brain wave correlates of psychiatric disorders, in keeping with the tradition of the late Dr. Samuel Sutton. In 1994, they received a new project grant from the National Institute of Mental Health (NIMH) to study brain event-related potentials (ERPs) in schizophrenic patients. In a preliminary study, they found evidence of left temporal lobe dysfunction in schizophrenia, which was particularly evident among patients with positive symptoms such as hallucinations. This research is being done in collaboration with the Schizophrenia Research Unit. Dr. Esther Rabinowicz, a postdoctoral fellow, has received a Scottish Rite Research Grant and a Gwill Newman Young Investigator Award from the National Alliance for Research on Schizophrenia and Depression (NARSAD) to do work related to this project.
<P ALIGN="JUSTIFY">
With NIMH funding, Drs. Bruder and Towey continue their study of cerebral asymmetry in affective disorders. In one collaboration with the Depression Evaluation Unit (DES) of the Department of Therapeutics, depressed patients did not show the normal right-brain advantage for pitch discrimination and also failed to show hemispheric asymmetries of the "classic P300," an important ERP measure of brain activity. Another collaboration includes DES and Harvard Medical School researchers as part of a multicenter study of Prozac, the first large-scale study of the effects of this widely used antidepressant on brain/cognitive function. Findings from this study indicate that dichotic listening and neuropsychological tests (word and design fluency) are predictive of outcome of treatment with Prozac. Preliminary findings from a collaborative study with Dr. Flemming Graae and others in the Department of Child Psychiatry suggest electrophysiological abnormalities for adolescent suicide attempters in response to slides of faces expressing emotions. In a collaboration with the Lowenstein Foundation, Drs. Bruder and Towey recently began a study of language function and hemispheric lateralization in children at risk for disruptive behavior disorders.
<P ALIGN="JUSTIFY">
Drs. Towey and Bruder also continue their NIMH-funded study of ERP correlates of cognitive function in obsessive-compulsive disorder (OCD). This project involves a collaboration with Drs. Liebowitz and Fallon of the Therapeutics department's Anxiety Disorders Clinic. Thusfar, their ERP/EEG findings have supported hypotheses of overaroused and overfocused attention in OCD, predicted subsequent response to treatment with serotonin-reuptake inhibitors, and distinguished two major subtypes in OCD based on enhanced ERP negativities, symptom severity, and neurological soft signs.
<H3 ALIGN="JUSTIFY">
<B>Light Therapy Unit</B>
</H3>
<P ALIGN="JUSTIFY">
Drs. Michael Terman and Jian-su-Terman, who direct the Light Therapy Unit, have been studying the effects of bright light exposure on alleviating winter depression (seasonal affective disorder or SAD). They are continuing with NIMH-sponsored clinical trials of their 30 min/10,000 lux treatment method in collaboration with both the DES and the Department of Analytical Psychopharmacology. In an expansion of the light treatment paradigm, they have begun evaluating potential antidepressant effects of high-density negative air ions in a placebo-controlled trial. The temporal phase of nocturnal melatonin secretion is being assessed under both of these treatments. With Steven Fairhurst, Dr. Michael Terman has developed a computer model of natural outdoor illumination transitions which he has used to drive a novel bedroom-lighting device that provides simulated dusk and dawn transitions to sleeping patients. Such treatment appears to promote clinical remissions of winter depression, along with melatonin phase shifts and elimination of hypersomnia. In related animal laboratory work, the Termans are collaborating with Dr. Ziad Boulos of the Institute of Circadian Physiology at Cambridge University, in a study of dusk and dawn twilight effects on the phase and duration of daily activity in hamsters. With Dr. Virginia Lubkin of the New York Eye and Ear Infirmary, Dr. Michael Terman is evaluating light-deprivation-related symptoms in glaucoma patients. With Dr. Douglas M. Holmes of the Hebrew Home for the Aged in Riverdale, he is assessing behavioral effects of bright-light administration to patients with Alzheimer's disease.
<P ALIGN="JUSTIFY">
The Light Therapy Unit has received international scholarly as well as media attention. Dr. Michael Terman serves as past President of the Society for Light Treatment and Biological Rhythms (SLTBR), Chair of the Joint Task Force on Light Treatment for Sleep Disorders (American Sleep Disorders Association and SLTBR), and President of the newly formed Center for Environmental Therapeutics.
<H3 ALIGN="JUSTIFY">
<B>Timing Unit</B>
</H3>
<P ALIGN="JUSTIFY">
Dr. Gibbon continues his NIMH-funded work on temporal memory and decision processes in animals. His competing continuation grant received a MERIT award in 1994. This project focuses on properties of variability in temporal memory. A postdoctoral fellow, Dani Brunner, continues her NIMH-funded study of this work in collaboration with Dr. Gibbon. Another postdoctoral fellow, Lynn Aronson, received a National Science Foundation (NSF) award to apply Dr. Gibbon's theory of temporal memory to associative learning problems, critical for higher cognitive processing. Such work studies the basic building blocks required for understanding associative and mnemonic deficits in clinical populations. In a new collaboration with Drs. Meck of the Duke University Department of Psychology, and Malapani of Inserm 289, Hospital Salpetriere, Paris, Dr. Gibbon is also studying temporal processing deficits in Parkinson's disease patients. These patients exhibit severe timing deficits when off medication. New studies on this problem are being pursued with Dr. Yaakov Stern of the Sergievsky Center with Huntington's as well as Parkinson's patients. A grant application on this work is currently pending.
<H3 ALIGN="JUSTIFY">
<B>Pain Unit</B>
</H3>
<P ALIGN="JUSTIFY">
Drs. Clark and Janal direct the Pain Unit, which continues to study the dimensions and clusters underlying pain and emotion, and memory for pain. A renewal application was submitted in November 1994 to continue funding for this project from the National Institute of Neurological Diseases and Stroke. This project has produced an instrument for the measurement of clinical pain, the COPE. Although the COPE scale is similar to the McGill Pain Questionnaire, its structure, content, and analytical power are substantially improved.
<P ALIGN="JUSTIFY">
In one study, responses to the COPE scale revealed differences among six ethnocultural and sex groups in their response to cold-pressor pain. It is being used now to study the response of healthy volunteers to laboratory pain and stress, and in the study of various patient groups: women with premenstrual syndrome (with Dr. Jean Endicott, Research Assessment and Training); patients with shingles pain (with Dr. R. Dworkin, Anesthesiology); and post-surgical patients (with Dr. R. Siegfried, Anesthesiology).
<P ALIGN="JUSTIFY">
Chinese and Russian translations of the COPE are being evaluated, with, respectively, Dr. J. Yang, Chief of Anesthesiology at the University of Hong Kong, and Academician E. M. Tsirulnikov of the Sechenov Institute in St. Petersburg, Russia. Additional funding is being sought for both projects.
<P ALIGN="JUSTIFY">
Drs. Clark and Janal continue their collaboration with Dr. Murray Glusman on his NIH-funded study of silent myocardial ischemia. This investigation of ST-segment depression of the electrocardiogram (a measure of the amount of ischemia present in the muscle) demonstrated that the asymptomatic patients are silent because they suffer a sensory deficit, and were not more stoical than symptomatic patients. Preliminary findings indicate that symptomatic patients may over-report symptoms of distress, while silent patients appear more like the normative group.
<P ALIGN="JUSTIFY">
Dr. Clark is a co-investigator with Dr. R. Dworkin of the Department of Anesthesiology on an NIMH-funded study of pain sensitivity in schizophrenia. Dr. Clark consults on pain measurement with: Dr. Karen Gil, Duke University (sickle cell anemia; funded); Dr. Mark Rus, New York Hospital-Cornell Medical Center (self-mutilating patients; funded in 1994); and Dr. Ralph Wharton, Liaison Psychiatry (spinal injury and painful dysesthesia; prior and continuing funding). Dr. Clark also collaborated with Dr. F. Kronenberg on an alternative medicine grant application which was funded in 1994.
<P ALIGN="LEFT"><B>
<!--<B>Drs. John Gibbon, left, and <BR>
Nancy Wexler, second from right, with colleagues at the Department of Psychiatry Annual Meeting.</B>-->
</B>
<!-- This document was created using BeyondPress(TM) 1.0-439896. -->
</BODY></HTML>
</DOC>
<DOC>
<DOCNO>WT02-B10-167</DOCNO>
<DOCOLDNO>IA093-000995-B029-279</DOCOLDNO>
<DOCHDR>
http://www.nyspi.cpmc.columbia.edu:80/NYSPI/PIDPT_BS.HTM 156.111.80.30 19970121072721 text/html 4384
HTTP/1.0 200 OK
MIME-Version: 1.0
Server: GLACI/2.01
Date: Tue Jan 21 02:31:27 1997
Content-Type: text/html
Content-Length: 4254
</DOCHDR>
<HTML>
<HEAD><TITLE>Biostatistics</TITLE></HEAD>
<BODY BACKGROUND="..\IMAGES\MARBLE.JPG">

<H1 ALIGN="CENTER">
Biostatistics
</H1>
<HR>
<H2 ALIGN ="CENTER"><P ALIGN="CENTER">
<A HREF=".\depts\biostat\index.htm">Biostatistics Home Page</A><HR></H2>
<P ALIGN="CENTER">
<B>Christine Waternaux, Ph.D., Director</B>
<P ALIGN="JUSTIFY">
The Division of Biostatistics was established in January, 1994. The mission of the division is to provide investigators at Psychiatric Institute with access to and training in state-of-the-art statistical techniques as needed for the optimal use of their research data. This includes developing and applying new methodology for the design and analysis of psychiatric studies, participating in major funded research, teaching statistics to researchers and post-doctoral fellows, and providing short-term consultations on data-analytic and design issues for grant submission and manuscript preparation.
<H3 ALIGN="JUSTIFY">
<B>Methodological Research</B>
</H3>
<P ALIGN="JUSTIFY">
Methodological research in the division focuses on problems of particular relevance to psychiatric studies. Areas of expertise in the division include analysis of longitudinal studies with generalized linear models and variance components models, methods for dealing with missing data, causal models, and methodology for combining information from different sources (e.g., meta-analysis). For example, Dr. Christine Waternaux, Director, is investigating methods for power computations with longitudinal repeated measures. She has also investigated and published on the use of hierarchical models for combining psychiatric data. Dr. Eva Petkova, Associate Biostatistician, is specializing in statistical models for the analysis of longitudinal studies with informative drop-out. She is developing methodologies for the analysis of clinical trials when the traditional intent-to-treat approach is not appropriate because most drop-outs switch treatments. Dr. Xinhua Liu, Associate Biostatistician, is experienced in analyzing cohort data (e.g., New York gay man cohort) which traditionally have high dropout rates and a large proportion of missing observations. Her research is addressing the problem of adequacy of different analytical techniques in the presence of missing data.
<H3 ALIGN="JUSTIFY">
<B>Collaborative and Consultative Activities</B>
</H3>
<P ALIGN="JUSTIFY">
Division staff have been very active in their collaborative and consultative efforts, thus demonstrating the great need for such services. For instance, in 1994, staff provided statistical input and participated in nineteen grant submissions. In April 1994, Dr. Christine Waternaux became the Director of the Biostatistics and Measurement Core of the NIMH-funded Clinical Research Center for the Study of Youth Depression, Anxiety, and Suicide (Principal Investigator: Dr. David Shaffer). In September 1994, Dr. Waternaux became the Director of the Statistics and Computing Core of the Clinical Research Center for the Study of Suicidal Behavior (Principal Investigator: Dr. J. John Mann). Division staff are also participating in consultations and meetings with the Statistics, Epidemiology, and Data Management Core of the HIV Center for Clinical and Behavioral Studies (Directors: Drs. Anke Erhardt and Zena Stein).
<P ALIGN="JUSTIFY">
As part of its training component, the division conducts weekly workshops in biostatistics and data management. These workshops illustrate analytic and data management issues, and explore emerging statistical methodologies in both fields. Topics covered this year have included random regression models, principles of modeling, meta-analysis, generalized estimating equations, and structural equation modeling. Division staff are also working with the Department of Postgraduate Education and with members of the NIMH Training Programs for Clinical and Research Fellows on matters concerning the statistical curriculum.
<P ALIGN="LEFT"><B>
<!--<B>Dr. Christine Waternaux presenting at the Psychiatric Institute Annual Scientific Conference, and participating in a research meeting with Mr. Mark Davies.</B>-->
</B>
<!-- This document was created using BeyondPress(TM) 1.0-439896. -->
</BODY></HTML>
</DOC>
<DOC>
<DOCNO>WT02-B10-168</DOCNO>
<DOCOLDNO>IA093-000995-B029-297</DOCOLDNO>
<DOCHDR>
http://www.nyspi.cpmc.columbia.edu:80/NYSPI/PIDPT_CH.HTM 156.111.80.30 19970121072731 text/html 13176
HTTP/1.0 200 OK
MIME-Version: 1.0
Server: GLACI/2.01
Date: Tue Jan 21 02:31:38 1997
Content-Type: text/html
Content-Length: 13045
</DOCHDR>
<HTML>
<HEAD><TITLE>Child Psych</TITLE></HEAD>
<BODY BACKGROUND="..\IMAGES\MARBLE.JPG">

<H1 ALIGN="CENTER">
Child Psychiatry
</H1>
<P ALIGN="CENTER">
<B>David Shaffer, F.R.C.P., Chief of Psychiatric Research<BR>
Hector Bird, M.D., Deputy Director<BR>
Clarice Kestenbaum, M.D., Director, Fellowship Program<BR>
Ian A. Canino, M.D., Assistant Director, Fellowship Program<BR>
Laurence Greenhill, M.D., Psychiatrist (Research) II<BR>
Jennifer Havens, M.D., Psychiatrist (Research) II<BR>
Owen Lewis, M.D., Psychiatrist (Research) II<BR>
Boris Rubenstein, M.D., Psychiatrist (Research) II<BR>
Jonathan Slater, M.D., Psychiatrist II<BR>
Agnes Whitaker, M.D., Psychiatrist (Research) II<BR>
Anke A. Ehrhardt, Ph.D., Research Scientist VI<BR>
Heino Meyer-Bahlburg, Ph.D., Research Scientist VI<BR>
Mark Davies, M.P.H., Research Scientist V<BR>
Richard Feldman, Ph.D., Research Scientist V<BR>
Madelyn Gould, Ph.D., Research Scientist V<BR>
John Piacentini, Ph.D., Research Scientist V<BR>
Suzanne Salzinger, Ph.D., Research Scientist V<BR>
Gail Wasserman, Ph.D., Research Scientist V<BR>
Laurie Miller, Ph.D., Co-Director, Barbara Jonas Center</B>
<P ALIGN="JUSTIFY">
During 1994, there were developments that will ensure the department's continuing strength during a time of change. The NIMH-supported Child Psychiatry Clinical Research Center and the Research Training Grant were successfully renewed for a further five years. Initiatives were started to obtain funding for an endowed chair in Child Psychopharmacology. Several talented research trainees obtained new Career Development Awards and other support that will extend the department's funded research activities in measurement, developmental psychopathology, and biological psychology. The Child Training and Clinical Program adapted to the changing clinical climate by providing clinics and training in shorter and more focused forms of psychotherapy. The Clinical Department further developed its programs for the increasing number of children whose families are affected by HIV infection.
<H3 ALIGN="JUSTIFY">
<B>New Research Activities</B>
</H3>
<P ALIGN="JUSTIFY">
The NIMH-supported Clinical Research Center and Research Training Program in Child Psychiatry were each renewed for a further five years.
<P ALIGN="JUSTIFY">
NIMH support was received by David Shaffer, Prudence Fisher, and Christopher Lucas to develop the Diagnostic Interview Schedule for Children for epidemiological use and as a diagnostic aid in a clinic setting. Jennifer Havens and Claude Mellins received a grant from the SAMHSA to develop a demonstration service for the mental health needs of families affected by HIV.
<P ALIGN="JUSTIFY">
NIMH Scientist Development Awards were received by Christopher Lucas, M.D., for a research program on measurement in child psychopathology and by Cheryl Slomkowski, Ph.D., to study sibling influences on antisocial behavior.
<P ALIGN="JUSTIFY">
Contracts were received from NIMH and NICHD by Christina Hoven and Hector Bird (Choices for Children in Need of Mental Health Services) and Gail Wasserman (Norming and Validating the Early-Adolescent HOME Scale).
<P ALIGN="JUSTIFY">
Awards from private foundations included an Aaron Diamond Foundation Award to Claude Mellins to study the impact of HIV on families; from the Klingenstein Third Generation Family Foundation to David Shaffer to implement suicide screening projects in local high schools; from the Carmel Hill Fund to David Shaffer and Christopher Lucas to study suicide screening at Boystown of America; and from the American Suicide Foundation to Susan Wolk to study serotonin measures in adults with childhood-onset major depression. Lawrence Greenhill, M.D. was supported by Richwood Pharmaceuticals to investigate the effects of Adderall and methylphenidate in children with ADHD.
<P ALIGN="JUSTIFY">
The Department of Child Psychiatry has several sources for funding internal grants. During the past year the following awards were made: from the Viola Bernard Endowment Fund to Richard Gaines, Ph.D.; from the American Suicide Foundation to Susan Wolk, M.D., John Piacentini, Ph.D., Daniel Pine, M.D., and David Castro-Blanco, Ph.D.; from the CRC Pilot Fund to Janet Fairbanks, M.D., Richard Gaines, Ph.D., Madelyn Gould, Ph.D., Arthur Green, M.D., Noreen Hernandez, Ph.D., Ronan VanRossem, Ph.D., Laura Whitman, M.D., Susan Wolk, M.D., and Jonathan Slater, M.D.; from the PIRSG Fund to Jorge Armenteros, M.D., Judith Feldman, Ph.D., and Arturo Sanchez-Lacay, M.D.
<P ALIGN="JUSTIFY">
The Department was supported by the Roddy D. Brickell Foundation to provide a broad program of support for research and services relating to child and adolescent suicide and by the American Suicide Foundation to fund small suicide-related research projects.
<P ALIGN="JUSTIFY">
The Department was responsible for sponsoring a joint Italian-American Research Conference at the Italian Academy of Columbia University for Child Psychiatrists from the mainland of Italy.
<H3 ALIGN="JUSTIFY">
<B>Research Findings</B>
</H3>
<P ALIGN="JUSTIFY">
Drs. Gail Wasserman, Ph.D. and Daniel Pine, M.D., in the Lowenstein Center for the Study of Disruptive Disorders, have noted significant relationships between aggressive behavior and cardiovascular function and Body Mass Index. Center scientists have also identified significant short-term predictors of persistence and desistance of aggressive behavior in young children.
<P ALIGN="JUSTIFY">
Drs. Laurie Miller and Rachel Klein, in the Jonas Center for the Prevention of Disruptive Disorders, are undertaking an intensive prevention study with an emphasis on parent training. Preliminary data from a small number of subjects show positive effects that could have implications in larger studies for prevention of antisocial behavior.
<P ALIGN="JUSTIFY">
Dr. Shaffer has developed a screen that can be used in large samples of adolescents to identify teens at risk for suicide. This research has been well received and has led to grants from the Klingenstein Third Generation Foundation to implement the strategies and techniques in a public school setting at low cost.
<P ALIGN="JUSTIFY">
Drs. Bird and Hoven have developed measures of impairment that have been tested in several large samples. These techniques differentiate purely symptomatic but well-functioning individuals from those who would be more properly classed as patients. This work is important in the field of epidemiology for the task of defining "caseness." Dr. Madelyn Gould, Ph.D., undertaking a large study of suicide clusters, has suggestive evidence that children who die in a cluster are less disturbed and commit suicide more impulsively than those who die in non-epidemic circumstances. This finding points to the importance of social psychological factors in facilitating suicide in young people.
<P ALIGN="JUSTIFY">
The Diagnostic Interview Schedule for Children, developed by David Shaffer, M.D. and his colleagues Prudence Fisher, M.S. and Christopher Lucas, M.D., is being revised under NIMH contract to achieve compatibility with DSM-IV and ICD-10. The interview has achieved broad currency and is now being translated into several languages and is being used in a large number of research projects. In a study in Boystown of America Institutions, it has been found to improve the accuracy and sensitivity of initial screening and triage leading to diagnosis based quality control at low cost.
<H3 ALIGN="JUSTIFY">
<B>Honors</B>
</H3>
<P ALIGN="JUSTIFY">
Hector Bird, M.D. was appointed to the Child and Adolescent Development Risk and Prevention Committee of the NIMH and to the Editorial Board of the Journal of Child and Family Studies.
<P ALIGN="JUSTIFY">
Anke Ehrhardt, Ph.D. received tenure of title as Professor of Medical Psychology and Psychiatry, and joined the scientific review committee of AMFAR.
<P ALIGN="JUSTIFY">
Madelyn Gould, Ph.D. was appointed to the chairmanship of the DrPH Committee of Epidemiology at the School of Public Health and was appointed statistical consultant to the Journal of the American Academy of Child and Adolescent Psychiatry.
<P ALIGN="JUSTIFY">
Jennifer Havens, M.D. was elected Chairman of the Multi-site Steering Committee of HIV-AIDS Mental Health Services Demonstration Program and was appointed to the Mayor's HIV Health and Human Services Planning Council.
<P ALIGN="JUSTIFY">
Heino Meyer-Bahlburg, Ph.D. was given the Distinguished Scientist Achievement Award from the Society for the Scientific Study of Sex.
<P ALIGN="JUSTIFY">
Daniel Pine, M.D. received first prize in the APA Residents' Research Award for the New York District.
<P ALIGN="JUSTIFY">
David Shaffer was appointed to the APA Committee on Psychiatric Diagnosis and Assessment and was appointed Chairman of the Ittleson Award Board of the APA.
<H3 ALIGN="JUSTIFY">
<B>Clinical Services</B>
</H3>
<P ALIGN="JUSTIFY">
The Pediatric Psychiatry Division at Presbyterian Hospital, under the direction of Drs. Richard Gaines, Ph.D. and Jennifer Havens, M.D., is the major provider of psychiatric services to children and adolescents in northern Manhattan. In 1994, the outpatient service at Babies and Children's Hospital, the Neurological Institute, the Family Center (child abuse intervention program), and the On-Site School Program recorded 26,421 visits, a 5% increase over 1993. Major increments occurred in the Family Center (12% increase), which provides psychiatric services to HIV-infected and/or drug-exposed children. The Special Needs Clinic, founded in 1991, has continued to draw the attention of both private foundations and government agencies. Within the last year, major awards included Ryan White I funds, a contract from SAMSHA, New York State Office of Mental Health Family Support Funds, and the Child Welfare Fund.
<H3 ALIGN="JUSTIFY">
<B>Training Programs</B>
</H3>
<P ALIGN="JUSTIFY">
The Child and Adolescent Residency Training Program under the direction of Drs. Clarice J. Kestenbaum and lan A. Canino provides training for graduate psychiatrists wishing to pursue a career in administrative, clinical, academic, research, or hospital-based child psychiatry. The program provides training in the most important and useful methods of evaluation, diagnosis, and treatment, ensures familiarity with a range of clinical problems, provides trainees with an introduction to research methods and strategies and imparts a sense of competence in clinical teaching and administration. A three-year course in General Residency Training in Child Psychiatry is under the Directorship of Dr. Owen Lewis. Medical School Education in Child Psychiatry is under the Directorship of Dr. Donna Moreau. Dr. Steven Rosenheck directs training in Family Therapy and Dr. Ken Gorfinkel directs training in Cognitive Behavior Therapy.
<P ALIGN="JUSTIFY">
The residency is divided into discrete rotations in different clinical settings including one of the three state facilities with which we are affiliated: Manhattan Children's Psychiatric Center, Rockland Children's Psychiatric Center, and Queens Children's Psychiatric Center. The program of Manhattan Children's Psychiatric Center will be closing in 1995.
<P ALIGN="JUSTIFY">
There are six to eight openings for child fellowship training each year. Two are designated for a five-year track that integrates child, adolescent, and general psychiatry training. A special track has been established to study culturally sensitive approaches for inner city minority children. An NIMH grant (Principal Investigator: Ian Canino, M.D.) helps support two minority residents.
<P ALIGN="JUSTIFY">
In 1988, the CARING at Columbia fund was established to integrate some unusual programs in our residency training. These included a program to expose residents to group dynamics and social skill development of inner city children within a creative arts program (Museo del Barrio) and workshops provided by the Poets in Public Service.
<H3 ALIGN="CENTER">
<B>1994-1995 First Year Child and Adolescent Psychiatry Residents</B>
</H3>
<P ALIGN="CENTER">
Michael Feldman, M.D.
<P ALIGN="CENTER">
Nancy Lebowitz-Naegeli, M.D.
<P ALIGN="CENTER">
Lourdes Soto-Moreno, M.D.
<P ALIGN="CENTER">
Mehmet Tosyali, M.D.
<P ALIGN="CENTER">
Helen Smith, M.D.
<P ALIGN="CENTER">
Peter Walsh, M.D.
<H3 ALIGN="CENTER">
<B>1994-1995 Second Year Child and Adolescent Psychiatry Residents</B>
</H3>
<P ALIGN="CENTER">
Eric Bartky, M.D.
<P ALIGN="CENTER">
David Battista, M.D.
<P ALIGN="CENTER">
Diana Dorfman, M.D.
<P ALIGN="CENTER">
Susie Hou, M.D.
<P ALIGN="CENTER">
Karen Kieserman, M.D.
<P ALIGN="CENTER">
Roberto Negron, M.D.
<P ALIGN="CENTER">
Daniel Pine, M.D.
<P ALIGN="CENTER">
Elizabeth Wade Baisden, M.D.
<P ALIGN="CENTER"><B>
<!--<B>Dr. David Shaffer, center, with colleagues at a Child Research Center (CRC) executive meeting.</B>-->
</B>
<!-- This document was created using BeyondPress(TM) 1.0-439896. -->
</BODY></HTML>
</DOC>
<DOC>
<DOCNO>WT02-B10-169</DOCNO>
<DOCOLDNO>IA093-000995-B029-315</DOCOLDNO>
<DOCHDR>
http://www.nyspi.cpmc.columbia.edu:80/NYSPI/PIDPT_SP.HTM 156.111.80.30 19970121072739 text/html 14303
HTTP/1.0 200 OK
MIME-Version: 1.0
Server: GLACI/2.01
Date: Tue Jan 21 02:31:46 1997
Content-Type: text/html
Content-Length: 14172
</DOCHDR>
<HTML>
<HEAD><TITLE>Clinical and Genetic</TITLE></HEAD>
<BODY BACKGROUND="..\IMAGES\MARBLE.JPG">

<H1 ALIGN="CENTER">
Clinical and Genetic Epidemiology
</H1>
<P ALIGN="CENTER">
<B>Myrna M. Weissman, Ph.D., Chief of Psychiatric Research<BR>
Susan E. Hodge, D.Sc., Research Scientist VI<BR>
Priya Wickramaratne, Ph.D., Research Scientist V<BR>
Phillip B. Adams, Ph.D., Research Scientist III<BR>
Ris&euml; B. Goldstein, Ph.D., Research Scientist III<BR>
Virginia Warner, M.P.H., Research Scientist II</B>
<P ALIGN="JUSTIFY">
The major achievements of the Department of Clinical and Genetic Epidemiology include new funding, new awards, and new research findings.
<H3 ALIGN="JUSTIFY">
<B>New Funding</B>
</H3>
<P ALIGN="JUSTIFY">
Myrna M. Weissman, Ph.D. received a grant from The Upjohn Company to test and refine a computer-driven system for diagnosing psychiatric disorders in primary care. The Genetic Epidemiology Core, part of the Center to Study Youth Depression, Anxiety, and Suicide (David Shaffer, M.D., Principal Investigator) was funded April 1994 through March 1999. The epidemiology component of the PPG Psychobiology/Genetics/Treatment of Anxiety Disorders (Donald Klein, M.D., Principal Investigator) was funded May 1994 through April 1999. Dr. Weissman has also received notification that her MERIT award to study the genetics of panic disorder will be renewed September 1995 through August 2000. Notification was also received of a grant from Bristol Myers Squibb to study access and barriers to treatment.
<P ALIGN="JUSTIFY">
Three junior members of the department also received new funding.
<P ALIGN="JUSTIFY">
Susan Wolk, M.D. received a two-year grant from the American Suicide Foundation to measure serotonin in adults with childhood onset Major Depressive Disorder (MDD), and a Psychiatric Institute Research Scientist (PIRSG) pilot grant to study the continuity between childhood and adult depression, using biological measures.
<P ALIGN="JUSTIFY">
Ris&euml; Goldstein, Ph.D. received notification approving a two-year Aaron Diamond Fellowship beginning July 1995 to study predictors of substance abuse and barriers to treatment utilization in depressed children grown up.
<P ALIGN="JUSTIFY">
Veronica Vieland, Ph.D. received a two-year National Institutes of Health (NIH) Shannon Award to study sampling models and methods for complex genetic diseases. This grant has been funded by NIMH as a basic research grant for the period 1995-2000.
<H3 ALIGN="JUSTIFY">
<B>Awards and Honors</B>
</H3>
<P ALIGN="JUSTIFY">
Dr. Weissman received the National Alliance for Research on Schizophrenia and Depression (NARSAD) Selo Prize for her research. With the late Dr. Gerald L. Klerman, she received the National Academy of Sciences, Institute of Medicine's Rhoda and Bernard Sarnat International Prize for research in mental health. And she was elected President of the American Suicide Foundation.
<H3 ALIGN="JUSTIFY">
<B>New Research Findings in Family and Genetic Studies</B>
</H3>
<P ALIGN="JUSTIFY">
<B>Genetic Studies of Panic Disorder</B>  Working with Conrad Gilliam, Ph.D., and James Knowles, M.D., Ph.D., the department has tested 23 families (367 individuals) with panic disorder for linkage to 587 genetic markers in order to positionally identify genetic factors involved in panic disorder (Vieland et al., 1994). This work includes a systematic genomic screen using a set of CA repeat markers with average spacing of 13 centimorgans (cM) on a subset of the 13 most informative pedigrees. Essentially, all the markers have been run and the data is now being analyzed. The department has also been collecting "triads" (father, mother, and proband) to perform genetic association studies of panic disorder with candidate disease genes. Currently, 32 independence triads have been collected and <BR>
an increase to 50 triads is expected in the first quarter of 1995. Using 17 triads, the <BR>
GABA-*-1 and GABA-*-3 genes have been tested for linkage disequilibrium to panic disorder. Both were not in disequilibrium to panic disorder.
<P ALIGN="JUSTIFY">
<B>Development of Data Management Methods</B>  Dr. Adams has continued to modify his family genetics tracking programs by adding the capability to manage best-estimate diagnoses across studies in order to accommodate unlimited lanes of data in addition to multiple families within a single gel/blot, to accept studies which include repeated measures. Security routines have been added, output modes now include SAS, BMDP, and SSPC formats, and the program will read from scanned data files. These programs are being adapted for use by investigators at the Medical College of Virginia, the University of Iowa, Trinity College (Dublin), Johns Hopkins University, the University of Alabama, Harvard University and the NIMH.
<P ALIGN="JUSTIFY">
<B>Mathematical Genetics</B>  Concerns about whether ascertainment correction is even required for large pedigrees, about whether and how multiple probands in the same pedigree can be taken into account properly, and about how to apply sequential sampling strategies have occupied many investigators in recent years. Susan Hodge, D.Sc., and Veronica Vieland, Ph.D. showed that the common practice of conditioning on the observed pedigree structure, when data have been sequentially obtained, is in general not correct, except when ascertainment is "single." Moreover, in a major step forward for genetic epidemiology, they proved that the problem is literally intractable (again, except for single ascertainment).
<P ALIGN="JUSTIFY">
<B>The Genetic Phenomenon of "Anticipation"</B>  This study examines how one tests for anticipation, defined as an inheritance pattern wherein a disease is progressively more severe, or is more frequent, or occurs at earlier ages, in successive generations of affected individuals. Recently, anticipation has become a "hot topic" in psychiatric genetics, with several studies purporting to demonstrate its existence for schizophrenia, bipolar affective disorder, etc. If true anticipation does exist, this would be an important finding, which would point the way to a true gene for the disease, a gene most likely involving trinucleotide repeats (TNR's). However, there are serious statistical problems involved in the search for anticipation, and most published studies have not taken these problems sufficiently into account. Our study demonstrates some of these problems and ends on a note of caution for researchers.
<P ALIGN="JUSTIFY">
<B>Association Analysis</B>  This is another "hot topic" in psychiatric genetics. Everyone is doing association studies, but many researchers are misinterpreting their findings. Dr. Hodge wrote an editorial summarizing recent mathematical modelling findings concerning association analysis. Her summary was expressed in less technical language in order to be more accessible to psychiatric researchers.
<P ALIGN="JUSTIFY">
<B>Genetic Analysis Workshop</B>  The Genetic Analysis Workshops are held every two years and represent an opportunity for genetic epidemiologists from all over the world to come together and work on two or three problems that have been set ahead of time. <BR>
Dr. Hodge was primarily responsible for developing and formulating these problems for the 1994 workshop.
<P ALIGN="JUSTIFY">
<B>High Risk Studies and Longitudinal Studies</B>  An in-progress 15-year follow-up study of depressed, anxious, and normal children grown up has suggested the continuity between childhood and adult depression, with extremely high rates of suicide (4.4%) and suicide attempts (35%) in depressed children grown up. In addition to collection of longitudinal diagnostic information, biological studies are being conducted by Susan Wolk, M.D., and Jeremy Coplan, M.D., repeating and augmenting biological studies done during the initial treatment and study of these adolescents between 1978 and 1984. Preliminary findings suggest that non-suicidal MDD subjects may demonstrate nocturnal GH hypersecretion during adolescence as seen in prepubertal subjects with MDD. In contrast to the original reports, current studies indicate that adolescents with MDD and suicidal behavior at time of testing fail to show the increased GH secretion evident in their non-suicidal MDD counterparts irrespective of subsequent suicidal behavior.
<P ALIGN="JUSTIFY">
Electroencephalogram (EEG) studies in children and adolescents have not found any consistent pattern of sleep changes associated with major depression. Goetz et.al. found no differences in REM sleep between the adolescent depressives and normal controls. Longitudinal follow-up has revealed that suicidality is an important variable in the sleep measures in both the prepubertal and adolescent cohort. Data indicates that the depressed children who were suicidal at the time of the original testing demonstrate significantly increased REM density during their first REM period compared to depressed children who were not suicidal at the time of the testing and to normal control children. No differences in REM latency were identified between the depressed and normal adolescents.
<P ALIGN="JUSTIFY">
<B>Offspring of Depressed Parents</B>  A 10-year follow-up study of children at high risk for depression showed a high rate of recurrent depression and low prevalence of treatment even though these families come from clinics in which they or their parents received intensive treatment for their depression. Women had higher rates of untreated psychopathology than men, which goes against the help-seeking patterns normally observed. Further analysis is being done by Virginia Warner, M.P.H., Priya Wickramaratne, Ph.D., and Mark Olfson, M.D., to determine factors presenting barriers to treatment-seeking by these women.
<P ALIGN="JUSTIFY">
Also, data show that offspring of depressed parents showed higher rates of MDD and anxiety disorders compared to children of non-depressed parents. Offspring of depressed parents also showed significantly higher rates of alcohol dependency, a trend towards higher rates of any anxiety disorder, and higher rates of drug dependency. There appears to be an increasing linear trend in rates of offspring MDD with increasing number of episodes of MDD in parents.
<P ALIGN="JUSTIFY">
Using data from this study, Richard Rende, Ph.D. provided the first data on sibling resemblance for psychiatric disorders in offspring at high and low risk for depression. Sibling resemblance for depression was of a similar magnitude in both the high and low risk cohorts. However, striking differences were found for anxiety disorders, as sibling aggregation was much more noticeable in the high risk cohort. This finding suggests the genetic contribution to affective disorders may become manifest through early-emerging anxiety disorders.
<P ALIGN="JUSTIFY">
<B>Offspring of Opiate Addicts</B>  In a study of offspring of opiate addicts, recruitment and psychiatric assessment of an ethnically diverse sample of 156 methadone-maintained opiate addicts from local area methadone clinics and 200 of their offspring has been completed. Neurological examinations conducted by Abba Cargan, M.D. in the Department of Pediatric Neurology have been performed on 102 of the offspring. Preliminary findings include high rates of psychiatric treatment, psychiatric disorders, and substance use in the offspring. Further, neurological soft signs in the offspring, particularly slowness in executing motor tasks, are associated both with lifetime histories of disruptive behavior disorders and with deficits in intellectual functioning.
<H3 ALIGN="JUSTIFY">
<B>New Research Findings in Epidemiology</B>
</H3>
<P ALIGN="JUSTIFY">
<B>Cross National Epidemiology</B>  A major study on the cross national epidemiology of obsessive compulsive disorder (OCD) has been published, presenting data on the prevalence rates, age of onset, symptom profiles, and comorbidity of OCD. The study uses <BR>
DSM-III from community surveys in the US, Canada, Puerto Rico, Germany, Taiwan, Korea, and New Zealand. There is remarkable consistency in these countries where the annual rate for OCD ranges from 1.1/100 in Korea and New Zealand to 1.8/100 in Puerto Rico. The only exception is Taiwan (.4/100) which has the lowest rate of all psychiatric disorders. There is also consistency in the age of onset, comorbidity with major depression, and other anxiety disorders. There is variability among countries in the predominance of obsessions or compulsions. These findings suggest the robustness of OCD as a disorder in quite diverse parts of the world.
<P ALIGN="JUSTIFY">
Also published were data on the lifetime prevalence/100 and age at onset of major depression and bipolar disorder from the US, Canada, Puerto Rico, France, Germany, Italy, Lebanon, Taiwan, Korea, and New Zealand. The symptom profiles, comorbidity, secular trends, and marital status as a risk factor are also presented cross nationally. The lifetime rates for major depression vary widely across countries. The age at onset in early adulthood shows less variation. There was a preponderance of females in the rates of major depression across all countries. In contrast, the rates of bipolar disorder are more consistent across countries, and the sex ratios are nearly equal.
<H3 ALIGN="JUSTIFY">
<B>Clinical Studies</B>
</H3>
<P ALIGN="JUSTIFY">
Laura Mufson, Ph.D. is conducting a randomized controlled clinical trial of Interpersonal Psychotherapy for Depressed Adolescents (IPT-A) compared with clinical management type of treatment. Dr. Mufson adapted the original IPT manual for use with depressed adolescents; it was published by Guildford Press as a book titled Interpersonal Psychotherapy for Depressed Adolescents. Further plans include development of a Maintenance IPT-A treatment to administer to adolescents who have recovered during the three-month treatment in an attempt to prevent recurrence of depressive episodes. 
<P ALIGN="CENTER"><B>
<!--<B>Dr. Myrna Weissman</B>-->
</B>
<!-- This document was created using BeyondPress(TM) 1.0-439896. -->
</BODY></HTML>
</DOC>
<DOC>
<DOCNO>WT02-B10-170</DOCNO>
<DOCOLDNO>IA093-000995-B029-327</DOCOLDNO>
<DOCHDR>
http://www.nyspi.cpmc.columbia.edu:80/NYSPI/PIDPT_CB.HTM 156.111.80.30 19970121072750 text/html 6360
HTTP/1.0 200 OK
MIME-Version: 1.0
Server: GLACI/2.01
Date: Tue Jan 21 02:31:58 1997
Content-Type: text/html
Content-Length: 6230
</DOCHDR>
<HTML>
<HEAD><TITLE>Clinical Psychobio</TITLE></HEAD>
<BODY BACKGROUND="..\IMAGES\MARBLE.JPG">

<H1 ALIGN="CENTER">
Clinical Psychobiology
</H1>
<P ALIGN="CENTER">
<B>Jack M. Gorman, M.D., Director<BR>
Dolores Malaspina, M.D., Associate Director<BR>
Laszlo A. Papp, M.D., Research Associate<BR>
Charles A. Kaufmann, M.D., Psychiatrist (Research) II<BR>
Jeremy Coplan, M.D., Research Scientist V</B>
<P ALIGN="JUSTIFY">
The Department of Clinical Psychobiology, directed by Dr. Jack Gorman, consists of three separate components: schizophrenia research, anxiety disorders research, and depression research.
<H3 ALIGN="JUSTIFY">
<B>Schizophrenia Research</B>
</H3>
<P ALIGN="JUSTIFY">
A major focus of the Department of Clinical Psychobiology continues to be schizophrenia research. These efforts received important support with the funding of the Developing Clinical Research Center for the Study of Schizophrenia in August, 1994. This five-year grant is directed at elucidating the genetic and environmental determinants of schizophrenia. The study integrates research conducted on 38 inpatient research beds at Psychiatric Institute lead by Dr. Scott Clark, and at Creedmoor Psychiatric Center lead by Dr. Zafar Sharif.
<P ALIGN="JUSTIFY">
Studies currently underway with the Center's various cores include:
<P ALIGN="JUSTIFY">
<B>Diagnosis &amp; Assessment Core</B>  (Dr. Xavier Amador and colleagues)-Evaluation psychopathology and psychophysiology in inpatients and their first degree relatives; assessment of awareness of illness; assessment of affective deficits in patients.
<P ALIGN="JUSTIFY">
<B>Genetics Core</B>  (Drs. Charles Kaufmann, Dolores Malaspina, Jill Harkavy Friedman, and colleagues)-Clarification of the relative roles of gene and environment on putative biological markers for schizophrenia; reduction of etiologic heterogeneity through the identification of phenotypic characteristics of highly familial schizophrenia; recruitment of parent/affected offspring "triads" for linkage disequilibrium studies.
<P ALIGN="JUSTIFY">
<B>Epidemiology Core</B>  (Drs. Ezra Susser, Alan Brown, and colleagues)-Development of unique birth cohorts (located in California, Maryland, Massachusetts, Pennsylvania, Rhode Island, and the Netherlands) in which both genetic and epigenetic risk factors may be specified and their relative contributions to schizophrenia outcomes may be evaluated.
<P ALIGN="JUSTIFY">
<B>Neuroimmunology/Neuropathology Core</B>  (Drs. Norman Latov, Saud Sadiq, David Strauss, Andrew Dwork, and colleagues)-Replication of the finding of elevations in antibodies against the human heat shock protein in schizophrenia; evaluation of the specificity of this finding; mapping of the antigenic epitopes mediating the immune response recognizing of their similarity to proteins of known pathogens; identification of alterations in a neuronal protein, MAP2, in post-mortem subiculum.
<P ALIGN="JUSTIFY">
<B>Neuroimaging/Neurobiology Core</B>  (Drs. Dolores Malaspina, Ronald van Heertum, and colleagues)-Examining the role of dopamine D4 receptor alterations via SPECT, as well as examining the relationship between structural and functional hippocampal changes via MRI/MRS. These nascent neuroimaging efforts have been further strengthened by a major grant from the Mathers Foundation.
<H3 ALIGN="JUSTIFY">
<B>Anxiety Disorder Research</B>
</H3>
<P ALIGN="JUSTIFY">
Dr. Laszlo A. Papp is in charge of this group of studies which are based at Psychiatric Institute in the Biological Studies Unit and at the Phobia, Anxiety, and Stress Disorders Clinic at Hillside Hospital. Drs. Papp and Gorman continue to focus on the role of respiratory abnormalities in anxiety disorders. Aided by several RO1 grants, among them the largest NIMH-sponsored treatment study of panic disorder, they have evaluated the respiratory status of hundreds of panic patients before and after medication treatment and psychotherapy. In two independent samples, they have found significant medication-but not psychotherapy-also altered respiratory sensitivity. Respiratory challenges have also been conducted under "tryptophan depletion" condition and during "varying cognitive" environments. In collaboration with Drs. Pine, Schaffer, and Wasserman, the respiratory challenge strategy has been extended to include children with anxiety disorders. Drs. Papp and Ethan Gorenstein have begun to develop a new area of research-the assessment and treatment of patients with late-life disorders.
<P ALIGN="JUSTIFY">
Dr. Jeremy Coplan continues his work with Dr. Leonard Rosenblum in non-human primates, studying the neurobiological effects of separation, and developing animal models for human anxiety. Dr. Coplan is also involved with the Department of Child Psychiatry in a series of biological challenges in children, including a collaboration with Dr. Janet Fairbanks to study young children at risk for behavioral inhibition.
<P ALIGN="JUSTIFY">
Dr. Mindy Fullilove continues her promising work with patients with Post-Traumatic Stress Disorder, developing intervention strategies for use with inner city women with PTSD. Dr. Fullilove was appointed to the National Task Force on AIDS Development, to the editorial board of the American Journal of Psychiatry, and to the editorial board of Current Issues <BR>
in Public Health.
<P ALIGN="JUSTIFY">
Drs. Jack Gorman, Richard Sloan, and Peter Shapiro continue their work with cardiac transplant patients. They study the effect of psychological stress on the heart, focusing on heart rate variability as a biological risk factor for myocardial infarction.
<H3 ALIGN="JUSTIFY">
<B>Depression Studies</B>
</H3>
<P ALIGN="JUSTIFY">
Dr. Julie Hatterer continues to study "CSF Transthyretin in Refractory Depression." Together with Dr. Steven Roose and Dr. Joseph Herbert of New York University, we are pursuing this work along with other studies of thyroid hormone effects in depressed patients. 
<P ALIGN="CENTER"><B>
<!--<B>Dr. Jack Gorman participating in a workshop at the <BR>
Psychiatric Institute Annual Scientific Conference.</B>-->
</B>
<!-- This document was created using BeyondPress(TM) 1.0-439896. -->
</BODY></HTML>
</DOC>
<DOC>
<DOCNO>WT02-B10-171</DOCNO>
<DOCOLDNO>IA093-000995-B029-339</DOCOLDNO>
<DOCHDR>
http://www.nyspi.cpmc.columbia.edu:80/NYSPI/PIDPT_CP.HTM 156.111.80.30 19970121072758 text/html 5336
HTTP/1.0 200 OK
MIME-Version: 1.0
Server: GLACI/2.01
Date: Tue Jan 21 02:32:05 1997
Content-Type: text/html
Content-Length: 5206
</DOCHDR>
<HTML>
<HEAD><TITLE>Clinical Psych</TITLE></HEAD>
<BODY BACKGROUND="..\IMAGES\MARBLE.JPG">

<H1 ALIGN="CENTER">
Clinical Psychology
</H1>
<P ALIGN="CENTER">
<B>Rachel Gittelman Klein, Ph.D., Director<BR>
Salvatore Mannuzza, Ph.D., Research Scientist V<BR>
Susan Bram, Ph.D., Research Scientist IV</B>
<P ALIGN="JUSTIFY">
The Clinical Psychology department has remained active in several areas of research. A major focus is the investigation of optimal treatments for childhood and adolescent psychiatric disorders.
<H3 ALIGN="JUSTIFY">
<B>Major Depressive Disorders in Adolescents</B>
</H3>
<P ALIGN="JUSTIFY">
In 1994, we initiated a placebo-controlled investigation of the efficacy of standard antidepressants in adolescents with Major Depressive Disorder. Adolescent depression has been shown to be related to the adult form of the disorder in many ways: it predicts the occurrence of depression in adulthood, and it is associated with a family history of depression in adult relatives. Yet, several small studies have failed to document that its response to treatment follows the pattern observed in adult Major Depression. To remedy the limitations of small-sample studies, a group of researchers from several university centers have launched a large scale study of a tricyclic drug, imipramine, and a serotonergic agent, paroxetine. The study will provide the first powerful test of antidepressant efficacy in depressed adolescents.
<H3 ALIGN="JUSTIFY">
<B>Conduct Disorders in Children and Adolescents</B>
</H3>
<P ALIGN="JUSTIFY">
In 1993, we completed a treatment study of children and adolescents with conduct disorders, comparing lithium and methylphenidate to a placebo. We found a striking positive outcome in methylphenidate-treated children. However, significant family and social problems continued in many cases. In 1994, we developed a comprehensive treatment program to address the diverse serious problems experienced by young people with conduct disorders. An ambitious one-year-long treatment package was developed. It includes family interventions, teaching of parental management, and medication. It is currently being put to the test in a controlled design. This multi-treatment approach to one of the most challenging problems in child mental health is the first of its kind.
<P ALIGN="JUSTIFY">
In tandem with efforts to reverse conduct disorders, we have designed a program, headed by Laurie Miller, Ph.D., that attempts to prevent the development of conduct disorders. Toddlers, at high risk for the development of antisocial behavior, participate with their caretakers in a two-year program that optimizes conditions in the home. The program is designed to minimize the development of the early onset of child behavior problems which are known to be strongly predictive of later antisocial behavior. This work has continued during 1993, under the sponsorship of Barbara Jonas and the Lowenstein Foundation.
<H3 ALIGN="JUSTIFY">
<B>Risks for Mental Disturbance in Offspring of Adults with Mental Disorders</B>
</H3>
<P ALIGN="JUSTIFY">
Our interest in identifying risks for mental disturbance that may occur in young children due to mental disorders in their parents has led us to initiate a study of the offspring of adults who had Attention Deficit Hyperactivity Disorder (ADHD) in their own childhood. This study, initiated in 1994, will contribute to our knowledge of the inter-generational transmission of a very common and disabling childhood disorder. It will also potentially provide the basis for refined genetic studies, as well as prevention studies, by enabling the identification of characteristics in young children that are related to a parental history of ADHD.
<P ALIGN="JUSTIFY">
We are examining as well, the children of adults with anxiety disorders in order to provide understanding of the risks conferred to children from a variety of parental psychopathology. The diversity of our high-risk research will generate important information about the specificity of possible disadvantages associated with different mental disorders in families.
<H3 ALIGN="JUSTIFY">
<B>Collaborative Research Activities</B>
</H3>
<P ALIGN="JUSTIFY">
The department has a close collaboration with the Department of Child Psychiatry through joint research activities in the Child Psychiatry Clinical Research Center (CPCRC), which is dedicated to the study of depression, anxiety, and suicidality in children and adolescents. The department directs the Clinical Core of the CPCRC, through which established investigators and research fellows conduct studies that span the neuropsychology of adolescent major depression, the psychobiology of child and adolescent anxiety disorders, early temperamental characteristics in offspring of adults with panic disorder, interpersonal psychotherapy of adolescent major depression, the psychopathology and treatment of selective mutism, and the neurobiology of adolescent suicidality.
<P ALIGN="CENTER"><B>
<!--<B>Drs. Pardes, center, and Quitman, third from left, with graduating Psychology interns.</B>-->
</B>
<!-- This document was created using BeyondPress(TM) 1.0-439896. -->
</BODY></HTML>
</DOC>
<DOC>
<DOCNO>WT02-B10-172</DOCNO>
<DOCOLDNO>IA093-000995-B029-352</DOCOLDNO>
<DOCHDR>
http://www.nyspi.cpmc.columbia.edu:80/NYSPI/PIDPT_CL.HTM 156.111.80.30 19970121072805 text/html 8726
HTTP/1.0 200 OK
MIME-Version: 1.0
Server: GLACI/2.01
Date: Tue Jan 21 02:32:12 1997
Content-Type: text/html
Content-Length: 8596
</DOCHDR>
<HTML>
<HEAD><TITLE>Clinical Psychopharm</TITLE></HEAD>

<H1 ALIGN="CENTER">
Clinical Psychopharmacology
</H1>
<P ALIGN="CENTER">
<B>Alexander H. Glassman, M.D., Chief of Psychiatric Research<BR>
Steven P. Roose, M.D., Psychiatrist (Research) II<BR>
B. Timothy Walsh, M.D., Psychiatrist II</B>
<P ALIGN="JUSTIFY">
We have focused our research efforts in the following major areas:
<P ALIGN="JUSTIFY">
* the safety of antidepressant drugs in hospitalized depressed patients with cardiovascular disease;
<P ALIGN="JUSTIFY">
* the efficacy of various antidepressants in outpatients with late-life depression;
<P ALIGN="JUSTIFY">
* the relationship between depression and death with particular focus on heart attack patients with depression;
<P ALIGN="JUSTIFY">
* pharmacological and psychological treatment of <A HREF="/nyspi/depts/psypharm/eating~1/index.htm">eating disorders</A>;
<P ALIGN="JUSTIFY">
* smoking addiction, with special interest in the relationship between nicotine dependence and depression.
<H3 ALIGN="JUSTIFY">
<B>Psychopharmacology Research</B>
</H3>
<P ALIGN="JUSTIFY">
<B>Cardiovascular Effects of Antidepressants</B>  We are conducting a four-year study of the cardiovascular effects of a new group of antidepressants, the serotonin reuptake inhibitors. Though these drugs have different cardiovascular effects from the tricyclics, they are being used with a false sense of "safety" in patients with pre-existing cardiac disease. Our studies will determine if these drugs prove to be more effective and safe than our standard antidepressants in patients with complicated cardiac problems. These cardiac studies have also allowed us the opportunity to determine the efficacy of the new antidepressants in the most severely depressed patients. Initially, it appears that the serotonin reuptake inhibitors may not be as effective as the standard tricyclics in the treatment of the hospitalized depressed patient. 
<P ALIGN="JUSTIFY">
<B>Late Life Depression Clinic</B>  With the Department of Biological Psychiatry, we have opened a Late Life Depression Clinic focusing on the study of the phenomenology, biology, and treatment of depressed patients over the age of 60. Depression is a common illness in this growing segment of the population and there has been insufficient investigation to determine the safest and most effective treatment for them. This is the only research clinic focusing on depression in the elderly in New York City. Studies already completed in the clinic have demonstrated that the mild, chronic type of depression, called dysthymia, occurs in older age patients. Initial trials have suggested that medication may be of help for these patients. Currently, the clinic is conducting studies of the effectiveness of antidepressant medication in older age patients with both mild and more severe forms of depression. Ongoing studies are also directed at comparing the safety and efficacy of the serotonin reuptake inhibitors vs. the tricyclics in depressed patients with ischemic heart disease.
<P ALIGN="JUSTIFY">
<B>Antidepressant Studies in Patients After a Heart Attack</B>  There is now significant data to support the observation that depression dramatically increases the risk of dying after a heart attack. These data showing an increased mortality come in part from studies conducted in this department, arising both from our interest in the use of antidepressants in patients with heart disease and from our studies with smoking. What is not clear is if antidepressant drugs would be safe to use after a heart attack and, if they were used, if they would reduce 
<P ALIGN="JUSTIFY">
the risk of depression and the associated increase in mortality. Based on our long interest in the safety of antidepressant drugs in patients with heart disease, we propose and have been funded to look at the safety of these drugs immediately following an infarction. 
<P ALIGN="JUSTIFY">
<B>Cardiac Studies in Children and Adults</B>  We have obtained information suggesting that the cardiovascular effects of tricyclic antidepressants are substantially different in children and adolescents than in adults. We are examining the physiological basis for these differences to determine whether they may increase the vulnerability to arrhythmias in some young people.
<P ALIGN="JUSTIFY">
<B>Treatment of Bulimia Nervosa, Anorexia Nervosa, and Binge Eating Disorder</B>  We have recently completed a controlled treatment study of bulimia nervosa aimed at determining the relative efficacy of supportive therapy and cognitive-behavioral therapy (CBT), and the utility of adding antidepressant medication to these therapies. A controlled treatment study to compare the relative effectiveness of interpersonal therapy and CBT in women with bulimia nervosa has recently been initiated. We have also initiated a controlled trial using fluoxetine to facilitate weight gain in hospitalized patients with anorexia nervosa. Preliminary work regarding the effectiveness of CBT in the post-hospitalization prevention of relapse in anorexia nervosa has been completed, and we have initiated a controlled trial. We are also exploring the utility of CBT and of medication for the treatment of binge eating associated with obesity.
<P ALIGN="JUSTIFY">
<B>Eating Behavior Studies of Bulimia Nervosa and Binge Eating Disorder</B>  In continued collaborative studies with St. Luke's Medical Center, we are examining in detail the disturbances of eating behavior in these disorders. We have found increasing evidence of disturbance in the psychological and biological mechanisms responsible for the development of satiety in bulimia nervosa. We are also conducting studies to determine whether such disturbances also affect some obese individuals. 
<P ALIGN="JUSTIFY">
<B>Study and Treatment of Nicotine Dependence</B>  In previous studies, we found a larger than expected rate of a history of major depressive disorder in our samples of heavy smokers and a lower success rate among those with such a history. We are continuing our trials of the effectiveness of antidepressants, combined with behavioral counseling, on smoking cessation and long-term abstinence and we are examining biological, psychological, social, and demographic variables that may have an impact on smoking cessation. We are also collaborating with the Cancer Institute to study the molecular effects of smoking in tumor promotion with a view to improving cancer risk assessment. In addition, we are collaborating in an investigation of a genetic marker in dependent smokers. Perhaps most importantly, we are following smokers with a history of major depression who are able to stop and those who are not, to see if smoking cessation influences the subsequent frequency of serious depressions. 
<H3 ALIGN="JUSTIFY">
<B>Training and Patient Care</B>
</H3>
<P ALIGN="JUSTIFY">
The unit staff are active in a broad range of training programs. The educational objectives for all residents are to learn: 1) how to recognize and treat major depression and eating disorders; 2) principles of pharmacology that govern the use of psychotropic medications; 3) and how to design smoking cessation programs to allow psychiatric patients to better tolerate smoke-free hospitals.
<P ALIGN="JUSTIFY">
The 7th Floor Clinical Service of this department is a research unit devoted to the study and treatment of affective and eating disorders. Treatment modalities include antidepressants and ECT for depression, and antidepressants and cognitive behavior therapy for eating disorders.
<H3 ALIGN="JUSTIFY">
<B>Special Activities</B>
</H3>
<P ALIGN="JUSTIFY">
In addition to regional seminars in psychopharmacology, the department administers a statewide psychopharmacology "Hotline." This is a service offered to New York State Department of Mental Health facilities across the state through which physicians may, by phone, get immediate expert advice on any drug-related psychiatric problem. It functions to improve the level of patient care throughout the New York State psychiatric system. 
<P ALIGN="LEFT"><B>
<!--<B>Drs. Alexander Glassman, left, and Gerard Bruder, right, at the Psychiatric Institute Annual Scientific Conference.</B>
</B>
<P ALIGN="LEFT"><B>
<B>Dr. Timothy Walsh at the Psychiatric Institute Annual Scientific Conference.</B>
</B>
<P ALIGN="LEFT"><B>
<B>Dr. Steven Roose presenting at the Psychiatric Institute <BR>
Annual Scientific Conference.</B>-->
</B>
<!-- This document was created using BeyondPress(TM) 1.0-439896. -->
</BODY></HTML>
</DOC>
<DOC>
<DOCNO>WT02-B10-173</DOCNO>
<DOCOLDNO>IA093-000995-B029-364</DOCOLDNO>
<DOCHDR>
http://www.nyspi.cpmc.columbia.edu:80/NYSPI/PIDPT_CO.HTM 156.111.80.30 19970121072817 text/html 3531
HTTP/1.0 200 OK
MIME-Version: 1.0
Server: GLACI/2.01
Date: Tue Jan 21 02:32:24 1997
Content-Type: text/html
Content-Length: 3401
</DOCHDR>
<HTML>
<HEAD><TITLE>Comm Sciences</TITLE></HEAD>
<BODY BACKGROUND="..\IMAGES\MARBLE.JPG">

<H1 ALIGN="CENTER">
Communication Sciences
</H1>
<P ALIGN="CENTER">
<B>Joseph Jaffe, M.D., Chief of Psychiatric Research<BR>
Samuel W. Anderson, Ph.D., Research Scientist V</B>
<P ALIGN="JUSTIFY">
Two currently funded projects were the primary focus of the department in 1994.  <B>The National Academy of Science/National Research Council Twin Study of Handedness as a</B>
Marker for Survival Fitness  </B>Dr. Joseph Jaffe is Principal Investigator and Dr. Steven J.C. Shea <BR>
is Co-Investigator. 
<P ALIGN="JUSTIFY">
It has been claimed that left-handedness reduces life expectancy by nine years! Handedness and mortality were examined in a cohort of 9,043 male twins, all World War II veterans. Preliminary data relating direction and strength of handedness to crude death rate showed a mortality peak for weak right-handers rather than strong sinistrals, laying to rest an already shaky claim that had terrified the left-handed community. We now pursue our finding of peak mortality among weak right-handers. A current genetic theory proposes that the "weak dextral" phenotype actually conceals a "weak sinistral" genotype that yielded to the postnatal pressures of a "right-handed world." One implication of our finding is that reduced survival fitness may be the price of compliance with social pressures that violate powerful biological imperatives. We hypothesize (a) that changes in genetically-driven behaviors such as handedness due to social pressures shortens the life span of both singletons and fraternal twins, and, (b) that the known symbiotic relationship between identical twins protects them from such outcomes. Higher death rate in dizygotic than in monozygotic twins was previously reported for cardiovascular disease. This finding has now been confirmed and also applies to cancer deaths. 
<P ALIGN="JUSTIFY">
<B>The Effect on the Infant of Post-partum Depression in the Mother</B>  Dr. Beatrice Beebe is Principal Investigator and Drs. Samuel Anderson and Joseph Jaffe are Co-lnvestigators.
<P ALIGN="JUSTIFY">
Infants of depressed mothers are at risk for social, emotional, and cognitive difficulty that may outlast the depression. We propose that mother-infant communication can be disturbed by deviant interpersonal timing. A new technology requires only ten minutes of interaction to measure the coordination of vocal timing between mother and infant. Furthermore, the method is completely automated and free of clinical bias. 
<P ALIGN="JUSTIFY">
The technique is now being applied in a pilot study of depressed mothers and their infants, with a matched normal control group. Of the first 50 dyads studied, an important mode of mother-infant communication (simultaneous vocalizing) was less prevalent in depressed than in control dyads. This finding suggests one interpersonal timing mechanism, i.e., absence of coactive vocal contingency, whereby depressed mothers might transmit distress to their infants. Thus, the research contributes to our goal of an objective, automated test for early detection of risk for compromised social development.
<P ALIGN="JUSTIFY">
Dr. Beebe has also established didactic links to the Residency Program and the Psychoanalytic Clinic. 
<!-- This document was created using BeyondPress(TM) 1.0-439896. -->
</BODY></HTML>
</DOC>
<DOC>
<DOCNO>WT02-B10-174</DOCNO>
<DOCOLDNO>IA093-000995-B030-2</DOCOLDNO>
<DOCHDR>
http://www.nyspi.cpmc.columbia.edu:80/NYSPI/PIDPT_DP.HTM 156.111.80.30 19970121072833 text/html 8771
HTTP/1.0 200 OK
MIME-Version: 1.0
Server: GLACI/2.01
Date: Tue Jan 21 02:32:33 1997
Content-Type: text/html
Content-Length: 8641
</DOCHDR>
<HTML>
<HEAD><TITLE>Developmental Psych</TITLE></HEAD>
<BODY BACKGROUND="..\IMAGES\MARBLE.JPG">

<H1 ALIGN="CENTER">
Developmental Psychobiology
</H1>
<P ALIGN="CENTER">
<B>Myron A. Hofer, M.D., Chief of Psychiatric Research<BR>
Donald E. Hutchings, Ph.D., Research Scientist VI<BR>
Gordon A. Barr, Ph.D., Research Scientist V<BR>
Michael M. Myers, Ph.D., Research Scientist V<BR>
Brandon G. Yongue, Ph.D., Research Scientist V<BR>
Susan A. Brunelli, Ph.D., Research Scientist IV<BR>
Susan E. Carden, Ph.D., Research Scientist IV<BR>
William P. Fifer, Ph.D., Research Scientist IV<BR>
Harry N. Shair, Ph.D., Research Scientist IV<BR>
Ann Zmitrovich, Ph.D., Research Scientist III</B>
<P ALIGN="JUSTIFY">
The department's research centers on the processes involved in the development of behavior and its underlying biological systems. We aim to understand more precisely how natural events and behaviors affect the course of normal development, and how certain experiences can produce aberrant responses that constitute models of clinical conditions. Projects range from molecular genetic studies of gene expression for a peptide regulating salt appetite in rats to linguistic analysis of cues enabling human infants to recognize their own mothers' voices within hours of birth. Thus, we hope to describe mechanisms at several different levels of organization that determine the expression of genetic potential as this is influenced by the environment. The most pervasive early environment for humans and most other mammals is the mother-infant relationship. Many departmental projects are devoted to understanding the behavioral and physiological processes at work within that relationship. Knowledge of these processes is essential for a clear understanding of how the expression of genetic potential is regulated by the environment of early life and, in turn, how these experiences influence the risk for the expression of anxiety disorders, cardiovascular disease, and vulnerability to mental illness under stress later in life.
<H3 ALIGN="JUSTIFY">
<B>Departmental Research</B>
</H3>
<P ALIGN="JUSTIFY">
<B>Fetal Behavior and Intrauterine Influences</B>  Following his discovery that a newborn baby recognizes and prefers her/his own mother's voice within a few hours of birth, Dr. Fifer, in collaboration with Dr. Myers, has extended these observations into a program of research on fetal responses to sound and to maternal emotional state, and on preterm development of sleep-wake state organization. Together, Drs. Fifer, Myers, and Yongue have been funded to incorporate these approaches in a study of early markers of risk for Sudden Infant Death and other neurological disorders. This project involves a mutually beneficial technology exchange between the sophisticated research environment of New York State Psychiatric Institute and the high risk rural populations in the Pine Ridge Indian Reservation in South Dakota.
<P ALIGN="JUSTIFY">
With funding from a new National Institute on Drug Abuse (NIDA) grant, Drs. Hutchings and Zmitrovich have developed the first valid animal model for studying the developmental effects on the offspring of pregnant mothers who have been given methadone maintenance treatment. With a new post-doctoral fellow, E'mett Williams, they are now extending this work to the study of buprenorphine, a novel therapeutic compound for the treatment of heroin addiction in order to determine its safety for use during pregnancy.
<P ALIGN="JUSTIFY">
<B>The Early Development of Motivational Systems</B>  Dr. Barr's research focuses on the neural circuitry that mediates the functional effects of opioid peptides and opiate drugs. He is mapping the neural substrates for opiate induced analgesia and opiate induced reward to determine how those substrates change during normal pre- and postnatal development. Most recently, he and his co-workers have begun to describe in detail the opiate abstinence syndrome that is seen in the neonatal rat following chronic treatment with opiate drugs. Understanding the physiological mechanisms of that syndrome will aid in our understanding of the effects of prenatal exposure of human infants to heroin and methadone.
<P ALIGN="JUSTIFY">
Dr. Myers has found further evidence of important linkages between feeding behavior in infancy and certain longterm developmental effects individual of variation in this basic behavior of neonates. In studies of newborn human infants, he and his colleagues have found an unexpected relationship between high birth weight and reduced cardiovascular reactivity during feeding. In rat studies, he has gathered evidence that the longterm consequences of rapid weight gain early in life on obesity and hypertension are more pronounced in males. Investigations of the mechanisms underlying these findings are ongoing.
<P ALIGN="JUSTIFY">
Dr. Yongue continued his work on neural mechanisms underlying the ingestive behavior and cardiovascular function of inbred strains of rats. In the past year, his work has focused on findings from his laboratory that fetal neural grafts from a genetic hypertensive strain alter blood pressure and ingestive behavior in normotensive hosts. In addition, Drs. Yongue and Resit Canbeyli continued their investigations of neuroendocrine differences in salt appetite during early development in genetic hypertensive and normotensive rats.
<P ALIGN="JUSTIFY">
<B>Early Separation Anxiety</B>  Drs. Hofer, Brunelli, Shair, and Carden are studying the psychobiological mechanisms by which separation of young rats from their home nest, siblings, and mother induces a high rate of separation calling. They have found that this infant behavior responds (selectively) to drugs that alleviate or that produce severe anxiety in human adults. Thus, the brain systems involved appear to be remarkably similar to those thought to be responsible for human anxiety disorders. Dr. Brunelli completed initial studies on a genetically diverse strain of rats (N:NIH) that are now being selectively bred for high and for low levels of isolation distress calling during infancy. This line of work investigates the association of early separation distress with adult measures of anxiety, as a model for the development and inheritance of anxiety disorders. Dr. Carden has shown that the three different types of opioid receptors begin to contribute specifically to certain isolation and attachment behaviors of rat pups as soon as three days after birth. She has been able to measure differences in brain opioid levels (met-enkephalin) as a result of isolation, providing a potential link between attachment and brain mechanisms of reward.
<P ALIGN="JUSTIFY">
<B>An Animal Model of Sudden Infant Death Syndrome (SIDS)</B>  Two major difficulties in combating the Sudden Infant Death Syndrome are identifying which infants are at greatest risk for this devastating phenomenon, and predicting when these events might occur. Home monitoring of infants thought to be at risk has proved expensive and ineffectual. In our animal model of SIDS, Drs. Shair, Myers, and Hofer have recently found that, prior to experimental manipulation, high heart rate is a predictor of susceptibility to unexpected mortality. After our experimental procedures, low heart rate predicts impending death. These results show how animal models can suggest complex and unimagined patterns that may underlie the difficulties in predicting risk of human disease.
<H3 ALIGN="JUSTIFY">
<B>Research Training</B>
</H3>
<P ALIGN="JUSTIFY">
The department continues to play a central role in an NIMH-funded Research Training Program for postdoctoral fellows in the Psychobiological Sciences, directed by Dr. Hofer. The 20 faculty members represent five other departments from Psychiatric Institute and the Perinatology Division of the Pediatrics department at Columbia-Presbyterian Medical Center. In addition, undergraduate and graduate students from Columbia, Hunter College, and several other universities conduct research and receive training in the department. Dr. Jonathan Polan, Associate Professor of Psychiatry at Cornell, began a two-year advanced research training fellowship in this department with funding from the Reader's Digest Foundation . 
<P ALIGN="LEFT"><B>
<!--<B>Drs. William Tucker, left, and Myron Hofer, right, at the Department of Psychiatry Annual Meeting.</B>
</B>
<P ALIGN="LEFT"><B>
<B>Drs. James Satriano, left, and Harry Shair, right, at the Department of Psychiatry Annual Meeting.</B>
</B>-->
<!-- This document was created using BeyondPress(TM) 1.0-439896. -->
</BODY></HTML>
</DOC>
<DOC>
<DOCNO>WT02-B10-175</DOCNO>
<DOCOLDNO>IA093-000995-B030-32</DOCOLDNO>
<DOCHDR>
http://www.nyspi.cpmc.columbia.edu:80/NYSPI/PIDPT_EP.HTM 156.111.80.30 19970121072902 text/html 10447
HTTP/1.0 200 OK
MIME-Version: 1.0
Server: GLACI/2.01
Date: Tue Jan 21 02:33:01 1997
Content-Type: text/html
Content-Length: 10316
</DOCHDR>
<HTML>
<HEAD><TITLE>Epidem of Mental</TITLE></HEAD>
<BODY BACKGROUND="..\IMAGES\MARBLE.JPG">

<H1 ALIGN="CENTER">
Epidemiology of Mental Disorders
</H1>
<P ALIGN="CENTER">
<B>Elmer L. Struening, Ph.D., Chief of Psychiatric Research<BR>
Patricia R. Cohen, Ph.D., Principal Research Scientist<BR>
William R. McFarlane, M.D., Chief, Biosocial Treatment Division<BR>
Bruce G. Link, Ph.D., Research Scientist V<BR>
John G. Pittman, M.S., Research Scientist IV<BR>
Howard Andrews, Ph.D., Research Scientist III<BR>
Susan Barrow, Ph.D., Research Scientist III<BR>
Rodrick Wallace, Ph.D., Research Scientist III</B>
<P ALIGN="JUSTIFY">
Dr. Elmer Struening (Principal Investigator), Dr. Susan Barrow (Co-Principal Investigator), Pilar C&oacute;rdova, Sala Nolan, Gloria Thomas, and Seon Mee Hong completed the data collection phase of their evaluation of A Project to Link Up Services (A-PLUS), a psychiatric assessment and case management program for mentally ill women residing in New York City shelters. A sample of 294 women were interviewed at the time of referral to A-PLUS, with follow-up interviews conducted 12 and 24 months after baseline. Current data analyses focus on the relationship of A-PLUS services to housing stability, psychiatric status, and use of treatment services. Preliminary findings indicate that a third of the sample remained homeless after two years; 10% were in institutional settings (hospitals, jails); and the remaining 56% were housed-either independently (17%), with relatives (12%), or in supportive community settings (27%).
<P ALIGN="JUSTIFY">
Dr. Struening (Principal Investigator), Dr. Barrow (Co-Principal Investigator) and Ms.  C&oacute;rdova extended the data collection phase for their Follow-up Study of Adult Shelter Residents, which has entailed tracing and reinterviewing a sample of over 1,000 men and women initially interviewed in a 1987 survey of municipal shelter residents. The primary locus of field activity has shifted from the shelter system to other institutional and community settings. Current analyses of preliminary data focus on residence history and baseline psychiatric/substance abuse status as predictors of subsequent patterns of homelessness and shelter use.
<P ALIGN="JUSTIFY">
Dr. Barrow, as Principal Investigator, is beginning a study of low demand interim housing services provided by outreach and drop-in programs that serve homeless adults living on the streets and in other public places. The evaluation will examine the programs' effectiveness in transitioning clients to permanent housing and linking them to psychiatric treatment, substance abuse programs, and other support services.
<P ALIGN="JUSTIFY">
Dr. Patricia Cohen was President of the Society for Multivariate Experimental Psychology during this year. Her presidential address, delivered at the annual meeting at Princeton University, was entitled Childhood Risks for Adult Personality Disorder: Method and Substance. It reviewed the impact of 36 risks measured during childhood on young adult personality disorder in the longitudinal cohort studied in the Children in the Community study on which she has been Principal Investigator over the past 12 years. A symposium on related issues was featured at the meeting of the American Academy of Child and Adolescent Psychiatry, where papers based on the same study were presented by Dr. Cohen on the continuity of disruptive disorders into adulthood, by Dr. Stephanie Kasen on the adult consequences of adolescent disorder, by Dr. Anne Provet on a comparison of environment, family, and child characteristics as childhood risks for adult psychopathology, by Dr. David Bernstein on continuity of personality disorder from adolescence to adulthood, by Dr. Jason Liu on neurasthenia in this cohort, and by Dr. Judith Brook on risks for and consequences of illicit drug use in adolescence. Dr. Cohen continued work on the two projects on this cohort and its offspring, on which she is Principal Investigator, and on two related projects on which she is Co-Principal Investigator. A Research Scientist Development Award was given to Dr. Cheryl Slomkowski, with Dr. Cohen and Dr. David Shaffer as mentors. She also continues as a member of the Services Review Group at the National Institutes of Mental Health (NIMH).
<P ALIGN="JUSTIFY">
Dr. Mark Olfson helped to conduct a statewide study of the general hospital inpatients treatment of schizophrenia, developed a scale to measure the inpatient treatment of schizophrenia, examined national trends in utilization of mental health services and prescription of psychotropic medications, and assisted with the development of a novel system to facilitate the diagnosis of mental disorders in primary care.
<P ALIGN="JUSTIFY">
Dr. Rodrick Wallace's work for the period again focused on understanding the processes of outward diffusion of social disintegration and its correlates of deterioration in public health and public order from collapsing inner city communities into larger metropolitan regions. This has resulted in a number of papers published and in press, including one which examines the diffusion of AIDS, TB, violent crime, and low birthweight in eight United States metropolitan areas containing over 54 million people. AIDS was found to be diffusing outward near size of the eight, TB near five, violent crime near two, and low birthweight near one. All four pathologies were found to be diffusing into the suburbs near New York City.
<P ALIGN="JUSTIFY">
Dr. Daniel Herman received a five-year Scientist Development Award from NIMH which will permit him to obtain additional training in epidemiological and statistical methods at Columbia University's School of Public Health, and to conduct research under the mentorship of several senior researchers. His mentors include Drs. Struening, Link, and Cohen (of Epidemiology of Mental Disorders), as well as Drs. Christina Hoven, Ezra Susser, and Janet Williams. Dr. Herman's primary research focus continues to be on the relationship between adverse childhood experiences and adverse psychosocial outcomes during adulthood such as mental disorder, substance abuse, and homelessness. He published a paper in the American Journal of Public Health on the association between childhood foster care experience and depressive symptoms in adulthood, and is currently examining childhood risk factors for homelessness in data collected as part of Dr. Link's nationwide study of formerly homeless people.
<P ALIGN="JUSTIFY">
Dr. Bruce Link conducted research as Principal Investigator on two projects-an NIMH-funded study of the experience of homelessness in a nationwide sample of formerly homeless people and an intervention study designed to help people with mental illness cope with stigma, which was funded by a NARSAD Senior Investigator Award. Dr. Link published a major paper in the American Journal of Public Health concerning the surprising number of people who have experienced homelessness in the United States. He is now analyzing data about the psychosocial and mental health risk factors for homelessness based on this nationwide data. With respect to his research interest in stigma, Dr. Link, Dr. Struening, and colleagues have developed an intervention and are testing it in a randomized trial in a clubhouse setting for people with severe mental illness.
<P ALIGN="JUSTIFY">
Dr. Howard Andrews, together with Dr. Doris Goldberg of the New York City Department of Health and Dr. Virginia Rauh of the Columbia School of Public Health's Division of Population and Family Health, have been developing several projects based on the linkage of large data sets containing information on childhood risk and educational outcomes. One paper has been accepted for publication and two grant proposals have been submitted. The proposals involve use of the linked dataset to conduct comprehensive evaluations of the Head Start Program in New York City, using school outcomes data, including identification of children with emotional disorders in the school system.
<P ALIGN="JUSTIFY">
John Pittman and Howard Andrews, co-directors of the department's Database Management and Statistical Analysis Unit (DBM/SAU), have developed five long-term contracts for data management and statistical analysis. Three full-time RFMH staff members are supported by these contracts. A grant proposal that would involve an additional contract has been submitted.
<P ALIGN="JUSTIFY">
The impact of a relative with severe mental illness on the well being of a designated caregiver is a multi-site longitudinal study of hospitalized psychiatric patients. Drs. Elmer Struening (Principal Investigator), Phyllis Vine, Ann Stueve, Bruce Link, Dolores Kreisman, and Ms. Maureen Ellis and Margaret Newmark are assessing the impact of a relative with severe mental illness on a designated caretaker and other members of the household. Baseline interviews have been administered to 180 designated caretakers at St. Luke's/Roosevelt Hospital Center and New York Hospital-Cornell Medical Center in Westchester County. The follow-up protocol has been completed on 75% of the baseline sample. The liaison teams are comprised of Drs. Sig Ackerman, Marcia G. Torres, and Ms. Judith Greenwald, and Dr. Ken Terkelsen, Ms. Judith Guberman and Susan G. Salit, respectively. Baseline data are being analyzed for initial reports and papers. Studies of change in caregivers as a function of symptom remission and behavioral stabilization in their relatives are in progress.
<P ALIGN="JUSTIFY">
The Biosocial Treatment Research Division finished collecting data for the Work in Family-Aided Assertive Community Treatment project (funded by a NIMH Community Support Project Grant), and was engaged in cleaning the data and preparing it for analysis. Preliminary analyses provided encouragement that our primary hypothesis for the study would be supported: that is, that FACT clients would be more likely to be employed than the conventional vocational rehabilitation (CVR) clients.
<P ALIGN="CENTER"><B>
<!--<B>Drs. Zena Stein, left, and Elmer Struening, center, with Dr. Struening's wife, Sue, at the 25 Years of Service Celebration.</B>-->
</B>
<!-- This document was created using BeyondPress(TM) 1.0-439896. -->
</BODY></HTML>
</DOC>
<DOC>
<DOCNO>WT02-B10-176</DOCNO>
<DOCOLDNO>IA093-000995-B030-39</DOCOLDNO>
<DOCHDR>
http://www.nyspi.cpmc.columbia.edu:80/NYSPI/PIDPT_EA.HTM 156.111.80.30 19970121072910 text/html 4415
HTTP/1.0 200 OK
MIME-Version: 1.0
Server: GLACI/2.01
Date: Tue Jan 21 02:33:17 1997
Content-Type: text/html
Content-Length: 4285
</DOCHDR>
<HTML>
<HEAD><TITLE>Epidem of Sub Abuse</TITLE></HEAD>
<BODY BACKGROUND="..\IMAGES\MARBLE.JPG">

<H1 ALIGN="CENTER">
Epidemiology of Substance Abuse
</H1>
<P ALIGN="CENTER">
<B>Denise Kandel, Ph.D., Chief of Psychiatric Research<BR>
Christine Schaffran, M.A., Research Scientist III</B>
<P ALIGN="JUSTIFY">
The department continues its investigations of the natural history of involvement in drugs, the risk factors and consequences of drug abuse, and the co-morbidity between substance abuse, other dysfunctional behaviors, and psychiatric disorders among children, adolescents, and adults. These issues are investigated outside the laboratory in population groups that are studied over time. The drugs of interest include cigarettes, alcohol, marijuana, other illicit drugs, and medically prescribed drugs.
<P ALIGN="JUSTIFY">
Our investigations are currently based on four samples:
<P ALIGN="JUSTIFY">
(l) a longitudinal cohort of former New York State high school students that we have followed for nineteen years from adolescence to the mid-thirties (N=1,160), with data from the two oldest children aged 9 to 17 (N=385), spouses and partners when living in the household (N=621), and teachers (422);
<P ALIGN="JUSTIFY">
(2) a national longitudinal sample of young adults (N=12,000) and the women's first-born preadolescent children aged 10 and over (N=581) from the National Longitudinal Survey of Youth (NLSY);
<P ALIGN="JUSTIFY">
(3) a random sample of 7th-12th graders representative of junior and senior high school students in public and private New York State schools, drawn from 53 schools throughout the state (N=7,611); and
<P ALIGN="JUSTIFY">
(4) multiple national cross-sectional samples of the general population aged 12 and over from the National Household Surveys on Drug Abuse, varying in size from 8,000 to 29,000 individuals.
<P ALIGN="JUSTIFY">
Our major activities have continued to focus on the impact of parental substance abuse-in particular, maternal use in pregnancy-on children's own drug use and development. We had discovered a significant relationship between maternal smoking during pregnancy on the child smoking thirteen years later, especially daughters, with controls for prenatal drinking, current maternal smoking, and other factors. This past year, we investigated the impact of prenatal drinking. Heavy prenatal maternal drinking increases the risk of the child drinking. However, prenatal smoking appears to have a more pervasive effect than prenatal drinking on adolescent drug use, since, in addition to its effect on smoking, it affects adolescent drinking.
<P ALIGN="JUSTIFY">
These findings are of great public health import and represent a substantial advance in our understanding of the etiology of substance use. The perinatal effects of maternal drug use suggest novel ways of examining latent and long-term effects of drug consumption during pregnancy. Such consumption may affect brain functioning in utero functionally and in ways that do not become apparent until the child has had opportunities to try the substances. Children whose mothers smoked during pregnancy may also be at greater risk of becoming dependent on a variety of drugs other than nicotine. This is an hypothesis that we plan to test in our further work. We are also exploring the processes, such as increases in behavioral problems in childhood, through which the maternal prenatal effect on drug use would express itself in adolescence.
<P ALIGN="JUSTIFY">
This past year, under support from the National Institute of Drug Abuse (NIDA), we initiated a new area of investigation on the relationship between patterns of drug use and drug dependence.
<P ALIGN="JUSTIFY">
The department has also been involved in two major collaborations. One collaboration is with members of the Department of Child Psychiatry in methodological studies of the epidemiology of psychiatric disorders in children and adolescents (child MECA). The second collaboration is with the Program on Human Development and Criminal Behavior at Harvard University, a prospective longitudinal study of individual and community risk factors for delinquency and substance abuse.
<!-- This document was created using BeyondPress(TM) 1.0-439896. -->
</BODY></HTML>
</DOC>
<DOC>
<DOCNO>WT02-B10-177</DOCNO>
<DOCOLDNO>IA093-000995-B030-53</DOCOLDNO>
<DOCHDR>
http://www.nyspi.cpmc.columbia.edu:80/NYSPI/PIDPT_GC.HTM 156.111.80.30 19970121072918 text/html 4998
HTTP/1.0 200 OK
MIME-Version: 1.0
Server: GLACI/2.01
Date: Tue Jan 21 02:33:25 1997
Content-Type: text/html
Content-Length: 4868
</DOCHDR>
<HTML>
<HEAD><TITLE>Gen Clinical Research</TITLE></HEAD>
<BODY BACKGROUND="..\IMAGES\MARBLE.JPG">

<H1 ALIGN="CENTER">
General Clinical Research Service
</H1>
<P ALIGN="CENTER">
<B>Lyle Rosnick, M.D., Director<BR>
Richard Brockman, M.D., Assistant Director<BR>
Andrew E. Skodol, M.D., Psychiatrist (Research) III</B>
<P ALIGN="JUSTIFY">
In 1994, the General Clinical Research Service (PI 5) continued to devote 12 to 15 of its beds to research and treatment of patients with severe personality disorders. The remainder of the beds were reserved for depressed and/or suicidal adults and teenagers who participated in studies sponsored by the Departments of Biological Psychiatry, Neuroscience, and Child Psychiatry. During the year, Drs. Craig Tomlinson and Adele Tutter did senior resident electives on the Service.
<P ALIGN="JUSTIFY">
The Unit for Personality Studies (UPS) research protocol, which utilized standardized instruments for the assessment of DSM-III-R personality disorders, continued in data-analytic and report-writing phases. Combining data collected on PI 5 patients with data on patients from the Psychoanalytic Center and the Depression Evaluation Service (DES), the Unit for Personality Studies published reports on the validity of self-report scales for personality disorders, the validity of self-defeating personality disorders and serotonergic sensitivity in borderline personality disorder. A paper on Axis I/Axis II comorbidity was accepted for publication. Papers on the relationship of anxiety disorders to personality disorders and on the specificity of dependent personality disorder for depression were submitted for publication. These studies continued under the direction of Andrew Skodol, M.D. with the participation of Drs. John Oldham, Steven Hyler, Lyle Rosnick, David Kellman, Ron Goldman, Jane Waters, Norman Doidge, Patrick McGrath, Peggy Gallaher, Susan Vaughan, Eric Hollander, and Dan Stein.
<P ALIGN="JUSTIFY">
This past year PI 5 continued to serve as the site of an investigation of electroconvulsive therapy (ECT) as a treatment for major depression. This project, sponsored by the Department of Biological Psychiatry, is headed by Dr. Harold Sackeim, Principal Investigator, with Joan Prudic, M.D., and D.P. Devanand, M.D., as Co-Principal Investigators, assisted <BR>
by M. Nobler, M.D. and Barbara Erwin-Mcguire, Ph.D. until August 1994, and Shoshana Peyser, M.S.W. thereafter. In 1994, twelve patients were admitted to PI 5 for this protocol. This work was given a MERIT Award from NIMH with funding through 1995 and an extension to 2000. The findings  from the second ECT study, completed in 1990, have been extensively published, with 81 articles in print or press, and eight more in review. Several data sets are in preparation for further publications. In addition, ten patients admitted to PI 5 also participated in a second multi-center study on continuation pharmacotherapy following ECT, now in its third year.
<P ALIGN="JUSTIFY">
The Division of Neurochemistry continued a large study of various forms of self-injuring behaviors. Over a period of three years, 180 individuals with depression, suicidal behavior, other self-injuring behavior and compulsive hair-pulling (trichotillomania) will be studied in a battery of neuropharmacological and psychological assessments. This research project, led by Dr. Barbara Stanley, is a continuation of previous research that has been carried out by the Division of Neurochemistry over the last seven years and will focus on dysregulation of the serotonin neurotransmitter system in people at high risk for various self-directed, damaging behaviors, particularly suicide. Clinical applications of the results of the study will include developing strategies to reduce the risk of dangerous suicidal behavior among people at high risk for such behavior. In addition, this study will obtain genetic material from 500 individuals, providing a database for the study of possible genetic markers of these conditions. Data from this study will also provide an opportunity to examine biological correlates of severe character pathology. In addition to the scientific and medical value of these investigations, the applied goal of this kind of research should lead to strategies which may enable doctors to reduce the risk of dangerous behaviors, allowing patients to avoid hospitalizations and continue safely in outpatient treatment.
<P ALIGN="LEFT"><B>
<!--<B>Drs. Stanley Heller, left, <BR>
and Lyle Rosnick at the Psychiatric Institute Annual Scientific Conference.</B>
</B>
<P ALIGN="LEFT"><B>
<B>Celebrating Nurse Recognition Day are <BR>
Gretchen Seirmarco, M.S., R.N., C.S., left, and <BR>
Jayne Arzapalo, R.N., M.S., Head Nurse, 5 South.</B>
</B>-->
<!-- This document was created using BeyondPress(TM) 1.0-439896. -->
</BODY></HTML>
</DOC>
<DOC>
<DOCNO>WT02-B10-178</DOCNO>
<DOCOLDNO>IA093-000995-B030-71</DOCOLDNO>
<DOCHDR>
http://www.nyspi.cpmc.columbia.edu:80/NYSPI/PIDPT_GE.HTM 156.111.80.30 19970121072931 text/html 15809
HTTP/1.0 200 OK
MIME-Version: 1.0
Server: GLACI/2.01
Date: Tue Jan 21 02:33:33 1997
Content-Type: text/html
Content-Length: 15678
</DOCHDR>
<HTML>
<HEAD><TITLE>Geriatrics and Geron</TITLE></HEAD>
<BODY BACKGROUND="..\IMAGES\MARBLE.JPG">

<H1 ALIGN="CENTER">
Geriatrics and Gerontology
</H1>
<P ALIGN="CENTER">
<B>Barry J. Gurland, M.D., Chief of Psychiatric Research<BR>
John A. Toner, Ed.D., Research Scientist V<BR>
David E. Wilder, Ph.D., Research Scientist V<BR>
Jeanne Teresi, Ed.D., Ph.D., Research Scientist IV<BR>
Peter Cross, M.Phil., Research Scientist III<BR>
Eloise H.P. Killefer, M.Ed., Research Scientist III</B>
<P ALIGN="JUSTIFY">
During 1994, the department (also known as the Center for Geriatrics and Gerontology) was involved in the following on-going research projects.
<H3 ALIGN="JUSTIFY">
<B>Research Projects</B>
</H3>
<P ALIGN="JUSTIFY">
<B>The Morris W. Stroud III Program on Scientific Approaches to Quality of Life in Health and Aging</B>  This program is supported by a bequest from the late Dr. Stroud, a pioneer in rehabilitation medicine. Drs. Barry Gurland and Sidney Katz (Professor Emeritus of Geriatric Medicine at Columbia) are Co-Directors. An important theme of this program deals with changes in qualities of life accompanying mental health problems in aging. Related secondary analyses of data sets from the Center's major collaborative studies, the North Manhattan Aging Project, Active Life Expectancy Study, and Growing Older in New York City survey, have been supported by this program, leading to better understanding of the relative usefulness of competing concepts of dementia and depression for predicting problems in the quality of everyday living and demands on services. Ethno-racial comparisons revealed that substantial differences between Latinos, African-Americans, and Non-Latino Whites in rates of dementia and depression could be linked to corresponding impacts on qualities of life. The laptop computer-assisted interview covering qualities of life, developed by Dr. Jiming Chen, has now been administered to over 2,500 elders in their homes. 
<P ALIGN="JUSTIFY">
The Stroud Program continued formal mentorship and partial support for Dr. Zachary Pine's Career Development Award to develop objective measures for assessing impairments of functioning in dementia, and to investigate affective responses to disability. The Program also continued mentorship of Dr. Terry Fulmer's National Brookdale Fellowship in finding objective measures of the match between capacity for independence and permitted autonomy in elders with mental disorders. With Dr. Steven Albert of the Sergievsky Center, the Stroud Program delivered a course on health related qualities of life, thus initiating the first formal curriculum in this field. Corresponding content has been inserted in the offerings of the Geriatric Education Center.
<P ALIGN="JUSTIFY">
<B>North Manhattan Aging Project (NMAP)</B>  (Barry Gurland, M.D., Principal Investigator, and David Wilder, Ph.D., Co-Principal Investigator). NMAP was renewed for a second five-year period as part of the Program Project (Epidemiology of Dementia in an Urban Community) funded by the National Institute on Aging (NIA) and conducted in collaboration with Drs. Richard Mayeux and Yaakov Stern of the Sergievsky Center and Psychiatric Institute. During the first five years, a case registry was established to identify and assess all cases of Alzheimer's and related dementias in the area of North Manhattan bounded by 155th Street to the south, 181st Street to the north, and by the Hudson and Harlem rivers, so that cross-cultural epidemiologic comparisons can be made among elderly Latino, African-American and Non-Latino White residents. A case reporting component of the registry occupied the first three years of the study and has been followed by a survey component. Each component evaluated over 2,000 of the target area elders. Prevalence of dementia among elders aged 65 and older was estimated from the case reporting component using thirteen different case definitions. Larger estimates resulted from the survey component, which was more successful than the reporting component in identifying early stage dementias in the community. Higher rates were found among Latinos and African-Americans than Non-Latino Whites in both registry components. Separate multiple regression analyses of the case reporting and survey component samples both showed age and education to be significantly related to rates of dementia, but neither gender nor ethnic/race, was significantly related when age and education were controlled. The continuation award maintains the collaboration with the Sergievsky Center and includes a study of the function/quality complex in borderzone cognitive impairment (Dr. Barry Gurland, Principal Investigator) and the survey and assessment core (Dr. David Wilder, Principal Investigator).
<P ALIGN="JUSTIFY">
Dr. Jeanne Teresi has led the statistical strategies, based on her work on item response theory, for deriving culture-fair scales for assessment of cognitive impairment. Ms. Eloise Killeffer has worked to effect closure on the informant interview sector of the North Manhattan Aging Project (963 completed interviews and a better than 90% response rate). These informant data have refined the distinguishing features of early dementia, its consequences for patient and family, and the estimation of service needs and fulfillment.
<P ALIGN="JUSTIFY">
<B>Active Life Expectancy Among Urban Minority Elders</B>  With Dr. Rafael Lantigua, Principal Investigator, Dr. David Wilder, Co-Principal Investigator, and Drs. Barry Gurland and Sidney Katz, Co-Investigators, this project began the fourth year of a five-year study of transitions in function among elders in North Manhattan. It is funded by the National Institute on Aging, in collaboration with the Division of General Medicine and the Sergievsky Center, and coordinated with the North Manhattan Aging Project and the Stroud Program. Initial bilingual (Spanish and English) interviews were completed with a probability sample of over 2,100 community elders in their homes, and informant interviews and examinations by physicians were conducted for large subsamples (n=948 and 1,178 respectively). First follow-up assessments are currently underway, and second follow-ups are scheduled for the fifth year of the study. Cross-sectional analysis has included ethno-racial comparisons of disability and accompanying depression, development and refining of quality of life measures, and comparing informant and subject reports of functioning with performance test results.
<P ALIGN="JUSTIFY">
<B>Quality of Life and Care of Elders in New York City</B>  Analyses continue on data from this study of 1,570 older New Yorkers, which was conducted in collaboration with the New York Community Trust Center for Policy on Aging and the Fordham University Third Age Center. Dr. Barry Gurland is the Principal Investigator of this study, and Dr. Cathy Berkman is the <BR>
Co-Principal Investigator. With special emphasis on the very old and minority persons (African-American and Latino), the study focused on functional impairment, depression, and cognitive impairment. A report on the study was disseminated in 1993-94 among planning agencies by the New York Community Trust. Data analysis is now focused on the relationship between economic status, depression, and disability, and other aspects of quality of life in the elderly. Analyses in 1994 showed that rates of chronic physical and mental illness are highly related to income even in the middle income ranges. A comparison of cognitive impairment observed in the recent 1990 study and in our previous 1975 survey, indicate that prevalence of dementia may have increased over this period of time.
<P ALIGN="JUSTIFY">
<B>Laboratory for Investigation of Objective Functioning</B>  Under the direction of Dr. Zachary Pine, a physician specializing in physical medicine and rehabilitation, a laboratory has been established for the investigation of neural and physiological mechanisms underlying impaired function in the tasks of daily living. This work is supported by a Federal Individual Physician Scientist Career Development Award, with clinical mentoring provided by Dr. Barry Gurland. Techniques have been developed and piloted for measuring impairments in vision, strength, sensation, and joint range of motion. Performance measures of integrated tasks such as ambulation and reaching for objects are also employed. Brain strategies underlying reaching tasks are being analyzed using computer-based motion tracking. The technique employs miniature electromagnetic sensors, and is designed for portability. This new and mobile system of investigation will focus upon early changes in functioning in dementia, which may be subclinical.
<P ALIGN="JUSTIFY">
<B>Quality of Life (QoL) Assessment in Health and Aging Seminar</B>  This seminar is sponsored by the Stroud Program as part of an effort to foster quality of life research, including its applications to mental health and disorders. Taught jointly by Dr. Steven Albert and Dr. Barry Gurland, the course offers a state-of-the-art assessment of quality of life (QoL) inquiry. The course is offered through the School of Public Health at Columbia University for the spring semester. The following topics are covered as part of the seminar: health utility measurements, assessment in special populations, applications to quality assurance, medical technology, policy analysis, and related topics.
<P ALIGN="JUSTIFY">
<B>New York Statewide Psychogeriatric Program</B>  This program is co-directed by Drs. John Toner and Barry Gurland, and supported by the New York State Office of Mental Health. It consists of two major components-education and research-organized around a geriatric psychiatry fellowship at Willard Psychiatric Center and Binghamton Psychiatric Center, both in upstate New York. The program focuses on preparing psychiatrists in the practice of geriatric psychiatry related to the transition of the public mental health system from a concentration on inpatients to integrated hospital and community mental health sites of service. The research is conducted by faculty-fellow partnerships working on the knowledge base underlying the development and implementation of innovative clinical modules. Current research activities include: a cross-national collaborative project on community reinvestment in New York State and the United Kingdom; a 25-year follow-up of the 1968-69 US-UK Cross National Diagnostic Study cohort; and studies of the diagnosis of dementia in the non-communicating elderly, the development of a scale for delusional depression, the effects of DNR on nursing home staff behaviors, causes of agitated behaviors in dementia, psychiatric differences between vascular and organic brain disorders, and a 10-year retrospective autopsy study of cerebral arteriosclerosis.
<P ALIGN="JUSTIFY">
<B>Research Training and Information Transfer (RTIT)</B>  The RTIT Core of the Center for Alzheimer's Disease Research (Dr. Michael Shelanski, Principal Investigator) is now in the first year of its five-year renewal (1994-99) under Dr. Barry Gurland, Principal Investigator, and Dr. Ruth Bennett, Project Director. Content on Alzheimer's disease (AD) continues to be integrated into a course entitled "Long Term Care with an Emphasis on AD," offered within the School of Public Health. A new mini-residency was designed by Dr. Virginia Barrett, entitled "The Effect of Information on Quality of Life of Elders with Dementia and Their Families." A program of transfer of information to community advocates was initiated under Dr. Jiming Chen and Aline Ratau and entitled "Community Empowerment through Research Information." This involves the communication of relevant research information about North Manhattan elders to community agencies serving these elders. Co-sponsorship of events included the Alzheimer Information Day at the Columbia Presbyterian Medical Center on December 7, 1994.
<P ALIGN="JUSTIFY">
<B>Organization and Effectiveness of Home-Delivered Services to Elders</B>  In 1994, this became a new focus of research under the leadership of Peter Cross with Dr. Jeanne Teresi and Eloise Killeffer. Such services-most notably, personal care services-have been among the most rapidly growing health services, swelling to over a billion dollars a year of public money in New York City alone. Of special interest is the articulation of home-based services with mental health and general medical services. This new thrust was inaugurated in a Stroud Distinguished Lecture by Dr. Morton Kramer in May 1993. Preliminary work has included a secondary analysis of data from the North Manhattan Aging Project on home care recipients to examine putative home care eligibility criteria, submitted as a contract report to the Agency for Health Care Policy and Research, and a report on possible reforms of home care, submitted to the New York State Department of Health. Ongoing studies of home care are planned for the Upper West Side of Manhattan, an area with a high rate and number of home-care recipients. Home-care utilization data for this area has been obtained and analyzed preliminary to submission for funding of a large longitudinal study of the home-care population with special focus on their mental health problems and use of mental health services.
<H3 ALIGN="JUSTIFY">
<B>Columbia University-New York Geriatric Education Center</B>
</H3>
<P ALIGN="JUSTIFY">
This project is a new three-year initiative under the direction of Dr. Terry Fulmer, with Co-directors Drs. Barry Gurland and Rafael Lantigua from Columbia University, Dr. Mathy Mezey from New York University, and Dr. Robert Kennedy from Beth Abraham Hospital. Funded by the Federal Bureau of Health Professions, it is a consortium of three institutions providing a five-day certificate program in interdisciplinary geriatric training to a wide range of professionals throughout New York State. It includes three days of core activities on geriatric assessment, multiculturalism, elder abuse, long-term care, nutrition, bioethics, Alzheimer's disease, and quality of life. In addition there are two days of intensive work in a choice of specialty modules on any core topic of geropsychiatry, rehabilitation medicine, occupational and physical therapy, dentistry, social work, and nursing. Full day conferences provide additional opportunities for learning. The interdisciplinary and multi-cultural focus provides professionals with the most up-to-date material available. The train-the-trainer approach with a short term intensive learning experience promotes leadership with the enthusiasm to institute change and to improve the quality of health care the elderly.
<H3 ALIGN="LEFT">
<B>Community Outreach Education on Alzheimer's Disease (AD) in <BR>
North Manhattan and Harlem</B>
</H3>
<P ALIGN="JUSTIFY">
Funded by the National Institute on Aging (NIA) for the period 1992-95 (Dr. Ruth Bennett, Principal Investigator) this project continued its regional AD outreach education work. A brochure describing all programs and services related to AD continues to be circulated. The North Manhattan Community Information Center on Memory Loss, an AD resource center funded by this grant at the Fort Washington Houses and Services for the Elderly, has reached over 50 community service organizations including churches and senior centers in Harlem and North Manhattan, which have received talks from Center bilingual outreach workers. Initial requests are highest for respite and support services.
<!-- This document was created using BeyondPress(TM) 1.0-439896. -->
</BODY></HTML>
</DOC>
<DOC>
<DOCNO>WT02-B10-179</DOCNO>
<DOCOLDNO>IA093-000995-B030-88</DOCOLDNO>
<DOCHDR>
http://www.nyspi.cpmc.columbia.edu:80/NYSPI/PIDPT_HV.HTM 156.111.80.30 19970121072941 text/html 18722
HTTP/1.0 200 OK
MIME-Version: 1.0
Server: GLACI/2.01
Date: Tue Jan 21 02:33:47 1997
Content-Type: text/html
Content-Length: 18591
</DOCHDR>
<HTML>
<HEAD><TITLE>HIV Center</TITLE></HEAD>
<BODY BACKGROUND="..\IMAGES\MARBLE.JPG">

<H1 ALIGN="CENTER">
HIV Center for Clinical and Behavioral Studies
</H1>
<P ALIGN="CENTER">
<B>Anke A. Ehrhardt, Ph.D., Director<BR>
Zena A. Stein, M.A., M.B., B.Ch., Co-Director</B>
<HR>
<H4 ALIGN="CENTER"><A HREF="http://cpmcnet.columbia.edu/dept/pi/hiv/">CPMC - Behavioral Sciences Research Training in HIV Infection</A></H4>
<HR>
<P ALIGN="JUSTIFY">
In September, 1987, the National Institute of Mental Health in conjunction with the National Institute of Drug Abuse (NIDA) awarded a five-year research grant to establish the HIV Center for Clinical and Behavioral Studies at the New York State Psychiatric Institute and Columbia-Presbyterian Medical Center (CPMC) in New York City. In 1992, the Center underwent a successful renewal process and was awarded another research grant from the National Institute of Mental Health for the next five years-February 1, 1993 to January 31, 1998.
<P ALIGN="JUSTIFY">
The mission of the first phase of the HIV Center was to study all aspects of HIV infection in order to develop appropriate treatment and intervention strategies. In its second five years, the HIV Center continues to be dedicated to interdisciplinary studies on the prevention of sexual transmission of HIV, with efforts focused within the thematic context-Determinants of Sexual Risk Behavior and Model Interventions for Behavior Change-and targeting heterosexual women and men, gay men, children, and adolescents. Sexual-risk behavior and behavior change are tackled from many different perspectives: with both genders (exploring the gender-specificity of behavioral determinants), at different developmental points (childhood, adolescence, and adulthood), in various social contexts (the individual level, the couple level, the parent/child dyad, and social networks), with infected people and people at risk, among ethnically diverse populations, for special populations (depressed adolescent girls, homeless mentally ill men and women), and for different sexual orientations.
<P ALIGN="JUSTIFY">
The studies on behavior focus on the elucidation of determinants that can be modified to increase safer sex. The intervention studies are clinical trials with relatively small samples, allowing detailed examination of a large number of determinants and identification of components critical to the success of larger programmatic interventions. Thus, the goal is to isolate key elements of behavior change that can subsequently be used by programs in local communities, nationwide, and internationally.
<H3 ALIGN="JUSTIFY">
<B>HIV Center Cores</B>
</H3>
<P ALIGN="JUSTIFY">
The core and project concept that worked effectively during the first five years of the HIV Center has been retained.
<P ALIGN="JUSTIFY">
Cores of the HIV Center are:
<P ALIGN="JUSTIFY">
<B>Psychosocial/Qualitative Assessment Core (Principal Investigator, Susan Tross, Ph.D.) </B>guides and advises HIV Center projects and assures that psychological and social theory and methods are kept sharply in focus in the design, implementation, and evaluation of research assessment. Issues of acculturation and transculturation are given special attention. The core played a major role in the development and leadership of several successful grant proposals that were developed and/or funded in 1994. Dr. Tross is a Co-investigator on the NIMH-funded HIV Risk in NYC's Homosexually Active Latin American Men, with Dr. Alex Carballo-Di&eacute;guez as Principal Investigator. A SAMHSA grant, Mental Health Services for Families Affected by HIV, is directed by Dr. Jennifer Havens as Principal Investigator. And the NIMH has also funded the AIDS Prevention Behavioral Consortium
<P ALIGN="JUSTIFY">
<B>Psychosexual Assessment Core (Principal Investigator, Heino Meyer-Bahlburg, Ph.D.) </B>develops and provides instruments for the assessment of sexual risk behavior, oversees the quality control of assessments, and trains and monitors sex interviewers.
<P ALIGN="JUSTIFY">
<B>Statistics, Epidemiology, and Data Management Core (Principal Investigator, Zena Stein, M.D.)</B> advises in the solution of design problems and analysis of project data, maintains an overview of multidisciplinary data, provides statistical review of manuscripts, conducts regularly scheduled clinics, workshops, and seminars, and oversees data entry applications, project management procedures, and quality control procedures. The core includes the Data Bank, coordinated and managed by Dr. Meyer-Bahlburg, resulting from the studies of disease progression among gay men and injection-drug using men and women that was begun during the first five years of the HIV Center.
<P ALIGN="JUSTIFY">
<B>Information Exchange Core (Principal Investigator, Patricia A. Warne, Ph.D.)</B> provides a mechanism for bidirectional communication between the HIV Center and professional and general communities locally, nationally, and internationally. The core comprises the Community Liaison Program, led by Joyce Hunter, the Media-Based Intervention/Education Program, the International Program, and the Professional Education/Information Dissemination Program. In 1994, the Media-Based Intervention/Education Program produced two AIDS-prevention public service announcements, one for adolescent/young adult women, and the other for adolescent/young adult men. Both will be aired on WNYC-TV and on Time Warner Cable of New York City in Spring 1995. Also underway is a project to develop and air AIDS-prevention/education radio spots for heterosexually active young African-American adults. The AIDS-prevention video, Breaking the Silence, developed with Latinas and taped in Washington Heights, premiered in 1994 at a reception for the community at Columbia-Presbyterian Medical Center. The latest HIV Center video, Working It Out: Scenes from the Lives of Lesbian and Gay Youth, was produced this year and is being used by service providers working with lesbian and gay adolescents to effect HIV risk reduction behaviors.
<P ALIGN="JUSTIFY">
<B>Ethics, Policy, and Legal Core (Principal Investigator, Ronald Bayer, Ph.D.)</B> collaborates with the Columbia University School of Public Health to bring together ethicists, <BR>
public policy experts, clinicians, philosophers, lawyers, and economists to serve the HIV Center by providing consultation to the research projects, initiating empirical studies on questions with an ethical or policy dimension, and providing an institutional context in which core members present their own ongoing HIV-related research on ethical, legal, and policy issues for critical review at monthly meetings.
<H3 ALIGN="JUSTIFY">
<B>HIV Center Projects</B>
</H3>
<P ALIGN="JUSTIFY">
<B>Determinants of Sexual Problem Behaviors in Childhood (Principal Investigator, Heino Meyer-Bahlburg, Ph.D.)</B> studies the emergence of sexual problem behaviors in children who are at increased risk for disruptive behavior/conduct disorders. The project adds onto a longitudinal project in the Lowenstein Center of the Department of Child and Adolescent Psychiatry on determinants of disruptive behavior/conduct disorders among elementary school-aged boys who are the younger brothers of juveniles adjudicated in New York Family Court for personal or property offenses. Developing methods for the study of childhood sexual problem behaviors among both boys and girls, HIV Center investigators aim to identify predictors of sexual problem behaviors and to explore whether or not those factors also predict disruptive behavior/conduct disorders. Thus far, they have found that parent-child communication about sex seems largely limited to negative statements, and that many parents, uncertain about how to talk to their children about sex, express great need for assistance in this area. Results from this study will contribute to the development of programs to prevent sexual problem behaviors in childhood and early adolescence.
<P ALIGN="JUSTIFY">
<B>HIV Risk and Coming-Out Among Gay and Lesbian Adolescents (Principal Investigator, Margaret Rosario, Ph.D.) </B>examines the developmental process of establishing one's sexual identity, the effect of that coming-out process on HIV-related and non-HIV-related risk behaviors, and the social norms and socially competent responses for negotiating safer sex and coming-out among adolescents who self-identify as gay, lesbian, or bisexual. The first <BR>
data from the study indicate that these adolescents are at risk for HIV and that their coming-out experiences contribute to HIV risk behaviors. For example, over 40% of the adolescents self-identifying as lesbian reported having had at least one male sexual partner who injected drugs, had a sexually-transmitted disease (STD), was HIV-positive or had AIDS, or was gay or bisexual. Lesbians reporting at least one lifetime male sexual partner who was gay or bisexual were likely to have been rejected by their mothers or fathers for being lesbian. Thus, HIV prevention programs must target lesbian girls. This study will provide guidelines for tailoring HIV prevention programs to adolescents who are struggling with issues of establishing their sexual identity.
<P ALIGN="JUSTIFY">
<B>AIDS Prevention for Girls in Therapy for Depression (Principal Investigator, Donna Moreau, M.D.)</B> has developed and will implement and evaluate a prevention program to delay the initiation of sexual activity and to eliminate or reduce HIV-related risk behaviors among high-risk adolescents-depressed Latino adolescent girls living in New York City. A central question in the AIDS prevention program is whether mothers can play a role in preventing sexual risk behaviors in their daughters, who are recruited from the Child Psychiatry Outpatient Clinic at Columbia-Presbyterian Medical Center.
<P ALIGN="JUSTIFY">
In order to reduce the incidence of sexual behaviors that place women and men at risk for HIV and other STDs, the project <B>Sexual Risk Behavior Change in Heterosexual Women and Men (Principal Investigator, Anke A. Ehrhardt, Ph.D.)</B> has developed and is testing an HIV/STD prevention program for heterosexual African-American, Latino, and Caucasian women who do not currently use drugs and who are of unknown or negative HIV serostatus. The women's study assesses barriers and facilitators of safer sex with an emphasis on issues of sexuality and gender, analyzing specific determinants of sexual risk behavior in the context of women's actual lives. Working with women recruited from a family planning clinic in Brooklyn, investigators are conducting a randomized clinical trial of eight- and four-session versions of a culturally sensitive intervention program. The study thus can test the validity and relevance of a theoretical model of HIV risk reduction. A qualitative, exploratory investigation has also been initiated with heterosexual men recruited from an STD clinic to identify gender-specific barriers to sexual behavior change and potential strategies for developing interventions for heterosexual men.
<P ALIGN="JUSTIFY">
<B>Primary Prevention for Male HIV-Serodiscordant Couples (Principal Investigator, Robert H. Remien, Ph.D.)</B> is a three-year study of 90 male couples having Puerto Rican and /or Anglo members who are of known discordant HIV serostatus. The investigators assess the contextual and psychological determinants of sexual risk behavior for both the couple and the individual in order to provide the foundation for a theory-driven intervention to reduce high-risk sexual behavior in this population.
<P ALIGN="JUSTIFY">
More than half the participating couples are discrepant in reporting risk behavior, and one-third disagree about what is risky. There are also ethnic differences in sexual behavior of Anglo and Puerto Rican men. In addition to reducing sexual risk behavior, the intervention under development will aim to increase and sustain mutual support and <BR>
care-giving and decrease adverse reactions to HIV in the relationship.
<P ALIGN="JUSTIFY">
Having studied the determinants of HIV risk behaviors among psychiatric patients in the Fort Washington shelter for men in New York City, investigators of the <B>Critical Time Intervention to Reduce HIV Risk Behaviors Among Homeless Mentally Ill Individuals Project (Principal Investigator, Ezra Susser, M.D., Dr.P.H.)</B> have now proceeded with the development and testing of an intervention to reduce the frequency of unprotected sex among minority homeless mentally ill men. This population is mainly African-American and Latino, chronically ill, socially disadvantaged, and often afflicted by cognitive impairments that impede social learning. Thus, the culturally appropriate intervention is highly focused on one or two outcomes, uses skills training methods that have proven effective in schizophrenia, targets critical barriers to behavior change, takes account of the patterns of sexual relationships among these patients, and addresses the relationship between psychiatric symptoms and risky sexual behaviors.
<P ALIGN="JUSTIFY">
The past year has also seen the completion of an elicitation study among homeless mentally ill women and the development of a grant application to support an intervention trial in this vulnerable population.
<H3 ALIGN="JUSTIFY">
<B>Cohort Studies: Progression Of HIV Infection</B>
</H3>
<P ALIGN="JUSTIFY">
In addition to the cores and current projects of the HIV Center, several independently funded studies have arisen at CPMC that follow the cohorts of gay men and injection drug-using men and women assembled and studied by the HIV Center during its first five years. These include a program project on oral findings in HIV infection at the Columbia University School of Dental and Oral Surgery (Principal Investigator, Ira B. Lamster, D.D.S.) and a Dana Foundation drug trial consortium to study the treatment of HIV dementia and related cognitive disorders (Principal Investigator, Richard Mayeux, M.D.). Both of these programs are connected to the HIV Center with subcontracts (Principal Investigator, Anke A. Ehrhardt, Ph.D.) to utilize the Center's Data Bank. Through these collaborations, the Center has maintained its links with clinical and basic science colleagues and has continued to address issues of disease progression, treatment, and care.
<H3 ALIGN="JUSTIFY">
<B>Training Activities</B>
</H3>
<P ALIGN="JUSTIFY">
The Behavioral Sciences Research Training Program in HIV Infection (Program Director, Zena Stein, M.D.; Training Director, Robert Kertzner, M.D.) provides postdoctoral fellowship training for research on behavioral, mental health, and public health issues in HIV infection. The HIV Center is also the training site for four Aaron Diamond Foundation Postdoctoral Fellows, the most recent being Blanca Ortiz-Torres, Ph.D., who was awarded a fellowship to study gender scripts and safer sex among Latinas, under the mentorship of Anke A. Ehrhardt, Ph.D.
<P ALIGN="JUSTIFY">
Dr. Stein directs an international training program in the epidemiology of AIDS in South Africa, supported by a training grant from the Fogarty International Center.
<H3 ALIGN="JUSTIFY">
<B>Conferences</B>
</H3>
<P ALIGN="JUSTIFY">
In July, 1994, HIV Center investigators attended the Second International Conference on the Biopsychosocial Impact of HIV Infection in Brighton, England, where they made 10 oral and eight poster presentations. In addition, Dr. Ehrhardt delivered a plenary address, Gender Risk Behavior and Intervention Programs For Women. At the Tenth International Conference on AIDS in Yokohama, Japan in August, 1994, Dr. Stein delivered a plenary address on methods women can use for HIV prevention, and Joyce Hunter moderated a panel, Reproductive Health and HIV/AIDS, and was an organizer of the Women's Satellite Conference for the International AIDS Society.
<H3 ALIGN="JUSTIFY">
<B>Other Grant Support</B>
</H3>
<P ALIGN="JUSTIFY">
HIV Center investigators have played a key role in the following grants:
<P ALIGN="JUSTIFY">
Ezra S. Susser, M.D., Dr.P.H., is Principal Investigator and Heino Meyer-Bahlburg, Ph.D., Co-Investigator of a NIMH grant to study HIV risk behavior among homeless mentally ill men.
<P ALIGN="JUSTIFY">
Francine Cournos, M.D., is Principal Investigator of a training grant from SAMHSA, HIV Training for Providers to the Severely Mentally Ill.
<P ALIGN="JUSTIFY">
Susan Tross, Ph.D. is Principal Investigator of the Centers for Disease Control (CDC)-funded Lower East Side Health Project assessing the efficacy of a peer outreach/media distribution program for HIV-related condom use attitudes, intentions, and behavior in inner city women who are sexual partners of injection drug users. She is Co-Investigator of a grant from SAMHSA to develop and evaluate mental health services for families affected by HIV (Principal Investigator, Jennifer Havens, M.D.). Dr. Tross is also Clinical Director of the Comprehensive Care Center for Addicted Mothers and Infants supported by NIDA at <BR>
St. Luke's/Roosevelt Hospital Center.
<P ALIGN="JUSTIFY">
Dr. Alex Carballo-Di&eacute;guez was awarded a grant from NIMH to explore interethnic variations in factors associated with sexual risk behavior among Latin American men in New York City who have sex with men.
<P ALIGN="JUSTIFY">
Current recipients of Aaron Diamond Foundation Postdoctoral Fellowships from the HIV Center are Claude A. Mellins, Ph.D (Mentor, Anke A. Ehrhardt, Ph.D.) to study stress, social support, and psychosocial functioning of HIV-infected mothers and children; Robert Klitzman, M.D. (Mentor, Mervyn Susser, M.D.) to study self-disclosure of HIV serostatus; and Paul Colson, Ph.D. (Mentor, Ezra Susser, M.D., Dr. P.H.) to study adherence to TB chemoprophylaxis among the homeless mentally ill.
<P ALIGN="JUSTIFY">
Overall, the HIV Center strives to stay at the forefront of the HIV/AIDS epidemic, conducting research on heterosexual transmission, on ways women can protect themselves, on young people, on gay men who are at particularly high risk, and on populations with special mental health needs. The Center continues to serve as a resource for exchange with communities in New York, the United States, and many parts of the world.
<P ALIGN="CENTER"><B>
<!--<B>From left to right, Joan McKinnon, Maryse Joseph, George Todak, and <BR>
Ronda Friedman at work on an HIV Center project.</B>-->
</B>
<!-- This document was created using BeyondPress(TM) 1.0-439896. -->
</BODY></HTML>
</DOC>
<DOC>
<DOCNO>WT02-B10-180</DOCNO>
<DOCOLDNO>IA093-000995-B030-103</DOCOLDNO>
<DOCHDR>
http://www.nyspi.cpmc.columbia.edu:80/NYSPI/PIDPT_LI.HTM 156.111.80.30 19970121072949 text/html 7612
HTTP/1.0 200 OK
MIME-Version: 1.0
Server: GLACI/2.01
Date: Tue Jan 21 02:33:56 1997
Content-Type: text/html
Content-Length: 7482
</DOCHDR>
<HTML>
<HEAD><TITLE>Lithium</TITLE></HEAD>
<BODY BACKGROUND="..\IMAGES\MARBLE.JPG">

<H1 ALIGN="CENTER">
Lithium Studies and Manic Depression
</H1>
<P ALIGN="CENTER">
<B>Ronald R. Fieve, M.D., Chief of Psychiatric Research</B>
<P ALIGN="JUSTIFY">
This past year the Department of Lithium Studies continued to screen for mood disorders in new patients who came to the clinic from the neighboring community, New York City, and the surrounding states. We treated patients by giving them psychotropic medications that have been shown to correct alterations in brain chemistry and to address their social needs. In turn, we collected detailed data for our research projects that focus on the multifactorial causes of mood disorders. Our research encompasses the genetic, biological, psychogenic, and environmental factors and their interplay.
<P ALIGN="JUSTIFY">
Once more we were reminded of the fact that the clinic model we have been using for over 20 years at the New York State Psychiatric Institute is presently the new focus of New York State's mental health system as it is emphasizing "preventive" psychiatric services at the community level (OMH News, September 1994) rather than treatment after an acute episode occurs. The "well-patient" community clinics, which Dr. Fieve and his team initiated in the early 1970s, are an effective and low-cost way of treating large numbers of patients who live at home and receive treatment on an outpatient basis.
<P ALIGN="JUSTIFY">
Our research this year was supported by the Marmot Foundation, the Milhauser grant, and the Depression Research Fund.
<H3 ALIGN="JUSTIFY">
<B>Treatment</B>
</H3>
<P ALIGN="JUSTIFY">
Our specialized clinic at Psychiatric Institute focuses on patients who otherwise would not have access to therapy because of their financial and socioeconomic status. The main goal was to prevent or reduce the frequency and severity of subsequent affective episodes and make them functioning members of the community.
<P ALIGN="JUSTIFY">
The Lithium Clinic's Head Research Nurse, Annemarie Schlegel, RN, participated in treatment, research, and clinical care of patients.
<H3 ALIGN="JUSTIFY">
<B>Research</B>
</H3>
<P ALIGN="JUSTIFY">
<B>Psychopharmacotherapy  </B>Projects during the year have included a study comparing a new third generation antidepressant paroxetine (Paxil) with a traditional tricyclic antidepressant imipramine (Tofranil) in depressed patients. There were no significant differences between the two drugs in alleviating the symptoms of depression. However, paroxetine appeared to have more beneficial effects on the anxiety symptoms that are frequently associated with depression when compared to imipramine. Side effects for paroxetine were typical of other drugs that enhance serotonergic function but different from those of imipramine. We found paroxetine to be an effective and safe medication for controlling depression especially in the elderly, whose treatment often is complicated by age and related comorbid conditions such as cardiovascular disease.
<P ALIGN="JUSTIFY">
We also continued our study on the effectiveness of fluoxetine (Prozac), the first of the new class of antidepressant compounds (the so-called, selective serotonin reuptake inhibitors) in the treatment of major depressive disorder. We found Prozac to be as effective in treating depression as the standard tricyclic antidepressants. Patients taking Prozac experienced fewer side effects when compared with the traditionally used antidepressants. We demonstrated that Prozac can be prescribed to patients suffering from dysthymia, (the milder form of major depression) and obsessive-compulsive disorder, as well as to patients who suffer from bulimia.
<P ALIGN="JUSTIFY">
Dr. Fieve's book Prozac: Questions and Answers for Patients, Family, and Physicians, published by Avon Books in April 1994, puts forth for the general public the current thinking of our research group about Prozac.
<P ALIGN="JUSTIFY">
Using a longitudinal life-table model analysis, we assessed the prophylactic efficacy of lithium alone, administered within the context of a naturalistic clinical setting, by calculating the probability patients remaining free of an affective episode (manic or depressive) over a five-year course. In addition, for those who suffered a manic or depressive relapse, we attempted to analyze the subsequent course of patients who were then restabilized on lithium plus either a neuroleptic, carbamazepine, or a benzodiazepine, or lithium plus an antidepressant. Lithium alone offered an average 83% probability against an affective relapse after one year, 52% after three years, and 37% after five years. For patients who failed on lithium alone, it appeared that combination treatment offered greater protection against subsequent affective relapses than the initial course on lithium alone.
<P ALIGN="JUSTIFY">
We also continued to investigate alternatives to lithium to help those patients who are not able to take lithium due to kidney disease, cardiovascular problems, severe lithium intolerance, or electrolyte conditions. Our studies show carbamazepine, valproic acid, and klonopin to be effective alternatives in many manic depressive patients. In addition, we examined personality traits before and after pharmacological treatment for depression. We concluded, based on our data, that the melancholic subtype of depression is associated with greater frequency of Cluster A personality disorders than the non-melancholics. The department's research was done in collaboration with The Foundation for Depression and Manic Depression and Dr. Fieve's team at Columbia University.
<P ALIGN="JUSTIFY">
<B>Genetics  </B>In a collaborative study with Dr. Miron Baron of the Department of Medical Genetics, we continued to collect epidemiological data from our Columbia University and Foundation patient populations. This study also included bipolar patients from other clinics in the US and abroad, thus making it the largest bipolar pedigree study reported to date. Results suggest that X-chromosome linkage can be applied to a small subgroup of bipolar cases; however, in light of conflicting findings and methodological uncertainties in studying a disorder with unclear phenotype and complex linkage data, an extension and re-evaluation of published data will be required to further an understanding of this intriguing hypothesis.
<H3 ALIGN="JUSTIFY">
<B>Education</B>
</H3>
<P ALIGN="JUSTIFY">
We continue to educate the public at large as well as professionals at conferences <BR>
in the US and abroad. The staff was also available for Columbia students and for resident teaching.
<P ALIGN="JUSTIFY">
Dr. Fieve appeared on CNN-"Sonya Live," on Channel 17-"Turning Point," Channel 1-"Good Day New York," and a number of radio shows discussing the affective disorders, in particular, depression and the effectiveness of Prozac and other SSRIs in treatment of this often debilitating illness. Two posters at the 33rd Annual ACNP meeting addressed the issues of the relationship between melancholia and personality and placebo response in depressive illness.
<P ALIGN="JUSTIFY">
At the sesquicentennial meeting of the American Psychiatric Association this past year, Dr. Fieve's work on lithium was considered one of several "milestones in American Psychiatry's first 150 years."
<!-- This document was created using BeyondPress(TM) 1.0-439896. -->
</BODY></HTML>
</DOC>
<DOC>
<DOCNO>WT02-B10-181</DOCNO>
<DOCOLDNO>IA093-000995-B030-119</DOCOLDNO>
<DOCHDR>
http://www.nyspi.cpmc.columbia.edu:80/NYSPI/PIDPT_ME.HTM 156.111.80.30 19970121073011 text/html 15594
HTTP/1.0 200 OK
MIME-Version: 1.0
Server: GLACI/2.01
Date: Tue Jan 21 02:34:07 1997
Content-Type: text/html
Content-Length: 15463
</DOCHDR>
<HTML>
<HEAD><TITLE>Medical Genetics</TITLE></HEAD>
<BODY BACKGROUND="..\IMAGES\MARBLE.JPG">

<H1 ALIGN="CENTER">
Medical Genetics
</H1>
<P ALIGN="CENTER">
<B>L. Erlenmeyer-Kimling, Ph.D., Acting Chief of Psychiatric Research<BR>
Miron Baron, M.D., Psychiatrist (Research) II<BR>
Charles A. Kaufmann, M.D., Psychiatrist (Research) II<BR>
Dolores Malaspina, M.D., Psychiatrist (Research) II<BR>
David Friedman, Ph.D., Research Scientist VI<BR>
T. Conrad Gilliam, Ph.D., Research Scientist VI<BR>
Harlow K. Fischman, Ph.D., Research Scientist V<BR>
M. Bento Soares, Ph.D., Research Scientist V<BR>
Nancy S. Wexler, Ph.D., Head, Division of Neurology</B>
<P ALIGN="JUSTIFY">
After achieving major breakthroughs in recent years, the Department of Medical Genetics continued to pursue research into the genetic basis of psychiatric and neurologic disorders. 
<H3 ALIGN="JUSTIFY">
<B>Molecular Genetics Unit</B>
</H3>
<P ALIGN="JUSTIFY">
Research in the Molecular Genetics Unit (MGU), directed by Dr. Conrad Gilliam, continues to focus on the genetics and pathogenesis of single-locus and complex heritable disorders in humans. In 1994, the MGU focused on seven major efforts: (1) continuing the gene-mapping effort to identify the spinal muscular atrophy (SMA) gene; (2) beginning studies of the pathogenesis of heritable disorders by expressing and characterizing the copper-transporting ATPase that was identified by the MGU as the Wilson disease gene in 1993; (3) beginning a collaboration with Dr. Jurg Ott's Department of Statistical Genetics on the genetic mapping of an autosomal recessive form of retinitis pigmentosa on chromosome 6, in which the lab is continuing to narrow the disease locus; (4) beginning a collaborative effort with a group in Finland to identify a rare single-locus gene for epilepsy; continuing large scale efforts to map predisposition genes for (5) bipolar affective disorder and (6) panic disorder; and (7) performing linkage studies on a small set of families with schizophrenia.
<P ALIGN="JUSTIFY">
The search for the SMA gene, now in its final stage, has led to the identification in the MGU of two genes as candidates for the disease locus. These genes, along with two genes identified by others, are preferentially deleted in SMA patients. The MGU has identified a basic transcription factor sub-unit and a cell cycle regulatory protein kinase that map to the deletion region in SMA patients and has formulated a theory about the role of the protein products of the genes in forming a nucleotide excision repair complex to protect against increased oxidative metabolism that is known to damage DNA.
<P ALIGN="JUSTIFY">
In the work on bipolar disorder, carried out collaboratively with Dr. Baron's Psychogenetics Division, genotyping of 100 DNA markers in 47 large families has led to detection of strong linkage to chromosome 21q22.3 in a single family. The data, which have proved to be robust to rigorous testing for a number of parameters, constitute one of the strongest linkage findings with respect to a psychiatric disease in a single family and are consistent with the presence of a single-locus gene that predisposes to bipolar affective illness in at least a small fraction of cases of this disorder.
<P ALIGN="JUSTIFY">
Dr. James Knowles was recruited into the MGU as Assistant Professor to oversee the panic disorder studies and to design new strategies to identify loci for psychiatric genetics diseases.
<H3 ALIGN="JUSTIFY">
<B>Psychogenetics Division</B>
</H3>
<P ALIGN="JUSTIFY">
The Psychogenetics Division, directed by Dr. Miron Baron, continues its studies designed to localize and characterize susceptibility genes for bipolar and other mood disorders in a genome-wide search using DNA markers, in collaboration with the department's MGU and with Dr. Jurg Ott's Department of Statistical Genetics. Collaborating with Dr. Jean Endicott's Department of Research Assessment and Training, the Psychogenetics Division has assembled, in North America and Israel, the largest sample of bipolar families reported to date, thus affording substantial statistical power to detect or exclude susceptibility genes. As recently reported in Nature, a potentially important fruit of this labor is a possible linkage between bipolar disorder and chromosome 22 (also mentioned above under the MGU).
<H3 ALIGN="JUSTIFY">
<B>Huntington's Disease Research Group</B>
</H3>
<P ALIGN="JUSTIFY">
The Huntington's Disease (HD) Research Group, directed by Dr. Nancy Wexler, began work on the nature of the protein ("huntingtin") made by the HD gene. The protein, which has never been described, is made by both the normal gene and the HD allele, although in much larger quantity by the latter owing to the excessive number of trinucleotide repeats that made up the HD allele. Although the disease attacks a specific portion of the brain, the protein is found in all body cells. The task is to discover its normal function, as well as its altered function, in HD. The HD Research Group is collaborating with Dr. Efstratiadis of Columbia University in creating a mouse model of HD, using expanded trinucleotide repeats from children with juvenile onset HD from the large Venezuelan pedigree studied by Dr. Wexler. Use of the mouse model to "knock out" the HD gene is expected to discover the normal function of the gene and how the expanded repeat causes its lethal damage in HD. Dr. Wexler received the American Academy of Achievement's Golden Plate Award and the J. Allyn Taylor International Prize in Medicine.
<H3 ALIGN="JUSTIFY">
<B>Keck Laboratory</B>
</H3>
<P ALIGN="JUSTIFY">
The Keck Laboratory, directed by Dr. Marcelo Bento Soares, has been selected to be responsible for generating most of the cDNA libraries for a major multi-institutional, worldwide effort that has been initiated with the goal of obtaining partial nucleotide sequences from human genes. The cDNA libraries will be arrayed at the Lawrence Livermore National Laboratories. The information will be deposited in Genbank as well as being available worldwide for laboratories pursuing large scale mapping of human genes.
<P ALIGN="JUSTIFY">
The Keck Laboratory plays a major part in the Columbia University program, funded by the National Center for Human Genome Research, which is generating a complete physical map of human chromosome 13.
<H3 ALIGN="JUSTIFY">
<B>NIMH Genetics Initiative</B>
</H3>
<P ALIGN="JUSTIFY">
The New York site of the NIMH Genetics Initiative, directed by Drs. Charles Kaufmann, Dolores Malaspina, and Jill Harkavy Friedman, continues to identify and evaluate families with several schizophrenic members. The several sites of the Genetics Initiative have ascertained 108 families with 910 individuals, making it the largest systematically acquired sample of multiply-affected schizophrenic pedigrees in the world. The study has now been re-funded by the NIMH for sample expansion, pedigree extension, and subject re-evaluation. Pedigrees from the Genetics Initiative have been genotyped in collaboration with the MGU in an effort to respond to preliminary linkage results reported by other groups. The focus has been on chromosomes 5, 17, and 22, based not only on reports by others but also on several aspects of the Psychiatric Institute investigators' own work. Linkage to chromosome 5p or chromosome 22q appears to have been excluded; analyses of possible linkage to chromosome 17q is under way.
<P ALIGN="JUSTIFY">
<B>Schizophrenia Developing Clinical Research Center (SDCRC)</B>  Dr. Kaufmann, heading the Laboratory for Molecular Neurobiology, and Dr. Malaspina, heading the Laboratory of Clinical Neurobiology, have been closely involved in the establishment of the Schizophrenia Developing Clinical Research Center (SDCRC) as Co-principal Investigator and Coordinator, respectively. In conjunction with the SDCRC and the Genetics Initiative, and in several other collaborative efforts, these researchers have been engaged in tackling a large number of important problems concerned with schizophrenia. These include efforts to determine the relative importance of prefrontal versus temporal lobe dysfunction in patients from families with minimal versus heavy loading of schizophrenic relatives; examination of other features associated with high familial loading for schizophrenia; and research into a variety of other questions, such as the prevalence of schizotypal personality disorder in relatives of schizophrenic proband pairs and the evaluation of possible evidence for the phenomena of anticipation and imprinting in multiply-affected pedigrees.
<P ALIGN="JUSTIFY">
Dr. Malaspina has commenced several projects in SPECT functional brain imaging, in which the dopamine 3 (D4) receptor is being quantified among groups of schizophrenic patients and normals, and brain activity during an olfactory neuroactivation task is being examined. Ongoing studies also include examination of tonic cardio-vagal tone in schizophrenia, investigation of neural pathways significant to olfactory discrimination, and study of traumatic brain injury as an environmental exposure relevant to schizophrenia.
<H3 ALIGN="JUSTIFY">
<B>Division of Developmental Behavioral Studies</B>
</H3>
<P ALIGN="JUSTIFY">
The Division of Developmental Behavioral Studies, directed by Dr. Erlenmeyer-Kimling, continued a search for pedigrees with several schizophrenic relatives in Croatia. The search is being conducted in collaboration with Dr. Endicott's Department of Research Assessment and Training, Dr. Gilliam's MGU, and Dr. Ott's Department of Statistical Genetics, as well as with a group of Croatian colleagues. Despite the difficulties of collecting these pedigrees in current circumstances in Croatia, 30 multiply-affected pedigrees have now been entered into the study. These families include 196 individuals on whom diagnostic interviewing and collection of blood samples for DNA analyses are proceeding. In addition, histories are being collected on another 194 members of these families. Efforts to expand the sample are continuing.
<P ALIGN="JUSTIFY">
Dr. Erlenmeyer-Kimling's research group completed the 23rd year of the NIMH MERIT-awarded longitudinal study following offspring of schizophrenic, affectively ill, and normal parents from childhood to adulthood. Recent analyses of the adulthood psychiatric diagnoses of the first of two independently ascertained time samples in this study shows the prevalence rates of schizophrenia and related psychoses to be 18% in the offspring of schizophrenic parents, 10% (chiefly schizoaffective disorders) in offspring of affectively ill parents, and 1% in offspring of normal controls by the age of 31. Other Axis I (psychotic and nonpsychotic major psychiatric disorders) and Axis II (personality disorders) diagnoses have also been recently investigated in the first sample. Diagnostic interviews for both Axis I and Axis II are now being completed with the second sample at age 27. Analyses continue to confirm that childhood attentional dysfunctions in psychiatrically normal children of schizophrenic parents are moderately predictive of adulthood schizophrenia-related psychopathology. Childhood neuromotor, memory, and other neurobiological dysfunctions, as well as social behavior and personality characteristics, are being investigated with respect to their relationship with specific types of later psychiatric outcomes in the offspring in both samples of this study. Dr. Elizabeth Squires-Wheeler continues to collaborate in the investigation, especially in the effort to redefine the diagnostic boundaries of conditions related to schizophrenia and the genetic aspects of the schizophrenia spectrum.
<H3 ALIGN="JUSTIFY">
<B>Cognitive Electrophysiology Laboratory</B>
</H3>
<P ALIGN="JUSTIFY">
Dr. David Friedman's Cognitive Electrophysiology Laboratory is engaged in a series of interrelated investigations concerned with cognitive event-related brain potentials, memory, and attentional function in normal development and disease states. A project on cognitive development examines the maturation of the brain's electrical activity in relationship to the development of memory function during childhood, adolescence, and young adulthood. Similarly, an investigation of the effects of aging on these types of phenomena is aimed at a better understanding of these basic memory processes and how they change, in relationship to brain activity, in normal aging. An interesting and potentially important finding that has resulted from these studies is that the reduced memory function of normally aging older adults (in comparison to young adults) may be due to inefficiency in frontal lobe function. Studies of Alzheimer's disease and schizophrenia (in collaboration with Dr. Gerard Bruder of the Department of Biopsychology) are also geared towards an understanding of how basic memory processes are either maintained or deteriorate in these disease states. New studies of Alzheimer's disease patients are concerned with how their memory function may be affected by disorders of attention, which also appear early in the course of this devastating illness. Drs. Friedman and Squires-Wheeler continue to collaborate on analyses relating event-related potentials collected during adolescence to the development of psychopathology in Dr. Erlenmeyer-Kimling's longitudinal high risk project described above.
<H3 ALIGN="JUSTIFY">
<B>Psychogenetic Stress Studies</B>
</H3>
<P ALIGN="JUSTIFY">
Dr. Fischman continued his long-term studies on the effects of psychogenic stress on the genetic system, begun in collaboration with the late Dr. Dennis Kelly of the Department of Developmental Psychobiology. These studies had previously shown that a wide variety of psychological stressors elicited damage in the genetic systems of rats, increasing both DNA and chromosomal damage and raising the level of Sister Chromatid Exchanges (SCEs).
<P ALIGN="JUSTIFY">
Rats subjected to repeated stress over a period of time demonstrate a reduction in behavioral and physiological responsiveness, a process known as habituation. To study whether this response also applies to genetic damage, Dr. Fischman subjected groups of rats to a variety of stressors in an unpatterned manner for 72 to 240 hours respectively. Both types of stress increased SCEs and chromosome aberrations, but the level of chromosome aberrations was lower in the 240-hour stressed rats, thus mirroring genotoxically the phenomenon of physiological habituation. SCEs, on the contrary, increased in the longer-stressed animals. Thus, SCE induction by stressors may be cumulative and long lasting, whereas chromosome aberrations are of shorter duration. An alternative explanation is that chromosome aberrations are effected by the same mechanism that accounts for habituation but SCEs are not. 
<P ALIGN="LEFT"><B>
<B>Drs. Miron Baron, left, and Alexander Prikhojan at the Director's Holiday Brunch.</B>
</B>
<P ALIGN="LEFT"><B>
<!--<B>From left to right,  Drs. John Mann,  Charles Kaufmann, and Steven Hyler  at the Psychiatric Institute Annual Scientific Conference.</B>
</B>
<P ALIGN="LEFT"><B>
<B>From left to right, Drs. Elizabeth Wheeler, L. Erlenmeyer-Kimling, and Dolores Kreisman at the Psychiatric Institute Annual Scientific Conference.</B>-->
</B>
<!-- This document was created using BeyondPress(TM) 1.0-439896. -->
</BODY></HTML>
</DOC>
<DOC>
<DOCNO>WT02-B10-182</DOCNO>
<DOCOLDNO>IA093-000995-B030-139</DOCOLDNO>
<DOCHDR>
http://www.nyspi.cpmc.columbia.edu:80/NYSPI/PIDPT_NE.HTM 156.111.80.30 19970121073029 text/html 6929
HTTP/1.0 200 OK
MIME-Version: 1.0
Server: GLACI/2.01
Date: Tue Jan 21 02:34:33 1997
Content-Type: text/html
Content-Length: 6799
</DOCHDR>
<HTML>
<HEAD><TITLE>Neurobiology</TITLE></HEAD>
<BODY BACKGROUND="..\IMAGES\MARBLE.JPG">

<H1 ALIGN="CENTER">
Neurobiology and Behavior
</H1>
<P ALIGN="CENTER">
<B>John Koester, Ph.D., Acting Director<BR>
James H. Schwartz, M.D., Ph.D., Research Scientist VII<BR>
Claude Ghez, M.D., Research Scientist VI<BR>
Irving Kupferman, Ph.D., Research Scientist VI<BR>
Robert Hawkins, Ph.D., Research Scientist V<BR>
Samuel Schacher, Ph.D., Research Scientist V<BR>
Craig H. Bailey, Ph.D., Research Scientist V</B>
<P ALIGN="CENTER">
<B>Howard Hughes Medical Institute</B>
<P ALIGN="CENTER">
<B>Eric R. Kandel, M.D., Director, University Professor of Physiology &amp; Cellular Biophysics &amp; <BR>
Psychiatry in the Center for Neurobiology &amp; Behavior<BR>
Steven Siegelbaum, Ph.D., Professor of Pharmacology in the Center for Neurobiology &amp; Behavior</B>
<P ALIGN="JUSTIFY">
The Center for Neurobiology and Behavior consists of eleven independent laboratories, including two laboratories of the Howard Hughes Medical Institute. The overall research goal of the Center is to provide an analysis of neural development, behavior, learning, and diseases of the nervous system in terms of their underlying cellular and molecular mechanisms. The subjects used in these studies range from simple invertebrate animals to humans.
<H3 ALIGN="JUSTIFY">
<B>Learning and Memory</B>
</H3>
<P ALIGN="JUSTIFY">
A cross-species approach to understanding the mechanisms of memory and learning has been applied, using two preparations: (1) the defensive gill and siphon withdrawal reflex of the sea hare, Aplysia californica, which undergoes habituation, sensitization, and classical conditioning; and (2) the mammalian hippocampus, which exhibits two pronounced types of long-lasting synaptic plasticity that are thought to underly long-term memory-long-term potentiation (LTP) and long-term depression (LTD). These two complementary approaches have led to a number of fundamental observations concerning the mechanisms that underly learning and memory.
<P ALIGN="JUSTIFY">
In studies using Aplysia, Dr. Bailey has examined the subcellular and molecular mechanisms that mediate the formation of new synaptic connections associated with long-term memory. In collaboration with Dr. Kandel, he has utilized gene transfer and mutation experiments to further define the signaling events responsible for the internalization of cell adhesion molecules during the initial stages of learning-related synaptic growth. Dr. Schwartz has elucidated important new regulatory steps in the ubiquitin pathway that are involved in the acquisition of long-term memory and memory storage processes. In addition, persistent activation of protein kinase C has been shown to be required for intermediate stage memory.
<P ALIGN="JUSTIFY">
Dr. Hawkins has further defined the contributions of mechanosensory sensory cells to plasticity of the gill-withdrawal reflex in Aplysia and of cyclic-guanosinemonophosphate to LTP in the hippocampus. Dr. Siegelbaum has identified the mechanism of induction and site of expression of long-term depression of synaptic transmission in the mammalian hippocampus.
<P ALIGN="JUSTIFY">
To study explicit learning and memory, new strains of transgenic mice have been developed by Dr. Kandel, in collaboration with Stanley McKnight of the University of Washington in Seattle. They have been used to examine the behavioral effects of ablations of the regulatory and catalytic subunits of protein kinase A. This kinase was found to be required for both the early and late phase of LTP in the CA3 region of the hippocampus, but only for the late phase in the CA1 region.
<H3 ALIGN="JUSTIFY">
<B>Neural Development</B>
</H3>
<P ALIGN="JUSTIFY">
Dr. Schachter has provided evidence that regulation of expression and distribution of a family of cell surface adhesion molecules can regulate cell-cell interactions and synapse formation during the initial establishment of specific connections. The regulation of the same cell surface molecules contributes to the functional and structural changes associated with long-term synaptic plasticity.
<P ALIGN="JUSTIFY">
Using gene-cloning techniques, Dr. Role has identified a family of genes that contributes to the regulation of nicotinic acetylcholine receptor subunit expression that occurs with innervation in vitro. The gene product thus identified mimics the effects of presynaptic input in increasing the expression of a particular subset of acetylcholine subunit genes and likewise alters the resultant expression of the final acetylcholine receptor.
<H3 ALIGN="JUSTIFY">
<B>Ion Channels</B>
</H3>
<P ALIGN="JUSTIFY">
Dr. Siegelbaum has proposed a molecular mechanism for the ligand-activation of cyclic nucleotide-gated ion channels, based on studies using molecular biological techniques to engineer chimeric channels. Dr. Koester has investigated the mechanism and role of frequency-dependent action potential broadening. This phenomenon, which increases both chemical and electrical synaptic transmission, was shown to be caused by the complex interaction of several types of voltage-gated ion channels.
<H3 ALIGN="JUSTIFY">
<B>Behavior</B>
</H3>
<P ALIGN="JUSTIFY">
Dr. Hen, who joined the Center this year, has determined that genetically engineered mice lacking the serotonin-1B receptor are less responsive to cocaine. These results suggest that the serotonin-1B receptor is mediating some of the reinforcing effects of cocaine. Dr. Qian, another new arrival to the Center, has provided the Center with a new level of expertise in neural modeling. He has recently finished setting up a computational neuroscience and visual psychophysics laboratory, to be used to study the neural mechanisms that underly motion and depth perception.
<P ALIGN="JUSTIFY">
Through studies of human reaching, Dr. Ghez has discovered that distinct sensorimotor transformations are responsible for both specifying and learning handpaths, joint angles, and joint torques. Moreover, he found that joint torque specification is based on short-term learning that requires proprioceptive information. Research performed in collaboration with Dr. Martin on cats points to the intermediate cerebellum as a critical structure for the control and possibly the learning of limb dynamics.
<P ALIGN="JUSTIFY">
In an ongoing study of motivated behaviors, using feeding behavior in Aplysia as a model, Dr. Kupfermann has demonstrated extensive and highly specific distributions in the nervous system of chemosensory fibers that have their cell bodies of origin in the periphery. These data suggest a parallel distributed organization of sensory input. 
<!-- This document was created using BeyondPress(TM) 1.0-439896. -->
</BODY></HTML>
</DOC>
<DOC>
<DOCNO>WT02-B10-183</DOCNO>
<DOCOLDNO>IA093-000995-B030-153</DOCOLDNO>
<DOCHDR>
http://www.nyspi.cpmc.columbia.edu:80/NYSPI/PIDPT_NR.HTM 156.111.80.30 19970121073055 text/html 10070
HTTP/1.0 200 OK
MIME-Version: 1.0
Server: GLACI/2.01
Date: Tue Jan 21 02:34:51 1997
Content-Type: text/html
Content-Length: 9940
</DOCHDR>
<HTML>
<HEAD><TITLE>Neuroscience</TITLE></HEAD>
<BODY BACKGROUND="..\IMAGES\MARBLE.JPG">

<H1 ALIGN="CENTER">
Neuroscience
</H1>
<P ALIGN="CENTER">
<B>J. John Mann, M.D., Chief of Psychiatric Research</B>
<P ALIGN="CENTER">
<B>Division of Neurochemistry</B>
<P ALIGN="CENTER">
<B>Stephen Rayport, M.D., Ph.D., Psychiatrist (Research) I<BR>
Ronald Winchel, M.D., Psychiatrist (Research) II<BR>
Hadassah Tamir, Ph.D., Research Scientist VI<BR>
Mark D. Underwood, Ph.D., Research Scientist V</B>
<P ALIGN="CENTER">
<B>Division of Neuropathology</B>
<P ALIGN="CENTER">
<B>Victoria Arango, Ph.D., Research Scientist VII<BR>
Andrew Dwork, M.D., Pathologist II<BR>
Jonathan Javitch, M.D., Ph.D., Research Associate</B>
<P ALIGN="CENTER">
<B>Division of Brain Imaging</B>
<P ALIGN="CENTER">
<B>Kevin M. Malone, M.D. Research Scientist VI<BR>
Claire Metz, Ph.D., Research Scientist II</B>
<P ALIGN="JUSTIFY">
In 1994, the Department of Neuroscience underwent a significant reorganization that greatly heightened its multidisciplinary approach to psychiatric research, integrating psychology, psychiatry, pharmacology, and basic neuroscience in order to examine the biological substrate of mental illness at multiple levels. The department comprises three divisions to pursue the application of postmortem and in vivo studies of psychiatric disorders. The Division of Neurochemistry develops laboratory probes for clinical studies of the serotonergic and other monoamine systems, and organizes clinical studies. The Division of Neuropathology conducts postmortem brain studies and provides neuropathology services to the Office of Mental Health. The Division of Brain Imaging conducts functional and structural brain imaging studies.
<H3 ALIGN="JUSTIFY">
<B>Division of Neurochemistry</B>
</H3>
<P ALIGN="JUSTIFY">
The major area of investigation for the Division of Neurochemistry has been the biological basis of suicidal behaviors. Dr. John Mann is the Director of the NIMH-funded Clinical Research Center for the Study of Suicidal Behavior. The Center supports a range of studies into the risk factors for suicidal behavior. Dr. Barbara Stanley and Dr. Ronald Winchel are conducting neurochemical and psychological investigations in individuals who manifest impulsive self-injury and trichotillomania (compulsive hair-pulling). Drs. John Mann and Kevin Malone have developed methods using Positron Emission Tomography (PET) for visualizing regional brain responses to serotonin activation. This technique allows identification of high risk patients and the localization of regional brain abnormalities in high-risk patients. Other studies are in progress examining possible genetic influences on the manifestation of suicidal and other self-harming behaviors. In collaboration with <BR>
Dr. Conrad Gilliam, a candidate gene approach has been adopted, focused on key serotonin-related genes. Dr. Bruce Parsons has a NARSAD award to continue his work on the autoradiographic analysis of dopamine receptors and uptake sites in postmortem tissues both from adults and adolescents who have committed suicide.
<P ALIGN="JUSTIFY">
Dr. Stephen Karpiak and Heljo Laev continue to detail the CNS injury cascade that occurs with excitotoxic (glutamate) damage. Using cortical and spinal cell cultures, they have described the sequelae of plasma membrane pathology associated with trauma and excitotoxic injury, and found the lipid GM1 to be an effective neuroprotective agent against such injuries. In a collaborative effort with Dr. B. L. Hungund, they have reported similar findings when studying acute alcohol toxicity.
<P ALIGN="JUSTIFY">
Dr. Tamir and her associates are continuing their work on secretogogue-induced gating of chloride channels in the secretory vesicles of parafollicular cells (PF). They have shown that PF cells of the thyroid have features of both neurons and endocrine cells. Thyroid PF cells are neural cres-derived endocrine cells that secrete serotonin and calcitonin. The function of secretory vesicles in neurons is important for neurotransmission and, therefore, for disease and therapeutics.
<P ALIGN="JUSTIFY">
Dr. Mark Underwood conducts research into the regulation of regional cerebral blood flow by the serotonergic system. The coupling of metabolism and blood flow is a fundamental assumption governing the interpretation of functional brain imaging studies using blood flow as a guide to neuronal activity. Dr. Underwood is one of the few scientists studying the validity of this assumption.
<P ALIGN="JUSTIFY">
Enormous technical advances have allowed the use of brain imaging techniques to be applied to the study of neurotransmitter systems in both postmortem and living brain. Dr. Underwood has spearheaded the laboratory, applying these techniques to postmortem brain studies.
<P ALIGN="JUSTIFY">
In postnatal mesolimbic cultures, Drs. Rayport and Sulzer have pursued studies of the synaptic physiology and psychopharmacology of mesolimbic neurons. They have found that glutamate may be a cotransmitter in mesolimbic dopamine neurons. Pursuing their weak base mechanism of amphetamine action, they have directly monitored amphetamine-induced dopamine release in real time and further confirmed the model. Using fluorophobes, they have shown that dopamine receptor subtypes are frequently colocalized on nucleus accumbens neurons. Finally, they have found that methamphetamine neurotoxicity involves an intracellular free radical mechanism.
<P ALIGN="JUSTIFY">
Dr. Stephen Rayport received a five-year award from the NIH, a Burroughs Wellcome Fund Scholar Award in Experimental Therapeutics, and a two-year award from the Scottish Rite for schizophrenia research.
<H3 ALIGN="JUSTIFY">
<B>Division of Neuropathology</B>
</H3>
<P ALIGN="JUSTIFY">
The Division of Neuropathology conducts basic and clinical research, participates in postgraduate medical education, and operates the New York State Office of Mental Health (OMH) Central Reference Laboratory (CRL) in Neuropathology. The Neuropathology division examines the brains of OMH patients obtained at autopsy. Drs. Andrew Dwork and Mavis Kaufman, in collaboration with Dr. Isak Prohovnik of the Division of Brain Imaging, have continued their studies of senile degenerative changes in schizophrenia. One achievement of this project has been to catalogue several thousand brains collected by the division. This collection, started in the preneuroleptic era, is now being studied with modern neuropathologic techniques.
<P ALIGN="JUSTIFY">
Dr. Dwork has continued structural and functional studies of nicotinic acetylcholine receptors in the central nervous system, with particular attention to the interactions of these receptors with neuroleptic drugs.
<P ALIGN="JUSTIFY">
Dr. Victoria Arango, in collaboration with Drs. Mark Underwood, Andrew Dwork, Bruce Parsons, Victor Arkhipov, and John Mann, is conducting a program of postmortem studies of suicide victims utilizing a combination of quantitative receptor autoradiography, in situ hybridization histochemistry, and morphometry of brain stem nuclei. A parallel set of postmortem studies are being conducted by the same investigators in alcoholics in order to determine the neurochemical and morphological consequences of acute and chronic alcohol consumption.
<P ALIGN="JUSTIFY">
Dr. Jonathan Javitch has worked in collaboration with Dr. Arthur Karlin of the Center for Molecular Recognition to map the binding sites for antipsychotic drugs in dopamine D2-like receptors. They have expressed human D2 receptors in cultured cells and are localizing the site of interaction of a photoaffinity-labeled drug with the receptor. This approach will be extended to D3 and D4 receptors to compare and contrast the binding sites for typical and atypical antipsychotics. Dr. Javitch has also demonstrated the existence of reduced cysteine residues near the binding site of the D2 receptor and is identifying the role of these cysteines using a combination of protein chemistry and site-directed mutagenesis.
<P ALIGN="JUSTIFY">
Dr. Andrew Dwork was successful in receiving funding from NIMH on "Effects of Education and Occupation on Synaptic Density," and from the Smokeless Tobacco Research Council. Dr. Javitch is supported by a Scientist Development Award from NIMH. Drs. Arango and Mann are supported by multiyear grants from NIMH and NIDA for the postmortem human brain research. Drs. Bruce Parsons and Avi Molcho have NARSAD awards for postmortem neurochemical studies of suicide.
<H3 ALIGN="JUSTIFY">
<B>Division of Brain Imaging</B>
</H3>
<P ALIGN="JUSTIFY">
The Division of Brain Imaging has begun a transition from the use of the 133Xe rCBF method to the use of SPECT and PET. NIH-funded projects include Dr. Devanand's study of blood flow in early cases of suspected dementia using SPECT, aneurysmal subarachnoid hemorrhage with Dr. Solomon using 133Xe, and a new study of sickle-cell disease, directed by Dr. Prohovnik, that is part of the Comprehensive Sickle Cell Center of Columbia University, under the direction of Dr. S. Piomelli. Work with functional magnetic resonance has begun. The new high field strength research group is bringing the five Tesla magnet on line.
<P ALIGN="JUSTIFY">
A major technological project to be finished this year includes the establishment of software to do PET image analysis of activation studies and volumetric analysis of MRI. Other funded projects are: a study of cerebral Lyme disease by Dr. Brian Fallon, a study of cerebral blood flow responses to anger by Dr. Peter Shapiro, and a study of cerebral blood flow responses to mood change by Dr. Eric Rubin. PET projects involve studies by Drs. Kevin Malone and John Mann on the serotonergic responsivity in major depression and the relation to suicide risk.
<!-- This document was created using BeyondPress(TM) 1.0-439896. -->
</BODY></HTML>
</DOC>
<DOC>
<DOCNO>WT02-B10-184</DOCNO>
<DOCOLDNO>IA093-000995-B030-171</DOCOLDNO>
<DOCHDR>
http://www.nyspi.cpmc.columbia.edu:80/NYSPI/PIDPT_CE.HTM 156.111.80.30 19970121073111 text/html 6108
HTTP/1.0 200 OK
MIME-Version: 1.0
Server: GLACI/2.01
Date: Tue Jan 21 02:35:17 1997
Content-Type: text/html
Content-Length: 5978
</DOCHDR>
<HTML>
<HEAD><TITLE>Psychoanalytic Ctr</TITLE></HEAD>
<BODY BACKGROUND="..\IMAGES\MARBLE.JPG">

<H1 ALIGN="CENTER">
Psychoanalytic Center for Training and Research
</H1>
<P ALIGN="CENTER">
<B>Roger A. MacKinnon, M.D., Director<BR>
Stanley Bone, M.D., Associate Director<BR>
Milton Viederman, M.D., Associate Director</B>
<P ALIGN="JUSTIFY">
June 1994 graduates of the Center were: Stephen Donovan, M.D., Judith Marcus, M.D., David Pelino, M.D., George Sagi, M.D., Larry Sandberg, M.D., Meriamne Singer, M.D., Mark Sorensen, Nina Toshav, M.D. and Ilene Lefcourt, M.D.
<P ALIGN="JUSTIFY">
At that time, Morton Aronson, M.D. was presented with the George S. Goldman Award for Achievement in Clinical Psychoanalysis and Psychoanalytic Education, Helen Meyers, M.D. received the Howard Klar Award for Excellence in teaching and Sam Perry, M.D. received the John Weber Award for Psychoanalytic Research, posthumously.
<P ALIGN="JUSTIFY">
In 1994, the following were appointed as new faculty members: Stephen Donovan, M.D., Judith Marcus, M.D., David Pelino, M.D., George Sagi, M.D., Larry Sandberg, M.D., Meriamne Singer, M.D., Mark Sorensen, Nina Toshav, M.D. and Ilene Lefcourt, M.D.
<P ALIGN="JUSTIFY">
Helen Meyers, M.D. was the Sandor Rado Lecturer and presented "The Uses and Abuses of Reality" on April 5, 1994. Daniel Shapiro, M.D. was honored with the George E. Daniels Merit M.D. Award.
<P ALIGN="JUSTIFY">
At the New Candidates Dinner, on September 27, 1993, Arnold Wilson, Ph.D. received the Alexander Beller Award.
<P ALIGN="JUSTIFY">
From January through December 1994, the Admissions Service received 128 requests for application; 39 applications were received; 35 applicants were seen; 14 applicants accepted for analysis. There are a total of 21 private patients in analysis.
<P ALIGN="JUSTIFY">
Significant progress has been made with our major research project. Two of our <BR>
PGY-IV residents, Randall Marshall, M.D. and Susan Vaughan, M.D., have used their PGY-IV elective time to collaborate with Steven Roose, M.D. and Roger MacKinnon, M.D. to develop a protocol for a feasibility study to evaluate the possibility of a major prospective outcome study, possibly multi-centered.
<P ALIGN="JUSTIFY">
The research help and guidance from some of the department's most outstanding clinical investigators has made this project possible. Ronald Rieder, M.D., in particular, has helped and, with his support, both Dr. Marshall and Dr. Vaughan have obtained research fellowships that will allow them to devote significant time to this project. The Center is very grateful to the Psychiatric Institute faculty who are helping with our research effort. The Executive Committee of the Center has endorsed the project with its multiple rating scales, independent raters, and audiotaping of sessions. Thus far, nine psychoanalytic cases have accepted the study. The Center is supporting the inclusion of a parallel group of long-term analytic psychotherapy cases treated by residents under the supervision of Lisa Mellman, M.D. and our supervisory faculty. We have obtained a small grant from the Dorgan Fund to support most of the expenses.
<P ALIGN="JUSTIFY">
In 1993, the Center, in collaboration with the Association for Psychoanalytic Medicine, established the Psychodynamic Psychotherapy Division, an advanced course in psychoanalytically oriented psychotherapy for clinical psychiatrists who have recently completed training. The program was developed by Roger MacKinnon, M.D., Don Meyers, M.D., and Fred Kass, M.D. The course, which meets one evening per week for one year, is designed as a skills enhancing experience for those psychiatrists who are uncertain about formal psychoanalytic training, who have ruled out such training because of other career commitments, or who seek additional supervision and course work in psychotherapy.
<P ALIGN="JUSTIFY">
At the American Psychoanalytic Meetings in May 1994, Jacob Arlow, M.D., Jane Asch, M.D., Jose Barchilon, M.D., Edward Brennan, M.D., Deborah Cabaniss, M.D., Stanley Coen, M.D., Nathaniel Donson, Gerald Fogel, Otto Kernberg, M.D., Paulina Kernberg, M.D., Burton Lerner, M.D., Helen Meyers, M.D., Richard Munich, M.D., Bernard Pacella, M.D., Roy Schafer, Ph.D., Sally Severino, M.D., Daniel Shapiro, M.D., and C. Philip Wilson, M.D. participated in programs of the meetings.
<P ALIGN="JUSTIFY">
At the December 1994 meetings of the American Psychoanalytic Association, Morton Aronson, M.D., Jose Barchilon, M.D., Deborah Cabaniss, M.D., Stanley Coen, M.D., Arnold Cooper, M.D., Katherine Dalsimer, Ph.D., Lawrene Deutsch, M.D., Jeff Halpern, M.D., Jules Kerman, M.D., Otto Kernberg, M.D., Paulina Kernberg, M.D., Lucy LaFarge, M.D., Frederick Lane, M.D., Burton Lerner, M.D., Elena Lister, M.D., Eric Marcus, M.D., Helen Meyers, M.D., Richard Munich, M.D., David Olds, M.D., Ethel Person, M.D., Ellen Peyser, M.D., Steven Roose, M.D., John Munder Ross, Ph.D., Roy Schafer, Ph.D., Beth Seelig, M.D., Sally Severino, M.D., Daniel Shapiro, M.D., Ellen Handler Spitz, Ph.D., Milton Viederman, M.D., and C. Philip Wilson, M.D. participated in programs at the meetings.
<P ALIGN="JUSTIFY">
During the May and December 1994 meetings of the American Psychoanalytic Association, Lucy LaFarge, M.D., Eric Marcus, M.D. and Lawrence Shaderowfsky, M.D. were certified by the American Board of Standards to be Training and Supervising Analysts. Peter Buckley, M.D. was certified to be a Supervising Analyst.
<P ALIGN="JUSTIFY">
The Psychoanalytic Center is sad to report the death of a member of our faculty, Samuel W. Perry III, M.D. 
<P ALIGN="LEFT"><B>
<!--<B>Drs. Gloria Stern and Robert Glick at the Psychoanalytic Center's Alumni Luncheon.</B>
</B>
<P ALIGN="LEFT"><B>
<B>Drs. Mark Sorensen, Ilene Lefcourt, and Meriamne Singer at the Psychoanalytic Center's Alumni Luncheon.</B>-->
</B>
<!-- This document was created using BeyondPress(TM) 1.0-439896. -->
</BODY></HTML>
</DOC>
<DOC>
<DOCNO>WT02-B10-185</DOCNO>
<DOCOLDNO>IA093-000995-B030-185</DOCOLDNO>
<DOCHDR>
http://www.nyspi.cpmc.columbia.edu:80/NYSPI/PIDPT_RA.HTM 156.111.80.30 19970121073120 text/html 9652
HTTP/1.0 200 OK
MIME-Version: 1.0
Server: GLACI/2.01
Date: Tue Jan 21 02:35:27 1997
Content-Type: text/html
Content-Length: 9522
</DOCHDR>
<HTML>
<HEAD><TITLE>Research Assess</TITLE></HEAD>
<BODY BACKGROUND="..\IMAGES\MARBLE.JPG">

<H1 ALIGN="CENTER">
Research Assessment and Training
</H1>
<P ALIGN="CENTER">
<B>Jean Endicott, Ph.D., Director<BR>
Jennifer Downey, M.D., Psychiatrist II<BR>
Lawrence Sharpe, M.D., Psychiatrist (Research) II<BR>
Richard Blumenthal, Ph.D., Research Scientist V<BR>
Deborah Hasin, Ph.D., Research Scientist V<BR>
John Nee, Ph.D., Research Scientist V<BR>
Robert Simon, M.A., Research Scientist IV</B>
<P ALIGN="JUSTIFY">
The department has continued to develop and improve procedures to aid clinicians and investigators in the assessment of both patients and nonpatients. Data collection and recording procedures (along with training programs for clinicians and computer programs to assist in the scoring and analysis of the data) are made available to investigators and clinicians at Psychiatric Institute, in other New York State facilities, as well as elsewhere in the United States and abroad. These procedures are primarily focused upon diagnosis, evaluation of severity symptoms and functioning, quality of life enjoyment and satisfaction, and work productivity. Substantive research studies are also conducted by members of the department. Some ongoing during 1994 are briefly described below.
<H3 ALIGN="JUSTIFY">
<B>Major Mood Disorder Studies</B>
</H3>
<P ALIGN="JUSTIFY">
A number of the projects directed by Dr. Jean Endicott and her staff are focused upon the course of illness of patients who have major mood disorders. A large scale NIMH-funded multifacility long-term follow-up study of 955 patients with major mood disorders is still ongoing. To date, subjects have been followed between 14 and 17 years. During the intake episode and in subsequent episodes, depressed subjects who have active alcoholism have only half the likelihood of recovery of those who are not abusing alcohol. During the first 10 years of follow-up, patients with manic-depressive (bipolar) disorder had a mean of <BR>
4.5 hospitalizations and continued to have remissions and recurrences with no evidence of a tendency for the disorder to become less active. Patients who entered the study with a first episode of major depressive disorder also were at high risk to have at least one additional period of major depressive disorder (over 50% did so) and to attempt suicide <BR>
(25% did so). These findings, coupled with those reported previously indicate that the major mood disorders tend to recur or become chronic and are associated with major negative consequences for the majority of patients who suffer from them.
<P ALIGN="JUSTIFY">
Other studies funded by NICHD of women who have had prior episodes of major depressive disorder indicate that they are at a very high risk of having subsequent episodes, particularly if they report having severe dysphoric mood changes premenstrually. Dr. Endicott's group participated in a large multifacility study of the treatment of Premenstrual Dysphoric Disorder with sertraline or placebo which indicated that sertraline was quite effective in treating this condition. These findings were in keeping with previous work of Dr. Endicott and her group and support efforts to encourage women to obtain treatment for severe premenstrual mood changes.
<P ALIGN="JUSTIFY">
The follow-up studies conducted by Dr. Endicott's group as well as the findings from a NARSAD-supported study of the barriers to seeking and receiving treatment indicate that most patients with a major mood disorder still delay or never seek treatment when such is warranted. Although the reasons for this are multiple, two major problems continue to be cost and stigma.
<P ALIGN="JUSTIFY">
Members of the department have continued to participate in studies of the genetics of mood disorders. Dr. Endicott received funding from NIMH for a new multifacility linkage study of recurrent major depressive disorders. Dr. Endicott's staff will be responsible for making the "best estimate" diagnoses for the subjects from all five facilities. The staff has continued to work with Drs. Baron, Gilliam, and Ott on a linkage study of bipolar disorder with mania. The group recently published findings supportive of possible linkage of the disorder to a gene on chromosome 21.
<H3> ALIGN="JUSTIFY">
<B>Alcohol and Drug Problem Studies</B>
</H3
<P ALIGN="JUSTIFY">
Dr. Deborah Hasin and her staff continued to work on multiple facets of alcohol and drug problems, including diagnostic assessment, investigation of longitudinal course, issues of psychiatric comorbidity, and general population patterns. This work is funded by NIAAA and NIDA.
<P ALIGN="JUSTIFY">
Analyses of her follow-up study of 969 community residents who were at high risk for alcohol dependence showed that most of those who met criteria for alcohol dependence at the time of the first interview did so only at a mild level and were much more likely to manifest psychological aspects of alcohol dependence than physiological aspects (such as a full withdrawal syndrome). Analyses of one-year follow-up interviews showed that severity of alcohol dependence at the initial interview predicted continuing difficulties with alcoholism one year later. Severity of alcoholism outweighed sex, age, social status, and depression in predicting ongoing problems with alcoholism.
<P ALIGN="JUSTIFY">
Dr. Hasin's group is in early stages of a longitudinal study of the course of drug and alcohol dependence in patients who have substance abuse problems as well as varying types and levels of psychiatric difficulties. Several hundred patients will be evaluated when they enter treatment and will be followed up every six months for two years to determine the relationship of the psychiatric and substance abuse problems, and how these appear to be affected by treatment.
<P ALIGN="JUSTIFY">
Dr. Hasin has also collaborated with colleagues at NIAAA in investigating help-<BR>
seeking for alcohol problems among former drinkers in the U.S. The information came from a national survey of about 40,000 Americans. A substantial minority (about 40%) of former drinkers had met criteria for DSM-IV alcohol abuse or dependence at some time in the past. However, only a small proportion (7%) of those who had stopped drinking had sought help for alcohol problems. Those who had sought specialized help were likely to have reported a sense of compulsion to drink, heavier alcohol consumption, and social pressure to cut down on their drinking.
<H3> ALIGN="JUSTIFY">
<B>Infertility Studies</B>
</H3>
<P ALIGN="JUSTIFY">
Dr. Jennifer Downey has continued to study women who suffer from infertility and the possible effects of the new reproductive technologies on their likelihood of development of a mental disorder. A paper by one of Dr. Downey's graduate students based upon this work recently won first prize in a competition for best paper by a trainee sponsored by the American Society for Psychosomatic Obstetrics and Gynecology.
<H3 ALIGN="JUSTIFY">
<B>Menstrual Cycle Studies</B>
</H3>
<P ALIGN="JUSTIFY">
Dr. Dianne Schechter's NIMH-funded work has focused upon efforts to identify factors that may be associated with the pathophysiology of severe premenstrual dysphoric mood changes. She has examined several endocrine parameters and their association with severity of premenstrual mood changes in women who have been studied intensively over at least five menstrual cycles. The strongest relationships were a positive association between luteal phase pregnanediol levels and severity of mood changes and a negative association of the severity of mood changes and late follicular estrone and luteal estrone levels. The results of the study supported efforts to obtain funding to study a larger sample of subjects and a proposal was submitted to NIMH.
<P ALIGN="JUSTIFY">
A NARSAD-funded study of menstrual cycle fluctuations in severity of psychotic and affective symptoms in women with schizophrenia or schizoaffective disorder is being conducted by Dr. Schechter in collaboration with the Schizophrenia Research Unit. Preliminary data suggests that, at least for some women, symptom severity may decrease just prior to ovulation and increase just prior to menses and perhaps just after ovulation. If these findings are confirmed with a larger sample, they would have implications for a better understanding of the pathophysiology of the symptom formation and for treatment and management.
<H3 ALIGN="JUSTIFY">
<B>Reliability and Validity Studies</B>
</H3>
<P ALIGN="JUSTIFY">
Reliability and validity studies of procedures developed by members of the department was conducted, new training materials were prepared, and consultation was given to other investigators who plan to employ them in their studies. Those of primary focus during 1994 were the Psychiatric Research Interview for Substance and Mental Disorders (PRISM) developed by Dr. Hasin and colleagues and the Work Productivity Scale developed by Dr. Endicott.
<P ALIGN="JUSTIFY">
Dr. Dianne Schechter continued to direct the Mental Health Clinical Research Center Normal Controls project. Over 40 investigators successfully recruited subjects for their studies from the pool of over 1,000 subjects who have been enrolled in this project. 
<P ALIGN="CENTER"><B>
<!--<B>Dr. Jean Endicott, left, and Ms. Rose Bender at the 25 Years of Service Celebration.</B>-->
</B>
<!-- This document was created using BeyondPress(TM) 1.0-439896. -->
</BODY></HTML>
</DOC>
<DOC>
<DOCNO>WT02-B10-186</DOCNO>
<DOCOLDNO>IA093-000995-B030-199</DOCOLDNO>
<DOCHDR>
http://www.nyspi.cpmc.columbia.edu:80/NYSPI/PIDPT_SO.HTM 156.111.80.30 19970121073128 text/html 9012
HTTP/1.0 200 OK
MIME-Version: 1.0
Server: GLACI/2.01
Date: Tue Jan 21 02:35:35 1997
Content-Type: text/html
Content-Length: 8882
</DOCHDR>
<HTML>
<HEAD><TITLE>Social Psych</TITLE></HEAD>
<BODY BACKGROUND="..\IMAGES\MARBLE.JPG">

<H1 ALIGN="CENTER">
Social Psychiatry
</H1>
<P ALIGN="CENTER">
<B>Bruce P. Dohrenwend, Ph.D., Chief of Psychiatric Research<BR>
Andrew E. Skodol, M.D., Psychiatrist (Research) III</B>
<P ALIGN="JUSTIFY">
The focus of the research of this department is on adversity, stress, and psychiatric disorders. One of the important activities of the past year has been the editing of papers on this topic that were presented at the March 1994 annual meeting of the American Psychopathological Association. The program was organized by Dr. Dohrenwend and the papers will appear in a monograph to be published by the American Psychiatric Press. In addition, Drs. Dohrenwend and Skodol have been involved in organizing a symposium of the World Psychiatric Association Section of Epidemiology and Community Psychiatry to be held in New York May 15-17, 1995 on Search for the Causes of Psychiatric Disorders: Epidemiological Approaches. At the same time, three major investigations of adversity, stress, and psychiatric disorders have continued and planning has begun for two additional investigations. The following are brief descriptions of the on-going studies and of the plans for new research.
<H3 ALIGN="JUSTIFY">
<B>On-going Studies</B>
</H3>
<P ALIGN="JUSTIFY">
<B>Social and Psychological Factors in Episodes of Schizophrenia and Major Depression  </B>This project has sought to determine the relative importance and specificity of three sets of factors (remote and recent life events, personal dispositions, situational contexts) for episodes of major depression by contrast with episodes of schizophrenic disorder.
<P ALIGN="JUSTIFY">
Analyses of data collected under the above grant have continued even though a substantial number of papers have been previously published and reported and even though the NIMH-funded project period has ended. The retrospective case-control design of the project focuses on a sample of 96 major depressives, 65 persons with schizophrenia and other nonaffective psychotic disorders, and 404 controls from the general population. Data collection occurred in New York City. The most important analyses to date will be included in the book from the 1994 APPA meeting mentioned above. The results indicate, for example, that recent life events play a far more important role in the occurrence of episodes of major depression than in episodes of nonaffective psychotic disorders, including DSM-III schizophrenia, regardless of whether first episodes or recurrences are the outcomes being investigated.
<P ALIGN="JUSTIFY">
<B>Social Stress, Social Selection, and Psychiatric Disorders</B>  This on-going project started on January 1, 1982, with grant support from NIMH. Based on over two years of preliminary research, it involves study of the roles of social, psychological, and family history factors in the etiology of the main types of psychopathology that are inversely related to socioeconomic status: schizophrenia, major depression, substance use disorders, alcoholism, and antisocial personality.
<P ALIGN="JUSTIFY">
Israel was chosen as the research setting for two main reasons: (1) it is an open class society in which ethnic assimilation is taking place as required by the theoretical framework of the study, and (2) a well-kept Population Register was available as an aid to the type of sampling that facilitates obtaining unbiased estimates of rates of disorder. From a screened and diagnosed probability sample of 4,914 young adults, 340 cases, 191 controls, and a sample of their adult siblings have been chosen for intensive study. Brief telephone interviews were conducted with most of these 531 persons following the Scud missile attacks on Israel during the Gulf War.
<P ALIGN="JUSTIFY">
In previous years, we summarized major findings from the epidemiological study on the role of socioeconomic status that were published in the February 21, 1992 issue of Science and in descriptive analyses of the epidemiological data published in Psychological Medicine. Further descriptive analyses of the epidemiological data were published in 1994 in the Archives of General Psychiatry. Many of the main analyses of the case/control data have been conducted, along with some further analyses of data from the telephone interviews following the Scud attacks during the Gulf War. As in the New York study described above, some of the findings from the case/control study in Israel show that recent life events are more important in the occurrence of episodes of major depression than in exacerbations of schizophrenic disorder. The importance of this corroboration of the New York results is that the New York cases consisted of samples of patients whereas the research in Israel involves persons with these disorders who have been sampled from the general population. In addition to these similarities in the findings from the two studies on the relative importance of recent life events in the two disorders, some striking contrasts are also beginning to emerge, especially on the types of negative events involved in precipitating depression and in the role of family history in major depression. These will be written up along with other results from the case/control study in Israel during the following year and submitted for journal publication, as will results from the Scud follow-up.
<P ALIGN="JUSTIFY">
<B>Myofacial Pain Dysfunction Syndrome and Life Stress</B>  This project started in July 1, 1982 with grant support from NIDR. The first investigation was a longitudinal study of 136 pain patients and 131 controls. Detailed interviews were conducted with the respondents at entrance into the study and at monthly intervals for the period of one year. The purpose was to examine the role of environmental stress in episodes of myofascial pain. The main analyses have been completed, published, or accepted for publication.
<P ALIGN="JUSTIFY">
The problems addressed in the second study have grown out of a finding from the first study that there are unusually high rates of major depression in the pain cases compared to controls. These results, consistent with findings from research by others on various types of chronic pain of unknown origin and depression, strongly indicate that the two are related. The results are equivocal about the direction of the relationship and, consequently, have not thrown much light on such competing theories as those suggesting that pain is "masked" depression or that depression is a reaction to the stress of chronic pain.
<P ALIGN="JUSTIFY">
The aims in the second study, which started four years ago with a four-year competing continuation grant, involve an attempt to understand the relationship between depression and pain in persons suffering from temporomandibular pain dysfunction syndrome (TMPDS). To do so, an attempt is being made (1) to establish retrospectively the times of onset of depression and TMPDS in a new sample of TMPDS cases with and without a history of depression and (2) to investigate the rates of major depression in the adult first-degree relatives of the TMPDS cases and controls with and without a history of depression.
<P ALIGN="JUSTIFY">
Field work has been completed with samples of 164 pain cases, 175 controls, and 225 first-degree relatives of these cases and controls. We expect to have major findings to report in the coming year.
<H3 ALIGN="JUSTIFY">
<B>New Research Initiatives</B>
</H3>
<P ALIGN="JUSTIFY">
We are planning two new research initiatives that involve submission of substantial grant applications to NIMH. The first is a follow-up of respondents first interviewed an average of 12 years ago in the epidemiological research in Israel. Its purpose will be to build on the findings from the previous epidemiological and case/control studies by adding longitudinal and prospective components to the research.
<P ALIGN="JUSTIFY">
The second new undertaking involves the preparation of a grant application to analyze data previously collected by the Research Triangle Institute (RTI) in response to a Congressional mandate to investigate post-traumatic stress disorder (PTSD) and other psychological problems in U.S. veterans of the war in Vietnam. RTI began this ground-<BR>
breaking study of nationwide samples of Vietnam Theater veterans, other Vietnam Era veterans, and nonveterans, totaling 3,016 respondents in 1984. The strikingly high rates of PTSD that they found in both male and female Theater veterans and the ethnic/racial differences in these rates virtually demand more analysis, and we plan to focus on these differences. 
<P ALIGN="CENTER"><B>
<!--<B>Drs. Bruce Dohrenwend, left, and Andrew Skodol.</B>-->
</B>
<!-- This document was created using BeyondPress(TM) 1.0-439896. -->
</BODY></HTML>
</DOC>
<DOC>
<DOCNO>WT02-B10-187</DOCNO>
<DOCOLDNO>IA093-000995-B030-231</DOCOLDNO>
<DOCHDR>
http://www.nyspi.cpmc.columbia.edu:80/NYSPI/PIDPT_ST.HTM 156.111.80.30 19970121073156 text/html 3244
HTTP/1.0 200 OK
MIME-Version: 1.0
Server: GLACI/2.01
Date: Tue Jan 21 02:35:43 1997
Content-Type: text/html
Content-Length: 3114
</DOCHDR>
<HTML>
<HEAD><TITLE>Statistical Genetics</TITLE></HEAD>
<BODY BACKGROUND="..\IMAGES\MARBLE.JPG">

<H1 ALIGN="CENTER">
Statistical Genetics
</H1>
<P ALIGN="CENTER">
<B>Jurg Ott, Ph.D., Chief of Psychiatric Research<BR>
Joseph D. Terwilliger, Ph.D., Research Scientist III</B>
<HR>
<H3 ALIGN="CENTER"><A HREF= "http://linkage.cpmc.columbia.edu/home.html">Statistical Genetics - Home Page at Columbia University</A></H3>
<HR>
<P ALIGN="JUSTIFY">
The main task of the Department of Statistical Genetics is to pursue
research in <A HREF = "http://linkage.cpmc.columbia.edu:80/./">genetic linkage analysis</A>, primarily for the genetic mapping of psychiatric traits. This research is also used in building genetic maps of marker loci, which, in turn, enhance the power for mapping disease genes. The work falls into two broad categories: 1) developing new and improving existing methods of linkage analysis and genetic mapping, and <BR>
2) applying these techniques to family data gathered by other researchers at Psychiatric Institute and elsewhere. Work in the first category is carried out with mathematical-analytical tools, if feasible, but computers must often be used to furnish numerical results (e.g., by computer simulation) when a problem is too complicated to be solved analytically. Newly developed methods are made available to other researchers in the form of computer programs, which are written by the researcher developing the method.
<P ALIGN="JUSTIFY">
Drs. Terwilliger and Ott wrote a handbook on human linkage analysis which was published by Johns Hopkins University Press. It is a self-study book that makes it possible for researchers to learn how to carry out linkage analysis on computers.
<P ALIGN="JUSTIFY">
Dr. Terwilliger received a NARSAD Young Investigator Award to explore novel methods of carrying out linkage analysis in complex traits such as schizophrenia.
<P ALIGN="JUSTIFY">
Together with one of his former students, Dr. Suzanne Leal, Dr. Ott published a new method for obtaining approximate confidence intervals for genetic risks. This method evaluates the effect on the risk of not exactly knowing allele frequencies and recombination fractions, that is, it provides a realistic assessment of the accuracy of a risk estimate.
<P ALIGN="JUSTIFY">
Collaboration with Drs. Baron, Endicott, and Gilliam continued on the search for susceptibility genes for bipolar disorder; with Dr. Weissman on panic disorder; with Dr. Shaffer on suicide, and with Dr. Erlenmeyer-Kimling on schizophrenia.
<P ALIGN="JUSTIFY">
Grant support was received from various sources. The Muscular Dystrophy Association renewed its grant to carry out statistical investigations for the Spinal Muscular Atrophy gene on chromosome 5. The MERIT award grant from NIMH was renewed for another year. A conference grant from the National Center for Human Genome Research was renewed to hold a Workshop on Statistical Methods in Genetic Mapping.
<P ALIGN="CENTER"><B>
<!--<B>Dr. Jurg Ott</B>-->
</B>
<!-- This document was created using BeyondPress(TM) 1.0-439896. -->
</BODY></HTML>
</DOC>
<DOC>
<DOCNO>WT02-B10-188</DOCNO>
<DOCOLDNO>IA093-000995-B030-249</DOCOLDNO>
<DOCHDR>
http://www.nyspi.cpmc.columbia.edu:80/NYSPI/PIDPT_DA.HTM 156.111.80.30 19970121073208 text/html 12490
HTTP/1.0 200 OK
MIME-Version: 1.0
Server: GLACI/2.01
Date: Tue Jan 21 02:36:11 1997
Content-Type: text/html
Content-Length: 12359
</DOCHDR>
<HTML>
<HEAD><TITLE>Substance Abuse</TITLE></HEAD>
<BODY BACKGROUND="..\IMAGES\MARBLE.JPG">

<H1 ALIGN="CENTER">
Substance Abuse
</H1>
<P ALIGN="CENTER">
<B>Herbert D. Kleber, M.D., Director<BR>
Marian W. Fischman, Ph.D., Co-Director<BR>
Frances Rudnick Levin, M.D., Psychiatrist II<BR>
Richard W. Foltin, Ph.D., Research Scientist V<BR>
Sandra D. Comer, Ph.D., Research Scientist III<BR>
Suzette M. Evans, Ph.D., Research Scientist III<BR>
Margaret Haney, Ph.D., Research Scientist III</B>
<P ALIGN="JUSTIFY">
The Division on Substance Abuse started the year with existing faculty of Herbert D. Kleber, M.D., Director, Marian W. Fischman, Ph.D., Co-Director, Sandra Comer, Ph.D., Suzette M. Evans, Ph.D., Richard W. Foltin, Ph.D., and Frances R. Levin, M.D. In February 1994, Margaret Haney, Ph.D. joined the division.
<H3 ALIGN="JUSTIFY">
<B>Research Projects</B>
</H3>
<P ALIGN="JUSTIFY">
Research in the division focuses on the antecedents and consequences of substance use and abuse, with particular emphasis on the development and testing of novel approaches to the treatment of substance abuse. The division is unique in its ability to examine substance abuse issues at three levels: in non-human primates, in controlled laboratory research with human subjects, and, clinically, in treating cocaine-abusing patients. Faculty in this division not only conduct their own research, but, consistent with the major goals of the division, foster collaborative research both at the New York State Psychiatric Institute and across the Columbia-Presbyterian Medical Center complex.
<P ALIGN="JUSTIFY">
In October 1994, the Division on Substance Abuse, in collaboration with Drs. Edward Nunes and Ronald Van Heertum at Columbia-Presbyterian Medical Center, received a Medications Development Center grant from NIDA to develop novel medication approaches to treat cocaine and heroin abuse. The Core, in addition to providing centralized coordination and support, will carry out pilot studies on promising medications and provide funding for small pilot studies, including those of interest to the Research Fellows. Project 1, headed by Drs. Fischman and Comer, will focus on developing a laboratory model of smoked heroin and then use it in the Residential Laboratory to evaluate both new medications for opiate addiction, e.g., depot naltrexone and methoclocinnamox, as well as improving outcome and acceptability of existing medications such as methadone and naltrexone. In Project 2, Dr. Gottschalk, a Substance Abuse Research Fellow, is working with Dr. Van Heertum, examining the temporal course of cocaine's effects on regional brain activity using PET. These studies will examine human brain activation by intravenous cocaine in chronic abusers, using PET imaging techniques for measuring cerebral blood flow. The first experiment will examine direct drug effects of cocaine, tolerance effects, and conditioned cue response. Project 3, headed by Dr. Nunes, will evaluate treatment-seeking cocaine abusers and then use existing psychiatric medications to see whether treating specific disorders, such as depression, will improve outcome and retention. In addition, this project will use both a cue reaction paradigm and a novel clinical trial design to test new medications such as amoxapine and risperidone for cocaine treatment. A Cocaine Research Clinic will be opened on PI 11 to carry out this project and the Core pilot studies.
<P ALIGN="JUSTIFY">
Dr. Richard Foltin is continuing his series of studies in non-human primates. His research project with baboons is providing both an animal model for assessing the behavioral mechanisms of action of anorectic drugs, with new substances evaluated as they are developed, and a behavioral economics model of eating behavior. Drs. Fischman, Foltin, Comer, and Haney are conducting similar studies in human subjects to investigate the neurochemical basis for the control of eating behavior in humans and to evaluate the commonalities and differences between food and drugs. Dr. Foltin, in collaboration with Dr. Evans, has another non-human primate research grant to develop and test a novel animal model of cocaine craving in rhesus monkeys. The availability of an animal model that operationalizes the concept of drug craving, i.e., cocaine-seeking rather than cocaine-<BR>
taking behavior, will provide an immense benefit to the development of pharmacotherapies specifically aimed at the alleviation of drug craving and subsequent drug taking.
<P ALIGN="JUSTIFY">
Drs. Fischman and Foltin are continuing their research on the effects of cocaine, cocaine self-administration, and the interaction of cocaine with potential therapeutic agents using a controlled laboratory environment. Drs. Fischman and Foltin have developed a laboratory model of cocaine use in which volunteer cocaine-using research subjects can take repeated doses of cocaine, much as they might outside of the laboratory during a cocaine "binge." They measure cocaine self-administration before and during maintenance on a potential treatment medication to assess whether these proposed pharmacological adjuncts to cocaine treatment interfere with the reinforcing efficacy of cocaine. This is an efficient and scientifically useful adjunct to traditional clinical trial procedures for the evaluation of the therapeutic efficacy of potential treatment medications.
<P ALIGN="JUSTIFY">
Cocaine abuse by patients maintained on methadone has become a serious problem. Unfortunately, little is known about the effects of these two drugs in combination, and the clinical treatment efforts for this group have not been particularly effective. Drs. Fischman and Foltin are currently investigating the efficacy of buprenorphine as a treatment for both cocaine abuse and opiate dependence by examining the propensity to take cocaine in subjects maintained on either methadone or buprenorphine. Dr. Levin has been working with Dr. Foltin in developing protocols for optimal tapering of subjects off methadone and onto buprenorphine. This research will have clinical implications when buprenorphine is routinely used in methadone programs. Drs. Fischman, Evans, and Levin are evaluating another potentially useful medication for the treatment of cocaine abusers. They are studying <BR>
cis-flupenthixol, evaluating its safety in combination with cocaine and its efficacy both orally and in depot form. Drs. Foltin and Fischman are also conducting a laboratory analysis of cocaine abstinence including assessing changes in affect and reports of withdrawal symptoms following the termination of different doses and durations of a cocaine binge, changes in ratings of cocaine "craving" during abstinence, and differences in cocaine abstinence based on route of administration.
<P ALIGN="JUSTIFY">
Drs. Fischman, Foltin, Comer, and Haney are conducting research on the workplace implications of drug use. The Substance Use Research Center is designed for continuous observation of human behavior over extended periods of time. Subjects can live under conditions in which sleep-waking cycles, daytime work activities, and evening recreational activities simulate those in the natural ecology. The effects of acute and chronic administration of frequently used drugs and medications on human capacities that are commonly used in the workplace are being evaluated. In addition, other studies will focus on residual drug effects, i.e., "hangover" on workplace performance, and the modification of drug use under workplace conditions.
<P ALIGN="JUSTIFY">
In collaboration with Dr. Fischman, Dr. Evans is continuing to conduct studies to assess the abuse liability of newly developed sedatives/anxiolytics prior to their marketing, as well as currently marketed sedatives/anxiolytics. Such procedures provide profiles of physiological and behavioral effects of these compounds including performance and memory impairment, as well as an estimate of the likelihood that they will be abused if they become commercially available. In October 1994, Dr. Fischman, in collaboration with Drs. Evans and Haney, received an NIH Women's Supplement to evaluate in women with premenstrual syndrome the effects of alprazolam on workplace performance.
<P ALIGN="JUSTIFY">
In line with the research mission of Psychiatric Institute, Drs. Kleber, Levin, and Evans have intensified their efforts in epidemiologic studies and new treatments for dually diagnosed patients, i.e., individuals with a substance abuse disorder (primarily cocaine) and another psychiatric disorder. To treat cocaine abuse more adequately, future studies may need to be targeted at different subgroups of cocaine abusers and to develop interventions appropriate to those populations.
<P ALIGN="JUSTIFY">
A NIDA-funded grant under the direction of Dr. Kleber and his associates, Drs. Levin and Evans, is assessing the prevalence of attention deficit hyperactivity disorder (ADHD) among cocaine abusers seeking treatment, including documentation of prevalence rates among specific minority populations. At the same time, parallel studies with cocaine abusers diagnosed with ADHD are being conducted in the research laboratory and these studies will focus on the interaction of cocaine with pharmacologic treatments for ADHD. Lastly, as part of the Core of the recently funded Center Grant, they will conduct an outpatient treatment study to assess the efficacy of methylphenidate and desipramine in reducing cocaine use in cocaine abusers with ADHD. Another subgroup of interest is cocaine abusers with schizophrenic symptoms. Drs. Levin and Evans are conducting studies to determine the effectiveness of the neuroleptics flupenthixol and risperidone in treating both the psychotic symptoms and reducing cocaine abuse in this patient population.
<P ALIGN="JUSTIFY">
Dr. Levin recently received a Scientist Development Clinical Award to assess cocaine abusers for psychiatric co-morbidity and develop interventions appropriate to those subpopulations. In addition, Dr. Levin received a Clinical Trials Award to determine the effectiveness of the neuroleptics, flupenthixol and risperidone, in treating cocaine abusers with schizophrenia or schizo-affective illness. 
<H3 ALIGN="JUSTIFY">
<B>Education and Training</B>
</H3>
<P ALIGN="JUSTIFY">
Drs. Kleber and Levin have been actively involved with the Substance Abuse Steering Committee, co-chaired by Dr. Kleber and Dr. Oldham, in developing a new substance abuse curriculum for first- and second-year medical students. In addition, Drs. Kleber and Levin began a program to teach all housestaff at Columbia-Presbyterian Medical Center key aspects of the diagnosis and treatment of substance abuse. They are also working with Dr. Edward Nunes on courses for PGY-III and IV psychiatric residents.
<P ALIGN="JUSTIFY">
The Division continues to play a central role in a National Institute on Drug Abuse (NIDA)-funded Research Fellowship in Substance Abuse Disorders for research fellows directed by Dr. Kleber and by the associate directors, Drs. Frances Levin and Edward Nunes. The purpose of this fellowship is to train candidates for careers in clinical research in substance abuse and dependence. The program is designed as a two-year curriculum with emphasis on four different components: didactic introduction to clinical research in the addictions, clinical experience, research apprenticeship-preceptorship, and development of teaching skills. From January-June 1994, the Division had two fellows-Michael Hwang, M.D., and Denise Hien, Ph.D. The former is now working as Director of the Anxiety Clinic at the Veterans Administration Hospital in New York City and is also Assistant Professor of Psychiatry at New York University. The latter received a FIRST Award from NIDA and is carrying out the research at St. Luke's/Roosevelt Hospital Center. In July 1994, the division had two new Research Fellows, Dr. Christopher P. Gottschalk and Dr. Eric Collins. Dr. Angela Seracini, who is currently working with Dr. Nunes on the DES, will join the fellowship in January 1995. 
<P ALIGN="CENTER"><B>
<!--<B>From left to right, Drs. Richard Foltin, Margaret Haney, Marian Fischman, <BR>
and Sandra Comer.</B>-->
</B>
<!-- This document was created using BeyondPress(TM) 1.0-439896. -->
</BODY></HTML>
</DOC>
<DOC>
<DOCNO>WT02-B10-189</DOCNO>
<DOCOLDNO>IA093-000995-B030-271</DOCOLDNO>
<DOCHDR>
http://www.nyspi.cpmc.columbia.edu:80/NYSPI/PIDPT_WH.HTM 156.111.80.30 19970121073235 text/html 4045
HTTP/1.0 200 OK
MIME-Version: 1.0
Server: GLACI/2.01
Date: Tue Jan 21 02:36:33 1997
Content-Type: text/html
Content-Length: 3915
</DOCHDR>
<HTML>
<HEAD><TITLE>Wash Heights</TITLE></HEAD>
<BODY BACKGROUND="..\IMAGES\MARBLE.JPG">

<H1 ALIGN="CENTER">
Washington Heights Community Service
</H1>
<P ALIGN="CENTER">
<B>Francine Cournos, M.D., Director<BR>
Ewald Horwath, M.D., Director, Inpatient Unit<BR>
Pelligrino Sarti, M.D., Director, Audubon Avenue Clinic<BR>
Siobhan Coomaraswamy, M.D., Director, Inwood Mental Health Center<BR>
Meg. S. Kaplan, Ph.D., Director, Sexual Behavior Clinic<BR>
Richard Herman, M.A., Administrator</B>
<P ALIGN="JUSTIFY">
Washington Heights Community Service outpatient programs had a very productive and stable year. Compared to 1993, our census increased by 36 patients, and we delivered 391 more visits, which represents a slight increase. In September 1994, our outpatient programs successfully completed their state certification site visit, and were praised for the excellent clinical care delivered.
<P ALIGN="JUSTIFY">
Some notable staff changes occurred. Alexis Brosen, M.D., resigned her position as director of the Inwood Clinic, and Siobhan Coomaraswamy, M.D. became the new director. Other changes at Inwood included the arrival of two new psychiatrists, Richard Kreuger, M.D. and Dora Cardenas, M.D., and the departure of two psychiatrists, Sarah Hartman, M.D. and Raul Soto, M.D. On the PI 6 in-patient unit, Deborah Cabaniss, M.D. resigned and Mary Bongiovi, M.D. became the new attending psychiatrist.
<P ALIGN="JUSTIFY">
We were able to significantly improve therapeutic activities for our inpatients and outpatients under the leadership of Elaine Mullen, OTR. Ms. Mullen reorganized group programming in the PI 6 inpatient unit and helped recruit two new occupational therapists.
<P ALIGN="JUSTIFY">
WHCS faculty remained active in the area of HIV/AIDS and people with mental illness. In addition to continued publications of our research findings, the second year of our federal Center for Mental Health Services training grant allowed us to train more than 2,000 mental health providers. We held three large conferences (New York, Albany, Buffalo) and conducted  on-site workshops and grand rounds at numerous mental health programs in the tri-state area. Four thousand copies of the HIV Risk Reduction Manual, written by WHCS staff, were distributed throughout the English-speaking world. This manual is based on ongoing HIV risk reduction groups at the Audubon and Inwood Clinics. Dr. Francine Cournos authored Commonly Asked Questions about HIV/AIDS and People with Mental Illness, which was distributed nationwide by the National Alliance for the Mentally Ill. In addition, WHCS worked with Housing Works, Inc., a program for HIV infected people, in the development of their mental health services.
<P ALIGN="JUSTIFY">
WHCS continues to be a popular site for the training of students of all disciplines.
<P ALIGN="CENTER">
<B>WASHINGTON HEIGHTS COMMUNITY SERVICE<BR>
AVERAGE MONTHLY STATISTICS</B>
<P ALIGN="JUSTIFY">
&#009;<B>Audubon&#009;Inwood</B>
<P ALIGN="JUSTIFY">
Clinic Care Census&#009;420&#009;229
<P ALIGN="JUSTIFY">
Clinic Care Visits&#009;691&#009;450
<P ALIGN="JUSTIFY">
Continuing Treatment Census&#009;84&#009;145
<P ALIGN="JUSTIFY">
Continuing Treatment Full Days of Service&#009;1,017&#009;1,483
<P ALIGN="LEFT"><B>
<!--<B>Dr. Eric Kandel presenting at the Psychiatric Institute Annual Scientific Conference.</B>
</B>
<P ALIGN="LEFT"><B>
<B>Dr. Francine Cournos reviewing posters at the Psychiatric Institute Annual Scientific Conference.</B>
</B>
<P ALIGN="LEFT"><B>
<B>Mr. David Lane, Librarian, with  Yissel Lopez, a youth worker.</B>
</B>
<P ALIGN="LEFT"><B>
<B>Dr. Laura Whitman  leading a Child Psychiatry  Fellow Seminar.</B>
</B>
<P ALIGN="LEFT"><B>
<B>Drs. Mark Underwood and Victoria Arango with Patrick McDevitt, seated.</B>-->
</B>
<!-- This document was created using BeyondPress(TM) 1.0-439896. -->
</BODY></HTML>
</DOC>
<DOC>
<DOCNO>WT02-B10-190</DOCNO>
<DOCOLDNO>IA093-000995-B031-458</DOCOLDNO>
<DOCHDR>
http://www.nyspi.cpmc.columbia.edu:80/NYSPI/.\depts\biostat\index.htm 156.111.80.30 19970121074302 text/html 2779
HTTP/1.0 200 OK
MIME-Version: 1.0
Server: GLACI/2.01
Date: Tue Jan 21 02:47:10 1997
Content-Type: text/html
Content-Length: 2649
</DOCHDR>
<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 3.2//EN"><HTML><HEAD>   <TITLE>NYSPI Division of Biostatistics Home Page</TITLE></HEAD><BASE HREF="http://www.nyspi.cpmc.columbia.edu/NYSPI/depts/biostat/index.htm"><BODY TEXT="#000055" BGCOLOR="#FFFFFF" LINK="#000000" VLINK="#550000" body <H1><CENTER><TABLE BORDER=5 CELLSPACING=5 CELLPADDING=5 WIDTH="100%" BGCOLOR="#AAFFFF" ><TR><TD><CENTER><P><FONT SIZE=+3><I>Welcome </I>to the <FONT COLOR="#800040">N</FONT></FONT><FONT COLOR="#800040"><FONT SIZE=+2>ew</FONT><FONT SIZE=+3>Y</FONT><FONT SIZE=+2>ork </FONT><FONT SIZE=+3>S</FONT><FONT SIZE=+2>tate </FONT><FONT SIZE=+3>P</FONT><FONT SIZE=+2>sychiatric</FONT><FONT SIZE=+3> I</FONT><FONT SIZE=+2>nstitutute (NYSPI)</FONT></FONT></P></CENTER><CENTER><P><FONT COLOR="#000000"><FONT SIZE=+3>Home Page of the Division of Biostatistics</FONT></FONT></P></CENTER></TD></TR></TABLE></CENTER><P><htm></P><TABLE BORDER=5 BGCOLOR="#C0C0C0" ><TR><TH Colspan="5"<h2><FONT COLOR="#FF0000">Contacting NYSPI's Division of Biostatistics</FONT></TH></TR><TR><TH><FONT COLOR="#FF0000">Address</FONT></TH><TH><FONT COLOR="#FF0000">Telephone Number</FONT></TH><TH><FONT COLOR="#FF0000">Fax Number </FONT></TH><TH><FONT COLOR="#FF0000">&quot;e-mail&quot;</FONT></TH></TR><TR><TH><BR>722 West 168th Street, <BR>New York, New York 10032 <BR></TH><TH>(212) 960-5766 </TH><TH>(212) 960-2465</TH><TH><FONT COLOR="#0000FF"><A HREF="mailto:biostat@child.cpmc.columbia.edu">BIOSTAT@child.cpmc.columbia.edu</A></FONT></TH></TR></TABLE><TABLE BORDER=5 BGCOLOR="#FF80C0" > <TR><TH Colspan="5"> <H2><FONT COLOR="#408080"><u>Web</u> <u>Pages</u> Area Selection</FONT></H2></TH></TR><ul><TR><TH><H3><br><li>(1)<FONT COLOR="#0000FF"><br>

If you are working within <br>the NYSPI environment, <br><A HREF="internal.htm"> please click here <br> </a> to find out about the Division of Biostatistic's mission, staff, ways to contact us, links to other sitesand more! 

</FONT></H3></TH><th> </ul><BR><H3><li>(2)<FONT COLOR="#0000FF"><br>

If you are a visitor to the Division of Biostatistics at NYSPI and would like an overview of what we do, <br>
<A HREF="external.htm"> please click here. </FONT></A></H3></TH>
<TH> <H3><li>(3)<FONT COLOR="#0000FF"><A HREF="http://www.nyspi.cpmc.columbia.edu/"> 

<br> Please click here for 

</a>NYSPI's General Home Page </FONT></H3> </TH> </TR></TABLE><h6><P><BR><FONT COLOR="#8000FF">Last modified during the month of January 1997</FONT><BR><BR></HTM></P> <p><font size=1>Page created by Joshua
Bender: </font><a href="mailto:jbender@neuron.cpmc.columbia.edu"><font
size=1>jbender@neuron.cpmc.columbia.edu</font></a><br> </p> </BODY></HTML>
</DOC>
<DOC>
<DOCNO>WT02-B10-191</DOCNO>
<DOCOLDNO>IA093-000995-B031-472</DOCOLDNO>
<DOCHDR>
http://www.nyspi.cpmc.columbia.edu:80/nyspi/depts/psypharm/eating~1/index.htm 156.111.80.30 19970121074310 text/html 2123
HTTP/1.0 200 OK
MIME-Version: 1.0
Server: GLACI/2.01
Date: Tue Jan 21 02:47:18 1997
Content-Type: text/html
Content-Length: 1993
</DOCHDR>
<!DOCTYPE HTML PUBLIC "-//W3O/DTD HTML//EN">

<html>
<head>
<title>NYSPI Eating Disorders Unit</title>
<meta name="FORMATTER" content="Microsoft FrontPage 1.1">
</head>
<BGCOLOR="#FFFFFF">
<frameset rows="15%,85%">
    <frame src="frbanner.htm" name="banner" marginwidth="1"
    marginheight="1">
    <frameset cols="35%,65%">
        <frame src="frconten.htm" name="contents" marginwidth="1"
        marginheight="1">
        <frame src="frmain.htm" name="main" marginwidth="1"
        marginheight="1">
    </frameset>
    <noframes>
<BGCOLOR="#FFFFFF">
    <p>&#160;</p>
    <h1 align="center">Eating Disorders Unit</h1>
    <hr>
    <p>At present time the <a href="Unitdata.htm">Eating
    Disorders Unit at the New York State Psychiatric Institute</a>
    is conducting research studies of the psychobiology and
    treatment of eating disorders. Individuals with eating
    disorders who meet eligibility criteria and who are willing
    to participate may be eligible to receive inpatient or
    outpatient care at no charge.</p>
    <p><b>What is an Eating Disorder?</b></p>
    <p>Eating disorders, like <a href="anorexia.htm">anorexia
    nervosa</a> and <a href="bulimia.htm">bulimia nervosa</a>,
    are characterized by excessive concern with shape and weight
    and by severe disturbances in eating behavior. Both disorders
    primarily affect girls or young women. Individuals with
    anorexia nervosa are severely underweight while individuals
    with bulimia nervosa are at or above normal weight. The <a
    href="txanorex.htm">treatment of anorexia</a> and <a
    href="txbulimi.htm">the treatment of bulimia</a> differ in
    some respects.</p>
    <hr>
    <h5>Created by <a href="mailto:jjb41@columbia.edu">Jerald
    Block, MD</a><br>
    Copyright &#169; 1996 [New York State Psychiatric Institute].
    All rights reserved.<br>
    Revised: September 23, 1996.</h5>
    </body>
    </noframes>
</frameset>
</html>
</DOC>
<DOC>
<DOCNO>WT02-B10-192</DOCNO>
<DOCOLDNO>IA093-000995-B031-521</DOCOLDNO>
<DOCHDR>
http://www.nyspi.cpmc.columbia.edu:80/NYSPI/internal.htm 156.111.80.30 19970121074406 text/html 218
HTTP/1.0 200 OK
MIME-Version: 1.0
Server: GLACI/2.01
Date: Tue Jan 21 02:48:13 1997
Content-Type: text/html
</DOCHDR>
<BODY><H1>Error 404</H1>
Unable to open the specified file<hr><ADDRESS>httpd-info@glaci.com</ADDRESS></BODY>
</DOC>
<DOC>
<DOCNO>WT02-B10-193</DOCNO>
<DOCOLDNO>IA093-000995-B031-537</DOCOLDNO>
<DOCHDR>
http://www.nyspi.cpmc.columbia.edu:80/NYSPI/external.htm 156.111.80.30 19970121074419 text/html 218
HTTP/1.0 200 OK
MIME-Version: 1.0
Server: GLACI/2.01
Date: Tue Jan 21 02:48:24 1997
Content-Type: text/html
</DOCHDR>
<BODY><H1>Error 404</H1>
Unable to open the specified file<hr><ADDRESS>httpd-info@glaci.com</ADDRESS></BODY>
</DOC>
<DOC>
<DOCNO>WT02-B10-194</DOCNO>
<DOCOLDNO>IA093-000995-B031-548</DOCOLDNO>
<DOCHDR>
http://www.nyspi.cpmc.columbia.edu:80/nyspi/depts/psypharm/eating~1/Unitdata.htm 156.111.80.30 19970121074433 text/html 2811
HTTP/1.0 200 OK
MIME-Version: 1.0
Server: GLACI/2.01
Date: Tue Jan 21 02:48:37 1997
Content-Type: text/html
Content-Length: 2681
</DOCHDR>
<!DOCTYPE HTML PUBLIC "-//IETF//DTD HTML//EN">

<html>

<head>
<title>Getting Help</title>
<meta name="GENERATOR" content="Microsoft FrontPage 1.1">
</head>

<body BGCOLOR="#FFFFFF">
<p><b>Where Can I Get Help?</b> </p>
<p>If you meet <a href="diagAnor.htm">the diagnostic criteria for anorexia nervosa</a> or <a href="diagBuli.htm">the criteria for bulimia nervosa</a> 
you may be eligible to receive <strong>free </strong><b>treatment</b> as part of the research program at the 
Eating Disorders Unit at the New York State Psychiatric Institute, located at the Columbia 
Presbyterian Medical Center in New York City. The Eating Disorders Unit is a nationally 
recognized treatment/research program which provides both inpatient and outpatient 
treatment. The clinic is staffed by psychiatrists, psychologists, social workers, nurses, and 
research personnel, all with training and experience in the treatment of eating disorders. 
The purpose of the clinic is to study bulimia nervosa and anorexia nervosa and to find 
more effective treatments for each. Since ours is a research program, we offer free 
treatment to women with moderate to severe eating disorders who are appropriate for our 
current research and treatment studies. The Eating Disorders Unit receives support from 
private grants and from the federal and state governments.</p>
<p><b>How Do I Get More Information?</b> </p>
<p>If you would like further information, to make a referral, or to apply to the program, 
please contact us at the Eating Disorders Clinic. When you call you will be given a more 
detailed description of the program and asked a series of questions. A personal interview 
is then scheduled, to determine eligibility for participation and to provide additional 
information. You can reach us weekdays from 9 a.m. to 5 p.m. E.S.T. at 212-960-5746 or 
E-mail us:<i> </i><a href="mailto:EDRU@nypimail.cpmc.columbia.edu"><i>EDRU@nypimail.cpmc.columbia.edu</i></a><i> [*see below first]. </i></p>
<p><i>*Note: We treat all forms of patient information as highly confidential material. The 
Internet, however, is NOT a secure means of communication. People have been known 
to &quot;hack&quot; into e-mail. Thus, please exercise appropriate caution concerning what 
details you choose to communicate to us via e-mail.</i></p>
<hr>
<p><font size=2><strong>Created by </strong></font><a href="mailto:jjb41@columbia.edu"><font size=2><strong>Jerald Block, MD</strong></font></a><font size=2><strong><br>
Copyright &#169; 1996 [New York State Psychiatric Institute]. All rights reserved.<br>
Revised: September 06, 1996.</strong></font></p>
</body>

</html>
</DOC>
<DOC>
<DOCNO>WT02-B10-195</DOCNO>
<DOCOLDNO>IA093-000995-B031-559</DOCOLDNO>
<DOCHDR>
http://www.nyspi.cpmc.columbia.edu:80/nyspi/depts/psypharm/eating~1/anorexia.htm 156.111.80.30 19970121074442 text/html 1598
HTTP/1.0 200 OK
MIME-Version: 1.0
Server: GLACI/2.01
Date: Tue Jan 21 02:48:49 1997
Content-Type: text/html
Content-Length: 1468
</DOCHDR>
<!DOCTYPE HTML PUBLIC "-//IETF//DTD HTML//EN">

<html>

<head>
<title>What is anorexia nervosa?</title>
<meta name="GENERATOR" content="Microsoft FrontPage 1.1">
</head>

<body BGCOLOR="#FFFFFF">
<p><b>What is Anorexia Nervosa?</b> </p>
<p>Anorexia nervosa is characterized by self-maintained low weight and loss of menstrual periods 
accompanied by an intense fear of fatness and a distorted body image. There are two types of 
anorexia nervosa: restricting and binge-eating/purging. Individuals with restricting type severely limit 
their food intake and/or exercise excessively. Individuals with binge-eating/purging type engage in 
binge-eating; self-induced vomiting; or the abuse of laxatives, diuretics, or enemas. </p>
<p><b>Who Gets Anorexia Nervosa?</b> </p>
<p>About 95% of patients with anorexia nervosa are women. Most of them develop the disorder in 
late adolescence or early adulthood. Despite the large number of women who report some sort of 
eating disturbance, only a small number (0.5-1.0%) actually meet full<b> </b><a href="diagAnor.htm">diagnostic criteria for anorexia 
nervosa.</a></p>
<hr>
<p><font size=2><strong>Created by </strong></font><a href="mailto:jjb41@columbia.edu"><font size=2><strong>Jerald Block, MD</strong></font></a><font size=2><strong><br>
Copyright &#169; 1996 [New York State Psychiatric Institute]. All rights reserved.<br>
Revised: September 06, 1996.</strong></font></p>
</body>

</html>
</DOC>
<DOC>
<DOCNO>WT02-B10-196</DOCNO>
<DOCOLDNO>IA093-000995-B031-572</DOCOLDNO>
<DOCHDR>
http://www.nyspi.cpmc.columbia.edu:80/nyspi/depts/psypharm/eating~1/bulimia.htm 156.111.80.30 19970121074449 text/html 1696
HTTP/1.0 200 OK
MIME-Version: 1.0
Server: GLACI/2.01
Date: Tue Jan 21 02:48:57 1997
Content-Type: text/html
Content-Length: 1566
</DOCHDR>
<!DOCTYPE HTML PUBLIC "-//IETF//DTD HTML//EN">

<html>

<head>
<title>What is bulimia nervosa?</title>
<meta name="GENERATOR" content="Microsoft FrontPage 1.1">
</head>

<body BGCOLOR="#FFFFFF">
<p><b>What is Bulimia Nervosa?</b> </p>
<p>Bulimia nervosa is characterized by binge-eating and inappropriate methods of weight control 
accompanied by excessive shape and weight concerns. A binge is defined as an episode in which 
one eats a much larger amount of food than most people would in a similar situation and 
experiences a sense of loss of control. There are two types of bulimia nervosa: purging and 
nonpurging. Individuals with purging bulimia nervosa self-induce vomiting or abuse laxatives, 
diuretics or enemas to counteract the effects of binge-eating; Individuals with nonpurging type fast 
or exercise excessively following episodes of binge-eating. </p>
<p><b>Who Gets Bulimia Nervosa?</b> </p>
<p>About 90% of patients with bulimia nervosa are women. Most of them develop the disorder in 
early adulthood. While many women report various symptoms of bulimia nervosa, only 1-3% of 
young women meet the full<b> </b><a href="diagBuli.htm"><b>diagnostic criteria for the disorder</b></a>. </p>
<hr>
<p><font size=2><strong>Created by </strong></font><a href="mailto:jjb41@columbia.edu"><font size=2><strong>Jerald Block, MD</strong></font></a><font size=2><strong><br>
Copyright &#169; 1996 [New York State Psychiatric Institute]. All rights reserved.<br>
Revised: September 06, 1996.</strong></font></p>
</body>

</html>
</DOC>
<DOC>
<DOCNO>WT02-B10-197</DOCNO>
<DOCOLDNO>IA093-000995-B031-584</DOCOLDNO>
<DOCHDR>
http://www.nyspi.cpmc.columbia.edu:80/nyspi/depts/psypharm/eating~1/txanorex.htm 156.111.80.30 19970121074456 text/html 2014
HTTP/1.0 200 OK
MIME-Version: 1.0
Server: GLACI/2.01
Date: Tue Jan 21 02:49:04 1997
Content-Type: text/html
Content-Length: 1884
</DOCHDR>
<!DOCTYPE HTML PUBLIC "-//IETF//DTD HTML//EN">

<html>

<head>
<title>Treatment of anorexia</title>
<meta name="GENERATOR" content="Microsoft FrontPage 1.1">
</head>

<body BGCOLOR="#FFFFFF">
<p><b>What Treatment is Available for Anorexia Nervosa?</b> </p>
<p>Our inpatient facility <a href="Unitdata.htm">provides treatment</a> for women from ages 16 through 45 who meet 
<a href="diagAnor.htm">diagnostic criteria for anorexia nervosa</a>. The average length of stay is three to four 
months. Treatment is multi-disciplinary and consists of nutritional management, group and 
individual psychotherapy, and behavioral interventions geared towards normalizing eating 
behavior and weight. Patients are placed on a well-balanced diet and their weight is 
gradually restored to a normal range (90% of <a href="metropol.htm">expected body weight</a> and above). 
Psychotherapy is used to treat emotional problems associated with the eating disorder as 
well as to help restructure distorted thoughts about eating and weight. </p>
<p>Treatment is offered at <strong>no cost</strong> in exchange for participation in ongoing research studies. 
Currently this entails participating in a seven week trial of fluoxetine, a widely used 
antidepressant medication, during the inpatient stay. Upon discharge, patients who 
received treatment on the inpatient unit may be eligible to receive up to one year of free 
outpatient psychotherapy as part of our investigation of relapse prevention in the treatment 
of anorexia nervosa. </p>
<hr>
<p><font size=2><strong>Created by </strong></font><a href="mailto:jjb41@columbia.edu"><font size=2><strong>Jerald Block, MD</strong></font></a><font size=2><strong><br>
Copyright &#169; 1996 [New York State Psychiatric Institute]. All rights reserved.<br>
Revised: September 06, 1996.</strong></font></p>
</body>

</html>
</DOC>
<DOC>
<DOCNO>WT02-B10-198</DOCNO>
<DOCOLDNO>IA093-000995-B033-125</DOCOLDNO>
<DOCHDR>
http://www.nyspi.cpmc.columbia.edu:80/nyspi/depts/psypharm/eating~1/txbulimi.htm 156.111.80.30 19970121075609 text/html 2161
HTTP/1.0 200 OK
MIME-Version: 1.0
Server: GLACI/2.01
Date: Tue Jan 21 03:00:11 1997
Content-Type: text/html
Content-Length: 2031
</DOCHDR>
<!DOCTYPE HTML PUBLIC "-//IETF//DTD HTML//EN">

<html>

<head>
<title>The treatment of bulimia</title>
<meta name="GENERATOR" content="Microsoft FrontPage 1.1">
</head>

<body BGCOLOR="#FFFFFF">
<p><b>What Treatment is Available for Bulimia Nervosa?</b> </p>
<p>We offer both inpatient and outpatient treatment to women age 18 through 50 who meet 
<a href="diagBuli.htm">diagnostic criteria for bulimia nervosa</a>. </p>
<p>Research studies currently underway for bulimia nervosa aim to clarify the importance of 
a variety of psychological and biological disturbances in the development of this eating 
disorder. Eligible individuals who <a href="Unitdata.htm">participate in these studies</a> may receive inpatient or 
outpatient care at <strong>no charge</strong>.</p>
<p>In the past we have conducted studies examining the use of cognitive behavioral therapy 
(CBT) and interpersonal psychotherapy (IPT) in the treatment of bulimia nervosa. 
Cognitive behavioral therapy focuses on how one's attitudes about food, dieting, weight, 
and body shape may affect behavior. Interpersonal therapy focuses on examining 
interpersonal relationships and how they affect eating habits and attitudes. </p>
<p>Since the research on the unit frequently changes, we are unable to provide details on 
what studies are currently available. You can, of course, contact us for more details. 
Typical research can take anywhere from an afternoon to a few months. Participants in the 
IPT &amp; CBT study mentioned above received approximately 19 sessions of individual 
psychotherapy (either cognitive behavioral or interpersonal) free of charge over the 
course of four months. </p>
<hr>
<p><font size=2><strong>Created by </strong></font><a href="mailto:jjb41@columbia.edu"><font size=2><strong>Jerald Block, MD</strong></font></a><font size=2><strong><br>
Copyright &#169; 1996 [New York State Psychiatric Institute]. All rights reserved.<br>
Revised: September 06, 1996.</strong></font></p>
</body>

</html>
</DOC>
<DOC>
<DOCNO>WT02-B10-199</DOCNO>
<DOCOLDNO>IA093-000995-B033-176</DOCOLDNO>
<DOCHDR>
http://www.nyspi.cpmc.columbia.edu:80/nyspi/depts/psypharm/eating~1/diagAnor.htm 156.111.80.30 19970121075642 text/html 1812
HTTP/1.0 200 OK
MIME-Version: 1.0
Server: GLACI/2.01
Date: Tue Jan 21 03:00:46 1997
Content-Type: text/html
Content-Length: 1682
</DOCHDR>
<!DOCTYPE HTML PUBLIC "-//IETF//DTD HTML//EN">

<html>

<head>
<title>Diagnostic Criteria for Anorexia</title>
<meta name="GENERATOR" content="Microsoft FrontPage 1.1">
</head>

<body BGCOLOR="#FFFFFF">
<p><b>What are the Diagnostic Criteria for Anorexia Nervosa?</b> </p>
<p>The following are required for the diagnosis of anorexia nervosa: </p>
<ul>
<li>being underweight (less than 85% of <a href="metropol.htm">expected body weight</a>)</li>
<li>loss of menstrual periods, or menses present only following hormone administration 
(e.g., estrogen or birth control pills) </li>
<li>intense fear of gaining weight or becoming fat, even though underweight </li>
<li>distorted body image, undue influence of body weight or shape on self-evaluation, or 
denial of the seriousness of the current low body weight </li>
</ul>
<p>These criteria are established by the American Psychiatric Association and published in 
the <i>Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition</i>. </p>
<p>You may refer to the following cases for additional information on anorexia. They are 
based on two different patient's medical histories. The stories have been altered so as to 
protect the identity of the patients.</p>
<ul>
<li><a href="Acase1.htm">Case I</a></li>
<li><a href="acase2.htm">Case II</a><hr>
</li>
</ul>
<p><font size=2><strong>Created by </strong></font><a href="mailto:jjb41@columbia.edu"><font size=2><strong>Jerald Block, MD</strong></font></a><font size=2><strong><br>
Copyright &#169; 1996 [New York State Psychiatric Institute]. All rights reserved.<br>
Revised: September 06, 1996.</strong></font></p>
</body>

</html>
</DOC>
<DOC>
<DOCNO>WT02-B10-200</DOCNO>
<DOCOLDNO>IA093-000995-B033-189</DOCOLDNO>
<DOCHDR>
http://www.nyspi.cpmc.columbia.edu:80/nyspi/depts/psypharm/eating~1/diagBuli.htm 156.111.80.30 19970121075656 text/html 2234
HTTP/1.0 200 OK
MIME-Version: 1.0
Server: GLACI/2.01
Date: Tue Jan 21 03:01:05 1997
Content-Type: text/html
Content-Length: 2104
</DOCHDR>
<!DOCTYPE HTML PUBLIC "-//IETF//DTD HTML//EN">

<html>

<head>
<title>Diagnostic criteria for Bulimia</title>
<meta name="GENERATOR" content="Microsoft FrontPage 1.1">
</head>

<body BGCOLOR="#FFFFFF">
<p><b>What are the Diagnostic Criteria for Bulimia Nervosa?</b> </p>
<p>The following are required for the diagnosis of bulimia nervosa: </p>
<ul>
<li>regular (at least twice a week) episodes of binge-eating characterized by both: </li>
</ul>
<blockquote>
<p>1) eating, in a discrete period of time (e.g., within any 2-hour period), an amount of food that is definitely 
larger than most people would eat during a similar period of time under similar circumstances </p>
</blockquote>
<blockquote>
<p>2) a sense of loss of control over eating during these episodes (e.g., a feeling that one cannot stop eating or 
control what or how much one is eating) </p>
</blockquote>
<ul>
<li>regular (at least twice a week) inappropriate compensatory behavior, such as self-induced vomiting; abusing 
laxatives, diuretics or enemas; fasting; or excessive exercise. </li>
<li>undue influence of body weight or shape on self-evaluation </li>
<li>anorexia nervosa is not present (i.e., weight is greater than 85% of expected body weight) </li>
</ul>
<p>These criteria are established by the American Psychiatric Association and published in the <i>Diagnostic and Statistical 
Manual of Mental Disorders, Fourth Edition</i>. </p>
<p>You may refer to the following cases for additional information on bulimia. They are based on two different patient's 
medical histories. The stories have been altered so as to protect the identity of the patient.</p>
<ul>
<li><a href="Bcase1.htm">Case I</a></li>
<li><a href="Bcase2.htm">Case II</a><hr>
</li>
</ul>
<p><font size=2><strong>Created by </strong></font><a href="mailto:jjb41@columbia.edu"><font size=2><strong>Jerald Block, MD</strong></font></a><font size=2><strong><br>
Copyright &#169; 1996 [New York State Psychiatric Institute]. All rights reserved.<br>
Revised: September 06, 1996.</strong></font></p>
</body>

</html>
</DOC>
<DOC>
<DOCNO>WT02-B10-201</DOCNO>
<DOCOLDNO>IA093-000995-B033-207</DOCOLDNO>
<DOCHDR>
http://www.nyspi.cpmc.columbia.edu:80/nyspi/depts/psypharm/eating~1/metropol.htm 156.111.80.30 19970121075708 text/html 7778
HTTP/1.0 200 OK
MIME-Version: 1.0
Server: GLACI/2.01
Date: Tue Jan 21 03:01:12 1997
Content-Type: text/html
Content-Length: 7648
</DOCHDR>
<!DOCTYPE HTML PUBLIC "-//IETF//DTD HTML//EN">

<html>

<head>
<title>Metropolitan Life Weight Table</title>
<meta name="GENERATOR" content="Microsoft FrontPage 1.1">
</head>

<body BGCOLOR="#FFFFFF">
<p align=center><b>EXPECTED BODY WEIGHTS FOR WOMEN</b> </p>
<p>If height is between the heights on the chart (i.e., 5'1 1/4'') round height <strong>down</strong> to the nearest &#189; inch 
(i.e., 5'1''). </p>
<div align=center><center>
<table border=12 cellpadding=4 cellspacing=4 width=75%>
<caption align=top>Actual Height and Weight as Compared to Percent of Ideal Weight</caption>
<tr><th width=14%><font size=3>Height</font></th><th width=14%><font size=3>65% of 
ideal</font></th><th width=14%><font size=3>75% </font></th><th width=14%><font size=3>85%</font></th><th width=14%><font size=3>90%</font></th><th width=15%><font size=3>100%</font></th></tr>
<tr><th width=14%><font size=3>4' 10''</font></th><td align=center width=14%>70 lbs</td><td align=center width=14%>81</td><td align=center width=14%>91</td><td align=center width=14%>97</td><td align=center width=15%>107</td></tr>
<tr><th width=14%><font size=3>4' 10 &#189;''</font></th><td align=center width=14%>71</td><td align=center width=14%>82</td><td align=center width=14%>92</td><td align=center width=14%>98</td><td align=center width=15%>109</td></tr>
<tr><th width=14%><font size=3>4' 11''</font></th><td align=center width=14%>72</td><td align=center width=14%>83</td><td align=center width=14%>94</td><td align=center width=14%>99</td><td align=center width=15%>110</td></tr>
<tr><th width=14%><font size=3>4' 11 &#189;''</font></th><td align=center width=14%>73</td><td align=center width=14%>84</td><td align=center width=14%>95</td><td align=center width=14%>101</td><td align=center width=15%>112</td></tr>
<tr><th width=14%><font size=3>5' 0''</font></th><td align=center width=14%>74</td><td align=center width=14%>85</td><td align=center width=14%>96</td><td align=center width=14%>102</td><td align=center width=15%>113</td></tr>
<tr><th width=14%><font size=3>5' &#189;''</font></th><td align=center width=14%>75</td><td align=center width=14%>86</td><td align=center width=14%>98</td><td align=center width=14%>103</td><td align=center width=15%>115</td></tr>
<tr><th width=14%><font size=3>5' 1''</font></th><td align=center width=14%>76</td><td align=center width=14%>87</td><td align=center width=14%>99</td><td align=center width=14%>105</td><td align=center width=15%>116</td></tr>
<tr><th width=14%><font size=3>5' 1 &#189;''</font></th><td align=center width=14%>77</td><td align=center width=14%>89</td><td align=center width=14%>100</td><td align=center width=14%>106</td><td align=center width=15%>118</td></tr>
<tr><th width=14%><font size=3>5' 2''</font></th><td align=center width=14%>78</td><td align=center width=14%>90</td><td align=center width=14%>102</td><td align=center width=14%>108</td><td align=center width=15%>120</td></tr>
<tr><th width=14%><font size=3>5' 2 &#189;''</font></th><td align=center width=14%>79</td><td align=center width=14%>91</td><td align=center width=14%>103</td><td align=center width=14%>109</td><td align=center width=15%>121</td></tr>
<tr><th width=14%><font size=3>5' 3''</font></th><td align=center width=14%>80</td><td align=center width=14%>92</td><td align=center width=14%>105</td><td align=center width=14%>111</td><td align=center width=15%>123</td></tr>
<tr><th width=14%><font size=3>5' 3 &#189;''</font></th><td align=center width=14%>82</td><td align=center width=14%>94</td><td align=center width=14%>107</td><td align=center width=14%>113</td><td align=center width=15%>125</td></tr>
<tr><th width=14%><font size=3>5' 4''</font></th><td align=center width=14%>84</td><td align=center width=14%>96</td><td align=center width=14%>109</td><td align=center width=14%>115</td><td align=center width=15%>128</td></tr>
<tr><th width=14%><font size=3>5' 4 &#189;''</font></th><td align=center width=14%>85</td><td align=center width=14%>97</td><td align=center width=14%>110</td><td align=center width=14%>117</td><td align=center width=15%>130</td></tr>
<tr><th width=14%><font size=3>5' 5''</font></th><td align=center width=14%>86</td><td align=center width=14%>99</td><td align=center width=14%>112</td><td align=center width=14%>119</td><td align=center width=15%>132</td></tr>
<tr><th width=14%><font size=3>5' 5 &#189;''</font></th><td align=center width=14%>87</td><td align=center width=14%>100</td><td align=center width=14%>114</td><td align=center width=14%>120</td><td align=center width=15%>134</td></tr>
<tr><th width=14%><font size=3>5' 6''</font></th><td align=center width=14%>89</td><td align=center width=14%>102</td><td align=center width=14%>115</td><td align=center width=14%>122</td><td align=center width=15%>136</td></tr>
<tr><th width=14%><font size=3>5' 6 &#189;''</font></th><td align=center width=14%>90</td><td align=center width=14%>103</td><td align=center width=14%>117</td><td align=center width=14%>124</td><td align=center width=15%>138</td></tr>
<tr><th width=14%><font size=3>5' 7''</font></th><td align=center width=14%>91</td><td align=center width=14%>105</td><td align=center width=14%>119</td><td align=center width=14%>126</td><td align=center width=15%>140</td></tr>
<tr><th width=14%><font size=3>5' 7 &#189;''</font></th><td align=center width=14%>93</td><td align=center width=14%>106</td><td align=center width=14%>120</td><td align=center width=14%>128</td><td align=center width=15%>142</td></tr>
<tr><th width=14%><font size=3>5' 8''</font></th><td align=center width=14%>94</td><td align=center width=14%>108</td><td align=center width=14%>122</td><td align=center width=14%>129</td><td align=center width=15%>144</td></tr>
<tr><th width=14%><font size=3>5' 8 &#189;''</font></th><td align=center width=14%>95</td><td align=center width=14%>109</td><td align=center width=14%>124</td><td align=center width=14%>131</td><td align=center width=15%>146</td></tr>
<tr><th width=14%><font size=3>5' 9''</font></th><td align=center width=14%>97</td><td align=center width=14%>111</td><td align=center width=14%>126</td><td align=center width=14%>133</td><td align=center width=15%>148</td></tr>
<tr><th width=14%><font size=3>5' 9 &#189;''</font></th><td align=center width=14%>98</td><td align=center width=14%>112</td><td align=center width=14%>127</td><td align=center width=14%>135</td><td align=center width=15%>150</td></tr>
<tr><th width=14%><font size=3>5' 10''</font></th><td align=center width=14%>99</td><td align=center width=14%>114</td><td align=center width=14%>129</td><td align=center width=14%>137</td><td align=center width=15%>152</td></tr>
</table>
</center></div>
<p>Data collected by the Metropolitan Life Insurance Company. Derived primarily from data of the 
Build and Blood Pressure Study, Society of Actuaries, 1959. New York, Metropolitan Life 
Insurance Company, 1960. </p>
<p><font size=3><strong>Note</strong></font>: There are alternative methods to calculate one's ideal body weight. While the above chart 
has significant flaws, it is useful in that the target weights are straightforward, consistent, and easy to 
calculate. Moreover, it is clinically useful and is the method of calculation used in our Eating 
Disorders Unit.</p>
<hr>
<p><font size=2><strong>Created by </strong></font><a href="mailto:jjb41@columbia.edu"><font size=2><strong>Jerald Block, MD</strong></font></a><font size=2><strong><br>
Copyright &#169; 1996 [New York State Psychiatric Institute]. All rights reserved.<br>
Revised: September 06, 1996.</strong></font></p>
</body>

</html>
</DOC>
<DOC>
<DOCNO>WT02-B10-202</DOCNO>
<DOCOLDNO>IA093-000995-B033-356</DOCOLDNO>
<DOCHDR>
http://www.nyspi.cpmc.columbia.edu:80/nyspi/depts/psypharm/eating~1/Acase1.htm 156.111.80.30 19970121075930 text/html 15348
HTTP/1.0 200 OK
MIME-Version: 1.0
Server: GLACI/2.01
Date: Tue Jan 21 03:03:35 1997
Content-Type: text/html
Content-Length: 15217
</DOCHDR>
<!DOCTYPE HTML PUBLIC "-//IETF//DTD HTML//EN">

<html>

<head>
<title>Anorexia - Case #1</title>
<meta name="GENERATOR" content="Microsoft FrontPage 1.1">
</head>

<body BGCOLOR="#FFFFFF">
<h3 align=center>Case Example #1 </h3>
<p align=center>(names and details altered to prevent identification)</p>
<p>A 23-year-old woman from Arkansas wrote a letter to the head of a New York research 
group after seeing a television program in which he described his work with patients with 
unusual eating patterns. In the letter, which requested that she be accepted into his 
program, the woman described her problems as follows: </p>
<h5><font size=3><strong>Several years ago, in college, I started using laxatives to lose weight. I started with a 
few and increased the number as they became ineffective. After 2 years I was taking 
250-300 Ex-Lax pills at one time with a glass of water, 20 per gulp. I would lose as 
much as 20 pounds in a 24-hour period, mostly water and some food, [and would be] 
dehydrated so that I couldn't stand, and could barely talk. I ended up in the 
university infirmary several times with diagnoses of food poisoning, severe 
gastrointestinal flu, etc., with bland diets and medications. I was released within a 
day or two. A small duodenal ulcer appeared and disappeared on X-rays in 1975. </strong></font></h5>
<h5><font size=3><strong>I would not eat for days, then would eat something, and, overcome by guilt at eating, 
and hunger, would eat, eat, eat. A girl on my dorm floor told me that she occasionally 
forced herself to vomit so that she wouldn't gain weight. I did this every once in a 
while and discovered that I could consume large amounts of food, vomit, and still lose 
weight. This was spring of 1975. 1 lost nearly 50 pounds over a few months, to 90 
pounds. My hair started coming out in handfuls, and my teeth were loose. </strong></font></h5>
<h5><font size=3><strong>I never felt lovelier or more confident about my appearance: physically liberated, 
streamlined, close-to-the-bone. I was flat everywhere except my stomach when I 
binged, when I would be full-blown and distended. When I bent over, each rib and 
back vertebra was outlined. After vomiting, my stomach was once more flat, empty. 
The more I lost, the more I was afraid of getting fat. I was afraid to drink water for 
days at a time because it would add pounds on the scale and make me miserable. Yet 
I drank (or drink; perhaps I should be writing this all in the present tense) easily a 
half-gallon of milk and other liquids at once when bingeing. I didn't need the laxatives 
as much to get rid of food and eventually stopped using them altogether (although I 
am still chronically constipated, I become nauseous whenever I see them in the 
drugstore). </strong></font></h5>
<h5><font size=3><strong>I exercised for hours each day to tone my figure from the weight fluctuations, and 
joined the university track team. I wore track shoes all the time and ran to classes 
and around town, stick-legs pumping. I went to track practice daily after being sick, 
until I was forced to quit; a single lap would make me dizzy, with cramps in my 
stomach and legs. </strong></font></h5>
<h5><font size=3><strong>At some point during my last semester before dropping out I came across an article 
on anorexia nervosa. It frightened me; my own personal obsession with food and 
body weight was shared by other people. I had not menstruated in 2 years. So, I 
forced myself to eat and digest healthy food. Hated it. I studied nutrition and 
gradually forced myself to accept a new attitude toward food&#151;vitalizing&#151;something 
needed for life. I gained weight, fighting panic. In a rigid, controlled way I have 
maintained myself nutritionally ever since: 105-115 pounds at 5'6&quot;. I know what I 
need to survive and I eat it&#151;a balanced diet with the fewest possible calories, mostly 
vegetables, fruits, fish, fowl, whole grain products, and so on. In 5 years I have not 
eaten anything like pizza, pastas or pork, sweets, or anything fattening, fried or rich 
without being very sick. Once I allowed myself an ice cream cone. But I am usually 
sick if I deviate as much as one bite. </strong></font></h5>
<h5><font size=3><strong>It was difficult for me to face people at school, and I dropped courses each semester, 
collecting incompletes but finishing well in the few classes I stayed with. The 
absurdity of my reclusiveness was even evident to me during my last semester when I 
signed up for correspondence courses, while living only two blocks from the 
correspondence university building on campus. I felt I would only be able to face 
people when I lost &quot;just a few more pounds.&quot; </strong></font></h5>
<h5><font size=3><strong>Fat. I cannot stand it. This feeling is stronger and more desperate than any horror at 
what I am doing to myself. If I gain a few pounds I hate to leave the house and let 
people see me. Yet I am sad to see how I have pushed aside the friends, activities, 
and state of energized health that once rounded my life. </strong></font></h5>
<h5><font size=3><strong>For all of this hiding, it will surprise you to know that I am by profession a model. 
Last year when I was more in control of my eating-vomiting I enjoyed working in 
front of a camera, and I was doing well. Lately I've been sick too much and feel 
out-of-shape and physically unself-confident for the discipline involved. I keep myself 
supported during this time with part-time secretarial work, and whatever unsolicited 
photo bookings my past clients give me. For the most part I do the secretarial work. 
And I can't seem to stop being sick all of the time. </strong></font></h5>
<h5><font size=3><strong>The more I threw up when I was in college, the longer it took, and the harder it 
became. I needed to use different instruments to induce vomiting. Now I double two 
electrical cords and shove them several feet down into my throat. This is preceded by 
6-10 doses of ipecac [an emetic]. My knees are calloused from the time spent 
kneeling sick. The eating-vomiting process takes usually 2-3 hours, sometimes as 
long as 8. I dread the gagging and pain and sometimes my throat is very sore and I 
procrastinate using the ipecac and cords. I sit on the floor, biting my nails, and pulling 
the skin off around my nails with tweezers. Usually I wear rubber gloves to prevent 
this somewhat. </strong></font></h5>
<h5><font size=3><strong>After emptying my stomach completely I wash thoroughly. In a little while I will 
hydrate myself with a bottle of diet pop, and take a handful of Lasix [furosemide; a 
diuretic] 40 mg (which I have numerous prescriptions for). Sometimes I am faint, 
very cold. I splash cool water on my face, smooth my hair, but my hands are shaking 
some. I will take aspirin if my hands hurt sharply . . . so I can sleep later. My lips, 
fingers are bluish and cold. I see in the mirror that blood vessels are broken. There 
are red spots over my eyes. They always fade in a day or two. There is a certain 
relief when it is over, that the food is gone, and I am not horribly fat from it. And I 
cry often . . . for some rest, some calm. It is foolish for me to cry for someone, 
someone to help me; when it is only me who is hiding and hurting myself. </strong></font></h5>
<h5><font size=3><strong>Now there is a funny new split in my behavior, this honesty about my illness. 
Hopefully it will bring me more help than humiliation. Sometimes I feel a hypocrisy in 
my actions, and in the frightened, well-ordered attempts to seek out help. All the 
while I am still sick, night after night after night. And often days as well. </strong></font></h5>
<h5><font size=3><strong>Two sets of logic seem to be operating against each other, each determined, each 
half-canceling the effects of the other. It is the part of me which forced me to eat 
that I'm talking about . . . which cools my throat with water after hours of heaving, 
which takes potassium supplements to counteract diuretics, and aspirin for torn 
hands. It is this part of me, which walks into a psychiatrist's office twice weekly and 
sees the liability of hurting myself seriously, which makes constant small efforts to 
repair the tearing-down. </strong></font></h5>
<h5><font size=3><strong>It almost sounds as if I am being brutalized by some unrelenting force. Ridiculous to 
feel this way, or to stand and cry, because the hands that cool my throat and try to 
make small repairs only just punched lengths of cord into my stomach. No demons, 
only me. </strong></font></h5>
<h5><font size=3><strong>For your consideration, I am </strong></font></h5>
<h5><font size=3><strong>Gratefully yours, </strong></font></h5>
<h5><font size=3><strong>Nancy Lee Duval </strong></font></h5>
<p>Ms. Duval was admitted to the research ward for study. Additional history revealed that 
her eating problems began gradually during her adolescence, and had been severe for the 
past 3-4 years. At age 14 she weighed 128 pounds and had reached her adult height of 
5'6&quot;. She felt &quot;terribly fat&quot; and began to diet without great success. At age 17 she weighed 
165 pounds and began to diet more seriously for fear that she would be ridiculed and went 
down to 130 pounds over the next year. She recalled feeling very depressed, 
overwhelmed, and insignificant. She began to avoid difficult classes so that she would 
never get less than straight A's, and began to lie about her school and grade performance 
for fear of being humiliated. She had great social anxiety in dealing with boys, which 
culminated in her transferring to a girls' school for the last year of high school. </p>
<p>When she left for college, her difficulties increased. She had trouble deciding how to 
organize her time&#151;whether to study, to date, or to see friends. She became more 
desperate to lose weight and began to use laxatives, as she describes in her letter. At age 
20, in her sophomore year of college, she reached her lowest weight of 88 pounds (70% 
of ideal body weight) and stopped menstruating. </p>
<p>As Ms. Duval describes in her letter, she recognized that there was a problem and 
eventually forced herself to gain weight. Nonetheless, the overeating and vomiting she had 
begun the previous year worsened. As she was preoccupied with her weight and her 
eating, her school performance suffered, and she dropped out of school midway through 
college at age 21. </p>
<p>Ms. Duval is the second of four children and the only girl. She comes from an 
upper-middle-class professional family. From the patient's description, it sounds as 
though the father has a history of alcoholism. There are clear indications of difficulties 
between the mother and the father, and between the boys and the parents; but no other 
family member has ever had psychiatric treatment.</p>
<hr>
<h3 align=center>Discussion </h3>
<p>Ms. Duval has Anorexia Nervosa, a disorder that was first described 300 years ago and 
given its current name in 1868. Although theories about the cause of the disorder have 
come and gone, the essential features have remained unchanged. Ms. Duval poignantly 
describes these features. </p>
<p>She had an intense and irrational fear of becoming obese, even when she was emaciated. 
Her body image was disturbed in that she perceived herself as fat when her weight was 
average and &quot;never lovelier&quot; when, to others, she must have appeared grotesquely thin. 
She lost about 30% of her body weight by relentless dieting and exercising, self-induced 
vomiting, and use of cathartics and diuretics. She had not menstruated for the past 3 years. </p>
<p>Significantly, Ms. Duval's dieting takes place despite persistent hunger; thus, the anorexia 
(loss of appetite) in the name of the disorder is a misnomer. In fact, she also has recurrent 
episodes of binge eating&#151;rapid, uncontrolled consumption of high-caloric foods. These 
binges are followed by vomiting and remorse. This pattern of recurrent binge eating and 
purging, if it occurred by itself, would warrant the diagnosis of Bulimia Nervosa, Purging 
Type. However, when it occurs during the course of Anorexia Nervosa, only the diagnosis 
of Anorexia Nervosa is made, but qualified as Binge Eating/Purging Type. </p>
<p>When an emaciated patient with Anorexia Nervosa insists that she is fat, this suggests the 
presence of a somatic delusion, as might be seen in Schizophrenia or Major Depression. 
However, such a patient is generally not considered to have a delusion because she is 
describing how she experiences herself rather than disputing the facts of her weight. </p>
<hr>
<h3 align=center>Follow-up </h3>
<p>Ms. Duval remained in the research ward for several weeks, during which time she 
participated in research studies and, under the structure of the hospital setting, was able to 
give up her abuse of laxatives and diuretics. After her return home, she continued in 
treatment with a psychiatrist in psychoanalytically oriented psychotherapy two times a 
week, which she had begun 6 months previously. That therapy continued for 
approximately another 6 months, when her family refused to support it. The patient also 
felt that, although she had gained some insight into her difficulties she had been unable to 
change her behavior </p>
<p>Two years after leaving the hospital, she wrote that she was &quot;doing much better.&quot; She had 
reenrolled in college, and was completing her course work satisfactorily. She had seen a 
nutritionist, and felt that form of treatment was useful for her in learning what a normal 
diet was and how to maintain a normal weight. She was also receiving counseling from 
the school guidance counselors, but she did not directly relate that to her eating 
difficulties. Her weight was normal and she was menstruating regularly. She continued to 
have intermittent difficulty with binge eating and vomiting, but the frequency and severity 
of these problems were much reduced. She no longer abused diuretics or laxatives. </p>
<p>&#160;</p>
<hr>
<p><font size=2><strong>From:</strong></font></p>
<p><font size=2><cite><strong>Spitzer RL, Skodol AE, Gibbon M, et al.: </strong></cite><cite><strong><u>Psychopathology: A Case Book</u></strong></cite><cite><strong>. New York, McGraw-Hill, 
1983.</strong></cite></font></p>
<p><font size=2><cite><strong>Spitzer RL, Gibbon M, Skodol AE, et al.: </strong></cite><cite><strong><u>DSM-IV Casebook: A Learning Companion to the 
Diagnostic and Statistical Manual of Mental Disorders</u></strong></cite><cite><strong>, Fourth Edition. American Psychiatric 
Press, 1994.</strong></cite></font></p>
<hr>
<p><font size=2><strong>Created by </strong></font><a href="mailto:jjb41@columbia.edu"><font size=2><strong>Jerald Block, MD</strong></font></a><font size=2><strong><br>
Copyright &#169; 1995 [New York Psychiatric Institute]. All rights reserved.<br>
Revised: September 06, 1996.</strong></font></p>
</body>

</html>
</DOC>
<DOC>
<DOCNO>WT02-B10-203</DOCNO>
<DOCOLDNO>IA093-000995-B033-366</DOCOLDNO>
<DOCHDR>
http://www.nyspi.cpmc.columbia.edu:80/nyspi/depts/psypharm/eating~1/acase2.htm 156.111.80.30 19970121075938 text/html 5948
HTTP/1.0 200 OK
MIME-Version: 1.0
Server: GLACI/2.01
Date: Tue Jan 21 03:03:45 1997
Content-Type: text/html
Content-Length: 5818
</DOCHDR>
<!DOCTYPE HTML PUBLIC "-//IETF//DTD HTML//EN">

<html>

<head>
<title>Anorexia - Case #2</title>
<meta name="GENERATOR" content="Microsoft FrontPage 1.1">
</head>

<body BGCOLOR="#FFFFFF">
<h3 align=center>Case Example #2</h3>
<p align=center>(names and details altered to prevent identification)</p>
<p>When Peggy was first evaluated for admission to an inpatient eating disorder program, she was a 
20-year-old woman who had difficulty supporting her 5'3&quot; body with a weight of only 67 pounds. 
She had begun to lose weight 4 years earlier, initially dieting to lose an unwanted 6 pounds. 
Encouraged by compliments on her new body, she proceeded to lose 8 more pounds. Over the 
next 2 years she continued to lose weight, increased her physical activity until her weight reached a 
low of 64 pounds, and stopped menstruating. She was admitted to a medical unit, treated for 
peptic ulcer disease, and discharged, only to he admitted 3 months thereafter to the psychiatric unit 
of a general hospital. During that 8-week hospitalization, she went from 84 pounds to 100 pounds. 
She did well until she went off to college, where, with increased academic and social demands, she 
again began to diet until she weighed only 67 pounds. Her eating habits were ritualized: she cut 
food into very small pieces, moved them around on the plate, and ate very slowly. She resisted 
eating foods with high fat and carbohydrate content. She was troubled by the changes in her body, 
and became increasingly anxious as her figure developed. She was forced to drop out of school 
and to accept another hospitalization . </p>
<p>Peggy was motivated to comply with treatment, but her fears of gaining weight and becoming obese 
affected her progress. She was expected to gain a minimum of 2 pounds every week, and she was 
restricted to bed rest if she failed to gain sufficient weight. In psychotherapy Peggy was gradually 
guided to discuss her feelings and to actually look at herself in the mirror. She was initially instructed 
to look at one part of her body for a minimum of 10 seconds, and the time was progressively 
increased until she could look at her whole body without any anxiety. Her menses returned at a 
weight of 93 pounds. After 7 months of individual and family treatment, she was discharged at a 
weight of 100 pounds. Peggy returned to college, worked part time, and lived with her parents. </p>
<hr>
<h3 align=center>Discussion </h3>
<p>As is usually the case with Anorexia Nervosa, the characteristic signs and symptoms leave little 
doubt concerning the correct diagnosis. Peggy has all of the salient features, including refusal to 
maintain body weight at or above a minimally normal weight for age and height; intense fear of 
gaining weight or of becoming fat, even though underweight; disturbance in the way in which her 
body weight or shape is experienced (anxiety when viewing her body); and in postmenarchal 
females, amenorrhea. Because her method of losing weight has never involved purging 
(self-induced vomiting or use of laxatives or diuretics) or binge eating (consumption of large 
amounts of food with a sense of loss of control), the subtype is specified as Restricting Type. </p>
<p>Peggy exhibited compulsive ritualistic behavior with regard to food (e.g., cutting her food into very 
small pieces and moving it around on her plate before eating it), a feature commonly see in patients 
with Anorexia Nervosa. Although her compulsive eating behavior might suggest the possible 
additional diagnosis of Obsessive-Compulsive Disorder, a separate diagnosis is not given as the 
compulsive behavior is accounted for by the diagnosis of Anorexia Nervosa. </p>
<p>During the course of the Anorexia Nervosa, Peggy experienced depression and panic attacks. 
There is insufficient information about these symptoms to make a definitive diagnosis of a Mood or 
an Anxiety Disorder. However, the occurrence of these comorbid disorders is common in patients 
with Anorexia Nervosa. </p>
<p>Anorexia Nervosa is a serious and often life-threatening disorder. This case illustrates that with 
expert treatment, a good outcome is possible. </p>
<hr>
<h3 align=center>Follow up </h3>
<p>Over the next 10 years, Peggy graduated from college with a degree in nutrition and was selected 
to do an internship with a major corporation. She has excelled in her work, receiving several 
promotions. She married, but the relationship deteriorated as her husband became physically 
abusive. She moved out, obtained a court order of protection, and eventually a divorce. Her most 
recent correspondence told of her return to graduate school (all expenses paid and full salary), a 
new romance, and success in a marathon (third place in a 26-mile race). She has maintained her 
weight at around 116 pounds and menstruates normally. She did seek counseling to sort out issues 
related to her broken marriage and her estrangement from her sister, which has since been 
resolved. She describes her life now as full and satisfying. </p>
<hr>
<p><font size=2><strong>From:</strong></font></p>
<p><font size=2><cite><strong>Spitzer RL, Gibbon M, Skodol AE, et al.: </strong></cite><cite><strong><u>DSM-IV Casebook: A Learning Companion to the Diagnostic and 
Statistical Manual of Mental Disorders</u></strong></cite><cite><strong>, Fourth Edition. American Psychiatric Press, 1994.</strong></cite></font></p>
<hr>
<p><font size=2><strong>Created by </strong></font><a href="mailto:jjb41@columbia.edu"><font size=2><strong>Jerald Block, MD</strong></font></a><font size=2><strong><br>
Copyright &#169; 1996 [New York State Psychiatric Institute]. All rights reserved.<br>
Revised: September 06, 1996.</strong></font></p>
</body>

</html>
</DOC>
<DOC>
<DOCNO>WT02-B10-204</DOCNO>
<DOCOLDNO>IA093-000995-B033-381</DOCOLDNO>
<DOCHDR>
http://www.nyspi.cpmc.columbia.edu:80/nyspi/depts/psypharm/eating~1/Bcase1.htm 156.111.80.30 19970121075946 text/html 6493
HTTP/1.0 200 OK
MIME-Version: 1.0
Server: GLACI/2.01
Date: Tue Jan 21 03:03:54 1997
Content-Type: text/html
Content-Length: 6363
</DOCHDR>
<!DOCTYPE HTML PUBLIC "-//IETF//DTD HTML//EN">

<html>

<head>
<title>Bulimia - Case #1</title>
<meta name="GENERATOR" content="Microsoft FrontPage 1.1">
</head>

<body BGCOLOR="#FFFFFF">
<h3 align=center>Case Example #1 </h3>
<p align=center>(names and details altered to prevent identification)</p>
<p>Abby Thurmond, age 42, had not had a food binge for over 2 years when she flew from Miami to Chicago to attend the 
wedding of her friend's daughter. Single, independent, and devoted to her work, Abby had just sold her first screenplay. She 
was pleased, but she was also experiencing the &quot;postpartum&quot; letdown that always occurred when she finished a major 
project. </p>
<p>Despite knowing, from 2 years in Overeaters Anonymous (OA), that she needed to keep a safe distance from food, 
especially in emotionally hard times, Abby spent the entire day of the wedding rehearsal party in the company of food. She 
stood in her friend's kitchen for hours cutting, chopping, sorting, arranging, and, eventually, picking at the food. </p>
<p>When night and the guests came, the flurry of activity made it easy for Abby to disappear&#151;physically and 
emotionally&#151;into a binge. She started with a plate of what would have been an &quot;abstinent&quot; meal (an OA concept for 
whatever is included on one's meal plan): pasta salad, green salad, cold cuts, and a roll. Although the portions were 
generous, Abby wanted more. She spent the next 5 hours eating, at first trying to graze among the guests, but then, when 
shame set in, retreating to dark corners of the room to take frantic, stolen bites. </p>
<p>Abby stuffed herself with crackers, cheeses, breads, chicken, turkey, pasta, and salads, but all that was a prelude to what 
she really wanted&#151;sugar. She'd been waiting for the guests to leave the dining room, where the desserts were. When they 
finally did, she cut herself two pieces of cake, then two more, then ate directly from the serving tray, shoveling the food into 
her mouth. She reached for cookies, more cake, and cookies again. Heart racing, terrified of being discovered, Abby finally 
tore herself away and slipped out onto the terrace. </p>
<p>By now, in what she thought of as a &quot;food trance,&quot; Abby piled her plate with bread, onto which she smeared some 
unidentifiable spread. Though the food tasted like mud, Abby kept eating. Soon. other guests came out to the terrace, leaving 
Abby feeling she had to move again, which she did, stepping into the kitchen&#151;and the light. When Abby glanced down at 
her plate, she was horrified; ants were crawling all over it. Instead of reflexively spitting out the food, Abby, overcome by 
shame, could only swallow. Then her eyes began to search the debris on her plate for uncontaminated morsels. Witnessing 
her own madness, Abby began to cry. She flung the plate into the trash and ran to her room. </p>
<p>That event marked the beginning of a 6-month relapse into binge eating&#151;Abby's worst experience with bingeing since the 
problem began 15 years earlier. During the relapse, she binged on sugar foods and refined carbohydrates, returned to 
cigarette smoking to control the bingeing, and once again was driven to &quot;get rid&quot; of the calories by incessant exercise after 
each binge, walking 4 or 5 hours at a time, dragging her bicycle up and down six flights of stairs, and biking miles after 
dark in a dangerous city park. </p>
<hr>
<h3 align=center>Discussion </h3>
<p>The term <i>eating binge</i> is often used by people to describe occasions on which they eat more food than they should. 
However Abby's description of her eating episode at the wedding rehearsal leaves little doubt that her episodes of binge 
eating, during which she has no control over how much she eats, represent a serious symptom. In diagnosing a person with 
recurrent eating binges, the first question is whether or not that person regularly compensates for the overeating by some 
drastic inappropriate behavior. If the answer is no, the diagnosis is probably Binge-Eating Disorder, a nonofficial 
diagnosis that is included in a DSM-IV appendix of diagnoses requiring further study. If the answer is yes and as is usually 
the case, self-evaluation is unduly influenced by body shape and weight, the diagnosis is Bulimia Nervosa. Most patients 
with Bulimia Nervosa compensate for the binge eating by some method of purging&#151;either self-induced vomiting (most 
common) or the use of diuretics or laxatives. Abby's disorder is an example of the relatively unusual diagnosis of Bulimia 
Nervosa, Nonpurging Type, in which the patient uses methods such as excessive exercise (Abby's method) or fasting. </p>
<hr>
<h3 align=center>Follow-up </h3>
<p>Throughout the relapse, Abby went to therapy and to OA. But the bingeing worsened, as did the accompanying isolation and 
depression, which kept her awake, often crying uncontrollably, until the early morning hours. Finally, her therapist, a social 
worker, referred her to a psychiatrist, who put her on an antidepressant that has been used to control binge eating and on a 
structured food plan that excluded refined sugars, breads, crackers, and similar carbohydrates. Within a few weeks, Abby 
was able to stop bingeing, come out of the depression, and resume her life. After 2 years on the medication, no binges, and 
the gradual reintroduction of breads and related carbohydrates into her diet, Abby was able to stop taking the 
antidepressant, without depression or a return to binge eating. She continues to be active in OA. </p>
<hr>
<p><font size=2><strong>From:</strong></font></p>
<p><font size=2><cite><strong>Spitzer RL, Gibbon M, Skodol AE, et al.: </strong></cite><cite><strong><u>DSM-IV Casebook: A Learning Companion to the Diagnostic and Statistical Manual of Mental 
Disorders</u></strong></cite><cite><strong>, Fourth Edition. American Psychiatric Press, 1994.</strong></cite></font></p>
<hr>
<p><font size=2><strong>Created by </strong></font><a href="mailto:jjb41@columbia.edu"><font size=2><strong>Jerald Block, MD</strong></font></a><font size=2><strong><br>
Copyright &#169; 1996 [New York State Psychiatric Institute]. All rights reserved.<br>
Revised: September 06, 1996.</strong></font></p>
</body>

</html>
</DOC>
<DOC>
<DOCNO>WT02-B10-205</DOCNO>
<DOCOLDNO>IA093-000995-B033-392</DOCOLDNO>
<DOCHDR>
http://www.nyspi.cpmc.columbia.edu:80/nyspi/depts/psypharm/eating~1/Bcase2.htm 156.111.80.30 19970121075955 text/html 4785
HTTP/1.0 200 OK
MIME-Version: 1.0
Server: GLACI/2.01
Date: Tue Jan 21 03:04:02 1997
Content-Type: text/html
Content-Length: 4655
</DOCHDR>
<!DOCTYPE HTML PUBLIC "-//IETF//DTD HTML//EN">

<html>

<head>
<title>Bulimia - Case #2</title>
<meta name="GENERATOR" content="Microsoft FrontPage 1.1">
</head>

<body BGCOLOR="#FFFFFF">
<h3 align=center>Case Example #2</h3>
<p align=center>(names and details altered to prevent identification)</p>
<p>Gregory, a 43-year-old theatrical manager, was evaluated at an eating disorders clinic in San Francisco. Although he had 
lost 58 pounds in the last 5 months, dropping from 250 to 192 pounds on a 6'1&quot; frame, he was still terrified of getting fat. </p>
<p>Gregory first began to diet 5 months earlier when his wife told him he was &quot;a fat slob&quot; and implied that she might be 
considering a divorce. This terrified him and started him on a strict dietary regimen: an omelet and bran for breakfast, 
coffee for lunch, and salad and shrimp or chicken for dinner. His original goal was to lose about 50 pounds. When dieting 
did not result in sufficiently rapid loss of weight, he started sticking his finger down his throat to induce vomiting after 
meals. </p>
<p>Gregory is now &quot;obsessed&quot; with food. Before he goes to a restaurant, he worries about what he will order. He has done a 
study of what he eats in terms of what is easiest to purge, and he knows all the bathrooms in the areas he frequents. He 
cannot bear feeling full after eating and worries that his stomach is &quot;fat.&quot; Three or four times a week he is unable to resist 
the urge to &quot;binge.&quot; At those times he feels that his eating is out of control, and he may gobble down as much as three 
hamburgers, two orders of french fries, a pint of ice cream, and two packages of Oreo cookies. He always induces vomiting 
after a binge. He has never used laxatives, diuretics, or diet pills to lose weight. </p>
<p>Gregory is also preoccupied with being thin. He has progressively revised downward his original goal in dieting, first to 
190, and then to 185 pounds. He has begun to exercise, walking at least an hour a day and, more recently, working out with 
weights several times a week. He believes that women look at him differently now: when he was heavy, they glanced at him 
casually; now their response is &quot;admiring.&quot; </p>
<p>Gregory has always been somewhat heavy, turning to food in times of stress, but he never worried about his weight until his 
wife criticized his appearance. He can no longer enjoy any meals and feels he has lost control of this area of his life as he 
cannot stop dieting, even though his wife has told him he is now too thin. He therefore recently saw his internist, who found 
no physical problems and referred him for psychiatric evaluation. </p>
<hr>
<h3 align=center>Discussion </h3>
<p>Gregory's eating disorder began, as is often the case, with a reasonable attempt to lose some weight. He soon became 
preoccupied with losing weight and continued to view his body as &quot;fat&quot; even though others did not. This preoccupation with 
losing weight and distorted body image suggest Anorexia Nervosa, but this diagnosis is not made as Gregory has not let his 
weight go far below the normal minimum for his size. </p>
<p>Gregory's binges (recurrent eating of a large amount of food with a sense of loss of control), his recurrent inappropriate 
compensatory behavior in order to avoid weight gain (in his case, by self-induced vomiting), and the overconcern with 
weight and shape indicate Bulimia Nervosa. As is usually the case in Bulimia Nervosa, the predominant method for 
avoiding weight gain is vomiting, hence the diagnosis is further qualified as Purging Type. Less common methods for 
avoiding weight gain are misuse of laxatives or diuretics (also considered as Purging Type), fasting, and excessive 
exercise. </p>
<p>This case is unusual in that Bulimia Nervosa, like Anorexia Nervosa, is far more common in women than in men </p>
<hr>
<p><font size=2><strong>From:</strong></font></p>
<p><font size=2><cite><strong>Spitzer RL, Gibbon M, Skodol AE, et al.: </strong></cite><cite><strong><u>DSM-IV Casebook: A Learning Companion to the Diagnostic and Statistical Manual of Mental 
Disorders</u></strong></cite><cite><strong>, Fourth Edition. American Psychiatric Press, 1994.</strong></cite></font></p>
<hr>
<p><font size=2><strong>Created by </strong></font><a href="mailto:jjb41@columbia.edu"><font size=2><strong>Jerald Block, MD</strong></font></a><font size=2><strong><br>
Copyright &#169; 1996 [New York State Psychiatric Institute]. All rights reserved.<br>
Revised: September 06, 1996.</strong></font></p>
</body>

</html>
</DOC>
<DOC>
<DOCNO>WT02-B10-206</DOCNO>
<DOCOLDNO>IA093-000995-B028-390</DOCOLDNO>
<DOCHDR>
http://www.nyspi.cpmc.columbia.edu:80/NYSPI/PI_RFMH.HTM 156.111.80.30 19970121072142 text/html 4602
HTTP/1.0 200 OK
MIME-Version: 1.0
Server: GLACI/2.01
Date: Tue Jan 21 02:25:40 1997
Content-Type: text/html
Content-Length: 4472
</DOCHDR>
<TITLE>N.Y.S.P.I. - Research Foundation for Mental Hygiene, Inc.</TITLE>
<BODY BACKGROUND="..\IMAGES\MARBLE.JPG">
<H2>The Research Foundation for Mental Hygiene, Inc.</H2>
<HR>
<B>Abel Lajtha, Ph.D., <I>President</I></B><P>
<!--<IMG SRC = "FURLONGC.GIF"><B>  Patrick L. Furlong, <I>Managing Director</I></B><P>-->
<B>Stewart O. Hughes, <I>Managing Director</I></B><P>
<IMG SRC = "PAPP1.GIF"><B>  Steven M. Papp, <I>Director of Administration - RFMH at NYSPI</I></B><P>
<IMG SRC = "MUCHA1.GIF"><B>  Frank L. Mucha, <I>Deputy Director of Administration - RFMH at NYSPI</I></B><P>
<HR>
<P>
The Research Foundation for Mental Hygiene, Inc. is a not-for-profit membership corporation organized in 1952, for the purpose of assisting and enhancing the research and training objectives of the New York State Department of Mental Hygiene and its component agencies; the Office of Mental Health, the Office of Mental Retardation and Developmental Disabilities and the Division of Alcoholism and Alcohol Abuse.  It is governed by a Board of Directors, consisting of twenty-two prominent scientists, administrators and government officials, which is responsible for setting the operational policies of the corporation.
<P>
Through an agreement with New York State, the Foundation has been designated as the organization responsible for administering and directing the conduct of all sponsored research programs carried out by scientists at Department research institutes or facilities.  In this role the Foundation provides an organizational bridge between the scientist and those wishing to support his or her work, be it the Federal Government, State Government, Industry, Individuals, Foundations or, as is frequently the case, a combination of multiple sponsors.  We see ourselves as unique in our ability to bring together the resources of organizations having different legal or management systems.  We do this in a well coordinated, fiscally sound fashion.
<P>
The Foundation manages grant and contract funds exceeding sixty million dollars annually.  Its member scientists have been involved in hundreds of pioneering studies in the basic and clinical sciences, many of which have led to major breakthroughs in the care and treatment of mentally disabled persons.  For their efforts, our member scientists have received numerous awards and honors, placing them and their work at the forefront of science throughout the world.
<P>
Along with our basic and clinical research, we are frequently asked to
undertake special projects on behalf of the New York State Department of
Mental Hygiene.  These typically involve operational needs of the
Department.  Included in these projects have been evaluation studies of
service programs, needs assessment and epidemiological studies and
development of clinical and administrative computerized information
systems.  While these efforts are normally undertaken at one of the four
research institutes operated by the Department, they may also take place
at one of the thirty Adult and Children's Psychiatric Centers operated by
the Office of Mental Health, the thirteen Developmental Disabilities
Services Offices operated by the Office of Mental Retardation
Developmental Disabilities, or the thirteen Alcoholism Treatment Centers operated by the Division of Alcoholism and Alcohol Abuse.
<P>
Our designation by the Internal Revenue Service  as a 501(c)(3) Corporation means that all donations are fully tax deductible.  In addition, we can accommodate the wishes of individuals in their estate planning, should they be interested in providing general or designated support of our programs.
<P>
As our focus is research and treatment of the mentally disabled, a major concern is the transfer of new knowledge, technology and treatment methods to the service system.  We do this by publishing the results of our research and by sponsoring symposia and training programs.  Where patentable technology is involved, depending on the sponsorship, we have the capacity to enter into various types of licensing or other agreements with industry to insure expeditious development and commercialization.
<P>
Our research is conducted at the following Institutes:
<UL>
<LI>New York State Psychiatric Institute
<LI>The Nathan S. Kline Institute for Psychiatric Research
<LI>New York State Institute for Basic Research in Developmental Disabilities
<LI>Research Institute on Alcoholism
</UL>
</BODY>



</DOC>
<DOC>
<DOCNO>WT02-B10-207</DOCNO>
<DOCOLDNO>IA093-000995-B030-431</DOCOLDNO>
<DOCHDR>
http://www.nyspi.cpmc.columbia.edu:80/NYSPI/PIDPT_V.HTM 156.111.80.30 19970121073512 text/html 2092
HTTP/1.0 200 OK
MIME-Version: 1.0
Server: GLACI/2.01
Date: Tue Jan 21 02:39:05 1997
Content-Type: text/html
Content-Length: 1962
</DOCHDR>
<HTML>
<HEAD><TITLE>Support Services</TITLE></HEAD>
<BODY BACKGROUND="..\IMAGES\MARBLE.JPG">

Volunteer Services
</H1>
<P ALIGN="RIGHT">
<B>Matt Gold, C.T.R.S., Acting Director</B>
<P ALIGN="JUSTIFY">
During 1994, approximately 100 volunteers served the Institute while working with researchers, clinicians, and administrative personnel. A number of these volunteers were students from a variety of clinical disciplines, such as Recreational Therapy, Occupational Therapy, and Social Work, who were completing internships under the supervision of Institute staff. The majority of volunteers, however, were people who wanted to contribute to the field of psychiatry as well as gain some invaluable experience for their future. In many cases, people who were dissatisfied with their present careers volunteered their service as a means of sampling a career in mental health.
<P ALIGN="JUSTIFY">
Prospective volunteers were first interviewed by the Coordinator of Volunteer Services to determine what they may have to offer the Institute, and to determine what the Institute may have to offer them. A referral was then made to the appropriate department head or liaison. Areas that made regular use of volunteers during this period included several research projects, clinical units, and departments. Volunteers led diverse patient groups, such as Writers' Workshop, Crafts, and Computer Class.
<P ALIGN="JUSTIFY">
Under the guidance of Dr. Jane Fried, Chairperson of the Infection Control Committee, efforts were made in 1994 to make the Institute a safer environment in which volunteers would work. Policy was initiated that required all prospective volunteers to attend orientation to Fire Safety and Infection Control procedures. They were also required to submit a physical health history that documented their TB status and history of vaccinations. No volunteer could be registered without having satisfied these requirements.

</BODY></HTML>
</DOC>
<DOC>
<DOCNO>WT02-B10-208</DOCNO>
<DOCOLDNO>IA093-000995-B030-329</DOCOLDNO>
<DOCHDR>
http://www.nyspi.cpmc.columbia.edu:80/NYSPI/PIDPT_NU.HTM 156.111.80.30 19970121073332 text/html 4628
HTTP/1.0 200 OK
MIME-Version: 1.0
Server: GLACI/2.01
Date: Tue Jan 21 02:37:35 1997
Content-Type: text/html
Content-Length: 4498
</DOCHDR>
<HTML>
<HEAD><TITLE>Support Services</TITLE></HEAD>
<BODY BACKGROUND="..\IMAGES\MARBLE.JPG">


<ALIGN="LEFT">
Nursing Department
</H1>
<P ALIGN="RIGHT">
<B>Marcia Lipper Michaelson, R.N., M.S., C.S., Director</B>
<P ALIGN="JUSTIFY">
During 1994, the Department of Nursing attained full staffing. Nurses and Mental Health Therapy Aides applied for both full and part-time positions at Psychiatric Institute, because of interesting assignments in our research areas and acute setting, and opportunities to attend sophisticated education programs.
<P ALIGN="JUSTIFY">
The Nursing Staff Development department focused on a number of topics pertinent to our patient population. Education was provided concerning the Adolescent and Older Adult, as well as Dual Diagnosis, Cultural Awareness, and the Interrelationship of Physical/<BR>
Mental Illness.
<P ALIGN="JUSTIFY">
The department's most significant contribution to the Institute was the continuation of exemplary nursing practice. As with many other institutions offering nursing services, the department provides twenty-four-hour per day care. While there is overlapping of duties on each shift, each tour provides its own special contributions, as patients' and families' needs change throughout the day. Due to their expertise, proximity, and direct care responsibilities nurses and aides respond immediately to both psychiatric and medical emergencies, providing necessary interventions and support.
<P ALIGN="JUSTIFY">
Two nursing staff members received awards for outstanding service. Ms. Gretchen Seirmarco was selected for the 1994 Nursing Excellence Award, and Mr. Peter Biggins was recognized by his colleagues for the 1994 Mental Health Therapy Aide Award for Excellence.
<P ALIGN="JUSTIFY">
Group work remained a priority on a number of units and two new groups began. On PI6 ICU, Allen Spatafore, R.N. is leading Current Events, and on PI5 South, Frances Martinez, M.H.T.A. is running a Crafts Group. Other ongoing groups led by nursing personnel are: Horticulture, Smoking Cessation, Patient Pass, and Health Education on the Schizophrenia Research Unit. Washington Heights inpatient staff lead forums concerning Discharge Planning, Psychoeducation, Current Events, Unit Orientation, and issues concerning people with Mental Illness/Chemical Abuse. Nurses and mental health therapy aides of the General Clinical Research Unit are involved in Discharge, Health Awareness, Women's, Crafts, and Addictions Groups. Clinical Psychopharmacology nursing service staff members lead Multi-Family and Eating Disorder Groups. Children in the Day Hospital Program attend Social Skills Training, as well as Boys' and Girls' Groups.
<P ALIGN="JUSTIFY">
Outpatient nurses and aides greatly contribute to patients remaining in the community. When patients have exacerbations of problems/symptoms, they may often be first noted by OPD staff who provide assessment and assist them in obtaining appropriate treatment.
<P ALIGN="JUSTIFY">
Nurses in outpatient research settings are also facilitating protocols and contributing to the research efforts. Registered nurses are employed by the Children's Day Program, Biological Psychiatry, Clinical Psychopharmacology, and Brain Imaging, as well as in the Lithium, Anxiety Disorders, HIV, and Depression Evaluation Clinics.
<P ALIGN="JUSTIFY">
Nursing personnel are also encouraged to share their expertise in the community. Ms. Kathleen Ibrahim, Assistant to the Director of Nursing for Staff Development, presented "Perspectives on Multiple Family Group Therapy with Eating Disordered Patients," at the Society for Education and Research in Psychiatric-Mental Health Nursing. Linda Fitzsimons, ECT Nurse, was a guest lecturer at Adelphi University's Masters Degree in Social Work Program where she spoke on "Group Psychotherapy with the Elderly"; she also contributed to a number of publications concerning ECT and depression.
<P ALIGN="JUSTIFY">
A number of personnel were also awarded advanced degrees, certificates, or honors. Kathleen Ibrahim completed the Psychiatric/Mental Health Nursing program in Psychoanalysis at Columbia University School of Nursing. Other degree recipients included: Lonnie Crews, M.H.T.A. earned an Associate in Applied Science, with a major in nursing; and Nevada Solano, M.H.T.A. earned an Associate in Human Services. Mary Ellen Lovrin, R.N. and Dee Mancuso, R.N. were inducted into the International Nursing Honor Society.
</BODY></HTML>

</DOC>
<DOC>
<DOCNO>WT02-B10-209</DOCNO>
<DOCOLDNO>IA093-000995-B030-384</DOCOLDNO>
<DOCHDR>
http://www.nyspi.cpmc.columbia.edu:80/NYSPI/PIDPT_RT.HTM 156.111.80.30 19970121073424 text/html 4392
HTTP/1.0 200 OK
MIME-Version: 1.0
Server: GLACI/2.01
Date: Tue Jan 21 02:38:22 1997
Content-Type: text/html
Content-Length: 4262
</DOCHDR>
<HTML>
<HEAD><TITLE>Support Services</TITLE></HEAD>
<BODY BACKGROUND="..\IMAGES\MARBLE.JPG">

<H1 ALIGN="LEFT">
Recreational Therapy
</H1>
<P ALIGN="RIGHT">
<B>Matt Gold, C.T.R.S., Director</B>
<P ALIGN="JUSTIFY">
During 1994, the Recreational Therapy department of Psychiatric Institute continued its work towards enabling the inpatients to attain more fulfilling and independent leisure lifestyles.
<P ALIGN="JUSTIFY">
Therapeutic Recreation is the use of leisure services to improve or maintain physical, emotional, cognitive, and/or social functioning to assist patients in expressing independent leisure lifestyles. During this year, the staff of the department again functioned as active members of their respective interdisciplinary treatment teams. Their responsibilities included assessing patients' levels of leisure functioning, planning and implementing a variety of activities, charting patients' progress, participating in team meetings, maintaining their own level of professional preparedness, and contributing to the education and training of the many volunteers, students, new practitioners, and interns who come to the Institute. Recreational Therapy services were offered during days and evenings. The major focus of this treatment modality was activity groups, but individual attention was also provided, as appropriate.
<P ALIGN="JUSTIFY">
The Recreational Therapy department offered a weekly average of well over 40 regularly scheduled groups on the inpatient units, in addition to individual work with the patients, and special event programming. In all, the department provided almost 50 hours per week of group and individual service. Groups included sports and movement groups, crafts and hobby groups, and discussion groups.
<P ALIGN="JUSTIFY">
1994 was an active period of personnel change within the department. Kay Gimmestad resigned from her position as half-time Recreation Therapist on the Schizophrenia Research Unit. Johnny Lopez, C.T.R.S., and Robert Goldstein, C.T.R.S., were hired to provide evening and weekend programming. Leon Sanders resigned his position as Senior Recreation Therapist within the Washington Heights Community Service, to accept a similar position at another OMH facility. Wendi Hapke, C.T.R.S. was hired as a Recreation Therapist on the Clinical Psychopharmacology Unit. Lori Alpert, C.T.R.S. was hired as a Senior Recreation Therapist on the WHCS-lntensive Care Unit. Patricia Smith was promoted to a Senior Recreation Therapist position and was named Assistant Director of the department as she continued her work on the General Clinical Research Service.
<P ALIGN="JUSTIFY">
Special Event Programming also figured prominently in the department's service during the summer. Included were trips, barbecues on the Porch, and a softball game and picnic. During National Therapeutic Recreation Week in July, department members joined their colleagues within the Therapeutic Recreation department at Presbyterian Hospital for a softball game against local radio station WMXV to raise funds for the Columbia-Presbyterian Medical Center (CPMC) Neighborhood Fund.
<P ALIGN="JUSTIFY">
Again meeting its responsibility to the community at large, the medical center, and to the staff of the Institute, the department made the gym available to the Audubon O.P.D., Neuro 12 and Eye 6, the Presbyterian Hospital Employees' Recreation Association, a community-based Karate Club, an Exercise Class for staff, and a staff basketball group.
<P ALIGN="JUSTIFY">
Department members improved their own clinical skills by attending professional conferences and workshops, such as the Mid-Eastern Symposium on Therapeutic Recreation, the Therapeutic Recreation Forum, and the Annual Conference sponsored by the American Therapeutic Recreation Association. Matt Gold continued teaching Cardio-Pulmonary Resuscitation this year, as one of the Institute's American Heart Association C.P.R. instructors.
<P ALIGN="JUSTIFY">
Mr. Gold continued his active involvement in professional organizations, and helped form the New York State Therapeutic Recreation Association, representing Therapeutic Recreation professionals within New York State. He serves as this organization's Treasurer.
</BODY></HTML>
</DOC>
<DOC>
<DOCNO>WT02-B10-210</DOCNO>
<DOCOLDNO>IA093-000995-B030-315</DOCOLDNO>
<DOCHDR>
http://www.nyspi.cpmc.columbia.edu:80/NYSPI/PIDPT_CC.HTM 156.111.80.30 19970121073318 text/html 1057
HTTP/1.0 200 OK
MIME-Version: 1.0
Server: GLACI/2.01
Date: Tue Jan 21 02:37:24 1997
Content-Type: text/html
Content-Length: 928
</DOCHDR>
<HTML>
<HEAD><TITLE>Support Services</TITLE></HEAD>
<BODY BACKGROUND="..\IMAGES\MARBLE.JPG">


<H1 ALIGN="LEFT">
Computer Center
</H1>
<P ALIGN="RIGHT">
<B>Donald C. Ross, Ph.D., Director</B>
<P ALIGN="JUSTIFY">
The Psychiatric Institute Computer Center (PICC) has consolidated with the Computer Center at Nathan Kline Institute (NKI) to form the Integrated Research Information System (IRIS). The mainframe computer, now located at NKI, is an IBM ES/9000 with 64 MB of memory. The PICC continues to serve users with computer programming and statistical consultation; remote terminals and PCs are used to access the mainframe.
<P ALIGN="JUSTIFY">
PICC also provides its users with technical support for Macintosh and IBM clones. A large variety of up-to-date statistical and graphics (illustration, statistics related) software on PCs is provided as well as professional consulting in these areas.
</BODY></HTML>
</DOC>
<DOC>
<DOCNO>WT02-B10-211</DOCNO>
<DOCOLDNO>IA093-000995-B030-357</DOCOLDNO>
<DOCHDR>
http://www.nyspi.cpmc.columbia.edu:80/NYSPI/PIDPT_RX.HTM 156.111.80.30 19970121073354 text/html 3809
HTTP/1.0 200 OK
MIME-Version: 1.0
Server: GLACI/2.01
Date: Tue Jan 21 02:38:00 1997
Content-Type: text/html
Content-Length: 3679
</DOCHDR>
<HTML>
<HEAD><TITLE>Support Services</TITLE></HEAD>
<BODY BACKGROUND="..\IMAGES\MARBLE.JPG">

<H1 ALIGN="LEFT">
Pharmacy
</H1>
<P ALIGN="RIGHT">
<B>Stephen McMillan, M.S., R.Ph., Director</B>
<P ALIGN="JUSTIFY">
During 1994, the Pharmacy of the Psychiatric Institute continued to provide services for the two patient populations it serves. The inpatients, both acute care and research, were maintained on our modified unit-dose system. This system provides the staff with patient-specific packaging, thus minimizing the potential for error. Additionally, it allows the pharmacy to track with greater precision such issues as non-compliance, missed or refused dosages, and cost containment. Maintained via our computerized profile and order entry system, Pharmakon, the patients are consistently monitored for potential adverse events.
<P ALIGN="JUSTIFY">
Our outpatient population is comprised of both Washington Heights Community Services (WHCS) patients and those research outpatients who are maintained in our Compassionate Care program. The WHCS patients, also maintained within the Pharmakon system, have a computerized patient profile by which we perform prospective Drug Utilization Review (DUR) activities. The research outpatients are currently maintained on a manual profile system with the goal of computerization in early 1995. They, too, are monitored for any potential adverse events that could arise from the medications which they take.
<P ALIGN="JUSTIFY">
Patient education activities continued throughout 1994. All outpatients who picked up their medications at the pharmacy were offered written and verbal counselling in accordance with OBRA '90 regulations. In conjunction with requests from the WHCS or research clinics, written or verbal information was distributed to any patients requesting such who did not present at the pharmacy. On the inpatient side, with the help of the medical and nursing staff, written and verbal medication information was disseminated upon request.
<P ALIGN="JUSTIFY">
Continuous Quality Improvement (CQI) principles were also stressed throughout the year. In addition to those indices which are presently monitored, the Pharmacy, Nursing, Medical Staff, and Quality Assurance departments formed a CQI committee specifically designed to address the process by which medications are "delivered" to the patient. A strategic plan was formulated for the committee, and we have nearly completed the first of our many intended projects.
<P ALIGN="JUSTIFY">
1994 was also a year of many changes. After nearly 22 years of dedicated service, Valerio Nuccitelli, R.Ph. retired in July and was feted with a surprise retirement party. Stephen McMillan, M.S., R.Ph., former Director of Pharmacy at the St. Lawrence Psychiatric Center, assumed the Director's role at Pl. In addition, Mr. McMillan has since been appointed to the OMH Pharmacy and Therapeutics Committee as well as to a statewide multidisciplinary committee which is concerned with the processes by which medication is "delivered" within OMH. The addition of new computer equipment and software, as well as access to the on-line information superhighway, has allowed the Pharmacy to tap into a myriad of clinical and support information, thus providing opportunities by which to improve patient care. Computerization of our drug purchasing enabled us to provide quality drug products at the best possible price.
<P ALIGN="JUSTIFY">
We look to 1995 with great anticipation. We will continue to implement CQI principles as we strive to provide streamlined, professional, and courteous service to the patients and employees of the Institute.
</BODY></HTML>
</DOC>
<DOC>
<DOCNO>WT02-B10-212</DOCNO>
<DOCOLDNO>IA093-000995-B030-370</DOCOLDNO>
<DOCHDR>
http://www.nyspi.cpmc.columbia.edu:80/NYSPI/PIDPT_QA.HTM 156.111.80.30 19970121073402 text/html 4663
HTTP/1.0 200 OK
MIME-Version: 1.0
Server: GLACI/2.01
Date: Tue Jan 21 02:38:09 1997
Content-Type: text/html
Content-Length: 4533
</DOCHDR>
<HTML>
<HEAD><TITLE>Support Services</TITLE></HEAD>
<BODY BACKGROUND="..\IMAGES\MARBLE.JPG">

<H1 ALIGN="LEFT">
Quality Assurance
</H1>
<P ALIGN="RIGHT">
<B>Ruth Corn, M.S.W., Director</B>
<P ALIGN="JUSTIFY">
1994 was a year for the Institute to strengthen the principles and practices of its Quality Improvement Program led by the Department of Quality Assurance. This approach combines problem solving and continuous quality improvement efforts in order to ensure quality care.
<P ALIGN="JUSTIFY">
Quality Improvement (QI) activities focused on planning, measuring, assessing, and improving care in functions and processes involving clinical, administrative, support, and managerial services. A multi-disciplinary approach to reviewing and improving systems continued to be the core of comprehensive monitoring, evaluation, and preventive activities. The Medical Staff Executive Committee and the Medical Staff Organization's many multi-disciplinary committees reviewed clinical practice with active leadership and participation of the staff of the Department of Quality Assurance. Consultation and guidance regarding QI activities were provided to Nursing, Social Work, Occupational Therapy, Recreation Therapy, Pharmacy, Infection Control, Dietetic Services, Housekeeping, Safety, and Education and Training. The monitoring of research protocols was conducted by the Research Monitor under the supervision of the Director for Quality Assurance with excellent results. The Research Monitor also took on an educative role in working with the staff of the outpatient research clinics regarding documentation and had much success in this endeavor. In addition, the plan to add a Program Evaluation Specialist to the Department of Quality Assurance was realized in the fall of 1994. The Program Evaluation Specialist has been able to develop specific trending and patterning reports over time regarding several patient care processes, and, in addition, is consultant to QI teams on the preparation and analysis of data in evaluating and improving specific functions of patient care. In the latter part of 1994, a questionnaire was developed by the Program Evaluation Specialist to assess the computer literacy and training needs of the clinical staff. Educational courses are now being set up to meet these needs by the Education and Training Department.
<P ALIGN="JUSTIFY">
A major organizational change occurred in March, 1994 with the establishment of a QI Council, chaired by the Director for Quality Assurance and composed of senior level representatives of various disciplines and programs. This council has become a central structure in providing leadership to promote the education of all staff in the methods and philosophy of the CQI process, in providing a forum for the identification of opportunities for improvement, in setting priorities for assessment and improvement, in identifying and convening interdepartmental teams for QI projects, and in recommending actions to improve and/or maintain improvement. The Council became the main coordinating group for carrying out the QI Program throughout the Institute. Some of the QI Projects that were initiated and completed in 1994 were: Medication Management Project, the Inpatient Adolescent Education Project, the Patient/Family Education Project, the Victims of Abuse Policy Project, and the Medical Records Documentation Project. Coping with Psychiatric Emergencies Project was begun in 1994 and is in progress.
<P ALIGN="JUSTIFY">
The Department of Quality Assurance continued its responsibility for credentialing and privileging of physicians as well as for the ongoing activities of the Department of Medical Records, Education and Training, and Utilization Review. The Medical Records Department increased its staffing and therefore was able to improve the turnaround time for research requests as well as to facilitate the timeliness of Medical Records completion. The Department of Education and Training organized special educational lectures and seminars on the topics of Child and Adolescents, The Aging Process, and Trauma and Abuse, and sponsored the annual Ethics lecture on "Boundary Violations in Clinical Practice."
<P ALIGN="JUSTIFY">
Much of this year's work by the Department of Quality Assurance focused on interpreting, communicating and implementing the new JCAHO Standards for the Institute. Preparation for the expected JCAHO Survey in March, 1995 was a major emphasis for the department and the Institute.

</BODY></HTML>
</DOC>
<DOC>
<DOCNO>WT02-B10-213</DOCNO>
<DOCOLDNO>IA093-000995-B028-324</DOCOLDNO>
<DOCHDR>
http://www.nyspi.cpmc.columbia.edu:80/NYSPI/PI_ADMIN.HTM 156.111.80.30 19970121072051 text/html 805
HTTP/1.0 200 OK
MIME-Version: 1.0
Server: GLACI/2.01
Date: Tue Jan 21 02:24:58 1997
Content-Type: text/html
Content-Length: 676
</DOCHDR>
<TITLE>N.Y.S.P.I. Administration</TITLE>
<BODY BACKGROUND="..\IMAGES\MARBLE.JPG">
<H2>N.Y.S.P.I. Administration</H2>
<HR>
<IMG SRC = "OLDHAM1.GIF"><B>  John M. Oldham, M.D. - Director</B><P>
<IMG SRC = "GORMAN1.GIF"><B>  Jack M. Gorman, M.D. - Deputy Director</B><P>
<IMG SRC = "PAPP1.GIF"><B>  Steven M. Papp, M.B.A. - Deputy Director, Administration</B><P>
<!-- <IMG SRC = "KLEIN1.GIF"><B>  Donald F. Klein, M.D. - Director, Office of Research and Development</B><P>
-->
<IMG SRC = "STRAUSS1.GIF"><B>  David Strauss, M.D. - Clinical Director</B><P>
<IMG SRC = "CORN1.GIF"><B>  Ruth Corn, M.S.W. - Director, Standards and Quality Assurance</B><P>
</BODY>




</DOC>
<DOC>
<DOCNO>WT02-B10-214</DOCNO>
<DOCOLDNO>IA093-000995-B030-398</DOCOLDNO>
<DOCHDR>
http://www.nyspi.cpmc.columbia.edu:80/NYSPI/PIDPT_BK.HTM 156.111.80.30 19970121073433 text/html 3543
HTTP/1.0 200 OK
MIME-Version: 1.0
Server: GLACI/2.01
Date: Tue Jan 21 02:38:39 1997
Content-Type: text/html
Content-Length: 3413
</DOCHDR>
<HTML>
<HEAD><TITLE>Support Services</TITLE></HEAD>
<BODY BACKGROUND="..\IMAGES\MARBLE.JPG">

<H1 ALIGN="LEFT">
Research Library
</H1>
<P ALIGN="RIGHT">
<B>David T. Lane, M.S., Director</B>
<P ALIGN="JUSTIFY">
During the year, the collection continued its rapid growth with the acquisition of many new books and journals. The journal collection was enhanced with several new titles from areas of current research and clinical interest. Notable among these were Anxiety and Human Brain Mapping. The subscription to Anxiety was initiated due to the ongoing interest in anxiety and panic disorder at the Institute. Together with Journal of Anxiety Disorders, this journal offers a convenient source for maintaining literature awareness in the anxiety disorders field. Human Brain Mapping is a richly illustrated journal which offers a source for the many Institute scientists investigating brain imaging and behavior. Book acquisitions included the latest edition of the DSM publications, which now consume almost an entire shelf. The library maintains a collection of all the DSMs from the first psychodynamically based system, published in 1952, to the present multiaxial classification.
<P ALIGN="JUSTIFY">
Literature searching on compact disc continued to be a heavily used service of the library. An estimated 8,000 search sessions were conducted during the year on the four work stations provided. The terminals were busy throughout the day and waiting lines were a common occurrence. The work stations were also busy during Saturday hours. During the year, the library attempted to improve the delivery of database services by entering into an agreement with Columbia University to subscribe to PsychInfo, a psychological database that offers many improvements over the PsychLit database currently used by the library. Among these benefits are increased coverage, faster response time, and lower cost. <BR>
The database will also be on the ColumbiaNet system, making it accessible from office computers throughout the Institute. It will no longer be necessary to travel to the library to conduct searches.
<P ALIGN="JUSTIFY">
Interlibrary loans to other institutions have continued to be an important function of the library. Memberships in clearinghouse organizations such as the Medical Library Center of New York and the Northeast Regional Medical Library network have enhanced the library's visibility and have made the collection accessible to libraries throughout the country. Any library with a computer terminal and a subscription to the journal holdings microfiche of the Medical Library Center can request an interlibrary loan of a journal article and know in advance that it is in the library's collection. As a result, interlibrary loan statistics have risen this year to an all time high of 5,800 loans supplied to other institutions. By participating in these programs, the library has taken advantage of an excellent opportunity to share its resources and contribute to scientific scholarship.
<P ALIGN="CENTER">
<B>Library Records</B>
<P ALIGN="JUSTIFY">
Circulation
<P ALIGN="JUSTIFY">
Books&#009;8,741
<P ALIGN="JUSTIFY">
Journals&#009; 9,435
<P ALIGN="JUSTIFY">
Total&#009;18,176
<P ALIGN="JUSTIFY">
Interlibrary Loan
<P ALIGN="JUSTIFY">
Loans filled for other libraries&#009;5,678
<P ALIGN="JUSTIFY">
Loans requested by clientele&#009;190
</BODY></HTML>

</DOC>
<DOC>
<DOCNO>WT02-B10-215</DOCNO>
<DOCOLDNO>IA093-000995-B030-344</DOCOLDNO>
<DOCHDR>
http://www.nyspi.cpmc.columbia.edu:80/NYSPI/PIDPT_OT.HTM 156.111.80.30 19970121073345 text/html 3881
HTTP/1.0 200 OK
MIME-Version: 1.0
Server: GLACI/2.01
Date: Tue Jan 21 02:37:51 1997
Content-Type: text/html
Content-Length: 3751
</DOCHDR>
<HTML>
<HEAD><TITLE>Support Services</TITLE></HEAD>
<BODY BACKGROUND="..\IMAGES\MARBLE.JPG">

<H1 ALIGN="LEFT">
Occupational Therapy
</H1>
<P ALIGN="RIGHT">
<B>Barbara Bouley, M.A., O.T.R./L., C.S.W., Director</B>
<P ALIGN="JUSTIFY">
During 1994, department members provided more than 86 hours of weekly activity group programming to improve individual patients' ability to function more independently in their various life roles.
<P ALIGN="JUSTIFY">
The department added three new staff members during the year. Elaine Toskos, M.A., O.T.R./L and Ana Maria Loaiza, B.S., O.T./L joined the staff of the Intensive Care Unit, bringing the number of Occupational Therapy staff members on the unit to three. Lauren Roth, B.S., O.T.R./L, a Senior Occupational Therapist, joined the staff of the Audubon Clinic Continuing Treatment Program. Ms. Roth initiated a therapeutic community outreach activity in which several of her clients taught table games to clients of a nearby geriatric center. The program was successful in promoting the development of social skills in both populations and in increasing the self esteem of the psychiatric clients.
<P ALIGN="JUSTIFY">
On the Schizophrenia Research Unit, Jodi Carlson, M.S., O.T.R./L initiated data collection for her clinical research study, "Effectiveness of Social Skills Training of Schizophrenic Patients." She also developed a second research study, "Sensory Integration Treatment of Schizophrenia," with Scott Clark, M.D. Ms. Carlson began two new groups, Power Walking, which provides patients with low impact exercise to improve physical health and expand leisure interests, and Let's Move!, a sensorimotor group which is designed to improve patients' ability to attend to their surroundings and increase adaptive motor responses.
<P ALIGN="JUSTIFY">
Elaine Mullen, M.S., O.T.R./L continued to coordinate expansion of the activities program on the Intensive Care Unit, increasing the number of groups to more than 40 per week, with all disciplines assisting in group leadership. Bette Gifford, A.S., C.O.T.A./L added two new groups on the ICU-Sewing, a group designed to improve patients' task skills and to enhance their creative expression through structured sewing projects, and Memory Group, a group which utilized games requiring attention, memory, concentration, and decision making to improve patients' cognitive functioning. Jose Ortiz, A.S., C.O.T.A./L, led Shopping and Cooking groups to promote the development of independent shopping and meal preparation skills in patients of the ICU. His Shopping group included instruction in unit pricing and reading of food labels in order to improve patients' budgeting skills and compliance with special diets after discharge.
<P ALIGN="JUSTIFY">
On the General Clinical Research Service, Barbara Bouley, M.A., O.T.R./L, C.S.W. began a Cognitive Behavioral Therapy Group based on Dr. Marsha Linehan's model of Dialectical Behavioral Therapy. This group provided psychoeducation in four skill areas-mindfulness, interpersonal effectiveness, emotion regulation, and distress tolerance-to help patients with borderline personality disorder improve their behavioral coping skills.
<P ALIGN="JUSTIFY">
Jeffrey Tomlinson, O.T.R./L, M.S.W., C.S.W. received a Merit of Service Award from the American Association of Occupational Therapy in July, 1994 in recognition of his service on the AOTA's Mental Health Special Interest Section and on a Mental Health Task Force of the Association's Council on Education.
<P ALIGN="JUSTIFY">
Staff members supervised 64 Occupational Therapy students during the year. These included four Level II affiliating students, 18 Level I clerkship students, and 42 student observers.

</BODY></HTML>
</DOC>
<DOC>
<DOCNO>WT02-B10-216</DOCNO>
<DOCOLDNO>IA093-000995-B030-415</DOCOLDNO>
<DOCHDR>
http://www.nyspi.cpmc.columbia.edu:80/NYSPI/PIDPT_SS.HTM 156.111.80.30 19970121073448 text/html 4944
HTTP/1.0 200 OK
MIME-Version: 1.0
Server: GLACI/2.01
Date: Tue Jan 21 02:38:55 1997
Content-Type: text/html
Content-Length: 4814
</DOCHDR>
<HTML>
<HEAD><TITLE>Support Services</TITLE></HEAD>
<BODY BACKGROUND="..\IMAGES\MARBLE.JPG">

<H1 ALIGN="LEFT">
Social Work
</H1>
<P ALIGN="RIGHT">
<B>Jane A. Waters, A.C.S.W., Director</B>
<P ALIGN="JUSTIFY">
A few changes in staff occurred in 1994. Barbara Erwin McGuire, Ph.D. left her position as the social worker on the ECT research project and Late Life Depression Clinic and was replaced by Shoshana Peyser, C.S.W. at the end of the year. Grant Stitt, C.S.W. resigned his position as social worker on the inpatient Washington Heights Community Service unit. Two new bilingual staff members have joined the Community Service. Quisqueya Meyreles, C.S.W., who trained as a social work intern in the Inwood Clinic during the 1993-1994 academic year, joined the Audubon and Inwood Clinics. Shane McGrail, C.S.W. was hired to replace Mr. Stitt on the inpatient community service.
<P ALIGN="JUSTIFY">
In addition to continuing her assignment as social worker in the Memory Disorders Clinic, Bobba Moody, C.S.W. has joined Shoshana Peyser, C.S.W. and Nancy Turret, C.S.W. in the Late Life Depression Clinic, which continued to experience a growth in its patient population and numbers of research protocols over the year. In the clinic, the social workers provide structured interviews and ratings of research subjects as well as assist in recruitment, evaluation, and referral of patients.
<P ALIGN="JUSTIFY">
The outpatient community clinics also experienced a growth in census, not only in the new MICA program at Inwood, but throughout the clinics and day programs.
<P ALIGN="JUSTIFY">
On the inpatient research units, staff continued their clinical assignments to provide assessment, treatment, and discharge planning for patients and their families and as supervisors of social work trainees in all aspects of clinical social work. Many staff also serve as cotherapists with and/or supervisors of residents and other staff and trainees in family or group treatment. Some highlights of the year 1994 in these areas were the Cognitive Behavioral Therapy group for eating disorder patients co-led by Carla Sadik, C.S.W. and Barbara Bouley, M.A., O.T.R./L, C.S.W. Ms. Sadik also continued to develop her eating disorder lunch/shopping group, which challenges these patients to practice normal eating in restaurants outside of the hospital and to deal with their changed bodies by trying on clothing appropriate to their increased body habitus as they approach their target weights. This group provides a forum for dealing with the many body-image and self-esteem problems presented by these patients.
<P ALIGN="JUSTIFY">
On the Schizophrenia Research Unit, Ellen Lukens, Ph.D. and Helle Thorning, C.S.W. have continued their research in the effectiveness of psychoeducational multiple family groups for this disorder. Ms. Thorning is also studying the impact of schizophrenia on family life with a focus on the experience of loss and its effect on siblings. Dr. Lukens has also provided supervision for other unit staff on psychosocial research and for the multiple family group on the Clinical Psychopharmacology Unit. Ms. Thorning and Dr. Lukens have also continued to present their research and to conduct workshops at other facilities and at the Annual Schizophrenia Conference for families and consumers hosted by the Columbia University Department of Psychiatry.
<P ALIGN="JUSTIFY">
Two new groups led by social workers in the outpatient clinics include a parenting group in the Audubon Clinic led by Cynthia Kolbowski, C.S.W. and a Latino Women's Group led by Quisqueya Meyreles, C.S.W. which utilized a culturally sensitive mixture of films, short stories, music, and food to address common themes.
<P ALIGN="JUSTIFY">
In the Memory Disorders Clinic, Bobba Moody, C.S.W. and Deborah Thorne, C.S.W. initiated a support and educational group for caregivers and family members of Alzheimer's patients. Ms. Moody served on two panels at meetings outside the Institute: "The Scientist-Practitioner" at the annual meeting of the New York State Society of Clinical Social Work and "Social and Economic Issues Related to Parkinson's Disease" at the Parkinson's Disease International Symposium.
<P ALIGN="JUSTIFY">
The social work student program continues to be highly sought after. In the 1993-1994 academic year, 16 students were placed at Psychiatric Institute for the practicum during the second year of their Masters in Social Work program. Our ten-week long summer internship was also highly subscribed, with six students and one new M.S.W. graduate completing the placement for which students at Hunter and New York University Schools of Social Work receive academic credit. In the fall of 1994, 17 students began their second-year placements in the department.

</BODY></HTML>
</DOC>
<DOC>
<DOCNO>WT02-B10-217</DOCNO>
<DOCOLDNO>IA093-000995-B028-373</DOCOLDNO>
<DOCHDR>
http://www.nyspi.cpmc.columbia.edu:80/NYSPI/PI_RCSDP.HTM 156.111.80.30 19970121072117 text/html 935
HTTP/1.0 200 OK
MIME-Version: 1.0
Server: GLACI/2.01
Date: Tue Jan 21 02:25:25 1997
Content-Type: text/html
Content-Length: 806
</DOCHDR>
<TITLE>N.Y.S.P.I. Research Support and Clinical Support Departments</TITLE>
<BODY BACKGROUND="..\IMAGES\MARBLE.JPG">
<H2>N.Y.S.P.I. Research Support and Clinical Support Departments</H2>
<HR>
<UL>
<LI><H4><A HREF="PIDPT_AC.HTM">Comparative Medical Science</A></H4>
<LI><H4><A HREF="PIDPT_CC.HTM">Computer Center</A></H4>
<LI><H4><A HREF="PIDPT_NU.HTM">Nursing Department</A></H4>
<LI><H4><A HREF="PIDPT_OT.HTM">Occupational Therapy</A></H4>
<LI><H4><A HREF="PIDPT_RX.HTM">Pharmacy</A></H4>
<LI><H4><A HREF="PIDPT_QA.HTM">Quality Assurance</A></H4>
<LI><H4><A HREF="PIDPT_RT.HTM">RecreationalTherapy</A></H4>
<LI><H4><A HREF="PIDPT_BK.HTM">Research Library</A></H4>
<LI><H4><A HREF="PIDPT_SS.HTM">Social Work</A></H4>
<LI><H4><A HREF="PIDPT_V.HTM">Volunteer Services</A></H4>
</UL>
</BODY>
</DOC>
<DOC>
<DOCNO>WT02-B10-218</DOCNO>
<DOCOLDNO>IA093-000995-B030-299</DOCOLDNO>
<DOCHDR>
http://www.nyspi.cpmc.columbia.edu:80/NYSPI/PIDPT_AC.HTM 156.111.80.30 19970121073304 text/html 1846
HTTP/1.0 200 OK
MIME-Version: 1.0
Server: GLACI/2.01
Date: Tue Jan 21 02:37:11 1997
Content-Type: text/html
Content-Length: 1716
</DOCHDR>
<HTML>
<HEAD><TITLE>Support Services</TITLE></HEAD>
<BODY BACKGROUND="..\IMAGES\MARBLE.JPG">


<H1 ALIGN="LEFT">
Comparative Medical Science
</H1>
<P ALIGN="RIGHT">
<B>Mohamed Osman, D.V.M., Ph.D., Director</B>
<P ALIGN="JUSTIFY">
The Department of Comparative Medical Science remains fully accredited by the American Association for the Accreditation of Laboratory Animal Care. This animal care facility serves scientists at Psychiatric Institute, the Center for Neurobiology and Behavior, and the Howard Hughes Medical Institute, and provides the best possible care for all animals. During the past year, we have made several advances in both the physical aspects of the facility and in the efficiency of its operations. Renovation of the steam exhaust system was completed, markedly improving the work environment for our staff. In addition, an automatic system for providing water to animals was installed. This system is labor saving, economical, and easier to sanitize than our previous water system. In response to the increasing care of transgenic mice, we have also revised our procedures to include autoclaving their cages to ensure the elimination of potentially harmful microorganisms.
<P ALIGN="JUSTIFY">
Our continuing education program has been highly effective. All personnel involved in animal research have now attended at least one seminar covering the rules and regulations that govern laboratory animal care, as well as animal procedures, and animal care preventive medicine. Dr. Marshall Primack continues to manage our Occupational Health Program. Our animal health monitoring system demonstrates that all the animals housed in PI are healthy.
<H1 ALIGN="LEFT">
</BODY></HTML>
</DOC>
<DOC>
<DOCNO>WT02-B10-219</DOCNO>
<DOCOLDNO>IA093-000995-B029-142</DOCOLDNO>
<DOCHDR>
http://www.nyspi.cpmc.columbia.edu:80/NYSPI/MAILWARN.HTM 156.111.80.30 19970121072454 text/html 945
HTTP/1.0 200 OK
MIME-Version: 1.0
Server: GLACI/2.01
Date: Tue Jan 21 02:29:01 1997
Content-Type: text/html
Content-Length: 816
</DOCHDR>
<html>

<head>
<title>Warning</title>
</head>

<body BACKGROUND="/IMAGES/MARBLE.JPG">
<center>
<h1>WARNING! Netscape 3.0 Users! WARNING!</h1>
<h2>If you are using Netscape 3.0 <U>DO NOT</U> access the </h2>
<h2>following page unless you<u> disable the </u></h2>
<h2><u>Perl Script helper application.</u></h2>
<h2>See your Netscape help file for instructions.</h2>
<p>&nbsp;</h2>
</CENTER>
<h2><a href="http://www.nyspi.cpmc.columbia.edu/"><font size=4>Back to
NYSPI's Homepage</font></a></h2><h2><a 
href="http://www.nyspi.cpmc.columbia.edu/cgi-bin/status.pl"><font
size=4>NYSPI-Phone/Mail Directory </font></a></h2>
 <h2><font size=2>Mail to: </font><a
href="mailto:webgroup@rf1.cpmc.columbia.edu"><font
size=2>webgroup@rf1.cpmc.columbia.edu</font></a></h2> <p>&nbsp;</p>
</body>

</html>
</DOC>
<DOC>
<DOCNO>WT02-B10-220</DOCNO>
<DOCOLDNO>IA093-000995-B029-18</DOCOLDNO>
<DOCHDR>
http://www.nyspi.cpmc.columbia.edu:80/NYSPI/PI_IRSCS.HTM 156.111.80.30 19970121072240 text/html 12692
HTTP/1.0 200 OK
MIME-Version: 1.0
Server: GLACI/2.01
Date: Tue Jan 21 02:26:46 1997
Content-Type: text/html
Content-Length: 12561
</DOCHDR>
<TITLE>N.Y.S.P.I. Internet Resources</TITLE>
<BODY BACKGROUND="..\IMAGES\MARBLE.JPG">
<H2>N.Y.S.P.I. Internet Resources</H2>
<HR>
<UL>
<LI><H3><A HREF="#Grants_Funding">Grants/Funding</A></H3>
<LI><H3><A HREF="#Orgs_Assoc_Gov_Inst">Organizations/Associations/Government/Institutes</A></H3>
<LI><H3><A HREF="#Educ_Depts">Educational Departments</A></H3>
<LI><H3><A HREF="#Online_Mags">Online Journals and Magazines</A></H3>
<LI><H3><A HREF="#Gen_Ref">General References of Interest</A></H3>
<LI><H3><A HREF="#Internet_News">Internet News Groups</A></H3>
<LI><H3><A HREF="#Software_Sites">Software Sites</A></H3>
<LI><H3><A HREF="#Corporate_Sites">Corporate Sites</A></H3>
<LI><H3><A HREF="#Search_Engines">Search Engines</A><H3>
</UL>
<HR>
<H3><A Name="Grants_Funding">Grants/Funding</A></H3>
<ul>
<li><a href="http://medoc.gdb.org/best/fed-fund.html">Federally-Funded Research in the U.S.</a>
- These databases contain the names and addresses of Principal Investigators, grant titles, abstracts, and keywords associated with grants funded by the federal government.
<li><a href="http://www.med.nyu.edu/nih-guide.html">NIH-Guide to Grants and Contracts Database</a>
</ul>
<HR>
<H3><A Name="Orgs_Assoc_Gov_Inst">Organizations/Associations/Government/Institutes</A></H3>
<ul>
<li><a href="http://www.med.umich.edu/aacap/homepage.html">AACAP - American Academy of Child and Adolescent Psychiatry</a>
<li><a href="http://www.med.umich.edu/aacap/aacap.meeting.html">American Academy of Child and Adolescent Psychiatry's Meeting</a>
<li><a href="http://www.hanover.edu/psych/APS/aps.html">American Psychological Society (APS)</a>
<li><a href="http://tezcat.com/~tina/sidran.html">The Sidran Foundation</a>
- a national non- profit organization devoted to advocacy, education and research on behalf of people with psychiatric disabilities.
<li><a href="http://www-toxnet.nlm.nih.gov/">Environmental Health and Toxicology WWW Server of The National Library of Medicine</a>
<li><a href="http://www.nlm.nih.gov/">HyperDOC: The National Library of Medicine (NLM)</a>
- The National Library of Medicine (NLM) is the world's largest library dealing with a single scientific/professional topic. It cares for over 4.5 million holdings (including books, journal, reports, manuscripts and audio-visual items). The NLM offers extensive on-line information services (dealing with clinical care, toxicology and environmental health, and basic biomedical research), has several active research and development components (including an extramural grants program), houses an extensive History of Medicine collection, and provides several programs designed to improve the nation's medical library system.
<li><a href="http://hal.fmhi.usf.edu/">Florida Mental Health Institute</a>
<li><a href="http://www.nas.edu/">Institute of Medicine</a> - The Institute of Medicine was established in 1970 by the National Academy of Sciences to secure the services of eminent members of appointed professions for the examination of policy matters pertaining to the health of the public. The Institute acts under the responsibility given to the National Academy of Sciences in 1863 by its charter to be an advisor to the federal government and, upon its own initiative, to study problems of medical care, research, and education.
<li><a href="http://www.jax.org/">THE JACKSON LABORATORY HOME PAGE</a> - Founded in 1929, The Jackson Laboratory has a threefold mission: to conduct research in basic genetics and the role of genes in health and disease; to educate the scientific community; and to provide genetically defined mice and other genetic resources to the world.
<li><a href="http://www.ciit.org/">CIIT - Chemical Industry Institute of Toxicology</a>
- CIIT is located in Research Triangle Park, North Carolina. Founded in 1974, CIIT is a not-for-profit toxicology research institute dedicated to providing an improved scientific basis for understanding and assessing the potential adverse effects of chemicals, pharmaceuticals, and consumer products on human health.
<li><a href="http://www.nih.gov/">NIH Home Page</a> - Begun as a one-room Laboratory of Hygiene in 1887, the National Institutes of Health today is one of the world's foremost biomedical research centers, and the Federal focal point for biomedical research in the U.S. The NIH mission is to uncover new knowledge that will lead to better health for everyone. NIH works toward that mission by: conducting research in its own laboratories; supporting the research of non-Federal scientists in universities, medical schools, hospitals, and research institutions throughout the country and abroad; helping in the training of research investigators; and fostering communication of biomedical information.
<li><a href="http://wwwetb.nlm.nih.gov/">Educational Technology Branch</a>
- Welcome to the Educational Technology Branch (ETB) home page. ETB conducts research and development in computer and multimedia technologies, disseminates information about these technologies to the National Library of Medicine's various constituencies, and supports their application in health professions education.
</ul>
<HR>
<H3><A Name="Educ_Depts">Educational Departments</A></H3>
<ul>
<li><a href="http://www.med.umich.edu/psychiatry/homepage.html">University of Michigan Psychiatry</a>
<li><a href="http://www.psychiatry.pitt.edu/">University of Pittsburgh - Psychiatry</a>
<li><a href="http://www.gatech.edu/aimosaic/cognitive-psychology.html">Georgia Tech - Cognitive Psychology</a>
<li><a href="http://fnord.dur.ac.uk/">Durham University Psychology Department</a>
<li><a href="http://psych.hanover.edu/">Hanover College Psychology Department</a>
<li><a href="http://www.psych.indiana.edu/">Imfosms University Cognitive Science program</a>
<li><a href="http://www.psych.nwu.edu/">Northwestern University Psychology Department</a>
<li><a href="http://avocado.pc.helsinki.fi/">Psycho hackers at University of Helsinki, Finland</a>
<li><a href="http://wizard.psych.purdue.edu/">Purdue University Psychological Sciences</a>
<li><a href="http://www.sci.sdsu.edu/Psy/">SDSU Department of Psychology</a>
<li><a href="http://jsucc.jsu.edu/psychology/sebac.html">SouthEastern Behavior Analysis Center</a>
<li><a href="http://matia.stanford.edu/">Stanford University - Psychology Department</a>
<li><a href="http://matia.stanford.edu/cogsci.html">Stanford University - Cognitive & Psychological Sciences</a>
<li><a href="http://mambo.ucsc.edu/psl/ucsc_psych.html">UCSC - Psychology Department</a>
<li><a href="http://www.psych.bangor.ac.uk/">Univeristy of Wales, Bangor - Psychology</a>
<li><a href="http://www.psychologie.uni-freiburg.de/">Universitt Freiburg - Psychologisches Institut</a>
<li><a href="http://www.psych.rochester.edu/">University of Rochester - Psychology Home Page</a>
<li><a href="http://ctipsych.york.ac.uk/ctipsych.html">University of York CTI - Psychology</a>
<li><a href="http://www.vanderbilt.edu/AnS/psychology/HomePage.html">Vanderbilt University - Psychology Department (Arts&Science)</a>
<li><a href="http://www.yale.edu/HTML/YalePsych-Info.html">Yale University - Psychology Department Overview</a>
<li><a href="http://hal.fmhi.usf.edu/mhlpstatement.html">University of Southern Florida - Mental Health Law Research</a>
<lI><a href="gopher://129.109.4.55/">University of Texas Medical Branch Psychiatry Department</A>- gopher server which contains information about their clinical programs, faculty, and more.
</ul>
<HR>
<H3><A Name="Online_Mags">Online Journals and Magazines</A></H3>
<ul>
<li><a href="http://info.cern.ch/hypertext/DataSources/bySubject/Psychology/Psycoloquy.html">Psycoloquy -- Psychology</a>
- a refereed electronic journal (ISSN 1055-0143) sponsored on an experimental basis by the American Psychological Association and currently estimated to reach a readership of 20,000. PSYCOLOQUY publishes brief reports of new ideas and findings on which the author wishes to solicit rapid peer feedback, international and interdisciplinary ("Scholarly Skywriting"), in all areas of psychology and its related fields
<LI><a href="http://hcrl.open.ac.uk/psyche/psyche">Psyche</A>: a refereed electronic interdisciplinary journal of research on consciousness.
<li><a href="http://www.thegroup.net/ppm/ppmhome.htm">Practical Psychology Magazine</a>
- dedicated to the art of living well - off the net. PPM covers a broad range of topics from sports psychology to sexuality providing short articles with practical suggestions.
<li><a href="http://psych.hanover.edu/Krantz/journal.html">Index - Electronic Journals and Periodicals in Psychology and Related Fields</a>
</ul>
<HR>
<H3><A Name="Gen_Ref">General References of Interest</A></H3>
<uL>
<li><a href="http://alpha.acast.nova.edu/health/psy/psy.html">Index - Psychological Resources</a>
<li><a href="http://www.uvm.edu/~cbcl/">The Achenbach Child Behavior Checklist</A>
<li><a href="http://http2.sils.umich.edu/Public/nirg/nirg1.html">The Neurosciences Internet Resouce Guide</A> from the University of Michigan School of Information and Library Studies
<li><a href="http://www.med.umich.edu/aacap/facts.index.html">Facts for Families</a>
- educate parents and families about psychiatric disorders affecting children and adolescents, the Academy publishes these 46 information sheets which provide concise and up-to-date material on issues
such as the depressed child, teen suicide, stepfamily problems and child sexual abuse.
<li><a href="http://www.lap.umd.edu/">Lab for Automation Psychology Info Server</a>
<li><a href="http://hcrl.open.ac.uk/virtualsummer.html">Virtual Summer School at UK's Open University</a>
- Students of Cognitive Psychology used Internet Videoconferencing and a range of other communications technologies to participate in tutorials and practical lab activities.
<li><a href="http://hawaii.cogsci.uiuc.edu/invent/invention.html">Psychology of Invention - Attempts at flight</a>
- photographs of early airplanes
</ul>
<HR>
<H3><A Name="Internet_News">Internet News Groups</A></H3>
<ul>
<li><a href="news: sci.med.psychobiology">sci.med.psychobiology</A>
<li><a href="news: sci.psychology.digest">sci.psychology.digest</A>: which contains articles from PSYCOLOQUY
<li><a href="news: bionet.sci-resources">Usenet - bionet.sci-resources</a> - Information about funding agencies, etc. (Moderated)
<li><a href="news: clari.tw.health.aids">Usenet - clari.tw.health.aids</a> - HIV and AIDS research, politics
</ul>
<HR>
<H3><A Name="Software_Sites">Software Sites</A></H3>
<ul>
<li>anonymous ftp site at <a href="ftp://ftp.iupui.edu/pub">Indiana University School of Medicine</A> maintained by Dr. Marvin Miller
</ul>
<HR>
<H3><A Name="Corporate_Sites">Corporate Sites</A></H3>
<ul>
<li><a href="http://venus.mcs.com/~cascade/html/psych.html">Confidential Assessment Services</a>
- Confidential Assessment Services offers your company an accurate and scientifically proven way to assess the underlying personality traits of current and potential employees. Abnormalities and potentially destructive traits such as deviant thinking and experience, social withdrawal, problematic anger, substance abuse, and suicidal, homicidal, or other violent tendencies are revealed via 567 true/false questions.
<li><a href="http://www.cts.com/~habtsmrt/">HabitSmart</a>
- an outpatient agency, staffed by licensed psychologists, which provides a variety of services to individuals with addictive behavior problems
<li><a href="http://sunshine.io.com/">Sunshine Inc.</a>
- a team of international experts in the fields of psychology, neuro-anatomy, and the spiritual sciences dedicated in helping you with dream guidance, counseling, and spiritual growth.
<li><a href="http://www.past.com/">Psychological And Sociological Technologies</a>
</ul>
<HR>
<H3><A Name="Search_Engines">Search Engines</A></H3>
<ul>
<li><a href="http://cpmcnet.columbia.edu/www/search2.cgi?query=Psychiatry&index=alla&href=/dept/pi/">Columbia University referenced by Psychiatry </A> <BR>
<li><a href="http://www.yahoo.com">Yahoo Search Engine</a>
<li><a href="http://lycos.cs.cmu.edu/lycos-form.html">Lycos Search Engine</a>
</ul>
<HR>
If you find any interesting or useful references that you would like
included on this page, e-mail me and include the <a href ="http://www.ncsa.uiuc.edu/demoweb/url-primer.html">URL</A>.
<P>
Page created by <CITE>rfroman@rf1.cpmc.columbia.edu</CITE>
Last updated Thursday, December 9, 1994
<HR>
</BODY>

</DOC>
<DOC>
<DOCNO>WT02-B10-221</DOCNO>
<DOCOLDNO>IA093-000995-B028-309</DOCOLDNO>
<DOCHDR>
http://www.nyspi.cpmc.columbia.edu:80/NYSPI/PI_CAREV.HTM 156.111.80.30 19970121072043 text/html 6723
HTTP/1.0 200 OK
MIME-Version: 1.0
Server: GLACI/2.01
Date: Tue Jan 21 02:24:50 1997
Content-Type: text/html
Content-Length: 6593
</DOCHDR>
<HTML>
<HEAD><TITLE>Clinical and Administrative Support</TITLE></HEAD>
<BODY BACKGROUND="..\IMAGES\MARBLE.JPG">


<B><H1><B>Jack M. Gorman, M.D.</B><BR>
Deputy Director</B></H1><BR>
<IMG SRC="/NYSPI/GORMAN1.GIF" ALIGN=LEFT>
<P ALIGN="JUSTIFY">
In 1994, we reaffirmed the threefold mission of the Psychiatric Institute: state-of-the-art research, outstanding clinical service, and excellent teaching. Although PI may be best known internationally for its research accomplishments, we continued to stress that all of our efforts ultimately serve one goal: to find and provide the best possible therapies for people suffering with mental illness.
<P ALIGN="JUSTIFY">
  Construction of PI's new building has remained very close to schedule, thanks to the continued efforts of Dr. Oldham, Mr. Papp, and Ms. Corn. They have been assisted in this very complicated endeavor by many people, including Mr. Peter Reynolds and Mr. Hal Seligson. At every step of the way many things could easily have derailed this construction; each time these people have worked very hard to keep things on track. We now anticipate opening the building in slightly more than two years.
<P ALIGN="JUSTIFY">
In l994, Dr. David Strauss filled in ably as Acting Clinical Director after Dr. Russakoff's departure. An important new committee was established, the Quality Improvement (QI) Council, chaired by Ms. Corn. The QI Council is charged with the responsibility of developing and monitoring an ongoing process of continuous quality improvement at Psychiatric Institute. Many QI projects have already been initiated, and each has involved staff from many disciplines. It is the aim of the QI Council and of the QI Cabinet that all employees at Psychiatric Institute play a major and ongoing role in identifying areas for improvement, helping to implement changes, and assessing the progress we are making.
<P ALIGN="JUSTIFY">
In 1994, after many years of dedicated service to PI, Mr. Valerio Nuccitelli retired as director of our pharmacy. We were fortunate to have Mr. Stephen McMillan join us as the new pharmacy director. He has already made an outstanding contribution to the Institute.
<P ALIGN="JUSTIFY">
The multidisciplinary approach is key to our clinical efforts. Under the direction of the President of the Medical Staff Organization, Dr. Ewald Horwath, we have seen our medical staff take a larger role in assuring the quality of our clinical care. Every discipline is involved including Nursing, directed by Ms. Marcia Michaelson, Social Work, directed by Ms. Jane Waters, Occupational Therapy, directed by Ms. Barbara Bouley, Recreational Therapy, directed by Mr. Matt Gold, and Pharmacy, directed by Mr. Stephen McMillan. Mr. Gold also directs our very important volunteer program and made important steps this year to strengthen it.
<P ALIGN="JUSTIFY">
All of these disciplines work directly with our inpatient and outpatient services. Dr. Evelyn Attia led the Clinical Psychopharmacology service on PI7 which specialized in research involving patients with depression or eating disorders. The General Clinical Research Service, led by Dr. Lyle Rosnick on PI5, continued to hospitalize patients enrolled in several research protocols, including adolescents with suicidal behavior, patients needing ECT, and adults with suicidal behavior. In addition, patients with severe character disorders were also admitted to PI5. The Schizophrenia Research Unit, on PI4, had new leadership; Dr. Scott Clark stepped in to assume many of the unit chief responsibilities with the appointment of Dr. Strauss to the position of Clinical Director. Dr. Clark immediately began working to boost the census of PI4 and to solidify its relationship with its associated unit, the Schizophrenia Research Unit at Creedmoor Psychiatric Center. The latter came under the direction of Dr. Zafir Sharif in 1994. These two units form the foundation of the Developing Clinical Research Center that was funded in August 1994, by the National Institute of Mental Health.
<P ALIGN="JUSTIFY">
All of our research outpatient clinics continued to provide both outstanding care and important training sites in 1994. Of particular note was the funding by NIMH of a Hispanic Treatment Program, directed by Dr. Michael Liebowitz. This development makes it increasingly possible for us to be responsive to our community.
<P ALIGN="JUSTIFY">
The Washington Heights Community Service continued to be a model care-provider for patients with serious mental illness. Operating both an inpatient unit (on PI6, directed by Dr. Ewald Horwath) and two outpatient clinics (the Audubon Clinic, directed by Dr. Pellegrino Sarti, and the Inwood Clinic, directed by Dr. Siobhan Coomaraswamy), the Washington Heights Community Service continues to reflect the vision and dedication of its director, Dr. Francine Cournos.
<P ALIGN="JUSTIFY">
Our educational programs continue to be national resources. The residency education program, directed by Dr. Ronald Rieder, with assistance from Dr. Lisa Mellman, once again maneuvered successfully through the "Match," so that PI's residents continue to be among the best of any program in the United States. Dr. Rieder also continued to direct two NIMH-funded research fellowship programs. Medical students also continued to rate our educational programs very highly, thanks to the direction of Dr. Eric Marcus with assistance from Dr. Janice Cutler. We also continued major training programs in social work, psychology, nursing, and occupational and recreational therapy. For new and continuing employees we maintain many levels of educational programs, directed by Dr. Sandra Rosenblum.
<P ALIGN="JUSTIFY">
All of this work must take place in an environment that is safe and functions optimally. Here we recognize the efforts of Mr. Willie Herriott and our Safety Department and of Mr. Harold Jones and our Housekeeping Department. Resources are preciously few for these two departments, yet they continue to provide us with a very high level of service, for which all employees at PI are grateful.
<P ALIGN="JUSTIFY">
PI is only one year away from celebrating its 100th birthday, and it continues to provide a unique environment for the highest quality patient care, research, and education. This is because no matter how difficult things become, we have a group of clinicians, researchers, and support staff who are second to none, and who are dedicated to carrying out our nearly 100-year-old mission. <BR>
</BODY>
<!-- <IMG SRC="GORMNSIG.JPG" WIDTH=272 HEIGHT=105 ALIGN=RIGHT> -->

</DOC>
<DOC>
<DOCNO>WT02-B10-222</DOCNO>
<DOCOLDNO>IA093-000995-B031-504</DOCOLDNO>
<DOCHDR>
http://www.nyspi.cpmc.columbia.edu:80/NYSPI/depts/biostat/index.htm 156.111.80.30 19970121074351 text/html 2779
HTTP/1.0 200 OK
MIME-Version: 1.0
Server: GLACI/2.01
Date: Tue Jan 21 02:47:49 1997
Content-Type: text/html
Content-Length: 2649
</DOCHDR>
<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 3.2//EN"><HTML><HEAD>   <TITLE>NYSPI Division of Biostatistics Home Page</TITLE></HEAD><BASE HREF="http://www.nyspi.cpmc.columbia.edu/NYSPI/depts/biostat/index.htm"><BODY TEXT="#000055" BGCOLOR="#FFFFFF" LINK="#000000" VLINK="#550000" body <H1><CENTER><TABLE BORDER=5 CELLSPACING=5 CELLPADDING=5 WIDTH="100%" BGCOLOR="#AAFFFF" ><TR><TD><CENTER><P><FONT SIZE=+3><I>Welcome </I>to the <FONT COLOR="#800040">N</FONT></FONT><FONT COLOR="#800040"><FONT SIZE=+2>ew</FONT><FONT SIZE=+3>Y</FONT><FONT SIZE=+2>ork </FONT><FONT SIZE=+3>S</FONT><FONT SIZE=+2>tate </FONT><FONT SIZE=+3>P</FONT><FONT SIZE=+2>sychiatric</FONT><FONT SIZE=+3> I</FONT><FONT SIZE=+2>nstitutute (NYSPI)</FONT></FONT></P></CENTER><CENTER><P><FONT COLOR="#000000"><FONT SIZE=+3>Home Page of the Division of Biostatistics</FONT></FONT></P></CENTER></TD></TR></TABLE></CENTER><P><htm></P><TABLE BORDER=5 BGCOLOR="#C0C0C0" ><TR><TH Colspan="5"<h2><FONT COLOR="#FF0000">Contacting NYSPI's Division of Biostatistics</FONT></TH></TR><TR><TH><FONT COLOR="#FF0000">Address</FONT></TH><TH><FONT COLOR="#FF0000">Telephone Number</FONT></TH><TH><FONT COLOR="#FF0000">Fax Number </FONT></TH><TH><FONT COLOR="#FF0000">&quot;e-mail&quot;</FONT></TH></TR><TR><TH><BR>722 West 168th Street, <BR>New York, New York 10032 <BR></TH><TH>(212) 960-5766 </TH><TH>(212) 960-2465</TH><TH><FONT COLOR="#0000FF"><A HREF="mailto:biostat@child.cpmc.columbia.edu">BIOSTAT@child.cpmc.columbia.edu</A></FONT></TH></TR></TABLE><TABLE BORDER=5 BGCOLOR="#FF80C0" > <TR><TH Colspan="5"> <H2><FONT COLOR="#408080"><u>Web</u> <u>Pages</u> Area Selection</FONT></H2></TH></TR><ul><TR><TH><H3><br><li>(1)<FONT COLOR="#0000FF"><br>

If you are working within <br>the NYSPI environment, <br><A HREF="internal.htm"> please click here <br> </a> to find out about the Division of Biostatistic's mission, staff, ways to contact us, links to other sitesand more! 

</FONT></H3></TH><th> </ul><BR><H3><li>(2)<FONT COLOR="#0000FF"><br>

If you are a visitor to the Division of Biostatistics at NYSPI and would like an overview of what we do, <br>
<A HREF="external.htm"> please click here. </FONT></A></H3></TH>
<TH> <H3><li>(3)<FONT COLOR="#0000FF"><A HREF="http://www.nyspi.cpmc.columbia.edu/"> 

<br> Please click here for 

</a>NYSPI's General Home Page </FONT></H3> </TH> </TR></TABLE><h6><P><BR><FONT COLOR="#8000FF">Last modified during the month of January 1997</FONT><BR><BR></HTM></P> <p><font size=1>Page created by Joshua
Bender: </font><a href="mailto:jbender@neuron.cpmc.columbia.edu"><font
size=1>jbender@neuron.cpmc.columbia.edu</font></a><br> </p> </BODY></HTML>
</DOC>
<DOC>
<DOCNO>WT02-B10-223</DOCNO>
<DOCOLDNO>IA093-000995-B033-142</DOCOLDNO>
<DOCHDR>
http://www.nyspi.cpmc.columbia.edu:80/NYSPI/depts/biostat/internal.htm 156.111.80.30 19970121075618 text/html 1965
HTTP/1.0 200 OK
MIME-Version: 1.0
Server: GLACI/2.01
Date: Tue Jan 21 03:00:26 1997
Content-Type: text/html
Content-Length: 1835
</DOCHDR>
<htm>
<head>
<h1>
<title>the Division of Biostatistics' Internal Home Page</title>
<body text="#000055" body bgcolor="#ffffff" link="#000000" vlink="#550000" 

<h1>
<Font Color=#FF0000>
NYSPI Division of Biostatistics </Font>
<br><Font Color=#0000FF Face="Times New Roman">
Internal Home Page </h1>
<h2>
<em><Font Color=#408080>Table of Contents</em></Font><br>
<br>
<h2>
<a href="mission.htm">Our Mission </a>
<br>
<br>
<a href="message.htm">A Message From Our Director</a>
<br>
<br>
<a href="staff.htm">Our Staff </a>
<br>
<br>
<a href="calendar.htm">Calendar of Events </a>
<br>
<br>
<a href="opport.htm">Opportunities</a>
<br>
<br>
<a href="statlink.htm">Statistical Links of Interest</a>
<a href="http://lib.stat.cmu.edu/otherplaces/"></a> </h2>


<TABLE Border=5 BGCOLOR="#FF80C0">

<CAPTION> </CAPTION>
<TR>
	<TH Colspan="10"><h2>  <Font Color=#FF0000> NYSPI Division of Biostatistics <Font Color=#0000FF>Page Jumps</h2></Font></TH></TR>
<TR>

	<TH><Font Color=#408080> <a href="index.htm"> <Font Color=#000080> Biostatistics Division <br>
		Home Page </a>		</TH>		
	
	<TH><Font Color=#408080> <a href="internal.htm"><Font Color=#000080> Internal <br>
		Home Page</a>		</TH>		

	<TH> <a href="mission.htm"><Font Color=#000080> Our Mission </a>	</TH>
	
	<TH> <a href="message.htm"><Font Color=#000080> Director's Message 	</TH>	
	
	<TH> <a href="staff.htm"><Font Color=#000080> Staff Info.		</TH>
	
	<TH> <a href="calendar.htm"><Font Color=#000080> Calendar		</TH>
	
	<TH> <a href="Opport.htm"><Font Color=#000080> Opportunities		</TH>		
	
	<TH> <a href="statlink.htm"><Font Color=#000080> Stat. Links 		</TH>
	
	

</TR>

</TR>

</TABLE>


<br>
<br>
<br>
<br>
<br>
<br>
<br>
<br>
<br>
<br>
<br>
<br>
<br>
<br>
<br>
<br>
</body>
</htm>

</DOC>
<DOC>
<DOCNO>WT02-B10-224</DOCNO>
<DOCOLDNO>IA093-000995-B033-157</DOCOLDNO>
<DOCHDR>
http://www.nyspi.cpmc.columbia.edu:80/NYSPI/depts/biostat/external.htm 156.111.80.30 19970121075625 text/html 1730
HTTP/1.0 200 OK
MIME-Version: 1.0
Server: GLACI/2.01
Date: Tue Jan 21 03:00:34 1997
Content-Type: text/html
Content-Length: 1600
</DOCHDR>
<htm>
<head>
<title>The Division of Biostatistics' External Home Page</title>
<body text="#000055" body bgcolor="#ffffff" link="#000000" vlink="#550000" 
<br>
<h1><Font Color=#FF0000>NYSPI Division of Biostatistics <br><Font Color=#0000FF >Visitor Page
<br>
<h2><em> <Font Color=#408080>Table of Contents</em>
<br></font>
<br>
<h2>
<a href="mission2.htm">Our Mission </a>
<br>
<br>
<a href="message2.htm">A Message From Our Director</a>
<br>
<br>
<a href="staff-e.htm">Our Staff </a>
<br>
<br>
<a href="statlnk2.htm">Statistical Links of Interest</a>
<br>
<br>
<a href="Opport2.htm">Opportunities</a> 
</h2><TABLE Border=5 BGCOLOR="#FF80C0">

<CAPTION> </CAPTION>
<TR>
	<TH Colspan="8"><h2> <Font Color=#FF0000>NYSPI Division of Biostatistics Biostatistics <Font Color=#0000FF>Page Jumps</h2></Font></TH></TR>
<TR>

	<TH><Font Color=#408080> <a href="index.htm"> <Font Color=#000080> Biostatistics Division <br>
		Home Page </a>		</TH>		
	
	<TH><Font Color=#408080> <a href="external.htm"><Font Color=#000080> Visitor<br>
		Home Page</a>		</TH>		

	<TH> <a href="mission2.htm"> <Font Color=#000080> Our Mission </a>	</TH>
	
	<TH> <a href="message2.htm"><Font Color=#000080> Director's Message 	</TH>	
	
	<TH> <a href="staff-e.htm"><Font Color=#000080> Staff Info.		</TH>
		
	<TH> <a href="Opport2.htm"><Font Color=#000080> Opportunities		</TH>		
	
	<TH> <a href="statlnk2.htm"><Font Color=#000080> Stat. Links 		</TH>
	
	

</TR>

</TR>

</TABLE>
<br>
<br>
<br>
<br>
<br>
<br>
<br>
<br>
<br>
<br>
<br>
<br>
</body>
</htm>

</DOC>
<DOC>
<DOCNO>WT02-B10-225</DOCNO>
<DOCOLDNO>IA093-000995-B033-220</DOCOLDNO>
<DOCHDR>
http://www.nyspi.cpmc.columbia.edu:80/NYSPI/depts/biostat/mission.htm 156.111.80.30 19970121075722 text/html 2600
HTTP/1.0 200 OK
MIME-Version: 1.0
Server: GLACI/2.01
Date: Tue Jan 21 03:01:27 1997
Content-Type: text/html
Content-Length: 2470
</DOCHDR>
<htm>
<head>
<h1>
<title>the Division of Biostatistics' Mission Page</title>
<body text="#000055" body bgcolor="#ffffff" link="#000000" vlink="#550000" 
<h1><Font Color=#FF0033>
NYSPI Division of Biostatistics </Font>
<br> <Font Color=#0000FF >Mission Statement </Font></h1>
<br><h2>

<em><Font Color=#408080>Our Mission</h2></font>

<h3>is to provide investigators in the NYSPI with access to and training in the state-of-the-art statistical methods as needed for the optimal use of their research data.  We participate in the designing  and analyzing of psychiatric 
studies; we provide short-term statistical consultation for grants submission and manuscript preparation; and we run a <a href="calendar.htm">biostatistics seminar series</a>.  
<br>
We are involved with:
<br>
<br>
1) 	Application of statistics in psychiatric research; 
<br>
2) 	Development of new statistics techniques for specialized 
psychiatric problems, including brain imaging, analysis of 
data with informative missingness, and hierarchical longitudinal
modeling; 
<br>
3) 	Specialized education of statistics doctoral  students and postdoctoral fellows interested in psychiatric and  neurological research;
<br>
4)	Instructing data analysts working in the area of psychiatry 
on modern statistics and 
<br>
5)	Statistical education of psychiatry research fellows.
<br>
<br>
<br>
<TABLE Border=5 BGCOLOR="#FF80C0">

<CAPTION> </CAPTION>
<TR>
	<TH Colspan="10"><h2>  <Font Color=#FF0000> NYSPI Division of Biostatistics <Font Color=#0000FF>Page Jumps</h2></Font></TH></TR>
<TR>

	<TH><Font Color=#408080> <a href="index.htm"> <Font Color=#000080> Biostatistics Division <br>
		Home Page </a>		</TH>		
	
	<TH><Font Color=#408080> <a href="internal.htm"><Font Color=#000080> Internal <br>
		Home Page</a>		</TH>		

	<TH> <a href="mission.htm"><Font Color=#000080> Our Mission </a>	</TH>
	
	<TH> <a href="message.htm"><Font Color=#000080> Director's Message 	</TH>	
	
	<TH> <a href="staff.htm"><Font Color=#000080> Staff Info.		</TH>
	
	<TH> <a href="calendar.htm"><Font Color=#000080> Calendar		</TH>
	
	<TH> <a href="Opport.htm"><Font Color=#000080> Opportunities		</TH>		
	
	<TH> <a href="statlink.htm"><Font Color=#000080> Stat. Links 		</TH>
	
	

</TR>

</TR>

</TABLE>




<br>
<br>
<br>
<br>
<br>
<br>
<br>
<br>
<br>
<br>
<br>
<br>
<br>
<br>
<br>
<br>
</body>
</htm>

</DOC>
<DOC>
<DOCNO>WT02-B10-226</DOCNO>
<DOCOLDNO>IA093-000995-B033-232</DOCOLDNO>
<DOCHDR>
http://www.nyspi.cpmc.columbia.edu:80/NYSPI/depts/biostat/message.htm 156.111.80.30 19970121075731 text/html 5457
HTTP/1.0 200 OK
MIME-Version: 1.0
Server: GLACI/2.01
Date: Tue Jan 21 03:01:38 1997
Content-Type: text/html
Content-Length: 5327
</DOCHDR>
<htm>
<head>
<h1>
<title>the Division of Biostatistics' Director Message Page</title>
<body text="#000055" body bgcolor="#ffffff" link="#000000" vlink="#550000" 

<border=0>
<h1><font color="ff0000#">
NYSPI Division of Biostatistics </font><br>
<Font Color=#0000FF> A Message from the Director </Font>
<br>
<h2>
<em><Font Color=#408080>Dr. Christine Waternaux</h2></em></font>
<br> 
<h3>
<Font Color=#408080>Background</font>
<br>
<br>
The Division of Biostatistics was established in January, 1994. The mission of the division is to provide investigators at Psychiatric Institute with access to and training in state-of-the-art statistical techniques as needed for the optimal use of their research data. This includes developing and applying new methodology for the design and analysis of psychiatric studies, participating in major funded research, teaching statistics to researchers and post-doctoral fellows, and providing short-term consultations on data-analytic and design issues for grant submission and manuscript preparation. 
<br>
<br><Font Color=#408080> 
<em>Methodological Research </em> </font>
<br>
<br>
Methodological research in the division focuses on problems of particular relevance to psychiatric studies. Areas of expertise in the division include analysis of longitudinal studies with generalized linear models and variance components models, methods for dealing with missing data, causal models, and methodology for combining information from different sources (e.g., meta-analysis). 
<br>
<br>
For example, Dr. Christine Waternaux, Director, is investigating methods for power computations with longitudinal repeated measures. She has also investigated and published on the use of hierarchical models for combining psychiatric data. 
<br>
<br>
Dr. Eva Petkova, Associate Biostatistician, is specializing in statistical models for the analysis of longitudinal studies with informative drop-out. She is developing methodologies for the analysis of clinical trials when the traditional intent-to-treat approach is not appropriate because most drop-outs switch treatments. 
<br>
<br>
Dr. Xinhua Liu, Associate Biostatistician, is experienced in analyzing cohort data (e.g., New York gay man cohort) which traditionally have high dropout rates and a large proportion of missing observations. Her research is addressing the problem of adequacy of different analytical techniques in the presence of missing data. 
<br>
<br><Font Color=#408080> 
<em> Collaborative and Consultative Activities </em> </font>
<br>
<br>
Division staff have been very active in their collaborative and consultative efforts, thus demonstrating the great need for such services. For instance, in 1994, staff provided statistical input and participated in nineteen grant submissions. In April 1994, Dr. Christine Waternaux became the Director of the Biostatistics and Measurement Core of the NIMH-funded Clinical Research Center for the Study of Youth
Depression, Anxiety, and Suicide (Principal Investigator: Dr. David Shaffer). 
<br>
<br>
In September 1994, Dr. Waternaux became the Director of the Statistics and Computing Core of the Clinical Research Center for the Study of Suicidal Behavior (Principal Investigator: Dr. J. John Mann).  Division staff are also participating in consultations and meetings with the Statistics, Epidemiology, and Data Management Core of the HIV Center for Clinical and Behavioral Studies (Directors: Drs. Anke Erhardt and Zena Stein). 
<br>
<br>
As part of its training component, the division conducts weekly workshops in biostatistics and data management. These workshops illustrate analytic and data management issues, and explore emerging statistical methodologies in both fields. 
<br>
<br>
Topics covered this year have included random regression models, principles of modeling, meta-analysis, generalized estimating equations, and structural equation modeling. Please take a look at our <a href="calendar.htm">calendar section</a>  of the home page for more up-to-date information.
<br>
<br>
<a href="staff.htm">Division staff  </a>  are also working with the Department of Postgraduate Education and with members of the NIMH Training Programs for Clinical and Research Fellows on matters concerning the statistical curriculum.
<br>
<br>
</h3>

<TABLE Border=5 BGCOLOR="#FF80C0">

<CAPTION> </CAPTION>
<TR>
	<TH Colspan="10"><h2>  <Font Color=#FF0000> NYSPI Division of Biostatistics <Font Color=#0000FF>Page Jumps</h2></Font></TH></TR>
<TR>

	<TH><Font Color=#408080> <a href="index.htm"> <Font Color=#000080> Biostatistics Division <br>
		Home Page </a>		</TH>		
	
	<TH><Font Color=#408080> <a href="internal.htm"><Font Color=#000080> Internal <br>
		Home Page</a>		</TH>		

	<TH> <a href="mission.htm"><Font Color=#000080> Our Mission </a>	</TH>
	
	<TH> <a href="message.htm"><Font Color=#000080> Director's Message 	</TH>	
	
	<TH> <a href="staff.htm"><Font Color=#000080> Staff Info.		</TH>
	
	<TH> <a href="calendar.htm"><Font Color=#000080> Calendar		</TH>
	
	<TH> <a href="Opport.htm"><Font Color=#000080> Opportunities		</TH>		
	
	<TH> <a href="statlink.htm"><Font Color=#000080> Stat. Links 		</TH>
	
	

</TR>

</TR>

</TABLE>




<br>
<br>
<br>
</body>
</htm>




</DOC>
<DOC>
<DOCNO>WT02-B10-227</DOCNO>
<DOCOLDNO>IA093-000995-B033-246</DOCOLDNO>
<DOCHDR>
http://www.nyspi.cpmc.columbia.edu:80/NYSPI/depts/biostat/staff.htm 156.111.80.30 19970121075743 text/html 3248
HTTP/1.0 200 OK
MIME-Version: 1.0
Server: GLACI/2.01
Date: Tue Jan 21 03:01:48 1997
Content-Type: text/html
Content-Length: 3118
</DOCHDR>
<htm> <head><title>the Division of Biostatistics' Staff Home Page</title><body text="#000055" body bgcolor="#ffffff" link="#000000" vlink="#550000" <font color="ff0000#"><h1><Font Color=#FF0000><h1>NYSPI Division of Biostatistics <Font Color=#0000FF <br>Staff Page<br></font><h3><TABLE Border=2 BGCOLOR="#C0C0C0"><CAPTION> </CAPTION><TR><TH Colspan="10"> <Font Color=#FF0000>Staff Information</Font></TH></TR><TR><TH> <Font Color==#0000FF > Name </TH><TH> <Font Color=#=#0000FF >Main Research Areas and Interests </TH><TH> <Font Color=#0000FF >Telephone </TH><TH> <Font Color==#0000FF >e-mail </TH></TR><TR><TD>Christine Waternaux, Ph.D.Division, Chair</TD><TD> Longitudinal mixed effects models, Meta analysis, Variance components</TD><TD>960-5766</TD><TD><I><A HREF="mailto:waternac@child.cpmc.columbia.edu">waternac@child.cpmc.columbia.edu</A></I></TD></TR> <TR><TD>Steve Ellis, Ph.D. </TD><TD>Bootstrap and other computer intensive statistical techniques, brain image analysis, stability of plane fitting</TD><TD>960-2200 <br> Ext. 489</TD><TD><I><A HREF="mailto:ellis@neuron.cpmc.columbia.edu">ellis@neuron.columbia.edu</A></I></TD></TR> <TR><TD>Xinhua Liu, Ph.D.</TD> <td>Generalized estimating equations, Survival analysis, Longitudinal Data Analysis</TD><TD>960-5587</TD><TD><I><A HREF="mailto:liux@child.cpmc.columbia.edu">liux@child.cpmc.columbia.edu</A></I></TD></TR> <TR><TD>Michael Parides, Ph.D. </TD><TD> Statistical issues in survey methodology,  Discrete data analysis </TD><TD>740-0012, <br>960-5688</TD><TD><I><A HREF="mailto:paridesm@child.cpmc.columbia.edu">paridesm@child.cpmc.columbia.edu</A></I></TD></TR> <TR><TD> Eva Petkova Ph.D. </TD><TD> Statistical modeling, Causal statistical inference, Evaluation and comparison of antidepressant drugs </TD><TD>960-5875</TD><TD><I><A HREF="mailto:petkovae@child.cpmc.columbia.edu">petkovae@child.cpmc.columbia.edu</A></I></TD></TR> <TR><TD>Rezi Zawadski, M.S.</TD><TD> Huntington's disease </TD><TD>923-7394</TD><TD><I><A HREF="mailto:rz@columbia.edu">rz@columbia.edu  </A></I></TD></TR> <h2></TABLE><br><TABLE Border=5 BGCOLOR="#FF80C0"><CAPTION> </CAPTION><TR>	<TH Colspan="10"><h2>  <Font Color=#FF0000> NYSPI Division of Biostatistics <Font Color=#0000FF>Page Jumps</h2></Font></TH></TR><TR>	<TH><Font Color=#408080> <a href="index.htm"> <Font Color=#000080> Biostatistics Division <br>		Home Page </a>		</TH>				<TH><Font Color=#408080> <a href="internal.htm"><Font Color=#000080> Internal <br>		Home Page</a>		</TH>			<TH> <a href="mission.htm"><Font Color=#000080> Our Mission </a>	</TH>		<TH> <a href="message.htm"><Font Color=#000080> Director's Message 	</TH>			<TH> <a href="staff.htm"><Font Color=#000080> Staff Info.		</TH>		<TH> <a href="calendar.htm"><Font Color=#000080> Calendar		</TH>		<TH> <a href="Opport.htm"><Font Color=#000080> Opportunities		</TH>				<TH> <a href="statlink.htm"><Font Color=#000080> Stat. Links 		</TH>		</TR></TR></TABLE><p><font size=1>Page created by Joshua
Bender: </font><a href="mailto:jbender@neuron.cpmc.columbia.edu"><font
size=1>jbender@neuron.cpmc.columbia.edu</font></a><br> </p></body></html>
</DOC>
<DOC>
<DOCNO>WT02-B10-228</DOCNO>
<DOCOLDNO>IA093-000995-B033-260</DOCOLDNO>
<DOCHDR>
http://www.nyspi.cpmc.columbia.edu:80/NYSPI/depts/biostat/calendar.htm 156.111.80.30 19970121075752 text/html 4069
HTTP/1.0 200 OK
MIME-Version: 1.0
Server: GLACI/2.01
Date: Tue Jan 21 03:02:00 1997
Content-Type: text/html
Content-Length: 3939
</DOCHDR>
<htm><head><title>The Division of Biostatistics' Staff Home Page</title><BODY text="#000055" body bgcolor="#ffffff" link="#000000" vlink="#550000"><border=0><h1><font color="ff0000#">NYSPI Division of Biostatistics </font><br><Font Color=#0000FF>Calendar Page</Font><br></font color="ff0000#"><br><center><TABLE Border BGCOLOR="#C0C0C0"><CAPTION> </CAPTION><TR><TH Colspan="10"><Font Color=#FF0000><h2>1996 Calendar   of   Events, <br>1997 is forthcoming...</h2> </Font><Font Color=#0000FF>All events are to be held in "Old PI", 10 North, Classrooms A & B on Tuesdays, 2:00-3:00</Font></TH></TR><h3><TR><TH>Date</TH><TH>Type of Event</TH><TH>Topic</TH><TH>Speaker</TH><TH>e-mail</TH><TH></TH></TR><TR><TD>September 17, 24, Oct 1, 8  (1996) </TD><TD>Seminar</TD><TD> Second Series on Splus</TD><TD>Eva Petkova, Ph.D.</TD><TD><I><A HREF="mailto:petkovae@child.cpmc.columbia.edu">petkovae@child.cpmc.columbia.edu</A></I></TD></TR> <TR><TD>October 22, 1996</TD><TD>Journal Club</TD><TD>Sun and Sherman (1996)"Some Permutation Tests for Survival Data", Biometrics 52(1), pages 87-97</TD><TD>Michael Parides, Ph.D.</TD><TD><I><A HREF="mailto:paridesm@child.cpmc.columbia.edu">paridesm@child.cpmc.columbia.edu</A></I></TD></TR> <TR><TD>October 29, 1996<TD>Seminar </TD> </TD><TD>Segmentation of Brain Images: An Adventure in Statistical Computing</TD><TD>Steve Ellis, Ph.D. </TD><TD><I><A HREF="mailto:ellis@neuron.columbia.edu ">ellis@neuron.columbia.edu </A></I></TD></TR> <TR><TD>November 12, 1996</TD><TD> Seminar  </TD><TD> Analysis of data from a two-period crossover study</TD><TD> Michael Parides, Ph.D.  </TD><TD><I><A HREF="mailto:paridesm@child.cpmc.columbia.edu">paridesm@child.cpmc.columbia.edu</A></I></TD></TR> <TR><TD> November 19, 1996</TD><TD> Journal Club </TD><TD> S. Baker (1996) "The analysis of categorical case-control data subject to nonignorable nonresponse" Biometrics 52 (1), pages 362-369</TD><TD>Xinhua Lieu, Ph.D.</TD><TD><I><A HREF="mailto:liux@child.cpmc.columbia.edu ">liux@child.cpmc.columbia.edu</A></I></TD></TR> <TR><TD> November 26, 1996</TD><TD> Seminar</TD><TD> Documentation: Standards/</TD><TD>Mark Davies, Ph.D.</TD><TD><I><A HREF="mailto:liux@child.cpmc.columbia.edu ">liux@child.cpmc.columbia.edu</A></I></TD></TR> <TR><TD> December 3, 1996 </TD><TD> Seminar</TD><TD> TBA </TD><TD>TBA.</TD><TD><I><A HREF="mailto:liux@child.cpmc.columbia.edu">liux@child.cpmc.columbia.edu</A></I></TD></TR> <TR><TD> December 10, 1996</TD><TD> Seminar</TD><TD> Bootstrapping Survival Analysis</TD><TD>Steve Ellis, Ph.D.</TD><TD><I><A HREF="mailto:ellis@neuron.columbia.edu ">ellis@neuron.columbia.edu </A></I></TD></TR>  <TR><TD> December 17, 1996</TD><TD> End of the Year Party</TD><TD> Probabilities of Having Fun</TD><TD>All of You!</TD><TD><I><A HREF="mailto:liux@child.cpmc.columbia.edu ">petkovae@child.cpmc.columbia.edu</A></I></TD></TR> <h2></TABLE><br><TABLE Border=5 BGCOLOR="#FF80C0"><CAPTION> </CAPTION><TR>	<TH Colspan="10"><h2>  <Font Color=#FF0000> NYSPI Division of Biostatistics <Font Color=#0000FF>Page Jumps</h2></Font></TH></TR><TR>	<TH><Font Color=#408080> <a href="index.htm"> <Font Color=#000080> Biostatistics Division <br>		Home Page </a>		</TH>				<TH><Font Color=#408080> <a href="internal.htm"><Font Color=#000080> Internal <br>		Home Page</a>		</TH>			<TH> <a href="mission.htm"><Font Color=#000080> Our Mission </a>	</TH>		<TH> <a href="message.htm"><Font Color=#000080> Director's Message 	</TH>			<TH> <a href="staff.htm"><Font Color=#000080> Staff Info.		</TH>		<TH> <a href="calendar.htm"><Font Color=#000080> Calendar		</TH>		<TH> <a href="Opport.htm"><Font Color=#000080> Opportunities		</TH>				<TH> <a href="statlink.htm"><Font Color=#000080> Stat. Links 		</TH>		</TR></TR></TABLE><br><br> <p><font size=1>Page created by Joshua
Bender: </font><a href="mailto:jbender@neuron.cpmc.columbia.edu"><font
size=1>jbender@neuron.cpmc.columbia.edu</font></a><br> </p> </body></html>
</DOC>
<DOC>
<DOCNO>WT02-B10-229</DOCNO>
<DOCOLDNO>IA093-000995-B033-268</DOCOLDNO>
<DOCHDR>
http://www.nyspi.cpmc.columbia.edu:80/NYSPI/depts/biostat/opport.htm 156.111.80.30 19970121075800 text/html 1957
HTTP/1.0 200 OK
MIME-Version: 1.0
Server: GLACI/2.01
Date: Tue Jan 21 03:02:08 1997
Content-Type: text/html
Content-Length: 1827
</DOCHDR>
<htm>
<head>
<title>the Division of Biostatistics' Opportunities Page</title>
<body text="#000055" body bgcolor="#ffffff" link="#000000" vlink="#550000" 
<br>
<br>
<h1><br><font color="ff0000#">
<h1>NYSPI Division of Biostatistics </h1> </font color="ff0000#">
<Font Color=#0000FF >Opportunity Announcements
<h2></font>
<center><br></h1>
<h2>
<a href="Training.htm">Current Training Modules</a>
<br><br>
<a href="Fellship.htm">Fellowship Announcement</a></center>
<br></h2>
<br><h3>
<br>All announcements appearing here have been previously published in journals and newspapers. <br>
 Please note that for all job anouncements, the following applies:<br>
<br>
<i>"Columbia University is an Affirmative Action, Equal Opportunity Employer, <br>
encouraging women and minorities to apply."</i>
<br>
<br>
<TABLE Border=5 BGCOLOR="#FF80C0">

<CAPTION> </CAPTION>
<TR>
	<TH Colspan="10"><h2>  <Font Color=#FF0000> NYSPI Division of Biostatistics <Font Color=#0000FF>Page Jumps</h2></Font></TH></TR>
<TR>

	<TH><Font Color=#408080> <a href="index.htm"> <Font Color=#000080> Biostatistics Division <br>
		Home Page </a>		</TH>		
	
	<TH><Font Color=#408080> <a href="internal.htm"><Font Color=#000080> Internal <br>
		Home Page</a>		</TH>		

	<TH> <a href="mission.htm"><Font Color=#000080> Our Mission </a>	</TH>
	
	<TH> <a href="message.htm"><Font Color=#000080> Director's Message 	</TH>	
	
	<TH> <a href="staff.htm"><Font Color=#000080> Staff Info.		</TH>
	
	<TH> <a href="calendar.htm"><Font Color=#000080> Calendar		</TH>
	
	<TH> <a href="Opport.htm"><Font Color=#000080> Opportunities		</TH>		
	
	<TH> <a href="statlink.htm"><Font Color=#000080> Stat. Links 		</TH>
	
	

</TR>

</TR>

</TABLE>

</TR>

</TR>

</TABLE>



<br>
<br>
<br> 
</body>
</html>

</DOC>
<DOC>
<DOCNO>WT02-B10-230</DOCNO>
<DOCOLDNO>IA093-000995-B033-275</DOCOLDNO>
<DOCHDR>
http://www.nyspi.cpmc.columbia.edu:80/NYSPI/depts/biostat/statlink.htm 156.111.80.30 19970121075808 text/html 1943
HTTP/1.0 200 OK
MIME-Version: 1.0
Server: GLACI/2.01
Date: Tue Jan 21 03:02:16 1997
Content-Type: text/html
Content-Length: 1813
</DOCHDR>
<htm>
<head>
<title>the Division of Biostatistics' Statlink Page</title>
<body text="#000055" body bgcolor="#ffffff" link="#000000" vlink="#550000" 
<H1>
<font color="ff0000#">
<h1>NYSPI Division of Biostatistics
<br> <Font Color=#0000FF >Statistical resources</H1>
<br></font color="ff0000#">
<h2>
<a href="http://lib.stat.cmu.edu/otherplaces/">Stat Lib Index</a>
<br>
<br>
<a href="http://www.amstat.org/">American Statistical Association</a>
<br>
<br>
<a href="http://www.ieor.columbia.edu/~sigman/CAP.html">Center for Applied Probability (CAP)
Columbia University   New York City</a>
<br>
<br>
<a href="http://www.stat.ucla.edu/journals/jss/">Free Journal Of Statistical Software
<br>(Articles, Data, Program codes, chat room and more)</a>
<br>
<br>
<a href="http://www.sas.com/">SAS Home page</a>
<br>
<br>
<TABLE Border=5 BGCOLOR="#FF80C0">

<CAPTION> </CAPTION>
<TR>
	<TH Colspan="10"><h2>  <Font Color=#FF0000> NYSPI Division of Biostatistics <Font Color=#0000FF>Page Jumps</h2></Font></TH></TR>
<TR>

	<TH><Font Color=#408080> <a href="index.htm"> <Font Color=#000080> Biostatistics Division <br>
		Home Page </a>		</TH>		
	
	<TH><Font Color=#408080> <a href="internal.htm"><Font Color=#000080> Internal <br>
		Home Page</a>		</TH>		

	<TH> <a href="mission.htm"><Font Color=#000080> Our Mission </a>	</TH>
	
	<TH> <a href="message.htm"><Font Color=#000080> Director's Message 	</TH>	
	
	<TH> <a href="staff.htm"><Font Color=#000080> Staff Info.		</TH>
	
	<TH> <a href="calendar.htm"><Font Color=#000080> Calendar		</TH>
	
	<TH> <a href="Opport.htm"><Font Color=#000080> Opportunities		</TH>		
	
	<TH> <a href="statlink.htm"><Font Color=#000080> Stat. Links 		</TH>
	
	

</TR>

</TR>

</TABLE>



<br>
<br> 
</body>
</html>



</DOC>
<DOC>
<DOCNO>WT02-B10-231</DOCNO>
<DOCOLDNO>IA093-000995-B033-284</DOCOLDNO>
<DOCHDR>
http://www.nyspi.cpmc.columbia.edu:80/NYSPI/depts/biostat/Opport.htm 156.111.80.30 19970121075818 text/html 1957
HTTP/1.0 200 OK
MIME-Version: 1.0
Server: GLACI/2.01
Date: Tue Jan 21 03:02:25 1997
Content-Type: text/html
Content-Length: 1827
</DOCHDR>
<htm>
<head>
<title>the Division of Biostatistics' Opportunities Page</title>
<body text="#000055" body bgcolor="#ffffff" link="#000000" vlink="#550000" 
<br>
<br>
<h1><br><font color="ff0000#">
<h1>NYSPI Division of Biostatistics </h1> </font color="ff0000#">
<Font Color=#0000FF >Opportunity Announcements
<h2></font>
<center><br></h1>
<h2>
<a href="Training.htm">Current Training Modules</a>
<br><br>
<a href="Fellship.htm">Fellowship Announcement</a></center>
<br></h2>
<br><h3>
<br>All announcements appearing here have been previously published in journals and newspapers. <br>
 Please note that for all job anouncements, the following applies:<br>
<br>
<i>"Columbia University is an Affirmative Action, Equal Opportunity Employer, <br>
encouraging women and minorities to apply."</i>
<br>
<br>
<TABLE Border=5 BGCOLOR="#FF80C0">

<CAPTION> </CAPTION>
<TR>
	<TH Colspan="10"><h2>  <Font Color=#FF0000> NYSPI Division of Biostatistics <Font Color=#0000FF>Page Jumps</h2></Font></TH></TR>
<TR>

	<TH><Font Color=#408080> <a href="index.htm"> <Font Color=#000080> Biostatistics Division <br>
		Home Page </a>		</TH>		
	
	<TH><Font Color=#408080> <a href="internal.htm"><Font Color=#000080> Internal <br>
		Home Page</a>		</TH>		

	<TH> <a href="mission.htm"><Font Color=#000080> Our Mission </a>	</TH>
	
	<TH> <a href="message.htm"><Font Color=#000080> Director's Message 	</TH>	
	
	<TH> <a href="staff.htm"><Font Color=#000080> Staff Info.		</TH>
	
	<TH> <a href="calendar.htm"><Font Color=#000080> Calendar		</TH>
	
	<TH> <a href="Opport.htm"><Font Color=#000080> Opportunities		</TH>		
	
	<TH> <a href="statlink.htm"><Font Color=#000080> Stat. Links 		</TH>
	
	

</TR>

</TR>

</TABLE>

</TR>

</TR>

</TABLE>



<br>
<br>
<br> 
</body>
</html>

</DOC>
<DOC>
<DOCNO>WT02-B10-232</DOCNO>
<DOCOLDNO>IA093-000995-B033-294</DOCOLDNO>
<DOCHDR>
http://www.nyspi.cpmc.columbia.edu:80/NYSPI/depts/biostat/mission2.htm 156.111.80.30 19970121075826 text/html 2122
HTTP/1.0 200 OK
MIME-Version: 1.0
Server: GLACI/2.01
Date: Tue Jan 21 03:02:34 1997
Content-Type: text/html
Content-Length: 1992
</DOCHDR>
<htm>
<head>
<title>the Division of Biostatistics' Mission Page</title>
<body text="#000055" body bgcolor="#ffffff" link="#000000" vlink="#550000" 
<br><br><font color="ff0000#">
<h1>NYSPI Division of Biostatistics 
<br> <Font Color==#0000FF >Mission Statement <br></font color="ff0000#"> </h1>
<h2><Font Color=#408080><em>Our Mission<em>
<h3>
<br><Font Color=#0000A0><Font Color=#000080>
1) 	Application of statistics in psychiatric research; 
<br>
2) 	Development of new statistics techniques for specialized 
psychiatric problems, including brain imaging, analysis of 
data with informative missingness, and hierarchical longitudinal
modeling; 
<br>
3)	Specialized education of statistics doctoral  students and postdoctoral fellows interested in psychiatric and  neurological research;
<br>
4)	Instructing data analysts working in the area of psychiatry on modern statistics and 
<br>
5)	Statistical education of psychiatry research fellows.
<br>
<br>
</h2><TABLE Border=5 BGCOLOR="#FF80C0">

<CAPTION> </CAPTION>
<TR>
	<TH Colspan="8"><h2> <Font Color=#FF0000>NYSPI Division of Biostatistics Biostatistics <Font Color=#0000FF>Page Jumps</h2></Font></TH></TR>
<TR>

	<TH><Font Color=#408080> <a href="index.htm"> <Font Color=#000080> Biostatistics Division <br>
		Home Page </a>		</TH>		
	
	<TH><Font Color=#408080> <a href="external.htm"><Font Color=#000080> Visitor<br>
		Home Page</a>		</TH>		

	<TH> <a href="mission2.htm"> <Font Color=#000080> Our Mission </a>	</TH>
	
	<TH> <a href="message2.htm"><Font Color=#000080> Director's Message 	</TH>	
	
	<TH> <a href="staff-e.htm"><Font Color=#000080> Staff Info.		</TH>
		
	<TH> <a href="Opport2.htm"><Font Color=#000080> Opportunities		</TH>		
	
	<TH> <a href="statlnk2.htm"><Font Color=#000080> Stat. Links 		</TH>
	
	

</TR>

</TR>

</TABLE>
<br>
<br>
<br>
<br>
<br>
<br>
<br>
<br>
<br>
<br>
<br>
<br>
<br>
<br>
<br>
</body>
</htm>

</DOC>
<DOC>
<DOCNO>WT02-B10-233</DOCNO>
<DOCOLDNO>IA093-000995-B033-304</DOCOLDNO>
<DOCHDR>
http://www.nyspi.cpmc.columbia.edu:80/NYSPI/depts/biostat/message2.htm 156.111.80.30 19970121075833 text/html 5332
HTTP/1.0 200 OK
MIME-Version: 1.0
Server: GLACI/2.01
Date: Tue Jan 21 03:02:41 1997
Content-Type: text/html
Content-Length: 5202
</DOCHDR>
<htm>
<head>
<title>The Division of Biostatistics' Director Message Page</title>
<body text="#000055" body bgcolor="#ffffff" link="#000000" vlink="#550000" 
<br>
<h1>
<font color="ff0000#">
NYSPI Division of Biostatistics 
</font color="ff0000#">
<Font Color==#0000FF  >
<br>A Message from the Director </Font>
<br>
<h2>
<br>
 <h2><Font Color=#408080><em>Dr. Christine Waternaux  </font> 
<br></em>
<br><h3>The Division of Biostatistics was established in January, 1994. The mission of the division is to provide investigators at Psychiatric Institute with access to and training in state-of-the-art statistical techniques as needed for the optimal use of their research data. This includes developing and applying new methodology for the design and analysis of psychiatric studies, participating in major funded research, teaching statistics to researchers and post-doctoral fellows, and providing short-term consultations on data-analytic and design issues for grant submission and manuscript preparation. 
<br>
<br>
<em> <Font Color=#408080> Methodological Research </em></font>
<br>
<br>
Methodological research in the division focuses on problems of particular relevance to psychiatric studies. Areas of expertise in the division include analysis of longitudinal studies with generalized linear models and variance components models, methods for dealing with missing data, causal models, and methodology for combining information from different sources (e.g., meta-analysis). 
<br>
<br>
For example, Dr. Christine Waternaux, Director, is investigating methods for power computations with longitudinal repeated measures. She has also investigated and published on the use of hierarchical models for combining psychiatric data. 
<br>
<br>
Dr. Eva Petkova, Associate Biostatistician, is specializing in statistical models for the analysis of longitudinal studies with informative drop-out. She is developing methodologies for the analysis of clinical trials when the traditional intent-to-treat approach is not appropriate because most drop-outs switch treatments. 
<br>
<br>
Dr. Xinhua Liu, Associate Biostatistician, is experienced in analyzing cohort data (e.g., New York gay man cohort) which traditionally have high dropout rates and a large proportion of missing observations. Her research is addressing the problem of adequacy of different analytical techniques in the presence of missing data. 
<br>
<br>
<em><Font Color=#408080>  Collaborative and Consultative Activities </em></font>
<br>
<br>
Division staff have been very active in their collaborative and consultative efforts, thus demonstrating the great need for such services. For instance, in 1994, staff provided statistical input and participated in nineteen grant submissions. In April 1994, Dr. Christine Waternaux became the Director of the Biostatistics and Measurement Core of the NIMH-funded Clinical Research Center for the Study of Youth
Depression, Anxiety, and Suicide (Principal Investigator: Dr. David Shaffer). 
<br>
<br>
In September 1994, Dr. Waternaux became the Director of the Statistics and Computing Core of the Clinical Research Center for the Study of Suicidal Behavior (Principal Investigator: Dr. J. John Mann).  Division staff are also participating in consultations and meetings with the Statistics, Epidemiology, and Data Management Core of the HIV Center for Clinical and Behavioral Studies (Directors: Drs. Anke Erhardt and Zena Stein). 
<br>
<br>
As part of its training component, the division conducts weekly workshops in biostatistics and data management. These workshops illustrate analytic and data management issues, and explore emerging statistical methodologies in both fields. 
<br>
<br>
Topics covered this year have included random regression models, principles of modeling, meta-analysis, generalized estimating equations, and structural equation modeling.
<br>
<br>
Division staff are also working with the Department of Postgraduate Education and with members of the NIMH Training Programs for Clinical and Research Fellows on matters concerning the statistical curriculum.
<br>
<br>
</h4>
</h2><TABLE Border=5 BGCOLOR="#FF80C0">

<CAPTION> </CAPTION>
<TR>
	<TH Colspan="8"><h2> <Font Color=#FF0000>NYSPI Division of Biostatistics Biostatistics <Font Color=#0000FF>Page Jumps</h2></Font></TH></TR>
<TR>

	<TH><Font Color=#408080> <a href="index.htm"> <Font Color=#000080> Biostatistics Division <br>
		Home Page </a>		</TH>		
	
	<TH><Font Color=#408080> <a href="external.htm"><Font Color=#000080> Visitor<br>
		Home Page</a>		</TH>		

	<TH> <a href="mission2.htm"> <Font Color=#000080> Our Mission </a>	</TH>
	
	<TH> <a href="message2.htm"><Font Color=#000080> Director's Message 	</TH>	
	
	<TH> <a href="staff-e.htm"><Font Color=#000080> Staff Info.		</TH>
		
	<TH> <a href="Opport2.htm"><Font Color=#000080> Opportunities		</TH>		
	
	<TH> <a href="statlnk2.htm"><Font Color=#000080> Stat. Links 		</TH>
	
	

</TR>

</TR>

</TABLE>



<br>

<br>
<br>
<br>
<br>
<br>
<br>
<br>
<br>
<br>
<br>
<br>
<br>
<br>
<br>
<br>
<br>
</body>
</htm>






</DOC>
<DOC>
<DOCNO>WT02-B10-234</DOCNO>
<DOCOLDNO>IA093-000995-B033-316</DOCOLDNO>
<DOCHDR>
http://www.nyspi.cpmc.columbia.edu:80/NYSPI/depts/biostat/staff-e.htm 156.111.80.30 19970121075857 text/html 3209
HTTP/1.0 200 OK
MIME-Version: 1.0
Server: GLACI/2.01
Date: Tue Jan 21 03:02:57 1997
Content-Type: text/html
Content-Length: 3079
</DOCHDR>
<htm> <head><title>the Division of Biostatistics' Staff Home Page</title><body text="#000055" body bgcolor="#ffffff" link="#000000" vlink="#550000" <font color="ff0000#"><h1><Font Color=#FF0000><h1>NYSPI Division of Biostatistics <Font Color==#0000FF ><br>Staff Page<br></font><h3><TABLE Border=2 BGCOLOR="#C0C0C0"><CAPTION> </CAPTION><TR><TH Colspan="10"> <Font Color=#FF0000>Staff Information</Font></TH></TR><TR><TH> <Font Color==#0000FF > Name </TH><TH> <Font Color==#0000FF >Main Research Areas and Interests </TH><TH> <Font Color=#=#0000FF >Telephone </TH><TH> <Font Color=#=#0000FF >e-mail </TH></TR><TR><TD>Christine Waternaux, Ph.D.Division, Chair</TD><TD> Longitudinal mixed effects models, Meta analysis, Variance components</TD><TD>960-5766</TD><TD><I><A HREF="mailto:waternac@child.cpmc.columbia.edu">waternac@child.cpmc.columbia.edu</A></I></TD></TR> <TR><TD>Steve Ellis, Ph.D. </TD><TD>Bootstrap and other computer intensive statistical techniques, brain image analysis, stability of plane fitting</TD><TD>960-2200 <br> Ext. 489</TD><TD><I><A HREF="mailto:ellis@neuron.cpmc.columbia.edu">ellis@neuron.columbia.edu</A></I></TD></TR> <TR><TD>Xinhua Liu, Ph.D.</TD> <td>Generalized estimating equations, Survival analysis, Longitudinal Data Analysis</TD><TD>960-5587</TD><TD><I><A HREF="mailto:liux@child.cpmc.columbia.edu">liux@child.cpmc.columbia.edu</A></I></TD></TR> <TR><TD>Michael Parides, Ph.D. </TD><TD> Statistical issues in survey methodology,  Discrete data analysis </TD><TD>740-0012, <br>960-5688</TD><TD><I><A HREF="mailto:paridesm@child.cpmc.columbia.edu">paridesm@child.cpmc.columbia.edu</A></I></TD></TR> <TR><TD> Eva Petkova Ph.D. </TD><TD> Statistical modeling, Causal statistical inference, Evaluation and comparison of antidepressant drugs </TD><TD>960-5875</TD><TD><I><A HREF="mailto:petkovae@child.cpmc.columbia.edu">petkovae@child.cpmc.columbia.edu</A></I></TD></TR> <TR><TD>Rezi Zawadski, M.S.</TD><TD> Huntington's disease </TD><TD>923-7394</TD><TD><I><A HREF="mailto:rz@columbia.edu">rz@columbia.edu  </A></I></TD></TR> <h2></TABLE><br></h2><TABLE Border=5 BGCOLOR="#FF80C0"><CAPTION> </CAPTION><TR>	<TH Colspan="8"><h2> <Font Color=#FF0000>NYSPI Division of Biostatistics Biostatistics <Font Color=#0000FF>Page Jumps</h2></Font></TH></TR><TR>	<TH><Font Color=#408080> <a href="index.htm"> <Font Color=#000080> Biostatistics Division <br>		Home Page </a>		</TH>				<TH><Font Color=#408080> <a href="external.htm"><Font Color=#000080> Visitor<br>		Home Page</a>		</TH>			<TH> <a href="mission2.htm"> <Font Color=#000080> Our Mission </a>	</TH>		<TH> <a href="message2.htm"><Font Color=#000080> Director's Message 	</TH>			<TH> <a href="staff-e.htm"><Font Color=#000080> Staff Info.		</TH>			<TH> <a href="Opport2.htm"><Font Color=#000080> Opportunities		</TH>				<TH> <a href="statlnk2.htm"><Font Color=#000080> Stat. Links 		</TH>		</TR></TR></TABLE> <p><font size=1>Page created by Joshua
Bender: </font><a href="mailto:jbender@neuron.cpmc.columbia.edu"><font
size=1>jbender@neuron.cpmc.columbia.edu</font></a><br> </p> </body></html>
</DOC>
<DOC>
<DOCNO>WT02-B10-235</DOCNO>
<DOCOLDNO>IA093-000995-B033-332</DOCOLDNO>
<DOCHDR>
http://www.nyspi.cpmc.columbia.edu:80/NYSPI/depts/biostat/statlnk2.htm 156.111.80.30 19970121075909 text/html 1901
HTTP/1.0 200 OK
MIME-Version: 1.0
Server: GLACI/2.01
Date: Tue Jan 21 03:03:17 1997
Content-Type: text/html
Content-Length: 1771
</DOCHDR>
<htm>
<head>
<title>the Division of Biostatistics' Statlink Page</title>
<body text="#000055" body bgcolor="#ffffff" link="#000000" vlink="#550000" 
<br><H1>
<br><font color="ff0000#">
NYSPI Division of Biostatistics </font>
<br><Font Color==#0000FF >Statistical resources</Font></H1>
<br></font color="ff0000#">
<br>
<h2>
<a href="http://lib.stat.cmu.edu/otherplaces/">Stat Lib Index</a>
<br>
<br>
<a href="http://www.amstat.org/">American Statistical Association</a>
<br>
<br>
<a href="http://www.ieor.columbia.edu/~sigman/CAP.html">Center for Applied Probability (CAP)
Columbia University   New York City</a>
<br>
<br>
<a href="http://www.stat.ucla.edu/journals/jss/">Free Journal Of Statistical Software
<br>(Articles, Data, Program codes, chat room and more)</a>
<br>
<br>
<a href="http://www.sas.com/">SAS Home page</a>
<br></h2>

</h2><TABLE Border=5 BGCOLOR="#FF80C0">

<CAPTION> </CAPTION>
<TR>
	<TH Colspan="8"><h2> <Font Color=#FF0000>NYSPI Division of Biostatistics Biostatistics <Font Color=#0000FF>Page Jumps</h2></Font></TH></TR>
<TR>

	<TH><Font Color=#408080> <a href="index.htm"> <Font Color=#000080> Biostatistics Division <br>
		Home Page </a>		</TH>		
	
	<TH><Font Color=#408080> <a href="external.htm"><Font Color=#000080> Visitor<br>
		Home Page</a>		</TH>		

	<TH> <a href="mission2.htm"> <Font Color=#000080> Our Mission </a>	</TH>
	
	<TH> <a href="message2.htm"><Font Color=#000080> Director's Message 	</TH>	
	
	<TH> <a href="staff-e.htm"><Font Color=#000080> Staff Info.		</TH>
		
	<TH> <a href="Opport2.htm"><Font Color=#000080> Opportunities		</TH>		
	
	<TH> <a href="statlnk2.htm"><Font Color=#000080> Stat. Links 		</TH>
	
	

</TR>

</TR>

</TABLE>
</body>
</html>



</DOC>
<DOC>
<DOCNO>WT02-B10-236</DOCNO>
<DOCOLDNO>IA093-000995-B033-343</DOCOLDNO>
<DOCHDR>
http://www.nyspi.cpmc.columbia.edu:80/NYSPI/depts/biostat/Opport2.htm 156.111.80.30 19970121075918 text/html 1886
HTTP/1.0 200 OK
MIME-Version: 1.0
Server: GLACI/2.01
Date: Tue Jan 21 03:03:27 1997
Content-Type: text/html
Content-Length: 1756
</DOCHDR>
<htm>
<head>
<title>the Division of Biostatistics' Opportunities Page</title>
<body text="#000055" body bgcolor="#ffffff" link="#000000" vlink="#550000" 
<br>
<br>
<h1><br><font color="ff0000#">
<h1>NYSPI Division of Biostatistics </h1>
</font color="ff0000#">
<font color==#0000FF > Opportunity Information</font>
<br>
<br>
<br>
<h2><center><Font Color=#0000FF>
<a href="Train2.htm">Current Training Modules</a>
<br><br>
<a href="Fellsh2.htm">Fellowship Announcement</a></center>
<br></h2></Font>
<br>
<br><h3>All announcements appearing here have been previously published in journals and newspapers. <br>
 Please note that for all job anouncements, the following applies:<br>
<br>
<i>"Columbia University is an Affirmative Action, Equal Opportunity Employer, <br>
encouraging women and minorities to apply."</i>
</h2><TABLE Border=5 BGCOLOR="#FF80C0">

<CAPTION> </CAPTION>
<TR>
	<TH Colspan="8"><h2> <Font Color=#FF0000>NYSPI Division of Biostatistics Biostatistics <Font Color=#0000FF>Page Jumps</h2></Font></TH></TR>
<TR>

	<TH><Font Color=#408080> <a href="index.htm"> <Font Color=#000080> Biostatistics Division <br>
		Home Page </a>		</TH>		
	
	<TH><Font Color=#408080> <a href="external.htm"><Font Color=#000080> Visitor<br>
		Home Page</a>		</TH>		

	<TH> <a href="mission2.htm"> <Font Color=#000080> Our Mission </a>	</TH>
	
	<TH> <a href="message2.htm"><Font Color=#000080> Director's Message 	</TH>	
	
	<TH> <a href="staff-e.htm"><Font Color=#000080> Staff Info.		</TH>
		
	<TH> <a href="Opport2.htm"><Font Color=#000080> Opportunities		</TH>		
	
	<TH> <a href="statlnk2.htm"><Font Color=#000080> Stat. Links 		</TH>
	
	

</TR>

</TR>

</TABLE>
<br>
<br>
<br> 
</body>
</html>

</DOC>
<DOC>
<DOCNO>WT02-B10-237</DOCNO>
<DOCOLDNO>IA093-000995-B033-402</DOCOLDNO>
<DOCHDR>
http://www.nyspi.cpmc.columbia.edu:80/NYSPI/depts/biostat/Training.htm 156.111.80.30 19970121080004 text/html 2817
HTTP/1.0 200 OK
MIME-Version: 1.0
Server: GLACI/2.01
Date: Tue Jan 21 03:04:11 1997
Content-Type: text/html
Content-Length: 2687
</DOCHDR>
<htm>
<head>
<title>the Division of Biostatistics' Opportunities Page</title>
<body text="#000055" body bgcolor="#ffffff" link="#000000" vlink="#550000" 
<br>
<h1><br><font color="ff0000#">
<h1>NYSPI Division of Biostatistics </h1>
<br></font color="ff0000#">

<br>
<h3>
Subject:       Postdoctoral training in statistics for psychologists
<br>
<br>
<br>
<br>
POSTDOCTORAL FELLOWSHIP IN BIOSTATISTICS 
<br>
<br>
COLUMBIA UNIVERSITY in the City of New York has an immediate opening
for an NIH-funded postdoctoral training fellowship in Biostatistics
and Mental Health Research.  
<br>
<br>
Persons with doctorates in psychology,
psychiatry, epidemiology, sociology, or related fields, who have a
solid background in mathematics and who enjoy quantitative research
are invited to apply.  Fellows study statistical and biostatistical
methods while pursing research in mental health.  After two years they
earn an MS in Biostatistics.  
<br>
<br>
Government regulations require that
fellows be US citizens or permanent residents.  Inquires should be
made to Dr. Christine Waternaux, Division of Biostatistics, Columbia
University School of Public Health, 600 W 168 Street, New York,  NY 
10032.  E-mail queries can be sent to <I><A HREF="mailto:gb12.columbia.edu">gb12.columbia.edu</A></I>
<br>
<br>
<br><h3>
<br>All announcements appearing here have been previously published in journals and newspapers. <br>
 Please note that for all job anouncements, the following applies:<br>
<br>
<i>"Columbia University is an Affirmative Action, Equal Opportunity Employer, <br>
encouraging women and minorities to apply."</i>


<br>
</h3>
<br>

<TABLE Border=5 BGCOLOR="#FF80C0">

<CAPTION> </CAPTION>
<TR>
	<TH Colspan="10"><h2>  <Font Color=#FF0000> NYSPI Division of Biostatistics <Font Color=#0000FF>Page Jumps</h2></Font></TH></TR>
<TR>

	<TH><Font Color=#408080> <a href="index.htm"> <Font Color=#000080> Biostatistics Division <br>
		Home Page </a>		</TH>		
	
	<TH><Font Color=#408080> <a href="internal.htm"><Font Color=#000080> Internal <br>
		Home Page</a>		</TH>		

	<TH> <a href="mission.htm"><Font Color=#000080> Our Mission </a>	</TH>
	
	<TH> <a href="message.htm"><Font Color=#000080> Director's Message 	</TH>	
	
	<TH> <a href="staff.htm"><Font Color=#000080> Staff Info.		</TH>
	
	<TH> <a href="calendar.htm"><Font Color=#000080> Calendar		</TH>
	
	<TH> <a href="Opport.htm"><Font Color=#000080> Opportunities		</TH>		
	
	<TH> <a href="statlink.htm"><Font Color=#000080> Stat. Links 		</TH>
	
	

</TR>

</TR>

</TABLE>


</TR>

</TR>

</TABLE>

<br>
<br>
<br> 
</body>
</html>

</DOC>
<DOC>
<DOCNO>WT02-B10-238</DOCNO>
<DOCOLDNO>IA093-000995-B033-419</DOCOLDNO>
<DOCHDR>
http://www.nyspi.cpmc.columbia.edu:80/NYSPI/depts/biostat/Fellship.htm 156.111.80.30 19970121080020 text/html 2822
HTTP/1.0 200 OK
MIME-Version: 1.0
Server: GLACI/2.01
Date: Tue Jan 21 03:04:24 1997
Content-Type: text/html
Content-Length: 2692
</DOCHDR>
<htm>
<head>
<title>the Division of Biostatistics' Opportunities Page</title>
<body text="#000055" body bgcolor="#ffffff" link="#000000" vlink="#550000" 
<h1>
<h1><Font Color=#FF0000>NYSPI Division of Biostatistics </Font> 

<br><Font Color=#0000FF> Postdoctoral training / fellowship Information</Font></h1>
<h3>
<br>
<br>
Subject:       Postdoctoral training in statistics for psychologists
<br>
<br>
<br>
<br>
POSTDOCTORAL FELLOWSHIP IN BIOSTATISTICS 
<br>
<br>
COLUMBIA UNIVERSITY in the City of New York has an immediate opening
for an NIH-funded postdoctoral training fellowship in Biostatistics
and Mental Health Research.  
<br>
<br>
Persons with doctorates in psychology,
psychiatry, epidemiology, sociology, or related fields, who have a
solid background in mathematics and who enjoy quantitative research
are invited to apply.  Fellows study statistical and biostatistical
methods while pursing research in mental health.  After two years they
earn an MS in Biostatistics.  
<br>
<br>
Government regulations require that
fellows be US citizens or permanent residents.  Inquires should be
made to Dr. Christine Waternaux, Division of Biostatistics, Columbia
University School of Public Health, 600 W 168 Street, New York,  NY 
10032.  E-mail queries can be sent to <I><A HREF="mailto:gb12.columbia.edu">gb12.columbia.edu</A></I>
<br>
<br>
<br><h3>
<br>All announcements appearing here have been previously published in journals and newspapers. <br>
 Please note that for all job anouncements, the following applies:<br>
<br>
<i>"Columbia University is an Affirmative Action, Equal Opportunity Employer, <br>
encouraging women and minorities to apply."</i>

<br>
</h3>
<TABLE Border=5 BGCOLOR="#FF80C0">

<CAPTION> </CAPTION>
<TR>
	<TH Colspan="10"><h2>  <Font Color=#FF0000> NYSPI Division of Biostatistics <Font Color=#0000FF>Page Jumps</h2></Font></TH></TR>
<TR>

	<TH><Font Color=#408080> <a href="index.htm"> <Font Color=#000080> Biostatistics Division <br>
		Home Page </a>		</TH>		
	
	<TH><Font Color=#408080> <a href="internal.htm"><Font Color=#000080> Internal <br>
		Home Page</a>		</TH>		

	<TH> <a href="mission.htm"><Font Color=#000080> Our Mission </a>	</TH>
	
	<TH> <a href="message.htm"><Font Color=#000080> Director's Message 	</TH>	
	
	<TH> <a href="staff.htm"><Font Color=#000080> Staff Info.		</TH>
	
	<TH> <a href="calendar.htm"><Font Color=#000080> Calendar		</TH>
	
	<TH> <a href="Opport.htm"><Font Color=#000080> Opportunities		</TH>		
	
	<TH> <a href="statlink.htm"><Font Color=#000080> Stat. Links 		</TH>
	
	

</TR>

</TR>

</TABLE>



<br>
<br> 
</body>
</html>

</DOC>
<DOC>
<DOCNO>WT02-B10-239</DOCNO>
<DOCOLDNO>IA093-000995-B033-428</DOCOLDNO>
<DOCHDR>
http://www.nyspi.cpmc.columbia.edu:80/NYSPI/depts/biostat/Train2.htm 156.111.80.30 19970121080030 text/html 2746
HTTP/1.0 200 OK
MIME-Version: 1.0
Server: GLACI/2.01
Date: Tue Jan 21 03:04:38 1997
Content-Type: text/html
Content-Length: 2616
</DOCHDR>
<htm>
<head>
<title>the Division of Biostatistics' Opportunities Page</title>
<body text="#000055" body bgcolor="#ffffff" link="#000000" vlink="#550000" 
<h1><br><font color="ff0000#">
<h1>NYSPI Division of Biostatistics
<br> <Font Color=#0000FF >Postdoctoral Training Information</Font> 
</h1>
</font color="ff0000#">
<h3>
Subject:       Postdoctoral training in statistics for psychologists
<br>
<br>
POSTDOCTORAL FELLOWSHIP IN BIOSTATISTICS 
<br>
<br>
COLUMBIA UNIVERSITY in the City of New York has an immediate opening
for an NIH-funded postdoctoral training fellowship in Biostatistics
and Mental Health Research.  
<br>
<br>
Persons with doctorates in psychology,
psychiatry, epidemiology, sociology, or related fields, who have a
solid background in mathematics and who enjoy quantitative research
are invited to apply.  Fellows study statistical and biostatistical
methods while pursing research in mental health.  After two years they
earn an MS in Biostatistics.  
<br>
<br>
Government regulations require that
fellows be US citizens or permanent residents.  Inquires should be
made to Dr. Christine Waternaux, Division of Biostatistics, Columbia
University School of Public Health, 600 W 168 Street, New York,  NY 
10032.  E-mail queries can be sent to <I><A HREF="mailto:gb12.columbia.edu">gb12.columbia.edu</A></I>
<br>
<br>

<br><h3>
<br>All announcements appearing here have been previously published in journals and newspapers. <br>
 Please note that for all job anouncements, the following applies:<br>
<br>
<i>"Columbia University is an Affirmative Action, Equal Opportunity Employer, <br>
encouraging women and minorities to apply."</i>


</h2><TABLE Border=5 BGCOLOR="#FF80C0">

<CAPTION> </CAPTION>
<TR>
	<TH Colspan="8"><h2> <Font Color=#FF0000>NYSPI Division of Biostatistics Biostatistics <Font Color=#0000FF>Page Jumps</h2></Font></TH></TR>
<TR>

	<TH><Font Color=#408080> <a href="index.htm"> <Font Color=#000080> Biostatistics Division <br>
		Home Page </a>		</TH>		
	
	<TH><Font Color=#408080> <a href="external.htm"><Font Color=#000080> Visitor<br>
		Home Page</a>		</TH>		

	<TH> <a href="mission2.htm"> <Font Color=#000080> Our Mission </a>	</TH>
	
	<TH> <a href="message2.htm"><Font Color=#000080> Director's Message 	</TH>	
	
	<TH> <a href="staff-e.htm"><Font Color=#000080> Staff Info.		</TH>
		
	<TH> <a href="Opport2.htm"><Font Color=#000080> Opportunities		</TH>		
	
	<TH> <a href="statlnk2.htm"><Font Color=#000080> Stat. Links 		</TH>
	
	

</TR>

</TR>

</TABLE><br>
<br> 
</body>
</html>

</DOC>
<DOC>
<DOCNO>WT02-B10-240</DOCNO>
<DOCOLDNO>IA093-000995-B033-437</DOCOLDNO>
<DOCHDR>
http://www.nyspi.cpmc.columbia.edu:80/NYSPI/depts/biostat/Fellsh2.htm 156.111.80.30 19970121080038 text/html 2787
HTTP/1.0 200 OK
MIME-Version: 1.0
Server: GLACI/2.01
Date: Tue Jan 21 03:04:46 1997
Content-Type: text/html
Content-Length: 2657
</DOCHDR>
<htm>
<head>
<title>the Division of Biostatistics' Opportunities Page</title>
<body text="#000055" body bgcolor="#ffffff" link="#000000" vlink="#550000" 
<h1><font color="ff0000#">
<h1>NYSPI Division of Biostatistics 
<br>
<br>
<Font Color=#=#0000FF >Postdoctoral training / fellowship Information </font></h1>
<br>
<br>
<h3>
 <Font Color=#000080>
Subject:       Postdoctoral training in statistics for psychologists
<br>
<br>
POSTDOCTORAL FELLOWSHIP IN BIOSTATISTICS 
<br>
<br>
COLUMBIA UNIVERSITY in the City of New York has an immediate opening
for an NIH-funded postdoctoral training fellowship in Biostatistics
and Mental Health Research.  
<br>
<br>
Persons with doctorates in psychology,
psychiatry, epidemiology, sociology, or related fields, who have a
solid background in mathematics and who enjoy quantitative research
are invited to apply.  Fellows study statistical and biostatistical
methods while pursing research in mental health.  After two years they
earn an MS in Biostatistics.  
<br>
<br>
Government regulations require that
fellows be US citizens or permanent residents.  Inquires should be
made to Dr. Christine Waternaux, Division of Biostatistics, Columbia
University School of Public Health, 600 W 168 Street, New York,  NY 
10032.  E-mail queries can be sent to <I><A HREF="mailto:gb12.columbia.edu">gb12.columbia.edu</A></I>
<br>
<br><h3>
<br>All announcements appearing here have been previously published in journals and newspapers. <br>
 Please note that for all job anouncements, the following applies:<br>
<br>
<i>"Columbia University is an Affirmative Action, Equal Opportunity Employer, <br>
encouraging women and minorities to apply."</i>

<br>
</h3>
</h2><TABLE Border=5 BGCOLOR="#FF80C0">

<CAPTION> </CAPTION>
<TR>
	<TH Colspan="8"><h2> <Font Color=#FF0000>NYSPI Division of Biostatistics Biostatistics <Font Color=#0000FF>Page Jumps</h2></Font></TH></TR>
<TR>

	<TH><Font Color=#408080> <a href="index.htm"> <Font Color=#000080> Biostatistics Division <br>
		Home Page </a>		</TH>		
	
	<TH><Font Color=#408080> <a href="external.htm"><Font Color=#000080> Visitor<br>
		Home Page</a>		</TH>		

	<TH> <a href="mission2.htm"> <Font Color=#000080> Our Mission </a>	</TH>
	
	<TH> <a href="message2.htm"><Font Color=#000080> Director's Message 	</TH>	
	
	<TH> <a href="staff-e.htm"><Font Color=#000080> Staff Info.		</TH>
		
	<TH> <a href="Opport2.htm"><Font Color=#000080> Opportunities		</TH>		
	
	<TH> <a href="statlnk2.htm"><Font Color=#000080> Stat. Links 		</TH>
	
	

</TR>

</TR>

</TABLE>

<br>
<br>
<br> 
</body>
</html>

</DOC>
<DOC>
<DOCNO>WT02-B10-241</DOCNO>
<DOCOLDNO>IA093-000995-B031-401</DOCOLDNO>
<DOCHDR>
http://www.nyspi.cpmc.columbia.edu:80/NYSPI/JOBS/RF970014.htm 156.111.80.30 19970121074222 text/html 1644
HTTP/1.0 200 OK
MIME-Version: 1.0
Server: GLACI/2.01
Date: Tue Jan 21 02:46:28 1997
Content-Type: text/html
Content-Length: 1514
</DOCHDR>
<html>
<BODY BACKGROUND="/IMAGES/MARBLE.JPG">
<CENTER>
<H3>RESEARCH FOUNDATION FOR MENTAL HYGIENE, Inc.</H3>
<B>New York State Psychiatric Institute Division</B><BR>
<B>722 West 168th Street, New York, NY 10032<BR></B>
<B>Ph: (212)-960-5801    Fax: (212)-740-5329<BR></B></CENTER>
<pre>
                                                       January 16, 1997
<CENTER>
<B>JOB POSTING</B>
</CENTER>
<B>
POSITION:</B>          Research Assistant II - Grade 5
                   Salary: $16,962 + $768 Location Pay
<B>
LOCATION:</B>          New York State Psychiatric Institute
                   Medical Genetics
<B>
DUTIES:</B>            Responsibilities: extracting DNA from samples; mixing 
                   solutions; entering data into labman database; keeping 
                   track of needed supplies; washing and autoclaving 
                   glassware; filing and xeroxing.
<B>
EDUCATION:</B>         H.S. graduate.  Some college with relevant courses.

<B>TRAINING & </B>
<B>EXPERIENCE:</B>        Experience in DNA extraction and mixing solutions 
                   preferred.

<B>SPECIAL</B>
<B>REQUIREMENTS:</B>       Previous lab work.
<p>
<p>
Interested persons should respond, in writing, to the Research Foundation
Personnel office, NYS Psychiatric Institute, 722 West 168th Street, 
New York, NY 10032. For additional information call: 212-960-2347
An Affirmative Action/Equal Opportunity Employer.
<p>
<B>Posting ref.#: RF-97 0014/0122</B>
</pre>
</DOC>
<DOC>
<DOCNO>WT02-B10-242</DOCNO>
<DOCOLDNO>IA093-000995-B031-118</DOCOLDNO>
<DOCHDR>
http://www.nyspi.cpmc.columbia.edu:80/NYSPI/JOBS/RF960164.htm 156.111.80.30 19970121073834 text/html 3076
HTTP/1.0 200 OK
MIME-Version: 1.0
Server: GLACI/2.01
Date: Tue Jan 21 02:42:41 1997
Content-Type: text/html
Content-Length: 2946
</DOCHDR>
<html>
<BODY BACKGROUND="/IMAGES/MARBLE.JPG">
<CENTER>
<H3>RESEARCH FOUNDATION FOR MENTAL HYGIENE, Inc.</H3>
<B>New York State Psychiatric Institute Division</B><BR>
<B>722 West 168th Street, New York, NY 10032<BR></B>
<B>Ph: (212)-960-5801    Fax: (212)-740-5329<BR></B></CENTER>
<pre>
                                                       December 10, 1996
<CENTER>
<B>JOB POSTING</B>
</CENTER>
<B>
POSITION:</B>          Research Scientist II - Grade 22
                   Salary: $43,470-$51,099 ($26,082-$30,659)  60% 
                   Depending on education and experience
<B>
LOCATION:</B>          New York State Psychiatric Institute
                   CHILD PSYCHIATRY
<B>
DUTIES:</B>            Psychologist needed to implement various aspects of 
                   follow-up study of children with Attention-deficit 
                   Hyperactivity Disorder (ADHD).  Duties include: presenting 
                   study to school principals and teachers to enlist their 
                   participation; overseeing coordination and administration 
                   of school participation and recruitment of normal control 
                   group; explaining follow-up studies to participating 
                   families and new families; performing cognitive and 
                   achievement tests to children and adults; writing clinical 
                   summary reports; supervising testing performed by Research 
                   Assistants; providing educational sessions about ADHD at 
                   teachers conferences.
<B>
EDUCATION:</B>         Bachelor's degree and three years of professional research 
                   experience in psychology; or a master's degree in the 
                   above field and two years of such experience; or a 
                   doctorate in that field.  Ph.D. preferred.

<B>TRAINING & </B>
<B>EXPERIENCE:</B>        Candiate must know how to administer and score the 
                   WISC-III, WIAT, and WAIS-R and must be familiar with the 
                   interpretation of standard child behavioral measures.  
                   Must be able to write clinical reports.  Preference will 
                   be given to candidates who have experience working with 
                   ADHD populations.  Must be familiar with standard 
                   treatments of this diorder.

<B>SPECIAL</B>
<B>REQUIREMENTS:</B>       Saturday work required.  Candidate must possess excellent 
                   interpersonal, administrative and writing skills.
                   
<p>
<p>
Interested persons should respond, in writing, to the Research Foundation
Personnel office, NYS Psychiatric Institute, 722 West 168th Street, 
New York, NY 10032. For additional information call: 212-960-2554
An Affirmative Action/Equal Opportunity Employer.
<p>
<B>Posting ref.#: RF-96 0164/1216</B>
</pre>
</DOC>
<DOC>
<DOCNO>WT02-B10-243</DOCNO>
<DOCOLDNO>IA093-000995-B031-347</DOCOLDNO>
<DOCHDR>
http://www.nyspi.cpmc.columbia.edu:80/NYSPI/JOBS/RF970011.htm 156.111.80.30 19970121074142 text/html 3184
HTTP/1.0 200 OK
MIME-Version: 1.0
Server: GLACI/2.01
Date: Tue Jan 21 02:45:50 1997
Content-Type: text/html
Content-Length: 3054
</DOCHDR>
<html>
<BODY BACKGROUND="/IMAGES/MARBLE.JPG">
<CENTER>
<H3>RESEARCH FOUNDATION FOR MENTAL HYGIENE, Inc.</H3>
<B>New York State Psychiatric Institute Division</B><BR>
<B>722 West 168th Street, New York, NY 10032<BR></B>
<B>Ph: (212)-960-5801    Fax: (212)-740-5329<BR></B></CENTER>
<pre>
                                                       January 14, 1997
<CENTER>
<B>JOB POSTING</B>
</CENTER>
<B>
POSITION:</B>          Research Scientist IV - Grade 27
                   Salary: $56,631 ($33,978)  60% 
<B>
LOCATION:</B>          New York State Psychiatric Institute
                   Substance Abuse Research
<B>
DUTIES:</B>            The Biostatistician will provide biostatistical support to 
                   the Novel Medications Approaches for Substance Abuse 
                   Center.  He/she will consult with the various 
                   investigators participating in the center regarding 
                   statistical issues in the design and analysis of data 
                   including methodological issues such as selection of 
                   proper control groups, power analysis, etc.  The 
                   individual will be involved in data management, program 
                   development and analysis and write up of results. He/she 
                   will also obtain and evaluate new programs and 
                   methodologies for use in the center and will advise staff 
                   on their application.  He/she will provide at least three 
                   training sessions per year on applied statistical 
                   techniques and will meet every other week with the 
                   research team to discuss issues related to data management 
                   and analysis.  He/she will maintain a working relationship 
                   with the Director of the Department of Biostatistics who 
                   advises the Center.
<B>
EDUCATION:</B>         Ph.D. preferred with 2 years relevant experience, 
                   preferably in clinical research/substance abuse.

<B>TRAINING & </B>
<B>EXPERIENCE:</B>        At least 2 years relevant experience in an academic 
                   research environment preferebly working in a unit with 
                   multiple investigators.  Background in analysis of large 
                   data sets.  Background in substance abuse and medications 
                   trials helpful.

<B>SPECIAL</B>
<B>REQUIREMENTS:</B>       Must be able to work well within a large center serving a 
                   number of investigators.  Flexibility in approaches 
                   necessary to deal with the needs of varying studies.
<p>
<p>
Interested persons should respond, in writing, to the Research Foundation
Personnel office, NYS Psychiatric Institute, 722 West 168th Street, 
New York, NY 10032. For additional information call: 212-740-0012
An Affirmative Action/Equal Opportunity Employer.
<p>
<B>Posting ref.#: RF-97 0011/0120</B>
</pre>
</DOC>
<DOC>
<DOCNO>WT02-B10-244</DOCNO>
<DOCOLDNO>IA093-000995-B031-333</DOCOLDNO>
<DOCHDR>
http://www.nyspi.cpmc.columbia.edu:80/NYSPI/JOBS/RF970010.htm 156.111.80.30 19970121074126 text/html 2172
HTTP/1.0 200 OK
MIME-Version: 1.0
Server: GLACI/2.01
Date: Tue Jan 21 02:45:26 1997
Content-Type: text/html
Content-Length: 2042
</DOCHDR>
<html>
<BODY BACKGROUND="/IMAGES/MARBLE.JPG">
<CENTER>
<H3>RESEARCH FOUNDATION FOR MENTAL HYGIENE, Inc.</H3>
<B>New York State Psychiatric Institute Division</B><BR>
<B>722 West 168th Street, New York, NY 10032<BR></B>
<B>Ph: (212)-960-5801    Fax: (212)-740-5329<BR></B></CENTER>
<pre>
                                                       January 14, 1997
<CENTER>
<B>JOB POSTING</B>
</CENTER>
<B>
POSITION:</B>          Research Scientist I or II - Grade 18-22
                   Salary: $35,237-$48,556 ($21,142-$48,556) 60%-100% + $768 Location Pay
                   Depending on education, experience and availability
<B>
LOCATION:</B>          New York State Psychiatric Institute
                   CHILD PSYCHIATRY
<B>
DUTIES:</B>            Measurement projects in Child Psychiatry.  
                   Responsibilities: coordinating research projects, grant 
                   preparation, budget management, training on diagnostic 
                   interviews, preparing training materials and curricula, 
                   revising and writing diagnostic assessments.  Tasks:
                   1)budget management; 2)help on DISC algorithms; 3)training
                   materials; 4)training; 5)kiddie SADS.
<B>
EDUCATION:</B>         Master's or Doctorate in mental health field preferred.

<B>TRAINING & </B>
<B>EXPERIENCE:</B>        Experience in child/adolescent mental health preferred.  
                   Salary commensurate with experience.

<B>SPECIAL</B>
<B>REQUIREMENTS:</B>       Must be experienced in diagnostic interviews and have good 
                   communication and writing skills.  Driver's license 
                   preferred.
<p>
<p>
Interested persons should respond, in writing, to the Research Foundation
Personnel office, NYS Psychiatric Institute, 722 West 168th Street, 
New York, NY 10032. For additional information call: 212-960-2357
An Affirmative Action/Equal Opportunity Employer.
<p>
<B>Posting ref.#: RF-97 0010/0120</B>
</pre>
</DOC>
<DOC>
<DOCNO>WT02-B10-245</DOCNO>
<DOCOLDNO>IA093-000995-B031-368</DOCOLDNO>
<DOCHDR>
http://www.nyspi.cpmc.columbia.edu:80/NYSPI/JOBS/RF970012.htm 156.111.80.30 19970121074156 text/html 1892
HTTP/1.0 200 OK
MIME-Version: 1.0
Server: GLACI/2.01
Date: Tue Jan 21 02:46:02 1997
Content-Type: text/html
Content-Length: 1762
</DOCHDR>
<html>
<BODY BACKGROUND="/IMAGES/MARBLE.JPG">
<CENTER>
<H3>RESEARCH FOUNDATION FOR MENTAL HYGIENE, Inc.</H3>
<B>New York State Psychiatric Institute Division</B><BR>
<B>722 West 168th Street, New York, NY 10032<BR></B>
<B>Ph: (212)-960-5801    Fax: (212)-740-5329<BR></B></CENTER>
<pre>
                                                       January 16, 1997
<CENTER>
<B>JOB POSTING</B>
</CENTER>
<B>
POSITION:</B>          Research Assistant VI - Grade 12
                   Salary: $25,109-$30,080 + $768 Location Pay
                   Depending on education and experience
<B>
LOCATION:</B>          New York State Psychiatric Institute
                   Psychobiology
<B>
DUTIES:</B>            The incumbent will be responsible for the tracking and 
                   cleaning of data, review of subject charts.  Other duties 
                   will include photocopying research materials.  He/she will 
                   assist Dr. Susser in the daily administrative management 
                   of the project and will be responsible for coordinating 
                   all meetings and travel arrangements when necessary.
<B>
EDUCATION:</B>         Bachelor's degree or a minimum of two years experience in 
                   management field.

<B>TRAINING & </B>
<B>EXPERIENCE:</B>        Computer skills, word processing, database, spreadsheets, 
                   Epi-Info, E-mail.
<p>
<p>
Interested persons should respond, in writing, to the Research Foundation
Personnel office, NYS Psychiatric Institute, 722 West 168th Street, 
New York, NY 10032. For additional information call: 212-960-5505
An Affirmative Action/Equal Opportunity Employer.
<p>
<B>Posting ref.#: RF-97 0012/0122</B>
</pre>
</DOC>
<DOC>
<DOCNO>WT02-B10-246</DOCNO>
<DOCOLDNO>IA093-000995-B031-94</DOCOLDNO>
<DOCHDR>
http://www.nyspi.cpmc.columbia.edu:80/NYSPI/JOBS/RF960157.htm 156.111.80.30 19970121073817 text/html 1849
HTTP/1.0 200 OK
MIME-Version: 1.0
Server: GLACI/2.01
Date: Tue Jan 21 02:42:25 1997
Content-Type: text/html
Content-Length: 1719
</DOCHDR>
<html>
Two consecutive operators (rfwwprf : 38)
<CENTER>
<H3>RESEARCH FOUNDATION FOR MENTAL HYGIENE, Inc.</H3>
<B>New York State Psychiatric Institute Division</B><BR>
<B>722 West 168th Street, New York, NY 10032<BR></B>
<B>Ph: (212)-960-5801    Fax: (212)-740-5329<BR></B></CENTER>
<pre>
                                                       November 18, 1996
<CENTER>
<B>JOB POSTING</B>
</CENTER>
<B>
POSITION:</B>          Research Scientist III - Grade 25
                   Salary: $50,975 ($15,292)  30% 
<B>
LOCATION:</B>          New York State Psychiatric Institute
                   EPIDEMIOLOGY OF MENTAL DISORDERS
<B>
DUTIES:</B>            Data analyst position requiring structual equation 
                   modeling, testing growth curve models, and retrospective 
                   bias models.
                   
<B>
EDUCATION:</B>         Bachelor's degree and four years of professional research 
                   experience in the appropriate field; or a master's degree 
                   and three years of such experience; or a doctorate in the 
                   appropriate field and one year of such experience.

<B>TRAINING & </B>
<B>EXPERIENCE:</B>        A record of publications in personality disorders.  
                   Extensive experience working on large data sets with 
                   multiple time points.
<p>
<p>
Interested persons should respond, in writing, to the Research Foundation
Personnel office, NYS Psychiatric Institute, 722 West 168th Street, 
New York, NY 10032. For additional information call: 212-928-0631
An Affirmative Action/Equal Opportunity Employer.
<p>
<B>Posting ref.#: RF-96 0157/1122</B>
</pre>
</DOC>
<DOC>
<DOCNO>WT02-B10-247</DOCNO>
<DOCOLDNO>IA093-000995-B031-70</DOCOLDNO>
<DOCHDR>
http://www.nyspi.cpmc.columbia.edu:80/NYSPI/JOBS/RF960140.htm 156.111.80.30 19970121073753 text/html 1806
HTTP/1.0 200 OK
MIME-Version: 1.0
Server: GLACI/2.01
Date: Tue Jan 21 02:41:59 1997
Content-Type: text/html
Content-Length: 1676
</DOCHDR>
<html>
Two consecutive operators (rfwwprf : 38)
<CENTER>
<H3>RESEARCH FOUNDATION FOR MENTAL HYGIENE, Inc.</H3>
<B>New York State Psychiatric Institute Division</B><BR>
<B>722 West 168th Street, New York, NY 10032<BR></B>
<B>Ph: (212)-960-5801    Fax: (212)-740-5329<BR></B></CENTER>
<pre>
                                                       September 27, 1996
<CENTER>
<B>JOB POSTING</B>
</CENTER>
<B>
POSITION:</B>          Research Assistant III - Grade 7
                   Salary: $18,946-$23,086 ($4,736-$5,771)  25% 
                   Depending on education and experience
<B>
LOCATION:</B>          Albany
                   EPIDEMIOLOGY-MENTAL DISORDERS
<B>
DUTIES:</B>            This position is available at our Albany field office.  It 
                   entails assisting the field coordinator in supervision of 
                   field sampling, enumeration, and recruitment; maintaining 
                   records of project expenditures; and managing fax 
                   communications and xeroxing duties.
<B>
EDUCATION:</B>         High school graduate.  Some college preferable.

<B>TRAINING & </B>
<B>EXPERIENCE:</B>        Experience with wordperfect 5.1 or 6.0; general office 
                   experience.

<B>SPECIAL</B>
<B>REQUIREMENTS:</B>       Resides in or near Albany area.
<p>
<p>
Interested persons should respond, in writing, to the Research Foundation
Personnel office, NYS Psychiatric Institute, 722 West 168th Street, 
New York, NY 10032. For additional information call: 212-740-1460
An Affirmative Action/Equal Opportunity Employer.
<p>
<B>Posting ref.#: RF-96 0140/1003</B>
</pre>
</DOC>
<DOC>
<DOCNO>WT02-B10-248</DOCNO>
<DOCOLDNO>IA093-000995-B031-37</DOCOLDNO>
<DOCHDR>
http://www.nyspi.cpmc.columbia.edu:80/NYSPI/JOBS/RF960098.htm 156.111.80.30 19970121073727 text/html 2101
HTTP/1.0 200 OK
MIME-Version: 1.0
Server: GLACI/2.01
Date: Tue Jan 21 02:41:34 1997
Content-Type: text/html
Content-Length: 1971
</DOCHDR>
<html>
<body>
<CENTER>
<H3>RESEARCH FOUNDATION FOR MENTAL HYGIENE, Inc.</H3>
<B>New York State Psychiatric Institute Division</B><BR>
<B>722 West 168th Street, New York, NY 10032<BR></B>
<B>Ph: (212)-960-5801    Fax: (212)-740-5329<BR></B></CENTER>
<pre>
                                                       July 16, 1996
<CENTER>
<B>JOB POSTING</B>
</CENTER>
<B>
POSITION:</B>          Research Assistant V - Grade 11
                   Salary: $23,735 + $768 Location Pay
<B>
LOCATION:</B>          New York State Psychiatric Institute
                   MEDICAL GENETICS
<B>
DUTIES:</B>            Incumbent will be involved in molecular research to map 
                   human chromosome at high resolution.  Their primary duties 
                   will involve: DNA sequencing, polymer chain reaction 
                   amplification of DNA clones, development characterization 
                   of highly polymorphic PCR-based DNA marker for genetic 
                   mapping of chromosome, interpretation of DNA marker allele 
                   data, and execution of other related techniques such as 
                   southern blotting and phage amplification.  Performing 
                   other related duties necessary to the functioning of the 
                   lab, research project or work unit.
                   Ordering and maintaining lab supplies.
<B>
EDUCATION:</B>         B.S. degree in biology or related science, or equivalent 
                   in education, training and experience.

<B>TRAINING & </B>
<B>EXPERIENCE:</B>        PCR and recombinant DNA techniques.
<p>
<p>
Interested persons should respond, in writing, to the Research Foundation
Personnel office, NYS Psychiatric Institute, 722 West 168th Street, 
New York, NY 10032. For additional information call: 212-960-2347
An Affirmative Action/Equal Opportunity Employer.
<p>
<B>Posting ref.#: RF-96 0098/0722</B>
</pre>
</DOC>
<DOC>
<DOCNO>WT02-B10-249</DOCNO>
<DOCOLDNO>IA093-000995-B031-388</DOCOLDNO>
<DOCHDR>
http://www.nyspi.cpmc.columbia.edu:80/NYSPI/JOBS/RF970013.htm 156.111.80.30 19970121074211 text/html 2333
HTTP/1.0 200 OK
MIME-Version: 1.0
Server: GLACI/2.01
Date: Tue Jan 21 02:46:17 1997
Content-Type: text/html
Content-Length: 2203
</DOCHDR>
<html>
<BODY BACKGROUND="/IMAGES/MARBLE.JPG">
<CENTER>
<H3>RESEARCH FOUNDATION FOR MENTAL HYGIENE, Inc.</H3>
<B>New York State Psychiatric Institute Division</B><BR>
<B>722 West 168th Street, New York, NY 10032<BR></B>
<B>Ph: (212)-960-5801    Fax: (212)-740-5329<BR></B></CENTER>
<pre>
                                                       January 16, 1997
<CENTER>
<B>JOB POSTING</B>
</CENTER>
<B>
POSITION:</B>          Research Technician - Grade 16
                   Salary: $31,503 ($15,751)  50% 
<B>
LOCATION:</B>          New York State Psychiatric Institute
                   Child & Adolescent Psychiatry
<B>
DUTIES:</B>            Coordinate orders, distribution of materials, technical 
                   support of the DISC-IV.  Preparation and assembly of 
                   orders of the DISC-IV.  Develop and maintain databases of 
                   callers and types of services requested for technical 
                   support. Must be willing to receive and answer calls from 
                   9:00 a.m.to 10:00 p.m., work evening and weekends.  The 
                   incumbent will provide technical support for callers on the 
                   administration and programming of the computerized DISC.
<B>
EDUCATION:</B>         Master's degree in Business or Bachelor's degree with at 
                   least two years of experience, or equivalent in education, 
                   training and experience.

<B>TRAINING & </B>
<B>EXPERIENCE:</B>        Strong computer skills (IBM), particularly programming and 
                   database management.  Experience in business and 
                   administrative tasks.  Ability to work independently with 
                   very limited supervision. Expertise in the DISC.

<B>SPECIAL</B>
<B>REQUIREMENTS:</B>       Must have driver's license.
<p>
<p>
Interested persons should respond, in writing, to the Research Foundation
Personnel office, NYS Psychiatric Institute, 722 West 168th Street, 
New York, NY 10032. For additional information call: 212-960-2424
An Affirmative Action/Equal Opportunity Employer.
<p>
<B>Posting ref.#: RF-97 0013/0122</B>
</pre>
</DOC>
<DOC>
<DOCNO>WT02-B10-250</DOCNO>
<DOCOLDNO>IA093-000995-B031-418</DOCOLDNO>
<DOCHDR>
http://www.nyspi.cpmc.columbia.edu:80/NYSPI/JOBS/RF970015.htm 156.111.80.30 19970121074235 text/html 2326
HTTP/1.0 200 OK
MIME-Version: 1.0
Server: GLACI/2.01
Date: Tue Jan 21 02:46:41 1997
Content-Type: text/html
Content-Length: 2196
</DOCHDR>
<html>
<BODY BACKGROUND="/IMAGES/MARBLE.JPG">
<CENTER>
<H3>RESEARCH FOUNDATION FOR MENTAL HYGIENE, Inc.</H3>
<B>New York State Psychiatric Institute Division</B><BR>
<B>722 West 168th Street, New York, NY 10032<BR></B>
<B>Ph: (212)-960-5801    Fax: (212)-740-5329<BR></B></CENTER>
<pre>
                                                       January 16, 1997
<CENTER>
<B>JOB POSTING</B>
</CENTER>
<B>
POSITION:</B>          Programmer/Analyst - Grade 18
                   Salary: $35,237 ($17,618)  50% 
<B>
LOCATION:</B>          New York State Psychiatric Institute
                   Child & adolescent Psychiatry
<B>
DUTIES:</B>            Develop algorithm scoring programs for diagnostic 
                   interviews and other screening materials regarding 
                   psychiatric symptoms in children and adolescents.  
                   Preparation of algorithms for the DISC-IV.  Develop 
                   similar psychiatric screening questionnaires for children 
                   and adolescents.  Analyze and report on research data.  
                   Perform other related duties as assigned.
<B>
EDUCATION:</B>         Master's degree in Psychology, Epidemiology or 
                   Biostatistics or Bachelor's degree with at least two years 
                   of experience or equivalent in education, training and 
                   experience.

<B>TRAINING & </B>
<B>EXPERIENCE:</B>        Strong computer skills (IBM).  Experience with word 
                   processing, desktop publishing and database management.  
                   Experience in Programming and/or statistical analyses 
                   highly desirable.  Ability to work independently with 
                   limited supervision.

<B>SPECIAL</B>
<B>REQUIREMENTS:</B>       Must have SAS programming experience.
<p>
<p>
Interested persons should respond, in writing, to the Research Foundation
Personnel office, NYS Psychiatric Institute, 722 West 168th Street, 
New York, NY 10032. For additional information call: 212-960-2424
An Affirmative Action/Equal Opportunity Employer.
<p>
<B>Posting ref.#: RF-97 0015/0122</B>
</pre>
</DOC>
<DOC>
<DOCNO>WT02-B10-251</DOCNO>
<DOCOLDNO>IA093-000995-B031-311</DOCOLDNO>
<DOCHDR>
http://www.nyspi.cpmc.columbia.edu:80/NYSPI/JOBS/RF970009.htm 156.111.80.30 19970121074110 text/html 2487
HTTP/1.0 200 OK
MIME-Version: 1.0
Server: GLACI/2.01
Date: Tue Jan 21 02:45:18 1997
Content-Type: text/html
Content-Length: 2357
</DOCHDR>
<html>
<BODY BACKGROUND="/IMAGES/MARBLE.JPG">
<CENTER>
<H3>RESEARCH FOUNDATION FOR MENTAL HYGIENE, Inc.</H3>
<B>New York State Psychiatric Institute Division</B><BR>
<B>722 West 168th Street, New York, NY 10032<BR></B>
<B>Ph: (212)-960-5801    Fax: (212)-740-5329<BR></B></CENTER>
<pre>
                                                       January 14, 1997
<CENTER>
<B>JOB POSTING</B>
</CENTER>
<B>
POSITION:</B>          Research Assistant VII - Grade 13
                   Salary: $26,605 ($13,302)  50% 
<B>
LOCATION:</B>          New York State Psychiatric Institute
                   DIVISION OF SUBSTANCE ABUSE
<B>
DUTIES:</B>            Under the general supervision of the Principal 
                   Investigator and Research Technician, the assistant will: 
                   1)implement research studies described in funded grants as 
                   approved by the Institutional Review Board; 2)help 
                   coordinate protocols such as telephone interviews,
                   screening interviews, physicals and psychiatric 
                   interviews; 3)perform ECG's, draw blood samples, do urine 
                   screens and take vital signs; 4)maintain data base, help 
                   with data analyses and graphics; 5)monitor laboratory 
                   sessions; 6)maintain laboratory supplies and equipment.
<B>
EDUCATION:</B>         Bachelor's degree with emphasis on behavioral sciences.

<B>TRAINING & </B>
<B>EXPERIENCE:</B>        Some experience in a behavioral science laboratory and/or 
                   human subject research.  Data entry skills; experience 
                   with Macintosh computers preferred.

<B>SPECIAL</B>
<B>REQUIREMENTS:</B>       Must be well-organized and able to work with minimal 
                   supervision.  Must be meticulous in carrying out research 
                   protocols and enjoy working with human research subjects.  
                   Must be available some Saturdays.
<p>
<p>
Interested persons should respond, in writing, to the Research Foundation
Personnel office, NYS Psychiatric Institute, 722 West 168th Street, 
New York, NY 10032. For additional information call: 212-960-5895
An Affirmative Action/Equal Opportunity Employer.
<p>
<B>Posting ref.#: RF-97 0009/0120</B>
</pre>
</DOC>
<DOC>
<DOCNO>WT02-B10-252</DOCNO>
<DOCOLDNO>IA093-000995-B031-432</DOCOLDNO>
<DOCHDR>
http://www.nyspi.cpmc.columbia.edu:80/NYSPI/JOBS/RF970016.htm 156.111.80.30 19970121074242 text/html 2588
HTTP/1.0 200 OK
MIME-Version: 1.0
Server: GLACI/2.01
Date: Tue Jan 21 02:46:50 1997
Content-Type: text/html
Content-Length: 2458
</DOCHDR>
<html>
<BODY BACKGROUND="/IMAGES/MARBLE.JPG">
<CENTER>
<H3>RESEARCH FOUNDATION FOR MENTAL HYGIENE, Inc.</H3>
<B>New York State Psychiatric Institute Division</B><BR>
<B>722 West 168th Street, New York, NY 10032<BR></B>
<B>Ph: (212)-960-5801    Fax: (212)-740-5329<BR></B></CENTER>
<pre>
                                                       January 17, 1997
<CENTER>
<B>JOB POSTING</B>
</CENTER>
<B>
POSITION:</B>          Data Analyst - Grade 31
                   Salary: $69,688-$80,263 + $768 Location Pay
                   Depending on education and experience
<B>
LOCATION:</B>          New York State Psychiatric Institute
                   Child & Adolescent Psychiatry
<B>
DUTIES:</B>            The position involves research, development and testing of 
                   new computerized methods for the diagnosis of disorders in 
                   children and adolescents.  Direct complex project and 
                   supervise a small team of programmers developing a variety 
                   of Internet and Computer-based Interviewing projects.  
                   Developing new software using VB/C++/VB/Access.  
                   Development and implementation of Internet screening 
                   protocols and techniques.  Development and testing of 
                   stand-alone automated screening system.  Further 
                   development of computer-telephony based screening.
<B>
EDUCATION:</B>         B.S. and four years experience or M.S. and three years 
                   experience required.

<B>TRAINING & </B>
<B>EXPERIENCE:</B>        Three to five years experience required with proven track 
                   record in C, C++, Java, Visual Basic, HTML coding, and 
                   Client-server development.  Microsoft certification 
                   desirable.  Experience in WEB site construction.

<B>SPECIAL</B>
<B>REQUIREMENTS:</B>       Knowledge of setting up and maintaining complex WEB pages
                   containing sophisticated interactive multimedia and 
                   database functionality.
<p>
<p>
Interested persons should respond, in writing, to the Research Foundation
Personnel office, NYS Psychiatric Institute, 722 West 168th Street, 
New York, NY 10032. For additional information call: 212-960-2358
An Affirmative Action/Equal Opportunity Employer.
<p>
<B>Posting ref.#: RF-97 0016/0122</B>
</pre>
</DOC>
<DOC>
<DOCNO>WT02-B10-253</DOCNO>
<DOCOLDNO>IA093-000995-B031-57</DOCOLDNO>
<DOCHDR>
http://www.nyspi.cpmc.columbia.edu:80/NYSPI/JOBS/RF960101.htm 156.111.80.30 19970121073739 text/html 2064
HTTP/1.0 200 OK
MIME-Version: 1.0
Server: GLACI/2.01
Date: Tue Jan 21 02:41:45 1997
Content-Type: text/html
Content-Length: 1934
</DOCHDR>
<html>
<BODY BACKGROUND="/IMAGES/MARBLE.JPG">
<CENTER>
<H3>RESEARCH FOUNDATION FOR MENTAL HYGIENE, Inc.</H3>
<B>New York State Psychiatric Institute Division</B><BR>
<B>722 West 168th Street, New York, NY 10032<BR></B>
<B>Ph: (212)-960-5801    Fax: (212)-740-5329<BR></B></CENTER>
<pre>
                                                       July 18, 1996
<CENTER>
<B>JOB POSTING</B>
</CENTER>
<B>
POSITION:</B>          Programmer/Analyst I or II - Grade 18-21
                   Salary: $35,237-$43,667 ($17,618-$30,566) 50%-70% 
                   Depending on education, experience and availability
<B>
LOCATION:</B>          New York State Psychiatric Institute
                   ANXIETY DISORDERS CLINIC/THERAPEUTICS
<B>
DUTIES:</B>            Supervise data preparation process (e.g. data entry,
                   data editing), maintain and update tracking system,
                   miscellaneous administrative functions.  Supervise or
                   assist in supervising 10-station LAN running Novell
                   netware.
<B>
EDUCATION:</B>         BS and 2 years related experience or 4 years related 
                   experience.  MS preferred.

<B>TRAINING & </B>
<B>EXPERIENCE:</B>        Must have experience managing large databases.  Must have 
                   experience in SAS and FoxPro.  Experience managing PC 
                   networks helpful.  Biostatistics background helpful.

<B>SPECIAL</B>
<B>REQUIREMENTS:</B>       Must be detail-oriented.  Must be organized, careful and 
                   neat.
                   
<p>
<p>
Interested persons should respond, in writing, to the Research Foundation
Personnel office, NYS Psychiatric Institute, 722 West 168th Street, 
New York, NY 10032. For additional information call: 212-960-5602
An Affirmative Action/Equal Opportunity Employer.
<p>
<B>Posting ref.#: RF-96 0101/0724</B>
</pre>
</DOC>
<DOC>
<DOCNO>WT02-B10-254</DOCNO>
<DOCOLDNO>IA093-000995-B031-106</DOCOLDNO>
<DOCHDR>
http://www.nyspi.cpmc.columbia.edu:80/NYSPI/JOBS/RF960162.htm 156.111.80.30 19970121073826 text/html 1713
HTTP/1.0 200 OK
MIME-Version: 1.0
Server: GLACI/2.01
Date: Tue Jan 21 02:42:33 1997
Content-Type: text/html
Content-Length: 1583
</DOCHDR>
<html>
<BODY BACKGROUND="/IMAGES/MARBLE.JPG">
<CENTER>
<H3>RESEARCH FOUNDATION FOR MENTAL HYGIENE, Inc.</H3>
<B>New York State Psychiatric Institute Division</B><BR>
<B>722 West 168th Street, New York, NY 10032<BR></B>
<B>Ph: (212)-960-5801    Fax: (212)-740-5329<BR></B></CENTER>
<pre>
                                                       December 10, 1996
<CENTER>
<B>JOB POSTING</B>
</CENTER>
<B>
POSITION:</B>          Research Assistant VII - Grade 13
                   Salary: $26,605 ($19,953)  75% 
<B>
LOCATION:</B>          Albany
                   EPIDEMIOLOGY OF MENTAL DISORDERS
<B>
DUTIES:</B>            To assist field supervisor in sampling and data 
                   collection; editing protocols; and general office 
                   responsibilities.
                   
<B>
EDUCATION:</B>         Bachelor's degree preferred.
                   

<B>TRAINING & </B>
<B>EXPERIENCE:</B>        Experience working on large research project.  Minimum 
                   three years experience in Microsoft Windows and 
                   WordPerfect.

<B>SPECIAL</B>
<B>REQUIREMENTS:</B>       This is an Albany based position.  Candidate must live 
                   within commutable distance.
<p>
<p>
Interested persons should respond, in writing, to the Research Foundation
Personnel office, NYS Psychiatric Institute, 722 West 168th Street, 
New York, NY 10032. For additional information call: 212-740-1460
An Affirmative Action/Equal Opportunity Employer.
<p>
<B>Posting ref.#: RF-96 0162/1216</B>
</pre>
</DOC>
<DOC>
<DOCNO>WT02-B10-255</DOCNO>
<DOCOLDNO>IA093-000995-B031-285</DOCOLDNO>
<DOCHDR>
http://www.nyspi.cpmc.columbia.edu:80/NYSPI/JOBS/RF970007.htm 156.111.80.30 19970121074054 text/html 1565
HTTP/1.0 200 OK
MIME-Version: 1.0
Server: GLACI/2.01
Date: Tue Jan 21 02:45:01 1997
Content-Type: text/html
Content-Length: 1435
</DOCHDR>
<html>
<BODY BACKGROUND="/IMAGES/MARBLE.JPG">
<CENTER>
<H3>RESEARCH FOUNDATION FOR MENTAL HYGIENE, Inc.</H3>
<B>New York State Psychiatric Institute Division</B><BR>
<B>722 West 168th Street, New York, NY 10032<BR></B>
<B>Ph: (212)-960-5801    Fax: (212)-740-5329<BR></B></CENTER>
<pre>
                                                       January 14, 1997
<CENTER>
<B>JOB POSTING</B>
</CENTER>
<B>
POSITION:</B>          Research Assistant III - Grade 7
                   Salary: $18,946-$23,086 + $768 Location Pay
                   Depending on education and experience
<B>
LOCATION:</B>          New York State Psychiatric Institute
                   Neuroscience
<B>
DUTIES:</B>            This position entails the conduct of a variety of 
                   molecular biological methods including PCR, sequencing, 
                   Westerns, Northern, Southerns and in situ hybridization.
<B>
EDUCATION:</B>         Minimum BA/BS.

<B>TRAINING & </B>
<B>EXPERIENCE:</B>        Some experience in molecular biological laboratory assays 
                   preferable.
<p>
<p>
Interested persons should respond, in writing, to the Research Foundation
Personnel office, NYS Psychiatric Institute, 722 West 168th Street, 
New York, NY 10032. For additional information call: 212-960-5571
An Affirmative Action/Equal Opportunity Employer.
<p>
<B>Posting ref.#: RF-97 0007/0120</B>
</pre>
</DOC>
<DOC>
<DOCNO>WT02-B10-256</DOCNO>
<DOCOLDNO>IA093-000995-B031-203</DOCOLDNO>
<DOCHDR>
http://www.nyspi.cpmc.columbia.edu:80/NYSPI/JOBS/RF970003.htm 156.111.80.30 19970121073950 text/html 2444
HTTP/1.0 200 OK
MIME-Version: 1.0
Server: GLACI/2.01
Date: Tue Jan 21 02:43:57 1997
Content-Type: text/html
Content-Length: 2314
</DOCHDR>
<html>
<BODY BACKGROUND="/IMAGES/MARBLE.JPG">
<CENTER>
<H3>RESEARCH FOUNDATION FOR MENTAL HYGIENE, Inc.</H3>
<B>New York State Psychiatric Institute Division</B><BR>
<B>722 West 168th Street, New York, NY 10032<BR></B>
<B>Ph: (212)-960-5801    Fax: (212)-740-5329<BR></B></CENTER>
<pre>
                                                       January 06, 1997
<CENTER>
<B>JOB POSTING</B>
</CENTER>
<B>
POSITION:</B>          Research Assistant V - Grade 11
                   Salary: $23,735 + $768 Location Pay
<B>
LOCATION:</B>          New York State Psychiatric Institute
                   CHILD PSYCHIATRY
<B>
DUTIES:</B>            Research assistant needed to help with all aspects of a 
                   complex, multisite follow-up study of children with 
                   Attention-deficit hyperactivity disorder.  Duties include, 
                   but are not limited to, scheduling appointments; preparing 
                   and mailing data packets; logging in receipt of data 
                   forms; tracking missing forms from raters, parents and 
                   teachers; checking paper forms for completeness; accessing 
                   computer to run algorithms; reading questionnaires to 
                   children and parents during assessments; administering 
                   structured interviews to parents and children; 
                   administering computer assisted tasks to children; 
                   entering and organizing data.
<B>
EDUCATION:</B>         Bachelor's degree in psychology, education, child 
                   development or related field.

<B>TRAINING & </B>
<B>EXPERIENCE:</B>        Previous administrative experience.  Also, experience 
                   working with children.  Familiarity with personal computer,
                   work processing, spreadsheet and data base programs.

<B>SPECIAL</B>
<B>REQUIREMENTS:</B>       Evening and Saturday hours required.
<p>
<p>
Interested persons should respond, in writing, to the Research Foundation
Personnel office, NYS Psychiatric Institute, 722 West 168th Street, 
New York, NY 10032. For additional information call: 212-960-2554
An Affirmative Action/Equal Opportunity Employer.
<p>
<B>Posting ref.#: RF-97 0003/0110</B>
</pre>
</DOC>
<DOC>
<DOCNO>WT02-B10-257</DOCNO>
<DOCOLDNO>IA093-000995-B031-83</DOCOLDNO>
<DOCHDR>
http://www.nyspi.cpmc.columbia.edu:80/NYSPI/JOBS/RF960146.htm 156.111.80.30 19970121073807 text/html 2248
HTTP/1.0 200 OK
MIME-Version: 1.0
Server: GLACI/2.01
Date: Tue Jan 21 02:42:11 1997
Content-Type: text/html
Content-Length: 2118
</DOCHDR>
<html>
<BODY BACKGROUND="/IMAGES/MARBLE.JPG">
<CENTER>
<H3>RESEARCH FOUNDATION FOR MENTAL HYGIENE, Inc.</H3>
<B>New York State Psychiatric Institute Division</B><BR>
<B>722 West 168th Street, New York, NY 10032<BR></B>
<B>Ph: (212)-960-5801    Fax: (212)-740-5329<BR></B></CENTER>
<pre>
                                                       October 11, 1996
<CENTER>
<B>JOB POSTING</B>
</CENTER>
<B>
POSITION:</B>          Jr. Administrative Assistant - Grade 14
                   Salary: $28,170 + $768 Location Pay
<B>
LOCATION:</B>          New York State Psychiatric Institute
                   CHILD PSYCHIATRY
<B>
DUTIES:</B>            Incumbent will be responsible for administrative support 
                   for various studies of children with psychiatric 
                   disorders.  These duties include: organizing recruitment 
                   of new subjects; telephone screenings; greeting and 
                   orienting patients; building rapport with study families 
                   through regular correspondence and phone calls; 
                   administering structured telephone interviews; handling 
                   all aspects of scheduling including contacting families, 
                   staffing appointments and booking space; processing 
                   subject fee payments; paying bills; booking meetings; and 
                   taking minutes at staff meetings.
<B>
EDUCATION:</B>         Bachelor's degree in psychology, education or related 
                   field preferred.

<B>TRAINING & </B>
<B>EXPERIENCE:</B>        Previous administrative experience in psychiatric research 
                   required.  Incumbent must be familiar with word processing 
                   software.
<p>
<p>
Interested persons should respond, in writing, to the Research Foundation
Personnel office, NYS Psychiatric Institute, 722 West 168th Street, 
New York, NY 10032. For additional information call: 212-960-2554
An Affirmative Action/Equal Opportunity Employer.
<p>
<B>Posting ref.#: RF-96 0146/1018</B>
</pre>
</DOC>
<DOC>
<DOCNO>WT02-B10-258</DOCNO>
<DOCOLDNO>IA093-000995-B031-261</DOCOLDNO>
<DOCHDR>
http://www.nyspi.cpmc.columbia.edu:80/NYSPI/JOBS/RF970005.htm 156.111.80.30 19970121074038 text/html 2245
HTTP/1.0 200 OK
MIME-Version: 1.0
Server: GLACI/2.01
Date: Tue Jan 21 02:44:42 1997
Content-Type: text/html
Content-Length: 2115
</DOCHDR>
<html>
<BODY BACKGROUND="/IMAGES/MARBLE.JPG">
<CENTER>
<H3>RESEARCH FOUNDATION FOR MENTAL HYGIENE, Inc.</H3>
<B>New York State Psychiatric Institute Division</B><BR>
<B>722 West 168th Street, New York, NY 10032<BR></B>
<B>Ph: (212)-960-5801    Fax: (212)-740-5329<BR></B></CENTER>
<pre>
                                                       January 14, 1997
<CENTER>
<B>JOB POSTING</B>
</CENTER>
<B>
POSITION:</B>          Research Scientist I - Grade 18
                   Salary: $35,237 ($17,618)  50% 
<B>
LOCATION:</B>          New York State Psychiatric Institute
                   Therapeutics/Anxiety Disorders Clinic
<B>
DUTIES:</B>            Candidate will be responsible for screening all potential 
                   patients.  She/he will also be responsible for 
                   administering structured diagnostic interviews for all 
                   patients accepted into one of the anxiety clinic 
                   protocols.  The incumbent will also be conducting 
                   independent evaluations of patients enrolled in treatment 
                   studies.  Other duties, such as coordination and 
                   monitoring of ongoing clinical trials may be assigned as
                   needed.
<B>
EDUCATION:</B>         Bachelor's degree and 2 years of professional research 
                   experience in psychology, or a master's degree and 1 year 
                   of professional research experience.  Two years minimum of 
                   clinical experience preferred.

<B>TRAINING & </B>
<B>EXPERIENCE:</B>        Training in clinical assessment and structured clinical 
                   interviews.

<B>SPECIAL</B>
<B>REQUIREMENTS:</B>       Must be bilingual in English/Spanish.
<p>
<p>
Interested persons should respond, in writing, to the Research Foundation
Personnel office, NYS Psychiatric Institute, 722 West 168th Street, 
New York, NY 10032. For additional information call: 212-960-2427
An Affirmative Action/Equal Opportunity Employer.
<p>
<B>Posting ref.#: RF-97 0005/0120</B>
</pre>
</DOC>
<DOC>
<DOCNO>WT02-B10-259</DOCNO>
<DOCOLDNO>IA093-000995-B031-151</DOCOLDNO>
<DOCHDR>
http://www.nyspi.cpmc.columbia.edu:80/NYSPI/JOBS/RF960167.htm 156.111.80.30 19970121073858 text/html 2453
HTTP/1.0 200 OK
MIME-Version: 1.0
Server: GLACI/2.01
Date: Tue Jan 21 02:43:04 1997
Content-Type: text/html
Content-Length: 2323
</DOCHDR>
<html>
Two consecutive operators (rfwwprf : 38)
<CENTER>
<H3>RESEARCH FOUNDATION FOR MENTAL HYGIENE, Inc.</H3>
<B>New York State Psychiatric Institute Division</B><BR>
<B>722 West 168th Street, New York, NY 10032<BR></B>
<B>Ph: (212)-960-5801    Fax: (212)-740-5329<BR></B></CENTER>
<pre>
                                                       December 11, 1996
<CENTER>
<B>JOB POSTING</B>
</CENTER>
<B>
POSITION:</B>          Assistant Research Scientist - Grade 14
                   Salary: $28,170-$33,750 ($14,085-$33,750) 50%-100% + $768 Location Pay
                   Depending on education, experience and availability
<B>
LOCATION:</B>          New York State Psychiatric Institute
                   RESEARCH ASSESSMENT & TRAINING
<B>
DUTIES:</B>            TWO FULL-TIME POSITIONS & ONE PART-TIME POSITION AVAILABLE
                   Conduct follow-up interviews on large scale abuse 
                   psychiatric study using a semi-structured diagnostic 
                   interview. Responsibilities include: contacting and 
                   locating subjects at six month intervals, conducting
                   interviews in the community, writing detailed narratives, 
                   editing and correcting interview books and narratives,
                   attending weekly staff meetings. Other duties as assigned.
                   
<B>
EDUCATION:</B>         B.A. degree with related experience acceptable. M.A. 
                   degree in Psychology or related field preferred.

<B>TRAINING & </B>
<B>EXPERIENCE:</B>        Familiarity with DSM-IV, previous work with substance 
                   using population, demonstrated ability to located 
                   hard-to-follow subjects.

<B>SPECIAL</B>
<B>REQUIREMENTS:</B>       Current driver's license.  Willingness to interview 
                   subjects in a variety of settings and locations.  
                   Willingness to work evening and weekends.
<p>
<p>
Interested persons should respond, in writing, to the Research Foundation
Personnel office, NYS Psychiatric Institute, 722 West 168th Street, 
New York, NY 10032. For additional information call: 212-960-5529
An Affirmative Action/Equal Opportunity Employer.
<p>
<B>Posting ref.#: RF-96 0167/1217</B>
</pre>
</DOC>
<DOC>
<DOCNO>WT02-B10-260</DOCNO>
<DOCOLDNO>IA093-000995-B031-137</DOCOLDNO>
<DOCHDR>
http://www.nyspi.cpmc.columbia.edu:80/NYSPI/JOBS/RF960165.htm 156.111.80.30 19970121073846 text/html 1694
HTTP/1.0 200 OK
MIME-Version: 1.0
Server: GLACI/2.01
Date: Tue Jan 21 02:42:49 1997
Content-Type: text/html
Content-Length: 1564
</DOCHDR>
<html>
Two consecutive operators (rfwwprf : 38)
<CENTER>
<H3>RESEARCH FOUNDATION FOR MENTAL HYGIENE, Inc.</H3>
<B>New York State Psychiatric Institute Division</B><BR>
<B>722 West 168th Street, New York, NY 10032<BR></B>
<B>Ph: (212)-960-5801    Fax: (212)-740-5329<BR></B></CENTER>
<pre>
                                                       December 11, 1996
<CENTER>
<B>JOB POSTING</B>
</CENTER>
<B>
POSITION:</B>          Research Assistant IV - Grade 9
                   Salary: $21,182-$25,598 ($10,591-$12,799)  50% 
                   Depending on education and experience
<B>
LOCATION:</B>          New York State Psychiatric Institute
                   RESEARCH ASSESSMENT & TRAINING
<B>
DUTIES:</B>            Assist with the development of code books, revision of 
                   data cleaning programs and data tracking.  Review and 
                   edit diagnostic interviews, prepare interview books for 
                   data entry.  Other duties as assigned.
<B>
EDUCATION:</B>         B.A. degree in Psychology or related field.

<B>TRAINING & </B>
<B>EXPERIENCE:</B>        Computer competence; knowledge of Windows-based 
                   applications including WordPerfect.
<p>
<p>
Interested persons should respond, in writing, to the Research Foundation
Personnel office, NYS Psychiatric Institute, 722 West 168th Street, 
New York, NY 10032. For additional information call: 212-960-5529
An Affirmative Action/Equal Opportunity Employer.
<p>
<B>Posting ref.#: RF-96 0165/1217</B>
</pre>
</DOC>
<DOC>
<DOCNO>WT02-B10-261</DOCNO>
<DOCOLDNO>IA093-000995-B031-24</DOCOLDNO>
<DOCHDR>
http://www.nyspi.cpmc.columbia.edu:80/NYSPI/JOBS/RF960084.htm 156.111.80.30 19970121073717 text/html 2489
HTTP/1.0 200 OK
MIME-Version: 1.0
Server: GLACI/2.01
Date: Tue Jan 21 02:41:22 1997
Content-Type: text/html
Content-Length: 2359
</DOCHDR>
<html>
Two consecutive operators (rfwwprf : 38)
<CENTER>
<H3>RESEARCH FOUNDATION FOR MENTAL HYGIENE, Inc.</H3>
<B>New York State Psychiatric Institute Division</B><BR>
<B>722 West 168th Street, New York, NY 10032<BR></B>
<B>Ph: (212)-960-5801    Fax: (212)-740-5329<BR></B></CENTER>
<pre>
                                                       June 18, 1996
<CENTER>
<B>JOB POSTING</B>
</CENTER>
<B>
POSITION:</B>          Research Scientist III - Grade 25
                   Salary: $50,975 + $768 Location Pay
<B>
LOCATION:</B>          New York State Psychiatric Institute
                   CLINICAL AND GENETIC EPIDEMIOLOGY
<B>
DUTIES:</B>            Coordinate activities of the Genetic Epidemiology Core of 
                   a Center Grant.  Develop methodology for studies of 
                   childhood psychiatric disorders and conduct analyses of 
                   large epidemiologic studies of psychiatric disorders in 
                   children; provide assistance to other researchers engaged 
                   in genetic-epidemiologic studies; prepare manuscripts for 
                   publication; develop research grants for funding.  
                   Opportunity to develop independent research in related 
                   areas.
<B>
EDUCATION:</B>         BA and four years of professional research experience in 
                   the appropriate field; or a MA and three years of such 
                   experience; or a doctorate in the appropriate field and 
                   one year of such experience. Ph.D. in Epidemiology or 
                   other appropriate discipline preferred.

<B>TRAINING & </B>
<B>EXPERIENCE:</B>        Experience or training in epidemiology or genetic 
                   epidemiology and research or clinical experience in child 
                   psychopathology.

<B>SPECIAL</B>
<B>REQUIREMENTS:</B>       Prior experience in child psychiatric research; experience 
                   with large data sets.
<p>
<p>
Interested persons should respond, in writing, to the Research Foundation
Personnel office, NYS Psychiatric Institute, 722 West 168th Street, 
New York, NY 10032. For additional information call: 212-960-5880
An Affirmative Action/Equal Opportunity Employer.
<p>
<B>Posting ref.#: RF-96 0084/0624</B>
</pre>
</DOC>
<DOC>
<DOCNO>WT02-B10-262</DOCNO>
<DOCOLDNO>IA093-000995-B031-298</DOCOLDNO>
<DOCHDR>
http://www.nyspi.cpmc.columbia.edu:80/NYSPI/JOBS/RF970008.htm 156.111.80.30 19970121074102 text/html 2094
HTTP/1.0 200 OK
MIME-Version: 1.0
Server: GLACI/2.01
Date: Tue Jan 21 02:45:09 1997
Content-Type: text/html
Content-Length: 1964
</DOCHDR>
<html>
<BODY BACKGROUND="/IMAGES/MARBLE.JPG">
<CENTER>
<H3>RESEARCH FOUNDATION FOR MENTAL HYGIENE, Inc.</H3>
<B>New York State Psychiatric Institute Division</B><BR>
<B>722 West 168th Street, New York, NY 10032<BR></B>
<B>Ph: (212)-960-5801    Fax: (212)-740-5329<BR></B></CENTER>
<pre>
                                                       January 14, 1997
<CENTER>
<B>JOB POSTING</B>
</CENTER>
<B>
POSITION:</B>          Computer Support Technician - Grade 14
                   Salary: $28,170 + $768 Location Pay
<B>
LOCATION:</B>          New York State Psychiatric Institute
                   Information Systems
<B>
DUTIES:</B>            Duties include, but are not limited to: system 
                   installation and configuration; data recovery; 
                   installation of boards and peripherals; ordering of 
                   computer supplies; software installation; some data entry; 
                   training users in standard applications (i.e. Windows, 
                   WordPerfect, spreadsheet applications, basic HTML, basic 
                   e-mail); operate scanning equipment.  Work with help desk
                   application; other appropriate duties as assigned and 
                   required.
<B>
EDUCATION:</B>         Bachelor's degree preferred but not required.

<B>TRAINING & </B>
<B>EXPERIENCE:</B>        At least one year's experience in troubleshooting 
                   microcomputer hardware and software.

<B>SPECIAL</B>
<B>REQUIREMENTS:</B>       Ability to work well both independently and as a member
                   of a team.
<p>
<p>
Interested persons should respond, in writing, to the Research Foundation
Personnel office, NYS Psychiatric Institute, 722 West 168th Street, 
New York, NY 10032. For additional information call: 212-960-5782
An Affirmative Action/Equal Opportunity Employer.
<p>
<B>Posting ref.#: RF-97 0008/0120</B>
</pre>
</DOC>
<DOC>
<DOCNO>WT02-B10-263</DOCNO>
<DOCOLDNO>IA093-000995-B031-168</DOCOLDNO>
<DOCHDR>
http://www.nyspi.cpmc.columbia.edu:80/NYSPI/JOBS/RF960169.htm 156.111.80.30 19970121073918 text/html 3208
HTTP/1.0 200 OK
MIME-Version: 1.0
Server: GLACI/2.01
Date: Tue Jan 21 02:43:17 1997
Content-Type: text/html
Content-Length: 3078
</DOCHDR>
<html>
<BODY BACKGROUND="/IMAGES/MARBLE.JPG">
<CENTER>
<H3>RESEARCH FOUNDATION FOR MENTAL HYGIENE, Inc.</H3>
<B>New York State Psychiatric Institute Division</B><BR>
<B>722 West 168th Street, New York, NY 10032<BR></B>
<B>Ph: (212)-960-5801    Fax: (212)-740-5329<BR></B></CENTER>
<pre>
                                                       January 03, 1997
<CENTER>
<B>REVISED JOB POSTING</B>
</CENTER>
<B>
POSITION:</B>          Programmer Analyst/Data Manager - Grade 18
                   Salary: $35,237-$39,599 + $768 Location Pay
                   Depending on education and experience
<B>
LOCATION:</B>          New York State Psychiatric Institute
                   RFMH BUSINESS OFFICE 
<B>
DUTIES:</B>            TWO POSITIONS AVAILABLE
                   Assist in the development of a multi-application, 
                   multi-user, administrative management system using a 
                   relational database environment.  Reporting directly to 
                   the Management Systems Coordinator, the candidate will 
                   develop, enhance, debug and document new and existing 
                   applications.  The candidate will also assist in the 
                   running of various existing reports as required and 
                   develop ad-hoc reports on a moment's notice.  Duties  
                   also include assisting with network, software, 
                   communications, hardware and Intranet and Internet 
                   applications.
<B>
EDUCATION:</B>         B.S. in computer science with two years related experience 
                   or four years of related programming experience in 
                   KnowledgeMan by MDBS or similar database programming 
                   environment with expertise in MS-DOS and Windows.
                   

<B>TRAINING & </B>
<B>EXPERIENCE:</B>        Experience in various applications software (e.g., Access, 
                   Visual Basic) as well as communications software.  
                   Experience with Novell 3.12 network and WWW applications 
                   is also useful.
                   

<B>SPECIAL</B>
<B>REQUIREMENTS:</B>       Extensive knowledge of MS-DOS and Windows.  Ability to 
                   work quickly and effectively with or without supervision; 
                   ability to work well with different groups of people.  
                   Self-motivated with good oral and written communication 
                   skills.  Strong analytical and problem-solving skills.  
                   Ability to learn quickly and adapt to new software and 
                   hardware configurations and requirements.
                   
<p>
<p>
Interested persons should respond, in writing, to the Research Foundation
Personnel office, NYS Psychiatric Institute, 722 West 168th Street, 
New York, NY 10032. For additional information call: 212-960-5755
An Affirmative Action/Equal Opportunity Employer.
<p>
<B>Posting ref.#: RF-96 0169/1216</B>
</pre>
</DOC>
<DOC>
<DOCNO>WT02-B10-264</DOCNO>
<DOCOLDNO>IA093-000995-B031-271</DOCOLDNO>
<DOCHDR>
http://www.nyspi.cpmc.columbia.edu:80/NYSPI/JOBS/RF970006.htm 156.111.80.30 19970121074046 text/html 2703
HTTP/1.0 200 OK
MIME-Version: 1.0
Server: GLACI/2.01
Date: Tue Jan 21 02:44:54 1997
Content-Type: text/html
Content-Length: 2573
</DOCHDR>
<html>
<BODY BACKGROUND="/IMAGES/MARBLE.JPG">
<CENTER>
<H3>RESEARCH FOUNDATION FOR MENTAL HYGIENE, Inc.</H3>
<B>New York State Psychiatric Institute Division</B><BR>
<B>722 West 168th Street, New York, NY 10032<BR></B>
<B>Ph: (212)-960-5801    Fax: (212)-740-5329<BR></B></CENTER>
<pre>
                                                       January 14, 1997
<CENTER>
<B>JOB POSTING</B>
</CENTER>
<B>
POSITION:</B>          Research Scientist II - Grade 22
                   Salary: $43,470 ($21,735-$43,470)  50%-100% + $768 Location Pay
                   Depending on availability
<B>
LOCATION:</B>          New York State Psychiatric Institute
                   Therapeutics/Anxiety Disorders Clinic
<B>
DUTIES:</B>            The incumbent will be responsible for behavioral 
                   assessments of patients which include cognitive testing 
                   and administration of structured interviews. He/she will 
                   also be responsible for individual intensive behavior 
                   therapy treatment of patients - must be willing to travel 
                   to patients' homes for assessments, as well as to satellite 
                   clinic for treatment of off-site patients.
                   Candidate must also be able to spend 4 weeks in 
                   Philadelphia for supervison and reliability meetings.
                   Independent evaluations of other anxiety clinic patients 
                   will also be required.
<B>
EDUCATION:</B>         Bachelor's degree and 3 years of professional research 
                   experience in appropriate field; or a master's and 2 years 
                   experience; or a doctorate.

<B>TRAINING & </B>
<B>EXPERIENCE:</B>        Previous experience in anxiety disorders and structured 
                   clinical interviewing, as well as research experience 
                   preferred.  Prior training in behavior therapy also 
                   preferred.

<B>SPECIAL</B>
<B>REQUIREMENTS:</B>       Bilingual in English/Spanish a plus.  Must be flexible as
                   treatment hours are determined by patients availability.  
                   Weekends may be required.
<p>
<p>
Interested persons should respond, in writing, to the Research Foundation
Personnel office, NYS Psychiatric Institute, 722 West 168th Street, 
New York, NY 10032. For additional information call: 212-960-2427
An Affirmative Action/Equal Opportunity Employer.
<p>
<B>Posting ref.#: RF-97 0006/0120</B>
</pre>
</DOC>
<DOC>
<DOCNO>WT02-B10-265</DOCNO>
<DOCOLDNO>IA093-000995-B029-54</DOCOLDNO>
<DOCHDR>
http://www.nyspi.cpmc.columbia.edu:80/NYSPI/JOBS/JOBINDEX.HTM 156.111.80.30 19970121072300 text/html 3525
HTTP/1.0 200 OK
MIME-Version: 1.0
Server: GLACI/2.01
Date: Tue Jan 21 02:27:06 1997
Content-Type: text/html
Content-Length: 3395
</DOCHDR>
<html>
<head>
<title>RESEARCH FOUNDATION FOR MENTAL HYGIENE, Inc.</title>
</head>
<body>
<CENTER>
<H3>RESEARCH FOUNDATION FOR MENTAL HYGIENE, Inc.</H3>
<B>New York State Psychiatric Institute Division</B><BR>
<B>722 West 168th Street, New York, NY 10032<BR></B>
<B>Ph: (212)-960-5801    Fax: (212)-740-5329<BR></B></CENTER>
<p>
<CENTER>
<A><B>Job Opportunities as of January     17, 1997</B></A>
</CENTER>
<p>
<pre>
<B>Posting #      Title                                Grade  Date</B>
<p>
<B><A HREF="RF960084.htm">RF960084     Research Scientist III                  25     1996/06/18</A></B><BR>
<B><A HREF="RF960098.htm">RF960098     Research Assistant V                    11     1996/07/16</A></B><BR>
<B><A HREF="RF960101.htm">RF960101     Programmer/Analyst I or II              18-21  1996/07/18</A></B><BR>
<B><A HREF="RF960140.htm">RF960140     Research Assistant III                  7      1996/09/27</A></B><BR>
<B><A HREF="RF960146.htm">RF960146     Jr. Administrative Assistant            14     1996/10/11</A></B><BR>
<B><A HREF="RF960157.htm">RF960157     Research Scientist III                  25     1996/11/18</A></B><BR>
<B><A HREF="RF960162.htm">RF960162     Research Assistant VII                  13     1996/12/10</A></B><BR>
<B><A HREF="RF960164.htm">RF960164     Research Scientist II                   22     1996/12/10</A></B><BR>
<B><A HREF="RF960165.htm">RF960165     Research Assistant IV                   9      1996/12/11</A></B><BR>
<B><A HREF="RF960167.htm">RF960167     Assistant Research Scientist            14     1996/12/11</A></B><BR>
<B><A HREF="RF960169.htm">RF960169     Programmer Analyst/Data Manager         18     1997/01/03</A></B><BR>
<B><A HREF="RF970002.htm">RF970002     Research Assistant I                    3      1997/01/06</A></B><BR>
<B><A HREF="RF970003.htm">RF970003     Research Assistant V                    11     1997/01/06</A></B><BR>
<B><A HREF="RF970004.htm">RF970004     Jr Administrative Assistant             14     1997/01/13</A></B><BR>
<B><A HREF="RF970005.htm">RF970005     Research Scientist I                    18     1997/01/14</A></B><BR>
<B><A HREF="RF970006.htm">RF970006     Research Scientist II                   22     1997/01/14</A></B><BR>
<B><A HREF="RF970007.htm">RF970007     Research Assistant III                  7      1997/01/14</A></B><BR>
<B><A HREF="RF970008.htm">RF970008     Computer Support Technician             14     1997/01/14</A></B><BR>
<B><A HREF="RF970009.htm">RF970009     Research Assistant VII                  13     1997/01/14</A></B><BR>
<B><A HREF="RF970010.htm">RF970010     Research Scientist I or II              18-22  1997/01/14</A></B><BR>
<B><A HREF="RF970011.htm">RF970011     Research Scientist IV                   27     1997/01/14</A></B><BR>
<B><A HREF="RF970012.htm">RF970012     Research Assistant VI                   12     1997/01/16</A></B><BR>
<B><A HREF="RF970013.htm">RF970013     Research Technician                     16     1997/01/16</A></B><BR>
<B><A HREF="RF970014.htm">RF970014     Research Assistant II                   5      1997/01/16</A></B><BR>
<B><A HREF="RF970015.htm">RF970015     Programmer/Analyst                      18     1997/01/16</A></B><BR>
<B><A HREF="RF970016.htm">RF970016     Data Analyst                            31     1997/01/17</A></B><BR>
</pre>
</body>
</html>
</DOC>
<DOC>
<DOCNO>WT02-B10-266</DOCNO>
<DOCOLDNO>IA093-000995-B031-187</DOCOLDNO>
<DOCHDR>
http://www.nyspi.cpmc.columbia.edu:80/NYSPI/JOBS/RF970002.htm 156.111.80.30 19970121073940 text/html 1562
HTTP/1.0 200 OK
MIME-Version: 1.0
Server: GLACI/2.01
Date: Tue Jan 21 02:43:44 1997
Content-Type: text/html
Content-Length: 1432
</DOCHDR>
<html>
<BODY BACKGROUND="/IMAGES/MARBLE.JPG">
<CENTER>
<H3>RESEARCH FOUNDATION FOR MENTAL HYGIENE, Inc.</H3>
<B>New York State Psychiatric Institute Division</B><BR>
<B>722 West 168th Street, New York, NY 10032<BR></B>
<B>Ph: (212)-960-5801    Fax: (212)-740-5329<BR></B></CENTER>
<pre>
                                                       January 06, 1997
<CENTER>
<B>JOB POSTING</B>
</CENTER>
<B>
POSITION:</B>          Research Assistant I - Grade 3
                   Salary: $15,451 + $768 Location Pay
<B>
LOCATION:</B>          New York State Psychiatric Institute
                   NEUROBIOLOGY AND BEHAVIOR
<B>
DUTIES:</B>            Research assistant to aid in the development of 
                   transgenic and knockout mice, and in their behavioral 
                   testing.  Additional lab responsibilities and some library 
                   work will also be expected.
<B>
EDUCATION:</B>         BA/BS.

<B>TRAINING & </B>
<B>EXPERIENCE:</B>        Prior experience in molecular biology or animal behavior 
                   helpful but not required.
<p>
<p>
Interested persons should respond, in writing, to the Research Foundation
Personnel office, NYS Psychiatric Institute, 722 West 168th Street, 
New York, NY 10032. For additional information call: 212-960-5551
An Affirmative Action/Equal Opportunity Employer.
<p>
<B>Posting ref.#: RF-97 0002/0110</B>
</pre>
</DOC>
<DOC>
<DOCNO>WT02-B10-267</DOCNO>
<DOCOLDNO>IA093-000995-B031-242</DOCOLDNO>
<DOCHDR>
http://www.nyspi.cpmc.columbia.edu:80/NYSPI/JOBS/RF970004.htm 156.111.80.30 19970121074021 text/html 2269
HTTP/1.0 200 OK
MIME-Version: 1.0
Server: GLACI/2.01
Date: Tue Jan 21 02:44:06 1997
Content-Type: text/html
Content-Length: 2139
</DOCHDR>
<html>
<BODY BACKGROUND="/IMAGES/MARBLE.JPG">
<CENTER>
<H3>RESEARCH FOUNDATION FOR MENTAL HYGIENE, Inc.</H3>
<B>New York State Psychiatric Institute Division</B><BR>
<B>722 West 168th Street, New York, NY 10032<BR></B>
<B>Ph: (212)-960-5801    Fax: (212)-740-5329<BR></B></CENTER>
<pre>
                                                       January 13, 1997
<CENTER>
<B>JOB POSTING</B>
</CENTER>
<B>
POSITION:</B>          Jr Administrative Assistant - Grade 14
                   Salary: $28,170-$33,750 + $768 Location Pay
                   Depending on education and experience
<B>
LOCATION:</B>          New York State Psychiatric Institute
                   Administration
<B>
DUTIES:</B>            Reporting to the Deputy Director of Administration, the 
                   candidate will be responsible for providing general 
                   administrative support to him and his assistant including, 
                   but not limited to: preparing correspondence, answering 
                   telephones, scheduling meetings and appointments, updating 
                   institute's calendar information on the Internet; some 
                   secretarial and clerical duties as assigned by other 
                   senior personnel.  Other duties may be assigned as needed.
<B>
EDUCATION:</B>         Some college preferred, but not required.

<B>TRAINING & </B>
<B>EXPERIENCE:</B>        Minimum four years of relevant experience.  Familiarity 
                   with non-profit organizations and grantsmanship useful.

<B>SPECIAL</B>
<B>REQUIREMENTS:</B>       Excellent organizational and communication skills.  Must 
                   be proficient with WordPerfect and Lotus 1-2-3 and able to 
                   learn new programs as required.
<p>
<p>
Interested persons should respond, in writing, to the Research Foundation
Personnel office, NYS Psychiatric Institute, 722 West 168th Street, 
New York, NY 10032. For additional information call: 212-960-5801
An Affirmative Action/Equal Opportunity Employer.
<p>
<B>Posting ref.#: RF-97 0004/0120</B>
</pre>
</DOC>
<DOC>
<DOCNO>WT02-B10-268</DOCNO>
<DOCOLDNO>IA093-000995-B029-126</DOCOLDNO>
<DOCHDR>
http://www.nyspi.cpmc.columbia.edu:80/NYSPI/PHONE/nypidirk.HTM 156.111.80.30 19970121072432 text/html 494742
HTTP/1.0 200 OK
MIME-Version: 1.0
Server: GLACI/2.01
Date: Tue Jan 21 02:27:18 1997
Content-Type: text/html
Content-Length: 494610
</DOCHDR>
<HTML>
<HEAD>
<TITLE>
NYSPI Phone/EMail Directory
</TITLE>
</HEAD>
<BODY>
<BODY BACKGROUND="..\..\IMAGES\MARBLE.JPG">
<H1>NYSPI Phone/EMail Directory</H1>
<HR>
To Locate a Person in this directory use [Ctrl+F] or [Edit/Find] if your browser supports it.
<HR>
To request a correction or addition to this directory, please contact Carol Card at Ext.5801 or E-Mail to: <Address><A HREF= "mailto: ccard@rf1.cpmc.columbia.edu"> ccard@rf1.cpmc.columbia.edu</A></Address>
<HR>
<!-- The following table has been generated by the Internet Assistant Wizard for Microsoft Excel. You can find this add-in on "http://www.microsoft.com/msoffice/freestuf/msexcel/index.htm" -->
<!-- ------------------------- -->
<!-- START OF CONVERTED OUTPUT -->
<!-- ------------------------- -->
<!-- The following table has been generated by the Internet Assistant Wizard for Microsoft Excel. You can find this add-in on "http://www.microsoft.com/msoffice/freestuf/msexcel/index.htm" -->
<!-- ------------------------- -->
<!-- START OF CONVERTED OUTPUT -->
<!-- ------------------------- -->
<Table border>
<TR ALIGN="center" VALIGN="middle"><FONT FACE="Arial" SIZE=+2>
<TD BGCOLOR=#69FFFF><B>
NAME</B></TD>
<TD BGCOLOR=#69FFFF><B>
DEPARTMENT</B></TD>
<TD BGCOLOR=#69FFFF><B>
MAILBOX</B></TD>
<TD BGCOLOR=#69FFFF><B>
PHONE</B></TD>
<TD BGCOLOR=#69FFFF><B>
FAX</B></TD>
<TD BGCOLOR=#69FFFF><B>
EMAIL</B></TD>
</FONT></TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
LINDA ABBATE</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
THERAPEUTICS</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2380</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
JOHN ACITO</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NURSING</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
SIGURD ACKERMAN</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
PSYCHIATRY AFFILIATES</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ULLA ADAMO</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
MEDICAL GENETICS</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5660</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
PHILLIP ADAMS</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CLINICAL &amp; GEN EPID</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5699</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ELIZABETH ADORNO</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
BIOLOGICAL PSYCHIATRY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5855</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial">
Fax: 960-5854</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial">
adornol@nypsych.cpmc.columbia.edu</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
VITO AGOSTI</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
THERAPEUTICS</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5605</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
EDITH AGUILAR</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NURSING</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
GEARY AHERN</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
PSYCHIATRY AFFILIATES</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
IVETTE AHMED</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NURSING</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
JEANNIE AHN</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NEUROBIOLOGY AND BEHAVIOR</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CARMEN ALBALADEJO</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NEUROTOXICOLOGY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
DETRA ALLEN</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
EPIDEMIOLOGY OF MENTAL DISORDERS</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
JUDITH ALLEN</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
MEDICAL GENETICS</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CARLOS ALMEIDA</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
WASHINGTON HEIGHTS COMMUNITY SERV.</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
GRISELDA ALMONTE</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NEUROBIOLOGY AND BEHAVIOR</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ELIZABETH ALONSO</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
WASHINGTON HEIGHTS COMMUNITY SERV.</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
LUZ ALVARADO</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CHILD PSYCHIATRY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
KATHY AMADEO</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
THERAPEUTICS</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
XAVIER AMADOR</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CLINICAL PSYCHOBIOLOGY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2352</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
OLIVE AMOAHMENSAH</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NURSING</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
IVAN AMODT</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CLINICAL PSYCHOBIOLOGY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
DELVA AMORE</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NYS ADMINISTRATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2217</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
JEAN ANDERSON</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NURSING</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2392</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
KAREN ANDERSON</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
PSYCHIATRIC EDUCATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
MARTHA ANDERSON</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
THERAPEUTICS</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5786</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NORRIS ANDERSON</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NYS ADMINISTRATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
SAMUEL ANDERSON</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
COMMUNICATION SCIENCES</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5830 / 5828</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
JONNY ANDIA</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
HIV CTR CLIN. &amp; BEHAV. STUDIES</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
HOWARD ANDREWS</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
EPIDEMIOLOGY OF MENTAL DISORDERS</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5686</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
SHIRLEY ANDREWS</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NYS ADMINISTRATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
SATISH ANJILVEL</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NEUROSCIENCE</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
KATHY ANTONELLI</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
RESEARCH FOUNDATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2338</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial">
KANTONEL@rf1.cpmc.columbia.edu</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
VICTORIA ARANGO</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NEUROSCIENCE</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2488</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
JOSE ARAVENA</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NYS ADMINISTRATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
VICTOR ARKHIPOV</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NEUROSCIENCE</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5843</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
STAN ARKOW</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ADULT PSYCHIATRY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
JORGE ARMENTEROS</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CHILD PSYCHIATRY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2289 / 5584</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
THOMAS ARMISTEAD</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
PSYCHIATRIC EDUCATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CATHERINE ARMSTRONG</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NEUROSCIENCE</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
JUNE ARMUS</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
THERAPEUTICS</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5734</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
PHILIP ART</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NYS ADMINISTRATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
JAYNE ARZAPALO</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NURSING</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
EILEEN ASARNOW</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ADULT PSYCHIATRY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
BARBARA ASCHE</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CLINICAL PSYCHOLOGY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5592</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NICHOLAOS ASLANIS</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NYS ADMINISTRATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
GAYLE AUGENBAUM</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
PSYCHIATRIC EDUCATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
RICHARD AUSTIN</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
HIV CTR CLIN. &amp; BEHAV. STUDIES</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
FRED AVERICK</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
RESEARCH FOUNDATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5808</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial">
FAVERICK@rf1.cpmc.columbia.edu</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
JALILA AYBAR</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CHILD PSYCHIATRY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2288</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
RENEE AZIMA-HELLER</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NEUROSCIENCE</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2499</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
BONNIE BADENCHINI</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ADULT PSYCHIATRY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
PREETI BAGCHI</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ANALYTICAL PSYCHOPHARMACOLOGY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
EMILIA BAGIELLA</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
PRESBYTERIAN HOSP. LIASION SERVICE</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CRAIG BAILEY</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NEUROBIOLOGY AND BEHAVIOR</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2404</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ANTOINE BAILOUS</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NYS ADMINISTRATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5780</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ANTOINE BAILOUS</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NYS ADMINISTRATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
SAMUEL BAILUM</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NURSING</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
DAWN BAIRD</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
DIVISION OF SUBSTANCE ABUSE</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
MIHRAN BAKALIAN</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NEUROSCIENCE</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
POULABI BANERJEE</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
MEDICAL GENETICS</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
STEVEN BANKS</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CHILD PSYCHIATRY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CARMEN BANTON</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
EDUCATION AND TRAINING</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2536</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ALAN BARASCH</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
PSYCHIATRIC EDUCATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
AMIRAM BARKAI</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ANALYTICAL PSYCHOPHARMACOLOGY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2282 / 5557</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
BARBARA BARNETT</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
THERAPEUTICS</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
MIRON BARON</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
MEDICAL GENETICS</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5630</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
EVELYN BARONIAN</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CLINICAL PSYCHOPHARMACOLOGY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
GORDON BARR</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
DEVELOPMENTAL PSYCHOBIOLOGY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5709</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
VIRGINIA BARRETT</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CLINICAL PSYCHOBIOLOGY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
SUSAN BARROW</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
EPIDEMIOLOGY OF MENTAL DISORDERS</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
JOHN BARSA</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
PRESBYTERIAN HOSP. LIASION SERVICE</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
BALAPAL BASAVARJAPPA</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ANALYTICAL PSYCHOPHARMACOLOGY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
SUSAN BAUMES</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
MEDICAL GENETICS</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
FRANCIS BAXTER</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NYS ADMINISTRATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
KAREN BEARMAN</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CHILD PSYCHIATRY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
INA BECKER</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ADULT PSYCHIATRY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ELZBIETA BEDNAROWICZ</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
INSTITUTE ADMINISTRATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NATALIE BEEN</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
SOCIAL SERVICES</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2515</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
DEBORAH-AN BEETE</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
HIV CTR CLIN. &amp; BEHAV. STUDIES</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
MARIETTA BELL</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
MEDICAL GENETICS</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2477</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
MARIJANE BELL</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NURSING</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2477</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ROSE BENDER</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
RESEARCH ASSESSMENT &amp; TRAINING</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ALAN BERKMAN</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
HIV CTR CLIN. &amp; BEHAV. STUDIES</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
GENYA BERNSTEIN</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ADULT PSYCHIATRY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ABRAH BESSLER</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CLINICAL PSYCHOLOGY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
411</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
MARIA BETITA</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NURSING</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
PRABHA BETNE</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
HIV CTR CLIN. &amp; BEHAV. STUDIES</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CLAUDIA M. BIAL</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
INSTITUTE ADMINISTRATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2421</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
PETER BIGGINS</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NURSING</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CARINA BILICH</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CLINICAL PSYCHOPHARMACOLOGY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
HECTOR BIRD</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CHILD PSYCHIATRY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2591</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
VICTOR BISONO</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CU PSYCHIATRY ADMINISTRATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
JEROLD BLOCK</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
PSYCHIATRIC EDUCATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5545</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CARLA BLUMENTHAL</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
SOCIAL SERVICES</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2519</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
RICHARD BLUMENTHAL</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
RESEARCH ASSESSMENT &amp; TRAINING</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5683</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
MARIA BONALDO</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
MEDICAL GENETICS</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
STANLEY BONE</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
WASHINGTON HEIGHTS COMMUNITY SERV.</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2434</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
MARY BONGIOVI</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
WASHINGTON HEIGHTS COMMUNITY SERV.</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
PETER BOOKSTEIN</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
PSYCHIATRIC EDUCATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5643</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
SANDRA BORDEN</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
MEDICAL GENETICS</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5665</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ROUSSOUDAN BOURTCHOULADZE</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NEUROBIOLOGY AND BEHAVIOR</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CHARLES BOWEN</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NYS ADMINISTRATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5776</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
MARTHA BOYER</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NYS HUMAN RESOURCES</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2534 / 2234</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
RONALD BRADY</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
THERAPEUTICS</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ADRIENNE BRAITHWAITE</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
HIV CTR CLIN. &amp; BEHAV. STUDIES</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2353</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
STEPHEN BRAND</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
WASHINGTON HEIGHTS COMMUNITY SERV.</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
BETH BRODSKY</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NEUROSCIENCE</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5838</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
MONICA BROME</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NYS ADMINISTRATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ALAN BROWN</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CLINICAL PSYCHOBIOLOGY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CHARLES BROWN</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
MEDICAL GENETICS</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2524</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial">
Fax: 781-2661</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial">
brownch@nypsych.cpmc.columbia.edu</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
LUCINDA BROWN</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
HIV CTR CLIN. &amp; BEHAV. STUDIES</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
SUSAN BROWNE</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
THERAPEUTICS</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2442</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
GERARD BRUDER</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
BIOPSYCHOLOGY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2468</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial">
Fax: 795-5886</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial">
bruderg@nypsych.cpmc.columbia.edu</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
SUSAN BRUNELLI</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
DEVELOPMENTAL PSYCHOBIOLOGY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5710</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
DANIELA BRUNNER</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
BIOPSYCHOLOGY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2471</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
DEBRA BRYANT</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NURSING</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
OLESIA BUIAKOVA</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
MEDICAL GENETICS</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
RAGBIR BUNSEE</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NYS ADMINISTRATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
RUSSELL BURDEN</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NURSING</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
AINSLEY BURKE</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
RESEARCH ASSESSMENT &amp; TRAINING</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
BEVERLY BURKE-BLISS</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
HIV CTR CLIN. &amp; BEHAV. STUDIES</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
JOHN BURTON</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
PSYCHIATRIC EDUCATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5646</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
PAMELA BUTLER</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CLINICAL PSYCHOBIOLOGY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CARMEN CABRERA</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NURSING</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
JESUS CABRERA</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
THERAPEUTICS</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
LUCILA CABRERA</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NYS ADMINISTRATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5547</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
VICTOR CABRERA</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
COMPUTER CENTER</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5723</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
DENISE CALAPRICE</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CHILD PSYCHIATRY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
LORRAINE CALEV</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NURSING</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ANN CAMAC</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
PSYCHIATRIC EDUCATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CARL CAMPBELL</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NEUROSCIENCE</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5848 / 5564</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial">
campbell@neuron.cpmc.columbia.edu</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
RAPHAEL CAMPEAS</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
THERAPEUTICS</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2365</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
IAN CANINO</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CHILD PSYCHIATRY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2332</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
LOUIS CARABALLO</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CHILD PSYCHIATRY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ALEX CARBALLO-DIEGUEZ</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
HIV CTR CLIN. &amp; BEHAV. STUDIES</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2261</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
SUSAN CARDEN</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
DEVELOPMENTAL PSYCHOBIOLOGY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5706</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
DORA CARDENAS</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
WASHINGTON HEIGHTS COMMUNITY SERV.</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CARMEN CARDONA</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
WASHINGTON HEIGHTS COMMUNITY SERV.</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5662</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
JAMES CAREY</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
WASHINGTON HEIGHTS COMMUNITY SERV.</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
JANEL CARINO</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CLINICAL PSYCHOPHARMACOLOGY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5741</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
JODI CARLSON</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
OCCUPATIONAL THERAPY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2516</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
MARLENE CARLSON</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CLINICAL &amp; GEN EPID</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5678</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
JOHN CARTER</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NYS ADMINISTRATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
TODD CARTER</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
MEDICAL GENETICS</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2543</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
IVETTE CASANOVA</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
RESEARCH FOUNDATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5803</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial">
ICASANOV@rf1.cpmc.columbia.edu</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CAROL CATON</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ADULT PSYCHIATRY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
RENE CEPEDA</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NURSING</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
VERNESSA CEPHAS</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
RESEARCH ASSESSMENT &amp; TRAINING</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
FELIX CHALAS</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NYS ADMINISTRATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
IRENE CHALDARIS</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
RESEARCH ASSESSMENT &amp; TRAINING</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5509</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
WILLIAM CHAMBERS</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CHILD PSYCHIATRY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
BING CHAN</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NEUROTOXICOLOGY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2502</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
VICTORIA CHAN</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CHILD PSYCHIATRY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
FRANCE CHAPUT</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CHILD PSYCHIATRY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
604</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
EDWARD CHARLES</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ADULT PSYCHIATRY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CHUN CHEN</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NYS ADMINISTRATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
DONNA CHEN</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
PSYCHIATRIC EDUCATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5546</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
JIAYUN CHEN</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NEUROPATHOLOGY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
KEWEN CHEN</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CHILD PSYCHIATRY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
MARY CHEN</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NEUROBIOLOGY AND BEHAVIOR</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2404</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
JEFFREY CHENG</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
MEDICAL GENETICS</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2461</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial">
Fax: 781-2661</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial">
changje@nypsych.cpmc.columbia.edu</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
PO-HUANG CHIANG</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CHILD PSYCHIATRY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5598</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
TEAVER CHILES</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NYS ADMINISTRATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
SARAH CHURCH</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
RESEARCH ASSESSMENT &amp; TRAINING</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ANTONIO CIFUENTES</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
COMPARATIVE MEDICAL SCIENCE</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
SCOTT CLARK</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ADULT PSYCHIATRY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5816</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
W CLARK</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
BIOPSYCHOLOGY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2480</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
GEORGIA CLOSE</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
RESEARCH ASSESSMENT &amp; TRAINING</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
RONDA CLOUSE</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
HIV CTR CLIN. &amp; BEHAV. STUDIES</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2371</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
STEPHANIE COARD</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CHILD PSYCHIATRY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
SHEILA COFFEY</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
RESEARCH FOUNDATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5864</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial">
SCOFFEY@rf1.cpmc.columbia.edu</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
STEPHEN COFFEY</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
THERAPEUTICS</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2586</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
PATRICIA COHEN</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
EPIDEMIOLOGY OF MENTAL DISORDERS</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
DANIEL COLEMAN</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NEUROBIOLOGY AND BEHAVIOR</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
LILLIAN COLEMAN</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NURSING</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CAROL COLES</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NURSING</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ERIC COLLINS</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
DIVISION OF SUBSTANCE ABUSE</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
PAMELA COLLINS</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
PSYCHIATRIC EDUCATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
PAUL COLSON</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
HIV CTR CLIN. &amp; BEHAV. STUDIES</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
SANDRA COMER</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
DIVISION OF SUBSTANCE ABUSE</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
HEATHER CONKLIN</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
BIOLOGICAL PSYCHIATRY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2564</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial">
conklin@nypsych.cpmc.columbia.edu</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
PATRICIA CONNOLLY</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
HIV CTR CLIN. &amp; BEHAV. STUDIES</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2299</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
SARAH CONOVER</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
HIV CTR CLIN. &amp; BEHAV. STUDIES</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
EDUARDO CONSTANTINO</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ADULT PSYCHIATRY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ELENA CONTRERAS</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
DIVISION OF SUBSTANCE ABUSE</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
GEORGE CONTRERAS</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
HIV CTR CLIN. &amp; BEHAV. STUDIES</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
SIOBHAN COOMARASWAMY</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
WASHINGTON HEIGHTS COMMUNITY SERV.</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2482</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
BETTY COOPER</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
GENERAL CLINICAL RESEARCH SERVICES</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2223</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
JEREMY COPLAN</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CLINICAL PSYCHOBIOLOGY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2422</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
EVELYN CORA</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
PRESBYTERIAN HOSP. LIASION SERVICE</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ORLANDO CORDOVA</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
EPIDEMIOLOGY OF MENTAL DISORDERS</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
RUTH CORNROTH</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
QUALITY ASSURANCE</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CARMEN CORREA</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NURSING</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2391</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
KAREN A. CORT</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
THERAPEUTICS</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2307</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
JUANA COSTIGAN</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
PHARMACY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2491</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
FRANCINE COURNOS</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
WASHINGTON HEIGHTS COMMUNITY SERV.</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2412</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ERNEST COURTRIER</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NYS ADMINISTRATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
LIRIO COVEY</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CLINICAL PSYCHOPHARMACOLOGY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5736</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
PETER CROSS</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
GERIATRICS</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
BENNIE CROUCH</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NYS ADMINISTRATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
DIANA CROUCH</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NURSING</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2285</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ISABEL CRUZ</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NURSING</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
XIOMARA CRUZ</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NURSING</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
JULIE CUNJAK</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CLINICAL &amp; GEN EPID</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
JANIS CUTLER</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
MEDICAL GENETICS</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5556</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
YAEL CYCOWICZ</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
MEDICAL GENETICS</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2394</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial">
Fax: 781-2661</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial">
cycowic@nypsych.cpmc.columbia.edu</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
JOANNE D'AMATO</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
RESEARCH FOUNDATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5802</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
KAMNA DAS</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
MEDICAL GENETICS</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5624</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
RENEE DAVENPORT</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
EPIDEMIOLOGY OF BRAIN DISORDERS</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
VERNEICE DAVENPORT</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NYS ADMINISTRATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5774</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CARL DAVID</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NYS ADMINISTRATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
MARK DAVIES</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CHILD PSYCHIATRY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2291</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
SHARON DAVIES</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
THERAPEUTICS</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2416</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
LUZ DAVILA</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NURSING</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
JEMEL DE CHABERT</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
COMPARATIVE MEDICAL SCIENCE</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
MARYBETH DE JESUS</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
THERAPEUTICS</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
VICENTE DE JESUS</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CHILD PSYCHIATRY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
MANUEL DE LA NUEZ</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
THERAPEUTICS</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
MARIA DE PENA</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CLINICAL PSYCHOPHARMACOLOGY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
LARA DE SANTI</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CLINICAL PSYCHOBIOLOGY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
PATRICIA DE VONISH</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CHILD PSYCHIATRY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
SUSAN DEAKINS</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
PUBLIC PSYCHIATRY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CAROLINE DECASTRO</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NURSING</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
REBECCA DECHABERT</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NYS HUMAN RESOURCES</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5893</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ANDREW DEIESO</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NYS ADMINISTRATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
DAISY C DELGADO</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
THERAPEUTICS</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2306</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
DEBORAH DELIYANNIDES</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
THERAPEUTICS</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2342</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
LEPHENE DEOLUS</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NYS ADMINISTRATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
THOMAS DEUEL</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NEUROBIOLOGY AND BEHAVIOR</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
HELEN DEUTSCH</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NURSING</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
370</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
DEVANGERE DEVANAND</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
BIOLOGICAL PSYCHIATRY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5855</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
MICHAEL DEVLIN</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CLINICAL PSYCHOPHARMACOLOGY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5748</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
MARCELLA DEVOTO</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
MEDICAL GENETICS</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2482</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
SUZANNE DEWINDT</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NURSING</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
KIMBERLY DIAMOND</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
THERAPEUTICS</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ZELDA DIATLO</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
WASHINGTON HEIGHTS COMMUNITY SERV.</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
IRENE DIAZ</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NEUROSCIENCE</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
LEONOR DIAZ</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NURSING</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
GABRIEL DICHTER</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
BIOLOGICAL PSYCHIATRY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5614</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial">
Fax: 960-5854</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial">
dichter@nypsych.cpmc.columbia.edu</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
DORY DICKMAN</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CHILD PSYCHIATRY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
MAXIE DIGGS</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NYS ADMINISTRATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
JOHN DIVITTORIO</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NYS ADMINISTRATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
419</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
MARY-JO DOBBINS</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ADULT PSYCHIATRY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
BRUCE DOHRENWEND</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
SOCIAL PSYCHIATRY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CURTIS DOLEZAL</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
HIV CTR CLIN. &amp; BEHAV. STUDIES</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ANN DOLINSKY</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
PSYCHIATRIC EDUCATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
BOANERGES DOMINGUEZ</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ADULT PSYCHIATRY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
LOURDES DOMINGUEZ</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ADULT PSYCHIATRY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
EUNICE DONG</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
DIVISION OF SUBSTANCE ABUSE</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5707</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial">
dongeun@nypsych.cpmc.columbia.edu</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
DOROTHY DONNELLY</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CHILD PSYCHIATRY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5583</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
MICHAEL DONOVAN</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
DIVISION OF SUBSTANCE ABUSE</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
STEPHEN DONOVAN</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
THERAPEUTICS</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5768</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
RENEE DOOLITY</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NURSING</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
420</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial">
Fax: 960-5854</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial">
doolity@nypsych.cpmc.columbia.edu</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
GEORGE DOONEIEF</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
MEDICAL GENETICS</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2557</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CAROLYN DOUGLAS</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ADULT PSYCHIATRY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
MANUELA DOUGLASS</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NEUROSCIENCE</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
LEO DOWNES</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
INSTITUTE ADMINISTRATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2585</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
JENNIFER DOWNEY</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
RESEARCH ASSESSMENT &amp; TRAINING</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2297</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ERICA DRATT</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NURSING</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
MELISSA DUBROFF</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
PSYCHIATRIC EDUCATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5644</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
TERRY DUGAN</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
HIV CTR CLIN. &amp; BEHAV. STUDIES</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
EDWARD J. DUNNE</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
HIV CTR CLIN. &amp; BEHAV. STUDIES</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
MAUREEN DURKIN</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
EPIDEMIOLOGY OF BRAIN DISORDERS</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ANDREW DWORK</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NEUROPATHOLOGY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2271 / 5563</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
PAULA EAGLE</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ADULT PSYCHIATRY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CAROLINE EBANKS</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CLINICAL &amp; GEN EPID</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
RONALD EBRON</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NYS ADMINISTRATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
LISA ECKLUND-FLORES</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
DEVELOPMENTAL PSYCHOBIOLOGY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ANKE EHRHARDT</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
HIV CTR CLIN. &amp; BEHAV. STUDIES</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2432</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
MARGARET EISENSTADT</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NURSING</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
KWAME EL</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NURSING</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
INEZ ELLIOTT</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
DEVELOPMENTAL PSYCHOBIOLOGY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2393</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
MARY ELLIOTT</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NURSING</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
LANITA ELLIS</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NYS ADMINISTRATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5547</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
STEVEN ELLIS</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NEUROSCIENCE</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NOEMI ENCHAUTEGUI</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
HIV CTR CLIN. &amp; BEHAV. STUDIES</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
JEAN ENDICOTT</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
RESEARCH ASSESSMENT &amp; TRAINING</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5536</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
WILLIAM ENGLISH</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NURSING</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CHARLES ENTELIS</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
WASHINGTON HEIGHTS COMMUNITY SERV.</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
LINDA ERICKSON</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NURSING</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
L ERLENMEYERKIMLING</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
MEDICAL GENETICS</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5620</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
JOSE ESPINAL</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
COMPARATIVE MEDICAL SCIENCE</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CHRISTINE ESPOSITO-TORRES</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CHILD PSYCHIATRY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ALI ETEDALI</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
THERAPEUTICS</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
UNA EUROPE</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NURSING</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
KYLE EVANS</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NURSING</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2510</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
LAVERNE EVANS</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
SOCIAL SERVICES</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2229</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
SUZETTE EVANS</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
DIVISION OF SUBSTANCE ABUSE</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5895</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
THERESA EXNER</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
HIV CTR CLIN. &amp; BEHAV. STUDIES</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
MONICA FABIANI</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
MEDICAL GENETICS</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5669</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial">
Fax: 781-2661</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial">
fabiani@nypsych.cpmc.columbia.edu</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
JANET FAIRBANKS</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CHILD PSYCHIATRY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
STEPHEN FAIRHURST</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
BIOPSYCHOLOGY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
BRIAN FALLON</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
THERAPEUTICS</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2487</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
BRUCE FALZONE</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NYS ADMINISTRATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5687</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
BIN FAN</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CHILD PSYCHIATRY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
YUN FAN</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NEUROSCIENCE</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
SHEN JANG FANN</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
MEDICAL GENETICS</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
MIRA FEIN</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ANALYTICAL PSYCHOPHARMACOLOGY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5589</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
TOVAH FELDHAMMER</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ADULT PSYCHIATRY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
JUDITH FELDMAN</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CHILD PSYCHIATRY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2286</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
RICHARD FELDMAN</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CHILD PSYCHIATRY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2552</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ALINE FELTON</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
RESEARCH FOUNDATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5791</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial">
AFELTON@rf1.cpmc.columbia.edu</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
KENIA FERNANDEZ</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
HIV CTR CLIN. &amp; BEHAV. STUDIES</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
RONALD FIEVE</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
LITHIUM &amp; MANIC DEPRESSIVE STUDIES</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5882</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
WILLIAM FIFER</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
DEVELOPMENTAL PSYCHOBIOLOGY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5708 / 2467 / 5696</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
FRANCINE FINCH</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
EPIDEMIOLOGY OF MENTAL DISORDERS</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
MOLLY FINNERTY</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
PSYCHIATRIC EDUCATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
MICHAEL FIRST</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
BIOMETRICS</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5531 / 5850</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
MARIAN FISCHMAN</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
DIVISION OF SUBSTANCE ABUSE</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
443</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
PRUDENCE FISHER</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CHILD PSYCHIATRY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2357</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
AVRIM FISHKIND</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
PSYCHIATRIC EDUCATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
RISA FISHMAN</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
PSYCHIATRIC EDUCATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5548</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
MARGARET FITZGERALD-MALON</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
PSYCHIATRIC EDUCATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5517</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
MARGRET FITZGERALD-MALONE</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
DIVISION OF SUBSTANCE ABUSE</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5517</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
LINDA FITZSIMONS</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NURSING</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5622</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial">
Fax: 960-5854</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial">
fitzman@nypsych.cpmc.columbia.edu</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
SUSANNE FLATER</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NURSING</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
JAMES FLAX</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
PSYCHIATRY AFFILIATES</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
LEE FLEMING</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NYS ADMINISTRATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ALAN FLISHER</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CHILD PSYCHIATRY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
GARY FLOWERS</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NYS ADMINISTRATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
RICHARD FOLTIN</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
DIVISION OF SUBSTANCE ABUSE</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5570</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
MARA FOLZ</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
BIOLOGICAL PSYCHIATRY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
438</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial">
Fax: 960-5854</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial">
folzmar@nypsych.cpmc.columbia.edu</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
REGAN FONG</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
BIOPSYCHOLOGY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
685</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial">
fongreg@nypsych.cpmc.columbia.edu</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
JUDITH FORMAN</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CHILD PSYCHIATRY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2550</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
DIANA FORTI</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
THERAPEUTICS</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5500</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
LAUREN FREEDMAN</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
MEDICAL GENETICS</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2348</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
JANE FRIED</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CHILD PSYCHIATRY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5833</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CATHY FRIEDMAN</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ADULT PSYCHIATRY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
DAVID FRIEDMAN</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
MEDICAL GENETICS</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2476</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial">
Fax: 781-2661</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial">
friedma@nypsych.cpmc.columbia.edu</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
KARL FRITCH</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CLINICAL &amp; GEN EPID</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5840</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
RICHARD FROMAN</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
RESEARCH FOUNDATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5755</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial">
RFROMAN@rf1.cpmc.columbia.edu</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
VICTORIA FRYE</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
EPIDEMIOLOGY OF BRAIN DISORDERS</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5822</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
DINGYI FU</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NEUROSCIENCE</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
JESUS FUENTES</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NYS ADMINISTRATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
MINDY FULLILOVE</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
HIV CTR CLIN. &amp; BEHAV. STUDIES</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ROBERT FULLILOVE</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
HIV CTR CLIN. &amp; BEHAV. STUDIES</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ANTHONY FURBY</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NYS ADMINISTRATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ABBY FYER</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
THERAPEUTICS</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2362</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
HATTIE GAILLARD</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NURSING</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
PEGGY GALLAHER</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
EPIDEMIOLOGY OF MENTAL DISORDERS</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
SVETLANA GAPON</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NEUROBIOLOGY AND BEHAVIOR</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
WILLIAM GARCIA</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NYS ADMINISTRATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CLAUDIA GARCIA-LEEDS</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
HIV CTR CLIN. &amp; BEHAV. STUDIES</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ROBIN GARFINKEL</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
THERAPEUTICS</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2426</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
DINAH GAY</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
HIV CTR CLIN. &amp; BEHAV. STUDIES</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
DARON GELDWERT</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NEUROPATHOLOGY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
JANICE GELFAND</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ADULT PSYCHIATRY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
KELLY GEORGE</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CLINICAL PSYCHOLOGY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
JESSICA GERALD</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
THERAPEUTICS</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
MARK GERALD</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ADULT PSYCHIATRY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
SANA GHEITH</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CLINICAL PSYCHOBIOLOGY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CLAUDE GHEZ</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NEUROBIOLOGY AND BEHAVIOR</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2398</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
MARIA GHILARDI</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NEUROBIOLOGY AND BEHAVIOR</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
JOHN GIBBON</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
BIOPSYCHOLOGY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5716</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
MIRIAM GIBBON</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
BIOMETRICS</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5522</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
BETTE GIFFORD</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
OCCUPATIONAL THERAPY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
THOMAS GILLIAM</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
MEDICAL GENETICS</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5640</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
MILES GILLIOM</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
DEVELOPMENTAL PSYCHOBIOLOGY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
JAY GINGRICH</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
PSYCHIATRIC EDUCATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5553</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ALEXANDER GLASSMAN</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CLINICAL PSYCHOPHARMACOLOGY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5750</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
HILLARY R. GLICK</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NEUROSCIENCE</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2513</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NAOMI GLICKEN</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
SOCIAL SERVICES</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ELEANOR GLOMB</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
RESEARCH ASSESSMENT &amp; TRAINING</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
PATRICIA GLOSTER</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NURSING</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
SRILAKSHMI GNANASEKARAN</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
DEVELOPMENTAL PSYCHOBIOLOGY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
DEBORAH GOETZ</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
THERAPEUTICS</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5621</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
RAYMOND GOETZ</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
THERAPEUTICS</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2555</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ELAINE GOFF</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CLINICAL &amp; GEN EPID</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
KATHLEEN GOGGIN</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
THERAPEUTICS</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
MATTHEW GOLD</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
RECREATIONAL THERAPY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2240</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
KAREN GOLDBERG</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
SOCIAL SERVICES</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5658</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
JULI GOLDFEIN</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CLINICAL PSYCHOPHARMACOLOGY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2316</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
G GOLDIN</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
PSYCHIATRIC EDUCATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
HEATHER GOLDMAN</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CLINICAL &amp; GEN EPID</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5502</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
RISE GOLDSTEIN</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CLINICAL &amp; GEN EPID</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5849</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
MELINDA GONZALES</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CLINICAL PSYCHOLOGY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
DAVID GONZALEZ</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NYS ADMINISTRATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
318</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
MAGALY GONZALEZ</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NURSING</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
MONIKA GONZALEZ</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
COMPARATIVE MEDICAL SCIENCE</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
GREGORY GOODWIN</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
DEVELOPMENTAL PSYCHOBIOLOGY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
KIM GORE</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NYS ADMINISTRATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ETHAN GORENSTEIN</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
PRESBYTERIAN HOSP. LIASION SERVICE</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
KENNETH GORFINKLE</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
PRESBYTERIAN HOSP. LIASION SERVICE</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
HARALD GORING</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
MEDICAL GENETICS</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
JACK GORMAN</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CLINICAL PSYCHOBIOLOGY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2361 / 2503</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial">
Fax: 795-3538</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial">
gormanj@nypsych.cpmc.columbia.edu</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CHRISTOPHE GOTTSCHALK</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
DIVISION OF SUBSTANCE ABUSE</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
MADELYN GOULD</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CHILD PSYCHIATRY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2329</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
WANDA GRANT</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
HIV CTR CLIN. &amp; BEHAV. STUDIES</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2433</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
RUTH GRAVER</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
WASHINGTON HEIGHTS COMMUNITY SERV.</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
DIANE GRAY</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CHILD PSYCHIATRY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2549</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
SAMUEL GREEN</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
THERAPEUTICS</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5866</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
JUDY GREENE</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CHILD PSYCHIATRY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2424</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
BEVERLY GREENFIELD</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
GERIATRICS</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
LAURENCE GREENHILL</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CHILD PSYCHIATRY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2340</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
STEVEN GREENWALD</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CLINICAL &amp; GEN EPID</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2350</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
PAMELA GRIESLER</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CHILD PSYCHIATRY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
KENNETH GRIFFIN</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
HIV CTR CLIN. &amp; BEHAV. STUDIES</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
JENNYLIND GRIFFITHHUDSON</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NYS ADMINISTRATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
JANE H. GRUEN</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
RESEARCH FOUNDATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2323</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial">
JGRUEN@rf1.cpmc.columbia.edu</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
MICHAEL GRUNEBAUM</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
PSYCHIATRIC EDUCATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ADINA GRUNN</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
MEDICAL GENETICS</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NELSON GUERRERO</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
RESEARCH FOUNDATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5806</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial">
NGUERRER@rf1.cpmc.columbia.edu</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
BRIDGET GUGLICH</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NURSING</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
BARRY GURLAND</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
GERIATRICS</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ENNETTE GUZMAN</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
HIV CTR CLIN. &amp; BEHAV. STUDIES</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ELIZABETH HAASE</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
PSYCHIATRIC EDUCATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ANDREW HABERMAN</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
RESEARCH FOUNDATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2520</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial">
AHABERMA@rf1.cpmc.columbia.edu</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ANTONY HACKING</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NEUROBIOLOGY AND BEHAVIOR</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
FATEMEH HAGHIGHI</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
MEDICAL GENETICS</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CLAIRE HAIMAN</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CLINICAL PSYCHOPHARMACOLOGY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
MARGARET HANEY</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
DIVISION OF SUBSTANCE ABUSE</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
VANESSA HANEY</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
HIV CTR CLIN. &amp; BEHAV. STUDIES</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
JOSEPHINE HARBURY</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
PSYCHIATRIC EDUCATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5638</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
JILL HARKAVY FRIEDMAN</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
MEDICAL GENETICS</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
MARIA HAROOTIAN</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NYS ADMINISTRATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
KEITH HARPER</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
DIVISION OF SUBSTANCE ABUSE</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
GLORIA HARRINGTON</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
RESEARCH FOUNDATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2322</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial">
GHARRING@rf1.cpmc.columbia.edu</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
JOHN HARRISON</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
LIBRARY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5675</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
DEBORAH HASIN</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
RESEARCH ASSESSMENT &amp; TRAINING</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5518</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
JENNIFER HAVENS</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CHILD PSYCHIATRY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ROBERT HAWKINS</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NEUROBIOLOGY AND BEHAVIOR</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2244</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
DEBORAH HAYMAN</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
RESEARCH FOUNDATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5804</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial">
DHAYMAN@rf1.cpmc.columbia.edu</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
DELORES HEANEY</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CLINICAL PSYCHOPHARMACOLOGY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5751</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ASHOK HEGDE</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NEUROBIOLOGY AND BEHAVIOR</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
GARY HEIMAN</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CLINICAL &amp; GEN EPID</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5572</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
FREDRIC HELLMAN</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
EPIDEMIOLOGY OF MENTAL DISORDERS</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
BETH HELLSTERN</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
THERAPEUTICS</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
KAREN HENRY-WAIGHT</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CLINICAL &amp; GEN EPID</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
DANIEL HERMAN</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
EPIDEMIOLOGY OF MENTAL DISORDERS</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
PAUL HERMAN</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
RESEARCH ASSESSMENT &amp; TRAINING</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
RICHARD HERMAN</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
WASHINGTON HEIGHTS COMMUNITY SERV.</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2413</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
JOSE HERNANDEZ</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
THERAPEUTICS</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2367</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NOREEN HERNANDEZ</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
DEVELOPMENTAL PSYCHOBIOLOGY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5698</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
WILLIE HERRIOTT</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NYS ADMINISTRATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2210</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
BETTY HERSEY</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NEUROTOXICOLOGY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5565</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CARL HESSELBART</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CHILD PSYCHIATRY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2384</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
JOHN HICKEY</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CU PSYCHIATRY ADMINISTRATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
699</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
VERONICA HINTON</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
DEVELOPMENTAL PSYCHOBIOLOGY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
DAVID HO</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
EDUCATIONAL RESEARCH LAB</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
AVERY HODGE</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NURSING</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
MARY HODGE</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NURSING</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
SUSAN HODGE</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CLINICAL &amp; GEN EPID</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5606</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
MYRON HOFER</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
DEVELOPMENTAL PSYCHOBIOLOGY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5691</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
SUSIE HOFFMAN</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
HIV CTR CLIN. &amp; BEHAV. STUDIES</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
OHILDA HOLGUIN</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
HIV CTR CLIN. &amp; BEHAV. STUDIES</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
DOLORIS HOLMAN</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NURSING</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
BESSIE HORLBACK</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NURSING</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ANDREW HORNSTEIN</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
PSYCHIATRY AFFILIATES</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
EWALD HORWATH</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
WASHINGTON HEIGHTS COMMUNITY SERV.</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5635</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ZEF HOT</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NURSING</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CHRISTINA HOVEN</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CHILD PSYCHIATRY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2551 / 5689 / 5688</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
KATHLEEN HOWARD</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
DEVELOPMENTAL PSYCHOBIOLOGY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CHARITA HOYLE-PARR</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ADULT PSYCHIATRY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NANCY HSIUNG</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
RESEARCH ASSESSMENT &amp; TRAINING</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5517</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
SHU HSIUNG</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NEUROSCIENCE</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5834</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
YANYOU HUANG</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NEUROBIOLOGY AND BEHAVIOR</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
YUNGYU HUANG</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NEUROSCIENCE</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5844</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
LEON HUDGESON</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NYS ADMINISTRATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
SARAH HUDSON</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NURSING</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NANCY HULBROCK</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
EPIDEMIOLOGY OF MENTAL DISORDERS</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
TERESA HUMARAN</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
PSYCHIATRIC EDUCATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5538</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
BASALINGAP HUNGUND</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ANALYTICAL PSYCHOPHARMACOLOGY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
PAULA HUNT</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
QUALITY ASSURANCE</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5782</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
JOYCE HUNTER</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
HIV CTR CLIN. &amp; BEHAV. STUDIES</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
JOAN HUNTINGTON</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CHILD PSYCHIATRY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2346</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
RAMONA HURD</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NURSING</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
GERALD HUROWITZ</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ADULT PSYCHIATRY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ITAY HURVITZ</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NEUROBIOLOGY AND BEHAVIOR</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
DONALD HUTCHINGS</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
DEVELOPMENTAL PSYCHOBIOLOGY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5717</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
GISLAINE HUTTINOT</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ANALYTICAL PSYCHOPHARMACOLOGY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5579</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
STEVEN HYLER</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
WASHINGTON HEIGHTS COMMUNITY SERV.</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5656</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ROSALINDA IACOVITTI</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
RESEARCH ASSESSMENT &amp; TRAINING</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5511</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
KATHLEEN IBRAHIM</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NURSING</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CHRISTIE IERONIMO</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
DIVISION OF SUBSTANCE ABUSE</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
372</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial">
ieronim@nypsych.cpmc.columbia.edu</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
SETA IZMIRLY</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NEUROBIOLOGY AND BEHAVIOR</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
JOAN JACKSON</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CTR. PSYCHOANALYTIC TRNG. &amp; RSCH.</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
EXA JACOBS</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NYS ADMINISTRATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2218</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
JOSEPH JAFFE</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
COMMUNICATION SCIENCES</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5634</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
WILLIAM JAFFEE</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CLINICAL &amp; GEN EPID</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
MARGARET JAFFER</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NURSING</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ZACHARY JAMISON</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NURSING</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
MALVIN JANAL</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
BIOPSYCHOLOGY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2484 / 2483</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
BEATRIZ JARAMILLO</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
HIV CTR CLIN. &amp; BEHAV. STUDIES</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
RENEE JARVIS</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
RESEARCH ASSESSMENT &amp; TRAINING</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2270</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
JONATHAN JAVITCH</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NEUROPATHOLOGY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5573</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
PIERRE JELENC</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
MEDICAL GENETICS</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2315</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
KATHLEEN JENKINS</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
WASHINGTON HEIGHTS COMMUNITY SERV.</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
HERMAN JIMENEZ</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NURSING</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
LORENA JIMENEZ</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
RESEARCH FOUNDATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5721</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial">
LJIMENEZ@rf1.cpmc.columbia.edu</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
LUZ JIMINEZ</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
INSTITUTE ADMINISTRATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NANCY JOACHIM</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CHILD PSYCHIATRY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2227</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
JANET JOHNSON</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
PSYCHIATRIC EDUCATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2283</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
JEFFREY JOHNSON</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
THERAPEUTICS</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5523</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
THOMAS JOHNSON</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
INSTITUTE ADMINISTRATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2276 / 2277</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
VIRGINIA JOHNSON</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NEUROSCIENCE</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5836</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
BARBARA JONES</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NURSING</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
HAROLD JONES</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NYS ADMINISTRATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5547</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
JILLIANN JONES</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NURSING</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CAREN JORDAN</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CHILD PSYCHIATRY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
FANCHEA JORDAN</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
THERAPEUTICS</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2438</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
MYRA JOYCE</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
DEVELOPMENTAL PSYCHOBIOLOGY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
GREOGORY JULIEN</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NYS ADMINISTRATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
LUIS JURADO</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NYS ADMINISTRATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
BOUCHRA KABLY</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NEUROBIOLOGY AND BEHAVIOR</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CAROLINE KAHN</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CLINICAL PSYCHOBIOLOGY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5739</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
DAVID KAHN</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ADULT PSYCHIATRY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
DENISE KANDEL</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CHILD PSYCHIATRY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
MEG KAPLAN</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
SEXUAL BEHAVIOR CLINIC</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NICK KARABETSO</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NYS ADMINISTRATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
421</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
MARIA KARGMAN</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
WASHINGTON HEIGHTS COMMUNITY SERV.</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CHRYSOULA KASAPIS</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
THERAPEUTICS</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
STEPHANIE KASEN</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
EPIDEMIOLOGY OF MENTAL DISORDERS</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
BETTY JEAN KASS</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ADULT PSYCHIATRY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
FREDERIC KASS</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ADULT PSYCHIATRY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
SUHAM KASSIR</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NEUROSCIENCE</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2580</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
MARIA KASTORSKY</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NURSING</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
KATHY KAUFMAN</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
HIV CTR CLIN. &amp; BEHAV. STUDIES</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
SYBIL KAUFMAN</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
QUALITY ASSURANCE</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5513</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CHARLES KAUFMANN</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
MEDICAL GENETICS</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2211</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
RALF KAYSER</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
BIOPSYCHOLOGY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
LAWRENCE KEGELES</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
PSYCHIATRIC EDUCATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2497</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
JOHN KEILP</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
BRAIN IMAGING</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5866</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
JESSICA KEITLEN</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
DIVISION OF SUBSTANCE ABUSE</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
LISA KENTGEN</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CLINICAL PSYCHOLOGY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2337</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ROBERT KERTZNER</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
HIV CTR CLIN. &amp; BEHAV. STUDIES</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2439</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ALLA KERZHNER</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NEUROBIOLOGY AND BEHAVIOR</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2410</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CLARICE KESTENBAUM</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CHILD PSYCHIATRY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ALFIA KHAIBULLINA</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NEUROSCIENCE</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
VADIM KHAIT</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NEUROSCIENCE</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
SHAZAH KHAWAJA</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NYS ADMINISTRATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5542</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
KAREN KIESERMAN</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
GENERAL CLINICAL RESEARCH SERVICES</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ELOISE KILLEFFER</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
GERIATRICS</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
MIN KYUNG KIM</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
BIOLOGICAL PSYCHIATRY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
407</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial">
Fax: 960-5854</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial">
kimmink@nypsych.cpmc.columbia.edu</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
OLIVER KIMS</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NYS ADMINISTRATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ANN KINNEY</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
EPIDEMIOLOGY OF BRAIN DISORDERS</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5819</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
KENNETH KIRSCHNER</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NEUROBIOLOGY AND BEHAVIOR</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
TZIPORA KIRSCHNER</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CLINICAL PSYCHOBIOLOGY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
HARRY KISSILEFF</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
PSYCHIATRY AFFILIATES</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
Harry Kitt</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NURSING</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
JOHN KITTLE</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NURSING</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
HERBERT KLEBER</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
DIVISION OF SUBSTANCE ABUSE</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5570 / 5832</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
DONALD KLEIN</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
THERAPEUTICS</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
410</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
HILLARY KLEIN</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
PSYCHIATRIC EDUCATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
RACHEL KLEIN</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CLINICAL PSYCHOLOGY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2598</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
MARJORIE KLEINMAN</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CHILD PSYCHIATRY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
393</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
JENNIE KLINE</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
EPIDEMIOLOGY OF BRAIN DISORDERS</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5818</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ROBERT KLITZMAN</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
HIV CTR CLIN. &amp; BEHAV. STUDIES</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ANGELA KLOT</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
SOCIAL SERVICES</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ALGIE KNOWLES</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
RESEARCH FOUNDATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5805</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial">
AKNOWLES@rf1.cpmc.columbia.edu</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
JAMES KNOWLES</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
MEDICAL GENETICS</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5645</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
THERESA KOENIG</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
THERAPEUTICS</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5735</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
HILARY KOEPPEL</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
RESEARCH ASSESSMENT &amp; TRAINING</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
JOHN KOESTER</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NEUROBIOLOGY AND BEHAVIOR</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2239</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CYNTHIA KOLBOWSKI</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
SOCIAL SERVICES</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ALAN KONG</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CHILD PSYCHIATRY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
JIANXIANG KONG</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
THERAPEUTICS</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5767</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ANNA KORENOVSKY</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NEUROSCIENCE</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2509</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
DONALD KORNFELD</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
PRESBYTERIAN HOSP. LIASION SERVICE</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
KENNETH KOVAL</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ADULT PSYCHIATRY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
RACHELL KRAMER</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CHILD PSYCHIATRY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2415</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
THOMAS KRANJAC</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ADULT PSYCHIATRY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2559</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
DOLORES KREISMAN</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
PUBLIC RELATIONS OFFICE</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2420</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
JUDITH KRONENBERG</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CTR. PSYCHOANALYTIC TRNG. &amp; RSCH.</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
KATHRYN KRUEGER</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ADULT PSYCHIATRY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
RICHARD KRUEGER</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
WASHINGTON HEIGHTS COMMUNITY SERV.</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
JOHN KUHL</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
BIOPSYCHOLOGY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2354</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
IRVING KUPFERMANN</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NEUROBIOLOGY AND BEHAVIOR</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2397</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
STEFAN KURYLKO</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NEUROBIOLOGY AND BEHAVIOR</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2248</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial">
kurylko@nypsych.cpmc.columbia.edu</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
MARIA LA PADULA</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CLINICAL PSYCHOLOGY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
KAAREL LAEV</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CU PSYCHIATRY ADMINISTRATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
698</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CEDRIC LAKE</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NYS ADMINISTRATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
KIM LANDAU</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CHILD PSYCHIATRY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
DAVID LANE</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
LIBRARY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5672</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
DMITRI LARIN</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
MEDICAL GENETICS</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2478</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
MARIA LARINO</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CLINICAL PSYCHOPHARMACOLOGY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
EVELYN LAUFER</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
GENERAL CLINICAL RESEARCH SERVICES</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
LEE LAWTON</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
MEDICAL GENETICS</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
SUZANNE LEAL</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
MEDICAL GENETICS</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2504</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
GENEVA LEAVY</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CU PSYCHIATRY ADMINISTRATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2493</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
HELEN LEE</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
EPIDEMIOLOGY OF MENTAL DISORDERS</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
SAI LEE</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NEUROTOXICOLOGY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2430</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
SANDRA LEE</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NEUROTOXICOLOGY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
EVE LEEMAN</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
WASHINGTON HEIGHTS COMMUNITY SERV.</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
THOMAS LEHNER</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
MEDICAL GENETICS</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2428</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
PAUL LEITE</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
BIOPSYCHOLOGY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
359</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial">
leitepa@nypsych.cpmc.columbia.edu</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
STEPHANIE LEMELLE</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
PSYCHIATRIC EDUCATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
AMARILIS LENDOF</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
WASHINGTON HEIGHTS COMMUNITY SERV.</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
LYDIA LEON</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
HIV CTR CLIN. &amp; BEHAV. STUDIES</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
JON LEVENSON</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
PRESBYTERIAN HOSP. LIASION SERVICE</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
BRUCE LEVIN</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
EPIDEMIOLOGY OF BRAIN DISORDERS</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5822</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
FRANCES LEVIN</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
DIVISION OF SUBSTANCE ABUSE</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5896</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
LAURA LEVINE</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
MEDICAL GENETICS</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
PETROS LEVOUNIS</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
PSYCHIATRIC EDUCATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5611</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
STEPHANIE LEVY</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
BIOLOGICAL PSYCHIATRY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2556</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial">
Fax: 960-5854</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial">
levyste@nypsych.cpmc.columbia.edu</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
OWEN LEWIS</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CHILD PSYCHIATRY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2548</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
SHANNON LEWIS</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
DIVISION OF SUBSTANCE ABUSE</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
VICTORIA LEWIS</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NYS ADMINISTRATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2221</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
SHUHUA LI</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NEUROSCIENCE</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
SHUOFENG LI</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
RESEARCH FOUNDATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2409</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial">
SLI@rf1.cpmc.columbia.edu</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
WENTIAN LI</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
MEDICAL GENETICS</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2507</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
LIDIA LIDAGOSTER</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
PSYCHIATRIC EDUCATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
MICHAEL LIEBOWITZ</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
THERAPEUTICS</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2370</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
BARBARA LILLISTON</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
RESEARCH ASSESSMENT &amp; TRAINING</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5535</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
LING LIN</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NEUROPATHOLOGY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
SHU-HSING LIN</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
HIV CTR CLIN. &amp; BEHAV. STUDIES</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
BRUCE LINK</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
SOCIAL PSYCHIATRY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
JOSHUA LIPSITZ</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
THERAPEUTICS</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2417</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
SARAH LISANBY</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
PSYCHIATRIC EDUCATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
DONGMEI LIU</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
BRAIN IMAGING</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
JEVONS LIU</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NEUROTOXICOLOGY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
483</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
KUOPEING LIU</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NEUROSCIENCE</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5841</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
STANLEY LIU</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
EPIDEMIOLOGY OF BRAIN DISORDERS</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5823</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
XINHUA LIU</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CHILD PSYCHIATRY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2439</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
EE LO</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ANALYTICAL PSYCHOPHARMACOLOGY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5587</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
SALOME LOOSER OTT</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
MEDICAL GENETICS</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CHARLES LOPEZ</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NURSING</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2522</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
MARIA LOPEZ</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NURSING</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NICHOLAS LOPEZ</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NEUROSCIENCE</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5827</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
JUDITH LORIMER</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
MEDICAL GENETICS</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
JOELLEN LOTH</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
RESEARCH ASSESSMENT &amp; TRAINING</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5528</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ANDREW LOTTERMAN</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
PSYCHIATRIC EDUCATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
RODNEY LOUIS</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CU PSYCHIATRY ADMINISTRATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
DAVID LOWENTHAL</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
PSYCHIATRIC EDUCATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
BRUCE LUBER</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
BIOLOGICAL PSYCHIATRY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5737</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial">
Fax: 960-5854</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial">
luberbr@nypsych.cpmc.columbia.edu</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
AINSLEY LUCAS</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NYS ADMINISTRATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CHRIS LUCAS</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CHILD PSYCHIATRY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2358</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
RONALD LUCIANO</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CHILD PSYCHIATRY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
697</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
LISSETTE LUGO</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
DIVISION OF SUBSTANCE ABUSE</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ELLEN LUKENS</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
SOCIAL SERVICES</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2562</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
SIMONA LUMERMAN</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CLINICAL PSYCHOLOGY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CARLOS LUNA</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
BIOPSYCHOLOGY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
TERRE LUSBY</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NURSING</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2542</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
YUJU MA</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CHILD PSYCHIATRY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ROGER MAC KINNON</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CTR. PSYCHOANALYTIC TRNG. &amp; RSCH.</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CATHARINE MACLAREN</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CHILD PSYCHIATRY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
JILL MADDOX</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
BIOLOGICAL PSYCHIATRY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5614</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial">
Fax: 960-5854</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial">
maddoxj@nypsych.cpmc.columbia.edu</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
SHIRA MAGUEN</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
HIV CTR CLIN. &amp; BEHAV. STUDIES</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
EDWARD MAIELLO</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NYS ADMINISTRATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5778</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
DOLORES MALASPINA</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CLINICAL PSYCHOBIOLOGY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
RICHARD MALKIN</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
THERAPEUTICS</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2526</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
KEVIN MALONE</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NEUROSCIENCE</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5842</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
DIANE MANCUSO</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NURSING</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
DONALD MANDELL</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
EPIDEMIOLOGY OF MENTAL DISORDERS</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
JOSEPH MANN</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NEUROSCIENCE</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2429</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
SALVATORE MANNUZZA</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
THERAPEUTICS</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2260</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CATHERINE MARCHIANDO</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ADULT PSYCHIATRY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
LYNN MARCINKO</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CLINICAL PSYCHOBIOLOGY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ERIC MARCUS</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
PSYCHIATRIC EDUCATION-UNDERGRADUATE</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5552 / 5839</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
KAREN MARDER</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
INSTITUTE ADMINISTRATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
DAVID MARKS</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CHILD PSYCHIATRY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
DIEGO MARMOLEJO</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NYS ADMINISTRATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
RANDALL MARSHALL</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
PSYCHIATRIC EDUCATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2454</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
SHERRY MARSHALL</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NURSING</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
JACQUELINE MARTIN</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CHILD PSYCHIATRY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5585</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
JOHN MARTIN</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NEUROBIOLOGY AND BEHAVIOR</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2399</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ABIGAIL MARTINEZ</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
WASHINGTON HEIGHTS COMMUNITY SERV.</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
FRANCES MARTINEZ</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NURSING</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
JOSE M. MARTINEZ</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
THERAPEUTICS</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2443</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
JENNY MASMELA</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
DEVELOPMENTAL PSYCHOBIOLOGY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
SCOTT MASTERS</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
PSYCHIATRIC EDUCATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
TOMAS MATEO</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NYS ADMINISTRATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ZACHARIAH MATHAI</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NYS ADMINISTRATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
389</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
TARA COX MATISE</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
MEDICAL GENETICS</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
JUAN MATOS</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NYS ADMINISTRATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
DOLORES MATTHEWS</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
PSYCHIATRIC EDUCATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5553</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
LAUREL MAYER</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
PSYCHIATRIC EDUCATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ROBIN MAYER</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
BIOLOGICAL PSYCHIATRY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5615</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial">
Fax: 960-5854</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial">
mayesro@nypsych.cpmc.columbia.edu</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
RICHARD MAYEUX</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
BIOLOGICAL PSYCHIATRY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
KALA MAYUR</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
MEDICAL GENETICS</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
THERESA MAZZEO</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
THERAPEUTICS</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
KATHLEEN MC ALLISTER</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
RESEARCH FOUNDATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial">
KMCALLI@rf1.cpmc.columbia.edu</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
MAUREEN B. MC CABE</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
BIOMETRICS</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
STEVEN MC CLOUD</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
RESEARCH ASSESSMENT &amp; TRAINING</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
DAVID MC DOWELL</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
DIVISION OF SUBSTANCE ABUSE</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ANDREW MCEACHERN</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NYS ADMINISTRATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
HELEN MCGOWAN</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
INSTITUTE ADMINISTRATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2301</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial">
Fax: 781-1346</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial">
mcgowan@nypsych.cpmc.columbia.edu</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
PATRICK MCGRATH</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
THERAPEUTICS</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5764</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
KAREN MCKINNON</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
WASHINGTON HEIGHTS COMMUNITY SERV.</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2435 / 2414</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
JULIO MEDINA</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NEUROTOXICOLOGY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NOMSA MEINDL</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NURSING</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
J MELENDEZ</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NYS ADMINISTRATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
310</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CLAUDE ANN MELLINS</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
HIV CTR CLIN. &amp; BEHAV. STUDIES</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2263</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
LISA MELLMAN</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
PSYCHIATRIC EDUCATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5549</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
THOMAS MELORE</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
THERAPEUTICS</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
LAURA MELTON</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CHILD PSYCHIATRY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
WEI MENG</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NURSING</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
WILSON MERCADO</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ANALYTICAL PSYCHOPHARMACOLOGY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5577</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ELIZABETH MERRITT</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NURSING</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
HEINO MEYERBAHLBURG</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
HIV CTR CLIN. &amp; BEHAV. STUDIES</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
QUISQUEYA MEYRELES</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
SOCIAL SERVICES</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
MARCIA MICHAELSON</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NURSING</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2390</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial">
Michael@nypsych.cpmc.columbia.edu</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
GLORIA MIELE</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
RESEARCH ASSESSMENT &amp; TRAINING</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5534</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CHRISTINE MILLER</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
DIVISION OF SUBSTANCE ABUSE</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
LAURIE MILLER</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CHILD PSYCHIATRY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2343</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
LISA MILLER</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CHILD PSYCHIATRY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2548</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
SHANNON MILLER</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
DIVISION OF SUBSTANCE ABUSE</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5862</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
SUTHERLAND MILLER</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
HIV CTR CLIN. &amp; BEHAV. STUDIES</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
YVETTE MILLER</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NURSING</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
LANA MILLS</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
RESEARCH FOUNDATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5803</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
LUIS MINAYA</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
LIBRARY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5673</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ELIZABETH MIRABELLO</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ADULT PSYCHIATRY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
RICHARD MOCCIA</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NURSING</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
JAMES MOELLER</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
BIOLOGICAL PSYCHIATRY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5613</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ROBERT MONROE</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NYS ADMINISTRATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
KATHERINE MONTAGUE</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
MEDICAL GENETICS</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2507</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
SONIA MONTIEL-PEREZ</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CLINICAL PSYCHOBIOLOGY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
LYNN MONTZ</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
PSYCHIATRIC EDUCATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5541</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
BOBBA MOODY</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
BIOLOGICAL PSYCHIATRY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5647</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial">
Fax: 960-5854</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial">
moodyba@nypsych.cpmc.columbia.edu</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ETHEL MOORE</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NYS ADMINISTRATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ROBERT E. MOORE</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CHILD PSYCHIATRY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
VIRGINIA MORALES</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NYS ADMINISTRATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ANDREW MORAN</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CHILD PSYCHIATRY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
DONNA MOREAU</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CHILD PSYCHIATRY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2592</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ANGELA MORRIS</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NURSING</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
KRISTINE MORRISSEY</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
HIV CTR CLIN. &amp; BEHAV. STUDIES</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
KENNETH MORT</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
EPIDEMIOLOGY OF MENTAL DISORDERS</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
FRANK L. MUCHA</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
RESEARCH FOUNDATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5800</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial">
Fax: 740-5329</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial">
FMUCHA@rf1.cpmc.columbia.edu</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
LAURA MUFSON</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CLINICAL PSYCHOLOGY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5561</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ALI MUHAMMAD</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NURSING</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ELAINE MULLEN</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
OCCUPATIONAL THERAPY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
LINDA MULLEN</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
PSYCHIATRIC EDUCATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5623</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
BARBARA MULLER</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
HIV CTR CLIN. &amp; BEHAV. STUDIES</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
BIRMANIA MUNOZ</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
PSYCHIATRIC EDUCATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2582</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
MARGARITA MUNOZ</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
PSYCHIATRIC EDUCATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CHRISTINE MURRAY</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NURSING</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
GEORGE MUSA</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CHILD PSYCHIATRY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
PHILIP MUSKIN</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
PRESBYTERIAN HOSP. LIASION SERVICE</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
AUDREY MYERS</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NYS ADMINISTRATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5701</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
MICHAEL MYERS</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
DEVELOPMENTAL PSYCHOBIOLOGY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5697</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
DIANA NAFTAL</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
HIV CTR CLIN. &amp; BEHAV. STUDIES</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
EVA NAVRATIL</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
RESEARCH FOUNDATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
468</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
MARIA NAZARIO</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
WASHINGTON HEIGHTS COMMUNITY SERV.</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
JOHN NEE</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
RESEARCH ASSESSMENT &amp; TRAINING</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5514</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ELIZABETH NELSON</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NEUROSCIENCE</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2312</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
HENRY NELSON</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NEUROPATHOLOGY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
MAUREEN NELSON</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
INSTITUTE ADMINISTRATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2255 / 5560</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial">
Fax: 927-2372</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial">
nelsonm@nypsych.cpmc.columbia.edu</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
LOURDES NEUGART</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
WASHINGTON HEIGHTS COMMUNITY SERV.</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
RICHARD NEUGEBAUER</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
EPIDEMIOLOGY OF BRAIN DISORDERS</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ERIC NEWMAN</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NEUROPATHOLOGY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ANTHONY NG</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
PSYCHIATRIC EDUCATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
BARBARA NGENE</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
THERAPEUTICS</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5735</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
LUIS NIEVES-ROSA</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
HIV CTR CLIN. &amp; BEHAV. STUDIES</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ANCA NITESCU</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
COMPUTER CENTER</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
MITCHELL NOBLER</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
BIOLOGICAL PSYCHIATRY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5617</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
HANA NOVACENKO</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ANALYTICAL PSYCHOPHARMACOLOGY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5588</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
EDWARD NUNES</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
THERAPEUTICS</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5581</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ALTAGRACIA NUNEZ</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NEUROTOXICOLOGY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
LISA O'DONNELL</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
THERAPEUTICS</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
LUCIA O'SULLIVAN</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
HIV CTR CLIN. &amp; BEHAV. STUDIES</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
KATJA OCEPEKWELIKSON</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
THERAPEUTICS</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
PATRICIA OKRENT</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ADULT PSYCHIATRY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
JOHN OLDHAM</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
INSTITUTE ADMINISTRATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2300</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
MARK OLFSON</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CLINICAL &amp; GEN EPID</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2293</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
LEWIS OPLER</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ADULT PSYCHIATRY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
SARA OPPENHEIM</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NEUROSCIENCE</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5575</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
MARIA OQUENDO</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
WASHINGTON HEIGHTS COMMUNITY SERV.</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5636</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
LEON ORGAN</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NYS ADMINISTRATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
DAVID ORTIZ</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ANALYTICAL PSYCHOPHARMACOLOGY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2319</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
SANDRA ORTIZ</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
RESEARCH FOUNDATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5801</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial">
SORTIZ@rf1.cpmc.columbia.edu</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
MOHAMED OSMAN</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
COMPARATIVE MEDICAL SCIENCE</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2599</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
JURG OTT</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
MEDICAL GENETICS</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2504</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
KELVIN OTTLEY</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NYS ADMINISTRATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
RUTH OTTMAN</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
EPIDEMIOLOGY OF BRAIN DISORDERS</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
DORIS PABON</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NURSING</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
DIANE PAGANO</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
MEDICAL RECORDS</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
MERCEDES PAINE</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CHILD PSYCHIATRY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
TRINIDAD PALMIERY</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
THERAPEUTICS</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ATHENA PAPADAKOS</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CLINICAL &amp; GEN EPID</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
SKY PAPE</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
MEDICAL GENETICS</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2538</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
LASZLO PAPP</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
THERAPEUTICS</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2419</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
STEVEN PAPP</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
INSTITUTE ADMINISTRATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2400</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial">
Fax: 927-2372</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial">
spapp@rf1.cpmc.columbia.edu</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
HERBERT PARDES</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
INSTITUTE ADMINISTRATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
RADHAKRISH PAREPALLI</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
PHARMACY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2490</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
MICHAEL PARIDES</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CHILD PSYCHIATRY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
BRUCE PARSONS</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
THERAPEUTICS</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5846</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
DIPAK PATEL</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NEUROTOXICOLOGY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
VILAS PATEL</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NEUROTOXICOLOGY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
TIMOTHY PATTERSON</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
INSTITUTE ADMINISTRATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2310</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NATALYA PAYKINA</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NEUROSCIENCE</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
MARIA PAZ</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NYS ADMINISTRATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
TIMOTHY PEDLEY</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
INSTITUTE ADMINISTRATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
GRACIELA PENCHASZADEH</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
MEDICAL GENETICS</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2347</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
JOANNE PEREZ</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CHILD PSYCHIATRY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2344 / 2314</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
JOSEFINA PEREZ</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NYS ADMINISTRATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
JULIAN PEREZ</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
DIVISION OF SUBSTANCE ABUSE</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
442</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
MARTHA PEREZ</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
INSTITUTE ADMINISTRATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2401</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ZUNILDA PEREZ</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NYS ADMINISTRATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CYNTHIA PERRY</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ADULT PSYCHIATRY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5583</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
LUTRICIA PERRY</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CTR. PSYCHOANALYTIC TRNG. &amp; RSCH.</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
PAULINE PERRY</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NYS ADMINISTRATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2341</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
EMILY PETERS</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
THERAPEUTICS</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2372</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
EVA PETKOVA</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
INSTITUTE ADMINISTRATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5875</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
KONSTANTIN PETRUKHIN</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
MEDICAL GENETICS</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
SHOSHANA PEYSER</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
BIOLOGICAL PSYCHIATRY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5618</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial">
Fax: 960-5854</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial">
peysers@nypsych.cpmc.columbia.edu</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
RITA PEZZULLO</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NEUROTOXICOLOGY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
THUY PHAM</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
DIVISION OF SUBSTANCE ABUSE</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ARTHUR PIERRE-LOUIS</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
PSYCHIATRIC EDUCATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CHRISTINE PIERSON</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NEUROSCIENCE</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2440</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
DAVID PIERSON</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NEUROTOXICOLOGY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2430</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
KATHLEEN PIKE</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CLINICAL PSYCHOPHARMACOLOGY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5753</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
DANIEL PINE</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CHILD PSYCHIATRY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2389</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
JEFFREY PINES</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ADULT PSYCHIATRY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
JOHN PITTMAN</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
EPIDEMIOLOGY OF MENTAL DISORDERS</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
409</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
RACHEL POUSSON</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
EPIDEMIOLOGY OF MENTAL DISORDERS</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
BARBARA POWELL</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NURSING</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
LAURA PRENDERGAST</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NEUROBIOLOGY AND BEHAVIOR</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
VITO PRESTIGIACOMO</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
RESEARCH ASSESSMENT &amp; TRAINING</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5582</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ROSEMARIE PRICE</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CHILD PSYCHIATRY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CARMEN PRIETO</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
THERAPEUTICS</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
325</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
MARSHALL PRIMACK</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
AUTORADIOGRAPHY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
TYRONE PRINGLE</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NYS ADMINISTRATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
DAVID PRINTZ</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
PSYCHIATRIC EDUCATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2544</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
JOAN PRUDIC</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
BIOLOGICAL PSYCHIATRY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5616</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
AUREA PUPO</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
INSTITUTE ADMINISTRATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
385</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
LING QIU</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
MEDICAL GENETICS</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CAROL QUINN</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NURSING</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
FREDERIC QUITKIN</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
THERAPEUTICS</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5784</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
MICHAEL QUITTMAN</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
WASHINGTON HEIGHTS COMMUNITY SERV.</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
MARK RABINOVICH</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
RESEARCH FOUNDATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2528</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial">
MRABINOV@rf1.cpmc.columbia.edu</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ESTHER RABINOWICZ</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
PSYCHIATRIC EDUCATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2459</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
JUDITH RABKIN</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
THERAPEUTICS</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5762</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
RICHARD RABKIN</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
THERAPEUTICS</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5785</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
WILFRID RABY</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
PSYCHIATRIC EDUCATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ANDREW RACHKO</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NYS ADMINISTRATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2560</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CATHY RADUNS</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
PSYCHIATRIC EDUCATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5645</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
LINDA RAFFAELE</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CHILD PSYCHIATRY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
MASADUR RAHMAN</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
HIV CTR CLIN. &amp; BEHAV. STUDIES</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
JACQUELINE RAIA</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CHILD PSYCHIATRY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
JOHN RAINER</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
INSTITUTIONAL REVIEW BOARD</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5663</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
PAMELA RAIZMAN</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CLINICAL PSYCHOPHARMACOLOGY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5738</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
JEANNE RAM</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NYS ADMINISTRATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5702</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ALEX RAMIREZ</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
HIV CTR CLIN. &amp; BEHAV. STUDIES</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ANGEL RAMIREZ</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
DIVISION OF SUBSTANCE ABUSE</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
EDWARD RANDALL</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NEUROTOXICOLOGY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5565</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ULLA RANTA</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
MEDICAL GENETICS</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
JULES RANZ</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
PUBLIC PSYCHIATRY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5655</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
SANTHI RATAKONDA</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
PSYCHIATRIC EDUCATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
MARGARET RAVELO</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CLINICAL &amp; GEN EPID</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
STEPHEN RAYPORT</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NEUROPATHOLOGY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5641</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
MURIEL REEVES</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CLINICAL PSYCHOLOGY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2596</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NICOLE REGENT</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
DIVISION OF SUBSTANCE ABUSE</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5570</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
SHIRLEY S. REID</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NYS HUMAN RESOURCES</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2233</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
MARY REILLY</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NYS ADMINISTRATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ROBERT REMIEN</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
HIV CTR CLIN. &amp; BEHAV. STUDIES</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2375</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
LARRY REMMERS</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CU PSYCHIATRY ADMINISTRATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2303</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
KAREN REVESZ</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
THERAPEUTICS</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
AMADA REYES</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
SOCIAL SERVICES</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2254</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
PETER REYNOLDS</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
INSTITUTE ADMINISTRATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5740 / 5732</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
MADELINE RHUM</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
DIVISION OF SUBSTANCE ABUSE</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
DAWN RICE</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NURSING</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
JUSTIN RICHARDSON</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ADULT PSYCHIATRY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
VALERIE RICHMOND</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
RESEARCH ASSESSMENT &amp; TRAINING</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
RONALD RIEDER</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
PSYCHIATRIC EDUCATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5554</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CYNTHIA RIVERA</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NYS ADMINISTRATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2200</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
HERIBERTO RIVERA</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NURSING</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
MARIA RIVERA</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
HIV CTR CLIN. &amp; BEHAV. STUDIES</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
RENE RIVERA</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CU PSYCHIATRY ADMINISTRATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2566</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
DIANE RIZZO</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
THERAPEUTICS</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5622</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
SIMONE A. ROBERTS</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
MEDICAL GENETICS</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2537</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
JOYCELIN ROBINSON</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NYS ADMINISTRATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
BRENDA ROCHE</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
HIV CTR CLIN. &amp; BEHAV. STUDIES</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CLARENCE RODRIGUES</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
EPIDEMIOLOGY OF MENTAL DISORDERS</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
MIGUEL RODRIGUEZ</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NYS ADMINISTRATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5547</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
PETER RODRIGUEZ</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
COMPARATIVE MEDICAL SCIENCE</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5501</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
SANDY RODRIGUEZ</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
DIVISION OF SUBSTANCE ABUSE</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
JOSEPHINE RODRIQUEZ</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
DEVELOPMENTAL PSYCHOBIOLOGY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
RONALD RODRIQUEZ</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NURSING</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
DAVID ROEMER</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
PSYCHIATRIC EDUCATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5642</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
EDWARD ROHS</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
EPIDEMIOLOGY OF MENTAL DISORDERS</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ANDREA ROJAS</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
PRESBYTERIAN HOSP. LIASION SERVICE</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
LISSETH ROJAS</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CHILD PSYCHIATRY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
MARY ROJAS</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CLINICAL &amp; GEN EPID</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ANGELO ROMAN</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NYS ADMINISTRATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5780</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ELIZABETH ROOSE</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
SOCIAL SERVICES</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2257</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
STEVEN ROOSE</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CLINICAL PSYCHOPHARMACOLOGY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5749</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
MARGARET ROSARIO</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
HIV CTR CLIN. &amp; BEHAV. STUDIES</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ARLENE ROSE</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NYS HUMAN RESOURCES</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2373</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
STEVEN C. ROSEN</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NEUROBIOLOGY AND BEHAVIOR</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2238 / 5425 / 5654</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
WILMA G. ROSEN</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ADULT PSYCHIATRY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
IRA ROSENBLUM</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
WASHINGTON HEIGHTS COMMUNITY SERV.</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
SANDRA ROSENBLUM</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
EDUCATION AND TRAINING</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2533 / 2318</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
STEPHEN ROSENHECK</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
SOCIAL SERVICES</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5654</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
LYLE ROSNICK</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
GENERAL CLINICAL RESEARCH SERVICES</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2532</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
AMANDA ROSS</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CU PSYCHIATRY ADMINISTRATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5847</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
DONALD ROSS</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
COMPUTER CENTER</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5810</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
SUSAN ROTGARD</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
DEVELOPMENTAL PSYCHOBIOLOGY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5692</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
LAUREN ROTH</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
WASHINGTON HEIGHTS COMMUNITY SERV.</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
JAMI ROTHENBERG</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
THERAPEUTICS</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ERIC RUBIN</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ADULT PSYCHIATRY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
498</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
BORIS RUBINSTEIN</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CHILD PSYCHIATRY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CHARLIE RUFFIN</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NYS ADMINISTRATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CARLOS RUIZ</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ADULT PSYCHIATRY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CARLOS RUIZ</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NYS ADMINISTRATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ALAN RUNDQUIST</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NURSING</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
MARNI RUNYON</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
THERAPEUTICS</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5602</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
JAMES RYAN</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
EDUCATIONAL RESEARCH LAB</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2577</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
HAROLD SACKEIM</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
BIOLOGICAL PSYCHIATRY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5856</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
RAMDIAL SADHU</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NYS ADMINISTRATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
HELGA SAEZ</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
HIV CTR CLIN. &amp; BEHAV. STUDIES</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
DAVID SAGMAN</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
PSYCHIATRIC EDUCATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ROBERT SAINBURG</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NEUROBIOLOGY AND BEHAVIOR</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
RAFAEL SALAZAR</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
DIVISION OF SUBSTANCE ABUSE</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ESTER SALMAN-LEYVA</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
THERAPEUTICS</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
SUZANNE SALZINGER</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CHILD PSYCHIATRY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
SHARON SAMET</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
RESEARCH ASSESSMENT &amp; TRAINING</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5508</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
OLGA SAMPERIO</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NURSING</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ISABEL SANCHEZ</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
DIVISION OF SUBSTANCE ABUSE</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2309</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
J. ARTURO SANCHEZ-LACAY</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CHILD PSYCHIATRY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
LAWRENCE SANDERS</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NYS ADMINISTRATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
LOUIS SANTOS</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NYS ADMINISTRATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
PELLEGRINO SARTI</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
WASHINGTON HEIGHTS COMMUNITY SERV.</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
JAMES SATRIANO</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
WASHINGTON HEIGHTS COMMUNITY SERV.</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5591</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
SAMUEL SCHACHER</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NEUROBIOLOGY AND BEHAVIOR</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2292</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
SYBIL SCHACHT</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
RESEARCH ASSESSMENT &amp; TRAINING</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5527</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CHRISTINE SCHAFFRAN</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CHILD PSYCHIATRY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
JACQUELINE SCHATZ</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CLINICAL PSYCHOBIOLOGY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
DANIEL SCHECHTER</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
PSYCHIATRIC EDUCATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5530</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
DIANNE SCHECHTER</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
RESEARCH ASSESSMENT &amp; TRAINING</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5533</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ALBERT SCHLUECK</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NEUROTOXICOLOGY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
FRANKLIN SCHNEIER</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
THERAPEUTICS</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2368</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
KARL SCHROEDER</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
PSYCHIATRY AFFILIATES</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ANNA SCHWARTZ</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ADULT PSYCHIATRY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
JAMES SCHWARTZ</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NEUROBIOLOGY AND BEHAVIOR</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
484</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
MARY SCIUTTO</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ADULT PSYCHIATRY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
DAVID SEAL</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
HIV CTR CLIN. &amp; BEHAV. STUDIES</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
VELDA SEALY</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NYS ADMINISTRATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
MICHELE C. SEARS</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
RESEARCH ASSESSMENT &amp; TRAINING</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5512</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
JENNY SEHAM</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
DIVISION OF SUBSTANCE ABUSE</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
STUART SEIDMAN</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
PSYCHIATRIC EDUCATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5543</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
GRETCHEN SEIRMARCO</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NURSING</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2369</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
HAROLD SELIGSON</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NYS ADMINISTRATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5701</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ANNE SELLEW</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ADULT PSYCHIATRY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ANGELA SERACINI</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
DIVISION OF SUBSTANCE ABUSE</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5593</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
JOSE SERRANO</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NURSING</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
DAVID SHAFFER</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CHILD PSYCHIATRY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2545</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CHANDRESH SHAH</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
INSTITUTE ADMINISTRATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5734</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial">
Fax: 927-2372</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial">
shahcha@nypsych.cpmc.columbia.edu</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
HARRY SHAIR</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
DEVELOPMENTAL PSYCHOBIOLOGY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5695</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
LORRAINE SHANNON</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NURSING</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2452</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
BARBARA SHAPIRO</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
MEDICAL GENETICS</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2541</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
PETER SHAPIRO</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
PRESBYTERIAN HOSP. LIASION SERVICE</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
LAWRENCE SHARPE</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
RESEARCH ASSESSMENT &amp; TRAINING</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5526</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ELIZABETH SHEEHAN</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
RESEARCH ASSESSMENT &amp; TRAINING</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5511</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
LINDA SHERMAN</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
INSTITUTIONAL REVIEW BOARD</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5756</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
TERENCE SHERMAN</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CU PSYCHIATRY ADMINISTRATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
602</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
MAYA SHETREAT</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NEUROPATHOLOGY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
PRAMWATTIE SHIELDS</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NYS ADMINISTRATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
MARY SHULER</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NURSING</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
DIKOMA SHUNGU</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NEUROSCIENCE</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
PETER SIDI</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
THERAPEUTICS</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2377</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ADALBERTO SIERRA</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NYS ADMINISTRATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
JONATHAN SILVER</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ADULT PSYCHIATRY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
RACHEL SILVERMAN</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NEUROBIOLOGY AND BEHAVIOR</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
RONA SILVERTON</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
MEDICAL GENETICS</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5729</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
JOAO SILVESTRE</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
THERAPEUTICS</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5627</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ROBERT SIMMONS</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NYS ADMINISTRATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
437</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
MIMI Y. SIMON</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
MEDICAL GENETICS</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2475</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NAOMI SIMON</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
PSYCHIATRIC EDUCATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5516</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ROBERT SIMON</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
RESEARCH ASSESSMENT &amp; TRAINING</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5510</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
HELEN SIMPSON</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
PSYCHIATRIC EDUCATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ANDREW SINGER</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
PSYCHIATRIC EDUCATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5540</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
TARA SINGER</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
RESEARCH ASSESSMENT &amp; TRAINING</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
YVONNE SINGLETARY</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NURSING</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
MARY SINGLETON</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NYS HUMAN RESOURCES</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2232</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
PAMELA SKLAR</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NEUROBIOLOGY AND BEHAVIOR</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ANDREW SKODOL</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
SOCIAL PSYCHIATRY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ANNE SKOMOROWSKY</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
PSYCHIATRIC EDUCATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ANNE SKROBALA FOTINO</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CHILD PSYCHIATRY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
JONATHAN SLATER</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CHILD PSYCHIATRY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
MARK SLAVIN</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NYS ADMINISTRATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
RICHARD SLOAN</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
PRESBYTERIAN HOSP. LIASION SERVICE</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CHERYL SLOMKOWSKI</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
EPIDEMIOLOGY OF MENTAL DISORDERS</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ELIZABETH SMALL</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
INSTITUTIONAL REVIEW BOARD</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5758 / 5757</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
LAUREN SMITH</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CU PSYCHIATRY ADMINISTRATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2308</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
MELISSA SMITH</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
RESEARCH ASSESSMENT &amp; TRAINING</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5532</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
PATRICIA SMITH</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
RECREATIONAL THERAPY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2517</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
MICHAEL SMYTH</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NYS ADMINISTRATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
MARCELO SOARES</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
MEDICAL GENETICS</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CHRISTINA SOBIN</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
PSYCHIATRIC EDUCATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2274</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NEVADA SOLANO</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NURSING</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
VERONIKA SOLT</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ADULT PSYCHIATRY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
DORENE SOO-HOO</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
DEVELOPMENTAL PSYCHOBIOLOGY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
GLORIA SOTO</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
EPIDEMIOLOGY OF MENTAL DISORDERS</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CHRISTINA SPANO</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
THERAPEUTICS</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ALAN SPATAFORE</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NURSING</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
SANDY SPEIER</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
SOCIAL SERVICES</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2251</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
WILLIAM SPENCER</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NURSING</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
SHEILA SPENCER\BORDEN</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
BIOPSYCHOLOGY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2473</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
MARGARET SPINELLI</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CLINICAL &amp; GEN EPID</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5860</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ROBERT SPITZER</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
BIOMETRICS</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5520</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
JAN SPYK</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NYS ADMINISTRATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ELIZABETH SQUIRES-WHEELER</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
MEDICAL GENETICS</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
BARBARA STANLEY</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NEUROSCIENCE</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2518</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
JAMES STAUB</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NEUROSCIENCE</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
DEBORAH STEDGESTROUD</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NURSING</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ZENA STEIN</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
EPIDEMIOLOGY OF BRAIN DISORDERS</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5812</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
YAAKOV STERN</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
HIV CTR CLIN. &amp; BEHAV. STUDIES</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ALLISON STERNLICHT</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CLINICAL PSYCHOBIOLOGY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
FAY STETNER</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CLINICAL PSYCHOPHARMACOLOGY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2505</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ELLEN STEVENSON</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ADULT PSYCHIATRY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CONNIE STEWART</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NYS HUMAN RESOURCES</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5893</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
JONATHAN STEWART</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
THERAPEUTICS</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5745</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
MYRA STEWART</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CU PSYCHIATRY ADMINISTRATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5815</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
AUDREY STJOHN</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NURSING</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
WILFRED STLOUIS</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NYS ADMINISTRATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
TRACEY STRASSER</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
RESEARCH ASSESSMENT &amp; TRAINING</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
DAVID STRAUSS</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
INSTITUTE ADMINISTRATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5790 / 5814</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial">
Fax: 795-3538</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial">
strauss@nypsych.cpmc.columbia.edu</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
JIUAN SU</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
BIOPSYCHOLOGY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
RAYMOND SUCKOW</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ANALYTICAL PSYCHOPHARMACOLOGY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
MAKIKO SUEHIRO</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NEUROSCIENCE</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
RICHARD SUGDEN</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
HIV CTR CLIN. &amp; BEHAV. STUDIES</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
GREGORY SULLIVAN</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
PSYCHIATRIC EDUCATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2439</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
MARIA SULLIVAN</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
PSYCHIATRIC EDUCATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5639</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
WINSTON SULLIVAN</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NYS ADMINISTRATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
DAVID SULZER</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NEUROPATHOLOGY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ZHONG-YI SUN</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NEUROBIOLOGY AND BEHAVIOR</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2405</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
YVETTE SURIEL</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
PRESBYTERIAN HOSP. LIASION SERVICE</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
EZRA SUSSER</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
HIV CTR CLIN. &amp; BEHAV. STUDIES</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5505 / 2266</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
MERVYN SUSSER</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
HIV CTR CLIN. &amp; BEHAV. STUDIES</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
MICHAEL SWEENEY</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CLINICAL PSYCHOLOGY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
FELICE TAGER</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
THERAPEUTICS</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
380</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
HADASSA TAMIR</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NEUROSCIENCE</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5837</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
BONNIE TAYLOR</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
THERAPEUTICS</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5783</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
MICHAEL TAYLOR</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NURSING</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
SHARON TAYLOR</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
INSTITUTE ADMINISTRATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2236</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CRAIG TENKE</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
BIOPSYCHOLOGY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2466</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial">
Fax: 795-5886</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial">
tenkecr@nypsych.cpmc.columbia.edu</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
JEANNE TERESI</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
GERIATRICS</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
MICHAEL TERMAN</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
BIOPSYCHOLOGY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5714 / 5712 / 2584</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
SUSAN TERRY</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
EPIDEMIOLOGY OF MENTAL DISORDERS</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2593</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
JOSEPH TERWILLIGER</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
MEDICAL GENETICS</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5863</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
EDWARD THAYER</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NYS HUMAN RESOURCES</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5600</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial">
Fax: 923-8629</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial">
thayere@nypsych.cpmc.columbia.edu</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
JOHANNE THEN</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CHILD PSYCHIATRY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ANITA THOMAS</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NURSING</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
SANTHI THOMAS</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NURSING</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
LISA THOMASON</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CHILD PSYCHIATRY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2547 / 2548</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
MARCUS THOMEER</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CHILD PSYCHIATRY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
HELLE THORNING</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
SOCIAL SERVICES</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5659</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ELIZABETH TILLINGHAST</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
PSYCHIATRIC EDUCATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5648</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
AUGUSTA TILNEY</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
PSYCHIATRIC EDUCATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
KIM TILSON</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CHILD PSYCHIATRY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
PATRICIA TIMCHEK</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
RESEARCH ASSESSMENT &amp; TRAINING</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
LINDA TIMMONS</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CU PSYCHIATRY ADMINISTRATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2305</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
BARBARA TIRPAK</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NURSING</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
GEORGE TODAK</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
HIV CTR CLIN. &amp; BEHAV. STUDIES</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2207</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CANDIDA TOLEDO</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NURSING</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
JORGE TOLENTINO</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NYS ADMINISTRATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
THERESA TOLIVER</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NYS ADMINISTRATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ZHANNA TOLOCHKO</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NEUROBIOLOGY AND BEHAVIOR</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
JEFFREY TOMLINSON</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
WASHINGTON HEIGHTS COMMUNITY SERV.</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
JOHN TONER</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
GERIATRICS</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
YVONNE TORO</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
INSTITUTE ADMINISTRATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5858</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
SALLY TORRES</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
RESEARCH FOUNDATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5781</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial">
STORRES@rf1.cpmc.columbia.edu</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ELAINE TOSKOS</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
OCCUPATIONAL THERAPY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
MEHMET TOSYALI</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CHILD PSYCHIATRY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2327</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
JAMES TOWEY</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
BIOPSYCHOLOGY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2464</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial">
toweyja@nypsych.cpmc.columbia.edu</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
PAUL TRAUTMAN</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CHILD PSYCHIATRY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2334</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
PAUL TRICARICO</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NURSING</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
VIPIN TRIVEDI</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ANALYTICAL PSYCHOPHARMACOLOGY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2279 / 2278</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
SUSAN TROSS</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
HIV CTR CLIN. &amp; BEHAV. STUDIES</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2525</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CHARLOTTE TROTT</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
MEDICAL GENETICS</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2394</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial">
Fax: 781-2661</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial">
trottch@nypsych.cpmc.columbia.edu</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ANNA TRULLI</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NYS HUMAN RESOURCES</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2235</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ANGELA TU</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CHILD PSYCHIATRY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2524</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
LORRAINE TUCKER</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NYS ADMINISTRATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NANCY TURRET</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
SOCIAL SERVICES</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5657</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NORMA ULMER</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NURSING</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
MARK UNDERWOOD</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NEUROSCIENCE</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2430</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
JEANNE UPSHAW</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
QUALITY ASSURANCE</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2345</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CHARLOTTE URWITZ</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
RESEARCH ASSESSMENT &amp; TRAINING</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
EVE VAGG</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
PHOTOGRAPHY &amp; MEDICAL ILLUSTRATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2317</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
MIREILLE VALBRUN</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NEUROBIOLOGY AND BEHAVIOR</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ELIE VALENCIA</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ADULT PSYCHIATRY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
SWATHY VALLERU</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
BRAIN IMAGING</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5870</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
RONAN VAN ROSSEM</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
RESEARCH ASSESSMENT &amp; TRAINING</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CRISTOBAL VARGAS</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NYS ADMINISTRATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5779</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
DELFIN VARGAS</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NYS ADMINISTRATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
439</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
DEBRA VASQUEZ</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
PRESBYTERIAN HOSP. LIASION SERVICE</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ROGER VAUGHAN</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
PSYCHIATRIC EDUCATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ANGEL VAZQUEZ</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NYS ADMINISTRATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ANGEL VAZQUEZ</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NYS ADMINISTRATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CARLOS VEGA</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
COMPARATIVE MEDICAL SCIENCE</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
DREW VELTING</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CHILD PSYCHIATRY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
SIMON VERA</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NYS ADMINISTRATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
HELEN VERDELI</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CLINICAL &amp; GEN EPID</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
DONNA VERMES</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NURSING</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ANDREA VERSENYI</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CHILD PSYCHIATRY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
FERNANDO VIANO</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
WASHINGTON HEIGHTS COMMUNITY SERV.</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
MARY VINCE</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
SEXUAL BEHAVIOR CLINIC</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
LYN VINNICK</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CLINICAL PSYCHOLOGY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
DANIELLE VINOCUR</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
DEVELOPMENTAL PSYCHOBIOLOGY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
EDWIN VIVAS</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NYS ADMINISTRATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
LESLIE VOGEL</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CHILD PSYCHIATRY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
GLENN WAGNER</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
THERAPEUTICS</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2331</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
EUGENIE WAITERS</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NURSING</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
SONDRA WALCOTT</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
EPIDEMIOLOGY OF MENTAL DISORDERS</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CHERYL WALKER</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NYS HUMAN RESOURCES</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5601</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ROBIN WALKER</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
WASHINGTON HEIGHTS COMMUNITY SERV.</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
TERESA WALKER</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NYS ADMINISTRATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
RODRICK WALLACE</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
EPIDEMIOLOGY OF MENTAL DISORDERS</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5685</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
B WALSH</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CLINICAL PSYCHOPHARMACOLOGY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5752</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
PETER WALSH</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CHILD PSYCHIATRY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
THERESE WALSH</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
DIVISION OF SUBSTANCE ABUSE</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
SHAONING WANG</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
DEVELOPMENTAL PSYCHOBIOLOGY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
PATRICIA WARNE</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
HIV CTR CLIN. &amp; BEHAV. STUDIES</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
VIRGINIA WARNER</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CLINICAL &amp; GEN EPID</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5859</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
LAKEYSHA WARREN</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NURSING</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ANDREW WASHINGTON</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NYS ADMINISTRATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ARNETTA WASHINGTON</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NYS HUMAN RESOURCES</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
475</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
BRUCE WASLICK</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CHILD PSYCHIATRY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2587</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
GAIL WASSERMAN</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CHILD PSYCHIATRY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2296</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ADELLA WASSERSTEIN</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
WASHINGTON HEIGHTS COMMUNITY SERV.</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CHRISTINE WATERNAUX</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
INSTITUTE ADMINISTRATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5766 / 2465</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
JANE WATERS</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
SOCIAL SERVICES</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2250</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial">
watersj@nypsych.cpmc.columbia.edu</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ALISSE WATERSTON</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
HIV CTR CLIN. &amp; BEHAV. STUDIES</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ANNA WATSON</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NYS ADMINISTRATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5773</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
JENNIFER WATSON</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CHILD PSYCHIATRY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
678</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial">
watsonj@nypsych.cpmc.columbia.edu</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
LAURIE WEBER</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
THERAPEUTICS</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
KEITTISHA WEEKES</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CU PSYCHIATRY ADMINISTRATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
694</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
LINDA WEEKESSIMMONS</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NYS ADMINISTRATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
PETER WEIDEN</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
PSYCHIATRY AFFILIATES</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
PAMELA WEINBERG</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
PSYCHIATRIC EDUCATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
STEPHEN WEINSTEIN</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
WASHINGTON HEIGHTS COMMUNITY SERV.</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
BELLA WEINSTOCK</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NURSING</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
MYRNA WEISSMAN</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CLINICAL &amp; GEN EPID</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5880</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
MICHAEL WELIKSON</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CHILD PSYCHIATRY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2335</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
LAWRENCE WELKOWITZ</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
THERAPEUTICS</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2441</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
LAURA WELLS</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
EDUCATION AND TRAINING</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2444</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
DAVID A. WENGER</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
EPIDEMIOLOGY OF MENTAL DISORDERS</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
LORETTA WESTON</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
MEDICAL GENETICS</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5668</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NANCY WEXLER</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
MEDICAL GENETICS</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2450 / 5667 / 5679</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
AGNES WHITAKER</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CHILD PSYCHIATRY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2290</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
EDITH WHITE</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
PSYCHIATRIC EDUCATION-UNDERGRADUATE</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ELIZABETH WHITE</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NURSING</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
MARGARET WHITE</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NURSING</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
LAURA WHITMAN</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CHILD PSYCHIATRY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2594</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
PRIYA WICKRAMARATNE</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
GERIATRICS</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5704</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
JUDITH WICKS</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CHILD PSYCHIATRY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2579</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ILONA WIENER</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
PRESBYTERIAN HOSP. LIASION SERVICE</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
HOLLY WILCOX</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CHILD PSYCHIATRY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2334</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
DAVID WILDER</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
GERIATRICS</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
BIANCA WILLIAMS</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
EPIDEMIOLOGY OF MENTAL DISORDERS</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CHRISTOPHE WILLIAMS</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CHILD PSYCHIATRY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5771</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CLEVESTON WILLIAMS</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NYS ADMINISTRATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5772</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
DANIEL WILLIAMS</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CHILD PSYCHIATRY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
EMETT WILLIAMS</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
DEVELOPMENTAL PSYCHOBIOLOGY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5692</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
JANET WILLIAMS</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
BIOMETRICS</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5521</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
LINDA WILLIAMS</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NYS ADMINISTRATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
SAMANTHA WILLIAMS</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
HIV CTR CLIN. &amp; BEHAV. STUDIES</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
GODFREY WILSON</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CLINICAL PSYCHOPHARMACOLOGY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
SCOTT WILSON</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
RESEARCH ASSESSMENT &amp; TRAINING</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
RONALD WINCHEL</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NEUROSCIENCE</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
RACHEL WINER</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CHILD PSYCHIATRY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
SUSAN WINTER</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
THERAPEUTICS</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2378</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
JAMES WOLBERG</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
PSYCHIATRIC EDUCATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
SARA WOLK</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CLINICAL PSYCHOPHARMACOLOGY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5746</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
SUSAN WOLK</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
PSYCHIATRIC EDUCATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2262</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
HENRIETTA WOLLAND</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
COMPUTER CENTER</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5811</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ROBERT WOLSKI</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
DIVISION OF SUBSTANCE ABUSE</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2448</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
JERRY WOLSKY</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
PHARMACY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2490</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
HONG WONG</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NEUROTOXICOLOGY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
SUSAN WONG</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
PSYCHIATRIC EDUCATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2201</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
STEVEN WOOD</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NEUROSCIENCE</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5730 / 5731</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
SALLY WOODRING</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CLINICAL PSYCHOPHARMACOLOGY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5747</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
DEBRA WOODRUFF</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
RESEARCH ASSESSMENT &amp; TRAINING</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2386</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
WENDY WORTH</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CLINICAL PSYCHOPHARMACOLOGY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5752</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
LAURIE WORTMAN</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NURSING</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ALLEN WRIGHT</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
EPIDEMIOLOGY OF MENTAL DISORDERS</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
FANG WU</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NEUROBIOLOGY AND BEHAVIOR</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
KUOMING WU</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NEUROTOXICOLOGY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2271</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
PING WU</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CHILD PSYCHIATRY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
YUANPEI XIN</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NEUROBIOLOGY AND BEHAVIOR</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
414</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
JIN XU</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CLINICAL &amp; GEN EPID</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
SCOTT YALE</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CLINICAL PSYCHOBIOLOGY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2568 / 2418</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NAOKI YAMAMOTO</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NEUROBIOLOGY AND BEHAVIOR</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CECILE YANCU</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
CHILD PSYCHIATRY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
RACHEL YARMOLINSKY</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
PHOTOGRAPHY &amp; MEDICAL ILLUSTRATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2267</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ANDREW YOOD</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ADULT PSYCHIATRY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
PIE YOUNG</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NEUROTOXICOLOGY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
HELGA YUAN</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
DIVISION OF SUBSTANCE ABUSE</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
2558</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
JOANIE YUNG</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NEUROTOXICOLOGY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
JOHN ZATONSKI</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NURSING</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ROSITA ZAWADZKI</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
HIV CTR CLIN. &amp; BEHAV. STUDIES</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
HONG TAO ZHANG</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
MEDICAL GENETICS</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ZHIHONG ZHENG</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ANALYTICAL PSYCHOPHARMACOLOGY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
HUI ZHU</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
NEUROBIOLOGY AND BEHAVIOR</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ELLEN ZIMMERLI</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
DEVELOPMENTAL PSYCHOBIOLOGY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
ANN ZMITROVICH</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
DEVELOPMENTAL PSYCHOBIOLOGY</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
5711</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
PHYLLIS ZOLAN</FONT></TD>
<TD ALIGN="left"><FONT FACE="Arial" SIZE=-1>
RESEARCH FOUNDATION</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="center"><FONT FACE="Arial" SIZE=-1>
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial">
</FONT></TD>
</TR>
</Table>
<!-- ------------------------- -->
<!--  END OF CONVERTED OUTPUT  -->
<!-- ------------------------- -->
</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT02-B10-269</DOCNO>
<DOCOLDNO>IA093-000995-B030-527</DOCOLDNO>
<DOCHDR>
http://www.nyspi.cpmc.columbia.edu:80/NYSPI/EVENTS/9703__ev.htm 156.111.80.30 19970121073638 text/html 218
HTTP/1.0 200 OK
MIME-Version: 1.0
Server: GLACI/2.01
Date: Tue Jan 21 02:40:46 1997
Content-Type: text/html
</DOCHDR>
<BODY><H1>Error 404</H1>
Unable to open the specified file<hr><ADDRESS>httpd-info@glaci.com</ADDRESS></BODY>
</DOC>
<DOC>
<DOCNO>WT02-B10-270</DOCNO>
<DOCOLDNO>IA093-000995-B031-3</DOCOLDNO>
<DOCHDR>
http://www.nyspi.cpmc.columbia.edu:80/NYSPI/EVENTS/9704__ev.htm 156.111.80.30 19970121073703 text/html 218
HTTP/1.0 200 OK
MIME-Version: 1.0
Server: GLACI/2.01
Date: Tue Jan 21 02:40:59 1997
Content-Type: text/html
</DOCHDR>
<BODY><H1>Error 404</H1>
Unable to open the specified file<hr><ADDRESS>httpd-info@glaci.com</ADDRESS></BODY>
</DOC>
<DOC>
<DOCNO>WT02-B10-271</DOCNO>
<DOCOLDNO>IA093-000995-B030-508</DOCOLDNO>
<DOCHDR>
http://www.nyspi.cpmc.columbia.edu:80/NYSPI/EVENTS/9702__ev.htm 156.111.80.30 19970121073627 text/html 218
HTTP/1.0 200 OK
MIME-Version: 1.0
Server: GLACI/2.01
Date: Tue Jan 21 02:40:35 1997
Content-Type: text/html
</DOCHDR>
<BODY><H1>Error 404</H1>
Unable to open the specified file<hr><ADDRESS>httpd-info@glaci.com</ADDRESS></BODY>
</DOC>
<DOC>
<DOCNO>WT02-B10-272</DOCNO>
<DOCOLDNO>IA093-000995-B030-491</DOCOLDNO>
<DOCHDR>
http://www.nyspi.cpmc.columbia.edu:80/NYSPI/EVENTS/9701__ev.htm 156.111.80.30 19970121073618 text/html 6918
HTTP/1.0 200 OK
MIME-Version: 1.0
Server: GLACI/2.01
Date: Tue Jan 21 02:40:23 1997
Content-Type: text/html
Content-Length: 6788
</DOCHDR>
<html>
<head>
<title>NYSPI - January - Calendar of Events</title>
</head>
<BODY BACKGROUND="/IMAGES/MARBLE.JPG">
<CENTER><H2>New York State Psychiatric Institute<BR></H2>
<p>
<H1>January - Calendar of Events</H1></CENTER>
<CENTER>
<HR>
To add an event to this page, please contact Sandra Ortiz at Ext.5801
 or E-Mail to: <Address><A HREF= "mailto: sortiz@rf1.cpmc.columbia.edu"> sortiz@rf1.cpmc.columbia.edu</A></Address>
<p>
(This page was last updated on - 01/08/97)
<HR>
<p>
<B><H2><CENTER>Wednesday, January  1</H2></B>
<LI><b>Child Psychiatry Grand Rounds:</b> "No Grand Rounds -- New Year's Day"<BR></LI>
<EM> 11:30a-01:00p</EM>
<p>
<p>
<B><H2><CENTER>Friday, January  3</H2></B>
<LI><b>Adult Psychiatry Grand Rounds:</b> "Clinical Grand Rounds: Intepersonal Psychoterapy"<BR></LI>
<B>Presenter: </B>Elizabeth Haase, M.D. - Senior Resident<BR>
Discussant: Myrna Weissman, Ph.D. - Professor of Epidemiology<BR>
Columbia University College of Pysicians & Surgeons<BR>
Abbott Laboratories<BR>
<EM>8th Floor Auditorium 11:00a-12:30p</EM>
<p>
<p>
<B><H2><CENTER>Tuesday, January  7</H2></B>
<LI><b>Sergievsky Center Seminars:</b> "Apoe And The Diagnosis Of Alzheimer's Disease"<BR></LI>
<B>Presenter: </B>Richard Mayeux, M.D., M.S.E.<BR>
Gertrude H. Sergievksy Center<BR>
<EM> 11:00A-12:00P</EM>
<p>
<p>
<B><H2><CENTER>Wednesday, January  8</H2></B>
<LI><b>Child Psychiatry Grand Rounds:</b> "Suffocation False Alarm Theory of Panic Disorder"<BR></LI>
<B>Presenter: </B>Donald F. Klein, M.D., Professor of Psychiatry Columbia University<BR>
<EM>8th Floor Auditorium - NYSPI 11:30a-01:00p</EM>
<p>
<p>
<B><H2><CENTER>Thursday, January  9</H2></B>
<LI><b>HIV GRAND ROUNDS:</b><BR></LI>
 "The Family Planning Attitudes and Experiences of Low-Income Women"<BR>
<B>Presenter: </B>Jacqueline Darroch Forrest, Ph.D.<BR>
Senior Vice President<BR>
Alan Guttmacher Institute<BR>
<EM>8th Floor Auditorium 09:30A-11:00A</EM>
<p>
<p>
<B><H2><CENTER>Friday, January 10</H2></B>
<LI><b>Adult Psychiatry Grand Rounds:</b><BR></LI>
 "Biology of PTSD in Trauma Survivors and their Children"<BR>
<B>Presenter: </B>Rachel Yehuda, Ph.D.<BR>
Associate Professor of Psychology<BR>
Mt. Sinai School of Medicine<BR>
Abbott Laboratories<BR>
<EM>8th Floor Auditorium 11:00a-12:30p</EM>
<p>
<p>
<B><H2><CENTER>Tuesday, January 14</H2></B>
<LI><b>Sergievsky Center Seminars:</b><BR></LI>
 "Sustained Attention Monitoring For Detection Of Early Cerebral Dysfunction<BR>
In Acute Global And Hemispheral Ischemia"<BR>
<B>Presenter: </B>Randy Marshall, M.D.<BR>
Department Of Neurology<BR>
Gertrude H. Sergievsky Center<BR>
<EM> 11:00A-12:00P</EM>
<p>
<p>
<LI><b>Scientific Seminar Program:</b> "Ontogeny of Nociception and Anti-Nociception"<BR></LI>
<B>Presenter: </B>Gordon A. Barr, Ph.D. - Professor of Psychology, Hunter College, CUNY<BR>
and Senior Research Scientist<BR>
Dept. of Neuroscience<BR>
<EM>1501 Conference Room 01:00p-02:00p</EM>
<p>
<p>
<B><H2><CENTER>Wednesday, January 15</H2></B>
<LI><b>Child Psychiatry Grand Rounds:</b><BR></LI>
 "Psychobiology of Depression in Children and Adolescents"<BR>
<B>Presenter: </B>Neil Ryan, M.D. - Professor of Psychiatry, Joaquim Puig-Antich Professor in<BR>
Child and Adoloscent Psychiatry-West Psychiatric Institute and Clinic<BR>
<EM>8th Floor Auditorium - NYSPI 11:30a-01:00p</EM>
<p>
<p>
<B><H2><CENTER>Thursday, January 16</H2></B>
<LI><b>HIV GRAND ROUNDS:</b><BR></LI>
 "Promoting Sexual Subjects in Urban Brazil: Decoding Gendered Scrips and the<BR>
Sexual Scene"<BR>
<B>Presenter: </B>Vera Paiva, Ph.D., Professor, Social Psychology Department, University of Sao<BR>
Paulo Researcher, Nucleo de Estudos para Prevencao da AIDS, Sao Paulo, Brazil<BR>
Visiting Scholar, Center for AIDS Prevention Studies, University of California<BR>
<EM>8th Floor Auditorium 09:30a-11:00a</EM>
<p>
<p>
<B><H2><CENTER>Friday, January 17</H2></B>
<LI><b>Adult Psychiatry Grand Rounds:</b><BR></LI>
 "Seasonal Affective and Sleep-Phase Disorders: Treatment Update and<BR>
Demonstration"<BR>
<B>Presenter: </B>Michael Terman, Ph.D.<BR>
Associate Professor of Clinical Psychology<BR>
Columbia University College of Pysicians & Surgeons<BR>
Abbott Laboratories<BR>
<EM> 11:00a-12:30p</EM>
<p>
<p>
<B><H2><CENTER>Tuesday, January 21</H2></B>
<LI><b>Sergievsky Center Seminars:</b><BR></LI>
 "Prenatal Exposure And Risk Of Schizophrenia: A New Era In Schizophrenia<BR>
Research"<BR>
<B>Presenter: </B>Ezra Susser, M.D.<BR>
Department Of Psychiatry<BR>
Gertrude H. Sergievsky<BR>
<EM> 11:00A-12:00P</EM>
<p>
<p>
<B><H2><CENTER>Wednesday, January 22</H2></B>
<LI><b>Child Psychiatry Grand Rounds:</b><BR></LI>
 "Gender Identity Disorder in Children: The Rose of Attachment"<BR>
<B>Presenter: </B>Susan W. Coates, Ph.D. - Clinical Associate Professor of Medical Psychology<BR>
St. Luke's-Roosevelt Hospital Center<BR>
<EM>8th Floor Auditorium - NYSPI 11:30a-01:00p</EM>
<p>
<p>
<B><H2><CENTER>Thursday, January 23</H2></B>
<LI><b>HIV GRAND ROUNDS:</b> "Project Respect:<BR></LI>
HIV Counseling and Testing that Works"<BR>
<B>Presenter: </B>Martin Fishbein, Ph.D., Professor of Psychology, University of Illinois,<BR>
Champaign, Illinois, Guest Researcher, Behavioral Intervention and Research<BR>
Branch, Division of STD Prevention, National Center for HIV<BR>
<EM>8th Floor Auditorium 09:30a-11:00a</EM>
<p>
<p>
<B><H2><CENTER>Friday, January 24</H2></B>
<LI><b>Adult Psychiatry Grand Rounds:</b> "Reforming American Healthcare: A Forlorn Hope?"<BR></LI>
<B>Presenter: </B>Ron Bayer, Ph.D.<BR>
Professor, Columbia University, School of Public Health<BR>
Abbott Laboratories<BR>
<EM>8th Floor Auditorium 11:00a-12:30p</EM>
<p>
<p>
<B><H2><CENTER>Tuesday, January 28</H2></B>
<LI><b>Sergievsky Center Seminars:</b><BR></LI>
 "Literacy And Cognitive Status Assessment: Harlem Aging Project"<BR>
<B>Presenter: </B>Steven M. Albert, PH.D.<BR>
Gertrude H. Sergievsky<BR>
<EM> 11:00A-12:00P</EM>
<p>
<p>
<B><H2><CENTER>Wednesday, January 29</H2></B>
<LI><b>Child Physchiatry Grand Rounds:</b><BR></LI>
 "Bereavement in the Family Members of Adolescent Suicide Victims"<BR>
<B>Presenter: </B>Prudence Fisher, M.S. - Research Scientist - NYSPI<BR>
<EM>8th Floor Auditorium - NYSPI 11:30a-01:00p</EM>
<p>
<p>
<B><H2><CENTER>Friday, January 31</H2></B>
<LI><b>Adult Psychiatry Grand Rounds:</b><BR></LI>
 "Multidisciplinary Perspectives on Early Antisocial Behavior"<BR>
<B>Presenter: </B>Gail Wasserman, Ph.D.<BR>
Professor of Clinical Psychology in Psychiatry<BR>
Columbia University College of Physicians & Surgeons<BR>
Abbott Laboratories<BR>
<EM>8th Floor Auditorium 11:30a-12:30p</EM>
<p>
<p>
</CENTER>
</body>
</html>
</DOC>
<DOC>
<DOCNO>WT02-B10-273</DOCNO>
<DOCOLDNO>IA093-000995-B029-32</DOCOLDNO>
<DOCHDR>
http://www.nyspi.cpmc.columbia.edu:80/NYSPI/EVENTS/Evntindx.HTM 156.111.80.30 19970121072247 text/html 974
HTTP/1.0 200 OK
MIME-Version: 1.0
Server: GLACI/2.01
Date: Tue Jan 21 02:26:55 1997
Content-Type: text/html
Content-Length: 845
</DOCHDR>
<html>
<head>
<title>NYSPI - Calendar of Events</title>
</head>
<BODY BACKGROUND="/IMAGES/MARBLE.JPG">

<CENTER><H2>New York State Psychiatric Institute<BR></H2>
<p>
<H1>Calendar of Events</H1></CENTER>
<CENTER>
<HR>
To add an event to the calendar, please contact Sandra Ortiz at Ext.5801
 or E-Mail to: <Address><A HREF= "mailto: sortiz@rf1.cpmc.columbia.edu"> sortiz@rf1.cpmc.columbia.edu</A></Address>
<HR>

<P>
<H3><A HREF="/NYSPI/EVENTS/9612__ev.htm">December - 1996</A></H3>
<P>
<H3><A HREF="/NYSPI/EVENTS/9701__ev.htm">January  - 1997</A></H3>
<P>
<!--<H3><A HREF="/NYSPI/EVENTS/9702__ev.htm">February - 1997</A></H3>-->
<P>
<!--<H3><A HREF="/NYSPI/EVENTS/9703__ev.htm">March    - 1997</A></H3>-->
<P>
<!--<H3><A HREF="/NYSPI/EVENTS/9704__ev.htm">April    - 1997</A></H3>-->
<P>
</CENTER
</body>
</html>


</DOC>
<DOC>
<DOCNO>WT02-B10-274</DOCNO>
<DOCOLDNO>IA093-000995-B030-477</DOCOLDNO>
<DOCHDR>
http://www.nyspi.cpmc.columbia.edu:80/NYSPI/EVENTS/9612__ev.htm 156.111.80.30 19970121073558 text/html 6116
HTTP/1.0 200 OK
MIME-Version: 1.0
Server: GLACI/2.01
Date: Tue Jan 21 02:40:04 1997
Content-Type: text/html
Content-Length: 5986
</DOCHDR>
<html>
<head>
<title>NYSPI - December - Calendar of Events</title>
</head>
<BODY BACKGROUND="/IMAGES/MARBLE.JPG">
<CENTER><H2>New York State Psychiatric Institute<BR></H2>
<p>
<H1>December - Calendar of Events</H1></CENTER>
<CENTER>
<HR>
To add an event to this page, please contact Sandra Ortiz at Ext.5801
 or E-Mail to: <Address><A HREF= "mailto: sortiz@rf1.cpmc.columbia.edu"> sortiz@rf1.cpmc.columbia.edu</A></Address>
<p>
(This page was last updated on - 12/16/96)
<HR>
<p>
<B><H2><CENTER>Tuesday, December  3</H2></B>
<LI><b>Ninth Annual Research Conference:</b> "Extensive Scientific Research Program"<BR></LI>
<B>Presenter: </B>New York Psychiatric Institute<BR>
Nathan S. Kline<BR>
<EM>Albany 10:00a-07:15p</EM>
<p>
<p>
<LI><b>Presentation:</b> "Meta Analysis"<BR></LI>
<B>Presenter: </B>Dr. Christine Waternaux, Director of the Division of Biostatistics<BR>
<EM> 02:00p-03:00p</EM>
<p>
<p>
<LI><b>Sergievsky Center Seminars:</b> "Risks vs. Benefits of Splitting Data"<BR></LI>
<B>Presenter: </B>Mary Northridge, Ph.D., Columbia University<BR>
Dan Wartenberg, Ph.D., University of Medicine and Dentistry of New Jersey<BR>
Gertrude H. Sergievsky<BR>
Presbyterian Hospital<BR>
<EM>19th Floor - Sergievsky Center Conf. Rm. 12:00p-01:00p</EM>
<p>
<p>
<B><H2><CENTER>Wednesday, December  4</H2></B>
<LI><b>Ninth Annual Research Conference:</b> "Extensive Scientific Research Program"<BR></LI>
<B>Presenter: </B>New York Psychiatric Institute<BR>
Nathan S. Kline<BR>
<EM>Albany 07:00a-07:15p</EM>
<p>
<p>
<LI><b>Child Psychiatry Grand Rounds:</b> "Family Studies in Autism"<BR></LI>
<B>Presenter: </B>Harry H. Wright, M.D.<BR>
Professor of Psychiatry<BR>
University of South Carolina School of Medicine<BR>
Open to All<BR>
<EM>8th Floor Auditorium, Old PI 11:30a-01:00p</EM>
<p>
<p>
<B><H2><CENTER>Thursday, December  5</H2></B>
<LI><b>Ninth Annual Research Conference:</b> "Extensive Scientific Research Program"<BR></LI>
<B>Presenter: </B>New York Psychiatric Institute<BR>
Nathan S. Kline<BR>
<EM>Albany 07:00a-12:30p</EM>
<p>
<p>
<LI><b>HIV Grand Rounds:</b><BR></LI>
 "Conducting Focus Groups with Girls About Sexual Cognitions and Behavior"<BR>
<B>Presenter: </B>Lucia O'Sullivan, Ph.D. - Postdoctoral Research Fellow<BR>
HIV Center for Clinical and Behavioral Studies<BR>
Eighth Floor Auditorium - NYSPI<BR>
<EM>722 West 168th Street, New York, NY 09:00a-11:00a</EM>
<p>
<p>
<LI><b>HIV Grand Rounds:</b> "Women's Gender Scripts: Implications for HIV Prevention"<BR></LI>
<B>Presenter: </B>Samantha Williams, Ph.D. - Postdoctoral Research Fellow<BR>
HIV Center for Clinical and Behavioral Studies<BR>
HIV Center for Clinical and Behavioral Studies<BR>
Eighth Floor, NYSPI<BR>
<EM>722 West 168th Street, New York, NY 09:00a-11:00a</EM>
<p>
<p>
<B><H2><CENTER>Tuesday, December 10</H2></B>
<LI><b>Presentation:</b> "Bootstrapping Survival Analysis"<BR></LI>
<B>Presenter: </B>Dr. Steve Ellis, Division of Biostatistics<BR>
<EM> 02:00p-03:00p</EM>
<p>
<p>
<LI><b>Sergievsky Center Seminars:</b> "School of Public Health Assembly"<BR></LI>
Gertrude H. Sergievsky Center<BR>
Sergievsky Center Conference Room<BR>
<EM>19th Floor - Presbyterian Hospital 12:00p-01:00p</EM>
<p>
<p>
<B><H2><CENTER>Wednesday, December 11</H2></B>
<LI><b>Child Psychiatry Grand Rounds:</b><BR></LI>
 "Inhibition, Attention, Self-Control and Time: A New Theory of ADHD"<BR>
<B>Presenter: </B>Russell A. Barkley, Ph.D.<BR>
Professor of Psychiatry in Neurology<BR>
University of Massachusetts<BR>
Open to All<BR>
<EM>8th Floor Auditorium, Old PI 11:30a-01:00p</EM>
<p>
<p>
<B><H2><CENTER>Thursday, December 12</H2></B>
<LI><b>HIV GRAND ROUNDS:</b><BR></LI>
 "Sexual Risk Behavior and HIV Prevention Among Latino Men Who Have Sex with Men"<BR>
<B>Presenter: </B>Alex Carballo-Dieguez, Ph.D. - Research Scientist<BR>
Assistant Professor of Clinical Psychology<BR>
Department of Psychiatry, Columbia University, New York, NY<BR>
HIV Center for Clinical and Behavioral Studies<BR>
722 West 168th St., New York, N.Y.  10032<BR>
<EM>Eight Floor Auditorium 09:30a-11:00a</EM>
<p>
<p>
<B><H2><CENTER>Friday, December 13</H2></B>
<LI><b>Research Chiefs Meeting:</b> "Research Chiefs Meeting"<BR></LI>
<B>Presenter: </B>John M. Oldham, M.D.<BR>
Open to NYSPI Research Chiefs only<BR>
<EM>NYSPI, 12th Floor Conference Room 09:00a-10:30A</EM>
<p>
<p>
<B><H2><CENTER>Tuesday, December 17</H2></B>
<LI><b>Journal Club:</b> "Journal Club<BR></LI>
(to be announced)"<BR>
<B>Presenter: </B>Dr. Xinhua Liu, Division of Biostatistics<BR>
<EM>to be announced 02:00p-03:00p</EM>
<p>
<p>
<LI><b>Sergievsky Center Seminars:</b> "The Women's Health Initiative Memory Study"<BR></LI>
<B>Presenter: </B>Sally Shumaker, Ph.D.<BR>
Bowman Gray - Wake Forest University<BR>
Sergievsky Center Conference Room<BR>
Sergievsky Center Conference Room<BR>
<EM>Presbyterian Hospital - 19th Floor 12:00p-01:00p</EM>
<p>
<p>
<B><H2><CENTER>Wednesday, December 18</H2></B>
<LI><b>Child Psychiatry Grand Rounds:</b> "Clinical Case Presentation"<BR></LI>
<B>Presenter: </B>Amador Dizon, M.D.<BR>
Postdoctoral Clinical Fellow in Child and Adolescent Psychiatry<BR>
Columbia University/NYSPI<BR>
Open to All<BR>
<EM>8th Floor Audiotrium, Old PI 11:30a-01:00p</EM>
<p>
<p>
<B><H2><CENTER>Thursday, December 19</H2></B>
<LI><b>HIV Grand Rounds:</b> "HIV Prevention and Ethnic Minorities:<BR></LI>
Changing the Public Health Agenda"<BR>
<B>Presenter: </B>Vicky M. Mays, Ph.D. - Professor<BR>
Department of Psychology - University of California at Los Angeles<BR>
Los Angeles, California<BR>
HIC Center for Clinical and Behavioral Studies<BR>
722 West 168th St., New York, NY  10032<BR>
<EM>Eighth Floor Auditorium 09:30a-11:00a</EM>
<p>
<p>
<B><H2><CENTER>Thursday, December 26</H2></B>
<LI><b>HIV Grand Rounds:</b> "No Meeting"<BR></LI>
<EM> 09:30a-11:00a</EM>
<p>
<p>
</CENTER>
</body>
</html>
</DOC>
<DOC>
<DOCNO>WT02-B10-275</DOCNO>
<DOCOLDNO>IA093-000995-B029-181</DOCOLDNO>
<DOCHDR>
http://www.nyspi.cpmc.columbia.edu:80/users/ethayer/educatio.htm 156.111.80.30 19970121072523 text/html 3347
HTTP/1.0 200 OK
MIME-Version: 1.0
Server: GLACI/2.01
Date: Tue Jan 21 02:29:30 1997
Content-Type: text/html
Content-Length: 3217
</DOCHDR>
<!DOCTYPE HTML PUBLIC "-//IETF//DTD HTML//EN">

<html>

<head>
<title>Education at NYSPI</title>
<meta name="GENERATOR" content="Microsoft FrontPage 1.1">
</head>

<body bgcolor="#FFFFFF">
<p><font size=5><strong>New York State Psychiatric
Institute</strong></font></p> 

<H3><A HREF="http://www.nyspi.cpmc.columbia.edu/">Back to the 
NYSPI Home Page </A>
<BR></H3>

<p><strong>EDUCATION</strong></p>
<blockquote> <p>The exciting connections being made between brain,
mind and behavior have made training in psychiatry and related
sciences a challenge of considerable intellectual complexity. The
variety of course offerings match the extraordinary diversity of
research and clinical activity of the Institute, from the most refined
brain research to the broadest epidemiological investigations, from
studies of brief, specifically targeted psychotherapies to studies of
services and health policy. <br> At Psychiatric Institute, clinical
education falls into several categories:<br> * Psychiatric Education
for medical students<br> * Residency Training for psychiatrists<br> *
Child Psychiatry Residency and Fellowships<br> * Post-Residency
Fellowship Training in Psychiatric Research <br> * Post-Residency
Fellowships in Public Psychiatry<br> * Internship Training Program in
Psychology<br> * Training Programs in Nursing, Social Work,
Occupational Therapy, and Recreational Therapy <br> <br> The Institute
also offers research fellowships in schizophrenia, affective disorders
and substance abuse, fellowships in consultation-liaison, in
geriatrics and in HIV-related disorders. The co-existence of all these
sub-specialties, as well as the immediate availability of the finest
research faculty and research technology provides an atmosphere of
extraordinary stimulation for the scores of professionals completing
their postgraduate studies here each year. The graduates of
Psychiatric Institute's educational programs continue to be the
leaders of their fields becoming heads of academic and clinical
departments, as well as public service programs, in centers and
communities across the country. They also assume leadership positions
in psychiatric, psychological and psychoanalytic organizations and
become editors of the most respected journals.</p> </blockquote>
<p><strong>PRACTICE AND RESEARCH IN PSYCHOTHERAPY</strong></p>
<blockquote> <p>Founded in 1945 in the Department of Psychiatry of
Columbia University's College of Physicians and Surgeons, the
Psychoanalytic Center for Training and Research is located at
Psychiatric Institute. The founders recognized that interpersonal
therapies and medicine would benefit from a close relationship which
emphasized the interaction of the biological sources of human
motivation with cultural, developmental and environmental forces. In
that context, the faculty provide courses on the theory and practice
of psychoanalytic psychotherapy and supervision of psychodynamic
psychotherapy. <br> <font size=1></font></p> </blockquote> <p><font
size=1>Page created by Gerry Segal: </font><a
href="mailto:segalge@acm.org"><font
size=1>segalge@nypsych.cpmc.columbia.edu</font></a><br> </p> </body>

</html>

</DOC>
<DOC>
<DOCNO>WT02-B10-276</DOCNO>
<DOCOLDNO>IA093-000995-B028-290</DOCOLDNO>
<DOCHDR>
http://www.nyspi.cpmc.columbia.edu:80/USERS/ETHAYER/BROCHURE.HTM 156.111.80.30 19970121072033 text/html 5472
HTTP/1.0 200 OK
MIME-Version: 1.0
Server: GLACI/2.01
Date: Tue Jan 21 02:24:40 1997
Content-Type: text/html
Content-Length: 5342
</DOCHDR>
<!DOCTYPE HTML PUBLIC "-//IETF//DTD HTML//EN">

<html>

<head>
<title>NYSPI Brochure</title>
<meta http-equiv="Content-Type" content="text/html;
charset=iso-8859-1"> <meta name="GENERATOR" content="Microsoft
FrontPage 1.1"> </head>

<body bgcolor="#FFFFFF">
<p><font size=5><strong>New York State Psychiatric
Institute</strong></font></p> 

<H3><A HREF="http://www.nyspi.cpmc.columbia.edu/">Back to the 
NYSPI Home Page </A>
<BR></H3>

<p><font size=3>
<A HREF="http://www.nyspi.cpmc.columbia.edu/users/ethayer/laborato.htm">
Laboratory Research - </A> 
<A HREF="http://www.nyspi.cpmc.columbia.edu/users/ethayer/clinical.htm">
Clinical Research - </A>
<A HREF="http://www.nyspi.cpmc.columbia.edu/users/ethayer/educatio.htm">
Education - </A>
<A HREF="http://www.nyspi.cpmc.columbia.edu/users/ethayer/accompli.htm">
Historic Highlights </A></font></p>

<p><font face="Geneva"><fontsize=4><b>THE INSTITUTE</font></b></font></p> 
<p><font face="Geneva"><font size=4>When the New York Pathological Laboratory
opened its doors at No. 1 Madison Avenue in 1896, it was destined --
by an act of the New York State legislature -- to be the main provider
of pathological laboratory services for all New York State mental
hospitals. But its first director, Ira Van Gieson, petitioned the New
York State Commission in Lunacy to change the mission of the
institution, redefining its goal as carrying out multidisciplinary
research in the field of psychiatry. With the Commission's approval,
Van Gieson first changed the name of the Laboratory to the New York
State Pathological Institute and then proceeded to hire a professional
team that included a physical anthropologist, a bacteriologist, a
biochemist and a comparative neurologist, an innovation in psychiatric
staffing that was declared unique in the American Journal of Insanity.
</font></font></p> <p><font face="Geneva"><font size=4>The solid
scientific footing on which the Institute stood from the start allowed
its second director, Adolph Meyer, to add education as a second focal
area, initiating postgraduate training for psychiatrists. With
education a priority throughout his career, Meyer is often said to
have trained almost all of the senior academic psychiatrists working
in the United States during the first half of the 20th
century.</font></font></p> <p><font face="Geneva"><font size=4>The
Institute expanded its capacity for clinical research in 1929 when its
new building, located at the recently established northern Manhattan
campus of Columbia-Presbyterian Medical Center, provided space for
in-patient beds. Affiliation with the University and the Hospital gave
the Institute a still broader opportunity for interdisciplinary
collaboration which has kept it in the vanguard of psychiatric
research throughout its long history. To this day, PI is ranked as a
leader among the best psychiatric facilities in the world because of
its deep commitment to research, training and clinical care, each of
the three aspects of its mission fostering excellence in the others.
Improved understanding and more successful treatment of mental
illness, as well as strong strides toward achieving the ultimate goal
of preventing psychiatric problems are the results of this dynamic
partnership. None of this could have been realized without the ongoing
support provided by the State of New York. </font></font></p> <p><font
face="Geneva"></font>&#160;</p> <p><font face="Geneva"><font
size=5><b>NEW YORK STATE PSYCHIATRIC INSTITUTE</font></b></font></p>
<p><font face="Geneva"><font size=4>722 West 168th Street<br> New
York, New York 10032 <br> (212) 960-2200<br> </font><font
face="Geneva"></font><font size=3><i>Affiliated with
Columbia-Presbyterian Medical Center</font></i></font></p> <p><font
face="Geneva"><font size=3><strong>JOHN M. OLDHAM, M.D.</font><font
face="Geneva"></strong></font><font size=2>. <br> </font><font
face="Geneva"></font><font size=3>Director</font></font></p> <p><font
face="Geneva"><font size=3><strong>JACK M. GORMAN, M.D.<br>
</strong>Deputy Director</font></font></p> <p><font
face="Geneva"><font size=3><strong>STEVEN M. PAPP, M.B.A.<br>
</strong>Deputy Director - Administration</font></font></p> <p><font
face="Geneva"><font size=3><strong>DAVID H. STRAUSS, M.D.<br>
</strong>Clinical Director</font></font></p> <p><font
face="Geneva"><font size=3><strong>DONALD F. KLEIN, M.D.</strong><br>
Director, Office of Research and Development</font></font></p>
<p><font face="Geneva"><font size=3><strong>RUTH CORN,
M.S.W.</strong><br> Director, Standards and Quality
Assurance</font></font></p> <p><font face="Geneva"></font>&#160;</p>
<p><font face="Geneva"><font size=5><b>NEW YORK STATE OFFICE OF MENTAL
HEALTH</font></b></font></p> <p><font face="Geneva"><font
size=3><strong>GEORGE E. PATAKI</strong><br>
Governor</font></font></p> <p><font face="Geneva"><font
size=3><strong>JAMES L. STONE, M.S.W.</strong><br> Commissioner of
Mental Health</font></font></p> <p><font face="Geneva"><font
size=3><strong>HEINZ LEHMANN, M.D.</strong><br> Deputy Commissioner
for Research</font></font></p> <p><font size=1>Page created by Gerry
Segal: </font><a href="mailto:segalge@acm.org"><font
size=1>segalge@nypsych.cpmc.columbia.edu</font></a><br> </p> </body>

</html>
</DOC>
<DOC>
<DOCNO>WT02-B10-277</DOCNO>
<DOCOLDNO>IA093-000995-B029-201</DOCOLDNO>
<DOCHDR>
http://www.nyspi.cpmc.columbia.edu:80/users/ethayer/accompli.htm 156.111.80.30 19970121072611 text/html 7359
HTTP/1.0 200 OK
MIME-Version: 1.0
Server: GLACI/2.01
Date: Tue Jan 21 02:30:03 1997
Content-Type: text/html
Content-Length: 7229
</DOCHDR>
<!DOCTYPE HTML PUBLIC "-//IETF//DTD HTML//EN">

<html>

<head>
<title>NYSPI Accomplishments</title>
<meta name="GENERATOR" content="Microsoft FrontPage 1.1">
</head>

<body bgcolor="#FFFFFF">
<p><font size=5><strong>New York State Psychiatric
Institute</strong></font></p> 

<H3><A HREF="http://www.nyspi.cpmc.columbia.edu/">Back to the 
NYSPI Home Page </A>
<BR></H3>

<p><font size=4><strong>PSYCHIATRIC
INSTITUTE ACCOMPLISHMENTS: A SAMPLING</strong></font><font
size=2><strong><br> </strong></font><strong></strong></p> <blockquote>
<p><strong>CONNECTION MADE BETWEEN PARESIS AND SYPHILIS.</strong><br>
A P.I. pathologist working with a researcher from Rockefeller
Institute discovered the relationship between paresis and the
spirochete responsible for syphilis.</p> </blockquote> <blockquote>
<p><strong>EPIDEMIOLOGY.</strong><br> The first epidemiological
studies of the environmental influences on psychiatric disorders were
begun here.</p> </blockquote> <blockquote> <p><strong>STUDY OF
EPILEPSY.</strong><br> The key experimental animal model for the study
of epilepsy originated at P.I.</p> </blockquote> <blockquote>
<p><strong>PSYCHIATRIC SERVICES FOR THE DEAF</strong><br> The first
clinical psychiatric unit for the deaf was established at the
Institute.</p> </blockquote> <blockquote> <p><strong>RORSCHACH
SCORING<br> </strong>The first use of the Rorschach scoring system in
the U.S. took place at P.I.</p> </blockquote> <blockquote>
<p><strong>GENETIC STUDIES OF SCHIZOPHRENIA.</strong><br> The first
psychiatric research program in genetics in the U.S. produced data
which gave evidence of a genetic predisposition to schizophrenia.</p>
</blockquote> <blockquote> <p><strong>BIOLOGICAL TREATMENTS FOR MENTAL
DISORDERS.</strong><br> 1. The earliest U.S. demonstration of the
positive effects of phenothiazines<br> ( a group of psychotropic
drugs) in arresting the symptoms of schizophrenia <br> took place at
the Institute.<br> 2. Medical research on the use of electroconvulsive
therapy was first undertaken <br> in this country at P.I.<br> 3.
Lithium carbonate, the most successful treatment of manic-depression,
was <br> introduced in the U.S. at the Institute when the first
lithium clinic in the country <br> opened here. Lithium has saved the
U.S. more than $145 billion since 1970.</p> </blockquote> <blockquote>
<p><strong>P300 BRAIN WAVE IDENTIFIED.</strong><br> A scientist at the
Institute isolated the wave in the electrical activity of the human
brain which is related to cognitive mental activity, thereby
stimulating the search for other components involved in thought
processes such as attending to stimuli and making decisions.</p>
</blockquote> <blockquote> <p><strong>ADVANTAGES OF BRIEF
HOSPITALIZATION.</strong><br> A pioneer study documented that patients
with chronic mental illnesses could benefit as much from a brief
hospital stay, reinforced by day hospital programs and community
support services, as from the traditionally longer hospital stay.</p>
</blockquote> <blockquote> <p><strong>CHILDHOOD DEPRESSION
CLINIC.</strong><br> The first such clinic in the world was
established here, providing services for children and adolescents
suffering from depressive and anxiety disorders. It was followed by
the establishment by the federal government of the first Clinical
Research Center for the Study of Child and Adolescent Suicidal
Behaviors, Affective Disorders and Anxiety States. <br> The concept of
&quot;cluster suicides&quot; among adolescents, originated here, has
led to widespread attention to triggers for such behaviors. </p>
</blockquote> <blockquote> <p><strong>PSYCHIATRIC DIAGNOSTIC MANUAL.
</strong><br> Researchers at the Institute led the development of the
DSM-III, DSM-III-R and were key to its most recent major revision,
DSM-IV, the official diagnostic manuals published by the American
Psychiatric Association and used universally by the profession. </p>
</blockquote> <blockquote> <p><strong>HUNTINGTON'S DISEASE
GENE.</strong><br> A P.I. investigator organized the international
collaboration of researchers, which led to the identification of the
gene for Huntington's disease.</p> </blockquote> <blockquote>
<p>W<strong>ILSON'S DISEASE GENE.</strong><br> A molecular geneticist
at P.I. and an international team of researchers identified the gene
responsible for Wilson's disease, a disorder which mimics symptoms of
schizophrenia and other neurological disorders.</p> </blockquote>
<blockquote> <p><strong>EPIDEMIOLOGY OF DEPRESSION.</strong><br> A
P.I. researcher, using data from a multi-national study, established
that rates of depression are on the rise in ever younger populations,
with the risk of depression two to three times higher among women. The
statistics hold true for almost all countries in the study.<br> <br>
<br> <strong>RESEARCH CENTERS.</strong><br> Because of its excellence,
P.I. was designated a Clinical Mental Health Research Center by the
National Institute of Mental Health in 1978. Since then, seven other
Centers have been established here: <br> * the Cellular Analysis of
Behavior, <br> * Clinical and Behavioral Studies of HIV, <br> * the
Study of Childhood Mental Disorders, <br> * Development of Medication
for Substance Abuse, <br> * the Study of the Genetic Origins and
Treatment of Schizophrenia, <br> * the Study of the Genetic Approach
to Neuroplasticity and Learning <br> * the Study of Suicidal Behavior.
<br> <br> In addition, Psychiatric Institute is one of the sites in
the U.S.named a Diagnostic Center for Collaborative Psychiatric
Linkage Studies in Schizophrenia. </p> </blockquote> <blockquote>
<p><strong>MERIT AWARDS</strong><br> Psychiatric Institute scientists
hold the prestigious MERIT Awards, grants from the National Institute
of Mental Health which provide long-term, stable support to
investigators &quot;whose research competence and productivity are
distinctly superior and who are likely to continue to perform in an
outstanding manner.&quot; The Awards are held for:<br> * Developmental
Effects of Early Maternal Separation<br> * Cocaine Effects in Humans:
Physiology and Behavior<br> * Methylphenidate in Childhood Behavior
Disorders<br> * Prospective Study of Children of Schizophrenic
Parents<br> * Behavioral and Neural Analyses of Learning in
Aplysia<br> * Genetic Studies of Depressive Disorders<br> * Research
in Electroconvulsive Therapy<br> * Linkage Analysis Methods in
Schizophrenia<br> * Temporal Memory and Interval Time Sense <br> <br>
<br> <strong>RESEARCH SCIENTIST AWARDS</strong><br> Senior
investigators hold coveted Research Scientist Awards which offer
long-term federal support for specific projects. The Awards are
for:<br> * Genetics of Affective Disorders<br> * Social Status and
Psychological Disorders<br> * Psychobiology of Anxiety Disorders<br> *
Developmental Effects of Early Maternal Separation<br> *
Epidemiological/Familial Aspects of Drug Use <br> </p> </blockquote>
<p><font size=1>Page created by Gerry Segal: </font><a
href="mailto:segalge@acm.org"><font
size=1>segalge@nypsych.cpmc.columbia.edu</font></a><br> </p> </body>

</html>
</DOC>
<DOC>
<DOCNO>WT02-B10-278</DOCNO>
<DOCOLDNO>IA093-000995-B029-157</DOCOLDNO>
<DOCHDR>
http://www.nyspi.cpmc.columbia.edu:80/users/ethayer/laborato.htm 156.111.80.30 19970121072505 text/html 4717
HTTP/1.0 200 OK
MIME-Version: 1.0
Server: GLACI/2.01
Date: Tue Jan 21 02:29:13 1997
Content-Type: text/html
Content-Length: 4587
</DOCHDR>
<!DOCTYPE HTML PUBLIC "-//IETF//DTD HTML//EN">

<html>

<head>
<title>Laboratory Research at NYSPI</title>
<meta name="GENERATOR" content="Microsoft FrontPage 1.1">
</head>

<body bgcolor="#FFFFFF">
<p><font size=5><strong>New York State Psychiatric
Institute</strong></font></p> 

<H3><A HREF="http://www.nyspi.cpmc.columbia.edu/">Back to the 
NYSPI Home Page </A>
<BR></H3>

<p><font size=4><strong>LABORATORY
RESEARCH</strong></font></p> <blockquote> <p><font size=3>The tools of
molecular genetics, i.e. modern DNA technology and linkage analysis as
well as examinations of clinical, biobehavioral and genetic markers
for behaviors, are used in the pursuit of information about brain
disorders. The first step toward pinpointing a disease locus on a
narrow region of a chromosome is to identify family groups in which
the prevalence of a particular disease is high. Histories are then
taken and blood samples are collected. From there, mathematical
analyses determine the likelihood that sophisticatedphysical mapping
techniques and sequencing work will yield specific information about
the disease gene. By these means, Psychiatric Institute scientists are
steadily making contributions to the major U.S. effort called the
Human Genome Project. <br> <br> Scientists in neurobiology and
behavior, located in twelve independent laboratories, are working to
provide analyses of neural development, behavior, learning and
diseases of the nervous system in terms of their underlying cellular
and molecular mechanisms. Researchers have made seminal discoveries
about learning and long and short term memory from the study of the
marine snail, Aplysia. They are now examining genetically altered
mice, making it possible to relate the action of known genes to the
physiology of specific cells in regions of the brain. <br> <br> Brain
imaging has become an essential tool in psychiatric research. Much has
been learned about how and where neurotransmitters, the chemical
messengers in the brain, convey information. Variations of intensity
of activity, interruption of transmission, depletion of specific
chemicals or changes in brain structure may be clues to disordered
states. Brain imaging is now being used in many studies at the
Institute, such as those relating to suicide and aggression, aging and
memory, and schizophria. <br> </font></p> </blockquote> <p><font
size=4><strong>OTHER RESEARCH</strong></font></p> <blockquote>
<p><font size=3>Epidemiological studies reveal much about the
prevalence of disease in certain populations. Surveys are being
conducted by Psychiatric Institute epidemiologists to determine the
prevalence of major depression, panic disorder and the social and
psychological factors involved in adversity and stress, for example.
What is the incidence of mental illness in the homeless in New York
City? What is the nature and extent of mental health problems in low
income populations? Which children will have need of special education
services? What brain disorders present at birth or arising early in
childhood will have effects on mood, behavior or cognition later on?
These are just a few of the questions being asked at Psychiatric
Institute. <br> <br> Scientists need standardized tools to conduct the
interviews which will achieve a diagnostic consensus of
psychopathology. Many of the most effective diagnostic interview
schedules used in countries all over the world have been developed at
Psychiatric Institute. These include the SADS (Schedule for Affective
Disorders and Schizophrenia), the SCID (Structured Clinical Interview
for DSM-III, DSM-III-R and DSM-IV), the DISC (Diagnostic Interview
Schedule for Children) and the GAS (Global Assessment Scale).
Psychiatric Institute researchers, known for their work on the
official diagnostic manuals of the American Psychiatric Association,
also developed the popular PRIME-MD (Primary Care Evaluation of Mental
Disorders) which enables the busy general practitioner to make rapid
and accurate diagnoses of depression, panic, bulimia and other common
mental disorders. The newest of these instruments, PRISM (Psychiatric
Research Interview for Substance and Mental Disorders), was quickly
and widely adopted as a practical and efficient tool in assessing
psychiatric disorders in people who use alcohol and other
drugs.</font></p> </blockquote> <p><font size=1>Page created by Gerry
Segal: </font><a href="mailto:segalge@acm.org"><font
size=1>segalge@nypsych.cpmc.columbia.edu</font></a><br> </p> </body>

</html>
</DOC>
<DOC>
<DOCNO>WT02-B10-279</DOCNO>
<DOCOLDNO>IA093-000995-B029-172</DOCOLDNO>
<DOCHDR>
http://www.nyspi.cpmc.columbia.edu:80/users/ethayer/clinical.htm 156.111.80.30 19970121072516 text/html 8572
HTTP/1.0 200 OK
MIME-Version: 1.0
Server: GLACI/2.01
Date: Tue Jan 21 02:29:21 1997
Content-Type: text/html
Content-Length: 8442
</DOCHDR>
<!DOCTYPE HTML PUBLIC "-//IETF//DTD HTML//EN">

<html>

<head>
<title>Clinical Research at NYSPI</title>
<meta name="GENERATOR" content="Microsoft FrontPage 1.1">
</head>

<body bgcolor="#FFFFFF">
<p><font size=5><strong>New York State Psychiatric
Institute</strong></font></p> 

<H3><A HREF="http://www.nyspi.cpmc.columbia.edu/">Back to the 
NYSPI Home Page </A>
<BR></H3>

<blockquote> <p><font
size=4><strong>P.I. SERVING THE COMMUNITY </strong></font><br> Both
the local community and the larger community receive the benefit of
Psychiatric Institute's innovative and skillful services. Not only
does the Institute provide the most up-to-date psychiatric inpatient
and outpatient treatment to people who participate in a variety of
research projects, but it offers State-supported general psychiatric
care to the residents of northern Manhattan. The Washington Heights
Community Service is a major source of psychiatric evaluation and
treatment available to people living in northern Manhattan. The
Service consists of a 22-bed intensive care inpatient unit at
Psychiatric Institute and two outpatient clinics, the Audubon Avenue
Clinic and the Inwood Mental Health Center where outpatient therapy,
continuation day treatment and vocational rehabilitation are among the
treatment modalities provided. The staff is largely bilingual in
recognition of the large Hispanic population which lives in Washington
Heights and Inwood. <br> <br> The information needed to shape policy
regarding long-term care for aged local residents in community-based
and residential facilities is being gathered by P.I. researchers.
Scientists from the Memory Disorders Clinic and from the North
Manhattan Aging Project are establishing a registry identifying all
cases of dementia in the Washington Heights area. <br> <br> The HIV
Center for Clinical and Behavioral Studies, engaged in educating
various high risk populations on how to prevent HIV infection, has
produced four prize-winning videotapes which emphasize the need to be
active on one's own behalf in promoting safe behaviors. Useful to
community groups and agencies, these tapes have been widely
distributed locally and across the nation.<br> <br> Clinicians from
Child Psychiatry provide on-site mental health services to those
children who need clinical support while attending classes in some of
the elementary and intermediate schools in Washington Heights, West
Harlem and Inwood. A small public school is also located on the actual
premises of the Institute; every attempt is made to provide children
suffering from psychiatric problems who are enrolled in research
studies at the Institute with the same education they would receive in
regular public schools. <br> <br> Summer employment in the form of
research apprenticeship programs at the Institute is available to
several local high school students. Teachers, too, may update their
skills in modern research techniques. And, since 1972, the
State-supported Youth Opportunity Program has provided low-income high
school students with after school jobs in the Institute laboratories,
offices and library. This program has consistently encouraged these
students to go on to college and many have pursued careers in science.
<br> <br> <font size=4><strong>CLINICAL RESEARCH
UNITS</strong></font><strong><br> <br> </strong>Several special
purpose clinics, combining research and treatment, serve people from
the neighborhood and the greater metropolitan area. Among them are
the:<br> * Anxiety Disorders Clinic<br> * Child &amp; Adolescent
Depression Clinic<br> * Children's Day Program<br> * Depression
Evaluation Service<br> * Eating Disorders Clinic<br> * General
Clinical Research Unit<br> * Hispanic Anxiety &amp; Depression
Clinic<br> * HIV Center for Clinical and Behavioral Studies<br> *
Huntington's Disease Clinic<br> * Late Life Depression Clinic<br> *
Memory Disorders Clinic<br> * Sexual Behavior Clinic<br> *
Schizophrenia Research Unit<br> * Smoking Cessation Clinic<br> *
Substance Abuse Clinic</p> <p><font size=4><strong>CLINICAL
RESEARCH</strong></font><br> <br> The Schizophrenia Research Center
has a dual purpose: to clarify the origins of schizophrenia and to
develop and test the most promising treatments for that disorder.
Research ranges from epidemiological studies of prenatal risk factors,
clarification of the relative roles genes and environment play in the
illness, and assessments of patients' awareness of illness to multiple
family group therapy.<br> <br> Differentiation and treatment of
various types of depression, matching the optimum anti-depressant
medication with a specific form of depressive disorder, has
established Psychiatric Institute's Depression Evaluation Service as
arguably the best such unit in New York City. The concept of dual
diagnosis is also receiving close scrutiny because many people who
abuse alcohol or cocaine may have an underlying depression and may be
using the alcohol or drugs as a form of self-medication. Treating the
depression often resolves the addiction. <br> <br> The Late Life
Depression Clinic takes into consideration the other illnesses and
conditions which can complicate the treatment of depression in elderly
people. Depression following stroke or heart attacks may be a risk
factor possibly decreasing longevity; treating it appropriately may be
life-saving. Electroconvulsive therapy (ECT), widely recognized as an
effective treatment for depression, has been an option. Now
researchers are testing rapid-rate transcranial magnetic stimulation
(rTMS) as a possible replacement for ECT because of its focal
precision. The National Institute of Aging supports studies of
Alzheimer's Disease and other dementias within the Memory Disorders
Clinic where researchers are also looking at the cognitive changes
that occur as a result of normal aging.<br> <br> The Anxiety Disorders
Clinic works to advance the understanding of DSM-IV anxiety disorders
with particular emphasis on panic disorder and agoraphobia, social
phobia, obsessive-compulsive disorder and post-traumatic stress
disorder. The Clinic is also the site of the only NIMH funded study of
hypochondria, believed to be a legitimate and treatable anxiety
disorder. Treatment is available for both Spanish and English speaking
patients.<br> <br> The HIV Center for Clinical and Behavioral Studies
is dedicated to interdisciplinary studies of the prevention of
transmission of HIV, working with populations at risk: children,
adolescents, gay men and heterosexual women and men. Risk behavior and
interventions for behavior change are approached from many different
perspectives - with both genders; at different developmental points;
with individuals and with couples, at the level of the parent/child
dyad and the social network; with infected people and people at risk;
among ethnically diverse populations; among special populations such
as the mentally ill homeless; and for different sexual orientations.
<br> <br> In collaboration with Presbyterian Hospital, Mental Health
Services for the Homeless are provided to the mentally ill men housed
in the Fort Washington Shelter. Scientists from Psychiatric Institute
have tested and validated new methods of treating the homeless
mentally ill, helping them to live independently. These interventions
appear to reduce the amount of time an individual remains homeless.
Likewise, psychiatric and case management services to mentally ill
women in other New York City shelters are provided. <br> <br> Within
the Center for the Study of Childhood Mental Disorders, children are
evaluated and treated for anxiety and depression. Innovative
therapeutic interventions for adolescent suicide attempters have been
developed and tested here. A small school on the premises of
Psychiatric Institute permits children to continue to receive the same
education they would get in neighborhood public schools as they are
being observed and treated for psychiatric disorders. Researchers are
also engaged in epidemiological studies to determine the antecedents
of juvenile delinquency, illicit drug use, high risk sexual behavior,
etc. </p> </blockquote> <p><font size=1>Page created by Gerry Segal:
</font><a href="mailto:segalge@acm.org"><font
size=1>segalge@nypsych.cpmc.columbia.edu</font></a><br> </p> </body>

</html>
</DOC>
<DOC>
<DOCNO>WT02-B10-280</DOCNO>
<DOCOLDNO>IA093-000995-B030-464</DOCOLDNO>
<DOCHDR>
http://www.nyspi.cpmc.columbia.edu:80/NYSPI/RFMHGRNT/RF_SPON.HTM 156.111.80.30 19970121073547 text/html 47052
HTTP/1.0 200 OK
MIME-Version: 1.0
Server: GLACI/2.01
Date: Tue Jan 21 02:39:53 1997
Content-Type: text/html
Content-Length: 46921
</DOCHDR>
<HTML>
<HEAD>
<TITLE>
NYSPI Sponsored Research
</TITLE>
</HEAD>
<BODY>
<H1 ALIGN="CENTER">
NYSPI Sponsored Research
</H1>
<P ALIGN="CENTER">
<B>Research Foundation for Mental Hygiene, Inc.</B>
<P ALIGN="CENTER">
<B>Psychiatric Institute Division</B>
<P ALIGN="CENTER">
<U>
<HR>
<!-- The following table has been generated by the Internet Assistant Wizard for Microsoft Excel.
You can find this add-in on"http://www.microsoft.com/msoffice/freestuf/msexcel/index.htm" -->
<!-- ------------------------- -->
<!-- START OF CONVERTED OUTPUT -->
<!-- ------------------------- -->
<Table border=0 width="100%">
<TR>
<TD ALIGN=center>Last Update: 01/16/97</TD>
<TD ALIGN=center>EMail: <A HREF = "mailto:faverick@rf1.cpmc.columbia.edu">faverick@rf1.cpmc.columbia.edu</A></TD>
</TR>
</Table>
<HR>
<Table border>
<TR VALIGN="top"><FONT FACE="Arial">
<TD BGCOLOR=#00FFFF ALIGN="center">
N A M E</TD>
<TD BGCOLOR=#00FFFF ALIGN="center">
S P O N S O R</TD>
<TD BGCOLOR=#00FFFF ALIGN="center">
T I T L E</TD>
</FONT>
</TR>
<p>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">X.AMADOR              </TD>
<TD ALIGN="left">MENTAL ILLNESS FD        </TD>
<TD ALIGN="left">Follow-Up Study of Schizophrenia </TD>
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">H.ANDREWS             </TD>
<TD ALIGN="left">COLUMBIA UNIV            </TD>
<TD ALIGN="left">Subcontract w/CU:  Leadership and Excellence in Alzheimer's Disease (LEAD) </TD>
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">H.ANDREWS             </TD>
<TD ALIGN="left">COLUMBIA UNIV            </TD>
<TD ALIGN="left">Subcontract with CU: Epidemiologic Study of Dementia After Stroke </TD>
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">H.ANDREWS             </TD>
<TD ALIGN="left">COLUMBIA UNIV            </TD>
<TD ALIGN="left">Subcontract w/ CU:Alzheimer's Disease Research Center </TD>
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">H.ANDREWS             </TD>
<TD ALIGN="left">COLUMBIA UNIV            </TD>
<TD ALIGN="left">Subcontract with CU: Epidemiology of Dementia in an Urban Community </TD>
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">V.ARANGO              </TD>
<TD ALIGN="left">AA09004-05               </TD>
<TD ALIGN="left">Monoamine Systems in Alcoholism and Suicide </TD>
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">V.ARANGO              </TD>
<TD ALIGN="left">WEST PSYCH-              </TD>
<TD ALIGN="left">Subcontract w/Western Psychiatric Institute: Youth Suicide: A Neurobiological and Psychological Study</TD>
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">C.BAILEY              </TD>
<TD ALIGN="left">MH37134-13               </TD>
<TD ALIGN="left">Morphological Basis of Synaptic Plasticity </TD>
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">M.BARON               </TD>
<TD ALIGN="left">MH43979-06               </TD>
<TD ALIGN="left">Genetic Linkage Studies in Affective Disorders </TD>
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">M.BARON               </TD>
<TD ALIGN="left">MH42535-07               </TD>
<TD ALIGN="left">Genetic Markers in Affective Disorders </TD>
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">G.BARR                </TD>
<TD ALIGN="left">DA06600-06               </TD>
<TD ALIGN="left">Development and Plasticity of Opiate Withdrawal </TD>
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">A.BROWN               </TD>
<TD ALIGN="left">NARSAD                   </TD>
<TD ALIGN="left">Genetic-Environmental Interactions in Schizophrenia:  A Birth Cohort Study </TD>
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">G.BRUDER              </TD>
<TD ALIGN="left">MH36295-12               </TD>
<TD ALIGN="left">Behavioral, ERP and EEG Asymmetry in Affective Disorders </TD>
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">G.BRUDER              </TD>
<TD ALIGN="left">MH36295-13 *PA           </TD>
<TD ALIGN="left">Behavioral, ERP and EEG Asymmetry in Affective Disorders </TD>
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">G.BRUDER              </TD>
<TD ALIGN="left">MH50715-03               </TD>
<TD ALIGN="left">Brain ERPs and Cognitive Demand in Schizophrenia </TD>
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">S.BRUNELLI            </TD>
<TD ALIGN="left">MH54027-01A1             </TD>
<TD ALIGN="left">Development of Anxiety in Selectively Bred Rats </TD>
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">P.BUTLER              </TD>
<TD ALIGN="left">MH50816-02               </TD>
<TD ALIGN="left">Clinical Studies of Neurotensin in Schizophrenia </TD>
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">A.CARBALLO            </TD>
<TD ALIGN="left">MH52031-03               </TD>
<TD ALIGN="left">HIV RIsk in NYC'S Homosexually Active Latin American Men </TD>
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">A.CARBALLO            </TD>
<TD ALIGN="left">REPROTECT LLC            </TD>
<TD ALIGN="left">Microbicidal Gel Aceptability Focus Group </TD>
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">P.COHEN               </TD>
<TD ALIGN="left">MH54161-01A2             </TD>
<TD ALIGN="left">Universal Transitions and Personal Turning Points </TD>
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">S.COMER               </TD>
<TD ALIGN="left">DA10975-01               </TD>
<TD ALIGN="left">A Laboratory Model of Craving for Smoked Drug by Monkeys </TD>
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">T.COOPER              </TD>
<TD ALIGN="left">STERLING DRUG            </TD>
<TD ALIGN="left">Sale of Dexamethasone Antibody to Sterling Winthrop, Inc. </TD>
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">T.COOPER              </TD>
<TD ALIGN="left">COLUMBIA UNIV            </TD>
<TD ALIGN="left">Subcontract w/CU: Perinatal Polydrug Abuse: Cocaine and Alcohol </TD>
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">D.DEVANAND            </TD>
<TD ALIGN="left">MH50038-03               </TD>
<TD ALIGN="left">Questionable Dementia: Course and Predictors of Outcome </TD>
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">D.DEVANAND            </TD>
<TD ALIGN="left">MH50513-03               </TD>
<TD ALIGN="left">Treatment of Dythymic Disorder in the Elderly </TD>
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">D.DEVANAND            </TD>
<TD ALIGN="left">MH55735-01A1             </TD>
<TD ALIGN="left">Treatment of Behavioral Symptoms in Alzheimer's Disease </TD>
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">L.E-KIMLING           </TD>
<TD ALIGN="left">MH19560-25               </TD>
<TD ALIGN="left">Prospective Study of Children of Schizophrenic Parents </TD>
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">L.E-KIMLING           </TD>
<TD ALIGN="left">MH46617-03               </TD>
<TD ALIGN="left">DNA Marker Study of Linkage to Schizophrenia in Croatia </TD>
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">L.E-KIMLING           </TD>
<TD ALIGN="left">STANLEY FDN              </TD>
<TD ALIGN="left">The High-Risk for Schizophrenia Studies:  Feasibility of (1) Analyzing Pooled Data and (2) Following-up Adult Offsp
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">L.E-KIMLING           </TD>
<TD ALIGN="left">NARSAD                   </TD>
<TD ALIGN="left">Pilot Studies for New High-Risk and Family Research in Schizophrenia </TD>
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">A.EHRHARDT            </TD>
<TD ALIGN="left">MH43520-09               </TD>
<TD ALIGN="left">HIV Center for Clinical and Behavioral Studies </TD>
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">J.ENDICOTT            </TD>
<TD ALIGN="left">PFIZER                   </TD>
<TD ALIGN="left">Double Blind Parallel Comparison of Sertraline & Placebo in Patients with Premenstrual Dysphoric Disorder  #92-R-00
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">J.ENDICOTT            </TD>
<TD ALIGN="left">NARSAD                   </TD>
<TD ALIGN="left">Barriers to Seeking or Receiving Treatment for Major Depressive Disorder </TD>
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">J.ENDICOTT            </TD>
<TD ALIGN="left">HD23512-09               </TD>
<TD ALIGN="left">Severe Premenstrual Syndromes: Risk/ Course/Mechanisms </TD>
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">J.ENDICOTT            </TD>
<TD ALIGN="left">PFIZER                   </TD>
<TD ALIGN="left">Pfizer Review </TD>
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">J.ENDICOTT            </TD>
<TD ALIGN="left">MH49493-03               </TD>
<TD ALIGN="left">Genetic Linkage Studies of Affective Disorders </TD>
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">J.ENDICOTT            </TD>
<TD ALIGN="left">INTERNEURON              </TD>
<TD ALIGN="left">PMS Clinical Trial Study--Protocol # PMS-001-4 </TD>
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">J.ENDICOTT            </TD>
<TD ALIGN="left">MH23864-24               </TD>
<TD ALIGN="left">Collaborative Depression Study </TD>
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">S.EVANS               </TD>
<TD ALIGN="left">DA09114-02               </TD>
<TD ALIGN="left">Vulnerbility to Anxiolytic Abuse in Women </TD>
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">J.FAIRBANKS           </TD>
<TD ALIGN="left">NARSAD                   </TD>
<TD ALIGN="left">High Risk Behaviorial Inhibition Study of Offspring of Depressed Adults </TD>
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">J.FAIRBANKS           </TD>
<TD ALIGN="left">ELI LILLY - AACAP        </TD>
<TD ALIGN="left">Quantitative EEG Pilot Study in Offspring of Adults with Depressive and Anxiety Disorders</TD>
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">B.FALLON              </TD>
<TD ALIGN="left">MH49409-04               </TD>
<TD ALIGN="left">Hypochondriasis: Controlled Treatment Study </TD>
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">B.FALLON              </TD>
<TD ALIGN="left">LYME RESEARCH FDN        </TD>
<TD ALIGN="left">Neurobiological and Neuropsychological Studies of Late Lyme Disease </TD>
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">B.FALLON              </TD>
<TD ALIGN="left">SOLVAY                   </TD>
<TD ALIGN="left">Fluvoxamine in Hypochondriasis </TD>
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">W.FIFER               </TD>
<TD ALIGN="left">HD32774-03               </TD>
<TD ALIGN="left">Perinatal Assessments in Risk Populations </TD>
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">W.FIFER               </TD>
<TD ALIGN="left">COLUMBIA UNIV *PA        </TD>
<TD ALIGN="left">Subcontract w/CU: Fetal Activity and Hypoxia During Development </TD>
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">M.FISCHMAN            </TD>
<TD ALIGN="left">TAP PHARM                </TD>
<TD ALIGN="left">Safety, Psychological Effects and Behavioral Effects of A-77000 </TD>
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">M.FISCHMAN            </TD>
<TD ALIGN="left">DA03476-13               </TD>
<TD ALIGN="left">Drug Effects on Behavior -- Workplace Implications </TD>
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">A.FLISHER             </TD>
<TD ALIGN="left">NARSAD                   </TD>
<TD ALIGN="left">Unmet Need for Psychiatric Services in Children with Schizophrenia, Major Affective Disorders, and Other Serious Me
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">R.FOLTIN              </TD>
<TD ALIGN="left">MH50451-04               </TD>
<TD ALIGN="left">Biopsychology of Human Feeding Behavior </TD>
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">R.FOLTIN              </TD>
<TD ALIGN="left">DA08464-03               </TD>
<TD ALIGN="left">A Novel Animal Model for Treating Cocaine Craving </TD>
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">R.FOLTIN              </TD>
<TD ALIGN="left">DA08105-04 *PA           </TD>
<TD ALIGN="left">Laboratory Analysis of Cocaine Abstinence </TD>
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">R.FOLTIN              </TD>
<TD ALIGN="left">DA04130-10               </TD>
<TD ALIGN="left">Anorectic Drugs -- Abuse and Behavioral Mechanisms of Action </TD>
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">L.FREEDMAN            </TD>
<TD ALIGN="left">NARSAD                   </TD>
<TD ALIGN="left">Working Memory and Negative Priming in Schizophrenic Patients, Normal Controls, and Thier Families</TD>
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">D.FRIEDMAN            </TD>
<TD ALIGN="left">AG05213-10               </TD>
<TD ALIGN="left">The Effects of Aging on Cognitive ERPD/Cardiac Waveffect </TD>
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">D.FRIEDMAN            </TD>
<TD ALIGN="left">HD14959-11A1             </TD>
<TD ALIGN="left">The Maturation of Cognitive-Related Brain Potentials </TD>
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">D.FRIEDMAN            </TD>
<TD ALIGN="left">AG09988-05               </TD>
<TD ALIGN="left">Age-Related ERP Measures in Alzheimer's Disease </TD>
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">A.FYER                </TD>
<TD ALIGN="left">MH46934-04               </TD>
<TD ALIGN="left">Familial Transmission of Simple Phobias and Fears </TD>
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">A.FYER                </TD>
<TD ALIGN="left">MH44175-06               </TD>
<TD ALIGN="left">Family Study of Obsessive Compulsive Disorder </TD>
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">A.FYER                </TD>
<TD ALIGN="left">SOLVAY                   </TD>
<TD ALIGN="left">Fluvoxamine in the Treatment of Social Phobia </TD>
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">C.GHEZ                </TD>
<TD ALIGN="left">NS31391-04               </TD>
<TD ALIGN="left">Cerebellar Control of Multijoint Limb Movement </TD>
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">C.GHEZ                </TD>
<TD ALIGN="left">NS22715-11               </TD>
<TD ALIGN="left">Trajectory Specification in Targeted Limb Movement </TD>
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">C.GHEZ                </TD>
<TD ALIGN="left">NORTHSHORE UNIV          </TD>
<TD ALIGN="left">PET and Parkinsonism:  A Multicenter Collaborative Study </TD>
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">J.GIBBON              </TD>
<TD ALIGN="left">MH41649-11               </TD>
<TD ALIGN="left">Theory of Animal Timing: Memory and Choice </TD>
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">T.GILLIAM             </TD>
<TD ALIGN="left">FAM OF SMA               </TD>
<TD ALIGN="left">Characterization of the S.M.A. Genes </TD>
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">T.GILLIAM             </TD>
<TD ALIGN="left">MDA                      </TD>
<TD ALIGN="left">Characterization of Deleted DNA from SMA Patients </TD>
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">J.GINGRICH            </TD>
<TD ALIGN="left">NARSAD                   </TD>
<TD ALIGN="left">Behavioral and Neurochemical Effects of Constitutive and Inducible Knockouts of the Synaptic Serotonin Transporter 
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">A.GLASSMAN            </TD>
<TD ALIGN="left">ELI LILLY                </TD>
<TD ALIGN="left">Fluox/Nortriptyline: Treatment of MDD in Cardiac Patients </TD>
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">A.GLASSMAN            </TD>
<TD ALIGN="left">PFIZER                   </TD>
<TD ALIGN="left">Double-Blind Parallel Comparison of Sertraline and Placebo for Smoking Cessation in Smokers with a History of Depre
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">A.GLASSMAN            </TD>
<TD ALIGN="left">DuPONT                   </TD>
<TD ALIGN="left">Naltrexone with a Nicotine Patch as Adjunctive Treatment to Psychosocial Therapy for Prevention of Smoking Relapse<
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">K.GOGGIN              </TD>
<TD ALIGN="left">AARON DIAMOND            </TD>
<TD ALIGN="left">Quality of Life and Death in HIV Illness: Integration of Longitudinal Data from Two Cohorts</TD>
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">J.GORMAN              </TD>
<TD ALIGN="left">IRI                      </TD>
<TD ALIGN="left">Corticotropin-Releasing Factor and Thymopoietin Levels During Lactate-Induced Panic in Patients with a Diagnosis of
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">J.GORMAN              </TD>
<TD ALIGN="left">MH41778-09               </TD>
<TD ALIGN="left">Carbon Dioxide Challenge of Panic Disorder </TD>
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">J.GORMAN              </TD>
<TD ALIGN="left">MH50727-03               </TD>
<TD ALIGN="left">Developing Scizophrenia Research Center </TD>
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">J.GORMAN              </TD>
<TD ALIGN="left">NYU MED CNTR             </TD>
<TD ALIGN="left">Subcontract with NYU Medical Center: Visual Processing Deficits in Schizophrenia: Mechanisms</TD>
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">M.GOULD               </TD>
<TD ALIGN="left">MH47559-05               </TD>
<TD ALIGN="left">Psychological Autopsy of Cluster Suicides </TD>
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">M.GOULD               </TD>
<TD ALIGN="left">MH52827-02               </TD>
<TD ALIGN="left">Epidemiologic Sequelae of Suicide in Schools </TD>
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">M.GOULD               </TD>
<TD ALIGN="left">MH56250-01               </TD>
<TD ALIGN="left">Sudden Death and Psychotropic Medication in Youth </TD>
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">L.GREENHILL           </TD>
<TD ALIGN="left">MH50454-05               </TD>
<TD ALIGN="left">Multimodal Treatment of ADHD in an Urban Setting </TD>
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">L.GREENHILL           </TD>
<TD ALIGN="left">MH47113-04               </TD>
<TD ALIGN="left">Biological Studies in Suicidal Adolescent Inpatients </TD>
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">L.GREENHILL           </TD>
<TD ALIGN="left">RICHWOOD PHARM           </TD>
<TD ALIGN="left">The Effects of Obetrol in Comparison to Methylphenidate in the Treatment of Children with Attention Deficit Hyperac
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">L.GREENHILL           </TD>
<TD ALIGN="left">MH60005                  </TD>
<TD ALIGN="left">Research Units in Pediatric Psychopharmocology </TD>
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">M.HANEY               </TD>
<TD ALIGN="left">AARON DIAMOND FDN        </TD>
<TD ALIGN="left">Behavioral Analysis of Human Cocaine Self-Administration </TD>
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">D.HASIN               </TD>
<TD ALIGN="left">DA08409-03               </TD>
<TD ALIGN="left">Course of Drug Use Disorders: Effects of Comorbidity </TD>
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">D.HASIN               </TD>
<TD ALIGN="left">AA08159-05               </TD>
<TD ALIGN="left">Alcohol Dependence: General Population Validity </TD>
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">M.HOFER               </TD>
<TD ALIGN="left">MH40430-14               </TD>
<TD ALIGN="left">The Developmental Effects of Early Maternal Separation </TD>
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">C.HOVEN               </TD>
<TD ALIGN="left">MH46091-04               </TD>
<TD ALIGN="left">Alternative Service Patterns for Children with SED </TD>
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">C.HOVEN               </TD>
<TD ALIGN="left">TI11283-01               </TD>
<TD ALIGN="left">Effects of Medicaid Managed Care on AOD and MH Services </TD>
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">J.HUNTER              </TD>
<TD ALIGN="left">NYC AIDS FUND            </TD>
<TD ALIGN="left">Working it Out: A Community Based Strategy For Dissemination of HIV Prevention Video for Gay, Lesbian and Bisexual 
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">D.HUTCHINGS           </TD>
<TD ALIGN="left">DA07822-04               </TD>
<TD ALIGN="left">Methadone During Pregnancy: Neurobehavioral Effects </TD>
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">J.KEILP               </TD>
<TD ALIGN="left">NARSAD                   </TD>
<TD ALIGN="left">Neuropsychological Characteristics of Suicide </TD>
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">H.KLEBER              </TD>
<TD ALIGN="left">DA08650-02               </TD>
<TD ALIGN="left">Treatment of Cocaine Abuse & Attenetion Deficit Disorder </TD>
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">H.KLEBER              </TD>
<TD ALIGN="left">DA09236-03               </TD>
<TD ALIGN="left">Novel Medication Approaches for Substance Abuse </TD>
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">R.KLEIN               </TD>
<TD ALIGN="left">MH35779-12               </TD>
<TD ALIGN="left">Methylphenidate in Childhood Behavior Disorders </TD>
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">R.KLEIN               </TD>
<TD ALIGN="left">SMITHKLINE               </TD>
<TD ALIGN="left">A Multi-Center, Double-Blind, Placebo-Controlled Study of Paroxine and Imapramine in Adolescents with Unipolar Majo
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">D.KLEIN               </TD>
<TD ALIGN="left">MH30906-19               </TD>
<TD ALIGN="left">MHCRC-New York State Psychiatric Institute </TD>
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">R.KLEIN               </TD>
<TD ALIGN="left">NARSAD                   </TD>
<TD ALIGN="left">Natural Course of Adolescent Major Depression </TD>
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">J.KLINE               </TD>
<TD ALIGN="left">AG10251-05               </TD>
<TD ALIGN="left">Epidemiology of Trisomy and Aging </TD>
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">J.KOESTER             </TD>
<TD ALIGN="left">NS19328-10               </TD>
<TD ALIGN="left">Cellular Neuronal Control of Behavior </TD>
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">I.KUPFERMANN          </TD>
<TD ALIGN="left">GM32099-14               </TD>
<TD ALIGN="left">Cellular Analysis of Behavior </TD>
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">I.KUPFERMANN          </TD>
<TD ALIGN="left">MH35564-23               </TD>
<TD ALIGN="left">Behavioral and Neural Analysis of Learning </TD>
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">M.LARUELLE            </TD>
<TD ALIGN="left">NARSAD                   </TD>
<TD ALIGN="left">SPECT Measeurment of the Dopamine Release Following Amphetamine Challenge in Schizophrenia</TD>
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">M.LARUELLE            </TD>
<TD ALIGN="left">MH54192-02               </TD>
<TD ALIGN="left">SPECT Imaging of Dopamine Function in Schizophrenia </TD>
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">M.LIEBOWITZ           </TD>
<TD ALIGN="left">GLAXO                    </TD>
<TD ALIGN="left">Double-Blind Placebo-Controlled Fixed Dose Evaluation of the Safety and Efficacy of Oral Ondansetron in Treatment o
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">M.LIEBOWITZ           </TD>
<TD ALIGN="left">MH55165-01A1             </TD>
<TD ALIGN="left">Long-Term Treatment of Social Phobia </TD>
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">M.LIEBOWITZ           </TD>
<TD ALIGN="left">SYNTHELABO               </TD>
<TD ALIGN="left">A Pilot Phase II Double-Blind, Placebo-Controlled, Dose Escalation (5, 10,20 mg) Befloxatone Study of 9 Wks Duratio
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">M.LIEBOWITZ           </TD>
<TD ALIGN="left">MH40121-12               </TD>
<TD ALIGN="left">Pharmacotherapy of Social Phobia </TD>
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">M.LIEBOWITZ           </TD>
<TD ALIGN="left">MH45436-05A2             </TD>
<TD ALIGN="left">Clomipramine and Behavior Theraphy in OCD </TD>
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">M.LIEBOWITZ           </TD>
<TD ALIGN="left">SOLVAY PHARM.            </TD>
<TD ALIGN="left">Brain Imaging Pre- and Post- Treatment in Social Phobia Patients </TD>
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">M.LIEBOWITZ           </TD>
<TD ALIGN="left">SMITHKLINE               </TD>
<TD ALIGN="left">A Double-blind, Placebo Controlled Trial to Evaluate the Clinical Effects of Immediate Release Paroxetine and Modif
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">B.LINK                </TD>
<TD ALIGN="left">NARSAD                   </TD>
<TD ALIGN="left">Developing an Intervention to Empower People with Mental Illness to Overcome Stigma</TD>
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">J.LIPSITZ             </TD>
<TD ALIGN="left">MH53985-01               </TD>
<TD ALIGN="left">Interpersonal Psychotherapy for Social Phobia </TD>
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">S.LISANBY             </TD>
<TD ALIGN="left">NARSAD                   </TD>
<TD ALIGN="left">The Neurobiology of Emotional Processing and the Treatment of Mood Disorders: Transcranial Magnetic Stimulation Stu
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">E.LUKENS              </TD>
<TD ALIGN="left">NARSAD                   </TD>
<TD ALIGN="left">A Prospective Study of Stress and Outcome Among Patients with Schizophrenia and Their Family Caregivers</TD>
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">D.MALASPINA           </TD>
<TD ALIGN="left">NARSAD                   </TD>
<TD ALIGN="left">Neurocardiologic Indices of Autonomic Nervous System in Schizophrenia </TD>
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">J.MANN                </TD>
<TD ALIGN="left">MH40210-12               </TD>
<TD ALIGN="left">Postmortem Neurochemical Studies in Suicide </TD>
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">J.MANN                </TD>
<TD ALIGN="left">MH46745-08               </TD>
<TD ALIGN="left">MHCRC for the Study of Suicidal Behavior </TD>
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">R.MARSHALL            </TD>
<TD ALIGN="left">SMITHKLINE               </TD>
<TD ALIGN="left">A Prospective, Double-Blind, Placebo-Controlled Trial of Paroxetine for Post- Traumatic Stress Disorder Among Civil
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">J.MARTIN              </TD>
<TD ALIGN="left">IBN-9421582              </TD>
<TD ALIGN="left">Motor Cortical Control of Reaching in Cats </TD>
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">P.MCGRATH             </TD>
<TD ALIGN="left">AA09539-05               </TD>
<TD ALIGN="left">Fluoxetine Therapy of Alcoholics with Primary Depression </TD>
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">L.MILLER              </TD>
<TD ALIGN="left">NARSAD                   </TD>
<TD ALIGN="left">Parental Depression and Child Maladjustment </TD>
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">D.MOREAU              </TD>
<TD ALIGN="left">MH50527-02               </TD>
<TD ALIGN="left">Validation Study of Panic Disorder </TD>
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">L.MUFSON              </TD>
<TD ALIGN="left">MH48715-05               </TD>
<TD ALIGN="left">Interpersonal Therapy for Depressed Adolescents </TD>
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">M.MYERS               </TD>
<TD ALIGN="left">COLUMBIA UNIV *PA        </TD>
<TD ALIGN="left">Subcontract w/CU: Fetal Activity and Hypoxia During Development </TD>
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">M.NOBLER              </TD>
<TD ALIGN="left">NARSAD                   </TD>
<TD ALIGN="left">Regional Cerebral Blood Flow in Depression: Effects of Antidepressant Medications</TD>
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">E.NUNES               </TD>
<TD ALIGN="left">DA08950-03               </TD>
<TD ALIGN="left">Sertraline Treatment of Depressed Methadone Patients </TD>
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">E.NUNES               </TD>
<TD ALIGN="left">DA09582-02               </TD>
<TD ALIGN="left">Early Phase II Trials for Cocaine Medication Development </TD>
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">J.OLDHAM              </TD>
<TD ALIGN="left">MENTAL ILLNESS           </TD>
<TD ALIGN="left">The Dopamine System </TD>
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">L.PAPP                </TD>
<TD ALIGN="left">MH53582-01A3             </TD>
<TD ALIGN="left">Psychosocial Treatment of Late-Life Anxiety Disorders </TD>
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">B.PARSONS             </TD>
<TD ALIGN="left">NARSAD                   </TD>
<TD ALIGN="left">Dopaminergic Aspects of Adolescent and Adult Suicide </TD>
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">B.PARSONS             </TD>
<TD ALIGN="left">UNIV OF ARKANSAS         </TD>
<TD ALIGN="left">Subcontract w/Univ of Arkansas: Brain Serotonin Receptors in Schizophrenia: Molecular and Autoradiographic Studies<
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">B.PARSONS             </TD>
<TD ALIGN="left">UNIV OF ARKANSAS         </TD>
<TD ALIGN="left">Subcontract w/Univ of Arkansas: Brain Serotonin Receptors in Schizophrenia: Molecular and Autoradiographic Studies<
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">F.QUITKIN             </TD>
<TD ALIGN="left">SYNTHELABO               </TD>
<TD ALIGN="left">A Pilot Phase II Double-blind Placebo-Controlled dose-escalation (5,10,20 mg.) Befloxatone Study of 9 Weeks Duratio
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">J.RABKIN              </TD>
<TD ALIGN="left">ROERIG                   </TD>
<TD ALIGN="left">Quality of Life of AIDS Longterm Survivors - One Year Follow-Up </TD>
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">J.RABKIN              </TD>
<TD ALIGN="left">PFIZER                   </TD>
<TD ALIGN="left">Open Trial of Sertraline in Outpatients w/HIV Spectrum Illness & Major Depresion</TD>
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">J.RABKIN              </TD>
<TD ALIGN="left">MH45652-08               </TD>
<TD ALIGN="left">Fluoxetine Effects on Depression & Immune Status in HIV </TD>
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">J.RABKIN              </TD>
<TD ALIGN="left">MH52037-04               </TD>
<TD ALIGN="left">Mood Effects of Testosterone VS Fluoxetine in HIV Illness </TD>
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">J.RABKIN              </TD>
<TD ALIGN="left">263-MD-428644            </TD>
<TD ALIGN="left">NIMH PO: Subsyndromal Depression in HIV-Workgroup </TD>
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">J.RABKIN              </TD>
<TD ALIGN="left">ALZA CORPORATION         </TD>
<TD ALIGN="left">A Randomized Controlled Trial of the Effect of Testosterone Replacement Testoderm..) Upon Body Composition in Hypog
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">S.RAYPORT             </TD>
<TD ALIGN="left">DA08675-03               </TD>
<TD ALIGN="left">Psychostimulant Action at Mesoaccumbens Synapses </TD>
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">R.REMIEN              </TD>
<TD ALIGN="left">NIMH-PO                  </TD>
<TD ALIGN="left">Coping Effectiveness Training (CET) in a New York City Group of HIV+ Gay Men </TD>
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">R.REMIEN              </TD>
<TD ALIGN="left">MH55932-01A1             </TD>
<TD ALIGN="left">Group Intervention for Male Couples of Mixed HIV Status </TD>
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">L.ROLE                </TD>
<TD ALIGN="left">DA09366-02               </TD>
<TD ALIGN="left">Presynaptic Aspects of Nicotine Addiction </TD>
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">S.ROOSE               </TD>
<TD ALIGN="left">SMITHKLINE BEECH         </TD>
<TD ALIGN="left">Paroxetine in Depressed Patients with Ischemic Heart Disease - A Multicenter Randomized Safety Study</TD>
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">S.ROOSE               </TD>
<TD ALIGN="left">QUINTILES PACIFIC        </TD>
<TD ALIGN="left">Double-Blind, Placebo-Controlled Study of Venlafaxine & Fluoxetine in Geriatric Outpatients with Major Depression</
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">E.RUBIN               </TD>
<TD ALIGN="left">NARSAD                   </TD>
<TD ALIGN="left">Depressed Mood Induction and Changes in Brain Activity </TD>
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">H.SACKEIM             </TD>
<TD ALIGN="left">MH47739-05               </TD>
<TD ALIGN="left">Continuation Pharmacotherapy Following ECT </TD>
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">H.SACKEIM             </TD>
<TD ALIGN="left">MH35636-15               </TD>
<TD ALIGN="left">Affective and Cognitive Consequences of ECT </TD>
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">H.SACKEIM             </TD>
<TD ALIGN="left">NARSAD                   </TD>
<TD ALIGN="left">Focal Magnetic Brain Stimulation:  Development of a New Treatment </TD>
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">S.SALZINGER           </TD>
<TD ALIGN="left">MH48917-04               </TD>
<TD ALIGN="left">Social Relationships of Abused Schoolchildren </TD>
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">J.SATRIANO            </TD>
<TD ALIGN="left">RR10189-02               </TD>
<TD ALIGN="left">Intro to Psychiatric Research for Minority Students </TD>
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">S.SCHACHER            </TD>
<TD ALIGN="left">NS27541-08               </TD>
<TD ALIGN="left">Strategies for Synapse Specificity </TD>
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">S.SCHACHER            </TD>
<TD ALIGN="left">NSF IBN-9421438          </TD>
<TD ALIGN="left">Synapse Formation and Plasticity: Synapse Elimination </TD>
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">D.SCHECHTER           </TD>
<TD ALIGN="left">NARSAD                   </TD>
<TD ALIGN="left">Course of Psychotic Disorders in Women: Severity of Symptoms in Relation to Menstrual Cycle Phases and Ovarian Ster
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">J.SCHWARTZ            </TD>
<TD ALIGN="left">NS29255-05A1             </TD>
<TD ALIGN="left">Protein Kinases -- Molecular Roles in Producing Behavior </TD>
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">A.SERACINI            </TD>
<TD ALIGN="left">AARON DIAMOND            </TD>
<TD ALIGN="left">Achieving Abstinence in Pregnant Cocaine Addicts: Novel Behavioral Approach </TD>
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">D.SHAFFER             </TD>
<TD ALIGN="left">AMERICAN MH FUND         </TD>
<TD ALIGN="left">Studies in Adoloescent Suicide </TD>
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">D.SHAFFER             </TD>
<TD ALIGN="left">MH43878-07               </TD>
<TD ALIGN="left">Center to Study Depression, Anxiety and Suicide </TD>
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">D.SHAFFER             </TD>
<TD ALIGN="left">MH52822-03               </TD>
<TD ALIGN="left">From Research to Practice: The CDISC in Clinical Services </TD>
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">D.SHAFFER             </TD>
<TD ALIGN="left">MH55189-01               </TD>
<TD ALIGN="left">Suicidal Youth Four Years After Preventive Screening </TD>
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">Z.SHARIF              </TD>
<TD ALIGN="left">ZENECA PHARM             </TD>
<TD ALIGN="left">Multicenter Double-Blind Placebo-Cntrl...Comparison of Seroquel & Haloperidol in Treatment of Hospitalized Subjects
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">Z.SHARIF              </TD>
<TD ALIGN="left">PFIZER                   </TD>
<TD ALIGN="left">Double-Blind..Placebo-Controlled Study..Efficacy and Safety of..Oral CP-88,059-1 in the Acute Exacerbation of Schiz
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">Z.SHARIF              </TD>
<TD ALIGN="left">NARSAD                   </TD>
<TD ALIGN="left">Pain Insensitivity and Thalamic Size in Schizophrenia </TD>
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">Z.SHARIF              </TD>
<TD ALIGN="left">PFIZER                   </TD>
<TD ALIGN="left">Phase III Six-Week Double-Blind Multicenter Placebo Controlled Study Evaluating the Efficacy & Safety of Three-Fixe
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">Z.SHARIF              </TD>
<TD ALIGN="left">JANSSEN PHARM            </TD>
<TD ALIGN="left">Mazapertine Dose-Finding Trial, Comparing Three Fixed Dosages of Mazapetine to Risperidone & Placebo: Multicenter, 
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">A.SKODOL              </TD>
<TD ALIGN="left">MH50839-01A3             </TD>
<TD ALIGN="left">Collaborative Longitudinal Study of Personality Disorders </TD>
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">C.SOBIN               </TD>
<TD ALIGN="left">NARSAD                   </TD>
<TD ALIGN="left">The Multi-Dimensional Assessment of Psychomotor Symptoms in Major Depression </TD>
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">B.STANLEY             </TD>
<TD ALIGN="left">PFIZER                   </TD>
<TD ALIGN="left">Open Study of Sertraline in Depressed Outpatients Discontinued from Fluoxetine </TD>
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">B.STANLEY             </TD>
<TD ALIGN="left">MH41847-06               </TD>
<TD ALIGN="left">Biochemical Aspects of Suicidal Behavior </TD>
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">J.STEWART             </TD>
<TD ALIGN="left">MH50949-03               </TD>
<TD ALIGN="left">Family Study of Atypical Depression and Melancholia </TD>
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">D.STRAUSS             </TD>
<TD ALIGN="left">MH49796-02               </TD>
<TD ALIGN="left">Autoimmune Phenomena in Schizophrenia </TD>
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">E.STREUNING           </TD>
<TD ALIGN="left">NYC #97206               </TD>
<TD ALIGN="left">CSS Case Management Study A-PLUS </TD>
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">E.STRUENING           </TD>
<TD ALIGN="left">MH88 M076567101          </TD>
<TD ALIGN="left">Secondary Analysis of Data From a NYSPI Epidemilogic Survey of Homeless ... </TD>
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">E.STRUENING           </TD>
<TD ALIGN="left">NYC #97206               </TD>
<TD ALIGN="left">CSS -  Shelter and Survey </TD>
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">E.STRUENING           </TD>
<TD ALIGN="left">NYC #97206               </TD>
<TD ALIGN="left">CSS - Residential Placement Management System </TD>
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">D.SULZER              </TD>
<TD ALIGN="left">DA07418-06A1             </TD>
<TD ALIGN="left">Amphetamine Action in Midbrain Dopamine Neuronal Culture </TD>
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">E.SUSSER              </TD>
<TD ALIGN="left">STANLEY FDN              </TD>
<TD ALIGN="left">Prenatal Risk Factors in Schizophrenia </TD>
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">E.SUSSER              </TD>
<TD ALIGN="left">NARSAD                   </TD>
<TD ALIGN="left">Prenatal Determinants of Schizophrenia </TD>
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">E.SUSSER              </TD>
<TD ALIGN="left">MH53147-01A3             </TD>
<TD ALIGN="left">Prenatal Determinants of Schizophrenia </TD>
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">E.SUSSER              </TD>
<TD ALIGN="left">CCU213472-01             </TD>
<TD ALIGN="left">Secondary Analysis of Sex, Games & Videotapes: An HIV Prevention Intervention for Homeless Men w/Severe & Persistan
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">H.TAMIR               </TD>
<TD ALIGN="left">DK52139-01               </TD>
<TD ALIGN="left">Serotonergic Vesicles:  Acidification and Secretion </TD>
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">H.TAMIR               </TD>
<TD ALIGN="left">AMER SUICIDE FDN         </TD>
<TD ALIGN="left">Signal-transduction G Proteins in the Brains of Suicide Victims </TD>
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">M.TERMAN              </TD>
<TD ALIGN="left">MH42931-08               </TD>
<TD ALIGN="left">Light Therapy for Seasonal Affective Disorder </TD>
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">J.TERWILLIGER         </TD>
<TD ALIGN="left">NARSAD                   </TD>
<TD ALIGN="left">Statistical Methods for Polygenic Trait Analysis </TD>
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">J.TOWEY               </TD>
<TD ALIGN="left">MH44815-06               </TD>
<TD ALIGN="left">Endogenous ERP's in Obsessive-Compulsive Disorder </TD>
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">S.TROSS               </TD>
<TD ALIGN="left">PRESB HOSPITAL           </TD>
<TD ALIGN="left">Subcontract w/Presbyterian Hospital: Mental Health Services for Families Affected by HIV</TD>
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">G.WAGNER              </TD>
<TD ALIGN="left">MH54931-02               </TD>
<TD ALIGN="left">Depression Treatment in Mobile & Homebound AIDS Patients </TD>
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">R.WALLACE             </TD>
<TD ALIGN="left">R WOOD JOHNSON           </TD>
<TD ALIGN="left">How Inner City Decay Affects Metropoloitan Regions and the Nation </TD>
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">T.WALSH               </TD>
<TD ALIGN="left">ELI LILLY                </TD>
<TD ALIGN="left">Fluoxetine vs. Placebo: Longterm Safety in Bulimia Nervosa </TD>
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">T.WALSH               </TD>
<TD ALIGN="left">MH49886-04               </TD>
<TD ALIGN="left">Psychological Treatment of Bulimia Nervosa </TD>
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">G.WASSERMAN           </TD>
<TD ALIGN="left">W T GRANT FDN            </TD>
<TD ALIGN="left">Unraveling Girls' Antisocial Behavior </TD>
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">M.WEISSMAN            </TD>
<TD ALIGN="left">UPJOHN                   </TD>
<TD ALIGN="left">Sleep Disturbances and Cross National Studies </TD>
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">M.WEISSMAN            </TD>
<TD ALIGN="left">MH50666-04               </TD>
<TD ALIGN="left">Depressed Chidren Grown Up </TD>
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">M.WEISSMAN            </TD>
<TD ALIGN="left">SOLVAY                   </TD>
<TD ALIGN="left">Solvay Cross National Study </TD>
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">M.WEISSMAN            </TD>
<TD ALIGN="left">MH28274-21               </TD>
<TD ALIGN="left">Genetic Studies of Depressive Disorders </TD>
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">A.WHALEY              </TD>
<TD ALIGN="left">MH55561-01A1             </TD>
<TD ALIGN="left">Cultural Mistrust and Psychiatric Diagnoses of Blacks </TD>
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">S.WOLK                </TD>
<TD ALIGN="left">AMER SUICIDE FDN         </TD>
<TD ALIGN="left">Serotonin Measures in Adults with Childhood-Onset MDD </TD>
</FONT></TR>
<TR VALIGN="top"><FONT FACE="Arial">
<TD ALIGN="left">P.WU                  </TD>
<TD ALIGN="left">NARSAD                   </TD>
<TD ALIGN="left">Service Use Patterns of Depressed Youth </TD>
</FONT></TR>
</TABLE>
</CENTER>
</body>
</html>
</DOC>
<DOC>
<DOCNO>WT02-B10-281</DOCNO>
<DOCOLDNO>IA093-000995-B028-441</DOCOLDNO>
<DOCHDR>
http://www.nyspi.cpmc.columbia.edu:80/NYSPI/RESPAPRS/RSP_INDX.HTM 156.111.80.30 19970121072218 text/html 2927
HTTP/1.0 200 OK
MIME-Version: 1.0
Server: GLACI/2.01
Date: Tue Jan 21 02:26:25 1997
Content-Type: text/html
Content-Length: 2797
</DOCHDR>
<TITLE>NYSPI - Research Materials</TITLE>


<BODY BACKGROUND="/IMAGES/MARBLE.JPG">

<H1>NYSPI - Research Materials</H1>
<HR>
<H2>Medical Genetics</H2>
<p>
<H3>"Naming norms for brief environmental sounds: Effects of age and dementia"</H3>
<P>
By:
<BR>
Monica Fabiani, Victoria A. Kazmerski, Yael M. Cycowicz,
and David Friedman
<BR>Cognitive Electrophysiology Laboratory
<BR>New York State Psychiatric Institute
<P>
Psychophysiology, in press
<P><P>
Brief non-tonal sounds are used in electrophysiology in
the novelty oddball paradigm.  These sounds vary in the
brain activity they elicit and in the degree to which they can
be identified, named, and remembered.  Because ease of sound
identification may influence sound processing, naming and
conceptual norms were determined for 100 sounds for 77 young
adults.  Naming ability decreases in normal and pathological
aging.  Therefore, norms were also derived for older adults and
for probable Alzheimer's disease patients.  With respect to the
young, perseverative naming behavior increased in these groups,
and sound and picture naming performance were correlated.
Finally, The sound naming performance of children aged 5-6,
9-11 and 14-16 years was compared.  Name and conceptual
agreements improved with age, whereas perseverative behavior
decreased. These normative data should be useful in guiding sound
selection in future studies and help clarify the relationships
between sound naming and other variables, including direct and
indirect memory performance.
<P>
This paper contains the following 6 files:
<P>
   1)   <A HREF="ftp://156.111.80.180/sys/users/rfmh/pub/research/readme.txt">README.TXT (this file)</A>
<P>
2-4)  <A HREF="ftp://156.111.80.180/sys/users/rfmh/pub/research/snd.zip">SND.ZIP</A>,<A HREF="ftp://156.111.80.180/sys/users/rfmh/pub/research/wav.zip"> WAV.ZIP</A>, and <A HREF="ftp://156.111.80.180/sys/users/rfmh/pub/research/wav(scl).zip">WAV(SCL).ZIP</A> which are, respectively, the sound files
     in Neuroscan format (*.snd), the sounds in wave format, and the scaled
     (i.e.volume adjusted) sounds in wave format.  Note that the norms were
     derived on the basis of the *.snd sound files.  The wave files are not
     identical due to translation factors.
<P>
5)  <A HREF="ftp://156.111.80.180/sys/users/rfmh/pub/research/scaling.txt">SCALING.TXT</A> contains the scaling factors to use with Neuroscan to obtain
     a volume of 92 dB.  Note that the wave and scaled wave sounds need to be
     calibrated for volume, because their actual intensity was not tested in
     our study.
<P>
6)   <A HREF="ftp://156.111.80.180/sys/users/rfmh/pub/research/sounddb.zip">SOUNDDB.ZIP</A> contains the sound norm database in Paradox (db) format.

</BODY>



</DOC>
<DOC>
<DOCNO>WT02-B10-282</DOCNO>
<DOCOLDNO>IA093-000995-B030-446</DOCOLDNO>
<DOCHDR>
http://www.nyspi.cpmc.columbia.edu:80/NYSPI/RFMHGRNT/FORM_HOM.htm 156.111.80.30 19970121073536 text/html 1324
HTTP/1.0 200 OK
MIME-Version: 1.0
Server: GLACI/2.01
Date: Tue Jan 21 02:39:39 1997
Content-Type: text/html
Content-Length: 1194
</DOCHDR>
<HTML>
<HEAD>
<TITLE>RFMH Forms</TITLE>

<META NAME="GENERATOR" CONTENT="Internet Assistant for Microsoft Word 2.0z">
</HEAD>
<BODY BACKGROUND="/images/marble.jpg">
<P>
<h1 align="center"><font size="7">SPONSORED RESEARCH</font></h1>

<h1 align="center"><font size="5">RESEARCH FOUNDATION FOR MENTAL HYGIENE,INC.</font></h1>
<P>
<P>
<h1 align="center"><font size="5">NEW YORK STATE PSYCHIATRIC INSTITUTE</font></h1>
<BR>
<BR>
<H1><CENTER><FONT SIZE=5>GRANT APPLICATION FORMS<BR></FONT></CENTER></H1>
<BR>
<BR>
<BR>
<A HREF="398blank.WK4"><B><FONT SIZE=5>BUDGET TEMPLATE FOR NIH GRANT APPLICATIONS </FONT></B></A><FONT SIZE=5>
</FONT>(PHS 398)
<P>
<A HREF="http://tram.rice.edu/TRAM/forms/index.html" ><B><FONT SIZE=5>NIH GRANT APPLICATION FORMS </FONT></B></A><FONT SIZE=4>
</FONT>(web link) 
<P>
<A HREF="http://www.nih.gov/grants/phs398/phs398.html" ><B><FONT SIZE=5>PHS 398 </FONT></B></A><FONT SIZE=4>
</FONT>(online version of NIH NEW AND RENEWAL grant application
package)
<P>
<A HREF="http://www.nih.gov/grants/funding/2590/2590.htm" ><B><FONT SIZE=5>PHS 2590  </FONT></B></A>
 (online version of NIH NONCOMPETING application package)
</BODY>
</HTML>

</DOC>
<DOC>
<DOCNO>WT02-B10-283</DOCNO>
<DOCOLDNO>IA093-000995-B028-427</DOCOLDNO>
<DOCHDR>
http://www.nyspi.cpmc.columbia.edu:80/NYSPI/RFMHGRNT/RF_SPON1.HTM 156.111.80.30 19970121072209 text/html 901
HTTP/1.0 200 OK
MIME-Version: 1.0
Server: GLACI/2.01
Date: Tue Jan 21 02:26:17 1997
Content-Type: text/html
Content-Length: 772
</DOCHDR>
<!DOCTYPE HTML PUBLIC "-//IETF//DTD HTML//EN">
<html>

<head>
<meta http-equiv="Content-Type"
content="text/html; charset=iso-8859-1">
<meta name="GENERATOR" content="Microsoft FrontPage 2.0">
<title>RFMH Sponsored Research Home</title>
</head>

<body background="/images/marble.jpg">

<h1 align="center"><font size="7">SPONSORED RESEARCH</font></h1>

<h1 align="center"><font size="5">RESEARCH FOUNDATION FOR MENTAL HYGIENE,
INC.</font></h1>

<h1 align="center"><font size="5">NEW YORK STATE PSYCHIATRIC INSTITUTE</font></h1>
<br>
<br>
<br>

<p><font size="5">
<a href="FORM_HOM.htm"><b>GRANT APPLICATION FORMS</b> </a>(including
budget template)</p>

<p><a href="RF_SPON.HTM"><b>NYSPI Sponsored Research</b></a>
</font></p>
</body>
</html>
</DOC>
<DOC>
<DOCNO>WT02-B10-284</DOCNO>
<DOCOLDNO>IA038-000734-B028-157</DOCOLDNO>
<DOCHDR>
http://zippo.com:80/home.htm 205.185.79.4 19970210062735 text/html 5880
HTTP/1.0 200 Document follows
Date: Mon, 10 Feb 1997 06:29:30 GMT
Server: NCSA/1.5
Content-type: text/html
Last-modified: Thu, 06 Feb 1997 21:46:51 GMT
Content-length: 5706
</DOCHDR>
<!DOCTYPE HTML PUBLIC "+//ISBN 82-7640-037::WWW//DTD HTML//EN//2.0" "HTML.DTD"
<HTML>
<HEAD>
<TITLE>Zippo Dot Com</TITLE>
</HEAD>
<body background="paper.gif">
<center><TABLE BORDER=4 cellpadding=5 width=600>
<th colspan=3>
<center><a href="copy.htm"><IMG SRC="tdn.gif" border=0 alt="The Daily News"> </a></center>
<center><strong><a href="zns.htm">About</a>  Zippo  and On-line<a href="rules.htm"> Membership</a>        Super Zippo's <a href="http://sub.zippo.com/comm.htm">Commercial/ISPs</a></strong>
</th>
<TR>
<TD width=200 valign=top>
<center><a href="http://www.aol.com"><IMG SRC="membweb1.gif" border=0></a></center>
<hr>
<strong>
<center>Top News Categories</center><hr></strong>
<ul>
<a href="http://drn.zippo.com/news-bin/wwwnews?alt.*">Alt</a><br>
<a href="http://drn.zippo.com/zippo-bin/wwwnews?alt.*">Alt.*</a> - Restricted<br> 
<a href="http://drn.zippo.com/news-bin/wwwnews?comp.*">Computer</a><br> 
<a href="http://drn.zippo.com/news-bin/wwwnews?humanities.*">Humanities</a><br>
<a href="http://drn.zippo.com/news-bin/wwwnews?misc.*">Misc</a><br>
<a href="http://drn.zippo.com/news-bin/wwwnews?news.*">News</a><br>
<a href="http://drn.zippo.com/news-bin/wwwnews?rec.*">Recreation</a><br>
<a href="http://drn.zippo.com/news-bin/wwwnews?sci.*">Science</a><br>
<a href="http://drn.zippo.com/news-bin/wwwnews?soc.*">Society </a><br>
<a href="http://drn.zippo.com/news-bin/wwwnews?talk.*">Talk</a><br>
<a href="http://drn.zippo.com/news-bin/wwwnews?zippo.*">Zippo </a><br></ul><p>
<center><strong>New ! <a href="http://drn.zippo.com/drn-bin/drnframe?*">Direct Read News +</a> Java</strong></center>

<hr>
<center><a href="http://techweb.cmp.com/techweb/ng/current/"><IMG SRC="nguide.gif" border=0 alt="NetGuide 4 Star Award" width=150 height=23></a></center>
<hr>
<center><strong>Zippo News Service</strong></center>
<a href="zns.htm">About</a> Zippo<br>
<a href="drnhelp.htm">About</a> Direct Read News<br>
<a href="advert.htm">Advertising</a> on Zippo Sites<br>
<a href="http://news.zippo.com/user/page">Connections</a> - User tests<br>
<a href="feeds.htm">Exchange</a> News Feeds<br> 
<a href="faqidx.htm">FAQs</a><br>
<a href="http://news.zippo.com/newsgrpr.txt">Free</a> & <a href="http://news.zippo.com/newsgrpm.txt"> Restricted</a> News Groups<br>
<a href="http://super.zippo.com">Jump to</a> Super Zippo<br>
<a href="rules.htm">Service</a> Policy
</td>
<TD valign=top width=200>
<center><strong>Inside this issue</strong></center>
<hr>
<a href="http://drn.zippo.com/news-bin/wwwnews?*.*">All</a> News Groups<br>
<a href=" http://drn.zippo.com/news-bin/wwwnews?newsgroups=*books*">Books</a><br>
<a href="http://drn.zippo.com/news-bin/wwwnews?newsgroups=*forsale*">Classifieds</a><br>
<a href="http://drn.zippo.com/news-bin/wwwnews?*.education*">Education</a><br>
<a href="http://drn.zippo.com/news-bin/wwwnews?*fan.*">Fan Clubs</a><br>
<a href="http://drn.zippo.com/news-bin/wwwnews?*.jobs*">Jobs</a><br>
<a href="http://drn.zippo.com/news-bin/wwwnews?newsgroups=*movies*">Movies</a><br>
<a href="http://drn.zippo.com/news-bin/wwwnews?newsgroups=*personals*"> Personals</a><br>
<a href="http://drn.zippo.com/news-bin/wwwnews?newsgroups=*politics*">Politics</a><br>
<a href="http://www.zippo.com/zsport.htm">Sports</a><br>
<a href="search.htm">Search</a> for a Newsgroup
<hr>
<center><a href="http://www.pointcom.com"><IMG SRC="5perct.gif" border=0 alt="The Point Top 5% Award" width=71 height=70></a>
<a href="http://www.mckinley.com/"><IMG SRC="vert4sta.gif" border=0 alt="Magellan 4 Star Award" width=90 height=70></a></center>
<hr>
<a href="hlinks.htm">Live News</a>
<li>Headline</li>
<li>Sports</li>
<li>Weather</li>
<li>Finance</li>
<hr>
<center><IMG SRC="hippo.gif" align=bottom alt="Hippo" width= 199 height=96><br>Spam Removal By Hippo.</center>
</TD>
<TD width=200 valign=top>
<center><strong>Zippo's Feature Section</strong></center>
<hr>
<center><strong><a href="editor.htm">Editorial</a></strong></center>
This issue: "O.J., the President, Howdy Doody and Apple Computer"<p>
<a href="mailto:editor@zippo.com">Send</a> a Letter to The Editor<br>
<a href="edread.htm">Read</a> Letters to the Editor
<hr>
<center><strong><a href="http://www.zippo.com/igallery/igallery.htm">Internet Gallery</a></strong></center>
February welcomes four talented photographers, and five unique bands to the individual Gallery showcases this month.

<hr>
<center><strong><a href="useweb.htm">User Pages</a></strong></center>
Some very creative Web Sites created by Super Zippo Subscribers.

<a href="useinfo.htm"> Setup Info </a>
<hr>
<center><strong><a href="http://www.zippo.com/appshome.htm">Application Software</a></strong></center>
Over 200 of the most current Internet Apps. Site is continually expanded and upgraded. Free Software.
<hr>
<center><strong><a href="ftpdl.htm">FTP Software Archives</a></strong></center>
Over 20 Gbytes of Free Software - BSD, CICA, FAQ's, Perl, Clip Art, ADA, Animations, and more.
<hr>
E-Mail Contacts:
<li>Tech Support <a href="mailto:rich@zippo.com">Rich</a></li>
<li>Subscriptions <a href="mailto:mike@zippo.com">Mike</a></li>
<li>Editorials <a href="mailto:joe@zippo.com">Joe Zip</a></li>
<li>Advertising <a href="mailto:bob@zippo.com">Bob</a></li>
<li>Commercial Info <a href="mailto:mike@zippo.com">Mike</a></li>
<li>Net Abuse <a href="mailto:bob@zippo.com">Bob</a></li><p>
</TD>
</tr>
</TABLE></center>
<center> Please direct questions to <a href="mailto:joe@zippo.com">Joe Zip</a> - Editor - Zippo News Services.
<center><h6><a href="copy.htm"> 1995,1996 </a>Zippo Dot Com Incorporated, All rights reserved</h6>
</center>
</body></html>


</DOC>
<DOC>
<DOCNO>WT02-B10-285</DOCNO>
<DOCOLDNO>IA038-000734-B027-74</DOCOLDNO>
<DOCHDR>
http://zippo.com:80/copy.htm 205.185.79.4 19970210062443 text/html 2742
HTTP/1.0 200 Document follows
Date: Mon, 10 Feb 1997 06:26:43 GMT
Server: NCSA/1.5
Content-type: text/html
Last-modified: Sat, 07 Dec 1996 02:14:48 GMT
Content-length: 2568
</DOCHDR>
<!DOCTYPE HTML SYSTEM "html.dtd"><HTML><HEAD><TITLE>Intellectual Property Notices</TITLE></HEAD><body background="paper.gif"><center><IMG SRC="ziplog.gif">

</center><p><center><h4>INTELLECTUAL PROPERTY NOTICES</h4></center><center>

<Table width=500><tr><td><h5>Copyright Notices</h5>

Zippo Dot Com Incorporated Copyright 1995-1996, Zippo Dot Com Incorporated, Sunnyvale, CA 94086 U.S.A. All rights reserved. Except as explicitly provided below, copyright in this program and all accompanying documentation is owned by Zippo Dot Com Incorporated. Any person may view, copy, print and distribute this document subject to the following conditions:<p>

This program/documentation/service may be used for informational, non-commercial purposes only under license from Zippo Dot Com Inc.; any copy must include these notices.<p>

This service includes data and information not owned by Zippo Dot Com Incorporated that is made available by computer on-line service providers; this information may only be used subject to the intellectual property rights and use restrictions, if any, of these providers.<p>

Use, duplication or disclosure of the United States Government is subject to the restrictions set forth in DFARS 252.227-7013 (c) (1) (ii) and FAR 52.227-19.<p>

<h5>Trade Secret Notice</h5>
Zippo Dot Com Incorporated retains all ownership rights to all software programs published by Zippo Dot Com Incorporated. The Zippo Daily News Service / Super Zippo News Service software program (Direct Read News(tm)) is a confidential trade secret of Zippo Dot Com Incorporated and you may not attempt to reverse engineer or decompile Zippo Dot Com Inc. programs or knowingly allow others to do so.<p>

<h5>Trademark Notices</h5>
"Zippo's Daily News", "Super Zippo's Daily News", "Direct Read News", "Zippo Dot Com Inc.", and their respective logos, are trademarks or registered trademarks of Zippo Dot Com Incorporated. All other product names mentioned herein, if any, are the trademarks of their respective owners.<p>

<h5>Disclaimers</h5>
USE OF THIS PROGRAM/DOCUMENTATION/SERVICE IS PROVIDED "AS IS" WITHOUT WARRANTY OF ANY KIND, EITHER EXPRESSED OR IMPLIED, INCLUDING, BUT NOT LIMITED TO, THE IMPLIED WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, OR NON-INFRINGEMENT. SPECIFICALLY, THIS DOCUMENT COULD INCLUDE INACCURACIES OR ERRORS IN THE SOFTWARE, DATA OR INFORMATION PROVIDED HEREUNDER.<p></tr></td></table></center>

<center><h6> 1995,1996 Zippo Dot Com Incorporated<br>All rights reserved </h6></center></body></html>
</DOC>
<DOC>
<DOCNO>WT02-B10-286</DOCNO>
<DOCOLDNO>IA038-000734-B027-106</DOCOLDNO>
<DOCHDR>
http://zippo.com:80/zns.htm 205.185.79.4 19970210062459 text/html 2413
HTTP/1.0 200 Document follows
Date: Mon, 10 Feb 1997 06:27:00 GMT
Server: NCSA/1.5
Content-type: text/html
Last-modified: Sat, 07 Dec 1996 02:16:34 GMT
Content-length: 2239
</DOCHDR>
<!DOCTYPE HTML SYSTEM "html.dtd"><HTML><HEAD><TITLE>The Daily News - Zippo's News Service</TITLE></HEAD><body background=paper.gif><center><IMG SRC="tdn.gif" ALIGN="BOTTOM"></center><p><center><h3>What is Zippo's News Service ?</h3></center>
<center><table width=520>
<tr>
<td>
Zippo News provides Internet Newsgroups and information unique to the Zippo Sites. Zippo Sites may be accessed through our proprietary Direct Read News  web interface, or with a traditional nntp news reader. <p>

Zippo News offers Three levels of service; Original Zippo - Public, Original Zippo Membership and Super Zippo - Subscription Access Only.<p>
<ul>
<li>Original Zippo - Free public access to approx 4,500 news groups through Direct Read News </li><p>
<li>Original Zippo - Membership access to over 5,000 groups through Direct Read News , as well as traditonal nntp news reader access. Membership also has access to the Zippo Apps site and Internet Gallery. </li><p>
<li>Super Zippo -</li>
<ul>
<li>Access to over 18,000 newsgroups through Direct Read News  or traditonal nntp access</li>
<li>Redundant News Sites, Super Zippo West and East, to provide backup, optimal Internet routing and least traffic selection</li>
<li>Subscribers' Mail Box *</li>
<li>Space for Subscribers' pages - 6 and 12 month subscriptions, non-binary. * </li>
<li>Usenet Image Archives - over 50,000 files as of this writing **</li>
<li>20 Gbytes plus of free software archives</li>
<li>Internet Gallery and apps site</li>
</ul>
</ul>
<h5>* Does not apply to service through an ISP<br>
** Does not apply to Express News Accounts</h5><p>

For a detailed description, and price information, for the various services -<p>

<a href="http://www.zippo.com/rules.htm">Original Zippo Membership</a><br>
<a href="http://sub.zippo.com/sscribe.htm">Super Zippo Subscriptions</a><br>
<a href="http://sub.zippo.com/xscribe.htm">Super Zippo Edu Express News</a><br>
<a href="http://sub.zippo.com/comm.htm">Super Zippo Commercial Accounts</a><br>
</td>
</tr>
</table>
<center>| <a href="home.htm">Home</a> | </center>

<center><h6><a href="copy.htm"> 1995,1996 </a>Zippo Dot Com Incorporated, All rights reserved</h6>
</center>
</body></html>
</DOC>
<DOC>
<DOCNO>WT02-B10-287</DOCNO>
<DOCOLDNO>IA038-000734-B027-136</DOCOLDNO>
<DOCHDR>
http://zippo.com:80/rules.htm 205.185.79.4 19970210062510 text/html 3318
HTTP/1.0 200 Document follows
Date: Mon, 10 Feb 1997 06:27:11 GMT
Server: NCSA/1.5
Content-type: text/html
Last-modified: Sat, 07 Dec 1996 02:16:07 GMT
Content-length: 3144
</DOCHDR>
<!DOCTYPE HTML SYSTEM "html.dtd">
<HTML><HEAD><TITLE>The Daily News Service</TITLE></HEAD>
<body background=paper.gif>
<center><IMG SRC="tdn.gif" ALIGN="BOTTOM"></center><p><center><table width=500>
<tr>
<td>
<center><h2>Original Zippo</h2></center>
<h4>Now, you can have immediate access to Original Zippo News, by selecting "continue" at the end of this page. Before you do, please take a moment to read the following text, to make sure Original Zippo services and policy meet your expectations for a News Service.</h4> 
<h4>News Groups - free to the public through Direct Read News  access</h4>

alt (except restricted), comp.*, sci.*, soc.*, news.*, rec.*, misc.*, talk.*, and zippo.* <p>
Full <a href="http://news.zippo.com/newsgrpr.txt">list</a> of free news groups.<p>

<h4>Membership Services</h4>
<ul>
<li>Membership can access through NNTP or Direct Read News</li>
<li>Membership can access <a href="http://news.zippo.com/newsgrpm.txt">restricted</a> access news groups</li>
</ul>
<hr>
<center><h3>The Few Simple Rules - For Everyone</h3></center>
<ol>
<li>No SPAM or Cross Posting to more than 15 newsgroups. If you are not sure what's appropriate, read the FAQs in <a href="http://drn.zippo.com/news-bin/wwwnews?news.announce.newusers">news.announce.newusers.</a><p></li>

<li>Access to restricted news groups is by specific request only, and only for adults. If you have selected the optional news groups, <strong>do not give your password to minors</strong>.</li><p>

<li>Don't do anything illegal. Pyramid schemes, and posting pictures of minors in  sexual context are examples of illegal posts. At the very least, it will get you removed from the service.</li><p>
<li>Zippo is not to be used as a feed for other services, and is not for resale or redistribution. Exceeding access to 500 news groups each day, or connecting for more than 6 hours during a 24 hour period, will cause the system to lock you out for 24 hours. Repeat violations will terminate a membership.</li><p>
</ol>
<center><h3>Rules for Us</h3></center>
<ol>
<li>We will do our very best to keep the servers running at all times and keep equipment in good repair</li><p>
<li>While the servers will get slower as more members are added and traffic builds, we will limit membership to a reasonable level </li><p>
<li>We will maintain news groups at approximately the same count and range of topics. We will routinely update hierarchies and replace obsolete groups with current groups in similar categories.</li><p>
<li>We will not edit, censor or cancel posts on content, and we will not take sides in disputes over appropriate posts.</li><p>
<li>We will continue to add features to the service, and upgrade program modules to enhance the performance of the service.</li><p>
</ol><p>
<h4>If you wish to become a member of the Zippo News Service please continue for <a href="http://sub.zippo.com/zscribe.htm">membership</a> and immediate access.</h4><p>
</td>
</tr>
</table></center>
<center><h6><a href="zcopy.htm"> 1995,1996 </a>Zippo Dot Com Incorporated<br> All rights reserved</h6>
</center>
</body></html>


</DOC>
<DOC>
<DOCNO>WT02-B10-288</DOCNO>
<DOCOLDNO>IA038-000734-B027-157</DOCOLDNO>
<DOCHDR>
http://zippo.com:80/drnhelp.htm 205.185.79.4 19970210062519 text/html 9981
HTTP/1.0 200 Document follows
Date: Mon, 10 Feb 1997 06:27:21 GMT
Server: NCSA/1.5
Content-type: text/html
Last-modified: Sat, 07 Dec 1996 02:14:59 GMT
Content-length: 9807
</DOCHDR>
<!DOCTYPE HTML SYSTEM "html.dtd">
<HTML><HEAD><TITLE>The Daily News Service</TITLE></HEAD>
<body background=paper.gif>
<center><IMG SRC="tdn.gif" ALIGN="BOTTOM"></center>
<hr>
<center><h2>Zippo News Service's Direct Read News  </h2></center>
<center><table width=600>
<tr>
<td>
<h3>Overview</h3>
<ul>
<li><strong>Zippo Direct Read News (tm)</strong> is a method of sorting, selecting, decoding, and reading Usenet News on a realtime basis, without using a news reader. <strong>Direct Read News</strong> is not a database of news articles. Our servers receive news on a continual basis, 24 hours each day. Direct Read News provides immeddiate access to all articles. <p>
The following help items explain how to navigate through the news systems and get the most information, with the fewest steps. Where appropriate, we also explained some of the common elements of Usenet News.<p></li>
</ul>
<h3>The Super Zippo Home Page, and Related Web Pages</h3>
<ul>
<li>There are actually four types of service available through the Zippo Home Page:</li><p>
<ul>
<li><strong>Direct Read News</strong>, which provides access to Usent News Groups. Whenever you click on a News Group Link, Direct Read News takes you to that section of Usenet News and displays; group lists, articles headers and content. Direct Read News handles all decode, multipart file assembly and disply chores for the user.</li><p>
<li><strong>Web Ftp</strong>, which moves software and image files from the Zippo Systems to the user's system. Clicking on a link in this section, connects the user to the correct file, and prompts the user with further instructions, prior to downloading the files to the user's system.</li><p>
<li><strong>Direct Ftp</strong> connection which requires an Ftp client, and can be used to download large software program and utility files.</li><p>
<li><strong>Direct NNTP News</strong> for users that prefer direct newsreader connection to the Zippo Systems. The nntp host name is <strong>snews.zippo.com</strong><p>
</ul>
<li>All of these services can be reached by clicking on the applicable Icon. The Zippo Direct Read News Server manages connections to these various protocols for you.</li>
</ul>
<h3>Newsgroup Selections</h3><p>
<ul>
<li>The newsgroup selections cover all newsgroups carried on  the Zippo News Server. The group list may be selected in total, or by newsgroup category, from the hyperlinks on the web pages. Listing will appear in several formats.</li><p>
<ul>
<li><IMG SRC="newsgrp.gif"> <strong> Bionet</strong> There are numerous links of this type on the home page. Clicking on one will take you to the applicable news category.
<li><IMG SRC="newsgrp.gif"> <strong>29 alt.books.*</strong> This level is displayed after a category selectionhad been made. Whenever a listing is followed by an asterisk, it means there are other related groups within the same major heading. In the case of this example, there are 29 individual newsgroups that fit into  the alt.books.* category. Clicking on the hypertext entry will display the newsgroups within the category.<p></li>
<li><IMG SRC="newsgrp.gif"> <strong>   45 alt.bored</strong> is a single newsgroup heading, there is no following asterisk, and there are 45 individual articles within the group. Clicking on the hypertext entry will display the individual articles within the newsgroup.<p></li>
</ul>
</ul>
<h3>Within A Specific News Group:</h3><p>
<ul>
<li><IMG SRC="newsgrp.gif"> <strong>alt.binaries.pictures.animals</strong> Clicking on the newsgroup icon will return you to the next highest level of the group hierarchy. In the case of this newsgroup, the icon would take you back to alt.binaries.pictures.* and all specific newsgroups under this listing.</li><p>
</ul>
<ul>
<li><strong>Page Controls</strong></li><p>
<ul>
<li><IMG SRC="oldart.gif"> Sort list by earliest article number</li><p>
<li><IMG SRC="newart.gif"> Sort list by the newest article number</li><p>
<li><IMG SRC="subj.gif"> Sort article list by subject</li><p>
<li><IMG SRC="auth.gif"> Sort article list by author</li><p>
<li><IMG SRC="olddate.gif"> Sort article list by earliest date</li><p>
<li><IMG SRC="newdate.gif"> Sort article list by newest date</li><p>
<li><IMG SRC="thread.gif"> Display  threaded article list, newest date first</li><p>
<li><IMG SRC="binonly.gif"> Display headers for binary files only, newest date first</li><p>
<li><IMG SRC="post.gif"> Post an article, new or in response</li><p>
<li><IMG SRC="postbi.gif"> Post a binary file, new</li><p>
<li><IMG SRC="postx.gif"> Post an article, new or in response - with x-archive instruction, requesting Internet Archive services to not store article</li><p>
<li><IMG SRC="postxb.gif"> Post a binary file, new - with x- archive instruction, requesting Internet Archive services to not store article</li><p>
<li><IMG SRC="prev.gif"> Jump to the previous list screen within the newsgroup, or previous article</li><p>
<li><IMG SRC="next.gif"> Jump to the next list screen within the newsgroup, or next article</li><p>
</ul>
</ul>
<ul>
<li> <IMG SRC="newstext.gif"> <strong>  00018 02/08 GINA  2 hi friends</strong>The leading icon defines the file type <p>
<ul>
<li><IMG SRC="newstext.gif"> Text</li>
<li><IMG SRC="photo.gif"> GIF, BMP, TIF</li>
<li><IMG SRC="newsbin.gif"> Binary Exec, Zip, UUE.</li>
<li><IMG SRC="video.gif"> AVI. MPG, MOV </li><p>
</ul>Icons are interactive, with the exception of "Text". Clicking on image Icons will decode the applicable article and display the image. Clicking on a Bin Icon will decode the file and download it to your system.<p>
<strong>00018</strong> This is the article number which is established when the article arrives at the server. <p>
<strong>02/08</strong> This is the date the article was originally posted to Usenet News. At times, either due to the number of systems the article passed through as it was propagated throughout the Internet, or if was just delayed in reaching an outbound feed to the Internet, this date may be earlier than the current date.<p>
<strong> GINA</strong> This is the name of the posting author<p>
<strong>2</strong> This is the number of lines of data posted within the article, other than header information.<p>
<strong> hi friends</strong> This is the article subject as defined by the author<p>
<strong>00018 02/08 GINA </strong>Combined in hypertext format,  clicking on this information will allow you to view the actual text of the article and display additional information about the article. As an example, you can initiate an e-mail response to the author of the article, reference cross postings, and display the full news header.<p>
</li>
</ul>
<h3>Building Custom Group Lists and Lookups with Direct Read News</h3>

You can "subscribe" to News Groups by bookmarking individual newsgroup pages, or by linking multiple groups or hierarchies to make custom lists as bookmarks. <p>
If you click on the Zippo news group list on the home page, you will get a list of the major zippo newsgroups and this URL will appear in your browser window -<br>
<center><strong>http://sdrn.zippo.com/news-bin/wwwnews?zippo.*</strong></center> <br>
The first part of the string, "http://sdrn.zippo.com/news-bin/wwwnews?", is a list query statement to the specific site you are using, and the "zippo.*" indicates the news hierarchy list to be retrieved. If you substitute "comp.*" for "zippo.*", Direct Read News will generate a list of all groups within the comp hierarchy. After this list is displayed, the page could be bookmarked for future list. <p>
Using a variety of symbols, lists  can be generated based on many sorts and selections, and each list may be bookmarked. <p>
The active symbols as of this writing are:<p>
<ul>
<li>* is a wild card search character. *.sports.* would find news groups that have sports in the group name, but do not start with the word sports. sports.* would find all groups that start with the word sports, and *.sports would find all groups that end with the word sports.</li><p>
<li> | is used to join multiple searches. As an example sports.*|*.sports would list all groups that started with sports or ended with sports. It could also be used as in alt.sports.*|rec.sports.* to find all sports in the alt or rec news hierarchies.</li><p>
<li> & is a limiting character, meaning the search will yield only groups with one word beyond the & symbol.</li><p>
<ul>Examples (list are abbreviated in  examples)<p>
<li> comp.* would list all comp newsgroups in the comp hierarchy - </li><br>
comp.forsale<br>
comp.pc.forsale<br>
comp.pc.ibm.forsale<br>
comp.misc<p>
<li>*.pc.* would list any group on the server with pc as a whole word anywhere in the name  - </li><br>
comp.binaries.ibm.pc.d<br>
comp.binaries.ibm.pc.wanted<br>
comp.ibm.pc.hardware<br>
comp.sys.ibm.pc.games.*<br>
comp.sys.ibm.pc.hardware.*<br>
comp.sys.ibm.pc.misc<br>
comp.sys.ibm.pc.programmer<br>
comp.sys.pc.hardware.misc<br>
demon.ip.support.pc.announce<br>
fido7.hardw.pc.cpu<br>
ger.pc.dos<br>
ger.pc.hard<br>
ger.pc.os2<br>
ger.pc.win<br>
<li>comp.& would all comp hierarchy groups with only one more descriptive word in the group name - </li><br>
comp.forsale<br>
comp.misc<br>
<li> comp*|*.pc.* would list all comp hierarchy groups, plus all pc groups, regardless the hierarchy - </li><br>
comp.windows.x.motif<br>
comp.windows.x.pex<br>
compuserve.announce<br>
compuserve.general<br>
demon.ip.support.pc.announce<br>
fido7.hardw.pc.cpu<br>
ger.pc.dos<br>
ger.pc.hard<br>
ger.pc.os2<br>
ger.pc.win<br>
in.pc.mac<br>
</ul>
</ul>
</td>
</tr>
</table></center>
<center><h6><a href="zcopy.htm"> 1995,1996 </a>Zippo Dot Com Incorporated<br> All rights reserved</h6>
</center>
</body></html>


</DOC>
<DOC>
<DOCNO>WT02-B10-289</DOCNO>
<DOCOLDNO>IA038-000734-B027-188</DOCOLDNO>
<DOCHDR>
http://zippo.com:80/advert.htm 205.185.79.4 19970210062545 text/html 2463
HTTP/1.0 200 Document follows
Date: Mon, 10 Feb 1997 06:27:42 GMT
Server: NCSA/1.5
Content-type: text/html
Last-modified: Sat, 07 Dec 1996 02:14:26 GMT
Content-length: 2289
</DOCHDR>
<!DOCTYPE HTML SYSTEM "html.dtd"><HTML><HEAD><TITLE>The Daily News - Zippo's News Service</TITLE></HEAD><body background=paper.gif><center><IMG SRC="tdn.gif" ALIGN="BOTTOM"></center><p><center>
<table border>
</table></center>
<p>
<center><table width=600>
<tr>
<td>
<center><h3>Advertising on Zippo's News Services</h3></center>

Zippo's News Services are comprised of Original Zippo, Super Zippo West and Super Zippo East Sites, a combination of free, subscription and membership news services. Zippo News Services are delivered through open public access, retail subscriptions, corporate accounts and participating Internet Service Providers. As of this writing, over 140,000 retail and commercial subscribers, and over 40,000 public service users, have access to Zippo News.<p>
Our Direct Read News  Pages are collectively displayed over 1,500,000 times each month. <a href="http://drn.zippo.com/news-bin/wwwnews?rec.outdoors.national-parks">Billboard Linked Ads</a> placed at the top of Direct Read News  pages, may appear on Original Zippo, Super Zippo West and Super Zippo East. Each fully placed billboard is displayed approximately 85,000 times each month and, because display is triggered only when a person has accessed a page, the number reflects the number of times the ad is actually seen by Zippo customers.<p>
A billboard ad may be any customer provided static, or animated, transparent gif image, 350 X 70 dots in size, and may be linked to the customer's URL. We can assist in converting graphics to the correct file format. Monthly display activity reports are furnished to each advertiser, indicating the number of times the ad is viewed at each of the applicable Zippo Sites. Ads are displayed across 18,000 News Groups at Super Zippo Sites and 5,000 News Groups on the Original Zippo Site. <p>
<ul>Ad Placement Costs
<li>One Site $100 per month</li>
<li>Two Sites $175 per month</li>
<li>Three Sites $200 per month</li>
</ul>
To place an ad, or to get further information, via e-mail <a href="mailto:mike@super.zippo.com">Advertising</a>, or call us at 408-720-7620.<p> 
<hr>
</td>
</tr>
</table></center><p>
<center><h6><a href="copy.htm"> 1995,1996 </a>Zippo Dot Com Incorporated, All rights reserved</h6>
</center>
</body></html>

</DOC>
<DOC>
<DOCNO>WT02-B10-290</DOCNO>
<DOCOLDNO>IA038-000734-B027-215</DOCOLDNO>
<DOCHDR>
http://zippo.com:80/feeds.htm 205.185.79.4 19970210062556 text/html 1319
HTTP/1.0 200 Document follows
Date: Mon, 10 Feb 1997 06:27:56 GMT
Server: NCSA/1.5
Content-type: text/html
Last-modified: Sat, 07 Dec 1996 02:15:18 GMT
Content-length: 1145
</DOCHDR>
<!DOCTYPE HTML SYSTEM "html.dtd"><HTML><HEAD><TITLE>The Daily News - Zippo's News Service</TITLE></HEAD><body background=paper.gif><center><IMG SRC="tdn.gif" ALIGN="BOTTOM"></center><p><center>
<table border>
</table></center>
<p>
<center><table width=600>
<tr>
<td>
<center><h3>Exchange Feeds</h3></center><p>
Zippo News is a composite of many full and specialized news feeds of US and International origin, as well as many direct posts to Zippo News Servers. We in and out process approximately 200,000 articles each day, in 15 minute increments, or stream mode, and have a very high news propagation rate.<p>
While not perfect, we do run an aggressive despamming program and have personnel assigned to resolve net abuse issues. We are particularly interesed in exchange feeds with edu domains. If you have an interest in receiving Zippo posts, or exchanging full or partial feeds, let us know. Please contact <a href="mailto:joe@zippo.com"> joe@zippo.com</a>.

</td>
</tr>
</table></center><p>
<center><h6><a href="copy.htm"> 1995,1996 </a>Zippo Dot Com Incorporated, All rights reserved</h6>
</center>
</body></html>

</DOC>
<DOC>
<DOCNO>WT02-B10-291</DOCNO>
<DOCOLDNO>IA038-000734-B027-245</DOCOLDNO>
<DOCHDR>
http://zippo.com:80/faqidx.htm 205.185.79.4 19970210062607 text/html 2320
HTTP/1.0 200 Document follows
Date: Mon, 10 Feb 1997 06:28:09 GMT
Server: NCSA/1.5
Content-type: text/html
Last-modified: Sat, 07 Dec 1996 02:15:12 GMT
Content-length: 2146
</DOCHDR>
<!DOCTYPE HTML PUBLIC "+//ISBN 82-7640-037::WWW//DTD HTML//EN//2.0" "HTML.DTD"
<HTML>
<HEAD>
<TITLE>Super Zippo</TITLE>
</HEAD>
<center> 
<body background="paper.gif">
<IMG SRC="tdn.gif">
</center><p>
<center><table cellpadding=5 width=500>
<TR>
<td>
<center><h3>Frequently Asked Questions</h3></center><P>
<ol>
<a href="faq.htm#a8"><li></a>Welcome to Zippo News Services</li><p>
<a href="faq.htm#a1"><li></a>What are the differences between Super Zippo and Original Zippo ?</li><p>

<a href="faq.htm#a2"><li></a>I just signed up for the service and I can't connect through nntp, or through Direct Read News.</li><p>

<a href="faq.htm#a3"><li></a>I have service through an ISP and I cannot access restricted Alt groups. </li><p>

<a href="faq.htm#a4"><li></a>I've posted to Super Zippo, or Zippo, and my posts aren't showing up.</li><p>

<a href="faq.htm#a5"><li></a>I've seen posts on other news servers that don't show up on the Zippo Servers.</li><p>

<a href="faq.htm#a6"><li></a>It takes a long time for articles to show up on Super Zippo, or Zippo, when they are posted on other news servers.</li><p> 

<a href="faq.htm#a7"><li></a>I use Agent to count new articles on news servers and sometimes Super Zippo and Zippo have less than others.</li><p>

<a href="faqnews.htm#a8"><li></a>How do I setup Agent as my newsreader to access Zippo's news server?</l><p>

<a href="faqnews.htm#a9"><li></a>How do I setup WinVN as my newsreader to access Zippo's news server?</l><p>

<a href="faqnews.htm#a10"><li></a>How do I setup NewsXpress as my newsreader to access Zippo's news server?</l><p>

<a href="faqnews.htm#a11"><li></a>How do I setup NewsWatcher as my newsreader to access Zippo's news server?</l><p>

<a href="faqnews.htm#a12"><li></a>How do I setup Microsoft's Internet News as my newsreader to access Zippo's news server?</li></p>

<a href="faqnews.htm#a13"><li></a>Can I use rtin to access Zippo's news server?</li><p>


</ol>

</TD>
</TR>
</TABLE></center>

<center><h6><a href="copy.htm"> 1995,1996 </a>Zippo Dot Com Incorporated, All rights reserved</h6>
</center>
</body></html>
</DOC>
<DOC>
<DOCNO>WT02-B10-292</DOCNO>
<DOCOLDNO>IA038-000734-B027-275</DOCOLDNO>
<DOCHDR>
http://zippo.com:80/search.htm 205.185.79.4 19970210062619 text/html 1137
HTTP/1.0 200 Document follows
Date: Mon, 10 Feb 1997 06:28:19 GMT
Server: NCSA/1.5
Content-type: text/html
Last-modified: Sat, 07 Dec 1996 02:16:09 GMT
Content-length: 964
</DOCHDR>
<!DOCTYPE HTML SYSTEM "html.dtd"><HTML><HEAD><TITLE>The Daily News - Zippo's News Service</TITLE></HEAD><body background=paper.gif><center><IMG SRC="tdn.gif" ALIGN="BOTTOM"></center><p><center><h3>Search for a Newsgroup</h3></center>
<center><table width=520>
<tr>
<td>
<center><form method=GET action="http://drn.zippo.com/news-bin/wwwnews">
<input type="text" name="newsgroups" size="40"><br>
<input type="submit" value="Find News Group"</form> <strong></center>
<center><h3>Direct Read News - News Group Search</h3></center></strong><p>
<a href="drnhelp.htm">Direct Read News </a> may also be used to build custom news groupsubscribe lists through the use of bookmarks, and for doing a wide variety of simple and compound searches. 
</td>
</tr>
</table></center>
<center>| <a href="home.htm">Home</a> | </center>

<center><h6><a href="copy.htm"> 1995,1996 </a>Zippo Dot Com Incorporated, All rights reserved</h6>
</center>
</body></html>
</DOC>
<DOC>
<DOCNO>WT02-B10-293</DOCNO>
<DOCOLDNO>IA038-000734-B027-302</DOCOLDNO>
<DOCHDR>
http://zippo.com:80/hlinks.htm 205.185.79.4 19970210062628 text/html 1755
HTTP/1.0 200 Document follows
Date: Mon, 10 Feb 1997 06:28:31 GMT
Server: NCSA/1.5
Content-type: text/html
Last-modified: Mon, 06 Jan 1997 19:36:03 GMT
Content-length: 1581
</DOCHDR>
<!DOCTYPE HTML PUBLIC "+//ISBN 82-7640-037::WWW//DTD HTML//EN//2.0" "HTML.DTD"
<HTML>
<HEAD>
<TITLE>Super Zippo</TITLE>
</HEAD>
<body background="paper.gif">
<center><IMG SRC="tdn.gif"></center><p>
<center>
<table border=5 cellpadding=5>
<th colspan=2>
<center><h2>Headline News and Sports News Sites</h2></center>
</th>
<tr>
<td  width=380 valign=top>
<h4>Headline News</h4>
<ul>
<a href="http://www.msnbc.com/"><IMG SRC="4bird2.gif" border=0></a></li><p>
<a href="http://www.boston.com:80/globe/"><IMG SRC="ban2.gif" border=0></a></li><p>
<a href="http://uttm.com/"><IMG SRC="ban5.gif" border=0></a><p>
<a href="http://www.cnn.com/"><IMG SRC="cnn.gif" border=0></a><p>
<a href="http://www.sjmercury.com/index.htm"><IMG SRC="mer.gif" border=0></a><p>
<a href="http://www.usatoday.com/"><IMG SRC="usatlogo.gif" border=0></a><p>
</ul>
</td>
<td  width=380 valign=top>
<h4>Sports News</h4>
<ul>
<a href="http://espnet.sportszone.com/"><IMG SRC="espn.gif" border=0></a><p>
<a href="http://www.foxnews.com/sports/"><IMG SRC="fox.gif" border=0></a><p>
<a href="http://pathfinder.com/@@VBnY4cHyJwMAQHlg/si/welcome.html"><IMG SRC="top.gif" border=0></a><p>
<a href="http://gnn.com/gnn/meta/sports/index.html"><IMG SRC="gnnsp.gif" border=0></a><p>
<a href="http://www.sportsnetwork.com/"><IMG SRC="snw.gif" border=0></a><p>

</ul>
</td>
</tr>
</table></center>
<center><h5>| <a href="home.htm">Home Page</a>|</h5></center><center><h6><a href="copy.htm"> 1995,1996 </a>Zippo Dot Com Incorporated, All rights reserved</h6>
</center>
</body></html>

</DOC>
<DOC>
<DOCNO>WT02-B10-294</DOCNO>
<DOCOLDNO>IA038-000734-B028-7</DOCOLDNO>
<DOCHDR>
http://zippo.com:80/editor.htm 205.185.79.4 19970210062637 text/html 6337
HTTP/1.0 200 Document follows
Date: Mon, 10 Feb 1997 06:28:38 GMT
Server: NCSA/1.5
Content-type: text/html
Last-modified: Thu, 06 Feb 1997 21:45:56 GMT
Content-length: 6163
</DOCHDR>
<!DOCTYPE HTML SYSTEM "html.dtd">
<HTML><HEAD><TITLE>The Daily News Service</TITLE></HEAD>
<body background=paper.gif>
<center><IMG SRC="editor.gif" ALIGN="BOTTOM"></center>
<hr>
<center><table width=600>
<tr>
<td>
<IMG SRC="joezip.gif" ALIGN=right><p>
<center><strong>"What do O.J., the President, Howdy Doody and Apple Computer have in common ?"
</strong></center><p>

Lately, Im just finding it difficult to generate much enthusiasm over the news. The press seems to be covering the same subjects in boiler plate fashion, Court TV is turning into Hard Copy with its new Lawyer Vs Lawyer format (is too, is not, is too, is not.....youre a baby, no - youre a baby....), and Men Behaving Badly is giving me factual content, but no current events. I even tried to jump start a thought process by reading  National Review and National Geographic on alternate days for the past week. Flat line, get the paddles.<p>
The local Mercury News led off yesterday with 4 high headlines, O.J. Must Pay. I dont care, I mean I reallllllly dont care.  This story remains what it always has been, a story of interest for polite racists on both sides of the coin. Outside of the principles, what is the other significance? Perhaps the multi-million dollar peripheral industry that spawned as a result of a routine homicide. I didnt know who Nicole Brown or Ron Goldman were before the murder, and I am sure I have learned nothing of factual content since. I always just thought of O.J. Simpson as a one time good running back, with a career buried under a really bad Buffalo Bills team. Not sure how rental car commercials and sports commentaries elevated him to the pre-murder status of a national hero or celebrity. Dont care.<p>
The President gave his State of the Union Address - Internet access and free money for everyone. Balance the budget, but no binding constitutional amendment. Huge tax breaks, as long as you live in poverty. Internet 2 is needed so sick children can get their homework. Minor problem of more corporations ordered to give away their products so Bill can meet his campaign promises.. Fortunately the address was preempted by almost everything, including the WBs sitcoms. <p>

Steve Wozniak has rejoined Apple in the role of a non-participating hood ornament, on the heels of (or in the slipstream of) Steve Jobs. Didnt Wozniak leave Apple not long after the companys initial climb to fame? Wasnt Wozniak squeezed into a box, left with nothing to do by Steve Jobs, until Wozniak lost interest and left the company? Wasnt Jobs squeezed out by Scully when Apple crossed the billion dollar threshold and the company outgrew its founders? Maybe this whole revival effort is more a function of Gil Amelios early basic training at Fairchild Semiconductor, where building buffer management committees was standard CYA practice.<p>

I think that Apple is suffering from Howdy Doody syndrome. A few years after Buffalo Bob was removed from the airwaves, there was a huge public outcry from baby boomers who were still  mourning the loss of their childhood keepsake.  One by one, the players were recalled to network duty, or Howdy Duty; Buffalo Bob, Howdy and Clarabelle. After two shows, and a lack of viewer momentum, the shows producers went on to call back: Princes Summer Fall Winter Spring, Mr. Bluster, and Flubadub.  Two or three more shows and the network canceled. The ingredients in the original show that could not be recalled were: the innocence of the 50s, the lack of alternative viewing, and an audience with enough imagination to block out Howdys strings without the aid of special effects.<p>

Outside of the investors and employees of Apple, I believe the question of revival is why?.  People don't drive around in new Packards, or carry portable Osborn Computers onto airplanes, or have much of a need for another type of hardware platform. Peter Drucker, a long, long time ago, said that strategic decisions a company  made today, may not show the results of those decisions for 20 years. Apple is showing the results of several strategic decisions in a more compressed time frame. The first was when they put the lid on the original Apple and introduced the closed platform Apple III and Lisa systems, while IBM went out with the easy open IBM PC. <p>

The next point was IBMs willingness to support clone manufacturers, while Apple sued anybody that came close to making a piece of hardware that could run Apple software. Remember the Ace ? Maybe it was just a moment of indecisiveness, when Apple couldnt choose between evolving as a hardware company or a software company, and concluded by trying to be both. The result was they couldnt establish market mass in hardware, or provide continual support and opportunity that software developers need to make the Apple system more useful and progressive.<p>

Then it seems like it got worse. Scully, a guy with a background in distribution and channel management, who was doing a commendable job in those respective areas, decided he would take a shot at ego product marketing, which resulted in the Scootin Newton. Apple planned Newtons for everyone.  Unfortunately, while the troops were off trying to figure out how to perfect character recognition for their little phone number keeper, they forgot to develop the MAC. Not sure how the organization didnt hear/see the MS based system steamroller running rampant through the market place.<p>
Today the market is left with some Apple system related questions that, after a year of reorganization, are still not being addressed, and none have anything to do with price. Is an Apple faster? Is it cheaper? What can it do that an MS based system cant do? Nostalgia will only carry a company so far, and I believe Apple is about to join Howdy Doody. <p>

Thanks<br>
Joe Zip<p>
<a href="mailto:editor@zippo.com">Send</a> a letter to the Editor <br>
<a href="edread.htm">Read</a> letters to the Editor
</td>
</tr>
</table></center>
<center><h6><a href="zcopy.htm"> 1995,1996 </a>Zippo Dot Com Incorporated<br> All rights reserved</h6>
</center>
</body></html>


</DOC>
<DOC>
<DOCNO>WT02-B10-295</DOCNO>
<DOCOLDNO>IA038-000734-B028-40</DOCOLDNO>
<DOCHDR>
http://zippo.com:80/edread.htm 205.185.79.4 19970210062649 text/html 34470
HTTP/1.0 200 Document follows
Date: Mon, 10 Feb 1997 06:28:49 GMT
Server: NCSA/1.5
Content-type: text/html
Last-modified: Sat, 08 Feb 1997 01:37:35 GMT
Content-length: 34295
</DOCHDR>
<!DOCTYPE HTML SYSTEM "html.dtd">
<HTML><HEAD><TITLE>The Daily News Service</TITLE></HEAD>
<body background=paper.gif>
<center><IMG SRC="editor.gif" ALIGN="BOTTOM"></center>

<center><table border cellpadding=10>
<th>
And the Readers Respond...
</th>
<tr>
<td>

<center><strong>"O.J., the President, Howdy Doody and Apple Computer"</strong></center><p>
<hr>
HI,<p>
     Well .. im not writing to flame ya or anything ... but i believe
the Mac O.S. is the easiest to use espescially for someone who isnt to familiar with
computers ... i think it just takes better management to compete with the other guy .... and i really hope its not to late to make a success out of the Mac ... i love my Mac and it seems like even I am tired of waiting for programs to be developed for it ... i really hope Apple comes through with a new O.S. that will do all the tasks that todays
computer geeks need and at the same time still remain the friendly Mac
O.S. at the same time ...  well .. if thats even possible   :-(<p>

<strong>Ed Note:</strong>Be nice to have a balanced market so there actually is a choice and the competition would make for faster product development.

<hr>
Take a lesson in writing... at least seperate your contridictions by
more than a few word.<p>

Anyway: have you actually looked into this at all?  Yes, Apple's are
faster.  Just check out anyone who has done independant benchmarks (e.g.
Byte).  Even at the same clockspeed a PowerPC chip outstrips a Pentium,
and the PowerPC will be available by fall at 500 MHz.  That, my friend,
is fast.<p>

Look into the PowerBook 3400, which will be available soon at 200 MHz.
Yes, a 200 MHz portable.<p>

For that matter, look at the 4400 (low cost), 9600 (incredible speed),
8600 (amazing industrial design and feature set)... clearly sexy
hardware is not a problem for Apple.<p>

That leaves software.  I urge you to take a few moments to catch up on
the latest Apple OS, code-named Rhapsody, that will benefit from Mac OS
and OpenStep technology.  A dream to develop on, simple and reliable to
use... this OS should inherit the benefits that OpenStep/Mach currently
enjoys (i.e. reboot once every 3 years or so)<p>

I don't have the time or the inclination to give you a full Mac
evangelist rant. (besides, I'm just as qualified in supporting and
developing on Windows95 and WinNT, so I don't do the bigot rant well).
However, I do want you to at least show that you've thought about and
researched on topics you write about.<p>
<strong>Ed Note:</strong>I'll get myself and the other 94.4% of the PC market on on it right away. 
<hr>
<center><strong>"The Winner....and still heavy weight champion"</strong></center><p>
Maybe there is some justice left in this world.  Good luck to your
father.
<hr>
Right on joe!<p>
It is people like your dad, that stand up for principle that
makes combating injustices worth it. If there were more like him,
then goverment would be smaller, the companies would not be
as arogant, there would be less law suits, because there would
be more people who get involved.

<hr>
It is interesting that as a parent, you try to instill in your offspring
the importance of being truthful.  This never changes.  .Even when you are
old, there is no defense against the truth.  Congrats to your Dad for doing
the right thing.  You must be very proud  of him!  You can still fight the
big guys.
<hr>
Good for your Dad, Joe!  It's about time people start standing up for their
rights.  I know from firsthand experience--I've been in litigation for
seven years in Florida with lawyers who were supposedly defending me, who
have then turned around to become my adversary--that the civil justice
system has become a forum to screw good people.  I have had to resort to
filing a malpractice action against one of the lawyers--the first of many
to come--"pro se" (i.e., myself without any assistance from attorneys).  I
can't wait to get him before a jury.  Of course, in my case, the judge was
as crooked as hell, and kept protecting those who had stolen the money.  He
refused to force the personal representative of the estate or any of the
attorneys to provide an accounting of the money, as required by law, and
said to appeal it if I didn't like his decision.  But then, the attorney
conveniently allowed the appeal time to lapse...smells like conspiracy to
me.  Anyway, good luck to your Dad...I hope he wins.  He sounds like he is
in the right frame of mind.

<hr>
Joe--<p>

Usually I start off a note by saying something on the order of 'I agree,
but, ...'  <p>

Not today. <p>

I applaud your father's stance and wish him the best luck in the world. 
Every entity, public or private, needs to be held accountable for it's
actions.<p>
<hr>
I hope that he, via your editorial, gets many letters of support.


<center><strong>"Extra ! CA Fed Judge eats too many veggies......and becomes one"</strong></center><p>
<hr>
I CONCUR.  KEEP UP THE GOOD WORK JOE.  SOMEONE HAS GOT TO KEEP THE PUBLIC
INFORMED.
<hr>
Isn't it amazing the the great guardians of "constitutional rights" are
the first to fall off the wagon when "constitutional rights" don't agree
with liberal ideology. <p>
Where is the media outrage at this infringement of our rights? I have
seen few reports critical of it.
<hr>
in the little city of vallejo where the city officials held closed door
meetings over the future of the white elephant marine world, once again
it's voters learn there is no santa claus, and your vote is no good. why?
because there have been no way shape or form for the citizens of this city
to vote or have a real say about what goes on in their city. <p>

In this land of ours, we are brain washed we have a vote. After the elections, 
both local and state wide, it appears that our law industry steps in and decide 
what we, the voters, should be allowed to have, not what we voted
to go into effect. <p>

In this city, the royal family of "elected" officials
have seen to it that a new broom cannot sweep clean. how you ask? By
setting the terms of office for it's city concil so there is never a
complete change of members. The majority of concil members are still in
power after election. This is to control and "guide" new commers into the
world of city goverment. This really means "we are going to control you".<p>

Now for the real world. Going down to city hall 7 times (different days and
times), I never found the mayor. there are no offices for city concil
members. The meeting room for city affairs could never have enough citizens
in it to possibly represent the "voice" of the citizens. Going further, say
there is a need for a citizen to reguest a waver or protest an action by
the city. There is a beutification committee for this to file the greevence
with, however, the committee tells you up front that they are an advisory
committee only and has no authority. Ain't it great? they protect their
butts from angles. No one to talk to and a committe which meets a
requiremeent of a means to "fight" city hall, but a system built in to make
sure no one is required to pay any attention to you. <p>

Question? is your city setup the same way? to make our vote really count, we need on the ballot in the area for people running for office a box marked "none of the above" . 
<hr>
Unbelievable isn't it?
I'm 52 years old having a career bad dream!
Regards, and again, keep it up
<hr>
Joe Zip, Ed.<p>
With the Clinton admistration overiding the clear intent of the
voters, with a federal judge making his own rules, what point is
there in an election? The current system of voting is to insure that
laws are made peacefully. Now that members of congress, and the
president have decided to overide the voters, this leaves the
supreme court to make the finale decision. If the courts do
not uphold the 10th admendment, then the line has been drawn,
the time has come for the people to demand the end of the
federal goverment.
<hr>
Joe Zip, Ed.<p>
RIGHT ON man!!...I've had it after 35 years in fruit land and I'm
happily cruising the seven seas.

<hr>
Seems that Serbia and California have the same
problem. Those in power have ignored the will of the 
people.<p>
Keep up the good work
<hr>
<center><strong>"Chestnuts roasting on an open fire.....rotten kids knocking at your door"</strong></center><p>
whoever you are. I'm writing from Germany and I can
tell you - it's bloody cold in this damned country.
I would like to saddle down in the states. How is
the situation on the job market? Hope to get my green card
next year.<br>
Maybe I'll hear from you.<br>
Bye for now
<hr>
Snow on the holidays isn't all it's cut out to be.  Most of us on the
East coast are thanking God that what's been coming down from the sky is
rain and not snow. You see the last time it snowed for Christmas it
didn't stop until Easter. In fact we skipped Spring all together. The
memories of the 23 storms from last year will keep us for a few
holidays. Where are those rotten kids that knocked at the doors? So many
people were looking for them last year but they couldn't be found. There
are just easier ways for kids to make money these days it seems. It's a
shame becuase many of the old folks were snowed in for days. Like the
weather things change.<p>
<strong>Ed Note:</strong>I heard a rumor, that the kids from the eastcoast took their snow shoveling money west, and used it for first round funding for tech startups. Er..sort of a snowballing effect, if you get my drift,...somebody stop me...I'm becoming a flake.
<hr>
Dear Editor:<p>

It looks like you would be happier in central Michigan than you are in 
California!  Since you are self-employed and your work can be done from 
anywhere in the world that has access to the internet, why not move to 
Michigan before next Christmas?  Of course, living in the deep freeze 
and driving over snow and ice for up to several months a year are not 
very pleasant, but it certainly looks a lot more like Christmas here.<p>

Or does it maybe really look a lot more like the original Christmas in 
California?  After all, Jesus was born in a warm Mediterranean climate, 
and not in the Siberian landscape of the upper midwest.<p>

Anyway, have a merry Christmas and a happy new year!

<hr>
<center><strong>"Psst. Hey kid. Wanna see pictures of a tree ?"</strong></center><p>
Dear Joe of the Jungle,

The real issue here is not the forest but the trees.  You see the fee solution 
came about because otherwise the Republicrats of the 103rd Congress were going 
to set up a Closure Committee much like the military to decide how to sell off 
parks to the highest bidder.  No Joke, Joe.  Your little vacation trips could 
have been to the Polan WeedEater National Woodlands or the Tropicana Treehugger 
Park and Recreation Area.  I wonder what their fees would be?<p>

The original auto fee for Yellowstone was $10 in 1916. Now you pay an 
additional per person fee.  But not your $1000 dollar quote.  If inflation were 
figured in by 1996 dollars you should be paying $83.  You won't be.  So 
whatever the fee increase, it's worth it. <p> 

Only 57 of 368 parks were off the closure consideration list originally 
proposed by the Republicrats.  Maybe some could be closed but really do we want 
to let the carpetbaggers into the temple?  Clinton agreed to the fee plan by 
insisting that the "Shut Down Your Government Congress" remove the closure plan 
and provide that all fees go to the parks.  There is no free ride the not from 
me you don't nineties.  Go to the park, help pay so you can go again.  The 
trees otherwise will have to make the supreme sacrifice for your freedom to 
stay home.<p>

Thom of the Flatlands<br>
Who still takes his son on a trip to see America each summer.

<hr>
To the Editor:<p>
	While I'm saddened that the cost of vacationing has skyrocketed
and entry fees at national parks have quadrupled, the trend of American
government has been to (regardless of admininstration or which party controls
Congress) reduce the burden of spending.  What's a few extra bucks to help save
Smokey the Bear from exctinction?<p>

Who's got time for a vacation anyway?  Wanna see a tree? 
Try alt.binaries.pictures.trees.<p>

Reduce speed ... toll booth 1000 feet ... Welcome to the information
highway.<p>

"They've been getting a free ride long enough!"<p>

<hr>
Hey Joe,   (  sounds like a song, bet you never heard that before <g> :>) 
)<p>

    Just read your editorial, great stuff.  I also got to travel some with
my Dad/Family.  Dosen't seem quite as much as you did.  I didn't get to see
most of the lower 48 till I joined the navy, but I hear where your coming
from.  I probably have it a little <g> bit easier than some, have a good
job (middle management stress, stress, stress, good mate (yea), and 40
acres in Kentucky (*BIG YEAAAAhhhhh*) where I'll eventually end up.  Thanks
for the message - Hope more people hear it.
<hr>
In your comment to my previous message you said you didn't know the costs 
of trees and animals had gone up.  Very cute.  It's the cost of 
maintaining the roads and the potties and the campgrounds and stuff like 
that that has gone up!!!!  And also the costs for fighting forest fires 
and clearing up trails after rock slides.  (Don't forget that Yosemite 
has had a few of those lately!)<p>  

I think the fee increase is great if Congress can keep their money 
grubbing hands off of the money and not rob it for the general fund and 
let the individual parks keep the bulk of it.  It's still quite a 
bargain!  Just think how much you'll have to pay if the Libertarians ever 
win a presidential election and sell all the parks off to developers.

<hr>
Joe<p>
	Read the editorial about the trees and parks and then read some of the
responses you got about it. Good Lord - Gag me with a "misplaced"
billing record! Looks like the blinding flashes from the picture taking
and all of the back-slapping of election day eve have left a good
percentage of the population impared. The flashes have them blinded and
the back slapping has apparently caused some type of additional brain
trama. They ought to see a doctor and have the doc send the bill to
their other buddy Bill. The only bridge to the future the Clintons and
their administration are building is one with toll booths at both ends.
<hr>
I like it!<p>

Did you forward a copy to The President and Her Husband?
<hr>
Dear Joe
    I was one of those fortunate individuals able to take my family on campimg trips although we never got out of the eastern states till the kids grew up (our old jalopies wouldn't make it)<p>
   But my four kids still remember those trips and they still go camping also. It was a wonderful way to take a cheap vacation then. It's still cheaper than motels and better for one's health. There was some good in the good old days     Yrs   
<hr>
I think you goofed!!!  Yes, the fees to enter parks are going up, but the 
rates are per car, not per person.  The old rate for Yosemite was $5 per 
car for a whole week, which is the same rate charged when the park 
opened.  (Though I guess back then it was per horse drawn buggy or 
wagon!)  The new rate is $20 PER CAR per week, still not per person!!!!!
There is a per person rate if you come in by bus, but I think it's only 
about $10 or so.  (Yes, people do take the bus to Yosemite, besides 
package tours you can take the train to Merced and get a Yosemite 
Transportation System bus to the park.)<p>

BTW, if you took that $5 charge from when the park opened and adjusted it 
for inflation it would be well over $100 nowadays!!  (Per the article in 
the SJ Murky News.)<p>
<strong>Ed Note:</strong>Didn't realize we were being so badly overcharged those days and I didn't realize that the direct labor and material costs for trees and animals had increased so dramatically.:) 
<hr>
I am writing in response to your editorial about the raise in fees for
national parks.  I agree that it is unfortunate to make entry fees more
expensive, but in my opinion it is even worse to allow maintenance and
staffing of the parks to continue to deteriorate.  There are stories of
park rangers living in shipping crates because there is no money to build
them proper housing.  Trails are going unmaintained, trash is uncollected,
public facilities such as campgrounds and bathrooms are falling apart.  The
government keeps on creating new national parks and monuments without
adding one cent to the park budget to pay for them!  The money *must* come
from somewhere.  Citizens won't accept tax increases, so the only other
source is entry fees.  Oh yeah, I can hear what comes next, "what about the
zillions of dollars in park concession profits??"  Believe me, it isn't
"zillions of dollars", and there isn't enough there to run a national park
all by itself, unless visitors are willing to buy $20 hamburgers.<p>

Bottom line is, I'm tired of hearing whining about entry fee increases for
public lands and institutions.  There's no point in keeping them at all if
they don't have the funding to be properly cared for!  Might as well sell
the land to the condo builders after all.
Subject: "Wanna see a tree" - still affordable<p>

I don't know what you're talking about in this editorial!  The current
entrance fee to the Grand Canyon is $10, which covers everybody in the
car, and is good for a week; the proposed fee increase would raise that
to $20, an increase of only $10.  For that matter, buy yourself a Golden
Eagle Pass for $25, which gets you unlimited access to all National Park
Service fee areas free for a year (they may raise the price of that as
well, but the highest it would go would be $35 for the coming year). 
Next time, try to get the facts first before fulminating.<p>
<strong>Ed Note:</strong> The info was pulled from a chart appearing in the San Jose Mercury News that broke down per person and per car potential charges. If there was a error in this, I apologize. Personally, I think $35 per truck load is too much for people to pay. The Golden Eagle Pass in the formal press release is listed as "not changed at the moment, but will.." and there are no official projections as to what the increase would be.<p>
I think it is a worthwhile bid for the Federal government to now try to manage nature in the form of more bathrooms and visitor centers - clearly enhancing the beauty of nature and cleaning up the environment for Sierra Club members in designer hiking boots.<p>
Why is it that the government sees rates at parks excessive for people over 62, and maintains a Golden Age Pass that is less than half the cost to everyone else, yet if you are among the 22% of the people that live in or close to poverty, you get hosed ?<p>
The clear message was that there are more future increases on the way. Maybe they will help to pay for making more natural rivers into purified public drinking fountains, and getting rid of all those pesky fish ?
<hr>
Joe--

I have noticed that you and I tend to agree on the big picture while
disagreeing on how to get to the designated milestone and who is going
to drive the tour bus.<p>

In the case of the raised fees at the National Parks, I, along with you
deplore the cost impact on the financially challenged.  (We used to,
when I was there, refer to them as the poor.) I believe that everyone
should have access to the parks, as I believe that everyone should have
the right to good schools, good medical care, good food, and good
housing.<p>

Unfortunately, as we have seen over the past decades, we don't have
enough money, or an adequate system, to ensure that everyone has good
housing, food, or medical care.  Joe, as I have watched the park budged
get slashed over the past several years, it has also become evident that
we don't have the money to support the current system.  One of the
reasons for this is that we have what is probably the lowest tax rate in
the developed nations.<p>

When you went to the parks as a kid the total traffic in a year probably
didn't equal the traffic in a month today.  Add to that recent cuts in
the number of park personnel,  cuts in maintenance dollars, and
increased costs in obtaining both workers and repair parts.  <p>

What you find out is that we are damned lucky to have parks available
for anyone, regardless of entrance price!<p>  

It boils down to one inescapable fact...government services cost money.
If you want the government to provide anything, be it national parks, a
national highway system, air traffic control, welfare...it is going to
cost the taxpayer money.  If, at the same time that you are wanting
services you are wanting lower taxes...then you wind up with lying
politicians, demoralized government workers, and unhappy voters.<p>

Back in his prime Robert Heinlein coined the acronym 'TANSTAAFL.'  It
applied then and it applies now.  There Ain't No Such Thing As A Free
Lunch!.<p>

Just as a mental exercise, next time you're out and around, look at the
infrastructure that the government at all levels has provided for your
use over the past 20-30 years. You'll see buildings, roads, airports,
and all of the nice to have things that go with them, such as books in
the libraries, traffic signals and signs, heat, and indoor plumbing. 
All of that infrastructure takes maintenance, all of that maintenance
requires workers, and all of those buildings that were provided need to
be staffed so that you can use the facilities.<p>

Joe, look carefully and I think you'll find that the infrastructure is
deteriorating.  There are no longer the libriarians that there used to
be, the books are not being replaced, the roads are cracking and it
takes longer and longer for the maintenance crew...what there is of
it...to show up.  Air traffic control is having major problems because
the computer systems and the radar isn't up to handling todays traffic
load.  The driver's license bureau has cut back on hours...and driver's
training is no longer an option in many high schools because of the high
cost of insurance and the higher cost of getting a good instructor.<p>

We, as a nation, have a choice.  We can pay the taxes, support the
infrastructure at the level where it needs to be to provide the
requisite amount of services, and we can provide all services to all
people or we can keep the tax rates low, charge user fees to support
those services that are nice to have and direct fund only those services
that are vital to the nation...and let the poorest third continue to
become even more disadvantaged.<p>

Mind you, Joe...<p>

This has nothing to do with Republicans or Democrats.  This has nothing
to do with politics at all.  This is simple economics.  You can't give
anything away unless someone is willing to pay for the acquisition cost.
<center><strong>California Votes Dope - Gets two. The 1996 Post Election "Duh" Awards</strong></center><p>

Enjoyed your editorial very much.  Being an optimist most of the time, I
feel that Slick Willy is reshaping the Executive Branch starting with his
cabinet, to a more moderate than "bleeding heart" liberal makeup.  We will survive
for four more years.  The Republican congress will prevent anything drastic and
hopefully Clinton will actually work in a bipartisan effort to balance the budget,
save Medicaide, Medicare, Social Security and maybe even do something
intelligent with the Health Care fiasco.<p>

Heaven forbid Gore or any other Democrat makes it the next time.
My wife and have cancelling each others vote for 26 years.
<hr>
I agree with most of your editorial Joe, save for your comments on Perot and those 
who voted for him. Taking a step back, I can see the Perot voters as folks who are 
sick of the politics of the late 20th century. I'm not saying, mind you, that Perot 
had a chance in hell... even if someone carpet bombed Dole's rocking chair and 
Clinton's hot tub. Most of them probably knew this.<p>
Perot's presence made a near-zero impact on this year's election, despite the 
tag-team crack. Four years ago, he had a kind of percentage, stolen from the right 
places, to have rocked the outcome, possibly. But his numbers this year were 
unimpressive.<p>
My take on the majority of the Perot voters that I know personally is as follows:<p>
Your average Perot voter falls into a general catigory. They are either a 
True-Believer (like that homeless guy on the bus that was yeling the merits of Ross 
and handing out strange literature...) or a Civic Minded Principalitarian. The True 
Believers thought he was going to win, that he was God, that he was The Answer. 
Insane, clearly. No one man is the Answer. These days, your lucky to get the Lesser 
Of Two Evils. The Civic Minded Principalitarians vote because they feel it is the 
duty of a loyal American to vote. But they fear the two major candidates. A vote for 
Perot is, at least, a vote for none of the above. A cop out? Maybe. Or maybe a 
protest. Is it a cop out to say 'I, at least, am not to blame for putting the 
President in the White House. Don't come crying to me when the stuff hits the fan'?<p>
You did, Joe. In almost as many words. 'Best of all, I won't have to take 
responsibility for the damage that will done by the Clintons over the next four 
years.' Looking at the pre-election poles, a vote for Dole was also a wasted vote. 
Why do it? Because if you didn't vote, you didn't TRY!<p>
OK, opinion vented.
<hr>
joe.. you couldn't have a better position. well said. i voted against the 
dope bill. i also voted against anything which helped any attorney fatten 
his or her pockets. as for propositions, i feel any law voted in by the 
population should stand as voted and not be challanged by political 
correct attornies who get the voted in propositions thrown out. as for 
the city politions who always ask where will we get funds if not from 
higher taxes, try this: lower you dam salery you over paid #$%^&! start 
cutting at the top not the services! look at vallejo and marine wworld. 
no voter voted on marine world to be financed by the city but the city 
"fathers" wanted "to better the city and create more jobs" bull.... the 
x mayor smiles on each trip to the bank for his efforts on that 
project. city goverments are running wild and need to be "reworked".
<hr>
	Seems to me that California got what you deserve in the election.  And
now some lawyer types say that California law probably makes it legal to
smoke marijuana in the workplace, but not tobacco.  Is it any wonder
that with three teenagers, I abandoned that misstate like a sinking ship
for a place that gives me freedom to be myself.<p>

	Live so far off the beaten track that anyone who comes by is either
totally lost, looking for me or a government agent.  I can breath the
air, shoot game, and smoke tobacco on my own land (even outdoors).  The
point is that I don't need a government to tell me how to live my life
and I won't settle for it.<p>

	I pity those who do.<p>

Just my penny.
<hr>
You ultraconservative types constantly decry the alleged "liberal bias" 
in the media.  So why do you applaud David Brinkley, who completely 
abandoned any pretense to being an objective journalist when he shot his 
mouth off about President Clinton on the air?  That was an especially 
egregious and indisputable example of journalistic bias.  Is it because 
in this particular case the bias was very clearly in your favor?<p>

In his new job as a commentator, David Brinkley will not have to pretend 
to be an objective journalist.  I would not have been critical of him if 
he were making those remarks as a commentator who happens to have a 
particular viewpoint.  I am criticizing him only because he made the 
remarks while serving as the anchor of an "impartial" news program.

<hr>
as a french citizen, i mind my own business and tell you that your
'comment' on the vote by Californians on prop 215 is pure bullshit<p>

Better Freedom than Hypocrisy and injustice as it is unfortunately 
still the case here.<p>

By the way I too have children<p>
<hr>
So nice to read the comments of one of the few Americans (apparently) who 
can still THINK!<p>

I, too, cannot believe how the 49% of voters who elected Clinton could be 
mindlessly loyal to a man David Brinkley so aptly pegged in his 
unplanned, but on-air comments.<p>

All I can say is:  Thank God enough Congressional districts voted 
Republican, allowing the Senate and House to keep a reign on this 
"liberal in conservative's clothing" administration -- at least for the 
next two years!<p>

And Heaven help us if, four years hence, the American public has "dumbed 
down" sufficiently to elect (I wince to even print it) AL GORE as 
Clinton's successor.
<hr>
  Your editorial claims that California's proposition 215, which
legalizes medical use of marijuana, was about "peace and love"
types pushing drugs.  This is simply not true.  It is a last resort
used to allow physicians to prescribe a substance which they have
determined is medically effective in counteracting AIDS-related
nausea and glaucoma.  A last resort made necessary solely because
the "politics" of the DEA has thwarted the legitimate medical use
of marijuana, despite extensive medical review and court hearings,
included the much-quoted case in which the judge declared marijuana
"safer than aspirin" in 1988 - only to be ignored.<p>
   Indeed, despite the DEA's view of politics, the voters passed not
only 215 in California, but Proposition 200 in Arizona, which
[to quote David Borden of DRCNet, http://www.drcnet.org/]
"legalizes prescription and medical use of marijuana and other
controlled substances, and replaces prison sentences for drug
possession with probation.  The bill is retroactive, which means
that some number of prisoners will be released.  Prop. 200 was
backed by numerous physicians and by prominent Arizona
conservatives, including recently retired Republican Senator
Dennis DeConcini and some former Reagan Administration officials."
Are these supporters of this more far-reaching proposal "peace & 
love ... generation X wanna be's"???<p>
   Certainly some of us who support the medicinal use of currently
banned drugs also would like to see complete legalization.  But we
never forced the anti-drug zombies to go so far as to prohibit licensed
physicians, with extensive medical research supporting them, from
administering the best possible treatment to their patients.  If that
detracts from the anti-drug position in a broader context, and suggests
that it never was based on logic or concern for anyone's well-being
at all, well, it isn't our fault.<p>
<hr>
  I thought I was the only one who thought Perot was working for
Clinton.  Or is Clinton working for Perot?  Perot did not get where
he is by doing stupid things.  I believe he knew exactly what he was
doing.<p>   
  I have read your editorials for a while and have agreed
wholeheartedly with all of them, but this is the best one yet.   I am
also proud to say I voted for Dole and would do it again. The only
good thing I can find about this election is that the Clintons will
not be able to pass any legislation to hurt the USA, they will
probably be too tied up in court to have any time...
<hr>
So it passed.   The let the ill people have it.<p>
BUT why not make its distribution through the police departments?   Every
CA City has a department, and the outlying rural areas are serviced by the
sheriff's offices.<p>
This is a STATE program, and with the computer tie-ins to the law
enforcement, a standard procedure can be established. <p> 
<hr>
<center><strong>The Ham or Chicken sandwich phenomena....or using more mustard and less Clinton</strong></center>
Joe,
Again I like your editorials. Wish I could be more political in my
publication. Actually, I have, but I have to keep it to a minimum.
Anyway, my wife and I operate our publishing business our of our home. Boy
would it be rough for either of us to become employees again.
<hr>
I think BC is going to wake up Wednesday morning and find out that
ethics and morals DO matter. I am not so much a pessimist as an
optimist. I always believe that what goes around comes around and that
you get your just reward in the end. I still have some faith in this
country and it's people and when it comes time to cast their vote,
people are going to hear that inner voice speaking loud and clear.
<hr>
Good job on the editorial Joe. Good analogies, good examples. Mayo
spoils much to quickly - especially in warm conditions. Mustard - you
needn't worry about - it'll still be good when you're ready to partake.
Personally, I'm worried about the outcome on Nov. 4. Its not even so
much the part about being stuck with another 4 years of bubba and the
mess we'll be left with. I'm personally worried that if the slickmeister
does get re-elected - what that says about the people that voted for
him. I hope society isn't slipping away into the "quick fix", tell me
what I want to hear just don't tell me the truth syndrome that appears
to be growing. Where I come from and the upbringing that I had was that
your word meant everything. People prided themselves on being able to
consumate a deal, large or small, with just a handshake. If you said you
were going to do something people expected and counted on you to do what
you said. Hell I'd be afraid to shake hands with slick willie. Afraid
that I'd come away with a couple of fingers or something missing. I am
bolstered by one thing. Even if loose willie does get re-elected he'll
be a lame duck and he won't be able to screw things up too bad. Hang in
there. We'll all be interested to see what happens in a few days.

</td>
</tr>
</table></center>
<center><h6><a href="zcopy.htm"> 1995 </a>Zippo Dot Com Incorporated<br> All rights reserved</h6>
</center>
</body></html>


</DOC>
<DOC>
<DOCNO>WT02-B10-296</DOCNO>
<DOCOLDNO>IA038-000734-B028-68</DOCOLDNO>
<DOCHDR>
http://zippo.com:80/useweb.htm 205.185.79.4 19970210062700 text/html 5944
HTTP/1.0 200 Document follows
Date: Mon, 10 Feb 1997 06:29:01 GMT
Server: NCSA/1.5
Content-type: text/html
Last-modified: Mon, 10 Feb 1997 02:04:54 GMT
Content-length: 5770
</DOCHDR>
<!DOCTYPE HTML SYSTEM "html.dtd">
<HTML><HEAD><TITLE>The Daily News - Zippo's News Service</TITLE></HEAD><body background=paper.gif>
<center><IMG SRC="tdn.gif" ALIGN="BOTTOM"></center><p>
<center><h3>Super Zippo Subscriber Web Sites</h3></center>
<center><table width=520>
<tr>
<td>

<img src="gal3dot.gif"> <a href="http://super.zippo.com/~doubtw/"> Tom's Hornsby Tapes</a><br>
<img src="gal3dot.gif"> <a href="http://super.zippo.com/~Mohawk/netscape.htm"> The Singing Tuscaroras</a><br>
<img src="gal3dot.gif"> <a href="http://super.zippo.com/~rufos/"> The House of Rufos</a><br>
<img src="gal3dot.gif"> <a href="http://super.zippo.com/~shadow/"> The Shadow's Place</a><br>
<img src="gal3dot.gif"> <a href="http://super.zippo.com/~shamu2/"> And All That Jazz</a><br>
<img src="gal3dot.gif"> <a href="http://super.zippo.com/~offroad/"> OffRoad Links</a><br>
<img src="gal3dot.gif"> <a href="http://super.zippo.com/~sulaiman/"> Slaymaan's Home Page</a><br>
<img src="gal3dot.gif"> <a href="http://super.zippo.com/~twilight/"> Twilight Zone Home Page</a><br>

<img src="gal3dot.gif"> <a href="http://super.zippo.com/~stephenl/"> Janeen & Stephen's Bandwidth HOG</a><br>
<img src="gal3dot.gif"> <a href="http://super.zippo.com/~hector/"> Hector's House</a><br>
<img src="gal3dot.gif"> <a href="http://super.zippo.com/~robfult/"> The Fultons</a><br>
<img src="gal3dot.gif"> <a href="http://super.zippo.com/~samson/"> Samson Alexae's List</a><br>
<img src="gal3dot.gif"> <a href="http://super.zippo.com/~aphex1/"> Aphex's Page</a><br>

<img src="gal3dot.gif"> <a href="http://super.zippo.com/~bobwood/"> Bob Wood's Page</a><br>
<img src="gal3dot.gif"> <a href="http://super.zippo.com/~ferrets/"> My Ferret's Webpage</a><br>
<img src="gal3dot.gif"> <a href="http://super.zippo.com/~teenview/"> Teen Views</a><br>
<img src="gal3dot.gif"> <a href="http://super.zippo.com/~ashworth/"> Brooklyn Products Inc. Webpage</a><br>
<img src="gal3dot.gif"> <a href="http://super.zippo.com/~metalhd/"> MetalHead's Home Page</a><br>
<img src="gal3dot.gif"> <a href="http://super.zippo.com/~kermit/"> Matthew Anderson's Page</a><br>
<img src="gal3dot.gif"> <a href="http://super.zippo.com/~btpeet/"> Peet's Peculiar Page</a><br>
<img src="gal3dot.gif"> <a href="http://super.zippo.com/~cleon51/"> Julie's Page</a><br>

<img src="gal3dot.gif"> <a href="http://super.zippo.com/~gbberns/"> Gary B. Berns Home on the Web</a><br>
<img src="gal3dot.gif"> <a href="http://super.zippo.com/~jderes/"> Joe Deres Prototype Web Page</a><br>
<img src="gal3dot.gif"> <a href="http://super.zippo.com/~amedonis/"> Estudio Contable Impositivo</a><br>
<img src="gal3dot.gif"> <a href="http://super.zippo.com/~ericmax/"> Thirty Thousand Feet</a><br>
<img src="gal3dot.gif"> <a href="http://super.zippo.com/~catbert/"> Shoshana's Scrapbook</a><br>
<img src="gal3dot.gif"> <a href="http://super.zippo.com/~canawar/"> The Canadian War Library</a><br>
<img src="gal3dot.gif"> <a href="http://super.zippo.com/~bridge/"> Bridge's Home Page</a><br>
<img src="gal3dot.gif"> <a href="http://super.zippo.com/~sstephen/"> Steve Selvaggio's Home Page</a><br>
<img src="gal3dot.gif"> <a href="http://super.zippo.com/~people/"> More People Pages</a><br>
<img src="gal3dot.gif"> <a href="http://super.zippo.com/~decior/"> Decio Rebello's Home Page</a><br>
<img src="gal3dot.gif"> <a href="http://super.zippo.com/~rincon/"> Surf Images</a><br>
<img src="gal3dot.gif"> <a href="http://super.zippo.com/~cosmosis/"> Who is Cosmosis?</a><br>

<img src="gal3dot.gif"> <a href="http://super.zippo.com/~markbyrn/"> The Freedman Lame Page</a><br>
<img src="gal3dot.gif"> <a href="http://super.zippo.com/~dfsimage/"> DFS Images</a><br>
<img src="gal3dot.gif"> <a href="http://super.zippo.com/~denza/"> The Denza Family Page!</a><br>
<img src="gal3dot.gif"> <a href="http://super.zippo.com/~dicknu/"> Raven HTML Lab</a><br>

<img src="gal3dot.gif"> <a href="http://super.zippo.com/~archive/"> Archive's Webpage</a><br>

<img src="gal3dot.gif"> <a href="http://super.zippo.com/~drkwatrs/"> Dark Waters</a><br>
<img src="gal3dot.gif"> <a href="http://super.zippo.com/~newgod/"> New God FM</a><br>
<img src="gal3dot.gif"> <a href="http://super.zippo.com/~kathon/"> Kathon's Home Page</a><br>
<img src="gal3dot.gif"> <a href="http://super.zippo.com/~nircha/"> Northern Illinois R/C Helicopter Association</a><br>
<img src="gal3dot.gif"> <a href="http://super.zippo.com/~jraitt"> Welcome To JR's Homepage</a><br>
<img src="gal3dot.gif"> <a href="http://super.zippo.com/~hangard/"> Welcome to Hangar D</a><br>
<img src="gal3dot.gif"> <a href="http://super.zippo.com/~mutawa/"> Unofficial Nokia 9000 Communicator Home Page</a><br>
<img src="gal3dot.gif"> <a href="http://super.zippo.com/~midimong/"> The World of Mong</a><br>

<img src="gal3dot.gif"> <a href="http://super.zippo.com/~flight/"> Steve's Flight School</a><br>
<img src="gal3dot.gif"> <a href="http://super.zippo.com/~sputum/"> S.P.U.T.U.M</a><br>
<img src="gal3dot.gif"> <a href="http://super.zippo.com/~fidosden/"> Uncle Fido's Dark Hole </a><br>
<img src="gal3dot.gif"> <a href="http://super.zippo.com/~nurfer/"> Farang's Home Page</a><br>
<img src="gal3dot.gif"> <a href="http://super.zippo.com/~feather/"> Feather's Babies</a><br>
<img src="gal3dot.gif"> <a href="http://super.zippo.com/~sjames/"> DaffyNet</a><br>
<img src="gal3dot.gif"> <a href="http://super.zippo.com/~lvalente/"> Leonardo Ferreira's Bookmarks</a><br>


</td>
</tr>
</table></center>

<hr>
<center>
| <a href="useinfo.htm">Member Page Setup Info</a>
| <a href="home.htm">Home</a> | </center>
<hr>
<center><h6><a href="copy.htm"> 1995,1996 </a>Zippo Dot Com Incorporated, All rights reserved</h6>
</center>
</body></html>
</DOC>
<DOC>
<DOCNO>WT02-B10-297</DOCNO>
<DOCOLDNO>IA038-000734-B028-93</DOCOLDNO>
<DOCHDR>
http://zippo.com:80/useinfo.htm 205.185.79.4 19970210062708 text/html 1935
HTTP/1.0 200 Document follows
Date: Mon, 10 Feb 1997 06:29:10 GMT
Server: NCSA/1.5
Content-type: text/html
Last-modified: Sat, 07 Dec 1996 02:16:13 GMT
Content-length: 1761
</DOCHDR>
<!DOCTYPE HTML SYSTEM "html.dtd">
<HTML><HEAD><TITLE>The Daily News - Zippo's News Service</TITLE></HEAD><body background=paper.gif>
<center><IMG SRC="tdn.gif" ALIGN="BOTTOM"></center><p>
<center><h3>Super Zippo Subscriber Web Sites/Setup Information</h3></center>
<center><table width=520>
<tr>
<td>

We appreciate your interest in creating your own User Pages with Super Zippo. If you have a 6- or 12-month subscription with Super Zippo, we can reserve 3MB of space to put up your user pages. We just need to get a URL address from you in the following format, replacing the "name" portion below:<p>

        <center>http://super.zippo.com/~name</center><p>

Needs to be between 6-8 lowercase, alphanumeric characters. Most use their SZ username, but you can use whatever you would like, as long as it does not conflict with another user of the service. Once we receive, we'll have the space reserved, and then confirm by email with instructions on how to proceed in uploading your files.<p> 

We'll also setup a link to the page at the Super Zippo Web site. With the user pages, we request that users not include any binary images consisting of adult-theme material,  or software archives, due to system bandwidth restrictions.<p> 

We hope this information is helpful. Please forward the information requested above, as well as your Super Zippo username to <a href="mailto:mike@zippo.com">mike@zippo.com</a>, in order to have access to the user pages setup.<p>

</td>
</tr>
</table></center>

<hr>
<center>
| <a href="useweb.htm">Current Member Pages</a>
| <a href="home.htm">Home</a> | </center>

<hr><center><h6><a href="copy.htm"> 1995,1996 </a>Zippo Dot Com Incorporated, All rights reserved</h6>
</center>
</body></html>
</DOC>
<DOC>
<DOCNO>WT02-B10-298</DOCNO>
<DOCOLDNO>IA038-000734-B028-125</DOCOLDNO>
<DOCHDR>
http://zippo.com:80/ftpdl.htm 205.185.79.4 19970210062718 text/html 5271
HTTP/1.0 200 Document follows
Date: Mon, 10 Feb 1997 06:29:20 GMT
Server: NCSA/1.5
Content-type: text/html
Last-modified: Wed, 05 Feb 1997 00:49:23 GMT
Content-length: 5097
</DOCHDR>
<!DOCTYPE HTML PUBLIC "+//ISBN 82-7640-037::WWW//DTD HTML//EN//2.0" "HTML.DTD"
<HTML>
<HEAD>
<TITLE>Super Zippo</TITLE>
</HEAD>
<body background="paper.gif">
<center><IMG SRC="tdn.gif"></center>
<p>
<center><table border width=640>
<tr>
<td width=100 valign="top"><IMG SRC="appshome.gif"></td>
<td width=210 valign="top"><strong><a href="http://ftp.zippo.com/archive/pub/animation/">Awesome Animations</a></strong> 197 CAD rendered 3D Animations and 3D clip art images. All images are royalty free</td>
<td width=100 valign="top"><IMG SRC="appshome.gif"></td>
<td width=210 valign="top"><strong><a href="http://ftp.zippo.com/archive/pub/ada/">Ada</a> New</strong> - 1.3 Gbytes of documentation, information and source code. A complete Ada 83 and Ada 95 development environment.</td>
</tr>
<tr>
<td valign="top"><IMG SRC="appshome.gif"></td>
<td valign="top"> <strong><a href="http://ftp.zippo.com/archive/pub/hawk/"> Blackhawk</a></strong> for Windows 95. A complete collection of Windows 95 utilities, applications and accessories</td>
<td valign="top"><IMG SRC="appshome.gif"></td>
<td valign="top"> <strong><a href="http://ftp.zippo.com/archive/pub/cica/"> CICA</a> New</strong> - The ultimate shareware collection for Windows 95, 3.1 and NT including Utilities, Drivers, Icons, Programming tools, and Internet related applications.</td>
</tr>
<tr>
<td valign="top"><IMG SRC="appshome.gif"></td>
<td valign="top"> <strong><a href="http://ftp.zippo.com/archive/pub/clib/"> C/C++ User's Group Library</a></strong> Cross platform: Internet tools, sound libraries, cross-compilers, postscript tools, and Unix text utilities.</td>
<td valign="top"><IMG SRC="appshome.gif"></td>
<td valign="top"> <strong><a href="http://ftp.zippo.com/archive/pub/clip/"> The Clip Art Image Library</a></strong> - Over 6,000 clip art images from England including black and white, color and image libraries. Covers over 18 major categories of clip art.</td>
</tr>
<tr>
<td valign="top"><IMG SRC=" appshome.gif "></td>
<td valign="top">The <strong><a href="http://ftp.zippo.com/archive/pub/doom/">Doom</a></strong> Volume 3 Toolkit. Over 2,400 levels for Doom 1 & 2, Heretic and Hexen. Graphic adds-ons, new weapons, editors, FAQs and documentation</td>
<td valign="top"><IMG SRC=" appshome.gif "></td>
<td valign="top"> <strong><a href="http://ftp.zippo.com/archive/pub/fbsd/">Free BSD 2.1.6</a> New</strong> - A full 4.4 BSD Lite based 32 bit operating system. Includes NNTP news, mail and complete development environment. </td>
</tr>

<tr>

<td valign="top"><IMG SRC=" appshome.gif "></td>
<td valign="top"> <strong><a href="http://ftp.zippo.com/archive/pub/gnu/"> GNU</a></strong> - Over 230 UNIX programs, 250 Mbytes of source code and compiled binaries for SunOS and Solaris. Includes complete development tools.</td>

<td valign="top"><IMG SRC=" appshome.gif "></td>
<td valign="top"> <strong> <a href="http://ftp.zippo.com/archive/pub/hobbes_os-2/"> Hobbes OS/2 archived</a> New</strong> - Two times bigger. Support for Warp. Thousands of programs including utiltities, games, graphics programs and C++ compiler. </td>
</tr>
<tr>
<td valign="top"><IMG SRC=" appshome.gif "></td>
<td valign="top"> <strong><a href="http://ftp.zippo.com/archive/pub/internet_info
/">Internet Info</a></strong> - 17,420 FAQ's, RFC's, Network Maps, and IEN's. Typical questions and answers, Ftp site lists, Internet Guides and usage instructions. </td>
<td valign="top"><IMG SRC=" appshome.gif "></td>
<td valign="top"> <strong><a href="http://ftp.zippo.com/archive/pub/x11/">X11R6</a> </strong> - The most current X consortium release. X Windows, X11R6 path 12, full Xfree 86, full source and pre-compiled ready to run bianries. Cross platform support.</td>
</tr>
<tr>
<td valign="top"><IMG SRC=" appshome.gif "></td>
<td valign="top"> <strong><a href="http://ftp.zippo.com/archive/pub/cica_nt/"> CICA NT</a> New</strong> - Program and System Utilities, Drivers, System patches and fixes, Network related programs, and games.</td>
<td valign="top"><IMG SRC=" appshome.gif "></td>
<td valign="top"> <strong><a href="http://ftp.zippo.com/archive/pub/perl/"> Perl</a></strong> 4 and 5 DOS / UNIX language for system administrators, programmers &  power users. Includes source code and hundreds of Perl Scripts. </td>
</tr>
<tr>
<td valign="top"><IMG SRC=" appshome.gif "></td>
<td valign="top"> <strong><a href="http://ftp.zippo.com/archive/pub/qrz/"> QRZ! Ham Radio</a> New</strong> - call sign database, 985,985 listings and over 7,000 files covering all facetts of amatuer radio. Runs on UNIX, DOS, Windows and OS/2. </td>
<td valign="top"><IMG SRC=" appshome.gif "></td>
<td valign="top"> <strong><a href="http://ftp.zippo.com/archive/pub/simtel/">Simtel</a></strong> for Windows. 950 of the latest Windows 3.X and Win 95 shareware programs and source code, programming utilities and general utilities.</td>
</tr>
</table></center>

<center><h6><a href="copy.htm"> 1995,1996 </a>Zippo Dot Com Incorporated, All rights reserved</h6>
</center>
</body></html>


</DOC>
<DOC>
<DOCNO>WT02-B10-299</DOCNO>
<DOCOLDNO>IA038-000734-B028-190</DOCOLDNO>
<DOCHDR>
http://zippo.com:80/zcopy.htm 205.185.79.4 19970210062758 text/html 2742
HTTP/1.0 200 Document follows
Date: Mon, 10 Feb 1997 06:29:58 GMT
Server: NCSA/1.5
Content-type: text/html
Last-modified: Sat, 07 Dec 1996 02:16:31 GMT
Content-length: 2568
</DOCHDR>
<!DOCTYPE HTML SYSTEM "html.dtd"><HTML><HEAD><TITLE>Intellectual Property Notices</TITLE></HEAD><body background="paper.gif"><center><IMG SRC="ziplog.gif">

</center><p><center><h4>INTELLECTUAL PROPERTY NOTICES</h4></center><center>

<Table width=500><tr><td><h5>Copyright Notices</h5>

Zippo Dot Com Incorporated Copyright 1995-1996, Zippo Dot Com Incorporated, Sunnyvale, CA 94086 U.S.A. All rights reserved. Except as explicitly provided below, copyright in this program and all accompanying documentation is owned by Zippo Dot Com Incorporated. Any person may view, copy, print and distribute this document subject to the following conditions:<p>

This program/documentation/service may be used for informational, non-commercial purposes only under license from Zippo Dot Com Inc.; any copy must include these notices.<p>

This service includes data and information not owned by Zippo Dot Com Incorporated that is made available by computer on-line service providers; this information may only be used subject to the intellectual property rights and use restrictions, if any, of these providers.<p>

Use, duplication or disclosure of the United States Government is subject to the restrictions set forth in DFARS 252.227-7013 (c) (1) (ii) and FAR 52.227-19.<p>

<h5>Trade Secret Notice</h5>
Zippo Dot Com Incorporated retains all ownership rights to all software programs published by Zippo Dot Com Incorporated. The Zippo Daily News Service / Super Zippo News Service software program (Direct Read News(tm)) is a confidential trade secret of Zippo Dot Com Incorporated and you may not attempt to reverse engineer or decompile Zippo Dot Com Inc. programs or knowingly allow others to do so.<p>

<h5>Trademark Notices</h5>
"Zippo's Daily News", "Super Zippo's Daily News", "Direct Read News", "Zippo Dot Com Inc.", and their respective logos, are trademarks or registered trademarks of Zippo Dot Com Incorporated. All other product names mentioned herein, if any, are the trademarks of their respective owners.<p>

<h5>Disclaimers</h5>
USE OF THIS PROGRAM/DOCUMENTATION/SERVICE IS PROVIDED "AS IS" WITHOUT WARRANTY OF ANY KIND, EITHER EXPRESSED OR IMPLIED, INCLUDING, BUT NOT LIMITED TO, THE IMPLIED WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, OR NON-INFRINGEMENT. SPECIFICALLY, THIS DOCUMENT COULD INCLUDE INACCURACIES OR ERRORS IN THE SOFTWARE, DATA OR INFORMATION PROVIDED HEREUNDER.<p></tr></td></table></center>

<center><h6> 1995,1996 Zippo Dot Com Incorporated<br>All rights reserved </h6></center></body></html>
</DOC>
<DOC>
<DOCNO>WT02-B10-300</DOCNO>
<DOCOLDNO>IA038-000734-B028-215</DOCOLDNO>
<DOCHDR>
http://zippo.com:80/faq.htm 205.185.79.4 19970210062806 text/html 10127
HTTP/1.0 200 Document follows
Date: Mon, 10 Feb 1997 06:30:09 GMT
Server: NCSA/1.5
Content-type: text/html
Last-modified: Sat, 07 Dec 1996 02:15:09 GMT
Content-length: 9953
</DOCHDR>
<!DOCTYPE HTML PUBLIC "+//ISBN 82-7640-037::WWW//DTD HTML//EN//2.0" "HTML.DTD"
<HTML>
<HEAD>
<TITLE>Super Zippo</TITLE>
</HEAD>
<center> 
<body background="paper.gif">
<IMG SRC="tdn.gif">
</center><p>
<center><table cellpadding=5 width=640>
<TR>
<td>
<center><h3>Frequently Asked Questions</h3></center><P>
<a name="a8">
<strong>Welcome to the Zippo News Service</strong><p>
Welcome to Zippo. Zippo News is the product of Zippo Dot Com of Sunnyvale California. Zippo News Services include free public access servers, membership servers, subscription servers, and commercial servers for ISPs and business end users. <p>
<a href="http://www.zippo.com">Original Zippo</a> offers sections for free public access, including an WinSock Apps section, as well as membership services for nntp access and restricted alt.* group access. <a href="http://www.zippo.com/rules.htm">Details</a><p>
<a href="http://super.zippo.com">Super Zippo</a>, an expanded service, is available only to subscription users and commercial customers.<a href="http://super.zippo.com/zns.htm"> Details</a><p>
Zippo provides Usenet, and other forms of Internet news, in a range of 180,000 - 220,000 + articles per day. Zippo offers full read and post access to its users and propagates news throughout the Internet every 15 minutes. Zippo receives news through; local posts, and numerous educational and commercial providers of both US and International origin.<p>
<a name="a1">
<strong>What are the difference between Super Zippo and Original Zippo ?</strong><p>

Super Zippo is a purely commercial subscription service. Original Zippo provides free public access through Direct Read News  , with membership only required for groups  requiring restricted access per current US law. The law covers point of origin and we are a US company. Membership also permits nntp news reader access.<p>

Super Zippo has multiple sites for users to access. Currently they are on the West Coast and East Coast. This provides less traffic per site, fewer geographic connecting hops, and redundant service in the event of an outage.<p>

Super Zippo provides 18,000 + news groups, Zippo provides 5,000+. Super Zippo adds groups constantly, Zippo is static, with the exception of updates. Super Zippo permits users to add local unique news groups, Zippo does not.<p>

Super Zippo does not have a time limit on usage, Zippo is limited to a max. of 6 hours in a 24 hour period.<p>

Super Zippo provides expanded FTP software selections, approx. 28 Gbytes to approx. 8 Gbytes for Zippo.<p>

Super Zippo has binary image archives, Zippo does not<p>

Super Zippo provides mailboxes to retail subscribers, Zippo does not.<p>

Super Zippo offers user web pages to 6 and 12 month subscribers.<p>

Super Zippo systems and lines are faster than Zippo. During periods of light access, the systems may appear to be similar in performance, however, as membership grows on Zippo, the system performance will be slower. Super Zippo runs a ratio of users to systems that is maintained at a lower level.<p>

Super Zippo is available at special rates to commercial users, ISPs and Corporate accounts, Zippo is not.<p>

<a name="a2">
<strong>I just signed up for the service and I can't connect through nntp, or through Direct Read News. What's wrong ?</strong><p>

Did you receive a confirming message from the service or from a Zippo Dot Com representative ? All memberships and subscriptions are automatically processed, 24 hours each day, and then confirmed. If you did not receive a confirmation e-mail within a few minutes of applying, contact us. The typical reson for no confirmation is an incorrect e-mail return address entered on the app.<p>
Super Zippo subscriptions and Zippo membership systems are not the same, one does not give access to the other. Frequently, users going to the wrong system is the problem. The home page and nntp system names, respectively, for Super Zippo are: http://super.zippo.com and snews.zippo.com. The home page and nntp system names for Zippo are http:/www.zippo.com and news.zippo.com. <p>
Case sensitive related issues are the next greatest cause for an inability to connect to either service. Our systems see uppercase and lower case letters as two distinctly different things. Aazz is not the same as AAZZ, or aazz. We took the approach as a security enhancement for passwords and e-mail addresses. Using upper and lower case distinction greatly decreases the probability of some one getting into a user's account.<p>
We entered the password incorrectly for a members account. So far we are running 99.8% accuracy, so the chances for this happening are 2 in 1000. When an e-mail is sent to us in reference to access, the first thing we do is a double test for incorrect entries. Once we have gone through this check, the chances of incorrect password are virtually zero.<p>
Incorrect browser or news reader setup where system information has not been entered, or a version of client software does not support password access. Send us an e-mail message, with the name and version of the access software you are using, and we will work through this with you. <p>
Attempted multiple connections will cause a disconnect. Both Super Zippo and Zippo memberships and subscriptions are for single user access. If a user id and password are already in use, and attempted second log on will interrupt the first. We are asked why we do this, usually with reference to a provider service where passwords may be used many times, simultaneously. <p>
The answer is that they are selling time and we are selling information. Time based services encourage as many people to be on line as possible because their billing is additive, they will charge for every minute a password is in use, so if 10 people are using the service, they will charge for all of them.  We are a flat rate subscription service and do not bill for time, so 10 connections under the same user names consumes 10 times the amount of system resources, but the revenue to us remains the same.<p>
<a name="a3">
<strong>I have service through an ISP and I cannot access restricted Alt groups. Are you censoring the news ?</strong><p>
Each ISP is provided with two sets of passwords. One permits general access, the second provides complete access. The ISP may distribute these passwords in a manner consistent with their local laws and service policies. <p>
<a name="a4">
<strong>I've posted to Super Zippo, or Zippo, and my posts aren't showing up, what is happening to them ? </strong><p>
Posts through nntp or Direct News, should show up on our servers between 15 minutes and half an hour of being posted. With as many as 220,000 articles coming each day, 15 minute batches of posts are the most efficient way of placing them on the system. If they do not show up within this time frame, and they would not be classified as SPAM,  something is wrong, and we would appreciate it if you would let us know.<p>
If the article is directed to a newsgroup that has a moderator, it will be directed to the moderator for approval, before it is posted. When approved, it will propagated back to us through the news network, so they will not appear instantly. If the moderator does not approve the post, it may never be posted. We keep a <a href="http://www.zippo.com/list.htm">list</a> of moderated newsgroups.<p>
If your post was SPAM, it may never show up. Major commercial messages in non-commercial groups are screened, as are articles cross posted to many groups that are not of common interest. If you are not sure if a post is SPAM, as us<p>
<a name="a5">
<strong> I've seen posts on other news servers that don't show up on the Zippo Servers ?</strong>
All news servers are independent. There is not a central hub, or and originating point for all news. Each server also has it's own policies on what groups to carry, what to feed outbound to other news services, and where they will get inbound news from. Generally, because we have many inbound news feeds, we get the bulk of the news that is placed into general circulation. If you consistently see posts on another server, that you do not see on Super Zippo or Zippo, send us a copy of the post header and we'll see if we can track it down, or arrange for a feed from the source.<p>
<a name="a6">
<strong> Why does it take so long for articles to show up on Super Zippo, or Zippo, when they are posted on other news servers. ?</strong>
I think the misleading term is "news". I think it should be called publicly distributed mail. News is not like broadcast news. The news migrates amongst perhaps 10,000 significant servers and, depending where you are in the overall flow, articles will be received in a few hours, or a few days. You may see a post on a server that took three connections to get there and a few hours. The same post may have taken 9 connections to get to us and 4 days. The reverse will also be true, where articles appear on our servers, but do not appear on other servers. <p>
<a name="a7">
<strong>I use Agent to count new articles on news servers and sometimes Super Zippo and Zippo have less. ?</strong><p>
It would be very easy for us to match or exceed the number of articles on other large news servers. All we would have to do is open the flood gates to SPAM and prevent any external post cancellations. We'd rather not. On a daily bases we remove at least 4,000 posts of "Make Money Fast" , approximately 8,000 posts by the guys that advertise dial-aporn hotlines by putting their number on a picture from alt.binary.pictures.erotica.girlfriends, etc. We hope our net articles are more worthwhile and will encourage people to post, when they see their messages won't be lost in a pile of garbage. <p>





</TD>
</TR>
</TABLE></center>

<center><h6><a href="copy.htm"> 1995,1996 </a>Zippo Dot Com Incorporated, All rights reserved</h6>
</center>
</body></html>
</DOC>
<DOC>
<DOCNO>WT02-B10-301</DOCNO>
<DOCOLDNO>IA038-000734-B028-247</DOCOLDNO>
<DOCHDR>
http://zippo.com:80/faqnews.htm 205.185.79.4 19970210062818 text/html 12519
HTTP/1.0 200 Document follows
Date: Mon, 10 Feb 1997 06:30:19 GMT
Server: NCSA/1.5
Content-type: text/html
Last-modified: Sat, 07 Dec 1996 02:15:15 GMT
Content-length: 12344
</DOCHDR>
<!DOCTYPE HTML PUBLIC "+//ISBN 82-7640-037::WWW//DTD HTML//EN//2.0" "HTML.DTD"
<HTML>
<HEAD>
<TITLE>Super Zippo</TITLE>
</HEAD>
<center> 
<body background="paper.gif">
<IMG SRC="tdn.gif">
</center><p>
<center><table cellpadding=5 width=640>
<TR>
<td>
<center><h3>Frequently Asked Questions</h3></center><P>

<a name=a8>
<img src="nwzrdra.gif"> <strong>How do I setup <strong>Agent</strong> as my newsreader to access Zippo's news server?</strong><p>

When initially starting Agent a <strong>Setup</strong> dialogue box will appear. The following fields need to be specified and are described below:<p>

<ul>
<li><strong>News (NNTP) Server:</strong><br>
<strong><tt>snews.zippo.com</tt></strong> (for the Super Zippo West news server)<br>
<tt><strong>snews2.zippo.com</tt></strong> (for the Super Zippo East news server)<br>
<tt><strong>news.zippo.com</tt></strong> (for the Original Zippo Membership)<p>


<li><strong>Mail (SMTP) Server:</strong> The SMTP server offered by your ISP, or the SMTP server included with a Super Zippo subscription.</li><p>

<li><strong>Email Address:</strong> The Email address provided by your ISP, or the mailbox included with a Super Zippo subscription.</li></ul><p>


<strong>Go Online now?</strong>: When this dialogue box appears, select <strong>NO</strong>. At this point you still need to specify your username and password settings, to pass the authentication process, before downloading the newsgroup list.<p>

Now go to the <b>Options</b> menu bar and select the <b>Preferences</b> option. Then select the <b>Profile</b> folder to enter the following information:
<ul>
<strong><li></strong>Check the <b>Server requires authorization login</b> options box to enable the <strong>User Name</strong> field. Once enabled, enter in your username.</li>
<strong><li></strong>Check the <b>Remember Password between sessions</b> options box to enable the <strong>Password</strong> field. Once enabled, enter in your password.</li></ul>

The authentication process is case-sensitive, so be sure to use upper-case and lower-case characters when appropriate. Now that your username and password are setup, you can select <b>Refresh Group List</b> from the <b>Online</b> pull-down menu. The newsgroup list will then begin to download.<p>

<hr>
<p><a name=a9>
<img src="nwzrdrb.gif"> <strong>How do I setup <strong>WinVN</strong> as my newsreader to access Zippo's news server?</strong><p>

When initially starting WinVN, create the winvn.ini and newsrc file by selecting OK for each. These are temporary files which eventually get used by the application once you specify your settings and a newsgroup list is downloaded.<p>

Within the initial <strong>Communications Options</strong> dialogue box, specify the following:<p>

<ul>
<li><strong>NNTP Server:</strong><br>
<strong><tt>snews.zippo.com</tt></strong> (for the Super Zippo West news server)<br>
<strong><tt>snews2.zippo.com</tt></strong> (for the Super Zippo East news server)<br>
<strong><tt>news.zippo.com</tt></strong> (for the Original Zippo Membership)<p>

<li><strong>Username:</strong> Enter your username for access to the services.</li><p>

<li><strong>Password:</strong> Enter your password. Your Username and Password settings will be used for the authentication process. Be sure to use upper-case and lower-case characters when appropriate, because the process is case sensitive.</li><p>

<li><strong>SMTP Server:</strong> You can use the SMTP server offered by your ISP, or the SMTP server included with a Super Zippo subscription.</li></ul><p>
 
Once these fields are entered, you can then select <strong>OK</strong>. The <strong>Personal Information</strong> dialogue box will then appear so that you can setup your email information.<br>
<ul><li><strong>Your name:</strong> your name</li><p>
<li><strong>Your email address:</strong> The mailbox provided by your ISP, or the mailbox included with a Super Zippo subscription.</li><p>
<li><strong>Reply-to email address:</strong> Usually the same as your email address. You would use the email address offered through your ISP, or the mailbox included with a Super Zippo subscription.</li></ul><p>

<strong>Request the latest group list from server?</strong> Select <strong>YES</strong> to initiate the download of the newsgroup list. The list should begin to download.<p>

<hr>
<p><a name=a10>
<img src="nwzrdrc.gif"> <strong>How do I setup <strong>NewsXpress</strong> as my newsreader to access Zippo's news server?</strong><p>
For Super Zippo, you would need NewsXpress V2.0 because it supports more than 16,000 newsgroups. Version 1.0 will only handle up to 16,000 so the entire Super Zippo newsgroup list will not download properly through this version. NewsXpress is currently only available in the 32-bit format so an alternative newsreader may be necessary if accessing through Windows 3x.<p>

At the initial <strong>Options</strong> dialogue box, you would enter the following information:<p>

<strong>Servers and Directory</strong> folder -<br>
<ul><li><strong>News (NNTP) server:</strong><br> 
<strong><tt>snews.zippo.com</tt></strong> (for the Super Zippo West news server)<br>
<strong><tt>snews2.zippo.com</tt></strong> (for the Super Zippo East news server)<br>
<strong><tt>news.zippo.com</tt></strong> (for the Original Zippo Membership)<p>

<li><strong>Username:</strong> Enter your username to access the services.</li><p>

<li><strong>Password:</strong> Enter your password. Your Username and Password settings will be used to pass the authentication process. Be sure to use upper-case and lower-case characters when appropriate because the process is case sensitive.</li><p>

<li><strong>SMTP Server:</strong> You can use the SMTP server offered by your ISP, or the SMTP server included with a Super Zippo subscription.</li></ul><p>
 
<strong>Personal Information</strong> folder -<br>
<ul><li><strong>Full Name:</strong> your name</li></br> 
<li><strong>E-Mail address:</strong> You would use the email address offered by your ISP, or the mailbox included with a Super Zippo subscription.</li></ul><p>

After these settings are specified, you would begin to download the newsgroup list by selecting <strong>Connect</strong> from the <strong>File</strong> pull-down menu. The newsgroup list should begin to download at this point.<p>

<hr>
<p><a name=a11>
<img src="nwzrdre.gif"> <strong>How do I setup <strong>NewsWatcher</strong> as my newsreader to access Zippo's news server?</strong><p>
The newest version of NewsWatcher 2.1.2 supports the authentication process, so you would need to get this version. The various preference settings will be described below for setting up NewsWatcher.<p>

At the <strong>Preferences</strong> dialogue box, you would need the following information. The <strong>Preference</strong> options can be found within the <strong>File</strong> menu. The necessary <strong>Topics</strong> are described below:<p>
<strong>Server Addresses -</strong>
<ul>
<li><strong>News Server:</strong><br>
<strong><tt>snews.zippo.com</tt></strong> (for the Super Zippo West news server)<br>
<strong><tt>snews2.zippo.com</tt></strong> (for the Super Zippo East news server)<br>
<strong><tt>news.zippo.com</tt></strong> (for the Original Zippo Membership)<p>

<li><strong>Mail Server:</strong>  The SMTP server offered through your ISP, or the SMTP server included with a Super Zippo subscription.</li></ul><p>

<strong>Personal Information -</strong>
<ul>
<li><strong>Full Name:</strong> your name</li>
<li><strong>Organization:</strong> <tt>(optional)</tt></li>
<li><strong>Email address:</strong> You would use the email address offered through your ISP, or the mailbox included with a Super Zippo subscription.</li></ul><p>

<strong>Authentication -</strong>
<ul>
<li><strong>Username:</strong> Enter your username to access the services.</li>
<li><strong>Password:</strong> Enter your password. Your Username and Password settings will be used to pass the authentication process. Be sure to use upper-case and lower-case characters when appropriate because the process is case sensitive.</li>
<li><strong>Always authenticate option:</strong> select <strong><tt>(yes)</tt></strong>. Zippo's news servers require authentication for reading and posting.</li>
<li><strong>Authenticate only when requested option:</strong> do not select this option. This option is for servers that require authentication on posting only.</li></ul><p>

<hr>
<p><a name=a12>
<img src="nwzrdrf.gif"> <strong>How do I setup Internet News as my newsreader to access Zippo's news server?</strong><p>
When you initially install MS's Internet News, you will be presented with the <strong>Internet News Configuration</strong> dialogue box. From here you would enter the following information:<p>

<strong>News Server:</strong><br>
<ul> 
<li><strong><tt>snews.zippo.com</tt></strong> (for the Super Zippo West news server)</li><br>
<li><strong><tt>snews2.zippo.com</tt></strong> (for the Super Zippo East news server)</li><br>
<li><strong><tt>news.zippo.com</tt></strong> (for the Original Zippo Membership)<p></li></ul>

<strong>My news server requires me to logon:</strong> select <tt><strong>(yes)</strong></tt><p>

<strong>Logon Settings:</strong>
<ul><strong><li>Account Name: </strong>Enter your username to access the services</li>
<strong><li>Password: </strong>Enter your password. Your Username and Password settings will be used to pass the authentication process. Be sure to use upper-case and lower-case characters when appropriate because the process is case sensitive.</li></ul><p> 

After select the <strong>Next</strong> button, the following information should also be filled out:<p>
<strong>Email address: </strong>You would use the email address offered through your ISP, or the mailbox included with a Super Zippo subscription.</li></ul><p>

If Internet News is already install you would select <strong>Options</strong> from the <strong>Message</strong> pull-down menu. From here the <strong>Options</strong> dialogue box will appear. Simply select the <strong>Add</strong> button and utilize the above information to add a new news server.<p>

<hr>
<p><a name=a13>
<img src="nwzrdrd.gif"> <strong>Can I use rtin to access Zippo's news server?</strong><p>
Newer versions of tin support the authentication process and can be used if your system is configured correctly. A few environmental variables need to be specified in order to successfully connect. If you do not have access to the specific files to make changes, you would need to contact your systems or network administrator.<p>
For the sake of simplicity, <strong>snews.zippo.com</strong> will be used to describe below. If Super Zippo East is used instead, be sure to specify <strong>snews2.zippo.com</strong> as the NNTP server instead. Original Zippo Members would utilize <strong>news.zippo.com</strong> as the NNTP server.<p>
<ul>
<li><strong>Define Server Name:</strong> Have <strong><tt>snews.zippo.com</tt></strong> specified as the NNTP server in the environment variable <strong><tt>NNTPSERVER</tt></strong>, or specified as the <strong><tt>/etc/nntpserver</tt></strong> file.</li><p>

<li><strong>Specify Password:</strong> because either of the servers utilizes username/password authentication, a password for the chosen server needs to be specified.<br>
Enter as:   <strong><tt>snews.zippo.com password</tt></strong><br>   (newsservername(spacebar)yourpassword) in the  <strong><tt>$HOME/.newsauth</tt></strong> file.</li><p>

<li><strong>Choosing a Zippo Username:</strong> The <strong>login name</strong> to your system has to match your chosen <strong>username</strong>. When the news server authenticates a user, it will utilize your login name as the Username. Be sure to have both match.</li></ul><p>

If you do not have access to these files, you may need to contact your systems administrator. You would also use <strong>rtin</strong> or <strong>tin -r</strong> to access either of the remote nntp servers.<p>

<hr>
<center><a href="faqidx.htm">Back</a></center>

</TD>
</TR>
</TABLE></center>

<center><h6><a href="copy.htm"> 1995,1996 </a>Zippo Dot Com Incorporated, All rights reserved</h6>
</center>
</body></html>
</DOC>
<DOC>
<DOCNO>WT02-B10-302</DOCNO>
<DOCOLDNO>IA038-000734-B027-34</DOCOLDNO>
<DOCHDR>
http://zippo.com:80/ 205.185.79.4 19970210062430 text/html 5880
HTTP/1.0 200 Document follows
Date: Mon, 10 Feb 1997 06:26:28 GMT
Server: NCSA/1.5
Content-type: text/html
Last-modified: Thu, 06 Feb 1997 21:46:51 GMT
Content-length: 5706
</DOCHDR>
<!DOCTYPE HTML PUBLIC "+//ISBN 82-7640-037::WWW//DTD HTML//EN//2.0" "HTML.DTD"
<HTML>
<HEAD>
<TITLE>Zippo Dot Com</TITLE>
</HEAD>
<body background="paper.gif">
<center><TABLE BORDER=4 cellpadding=5 width=600>
<th colspan=3>
<center><a href="copy.htm"><IMG SRC="tdn.gif" border=0 alt="The Daily News"> </a></center>
<center><strong><a href="zns.htm">About</a>  Zippo  and On-line<a href="rules.htm"> Membership</a>        Super Zippo's <a href="http://sub.zippo.com/comm.htm">Commercial/ISPs</a></strong>
</th>
<TR>
<TD width=200 valign=top>
<center><a href="http://www.aol.com"><IMG SRC="membweb1.gif" border=0></a></center>
<hr>
<strong>
<center>Top News Categories</center><hr></strong>
<ul>
<a href="http://drn.zippo.com/news-bin/wwwnews?alt.*">Alt</a><br>
<a href="http://drn.zippo.com/zippo-bin/wwwnews?alt.*">Alt.*</a> - Restricted<br> 
<a href="http://drn.zippo.com/news-bin/wwwnews?comp.*">Computer</a><br> 
<a href="http://drn.zippo.com/news-bin/wwwnews?humanities.*">Humanities</a><br>
<a href="http://drn.zippo.com/news-bin/wwwnews?misc.*">Misc</a><br>
<a href="http://drn.zippo.com/news-bin/wwwnews?news.*">News</a><br>
<a href="http://drn.zippo.com/news-bin/wwwnews?rec.*">Recreation</a><br>
<a href="http://drn.zippo.com/news-bin/wwwnews?sci.*">Science</a><br>
<a href="http://drn.zippo.com/news-bin/wwwnews?soc.*">Society </a><br>
<a href="http://drn.zippo.com/news-bin/wwwnews?talk.*">Talk</a><br>
<a href="http://drn.zippo.com/news-bin/wwwnews?zippo.*">Zippo </a><br></ul><p>
<center><strong>New ! <a href="http://drn.zippo.com/drn-bin/drnframe?*">Direct Read News +</a> Java</strong></center>

<hr>
<center><a href="http://techweb.cmp.com/techweb/ng/current/"><IMG SRC="nguide.gif" border=0 alt="NetGuide 4 Star Award" width=150 height=23></a></center>
<hr>
<center><strong>Zippo News Service</strong></center>
<a href="zns.htm">About</a> Zippo<br>
<a href="drnhelp.htm">About</a> Direct Read News<br>
<a href="advert.htm">Advertising</a> on Zippo Sites<br>
<a href="http://news.zippo.com/user/page">Connections</a> - User tests<br>
<a href="feeds.htm">Exchange</a> News Feeds<br> 
<a href="faqidx.htm">FAQs</a><br>
<a href="http://news.zippo.com/newsgrpr.txt">Free</a> & <a href="http://news.zippo.com/newsgrpm.txt"> Restricted</a> News Groups<br>
<a href="http://super.zippo.com">Jump to</a> Super Zippo<br>
<a href="rules.htm">Service</a> Policy
</td>
<TD valign=top width=200>
<center><strong>Inside this issue</strong></center>
<hr>
<a href="http://drn.zippo.com/news-bin/wwwnews?*.*">All</a> News Groups<br>
<a href=" http://drn.zippo.com/news-bin/wwwnews?newsgroups=*books*">Books</a><br>
<a href="http://drn.zippo.com/news-bin/wwwnews?newsgroups=*forsale*">Classifieds</a><br>
<a href="http://drn.zippo.com/news-bin/wwwnews?*.education*">Education</a><br>
<a href="http://drn.zippo.com/news-bin/wwwnews?*fan.*">Fan Clubs</a><br>
<a href="http://drn.zippo.com/news-bin/wwwnews?*.jobs*">Jobs</a><br>
<a href="http://drn.zippo.com/news-bin/wwwnews?newsgroups=*movies*">Movies</a><br>
<a href="http://drn.zippo.com/news-bin/wwwnews?newsgroups=*personals*"> Personals</a><br>
<a href="http://drn.zippo.com/news-bin/wwwnews?newsgroups=*politics*">Politics</a><br>
<a href="http://www.zippo.com/zsport.htm">Sports</a><br>
<a href="search.htm">Search</a> for a Newsgroup
<hr>
<center><a href="http://www.pointcom.com"><IMG SRC="5perct.gif" border=0 alt="The Point Top 5% Award" width=71 height=70></a>
<a href="http://www.mckinley.com/"><IMG SRC="vert4sta.gif" border=0 alt="Magellan 4 Star Award" width=90 height=70></a></center>
<hr>
<a href="hlinks.htm">Live News</a>
<li>Headline</li>
<li>Sports</li>
<li>Weather</li>
<li>Finance</li>
<hr>
<center><IMG SRC="hippo.gif" align=bottom alt="Hippo" width= 199 height=96><br>Spam Removal By Hippo.</center>
</TD>
<TD width=200 valign=top>
<center><strong>Zippo's Feature Section</strong></center>
<hr>
<center><strong><a href="editor.htm">Editorial</a></strong></center>
This issue: "O.J., the President, Howdy Doody and Apple Computer"<p>
<a href="mailto:editor@zippo.com">Send</a> a Letter to The Editor<br>
<a href="edread.htm">Read</a> Letters to the Editor
<hr>
<center><strong><a href="http://www.zippo.com/igallery/igallery.htm">Internet Gallery</a></strong></center>
February welcomes four talented photographers, and five unique bands to the individual Gallery showcases this month.

<hr>
<center><strong><a href="useweb.htm">User Pages</a></strong></center>
Some very creative Web Sites created by Super Zippo Subscribers.

<a href="useinfo.htm"> Setup Info </a>
<hr>
<center><strong><a href="http://www.zippo.com/appshome.htm">Application Software</a></strong></center>
Over 200 of the most current Internet Apps. Site is continually expanded and upgraded. Free Software.
<hr>
<center><strong><a href="ftpdl.htm">FTP Software Archives</a></strong></center>
Over 20 Gbytes of Free Software - BSD, CICA, FAQ's, Perl, Clip Art, ADA, Animations, and more.
<hr>
E-Mail Contacts:
<li>Tech Support <a href="mailto:rich@zippo.com">Rich</a></li>
<li>Subscriptions <a href="mailto:mike@zippo.com">Mike</a></li>
<li>Editorials <a href="mailto:joe@zippo.com">Joe Zip</a></li>
<li>Advertising <a href="mailto:bob@zippo.com">Bob</a></li>
<li>Commercial Info <a href="mailto:mike@zippo.com">Mike</a></li>
<li>Net Abuse <a href="mailto:bob@zippo.com">Bob</a></li><p>
</TD>
</tr>
</TABLE></center>
<center> Please direct questions to <a href="mailto:joe@zippo.com">Joe Zip</a> - Editor - Zippo News Services.
<center><h6><a href="copy.htm"> 1995,1996 </a>Zippo Dot Com Incorporated, All rights reserved</h6>
</center>
</body></html>


</DOC>
<DOC>
<DOCNO>WT02-B10-303</DOCNO>
<DOCOLDNO>IA011-000111-B041-104</DOCOLDNO>
<DOCHDR>
http://www.takeout-info.com:80/ 206.184.157.62 19970216170357 text/html 3665
HTTP/1.0 200 OK
Date: Sun, 16 Feb 1997 17:04:10 GMT
Server: BESTWWWD/1.0
MIME-version: 1.0
Content-type: text/html
Content-length: 3483
Last-modified: Thu, 02 Jan 1997 22:02:55 GMT
</DOCHDR>
<HTML>
<HEAD>
  <TITLE> Internet Takeout Place -- Takeout-Info.COM </TITLE>

  <META Name="description" Content="Restaurant takeout guide by category and
              takeout location.  Menu, Pricing and directions are also
              provided.">

  <META Name="keywords" Content="food, restaurant, food delivery, takeout,
              eating, drinking, menu, directions, fast food, coctails,
              healthy eating, health, restaurants, search, find, look up,
              local food, local places">


<!-- BODY BGCOLOR="00F0F0" -->
<BODY>
<CENTER>
<H1>
<FONT color="FF0000" SIZE=+3>
<EM>
<!-- Title on home page -->
     Takeout-Info.COM  <br>
</EM>
</FONT>
</H1>
</CENTER>


<CENTER>
<EM>
For more info: (408) 736-5852 <BR>
</EM>
</CENTER>

<br>
<br>

<H3>
We are building an international network of takeout restaurants that deliver,
to enable computer users everywhere to order from restaurants for delivery.
If  we
do not yet list your favorite takeout restaurant, please take a moment to 
<a href="mailto:moricz@best.com"> nominate it. </a>
This will help us grow.
</H3> 
<br>
<HR>
<br>
<H2>To order a nice hot meal...</H2>
<P>
Please provide us with your zip code and telephone number below.  We will 
list the participating restaurants in your area.  You may then click on the 
restaurant of your choice and examine their home page and delivery menu.
<BR>
</P>


<br>
<hr>


<FORM METHOD="POST" 
      ACTION="http://www.takeout-info.com/takeout/cgi-bin/food_new.cgi">

  <table cellpadding=2>
    <tr>
      <th align="left">
        <b> Enter your Zip or Postal Code: </b>
        <br>
      <th align="left">
        <table border>
        <tr><td width=120><INPUT NAME="zip" SIZE="10" VALUE="94041">
        </table>
        <br>
    <tr>
      <th align="left">
        <b> Your Telephone Area Code:</b>
        <br>
      <th align="left">
        <table border>
        <tr><td width=88><INPUT NAME="areacode" SIZE="3" MAXLENGTH="3" VALUE="408">
        </table>
        <br>
    <tr>
      <th align="left">
        <b> the first 3 digits of your phone number: </b>
        <br>
      <th align="left">
        <table border>
        <tr><td width=88><INPUT NAME="phonexch" SIZE="3" MAXLENGTH="3" VALUE="736">
        </table>
        <br>


    <tr>
      <th align="left">
        <B> Choose a selection from menu </B>
        <br>
      <th align="left">
        <table border>
        <!-- INPUT TYPE="text" NAME="selection" VALUE="Chinese" SIZE=20 -->
        <tr><td width=120>
        <SELECT NAME="selection">
        <OPTION> American
        <OPTION> Sandwiches
        <OPTION> Japanese
        <OPTION> Chinese
        <OPTION> Italian
        <OPTION> Indian
        <OPTION> Mexican
        </SELECT>
        </table>

    <tr>
      <th align="left">
      <th align="left">
        <INPUT TYPE="reset">
        <INPUT TYPE="submit" NAME="Action" VALUE="Send">
        <br>

  </table>
</FORM>
<P>



<br>
<hr>
<br>

<center>
<h3>
<font size=+1>

While you are waiting for your order to be delivered,
<A HREF="vitamins/index.html">
         please visit the website on herbal alternatives ...
</A>

</font>
</h3>
</center>



<!-- br -->
<!-- hr -->
<!-- br -->
<!-- p -->
<!-- h3 -->
<!-- This is where we are located: -->
<!-- h3 -->
<!-- br -->

<!-- center -->
<!-- IMG BORDER=0 WIDTH=425 HEIGHT=250  SRC="office_map.gif" -->
<!-- /center -->




<br>

</body>
<address>
<!--  Copyright &#169 1996 , by F. Chan  -->
</address>
</html>
</DOC>
<DOC>
<DOCNO>WT02-B10-304</DOCNO>
<DOCOLDNO>IA011-000111-B041-143</DOCOLDNO>
<DOCHDR>
http://www.takeout-info.com:80/vitamins/index.html 206.184.157.62 19970216170409 text/html 9116
HTTP/1.0 200 OK
Date: Sun, 16 Feb 1997 17:04:24 GMT
Server: BESTWWWD/1.0
MIME-version: 1.0
Content-type: text/html
Content-length: 8934
Last-modified: Tue, 11 Feb 1997 20:26:51 GMT
</DOCHDR>
<html>
<HEAD>
  <title>AAdvanced Herbal Alternatives</title>

  <META Name="description" Content="Blend of herbs formulated for overall
              health and energy.  Specifically designed for masculine
              and female functions, memory enhancement, weight loss,
              optimal rest and sleep and respiratory functions.
              Vitamins and herbs -- the natural alternatives!">

  <META Name="keywords" Content="natural sex, male potency, vitamins, health,
        herbs, collection, catalog, search, search engines, weight loss,
        Chinese herbs">

<EMBED SRC="../sound/vitamins.mid" autostart=true hidden=true>
<BGSOUND src="../sound/vitamins.mid">

<SCRIPT LANGUAGE="JavaScript">

/* Copyright (C)1996 Web Integration Systems, Inc. DBA Websys, Inc. FChan, Inc.
   All Rights Reserved.

   This applet can be re-used or modified, if credit is given in 
   the source code.

   We will not be held responsible for any unwanted effects due to the 
   usage of this applet or any derivative.  No warrantees for usability 
   for any specific application are given or implied.

   Chris Skinner,  January 30, 1996.
   Michael Moricz, July 4, 1996.
*/

<!-- Beginning of JavaScript Applet -------------------
function rot_banner_indx(seed)
{
        var m1  = "Welcome to F. Chan's homepage on health and nutrition        ";
        var m2  = "    Vitamins and herbs ...    ";
        var m3  = "    Safe, effective, no side effects, all natural ...     ";
        var m4  = "    Guaranteed to work!       ";
        var m5  = "Vitamins and herbs, vitamins and herbs, vitamins and herbs...   ";
        
        var msg=m1+m2+m3+m4+m5;
        var out = " ";
        var c   = 1;

        if (seed > 100) {
                seed--;
                var cmd="rot_banner_indx(" + seed + ")";
                timerTwo=window.setTimeout(cmd,100);
        }
        else if (seed <= 100 && seed > 0) {
                for (c=0 ; c < seed ; c++) {
                        out+=" ";
                }
                out+=msg;
                seed--;
                var cmd="rot_banner_indx(" + seed + ")";
                    window.status=out;
                timerTwo=window.setTimeout(cmd,100);
        }
        else if (seed <= 0) {
                if (-seed < msg.length) {
                        out+=msg.substring(-seed,msg.length);
                        seed--;
                        var cmd="rot_banner_indx(" + seed + ")";
                        window.status=out;
                        timerTwo=window.setTimeout(cmd,100);
                }
                else {
                        window.status=" ";
                        timerTwo=window.setTimeout("rot_banner_indx(100)",75);
                }
        }
}
// -- End of JavaScript code -------------- -->
</SCRIPT>

</HEAD>

<BODY BACKGROUND="herb.gif"
      onLoad="timerONE=window.setTimeout('rot_banner_indx(100)',500);">


<CENTER>
  <!-- BEGIN LOGO -->
  <!-- img width=440 height=40 border=1 ismap -->
  <img
  alt="Herbal Alternatives"
  src="../logo/herb.jpg">
  <!--  END LOGO  -->
</CENTER>

<BR>

<EM>
In recent years, modern science has discovered the long held belief
    of Chinese herbalists
that certain herbs have beneficial contribution to overall health
    and wellness.
Finally, in combination with ancient wisdom and the latest in western
    knowledge,
<font color="FF0000">Herbal Alternatives</font>  have been developed
    to enhance the quality of your life.
</EM>

<br>
<br>

   <hr>

<br>


<center>
<table border=4 cellspacing=4 cellpadding=2 width=100%>

<tr>
    <!-- --------------------------------------------- -->
    <!--             Masculine Herbal Complex          -->
    <!-- --------------------------------------------- -->
    <th align="center" width=400 height=80>
    <table>
      <tr>
      <th align="center">
        <a href="index_msc.html">
        <!-- a href="index_all.html#Masculine" -->
          <font color="FF0000" size=+1>Masculine Herbal Complex</font></a>
      <tr>
      <br>
      <th align="left">
        <ul>
        <li> Promotes physical endurance
        <li> Sensational sex booster
        </ul>
    </table>

    <!-- --------------------------------------------- -->
    <!--             Feminine Herbal Complex           -->
    <!-- --------------------------------------------- -->
    <th align="center" width=400 >
    <table>
      <tr>
      <th align="center">
        <a href="index_fmn.html">
          <font color="FF0000" size=+1>Feminine Herbal Complex</font></a>
      <tr>
      <br>
      <th align="left">
        <ul>
        <li> Promotes physical energy
        <li> Increases sexual desire
        </ul>
    </table>


<tr>
    <!-- --------------------------------------------- -->
    <!--             Mind Enhancement System           -->
    <!-- --------------------------------------------- -->
    <th align="center" width=400 height=80>
    <table>
      <tr>
      <th align="center">
        <a href="index_mind.html">
          <font color="FF0000" size=+1>Mind Enhancement System</font></a>
      <tr>
      <br>
      <th align="left">
        <ul>
        <li> Sharpens memory
        <li> Helps with concentration
        </ul>
    </table>

    <!-- --------------------------------------------- -->
    <!--             Herbal Rest and Relax             -->
    <!-- --------------------------------------------- -->
    <th align="center" width=400 >
    <table>
      <tr>
      <th align="center">
        <a href="index_hrr.html">
          <font color="FF0000" size=+1>Herbal Rest and Relax</font></a>
      <tr>
      <br>
      <th align="left">
        <ul>
        <li> Relieves headaches
        <li> Induces natural sleep
        </ul>
    </table>


<tr>
    <!-- --------------------------------------------- -->
    <!--        Weight Loss (Night trim) System        -->
    <!-- --------------------------------------------- -->
    <th align="center" width=400 height=80 >
    <table>
      <tr>
      <th align="center">
        <a href="index_weight.html">
          <font color="FF0000" size=+1>Weight Loss (Night trim) System
          </font></a>
      <tr>
      <br>
      <th align="left">
        <ul>
        <li> Increases the efficiency of metabolism
        <li> Lose inches while sleeping
        </ul>
    </table>

    <!-- --------------------------------------------- -->
    <!--             Herbal Respiratory Formula        -->
    <!-- --------------------------------------------- -->
    <th align="center" width=400 height=80 >
    <table>
      <tr>
      <th align="center">
        <a href="index_rfofh.html">
          <font color="FF0000" size=+1>Herbal Respiratory Formula</font></a>
      <tr>
      <br>
      <th align="left">
        <ul>
        <li> Relieves allergy and asthma symptoms
        <li> Opens up sinus
        </ul>
    </table>


<tr>
    <!-- --------------------------------------------- -->
    <!--             Optimal Life Formula              -->
    <!-- --------------------------------------------- -->
    <th align="center" width=400 height=80 >
    <table>
      <tr>
      <th align="center">
        <a href="index_opt.html">
          <font color="FF0000" size=+1>Optimal Life Formula</font></a>
      <tr>
      <br>
      <th align="left">
        <ul>
        <li> Strengthens the immune system
        <li> Slows down the aging process
        </ul>
    </table>

    <!-- --------------------------------------------- -->
    <!--             Herbal Cleansing Complex          -->
    <!-- --------------------------------------------- -->
    <th align="center" width=400 >
    <table>
      <tr>
      <th align="center">
        <a href="index_hcc.html">
          <font color="FF0000" size=+1>Herbal Cleansing Complex</font></a>
      <tr>
      <br>
      <th align="left">
        <ul>
        <li> Relieves constipation
        <li> Cleans and detoxifies the colon
        </ul>
    </table>

</table>
</center>

<br>

     <hr>

<br>
<table>
<tr><th>  <font size=+0> <a Href="order_online.html"> To order: </a></font>
    <th align="left">  <font size=+0> <a Href="order_online.html"> Online </a></font>      
    <th align="left">  <font size=+0> <a Href="order_online.html"> (click here) </a></font>

<tr><th><th align ="left"> <font size=+0> By phone  </font>
    <th align="left"> <font size=+0> 1-415-962-1288 </font></tr>
</table>
</h2>


<br>
<center>
<font size=+1> Site is visited since August 12, 1996:  </font><br>
<br>
<img src="../counter/cgi-bin/counter.script.cgi?vitamins">
</center>

<br>
<hr>

<br>
<center>
<font size=+1><a href="testimonial.html"> Product Testimonials </a> |</font>
<font size=+1><a href="../PowerSubmit/index.html"> Link to
                 <FONT COLOR="FF0000">PowerSubmit</FONT> </a></font>
</center>

</body>
<address>
<!--  Copyright &#169 1996 , by F. Chan  -->
</address>
</html>
</DOC>
<DOC>
<DOCNO>WT02-B10-305</DOCNO>
<DOCOLDNO>IA011-000111-B041-175</DOCOLDNO>
<DOCHDR>
http://www.takeout-info.com:80/vitamins/index_msc.html 206.184.157.62 19970216170419 text/html 8020
HTTP/1.0 200 OK
Date: Sun, 16 Feb 1997 17:04:35 GMT
Server: BESTWWWD/1.0
MIME-version: 1.0
Content-type: text/html
Content-length: 7838
Last-modified: Tue, 11 Feb 1997 20:14:08 GMT
</DOCHDR>
<html>
<HEAD>
  <title>Advanced Vitamin for Natural Sex and Male Potency Booster
         -- Masculine Herbal Complex</title>

  <META Name="description" Content="Advanced vitamins for natural sex and
        male potency Boosting.  Guaranteed to work or money back!
        Vitamins, herbs. Vitamins, herbs, vitamins, herbs, vitamins, herbs,
        vitamins, herbs, vitamins, herbs, vitamins, herbs, vitamins, herbs,
        vitamins, herbs.">

  <META Name="keywords" Content="natural sex, male potency, vitamins, health,
        herbs, Search Engines, weight loss">


<SCRIPT LANGUAGE="JavaScript">

/* Copyright (C)1996 Web Integration Systems, Inc. DBA Websys, Inc. FChan, Inc.
   All Rights Reserved.

   This applet can be re-used or modified, if credit is given in 
   the source code.

   We will not be held responsible for any unwanted effects due to the 
   usage of this applet or any derivative.  No warrantees for usability 
   for any specific application are given or implied.

   Chris Skinner,  January 30, 1996.
   Michael Moricz, July 4, 1996.
*/

<!-- Beginning of JavaScript Applet -------------------
function rot_banner_indx(seed)
{
        var m1  = "Bring back the MAGIC !     ";
        var m2  = "    Masculine Herbal Complex is composed of 11 herbs. ";
        var m3  = " It does three main functions:  ";
        var m4  = "    It helps balance the body's overall energy system,  ";
        var m5  = "    helps balance and protect the male reproductive or urogenital system   ";
        var m6  = "    and helps strengthen and boosts the male sexual functions.  ";
        
        var msg=m1+m2+m3+m4+m5+m6;
        var out = " ";
        var c   = 1;

        if (seed > 100) {
                seed--;
                var cmd="rot_banner_indx(" + seed + ")";
                timerTwo=window.setTimeout(cmd,100);
        }
        else if (seed <= 100 && seed > 0) {
                for (c=0 ; c < seed ; c++) {
                        out+=" ";
                }
                out+=msg;
                seed--;
                var cmd="rot_banner_indx(" + seed + ")";
                    window.status=out;
                timerTwo=window.setTimeout(cmd,100);
        }
        else if (seed <= 0) {
                if (-seed < msg.length) {
                        out+=msg.substring(-seed,msg.length);
                        seed--;
                        var cmd="rot_banner_indx(" + seed + ")";
                        window.status=out;
                        timerTwo=window.setTimeout(cmd,100);
                }
                else {
                        window.status=" ";
                        timerTwo=window.setTimeout("rot_banner_indx(100)",75);
                }
        }
}
// -- End of JavaScript code -------------- -->
</SCRIPT>

</HEAD>

<BODY BACKGROUND="herb.gif" BGCOLOR="00F0F0"
      onLoad="timerONE=window.setTimeout('rot_banner_indx(100)',500);">
<EMBED SRC="../sound/msc_new.mid" autostart=true hidden=true>
<BGSOUND src="../sound/msc_new.mid">


<CENTER>
<!-- BEGIN INTERNET LINK EXCHANGE CODE -->
 <a href="http://ad.linkexchange.com/X105896/gotoad.map"
 target="_top">
 <img width=440 height=40 border=1 ismap
 alt="Internet Link Exchange"
 src="http://ad.linkexchange.com/X105896/logoshowad?free"></a>
    
 <br><font size=1><a href="http://www.linkexchange.com/" target="_top">
 Member of the Internet Link Exchange</a></font><br>
 <!--  END INTERNET LINK EXCHANGE CODE  -->
</CENTER>

<HR>


<center>
<h1>
<FONT SIZE=+3>
Masculine Herbal Complex<br>
</FONT>
</h1>

<table>
<tr><th align="left">
<em>Specially formulated to enhance man's inner strength and prowess</em></th>
<tr><th align="left">
<em>by heightening masculine functions and energy level.</em></th>
</table>

</center>

<p>
<h2>
     <hr>
<FONT SIZE=+1>
<br>
Benefits Derived:
<ul>
<li> Sensational Sex Booster</li>
<li> Increases Sexual Desire</li>
<li> Stimulates harder and more frequent erections</li>
<li> Promotes sexual energy</li>
<li> Increases sperm count</li>
<li> Boosts physical endurance</li>
<li> Protects the prostate</li>
<li> Safe, effective, no side effects,
     <font color="FF0000"> all natural </font>
     sex pills</li>

</ul>
</FONT>
      <hr>


<br>
<FONT SIZE=+1>
Ingredients:
</FONT>

<FONT SIZE=+0>
<UL>
  <LI><B><EM>Chinese Ginseng</EM></B>
      - (Ren Shen) - lowers plasma glucose levels. It has a synergistic effect with insulin,
      it raises immunity, resistance to disease, raises metabolic rate and stimulates
      the sexual organ
  <LI><B><EM>Codonopsis Ginseng</EM></B>
      - (Dang Shen) - stimulates the sexual organ
  <LI><B><EM>Cnidium</EM></B>
      - (Chuan Xiang) - warms the kidney, good for back pain, for impotence and sterility
  <LI><B><EM>Astragalus</EM></B>
      - (Huang Qi) - immunostimulant that fights off disease, lowers blood pressure,
      may boost the number and activity of roving white blood cells, eliminates bacteria
      and viruses and destroy mutant cells that may become cancerous, inhibits free radicals
  <LI><B><EM>Atractylodes</EM></B>
      - (Bai Zhi) - good for upset stomach, diarrhea, epigastric tension, nausea and vomiting,
      stiff and painful joints, night blindness, helps control blood sugar levels
  <LI><B><EM>Ligusticum</EM></B>
      - (Nu Zhen Zi) - invigorates blood and energy, it is used for coronary heart disease,
      treats pain and headache, anti-hypertension, increases the flow of blood to the heart
  <LI><B><EM>Lotus Seed</EM></B>
      - (Lian Zi) - an astringent herb;  it helps the body retain fluid; as man
      gets older, the body has difficulty retaining fluid because of prostrate problems etc.
  <LI><B><EM>Epimedium</EM></B>
      - (Ying Yang Huo) - tonifies the kidneys and Yang, good for impotence, frequent
      urination, forgetfulness, cold and painful low back and knees, treats spasm and
      cramps on hands and feet, increases sexual activity, sexual desire, and sperm count
  <LI><B><EM>Cistanche</EM></B>
      - (Rou Cong Rong) - tonifies the kidneys and Yang, good for impotence, premature
      ejaculation, frequent urination, forgetfulness, infertility, increases growth
  <LI><B><EM>Cornus</EM></B>
      - (Shan Zhu Yu) - used for impotence, vertigo, dizziness, anti-fungal, anti-tumor,
      diuretic, decreases blood pressure, increase white blood cell count
  <LI><B><EM>Rehmannia</EM></B>
      - (Shen Di Huang) - tonifies the blood and nourish the Yin,  good for heart palpitations,
      insomnia, decreases cholesterol, decreases blood sugar levels,  and blood pressure
  <BR><BR>
  <LI><B><EM>Recommended Use:</EM></B>
      Two tablets each morning and night
</UL>
</FONT>


<br>
      <hr>
<p>
<font size=+0>
Bottle of 90 tablets at $32.00
</font>
<br>
<table>
<tr><th>  <font size=+0> <a Href="order_online.html"> To order: </a></font>
    <th align="left">  <font size=+0> <a Href="order_online.html"> Online </a></font>      
    <th align="left">  <font size=+0> <a Href="order_online.html"> (click here) </a></font>

<tr><th><th align ="left"> <font size=+0> By phone         </font>
    <th align="left"> <font size=+0> 1-800-757-3869 x5130  </font></tr>

<tr><th><th>
    <th align="left"> <font size=+0> 1-415-962-1288  outside the U.S.</font></tr>
</table>
</h2>


<!-- embed src="../counter/cgi-bin/counter_h.script.cgi?msc" -->
<!--         autostart=true hidden=true -->
<br>
<center>
<font size=+1> Site is visited since August 12, 1996:  </font><br>
<br>
<img src="../counter/cgi-bin/counter.script.cgi?msc">
</center>

<br>
<hr>

<p>
<center>
<font size=+1>
<a href="testimonial.html"> Product Testimonials </a> |
<a href="../PowerSubmit/"> Link to PowerSubmit </a> |
<a href="index.html"> Back to home page </a><br>
</font>
</center>

</body>
<address>
<!--  Copyright &#169 1996 , by F. Chan  -->
</address>
</html>
</DOC>
<DOC>
<DOCNO>WT02-B10-306</DOCNO>
<DOCOLDNO>IA011-000111-B041-237</DOCOLDNO>
<DOCHDR>
http://www.takeout-info.com:80/vitamins/index_fmn.html 206.184.157.62 19970216170449 text/html 7150
HTTP/1.0 200 OK
Date: Sun, 16 Feb 1997 17:05:05 GMT
Server: BESTWWWD/1.0
MIME-version: 1.0
Content-type: text/html
Content-length: 6968
Last-modified: Wed, 29 Jan 1997 07:46:53 GMT
</DOCHDR>
<html>
<HEAD>
  <title>AAdvanced Herbal Formulation to Balance and Support Female functions
         -- Feminine Herbal Complex</title>

  <META Name="description" Content="AAdvanced Herbal Formulation to Balance
        and Support Female functions.  Guaranteed to work or money back!
        Vitamins, herbs. Vitamins, herbs, vitamins, herbs, vitamins, herbs,
        vitamins, herbs, vitamins, herbs, vitamins, herbs, vitamins, herbs,
        vitamins, herbs.">

  <META Name="keywords" Content="natural sex, female balance, vitamins,
        health, herbs, Search Engines, weight loss">



<SCRIPT LANGUAGE="JavaScript">

/* Copyright (C)1996 Web Integration Systems, Inc. DBA Websys, Inc. Fchan, Inc.
   All Rights Reserved.

   This applet can be re-used or modified, if credit is given in 
   the source code.

   We will not be held responsible for any unwanted effects due to the 
   usage of this applet or any derivative.  No warrantees for usability 
   for any specific application are given or implied.

   Chris Skinner,  January 30, 1996.
   Michael Moricz, July 4, 1996.
*/

<!-- Beginning of JavaScript Applet -------------------
function rot_banner_indx(seed)
{
        var m1  = "Bring back the MAGIC !       ";
        var m2  = "    Increases energy level,    ";
        var m3  = "    Slows down the aging process,       ";
        var m4  = "    Safe, effective and all NATURAL,    ";
        var m5  = "    Guaranteed to work!";
        
        var msg=m1+m2+m3+m4+m5;
        var out = " ";
        var c   = 1;

        if (seed > 100) {
                seed--;
                var cmd="rot_banner_indx(" + seed + ")";
                timerTwo=window.setTimeout(cmd,100);
        }
        else if (seed <= 100 && seed > 0) {
                for (c=0 ; c < seed ; c++) {
                        out+=" ";
                }
                out+=msg;
                seed--;
                var cmd="rot_banner_indx(" + seed + ")";
                    window.status=out;
                timerTwo=window.setTimeout(cmd,100);
        }
        else if (seed <= 0) {
                if (-seed < msg.length) {
                        out+=msg.substring(-seed,msg.length);
                        seed--;
                        var cmd="rot_banner_indx(" + seed + ")";
                        window.status=out;
                        timerTwo=window.setTimeout(cmd,100);
                }
                else {
                        window.status=" ";
                        timerTwo=window.setTimeout("rot_banner_indx(100)",75);
                }
        }
}
// -- End of JavaScript code -------------- -->
</SCRIPT>

</HEAD>

<BODY BACKGROUND="herb.gif" BGCOLOR="00F0F0"
      onLoad="timerONE=window.setTimeout('rot_banner_indx(100)',500);">
<EMBED SRC="../sound/fmn.mid" autostart=true hidden=true>
<BGSOUND src="../sound/fmn.mid">
<center>
<h1>
<FONT SIZE=+3>
Feminine Herbal Complex<br>
</FONT>
</h1>

<table>
<tr><th align="left">
<em>A blend of Chinese herbs was formulated to address woman's needs by balancing</em></th>
<tr><th align="left">
<em>the energetic cycle and supporting the female functions.</em></th>
</table>

</center>

<p>
<h2>
     <hr>
<FONT SIZE=+1>
<br>
Benefits Derived:
<ul>
<li> Relieves menstrual cramps</li>
<li> Stimulates sexual organ</li>
<li> Increases sexual desire</li>
<li> Treats infertility</li>
<li> Slows down the aging process</li>
<li> Fights hot flashes</li>
<li> Helps regulate menstrual cycle</li>
<li> Relieves symptoms associated with menopause</li>
<li> Increases <font color="FF0000"> energy </font>
     level</li>

</ul>
</FONT>
      <hr>

<br>
<FONT SIZE=+1>
Ingredients:
</FONT>

<FONT SIZE=+0>
<UL>
  <LI><B><EM>Angelica Root</EM></B>
      - (Dang Gui) - tonifies, invigorates and and harmonizes the blood;
      it is used for hypertension, ringing of the ears, blurred vision, heart palpitations,
      anemia, angina, abdominal pains, and traumatic injuries.
  <LI><B><EM>Bupleurum</EM></B>
      - (Chai Hu) - moves stagnant liver Qi which is associated with stuck emotions
      of irritability, anger, frustration, mood swings, and menstrual  problems.
      Anti-inflammatory, anti-spasmodic and anti-pyretic
  <LI><B><EM>Astragalus</EM></B>
      - (Huang Qi) - helps boost the immune system
  <LI><B><EM>Rehmannia</EM></B>
      - (Shu Di Huang) - tonifies the blood  the Yin,  good for irregular menstruation
  <LI><B><EM>Polygonum</EM></B>
      - (Ho Shou Wu) - nourishes the blood  and used for aging and prematurely gray hair
  <LI><B><EM>Leonurus</EM></B>
      - (Yi Mu Cao) - tonifies the blood and promote regular menstruation,
      infertility, and helps with abdominal pain
  <LI><B><EM>Heolen</EM></B>
      - (Fu Ling) - diuretic, helps to get rid of excess water weight when bloating
      during period, promotes urination
  <LI><B><EM>Ostrea Concha</EM></B>
      - (Mu Li) - used for anxiety, restlessness, irritability, mood swings,
      poor temper, headache, insomnia
  <LI><B><EM>Ginger</EM></B>
      - (Gan Jiang) - very good for treating the stomach and the spleen;
      used for vomiting, abdominal fullness, cough,  phlegm and controls motion sickness
  <LI><B><EM>Licorice</EM></B>
      - (Gan Cao) - enters or treats all 12 meridians or organ systems and harmonizes
      the action of the herbs in the body, controls blood sugar, cholesterol,
      is anti-inflammatory, antifungal, antispasmodic, antibacterial, controls asthma,
      it inhibits and heals ulcers
  <LI><B><EM>Cnidium</EM></B>
       - (Chuan Xiong) - warms up the kidneys, good  for infertility,
      increases sexual ability, stimulates sexual organ
  <LI><B><EM>White Peony</EM></B>
       - (Bai Shao) - nourish the blood, helps with hot flashes and night
      sweats anti-spasmodic and helps with cramps
  <BR><BR>
  <LI><B><EM>Recommended Use:</EM></B>
      Two tablets each morning and night.
</UL>
</FONT>


<br>
      <hr>
<p>
<font size=+0>
Bottle of 90 tablets at $32.00
</font>
<br>
<table>
<tr><th>  <font size=+0> <a Href="order_online.html"> To order: </a></font>
    <th align="left">  <font size=+0> <a Href="order_online.html"> Online </a></font>      
    <th align="left">  <font size=+0> <a Href="order_online.html"> (click here) </a></font>

<tr><th><th align ="left"> <font size=+0> By phone         </font>
    <th align="left"> <font size=+0> 1-800-757-3869 x5130  </font></tr>

<tr><th><th>
    <th align="left"> <font size=+0> 1-415-962-1288  outside the U.S.</font></tr>
</table>
</h2>


<br>
<center>
<font size=+1> Site is visited since August 12, 1996:  </font><br>
<br>
<img src="../counter/cgi-bin/counter.script.cgi?fmn">
</center>

<br>
<hr>

<p>
<center>
<font size=+1>
<a href="testimonial.html"> Product Testimonials </a> |
<a href="../PowerSubmit/"> Link to PowerSubmit </a> |
<a href="index.html"> Back to home page </a><br>
</font>
</center>

</body>
<address>
<!--  Copyright &#169 1996 , by F. Chan  -->
</address>
</html>
</DOC>
<DOC>
<DOCNO>WT02-B10-307</DOCNO>
<DOCOLDNO>IA011-000111-B041-278</DOCOLDNO>
<DOCHDR>
http://www.takeout-info.com:80/vitamins/index_mind.html 206.184.157.62 19970216170502 text/html 5063
HTTP/1.0 200 OK
Date: Sun, 16 Feb 1997 17:05:19 GMT
Server: BESTWWWD/1.0
MIME-version: 1.0
Content-type: text/html
Content-length: 4881
Last-modified: Wed, 29 Jan 1997 07:48:51 GMT
</DOCHDR>
<html>
<HEAD>
  <title>Advanced Vitamin for Mental Energy
         -- Mind Enhancement Complex</title>

  <META Name="description" Content="Advanced vitamin for mental energy.
        Guaranteed to work or money back!
        Vitamins, herbs. Vitamins, herbs, vitamins, herbs, vitamins, herbs,
        vitamins, herbs, vitamins, herbs, vitamins, herbs, vitamins, herbs,
        vitamins, herbs.">

  <META Name="keywords" Content="memory enhancement, brain energizer,
        vitamins, health, herbs, Search Engines">



<SCRIPT LANGUAGE="JavaScript">

/* Copyright (C)1996 Web Integration Systems, Inc. DBA Websys, Inc. FChan, Inc.
   All Rights Reserved.

   This applet can be re-used or modified, if credit is given in 
   the source code.

   We will not be held responsible for any unwanted effects due to the 
   usage of this applet or any derivative.  No warrantees for usability 
   for any specific application are given or implied.

   Chris Skinner,  January 30, 1996.
   Michael Moricz, July 4, 1996.
*/

<!-- Beginning of JavaScript Applet -------------------
function rot_banner_indx(seed)
{
        var m1  = "Ginkgo biloba -- natural herb:       ";
        var m2  = "    increases blood flow to the brain,    ";
        var m3  = "    Guaranteed to work!";
        
        var msg=m1+m2+m3;
        var out = " ";
        var c   = 1;

        if (seed > 100) {
                seed--;
                var cmd="rot_banner_indx(" + seed + ")";
                timerTwo=window.setTimeout(cmd,100);
        }
        else if (seed <= 100 && seed > 0) {
                for (c=0 ; c < seed ; c++) {
                        out+=" ";
                }
                out+=msg;
                seed--;
                var cmd="rot_banner_indx(" + seed + ")";
                    window.status=out;
                timerTwo=window.setTimeout(cmd,100);
        }
        else if (seed <= 0) {
                if (-seed < msg.length) {
                        out+=msg.substring(-seed,msg.length);
                        seed--;
                        var cmd="rot_banner_indx(" + seed + ")";
                        window.status=out;
                        timerTwo=window.setTimeout(cmd,100);
                }
                else {
                        window.status=" ";
                        timerTwo=window.setTimeout("rot_banner_indx(100)",75);
                }
        }
}
// -- End of JavaScript code -------------- -->
</SCRIPT>

</HEAD>

<BODY BACKGROUND="herb.gif" BGCOLOR="00F0F0"
      onLoad="timerONE=window.setTimeout('rot_banner_indx(100)',500);">
<center>
<h1>
<FONT SIZE=+3>
Mind Enhancement Complex<br>
</FONT>
</h1>

<table>
<tr><th align="left">
<em>This herbal blend uses ginkgo biloba and ginseng for its influence in</em>
</th>
<tr><th align="left">
<em>mental alertness and performance.</em></th>
</table>

</center>

<p>
<h2>
     <hr>
<FONT SIZE=+1>
<br>
Benefits Derived:
<ul>
<li> Relieves anxiety</li>
<li> Increases memory, focus and attention</li>
<li> Energizes the brain</li>
<li> Increases learning ability</li>
</ul>
</FONT>

<FONT SIZE=+1>
<br>
Who Can Benefit:
<ul>
<li> The elderly and infirm</li>
<li> People with difficulty paying attention or maintaining concentration</li>
<li> People with a family history of Alzheimer's disease</li>
<li> People who consume greater than moderate amounts of alcohol</li>
</ul>
</FONT>

      <hr>

<br>
<table>
<tr><th><FONT SIZE=+0>Ingredients:</FONT>
    <th align="left"><FONT SIZE =+0>
        gingko biloba, chinese ginseng, codonopsis ginseng, licorice,
        </FONT>
<tr><th>
    <th align="left"><FONT SIZE=+0>
        angelica, malt leaf, gotu kola, B1, B6, B12, folic acid, magnesium,
        </FONT>
<tr><th>
    <th align="left"><FONT SIZE=+0>
        zinc, L-tyrosine, choline, lecithin
        </FONT>
</table>

<br>
      <hr>
<p>
<font size=+0>
Bottle of 90 tablets at $32.00
</font>
<br>
<table>
<tr><th>  <font size=+0> <a Href="order_online.html"> To order: </a></font>
    <th align="left">  <font size=+0> <a Href="order_online.html"> Online </a></font>      
    <th align="left">  <font size=+0> <a Href="order_online.html"> (click here) </a></font>

<tr><th><th align ="left"> <font size=+0> By phone         </font>
    <th align="left"> <font size=+0> 1-800-757-3869 x5130  </font></tr>

<tr><th><th>
    <th align="left"> <font size=+0> 1-415-962-1288  outside the U.S.</font></tr>
</table>
</h2>


<br>
<center>
<font size=+1> Site is visited since August 12, 1996:  </font><br>
<br>
<img src="../counter/cgi-bin/counter.script.cgi?mind">
</center>

<br>
<hr>

<p>
<center>
<font size=+1>
<a href="testimonial.html"> Product Testimonials </a> |
<a href="../PowerSubmit/"> Link to PowerSubmit </a> |
<a href="index.html"> Back to home page </a><br>
</font>
</center>

</body>
<address>
<!--  Copyright &#169 1996 , by F. Chan  -->
</address>
</html>
</DOC>
<DOC>
<DOCNO>WT02-B10-308</DOCNO>
<DOCOLDNO>IA011-000111-B041-315</DOCOLDNO>
<DOCHDR>
http://www.takeout-info.com:80/vitamins/index_hrr.html 206.184.157.62 19970216170513 text/html 6080
HTTP/1.0 200 OK
Date: Sun, 16 Feb 1997 17:05:30 GMT
Server: BESTWWWD/1.0
MIME-version: 1.0
Content-type: text/html
Content-length: 5898
Last-modified: Fri, 31 Jan 1997 02:35:27 GMT
</DOCHDR>
<html>
<HEAD>
  <title>Advanced Herb for Rest and Relaxation
         -- Herbal Rest and Relax</title>

  <META Name="description" Content="Advanced Herb for Rest and Relaxation
        Guaranteed to work or money back!
        Vitamins, herbs. Vitamins, herbs, vitamins, herbs, vitamins, herbs,
        vitamins, herbs, vitamins, herbs, vitamins, herbs, vitamins, herbs,
        vitamins, herbs.">

  <META Name="keywords" Content="natural sleep, natural rest, vitamins,
        health, herbs, Search Engines">



<SCRIPT LANGUAGE="JavaScript">

/* Copyright (C)1996 Web Integration Systems, Inc. DBA Websys, Inc. FChan, Inc.
   All Rights Reserved.

   This applet can be re-used or modified, if credit is given in 
   the source code.

   We will not be held responsible for any unwanted effects due to the 
   usage of this applet or any derivative.  No warrantees for usability 
   for any specific application are given or implied.

   Chris Skinner,  January 30, 1996.
   Michael Moricz, July 4, 1996.
*/

<!-- Beginning of JavaScript Applet -------------------
function rot_banner_indx(seed)
{
        var m1  = "Bring back the MAGIC !       ";
        var m2  = "    Tension headache reliever,    ";
        var m3  = "    Induces NATURAL sleep,       ";
        var m4  = "    Guaranteed to work!";
        
        var msg=m1+m2+m3+m4;
        var out = " ";
        var c   = 1;

        if (seed > 100) {
                seed--;
                var cmd="rot_banner_indx(" + seed + ")";
                timerTwo=window.setTimeout(cmd,100);
        }
        else if (seed <= 100 && seed > 0) {
                for (c=0 ; c < seed ; c++) {
                        out+=" ";
                }
                out+=msg;
                seed--;
                var cmd="rot_banner_indx(" + seed + ")";
                    window.status=out;
                timerTwo=window.setTimeout(cmd,100);
        }
        else if (seed <= 0) {
                if (-seed < msg.length) {
                        out+=msg.substring(-seed,msg.length);
                        seed--;
                        var cmd="rot_banner_indx(" + seed + ")";
                        window.status=out;
                        timerTwo=window.setTimeout(cmd,100);
                }
                else {
                        window.status=" ";
                        timerTwo=window.setTimeout("rot_banner_indx(100)",75);
                }
        }
}
// -- End of JavaScript code -------------- -->
</SCRIPT>

</HEAD>

<BODY BACKGROUND="herb.gif" BGCOLOR="00F0F0"
      onLoad="timerONE=window.setTimeout('rot_banner_indx(100)',500);">
<center>
<h1>
<FONT SIZE=+3>
Herbal Rest and Relax<br>
</FONT>
</h1>
</center>

<em>
In order to experience the benefits of proper rest, Herbal Rest and Relax
has been created to balance and quiet the mind.
This gentle calming effect allows sleep to come naturally.
Because the herbs do not induce an artificial, drug-like sleep,
they can also be used during the day to relax the mind and help one to
think more clearly.
And because it helps to calm the body as well as the mind, it can often
be useful in easing various muscle aches and pains.
</em>

<p>
<h2>
     <hr>
<FONT SIZE=+1>
<br>
Benefits Derived:
<ul>
<li> Relieves headaches</li>
<li> Relaxes muscle aches and pains</li>
<li> Induces sleep</li>
<li> Relaxes the mind</li>
</ul>
</FONT>
      <hr>

<br>
<FONT SIZE=+1>
Ingredients:
</FONT>

<FONT SIZE=+0>
<UL>
  <LI><B><EM>Oyster Shell</EM></B>
      - (Mu Li) - calms the spirit. Sedative, analgesic and tranquilizing
  <LI><B><EM>Dragon Bone</EM></B>
      - (Long Gu) - subdues the hyperactive liver Yang, calms the restless spirit;
      sedative and tranquilizing
  <LI><B><EM>Albizzia Bark</EM></B>
      - (He Huan Pi) - calms anger and anxiety. Sedative. Used for insomnia and
      palpitations, balances the heart and the liver
  <LI><B><EM>Zizyphus Seed</EM></B>
      - (Suan Zao Ren) - energy tonic for spleen and stomach, sedates, calms and
      tranquilizes the spirit
  <LI><B><EM>Rehmannia Root</EM></B>
      - (Sheng Di Huang) - balances and tonifies the blood and nourishes the Yin
  <LI><B><EM>Gardenia Fruit</EM></B>
      - (Zhi Zi) - dispels heat and dampness, sedative, relaxes muscles
  <LI><B><EM>Polygonum</EM></B>
      - (Bian Xu) - balances and tonifies the blood, detoxifies
  <LI><B><EM>Cnidium Rhizone</EM></B>
      - (Chuan Xiong) - warms deficient kidneys, anti-bacterial, tranquilizing, sedative
  <LI><B><EM>Lotus Seed</EM></B>
      - (Lian Zi) - nourishes the heart, spleen and kidney channels; relaxes muscles
      and used for insomnia
  <LI><B><EM>Schisandra Fruit</EM></B>
      - (Wu Wei Zi) - replenishes vital energy; one of the most highly values plants
      in the Chinese pharmacopoeia, known as "Five Flavors Fruit", a general restorative
      tonic for all organs, which is also considered a sedative
  <BR><BR>
  <LI><B><EM>Recommended Use:</EM></B>
      One to four tablets as needed.
</UL>
</FONT>


<br>
      <hr>
<p>
<font size=+0>
Bottle of 90 tablets at $29.00
</font>
<br>
<table>
<tr><th>  <font size=+0> <a Href="order_online.html"> To order: </a></font>
    <th align="left">  <font size=+0> <a Href="order_online.html"> Online </a></font>      
    <th align="left">  <font size=+0> <a Href="order_online.html"> (click here) </a></font>

<tr><th><th align ="left"> <font size=+0> By phone         </font>
    <th align="left"> <font size=+0> 1-800-757-3869 x5130  </font></tr>

<tr><th><th>
    <th align="left"> <font size=+0> 1-415-962-1288  outside the U.S.</font></tr>
</table>
</h2>


<br>
<hr>

<p>
<center>
<font size=+1>
<a href="testimonial.html"> Product Testimonials </a> |
<a href="../PowerSubmit/"> Link to PowerSubmit </a> |
<a href="index.html"> Back to home page </a><br>
</font>
</center>

</body>
<address>
<!--  Copyright &#169 1996 , by F. Chan  -->
</address>
</html>
</DOC>
<DOC>
<DOCNO>WT02-B10-309</DOCNO>
<DOCOLDNO>IA011-000111-B041-349</DOCOLDNO>
<DOCHDR>
http://www.takeout-info.com:80/vitamins/index_weight.html 206.184.157.62 19970216170525 text/html 4532
HTTP/1.0 200 OK
Date: Sun, 16 Feb 1997 17:05:40 GMT
Server: BESTWWWD/1.0
MIME-version: 1.0
Content-type: text/html
Content-length: 4350
Last-modified: Wed, 29 Jan 1997 07:53:52 GMT
</DOCHDR>
<html>
<HEAD>
<title>Weight Loss (Night trim) System</title>

  <META Name="description" Content="Weight Loss (Night trim) System:
        loosing weight while you sleep.  Guaranteed to work or money back!
        Vitamins, herbs. Vitamins, herbs, vitamins, herbs, vitamins, herbs,
        vitamins, herbs, vitamins, herbs, vitamins, herbs, vitamins, herbs,
        vitamins, herbs.">

  <META Name="keywords" Content="weight loss, night trim,
        vitamins, health, herbs, Search Engines">



<SCRIPT LANGUAGE="JavaScript">

/* Copyright (C)1996 Web Integration Systems, Inc. DBA Websys, Inc. FChan, Inc.
   All Rights Reserved.

   This applet can be re-used or modified, if credit is given in
   the source code.

   We will not be held responsible for any unwanted effects due to the 
   usage of this applet or any derivative.  No warrantees for usability 
   for any specific application are given or implied.

   Chris Skinner,  January 30, 1996.
   Michael Moricz, July 4, 1996.
*/

<!-- Beginning of JavaScript Applet -------------------
function rot_banner_indx(seed)
{
        var m1  = "Lose inches while you sleep ...    ";
        var m2  = "    Night trimming system ...    ";
        var m3  = "    Guaranteed to work!";

        var msg=m1+m2+m3;
        var out = " ";
        var c   = 1;

        if (seed > 100) {
                seed--;
                var cmd="rot_banner_indx(" + seed + ")";
                timerTwo=window.setTimeout(cmd,100);
        }
        else if (seed <= 100 && seed > 0) {
                for (c=0 ; c < seed ; c++) {
                        out+=" ";
                }
                out+=msg;
                seed--;
                var cmd="rot_banner_indx(" + seed + ")";
                    window.status=out;
                timerTwo=window.setTimeout(cmd,100);
        }
        else if (seed <= 0) {
                if (-seed < msg.length) {
                        out+=msg.substring(-seed,msg.length);
                        seed--;
                        var cmd="rot_banner_indx(" + seed + ")";
                        window.status=out;
                        timerTwo=window.setTimeout(cmd,100);
                }
                else {
                        window.status=" ";
                        timerTwo=window.setTimeout("rot_banner_indx(100)",75);
                }
        }
}
// -- End of JavaScript code -------------- -->
</SCRIPT>

</HEAD>

<body bgcolor="00F0F0"
      onLoad="timerONE=window.setTimeout('rot_banner_indx(100)',500);">
<center>
<h1>
<FONT SIZE=+3>
Weight Loss (Night trim) System<br>
</FONT>
</h1>

</center>

<em>
A natural amino acid supplement that lets you lose inches while you
sleep by helping you body use fat rather than store it.
</em>


<p>
<h2>
     <hr>
<FONT SIZE=+1>
<br>
Benefits Derived:
<ul>
<li> Helps to tone, firm and trim you body while you sleep</li>
<li> Increases the efficiency of your metabolism</li>
<li> Helps in reducing the body's fat composition</li>
</ul>

      <hr>

<br>
<table>
<tr><th><FONT SIZE=+0>Ingredients:</FONT>
    <th align="left"><FONT SIZE =+0>
        L-tyrosine, L-arginine, L-ornithine,special blend of inositol,
,
        </FONT>
<tr><th>
    <th align="left"><FONT SIZE=+0>
        choline bitartiate and calcium
        </FONT>
</table>

<br>
      <hr>
<p>
<font size=+0>
Bottle of 120 tablets at $33.00
</font>
<br>
<table>
<tr><th>  <font size=+0> <a Href="order_online.html"> To order: </a></font>
    <th align="left">  <font size=+0> <a Href="order_online.html"> Online </a></font>      
    <th align="left">  <font size=+0> <a Href="order_online.html"> (click here) </a></font>

<tr><th><th align ="left"> <font size=+0> By phone         </font>
    <th align="left"> <font size=+0> 1-800-757-3869 x5130  </font></tr>

<tr><th><th>
    <th align="left"> <font size=+0> 1-415-962-1288  outside the U.S.</font></tr>
</table>
</h2>


<br>
<center>
<font size=+1> Site is visited since August 12, 1996:  </font><br>
<br>
<img src="../counter/cgi-bin/counter.script.cgi?weight">
</center>

<br>
<hr>

<p>
<center>
<font size=+1>
<a href="testimonial.html"> Product Testimonials </a> |
<a href="../PowerSubmit/"> Link to PowerSubmit </a> |
<a href="index.html"> Back to home page </a><br>
</font>
</center>

</body>
<address>
<!--  Copyright &#169 1996 , by F. Chan  -->
</address>
</html>
</DOC>
<DOC>
<DOCNO>WT02-B10-310</DOCNO>
<DOCOLDNO>IA011-000111-B041-380</DOCOLDNO>
<DOCHDR>
http://www.takeout-info.com:80/vitamins/index_rfofh.html 206.184.157.62 19970216170534 text/html 4790
HTTP/1.0 200 OK
Date: Sun, 16 Feb 1997 17:05:53 GMT
Server: BESTWWWD/1.0
MIME-version: 1.0
Content-type: text/html
Content-length: 4608
Last-modified: Wed, 29 Jan 1997 07:53:23 GMT
</DOCHDR>
<html>
<HEAD>
<title>Herbal Respiratory Formula</title>

  <META Name="description" Content="Herbal Respiratory Formula: Balances and
        strengthens the immune system.  Guaranteed to work or money back!
        Vitamins, herbs. Vitamins, herbs, vitamins, herbs, vitamins, herbs,
        vitamins, herbs, vitamins, herbs, vitamins, herbs, vitamins, herbs,
        vitamins, herbs.">

  <META Name="keywords" Content="immune system, vital defense function,
        vitamins, health, herbs, Search Engines">



<SCRIPT LANGUAGE="JavaScript">

/* Copyright (C)1996 Web Integration Systems, Inc. DBA Websys, Inc. FChan, Inc.
   All Rights Reserved.

   This applet can be re-used or modified, if credit is given in 
   the source code.

   We will not be held responsible for any unwanted effects due to the 
   usage of this applet or any derivative.  No warrantees for usability 
   for any specific application are given or implied.

   Chris Skinner,  January 30, 1996.
   Michael Moricz, July 4, 1996.
*/

<!-- Beginning of JavaScript Applet -------------------
function rot_banner_indx(seed)
{
        var m1  = "Created for optimal respiratory and lung function ...    ";
        var m3  = "    Guaranteed to work!";

        var msg=m1+m3;
        var out = " ";
        var c   = 1;

        if (seed > 100) {
                seed--;
                var cmd="rot_banner_indx(" + seed + ")";
                timerTwo=window.setTimeout(cmd,100);
        }
        else if (seed <= 100 && seed > 0) {
                for (c=0 ; c < seed ; c++) {
                        out+=" ";
                }
                out+=msg;
                seed--;
                var cmd="rot_banner_indx(" + seed + ")";
                    window.status=out;
                timerTwo=window.setTimeout(cmd,100);
        }
        else if (seed <= 0) {
                if (-seed < msg.length) {
                        out+=msg.substring(-seed,msg.length);
                        seed--;
                        var cmd="rot_banner_indx(" + seed + ")";
                        window.status=out;
                        timerTwo=window.setTimeout(cmd,100);
                }
                else {
                        window.status=" ";
                        timerTwo=window.setTimeout("rot_banner_indx(100)",75);
                }
        }
}
// -- End of JavaScript code -------------- -->
</SCRIPT>

</HEAD>

<BODY BACKGROUND="herb.gif" BGCOLOR="00F0F0"
      onLoad="timerONE=window.setTimeout('rot_banner_indx(100)',500);">
<center>
<h1>
<FONT SIZE=+3>
Herbal Respiratory Formula<br>
</FONT>
</h1>
</center>

<em>
A unique blend of Chinese herbs have been created to support the body's
respiratory system.
They also help in fighting the effects of adverse environmental factors -
such as smoke, bacteria, pollen, pollution and allergenic particles,
which can cause respiratory sensitivities and even distress.
</em>


<p>
<h2>
     <hr>
<FONT SIZE=+1>
<br>
Benefits Derived:
<ul>
<li> Relieves asthma symptoms</li>
<li> Relieves allergy symptoms</li>
<li> Opens sinuses</li>
<li> Relieves cold symptoms</li>
</ul>
</FONT>


<FONT SIZE=+1>
<br>
Who Can Benefit:
<ul>
<li> People who smoke or are exposed to second hand smoke</li>
<li> People with a family history of respiratory, lung or sinus problems</li>
<li> People with persistent coughs, stuffy heads and frequent colds</li>
<li> People who snore</li>
</ul>
</FONT>

      <hr>

<br>
<table>
<tr><th><FONT SIZE=+0>Ingredients:</FONT>
    <th align="left"><FONT SIZE =+0>
        trichosanthis, cinnamon, perilla, platycodon, conicera,
        </FONT>
<tr><th>
    <th align="left"><FONT SIZE=+0>
        chrysanthemum, ginger
        </FONT>
</table>

<br>
      <hr>
<p>
<font size=+0>
Bottle of 90 tablets at $29.00
</font>
<br>
<table>
<tr><th>  <font size=+0> <a Href="order_online.html"> To order: </a></font>
    <th align="left">  <font size=+0> <a Href="order_online.html"> Online </a></font>      
    <th align="left">  <font size=+0> <a Href="order_online.html"> (click here) </a></font>

<tr><th><th align ="left"> <font size=+0> By phone         </font>
    <th align="left"> <font size=+0> 1-800-757-3869 x5130  </font></tr>

<tr><th><th>
    <th align="left"> <font size=+0> 1-415-962-1288  outside the U.S.</font></tr>
</table>
</h2>


<br>
<hr>

<p>
<center>
<font size=+1>
<a href="testimonial.html"> Product Testimonials </a> |
<a href="../PowerSubmit/"> Link to PowerSubmit </a> |
<a href="index.html"> Back to home page </a><br>
</font>
</center>

</body>
<address>
<!--  Copyright &#169 1996 , by F. Chan  -->
</address>
</html>
</DOC>
<DOC>
<DOCNO>WT02-B10-311</DOCNO>
<DOCOLDNO>IA011-000111-B041-412</DOCOLDNO>
<DOCHDR>
http://www.takeout-info.com:80/vitamins/index_opt.html 206.184.157.62 19970216170546 text/html 6108
HTTP/1.0 200 OK
Date: Sun, 16 Feb 1997 17:06:02 GMT
Server: BESTWWWD/1.0
MIME-version: 1.0
Content-type: text/html
Content-length: 5926
Last-modified: Fri, 31 Jan 1997 03:04:14 GMT
</DOCHDR>
<html>
<HEAD>
  <title>Optimal Life Formula</title>

  <META Name="description" Content="Optimal Life Formula: Balances and
        strengthens the immune system.  Guaranteed to work or money back!
        Vitamins, herbs. Vitamins, herbs, vitamins, herbs, vitamins, herbs,
        vitamins, herbs, vitamins, herbs, vitamins, herbs, vitamins, herbs,
        vitamins, herbs.">

  <META Name="keywords" Content="immune system, vital defense function,
        vitamins, health, herbs, Search Engines">



<SCRIPT LANGUAGE="JavaScript">

/* Copyright (C)1996 Web Integration Systems, Inc. DBA Websys, Inc. FChan, Inc.
   All Rights Reserved.

   This applet can be re-used or modified, if credit is given in 
   the source code.

   We will not be held responsible for any unwanted effects due to the 
   usage of this applet or any derivative.  No warrantees for usability 
   for any specific application are given or implied.

   Chris Skinner,  January 30, 1996.
   Michael Moricz, July 4, 1996.
*/

<!-- Beginning of JavaScript Applet -------------------
function rot_banner_indx(seed)
{
        var m1  = "Balances and strengthens the defense system ...     ";
        var m2  = "    Builds you up ...      ";
        var m3  = "    Guaranteed to work!";

        var msg=m1+m2+m3;
        var out = " ";
        var c   = 1;

        if (seed > 100) {
                seed--;
                var cmd="rot_banner_indx(" + seed + ")";
                timerTwo=window.setTimeout(cmd,100);
        }
        else if (seed <= 100 && seed > 0) {
                for (c=0 ; c < seed ; c++) {
                        out+=" ";
                }
                out+=msg;
                seed--;
                var cmd="rot_banner_indx(" + seed + ")";
                    window.status=out;
                timerTwo=window.setTimeout(cmd,100);
        }
        else if (seed <= 0) {
                if (-seed < msg.length) {
                        out+=msg.substring(-seed,msg.length);
                        seed--;
                        var cmd="rot_banner_indx(" + seed + ")";
                        window.status=out;
                        timerTwo=window.setTimeout(cmd,100);
                }
                else {
                        window.status=" ";
                        timerTwo=window.setTimeout("rot_banner_indx(100)",75);
                }
        }
}
// -- End of JavaScript code -------------- -->
</SCRIPT>

</HEAD>

<BODY BACKGROUND="herb.gif" BGCOLOR="00F0F0"
      onLoad="timerONE=window.setTimeout('rot_banner_indx(100)',500);">
<center>
<h1>
<FONT SIZE=+3>
Optimal Life Formula<br>
</FONT>
</h1>
</center>

<em>
Chinese herbalists have learned that certain herbs can stimulate the immune
system and promote energetic balance.
<font color="FF0000">Optimal Life Formula</font>
 is a unique blend of herbs that help support
and balance your life energies.
</em>


<p>
<h2>
     <hr>
<FONT SIZE=+1>
<br>
Benefits Derived:
<ul>
<li> Prolongs life</li>
<li> Strengthens the heart muscles</li>
<li> Slows down the aging process</li>
<li> Nourishes the liver</li>
<li> Strengthens the immune system</li>
</ul>
</FONT>

      <hr>

<br>
<FONT SIZE=+1>
Ingredients:
</FONT>

<FONT SIZE=+0>
<UL>
  <LI><B><EM>Chinese Ginseng</EM></B>
      - (Ren Shen) - to promote and balance body energy, immunostimulant, balance
      and regulate all the body system without causing negative reaction or damage
      to any, increase white blood cell count and production of  hemoglobin
  <LI><B><EM>Codonopsis Ginseng</EM></B>
      - (Dang Shen) - same function as Chinese Ginseng
  <LI><B><EM>Astragalus</EM></B>
      - (Huang Qi) - immune system building function
  <LI><B><EM>Ganoderma</EM></B>
      - (Ling Zhi) - most potent anti-aging herbs around; relaxes muscles, prolongs sleep,
      has an analgesic effect, increases the circulation of the coronary artery and cardiac
      muscles, lowers blood pressure and cholesterol, anti-bacterial, anti-allergenic,
      increases white blood cell count immunity
  <LI><B><EM>Angelica Root</EM></B>
      - ( Dang Gui) - builds up blood system and Yin
  <LI><B><EM>Polygonum</EM></B>
      - ( Ho Shou Wu) -  helps slow down the aging  process
  <LI><B><EM>Rehmannia</EM></B>
      - (Shu Di Huang) - tonifies the blood, nourishes the Yin, decreases blood sugar
      and blood cholesterol levels
  <LI><B><EM>Ligusticum</EM></B>
      - (Nu Zhen Zi) - invigorates the energy, (Qi) anti-hypertensive, antibiotic,
      anti-bacterial, anti-convulsive
  <LI><B><EM>Cuscuta</EM></B>
      - (Tu Si Zi) - nourishes the liver and treats the eyes, rich in vitamin A
  <LI><B><EM>Citrus</EM></B>
      - ( Chen Pi) - warms up the stomach and helps with digestion
  <LI><B><EM>Licorice</EM></B>
      - (Gan Cao) - detoxifies the body  and makes sure that all the energy enters
      the 12 meridians of the body  and combine all the herb functions together
  <BR><BR>
  <LI><B><EM>Recommended Use:</EM></B>
      Two tablets each morning and night.
</UL>
</FONT>


<br>
      <hr>
<p>
<font size=+0>
Bottle of 90 tablets at $28.50
</font>
<br>
<table>
<tr><th>  <font size=+0> <a Href="order_online.html"> To order: </a></font>
    <th align="left">  <font size=+0> <a Href="order_online.html"> Online </a></font>      
    <th align="left">  <font size=+0> <a Href="order_online.html"> (click here) </a></font>

<tr><th><th align ="left"> <font size=+0> By phone         </font>
    <th align="left"> <font size=+0> 1-800-757-3869 x5130  </font></tr>

<tr><th><th>
    <th align="left"> <font size=+0> 1-415-962-1288  outside the U.S.</font></tr>
</table>
</h2>


<br>
<hr>

<p>
<center>
<font size=+1>
<a href="testimonial.html"> Product Testimonials </a> |
<a href="../PowerSubmit/"> Link to PowerSubmit </a> |
<a href="index.html"> Back to home page </a><br>
</font>
</center>

</body>
<address>
<!--  Copyright &#169 1996 , by F. Chan  -->
</address>
</html>
</DOC>
<DOC>
<DOCNO>WT02-B10-312</DOCNO>
<DOCOLDNO>IA011-000111-B041-441</DOCOLDNO>
<DOCHDR>
http://www.takeout-info.com:80/vitamins/index_hcc.html 206.184.157.62 19970216170555 text/html 5685
HTTP/1.0 200 OK
Date: Sun, 16 Feb 1997 17:06:11 GMT
Server: BESTWWWD/1.0
MIME-version: 1.0
Content-type: text/html
Content-length: 5503
Last-modified: Fri, 31 Jan 1997 02:35:17 GMT
</DOCHDR>
<html>
<HEAD>
  <title>Herbal Cleansing Complex</title>

  <META Name="description" Content="Herbal Cleansing Complex.
        Guaranteed to work or money back!
        Vitamins, herbs. Vitamins, herbs, vitamins, herbs, vitamins, herbs,
        vitamins, herbs, vitamins, herbs, vitamins, herbs, vitamins, herbs,
        vitamins, herbs.">

  <META Name="keywords" Content="relieves constipation,
        vitamins, health, herbs, Search Engines">



<SCRIPT LANGUAGE="JavaScript">

/* Copyright (C)1996 Web Integration Systems, Inc. DBA Websys, Inc. Fchan, Inc.
   All Rights Reserved.

   This applet can be re-used or modified, if credit is given in 
   the source code.

   We will not be held responsible for any unwanted effects due to the 
   usage of this applet or any derivative.  No warrantees for usability 
   for any specific application are given or implied.

   Chris Skinner,  January 30, 1996.
   Michael Moricz, July 4, 1996.
*/

<!-- Beginning of JavaScript Applet -------------------
function rot_banner_indx(seed)
{
        var m1  = "Helps restore the natural function of the body       ";
        var m2  = "    Guaranteed to work!";
        
        var msg=m1+m2;
        var out = " ";
        var c   = 1;

        if (seed > 100) {
                seed--;
                var cmd="rot_banner_indx(" + seed + ")";
                timerTwo=window.setTimeout(cmd,100);
        }
        else if (seed <= 100 && seed > 0) {
                for (c=0 ; c < seed ; c++) {
                        out+=" ";
                }
                out+=msg;
                seed--;
                var cmd="rot_banner_indx(" + seed + ")";
                    window.status=out;
                timerTwo=window.setTimeout(cmd,100);
        }
        else if (seed <= 0) {
                if (-seed < msg.length) {
                        out+=msg.substring(-seed,msg.length);
                        seed--;
                        var cmd="rot_banner_indx(" + seed + ")";
                        window.status=out;
                        timerTwo=window.setTimeout(cmd,100);
                }
                else {
                        window.status=" ";
                        timerTwo=window.setTimeout("rot_banner_indx(100)",75);
                }
        }
}
// -- End of JavaScript code -------------- -->
</SCRIPT>

</HEAD>

<BODY BACKGROUND="herb.gif" BGCOLOR="00F0F0"
      onLoad="timerONE=window.setTimeout('rot_banner_indx(100)',500);">
<center>
<h1>
<FONT SIZE=+3>
Herbal Cleansing Complex<br>
</FONT>
</h1>
</center>

<em>
Herbalists have known for centuries that the body's delicate energetic
balance can be compromised when the digestive tract's elimination process
is not functioning properly.
Herbs like polygonum was used to help with constipation and apricot seed
to detoxify the body.
</em>


<p>
<h2>
     <hr>
<FONT SIZE=+1>
<br>
Benefits Derived:
<ul>
<li> Fights infection</li>
<li> Cleans the colon area</li>
<li> Relieves constipation</li>
<li> Stops diarrhea</li>
<li> Normalizes intestinal functions</li>
</ul>
</FONT>

      <hr>

<br>
<FONT SIZE=+1>
Ingredients:
</FONT>

<FONT SIZE=+0>
<UL>
  <LI><B><EM>Rhubarb</EM></B>
      - ( Da Huang) - cools, heats and moves the stool; used for constipation,
      has a purgative effect, anti-microbial, anti-bacterial, anti-fungal,
      anti-spasmodic and anti-cancer
  <LI><B><EM>Apricot Seed</EM></B>
      - (Xing Ren) - moistens and lubricates the intestines, moves stool,
      anti-parasitic, kills roundworms, hookworms, pinworms
  <LI><B><EM>Citrus</EM></B>
      - (Chen Pi) - helps dry damp and increases the normal peristaltic motion and
      warms the gastrointestinal effect for easier digestion of food and avoid constipation
  <LI><B><EM>Mirabilite</EM></B>
      - (Mang Xiao) - to cool heat and is immunostimulant and a purgative
  <LI><B><EM>Trichocanthes</EM></B>
      - (Gua Lou Zi) - stimulates the immune system, helps fight disease, antibiotic,
      anti-bacterial, anti-fungal, anti-cancer, moistens and lubricates the intestines
      and good for constipation
  <LI><B><EM>Halloysite</EM></B>
      - (Zhi Shi) - stops bleeding, used for blood in the stool, promotes healing good
      for diarrhea and treats dysentery, good for blood and mucous in the stool, it adheres
      to toxins and  protect the gastrointestinal membrane
  <LI><B><EM>Polygonum</EM></B>
      - (Ho Shou Wu) - detoxifies and lubricates and moistens the intestines,
      and has anti-aging effect
  <BR><BR>
  <LI><B><EM>Recommended Use:</EM></B>
      Two tablets each morning and night.
</UL>
</FONT>


<br>
      <hr>
<p>
<font size=+0>
Bottle of 90 tablets at $32.00
</font>
<br>
<table>
<tr><th>  <font size=+0> <a Href="order_online.html"> To order: </a></font>
    <th align="left">  <font size=+0> <a Href="order_online.html"> Online </a></font>      
    <th align="left">  <font size=+0> <a Href="order_online.html"> (click here) </a></font>

<tr><th><th align ="left"> <font size=+0> By phone         </font>
    <th align="left"> <font size=+0> 1-800-757-3869 x5130  </font></tr>

<tr><th><th>
    <th align="left"> <font size=+0> 1-415-962-1288  outside the U.S.</font></tr>
</table>
</h2>


<br>
<hr>

<p>
<center>
<font size=+1>
<a href="testimonial.html"> Product Testimonials </a> |
<a href="../PowerSubmit/"> Link to PowerSubmit </a> |
<a href="index.html"> Back to home page </a><br>
</font>
</center>

</body>
<address>
<!--  Copyright &#169 1996 , by F. Chan  -->
</address>
</html>
</DOC>
<DOC>
<DOCNO>WT02-B10-313</DOCNO>
<DOCOLDNO>IA011-000111-B042-21</DOCOLDNO>
<DOCHDR>
http://www.takeout-info.com:80/vitamins/order_online.html 206.184.157.62 19970216170603 text/html 6993
HTTP/1.0 200 OK
Date: Sun, 16 Feb 1997 17:06:22 GMT
Server: BESTWWWD/1.0
MIME-version: 1.0
Content-type: text/html
Content-length: 6811
Last-modified: Sun, 26 Jan 1997 23:31:57 GMT
</DOCHDR>
<HTML>

<HEAD>
     <META name="resource-type" content="document"> 
     <META name="keywords"      content="Search submit engine">
     <META name="author"        content="Michael Z. Moricz">
     <META name="date"          content="01/01/1997">

  <TITLE> Online Order Form </TITLE>
</HEAD>


<BODY>

<CENTER>
<H2><FONT COLOR="FF0000"><EM>
  Vitamin Online Order Form
</EM></FONT></H2>
</CENTER>

<HR>
<BR>

<B>
The following information is needed for online ordering:<BR>
(Or order by phone at 415-962-1288, or email us at
<A HREF="mailto:femychan@mailzone.com">femychan@mailzone.com</A>)
</B>

<BR>
<P>

<CENTER>
<FORM ACTION="cgi-bin/order_online.cgi" METHOD=post>
<TABLE>
<tr>
  <td align="left">
    <font color=000000><b>Your Name:</b></font></td>
  <td align="left" colspan=3>
    <input name="name" maxlength=69  size=50
           value=""></td></tr>

<tr>
  <td align="left">
    <font color=000000><b>Address:</b></font></td>
  <td align="left" colspan=3>
    <input name="addr" maxlength=69  size=50
           value=""></td></tr>

<tr>
  <td align="left">
    <font color=000000><b>City:</b></font></td>
  <td align="left" colspan=3>
    <input name="city" maxlength=69  size=50
           value=""></td></tr>

<tr>
  <td align="left">
    <font color=000000><b>State/Province: </b></font></td>
  <td align="left" colspan=3>
    <input name="state" maxlength=69  size=50
           value=""></td></tr>

<tr>
  <td align="left">
    <font color=000000><b>Country and zipcode: </b></font></td>
  <td align="left" colspan=3>
    <input name="country" maxlength=69  size=50
           value="USA"></td></tr>

<tr>
  <td align="left">
    <font color=000000><b>Telephone (optional): </b></font></td>
  <td align="left" colspan=3>
    <input name="tel" maxlength=69  size=50
           value=""></td></tr>

<tr>
  <td align="left">
    <font color=000000><b>Your Email: </b></font></td>
  <td align="left" colspan=3>
    <input name="email" maxlength=69  size=50
           value=""></td></tr>

<tr>
  <td align="center">
    <font color=000000><b>Products: </b></font></td>
  <td align="center">
    <font color=000000><b>Price (each)</b></font></td>
  <td align="center">
    <font color=000000><b>Quantity</b></font></td>
  <td align="center">
    <font color=000000><b>Total</b></font></td>
<!-- --------------------------------------------- -->
<tr>
  <td align="left">
    <font color=000000><b>Masculine Herbal Complex</b></font></td>
  <td align="right" width=50>
    <font color=000000><b>$ 32</b></font></td>
  <td align="left">
    <input name=msc_q maxlength=69 size=10 value=""></td>
  <td align="left">
    <input name=msc_pt maxlength=69 size=20 value=""></td>
<tr>
  <td align="left">
    <font color=000000><b>Feminine Herbal Complex</b></font></td>
  <td align="right" width=50>
    <font color=000000><b>$ 32</b></font></td>
  <td align="left">
    <input name=fmn_q maxlength=69 size=10 value=""></td>
  <td align="left">
    <input name=fmn_pt maxlength=69 size=20 value=""></td>
<tr>
  <td align="left">
    <font color=000000><b>Weight Loss (Night Trim)</b></font></td>
  <td align="right" width=50>
    <font color=000000><b>$ 33</b></font></td>
  <td align="left">
    <input name=weight_q maxlength=69 size=10 value=""></td>
  <td align="left">
    <input name=weight_pt maxlength=69 size=20 value=""></td>
<tr>
  <td align="left">
    <font color=000000><b>Herbal Rest and Relax</b></font></td>
  <td align="right" width=50>
    <font color=000000><b>$ 29</b></font></td>
  <td align="left">
    <input name=rest_q maxlength=69 size=10 value=""></td>
  <td align="left">
    <input name=rest_pt maxlength=69 size=20 value=""></td>
<tr>
  <td align="left">
    <font color=000000><b>Herbal Respiratory</b></font></td>
  <td align="right" width=50>
    <font color=000000><b>$ 29</b></font></td>
  <td align="left">
    <input name=respiratory_q maxlength=69 size=10 value=""></td>
  <td align="left">
    <input name=respiratory_pt maxlength=69 size=20 value=""></td>
<tr>
  <td align="left">
    <font color=000000><b>Optimal Life Formula</b></font></td>
  <td align="right" width=50>
    <font color=000000><b>$ 28.50</b></font></td>
  <td align="left">
    <input name=life_q maxlength=69 size=10 value=""></td>
  <td align="left">
    <input name=life_pt maxlength=69 size=20 value=""></td>
<tr>
  <td align="left">
    <font color=000000><b>Mind Enhancement</b></font></td>
  <td align="right" width=50>
    <font color=000000><b>$ 32</b></font></td>
  <td align="left">
    <input name=mind_q maxlength=69 size=10 value=""></td>
  <td align="left">
    <input name=mind_pt maxlength=69 size=20 value=""></td>
<tr>
  <td align="left">
    <font color=000000><b>Herbal Cleansing Complex</b></font></td>
  <td align="right" width=50>
    <font color=000000><b>$ 32</b></font></td>
  <td align="left">
    <input name=cleansing_q maxlength=69 size=10 value=""></td>
  <td align="left">
    <input name=cleansing_pt maxlength=69 size=20 value=""></td>
<!-- --------------------------------------------------------- -->
<tr>
  <td align="left">
  <td align="right" colspan=2>
    <font color=000000><b>Subtotal</b></font></td>
  <td align="left">
    <input name=subtotal_pt maxlength=69 size=20 value=""></td>
<tr>
  <td align="left">
  <td align="right" colspan=2>
    <font color=000000><b>4% shipping and handling</b></font></td>
  <td align="left">
    <input name=shipping_pt maxlength=69 size=20 value=""></td>
<tr>
  <td align="left">
  <td align="right" colspan=2>
    <font color=000000><b>Total</b></font></td>
  <td align="left">
    <input name=total_pt maxlength=69 size=20 value=""></td>



<tr>
  <td align="left">
    <font color=000000><b>Cardholder name: </b></font></td>
  <td align="left" colspan=3>
    <input name="card_holder" maxlength=69  size=50
           value=""></td></tr>

<tr>
  <td align="left">
    <font color=000000><b>Credit card number: </b></font></td>
  <td align="left" colspan=3>
    <input name="card" maxlength=69  size=50
           value=""></td></tr>

<tr>
  <td align="left">
    <font color=000000><b>Expiration date: </b></font></td>
  <td align="left" colspan=3>
    <input name="exp_date" maxlength=69  size=50
           value=""></td></tr>

<tr>
  <td align="left">
    <font color=000000><b>Credit card type: </b></font></td>
  <td align="left" colspan=3>
    <input type="radio" name="card_type" value="MC" CHECKED> MC
    <input type="radio" name="card_type" value="VISA"> VISA
    <input type="radio" name="card_type" value="VISA"> DISCOVER
    </td></tr>

<tr>
  <td align="left">
    <center><input type="reset" value="        Clear        "></center></td>
  <td align="left" colspan=3>
    <center><input type="submit" value="Submit Your Order "></center></td></tr>

</TABLE>
</FORM>
</CENTER>




</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT02-B10-314</DOCNO>
<DOCOLDNO>IA011-000111-B042-46</DOCOLDNO>
<DOCHDR>
http://www.takeout-info.com:80/vitamins/testimonial.html 206.184.157.62 19970216170612 text/html 4087
HTTP/1.0 200 OK
Date: Sun, 16 Feb 1997 17:06:29 GMT
Server: BESTWWWD/1.0
MIME-version: 1.0
Content-type: text/html
Content-length: 3905
Last-modified: Wed, 29 Jan 1997 07:42:14 GMT
</DOCHDR>
<html>
<HEAD>
  <title>Product Testimonial</title>

  <META Name="description" Content="Guaranteed to work or money back!
        Vitamins, herbs. Vitamins, herbs, vitamins, herbs, vitamins, herbs,
        vitamins, herbs, vitamins, herbs, vitamins, herbs, vitamins, herbs,
        vitamins, herbs.">

  <META Name="keywords" Content="vitamins, health, herbs, Search Engines">

</HEAD>


<BODY BACKGROUND="herb.gif" BGCOLOR="00F0F0">

<center>
<h1>
<FONT SIZE=+3>
Product Testimonials
</FONT>
</h1>
</center>

     <hr>

<H3>
<p>
After being hospitalized for the second time in five years for hypertension,
Sammy Blackmon Jr. underwent tests that showed him to be "borderline
diabetic with high cholesterol", an enlarged heart and blood pressure
so high it could cause a stroke.  The doctors were considering surgery.
After carefully following his doctor's recommeendations and supplementing
his diet with Diamite vitality products, his check up revealed that his
blood pressure has greatly improved, his heart has normalized, his
cholesterol count is down, and he has continued to use the products to
help his body heal itself.                                         
<hr>

<p>
Fifteen years ago, I went into the hospital for a minor operation. And 
although I came out of it fine, from that moment on I had a weight problem.
Eventually, I got up to 300 pounds and a size 48 suit. Along with the
excess weight came fatigue, high cholesterol, headaches and continuous body 
aches and pains. I felt left out, forgotten and depressed because of my
weight.
Then I began using the Night Trim and soon added the Fiber Tablets.
I quickly lost 20 pounds and went on to steadily lose an additional
25 pounds. Soon I was wearing a size 44. My clothes are hanging on me now
and I need smaller ones still. I haven't had to change the foods I eat, but
thanks to the Fiber Tablets, I'm able to control my appetite so I'm eating
less. I feel fantastic physically and have much more self-esteem. I've
still got some weight to lose and I know I can do it. I'm getting a lot
of compliments from the ladies so I'm not about to stop until I reach my
weight loss goal.
<br>
<pre>                                         Carlton Morris, Atlanta, GA
</pre>

<hr>
<p>
After several years of being overweight, I started controlling my eating
habits and began using the Night Trimming System because I was so
uncomfortable with my appearance. At 155 pounds, I was always the
overweight person in the group. I decided it was time for a change. I
wanted to be happy and proud of my figure. So I began eating two sensible
meals a day drinking plenty of water and using the Night Trimming. In just
6 weeks, I was able to lose 30 pounds. I'm down to 125 pounds and am still
losing.
<br>
<pre>                                         Angie Dexter, Dallas, TX
</pre>
<hr>
<p>
I've had problems with asthma for as long as I can remember. As a
hairdresser, it is aggravated especially when I work with chemicals. I have
started the Herbal Respiratory System. In just a few days, I could feel
a definite improvement. I am not wheezing as much.
<br>
<pre>                                        Fe Fermin, Palo Alto, CA
</pre>

<hr>
<p>
I have been using the Diamite Products for approximately three years.
Since that time, I have never felt more healthy and full of life! Since
the introduction of the Herbal Alternatives, I feel even better! The
Feminine Herbal Complex have helped balance my monthly cycle. Coupled
with the Optimal Life Formula, it gives me the energy boost I need!
<br>
<pre>                                        Henrietta Weiner, San Francisco, CA
</pre>





</H3>





<br>
<hr>




<p>
<center>
<font size=+1>
<a href="../PowerSubmit/">Link to PowerSubmit </a> |
<a href="index.html"> Back to home page </a><br>
</font>
</center>

</body>
<address>
<!--  Copyright &#169 1996 , by F. Chan  -->
</address>
</html>
</DOC>
<DOC>
<DOCNO>WT02-B10-315</DOCNO>
<DOCOLDNO>IA011-000111-B042-82</DOCOLDNO>
<DOCHDR>
http://www.takeout-info.com:80/PowerSubmit/index.html 206.184.157.62 19970216170625 text/html 4369
HTTP/1.0 200 OK
Date: Sun, 16 Feb 1997 17:06:39 GMT
Server: BESTWWWD/1.0
MIME-version: 1.0
Content-type: text/html
Content-length: 4187
Last-modified: Sun, 02 Feb 1997 00:45:29 GMT
</DOCHDR>
<HTML>
 
<HEAD>
     <META name="resource-type" content="document">
     <META name="author"        content="Michael Z. Moricz">
     <META name="date"          content="01/01/1997">


 
  <TITLE> PowerSubmit of the 21st Century </TITLE>

  <META name="description" content="PowerSubmit: Launch your Internet
              business globally with PowerSubmit.
              Promoting your website could never been easier.
              Let PowerSubmit accelerate the traffic to your website.
              Simple yet powerful, PowerSubmit, the most dynamic
              vehicle to your website promotion campaign.
              The best web site promotion on the web!">
  <META name="keywords" content="promote  submit  link  announce  web  hot
          cool  search  add  best  url  advertise  business  free  register
          promote  submit  link  announce  web  hot  cool  search  add  best
          url  advertise  business  free  register  promote  submit  link
          announce  web  hot  cool  search  add  best  url  advertise  business
          free  register  promote  submit  link  announce  web  hot  cool
          search  add  best  url  advertise  business  free  register  promote
          submit  link  announce  web  hot  cool  search  add  best  url
          advertise  business  free  register  promote  submit  link  announce
          web  hot  cool  search  add  best  url  advertise  business  free
          register">

</HEAD>
 
 
<!-- BODY BGCOLOR="000000" -->
<BODY BGCOLOR="FFFFFF">
 
<CENTER>
<H1><B><EM><FONT color="FF0000">
    PowerSubmit<BR>
    The Submission Engine for the 21st Century
</FONT></EM></B></H1>
</CENTER>
 
<HR>
<BR>
<FONT SIZE=+1><EM>
 
<P>
<FONT COLOR="0000FF">
Now that you have your web site on the Internet, are you getting all the
traffic you need for your business?  Is your web site the best kept secret
on the Information Superhighway?
</FONT>
</P>


<CENTER>
<!-- IMG SRC="cgi-bin/PS.cgi" -->
<IMG SRC="growing_all.gif">
</CENTER>

<BR>
<P>

<TABLE>
<TR>
  <TD align="left" valign="top" WIDTH=250>
    <FONT COLOR="FF0000"><EM><B>
    <UL>
    <LI><A HREF="index_why_PowerSubmit.html"></A>
        <A HREF="cgi-bin/select.cgi?why_PowerSubmit">
        <FONT COLOR="FF0000" SIZE=+1> Why PowerSubmit?</FONT></A>
        <BR><BR>
    <LI><A HREF="index_comparison.html"></A>
        <A HREF="cgi-bin/select.cgi?comparison">
        <FONT COLOR="FF0000" SIZE=+1> Reasons to Choose Us</FONT></A>
        <BR><BR>
    <LI><A HREF="index_power.html"></A>
        <A HREF="cgi-bin/select.cgi?free_demo">
        <FONT COLOR="FF0000" SIZE=+1> Free Demo</FONT></A>
        <BR><BR>
    <LI><A HREF="index_pricing.html"></A>
        <A HREF="cgi-bin/select.cgi?pricing">
        <FONT COLOR="FF0000" SIZE=+1> Pricing</FONT></A>
        <BR><BR>
    <LI><A HREF="index_register_power.html"></A>
        <A HREF="cgi-bin/select.cgi?form_to_register">
        <FONT COLOR="FF0000" SIZE=+1> Register</FONT></A>
        <BR><BR>
    <LI><A HREF="index_power.html"></A>
        <A HREF="cgi-bin/select.cgi?registered_user">
        <FONT COLOR="FF0000" SIZE=+1> For Registered Users</FONT></A>
        <BR><BR>
    <LI><A HREF="mailto:moricz@best.com">
        <FONT COLOR="FF0000" SIZE=+1> Contact Us</FONT></A>
        <BR><BR>
    </UL>
    </B></EM></FONT>

  <TD align="left" valign="top" WIDTH=350>
    <FONT COLOR="0000FF"><EM>
    <P>
    <FONT SIZE=+1> The PowerSubmit submission engine is the most simple
    yet powerful promotional campaign program on the Internet.
    With the click of the mouse, you can register your website
    to search engines, directories, indexes and free for all
    lists that provide the most traffic and greatest appeal.
    We could not have made it easier for you to promote your
    website as effectively and as efficiently as this.
    </FONT>
    <BR>
    </EM></FONT>

</TABLE>



</EM></FONT>
<BR>
 

<!-- Sound effects, while reading the options -->
<EMBED SRC="../referral/blue_danube.mid" autostart=true hidden=true>
<BGSOUND="../referral/blue_danube.mid">

 
<HR>

</BODY>
<ADDRESS>
  <FONT COLOR="0000FF">Copyright &#169 1996, 1997 by PowerSubmit, Inc.</FONT>
</ADDRESS>
</HTML>
</DOC>
